data_6hd2_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6hd2 _Structure_validation_residue.Date_analyzed 2019-08-23 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 53.2 t0 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 107.848 -1.168 . . . . 3.14 107.848 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.522 ' HA ' HG13 ' A' ' 255' ' ' ILE . 36.5 mt -113.01 140.41 33.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 120.854 0.359 . . . . 2.71 111.415 -167.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -135.31 137.18 42.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.316 -0.994 . . . . 2.82 108.316 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -47.87 -39.34 18.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.042 0.449 . . . . 2.71 111.855 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -81.32 -28.74 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.076 -0.511 . . . . 5.23 111.075 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -96.78 20.39 11.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.472 0.653 . . . . 3.38 110.906 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.48 130.68 53.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.466 -0.568 . . . . 1.76 109.466 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 256' ' ' LYS . 75.6 mmtt -109.52 122.27 47.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.918 0.39 . . . . 4.05 110.513 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -70.56 139.98 51.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.969 -0.56 . . . . 4.9 111.121 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.47 147.25 36.31 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.523 -0.762 . . . . 2.27 109.602 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 44' ' ' LEU . 14.0 Cg_endo -54.99 144.88 66.12 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.549 2.833 . . . . 2.45 113.71 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.44 ' HB2' ' HA ' ' A' ' 260' ' ' LYS . 14.1 t -46.32 45.26 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.111 1.523 . . . . 4.62 115.111 166.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' ' C ' ' A' ' 42' ' ' PRO . 3.7 pp -59.59 171.36 0.86 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.009 -0.541 . . . . 5.15 110.084 168.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 34.9 mmtp -53.69 123.23 37.19 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.806 0.336 . . . . 4.21 111.756 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.59 171.46 3.45 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.581 2.854 . . . . 2.76 113.27 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.483 HD21 ' HA3' ' A' ' 81' ' ' GLY . 68.0 mt -82.14 111.69 18.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 2.93 109.555 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 m -78.14 108.73 11.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.046 -0.353 . . . . 2.46 110.046 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -101.93 113.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.281 0.563 . . . . 2.17 110.573 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -126.55 92.29 3.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.988 -0.551 . . . . 1.87 109.851 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 7.7 p90 -129.04 23.16 5.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.944 -0.571 . . . . 3.97 110.961 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.95 -22.4 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.11 0.481 . . . . 2.48 110.093 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -99.47 7.75 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.72 -0.673 . . . . 2.54 110.646 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.68 121.27 14.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.142 -0.481 . . . . 1.41 111.182 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 m -109.12 106.84 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.847 -0.615 . . . . 1.41 110.435 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 p -78.58 147.22 33.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.84 109.478 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.67 -57.13 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.979 0.418 . . . . 1.45 111.766 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -147.23 156.48 42.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 3.72 110.911 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.93 134.06 67.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.196 -0.668 . . . . 1.35 109.196 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 172' ' ' SER . 66.8 tp -136.22 144.08 44.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 1.53 111.249 -170.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -105.29 118.54 36.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.568 -0.742 . . . . 1.49 109.296 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.03 66.33 0.97 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.29 -0.564 . . . . 2.18 111.09 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . 66.73 -52.93 0.22 Allowed Glycine 0 CA--C 1.523 0.568 0 CA-C-N 114.487 -1.233 . . . . 2.0 115.289 165.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -96.34 -26.62 15.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.898 0.38 . . . . 4.11 110.208 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.32 178.62 8.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 1.78 110.095 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -126.61 123.81 38.48 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.921 -0.77 . . . . 3.48 108.921 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -117.08 143.44 45.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.947 0.403 . . . . 1.99 111.36 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -114.75 123.46 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.542 -0.54 . . . . 1.75 109.542 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 2.02 111.329 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.57 152.65 27.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 2.19 109.17 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -83.63 135.04 34.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.787 0.327 . . . . 1.33 110.383 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -133.49 59.35 1.74 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.985 0.897 . . . . 2.65 109.576 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -87.07 -11.32 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 2.01 109.634 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -144.66 177.35 8.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.415 -1.328 . . . . 2.35 107.415 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.07 71.57 4.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.734 0.778 . . . . 1.92 110.423 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -82.75 -61.06 1.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.175 -0.92 . . . . 2.31 110.738 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -112.78 98.06 6.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 1.44 110.024 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.12 138.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.915 -0.584 . . . . 1.82 111.166 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.7 tp -136.67 113.47 10.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.048 -0.524 . . . . 1.8 110.152 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.65 124.15 7.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.466 0.65 . . . . 3.02 111.553 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.483 ' HA3' HD21 ' A' ' 47' ' ' LEU . . . -87.53 178.33 47.36 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.167 -0.924 . . . . 1.44 111.478 169.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -38.62 -142.13 0.0 OUTLIER Glycine 0 CA--C 1.535 1.299 0 O-C-N 124.669 0.864 . . . . 2.15 114.974 167.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -49.65 120.41 5.84 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 121.59 1.527 . . . . 3.17 112.152 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.5 mt -159.43 -169.48 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.706 -1.134 . . . . 4.55 109.173 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -126.78 41.8 3.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.717 0.294 . . . . 4.95 110.779 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.91 176.14 14.21 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.632 -0.794 . . . . 2.25 113.172 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 125' ' ' THR . 76.4 m -102.09 122.05 43.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.771 -0.455 . . . . 2.12 109.771 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 38.2 m-85 -104.01 106.42 16.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.019 0.437 . . . . 3.88 110.928 -175.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.453 ' NH2' ' HZ3' ' A' ' 123' ' ' TRP . 18.4 mtm180 -85.61 149.59 25.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 3.87 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.85 124.73 28.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 1.68 110.239 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 92' ' ' GLN . 7.2 tt -109.16 -34.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.464 -0.334 . . . . 2.16 111.392 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HG2' HG22 ' A' ' 91' ' ' ILE . 27.6 pt20 -169.98 169.17 8.27 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.865 -0.152 . . . . 1.95 110.718 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.457 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 11.3 p90 -153.66 160.39 42.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.98 110.845 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -147.55 162.27 39.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.6 -0.727 . . . . 1.07 109.55 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 118' ' ' LEU . 85.4 m-85 -106.2 152.3 23.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 3.99 111.278 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.492 ' CE1' ' HB2' ' A' ' 119' ' ' HIS . 13.6 m170 -108.72 142.85 38.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.814 -1.18 . . . . 2.2 107.814 173.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.579 ' HE1' ' HB ' ' A' ' 222' ' ' VAL . 6.4 t90 -152.61 116.67 4.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.529 -0.468 . . . . 6.08 110.74 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.74 154.75 31.25 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.953 -0.641 . . . . 2.19 112.003 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -67.58 -32.37 73.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.223 0.511 . . . . 3.08 110.617 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -106.56 140.36 39.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.943 -0.762 . . . . 3.48 108.943 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -64.05 -4.38 3.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.896 0.702 . . . . 3.85 112.896 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.17 21.4 24.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.439 -0.886 . . . . 2.37 112.847 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.6 pt20 -158.87 165.57 33.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.13 0.465 . . . . 2.62 110.415 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.95 -34.66 3.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.26 -0.971 . . . . 1.62 114.246 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.8 p -73.4 -34.76 65.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.388 0.594 . . . . 2.24 111.873 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.28 -163.86 0.16 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.445 -0.946 . . . . 3.72 108.445 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 50.62 55.4 9.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.485 0.66 . . . . 4.03 109.889 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.8 p -77.94 117.56 19.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.273 -0.876 . . . . 2.99 110.981 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 29.9 t -88.51 92.58 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.88 109.947 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.35 -67.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.652 1.22 . . . . 2.8 111.723 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -127.22 -3.53 6.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.337 -0.392 . . . . 5.35 111.503 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HB2' ' H ' ' A' ' 109' ' ' VAL . 64.3 mttm -69.56 178.17 2.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.041 -0.264 . . . . 3.58 110.479 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.8 pttt 147.77 109.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.746 0.819 . . . . 3.26 108.926 -160.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -121.39 166.66 13.78 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.146 -0.346 . . . . 1.71 110.073 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 103' ' ' GLN . . . -79.55 -17.89 52.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 1.57 112.441 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.448 ' HB2' ' CD1' ' A' ' 97' ' ' TRP . . . -156.65 164.36 38.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.932 0.396 . . . . 1.3 111.513 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.84 151.54 20.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.508 -0.769 . . . . 1.85 110.402 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 95' ' ' PHE . 39.7 tp -104.23 127.44 51.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.675 -0.491 . . . . 1.61 109.675 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 96' ' ' HIS . 22.6 t-160 -118.19 105.84 12.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.372 -0.376 . . . . 2.25 110.227 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.2 mp -100.23 125.92 46.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 1.51 110.689 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.444 ' HA ' HG11 ' A' ' 142' ' ' VAL . 46.4 t -98.5 125.18 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.926 0.393 . . . . 1.24 111.235 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -116.26 144.03 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.489 . . . . 2.86 109.681 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.469 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 11.2 t90 -117.9 137.93 52.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.16 -0.473 . . . . 4.96 111.294 -175.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 30.6 t30 -70.72 104.58 2.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.34 0.59 . . . . 2.3 111.238 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 87' ' ' THR . 7.7 t -67.62 -25.62 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.835 1.05 . . . . 2.77 113.835 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 64.8 pttt -68.39 -5.12 17.29 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.277 0.843 . . . . 3.79 113.277 -171.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -107.44 -0.78 22.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.049 -0.407 . . . . 3.34 111.638 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.88 30.3 4.89 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.149 -0.932 . . . . 2.37 115.148 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.469 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 14.9 t70 -163.27 121.27 1.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.931 0.865 . . . . 3.93 109.388 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 134' ' ' VAL . 55.3 p90 -66.44 -40.08 89.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 3.6 111.951 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -32.47 81.8 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.816 -0.707 . . . . 2.35 112.451 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 42.2 mmtm -66.34 -34.57 78.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.79 0.328 . . . . 3.75 110.215 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.34 -34.03 74.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.971 -0.558 . . . . 2.17 110.767 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 130' ' ' PHE . 63.3 t -65.06 -25.75 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 3.11 110.571 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.61 16.78 6.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 3.55 110.977 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 21.6 mt-30 -131.69 135.33 26.65 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 3.02 109.687 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 37.7 Cg_exo -60.59 -26.4 82.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.655 2.237 . . . . 1.93 112.725 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -113.92 19.18 16.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 2.29 111.07 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.15 -29.44 73.35 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.888 -0.672 . . . . 1.5 114.127 -172.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.8 158.61 34.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.066 0.433 . . . . 1.98 110.982 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -144.49 126.96 15.94 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.952 -0.759 . . . . 1.83 108.952 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 121' ' ' VAL . 32.2 m -125.49 149.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.933 0.397 . . . . 2.28 111.38 -173.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.53 122.7 47.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.614 -0.721 . . . . 2.89 110.187 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.8 109.76 2.89 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.29 -0.724 . . . . 0.95 111.29 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.7 mt -111.28 113.9 45.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.243 -0.28 . . . . 1.38 110.243 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -66.6 145.32 55.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.788 0.328 . . . . 1.37 111.01 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.48 124.09 51.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.779 -0.452 . . . . 1.48 109.779 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.2 141.97 47.44 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.559 -0.534 . . . . 2.52 109.559 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 45.1 t -85.45 132.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.061 0.457 . . . . 1.88 110.866 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.3 -105.08 0.21 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.997 -0.841 . . . . 1.53 110.997 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.7 t -71.19 142.33 50.65 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.301 -0.629 . . . . 2.08 109.301 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.68 151.86 45.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.558 -0.292 . . . . 1.36 111.059 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.0 tptt -108.48 99.11 31.32 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.657 -0.497 . . . . 1.78 109.657 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.54 -36.89 89.99 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.965 2.443 . . . . 1.34 112.742 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.07 75.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.991 -0.624 . . . . 0.75 113.115 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 26.2 tp -83.92 -17.23 41.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.224 0.512 . . . . 1.39 110.373 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -41.56 63.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 1.63 110.768 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HE3' ' OD1' ' A' ' 179' ' ' ASP . 65.3 mttm -49.2 -49.09 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.557 . . . . 3.26 112.415 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.5 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 14.8 p -79.99 -35.9 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.708 -0.397 . . . . 1.97 110.832 -177.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.438 ' HA ' ' CD1' ' A' ' 163' ' ' LEU . 78.2 t -59.8 -35.77 62.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.363 0.601 . . . . 1.64 110.452 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.52 -33.99 76.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.198 -0.91 . . . . 1.22 111.963 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.9 p -99.25 -3.66 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 111.793 0.294 . . . . 2.07 111.793 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 92.8 mt -55.6 -42.49 74.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.848 0.356 . . . . 1.95 111.916 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.99 -20.94 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.422 -0.353 . . . . 2.31 111.662 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 72.6 m -92.66 0.4 57.42 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.219 0.452 . . . . 1.78 112.219 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.09 34.52 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.578 -0.527 . . . . 1.42 109.578 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.447 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 82.6 tttt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.262 -0.881 . . . . 1.98 112.152 -172.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 171' ' ' LYS . 37.9 p -102.69 152.15 21.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.696 0.284 . . . . 1.4 111.118 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -71.62 146.6 48.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.885 0.374 . . . . 2.84 110.662 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.15 9.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.529 -0.843 . . . . 0.85 112.5 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 168' ' ' THR . 21.5 ptmt -90.87 155.58 18.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 2.22 110.914 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 60' ' ' LEU . 16.5 p -128.07 160.41 32.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.518 -0.765 . . . . 1.93 110.548 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -144.66 145.86 31.96 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.047 -0.353 . . . . 1.17 110.047 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.15 131.74 40.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.829 -0.434 . . . . 1.8 109.829 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -139.97 79.93 1.74 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.992 -0.744 . . . . 1.31 108.992 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 p -104.65 162.7 13.06 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.462 -0.79 . . . . 1.69 111.477 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 58.12 45.97 16.83 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.788 0.662 . . . . 2.26 112.788 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -99.06 135.46 40.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.974 -0.38 . . . . 4.84 109.974 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.426 ' OD1' ' HE3' ' A' ' 158' ' ' LYS . 6.3 p-10 -110.61 119.28 46.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 121.13 0.49 . . . . 2.51 110.675 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.86 -7.28 19.12 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.817 2.345 . . . . 1.47 112.639 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -63.36 -28.58 70.09 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.877 0.37 . . . . 3.16 110.688 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.75 59.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.172 -0.537 . . . . 1.12 112.977 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 74.9 mt -102.32 -7.06 22.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.583 0.23 . . . . 2.37 111.396 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.82 130.27 88.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.622 0.601 . . . . 3.87 112.622 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.82 -171.59 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.892 2.395 . . . . 2.51 111.369 173.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.75 -62.47 1.68 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.959 0.409 . . . . 3.23 110.613 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.501 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.3 m -91.05 144.77 25.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 2.03 110.279 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 44.3 tp -109.81 63.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.362 0.601 . . . . 2.5 110.549 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 4.2 m-20 -97.8 162.82 13.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.81 108.484 174.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.6 p90 -167.16 156.01 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.159 -0.616 . . . . 5.32 112.474 -174.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.424 ' NE1' ' HG2' ' A' ' 212' ' ' LYS . 12.1 m95 -107.25 149.16 28.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.875 -1.157 . . . . 4.55 107.875 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.8 t -131.28 103.46 6.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.472 0.653 . . . . 2.39 111.589 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.525 ' OH ' ' HA ' ' A' ' 253' ' ' ARG . 45.3 t80 -138.75 132.42 16.23 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 5.32 111.018 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.466 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 43.3 Cg_exo -58.3 130.07 35.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.596 2.198 . . . . 2.47 111.876 172.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -108.23 155.71 16.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.209 -0.519 . . . . 2.0 113.068 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.542 0.646 0 C-N-CA 123.431 0.692 . . . . 3.36 112.256 -177.769 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.519 0.199 . . . . 3.51 110.63 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 8.5 pt-20 -112.88 71.99 0.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.227 0.537 . . . . 3.37 110.746 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 28.7 p -96.87 -9.6 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.47 110.645 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.89 141.06 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.782 -0.645 . . . . 1.74 111.395 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.3 m -113.18 108.8 17.78 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.002 -0.74 . . . . 2.3 109.002 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.425 ' O ' ' HA ' ' A' ' 192' ' ' THR . 33.6 m95 -82.31 119.22 23.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.936 0.398 . . . . 6.37 111.985 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 48.5 mm -108.78 99.55 8.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.379 -0.971 . . . . 2.32 108.379 170.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.6 t -101.65 119.36 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.316 -0.402 . . . . 2.1 110.386 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 40.1 mt -74.68 137.92 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.829 0.347 . . . . 2.35 110.254 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 85.2 mttt -83.06 -8.64 59.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 3.47 110.68 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.501 ' HG2' ' H ' ' A' ' 187' ' ' SER . 8.4 tp10 -105.26 101.38 30.61 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.255 -0.43 . . . . 1.56 110.501 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 15.7 Cg_exo -69.23 141.48 47.5 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.757 2.305 . . . . 1.37 111.713 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.46 150.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.907 -0.405 . . . . 1.85 109.907 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 12.9 m -90.44 122.03 32.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.074 -0.512 . . . . 1.78 110.526 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.4 m -125.09 151.22 30.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.238 -0.653 . . . . 1.64 109.238 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 60.8 p -91.1 160.05 15.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.488 -0.485 . . . . 1.52 111.525 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.479 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.3 m -54.27 -45.56 72.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 1.81 110.803 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -55.74 -32.5 63.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 2.51 111.434 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -76.87 -52.09 10.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.479 -0.328 . . . . 1.02 110.846 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.579 ' HB ' ' HE1' ' A' ' 97' ' ' TRP . 15.7 m -64.04 -34.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.081 0.4 . . . . 1.88 112.081 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.4 mt -63.39 -30.68 71.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.689 0.281 . . . . 1.59 111.385 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -78.8 -20.18 50.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.313 . . . . 2.3 111.621 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -71.96 -24.48 61.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.275 0.559 . . . . 3.18 109.866 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -80.69 1.28 30.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.59 -0.732 . . . . 3.55 110.533 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -91.61 -9.03 45.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 2.74 110.635 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.06 153.98 39.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.092 0.472 . . . . 1.66 110.638 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.3 m120 -119.31 150.87 39.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.958 -0.564 . . . . 1.13 110.928 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 240' ' ' MET . 33.4 m-85 -77.46 -34.75 54.33 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.377 -0.972 . . . . 4.38 108.377 170.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.9 p-10 -74.31 163.84 27.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.078 -1.419 . . . . 1.62 112.39 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.72 -170.75 47.16 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.614 -1.175 . . . . 1.16 110.993 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.0 126.72 31.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.957 -0.386 . . . . 3.56 109.957 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.9 29.49 31.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.844 -0.694 . . . . 2.23 112.068 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 20.0 mm-40 -127.43 159.13 67.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.138 -0.319 . . . . 2.59 110.138 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.21 121.86 10.15 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 1.5 112.518 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.21 119.36 7.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.573 -0.74 . . . . 3.4 112.534 -174.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.3 mt-10 -131.72 146.74 52.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 2.47 109.206 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.44 125.3 42.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.394 -0.224 . . . . 2.6 110.394 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.548 ' HA ' ' CE2' ' A' ' 230' ' ' PHE . 55.5 ttm -69.45 90.79 0.54 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.515 0.51 . . . . 1.94 110.176 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.42 157.26 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 1.67 110.979 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 12.9 t70 68.47 -85.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.114 -0.948 . . . . 2.18 111.066 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 50.06 35.47 10.02 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.911 0.708 . . . . 2.64 112.911 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -137.36 158.97 43.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.424 0.63 . . . . 5.31 111.6 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -111.22 146.87 35.44 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.181 -0.918 . . . . 6.91 110.357 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.89 151.26 20.69 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.926 2.417 . . . . 3.72 112.892 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -78.31 159.74 28.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.439 -0.8 . . . . 3.34 110.681 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -113.79 153.69 45.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.42 . . . . 4.92 111.404 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.84 178.57 2.74 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.762 2.975 . . . . 4.01 113.39 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.562 ' C ' ' H ' ' A' ' 252' ' ' ASN . 4.2 mm? -51.11 -11.15 0.09 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.056 0.942 . . . . 4.9 113.021 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -59.49 41.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.092 0.957 . . . . 5.68 113.492 170.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 250' ' ' LEU . 2.9 t30 119.07 41.91 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.584 1.954 . . . . 5.11 112.296 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.64 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 7.4 ppt_? -145.52 121.44 10.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 6.74 110.896 160.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -137.48 122.4 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.656 -1.238 . . . . 3.08 107.656 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.522 HG13 ' HA ' ' A' ' 33' ' ' ILE . 29.4 mm -91.49 144.1 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 3.06 112.416 -165.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 67.6 mttm -127.97 146.6 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 3.01 109.101 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -138.17 103.85 5.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.572 0.225 . . . . 1.99 110.785 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 p -92.77 98.52 11.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.013 0.435 . . . . 2.47 111.014 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.86 154.3 27.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.248 -0.433 . . . . 5.03 110.018 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 43' ' ' SER . 49.2 pttt . . . . . 0 C--O 1.246 0.895 0 O-C-N 123.613 0.571 . . . . 4.82 111.335 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.869 0.366 . . . . 3.14 110.668 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 41.1 mt -97.18 126.54 49.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.985 -0.552 . . . . 2.71 110.562 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 16.7 t70 -112.73 117.41 32.13 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.379 -0.6 . . . . 2.82 109.379 171.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 p -56.05 -27.67 54.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.945 -0.57 . . . . 2.71 112.458 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.506 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 43.5 m80 -74.29 -18.04 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.185 0.517 . . . . 5.23 110.318 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -117.87 18.9 13.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.497 -0.774 . . . . 3.38 109.851 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.63 85.33 2.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.394 -0.595 . . . . 1.76 109.394 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -75.8 121.93 23.31 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.453 -0.794 . . . . 4.05 111.535 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 40.4 p90 -84.2 143.45 29.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.297 -0.411 . . . . 4.9 110.318 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -109.7 119.36 48.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.177 -0.465 . . . . 2.27 110.43 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.13 -15.24 46.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.758 2.305 . . . . 2.45 111.587 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.9 m -75.98 -19.21 58.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 4.62 110.746 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 89.5 mt -83.1 137.87 33.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.093 0.473 . . . . 5.15 110.259 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -118.54 135.19 23.53 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 4.21 110.73 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.99 158.09 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.94 3.094 . . . . 2.76 113.303 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.15 155.61 19.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 2.93 111.423 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 80' ' ' LYS . 34.7 p -129.1 136.04 49.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 2.46 108.984 173.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.31 136.78 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.383 -0.372 . . . . 2.17 110.981 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -119.29 89.34 3.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.508 -0.553 . . . . 1.87 109.508 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -103.1 5.72 38.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.786 -0.643 . . . . 3.97 110.254 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -51.88 -40.08 60.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 2.48 111.555 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -111.66 23.67 13.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.266 -0.425 . . . . 2.54 111.343 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.18 111.17 6.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.86 0.362 . . . . 1.41 111.014 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -106.22 108.47 20.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.282 -0.417 . . . . 1.41 110.863 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 176' ' ' THR . 17.3 m -77.43 148.74 35.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.223 -0.658 . . . . 1.84 109.223 174.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.44 -56.99 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.681 0.252 . . . . 1.45 111.681 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -154.18 164.9 37.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.161 0.505 . . . . 3.72 111.49 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.77 138.3 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.338 -0.846 . . . . 1.35 109.779 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.5 tp -130.29 139.57 50.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.593 -0.276 . . . . 1.53 111.09 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -91.46 117.02 29.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.195 0.521 . . . . 1.49 110.743 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 64' ' ' HIS . 15.7 m120 -115.59 150.05 37.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.182 -1.414 . . . . 2.18 107.182 170.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.71 38.2 0.49 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.65 -0.786 . . . . 2.0 114.536 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' ASN . 84.8 m-70 -132.61 -39.7 0.99 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.188 -0.671 . . . . 4.11 109.188 169.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.24 -170.31 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.311 -0.996 . . . . 1.78 108.311 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -108.63 135.53 49.73 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.128 -0.694 . . . . 3.48 109.128 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.67 111.61 24.18 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.289 -0.414 . . . . 1.99 110.71 -176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.77 113.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.114 -0.698 . . . . 1.75 109.114 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.52 134.04 35.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.983 0.421 . . . . 2.02 111.032 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -103.28 155.61 18.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.504 -0.771 . . . . 2.19 109.33 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.13 119.82 22.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.809 0.338 . . . . 1.33 110.139 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.35 56.18 1.12 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.718 0.771 . . . . 2.65 109.988 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -87.2 -16.57 34.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.473 -0.785 . . . . 2.01 109.881 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -153.13 176.55 11.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.966 -1.015 . . . . 2.35 108.673 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.69 73.57 7.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.234 0.54 . . . . 1.92 111.012 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 81.4 mttt -97.47 -65.15 0.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 2.31 112.481 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.49 101.51 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 1.44 110.223 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.1 t -119.56 143.4 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.993 0.425 . . . . 1.82 112.088 -169.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 tp -118.59 129.95 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.176 -0.675 . . . . 1.8 109.176 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 95.3 mttt -125.55 137.63 53.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.841 -0.429 . . . . 3.02 109.841 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.0 170.2 24.65 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.976 -0.557 . . . . 1.44 111.959 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.4 -147.88 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.817 0.363 . . . . 2.15 113.245 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 51.9 Cg_exo -52.19 119.7 6.18 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 121.904 1.736 . . . . 3.17 112.253 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 72.4 mt -155.03 -171.7 3.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.781 -1.1 . . . . 4.55 108.676 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.02 51.76 1.52 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 4.95 110.639 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.02 -173.78 19.74 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.531 -0.843 . . . . 2.25 112.902 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -108.48 127.6 54.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.015 -0.365 . . . . 2.12 110.015 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 124' ' ' ASN . 71.9 m-85 -103.66 101.77 11.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.404 0.621 . . . . 3.88 111.449 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -79.09 144.0 34.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.481 -0.781 . . . . 3.87 110.427 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.76 120.79 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.501 -0.555 . . . . 1.68 109.501 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.18 -36.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.319 . . . . 2.16 111.698 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -172.11 167.76 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.252 -0.647 . . . . 1.95 109.252 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.45 ' CD2' HD11 ' A' ' 118' ' ' LEU . 35.9 p90 -140.01 167.81 21.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.278 -0.569 . . . . 0.98 112.17 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -147.36 160.94 41.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.826 -1.176 . . . . 1.07 107.826 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.95 172.0 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.652 0.66 . . . . 3.99 111.032 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -129.45 146.03 51.35 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.697 -0.853 . . . . 2.2 108.697 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -157.32 133.38 9.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.164 0.506 . . . . 6.08 110.667 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 78.94 165.28 28.85 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.635 -0.793 . . . . 2.19 112.673 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.532 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 33.3 t 156.42 -96.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.661 -1.237 . . . . 3.08 107.661 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 75.6 mt -83.14 -153.84 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.713 -0.676 . . . . 3.48 109.303 167.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -45.81 -33.54 3.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.038 0.535 . . . . 3.85 112.124 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 113' ' ' LYS . . . 176.91 89.92 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.9 -0.667 . . . . 2.37 112.129 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 27.5 mt-30 -127.37 -177.69 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.376 . . . . 2.62 111.183 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.6 -29.56 2.76 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 109.048 -1.621 . . . . 1.62 109.048 -172.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 117' ' ' GLU . 3.3 t -68.66 67.58 0.14 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.296 -1.452 . . . . 2.24 112.474 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.467 ' CA ' ' HE1' ' A' ' 244' ' ' TRP . 28.8 tt0 -56.62 155.05 7.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 110.117 -0.327 . . . . 3.72 110.117 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 58.89 64.61 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.994 -0.743 . . . . 4.03 108.994 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.58 133.47 36.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.242 -0.89 . . . . 2.99 112.033 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.546 ' H ' ' HB3' ' A' ' 112' ' ' LYS . 40.6 t -78.61 90.61 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 114.922 -1.036 . . . . 2.88 108.894 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.48 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 33.7 t70 64.23 -71.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.135 0.897 . . . . 2.8 110.724 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.48 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 54.9 mttp -138.46 30.23 2.38 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.512 0.19 . . . . 5.35 111.512 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HB3' ' H ' ' A' ' 109' ' ' VAL . 25.4 ttpp -70.16 71.57 0.42 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.189 0.519 . . . . 3.58 110.086 174.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 102' ' ' GLY . 51.3 mtmt -99.77 96.45 7.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.45 . . . . 3.26 110.987 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -91.57 156.56 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.492 -0.929 . . . . 1.71 108.492 170.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.71 -9.69 55.4 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.481 0.488 . . . . 1.57 112.025 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.39 163.96 17.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.412 0.445 . . . . 1.3 110.322 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 105' ' ' SER . 33.2 tt0 -158.71 138.6 12.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.673 -0.694 . . . . 1.85 109.657 176.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.546 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 57.7 tp -102.51 132.86 48.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.024 -0.535 . . . . 1.61 110.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -119.86 102.41 8.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.188 0.518 . . . . 2.25 110.261 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.437 HD23 ' CB ' ' A' ' 93' ' ' PHE . 24.5 mt -83.96 116.98 23.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 1.51 110.581 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.54 127.23 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.34 0.59 . . . . 1.24 110.591 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 31.7 m-70 -124.45 144.11 50.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.898 -0.592 . . . . 2.86 110.062 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -111.42 131.23 55.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.891 -0.595 . . . . 4.96 110.755 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 88' ' ' TYR . 22.0 t30 -72.84 110.43 7.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.202 0.525 . . . . 2.3 110.742 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.9 p -66.34 -21.47 66.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 2.77 112.165 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -53.51 -27.49 25.93 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.384 0.513 . . . . 3.79 112.384 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.93 8.88 44.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.128 0.418 . . . . 3.34 112.128 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.09 -1.22 0.64 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.175 1.23 . . . . 2.37 116.175 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -168.79 136.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.416 1.108 . . . . 3.93 109.715 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.535 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.2 p90 -66.41 -38.63 87.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 3.6 111.687 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.16 97.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.838 -0.696 . . . . 2.35 111.904 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -70.72 -31.9 68.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.486 . . . . 3.75 110.241 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.621 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -65.59 -25.74 67.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.777 -0.647 . . . . 2.17 110.887 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -63.72 -19.62 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 3.11 110.993 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.39 -11.91 59.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.96 -0.463 . . . . 3.55 110.996 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 7.3 tt0 -111.14 136.39 20.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.637 -0.256 . . . . 3.02 110.623 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.8 Cg_exo -55.9 -27.15 61.73 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.34 2.694 . . . . 1.93 113.351 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 3.7 m-20 -111.5 27.07 10.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.109 0.48 . . . . 2.29 110.064 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.06 -36.49 31.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 1.5 113.503 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.8 mt -121.56 163.35 19.03 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.475 -0.427 . . . . 1.98 110.375 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.44 147.67 34.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.154 -0.475 . . . . 1.83 110.179 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.15 113.57 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.906 -0.405 . . . . 2.28 109.906 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.611 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 48.7 tp -93.4 108.32 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.092 -0.504 . . . . 2.89 110.079 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -93.92 148.35 18.97 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.932 -0.576 . . . . 0.95 112.99 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 mt -137.41 125.28 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.598 -0.519 . . . . 1.38 109.598 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 18.0 m-85 -71.06 139.12 50.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.474 -0.195 . . . . 1.37 110.474 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.7 mp -113.29 110.65 20.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.468 . . . . 1.48 110.701 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 19.4 ptpt -98.94 152.3 19.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.157 -0.683 . . . . 2.52 109.157 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.61 121.07 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.018 0.437 . . . . 1.88 110.495 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.01 -114.49 0.35 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.503 -0.639 . . . . 1.53 111.503 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.4 t -66.93 147.25 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.88 -0.415 . . . . 2.08 109.88 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.84 34.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.91 0.386 . . . . 1.36 111.669 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 216' ' ' SER . 56.7 mmtt -114.58 96.48 43.78 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.824 -0.625 . . . . 1.78 109.433 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.49 -33.92 93.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.687 2.258 . . . . 1.34 111.873 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.41 71.12 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.743 -0.662 . . . . 0.75 112.357 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 160' ' ' VAL . 62.0 tp -86.53 -26.35 24.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.216 0.532 . . . . 1.39 109.616 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -37.25 69.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.201 -0.909 . . . . 1.63 110.184 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -59.4 -37.69 78.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 3.26 111.279 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.616 ' O ' HG11 ' A' ' 162' ' ' VAL . 42.2 t -72.82 -43.39 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.154 0.502 . . . . 1.97 110.314 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 156' ' ' LEU . 33.9 t -59.77 -34.24 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 1.64 110.756 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.26 -31.05 72.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 1.22 112.014 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.616 HG11 ' O ' ' A' ' 159' ' ' VAL . 5.2 p -86.32 -4.73 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 2.07 111.012 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.52 -25.72 67.46 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.355 -0.384 . . . . 1.95 111.236 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.17 -32.31 72.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 2.31 111.279 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 m -88.5 -3.25 58.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.989 0.366 . . . . 1.78 111.989 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.58 41.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.327 0.584 . . . . 1.42 110.269 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.14 -31.24 70.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 1.98 111.421 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.9 p -117.43 158.17 24.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.785 -0.189 . . . . 1.4 111.174 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -55.03 147.0 16.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.351 0.596 . . . . 2.84 112.345 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.28 -22.01 31.89 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.331 -0.85 . . . . 0.85 112.25 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -72.84 139.84 47.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.116 0.484 . . . . 2.22 110.873 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.8 p -133.54 157.6 45.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.408 -0.814 . . . . 1.93 109.549 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.71 143.75 28.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.76 -0.459 . . . . 1.17 109.76 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.8 133.45 46.54 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.245 -0.65 . . . . 1.8 109.245 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -142.34 81.21 1.74 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.81 -0.632 . . . . 1.31 109.483 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 56' ' ' SER . 5.2 m -108.44 164.27 12.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.256 -0.429 . . . . 1.69 110.936 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.44 64.54 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.731 0.644 . . . . 2.26 111.773 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 53.2 t80 -115.22 144.65 43.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 4.84 110.145 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.61 102.33 25.59 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 2.51 111.348 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 16.0 Cg_exo -69.18 -12.16 33.33 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.917 2.412 . . . . 1.47 112.238 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -62.88 -24.48 67.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.393 -0.367 . . . . 3.16 110.957 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.62 68.28 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.601 -0.809 . . . . 1.12 111.797 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 83.5 mt -118.22 -38.01 3.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.646 -0.502 . . . . 2.37 109.646 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.07 131.71 83.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 3.87 110.566 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.84 -178.86 4.41 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.7 2.267 . . . . 2.51 112.727 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.65 -62.39 1.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.097 -0.501 . . . . 3.23 111.35 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.7 m -71.09 131.93 44.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 2.03 110.885 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.3 mt -111.32 63.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.079 0.466 . . . . 2.5 111.597 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 19.5 m-20 -105.6 173.23 6.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.741 -1.207 . . . . 1.81 107.741 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 46.9 p90 -164.65 150.24 10.15 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.325 -0.95 . . . . 5.32 113.235 -171.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.47 ' CE3' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m95 -109.35 151.27 26.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.817 -1.549 . . . . 4.55 106.817 166.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.7 t -139.5 130.86 26.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.603 0.716 . . . . 2.39 112.55 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.418 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 51.3 t80 -138.76 142.22 33.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.214 -0.903 . . . . 5.32 109.205 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.418 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 76.8 Cg_exo -52.0 149.07 21.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.429 2.086 . . . . 2.47 112.006 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -117.9 125.12 6.34 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.839 -0.696 . . . . 2.0 112.968 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 123.557 0.743 . . . . 3.36 111.112 179.579 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.359 -0.608 . . . . 3.51 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.4 OUTLIER -88.77 43.96 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.927 0.394 . . . . 3.37 110.857 -176.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 2.1 p -86.37 -9.05 57.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.257 0.466 . . . . 2.47 112.257 -174.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.14 148.15 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.012 0.434 . . . . 1.74 111.077 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.3 m -117.5 108.22 15.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.026 -0.731 . . . . 2.3 109.026 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 210' ' ' VAL . 59.2 t90 -84.98 124.3 31.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.114 0.483 . . . . 6.37 110.013 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 73.2 mt -130.93 120.49 47.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.018 -0.734 . . . . 2.32 109.018 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 14.5 p -115.92 131.51 68.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.577 -0.449 . . . . 2.1 110.962 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 92.7 mt -71.98 129.09 37.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.125 -0.488 . . . . 2.35 110.208 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 0.7 OUTLIER -56.91 -24.05 49.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.116 -0.947 . . . . 3.47 111.435 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.93 115.05 65.98 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 1.56 110.68 -170.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.507 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 12.2 Cg_exo -71.89 157.76 54.25 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.639 2.226 . . . . 1.37 111.925 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 45.2 pt -114.09 151.43 15.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.172 -0.677 . . . . 1.85 109.172 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.568 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 2.6 p -101.53 126.6 48.37 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.847 0.356 . . . . 1.78 111.215 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.73 155.03 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.533 -0.758 . . . . 1.64 109.206 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.6 t -87.88 152.85 21.77 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.607 -0.437 . . . . 1.52 110.803 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.484 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 15.8 m -51.13 -48.13 61.84 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.287 0.367 . . . . 1.81 111.57 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 2.7 mp0 -53.94 -42.64 69.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 2.51 110.755 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.77 -45.48 92.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.657 . . . . 1.02 110.312 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.69 -37.44 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.562 . . . . 1.88 110.565 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 219' ' ' SER . 97.7 mt -67.31 -34.01 76.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.63 . . . . 1.59 110.916 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 98.5 mttt -71.07 -22.83 62.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.326 . . . . 2.3 111.161 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -72.58 -31.0 64.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 3.18 109.189 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -78.26 -4.26 46.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.325 -0.852 . . . . 3.55 110.336 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 93.3 mttt -94.06 -0.15 55.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 2.74 110.094 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -73.75 150.99 40.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.798 -0.637 . . . . 1.66 109.66 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.506 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.5 m120 -111.97 125.26 53.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.601 0.715 . . . . 1.13 111.248 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -64.74 -32.23 73.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.41 -1.268 . . . . 4.38 110.018 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -70.03 160.8 31.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 1.62 111.719 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.11 179.37 52.87 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.895 -0.882 . . . . 1.16 110.895 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.58 137.2 42.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.858 0.829 . . . . 3.56 110.434 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 80.8 20.31 65.97 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.027 -0.606 . . . . 2.23 112.059 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -121.95 155.79 60.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 122.399 0.279 . . . . 2.59 110.263 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.76 125.14 18.13 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.916 2.41 . . . . 1.5 111.358 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -58.25 133.2 55.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.748 0.785 . . . . 3.4 112.59 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.13 120.19 18.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.62 -1.173 . . . . 2.47 108.508 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.5 116.91 7.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.739 0.304 . . . . 2.6 110.228 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 51.7 ttm -70.52 95.29 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.697 -0.683 . . . . 1.94 109.525 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.27 169.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.315 -0.402 . . . . 1.67 110.607 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.4 t70 71.35 -100.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.931 0.77 . . . . 2.18 109.983 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 45.55 32.58 1.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.489 . . . . 2.64 110.833 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.467 ' HE1' ' CA ' ' A' ' 106' ' ' GLU . 78.6 t90 -115.23 137.11 52.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.992 -0.373 . . . . 5.31 109.992 -171.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 82.5 mtm180 -90.55 127.04 54.19 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.546 -0.297 . . . . 6.91 111.043 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 245' ' ' ARG . 34.8 Cg_exo -61.14 150.77 82.84 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.262 2.642 . . . . 3.72 113.363 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -96.58 95.43 7.97 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.663 -0.698 . . . . 3.34 111.762 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -56.92 157.33 11.06 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.699 . . . . 4.92 112.104 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.79 177.84 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.747 2.964 . . . . 4.01 113.488 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 252' ' ' ASN . 87.4 mt -63.68 -10.96 21.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.982 -1.008 . . . . 4.9 111.397 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -52.86 49.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.626 1.713 . . . . 5.68 115.626 168.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.426 ' C ' HD21 ' A' ' 252' ' ' ASN . 0.2 OUTLIER 139.91 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.759 2.024 . . . . 5.11 113.193 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.474 ' CG ' ' H ' ' A' ' 254' ' ' GLN . 5.5 ttp180 97.37 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.186 -1.825 . . . . 6.74 110.839 156.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.474 ' H ' ' CG ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -157.95 162.1 38.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.874 -0.788 . . . . 3.08 108.874 -167.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 33' ' ' ILE . 9.5 mt -100.06 129.03 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.866 0.365 . . . . 3.06 110.667 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -81.95 152.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.426 -0.583 . . . . 3.01 109.426 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.73 166.27 14.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.278 -0.419 . . . . 1.99 110.975 -172.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 27.8 p -149.36 97.82 2.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.543 0.687 . . . . 2.47 110.724 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -132.53 104.93 6.93 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.151 -0.931 . . . . 5.03 108.728 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.599 -0.715 . . . . 4.82 109.96 -178.139 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.906 0.384 . . . . 3.14 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.502 ' HB ' ' CG ' ' A' ' 248' ' ' GLN . 0.4 OUTLIER -96.2 144.27 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 2.71 110.875 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -114.86 111.08 20.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 2.82 109.907 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -10.87 57.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.267 0.469 . . . . 2.71 112.267 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -59.77 -26.73 65.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.884 0.373 . . . . 5.23 110.934 175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -81.63 -15.42 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 3.38 111.357 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -62.19 109.84 1.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.472 0.654 . . . . 1.76 112.742 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -107.23 120.61 42.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.748 -1.115 . . . . 4.05 109.405 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -85.12 130.68 34.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.762 -0.654 . . . . 4.9 109.805 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 43' ' ' SER . 16.4 t70 -110.33 125.63 30.57 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.375 -0.375 . . . . 2.27 110.727 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.08 -9.73 23.76 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.951 2.434 . . . . 2.45 113.831 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.5 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . 43.4 t -78.88 -26.36 43.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.305 -0.628 . . . . 4.62 109.305 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.64 125.89 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 5.15 109.663 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -118.68 133.38 23.6 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.441 -0.8 . . . . 4.21 110.568 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.73 123.66 6.14 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.008 2.472 . . . . 2.76 111.539 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.5 mt -59.19 144.39 46.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 2.93 111.523 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.8 t -93.49 114.42 26.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.014 -1.106 . . . . 2.46 108.014 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.76 133.11 64.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.987 -0.552 . . . . 2.17 111.85 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 20.0 m -120.54 90.88 3.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.912 -0.585 . . . . 1.87 109.601 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -108.42 -2.26 19.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.06 -0.518 . . . . 3.97 111.403 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.37 -30.29 63.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.044 0.449 . . . . 2.48 110.228 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 19.6 mt-30 -76.16 -21.77 56.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 2.54 110.435 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 77' ' ' ALA . . . -69.33 150.69 47.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.755 -0.657 . . . . 1.41 111.501 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.743 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 77.9 m -141.41 128.82 21.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.867 -0.606 . . . . 1.41 110.274 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 176' ' ' THR . 22.9 m -74.91 147.76 40.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 1.84 110.056 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.2 mt -115.04 -52.32 2.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.421 -0.354 . . . . 1.45 110.985 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -163.99 164.69 23.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 3.72 111.33 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 tt -126.6 139.18 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.64 -0.709 . . . . 1.35 109.548 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.4 tp -126.56 137.19 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 1.53 111.344 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -92.32 107.88 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.329 -0.989 . . . . 1.49 108.329 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -113.34 68.06 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.02 -0.672 . . . . 2.18 109.969 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.64 -57.26 0.08 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 113.961 -1.472 . . . . 2.0 115.097 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -107.97 -22.79 12.28 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.389 0.276 . . . . 4.11 111.436 -169.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.42 178.29 10.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.662 0.268 . . . . 1.78 110.466 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.437 ' CZ ' HD11 ' A' ' 228' ' ' LEU . 96.8 m-85 -111.04 143.46 41.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.367 -0.379 . . . . 3.48 110.168 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -122.08 108.51 13.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.637 -0.256 . . . . 1.99 110.816 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 22.0 t -94.92 112.07 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.528 -0.545 . . . . 1.75 109.528 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.2 132.16 39.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.018 0.437 . . . . 2.02 111.866 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -103.83 157.73 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 2.19 109.249 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.743 ' OD1' ' HB ' ' A' ' 55' ' ' THR . 1.6 p-10 -91.09 125.54 35.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.15 0.5 . . . . 1.33 109.846 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 6.9 t70 -152.96 63.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.464 0.649 . . . . 2.65 110.313 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -76.68 1.81 15.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.065 0.935 . . . . 2.01 109.088 167.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -163.72 140.28 6.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.55 -1.648 . . . . 2.35 106.55 -177.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.15 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.713 0.768 . . . . 1.92 112.801 -168.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 70.8 mmtt -101.16 -47.25 4.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.314 -0.857 . . . . 2.31 110.199 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -105.5 99.42 9.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.762 -0.654 . . . . 1.44 110.268 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.34 127.64 65.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.042 -0.526 . . . . 1.82 111.554 -171.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.2 tp -119.56 117.37 28.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 1.8 109.783 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -160.82 122.68 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.173 -0.306 . . . . 3.02 110.173 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.83 -179.52 16.51 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-O 119.587 -0.563 . . . . 1.44 112.315 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -34.87 -135.43 0.0 OUTLIER Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.43 0.932 . . . . 2.15 115.43 166.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.69 167.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 123.365 2.71 . . . . 3.17 113.802 -172.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.4 pt? -33.51 82.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.622 1.341 . . . . 4.55 114.622 -146.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 21.7 p-10 -81.67 -77.3 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.437 -1.71 . . . . 4.95 112.543 175.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.22 131.93 0.81 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.723 -1.351 . . . . 2.25 109.723 -165.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.7 m -73.6 115.54 13.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.086 0.943 . . . . 2.12 111.769 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.6 m-85 -104.85 145.84 29.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.659 -0.7 . . . . 3.88 109.74 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.545 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 80.2 mtm180 -107.72 138.31 44.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.551 0.215 . . . . 3.87 110.777 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 tt -88.73 112.45 23.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.921 -0.77 . . . . 1.68 108.921 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.554 HD12 ' CE3' ' A' ' 123' ' ' TRP . 54.7 mt -125.54 -23.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.518 -0.473 . . . . 2.16 111.567 -174.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.1 pt20 -156.49 159.56 38.73 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.101 -0.374 . . . . 1.95 110.715 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.536 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 31.9 p90 -150.82 164.23 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.98 110.285 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.529 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 4.2 p-80 -137.98 158.53 44.13 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.656 0.597 . . . . 1.07 110.58 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -136.0 168.83 18.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.954 -0.387 . . . . 3.99 109.954 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -165.43 146.31 7.15 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.951 -0.389 . . . . 2.2 109.951 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.465 ' CZ3' ' HB2' ' A' ' 226' ' ' ARG . 83.1 t90 -140.22 147.97 40.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.233 -0.44 . . . . 6.08 109.833 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 84.76 165.61 40.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.682 -0.771 . . . . 2.19 113.164 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . 40.5 t 160.58 -89.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.115 0.966 . . . . 3.08 108.551 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.52 -156.55 0.55 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.983 -0.553 . . . . 3.48 110.027 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.79 -42.06 62.15 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.491 0.495 . . . . 3.85 111.361 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.28 46.63 0.56 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.351 -0.7 . . . . 2.37 111.351 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 104' ' ' GLY . 4.6 tt0 -116.74 -174.87 2.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.026 -0.731 . . . . 2.62 109.026 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 103' ' ' GLN . . . 131.39 -25.21 4.08 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.397 -0.906 . . . . 1.62 112.737 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 62.4 p -67.34 -36.58 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.68 0.622 . . . . 2.24 112.68 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 245' ' ' ARG . 34.5 tt0 82.41 174.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.282 -1.377 . . . . 3.72 107.282 -166.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.528 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 98.2 m-70 55.66 58.86 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 4.03 111.605 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -82.26 122.2 27.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.249 0.547 . . . . 2.99 110.311 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 23.1 t -89.04 91.84 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.764 -0.653 . . . . 2.88 109.682 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.472 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 27.2 t70 64.84 -70.14 0.09 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.015 0.822 . . . . 2.8 110.65 -174.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.472 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 0.3 OUTLIER -142.21 11.81 1.97 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.013 -0.539 . . . . 5.35 111.094 174.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 40.1 ttmt -81.19 84.9 6.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.068 0.461 . . . . 3.58 109.795 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 17.6 pttp -110.87 132.97 53.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 3.26 110.82 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -107.07 167.42 9.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.471 -0.331 . . . . 1.71 110.307 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB1' ' NE1' ' A' ' 97' ' ' TRP . . . -65.16 -36.14 83.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.373 -0.376 . . . . 1.57 111.885 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.87 165.48 35.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.637 0.256 . . . . 1.3 110.998 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -146.67 141.88 27.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.068 -0.716 . . . . 1.85 109.068 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 93' ' ' PHE . 48.7 tp -101.57 116.41 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.936 -0.574 . . . . 1.61 109.496 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.529 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 18.8 m170 -107.42 105.44 15.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 2.25 110.69 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.536 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.7 mp -94.18 125.72 38.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.861 -0.609 . . . . 1.51 110.461 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -92.41 137.51 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 1.24 110.43 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 36.3 m80 -131.64 140.44 49.37 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.133 -0.692 . . . . 2.86 109.133 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.554 ' CE3' HD12 ' A' ' 91' ' ' ILE . 47.1 m0 -110.44 129.99 55.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.121 0.263 . . . . 4.96 110.492 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -63.21 114.72 3.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.084 0.469 . . . . 2.3 110.748 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -80.5 -26.79 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.842 -0.617 . . . . 2.77 111.642 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -59.1 -24.45 62.96 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.753 0.279 . . . . 3.79 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -91.06 9.77 29.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.323 0.583 . . . . 3.34 110.721 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . 67.72 -4.09 4.46 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.221 -0.899 . . . . 2.37 115.333 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 21.8 t70 175.21 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.131 0.966 . . . . 3.93 109.936 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.432 ' O ' HG11 ' A' ' 134' ' ' VAL . 35.4 p90 -58.08 -34.94 70.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.036 -0.529 . . . . 3.6 111.053 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.54 -38.73 88.82 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.201 -0.523 . . . . 2.35 112.706 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 8.9 mmpt? -78.39 -37.32 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.131 0.491 . . . . 3.75 109.98 175.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.595 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -64.88 -34.36 78.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.365 -0.834 . . . . 2.17 112.312 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 130' ' ' PHE . 27.9 m -67.94 -9.18 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.848 0.314 . . . . 3.11 111.848 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -93.06 -6.16 48.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.26 0.552 . . . . 3.55 110.309 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.518 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 5.9 tt0 -107.29 131.63 21.56 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 3.02 109.317 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 50.9 Cg_exo -55.03 -22.07 29.54 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.968 2.445 . . . . 1.93 112.879 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.518 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.9 m-20 -111.56 28.6 8.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 2.29 110.605 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -80.85 -40.29 12.25 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.086 -0.578 . . . . 1.5 114.524 -173.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.94 158.38 18.28 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.218 -0.578 . . . . 1.98 109.95 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -143.67 117.84 9.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.855 0.36 . . . . 1.83 110.716 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.75 121.38 61.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.141 -0.482 . . . . 2.28 110.06 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 209' ' ' ILE . 60.9 tp -93.83 119.42 32.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.486 -0.561 . . . . 2.89 109.486 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.75 111.35 3.76 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.977 -0.63 . . . . 0.95 112.615 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.7 mt -110.96 107.57 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 110.221 -0.288 . . . . 1.38 110.221 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 96.8 m-85 -63.15 149.46 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.37 111.323 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mp -113.83 131.26 56.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.589 . . . . 1.48 110.121 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 216' ' ' SER . 17.4 ptpt -122.16 136.82 54.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.562 -0.532 . . . . 2.52 109.562 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 3.6 m -99.82 79.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.313 0.577 . . . . 1.88 112.262 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.583 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -157.89 60.05 0.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.684 -0.77 . . . . 1.53 112.024 168.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.583 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 7.7 t 158.78 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.64 -1.244 . . . . 2.08 107.64 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -76.43 139.07 40.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.815 0.34 . . . . 1.36 110.739 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 216' ' ' SER . 16.9 tptm -110.62 96.62 28.83 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.14 -0.482 . . . . 1.78 109.968 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.42 -36.18 97.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.971 2.448 . . . . 1.34 112.453 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.55 -6.68 66.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.196 -0.526 . . . . 0.75 113.597 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.1 tp -90.06 -21.18 22.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.773 0.787 . . . . 1.39 110.743 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.409 ' HA ' ' HB ' ' A' ' 160' ' ' VAL . 7.9 tp-100 -57.28 -34.77 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 1.63 111.648 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -47.37 -50.6 21.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.296 0.48 . . . . 3.26 112.296 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -81.05 -30.07 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.703 -0.399 . . . . 1.97 110.814 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.582 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 82.1 t -63.83 -35.62 73.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.2 0.524 . . . . 1.64 111.204 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.88 -22.51 60.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.293 -0.412 . . . . 1.22 111.516 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.55 -13.89 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.372 0.508 . . . . 2.07 112.372 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.589 HD11 ' N ' ' A' ' 164' ' ' ASP . 3.9 pp -60.13 -27.51 67.12 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.912 0.708 . . . . 1.95 112.912 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.589 ' N ' HD11 ' A' ' 163' ' ' LEU . 14.7 t70 -70.97 -25.03 62.54 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.954 -0.466 . . . . 2.31 110.664 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.3 m -76.69 -3.52 38.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.063 0.459 . . . . 1.78 111.136 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.2 pt -137.36 36.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.341 -0.615 . . . . 1.42 109.341 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -74.85 -25.36 58.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.665 -0.698 . . . . 1.98 111.255 -171.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 231' ' ' ASN . 0.1 OUTLIER -119.54 148.55 43.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.936 0.398 . . . . 1.4 111.139 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -55.09 126.08 23.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 2.84 112.017 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.93 -16.51 36.26 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.69 -0.767 . . . . 0.85 112.077 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -88.69 152.74 21.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.321 0.581 . . . . 2.22 110.796 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 t -143.78 159.19 42.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.466 -0.788 . . . . 1.93 109.078 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.96 130.86 20.39 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.855 -0.424 . . . . 1.17 109.855 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.28 132.94 55.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.369 -0.604 . . . . 1.8 109.369 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -140.69 77.94 1.63 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.019 -1.104 . . . . 1.31 108.019 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 56' ' ' SER . 4.9 m -106.73 156.98 18.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 1.69 111.757 -173.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.16 60.28 2.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.916 0.886 . . . . 2.26 112.254 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -131.58 130.46 42.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.649 -1.159 . . . . 4.84 108.829 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.46 140.75 21.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.01 0.433 . . . . 2.51 111.462 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.84 -6.52 14.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.918 2.412 . . . . 1.47 111.617 172.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -58.65 -42.41 88.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.305 -0.861 . . . . 3.16 111.568 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.06 -15.29 69.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.953 -0.641 . . . . 1.12 112.995 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.45 -10.58 48.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.502 0.192 . . . . 2.37 111.45 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.11 141.35 40.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.83 0.348 . . . . 3.87 111.018 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.87 -175.58 2.83 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.915 2.41 . . . . 2.51 112.722 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.64 -59.94 2.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.337 -0.392 . . . . 3.23 111.044 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 m -83.8 137.35 33.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 2.03 111.264 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.1 tp -109.18 64.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.352 0.596 . . . . 2.5 110.351 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 211' ' ' LEU . 19.1 m-20 -108.01 166.16 10.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.807 -0.812 . . . . 1.81 108.807 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -164.89 163.89 20.94 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.156 -0.618 . . . . 5.32 112.224 -167.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.34 130.99 55.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.05 -0.977 . . . . 4.55 108.375 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.2 p -95.32 106.22 18.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 2.39 111.393 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -135.99 125.43 16.02 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 5.32 111.882 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.38 132.55 5.15 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.694 2.263 . . . . 2.47 112.531 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -110.42 157.14 15.19 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.959 -0.564 . . . . 2.0 112.006 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 60.1 m . . . . . 0 C--N 1.324 -0.539 0 O-C-N 122.595 -0.356 . . . . 3.36 111.206 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.781 0.324 . . . . 3.51 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 8.1 pt-20 -80.51 65.29 5.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.193 0.521 . . . . 3.37 110.989 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.4 p -128.53 13.9 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.44 0.904 . . . . 2.47 113.44 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.18 138.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.43 0.633 . . . . 1.74 112.181 -171.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 24.6 m -111.28 113.43 25.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.277 -1.009 . . . . 2.3 108.277 168.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -97.47 113.89 25.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.271 0.558 . . . . 6.37 110.331 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.468 ' O ' HD13 ' A' ' 143' ' ' LEU . 48.7 mm -103.49 102.99 14.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.587 -0.733 . . . . 2.32 109.277 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.06 125.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.412 -0.588 . . . . 2.1 109.412 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 189' ' ' ASP . 15.8 tp -80.09 116.85 20.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.058 -0.349 . . . . 2.35 110.058 -176.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -61.82 -33.38 74.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.95 -0.568 . . . . 3.47 110.401 -177.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -95.75 103.07 11.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 1.56 110.165 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 14.7 Cg_exo -71.23 171.58 15.74 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.725 2.283 . . . . 1.37 112.135 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.9 pt -112.44 149.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.566 . . . . 1.85 109.945 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 5.5 p -105.18 132.2 51.69 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.03 -0.532 . . . . 1.78 110.641 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 26.9 m -128.47 165.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.976 -0.556 . . . . 1.64 110.181 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 21.0 t -94.34 153.0 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.669 -0.241 . . . . 1.52 110.682 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.554 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 17.1 p -54.54 -48.14 72.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.49 0.186 . . . . 1.81 111.272 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -54.79 -29.41 54.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.392 -0.367 . . . . 2.51 111.63 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.88 -45.91 33.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.064 -0.516 . . . . 1.02 110.362 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.562 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 34.7 m -78.56 -21.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 1.88 111.91 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 219' ' ' SER . 77.1 mt -65.06 -31.62 72.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.411 . . . . 1.59 110.489 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -74.61 -22.02 59.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.125 -0.489 . . . . 2.3 110.78 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.4 m-85 -77.48 -27.37 51.95 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.6 -0.889 . . . . 3.18 108.6 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.465 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 67.0 ttt180 -72.32 -20.06 61.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.535 -1.211 . . . . 3.55 110.651 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.16 -6.7 34.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 2.74 111.313 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.437 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 93.2 mt -65.22 154.78 37.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.916 0.389 . . . . 1.66 110.647 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -116.71 134.71 54.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.312 0.577 . . . . 1.13 110.713 -175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -78.72 -35.68 44.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.868 -1.06 . . . . 4.38 109.774 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.414 ' O ' HG22 ' A' ' 168' ' ' THR . 4.3 p-10 -72.64 169.35 16.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.049 -0.978 . . . . 1.62 111.888 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.01 177.25 38.19 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.303 -0.862 . . . . 1.16 111.177 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.37 125.37 25.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 3.56 110.487 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.14 7.74 42.99 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.728 -0.669 . . . . 2.23 113.397 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 44.3 mt-10 -112.32 157.54 39.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 117.393 0.597 . . . . 2.59 109.67 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.66 125.33 18.38 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.289 1.992 . . . . 1.5 110.613 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.43 118.48 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.84 0.829 . . . . 3.4 112.564 -171.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.99 116.37 31.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.583 -1.19 . . . . 2.47 107.901 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.97 125.14 25.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.063 0.459 . . . . 2.6 110.584 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 60.7 ttm -78.94 89.78 4.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 1.94 110.59 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.01 167.6 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.766 -0.827 . . . . 1.67 108.766 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 19.5 t70 66.48 -88.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.764 0.665 . . . . 2.18 110.056 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 63.09 -11.26 0.09 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.354 0.872 . . . . 2.64 113.354 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -153.77 175.11 13.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.142 -0.688 . . . . 5.31 109.142 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 106' ' ' GLU . 39.0 mtp85 -129.39 147.54 65.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.212 -0.292 . . . . 6.91 110.212 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.99 82.48 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.748 2.298 . . . . 3.72 111.561 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -98.78 118.18 34.94 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.049 -0.523 . . . . 3.34 111.315 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.502 ' CG ' ' HB ' ' A' ' 33' ' ' ILE . 16.2 mm-40 -124.16 156.31 66.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 4.92 109.465 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.18 129.54 6.03 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.404 2.736 . . . . 4.01 113.095 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -43.45 -57.21 3.19 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 124.121 0.888 . . . . 4.9 112.231 -171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 54.6 pttt -106.34 0.2 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.554 0.216 . . . . 5.68 111.422 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER 75.89 -47.97 0.58 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.601 0.761 . . . . 5.11 111.465 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 70.64 -108.81 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.607 -0.886 . . . . 6.74 108.607 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -140.93 136.75 32.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.231 -1.396 . . . . 3.08 107.231 165.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 75.6 mt -84.6 121.85 37.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.302 -0.559 . . . . 3.06 109.671 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.35 134.85 42.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.899 -0.778 . . . . 3.01 108.899 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.25 172.9 12.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.257 -0.429 . . . . 1.99 110.019 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.7 m -128.33 94.69 3.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.292 -0.563 . . . . 2.47 110.968 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -146.37 126.66 13.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.733 -0.839 . . . . 5.03 108.733 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 18.8 pttp . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.244 -0.884 . . . . 4.82 110.336 -179.42 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 107.067 -1.457 . . . . 3.14 107.067 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 55.5 mt -93.96 90.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.237 0.541 . . . . 2.71 111.116 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -77.15 106.23 8.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.604 -0.726 . . . . 2.82 109.849 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -40.61 30.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.402 -0.817 . . . . 2.71 112.777 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -70.48 -33.75 71.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 5.23 110.885 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 m -89.34 -30.26 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.459 -0.337 . . . . 3.38 111.252 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.87 89.93 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.043 0.449 . . . . 1.76 112.035 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -97.97 138.75 34.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.944 -0.571 . . . . 4.05 110.145 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.761 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 48.0 p90 -84.26 123.4 30.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.928 0.394 . . . . 4.9 110.65 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.97 139.0 23.07 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.32 -0.4 . . . . 2.27 110.076 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -90.17 22.82 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.812 2.341 . . . . 2.45 112.324 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 m -89.35 -18.8 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 4.62 110.65 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.444 HD21 ' OG ' ' A' ' 258' ' ' SER . 3.4 pp -97.55 156.91 16.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 5.15 110.255 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -99.03 144.22 27.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.432 -0.349 . . . . 4.21 110.954 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 31.1 Cg_endo -64.37 165.35 20.23 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.128 2.552 . . . . 2.76 112.184 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.6 146.23 24.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 2.93 111.743 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -110.61 107.15 16.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.678 -0.86 . . . . 2.46 108.678 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -90.76 102.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.411 -0.359 . . . . 2.17 110.873 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -119.26 89.47 3.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.119 0.485 . . . . 1.87 110.423 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.06 21.71 1.58 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.54 0.686 . . . . 3.97 110.423 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.31 -17.92 64.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.38 -0.827 . . . . 2.48 110.021 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.02 -5.02 38.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.729 -0.669 . . . . 2.54 109.811 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.61 158.76 35.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.707 -0.678 . . . . 1.41 111.838 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -150.16 143.38 25.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.199 -0.91 . . . . 1.41 109.076 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 176' ' ' THR . 14.5 m -91.1 165.37 13.54 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.14 -0.689 . . . . 1.84 109.14 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -119.36 -50.34 2.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.018 0.437 . . . . 1.45 111.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -157.9 152.58 25.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.256 -0.429 . . . . 3.72 111.072 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.475 HG12 HD11 ' A' ' 166' ' ' ILE . 14.6 tt -115.55 138.48 45.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.034 -0.728 . . . . 1.35 109.034 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.2 tp -135.82 141.17 44.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.207 0.527 . . . . 1.53 112.229 -170.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -100.16 105.6 17.22 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.797 -1.186 . . . . 1.49 107.797 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -138.56 73.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.158 0.504 . . . . 2.18 112.09 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.59 -52.71 0.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.838 -1.173 . . . . 2.0 111.997 161.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -147.41 -51.24 0.19 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.98 0.419 . . . . 4.11 110.094 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.58 169.77 8.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 1.78 111.491 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CZ ' HD11 ' A' ' 228' ' ' LEU . 34.4 m-85 -110.24 100.25 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.502 -0.772 . . . . 3.48 109.247 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -89.33 118.58 29.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 1.99 111.622 -170.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.454 HG23 HG13 ' A' ' 59' ' ' ILE . 21.3 t -100.71 114.07 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.65 -0.5 . . . . 1.75 109.65 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -80.26 138.77 36.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.038 0.385 . . . . 2.02 112.038 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.453 ' CE2' ' HD1' ' A' ' 93' ' ' PHE . 65.9 m-85 -105.32 163.32 12.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.691 -0.686 . . . . 2.19 109.747 170.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.58 113.53 25.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.894 -0.41 . . . . 1.33 109.894 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -124.55 57.87 1.24 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.868 0.842 . . . . 2.65 111.034 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -87.71 -9.26 54.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.082 0.944 . . . . 2.01 108.926 167.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.25 171.3 19.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.445 -1.252 . . . . 2.35 108.057 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.28 73.15 2.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.38 0.609 . . . . 1.92 110.857 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -92.35 -56.48 3.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.815 . . . . 2.31 109.67 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.21 101.71 11.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.719 -0.673 . . . . 1.44 109.722 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.31 135.23 63.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.191 0.52 . . . . 1.82 110.746 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 tp -140.07 110.56 6.69 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.342 -0.985 . . . . 1.8 108.342 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -148.89 125.62 11.13 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.006 -0.678 . . . . 3.02 112.683 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . -66.22 173.86 23.18 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.354 -0.839 . . . . 1.44 111.663 159.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 84' ' ' LEU . . . -41.83 -143.93 0.0 OUTLIER Glycine 0 CA--C 1.538 1.485 0 N-CA-C 114.996 0.758 . . . . 2.15 114.996 169.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.88 122.69 9.45 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.955 1.77 . . . . 3.17 112.447 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 82' ' ' GLY . 82.1 mt -138.77 -168.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.899 -1.046 . . . . 4.55 110.216 -174.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.64 57.17 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.022 0.379 . . . . 4.95 112.022 -167.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.51 -116.94 2.26 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.024 -1.084 . . . . 2.25 113.995 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 m -127.36 111.78 14.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.65 -0.5 . . . . 2.12 109.65 -171.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.71 ' HA ' ' CD2' ' A' ' 122' ' ' HIS . 9.8 m-85 -99.03 91.12 4.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.518 0.675 . . . . 3.88 112.3 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.57 146.77 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.016 -0.993 . . . . 3.87 109.532 172.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.4 tp -89.61 130.33 35.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.633 -0.506 . . . . 1.68 109.633 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.5 tt -106.31 -32.78 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.677 0.275 . . . . 2.16 111.481 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.437 ' HG2' HG23 ' A' ' 91' ' ' ILE . 3.8 pt20 -163.04 171.95 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 1.95 110.352 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' HD1' ' CE2' ' A' ' 70' ' ' PHE . 26.8 p90 -144.41 146.98 32.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.98 109.347 169.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.414 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 5.2 p-80 -134.28 160.16 38.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.8 -0.444 . . . . 1.07 109.8 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.17 167.91 19.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.948 0.404 . . . . 3.99 110.95 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.13 167.78 29.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.93 -0.767 . . . . 2.2 108.93 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.4 ' CZ3' ' HA ' ' A' ' 226' ' ' ARG . 82.0 t90 -151.2 151.11 31.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.15 0.282 . . . . 6.08 110.245 -170.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.547 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -113.37 159.71 13.53 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.838 -0.696 . . . . 2.19 112.164 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 -39.76 79.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.869 0.366 . . . . 3.08 111.857 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 102' ' ' GLY . 87.1 mt -111.27 146.02 37.75 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.809 -0.812 . . . . 3.48 108.809 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.26 12.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.684 0.624 . . . . 3.85 112.684 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 100' ' ' LEU . . . -118.66 17.83 10.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 2.37 111.97 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.433 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 14.0 pt20 -158.15 159.51 36.24 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.115 -0.328 . . . . 2.62 110.115 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.46 6.74 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 1.62 112.246 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.4 t -69.41 -45.81 68.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.748 0.309 . . . . 2.24 111.069 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.585 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 2.6 tp10 65.05 -162.64 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.528 -0.76 . . . . 3.72 109.093 -169.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.585 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 33.7 m80 53.27 49.28 20.19 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.171 0.986 . . . . 4.03 108.53 -167.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 112' ' ' LYS . 13.0 t -79.72 131.58 35.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.815 -1.539 . . . . 2.99 112.171 -168.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 28.4 t -98.98 107.55 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 114.359 -1.291 . . . . 2.88 109.633 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.36 42.95 20.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.56 0.695 . . . . 2.8 110.096 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm 61.15 20.71 11.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.887 -1.051 . . . . 5.35 112.497 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' C ' ' HG1' ' A' ' 108' ' ' THR . 51.5 tttp -94.01 112.34 24.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.59 -0.522 . . . . 3.58 109.59 169.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 50.7 mttp -98.55 168.03 10.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.18 0.514 . . . . 3.26 111.174 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -119.53 176.55 5.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.3 -0.863 . . . . 1.71 109.453 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.91 94.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.1 0.407 . . . . 1.57 112.1 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.8 168.5 25.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.267 -0.424 . . . . 1.3 109.961 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -142.52 140.37 31.8 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.599 -0.519 . . . . 1.85 109.599 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.421 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 36.8 tp -103.3 125.75 50.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.323 -0.621 . . . . 1.61 109.323 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 12.3 m170 -118.76 109.93 16.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.1 0.476 . . . . 2.25 112.1 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 120' ' ' LEU . 5.0 mp -94.33 116.43 28.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.701 -0.681 . . . . 1.51 109.484 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.3 124.24 48.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.105 0.478 . . . . 1.24 112.013 -171.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.71 ' CD2' ' HA ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -89.62 140.96 29.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 2.86 111.005 175.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -112.64 141.53 46.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 4.96 109.542 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -93.22 96.01 9.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 2.3 110.927 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.9 m -68.01 -16.94 64.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.934 -0.576 . . . . 2.77 111.251 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -52.63 -33.12 45.22 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.71 0.404 . . . . 3.79 111.804 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -107.85 -6.51 16.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.367 0.603 . . . . 3.34 110.484 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.52 38.55 9.5 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.232 -1.349 . . . . 2.37 113.785 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.556 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 22.8 t70 -166.31 110.48 0.79 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.634 -0.506 . . . . 3.93 109.634 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -57.26 -32.94 67.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 3.6 111.19 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.15 81.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.056 -0.593 . . . . 2.35 112.761 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.556 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 38.0 mmtm -88.29 -28.8 20.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 3.75 110.375 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.475 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -63.91 -36.28 83.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.021 -0.536 . . . . 2.17 110.685 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.488 ' O ' HD23 ' A' ' 203' ' ' LEU . 34.9 m -77.99 -2.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.372 -0.376 . . . . 3.11 111.236 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -109.01 19.23 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.278 0.561 . . . . 3.55 110.449 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -129.02 128.3 23.38 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.269 -1.011 . . . . 3.02 108.269 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.88 -31.59 73.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.097 2.532 . . . . 1.93 113.2 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -111.13 24.26 13.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 2.29 109.997 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -66.01 -50.23 53.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.016 -0.538 . . . . 1.5 112.497 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 79.4 mt -109.28 151.98 25.83 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.418 -0.586 . . . . 1.98 109.418 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -145.99 123.91 12.02 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.748 -0.834 . . . . 1.83 108.748 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.55 116.83 53.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.879 -0.328 . . . . 2.28 110.899 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 38.0 tp -83.38 115.69 22.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.668 -0.696 . . . . 2.89 109.696 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -106.16 128.88 9.52 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.038 -0.601 . . . . 0.95 112.623 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.7 122.61 70.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.387 -0.597 . . . . 1.38 109.387 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -69.75 146.39 51.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 1.37 110.301 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.34 130.46 56.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.413 -0.358 . . . . 1.48 110.149 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 216' ' ' SER . 26.2 pttm -125.32 151.59 45.84 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.457 -0.571 . . . . 2.52 109.457 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 40.7 t -84.84 121.42 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.094 0.473 . . . . 1.88 110.62 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.48 -114.72 0.33 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.504 -0.771 . . . . 1.53 111.201 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.3 p -74.01 156.3 37.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.206 -0.294 . . . . 2.08 110.206 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.22 148.88 37.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.808 0.337 . . . . 1.36 111.04 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 216' ' ' SER . 46.3 tptt -113.68 100.04 51.2 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.29 -0.414 . . . . 1.78 110.033 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.32 -31.33 73.42 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.663 2.242 . . . . 1.34 112.543 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.94 -19.34 71.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.063 -0.589 . . . . 0.75 112.979 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.478 ' O ' HG22 ' A' ' 160' ' ' VAL . 37.0 tp -112.07 -12.04 13.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.054 0.454 . . . . 1.39 110.792 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -40.52 79.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.909 -0.587 . . . . 1.63 111.142 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.98 -26.86 62.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.972 0.415 . . . . 3.26 110.314 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 162' ' ' VAL . 59.0 t -72.3 -44.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 1.97 109.504 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 41.6 t -62.58 -34.31 64.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.691 . . . . 1.64 110.361 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.2 -28.74 68.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.443 -0.798 . . . . 1.22 111.562 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 159' ' ' VAL . 8.8 p -97.73 -14.57 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.794 -0.363 . . . . 2.07 111.883 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.4 pp -70.75 -20.42 62.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.618 -0.433 . . . . 1.95 111.891 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 30.7 t70 -67.39 -24.42 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.235 0.54 . . . . 2.31 110.398 176.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.0 m -79.81 1.16 27.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 1.78 111.229 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.475 HD11 HG12 ' A' ' 59' ' ' ILE . 40.5 pt -137.28 37.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.779 -0.823 . . . . 1.42 108.779 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 87.1 tttt -58.45 -32.01 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.861 -1.063 . . . . 1.98 111.854 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -119.92 154.17 34.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.31 -0.404 . . . . 1.4 110.485 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.46 135.37 57.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 2.84 110.663 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.7 38.18 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.71 -0.757 . . . . 0.85 111.715 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -89.77 143.47 26.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 2.22 110.711 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.3 p -139.88 156.59 46.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.033 -0.53 . . . . 1.93 109.659 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.6 140.37 40.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.118 -0.327 . . . . 1.17 110.118 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.92 130.8 44.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.553 -0.536 . . . . 1.8 109.553 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.38 79.79 1.68 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.797 -0.446 . . . . 1.31 109.797 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' SER . 21.7 p -106.76 164.98 11.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 1.69 111.148 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 56.65 71.32 0.58 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.432 0.457 . . . . 2.26 111.255 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 55.1 t80 -123.59 142.37 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.754 0.311 . . . . 4.84 110.293 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.47 102.3 14.11 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.823 -0.626 . . . . 2.51 110.061 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 2.9 Cg_exo -75.83 -19.83 15.82 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.637 2.224 . . . . 1.47 111.688 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -56.6 -38.55 72.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.287 -0.87 . . . . 3.16 111.663 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.08 6.94 2.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.125 -0.489 . . . . 1.12 113.863 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.57 -13.61 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.272 0.536 . . . . 2.37 110.352 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.3 130.43 87.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.591 . . . . 3.87 111.356 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.62 -171.95 1.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.443 2.095 . . . . 2.51 111.384 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.91 -62.37 1.67 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.936 0.398 . . . . 3.23 110.203 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.4 m -75.06 123.1 24.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 2.03 110.936 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.3 tp -101.52 64.1 0.98 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.625 0.726 . . . . 2.5 109.47 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.593 ' HB3' ' O ' ' A' ' 258' ' ' SER . 12.3 m-20 -124.91 147.64 48.73 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.398 -0.964 . . . . 1.81 108.398 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 53.1 p90 -144.43 158.71 43.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.562 0.949 . . . . 5.32 113.562 -166.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -93.02 140.08 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.42 -1.326 . . . . 4.55 107.42 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 9.3 t -136.57 116.72 13.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.713 0.688 . . . . 2.39 112.684 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -140.31 132.38 14.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 5.32 110.632 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.18 125.4 10.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.598 1.532 . . . . 2.47 110.575 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.34 160.13 26.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.035 -0.602 . . . . 2.0 113.249 -168.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.664 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 14.0 m . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 109.65 -0.5 . . . . 3.36 109.65 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 196' ' ' SER . 30.9 tp . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 108.905 -0.776 . . . . 3.51 108.905 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -98.89 51.55 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.381 0.61 . . . . 3.37 110.897 -171.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.7 p -91.89 -5.72 52.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.926 -0.579 . . . . 2.47 110.859 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 133.18 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.064 0.459 . . . . 1.74 110.575 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 21.7 m -105.91 103.51 13.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.126 -0.694 . . . . 2.3 109.126 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.577 ' O ' ' HA ' ' A' ' 192' ' ' THR . 96.3 m95 -76.16 110.39 10.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.301 -0.409 . . . . 6.37 110.43 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 74.3 mt -115.38 101.18 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.201 -0.666 . . . . 2.32 109.201 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 41.3 t -113.44 126.03 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 121.035 -0.266 . . . . 2.1 110.852 -171.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 137.25 41.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.291 0.567 . . . . 2.35 111.306 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -68.38 -10.35 54.46 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.346 -0.843 . . . . 3.47 112.376 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -114.61 107.75 50.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.815 -0.354 . . . . 1.56 111.198 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.81 143.49 50.77 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.133 2.555 . . . . 1.37 112.417 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -96.43 158.86 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.29 -0.633 . . . . 1.85 109.29 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 6.6 m -106.91 139.36 41.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.967 0.413 . . . . 1.78 111.425 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -124.18 148.42 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.64 109.024 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.7 t -94.98 164.78 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.149 -0.315 . . . . 1.52 110.149 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.492 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 m -47.23 -48.09 24.43 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.775 0.658 . . . . 1.81 112.775 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.55 -33.98 56.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 2.51 111.413 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -78.38 -43.32 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.262 -0.426 . . . . 1.02 110.049 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.72 -38.93 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 1.88 110.929 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.4 mt -57.63 -36.03 71.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.766 -0.652 . . . . 1.59 111.303 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -77.2 -24.33 51.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.318 -0.401 . . . . 2.3 110.961 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -72.13 -34.04 68.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 3.18 109.491 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.4 ' HA ' ' CZ3' ' A' ' 97' ' ' TRP . 43.2 ttm180 -70.87 -11.1 60.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.093 -0.958 . . . . 3.55 110.987 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.445 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 99.6 mttt -89.96 -19.36 24.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.3 -0.409 . . . . 2.74 111.338 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.427 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 95.7 mt -64.61 146.03 55.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.321 0.582 . . . . 1.66 112.199 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.09 149.2 37.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.408 -0.815 . . . . 1.13 109.901 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -86.4 -32.12 21.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.464 -0.789 . . . . 4.38 110.027 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.95 166.49 22.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.085 -0.962 . . . . 1.62 111.959 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.99 -177.8 36.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.548 -0.751 . . . . 1.16 111.433 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.05 130.76 46.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.838 0.352 . . . . 3.56 110.743 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.6 33.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.808 -0.71 . . . . 2.23 112.919 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.84 160.48 66.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.37 -0.604 . . . . 2.59 109.37 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -53.06 123.02 12.18 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.476 2.117 . . . . 1.5 111.46 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -68.65 112.74 5.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 3.4 111.413 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -116.42 121.42 41.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.05 -0.977 . . . . 2.47 109.268 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -67.54 148.42 51.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 2.6 111.06 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 57.0 tpp -76.68 97.38 4.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.233 -0.894 . . . . 1.94 109.202 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.16 135.12 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.955 0.354 . . . . 1.67 111.955 -171.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.547 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 38.9 t70 70.59 -59.98 0.51 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.242 1.017 . . . . 2.18 111.037 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 84.24 -28.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.976 -1.011 . . . . 2.64 113.023 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -165.04 152.66 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.264 0.484 . . . . 5.31 112.07 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -139.72 71.99 36.19 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.408 -0.815 . . . . 6.91 109.565 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -120.25 57.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 123.498 2.798 . . . . 3.72 115.378 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -115.26 122.31 45.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.634 1.106 . . . . 3.34 110.827 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.405 ' HB2' ' HG2' ' A' ' 253' ' ' ARG . 16.5 mm-40 -122.91 162.7 37.56 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 111.697 0.258 . . . . 4.92 111.697 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.24 174.02 11.38 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.976 2.451 . . . . 4.01 113.512 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 252' ' ' ASN . 3.3 mm? -60.68 -11.01 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.591 -1.186 . . . . 4.9 113.451 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 252' ' ' ASN . 19.6 ptpt -59.44 41.25 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.611 1.338 . . . . 5.68 114.611 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 250' ' ' LEU . 6.3 t-20 118.48 -33.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.539 1.935 . . . . 5.11 110.069 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.554 ' N ' ' HD3' ' A' ' 253' ' ' ARG . 0.5 OUTLIER -90.69 89.6 7.59 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.586 0.708 . . . . 6.74 110.107 -177.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -155.39 154.1 31.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.92 -1.141 . . . . 3.08 107.92 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.474 HG21 ' O ' ' A' ' 256' ' ' LYS . 14.9 mt -124.84 136.82 59.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.602 -0.439 . . . . 3.06 110.766 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.474 ' O ' HG21 ' A' ' 255' ' ' ILE . 40.5 mtmt -76.99 165.53 24.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 3.01 109.472 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.761 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.48 159.01 27.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.532 -0.544 . . . . 1.99 109.532 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 41.8 m -151.91 97.64 2.36 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.884 -0.413 . . . . 2.47 109.884 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.38 110.46 10.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.651 -0.704 . . . . 5.03 109.249 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.438 -0.792 . . . . 4.82 110.165 178.759 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 108.212 -1.033 . . . . 3.14 108.212 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 61.3 mt -90.57 102.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 2.71 111.794 -167.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.08 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 2.82 109.944 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -60.1 -32.55 71.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.367 0.877 . . . . 2.71 113.367 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -68.85 -45.14 71.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.73 0.3 . . . . 5.23 111.083 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -82.09 -19.65 39.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.365 -0.38 . . . . 3.38 111.004 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.3 134.74 50.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.989 0.423 . . . . 1.76 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.76 116.31 28.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 4.05 110.401 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.51 124.4 26.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 4.9 109.82 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 258' ' ' SER . 29.9 t70 -118.9 143.37 33.6 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.128 -0.942 . . . . 2.27 110.137 -170.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' A' ' 44' ' ' LEU . 21.1 Cg_exo -67.36 119.13 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.157 1.905 . . . . 2.45 111.815 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 m -53.38 43.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.025 1.12 . . . . 4.62 114.025 169.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 45' ' ' LYS . 2.0 pt? -14.32 -66.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.304 1.842 . . . . 5.15 114.044 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' H ' ' HG ' ' A' ' 44' ' ' LEU . 27.5 mmtp -117.16 148.6 42.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 121.717 -0.615 . . . . 4.21 109.807 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.23 137.66 31.68 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.747 2.298 . . . . 2.76 112.696 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 190' ' ' TYR . 95.1 mt -66.61 127.41 32.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 2.93 111.06 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 22.7 t -84.12 115.16 22.25 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.652 -0.87 . . . . 2.46 108.652 174.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.9 107.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.521 . . . . 2.17 110.092 -173.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.5 t -133.63 91.74 2.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.142 0.496 . . . . 1.87 110.834 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.796 ' HH ' ' NE2' ' A' ' 122' ' ' HIS . 65.5 m-85 -108.98 0.53 20.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.795 -0.639 . . . . 3.97 110.192 172.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.474 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . 4.1 m-20 -69.29 -30.88 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 2.48 111.816 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.474 ' NE2' ' HB2' ' A' ' 52' ' ' ASP . 1.0 OUTLIER -98.67 -2.58 37.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.716 -0.394 . . . . 2.54 110.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.13 130.15 40.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.054 -0.521 . . . . 1.41 111.785 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -106.33 106.88 17.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 1.41 110.975 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.47 143.0 44.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.277 -0.419 . . . . 1.84 110.109 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.4 mt -114.71 -57.26 2.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.825 0.345 . . . . 1.45 111.85 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -155.41 159.28 39.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 3.72 111.052 -170.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 66' ' ' PHE . 13.2 tt -126.1 137.11 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.2 -0.667 . . . . 1.35 109.2 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.426 HD13 ' OG ' ' A' ' 172' ' ' SER . 27.3 tp -140.87 110.83 6.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.827 0.346 . . . . 1.53 111.809 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 66' ' ' PHE . 40.8 t30 -75.73 117.74 17.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.898 -0.778 . . . . 1.49 108.898 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -140.3 69.39 1.35 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.244 -0.583 . . . . 2.18 111.301 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.52 -67.3 0.51 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.497 -0.859 . . . . 2.0 112.798 165.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 243' ' ' ASN . 49.8 t60 -101.11 -29.53 12.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 4.11 111.1 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.79 -171.75 1.68 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.942 -0.572 . . . . 1.78 109.757 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 30.9 p90 -118.16 123.17 44.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 3.48 109.712 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -94.43 114.96 27.07 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.539 -0.755 . . . . 1.99 110.364 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 59.8 t -90.6 105.88 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 1.75 109.597 173.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.9 137.77 32.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.994 0.426 . . . . 2.02 111.472 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.99 170.07 8.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 2.19 110.681 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -97.45 101.43 12.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.831 -0.622 . . . . 1.33 109.345 174.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' OD1' ' HB3' ' A' ' 90' ' ' LEU . 16.0 m-20 -120.9 60.62 0.9 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.65 111.038 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.7 t -108.82 1.1 20.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.487 -0.779 . . . . 2.01 111.195 173.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.24 172.59 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.673 0.273 . . . . 2.35 111.03 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.41 65.7 5.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.891 -0.595 . . . . 1.92 110.989 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -130.77 1.92 4.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.532 . . . . 2.31 110.587 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.01 84.49 1.15 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.272 -0.64 . . . . 1.44 109.272 -168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.54 149.17 22.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.375 0.607 . . . . 1.82 112.539 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 48' ' ' SER . 40.0 tp -148.56 112.36 5.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.864 -1.062 . . . . 1.8 108.826 170.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HD3' ' OG1' ' A' ' 87' ' ' THR . 45.3 pttt -150.13 141.0 22.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.483 0.549 . . . . 3.02 112.483 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -57.68 172.68 2.87 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 115.628 -0.715 . . . . 1.44 111.928 156.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.94 -143.99 0.0 OUTLIER Glycine 0 CA--C 1.54 1.649 0 N-CA-C 117.793 1.877 . . . . 2.15 117.793 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.17 124.36 7.48 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.185 2.59 . . . . 3.17 114.174 -163.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 12.3 tp -142.13 -168.15 2.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.748 -1.569 . . . . 4.55 107.142 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.49 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 p-10 -148.82 89.08 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.13 0.877 . . . . 4.95 109.181 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 99.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.589 -0.815 . . . . 2.25 111.098 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.45 ' OG1' ' HD3' ' A' ' 80' ' ' LYS . 46.2 m -104.61 103.2 12.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.62 0.724 . . . . 2.12 112.494 -172.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.0 m-85 -126.34 98.26 5.37 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.203 -1.036 . . . . 3.88 108.203 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 27.5 mmt180 -141.69 89.03 2.17 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 112.192 0.441 . . . . 3.87 112.192 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 40.6 tp -156.82 158.89 37.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.745 -1.576 . . . . 1.68 106.745 160.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.504 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 6.1 tp -161.88 -46.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.816 1.189 . . . . 2.16 112.287 169.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 8.6 pt20 -158.8 172.2 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 1.95 111.479 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -146.57 144.05 29.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.118 -0.697 . . . . 0.98 109.118 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.6 p-80 -142.32 159.89 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.267 -0.424 . . . . 1.07 110.48 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 118' ' ' LEU . 81.3 m-85 -117.73 168.11 10.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 3.99 110.646 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.416 ' CE1' ' HE2' ' A' ' 64' ' ' HIS . 17.1 m-70 -122.91 170.99 9.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.085 -0.709 . . . . 2.2 109.085 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -156.24 129.37 8.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.868 0.366 . . . . 6.08 110.131 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 103' ' ' GLN . . . -89.59 -50.86 3.03 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.769 -0.65 . . . . 2.19 113.14 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 26.3 t 149.06 -50.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.348 1.059 . . . . 3.08 108.74 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.69 160.88 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 3.48 109.398 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 115' ' ' ALA . 35.0 t70 -71.71 67.16 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.423 0.63 . . . . 3.85 110.607 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.46 42.91 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.701 -0.761 . . . . 2.37 112.941 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.642 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 12.9 pt20 -172.27 143.03 1.41 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.018 0.409 . . . . 2.62 110.423 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.21 81.84 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 120.786 -0.721 . . . . 1.62 112.35 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 41.6 t -89.14 -8.34 53.93 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.12 0.415 . . . . 2.24 112.12 -177.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.564 ' HA ' ' NE1' ' A' ' 244' ' ' TRP . 7.7 tp10 72.3 157.46 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.287 0.367 . . . . 3.72 110.471 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.702 ' CD2' ' HH ' ' A' ' 193' ' ' TYR . 29.6 m170 54.61 67.31 1.03 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.074 0.464 . . . . 4.03 111.863 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -80.21 127.25 32.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.892 0.853 . . . . 2.99 111.016 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 38.1 t -103.29 105.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.58 -1.191 . . . . 2.88 110.157 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.03 45.43 21.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 2.8 110.293 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 64.27 14.29 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.685 -1.143 . . . . 5.35 112.077 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -89.03 126.16 35.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.69 -0.485 . . . . 3.58 109.69 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.61 155.08 21.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.046 -0.724 . . . . 3.26 109.046 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -109.51 -170.24 1.62 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.344 -0.389 . . . . 1.71 110.287 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -46.6 18.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.374 . . . . 1.57 110.916 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.09 163.95 38.42 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.945 -0.571 . . . . 1.3 110.448 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -129.11 145.56 51.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 1.85 110.046 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.585 HD11 ' CZ ' ' A' ' 95' ' ' PHE . 24.6 tp -111.73 112.2 23.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.246 -0.434 . . . . 1.61 109.861 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.422 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 46.9 m170 -110.93 105.27 14.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.15 -0.477 . . . . 2.25 111.335 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.01 110.77 22.03 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.053 -0.721 . . . . 1.51 109.053 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.5 t -86.9 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.047 0.451 . . . . 1.24 110.195 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.796 ' NE2' ' HH ' ' A' ' 51' ' ' TYR . 38.6 m80 -131.22 125.31 32.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.905 -0.588 . . . . 2.86 109.838 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.504 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -111.02 151.53 27.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.052 -0.721 . . . . 4.96 109.052 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.579 ' ND2' ' HA ' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -93.2 101.53 13.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.787 0.803 . . . . 2.3 111.244 178.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -64.49 -10.02 22.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.39 -0.823 . . . . 2.77 112.813 -173.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -69.65 -47.94 61.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.842 0.353 . . . . 3.79 110.468 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -84.4 -21.11 30.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.375 0.607 . . . . 3.34 110.493 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.46 -2.28 64.97 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.813 -1.315 . . . . 2.37 109.813 -171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.579 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 12.0 t70 73.3 -87.0 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.0 -1.1 . . . . 3.93 112.957 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -46.38 -40.12 11.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.069 0.766 . . . . 3.6 113.069 -168.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.454 ' O ' HG21 ' A' ' 134' ' ' VAL . . . -55.22 -61.12 7.73 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.022 -0.609 . . . . 2.35 112.324 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -73.69 -28.19 61.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.742 0.275 . . . . 3.75 111.742 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.63 62.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.473 0.546 . . . . 2.17 112.473 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 131' ' ' GLY . 34.4 m -64.92 -31.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.857 -0.337 . . . . 3.11 111.157 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -100.66 -28.3 12.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 3.55 110.855 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 8.9 tt0 -76.05 119.85 79.03 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 3.02 110.848 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.95 -17.1 54.96 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 1.93 111.365 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.458 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 m-20 -105.31 27.07 8.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.159 -0.928 . . . . 2.29 109.418 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.09 -82.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.382 0 CA-C-N 116.115 -0.493 . . . . 1.5 112.554 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.43 148.9 25.35 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.21 0.529 . . . . 1.98 110.661 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.46 104.51 7.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.486 -0.779 . . . . 1.83 109.177 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.59 129.29 60.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.314 -0.403 . . . . 2.28 111.28 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 34.4 tp -97.47 127.27 43.3 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.173 -0.677 . . . . 2.89 109.173 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -111.23 131.18 10.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.783 -0.722 . . . . 0.95 112.736 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.4 mt -137.69 106.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 1.38 109.508 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -62.93 156.43 24.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.936 0.398 . . . . 1.37 111.889 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.75 123.2 49.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 1.48 110.097 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.3 ptmm? -115.64 138.39 51.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.817 -0.629 . . . . 2.52 109.823 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 47.8 t -88.1 133.97 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.711 0.291 . . . . 1.88 110.991 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.614 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . 126.64 58.63 0.14 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.847 -0.692 . . . . 1.53 113.361 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 3.2 t 160.26 122.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.26 -1.015 . . . . 2.08 108.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.31 134.64 39.68 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.941 -0.304 . . . . 1.36 110.271 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -114.91 95.85 42.85 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.303 -0.408 . . . . 1.78 110.462 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.84 -39.25 92.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.152 2.568 . . . . 1.34 112.341 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.459 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -66.66 -21.05 70.67 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.926 -0.654 . . . . 0.75 112.82 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 160' ' ' VAL . 60.7 tp -91.88 -31.27 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 1.39 110.412 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.454 ' NE2' ' HG2' ' A' ' 221' ' ' GLN . 8.7 tp-100 -53.37 -40.98 65.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 1.63 112.27 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.5 pttt -55.41 -37.45 67.65 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.642 0.608 . . . . 3.26 112.642 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.453 ' O ' HG11 ' A' ' 162' ' ' VAL . 12.0 p -85.16 -32.64 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.434 -0.507 . . . . 1.97 110.959 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 44.1 t -64.96 -38.97 84.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 1.64 110.909 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.97 -35.3 79.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.78 -0.646 . . . . 1.22 111.429 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.466 HG12 ' CE2' ' A' ' 175' ' ' PHE . 8.3 p -88.04 -17.35 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.777 0.288 . . . . 2.07 111.777 -172.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.1 pp -74.42 -15.23 60.92 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.31 -0.556 . . . . 1.95 110.512 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.43 -24.62 64.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 2.31 110.434 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.2 m -84.47 1.85 43.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 1.78 111.359 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.4 pt -138.56 38.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.973 -0.751 . . . . 1.42 108.973 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -53.14 -41.54 65.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.837 -1.074 . . . . 1.98 111.947 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.6 p -102.69 149.83 24.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.426 -0.352 . . . . 1.4 110.434 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.16 137.4 57.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 2.84 110.31 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.64 -24.55 17.07 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.556 -0.831 . . . . 0.85 111.664 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.09 132.33 37.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.138 0.494 . . . . 2.22 110.734 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.426 ' OG ' HD13 ' A' ' 60' ' ' LEU . 4.0 m -117.71 154.11 32.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.845 -0.798 . . . . 1.93 108.845 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -145.21 137.5 25.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.869 -0.419 . . . . 1.17 109.869 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.88 131.99 47.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.543 -0.539 . . . . 1.8 109.543 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 162' ' ' VAL . 20.2 t80 -138.46 78.1 1.66 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.178 -1.045 . . . . 1.31 108.178 -176.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 13.0 m -97.45 139.81 32.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.508 -0.769 . . . . 1.69 112.817 -173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 24.7 m120 42.61 73.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.834 -1.075 . . . . 2.26 113.516 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.27 101.4 7.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.723 -0.671 . . . . 4.84 109.575 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -55.88 119.42 25.93 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 2.51 111.895 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.65 -5.46 17.11 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.682 2.254 . . . . 1.47 111.165 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.436 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 57.1 ttp180 -57.76 -37.17 73.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 3.16 111.272 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.15 -24.11 60.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.257 -0.497 . . . . 1.12 112.969 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.8 mt -81.12 -24.3 37.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.835 0.35 . . . . 2.37 111.01 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.37 128.37 92.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 3.87 111.089 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.48 -170.16 0.77 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.992 2.462 . . . . 2.51 113.375 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -75.5 -64.16 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.18 0.437 . . . . 3.23 112.18 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.548 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 3.5 m -80.26 134.32 36.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 2.03 111.17 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 95.0 mt -108.3 64.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.197 0.522 . . . . 2.5 110.96 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.46 ' HB2' ' HE3' ' A' ' 212' ' ' LYS . 55.9 m-20 -123.74 144.16 49.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.723 -1.214 . . . . 1.81 107.723 173.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.448 ' CD2' HD13 ' A' ' 47' ' ' LEU . 30.4 p90 -133.39 144.94 49.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.979 1.103 . . . . 5.32 113.979 -163.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 17.5 m95 -90.24 131.6 35.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.45 -1.25 . . . . 4.55 107.675 168.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.9 t -128.05 118.13 22.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.436 0.636 . . . . 2.39 111.737 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.702 ' HH ' ' CD2' ' A' ' 107' ' ' HIS . 20.0 p90 -139.75 153.84 70.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 5.32 110.678 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -72.39 136.43 26.34 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.813 2.342 . . . . 2.47 110.937 172.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.726 ' HA3' ' CD1' ' A' ' 208' ' ' TRP . . . -137.99 158.78 24.86 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.364 -0.922 . . . . 2.0 113.062 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.12 0.486 . . . . 3.36 111.005 -177.887 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 134' ' ' VAL . 56.9 tp . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.835 0.35 . . . . 3.51 110.847 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -92.24 77.72 5.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.559 . . . . 3.37 111.186 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 85.2 m -147.81 43.29 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 2.47 110.349 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.25 146.07 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 1.74 110.956 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 48.9 m -114.28 121.45 43.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.302 -0.629 . . . . 2.3 109.302 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.726 ' CD1' ' HA3' ' A' ' 195' ' ' GLY . 36.9 m95 -106.4 130.13 54.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 6.37 110.977 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 49.1 mm -121.71 116.06 48.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.85 . . . . 2.32 109.54 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 98.0 t -111.29 133.88 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.302 -0.259 . . . . 2.1 110.302 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.37 143.93 27.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.234 0.54 . . . . 2.35 110.751 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 189' ' ' ASP . 26.8 ttmt -53.24 -23.02 7.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.945 -1.025 . . . . 3.47 112.231 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.548 ' HG3' ' H ' ' A' ' 187' ' ' SER . 68.7 mm-40 -110.55 121.03 42.38 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.424 -0.353 . . . . 1.56 111.068 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -84.02 171.62 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.61 2.207 . . . . 1.37 111.246 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 31.0 pt -111.48 147.25 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.964 0.411 . . . . 1.85 109.963 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 23.0 p -100.17 146.42 26.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.334 0.588 . . . . 1.78 111.234 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -140.66 146.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.208 -0.905 . . . . 1.64 109.418 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 222' ' ' VAL . 59.5 m -101.86 168.22 9.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.887 -0.325 . . . . 1.52 111.372 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.544 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 49.1 m -48.49 -51.0 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.092 0.775 . . . . 1.81 113.092 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.7 -48.06 82.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.698 0.285 . . . . 2.51 111.275 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.454 ' HG2' ' NE2' ' A' ' 157' ' ' GLN . 18.1 mt-30 -59.3 -44.63 92.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.764 -0.458 . . . . 1.02 109.764 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 226' ' ' ARG . 95.9 t -60.51 -40.69 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.721 -0.672 . . . . 1.88 110.874 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.6 mt -60.43 -37.03 79.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 1.59 111.027 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -66.62 -33.86 76.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.472 -0.331 . . . . 2.3 110.887 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -67.46 -30.8 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.328 0.585 . . . . 3.18 109.751 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 222' ' ' VAL . 23.6 mtp180 -79.14 -3.93 47.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.487 -0.779 . . . . 3.55 111.294 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 47.3 mmtm -87.82 -19.49 27.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.104 -0.332 . . . . 2.74 110.104 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.25 139.82 57.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.921 -0.581 . . . . 1.66 111.434 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.419 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.93 149.32 38.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 1.13 110.315 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -79.57 -31.77 41.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 4.38 109.749 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 4.5 p-10 -73.95 165.16 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.129 -0.941 . . . . 1.62 112.397 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.77 171.23 42.89 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.506 -1.225 . . . . 1.16 110.834 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.01 141.58 57.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.216 0.508 . . . . 3.56 110.688 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.76 3.88 73.47 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.701 -0.761 . . . . 2.23 111.908 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -114.01 157.67 41.42 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.369 -0.234 . . . . 2.59 110.369 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 127.62 26.81 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.89 2.394 . . . . 1.5 111.785 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.42 116.93 5.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 3.4 111.547 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -121.68 119.75 32.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.577 -0.738 . . . . 2.47 109.127 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 226' ' ' ARG . 83.9 mt -67.1 149.5 50.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 2.6 111.861 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 55.7 tpp -75.36 103.76 5.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.084 -0.962 . . . . 1.94 108.903 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.23 139.16 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 1.67 112.121 -171.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.83 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.648 -1.16 . . . . 2.18 111.31 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . 0.503 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 33.1 m-80 55.76 31.37 17.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.044 0.537 . . . . 2.64 111.945 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.564 ' NE1' ' HA ' ' A' ' 106' ' ' GLU . 30.6 t90 -134.17 144.53 48.56 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.199 -0.313 . . . . 5.31 110.414 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.568 ' O ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -111.12 149.05 39.93 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.424 -0.213 . . . . 6.91 110.424 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.73 132.91 3.95 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 124.33 3.353 . . . . 3.72 114.246 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.38 151.0 46.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.223 -0.899 . . . . 3.34 110.926 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -123.81 150.09 61.24 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 4.92 110.466 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.37 175.26 10.29 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.598 2.865 . . . . 4.01 115.261 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 82.7 mt -63.53 -8.81 10.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.368 -1.742 . . . . 4.9 113.432 -173.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 252' ' ' ASN . 16.9 ttmm -58.17 44.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.467 1.284 . . . . 5.68 114.467 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.483 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 7.5 t-20 119.21 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 127.017 2.127 . . . . 5.11 109.52 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 42.8 mmt-85 -126.2 84.87 2.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.413 -0.958 . . . . 6.74 108.413 168.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -115.9 142.4 46.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 3.08 110.012 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.76 122.99 57.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 3.06 111.064 -174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 1.0 OUTLIER -97.86 145.13 26.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.523 -0.917 . . . . 3.01 108.523 167.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -123.64 93.01 3.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.512 -0.551 . . . . 1.99 109.512 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 54.1 m -80.18 97.41 6.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.628 0.728 . . . . 2.47 110.924 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -135.12 103.72 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.375 -1.284 . . . . 5.03 109.253 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 C--O 1.248 1.01 0 CA-C-N 116.154 -0.476 . . . . 4.82 110.67 178.49 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 113.776 1.028 . . . . 3.14 113.776 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.764 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 58.8 mt -98.97 139.66 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.372 -1.285 . . . . 2.71 110.981 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' H ' ' CD1' ' A' ' 255' ' ' ILE . 24.3 t70 -112.14 118.31 34.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.833 -0.432 . . . . 2.82 109.833 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -43.79 73.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.397 -0.82 . . . . 2.71 113.138 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.77 -42.1 91.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 5.23 110.792 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 255' ' ' ILE . 22.9 m -72.67 -28.11 62.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.019 -0.537 . . . . 3.38 110.904 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 255' ' ' ILE . . . -75.22 93.59 2.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.264 0.554 . . . . 1.76 110.95 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.94 142.19 28.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.475 -0.784 . . . . 4.05 110.665 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.5 m-85 -58.07 122.48 13.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.472 -0.785 . . . . 4.9 110.975 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.63 133.96 27.26 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.764 . . . . 2.27 109.857 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.15 59.75 3.06 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.971 2.447 . . . . 2.45 112.497 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.9 t -69.72 -53.59 17.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 4.62 110.121 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp 72.04 -54.66 0.68 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.31 -0.859 . . . . 5.15 111.733 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 43.7 mmtm -75.62 132.64 74.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 4.21 110.371 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.29 167.02 26.6 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.641 2.227 . . . . 2.76 112.273 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.406 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 61.3 tp -93.54 116.9 29.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.942 -0.572 . . . . 2.93 109.842 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 32.1 t -86.87 121.65 29.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.427 -0.583 . . . . 2.46 109.427 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.75 134.82 57.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.973 0.416 . . . . 2.17 110.716 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 28.4 t -128.54 91.03 3.16 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.309 0.576 . . . . 1.87 109.652 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.85 9.02 32.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 3.97 109.647 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -55.49 -39.1 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.404 -0.816 . . . . 2.48 111.201 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.2 mp0 -99.44 15.59 25.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 2.54 111.238 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 121.72 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 1.41 111.374 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -114.37 106.98 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.12 -0.491 . . . . 1.41 110.519 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.0 m -76.14 146.68 39.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.354 -0.61 . . . . 1.84 109.354 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.28 -56.69 1.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 1.45 111.925 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.45 155.8 32.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.724 0.297 . . . . 3.72 111.282 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -122.02 138.5 52.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.116 -0.493 . . . . 1.35 109.906 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 172' ' ' SER . 38.2 tp -134.63 138.48 44.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.013 0.435 . . . . 1.53 111.905 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.05 114.49 26.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.267 -0.879 . . . . 1.49 109.13 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -115.26 70.15 0.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 2.18 110.308 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.2 -59.04 0.16 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.164 -1.38 . . . . 2.0 115.531 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -110.91 -17.02 13.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.842 0.353 . . . . 4.11 111.089 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.38 174.66 14.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.981 -0.748 . . . . 1.78 108.981 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -138.4 135.47 35.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.637 -0.505 . . . . 3.48 109.637 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 94' ' ' HIS . 15.5 m120 -126.58 152.39 46.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.214 -0.448 . . . . 1.99 110.508 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.49 129.07 67.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.079 -0.51 . . . . 1.75 109.751 174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.79 131.63 34.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.081 -0.509 . . . . 2.02 111.433 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.84 153.21 21.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.634 -0.712 . . . . 2.19 109.674 172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 33.0 t70 -72.15 92.65 1.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.084 -0.507 . . . . 1.33 110.137 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -108.4 56.47 0.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.657 0.742 . . . . 2.65 111.206 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -103.16 -3.39 25.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.749 -0.66 . . . . 2.01 111.317 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.466 ' CG ' ' HE3' ' A' ' 76' ' ' LYS . 9.5 pt20 -148.66 165.0 32.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.215 -0.448 . . . . 2.35 110.122 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -81.1 73.28 8.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.189 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HD2' ' O ' ' A' ' 71' ' ' ASP . 15.2 ptpt -102.39 -41.18 6.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.591 -0.731 . . . . 2.31 110.998 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -113.2 96.9 6.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.676 -0.49 . . . . 1.44 109.676 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 95.3 t -124.16 150.91 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.768 -0.651 . . . . 1.82 110.856 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 79' ' ' LEU . 2.5 pt? -149.19 115.74 5.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.772 0.32 . . . . 1.8 110.523 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -139.04 125.09 19.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 3.02 110.62 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 85' ' ' ASP . . . -133.95 -178.19 15.44 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.521 -1.432 . . . . 1.44 109.521 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -26.51 -127.93 0.0 OUTLIER Glycine 0 N--CA 1.486 2.024 0 C-N-CA 125.089 1.328 . . . . 2.15 115.991 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.66 170.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.075 2.517 . . . . 3.17 112.99 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.7 pt? -31.9 114.14 0.14 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.389 1.255 . . . . 4.55 114.389 -144.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 9.8 p-10 -128.27 -128.09 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 113.424 -1.717 . . . . 4.95 112.284 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 106.05 161.3 22.73 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.193 -1.163 . . . . 2.25 110.193 -166.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.552 ' O ' HG23 ' A' ' 125' ' ' THR . 20.1 m -73.66 102.99 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.987 0.893 . . . . 2.12 110.715 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 68.2 m-85 -100.78 133.5 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 3.88 110.544 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HD2' ' CZ2' ' A' ' 123' ' ' TRP . 99.7 mtt180 -102.49 142.78 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.225 -0.443 . . . . 3.87 110.42 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.3 tp -77.64 125.15 28.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.618 -0.512 . . . . 1.68 109.618 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.52 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.4 tt -111.73 -40.72 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.834 0.35 . . . . 2.16 110.886 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -165.15 169.36 16.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.714 -0.476 . . . . 1.95 109.714 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HB3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 p90 -143.81 158.23 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.356 -0.238 . . . . 0.98 110.356 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.536 ' HB3' ' ND2' ' A' ' 67' ' ' ASN . 5.4 p-80 -132.34 158.91 40.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.616 -0.513 . . . . 1.07 109.616 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.82 149.93 28.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 3.99 110.375 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.469 ' ND1' ' HB3' ' A' ' 117' ' ' GLU . 13.4 m170 -100.48 153.05 19.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.504 -0.924 . . . . 2.2 108.504 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.418 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 75.0 t-105 -161.73 125.61 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.023 -0.362 . . . . 6.08 110.023 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -87.42 -171.51 47.27 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 111.319 -0.712 . . . . 2.19 111.319 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.429 ' HA ' ' HB ' ' A' ' 241' ' ' VAL . 11.2 t -78.52 -46.94 18.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.736 0.768 . . . . 3.08 109.995 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 102' ' ' GLY . 92.6 mt -83.95 146.61 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.429 . . . . 3.48 110.135 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.21 32.59 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.765 0.654 . . . . 3.85 112.765 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 100' ' ' LEU . . . -155.4 21.93 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.921 -0.656 . . . . 2.37 112.344 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -150.46 169.58 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.211 -0.292 . . . . 2.62 110.211 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.412 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 86.95 17.41 59.58 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.668 -0.777 . . . . 1.62 113.111 169.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 77.8 p -80.58 -8.86 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.963 0.382 . . . . 2.24 111.701 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 66.48 164.68 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.101 -0.703 . . . . 3.72 109.101 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.408 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 29.4 m80 58.11 46.73 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 4.03 110.704 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.5 m -78.4 117.71 19.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 2.99 110.097 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 46.2 t -84.22 99.67 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 114.549 -1.205 . . . . 2.88 110.887 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 69.58 -72.27 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.709 0.631 . . . . 2.8 110.599 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -146.06 5.56 0.99 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.814 -0.439 . . . . 5.35 109.814 173.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.06 97.15 11.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.973 -0.558 . . . . 3.58 110.085 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -110.89 145.22 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 3.26 109.512 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -105.06 179.03 4.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.303 -0.408 . . . . 1.71 110.203 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.02 53.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.026 0.441 . . . . 1.57 110.668 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.35 23.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.795 -0.639 . . . . 1.3 110.049 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 31.0 tt0 -147.73 146.38 29.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.97 -0.559 . . . . 1.85 110.255 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -99.45 107.3 19.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.548 -0.751 . . . . 1.61 109.604 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -109.52 102.41 11.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.11 0.481 . . . . 2.25 110.176 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 93' ' ' PHE . 5.0 mp -87.49 128.1 35.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.74 -0.664 . . . . 1.51 111.158 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.428 ' HA ' HG13 ' A' ' 142' ' ' VAL . 45.2 t -96.45 127.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.965 -0.561 . . . . 1.24 110.393 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 20.9 m80 -126.77 138.11 53.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.608 -0.516 . . . . 2.86 109.608 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.581 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 44.9 p-90 -112.52 144.78 41.43 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.545 0.528 . . . . 4.96 110.592 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.667 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 41.8 t-20 -75.38 109.89 9.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 2.3 110.752 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.581 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 8.9 t -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.068 0.766 . . . . 2.77 113.068 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.667 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 21.3 ptmt -71.3 -7.68 48.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.166 0.432 . . . . 3.79 112.166 -172.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.09 -17.59 6.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.349 0.595 . . . . 3.34 110.459 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.45 -4.95 85.64 Favored Glycine 0 C--N 1.325 -0.042 0 N-CA-C 109.734 -1.347 . . . . 2.37 109.734 -167.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 123' ' ' TRP . 13.1 t70 71.55 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.193 -1.504 . . . . 3.93 112.224 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 134' ' ' VAL . 95.7 m-85 -45.27 -31.4 1.53 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.256 1.206 . . . . 3.6 114.256 -168.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.53 -65.03 2.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.344 -0.932 . . . . 2.35 111.803 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -72.23 -30.78 65.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.979 0.363 . . . . 3.75 111.979 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -26.34 49.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.141 0.422 . . . . 2.17 112.141 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 130' ' ' PHE . 59.7 t -60.66 -34.75 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 3.11 110.71 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -119.9 18.77 12.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.479 -0.328 . . . . 3.55 111.466 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -132.16 113.83 14.79 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.755 -0.461 . . . . 3.02 109.755 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.506 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 38.0 Cg_exo -60.69 -14.63 32.54 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.023 2.482 . . . . 1.93 113.785 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.77 27.15 9.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.303 . . . . 2.29 110.552 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.443 ' O ' ' HE1' ' A' ' 88' ' ' TYR . . . -66.61 -86.84 0.07 OUTLIER Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.947 -0.57 . . . . 1.5 114.211 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.76 161.21 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.562 0.696 . . . . 1.98 112.708 -168.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.43 110.58 5.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.939 . . . . 1.83 110.177 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.428 HG13 ' HA ' ' A' ' 121' ' ' VAL . 21.2 m -107.32 152.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.812 -0.44 . . . . 2.28 109.812 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 10.2 tt -131.92 125.25 31.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.315 -0.254 . . . . 2.89 110.315 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.86 131.9 10.22 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.843 -0.694 . . . . 0.95 113.025 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -119.57 122.87 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.208 -0.293 . . . . 1.38 110.208 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -68.38 146.95 52.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.466 -0.334 . . . . 1.37 111.628 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.417 HD21 ' HB ' ' A' ' 215' ' ' ILE . 80.2 mt -124.47 114.52 19.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 1.48 110.219 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -107.24 153.73 22.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.71 -0.478 . . . . 2.52 109.71 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 44.1 t -90.08 127.64 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.987 0.423 . . . . 1.88 110.848 -175.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.07 -105.12 0.19 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.217 -0.753 . . . . 1.53 111.217 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.0 m -76.23 146.58 38.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.04 -0.356 . . . . 2.08 110.04 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.485 ' CA ' ' HB2' ' A' ' 218' ' ' SER . . . -70.0 146.99 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 1.36 111.298 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 216' ' ' SER . 51.6 tptt -112.89 99.76 49.2 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.603 -0.726 . . . . 1.78 109.67 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 11.1 Cg_endo -55.55 -36.34 94.26 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.735 2.29 . . . . 1.34 111.919 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.12 -28.89 72.88 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.8 -0.636 . . . . 0.75 113.06 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.4 tp -93.82 -19.85 20.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.226 -0.573 . . . . 1.39 110.153 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -46.01 91.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.174 -0.466 . . . . 1.63 110.461 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.9 pttp -57.42 -40.7 78.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.677 0.621 . . . . 3.26 112.677 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.68 -36.01 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.263 -0.575 . . . . 1.97 110.73 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 75.8 t -64.03 -36.45 76.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.125 0.488 . . . . 1.64 110.757 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.39 -31.34 70.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.04 -0.527 . . . . 1.22 110.465 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 158' ' ' LYS . 73.0 t -83.55 -27.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 2.07 111.476 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.3 pp -70.77 -13.39 62.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.222 0.534 . . . . 1.95 110.31 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.42 -24.8 65.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.85 -0.613 . . . . 2.31 110.211 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.3 m -83.41 -1.64 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.31 . . . . 1.78 111.556 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 163' ' ' LEU . 47.2 pt -139.67 26.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 1.42 109.962 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 229' ' ' ASN . 48.9 pttt -74.89 16.15 0.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.038 -0.528 . . . . 1.98 112.334 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.76 140.23 46.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.902 0.382 . . . . 1.4 110.408 174.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.32 120.16 7.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 2.84 111.876 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.49 30.72 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.631 -0.795 . . . . 0.85 112.462 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -88.17 148.98 24.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.908 0.385 . . . . 2.22 110.687 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 11.6 p -145.57 157.28 44.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.874 -0.603 . . . . 1.93 110.158 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -147.61 149.43 32.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.67 0.271 . . . . 1.17 110.52 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.97 136.79 46.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.017 0.437 . . . . 1.8 110.268 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -140.55 79.91 1.73 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.797 -0.816 . . . . 1.31 108.797 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.3 p -109.44 159.86 16.68 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.275 0.472 . . . . 1.69 112.275 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.35 47.16 21.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.509 -0.769 . . . . 2.26 112.345 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.13 98.29 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.891 0.377 . . . . 4.84 110.186 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.08 136.25 82.19 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.884 -0.598 . . . . 2.51 111.136 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.03 -4.27 13.18 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.123 2.549 . . . . 1.47 112.226 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -55.07 -42.68 73.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.872 -0.604 . . . . 3.16 112.136 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -58.97 -13.55 19.87 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 116.176 -0.465 . . . . 1.12 113.675 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.21 -7.65 44.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.852 0.326 . . . . 2.37 111.168 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.62 128.78 68.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 3.87 110.595 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.07 -178.39 4.15 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.827 2.351 . . . . 2.51 112.527 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.81 -63.21 1.46 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.561 0.219 . . . . 3.23 110.749 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.0 m -70.41 130.42 41.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 2.03 110.712 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.04 62.55 0.6 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.255 0.55 . . . . 2.5 110.107 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -94.21 128.28 40.56 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.329 -0.989 . . . . 1.81 108.329 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 52.6 p90 -139.66 147.45 41.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.067 0.766 . . . . 5.32 113.067 -169.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 28.6 m-90 -86.76 135.84 33.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.286 -0.87 . . . . 4.55 108.928 169.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 192' ' ' THR . 7.1 t -119.69 103.26 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.641 0.734 . . . . 2.39 110.346 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.473 ' HB3' ' CE2' ' A' ' 208' ' ' TRP . 4.6 t80 -137.48 137.08 21.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.098 -0.501 . . . . 5.32 110.783 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -89.56 128.83 1.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.745 2.297 . . . . 2.47 112.279 173.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.09 157.65 25.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.276 -0.487 . . . . 2.0 112.696 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 1.7 m . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 109.395 -0.594 . . . . 3.36 109.395 174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 196' ' ' SER . 42.9 tp . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 121.29 0.567 . . . . 3.51 110.967 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.96 41.46 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 3.37 109.57 -174.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 137' ' ' PRO . 4.6 p -84.11 2.49 39.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 2.47 112.362 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.03 129.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 120.95 0.405 . . . . 1.74 109.943 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.3 m -107.76 100.83 10.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.715 -0.846 . . . . 2.3 108.715 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.473 ' CE2' ' HB3' ' A' ' 193' ' ' TYR . 4.4 p-90 -90.24 100.96 13.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.914 0.864 . . . . 6.37 111.72 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 51.3 mm -88.85 105.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.065 -1.425 . . . . 2.32 109.671 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.1 t -106.78 128.99 61.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.965 -0.294 . . . . 2.1 110.544 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -85.89 140.85 30.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.419 0.628 . . . . 2.35 111.448 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -83.86 -21.71 31.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.149 -0.932 . . . . 3.47 110.92 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -88.33 113.38 55.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.271 -0.422 . . . . 1.56 109.873 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.93 155.81 15.25 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.668 2.245 . . . . 1.37 113.11 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.417 ' HB ' HD21 ' A' ' 147' ' ' LEU . 26.8 mm -106.19 146.44 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.771 -0.649 . . . . 1.85 109.609 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 15.1 m -99.57 127.93 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.451 -0.34 . . . . 1.78 111.322 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.9 m -122.48 151.51 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.921 -0.77 . . . . 1.64 108.921 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' SER . . . . . 0.485 ' HB2' ' CA ' ' A' ' 152' ' ' ALA . 8.0 t -97.1 163.82 12.77 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.277 -0.569 . . . . 1.52 111.159 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.528 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 24.9 m -50.82 -50.62 56.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 1.81 111.886 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -50.98 -36.29 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.934 0.397 . . . . 2.51 111.573 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.95 -48.32 54.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.146 -0.479 . . . . 1.02 110.894 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.418 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 29.4 m -74.92 -22.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 1.88 111.277 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 219' ' ' SER . 94.7 mt -68.28 -45.2 73.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.032 -0.359 . . . . 1.59 110.032 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -67.8 -29.46 68.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 2.3 110.659 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.49 -42.49 82.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 3.18 110.041 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 67.0 ttt180 -73.93 10.88 1.01 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.72 -0.673 . . . . 3.55 111.011 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.46 -8.6 38.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.06 -0.348 . . . . 2.74 110.06 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.81 132.45 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.08 -0.509 . . . . 1.66 111.039 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 167' ' ' LYS . 0.9 OUTLIER -101.53 140.41 35.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.907 -0.588 . . . . 1.13 110.218 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -78.86 -34.94 44.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.781 -1.099 . . . . 4.38 109.668 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.6 p-10 -70.8 163.86 26.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.84 -1.073 . . . . 1.62 111.875 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.92 174.4 51.25 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.231 -0.895 . . . . 1.16 111.197 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.55 127.5 32.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.95 0.375 . . . . 3.56 110.062 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.22 -2.58 56.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.859 -0.686 . . . . 2.23 112.635 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 41.3 mt-10 -102.2 159.97 27.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.065 -0.346 . . . . 2.59 110.065 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.96 128.68 30.89 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.181 . . . . 1.5 111.519 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -59.38 125.63 24.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 3.4 112.734 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 44.8 mt-10 -130.57 150.24 51.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.091 -1.078 . . . . 2.47 108.091 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.7 mt -90.97 133.38 35.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.525 -0.47 . . . . 2.6 110.866 -175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 ttm -76.83 89.3 3.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.359 -0.978 . . . . 1.94 108.359 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 99' ' ' SER . 21.7 m -133.55 153.24 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 1.67 110.198 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.4 t70 67.36 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.004 0.815 . . . . 2.18 110.356 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 43.39 32.22 0.48 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.555 0.534 . . . . 2.64 111.743 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -104.5 136.66 43.65 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.082 0.468 . . . . 5.31 110.597 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.528 ' H ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -70.3 144.3 91.93 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.267 -0.879 . . . . 6.91 110.434 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.63 131.93 43.49 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.792 2.328 . . . . 3.72 111.965 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.99 132.37 49.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 3.34 111.584 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.474 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 66.8 mm-40 -85.17 172.79 8.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.854 -0.795 . . . . 4.92 108.854 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 73.4 Cg_exo -43.06 110.51 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.406 2.071 . . . . 4.01 112.03 174.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -58.42 4.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.443 -1.253 . . . . 4.9 113.586 -167.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -69.59 -7.0 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.624 0.972 . . . . 5.68 113.624 -173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 7.7 p30 36.33 54.27 1.03 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.718 1.007 . . . . 5.11 113.718 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 252' ' ' ASN . 13.4 mmt180 76.11 -89.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.391 -0.596 . . . . 6.74 109.391 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.47 136.52 21.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.975 -1.12 . . . . 3.08 107.975 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 38' ' ' ALA . 17.0 mt -94.24 150.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.691 0.281 . . . . 3.06 111.033 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -104.55 131.44 51.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 3.01 110.558 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.31 97.55 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.256 -0.429 . . . . 1.99 110.164 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.3 p -95.73 96.46 9.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.367 -0.533 . . . . 2.47 111.609 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 257' ' ' ALA . 24.8 p90 -166.71 154.4 9.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 5.03 110.047 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.491 ' HZ1' ' HB3' ' A' ' 260' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.997 -0.547 . . . . 4.82 110.605 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.464 ' CB ' ' HG2' ' A' ' 248' ' ' GLN . 32.2 t70 . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 109.109 -0.7 . . . . 3.14 109.109 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 54.2 mt -101.98 103.57 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.904 0.705 . . . . 2.71 112.904 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -93.69 102.14 14.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.053 -0.721 . . . . 2.82 109.053 165.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 m -56.99 -28.46 62.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 2.71 112.353 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -69.84 -34.27 73.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.563 0.221 . . . . 5.23 111.281 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -85.7 -23.29 27.46 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.955 -0.298 . . . . 3.38 111.126 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -61.54 105.28 0.51 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.283 0.563 . . . . 1.76 111.716 174.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.28 138.05 36.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.526 -0.761 . . . . 4.05 111.235 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 99.2 m-85 -73.93 132.41 42.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.529 . . . . 4.9 110.112 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -120.81 124.09 27.67 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.427 -0.351 . . . . 2.27 110.725 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.35 -23.22 44.72 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.767 2.312 . . . . 2.45 112.036 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 m -65.7 -27.81 68.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.524 . . . . 4.62 111.396 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.7 mt -70.52 119.26 14.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.028 0.442 . . . . 5.15 111.01 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 59.0 tttm -99.29 131.43 25.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.407 -0.815 . . . . 4.21 109.294 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.3 154.44 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.862 3.041 . . . . 2.76 114.034 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.64 125.21 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.066 -0.97 . . . . 2.93 110.729 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 m -96.87 98.42 10.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.239 -0.652 . . . . 2.46 109.239 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.414 HG23 ' HG ' ' A' ' 79' ' ' LEU . 8.9 t -102.9 127.98 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.912 -0.585 . . . . 2.17 110.649 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -129.58 91.4 3.15 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.82 -0.437 . . . . 1.87 109.82 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.517 ' HH ' ' HB2' ' A' ' 181' ' ' ARG . 7.8 p90 -106.35 11.63 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.864 0.364 . . . . 3.97 110.92 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 2.48 111.067 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 48.9 mt-30 -94.33 6.17 49.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.987 -0.552 . . . . 2.54 111.964 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.51 133.72 49.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 1.41 111.603 -172.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -113.38 106.24 14.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 1.41 110.467 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 m -72.34 138.05 47.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.162 -0.472 . . . . 1.84 109.832 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 71' ' ' ASP . 82.6 mt -113.74 -58.21 2.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 1.45 112.427 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -158.9 161.44 36.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.868 0.366 . . . . 3.72 111.448 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -121.17 133.2 68.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.651 -0.87 . . . . 1.35 108.651 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 57.9 tp -137.3 119.05 15.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.56 0.578 . . . . 1.53 112.56 -171.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -79.18 114.06 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.102 -1.073 . . . . 1.49 108.102 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.434 ' HA ' ' HG3' ' A' ' 169' ' ' LYS . 53.8 t30 -140.34 70.59 1.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.654 -0.819 . . . . 2.18 112.423 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 103.27 -67.01 0.33 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.137 -1.03 . . . . 2.0 113.132 162.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.477 ' HB3' ' OD1' ' A' ' 243' ' ' ASN . 51.7 m80 -103.82 -27.55 12.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.048 0.452 . . . . 4.11 110.895 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.96 -169.98 2.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.755 -0.657 . . . . 1.78 110.159 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 95' ' ' PHE . 34.8 p90 -133.8 134.03 42.37 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.271 -1.011 . . . . 3.48 108.271 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 8.3 p30 -132.71 151.87 51.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.055 0.455 . . . . 1.99 111.398 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 98.2 t -106.46 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 1.75 109.84 176.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.39 138.38 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.464 . . . . 2.02 111.417 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.82 150.69 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.339 -0.846 . . . . 2.19 109.135 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.429 ' HB2' HD21 ' A' ' 57' ' ' LEU . 22.4 t70 -75.2 124.44 27.06 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.009 -0.367 . . . . 1.33 110.009 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -125.81 58.31 1.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.08 0.943 . . . . 2.65 110.448 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 p -96.41 -5.25 40.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.51 -0.768 . . . . 2.01 109.75 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -143.17 157.69 44.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.834 -1.075 . . . . 2.35 108.813 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.58 70.25 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.549 0.69 . . . . 1.92 109.769 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 68.5 mttm -92.75 -54.64 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.287 -0.869 . . . . 2.31 111.538 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.5 110.42 21.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.282 -0.417 . . . . 1.44 110.283 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.75 144.24 34.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.392 -0.367 . . . . 1.82 110.613 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 49' ' ' VAL . 9.6 tt -149.9 113.04 4.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.707 -0.849 . . . . 1.8 108.707 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -151.43 127.44 10.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.156 0.503 . . . . 3.02 111.385 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -67.89 174.01 30.01 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.784 -0.644 . . . . 1.44 111.635 164.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 45' ' ' LYS . . . -39.2 -142.73 0.0 OUTLIER Glycine 0 N--CA 1.472 1.076 0 N-CA-C 115.813 1.085 . . . . 2.15 115.813 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.52 121.32 6.95 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 121.856 1.704 . . . . 3.17 112.37 -173.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.521 ' HB3' ' HH ' ' A' ' 88' ' ' TYR . 70.8 mt -147.81 -168.17 3.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.528 -1.214 . . . . 4.55 108.713 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.707 ' H ' ' HH ' ' A' ' 88' ' ' TYR . 7.1 m-20 -129.24 70.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.444 0.535 . . . . 4.95 112.444 -174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 131.19 -125.56 4.5 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.794 -1.193 . . . . 2.25 115.072 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.77 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 85.6 m -131.51 115.68 16.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.692 -0.754 . . . . 2.12 109.755 -169.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.707 ' HH ' ' H ' ' A' ' 85' ' ' ASP . 78.7 m-85 -115.01 91.36 3.59 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.037 -0.665 . . . . 3.88 111.739 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.29 142.49 34.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 3.87 110.109 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -73.77 121.86 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 1.68 110.331 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.455 HG22 ' HG2' ' A' ' 92' ' ' GLN . 5.2 tp -107.92 -38.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 2.16 111.088 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 8.7 pt20 -170.25 168.06 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.625 -0.262 . . . . 1.95 110.498 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 41.6 p90 -141.31 145.89 36.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.648 -0.501 . . . . 0.98 109.648 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.8 p-80 -128.9 159.81 34.63 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.329 0.393 . . . . 1.07 110.695 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 t80 -135.74 158.13 45.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.959 -0.386 . . . . 3.99 109.959 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -162.65 171.12 17.37 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.734 0.302 . . . . 2.2 111.713 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.506 ' CZ2' ' HB ' ' A' ' 222' ' ' VAL . 23.1 m95 -138.99 148.74 43.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.588 -0.733 . . . . 6.08 110.459 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' N ' ' HA3' ' A' ' 104' ' ' GLY . . . -79.18 -37.38 25.02 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 116.022 -0.535 . . . . 2.19 113.499 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.503 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 47.1 t 162.93 -70.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.57 0.748 . . . . 3.08 109.35 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.38 158.33 26.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.359 -0.837 . . . . 3.48 109.68 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.22 62.05 0.13 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.558 0.536 . . . . 3.85 111.463 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.23 32.31 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.649 -0.786 . . . . 2.37 113.029 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.503 ' NE2' ' HB3' ' A' ' 99' ' ' SER . 13.6 pt20 -161.29 157.21 25.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.898 0.349 . . . . 2.62 110.485 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.485 ' HA3' ' N ' ' A' ' 98' ' ' GLY . . . 99.11 45.92 2.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.867 -0.682 . . . . 1.62 112.482 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 45.2 t -103.88 -28.4 11.62 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.284 -0.166 . . . . 2.24 111.264 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 105' ' ' SER . 8.5 tp10 68.07 169.3 0.27 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.196 -0.668 . . . . 3.72 109.196 -167.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.6 m170 60.59 35.13 20.07 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.482 0.658 . . . . 4.03 110.414 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.468 ' CG2' ' HA ' ' A' ' 113' ' ' LYS . 73.2 p -82.73 119.59 24.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.167 -0.924 . . . . 2.99 111.637 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 87.9 t -76.42 117.0 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.214 -0.903 . . . . 2.88 109.878 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.71 35.42 16.93 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.128 -0.693 . . . . 2.8 109.128 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.7 mttp 59.91 27.49 16.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.073 -0.967 . . . . 5.35 112.342 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -77.3 86.87 3.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.114 -0.328 . . . . 3.58 110.114 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 98.9 mttt -61.69 113.05 2.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.066 0.46 . . . . 3.26 111.477 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -83.88 177.34 8.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.551 -0.75 . . . . 1.71 109.108 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.86 -53.7 54.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.914 0.338 . . . . 1.57 111.914 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.2 169.56 4.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.124 -0.325 . . . . 1.3 110.124 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -148.94 141.81 24.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.987 -0.375 . . . . 1.85 109.987 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 34.5 tp -99.74 125.89 45.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.871 -0.604 . . . . 1.61 109.493 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.447 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.4 m170 -110.69 107.9 17.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 2.25 111.516 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 5.4 mp -93.39 113.35 25.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.786 -0.643 . . . . 1.51 110.19 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.04 127.65 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.294 0.569 . . . . 1.24 111.527 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.9 139.88 50.5 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.017 -1.105 . . . . 2.86 108.017 172.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.94 154.36 46.64 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.57 -0.452 . . . . 4.96 111.559 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.77 ' HA ' ' O ' ' A' ' 87' ' ' THR . 53.1 t30 -76.43 89.58 3.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 2.3 110.988 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.9 p -73.45 -9.2 58.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.538 0.94 . . . . 2.77 113.538 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 13.5 ptmm? -71.52 -46.02 60.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.963 -0.695 . . . . 3.79 109.736 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.496 ' CG ' ' HG3' ' A' ' 132' ' ' LYS . 67.6 m-85 -94.19 -15.56 24.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 3.34 111.138 173.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 129' ' ' ASP . . . 101.23 -1.04 54.2 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.835 -0.698 . . . . 2.37 111.57 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 128' ' ' GLY . 32.8 t70 81.52 -78.16 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.834 0.854 . . . . 3.93 112.185 172.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -56.3 -19.87 16.26 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.438 0.903 . . . . 3.6 113.438 -168.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.09 -67.52 1.62 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.723 -0.751 . . . . 2.35 112.165 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.496 ' HG3' ' CG ' ' A' ' 127' ' ' TYR . 45.0 mmtm -72.13 -21.25 61.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.416 0.524 . . . . 3.75 112.416 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.63 56.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 2.17 111.427 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.62 -36.29 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 3.11 110.418 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -106.4 -24.66 12.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.661 0.267 . . . . 3.55 111.283 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -95.47 105.13 18.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 3.02 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 72.4 Cg_endo -76.52 -0.46 10.45 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.424 2.083 . . . . 1.93 112.419 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.53 27.07 10.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.425 -0.352 . . . . 2.29 110.39 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.87 -53.92 8.96 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 120.808 -0.711 . . . . 1.5 112.849 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 91.5 mt -89.32 151.0 22.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 1.98 110.784 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.47 106.63 5.75 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.485 -0.78 . . . . 1.83 109.286 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 44.4 t -107.3 117.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.457 -0.338 . . . . 2.28 110.803 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.99 126.18 33.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.833 -0.621 . . . . 2.89 109.62 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.19 115.43 4.45 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.737 -0.744 . . . . 0.95 112.638 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.6 mt -104.91 111.48 34.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.137 -0.319 . . . . 1.38 110.137 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -67.99 144.61 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.695 0.283 . . . . 1.37 110.981 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.2 mp -115.71 131.94 56.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.43 -0.35 . . . . 1.48 110.315 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -121.5 143.91 49.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.147 -0.686 . . . . 2.52 109.147 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 42.5 t -88.43 129.6 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 1.88 111.374 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.59 -104.12 0.18 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.532 -0.758 . . . . 1.53 111.279 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 p -81.66 146.73 29.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.197 -0.297 . . . . 2.08 110.197 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.33 148.86 47.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.086 0.469 . . . . 1.36 111.621 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 216' ' ' SER . 49.3 tptt -111.5 103.76 55.39 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 1.78 109.444 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.83 -38.11 94.89 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.002 2.468 . . . . 1.34 112.299 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.46 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -62.13 -29.21 72.18 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 116.031 -0.531 . . . . 0.75 113.035 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.5 tp -94.48 -17.58 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.271 0.535 . . . . 1.39 110.392 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -43.78 92.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.828 -0.624 . . . . 1.63 110.233 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.0 pttt -56.87 -32.39 65.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 3.26 111.853 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.6 t -77.07 -41.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 1.97 110.47 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 156' ' ' LEU . 72.4 t -57.57 -36.93 55.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.745 -0.662 . . . . 1.64 111.331 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.02 -20.6 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.56 . . . . 1.22 112.405 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.0 t -96.6 -7.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.902 0.382 . . . . 2.07 111.332 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 84.6 mt -57.66 -42.1 82.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.854 0.687 . . . . 1.95 112.854 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.94 -24.81 66.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.81 0.338 . . . . 2.31 111.386 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.0 m -81.15 -8.98 59.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.476 -0.329 . . . . 1.78 111.26 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -134.21 36.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.364 0.602 . . . . 1.42 109.739 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.58 -32.92 74.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 1.98 111.451 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.9 p -116.93 155.73 28.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.888 0.375 . . . . 1.4 111.528 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.434 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 42.5 tttm -59.73 132.42 53.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.868 -0.605 . . . . 2.84 110.611 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.36 -17.14 40.73 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.756 -0.735 . . . . 0.85 111.555 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -75.28 107.83 7.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.941 0.4 . . . . 2.22 110.602 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.0 m -98.95 140.74 32.65 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.262 -0.644 . . . . 1.93 109.262 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.28 129.35 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.825 -0.435 . . . . 1.17 109.825 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.45 134.13 56.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 1.8 109.825 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.41 79.85 1.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.833 . . . . 1.31 108.752 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.0 p -105.27 152.87 22.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 1.69 112.095 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.27 62.98 2.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.724 -0.671 . . . . 2.26 112.131 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -134.67 98.1 3.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 4.84 110.768 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.15 140.44 88.15 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.822 -0.626 . . . . 2.51 111.112 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.16 -3.48 13.15 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.178 2.585 . . . . 1.47 112.17 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.517 ' HB2' ' HH ' ' A' ' 51' ' ' TYR . 40.0 ttp180 -55.5 -42.59 74.67 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.863 -0.608 . . . . 3.16 112.302 -175.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -63.0 -16.95 58.1 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.046 -0.597 . . . . 1.12 113.285 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.75 -16.26 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 2.37 110.948 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.05 133.8 36.42 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.456 . . . . 3.87 110.896 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.61 -170.47 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.921 2.414 . . . . 2.51 112.426 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.63 -49.87 60.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.621 0.248 . . . . 3.23 111.601 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.6 m -94.73 141.19 28.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 2.03 110.732 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.5 64.09 0.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.534 0.683 . . . . 2.5 109.735 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.434 ' O ' HD13 ' A' ' 211' ' ' LEU . 0.9 OUTLIER -80.45 163.59 23.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.514 -0.766 . . . . 1.81 109.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.704 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 30.6 p90 -165.57 142.88 5.68 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.679 -0.408 . . . . 5.32 110.872 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -123.91 106.64 10.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.026 -1.102 . . . . 4.55 108.026 170.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -82.61 121.48 26.87 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.811 0.671 . . . . 2.39 112.811 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -137.21 131.9 17.82 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.773 . . . . 5.32 110.387 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.77 129.36 20.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.738 2.292 . . . . 2.47 112.379 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.499 ' HA3' ' NE1' ' A' ' 208' ' ' TRP . . . -119.8 157.03 15.69 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.389 -0.434 . . . . 2.0 113.006 -174.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.41 0.624 . . . . 3.36 111.801 -175.638 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 30.9 tp . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 111.335 0.124 . . . . 3.51 111.335 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 5.6 pt-20 -80.83 109.79 15.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.543 0.687 . . . . 3.37 111.03 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 23.5 p -140.67 21.96 2.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.944 0.402 . . . . 2.47 110.668 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -104.8 138.12 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.005 0.431 . . . . 1.74 111.185 -176.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.6 m -112.84 111.83 22.88 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.074 -0.713 . . . . 2.3 109.074 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.499 ' NE1' ' HA3' ' A' ' 195' ' ' GLY . 97.4 m95 -81.97 116.78 21.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.648 0.261 . . . . 6.37 110.476 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 38.4 mm -101.73 98.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.695 -0.854 . . . . 2.32 108.695 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 38.1 t -85.67 116.99 29.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 2.1 111.937 -174.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 189' ' ' ASP . 56.0 tp -80.23 113.89 18.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.846 -0.427 . . . . 2.35 109.846 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 6.2 tmmm? -60.99 -21.62 63.72 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.399 0.518 . . . . 3.47 112.399 -176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -99.64 106.07 37.83 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 111.874 0.324 . . . . 1.56 111.874 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 10.1 Cg_exo -73.77 138.55 26.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.059 2.506 . . . . 1.37 111.689 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -91.58 152.12 3.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.839 0.352 . . . . 1.85 110.334 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 3.1 p -96.08 122.29 38.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.959 -0.564 . . . . 1.78 111.147 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.5 m -123.75 153.18 29.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 1.64 109.791 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 t -88.19 158.97 18.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.592 0.234 . . . . 1.52 111.23 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.476 ' HA ' HG21 ' A' ' 222' ' ' VAL . 29.6 t -54.6 -42.85 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 1.81 110.513 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -56.31 -27.3 55.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.51 111.78 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.2 -49.75 9.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.343 -0.389 . . . . 1.02 110.15 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.506 ' HB ' ' CZ2' ' A' ' 97' ' ' TRP . 35.1 m -66.51 -31.13 52.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 1.88 111.27 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.644 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 89.6 mt -60.52 -39.77 89.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 1.59 110.673 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -74.46 -25.03 59.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.12 -0.491 . . . . 2.3 111.157 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.69 -28.86 61.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.201 0.524 . . . . 3.18 109.749 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -86.29 -3.35 58.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.92 -0.582 . . . . 3.55 110.279 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.5 mmtt -88.05 -9.3 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 2.74 109.948 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.37 150.14 45.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.659 -0.7 . . . . 1.66 110.722 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -108.26 142.93 37.81 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.532 0.682 . . . . 1.13 110.393 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -78.49 -32.19 48.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.592 -1.185 . . . . 4.38 109.166 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -76.98 169.98 17.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.93 -1.032 . . . . 1.62 111.987 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 169' ' ' LYS . . . -96.34 179.05 34.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.006 -0.997 . . . . 1.16 111.204 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.52 137.67 57.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 3.56 110.426 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.17 62.69 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 2.23 112.894 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.49 153.26 69.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 117.085 0.443 . . . . 2.59 109.838 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.8 125.1 17.96 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.348 2.032 . . . . 1.5 111.187 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.422 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.8 pt-20 -64.16 127.57 32.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.577 0.703 . . . . 3.4 112.325 -172.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.79 124.05 38.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.768 -1.106 . . . . 2.47 108.365 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.14 145.89 55.28 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.956 0.408 . . . . 2.6 111.159 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 30.6 mtt -65.81 102.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.647 -0.706 . . . . 1.94 110.074 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.35 142.04 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.567 -0.742 . . . . 1.67 110.436 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 244' ' ' TRP . 38.9 t70 68.35 -90.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.326 -0.852 . . . . 2.18 110.487 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . 0.477 ' OD1' ' HB3' ' A' ' 64' ' ' HIS . 47.8 t30 65.75 -23.46 0.09 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.313 0.857 . . . . 2.64 113.313 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.438 ' H ' ' C ' ' A' ' 242' ' ' ASP . 63.3 t-105 -146.85 134.04 20.52 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.674 -0.641 . . . . 5.31 111.323 -169.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.489 ' CD ' ' H ' ' A' ' 245' ' ' ARG . 0.1 OUTLIER -93.22 102.57 7.54 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.222 -0.899 . . . . 6.91 108.975 174.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 245' ' ' ARG . 4.2 Cg_exo -74.83 -91.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.888 2.392 . . . . 3.72 115.101 -166.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.24 129.88 38.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.873 0.694 . . . . 3.34 112.873 -159.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.464 ' HG2' ' CB ' ' A' ' 32' ' ' ASP . 24.5 pt20 -82.53 179.16 2.04 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.575 -0.739 . . . . 4.92 110.176 171.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 248' ' ' GLN . 69.0 Cg_exo -53.83 132.79 51.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.829 1.686 . . . . 4.01 111.58 170.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.9 -39.68 19.62 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.666 -1.152 . . . . 4.9 112.606 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 253' ' ' ARG . 22.3 ptmt -61.29 -12.19 12.63 Favored 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 115.654 1.724 . . . . 5.68 115.654 -176.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 9.2 p30 37.82 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 118.806 2.891 . . . . 5.11 118.806 165.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 252' ' ' ASN . 35.2 ttm180 142.98 -118.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.399 1.88 . . . . 6.74 105.964 -163.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' A' ' 253' ' ' ARG . 19.5 tt0 -146.27 128.74 15.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.246 -1.39 . . . . 3.08 107.246 161.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 60.8 mt -91.04 146.37 6.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.783 -0.451 . . . . 3.06 109.783 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -116.61 137.03 52.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 3.01 110.499 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.25 160.64 24.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.19 -0.914 . . . . 1.99 109.503 -176.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 32.9 t -143.17 98.02 3.19 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.053 -0.659 . . . . 2.47 111.502 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -132.87 90.88 2.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.916 . . . . 5.03 108.584 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.243 0.736 0 CA-C-O 118.364 -0.827 . . . . 4.82 110.518 -176.699 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.662 ' HA ' ' OG1' ' A' ' 108' ' ' THR . 31.7 t70 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.978 -0.749 . . . . 3.14 108.978 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 110' ' ' ASP . 72.4 mt -67.47 126.95 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.807 -0.633 . . . . 2.71 110.917 -173.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.8 114.6 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.93 -0.577 . . . . 2.82 110.489 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -63.69 -31.54 72.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.71 111.728 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -76.19 -4.4 41.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.815 0.34 . . . . 5.23 111.533 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.0 m -102.41 -8.22 21.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.464 0.649 . . . . 3.38 109.929 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -78.2 120.39 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 1.76 110.758 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -95.41 132.34 40.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.252 -0.431 . . . . 4.05 110.232 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.72 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 27.4 m-85 -82.46 130.28 35.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.486 0.66 . . . . 4.9 111.883 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 258' ' ' SER . 25.3 t70 -125.2 140.55 36.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 2.27 109.248 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.96 90.94 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.801 2.334 . . . . 2.45 113.295 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.1 t -60.28 -38.18 82.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.933 -0.576 . . . . 4.62 110.392 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt 72.21 -67.1 0.27 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.464 -0.789 . . . . 5.15 111.996 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -101.44 128.08 30.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.51 0.195 . . . . 4.21 110.979 -175.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.55 160.91 26.13 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.048 2.499 . . . . 2.76 111.874 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 11.0 mp -80.0 143.76 33.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.368 0.507 . . . . 2.93 112.368 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -106.86 99.41 8.98 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.317 -0.856 . . . . 2.46 108.723 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 t -117.0 108.1 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.028 -0.533 . . . . 2.17 110.268 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.6 m -102.12 89.46 3.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.077 -0.51 . . . . 1.87 109.705 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -101.57 3.43 40.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.94 -0.763 . . . . 3.97 108.94 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.58 -33.06 69.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.45 -1.25 . . . . 2.48 111.859 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -103.6 13.14 33.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.693 0.257 . . . . 2.54 111.693 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.83 122.94 17.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 1.41 111.496 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 23.1 m -103.26 111.96 24.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.938 -0.573 . . . . 1.41 110.386 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -76.73 141.84 40.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.735 -0.468 . . . . 1.84 109.735 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.8 mt -118.54 -57.29 2.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.277 0.473 . . . . 1.45 112.277 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -156.49 148.1 22.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.643 -0.253 . . . . 3.72 110.722 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -108.92 137.21 42.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.608 -0.516 . . . . 1.35 109.608 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.8 tp -128.4 145.47 51.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.299 -0.41 . . . . 1.53 110.395 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.538 ' OD1' ' HE1' ' A' ' 240' ' ' MET . 52.1 t30 -117.16 124.18 48.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.933 0.397 . . . . 1.49 111.196 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.23 153.03 46.62 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.184 -1.043 . . . . 2.18 108.184 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.576 ' HA2' ' SD ' ' A' ' 240' ' ' MET . . . -69.91 33.08 0.39 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 115.478 0.951 . . . . 2.0 115.478 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -131.95 -36.96 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.521 -0.548 . . . . 4.11 109.521 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -171.01 -179.62 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.399 -0.963 . . . . 1.78 108.399 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -117.2 144.9 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.797 -1.186 . . . . 3.48 107.797 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 4.6 p30 -131.33 141.33 49.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.02 0.438 . . . . 1.99 111.468 -172.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.7 t -106.15 116.48 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.787 -0.642 . . . . 1.75 109.903 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.85 128.47 33.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.654 -0.703 . . . . 2.02 110.901 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -105.8 159.26 16.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.847 -0.615 . . . . 2.19 110.458 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 26.1 t70 -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.847 -0.615 . . . . 1.33 109.613 174.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.47 60.96 1.65 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.036 0.922 . . . . 2.65 110.334 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 m -92.2 -5.75 51.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.575 -0.739 . . . . 2.01 110.203 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 74' ' ' GLN . 1.6 mp0 -145.7 176.44 9.64 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.405 -0.961 . . . . 2.35 108.405 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 89' ' ' ARG . 18.1 m-20 -75.33 65.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.158 0.504 . . . . 1.92 110.675 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -84.8 -59.0 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 2.31 110.223 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -114.59 97.3 6.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.518 -0.764 . . . . 1.44 109.749 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.52 146.5 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.168 -0.469 . . . . 1.82 110.083 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tt -137.22 113.4 9.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 1.8 109.463 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.455 ' HD2' HG23 ' A' ' 87' ' ' THR . 12.6 ptmm? -148.09 124.23 10.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.258 0.552 . . . . 3.02 110.959 172.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -86.12 175.64 48.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.981 -0.848 . . . . 1.44 110.981 167.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.59 -142.92 0.0 OUTLIER Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.304 0.649 . . . . 2.15 114.508 165.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.49 120.6 5.95 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.518 1.478 . . . . 3.17 112.19 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -158.62 -168.23 2.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.838 -1.074 . . . . 4.55 108.883 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -125.34 45.71 2.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 121.181 -0.208 . . . . 4.95 110.989 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.74 158.79 7.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.43 -0.89 . . . . 2.25 113.123 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.455 HG23 ' HD2' ' A' ' 80' ' ' LYS . 92.1 m -98.23 114.74 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 2.12 109.814 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 65.6 m-85 -102.25 132.92 47.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.19 0.441 . . . . 3.88 112.19 -171.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.401 HH21 ' CG ' ' A' ' 75' ' ' ASP . 98.2 mtt180 -103.59 147.09 27.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 3.87 109.86 173.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 121' ' ' VAL . 48.4 tp -77.44 130.14 36.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.559 -0.291 . . . . 1.68 110.949 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -110.28 -40.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.376 . . . . 2.16 110.954 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -170.53 168.07 7.84 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.821 -0.437 . . . . 1.95 109.821 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 19.4 p90 -135.88 157.51 46.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.174 -0.21 . . . . 0.98 110.688 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -143.09 158.94 43.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.54 -0.541 . . . . 1.07 109.54 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.649 ' CE2' ' HG ' ' A' ' 118' ' ' LEU . 42.1 m-85 -111.76 166.16 11.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.589 0.233 . . . . 3.99 110.654 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 2.0 m80 -122.39 139.14 54.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.029 -0.73 . . . . 2.2 109.029 171.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.419 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 39.6 p90 -159.39 142.71 14.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.782 -0.451 . . . . 6.08 109.782 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB ' ' A' ' 241' ' ' VAL . . . 174.69 -168.04 40.53 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.181 -1.009 . . . . 2.19 112.913 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t 43.77 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.465 1.106 . . . . 3.08 112.312 -173.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' GLY . 89.3 mt -85.26 -159.32 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 3.48 109.647 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.61 66.48 9.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.91 0.386 . . . . 3.85 110.071 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 97' ' ' TRP . . . 82.29 120.39 0.6 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.889 -0.672 . . . . 2.37 112.595 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? 178.94 157.21 0.51 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.753 0.421 . . . . 2.62 110.491 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 96' ' ' HIS . . . 128.6 109.84 1.48 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.378 -0.915 . . . . 1.62 113.918 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.468 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 30.5 t -91.64 -47.23 7.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.604 -0.887 . . . . 2.24 108.604 169.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -119.17 48.14 1.55 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.744 -1.947 . . . . 3.72 105.744 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 78.2 t60 64.69 2.05 1.55 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.455 -1.702 . . . . 4.03 111.616 -171.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.662 ' OG1' ' HA ' ' A' ' 32' ' ' ASP . 21.2 p -144.27 179.41 7.25 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.765 -0.828 . . . . 2.99 108.765 158.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.0 t -142.31 92.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.332 0.515 . . . . 2.88 111.559 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 36.5 t70 42.36 44.11 3.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.394 0.678 . . . . 2.8 112.513 172.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 67.51 -43.29 0.46 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.291 0.636 . . . . 5.35 111.368 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 110' ' ' ASP . 9.2 mmmm -79.23 71.66 5.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.492 0.317 . . . . 3.58 110.389 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -52.54 120.81 6.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.39 -0.368 . . . . 3.26 110.389 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -104.84 -164.67 1.06 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 1.71 110.44 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.61 67.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.712 0.634 . . . . 1.57 112.712 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.4 172.41 6.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.31 -0.255 . . . . 1.3 110.31 -172.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.77 135.75 34.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.352 -0.61 . . . . 1.85 109.352 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.649 ' HG ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 tt -108.47 118.45 36.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 1.61 110.284 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.588 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -110.97 100.36 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.904 0.383 . . . . 2.25 110.837 -176.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.9 mp -88.03 108.62 19.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.269 -0.423 . . . . 1.51 110.451 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.413 ' O ' HD13 ' A' ' 90' ' ' LEU . 33.2 t -79.3 123.15 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 1.24 111.187 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 61.3 m80 -118.25 156.98 27.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.326 -0.62 . . . . 2.86 109.326 175.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.63 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 52.3 p-90 -133.9 144.04 48.63 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.264 -0.273 . . . . 4.96 110.264 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -65.82 107.64 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 2.3 111.069 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.63 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 9.5 t -69.46 -14.84 63.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 2.77 112.12 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.18 -14.1 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 3.79 111.231 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.69 3.72 53.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 3.34 110.617 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 62.42 -1.3 1.58 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.503 0.961 . . . . 2.37 115.503 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -169.6 139.46 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.141 0.97 . . . . 3.93 110.116 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.39 -44.06 88.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.919 -0.582 . . . . 3.6 111.294 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.401 ' O ' HG11 ' A' ' 134' ' ' VAL . . . -61.65 -34.91 90.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.106 -0.568 . . . . 2.35 112.156 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -72.47 -38.86 68.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.857 0.361 . . . . 3.75 110.656 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.582 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.07 -38.42 82.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 2.17 111.825 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 131' ' ' GLY . 8.9 p -67.41 -11.9 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.24 0.543 . . . . 3.11 111.285 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.6 15.06 10.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.987 0.422 . . . . 3.55 110.91 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -126.15 138.57 32.46 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.6 -32.04 62.42 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.361 2.708 . . . . 1.93 113.439 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.7 28.97 8.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.068 0.461 . . . . 2.29 110.252 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.99 -36.32 28.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.018 -0.61 . . . . 1.5 113.263 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.0 mt -108.34 157.63 18.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.769 0.319 . . . . 1.98 110.643 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -142.5 107.43 4.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.082 0.468 . . . . 1.83 110.522 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.588 ' HB ' ' CD2' ' A' ' 119' ' ' HIS . 7.8 m -94.02 119.67 42.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.188 0.518 . . . . 2.28 110.857 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 46.5 tp -89.1 112.5 23.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.889 -0.596 . . . . 2.89 109.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA3' ' HE1' ' A' ' 208' ' ' TRP . . . -99.49 132.18 10.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.812 -0.709 . . . . 0.95 112.321 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.8 mt -129.54 124.27 59.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.666 -0.494 . . . . 1.38 109.666 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.89 140.62 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.752 0.31 . . . . 1.37 110.709 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.6 128.55 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.429 -0.582 . . . . 1.48 109.429 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 15.6 ptpt -122.71 151.09 41.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.062 -0.348 . . . . 2.52 110.062 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.748 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 14.2 m -70.44 107.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.472 0.654 . . . . 1.88 111.716 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -155.16 -135.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.495 -0.775 . . . . 1.53 111.272 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.0 m -70.28 121.68 18.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.656 -0.498 . . . . 2.08 109.656 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.569 ' HB2' ' CB ' ' A' ' 218' ' ' SER . . . -83.64 104.53 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.337 -0.246 . . . . 1.36 110.337 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -70.68 126.43 92.2 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.031 -0.359 . . . . 1.78 110.031 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.28 -14.02 31.88 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.04 2.494 . . . . 1.34 112.556 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.526 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -58.64 -25.53 58.66 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.98 -0.555 . . . . 0.75 112.936 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 159' ' ' VAL . 48.0 tp -91.95 -32.05 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.189 0.519 . . . . 1.39 110.406 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -52.49 -38.93 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 1.63 112.142 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 41.6 pttt -61.27 -33.86 74.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.499 0.555 . . . . 3.26 112.499 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 162' ' ' VAL . 13.3 p -84.58 -36.81 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.581 -0.448 . . . . 1.97 110.775 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 156' ' ' LEU . 19.5 t -65.16 -39.18 84.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 1.64 110.72 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.2 -28.03 66.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.519 -0.764 . . . . 1.22 112.695 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 159' ' ' VAL . 10.0 p -92.2 -2.76 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.978 0.418 . . . . 2.07 111.136 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.29 -28.03 67.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.333 -0.394 . . . . 1.95 111.529 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -67.34 -25.21 65.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.497 -0.319 . . . . 2.31 111.431 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.7 t -84.4 -1.76 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 1.78 110.811 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.41 33.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.356 -0.979 . . . . 1.42 108.356 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -55.62 -35.55 66.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.479 -1.237 . . . . 1.98 111.787 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.1 p -106.72 152.62 23.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.082 0.468 . . . . 1.4 111.163 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -57.94 136.67 57.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 2.84 111.296 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.46 -15.04 57.75 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.734 -0.746 . . . . 0.85 112.917 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -86.81 151.23 23.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 2.22 111.34 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.5 p -142.2 151.43 42.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.394 -0.821 . . . . 1.93 109.816 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.65 148.51 44.13 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.911 -0.403 . . . . 1.17 109.911 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 135.53 51.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.791 0.329 . . . . 1.8 110.125 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -138.61 80.17 1.78 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.734 -0.839 . . . . 1.31 108.734 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.5 p -124.13 169.09 12.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.796 -0.638 . . . . 1.69 111.232 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.56 38.68 22.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.019 -0.537 . . . . 2.26 111.313 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -120.98 137.72 54.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.291 -0.413 . . . . 4.84 110.363 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -80.76 118.85 74.23 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.757 -0.656 . . . . 2.51 110.752 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.89 -21.66 27.92 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.929 2.419 . . . . 1.47 112.766 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -77.27 -2.52 35.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 3.16 111.05 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.11 -17.92 46.59 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 116.168 -0.469 . . . . 1.12 113.262 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.33 -38.09 65.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.63 0.215 . . . . 2.37 110.531 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 79.9 mt 54.69 85.17 0.2 Allowed Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.755 . . . . 3.87 112.778 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.33 136.76 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.296 2.664 . . . . 2.51 112.133 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -107.84 27.34 9.31 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.365 0.666 . . . . 3.23 110.501 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.0 t -153.51 103.14 2.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.661 -0.496 . . . . 2.03 109.661 -159.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.16 59.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.594 -0.443 . . . . 2.5 110.839 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -125.88 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.033 -1.099 . . . . 1.81 108.033 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 5.6 p90 -162.47 144.94 11.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.855 -0.738 . . . . 5.32 111.816 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.507 ' HB3' ' O ' ' A' ' 256' ' ' LYS . 48.6 m0 -92.63 129.07 38.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.778 -0.823 . . . . 4.55 108.778 168.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.4 t -84.67 94.04 8.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.12 0.962 . . . . 2.39 110.432 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.63 119.16 18.15 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 5.32 109.349 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.24 150.21 87.75 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.008 1.805 . . . . 2.47 111.218 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.86 123.27 5.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.475 -0.869 . . . . 2.0 112.824 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 109.273 -0.64 . . . . 3.36 109.273 175.005 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 203' ' ' LEU . 2.7 pp . . . . . 0 C--O 1.235 0.342 0 CA-C-O 121.477 0.656 . . . . 3.51 111.988 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 204' ' ' GLU . 0.0 OUTLIER -77.78 73.74 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.172 -0.922 . . . . 3.37 111.584 -172.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 7.8 p -99.52 7.24 45.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.441 -0.799 . . . . 2.47 110.702 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 t -118.86 151.05 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.292 0.568 . . . . 1.74 112.079 -169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 13.4 m -121.75 121.73 37.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.194 -1.039 . . . . 2.3 108.194 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.503 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.3 t90 -86.73 125.97 34.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.105 0.479 . . . . 6.37 110.214 -175.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.486 ' O ' HD13 ' A' ' 143' ' ' LEU . 44.4 mm -109.69 100.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.438 -0.801 . . . . 2.32 108.965 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 3.9 t -92.91 129.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.844 -0.342 . . . . 2.1 111.556 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.958 -0.756 . . . . 2.35 108.958 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.23 2.12 37.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.042 0.756 . . . . 3.47 113.042 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -111.65 105.31 56.66 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 121.072 -0.251 . . . . 1.56 110.915 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.423 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 19.6 Cg_exo -67.67 141.14 53.75 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.856 2.371 . . . . 1.37 112.326 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.0 pt -96.98 153.59 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.322 -0.399 . . . . 1.85 110.188 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.5 m -89.4 128.16 35.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.226 -0.443 . . . . 1.78 111.59 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.748 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 35.5 m -137.83 137.95 44.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.606 -0.725 . . . . 1.64 109.11 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' SER . . . . . 0.569 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 8.5 t -87.8 159.87 18.25 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.278 -0.569 . . . . 1.52 111.804 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.541 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.4 m -48.26 -46.02 35.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.615 -0.72 . . . . 1.81 111.586 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.86 -26.29 46.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.961 -0.563 . . . . 2.51 112.33 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -80.86 -48.36 12.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.582 -0.525 . . . . 1.02 109.582 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.99 -39.1 83.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.221 -0.899 . . . . 1.88 111.477 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.8 mt -62.05 -25.92 67.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 1.59 111.72 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -76.71 -19.67 57.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.584 -0.28 . . . . 2.3 111.337 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -68.92 -34.44 75.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.439 0.638 . . . . 3.18 110.072 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 28.2 ttm180 -76.23 -2.92 33.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.374 -0.83 . . . . 3.55 110.948 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -86.7 -3.75 59.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.392 . . . . 2.74 110.299 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.91 145.29 34.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.865 -0.607 . . . . 1.66 110.568 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.59 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.08 127.62 55.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 1.13 111.071 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.94 -34.37 74.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.914 -1.039 . . . . 4.38 110.874 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.59 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -69.49 162.38 27.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.674 -0.694 . . . . 1.62 111.933 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.84 166.4 42.96 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.677 -0.969 . . . . 1.16 110.677 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.79 133.43 50.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 3.56 110.803 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 95.51 6.71 59.59 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 2.23 111.87 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -119.01 158.04 49.04 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.518 -0.549 . . . . 2.59 109.518 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.08 122.99 12.11 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.919 2.413 . . . . 1.5 112.134 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.32 126.3 26.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 3.4 112.178 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 10.6 tp10 -124.55 134.53 52.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.288 -0.869 . . . . 2.47 110.221 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.81 107.97 2.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.575 . . . . 2.6 110.083 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.576 ' SD ' ' HA2' ' A' ' 63' ' ' GLY . 51.1 ttp -74.33 91.24 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 1.94 109.374 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.451 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 27.6 m -135.38 157.71 39.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.628 -0.715 . . . . 1.67 111.293 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 70.42 -81.47 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 124.129 0.893 . . . . 2.18 110.939 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . 0.485 HD22 ' HG2' ' A' ' 240' ' ' MET . 73.4 m-20 50.43 29.18 3.74 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.753 0.649 . . . . 2.64 112.753 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -148.07 152.76 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 5.31 108.876 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -80.38 148.94 67.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.609 -0.145 . . . . 6.91 110.609 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.89 164.11 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.485 2.79 . . . . 3.72 113.598 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.77 98.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.596 -0.729 . . . . 3.34 112.504 -170.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.501 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 27.0 mm-40 -61.25 163.83 9.94 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.537 -0.756 . . . . 4.92 110.586 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.603 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 72.0 Cg_endo -75.09 161.1 39.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 4.01 113.366 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -8.83 34.59 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.2 -0.909 . . . . 4.9 112.315 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.668 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 47.9 mmtm -55.29 49.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.571 1.693 . . . . 5.68 115.571 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER 124.91 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.979 2.112 . . . . 5.11 110.149 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.603 ' HD3' ' O ' ' A' ' 249' ' ' PRO . 4.3 mpt_? -138.42 100.25 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.336 -0.987 . . . . 6.74 108.336 167.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -128.84 148.43 50.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.581 -0.526 . . . . 3.08 109.581 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 21.6 mm -102.0 147.66 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.341 -0.391 . . . . 3.06 110.517 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 191' ' ' TRP . 45.3 mttp -135.71 166.39 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.637 -0.875 . . . . 3.01 108.637 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.72 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -144.28 114.89 7.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.634 -0.136 . . . . 1.99 110.634 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 21.3 m -97.2 100.71 12.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.283 0.563 . . . . 2.47 110.702 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -145.13 131.64 19.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.588 -0.733 . . . . 5.03 110.242 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.782 -0.627 . . . . 4.82 109.759 178.218 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 108.856 -0.794 . . . . 3.14 108.856 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 49.8 mt -88.34 91.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.372 0.606 . . . . 2.71 109.796 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.97 119.45 39.5 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.766 -0.652 . . . . 2.82 109.444 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -55.34 -33.41 63.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.797 . . . . 2.71 112.812 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -76.73 -34.83 58.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.12 0.486 . . . . 5.23 110.705 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -88.01 18.06 4.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.599 -0.728 . . . . 3.38 110.438 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.16 150.26 36.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 1.76 109.2 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -119.35 122.78 42.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.039 0.447 . . . . 4.05 110.472 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -82.59 126.22 32.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.673 -0.694 . . . . 4.9 109.952 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -145.8 97.74 4.55 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.773 -0.454 . . . . 2.27 109.773 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.04 28.89 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.657 2.238 . . . . 2.45 112.677 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -99.9 -5.92 27.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.289 -0.414 . . . . 4.62 110.827 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.66 152.1 21.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.545 -0.539 . . . . 5.15 109.545 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.25 135.72 20.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.681 -0.236 . . . . 4.21 110.723 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.35 136.94 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 2.76 111.364 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.65 131.6 43.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.857 0.361 . . . . 2.93 111.208 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -66.47 122.95 18.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.639 -0.71 . . . . 2.46 109.677 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 79' ' ' LEU . 3.0 t -109.38 103.0 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.237 -0.438 . . . . 2.17 110.141 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.697 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 6.7 m -105.18 89.33 3.1 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.81 -0.811 . . . . 1.87 108.81 177.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.3 p90 -124.46 6.43 8.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.906 0.384 . . . . 3.97 111.461 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.7 -19.27 65.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.409 -0.359 . . . . 2.48 111.418 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.9 mp0 -98.64 6.55 46.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.575 -0.284 . . . . 2.54 110.403 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.15 133.82 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 1.41 111.675 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.5 m -120.75 106.37 11.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.888 -0.596 . . . . 1.41 110.186 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.9 p -79.4 150.81 31.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.685 -0.487 . . . . 1.84 109.685 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.9 mt -122.07 -55.4 1.88 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.832 0.349 . . . . 1.45 111.616 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 58' ' ' ARG . 11.6 ptm85 -154.8 152.37 29.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.452 -0.34 . . . . 3.72 111.016 -172.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 tt -115.15 137.39 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.559 -0.534 . . . . 1.35 109.559 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.5 tp -134.07 142.32 47.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.726 0.298 . . . . 1.53 111.11 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -111.09 108.04 17.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.876 -0.787 . . . . 1.49 108.876 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -142.51 72.59 1.38 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.685 0.624 . . . . 2.18 112.685 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.14 -71.41 0.4 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.437 -1.363 . . . . 2.0 113.569 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -142.55 0.04 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.775 0.321 . . . . 4.11 111.585 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.44 174.75 13.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.803 -0.814 . . . . 1.78 108.803 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 95' ' ' PHE . 49.7 p90 -115.38 121.97 44.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 3.48 109.465 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -96.53 116.22 28.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.751 . . . . 1.99 110.46 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 42.0 t -93.05 106.1 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.584 -0.524 . . . . 1.75 109.584 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.62 129.26 37.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.887 -0.597 . . . . 2.02 111.589 -174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -111.52 153.98 25.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.347 -0.842 . . . . 2.19 110.265 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -76.54 110.95 11.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.922 -0.581 . . . . 1.33 110.626 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.455 ' HB2' ' CD ' ' A' ' 89' ' ' ARG . 6.2 p-10 -116.26 55.53 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.298 0.571 . . . . 2.65 111.392 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -104.91 -6.5 20.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.483 . . . . 2.01 111.025 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 76' ' ' LYS . 46.1 mt-30 -137.94 176.56 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.206 -0.664 . . . . 2.35 109.206 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -82.14 41.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.18 0.514 . . . . 1.92 110.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 34.9 mmtp -51.32 -60.69 2.85 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.897 -1.047 . . . . 2.31 110.673 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.697 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -130.87 96.75 4.15 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.285 -0.871 . . . . 1.44 110.159 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.5 m -111.95 147.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.404 0.621 . . . . 1.82 111.605 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.449 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.9 tp -129.29 119.43 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.857 -1.065 . . . . 1.8 108.466 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' A' ' 87' ' ' THR . 57.3 pttt -158.97 121.14 3.51 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.5 -0.48 . . . . 3.02 111.764 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.62 176.9 40.15 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 114.337 0.495 . . . . 1.44 114.337 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.33 -137.43 0.0 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.156 1.36 . . . . 2.15 115.755 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.8 148.76 3.58 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.081 2.521 . . . . 3.17 113.166 -168.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.1 pt? -39.95 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.038 1.866 . . . . 4.55 116.038 -157.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -85.94 -48.55 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.519 -0.764 . . . . 4.95 109.663 162.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 123.79 163.48 11.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.167 -0.54 . . . . 2.25 112.223 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.434 ' HA ' ' HB3' ' A' ' 80' ' ' LYS . 49.1 m -94.69 103.15 15.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 2.12 110.04 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -95.76 102.1 13.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.286 -0.416 . . . . 3.88 110.081 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.455 ' CD ' ' HB2' ' A' ' 72' ' ' ASP . 16.0 ptp180 -82.03 152.36 26.68 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.211 -0.306 . . . . 3.87 110.183 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.3 tp -76.47 122.86 25.15 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.737 -0.468 . . . . 1.68 109.737 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -108.38 -32.81 2.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.906 0.384 . . . . 2.16 110.164 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.3 pt20 -171.64 169.66 5.93 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.691 -0.485 . . . . 1.95 109.691 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -140.72 158.43 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.412 -0.588 . . . . 0.98 109.412 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -147.41 158.73 44.09 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.19 0.306 . . . . 1.07 110.73 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.672 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 66.5 m-85 -123.08 165.55 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 3.99 110.773 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -172.6 126.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.266 0.626 . . . . 2.2 109.661 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.473 ' CE3' ' HB2' ' A' ' 116' ' ' ALA . 14.8 p90 -161.8 -174.51 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.591 -0.277 . . . . 6.08 110.375 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.438 ' O ' ' HB ' ' A' ' 241' ' ' VAL . . . 89.92 99.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.512 -0.851 . . . . 2.19 111.681 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.7 t -143.08 -82.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.711 -0.848 . . . . 3.08 108.711 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.419 HD12 ' OE1' ' A' ' 103' ' ' GLN . 84.2 mt -95.75 -155.18 0.46 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.143 -0.688 . . . . 3.48 109.143 169.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.82 -48.31 67.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.077 0.399 . . . . 3.85 112.077 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.71 63.68 0.36 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.602 -0.808 . . . . 2.37 111.448 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 114' ' ' TYR . 13.1 pt20 -150.65 -172.11 4.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 2.62 110.761 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.29 8.71 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.62 111.474 -168.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.433 ' HB2' ' N ' ' A' ' 116' ' ' ALA . 48.2 t -78.46 -33.5 48.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.338 0.495 . . . . 2.24 112.338 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.501 ' CG ' ' H ' ' A' ' 107' ' ' HIS . 0.9 OUTLIER 69.85 -156.32 0.15 Allowed 'General case' 0 C--N 1.343 0.316 0 N-CA-C 107.363 -1.347 . . . . 3.72 107.363 -173.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.501 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 4.3 m-70 53.04 69.79 0.66 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.161 0.437 . . . . 4.03 110.046 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.3 t -98.71 117.43 33.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 120.024 -0.671 . . . . 2.99 110.136 -165.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 14.7 m -92.18 103.44 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.161 0.505 . . . . 2.88 110.785 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.2 t70 54.01 58.83 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.555 -0.748 . . . . 2.8 109.735 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 67.23 4.83 3.85 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.866 -1.061 . . . . 5.35 113.19 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -90.36 111.68 22.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.949 -0.389 . . . . 3.58 109.949 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -93.08 146.6 23.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.569 -0.9 . . . . 3.26 108.569 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 96.8 m-85 -95.93 176.44 6.11 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.601 -0.439 . . . . 1.71 109.935 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.0 -39.03 20.18 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.664 0.616 . . . . 1.57 112.664 -171.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 147' ' ' LEU . . . -145.34 149.97 35.76 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.606 -0.438 . . . . 1.3 111.801 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -110.88 141.55 44.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.055 -0.52 . . . . 1.85 110.563 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.672 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 13.0 tp -121.73 121.86 38.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.771 -0.649 . . . . 1.61 110.045 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.35 104.34 10.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 2.25 111.446 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -89.81 111.01 21.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.031 -0.531 . . . . 1.51 109.589 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.75 123.62 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.316 0.579 . . . . 1.24 110.766 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -115.74 145.53 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.64 -0.709 . . . . 2.86 109.912 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.454 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 9.1 t90 -112.0 133.47 54.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.973 -0.558 . . . . 4.96 110.719 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -78.17 111.84 14.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.084 -0.507 . . . . 2.3 110.231 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 t -58.34 -21.66 50.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.719 -0.673 . . . . 2.77 112.111 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -46.79 -32.18 3.51 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.557 0.947 . . . . 3.79 113.557 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.42 ' HE2' ' OE1' ' A' ' 136' ' ' GLN . 4.8 m-85 -97.38 -4.62 38.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.648 0.61 . . . . 3.34 112.648 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.87 14.9 2.91 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.575 0.59 . . . . 2.37 114.575 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.454 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 18.1 t70 -172.11 117.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.853 -0.795 . . . . 3.93 108.853 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -65.52 -33.14 75.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 3.6 111.819 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 134' ' ' VAL . . . -61.45 -33.66 85.51 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.881 -0.676 . . . . 2.35 112.133 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 69.9 mmtt -83.79 -24.98 30.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.797 0.332 . . . . 3.75 110.979 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.459 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.49 -21.85 63.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.358 -0.383 . . . . 2.17 111.912 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 131' ' ' GLY . 31.3 m -73.05 3.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 3.11 112.381 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 2.5 pt20 -97.15 -11.0 24.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 3.55 110.182 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.42 ' OE1' ' HE2' ' A' ' 127' ' ' TYR . 29.9 tt0 -101.81 136.48 19.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 3.02 109.867 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.65 -28.39 86.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.28 2.654 . . . . 1.93 112.656 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.415 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.8 p-10 -112.24 27.71 9.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 2.29 109.447 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.36 -37.64 86.29 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.725 -0.67 . . . . 1.5 111.747 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.416 ' HB2' HG22 ' A' ' 206' ' ' VAL . 86.8 mt -122.37 158.01 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.018 -0.734 . . . . 1.98 109.018 173.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.52 122.69 12.93 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.2 -0.296 . . . . 1.83 110.2 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.91 126.87 69.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.015 0.436 . . . . 2.28 110.697 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 49.0 tp -93.04 117.83 30.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.621 -0.718 . . . . 2.89 109.777 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -104.4 127.61 9.16 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.275 -0.488 . . . . 0.95 112.132 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.88 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.756 -0.461 . . . . 1.38 109.756 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.7 141.9 49.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.798 -0.183 . . . . 1.37 110.556 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 9.7 mp -121.27 135.32 55.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.118 0.485 . . . . 1.48 110.676 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 216' ' ' SER . 54.6 pttt -123.54 156.3 35.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.839 -0.8 . . . . 2.52 108.839 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 46.6 t -94.34 126.62 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.875 0.369 . . . . 1.88 110.568 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.22 -105.89 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.634 -0.586 . . . . 1.53 111.634 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.8 m -67.04 154.99 39.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.655 0.264 . . . . 2.08 110.315 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.33 157.27 16.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.015 -0.365 . . . . 1.36 110.015 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 216' ' ' SER . 28.2 mtpp -128.06 103.0 21.14 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.069 -0.345 . . . . 1.78 110.069 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.65 -33.93 61.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.362 2.708 . . . . 1.34 112.612 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.85 -28.64 73.67 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.75 112.502 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.7 tp -102.64 -23.64 13.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 1.39 110.543 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -38.43 70.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 1.63 110.047 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.3 -29.73 70.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.935 -0.575 . . . . 3.26 111.235 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.24 -48.54 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.21 0.528 . . . . 1.97 110.15 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 221' ' ' GLN . 43.2 t -65.33 -36.0 76.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.698 -0.683 . . . . 1.64 111.205 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.58 -28.22 69.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 1.22 112.231 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.52 -1.37 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.73 -0.388 . . . . 2.07 111.482 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.99 -22.21 60.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 1.95 111.778 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -66.6 -28.83 68.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.445 0.164 . . . . 2.31 111.366 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.4 p -83.26 -0.54 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.301 . . . . 1.78 111.739 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.29 34.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 1.42 108.883 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -67.73 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.87 -1.059 . . . . 1.98 111.883 -169.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.66 148.77 49.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 1.4 110.706 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -59.61 126.34 27.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.351 -0.84 . . . . 2.84 111.084 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 114.51 -21.46 14.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.819 -0.705 . . . . 0.85 112.693 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -88.67 153.15 21.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 2.22 111.26 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 42.6 p -144.21 161.62 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 1.93 110.732 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.47 151.63 37.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.148 -0.478 . . . . 1.17 109.816 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.64 131.95 41.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.815 -0.439 . . . . 1.8 109.815 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -141.53 81.77 1.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.085 -0.507 . . . . 1.31 109.839 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 46.0 p -98.85 166.54 11.25 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.278 -0.419 . . . . 1.69 111.363 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 66.17 32.2 8.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.814 -0.63 . . . . 2.26 112.418 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.616 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 68.3 t80 -66.63 132.3 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.331 -0.248 . . . . 4.84 110.331 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.22 100.25 0.68 Allowed Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 123.621 0.575 . . . . 2.51 110.567 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 11.1 Cg_exo -71.16 -36.24 7.54 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.71 2.274 . . . . 1.47 112.445 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.3 -9.96 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 3.16 110.637 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -70.93 0.97 26.64 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.063 -0.517 . . . . 1.12 113.14 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 86.4 mt -91.68 -14.58 29.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.197 -0.297 . . . . 2.37 110.197 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.5 mt 42.84 73.7 0.89 Allowed Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 113.462 0.912 . . . . 3.87 113.462 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.39 119.11 1.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.148 2.565 . . . . 2.51 111.127 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.3 mt-10 -112.39 25.08 11.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.778 0.431 . . . . 3.23 111.346 -171.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 213' ' ' GLU . 0.3 OUTLIER -168.3 90.06 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.047 -0.661 . . . . 2.03 110.605 -160.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.68 63.91 0.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.008 -1.108 . . . . 2.5 108.008 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 258' ' ' SER . 8.6 m-20 -87.71 -51.18 6.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.652 0.982 . . . . 1.81 113.652 -166.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -146.85 144.62 29.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.267 -0.573 . . . . 5.32 111.955 -172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -136.72 129.01 29.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.682 -0.69 . . . . 4.55 110.595 174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 192' ' ' THR . 7.6 t -171.91 74.01 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.93 0.872 . . . . 2.39 111.134 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -139.36 137.33 18.85 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.123 -0.489 . . . . 5.32 111.092 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.83 132.21 4.68 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.829 2.353 . . . . 2.47 111.812 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' HA3' ' HB ' ' A' ' 206' ' ' VAL . . . -99.22 106.27 3.19 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.532 -0.842 . . . . 2.0 112.61 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.322 -0.609 0 C-N-CA 122.922 0.489 . . . . 3.36 111.752 178.707 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.945 0.72 . . . . 3.51 112.945 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.78 88.74 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.469 -0.787 . . . . 3.37 111.458 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 3.3 p -118.15 16.46 14.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.097 -0.956 . . . . 2.47 109.561 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.419 ' HB ' ' HA3' ' A' ' 195' ' ' GLY . 51.0 t -117.57 149.71 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.835 -1.075 . . . . 1.74 109.744 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 87.3 m -117.19 117.13 28.73 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.374 -0.602 . . . . 2.3 109.374 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -84.98 133.05 34.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.375 0.607 . . . . 6.37 110.7 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 67.4 mt -121.29 141.78 40.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.363 -0.977 . . . . 2.32 108.363 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.42 146.33 31.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.201 0.524 . . . . 2.1 111.681 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.83 131.45 55.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.928 -0.768 . . . . 2.35 108.928 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.499 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 53.9 tttm -69.12 -7.6 37.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 3.47 111.644 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 187' ' ' SER . 10.1 tp10 -94.04 112.32 56.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.436 -0.347 . . . . 1.56 111.177 -175.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 4.9 Cg_exo -78.65 130.51 9.8 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.658 2.239 . . . . 1.37 111.09 171.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 34.1 pt -99.22 154.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.447 -0.575 . . . . 1.85 109.447 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 27.4 p -103.68 126.76 51.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.703 0.287 . . . . 1.78 111.711 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -114.83 147.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.15 -0.685 . . . . 1.64 109.15 173.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -93.6 166.55 12.18 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.532 -0.467 . . . . 1.52 110.78 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.561 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 44.0 m -50.19 -47.92 54.4 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.438 0.461 . . . . 1.81 112.209 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.69 -38.14 69.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.588 0.232 . . . . 2.51 111.391 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.408 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.1 mt-30 -67.38 -43.11 82.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 1.02 110.176 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.0 -41.78 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 1.88 111.031 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 219' ' ' SER . 90.2 mt -67.84 -44.1 77.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 1.59 111.689 -176.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -65.88 -24.42 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.912 0.338 . . . . 2.3 111.912 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.407 ' C ' ' H ' ' A' ' 227' ' ' LYS . 79.7 t80 -71.64 -36.03 70.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.033 0.444 . . . . 3.18 110.15 176.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -78.56 17.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.658 0.742 . . . . 3.55 110.439 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 225' ' ' PHE . 97.5 mttt -97.57 -19.22 18.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.196 -0.668 . . . . 2.74 109.196 171.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.05 134.51 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.603 -0.726 . . . . 1.66 111.236 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.515 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 12.4 m120 -96.92 144.23 27.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 1.13 110.147 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -79.79 -28.92 40.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.778 -1.101 . . . . 4.38 108.79 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -83.4 174.81 10.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 1.62 111.585 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.73 179.1 27.65 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.04 -0.982 . . . . 1.16 111.545 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.8 125.46 23.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.988 0.423 . . . . 3.56 111.579 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.72 20.1 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.845 -0.616 . . . . 2.23 113.507 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -133.14 157.22 78.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.898 0.349 . . . . 2.59 110.079 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.98 122.69 12.26 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.557 2.171 . . . . 1.5 111.692 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.515 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 38.5 tt0 -57.25 117.94 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.235 0.828 . . . . 3.4 113.235 -173.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 60.0 mm-40 -115.27 142.12 47.11 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.583 -1.189 . . . . 2.47 108.042 169.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.11 127.05 38.51 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.968 -0.293 . . . . 2.6 110.214 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 52.6 ttp -81.23 94.96 6.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.16 0.505 . . . . 1.94 110.07 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 98' ' ' GLY . 21.8 m -137.95 156.41 31.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.673 -0.694 . . . . 1.67 110.752 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.39 -80.23 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.914 0.758 . . . . 2.18 110.953 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 47.37 32.16 2.14 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.176 0.591 . . . . 2.64 112.193 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -146.89 174.55 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.232 0.539 . . . . 5.31 111.657 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -127.68 145.7 55.86 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.598 -0.728 . . . . 6.91 110.261 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.17 174.16 3.48 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.548 2.166 . . . . 3.72 112.48 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.86 158.86 34.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.785 -0.643 . . . . 3.34 112.33 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -114.45 170.5 5.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.491 -0.777 . . . . 4.92 109.601 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.83 175.77 9.88 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.859 2.373 . . . . 4.01 113.489 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.8 -7.39 1.61 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.788 1.235 . . . . 4.9 112.88 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -55.87 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.517 2.043 . . . . 5.68 116.517 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.561 ' C ' HD21 ' A' ' 252' ' ' ASN . 0.2 OUTLIER 131.04 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 126.665 1.986 . . . . 5.11 113.298 177.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -172.71 133.93 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.022 0.439 . . . . 6.74 111.574 166.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -114.16 150.61 33.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.394 -0.821 . . . . 3.08 109.486 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.8 mm -85.91 113.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.827 0.346 . . . . 3.06 110.573 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.42 ' HB3' HG22 ' A' ' 192' ' ' THR . 41.8 ttmt -109.34 143.41 38.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.058 -0.719 . . . . 3.01 109.058 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.95 164.0 29.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.724 0.297 . . . . 1.99 110.924 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 36.0 m -151.12 97.41 2.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.996 0.427 . . . . 2.47 109.985 175.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.84 95.95 4.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.215 -0.661 . . . . 5.03 109.215 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.718 -0.658 . . . . 4.82 110.399 -177.132 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 108.479 -0.934 . . . . 3.14 108.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 108' ' ' THR . 75.5 mt -67.55 125.25 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.59 0.709 . . . . 2.71 111.645 -173.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.88 122.91 29.57 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.935 -1.029 . . . . 2.82 108.81 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.6 p -57.22 -24.86 57.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.936 0.717 . . . . 2.71 112.936 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -81.34 -27.19 35.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 5.23 111.263 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 m -95.39 -28.7 14.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.422 . . . . 3.38 111.14 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.31 121.18 13.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 1.76 110.651 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.13 116.24 22.25 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.817 -0.438 . . . . 4.05 109.817 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -65.41 136.83 56.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 4.9 110.402 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 258' ' ' SER . 19.0 t70 -130.63 132.79 24.18 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.745 -0.661 . . . . 2.27 110.23 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.578 ' O ' HD22 ' A' ' 44' ' ' LEU . 23.3 Cg_exo -65.17 108.98 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.213 1.942 . . . . 2.45 112.55 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.682 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -53.08 -18.39 2.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.699 -0.682 . . . . 4.62 111.468 171.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER 50.65 -84.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.94 1.296 . . . . 5.15 113.177 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' H ' ' CG ' ' A' ' 44' ' ' LEU . 88.4 tttt -89.69 133.05 35.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.141 -0.318 . . . . 4.21 110.141 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.47 136.98 57.39 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.636 2.224 . . . . 2.76 111.519 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.03 141.66 43.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 2.93 110.096 -177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -102.48 97.19 7.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.898 -0.778 . . . . 2.46 108.898 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.26 108.7 23.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.589 -0.732 . . . . 2.17 109.175 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 61.5 m -108.31 91.51 3.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.982 0.42 . . . . 1.87 110.356 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -102.85 8.95 39.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.922 -0.581 . . . . 3.97 109.542 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.09 -29.59 57.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.963 -1.017 . . . . 2.48 111.156 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 53' ' ' GLN . 5.9 mt-30 -113.31 23.04 13.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.659 -0.7 . . . . 2.54 110.997 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.3 114.02 9.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.035 0.445 . . . . 1.41 110.54 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -115.56 112.26 21.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.41 110.617 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 p -77.96 156.18 30.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.077 -0.511 . . . . 1.84 110.246 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.4 mt -121.63 -56.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.612 -0.267 . . . . 1.45 111.449 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.73 156.67 23.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 3.72 111.515 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 166' ' ' ILE . 12.0 tt -107.12 137.73 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.515 -0.766 . . . . 1.35 109.7 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.0 tp -135.4 150.55 49.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.203 0.525 . . . . 1.53 111.683 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.501 ' HB2' ' HB ' ' A' ' 166' ' ' ILE . 49.0 t-20 -113.33 111.87 22.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.254 -1.387 . . . . 1.49 107.254 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -135.64 71.41 1.43 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.811 -0.756 . . . . 2.18 111.875 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.03 -83.67 0.62 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 119.917 -1.135 . . . . 2.0 112.918 160.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -112.29 -7.29 14.01 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.156 -0.218 . . . . 4.11 111.381 -173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.4 167.26 24.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 1.78 111.612 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 46.1 m-85 -110.34 105.53 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.632 -0.877 . . . . 3.48 108.632 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -99.0 124.82 44.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.469 -0.332 . . . . 1.99 111.764 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.68 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.074 -0.713 . . . . 1.75 109.074 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.29 163.29 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.705 0.764 . . . . 2.02 112.581 -170.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.57 164.64 27.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.424 -1.262 . . . . 2.19 108.372 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 106.15 14.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.689 -0.485 . . . . 1.33 109.689 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -112.24 57.05 0.65 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.575 0.702 . . . . 2.65 110.102 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.1 p -95.83 -20.85 18.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.953 -0.567 . . . . 2.01 111.425 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 7.9 pt20 -145.8 177.97 8.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 2.35 110.784 -171.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.21 63.44 0.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.556 -0.747 . . . . 1.92 110.586 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 74' ' ' GLN . 48.0 mttm -86.0 -69.02 0.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.956 -0.565 . . . . 2.31 111.356 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -115.21 102.48 9.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 1.44 109.61 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.05 142.74 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.186 -0.461 . . . . 1.82 111.788 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 tp -123.31 121.24 35.33 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 1.8 109.324 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -159.96 121.17 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.193 0.52 . . . . 3.02 110.696 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.7 28.55 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 119.606 -0.552 . . . . 1.44 112.033 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -41.01 -140.27 0.0 OUTLIER Glycine 0 CA--C 1.534 1.236 0 O-C-N 124.606 0.827 . . . . 2.15 114.373 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.09 122.94 8.05 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 121.918 1.745 . . . . 3.17 111.525 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 13.2 tp -175.2 -168.27 0.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.367 -1.345 . . . . 4.55 107.367 -165.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.521 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 20.8 t70 -135.9 72.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.798 0.726 . . . . 4.95 110.294 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 164.47 20.26 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 2.25 113.094 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.3 m -105.77 129.44 53.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.529 -0.545 . . . . 2.12 109.529 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -115.3 109.99 18.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.392 . . . . 3.88 111.09 -171.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.8 mtt180 -83.65 155.87 22.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.782 -0.451 . . . . 3.87 109.782 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.5 tp -83.21 131.61 35.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.132 -0.322 . . . . 1.68 110.132 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.666 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.8 tt -116.64 -47.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 2.16 111.375 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -166.56 165.11 16.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.732 -0.47 . . . . 1.95 109.732 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.538 ' CD2' HD11 ' A' ' 118' ' ' LEU . 15.5 p90 -133.84 167.2 21.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.945 -0.302 . . . . 0.98 110.418 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 66' ' ' PHE . 8.2 p-80 -147.51 158.6 44.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.164 -0.68 . . . . 1.07 109.164 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.74 163.65 23.86 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.376 -0.231 . . . . 3.99 110.376 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.541 ' HD1' ' HB3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -124.03 165.24 17.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.694 -0.854 . . . . 2.2 108.694 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.622 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 65.6 t-105 -133.03 140.54 47.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.412 . . . . 6.08 110.626 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.56 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -91.46 -71.17 1.2 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.726 -0.67 . . . . 2.19 112.732 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 24.7 t 165.48 -65.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.277 -1.009 . . . . 3.08 108.277 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.4 mt -111.36 168.02 9.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.312 -0.858 . . . . 3.48 108.869 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.71 61.78 3.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.564 0.697 . . . . 3.85 110.943 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -154.95 -24.35 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.505 -0.855 . . . . 2.37 113.537 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -152.15 176.51 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.304 0.552 . . . . 2.62 110.581 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.56 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 97.04 -33.15 5.97 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.788 -0.72 . . . . 1.62 113.003 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.3 p -71.1 -27.77 63.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.119 0.485 . . . . 2.24 110.76 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 3.6 tp10 58.81 -158.07 0.31 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.958 -1.127 . . . . 3.72 107.958 -166.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.513 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 19.3 m-70 54.76 65.21 1.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.817 -0.809 . . . . 4.03 108.817 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.501 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -93.05 133.61 36.03 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 2.99 109.953 -168.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -109.48 104.61 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.015 -0.365 . . . . 2.88 110.015 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.97 53.74 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.429 -0.805 . . . . 2.8 110.449 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 77.97 -11.22 1.23 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.201 -0.908 . . . . 5.35 111.826 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -93.97 108.82 20.59 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.432 . . . . 3.58 112.168 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 64.0 mttp -81.69 176.44 9.63 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.752 -0.833 . . . . 3.26 108.752 166.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -124.11 -173.19 2.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.243 -0.183 . . . . 1.71 111.094 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.6 -35.43 58.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.938 0.348 . . . . 1.57 111.938 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.77 168.65 26.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.37 -0.377 . . . . 1.3 110.165 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HB3' ' HD1' ' A' ' 96' ' ' HIS . 1.7 tm-20 -145.3 147.3 32.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.067 -0.716 . . . . 1.85 109.067 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.538 HD11 ' CD2' ' A' ' 93' ' ' PHE . 39.5 tp -126.02 122.03 34.69 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.291 0.369 . . . . 1.61 111.047 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -108.69 109.74 20.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.431 -0.35 . . . . 2.25 110.669 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.491 HD21 ' CB ' ' A' ' 93' ' ' PHE . 18.4 mt -93.67 105.21 17.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.935 -0.394 . . . . 1.51 109.935 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.6 118.34 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.334 0.587 . . . . 1.24 112.054 -173.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 52.0 m-70 -110.36 134.09 52.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.472 -0.785 . . . . 2.86 109.482 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.666 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 25.3 p-90 -111.18 148.05 33.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.476 . . . . 4.96 111.885 -172.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.9 110.2 1.27 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.41 -0.814 . . . . 2.3 111.181 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -60.46 -30.4 69.64 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.314 0.857 . . . . 2.77 113.314 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -80.3 -56.84 3.92 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.331 0.493 . . . . 3.79 112.331 -171.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.34 -19.24 56.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 3.34 111.719 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.41 72.68 Favored Glycine 0 C--N 1.318 -0.419 0 N-CA-C 110.314 -1.114 . . . . 2.37 110.314 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.617 ' OD2' ' HG ' ' A' ' 140' ' ' LEU . 22.7 t70 78.48 -78.07 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.95 -1.125 . . . . 3.93 113.162 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -50.33 -21.12 1.28 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.055 1.131 . . . . 3.6 114.055 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.99 -69.14 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.954 -1.117 . . . . 2.35 112.555 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 72.4 mmtt -89.15 -40.14 13.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.533 0.568 . . . . 3.75 112.533 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.8 -29.91 69.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.035 0.383 . . . . 2.17 112.035 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.16 -6.41 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.279 0.562 . . . . 3.11 110.848 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -114.6 19.1 16.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 3.55 110.311 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 22.9 mt-30 -131.25 127.2 21.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 108.782 -0.822 . . . . 3.02 108.782 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.23 -29.93 48.96 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.108 2.539 . . . . 1.93 113.688 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.96 24.26 12.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.728 0.299 . . . . 2.29 110.459 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.97 -70.41 1.07 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.073 -0.512 . . . . 1.5 113.829 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.617 ' HG ' ' OD2' ' A' ' 129' ' ' ASP . 6.5 mp -89.05 171.29 9.95 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.832 0.349 . . . . 1.98 110.801 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -141.39 104.11 4.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.618 -0.512 . . . . 1.83 109.618 172.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.67 111.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.799 -0.445 . . . . 2.28 109.799 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 57.8 tp -82.73 104.86 13.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 2.89 110.345 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -84.86 151.33 26.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.847 -0.692 . . . . 0.95 112.145 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.03 129.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.102 -0.332 . . . . 1.38 110.102 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 107' ' ' HIS . 3.2 m-85 -70.75 137.82 49.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.419 -0.355 . . . . 1.37 110.641 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.93 108.08 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.0 0.429 . . . . 1.48 110.445 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -106.02 164.5 11.92 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 2.52 108.863 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.8 m -106.3 138.42 31.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 1.88 111.847 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.24 -96.83 0.1 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.092 -0.958 . . . . 1.53 110.952 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -87.88 153.78 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.776 -0.453 . . . . 2.08 109.776 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.77 158.37 36.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.194 0.521 . . . . 1.36 112.113 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 216' ' ' SER . 30.5 mmmt -112.31 100.13 48.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.4 -0.818 . . . . 1.78 109.01 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.05 -40.4 59.31 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.089 2.526 . . . . 1.34 112.251 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.81 74.89 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.091 -0.576 . . . . 0.75 113.143 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.2 tp -92.41 -26.23 18.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.46 0.63 . . . . 1.39 110.2 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -35.66 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.63 109.638 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.47 -39.65 84.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.538 -0.755 . . . . 3.26 110.995 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.1 t -71.98 -48.04 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.184 0.516 . . . . 1.97 110.146 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.619 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 67.3 t -58.93 -32.62 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 1.64 110.971 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.41 -21.51 64.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.569 -0.741 . . . . 1.22 111.891 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.29 -12.92 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.505 0.558 . . . . 2.07 112.505 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -57.48 -21.49 37.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.718 0.636 . . . . 1.95 112.718 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.508 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.9 p-10 -64.61 -18.99 65.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 2.31 111.086 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -88.7 -5.99 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.855 0.36 . . . . 1.78 110.9 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 61' ' ' ASN . 14.3 pt -126.64 39.19 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.526 0.679 . . . . 1.42 109.983 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.66 -28.18 69.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.547 -0.751 . . . . 1.98 111.184 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.7 p -130.96 147.66 52.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.362 -0.381 . . . . 1.4 110.709 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -58.57 140.37 54.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.842 -0.617 . . . . 2.84 111.005 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.09 -10.77 55.34 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.951 -0.642 . . . . 0.85 112.131 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.9 144.58 31.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.449 . . . . 2.22 111.041 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.7 p -141.82 156.47 45.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.627 -0.715 . . . . 1.93 110.181 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.63 136.37 35.86 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.482 -0.327 . . . . 1.17 110.282 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.02 129.36 41.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.143 -0.481 . . . . 1.8 110.762 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -138.94 77.86 1.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.004 -1.11 . . . . 1.31 108.004 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.98 156.11 21.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.672 -0.694 . . . . 1.69 111.261 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 54.78 56.33 6.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.123 0.487 . . . . 2.26 112.003 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.536 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 73.0 m-85 -124.75 143.62 50.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.932 -0.576 . . . . 4.84 109.852 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 181' ' ' ARG . 6.4 m-20 -93.12 107.31 24.26 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 2.51 111.844 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 19.4 Cg_exo -69.1 -13.52 36.48 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.934 2.423 . . . . 1.47 112.001 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 179' ' ' ASP . 16.7 ptt180 -66.09 -16.85 64.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.375 . . . . 3.16 110.48 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.49 6.84 67.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.853 -0.612 . . . . 1.12 111.822 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 67.1 mt -110.96 -32.0 6.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.286 0.565 . . . . 2.37 109.557 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.06 127.11 73.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.41 -0.814 . . . . 3.87 111.339 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.37 -174.57 1.46 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.244 2.629 . . . . 2.51 113.099 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.77 -58.72 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.834 0.679 . . . . 3.23 112.834 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 19.7 m -61.52 125.06 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.801 0.334 . . . . 2.03 111.008 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.0 tp -104.22 62.67 0.74 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.588 0.708 . . . . 2.5 109.87 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.456 ' O ' HD12 ' A' ' 211' ' ' LEU . 24.2 m-20 -133.67 -177.86 4.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.994 -1.113 . . . . 1.81 107.994 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.2 p90 -163.01 155.03 18.14 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.308 -0.957 . . . . 5.32 112.625 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.467 ' CE2' ' HG3' ' A' ' 212' ' ' LYS . 57.4 m95 -96.35 142.31 28.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.752 -1.113 . . . . 4.55 109.331 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 256' ' ' LYS . 19.1 m -74.81 79.23 2.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.081 0.467 . . . . 2.39 109.786 173.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.404 ' HB3' ' CG2' ' A' ' 210' ' ' VAL . 41.0 t80 -117.89 103.08 50.7 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.629 . . . . 5.32 109.967 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.65 146.36 76.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.255 2.637 . . . . 2.47 113.087 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.666 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -139.66 153.15 22.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.508 -0.853 . . . . 2.0 112.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.882 0.372 . . . . 3.36 110.154 171.159 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.969 0.414 . . . . 3.51 112.022 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.41 67.12 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.732 0.777 . . . . 3.37 110.281 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.9 m -118.24 24.71 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.223 -0.899 . . . . 2.47 110.491 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 70.7 t -120.38 134.39 64.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.65 -0.705 . . . . 1.74 110.159 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.2 m -73.63 121.7 21.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.597 -0.729 . . . . 2.3 109.629 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.424 ' CE3' HG22 ' A' ' 192' ' ' THR . 0.0 OUTLIER -64.48 99.49 0.31 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.072 -0.967 . . . . 6.37 111.981 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 58.3 mt -142.43 100.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.326 -0.397 . . . . 2.32 110.368 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 73.3 t -117.25 119.14 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.286 -0.264 . . . . 2.1 110.286 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 189' ' ' ASP . 9.8 tp -62.06 123.2 17.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.228 -0.286 . . . . 2.35 110.228 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 191' ' ' TRP . 29.2 ttpp -65.59 -8.31 19.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.716 1.376 . . . . 3.47 114.716 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 36.3 tt0 -105.93 110.06 63.74 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 119.776 -0.77 . . . . 1.56 111.096 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 25.7 Cg_exo -64.49 137.66 56.18 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.776 2.317 . . . . 1.37 111.578 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -97.49 149.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.745 -0.465 . . . . 1.85 109.745 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.58 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 17.0 t -103.34 120.7 41.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.207 -0.664 . . . . 1.78 109.207 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.47 162.95 8.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.996 -0.372 . . . . 1.64 109.996 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 16.2 t -81.92 151.09 27.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.121 -0.325 . . . . 1.52 110.121 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.635 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 13.9 m -55.67 -43.17 76.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.405 -0.361 . . . . 1.81 110.83 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 12.3 tp10 -59.42 -32.51 70.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 2.51 111.019 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -67.18 -49.92 62.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 1.02 110.741 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.622 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 31.2 m -71.0 -29.75 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.351 . . . . 1.88 111.944 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 219' ' ' SER . 91.1 mt -63.9 -26.54 68.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 1.59 110.84 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 58.1 mtpt -82.68 -22.67 34.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 2.3 110.86 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.6 m-85 -70.12 -34.05 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.514 -0.55 . . . . 3.18 109.514 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.92 -14.62 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 3.55 111.042 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -95.61 -3.12 46.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.406 -0.361 . . . . 2.74 111.528 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.69 154.6 21.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.226 0.536 . . . . 1.66 111.224 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.45 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.3 m120 -119.81 159.48 24.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.266 -0.642 . . . . 1.13 109.266 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -105.62 -4.64 20.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 4.38 110.424 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.8 p-10 -85.1 176.14 8.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 1.62 110.091 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -104.09 169.12 17.37 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.143 -0.783 . . . . 1.16 111.143 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -55.24 143.58 27.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 3.56 110.647 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.76 23.83 54.8 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.052 -0.594 . . . . 2.23 112.923 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.4 153.33 76.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 117.247 0.523 . . . . 2.59 109.851 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.06 127.74 23.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.531 2.154 . . . . 1.5 111.01 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.0 118.68 4.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.623 0.725 . . . . 3.4 112.783 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -114.13 110.39 19.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.855 -1.066 . . . . 2.47 109.121 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.55 139.64 47.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.336 -0.393 . . . . 2.6 111.077 -176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.6 ttm -87.52 91.52 8.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.391 -0.596 . . . . 1.94 109.391 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.69 154.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.203 -0.453 . . . . 1.67 111.356 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.5 t70 69.06 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.077 0.861 . . . . 2.18 110.524 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 58.9 t30 56.3 20.38 4.59 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.177 0.806 . . . . 2.64 113.177 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -151.32 167.44 27.87 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.056 -0.403 . . . . 5.31 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -125.09 147.7 57.91 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 115.802 -0.635 . . . . 6.91 110.675 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -43.9 146.54 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.051 2.501 . . . . 3.72 112.553 168.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.94 142.65 47.84 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.196 1.184 . . . . 3.34 114.196 -166.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -74.76 159.55 82.89 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.675 -1.148 . . . . 4.92 110.303 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.57 174.48 8.76 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.454 2.77 . . . . 4.01 113.729 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.635 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 89.2 mt -66.14 -9.5 32.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.81 -1.086 . . . . 4.9 112.081 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 74.3 mmtt -58.67 46.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.623 1.342 . . . . 5.68 114.623 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 51.5 t30 120.19 6.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.559 1.944 . . . . 5.11 110.721 176.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 1.2 mpt_? -132.98 104.02 6.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.716 -0.674 . . . . 6.74 109.298 171.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -114.5 145.63 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.757 0.313 . . . . 3.08 111.099 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.3 mm -100.88 126.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.027 -0.533 . . . . 3.06 110.35 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.544 ' HB2' ' OG1' ' A' ' 192' ' ' THR . 96.4 mttt -117.19 150.78 38.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.703 -0.851 . . . . 3.01 108.703 172.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -115.94 95.8 5.28 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.705 -0.479 . . . . 1.99 109.705 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 68.6 m -80.69 94.66 6.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.728 -0.789 . . . . 2.47 110.506 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -140.19 111.02 6.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.3 -1.318 . . . . 5.03 108.833 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-N 116.053 -0.521 . . . . 4.82 110.956 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--O 1.231 0.103 0 N-CA-C 108.252 -1.018 . . . . 3.14 108.252 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -97.67 126.15 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.732 0.301 . . . . 2.71 111.757 -170.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.85 117.48 34.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.426 -0.352 . . . . 2.82 110.239 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -30.42 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.782 -0.645 . . . . 2.71 112.148 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -83.14 -15.61 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.589 -0.278 . . . . 5.23 111.495 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.443 HG21 ' CD1' ' A' ' 250' ' ' LEU . 88.5 m -98.23 -29.35 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.655 0.264 . . . . 3.38 111.26 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 130.62 44.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.76 111.259 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.39 124.31 45.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 4.05 109.93 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.14 113.33 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.488 -0.56 . . . . 4.9 109.488 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -118.62 118.72 33.32 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 2.27 109.669 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -53.82 91.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 123.583 2.855 . . . . 2.45 113.599 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 p -58.89 -30.85 68.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.743 -0.662 . . . . 4.62 110.844 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt 71.28 -64.92 0.36 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.323 -0.853 . . . . 5.15 111.65 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -76.0 130.63 77.74 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.737 0.303 . . . . 4.21 110.729 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.58 158.58 32.23 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.723 2.282 . . . . 2.76 111.925 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 48' ' ' SER . 6.5 tt -91.52 140.29 29.89 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.333 -0.617 . . . . 2.93 109.333 -178.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.488 ' N ' HD22 ' A' ' 47' ' ' LEU . 2.0 t -144.6 139.33 28.02 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.848 -0.797 . . . . 2.46 108.848 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.33 128.88 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.048 0.452 . . . . 2.17 111.929 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.5 t -118.94 90.04 3.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.079 -0.711 . . . . 1.87 109.079 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.76 13.84 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 3.97 110.421 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.69 -31.65 68.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 2.48 111.213 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 13.9 mt-30 -109.35 17.35 21.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 2.54 110.736 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.24 114.48 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.37 . . . . 1.41 110.922 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 m -101.35 106.24 17.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.049 -0.523 . . . . 1.41 110.734 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -85.42 151.49 23.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.799 -0.637 . . . . 1.84 109.712 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.24 -57.54 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 1.45 111.545 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -167.34 159.63 12.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.64 0.257 . . . . 3.72 111.036 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 14.1 tt -104.99 140.6 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.317 -0.623 . . . . 1.35 109.317 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -130.29 140.53 50.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.115 0.483 . . . . 1.53 111.555 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.22 108.6 20.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.732 -1.211 . . . . 1.49 107.732 170.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -137.83 71.55 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.572 -0.851 . . . . 2.18 111.791 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.62 -75.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 119.941 -1.123 . . . . 2.0 112.851 159.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.447 ' NE2' ' HB3' ' A' ' 243' ' ' ASN . 52.4 t-80 -112.59 -12.85 13.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.056 0.391 . . . . 4.11 112.056 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -154.2 175.99 12.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.997 0.427 . . . . 1.78 111.748 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.79 103.8 9.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.414 -0.958 . . . . 3.48 108.414 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.94 134.97 47.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.155 0.502 . . . . 1.99 111.87 -170.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 48.4 t -100.25 112.13 31.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.309 -0.626 . . . . 1.75 109.309 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.48 130.87 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 2.02 112.198 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -111.87 163.7 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.397 -0.964 . . . . 2.19 108.397 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.05 121.49 27.09 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.614 -0.434 . . . . 1.33 111.372 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.609 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 10.0 t0 -114.72 60.42 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.884 0.849 . . . . 2.65 109.75 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 t -116.47 -15.49 10.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 2.01 110.134 165.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -137.6 160.79 38.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.496 -0.557 . . . . 2.35 109.496 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -82.33 64.71 7.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.27 0.557 . . . . 1.92 110.207 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.553 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 67.6 mttm -79.18 -51.22 9.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.434 -0.803 . . . . 2.31 110.003 -177.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.88 105.2 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 1.44 109.215 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.14 139.98 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.046 0.451 . . . . 1.82 110.914 -172.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 14.7 tp -109.55 148.89 30.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.819 -0.628 . . . . 1.8 110.969 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 93.5 mttt -116.55 141.51 48.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.024 -1.102 . . . . 3.02 108.024 164.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.2 168.73 31.42 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.271 -0.966 . . . . 1.44 112.229 -165.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.513 ' HA3' ' HH ' ' A' ' 190' ' ' TYR . . . -60.63 -146.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 112.263 -0.335 . . . . 2.15 112.263 169.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.43 121.66 9.42 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.09 1.86 . . . . 3.17 112.095 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.423 HD22 ' CD1' ' A' ' 88' ' ' TYR . 8.3 tp -179.63 157.57 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.024 -1.102 . . . . 4.55 108.024 -175.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.57 111.32 13.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.987 1.106 . . . . 4.95 113.987 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.1 -101.66 0.96 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.441 -0.885 . . . . 2.25 114.858 161.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 89' ' ' ARG . 33.4 m -130.95 103.92 6.83 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.487 -0.56 . . . . 2.12 109.487 -167.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.501 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 1.3 m-85 -95.44 91.52 6.24 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.608 -0.437 . . . . 3.88 110.044 -172.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 55.9 mtt180 -107.27 146.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.717 0.294 . . . . 3.87 110.568 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 57.8 tp -77.84 123.86 27.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.552 -0.536 . . . . 1.68 109.552 171.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.1 -40.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.176 -0.465 . . . . 2.16 110.02 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -174.89 168.51 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.764 -0.653 . . . . 1.95 109.715 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.28 150.01 47.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.199 -0.667 . . . . 0.98 109.199 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 7.6 p-80 -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.632 0.254 . . . . 1.07 110.863 -172.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -134.37 158.89 42.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 3.99 110.347 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -165.13 179.39 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.644 0.259 . . . . 2.2 111.36 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.636 ' CD1' ' HA ' ' A' ' 242' ' ' ASP . 2.9 t90 74.0 -100.46 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.066 0.946 . . . . 6.08 110.407 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 53.02 15.58 3.57 Favored Glycine 0 N--CA 1.475 1.241 0 N-CA-C 115.278 0.871 . . . . 2.19 115.278 174.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.498 ' H ' ' HD1' ' A' ' 97' ' ' TRP . 48.3 p -45.7 -53.92 8.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.896 0.702 . . . . 3.08 112.896 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.7 mt -128.53 146.86 50.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.477 -0.564 . . . . 3.48 109.477 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.69 -13.23 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 3.85 111.613 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.55 -10.26 41.59 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.347 -0.93 . . . . 2.37 113.017 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.39 119.27 2.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.579 0.704 . . . . 2.62 111.725 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.28 41.32 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.658 -0.701 . . . . 1.62 111.794 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.4 p -105.8 -14.09 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 2.24 112.298 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.76 174.23 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.463 -0.569 . . . . 3.72 109.463 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.589 ' HE2' ' CD ' ' A' ' 117' ' ' GLU . 14.9 p80 44.09 68.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.312 1.053 . . . . 4.03 111.426 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.6 t -75.97 130.41 38.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.515 -1.22 . . . . 2.99 110.681 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 23.3 t -101.76 105.69 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 114.378 -1.283 . . . . 2.88 110.171 -172.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 55.31 50.76 14.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.568 -0.742 . . . . 2.8 109.472 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 68.33 1.14 2.77 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.238 -0.892 . . . . 5.35 112.607 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 47.8 tptt -89.75 123.72 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 3.58 110.968 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.69 155.96 27.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.809 -0.632 . . . . 3.26 110.31 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.69 168.89 9.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.101 -0.703 . . . . 1.71 109.101 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.43 79.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.274 0.472 . . . . 1.57 112.274 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.46 171.32 7.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.219 -0.66 . . . . 1.3 109.219 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.589 ' CD ' ' HE2' ' A' ' 107' ' ' HIS . 28.8 tt0 -142.24 138.43 31.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.067 0.461 . . . . 1.85 110.509 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.3 tp -102.43 126.49 49.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.43 -0.804 . . . . 1.61 109.448 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.402 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 42.4 m170 -107.98 110.27 21.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 2.25 111.147 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 6.8 mp -94.68 103.44 15.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.678 -0.49 . . . . 1.51 109.678 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.419 HG23 HG11 ' A' ' 142' ' ' VAL . 19.3 t -76.85 100.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.008 -0.542 . . . . 1.24 110.436 -176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 90' ' ' LEU . 3.2 p80 -138.97 76.19 1.56 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.755 1.021 . . . . 2.86 113.755 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.0 t90 178.91 99.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.345 0.658 . . . . 4.96 109.856 149.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.558 ' ND2' ' HB3' ' A' ' 133' ' ' ALA . 24.8 t-20 -124.62 90.48 3.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 118.612 -0.708 . . . . 2.3 111.561 157.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.5 m -81.28 -51.98 7.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 120.819 1.645 . . . . 2.77 111.492 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -43.57 -32.77 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 114.549 1.314 . . . . 3.79 114.549 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.98 -16.35 6.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.133 -0.627 . . . . 3.34 111.851 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.38 38.91 51.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.583 -0.607 . . . . 2.37 111.583 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.457 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 12.3 t70 -169.33 110.48 0.47 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.675 -0.861 . . . . 3.93 108.675 -171.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -63.44 -32.12 73.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.943 0.349 . . . . 3.6 111.943 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.71 98.64 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.921 -0.657 . . . . 2.35 112.818 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.457 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 31.7 mmmt -74.32 -20.99 59.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.276 0.56 . . . . 3.75 110.311 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.558 ' HB3' ' ND2' ' A' ' 124' ' ' ASN . . . -74.75 -20.95 59.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 2.17 111.988 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.6 t -61.11 -22.08 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.152 -0.476 . . . . 3.11 111.566 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -98.18 8.09 45.32 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.158 -0.339 . . . . 3.55 111.572 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.481 ' NE2' ' HD2' ' A' ' 137' ' ' PRO . 12.9 mm100 -122.86 127.47 25.72 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.662 0.267 . . . . 3.02 111.161 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.481 ' HD2' ' NE2' ' A' ' 136' ' ' GLN . 11.2 Cg_endo -55.3 -32.96 83.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.604 2.869 . . . . 1.93 113.465 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.61 28.42 8.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.796 -0.446 . . . . 2.29 109.796 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.19 -27.91 73.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.048 -0.596 . . . . 1.5 114.319 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.8 mt -137.19 170.29 16.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.459 . . . . 1.98 111.564 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.14 118.58 6.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 1.83 109.472 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 33.8 m -113.4 142.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 2.28 111.064 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.0 tp -95.46 103.85 15.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.786 . . . . 2.89 108.879 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.6 3.66 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.044 -0.598 . . . . 0.95 112.223 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 32.3 mt -102.62 124.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.866 -0.42 . . . . 1.38 109.866 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 48.8 m-85 -68.2 148.2 51.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 1.37 110.898 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.6 mp -118.56 138.3 52.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.498 -0.556 . . . . 1.48 109.498 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -143.23 146.55 33.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.891 -0.781 . . . . 2.52 108.891 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 95.7 t -83.79 130.87 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.099 0.476 . . . . 1.88 111.663 -171.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.45 -110.14 0.24 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.872 -0.891 . . . . 1.53 110.872 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 t -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.313 -0.625 . . . . 2.08 109.313 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.0 158.27 23.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.608 0.242 . . . . 1.36 110.987 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -115.94 106.2 50.06 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.922 -0.399 . . . . 1.78 109.922 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 51.1 Cg_exo -54.96 -35.77 90.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.08 2.52 . . . . 1.34 112.362 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.58 71.98 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.992 -0.623 . . . . 0.75 112.645 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.433 ' HB3' HE22 ' A' ' 221' ' ' GLN . 19.1 tp -88.05 -20.25 26.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.47 -0.567 . . . . 1.39 109.47 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 19.8 mm-40 -52.82 -37.34 59.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.546 -0.752 . . . . 1.63 110.647 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 175' ' ' PHE . 57.3 mttp -54.01 -54.27 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.458 0.474 . . . . 3.26 111.601 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.438 ' HA ' HG11 ' A' ' 162' ' ' VAL . 11.4 p -74.62 -37.26 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.91 0.386 . . . . 1.97 110.762 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 80.6 t -64.94 -34.97 74.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.419 0.628 . . . . 1.64 110.808 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.66 -32.84 71.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.063 -0.517 . . . . 1.22 111.317 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 159' ' ' VAL . 9.3 p -89.58 -20.74 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.17 0.433 . . . . 2.07 112.17 -173.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 228' ' ' LEU . 3.0 pp -67.84 -16.92 64.33 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.071 0.463 . . . . 1.95 111.161 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.452 ' N ' HD11 ' A' ' 163' ' ' LEU . 9.8 t70 -65.04 -23.35 67.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 2.31 110.325 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.7 m -89.73 1.71 55.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 1.78 111.935 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.96 39.23 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.513 0.673 . . . . 1.42 110.078 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 89.0 tttt -59.62 -22.59 62.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.146 -0.933 . . . . 1.98 111.666 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.1 p -120.18 137.56 54.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.51 -0.314 . . . . 1.4 110.812 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.514 ' HD2' ' O ' ' A' ' 230' ' ' PHE . 15.0 ptmm? -56.07 137.09 51.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.053 -0.521 . . . . 2.84 111.348 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.33 -30.46 8.23 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.976 -0.63 . . . . 0.85 111.816 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -81.8 153.79 26.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.06 0.457 . . . . 2.22 110.91 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.9 t -145.84 151.84 38.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.622 -0.717 . . . . 1.93 109.499 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -133.58 126.29 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.604 -0.271 . . . . 1.17 110.312 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.38 131.15 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 1.8 110.495 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -144.55 86.09 1.8 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 1.31 110.523 -176.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.6 p -95.99 160.92 14.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.703 0.287 . . . . 1.69 111.485 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 21.1 m120 65.19 29.8 11.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.774 -0.648 . . . . 2.26 112.331 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -87.47 119.9 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.464 -0.569 . . . . 4.84 109.464 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.74 112.7 63.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.995 0.426 . . . . 2.51 111.024 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.49 -17.83 60.92 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.82 2.347 . . . . 1.47 111.723 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -53.95 -40.07 66.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.554 -0.748 . . . . 3.16 110.861 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -64.89 -18.33 64.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.666 -0.697 . . . . 1.12 113.704 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.8 mt -96.83 -11.96 24.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.261 0.53 . . . . 2.37 111.701 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 96.7 mt -63.85 123.72 82.64 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.727 0.299 . . . . 3.87 111.563 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.46 ' HB2' ' HG2' ' A' ' 213' ' ' GLU . 2.5 Cg_endo -82.49 -170.04 0.86 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.221 2.614 . . . . 2.51 112.154 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.47 -66.19 0.92 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.159 0.8 . . . . 3.23 113.159 -174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 20.1 m -65.48 114.66 5.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.15 0.5 . . . . 2.03 111.357 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 17.8 tp -103.15 70.57 1.07 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 2.5 110.744 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 211' ' ' LEU . 3.0 m-20 -130.33 174.32 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.39 -0.967 . . . . 1.81 108.39 176.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.693 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 38.4 p90 -166.36 154.7 10.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.559 0.948 . . . . 5.32 113.559 -164.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.613 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 4.1 m95 -107.78 149.74 27.84 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.239 -1.393 . . . . 4.55 107.239 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.7 t -138.38 103.03 4.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.97 0.804 . . . . 2.39 112.799 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.39 157.84 69.88 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.924 -0.58 . . . . 5.32 110.492 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.04 137.21 78.28 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.731 2.288 . . . . 2.47 112.366 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -134.25 156.97 22.66 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.303 -0.475 . . . . 2.0 113.563 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.33 -0.254 0 C-N-CA 122.642 0.377 . . . . 3.36 110.04 179.781 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.764 0.316 . . . . 3.51 110.53 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.4 66.77 0.89 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.861 0.838 . . . . 3.37 109.581 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.0 11.76 30.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.774 -1.103 . . . . 2.47 111.026 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.73 149.63 22.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.077 0.465 . . . . 1.74 111.414 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.4 m -103.03 107.86 18.82 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 2.3 107.989 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -80.89 100.08 8.68 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.737 -0.468 . . . . 6.37 109.737 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 55.3 mt -99.91 100.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.01 -0.541 . . . . 2.32 109.742 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 45.4 t -85.11 119.35 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.251 -0.432 . . . . 2.1 110.852 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 189' ' ' ASP . 46.2 tp -80.41 122.43 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.439 . . . . 2.35 110.612 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -48.44 -28.74 3.46 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.082 1.142 . . . . 3.47 114.082 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.46 ' HG2' ' HB2' ' A' ' 185' ' ' PRO . 5.7 tp10 -102.98 114.42 65.25 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.396 -0.522 . . . . 1.56 110.926 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.436 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 90.5 Cg_endo -80.01 148.61 19.6 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.803 2.335 . . . . 1.37 111.893 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 34.4 pt -101.88 149.44 6.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 1.85 110.559 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.7 p -101.93 117.53 35.02 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.462 -0.79 . . . . 1.78 110.098 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 32.6 m -115.76 168.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.137 -0.483 . . . . 1.64 110.049 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.3 t -90.65 148.78 22.41 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.741 -0.384 . . . . 1.52 110.417 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.55 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 10.6 p -53.66 -45.0 70.11 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.507 0.505 . . . . 1.81 111.502 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.0 -31.53 71.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.647 -0.251 . . . . 2.51 111.306 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.433 HE22 ' HB3' ' A' ' 156' ' ' LEU . 54.5 mt-30 -62.51 -51.09 68.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.7 0.286 . . . . 1.02 110.628 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.65 -26.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.933 -0.307 . . . . 1.88 111.156 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 219' ' ' SER . 88.3 mt -69.44 -36.07 76.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 1.59 110.883 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -66.11 -31.44 72.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.064 0.459 . . . . 2.3 110.764 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -69.7 -39.32 76.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.594 -0.73 . . . . 3.18 109.754 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -72.0 -3.62 23.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.24 -0.891 . . . . 3.55 111.011 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 98.5 mttt -94.34 -1.38 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 2.74 110.665 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 163' ' ' LEU . 55.6 mt -90.41 155.08 19.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.037 -0.529 . . . . 1.66 110.775 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -112.36 155.7 23.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.51 -0.314 . . . . 1.13 110.354 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.514 ' O ' ' HD2' ' A' ' 169' ' ' LYS . 50.4 p90 -111.52 -18.42 12.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.215 -0.448 . . . . 4.38 110.293 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.509 HD21 ' HB2' ' A' ' 235' ' ' GLU . 6.2 p-10 -71.51 -31.83 67.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.62 111.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.455 ' CA ' ' HG2' ' A' ' 169' ' ' LYS . . . 97.99 -159.71 20.79 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.564 -0.827 . . . . 1.16 113.018 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.17 150.38 20.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.686 0.279 . . . . 3.56 110.34 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.19 4.22 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.01 -0.615 . . . . 2.23 112.685 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.509 ' HB2' HD21 ' A' ' 231' ' ' ASN . 41.6 mt-10 -134.92 159.55 71.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.447 -0.575 . . . . 2.59 109.447 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.91 129.92 37.87 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.772 2.315 . . . . 1.5 112.005 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.64 114.35 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 3.4 111.839 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.71 117.82 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.393 -0.595 . . . . 2.47 109.393 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.21 136.24 55.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.789 -0.642 . . . . 2.6 111.206 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.5 ttm -81.32 89.94 6.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.668 -0.697 . . . . 1.94 109.49 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.73 153.59 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 1.67 109.804 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.636 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 13.6 t70 64.75 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.885 0.741 . . . . 2.18 110.607 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . 0.447 ' HB3' ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER 52.23 27.33 4.61 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.56 0.948 . . . . 2.64 113.56 179.027 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.444 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 73.8 m95 -139.84 169.32 17.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.902 0.382 . . . . 5.31 110.81 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -117.35 148.91 43.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 6.91 111.573 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -33.23 138.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.921 3.747 . . . . 3.72 115.014 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.91 143.82 24.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.683 -1.144 . . . . 3.34 112.209 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 28.4 mm-40 -107.97 130.36 22.9 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 4.92 110.894 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 248' ' ' GLN . 27.4 Cg_exo -63.23 175.17 2.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.52 2.813 . . . . 4.01 113.956 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 37' ' ' THR . 49.8 mt -62.17 -11.19 13.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.207 -1.361 . . . . 4.9 113.402 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 18.5 ptpt -57.79 47.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.234 1.938 . . . . 5.68 116.234 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 7.5 t30 127.4 25.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 126.372 1.869 . . . . 5.11 111.106 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 252' ' ' ASN . 0.0 OUTLIER -141.94 110.76 6.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.083 -0.71 . . . . 6.74 109.083 166.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.02 121.81 45.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.072 -0.714 . . . . 3.08 109.072 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.6 mm -82.95 115.58 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.181 0.515 . . . . 3.06 112.262 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.56 127.5 40.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.639 -0.71 . . . . 3.01 109.555 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -116.37 146.09 42.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.717 -0.475 . . . . 1.99 109.717 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 19.5 m -142.41 96.43 2.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.426 0.631 . . . . 2.47 110.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.418 ' HA ' ' OD1' ' A' ' 189' ' ' ASP . 86.5 t80 -126.54 90.69 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.548 -0.908 . . . . 5.03 108.548 166.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.375 -0.821 . . . . 4.82 109.823 -177.54 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 113.465 0.913 . . . . 3.14 113.465 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 26.2 mm -101.6 134.37 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.718 -1.128 . . . . 2.71 111.2 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.408 ' HB3' ' OG1' ' A' ' 37' ' ' THR . 16.2 t70 -107.32 113.45 26.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.963 -0.384 . . . . 2.82 109.963 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -56.67 -33.11 66.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.319 0.859 . . . . 2.71 113.319 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -75.07 -41.29 59.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.876 -0.329 . . . . 5.23 111.109 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 7.3 p -72.55 -27.53 62.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.801 0.334 . . . . 3.38 110.532 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -69.89 84.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.277 0.56 . . . . 1.76 110.443 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -79.73 134.43 36.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.692 -0.685 . . . . 4.05 109.656 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 2.5 p90 -81.68 124.52 29.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.194 0.521 . . . . 4.9 110.297 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -118.0 119.9 33.12 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 2.27 109.621 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.32 24.57 0.31 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.999 2.466 . . . . 2.45 113.728 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.8 p -95.86 -17.21 21.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.268 0.556 . . . . 4.62 109.51 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.77 124.51 30.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.493 -0.776 . . . . 5.15 109.768 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -115.15 136.57 22.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.122 -0.49 . . . . 4.21 110.922 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.07 122.84 12.42 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.825 2.35 . . . . 2.76 112.049 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 6.2 mp -78.62 132.96 37.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 2.93 110.904 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.6 t -84.56 138.04 32.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.466 -0.568 . . . . 2.46 109.466 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.0 t -118.37 121.78 67.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.192 -0.458 . . . . 2.17 110.832 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.3 p -111.55 89.91 3.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.438 -0.578 . . . . 1.87 109.438 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HH ' ' HG3' ' A' ' 181' ' ' ARG . 30.4 p90 -109.84 10.01 24.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.687 -0.688 . . . . 3.97 110.098 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.8 -34.72 65.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.386 -0.825 . . . . 2.48 111.544 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.7 13.66 29.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.278 0.473 . . . . 2.54 112.278 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.29 113.57 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 1.41 111.923 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.8 m -107.33 109.83 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.847 -0.615 . . . . 1.41 110.547 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 178' ' ' PHE . 18.1 m -78.57 145.51 34.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.404 -0.362 . . . . 1.84 110.617 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -115.64 -55.77 2.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 1.45 111.718 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 58' ' ' ARG . 12.3 ptm180 -166.6 159.09 13.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 3.72 111.271 -173.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 tt -112.16 137.5 44.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 1.35 109.934 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -129.39 135.76 49.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.894 0.378 . . . . 1.53 111.681 -173.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.99 117.99 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.375 -0.972 . . . . 1.49 108.375 172.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -137.48 71.02 1.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.662 -0.815 . . . . 2.18 112.311 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 230' ' ' PHE . . . 99.53 -58.84 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.342 -0.932 . . . . 2.0 113.885 157.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -125.56 -9.1 6.83 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.691 -0.403 . . . . 4.11 111.82 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -160.49 177.74 10.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.804 -0.443 . . . . 1.78 109.804 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -139.3 136.72 35.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.256 -1.016 . . . . 3.48 108.256 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.01 151.93 48.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.063 0.459 . . . . 1.99 111.941 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.8 127.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.381 -0.827 . . . . 1.75 109.51 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.82 137.03 33.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 2.02 110.984 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -112.95 170.1 8.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.356 -0.838 . . . . 2.19 109.475 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 14.3 t70 -98.89 132.16 44.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.005 0.431 . . . . 1.33 110.92 174.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.509 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 22.6 t70 -137.1 62.29 1.6 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.227 -0.897 . . . . 2.65 109.118 170.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -80.67 -4.52 54.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.116 0.96 . . . . 2.01 108.626 166.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.546 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -163.63 148.98 11.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.026 -1.842 . . . . 2.35 106.026 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -61.68 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.138 0.97 . . . . 1.92 111.783 -171.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 61.7 mttm -91.9 -53.2 4.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.906 -1.043 . . . . 2.31 111.021 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.39 104.61 10.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.994 -0.548 . . . . 1.44 109.638 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.6 t -117.44 153.03 19.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.75 -0.463 . . . . 1.82 109.75 -176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tt -147.7 112.65 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 1.8 109.561 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.95 132.52 8.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.642 0.734 . . . . 3.02 111.622 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 47' ' ' LEU . . . -76.48 174.36 53.78 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 114.899 -1.046 . . . . 1.44 112.152 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.66 -142.88 0.0 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 124.259 0.623 . . . . 2.15 113.942 168.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.66 122.37 8.75 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 121.456 1.438 . . . . 3.17 111.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.476 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 7.9 tp -157.53 -167.66 2.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.947 -1.024 . . . . 4.55 108.428 -166.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.476 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 16.4 m-20 -123.64 32.67 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.741 0.305 . . . . 4.95 110.65 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.02 145.53 4.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.692 -0.766 . . . . 2.25 113.081 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.3 m -93.1 113.73 26.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.322 -0.622 . . . . 2.12 109.322 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 70.2 m-85 -101.33 127.91 47.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.155 0.503 . . . . 3.88 111.72 -171.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 123' ' ' TRP . 22.8 ptt180 -99.76 142.31 31.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.886 -0.597 . . . . 3.87 110.786 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 tt -92.42 120.09 32.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.371 -0.603 . . . . 1.68 109.371 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.633 HD12 ' CE3' ' A' ' 123' ' ' TRP . 36.8 mt -121.97 -15.65 6.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.42 -0.354 . . . . 2.16 111.099 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -166.54 162.71 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.167 -0.333 . . . . 1.95 110.227 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.454 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 41.4 p90 -140.49 140.5 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.22 -0.659 . . . . 0.98 109.22 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.473 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.4 p-80 -118.51 158.05 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.329 . . . . 1.07 110.227 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -133.69 156.97 46.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.143 -0.48 . . . . 3.99 109.967 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -152.07 139.4 19.43 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.753 -0.462 . . . . 2.2 109.753 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.618 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 68.9 t-105 -104.01 137.61 41.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.944 -0.571 . . . . 6.08 110.006 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -70.02 -60.97 4.55 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.962 -0.563 . . . . 2.19 113.165 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 29.0 t 162.23 -64.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 3.08 108.166 -176.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.0 mt -110.31 164.79 12.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.082 -0.963 . . . . 3.48 109.151 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -83.04 56.02 3.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.673 0.749 . . . . 3.85 110.86 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.75 -2.66 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.645 -0.707 . . . . 2.37 113.105 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.11 155.98 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.076 0.438 . . . . 2.62 110.385 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 100.67 -13.98 59.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.801 -0.714 . . . . 1.62 112.643 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.9 t -75.01 -32.84 61.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.49 . . . . 2.24 109.927 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 58.83 -159.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.55 -0.75 . . . . 3.72 110.122 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m80 58.37 30.72 20.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.428 -1.323 . . . . 4.03 107.428 -168.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.32 129.33 34.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.882 -1.508 . . . . 2.99 111.781 -166.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.2 m -100.15 111.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.825 -1.08 . . . . 2.88 110.606 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.63 43.21 12.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.964 -1.016 . . . . 2.8 110.406 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 68.3 20.95 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.125 -0.943 . . . . 5.35 112.078 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HE3' ' CZ ' ' A' ' 114' ' ' TYR . 4.4 tmmm? -102.81 89.55 3.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.985 0.422 . . . . 3.58 109.926 173.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -79.22 157.36 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 3.26 110.028 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.452 ' CZ ' ' HE3' ' A' ' 112' ' ' LYS . 82.2 m-85 -102.68 178.92 4.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.614 -0.266 . . . . 1.71 110.75 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.14 -47.22 68.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 1.57 111.381 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.415 ' HB3' ' CE3' ' A' ' 97' ' ' TRP . . . -155.77 168.16 28.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.041 -0.527 . . . . 1.3 110.539 -173.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -134.94 135.32 41.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 1.85 109.896 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.35 126.76 55.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.591 -0.522 . . . . 1.61 109.591 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.473 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -122.12 109.6 14.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.077 0.465 . . . . 2.25 111.695 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.3 mp -91.55 117.84 30.07 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.88 -0.785 . . . . 1.51 108.88 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.62 143.79 11.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.438 -0.346 . . . . 1.24 110.698 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 53.7 m-70 -138.81 134.7 33.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.633 -0.877 . . . . 2.86 108.633 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.633 ' CE3' HD12 ' A' ' 91' ' ' ILE . 37.5 m0 -111.23 140.99 45.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.457 -0.571 . . . . 4.96 109.457 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.79 112.97 2.03 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.889 -0.412 . . . . 2.3 109.889 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 t -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 2.77 110.828 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -63.35 -16.88 61.76 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.948 0.351 . . . . 3.79 111.948 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.96 -6.28 35.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.728 0.299 . . . . 3.34 110.711 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.77 18.84 0.76 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.16 -0.927 . . . . 2.37 115.189 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.511 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 21.7 t70 -170.59 125.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.652 0.726 . . . . 3.93 110.386 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.615 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.5 p90 -57.07 -40.72 77.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.98 -1.009 . . . . 3.6 111.054 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.01 -37.41 79.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.256 -0.497 . . . . 2.35 112.893 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.511 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 41.5 mmtm -76.9 -28.76 55.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 3.75 110.333 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -75.36 -35.04 61.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 2.17 111.133 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 130' ' ' PHE . 77.2 t -65.01 -25.87 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 3.11 110.37 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -95.38 17.94 13.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.053 0.454 . . . . 3.55 110.668 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 139' ' ' GLY . 4.3 tp-100 -131.24 121.77 18.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.168 -0.469 . . . . 3.02 109.952 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.79 -36.03 14.39 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.017 3.144 . . . . 1.93 113.619 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -110.74 27.65 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.965 0.412 . . . . 2.29 109.961 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -84.68 -42.65 7.19 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.159 -0.543 . . . . 1.5 113.541 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 69.0 mt -104.03 153.54 20.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.38 0.59 . . . . 1.98 110.469 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 122' ' ' HIS . . . -142.88 147.12 34.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.829 -0.623 . . . . 1.83 109.954 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.4 t -133.76 137.69 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.153 -0.476 . . . . 2.28 109.954 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -106.07 121.74 44.74 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.702 -0.481 . . . . 2.89 109.702 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.74 128.46 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.867 -0.682 . . . . 0.95 113.041 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.76 115.52 31.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.914 -0.402 . . . . 1.38 109.914 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -77.99 149.97 33.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.931 0.396 . . . . 1.37 111.168 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.04 134.94 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.835 -0.62 . . . . 1.48 110.361 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -127.16 144.52 51.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.471 -0.566 . . . . 2.52 109.471 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 19.6 m -86.75 130.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.389 0.614 . . . . 1.88 111.742 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.32 -104.54 0.18 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.224 -0.898 . . . . 1.53 111.391 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -81.19 150.98 28.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 2.08 109.919 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.31 149.84 45.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.224 -0.444 . . . . 1.36 111.229 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 216' ' ' SER . 22.5 tptm -119.45 96.14 49.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.003 -0.544 . . . . 1.78 109.904 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.56 -37.94 83.34 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.22 2.613 . . . . 1.34 112.524 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.94 -37.88 86.75 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.75 113.172 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 160' ' ' VAL . 61.9 tp -93.05 -22.43 19.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.082 0.441 . . . . 1.39 110.456 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -34.22 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 1.63 111.316 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -56.49 -41.75 77.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 3.26 110.904 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.58 -41.86 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 1.97 110.249 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 25.8 t -61.88 -33.81 59.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.374 0.606 . . . . 1.64 110.588 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.99 -37.06 78.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.797 -0.638 . . . . 1.22 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.91 -18.88 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 111.913 0.338 . . . . 2.07 111.913 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -66.32 -17.13 64.57 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.738 -0.385 . . . . 1.95 111.91 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.7 -24.06 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 2.31 110.881 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.5 m -84.8 0.43 50.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.264 -0.426 . . . . 1.78 111.427 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 163' ' ' LEU . 44.7 pt -137.4 44.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.345 0.593 . . . . 1.42 109.627 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.79 -36.98 80.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.436 -0.802 . . . . 1.98 111.697 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -114.51 151.93 32.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.708 -0.224 . . . . 1.4 110.734 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 21.4 pttm -63.56 140.85 58.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.046 0.45 . . . . 2.84 110.611 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.13 47.71 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.753 -0.737 . . . . 0.85 111.42 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.61 147.72 22.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.128 0.49 . . . . 2.22 111.144 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.3 p -144.11 150.42 38.08 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.502 -0.772 . . . . 1.93 109.49 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -135.43 133.71 38.88 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.737 -0.468 . . . . 1.17 109.737 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.07 129.83 43.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.156 0.503 . . . . 1.8 110.065 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -141.44 79.91 1.71 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.678 -0.86 . . . . 1.31 108.678 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.5 m -99.29 153.99 18.53 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.273 -0.876 . . . . 1.69 110.984 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.4 m120 54.78 77.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.188 0.595 . . . . 2.26 111.959 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.43 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 71.3 t80 -131.42 140.63 49.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.9 -0.591 . . . . 4.84 109.494 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.41 120.89 51.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.198 0.523 . . . . 2.51 110.639 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.27 -5.57 16.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.025 2.483 . . . . 1.47 111.948 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.414 ' HG3' ' HH ' ' A' ' 51' ' ' TYR . 42.1 ttp-105 -55.54 -36.95 67.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.773 -0.649 . . . . 3.16 110.975 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.05 8.08 61.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.968 -0.634 . . . . 1.12 112.417 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.6 mt -117.28 -38.95 3.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.984 0.421 . . . . 2.37 109.989 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.3 mt -73.1 131.44 83.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.727 -0.669 . . . . 3.87 111.101 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 5.8 Cg_exo -77.65 179.73 6.23 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.002 2.468 . . . . 2.51 112.361 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -84.76 -63.8 1.27 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.26 0.467 . . . . 3.23 112.26 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.3 t -78.06 134.7 37.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.653 0.263 . . . . 2.03 110.964 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.8 mt -113.21 60.84 0.64 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.946 0.403 . . . . 2.5 110.288 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 212' ' ' LYS . 4.5 m-20 -140.22 144.42 36.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.41 -0.959 . . . . 1.81 108.41 173.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.613 ' CD2' ' HA ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER 171.85 -171.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.415 -0.587 . . . . 5.32 109.415 -173.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 257' ' ' ALA . 25.7 p90 -81.3 151.24 28.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.487 -0.485 . . . . 4.55 110.127 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.442 ' OG1' HD13 ' A' ' 209' ' ' ILE . 4.7 t -167.29 116.92 0.84 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.573 0.702 . . . . 2.39 110.827 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.617 ' CD1' ' HD2' ' A' ' 251' ' ' LYS . 6.2 t80 -139.87 147.82 52.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.869 -0.789 . . . . 5.32 108.869 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 99.2 Cg_exo -47.64 151.19 3.51 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.628 2.219 . . . . 2.47 112.875 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.93 159.45 24.6 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.327 -0.851 . . . . 2.0 112.453 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 120.977 0.418 . . . . 3.36 110.166 -176.88 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.833 0.349 . . . . 3.51 110.988 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.86 93.23 4.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.177 -0.465 . . . . 3.37 111.707 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 5.7 p -139.25 24.49 2.51 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.779 0.659 . . . . 2.47 112.779 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.15 143.2 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.74 111.964 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.5 m -126.35 104.52 8.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.331 -0.618 . . . . 2.3 109.331 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -101.64 134.95 43.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.476 0.655 . . . . 6.37 112.144 -175.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.442 HD13 ' OG1' ' A' ' 192' ' ' THR . 7.9 mm -116.13 128.32 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.779 -1.1 . . . . 2.32 109.173 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 t -108.17 150.28 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.341 -0.614 . . . . 2.1 109.341 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -109.57 146.43 34.7 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.98 -0.288 . . . . 2.35 111.325 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 190' ' ' TYR . 37.5 ttmt -52.99 -60.28 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.765 0.654 . . . . 3.47 112.765 -176.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.86 114.88 34.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.696 -0.684 . . . . 1.56 111.68 -171.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.37 147.32 22.77 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.156 1.904 . . . . 1.37 110.5 174.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 pt -89.4 140.08 16.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.459 -0.496 . . . . 1.85 110.21 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 18.4 t -97.32 127.48 43.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.052 -0.522 . . . . 1.78 109.734 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 29.8 m -127.0 156.39 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.729 -0.668 . . . . 1.64 109.737 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.5 t -85.83 154.58 21.46 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.179 -0.304 . . . . 1.52 110.179 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.55 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 46.2 m -53.46 -42.35 67.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.001 0.188 . . . . 1.81 111.398 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 9.9 pt-20 -56.94 -27.77 61.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.605 -0.27 . . . . 2.51 111.634 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -77.08 -46.91 21.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.028 -0.36 . . . . 1.02 110.028 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.71 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 26.7 m -70.83 -28.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.88 111.228 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.7 mt -64.48 -33.57 76.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.298 -0.41 . . . . 1.59 110.558 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 65.2 mttp -74.97 -24.22 58.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 2.3 111.238 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.3 m-85 -67.0 -35.13 79.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.202 0.525 . . . . 3.18 109.851 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -84.45 13.96 4.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.696 -0.684 . . . . 3.55 110.578 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.0 mmtt -100.63 -14.96 17.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.79 -0.448 . . . . 2.74 109.79 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.9 mt -77.64 152.75 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 1.66 111.546 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.486 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 11.6 m120 -117.58 154.31 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 1.13 109.273 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 45.5 p90 -102.97 -11.55 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.492 -0.483 . . . . 4.38 110.252 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -75.26 169.5 17.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.821 -0.627 . . . . 1.62 111.022 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -85.89 171.72 45.15 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.867 -0.606 . . . . 1.16 111.889 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.64 128.58 36.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.961 0.41 . . . . 3.56 110.779 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 98.58 9.43 52.92 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.671 -0.695 . . . . 2.23 112.191 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -111.54 160.87 27.83 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.088 -0.338 . . . . 2.59 110.088 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.23 127.81 27.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.485 2.124 . . . . 1.5 111.165 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.09 110.3 1.02 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 3.4 111.517 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -117.28 115.23 24.86 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.001 -0.74 . . . . 2.47 109.001 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.3 135.0 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.267 0.556 . . . . 2.6 111.73 -172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.9 ttm -81.66 90.21 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.994 -1.003 . . . . 1.94 108.955 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.62 153.38 38.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.182 -0.463 . . . . 1.67 110.667 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.44 ' O ' ' HD1' ' A' ' 244' ' ' TRP . 16.7 t70 66.27 -88.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.36 1.037 . . . . 2.18 111.369 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.1 t30 47.67 43.19 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.55 0.531 . . . . 2.64 111.301 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.44 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 20.5 m95 -144.08 159.7 42.17 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.6 -0.687 . . . . 5.31 110.03 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -113.36 116.82 46.08 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.569 -0.53 . . . . 6.91 109.569 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -52.96 -86.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.177 2.585 . . . . 3.72 114.826 -167.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -108.29 99.49 8.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.239 0.542 . . . . 3.34 112.188 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -110.65 173.64 2.78 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 107.869 -1.16 . . . . 4.92 107.869 169.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.25 94.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.798 1.666 . . . . 4.01 111.129 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' A' ' 251' ' ' LYS . 1.6 pt? -64.34 -56.96 10.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.764 -0.653 . . . . 4.9 111.452 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.617 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 62.6 mmtt -122.46 -10.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.934 -0.306 . . . . 5.68 111.229 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.93 -48.19 0.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.152 0.981 . . . . 5.11 111.844 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 253' ' ' ARG . 67.3 mtt180 -89.17 -80.78 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 6.74 110.246 176.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -157.53 156.55 32.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.513 -0.551 . . . . 3.08 109.513 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 11.5 tt -112.8 148.72 15.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.637 0.256 . . . . 3.06 110.432 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.1 153.47 20.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.222 0.534 . . . . 3.01 111.158 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -131.01 171.44 13.23 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.153 -0.93 . . . . 1.99 109.032 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.5 p -163.46 98.8 0.91 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.985 0.421 . . . . 2.47 110.783 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.03 102.43 6.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.732 0.777 . . . . 5.03 109.963 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 17.1 pttm . . . . . 0 C--O 1.248 0.982 0 CA-C-N 115.007 -0.997 . . . . 4.82 110.226 -174.558 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.821 -0.437 . . . . 3.14 109.821 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 108' ' ' THR . 24.7 mm -71.41 128.24 34.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.981 0.896 . . . . 2.71 111.895 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.652 ' C ' ' H ' ' A' ' 36' ' ' HIS . 23.0 t70 -43.98 156.13 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.367 -1.742 . . . . 2.82 114.083 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' THR . 13.3 t -55.69 19.35 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.618 1.967 . . . . 2.71 113.434 172.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.652 ' H ' ' C ' ' A' ' 34' ' ' ASP . 33.5 p-80 -47.33 1.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.171 1.789 . . . . 5.23 114.663 -176.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' THR . 2.6 m -72.28 27.81 0.05 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.613 0.765 . . . . 3.38 109.086 163.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 36' ' ' HIS . . . -56.79 164.85 1.36 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.733 1.213 . . . . 1.76 112.884 -163.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.94 139.92 50.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.805 -1.088 . . . . 4.05 110.845 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.42 ' HB2' ' H ' ' A' ' 259' ' ' PHE . 7.9 p90 -59.93 123.76 18.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.141 -0.936 . . . . 4.9 112.241 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -86.72 133.16 40.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 2.27 110.618 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.84 -14.17 11.31 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.803 2.336 . . . . 2.45 114.354 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.9 p -93.11 -2.46 55.44 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.577 -0.449 . . . . 4.62 111.063 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.29 154.53 17.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.237 -0.438 . . . . 5.15 110.3 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -115.44 106.89 50.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 4.21 109.935 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.461 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 52.8 Cg_exo -56.1 120.07 7.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.614 2.21 . . . . 2.76 112.089 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 46' ' ' PRO . 12.7 mt -169.99 116.92 0.55 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.432 0.901 . . . . 2.93 113.432 -173.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 m -157.75 79.55 0.86 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.562 -0.903 . . . . 2.46 108.562 152.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.72 95.12 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.354 0.872 . . . . 2.17 113.354 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 39.7 m -142.23 85.44 1.92 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 121.439 1.927 . . . . 1.87 109.267 155.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.885 ' HH ' ' HE2' ' A' ' 122' ' ' HIS . 58.2 m-85 -134.18 19.14 3.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.208 -0.308 . . . . 3.97 111.052 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.73 -28.61 68.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 2.48 111.381 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -110.0 13.7 23.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.354 . . . . 2.54 111.634 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.1 127.01 29.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 1.41 111.383 -174.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -116.09 115.24 25.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.213 -0.449 . . . . 1.41 110.875 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 176' ' ' THR . 5.6 m -84.34 153.54 23.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.196 -0.456 . . . . 1.84 109.795 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -117.73 -57.23 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 1.45 111.926 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -170.01 164.63 9.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 3.72 111.436 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.2 tt -127.08 143.84 39.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.436 -0.802 . . . . 1.35 109.874 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 172' ' ' SER . 20.6 tp -144.75 121.14 10.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.955 0.354 . . . . 1.53 111.955 -173.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -68.5 109.1 3.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.967 -0.56 . . . . 1.49 109.495 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -141.4 70.63 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.786 -0.766 . . . . 2.18 112.766 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.67 -65.1 0.33 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.765 -1.207 . . . . 2.0 112.879 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -128.39 -11.92 5.08 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.948 -0.301 . . . . 4.11 111.473 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.96 -173.2 3.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 1.78 110.986 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.52 88.41 2.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 3.48 108.881 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.09 114.39 15.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.473 -0.785 . . . . 1.99 110.285 -171.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 5.5 p -94.1 124.13 46.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.887 -0.597 . . . . 1.75 110.184 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.87 132.62 40.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.867 -0.606 . . . . 2.02 111.604 -174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.25 152.63 22.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.184 -0.916 . . . . 2.19 109.784 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.76 129.4 45.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 1.33 109.828 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.09 63.97 1.4 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.89 -1.05 . . . . 2.65 109.961 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 p -79.91 -3.21 47.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.368 -0.833 . . . . 2.01 110.54 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.477 ' OE1' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -154.28 177.69 10.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.053 -1.462 . . . . 2.35 107.053 175.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.9 79.06 0.21 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.247 0.476 . . . . 1.92 111.5 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HE2' ' OE1' ' A' ' 74' ' ' GLN . 61.4 mttm -102.49 -66.13 0.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.597 -0.274 . . . . 2.31 110.682 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.01 84.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.391 0.615 . . . . 1.44 110.06 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' SER . 17.8 m -115.25 150.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 1.82 110.467 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.6 tp -100.6 124.6 46.4 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.978 -0.555 . . . . 1.8 110.413 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -125.67 133.4 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.718 -0.845 . . . . 3.02 108.718 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' CB ' ' A' ' 47' ' ' LEU . . . -149.93 170.79 30.0 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 119.477 -0.624 . . . . 1.44 111.666 -170.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.36 -146.69 0.0 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 123.859 0.388 . . . . 2.15 113.161 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.39 119.81 6.43 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 121.564 1.51 . . . . 3.17 111.781 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.1 mt -157.01 -178.07 7.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.454 -0.794 . . . . 4.55 109.843 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -127.45 67.2 1.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.338 -0.392 . . . . 4.95 111.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.2 -170.59 14.23 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.635 -0.793 . . . . 2.25 112.904 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.531 ' O ' HG22 ' A' ' 125' ' ' THR . 30.7 m -105.65 134.97 47.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 2.12 110.162 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.523 ' CE1' ' HA3' ' A' ' 139' ' ' GLY . 33.1 m-85 -114.87 119.37 36.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 3.88 110.428 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HD3' ' CB ' ' A' ' 125' ' ' THR . 39.6 mtp180 -91.93 143.33 26.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.376 -0.375 . . . . 3.87 111.085 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 tt -88.61 128.84 35.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.642 -0.503 . . . . 1.68 109.642 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.1 tt -113.62 -34.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 2.16 110.509 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.539 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 5.3 pt20 -165.44 174.86 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 1.95 109.54 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -155.32 156.64 35.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.98 110.712 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -147.2 161.15 41.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 1.07 109.346 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CE2' HD12 ' A' ' 118' ' ' LEU . 69.1 m-85 -107.06 166.7 10.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 3.99 111.002 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -128.99 146.62 50.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.464 -1.68 . . . . 2.2 106.464 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.652 ' O ' ' HA ' ' A' ' 242' ' ' ASP . 8.3 m-90 -133.53 -169.66 2.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.434 0.561 . . . . 6.08 111.388 -170.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.42 24.99 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.721 -1.351 . . . . 2.19 109.721 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.1 t -70.89 -15.07 62.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.128 0.964 . . . . 3.08 110.478 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.2 mt -128.86 150.49 50.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.881 -0.785 . . . . 3.48 108.881 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.82 6.36 2.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.285 0.476 . . . . 3.85 112.285 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.35 24.78 6.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.509 -0.853 . . . . 2.37 112.455 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 18.0 pt20 -158.67 162.76 37.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.995 -0.372 . . . . 2.62 109.995 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.7 -18.91 16.7 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.316 -0.945 . . . . 1.62 112.281 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 99.2 p -69.02 -34.6 75.5 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.258 -0.177 . . . . 2.24 111.275 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 107' ' ' HIS . 1.0 OUTLIER 71.03 -173.13 0.17 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.426 -0.953 . . . . 3.72 108.426 -175.109 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.599 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 1.8 m-70 57.86 37.75 27.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.647 0.736 . . . . 4.03 109.723 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.594 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.3 123.46 29.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.669 -1.151 . . . . 2.99 112.404 -173.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.65 102.37 13.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.237 -0.892 . . . . 2.88 110.469 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.86 55.08 5.62 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.673 -0.694 . . . . 2.8 109.663 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 68.27 24.31 7.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.035 -0.984 . . . . 5.35 112.22 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -93.21 90.49 6.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 3.58 110.53 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.59 146.74 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 3.26 110.437 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 94.5 m-85 -100.77 -168.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.381 -0.372 . . . . 1.71 110.107 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.16 34.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.723 0.297 . . . . 1.57 111.725 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.84 168.24 21.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.387 -0.369 . . . . 1.3 110.5 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -124.29 151.89 43.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 1.85 109.485 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.52 HD12 ' CE2' ' A' ' 95' ' ' PHE . 57.3 tp -115.61 147.72 40.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.233 -0.284 . . . . 1.61 110.233 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -121.75 114.91 21.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.393 -0.595 . . . . 2.25 109.393 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.58 91.58 4.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.843 0.354 . . . . 1.51 110.12 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 46.6 t -65.68 117.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.365 0.602 . . . . 1.24 111.701 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.885 ' HE2' ' HH ' ' A' ' 51' ' ' TYR . 76.8 m80 -138.66 125.58 21.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.089 -1.078 . . . . 2.86 108.089 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.662 ' CD1' ' HB2' ' A' ' 130' ' ' PHE . 88.4 m95 -110.82 144.91 39.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.622 -0.431 . . . . 4.96 111.258 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.443 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 56.4 t30 -62.69 100.79 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.419 -0.81 . . . . 2.3 110.317 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 87' ' ' THR . 10.3 t -70.63 -24.34 62.71 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.065 0.765 . . . . 2.77 113.065 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -68.14 -5.14 16.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.429 0.529 . . . . 3.79 112.429 -174.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -95.42 17.49 14.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.788 0.804 . . . . 3.34 109.543 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.22 -3.58 10.45 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.491 -1.231 . . . . 2.37 115.786 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -173.5 145.19 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.577 1.189 . . . . 3.93 109.949 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.662 ' HB2' ' CD1' ' A' ' 123' ' ' TRP . 25.1 p90 -67.95 -43.12 79.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.854 -0.612 . . . . 3.6 111.705 -176.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.15 -28.81 73.43 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.072 -0.585 . . . . 2.35 112.182 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -81.27 -34.75 31.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.496 -0.557 . . . . 3.75 109.496 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.39 66.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.745 -0.661 . . . . 2.17 111.63 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.05 -19.39 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.297 0.57 . . . . 3.11 110.764 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.34 16.73 22.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 3.55 110.655 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.83 118.49 44.68 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.815 0.341 . . . . 3.02 111.133 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.587 ' HA ' ' SG ' ' A' ' 205' ' ' CYS . 25.0 Cg_exo -64.18 -20.61 67.31 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.691 2.261 . . . . 1.93 111.965 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.04 28.39 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.992 0.738 . . . . 2.29 112.992 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . 128.34 94.49 0.8 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.827 -1.654 . . . . 1.5 114.609 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 20.8 mt -97.0 -175.85 3.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.914 -0.772 . . . . 1.98 108.914 167.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' HIS . . . -71.2 124.85 25.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.581 0.705 . . . . 1.83 110.372 -167.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.1 m -77.93 164.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.506 -1.225 . . . . 2.28 112.331 -167.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.7 tp -85.54 143.86 28.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.665 -1.152 . . . . 2.89 111.264 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 170.94 42.69 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.782 -1.099 . . . . 0.95 112.186 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.4 HG23 ' HA ' ' A' ' 214' ' ' PRO . 11.2 mt -86.63 142.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.572 0.225 . . . . 1.38 110.76 -176.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -63.13 157.09 23.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 1.37 111.532 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.4 mp -113.01 137.46 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 1.48 110.686 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -129.76 143.41 50.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.95 -0.759 . . . . 2.52 108.95 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 24.1 t -108.66 81.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.312 -0.555 . . . . 1.88 112.281 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -165.95 67.17 0.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.377 -0.916 . . . . 1.53 112.342 165.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.537 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 19.3 t 157.95 126.43 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.541 -1.281 . . . . 2.08 107.541 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 138.45 41.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.74 -0.384 . . . . 1.36 110.671 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -104.89 98.41 15.31 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.474 -0.565 . . . . 1.78 109.474 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.59 -24.44 69.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.599 2.199 . . . . 1.34 112.719 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.2 6.55 79.14 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.865 -0.683 . . . . 0.75 113.104 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -110.67 -13.99 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 1.39 110.904 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.76 -36.53 76.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 1.63 111.518 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -49.18 -44.19 42.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.713 0.292 . . . . 3.26 111.165 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.21 -42.01 37.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 1.97 110.437 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.719 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 48.7 t -63.74 -39.58 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.813 -0.631 . . . . 1.64 111.576 -176.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -69.98 -24.31 63.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.712 0.291 . . . . 1.22 111.698 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.87 -11.91 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.001 0.371 . . . . 2.07 112.001 -174.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -65.74 -17.07 64.36 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.963 -0.46 . . . . 1.95 111.559 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.409 ' N ' HD11 ' A' ' 163' ' ' LEU . 16.7 m-20 -66.42 -28.06 68.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 2.31 110.727 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.2 m -84.36 0.14 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.387 -0.369 . . . . 1.78 111.387 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.447 ' CG1' ' HA ' ' A' ' 163' ' ' LEU . 18.6 pt -137.97 57.1 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 1.42 109.337 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -74.71 -40.23 61.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.828 -0.623 . . . . 1.98 111.367 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.7 p -115.97 158.0 23.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.982 0.42 . . . . 1.4 111.647 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.21 132.76 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 2.84 110.484 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.52 -22.28 26.76 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.551 -0.833 . . . . 0.85 111.726 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -87.62 142.04 28.15 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.197 0.522 . . . . 2.22 110.736 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.406 ' HB3' HD11 ' A' ' 60' ' ' LEU . 6.7 p -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.227 -0.897 . . . . 1.93 110.368 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.26 134.32 32.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.548 -0.538 . . . . 1.17 109.548 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.28 133.68 44.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.069 0.462 . . . . 1.8 109.918 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -142.07 81.36 1.75 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.572 -0.74 . . . . 1.31 109.36 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' SER . 7.1 m -104.97 162.22 13.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.468 -0.333 . . . . 1.69 111.317 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.7 57.16 3.3 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.42 0.688 . . . . 2.26 111.989 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -126.76 132.25 51.12 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.531 -0.544 . . . . 4.84 109.531 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 5.3 p-10 -107.87 126.89 28.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.442 -0.345 . . . . 2.51 110.365 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 22.4 Cg_exo -66.42 -3.84 9.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.417 2.745 . . . . 1.47 113.333 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -58.98 -31.82 69.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 3.16 111.04 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.6 -30.58 72.97 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.141 -0.552 . . . . 1.12 112.361 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.3 mt -72.7 -34.33 67.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.014 0.435 . . . . 2.37 110.334 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.3 mt -71.43 118.75 68.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 3.87 110.51 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.9 -165.19 0.24 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.028 2.485 . . . . 2.51 113.289 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.92 -61.97 1.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.278 0.473 . . . . 3.23 112.278 -173.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.453 ' HB2' ' CG ' ' A' ' 213' ' ' GLU . 34.7 m -75.45 129.43 37.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 2.03 110.514 -176.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 46' ' ' PRO . 39.6 tp -105.43 63.43 0.69 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.016 -0.538 . . . . 2.5 110.082 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 21.9 m-20 -109.95 145.64 36.57 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.374 -0.973 . . . . 1.81 108.374 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -136.47 149.27 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.607 -0.837 . . . . 5.32 112.936 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.559 ' HB3' ' CG2' ' A' ' 255' ' ' ILE . 6.8 m-90 -93.78 141.68 28.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.49 -1.232 . . . . 4.55 108.445 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.9 t -136.8 109.92 7.76 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.456 0.646 . . . . 2.39 112.498 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.841 ' HH ' ' H ' ' A' ' 253' ' ' ARG . 54.9 t80 -139.22 138.21 20.42 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.627 -0.715 . . . . 5.32 110.506 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 48.7 Cg_exo -57.47 128.49 29.61 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.315 2.01 . . . . 2.47 111.494 172.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 208' ' ' TRP . . . -122.52 157.22 17.14 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.961 -0.637 . . . . 2.0 113.456 -171.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 13.5 m . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 3.36 109.733 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 196' ' ' SER . 16.2 tp . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 109.616 -0.513 . . . . 3.51 109.616 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.85 28.11 8.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.193 0.521 . . . . 3.37 111.076 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' ' 137' ' ' PRO . 68.3 m -80.06 -4.8 54.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.822 -0.626 . . . . 2.47 111.446 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.444 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 48.4 t -90.18 137.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.383 -0.229 . . . . 1.74 110.383 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.2 m -105.5 102.59 12.05 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.885 -0.413 . . . . 2.3 109.885 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.529 ' O ' ' HA ' ' A' ' 192' ' ' THR . 43.2 m0 -72.19 100.84 2.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.245 -0.28 . . . . 6.37 110.245 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 65.6 mt -105.51 99.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.211 -0.663 . . . . 2.32 109.211 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.6 t -111.21 122.46 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.244 -0.435 . . . . 2.1 110.67 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 3.7 mm? -69.28 134.09 48.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.328 0.585 . . . . 2.35 110.127 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.547 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 32.6 ttpt -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.676 -1.147 . . . . 3.47 111.509 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.453 ' CG ' ' HB2' ' A' ' 187' ' ' SER . 22.2 mm-40 -76.27 110.92 12.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 1.56 110.795 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.4 ' HA ' HG23 ' A' ' 145' ' ' ILE . 61.3 Cg_endo -74.91 154.19 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.623 2.216 . . . . 1.37 112.025 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.15 110.94 10.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.103 -0.499 . . . . 1.85 109.902 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 79.2 p -93.18 118.66 31.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.741 -0.466 . . . . 1.78 109.741 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 30.8 m -120.98 157.78 23.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.64 110.539 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.3 t -90.58 157.96 17.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.071 -0.513 . . . . 1.52 109.978 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.66 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 20.3 m -55.09 -46.59 75.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 1.81 110.732 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -52.65 -34.87 53.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 2.51 111.603 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -71.14 -50.11 36.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 1.02 110.203 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -71.88 -22.48 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.839 0.311 . . . . 1.88 111.839 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 219' ' ' SER . 83.0 mt -64.48 -43.83 92.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.81 -0.441 . . . . 1.59 109.81 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -68.72 -29.56 68.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 2.3 111.382 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.62 -30.37 64.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.53 . . . . 3.18 109.907 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -80.06 -2.68 45.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.741 -0.663 . . . . 3.55 110.346 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 33.4 mmtp -90.41 -6.52 54.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 2.74 110.064 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.61 146.68 26.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.887 -0.597 . . . . 1.66 110.807 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.579 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.8 m120 -118.79 125.83 50.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.659 -0.701 . . . . 1.13 109.521 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -78.76 -7.74 58.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 4.38 111.38 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.579 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.2 p-10 -77.58 162.71 26.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.831 0.348 . . . . 1.62 110.236 171.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.8 159.89 36.73 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.098 -0.801 . . . . 1.16 111.098 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.86 134.27 56.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 3.56 110.957 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.67 11.61 70.77 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.776 -0.647 . . . . 2.23 112.922 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -112.93 158.61 37.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.69 -0.485 . . . . 2.59 109.69 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.55 122.81 11.5 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.593 2.196 . . . . 1.5 111.819 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 120.18 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.381 -0.827 . . . . 3.4 112.383 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -127.82 136.55 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.329 -0.989 . . . . 2.47 108.329 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.12 133.38 33.63 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.758 -0.46 . . . . 2.6 109.758 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 51.8 ttm -75.12 88.28 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.099 0.476 . . . . 1.94 109.757 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.15 167.36 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.861 -0.792 . . . . 1.67 108.861 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.652 ' HA ' ' O ' ' A' ' 97' ' ' TRP . 0.7 OUTLIER 61.75 -90.85 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.402 0.439 . . . . 2.18 110.814 -174.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 43.13 45.8 4.82 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.271 0.558 . . . . 2.64 111.923 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.409 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 60.9 t-105 -153.14 153.06 32.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.331 -0.85 . . . . 5.31 108.979 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -100.58 130.35 25.75 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.089 -0.337 . . . . 6.91 110.089 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.27 53.33 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.769 2.313 . . . . 3.72 111.937 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -114.14 121.79 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.401 -0.818 . . . . 3.34 109.978 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -90.3 152.43 45.69 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.226 -0.443 . . . . 4.92 110.84 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.69 141.67 15.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.598 2.866 . . . . 4.01 112.807 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 251' ' ' LYS . 0.6 OUTLIER -40.59 -55.78 2.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.976 -1.011 . . . . 4.9 113.699 -171.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.546 ' N ' HD13 ' A' ' 250' ' ' LEU . 69.6 mmtt -114.33 -4.96 12.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.95 0.352 . . . . 5.68 111.95 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.1 p30 34.22 65.52 0.31 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.132 0.895 . . . . 5.11 112.345 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.841 ' H ' ' HH ' ' A' ' 193' ' ' TYR . 69.9 mtt180 -70.85 -90.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.85 -0.34 . . . . 6.74 111.08 -173.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -159.64 154.97 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.178 -0.675 . . . . 3.08 109.178 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.559 ' CG2' ' HB3' ' A' ' 191' ' ' TRP . 13.7 mt -118.78 113.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.159 -0.311 . . . . 3.06 110.159 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -76.85 165.76 24.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 3.01 110.706 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 191' ' ' TRP . . . -126.0 168.54 13.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 1.99 109.975 -175.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.9 p -138.07 95.99 3.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.201 0.524 . . . . 2.47 111.242 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.42 ' H ' ' HB2' ' A' ' 40' ' ' TYR . 49.9 t80 -136.91 119.06 15.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 5.03 110.304 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.526 ' HZ3' ' HB2' ' A' ' 260' ' ' LYS . 9.8 mtmp? . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.612 -0.708 . . . . 4.82 109.577 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 107.951 -1.129 . . . . 3.14 107.951 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.9 mt -82.99 85.1 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.543 0.687 . . . . 2.71 109.381 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -102.08 112.19 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.188 -0.914 . . . . 2.82 110.397 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m -54.85 -31.67 59.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 2.71 112.643 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -74.67 -38.6 62.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.126 0.488 . . . . 5.23 110.421 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 m -79.13 -29.26 43.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.737 -0.665 . . . . 3.38 111.083 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.22 116.2 6.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.76 110.695 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -92.42 129.49 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.146 -0.479 . . . . 4.05 109.921 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.725 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.3 p90 -63.2 121.91 14.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 4.9 110.256 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -105.65 125.78 32.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.54 -0.755 . . . . 2.27 109.397 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 15.5 Cg_exo -69.82 60.1 1.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.64 2.227 . . . . 2.45 111.789 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 m -63.5 -17.45 62.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 4.62 111.713 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 42' ' ' PRO . 80.5 mt 61.56 -86.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.394 0.677 . . . . 5.15 112.386 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 46' ' ' PRO . 85.7 tttt -65.66 130.79 94.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.916 0.389 . . . . 4.21 111.517 -175.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.434 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 56.9 Cg_endo -71.2 171.01 16.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.819 2.346 . . . . 2.76 111.23 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.78 131.43 40.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.734 -0.469 . . . . 2.93 109.734 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.4 m -108.78 115.12 29.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.949 -0.389 . . . . 2.46 109.949 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 22.0 t -123.0 110.77 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 2.17 110.286 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.636 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.0 m -92.18 90.28 7.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.525 -0.546 . . . . 1.87 109.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.0 9.84 38.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 3.97 111.556 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.05 -37.03 81.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 2.48 111.047 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -97.26 27.05 4.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.107 -0.497 . . . . 2.54 111.293 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.33 56.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.146 0.498 . . . . 1.41 112.057 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -146.87 106.03 3.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.828 -0.624 . . . . 1.41 110.178 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.3 p -89.01 158.8 17.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.488 -0.56 . . . . 1.84 109.488 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.17 -56.68 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.178 0.436 . . . . 1.45 112.178 -173.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.57 157.75 32.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.909 -0.317 . . . . 3.72 110.728 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -114.26 136.99 49.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 1.35 109.348 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' A' ' 172' ' ' SER . 64.9 tp -132.55 146.55 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.171 0.51 . . . . 1.53 111.306 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.1 111.54 24.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.591 -0.732 . . . . 1.49 109.354 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -109.44 67.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.385 -0.526 . . . . 2.18 110.487 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.91 -51.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.752 0 O-C-N 124.808 1.317 . . . . 2.0 115.477 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -106.44 -26.46 11.43 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 122.487 0.315 . . . . 4.11 110.623 -172.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.68 171.38 16.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.562 -0.29 . . . . 1.78 110.51 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 95' ' ' PHE . 13.1 p90 -130.24 114.55 15.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.143 -0.688 . . . . 3.48 109.143 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -116.89 145.6 43.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.99 111.562 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.13 119.33 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 1.75 109.445 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.93 125.64 29.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.804 -0.634 . . . . 2.02 110.049 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -105.69 151.2 24.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.703 -0.68 . . . . 2.19 109.242 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -83.49 106.35 15.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.745 0.307 . . . . 1.33 110.33 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -124.36 57.44 1.24 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.982 0.896 . . . . 2.65 110.594 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -92.98 -5.28 51.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.185 -0.916 . . . . 2.01 109.327 169.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.41 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -158.72 169.82 23.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.878 -1.056 . . . . 2.35 108.757 -178.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -78.17 72.71 4.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 1.92 111.17 -174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 65.6 mttm -81.1 -53.25 6.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.986 -0.552 . . . . 2.31 110.458 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -119.75 112.18 18.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.096 -0.502 . . . . 1.44 110.09 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 91.8 t -113.4 137.04 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.632 -0.713 . . . . 1.82 110.496 -176.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tt -129.19 113.6 15.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.134 -0.321 . . . . 1.8 110.134 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -147.84 125.01 11.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 3.02 110.457 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.93 -177.77 19.62 Favored Glycine 0 C--O 1.219 -0.793 0 CA-C-O 118.937 -0.924 . . . . 1.44 111.151 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.83 -130.18 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 O-C-N 124.971 1.041 . . . . 2.15 115.498 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.506 ' HD2' ' HH ' ' A' ' 190' ' ' TYR . 81.3 Cg_exo -44.61 169.49 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.68 2.92 . . . . 3.17 114.217 -170.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -31.07 102.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.268 1.509 . . . . 4.55 114.879 -147.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.598 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 8.4 p-10 -107.03 -100.9 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.19 -1.823 . . . . 4.95 112.793 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.598 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 94.05 152.73 29.62 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.385 -1.086 . . . . 2.25 110.385 -165.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.622 ' HB ' ' OG1' ' A' ' 125' ' ' THR . 14.5 m -69.67 113.9 7.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.932 0.866 . . . . 2.12 110.819 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.58 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 55.8 m-85 -110.19 107.12 16.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.365 . . . . 3.88 111.654 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.47 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 97.5 mtt180 -75.91 137.88 40.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 3.87 110.992 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.75 125.55 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.505 -0.554 . . . . 1.68 109.505 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.428 HG23 ' HG2' ' A' ' 92' ' ' GLN . 4.5 tt -111.57 -38.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.952 0.406 . . . . 2.16 110.973 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.428 ' HG2' HG23 ' A' ' 91' ' ' ILE . 24.8 pt20 -164.98 158.34 16.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.7 -0.482 . . . . 1.95 109.7 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.86 140.69 24.79 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.163 -0.31 . . . . 0.98 110.163 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -135.21 157.63 46.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.412 -0.358 . . . . 1.07 110.654 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 54.6 m-85 -113.77 169.16 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 3.99 110.495 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.401 ' CG ' ' HE1' ' A' ' 244' ' ' TRP . 0.3 OUTLIER -137.63 173.1 12.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.087 -0.708 . . . . 2.2 109.087 174.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.47 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 30.8 t-105 -151.33 127.03 10.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.857 -0.423 . . . . 6.08 109.857 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -94.24 140.85 15.25 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.093 -0.575 . . . . 2.19 112.255 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 t -46.82 -43.51 18.53 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.641 0.376 . . . . 3.08 111.863 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 103' ' ' GLN . 45.1 mt -122.78 152.71 40.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.532 -0.544 . . . . 3.48 109.532 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.05 -7.4 3.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.818 -0.628 . . . . 3.85 112.187 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.76 29.56 2.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.76 . . . . 2.37 112.505 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 7.6 tp60 -159.44 139.88 12.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.925 0.363 . . . . 2.62 110.873 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 244' ' ' TRP . . . 94.57 -28.99 9.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.861 -0.685 . . . . 1.62 112.402 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.451 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 1.2 m -89.55 -17.9 27.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.469 0.176 . . . . 2.24 111.127 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 60.02 -156.75 0.34 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.388 -0.369 . . . . 3.72 110.689 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.464 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 62.6 m80 63.33 69.37 0.57 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.381 -0.6 . . . . 4.03 109.381 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 5.6 t -104.09 118.38 36.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.113 0.482 . . . . 2.99 110.53 -167.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.0 t -85.54 105.65 14.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.365 -0.976 . . . . 2.88 108.365 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 66.88 -71.53 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.67 0.606 . . . . 2.8 110.652 -171.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -152.05 19.12 0.67 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 5.35 110.605 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 108' ' ' THR . 13.9 mmmm -107.75 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.018 -0.537 . . . . 3.58 111.553 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -80.31 156.19 26.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.91 . . . . 3.26 108.544 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -93.43 -171.29 2.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.8 0.333 . . . . 1.71 111.189 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.41 -27.36 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 1.57 111.752 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 147' ' ' LEU . . . -153.25 168.74 25.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.617 0.246 . . . . 1.3 110.533 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HG2' ' CE1' ' A' ' 107' ' ' HIS . 13.7 tp10 -151.8 152.6 32.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.372 -0.603 . . . . 1.85 109.372 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.501 HD12 ' CE2' ' A' ' 95' ' ' PHE . 38.2 tp -125.79 131.38 52.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.712 0.291 . . . . 1.61 110.963 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 107.72 14.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 2.25 110.705 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -102.22 109.55 21.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.105 -0.332 . . . . 1.51 110.105 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.02 129.22 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.188 -0.46 . . . . 1.24 111.49 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 19.0 m-70 -127.39 156.32 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 2.86 109.63 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -127.49 150.51 49.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 4.96 111.554 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.57 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 19.6 t30 -69.21 116.45 9.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.064 -0.971 . . . . 2.3 111.811 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.622 ' OG1' ' HB ' ' A' ' 87' ' ' THR . 53.2 p -63.16 -32.79 74.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.655 0.983 . . . . 2.77 113.655 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.57 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 60.9 pttt -74.28 -4.56 36.88 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.338 -0.545 . . . . 3.79 111.923 -173.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -91.42 -5.65 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.34 0.59 . . . . 3.34 109.546 170.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.9 19.32 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 115.569 0.987 . . . . 2.37 115.569 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -177.91 133.13 0.16 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.883 0.841 . . . . 3.93 109.802 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.601 ' O ' HG22 ' A' ' 134' ' ' VAL . 40.3 p90 -66.33 -42.97 87.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.633 . . . . 3.6 111.345 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.27 -33.25 86.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.108 -0.568 . . . . 2.35 112.231 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 127' ' ' TYR . 98.1 mttt -74.28 -34.11 63.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.027 -0.36 . . . . 3.75 110.027 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.35 66.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 2.17 110.765 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 130' ' ' PHE . 42.0 t -63.53 -18.25 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.203 0.525 . . . . 3.11 110.761 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.68 -9.62 53.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.126 -0.359 . . . . 3.55 111.178 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 205' ' ' CYS . 7.6 tt0 -104.41 126.44 31.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.232 -0.284 . . . . 3.02 110.232 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 73.1 Cg_exo -52.79 -31.2 50.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.548 2.832 . . . . 1.93 113.12 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.14 28.15 9.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.185 0.517 . . . . 2.29 109.848 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.03 -30.91 24.55 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.826 -0.625 . . . . 1.5 113.408 -172.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HB2' HG23 ' A' ' 206' ' ' VAL . 91.3 mt -112.21 157.58 20.72 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.574 -0.368 . . . . 1.98 110.3 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.57 123.16 10.45 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.814 -0.439 . . . . 1.83 109.814 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.88 129.88 71.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 116.292 -0.413 . . . . 2.28 110.012 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 209' ' ' ILE . 35.8 tp -90.99 134.24 34.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 2.89 109.835 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -115.41 145.77 18.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.069 -0.586 . . . . 0.95 112.018 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.4 mt -142.48 122.75 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.528 -0.545 . . . . 1.38 109.528 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.451 ' CZ ' HG12 ' A' ' 210' ' ' VAL . 44.2 m-85 -73.99 141.07 45.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.694 0.283 . . . . 1.37 111.032 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . 9.0 mp -119.2 121.22 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 1.48 110.041 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.82 147.74 41.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.109 -0.496 . . . . 2.52 109.798 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 62.1 t -87.07 130.16 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.901 0.381 . . . . 1.88 110.863 -174.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.11 -105.29 0.19 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.291 -0.724 . . . . 1.53 111.291 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.2 t -81.89 146.18 29.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 2.08 109.521 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.446 ' CA ' ' HB2' ' A' ' 218' ' ' SER . . . -66.62 152.12 45.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.183 0.515 . . . . 1.36 112.222 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -109.39 102.99 51.56 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.335 -0.848 . . . . 1.78 108.735 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.55 -32.93 65.99 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 123.095 2.53 . . . . 1.34 112.835 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.18 -15.95 72.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.094 -0.574 . . . . 0.75 113.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.3 tp -99.62 -9.03 23.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.346 0.593 . . . . 1.39 110.298 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -45.49 88.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.502 -0.772 . . . . 1.63 112.19 -173.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.476 ' O ' HG22 ' A' ' 162' ' ' VAL . 13.0 ptmm? -76.68 -27.89 55.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.433 -0.507 . . . . 3.26 111.813 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.37 -40.34 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.495 -0.482 . . . . 1.97 111.316 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.49 ' HA ' ' HG ' ' A' ' 163' ' ' LEU . 34.5 m -62.45 -28.74 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.197 0.522 . . . . 1.64 110.671 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.83 -30.55 71.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.556 -0.747 . . . . 1.22 111.173 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 158' ' ' LYS . 41.2 t -89.31 -16.33 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 2.07 111.269 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 77.0 mt -56.05 -31.8 63.49 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.229 0.455 . . . . 1.95 112.229 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.88 -30.12 70.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.78 0.324 . . . . 2.31 111.476 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.9 m -84.46 -3.15 58.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.567 -0.288 . . . . 1.78 111.769 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 44.5 pt -132.89 29.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.528 0.68 . . . . 1.42 109.312 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -60.06 -27.66 67.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.95 -1.023 . . . . 1.98 112.075 -172.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.8 p -119.54 152.97 36.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 1.4 111.598 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -54.39 127.94 29.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.064 -0.971 . . . . 2.84 111.648 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.18 -22.27 31.57 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.588 -0.815 . . . . 0.85 112.849 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -78.56 139.76 38.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.159 0.504 . . . . 2.22 111.307 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.415 ' HB2' HD13 ' A' ' 60' ' ' LEU . 27.4 t -127.06 146.56 50.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.178 -0.919 . . . . 1.93 109.39 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.38 127.08 23.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.438 -0.346 . . . . 1.17 110.08 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.7 132.03 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.501 . . . . 1.8 110.45 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.89 80.99 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.845 -0.616 . . . . 1.31 109.596 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 p -102.81 161.16 13.97 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.116 -0.493 . . . . 1.69 111.824 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 12.9 m120 57.04 66.71 1.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.569 -0.742 . . . . 2.26 111.546 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -119.86 139.18 52.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 4.84 110.191 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 181' ' ' ARG . 17.1 t0 -102.0 106.77 49.45 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 2.51 110.938 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.469 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 23.6 Cg_exo -64.81 -15.08 48.5 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.008 2.472 . . . . 1.47 111.924 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.493 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 29.2 ttp180 -68.78 -21.88 64.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.655 -0.702 . . . . 3.16 110.345 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -77.67 -8.8 87.18 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.774 -0.726 . . . . 1.12 111.855 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 97.0 mt -106.11 -18.26 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.997 0.427 . . . . 2.37 109.884 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 83.3 mt -73.28 126.34 90.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 3.87 110.028 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 59.8 Cg_endo -69.73 -176.28 1.43 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.438 2.758 . . . . 2.51 113.637 -173.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.77 -50.48 64.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.297 -0.411 . . . . 3.23 111.879 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 15.4 m -88.68 136.79 32.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.75 0.31 . . . . 2.03 110.367 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.2 tp -106.09 64.73 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.706 . . . . 2.5 109.893 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.41 -176.32 3.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.953 -1.128 . . . . 1.81 107.953 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.506 ' HH ' ' HD2' ' A' ' 83' ' ' PRO . 44.7 p90 -163.52 154.33 16.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.886 0.766 . . . . 5.32 112.855 -169.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -115.29 146.6 41.34 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.827 -1.175 . . . . 4.55 107.827 170.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -108.71 126.84 53.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.096 0.474 . . . . 2.39 111.126 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -133.17 154.08 81.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 5.32 109.989 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.31 129.82 15.45 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.404 2.069 . . . . 2.47 111.77 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -101.79 97.48 1.61 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.792 -0.718 . . . . 2.0 111.455 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--N 1.319 -0.742 0 N-CA-C 112.91 0.707 . . . . 3.36 112.91 -176.419 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.633 HD11 ' SG ' ' A' ' 205' ' ' CYS . 1.9 pp . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.798 0.333 . . . . 3.51 111.659 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 7.9 pt-20 -87.79 92.67 9.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.555 0.693 . . . . 3.37 111.083 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.633 ' SG ' HD11 ' A' ' 203' ' ' LEU . 93.9 m -138.83 32.84 2.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.804 -0.635 . . . . 2.47 110.709 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 140' ' ' LEU . 95.3 t -125.63 149.05 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.732 -0.667 . . . . 1.74 111.187 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.1 m -111.68 107.12 16.12 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.083 -1.08 . . . . 2.3 108.083 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -89.23 115.65 26.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.153 0.501 . . . . 6.37 110.333 -174.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.513 ' O ' HD13 ' A' ' 143' ' ' LEU . 63.5 mt -114.57 116.59 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.603 -0.726 . . . . 2.32 109.68 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.451 HG12 ' CZ ' ' A' ' 146' ' ' PHE . 24.3 t -109.71 129.8 63.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.253 -0.277 . . . . 2.1 110.253 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.73 126.44 29.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.818 0.342 . . . . 2.35 110.555 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -47.5 -24.16 0.78 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.561 0.948 . . . . 3.47 113.561 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 8.6 tp10 -106.81 123.7 37.76 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.644 0.259 . . . . 1.56 110.569 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.437 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 89.9 Cg_endo -81.77 158.63 18.77 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.671 2.248 . . . . 1.37 112.01 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 41.7 pt -113.97 154.35 15.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.844 0.354 . . . . 1.85 110.326 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.3 m -104.17 130.43 51.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.78 110.844 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 18.6 m -125.34 151.17 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.058 -0.719 . . . . 1.64 109.058 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' SER . . . . . 0.446 ' HB2' ' CA ' ' A' ' 152' ' ' ALA . 7.5 t -95.2 161.23 14.2 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.449 -0.501 . . . . 1.52 111.164 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.677 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 3.1 p -52.55 -47.18 66.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.32 -0.4 . . . . 1.81 111.658 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -52.6 -33.93 48.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.983 0.421 . . . . 2.51 111.382 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -78.48 -50.68 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 1.02 110.517 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.47 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 27.2 m -67.67 -23.53 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 1.88 111.653 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 219' ' ' SER . 84.7 mt -61.31 -33.39 73.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 1.59 110.717 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -74.76 -23.26 58.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 2.3 110.843 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 29.5 m-85 -68.88 -39.58 79.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.231 0.539 . . . . 3.18 109.802 174.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -76.08 -2.03 28.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.419 -0.81 . . . . 3.55 110.825 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 34.3 mmtp -91.88 -12.62 33.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.409 -0.359 . . . . 2.74 110.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.03 151.4 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 1.66 110.731 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.575 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 9.4 m120 -123.69 127.26 47.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.821 -0.627 . . . . 1.13 110.259 -175.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 65.4 m-85 -57.94 -33.62 69.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.767 -0.652 . . . . 4.38 111.004 173.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.575 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -72.69 164.19 26.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 1.62 111.884 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.73 171.75 43.56 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.536 -0.756 . . . . 1.16 111.309 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.91 123.27 17.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.994 0.426 . . . . 3.56 110.645 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 91.05 25.1 25.4 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.807 -0.633 . . . . 2.23 112.52 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 62.2 mt-10 -124.55 161.85 45.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.036 -0.357 . . . . 2.59 110.036 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 9.9 Cg_endo -52.15 123.06 11.74 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.164 2.576 . . . . 1.5 112.411 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.15 113.72 1.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.477 -0.783 . . . . 3.4 112.275 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -115.99 102.88 10.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.804 -0.813 . . . . 2.47 108.804 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.34 138.02 56.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.166 0.508 . . . . 2.6 111.332 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.629 ' HA ' ' CE1' ' A' ' 230' ' ' PHE . 50.4 ttm -79.1 90.77 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.166 -0.925 . . . . 1.94 110.54 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.9 m -124.44 153.31 30.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 1.67 110.19 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 76.7 m-20 72.04 -80.24 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.133 0.896 . . . . 2.18 109.678 -176.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 56.34 27.72 12.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.073 0.463 . . . . 2.64 111.393 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.561 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 26.8 m95 -142.37 156.67 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 5.31 110.597 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -106.4 137.75 19.52 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.477 -0.783 . . . . 6.91 109.803 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.86 146.14 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.069 3.179 . . . . 3.72 113.667 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.36 151.48 46.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.068 -0.969 . . . . 3.34 110.781 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 86.9 mm-40 -94.76 170.6 7.8 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.473 -0.785 . . . . 4.92 110.079 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 74.8 Cg_exo -44.05 143.21 3.4 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.415 2.076 . . . . 4.01 112.461 176.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.54 -38.45 55.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.03 -0.986 . . . . 4.9 109.749 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 253' ' ' ARG . 21.0 pttm -64.88 -14.8 60.79 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 115.209 1.559 . . . . 5.68 115.209 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.5 t30 24.58 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.783 2.512 . . . . 5.11 117.783 151.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 251' ' ' LYS . 15.5 tpp180 166.28 -125.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.912 -1.514 . . . . 6.74 106.912 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -127.48 133.95 49.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 3.08 109.88 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.6 131.06 35.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.83 -0.433 . . . . 3.06 109.83 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -120.7 133.21 55.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.115 -0.493 . . . . 3.01 110.898 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.725 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -143.82 129.41 19.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.246 -0.649 . . . . 1.99 109.246 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 p -92.23 97.6 10.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.827 -0.749 . . . . 2.47 111.172 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -126.01 92.4 3.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.683 0.754 . . . . 5.03 110.259 167.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.346 -0.843 . . . . 4.82 110.259 178.931 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB3' HD11 ' A' ' 250' ' ' LEU . 24.2 t70 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 122.054 0.93 . . . . 3.14 111.647 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 85.4 mt -102.82 141.79 18.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.33 -1.305 . . . . 2.71 109.918 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 19.3 t70 -120.93 121.62 38.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.827 0.346 . . . . 2.82 110.166 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -69.07 -28.77 66.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 2.71 112.054 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 35.1 m80 -60.54 -43.35 97.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.324 0.583 . . . . 5.23 110.314 173.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -71.98 -21.42 61.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.288 -0.869 . . . . 3.38 110.007 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.82 98.78 3.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.5 -0.773 . . . . 1.76 110.55 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -72.11 126.33 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.941 -0.572 . . . . 4.05 109.653 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 51.1 p90 -82.64 131.49 35.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 4.9 110.336 -172.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.14 138.74 26.57 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.821 -0.627 . . . . 2.27 110.005 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.81 13.2 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.223 2.615 . . . . 2.45 114.064 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -60.45 -52.48 65.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 4.62 109.899 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.1 mt 53.08 13.78 0.41 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.583 0.957 . . . . 5.15 113.583 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -56.72 111.55 3.44 Favored Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 123.408 0.443 . . . . 4.21 111.887 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -87.33 157.3 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.919 2.413 . . . . 2.76 111.99 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -83.1 154.48 24.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.047 -0.524 . . . . 2.93 110.369 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 38.5 t -129.62 131.02 46.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.295 -0.631 . . . . 2.46 109.295 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.89 137.37 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 2.17 111.433 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 47.7 m -127.75 90.94 3.19 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.033 -0.728 . . . . 1.87 109.033 171.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CD1' ' HB2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -133.03 16.42 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.879 -0.328 . . . . 3.97 111.883 -176.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.14 -22.04 64.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.966 0.413 . . . . 2.48 110.951 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.03 3.72 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 2.54 111.228 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.84 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.187 0.517 . . . . 1.41 111.853 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.8 m -98.62 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.064 -0.516 . . . . 1.41 110.506 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -81.24 149.67 28.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 1.84 110.494 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.1 mt -115.85 -49.71 2.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.071 0.462 . . . . 1.45 110.844 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -160.59 161.96 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.026 -0.534 . . . . 3.72 110.726 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.09 133.75 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.941 -0.762 . . . . 1.35 108.941 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.3 tp -129.34 131.21 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.975 0.417 . . . . 1.53 111.408 -172.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -80.81 109.3 15.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.742 -0.663 . . . . 1.49 109.355 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.91 68.89 0.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.968 0.413 . . . . 2.18 110.166 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 240' ' ' MET . . . 64.33 -53.58 0.09 OUTLIER Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.279 -1.328 . . . . 2.0 115.208 171.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -110.1 -19.86 12.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.788 0.328 . . . . 4.11 111.32 -169.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.96 177.61 10.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 1.78 110.247 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.681 ' CE1' HD13 ' A' ' 228' ' ' LEU . 29.2 m-85 -117.38 112.84 21.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.304 -0.628 . . . . 3.48 109.304 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.4 m120 -90.72 105.2 17.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.47 . . . . 1.99 110.783 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 60.1 t -82.26 105.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.752 -0.833 . . . . 1.75 108.752 171.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.12 132.47 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.016 -0.538 . . . . 2.02 111.084 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -112.02 155.74 23.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.462 -0.79 . . . . 2.19 109.032 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.14 110.39 15.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.933 0.397 . . . . 1.33 110.559 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -107.06 55.18 0.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.712 0.768 . . . . 2.65 109.939 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -96.94 -5.85 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.758 . . . . 2.01 110.771 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.447 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -154.03 166.63 32.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.372 -0.831 . . . . 2.35 109.18 178.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.91 36.74 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.36 0.504 . . . . 1.92 112.36 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 92.6 mttt -55.48 -63.58 1.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.246 -0.434 . . . . 2.31 110.656 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -103.55 115.96 31.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.872 -0.604 . . . . 1.44 110.341 -177.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.9 t -134.51 141.96 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 1.82 110.808 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . 58.6 tp -105.61 128.33 53.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.338 -0.616 . . . . 1.8 109.338 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 55.8 mtpt -119.92 124.76 46.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.244 0.545 . . . . 3.02 110.24 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.77 170.99 19.83 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.789 -0.924 . . . . 1.44 110.789 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.71 -148.95 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 O-C-N 123.657 0.269 . . . . 2.15 113.539 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.43 119.03 5.26 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 121.569 1.512 . . . . 3.17 112.451 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.629 ' HB3' ' HH ' ' A' ' 88' ' ' TYR . 59.2 mt -159.66 -171.14 3.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.078 -0.965 . . . . 4.55 108.938 -176.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -132.89 76.95 1.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.751 -0.38 . . . . 4.95 111.714 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.7 -178.68 17.29 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.247 -0.977 . . . . 2.25 114.206 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 m -105.76 120.1 40.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.859 -0.671 . . . . 2.12 109.363 176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.629 ' HH ' ' HB3' ' A' ' 84' ' ' LEU . 32.2 m-85 -105.41 104.79 14.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 3.88 111.436 -171.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 99.4 mtt180 -75.37 152.62 38.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.099 -0.5 . . . . 3.87 110.314 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.9 120.43 24.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.974 -0.38 . . . . 1.68 109.974 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.0 tt -110.26 -34.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.447 -0.342 . . . . 2.16 111.02 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 7.2 pt20 -173.86 174.52 3.04 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.661 -0.496 . . . . 1.95 109.661 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.525 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 20.4 p90 -147.09 161.65 40.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.861 -0.336 . . . . 0.98 111.02 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.463 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.7 p-80 -147.46 160.11 42.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.053 -0.721 . . . . 1.07 109.053 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -125.11 172.79 9.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.774 0.321 . . . . 3.99 110.899 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -127.24 117.14 21.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.712 -1.218 . . . . 2.2 107.712 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.56 ' NE1' ' HA ' ' A' ' 99' ' ' SER . 60.3 t-105 -101.49 112.33 24.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.778 0.323 . . . . 6.08 110.694 -173.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -63.32 -39.07 97.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.629 -0.714 . . . . 2.19 112.497 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.56 ' HA ' ' NE1' ' A' ' 97' ' ' TRP . 32.5 t 91.56 -17.92 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.266 1.026 . . . . 3.08 110.178 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.57 137.85 50.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.134 -1.062 . . . . 3.48 108.134 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.21 -24.96 65.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.652 0.982 . . . . 3.85 113.652 -168.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.99 7.53 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.914 -1.136 . . . . 2.37 113.863 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.99 152.58 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.383 0.591 . . . . 2.62 111.023 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 122.89 -27.27 5.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.64 -0.791 . . . . 1.62 112.692 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.2 t -71.29 -46.98 59.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.464 0.172 . . . . 2.24 111.464 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 61.46 -172.66 0.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.937 0.347 . . . . 3.72 111.937 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.9 m80 56.48 30.21 16.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.957 0.884 . . . . 4.03 108.664 -166.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.587 ' HG1' ' C ' ' A' ' 112' ' ' LYS . 2.0 t -83.13 153.6 24.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.997 -1.456 . . . . 2.99 113.122 -169.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.0 m -101.52 93.45 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.397 -0.82 . . . . 2.88 111.382 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.64 71.55 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.039 -0.982 . . . . 2.8 111.329 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 59.41 21.29 9.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.091 -0.958 . . . . 5.35 113.417 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.587 ' C ' ' HG1' ' A' ' 108' ' ' THR . 22.7 tptm -97.82 73.55 2.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.332 -0.618 . . . . 3.58 109.332 172.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.48 ' HZ1' HG22 ' A' ' 108' ' ' THR . 67.2 mttm -86.9 150.9 23.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.279 -0.418 . . . . 3.26 109.97 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 76.6 m-85 -110.71 -173.79 2.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.751 -0.462 . . . . 1.71 109.751 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.9 -38.97 69.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.623 0.601 . . . . 1.57 112.623 -172.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.53 169.02 17.65 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.929 -0.308 . . . . 1.3 111.527 -170.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -136.17 140.07 43.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.612 -0.722 . . . . 1.85 109.107 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.5 tp -109.63 133.67 52.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 1.61 110.245 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 39.8 m170 -120.38 106.1 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 2.25 110.684 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 5.3 mp -86.83 114.92 23.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.757 -0.46 . . . . 1.51 109.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.03 134.14 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.225 0.536 . . . . 1.24 110.571 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 74.4 m-70 -119.68 150.82 39.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 2.86 111.521 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -110.17 123.84 50.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.819 -1.082 . . . . 4.96 110.008 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.591 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 40.5 t-20 -79.37 117.99 20.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.113 -0.494 . . . . 2.3 110.426 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -73.93 -32.21 63.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.17 -0.468 . . . . 2.77 112.193 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.591 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 19.6 ptmt -63.24 -25.19 68.21 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.112 0.412 . . . . 3.79 112.112 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.539 ' HH ' ' NE2' ' A' ' 136' ' ' GLN . 37.2 m-85 -93.38 -11.87 31.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.906 0.384 . . . . 3.34 111.136 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.74 26.11 3.85 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.123 -0.944 . . . . 2.37 113.687 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -176.31 115.29 0.12 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.793 -0.447 . . . . 3.93 109.793 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.616 ' O ' HG21 ' A' ' 134' ' ' VAL . 50.8 p90 -57.81 -36.24 71.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 3.6 111.677 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.55 -44.9 96.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.875 -0.678 . . . . 2.35 112.444 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -64.4 -36.21 83.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.21 0.529 . . . . 3.75 109.984 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' GLY . . . -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 2.17 111.303 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 130' ' ' PHE . 72.0 t -61.73 -22.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.028 0.442 . . . . 3.11 111.083 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -77.0 -0.81 25.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 3.55 111.414 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.539 ' NE2' ' HH ' ' A' ' 127' ' ' TYR . 6.2 tt0 -126.26 131.77 24.07 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.79 -0.448 . . . . 3.02 109.79 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.17 -18.19 50.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.897 2.398 . . . . 1.93 112.76 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.439 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 13.1 m-20 -113.91 17.63 17.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.174 -0.676 . . . . 2.29 109.174 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -83.24 -11.23 81.11 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.437 -0.802 . . . . 1.5 113.934 -168.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.583 ' C ' HG11 ' A' ' 206' ' ' VAL . 80.1 mt -146.48 172.19 13.91 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.269 -0.271 . . . . 1.98 110.269 -175.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -156.94 121.34 4.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.363 -0.38 . . . . 1.83 110.671 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.582 ' O ' HG23 ' A' ' 209' ' ' ILE . 33.6 m -97.95 165.86 2.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 N-CA-C 108.637 -0.875 . . . . 2.28 108.637 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.5 tp -116.45 114.71 24.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.774 -0.454 . . . . 2.89 109.774 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -97.16 117.27 5.73 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.047 -0.597 . . . . 0.95 112.689 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.9 mt -118.87 127.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.306 -0.257 . . . . 1.38 110.306 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -78.4 147.22 34.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.366 -0.235 . . . . 1.37 110.366 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 8.1 mp -117.7 124.47 48.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 1.48 111.145 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -116.56 144.91 43.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.322 -0.622 . . . . 2.52 109.322 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 11.2 t -88.05 130.38 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.894 0.378 . . . . 1.88 110.356 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.09 -114.88 0.4 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.414 -0.674 . . . . 1.53 111.414 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.3 t -81.99 156.37 24.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.489 -0.56 . . . . 2.08 109.489 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.408 ' N ' ' HB2' ' A' ' 218' ' ' SER . . . -78.02 148.6 34.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 1.36 111.098 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 183' ' ' LEU . 82.5 tttt -113.19 110.4 51.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.771 -0.455 . . . . 1.78 109.771 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.5 -38.66 90.05 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.708 2.939 . . . . 1.34 113.565 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.3 -19.84 64.65 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.115 -0.564 . . . . 0.75 112.899 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.507 ' O ' HG22 ' A' ' 160' ' ' VAL . 55.5 tp -95.56 -16.56 22.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.025 0.44 . . . . 1.39 110.336 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -46.12 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.761 -0.654 . . . . 1.63 111.162 -173.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.29 -36.73 66.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.873 0.323 . . . . 3.26 111.873 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.12 -42.67 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.077 0.465 . . . . 1.97 110.556 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 156' ' ' LEU . 24.4 t -67.27 -29.73 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 1.64 110.811 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.21 -35.82 61.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.224 -0.444 . . . . 1.22 111.698 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.93 -19.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.654 0.264 . . . . 2.07 111.546 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.436 HD11 HD23 ' A' ' 228' ' ' LEU . 3.4 pp -74.71 -12.79 60.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.947 -0.301 . . . . 1.95 111.501 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.06 -31.08 69.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.947 0.403 . . . . 2.31 111.081 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.3 m -87.57 1.55 53.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.328 0.492 . . . . 1.78 112.328 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.6 pt -139.74 39.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.563 0.697 . . . . 1.42 110.598 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.601 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 84.8 tttt -54.0 -31.68 51.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.672 -1.149 . . . . 1.98 112.688 -176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -111.65 150.17 30.51 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.196 0.522 . . . . 1.4 111.959 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -58.31 128.16 35.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.388 -0.824 . . . . 2.84 111.502 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.65 -18.83 19.6 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.578 -0.82 . . . . 0.85 112.537 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -87.52 149.12 24.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.362 0.601 . . . . 2.22 111.215 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.5 p -134.96 157.26 47.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.053 -0.976 . . . . 1.93 109.702 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.81 139.05 29.13 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.153 -0.314 . . . . 1.17 110.153 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.55 135.04 48.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.623 -0.51 . . . . 1.8 109.623 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.409 ' CE1' ' HB2' ' A' ' 178' ' ' PHE . 22.8 t80 -136.23 81.46 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.242 0.544 . . . . 1.31 109.812 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.0 m -79.97 138.6 37.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.664 -0.698 . . . . 1.69 112.32 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 52.34 76.09 0.2 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.105 -0.952 . . . . 2.26 113.281 169.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.582 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 52.0 t80 -92.13 137.52 32.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.758 -0.46 . . . . 4.84 109.758 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -105.09 94.58 8.0 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.4 0.619 . . . . 2.51 110.94 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 12.3 Cg_exo -71.83 -9.49 24.88 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.653 2.235 . . . . 1.47 112.321 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -49.81 -39.54 38.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.196 0.522 . . . . 3.16 110.87 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -56.23 -26.98 51.57 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.281 -0.872 . . . . 1.12 113.061 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.412 ' HA ' ' HE2' ' A' ' 153' ' ' LYS . 90.2 mt -76.63 -29.65 56.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 2.37 112.571 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 185' ' ' PRO . 85.9 mt -33.14 -47.73 0.58 Allowed Pre-proline 0 N--CA 1.483 1.185 0 N-CA-C 116.237 1.939 . . . . 3.87 116.237 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 184' ' ' LEU . 14.1 Cg_exo -71.73 48.89 1.12 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.556 1.504 . . . . 2.51 114.029 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 187' ' ' SER . 0.0 OUTLIER -109.45 -6.19 15.53 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.998 -0.439 . . . . 3.23 111.766 173.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.456 ' OG ' ' HE2' ' A' ' 212' ' ' LYS . 46.1 t 72.84 128.43 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.782 0.676 . . . . 2.03 111.038 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.472 ' HA ' HD21 ' A' ' 211' ' ' LEU . 96.0 mt -113.81 59.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.395 -0.366 . . . . 2.5 110.174 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -144.43 153.08 41.54 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.997 -0.742 . . . . 1.81 108.997 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.448 ' HB3' ' HB ' ' A' ' 210' ' ' VAL . 0.1 OUTLIER 171.58 -168.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.121 -1.066 . . . . 5.32 108.121 -178.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.561 ' HB3' ' HA ' ' A' ' 257' ' ' ALA . 1.5 p90 -75.87 147.97 38.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.09 0.472 . . . . 4.55 110.265 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.3 t -107.28 75.91 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.8 0.81 . . . . 2.39 110.811 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.426 ' OH ' ' HD3' ' A' ' 253' ' ' ARG . 20.8 t80 -138.43 138.5 22.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.635 -0.711 . . . . 5.32 110.057 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.511 ' HA ' ' OG1' ' A' ' 207' ' ' THR . 33.0 Cg_endo -64.7 130.29 25.91 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.728 2.285 . . . . 2.47 112.832 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -125.29 142.85 14.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.862 -0.608 . . . . 2.0 112.12 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 C--N 1.325 -0.478 0 CA-C-O 121.579 0.704 . . . . 3.36 112.405 -177.784 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.978 0.418 . . . . 3.51 110.744 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -104.25 51.3 0.78 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 3.37 110.352 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 62.2 m -135.69 11.74 3.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.436 -0.802 . . . . 2.47 110.412 -176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.583 HG11 ' C ' ' A' ' 140' ' ' LEU . 15.9 m -136.23 100.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 1.74 110.46 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.511 ' OG1' ' HA ' ' A' ' 194' ' ' PRO . 1.4 t -151.21 89.8 1.54 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 115.358 1.614 . . . . 2.3 115.358 170.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.592 ' O ' HG21 ' A' ' 209' ' ' ILE . 0.1 OUTLIER -151.96 85.5 1.29 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.569 -0.707 . . . . 6.37 109.322 143.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.592 HG21 ' O ' ' A' ' 208' ' ' TRP . 0.1 OUTLIER -163.16 98.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.177 0.436 . . . . 2.32 112.177 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.502 HG23 ' CD1' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.11 136.61 59.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.469 -0.769 . . . . 2.1 109.893 165.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 188' ' ' LEU . 51.6 mt -114.1 123.19 49.05 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 2.35 110.631 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.456 ' HE2' ' OG ' ' A' ' 187' ' ' SER . 62.3 pttt -67.62 -36.77 81.44 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.122 0.415 . . . . 3.47 112.122 -174.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.411 ' HG2' ' HG3' ' A' ' 212' ' ' LYS . 25.0 mm-40 -99.14 117.21 64.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 1.56 111.166 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.65 148.25 58.89 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.525 2.15 . . . . 1.37 111.134 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -79.45 147.26 6.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 1.85 109.62 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.1 t -89.9 116.4 27.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.003 -0.544 . . . . 1.78 110.577 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -119.37 135.69 58.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.586 -0.894 . . . . 1.64 108.586 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 152' ' ' ALA . 13.2 t -96.95 170.43 9.16 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.992 -0.442 . . . . 1.52 111.502 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.567 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 11.0 p -51.48 -53.03 41.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.367 0.506 . . . . 1.81 112.367 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.47 -40.14 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 2.51 111.099 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -68.87 -51.08 44.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.966 -0.561 . . . . 1.02 110.071 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.9 m -69.25 -20.71 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 111.912 0.338 . . . . 1.88 111.912 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 219' ' ' SER . 57.9 mt -61.87 -42.41 99.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.019 0.437 . . . . 1.59 109.907 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.676 ' O ' ' HG ' ' A' ' 228' ' ' LEU . 62.5 mttm -66.62 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.511 -0.768 . . . . 2.3 110.865 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -73.23 -31.14 63.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.216 0.532 . . . . 3.18 110.496 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -83.35 -13.86 54.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.684 -0.689 . . . . 3.55 110.89 -174.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.531 ' HB2' ' HZ2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -100.62 -2.35 32.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.205 -0.452 . . . . 2.74 111.294 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.681 HD13 ' CE1' ' A' ' 66' ' ' PHE . 90.7 mt -73.62 152.43 40.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.064 0.459 . . . . 1.66 110.952 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.601 ' OD1' ' HE2' ' A' ' 167' ' ' LYS . 11.9 m120 -111.22 141.48 44.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.408 0.623 . . . . 1.13 111.037 -174.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.77 -31.47 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.731 -1.122 . . . . 4.38 108.815 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.8 p-10 -72.83 165.21 25.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.506 -1.224 . . . . 1.62 112.208 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.09 174.41 45.61 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.915 -1.039 . . . . 1.16 110.814 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.5 133.07 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.832 -0.433 . . . . 3.56 109.832 -176.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.26 3.84 88.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.694 -0.765 . . . . 2.23 113.27 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 32.6 mt-10 -98.66 164.34 17.18 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.657 -0.498 . . . . 2.59 109.657 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.44 126.51 22.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 1.5 111.571 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.51 109.34 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.647 -0.706 . . . . 3.4 111.763 -172.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -125.59 122.15 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.41 -0.814 . . . . 2.47 110.193 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.58 149.42 49.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.773 -0.649 . . . . 2.6 111.116 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.413 ' HE2' ' O ' ' A' ' 63' ' ' GLY . 53.5 mtt -73.0 102.55 3.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 1.94 109.352 175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.87 133.47 68.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 1.67 111.505 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.461 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 17.6 t70 63.62 -80.02 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.3 -0.864 . . . . 2.18 111.211 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 56.36 33.68 22.8 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.818 0.447 . . . . 2.64 111.804 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -125.35 144.75 50.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.468 -0.568 . . . . 5.31 109.468 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.575 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 0.1 OUTLIER -67.62 147.25 98.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.044 -0.525 . . . . 6.91 111.358 -178.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 61.1 Cg_exo -53.17 153.26 16.8 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.443 2.762 . . . . 3.72 112.348 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 118.57 16.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.317 -0.401 . . . . 3.34 111.585 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.531 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 48.6 mt-30 -68.89 171.44 6.37 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.771 -0.65 . . . . 4.92 109.684 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 66.1 Cg_exo -42.26 123.2 2.57 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.386 2.058 . . . . 4.01 111.853 173.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -55.96 -52.87 62.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.571 -0.74 . . . . 4.9 111.836 -163.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 253' ' ' ARG . 18.8 ptpt -62.21 -10.95 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.865 1.061 . . . . 5.68 113.865 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 10.4 p30 48.9 -42.59 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.887 2.551 . . . . 5.11 117.887 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 251' ' ' LYS . 20.0 ttt180 168.74 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.485 -0.931 . . . . 6.74 108.485 -164.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -129.33 136.12 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.063 -0.717 . . . . 3.08 109.063 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.1 mt -99.66 142.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.246 -0.279 . . . . 3.06 110.246 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -132.46 159.1 40.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.596 -0.275 . . . . 3.01 110.348 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 191' ' ' TRP . . . -130.57 157.7 42.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 1.99 110.971 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 191' ' ' TRP . 14.0 p -163.91 98.31 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.387 . . . . 2.47 110.275 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -162.08 150.13 14.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.39 -0.368 . . . . 5.03 110.374 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.38 -0.819 . . . . 4.82 109.673 -177.817 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 120.547 0.213 . . . . 3.14 111.007 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.8 mt -85.49 135.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 116.353 -0.385 . . . . 2.71 110.626 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -105.82 111.46 24.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.744 -0.465 . . . . 2.82 109.744 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.5 p -60.61 -27.24 67.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.037 -0.529 . . . . 2.71 112.321 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -66.56 -45.7 78.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 5.23 110.818 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 m -78.74 -25.9 44.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 3.38 110.667 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.12 116.93 3.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.129 0.49 . . . . 1.76 111.248 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -94.24 128.7 40.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 4.05 110.918 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.1 p90 -76.69 140.05 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.262 -0.426 . . . . 4.9 110.18 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.34 98.46 13.92 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.899 0.381 . . . . 2.27 110.007 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.18 -10.5 27.41 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.181 2.587 . . . . 2.45 113.14 -175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.6 p -78.96 -1.92 37.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.023 0.439 . . . . 4.62 110.565 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.501 HD12 ' OG ' ' A' ' 258' ' ' SER . 78.4 mt -89.54 138.27 31.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.387 -0.597 . . . . 5.15 109.387 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.36 140.25 26.3 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 4.21 110.879 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.44 138.07 84.44 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.128 2.552 . . . . 2.76 111.649 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 mt -72.94 138.3 46.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 2.93 110.457 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -91.81 120.52 32.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.009 -1.108 . . . . 2.46 108.009 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 79' ' ' LEU . 1.9 t -116.45 110.93 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.522 -0.308 . . . . 2.17 110.624 -172.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.9 t -94.91 88.38 5.27 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.034 -0.728 . . . . 1.87 109.034 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CE1' ' HG2' ' A' ' 181' ' ' ARG . 1.4 p90 -107.25 1.1 23.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.892 -0.594 . . . . 3.97 111.36 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.35 -32.83 65.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.242 -0.435 . . . . 2.48 111.557 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.471 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 1.2 mp0 -101.5 6.89 42.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.54 111.138 -176.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.63 128.1 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.812 0.339 . . . . 1.41 111.537 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -112.31 107.03 15.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.954 -0.566 . . . . 1.41 110.721 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 t -79.67 150.51 30.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 1.84 108.95 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.7 mt -117.79 -54.52 2.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 1.45 111.825 -173.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -161.91 159.58 26.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.322 -0.399 . . . . 3.72 110.841 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.1 tt -115.31 141.5 32.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.312 -0.625 . . . . 1.35 109.312 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 171' ' ' LYS . 61.5 tp -127.6 138.26 52.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.37 . . . . 1.53 110.89 -173.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -92.99 119.78 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.063 0.459 . . . . 1.49 110.547 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 49.0 m-80 -127.74 146.53 50.55 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.339 -0.985 . . . . 2.18 108.339 170.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.22 6.34 7.6 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.976 -0.631 . . . . 2.0 113.932 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -114.33 -54.29 2.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.165 0.482 . . . . 4.11 109.713 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 62' ' ' ASN . . . -140.53 163.22 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.336 -0.393 . . . . 1.78 110.416 174.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -111.47 99.77 8.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.805 -0.443 . . . . 3.48 109.805 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -86.55 138.83 31.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 1.99 111.72 -171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.3 t -114.59 113.25 43.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.476 -0.784 . . . . 1.75 108.977 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -72.66 140.53 47.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.913 -0.585 . . . . 2.02 112.076 -172.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -125.68 144.32 50.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 2.19 110.1 172.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.65 139.5 30.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.148 -0.478 . . . . 1.33 111.068 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.02 64.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.033 -0.985 . . . . 2.65 109.868 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -77.82 -11.06 59.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.982 0.896 . . . . 2.01 108.65 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.25 160.05 43.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.927 -1.488 . . . . 2.35 107.824 -176.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.97 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.688 0.618 . . . . 1.92 111.865 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 53' ' ' GLN . 90.0 mttt -109.54 -59.41 1.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.65 0.611 . . . . 2.31 112.65 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.84 102.15 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.06 0.457 . . . . 1.44 111.258 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.59 145.41 24.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.205 -0.452 . . . . 1.82 111.206 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.421 ' CD1' HG23 ' A' ' 49' ' ' VAL . 31.8 tp -134.39 112.88 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.935 -0.395 . . . . 1.8 109.935 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -150.98 123.23 8.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 3.02 111.538 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -97.17 176.06 31.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.762 -1.021 . . . . 1.44 110.905 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.17 -141.28 0.0 OUTLIER Glycine 0 CA--C 1.541 1.71 0 N-CA-C 115.331 0.892 . . . . 2.15 115.331 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.64 122.21 8.47 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.227 1.952 . . . . 3.17 112.329 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.563 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 14.1 tp -165.44 -170.3 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.976 -1.12 . . . . 4.55 107.976 -171.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.563 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 27.0 t70 -122.23 41.72 3.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.294 0.497 . . . . 4.95 110.997 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.77 174.91 13.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.858 -1.163 . . . . 2.25 114.229 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.0 m -101.86 124.18 47.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.073 -0.564 . . . . 2.12 110.12 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -114.07 113.16 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.071 0.463 . . . . 3.88 111.55 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.79 153.93 20.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.372 -0.376 . . . . 3.87 110.431 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.89 124.33 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.819 0.342 . . . . 1.68 110.615 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.536 ' HB ' ' CE3' ' A' ' 123' ' ' TRP . 14.2 tt -105.62 -34.02 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.918 0.389 . . . . 2.16 110.117 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -173.93 164.67 4.24 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.854 -0.795 . . . . 1.95 108.854 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -136.71 154.66 50.54 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.566 -0.902 . . . . 0.98 108.566 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.47 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.7 p-80 -139.78 158.8 43.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.943 0.401 . . . . 1.07 110.962 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.12 166.84 20.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 3.99 109.426 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.433 ' HE1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -144.46 157.69 44.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.451 -0.574 . . . . 2.2 109.451 175.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.598 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 73.1 t-105 -128.51 139.5 52.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 6.08 110.228 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 241' ' ' VAL . . . -95.06 -59.42 1.11 Allowed Glycine 0 C--O 1.218 -0.844 0 C-N-CA 120.837 -0.697 . . . . 2.19 112.74 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 28.8 p 163.07 -57.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.365 0.603 . . . . 3.08 110.648 -172.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.81 153.26 23.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.307 -0.86 . . . . 3.48 110.4 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.38 51.69 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.666 0.746 . . . . 3.85 110.243 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -176.02 1.64 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.151 -0.931 . . . . 2.37 112.434 -175.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -160.35 155.24 24.33 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.887 -0.782 . . . . 2.62 108.887 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 116.19 -27.12 8.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.192 -1.004 . . . . 1.62 111.873 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 t -70.39 -46.73 63.44 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.011 -0.366 . . . . 2.24 110.011 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 113' ' ' LYS . 8.1 mm-40 58.89 177.39 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.044 -0.525 . . . . 3.72 111.808 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.44 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 24.6 m80 59.76 14.45 4.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.962 -0.563 . . . . 4.03 111.286 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 113' ' ' LYS . 7.3 t -82.38 -178.8 7.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.11 -0.95 . . . . 2.99 113.088 -172.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.0 m -103.61 123.94 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.582 -1.19 . . . . 2.88 111.965 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 61.17 39.14 16.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.38 -1.282 . . . . 2.8 111.413 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 67.81 8.54 6.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.758 -0.656 . . . . 5.35 112.163 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.43 73.91 6.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.694 0.283 . . . . 3.58 110.707 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.515 ' HD3' ' OE1' ' A' ' 106' ' ' GLU . 91.9 mttt -69.07 150.25 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.222 0.534 . . . . 3.26 111.641 -176.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 81.4 m-85 -101.12 -177.26 3.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.174 -0.921 . . . . 1.71 109.848 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.63 67.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.917 0.389 . . . . 1.57 111.704 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.32 163.75 39.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.457 . . . . 1.3 110.224 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.44 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 44.3 tt0 -129.99 135.2 48.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.732 -0.47 . . . . 1.85 109.732 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.493 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 42.9 tp -110.78 132.5 54.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.066 -0.515 . . . . 1.61 109.907 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -128.09 111.34 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.792 0.33 . . . . 2.25 111.628 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 6.6 mp -92.71 113.46 25.74 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.151 -0.315 . . . . 1.51 110.151 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.73 122.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.162 0.506 . . . . 1.24 111.37 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -120.92 146.64 46.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.95 -0.568 . . . . 2.86 109.513 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.536 ' CE3' ' HB ' ' A' ' 91' ' ' ILE . 2.1 p90 -119.56 148.83 42.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.615 -0.513 . . . . 4.96 109.615 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -68.99 114.73 7.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.278 0.561 . . . . 2.3 110.37 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -68.19 -21.87 64.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.235 -0.893 . . . . 2.77 112.101 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.87 -21.6 64.83 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.861 0.363 . . . . 3.79 111.506 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.3 -3.17 34.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.003 0.43 . . . . 3.34 110.125 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.79 30.22 6.67 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 114.714 -1.13 . . . . 2.37 114.98 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.479 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 30.5 t70 -173.42 129.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.037 0.918 . . . . 3.93 110.214 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.598 ' O ' HG21 ' A' ' 134' ' ' VAL . 85.8 t80 -60.0 -46.4 89.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.961 -1.018 . . . . 3.6 110.842 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.66 99.24 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.227 -0.511 . . . . 2.35 112.832 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.479 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 73.6 mmtt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.07 0.462 . . . . 3.75 110.316 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.68 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.66 -0.7 . . . . 2.17 110.738 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.598 HG21 ' O ' ' A' ' 130' ' ' PHE . 99.6 t -64.83 -26.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.022 -0.535 . . . . 3.11 111.493 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -83.87 -4.66 58.85 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.023 -0.423 . . . . 3.55 111.451 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' A' ' 136' ' ' GLN . 3.1 tt0 -107.28 132.36 21.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.885 -0.413 . . . . 3.02 109.885 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 74.4 Cg_exo -52.46 -30.37 43.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.426 2.751 . . . . 1.93 113.499 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.91 25.18 12.05 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.646 0.26 . . . . 2.29 110.472 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.68 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -70.87 -33.63 65.99 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.579 -0.819 . . . . 1.5 113.394 -172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.7 mt -114.71 156.9 23.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.999 0.428 . . . . 1.98 110.069 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.0 106.57 6.14 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.284 -0.635 . . . . 1.83 109.284 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 91.3 t -103.94 116.45 47.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.093 -0.503 . . . . 2.28 110.353 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 44.5 tp -88.8 112.85 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.631 -0.713 . . . . 2.89 109.329 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -101.64 141.9 15.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.906 -0.664 . . . . 0.95 112.337 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.6 mt -133.64 131.75 57.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.453 -0.573 . . . . 1.38 109.453 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.4 148.99 25.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.921 -0.4 . . . . 1.37 109.921 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.9 mp -116.79 124.01 48.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 1.48 110.973 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 18.9 ptpt -108.1 150.52 27.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.271 -0.64 . . . . 2.52 109.271 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 92.3 t -95.01 130.55 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.133 0.492 . . . . 1.88 110.83 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.59 -103.61 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.794 -0.639 . . . . 1.53 111.731 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 p -71.07 147.22 48.71 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.839 0.352 . . . . 2.08 110.385 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.2 149.58 33.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.263 -0.426 . . . . 1.36 110.606 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.0 100.4 53.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.053 -0.521 . . . . 1.78 110.303 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.46 -35.02 64.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.41 2.74 . . . . 1.34 112.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.44 -21.36 64.47 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.347 -0.454 . . . . 0.75 113.524 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.501 ' HB3' ' NE2' ' A' ' 221' ' ' GLN . 27.1 tp -98.04 -6.25 32.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.3 0.55 . . . . 1.39 110.802 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.01 -41.24 74.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 1.63 111.805 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -66.04 -34.66 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.728 0.299 . . . . 3.26 111.085 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 162' ' ' VAL . 67.4 t -71.55 -50.29 40.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 1.97 110.823 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.406 ' HB ' ' HD2' ' A' ' 224' ' ' LYS . 32.9 m -65.61 -24.89 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 1.64 111.255 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.74 -34.1 58.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.499 . . . . 1.22 111.495 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 159' ' ' VAL . 6.0 p -81.89 -8.77 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 2.07 110.749 -175.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.34 -27.22 63.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.966 -0.561 . . . . 1.95 111.391 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.15 -34.66 73.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 2.31 111.413 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.3 t -89.25 -1.55 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.664 -0.244 . . . . 1.78 111.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 38.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.05 0.452 . . . . 1.42 110.374 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.9 -35.33 72.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 1.98 111.023 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 p -106.39 149.02 27.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.396 0.617 . . . . 1.4 111.52 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -57.41 126.94 29.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.901 -1.045 . . . . 2.84 111.18 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.5 -22.24 20.2 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.748 -0.739 . . . . 0.85 112.642 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.425 ' O ' HD11 ' A' ' 60' ' ' LEU . 64.8 mttm -79.62 150.28 31.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.167 0.508 . . . . 2.22 111.472 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 8.5 t -140.75 151.34 44.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.402 -0.817 . . . . 1.93 109.279 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -140.51 134.85 31.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.07 -0.344 . . . . 1.17 110.07 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.43 132.41 53.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.249 0.547 . . . . 1.8 110.402 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -141.51 80.79 1.75 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.611 -0.722 . . . . 1.31 109.585 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 32.0 p -101.34 160.9 14.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.274 0.472 . . . . 1.69 112.274 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.1 42.16 10.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.263 -0.88 . . . . 2.26 111.755 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.46 130.57 45.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 4.84 110.828 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 3.2 p30 -105.72 133.18 20.31 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 2.51 109.92 176.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 3.3 Cg_exo -77.93 -11.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.536 2.157 . . . . 1.47 111.439 173.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.511 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 18.4 mtm180 -57.68 -44.0 85.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.616 -0.72 . . . . 3.16 111.498 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.86 -6.48 56.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.83 -0.7 . . . . 1.12 112.978 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.42 ' O ' HG21 ' A' ' 215' ' ' ILE . 6.7 mp -108.7 -9.23 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.582 -0.364 . . . . 2.37 111.002 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 95.3 mt -70.75 140.83 86.81 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.913 0.387 . . . . 3.87 111.621 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.52 -167.98 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.273 2.648 . . . . 2.51 113.308 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.7 -59.74 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 3.23 111.309 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.51 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 9.7 m -91.05 140.44 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 2.03 110.949 -174.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 35.1 tp -106.02 62.78 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.549 0.69 . . . . 2.5 109.657 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 258' ' ' SER . 6.9 m-20 -122.45 171.79 8.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.829 -1.175 . . . . 1.81 107.829 176.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 51.7 p90 -167.71 163.5 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.831 1.049 . . . . 5.32 113.831 -163.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.565 ' CZ2' ' HG3' ' A' ' 212' ' ' LYS . 13.4 m-90 -105.37 141.94 36.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.223 -1.399 . . . . 4.55 107.223 164.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.4 t -138.86 109.13 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.409 0.623 . . . . 2.39 112.558 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.51 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 8.9 t80 -139.88 129.03 13.6 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 5.32 109.671 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.51 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 89.0 Cg_exo -48.9 134.92 29.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.058 2.505 . . . . 2.47 112.92 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -107.48 153.39 16.83 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.82 -0.627 . . . . 2.0 113.659 -170.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.9 p . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 123.68 0.792 . . . . 3.36 111.243 179.583 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.907 0.384 . . . . 3.51 110.727 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -112.78 85.94 2.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.563 0.697 . . . . 3.37 110.502 -177.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.5 p -111.93 3.43 17.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.167 -0.47 . . . . 2.47 111.07 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.04 134.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.281 0.563 . . . . 1.74 111.819 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.5 m -102.9 97.85 7.92 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.079 -1.452 . . . . 2.3 107.079 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -88.77 120.35 30.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.076 0.465 . . . . 6.37 110.815 -169.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 71.3 mt -126.18 118.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 2.32 109.356 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 191' ' ' TRP . 3.4 p -120.32 126.26 75.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.808 0.337 . . . . 2.1 110.602 -174.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.22 137.02 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.079 -0.51 . . . . 2.35 110.596 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.565 ' HG3' ' CZ2' ' A' ' 191' ' ' TRP . 33.6 ttmt -81.53 -1.36 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 3.47 110.756 -177.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -111.8 91.65 15.56 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.3 -0.63 . . . . 1.56 109.3 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 18.9 Cg_exo -66.61 147.44 81.81 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.775 2.317 . . . . 1.37 112.031 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.42 HG21 ' O ' ' A' ' 183' ' ' LEU . 38.8 pt -94.61 154.35 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 1.85 110.751 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.9 m -99.92 137.92 37.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.961 -0.563 . . . . 1.78 110.975 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 12.6 m -134.63 155.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.634 -0.712 . . . . 1.64 109.193 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 44.9 t -83.44 154.8 23.77 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.941 -0.303 . . . . 1.52 110.602 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.638 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 6.3 p -54.91 -45.56 74.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.583 -0.28 . . . . 1.81 110.531 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 43.5 mt-10 -55.69 -27.76 51.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.204 -0.453 . . . . 2.51 111.5 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.501 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 52.9 mt-30 -80.27 -47.39 14.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 1.02 110.454 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.598 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 35.1 m -71.91 -26.69 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 1.88 111.499 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.7 mt -66.72 -30.3 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.79 0.329 . . . . 1.59 110.445 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 96.1 mttt -69.43 -24.29 63.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 2.3 110.765 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 21.9 m-85 -75.73 -25.01 56.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 3.18 109.774 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -79.29 -10.94 59.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 3.55 110.189 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -90.29 -8.78 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 2.74 110.35 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.26 150.48 48.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 1.66 110.425 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.7 m120 -110.21 136.35 49.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.409 0.623 . . . . 1.13 110.613 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -76.93 -30.5 56.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.758 -1.11 . . . . 4.38 109.739 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.6 p-10 -73.61 164.38 26.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.128 -0.942 . . . . 1.62 112.132 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.83 174.32 46.0 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.073 -0.967 . . . . 1.16 111.079 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.11 135.84 55.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.243 0.521 . . . . 3.56 110.511 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 90.69 7.91 66.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.859 -0.686 . . . . 2.23 112.434 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -112.53 159.24 34.88 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.244 -0.28 . . . . 2.59 110.244 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.26 124.0 15.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.453 2.102 . . . . 1.5 110.911 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.435 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.9 pt-20 -62.01 123.93 19.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.819 0.819 . . . . 3.4 111.909 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 43.5 mt-10 -116.97 125.27 51.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.843 -1.071 . . . . 2.47 108.486 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -70.05 147.57 49.88 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.117 -0.492 . . . . 2.6 110.619 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 11.9 tpt -73.94 92.13 2.07 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.528 -0.916 . . . . 1.94 108.528 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.0 m -140.21 142.12 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 1.67 110.674 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 30.1 t70 66.42 -95.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.226 -0.897 . . . . 2.18 109.497 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 m120 53.25 19.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.483 0.549 . . . . 2.64 112.483 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -150.08 164.31 35.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.792 0.33 . . . . 5.31 110.406 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.414 ' HE ' ' NE2' ' A' ' 248' ' ' GLN . 12.6 ptm180 -107.78 148.12 36.74 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.926 -0.579 . . . . 6.91 110.898 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.97 161.98 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.625 2.883 . . . . 3.72 113.623 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.2 143.66 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.334 -0.848 . . . . 3.34 110.695 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.415 ' HB3' ' CD ' ' A' ' 249' ' ' PRO . 41.9 mt-30 -124.69 170.54 8.79 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.867 -0.606 . . . . 4.92 111.1 -169.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.415 ' CD ' ' HB3' ' A' ' 248' ' ' GLN . 6.5 Cg_exo -76.09 174.94 11.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.401 2.734 . . . . 4.01 115.031 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.42 -8.7 57.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 113.879 -1.51 . . . . 4.9 113.069 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 18.4 pttp -55.21 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.319 2.34 . . . . 5.68 117.319 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 3.3 p-10 134.62 28.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.976 1.71 . . . . 5.11 112.065 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.424 ' NE ' HD11 ' A' ' 255' ' ' ILE . 56.3 ttt180 -147.94 120.05 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.924 -0.399 . . . . 6.74 109.924 162.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -146.79 122.39 10.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.429 -1.322 . . . . 3.08 107.429 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.444 HD12 HG23 ' A' ' 255' ' ' ILE . 14.8 mt -124.85 145.83 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.006 0.432 . . . . 3.06 111.803 -168.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.46 143.55 48.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 3.01 110.041 169.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -118.59 92.72 3.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.157 -0.474 . . . . 1.99 110.097 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 69.0 m -105.55 100.67 10.23 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.288 -0.565 . . . . 2.47 111.724 -172.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -126.27 100.43 6.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.136 -1.061 . . . . 5.03 108.136 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.503 -0.761 . . . . 4.82 110.808 -173.279 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 108.053 -1.091 . . . . 3.14 108.053 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 57.1 mt -65.62 103.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.41 0.624 . . . . 2.71 111.191 -169.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' THR . 20.9 m-20 -83.44 102.66 12.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.929 -1.032 . . . . 2.82 108.947 176.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -55.02 -35.65 64.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.405 0.52 . . . . 2.71 112.405 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -84.66 -28.58 26.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.092 0.404 . . . . 5.23 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 5.7 m -89.12 -15.81 32.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.285 0.564 . . . . 3.38 110.91 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.02 142.16 56.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 1.76 110.747 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -104.32 116.45 32.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.376 -0.602 . . . . 4.05 109.376 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -87.59 87.18 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 4.9 110.835 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' OD2' ' HG ' ' A' ' 44' ' ' LEU . 19.6 t70 -73.93 119.72 77.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 2.27 110.91 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.57 -16.71 9.09 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.876 2.384 . . . . 2.45 112.918 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 m -70.25 -46.22 64.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.636 -0.505 . . . . 4.62 109.636 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.417 ' HG ' ' OD2' ' A' ' 41' ' ' ASP . 95.9 mt -54.29 144.52 20.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.417 -0.811 . . . . 5.15 111.008 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -117.1 124.07 29.49 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.672 -0.695 . . . . 4.21 109.835 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HA ' ' CE2' ' A' ' 190' ' ' TYR . 73.3 Cg_exo -51.52 122.76 10.81 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.258 1.972 . . . . 2.76 111.623 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.95 126.87 30.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.539 -0.755 . . . . 2.93 110.606 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.451 ' O ' HD11 ' A' ' 79' ' ' LEU . 53.7 p -67.35 136.19 54.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.706 -0.479 . . . . 2.46 109.706 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.46 97.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.818 -0.438 . . . . 2.17 109.818 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 9.8 m -97.14 88.62 4.53 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.478 -0.564 . . . . 1.87 109.478 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 181' ' ' ARG . 1.0 OUTLIER -129.23 18.09 5.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.5 0.667 . . . . 3.97 109.896 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.06 -28.83 69.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.016 -0.993 . . . . 2.48 110.216 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.2 7.84 45.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 2.54 111.256 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.71 133.64 55.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.738 0.304 . . . . 1.41 111.717 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.578 ' OG1' ' HE2' ' A' ' 76' ' ' LYS . 10.7 m -121.1 119.13 31.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.085 -0.507 . . . . 1.41 110.532 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 t -83.92 150.25 25.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.308 -0.405 . . . . 1.84 110.431 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.0 mt -116.71 -55.44 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 1.45 111.424 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -169.75 160.83 8.93 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.425 -0.352 . . . . 3.72 110.942 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 17.4 tt -109.32 144.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 1.35 109.281 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.6 tp -135.68 136.93 41.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.313 0.578 . . . . 1.53 111.779 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.445 ' CB ' ' HA ' ' A' ' 169' ' ' LYS . 4.2 m-20 -88.43 106.03 17.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.943 -1.026 . . . . 1.49 109.32 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 64' ' ' HIS . 44.6 m-80 -100.04 75.19 1.84 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.382 -0.372 . . . . 2.18 111.4 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.439 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 65.93 -26.15 0.15 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 115.56 0.984 . . . . 2.0 115.56 174.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 62' ' ' ASN . 25.5 p80 -163.76 -25.82 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.76 0.314 . . . . 4.11 111.533 -172.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.74 157.93 19.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.12 -0.326 . . . . 1.78 110.12 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -131.7 96.37 3.94 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.51 -0.922 . . . . 3.48 108.51 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -115.86 145.59 42.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.23 -0.896 . . . . 1.99 111.437 -170.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 58.8 t -93.71 121.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.781 -0.645 . . . . 1.75 110.049 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -86.52 125.05 33.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.69 -0.686 . . . . 2.02 109.787 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -103.83 164.38 11.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.919 0.39 . . . . 2.19 110.674 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.64 116.16 28.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.879 -0.6 . . . . 1.33 109.824 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -127.77 59.99 1.45 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.925 0.869 . . . . 2.65 110.795 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -75.9 -5.29 45.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.435 -0.802 . . . . 2.01 110.614 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -157.61 176.94 11.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 2.35 109.218 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.65 30.38 0.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.385 -0.371 . . . . 1.92 111.194 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.578 ' HE2' ' OG1' ' A' ' 55' ' ' THR . 2.4 ptpp? -50.77 -44.94 58.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.75 -0.659 . . . . 2.31 111.628 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.15 99.54 6.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.367 . . . . 1.44 110.119 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.2 m -129.0 168.36 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.386 0.613 . . . . 1.82 111.739 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 48' ' ' SER . 38.7 tp -137.19 111.45 8.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.04 -0.982 . . . . 1.8 108.416 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -150.45 126.34 10.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 3.02 111.419 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 173.94 24.28 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.965 -0.561 . . . . 1.44 113.347 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.78 -134.11 0.0 OUTLIER Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.349 0.976 . . . . 2.15 114.545 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -44.9 169.92 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.226 2.618 . . . . 3.17 112.712 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -35.8 150.34 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.472 1.286 . . . . 4.55 114.472 -154.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 13.8 p-10 174.58 -66.61 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.797 -1.092 . . . . 4.95 111.227 -156.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.6 141.8 2.44 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.371 -0.691 . . . . 2.25 111.371 -170.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.3 m -88.51 125.69 34.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.695 0.747 . . . . 2.12 111.033 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.501 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.2 m-85 -118.65 126.36 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.325 -0.398 . . . . 3.88 111.24 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.4 mtt180 -83.0 135.63 34.79 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.55 -0.295 . . . . 3.87 111.024 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.45 117.02 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.48 -0.563 . . . . 1.68 109.48 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.421 HG23 ' HG2' ' A' ' 92' ' ' GLN . 6.9 tt -110.12 -36.34 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.335 -0.393 . . . . 2.16 111.241 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 20.6 pt20 -162.86 168.31 21.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.339 -0.245 . . . . 1.95 110.339 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -141.1 149.31 41.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.921 -0.4 . . . . 0.98 109.921 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -140.4 158.02 44.64 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.151 0.282 . . . . 1.07 110.714 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.7 m-85 -108.86 153.2 23.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.407 -0.36 . . . . 3.99 110.108 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -105.52 153.55 21.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 2.2 111.903 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.634 ' CB ' ' HA2' ' A' ' 104' ' ' GLY . 0.7 OUTLIER 69.37 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.738 -1.119 . . . . 6.08 111.984 170.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 241' ' ' VAL . . . 69.69 118.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.161 -0.542 . . . . 2.19 112.055 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 23.1 t 176.16 -89.53 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.03 0.415 . . . . 3.08 111.435 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.72 170.82 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 3.48 111.382 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.05 45.14 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.409 -0.814 . . . . 3.85 111.341 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -176.56 20.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.905 . . . . 2.37 112.828 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -155.86 120.03 4.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 2.62 110.043 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.634 ' HA2' ' CB ' ' A' ' 97' ' ' TRP . . . 157.71 -26.52 0.45 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.817 -0.706 . . . . 1.62 111.551 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 114' ' ' TYR . 43.2 m -81.35 64.73 6.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.098 0.559 . . . . 2.24 110.283 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.15 143.06 55.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.75 -0.463 . . . . 3.72 109.75 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.447 ' O ' HG13 ' A' ' 33' ' ' ILE . 34.7 m80 61.65 25.64 15.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.984 0.421 . . . . 4.03 111.618 174.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.4 t -82.68 -175.54 5.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.5 . . . . 2.99 111.512 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 15.0 m -71.07 106.81 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 2.88 111.715 -166.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.0 t70 58.2 31.11 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.991 -1.459 . . . . 2.8 109.724 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.5 mttp 66.81 28.67 8.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.984 -1.007 . . . . 5.35 112.479 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -69.24 72.31 0.29 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.168 0.509 . . . . 3.58 110.488 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.75 114.29 2.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.415 -0.811 . . . . 3.26 112.584 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.5 ' H ' ' HB2' ' A' ' 105' ' ' SER . 67.2 m-85 -106.31 -163.16 0.9 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.343 -0.844 . . . . 1.71 109.276 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.61 95.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.13 0.789 . . . . 1.57 113.13 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.11 169.66 15.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.456 0.539 . . . . 1.3 112.456 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -122.59 135.01 54.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.501 -1.227 . . . . 1.85 108.25 171.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.488 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.3 tp -116.06 116.41 27.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.243 -0.28 . . . . 1.61 110.243 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -106.25 110.3 22.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 2.25 111.314 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.2 mp -88.21 102.71 15.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.601 -0.888 . . . . 1.51 108.601 173.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.31 120.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.727 -0.67 . . . . 1.24 110.783 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 12.7 m-70 -117.1 141.99 47.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.984 -0.747 . . . . 2.86 108.984 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.502 ' CZ2' ' HD2' ' A' ' 89' ' ' ARG . 61.5 p-90 -111.87 141.22 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.801 0.334 . . . . 4.96 110.854 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.448 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 44.4 t30 -62.12 110.63 1.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.473 0.654 . . . . 2.3 111.519 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.3 t -61.5 -33.45 73.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.934 -1.03 . . . . 2.77 112.872 -170.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 21.4 pttm -72.02 -6.81 44.96 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.239 0.829 . . . . 3.79 113.239 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.412 ' CZ ' ' HG3' ' A' ' 136' ' ' GLN . 43.4 m-85 -97.93 -4.23 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.568 -0.453 . . . . 3.34 110.836 172.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.5 26.55 5.24 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.074 -0.966 . . . . 2.37 114.779 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.37 122.91 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.547 0.673 . . . . 3.93 109.669 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.545 ' O ' HG22 ' A' ' 134' ' ' VAL . 46.3 p90 -69.37 -31.98 70.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 3.6 111.521 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.24 -37.23 92.66 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.751 -0.738 . . . . 2.35 112.007 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -70.49 -32.88 70.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.35 0.595 . . . . 3.75 109.61 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.73 -25.27 64.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 2.17 111.085 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 130' ' ' PHE . 93.8 t -68.5 -25.89 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 3.11 110.394 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -81.58 -13.82 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 3.55 110.774 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 127' ' ' TYR . 14.2 mm100 -111.18 135.91 20.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.051 -0.522 . . . . 3.02 110.1 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.11 -21.41 55.88 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.671 2.248 . . . . 1.93 112.796 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -113.0 25.45 11.39 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.931 -0.396 . . . . 2.29 109.931 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.76 -30.04 49.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.693 . . . . 1.5 113.892 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 88.1 mt -123.67 158.62 31.15 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.352 -0.499 . . . . 1.98 110.546 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.7 121.05 7.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 1.83 110.031 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 m -110.52 119.65 59.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.022 0.439 . . . . 2.28 110.418 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.2 tp -83.41 104.87 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.467 -0.568 . . . . 2.89 109.467 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -90.36 114.92 4.49 Favored Glycine 0 N--CA 1.446 -0.65 0 O-C-N 123.652 0.595 . . . . 0.95 112.363 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.7 mt -117.06 105.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.389 -0.597 . . . . 1.38 109.389 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 86.6 m-85 -66.24 154.47 39.78 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.122 0.487 . . . . 1.37 111.712 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.68 112.75 24.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.544 -0.753 . . . . 1.48 110.071 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -96.72 147.17 24.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.157 -0.683 . . . . 2.52 109.157 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.82 126.41 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 1.88 110.92 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.23 -106.79 0.22 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.421 -0.672 . . . . 1.53 111.421 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.7 m -69.13 140.64 54.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.824 -0.436 . . . . 2.08 109.824 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.43 152.62 45.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.562 -0.29 . . . . 1.36 110.805 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -108.6 95.29 16.01 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.941 -0.762 . . . . 1.78 108.941 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.02 -35.9 99.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.994 2.463 . . . . 1.34 112.966 -173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.43 -18.4 79.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.913 -0.66 . . . . 0.75 113.061 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.4 tp -90.15 -20.8 22.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.921 0.391 . . . . 1.39 110.805 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.647 HE21 ' HA ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -55.82 -34.25 65.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.947 -0.569 . . . . 1.63 112.154 -175.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -51.75 -41.1 61.34 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 112.534 0.568 . . . . 3.26 112.534 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.5 p -85.56 -38.96 13.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.347 -0.541 . . . . 1.97 111.018 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.419 HG11 ' HD2' ' A' ' 224' ' ' LYS . 31.4 t -63.22 -47.22 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 1.64 111.765 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -18.35 62.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.065 0.394 . . . . 1.22 112.065 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 162' ' ' VAL . 44.4 t -96.22 -1.59 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 121.197 0.523 . . . . 2.07 111.013 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.8 -24.97 66.22 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.901 0.381 . . . . 1.95 111.304 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.9 -31.68 71.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.46 -0.336 . . . . 2.31 110.717 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 44.5 m -76.9 -5.07 47.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 1.78 111.628 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.5 pt -137.78 45.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 1.42 109.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -67.05 -28.97 68.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.418 -0.81 . . . . 1.98 110.986 -175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 p -116.38 149.05 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.724 0.297 . . . . 1.4 110.723 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 61' ' ' ASN . 56.3 pttt -65.25 148.88 50.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.457 -0.338 . . . . 2.84 110.104 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.55 33.84 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.457 -0.878 . . . . 0.85 111.37 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -82.22 157.58 23.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.419 0.628 . . . . 2.22 111.146 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.2 p -141.72 154.04 45.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 1.93 109.122 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.13 122.95 20.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.969 -0.382 . . . . 1.17 109.969 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.25 144.66 56.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.967 -0.561 . . . . 1.8 111.314 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.36 81.2 1.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 1.31 110.327 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 p -112.25 159.12 18.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.495 -0.32 . . . . 1.69 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.6 43.59 25.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.06 -0.518 . . . . 2.26 111.386 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.08 140.35 52.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.401 -0.363 . . . . 4.84 110.23 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -92.15 110.33 43.59 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.392 -0.367 . . . . 2.51 110.467 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.23 -14.85 13.07 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.463 2.109 . . . . 1.47 112.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.545 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . 9.4 ttp180 -71.93 -24.15 61.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 3.16 111.267 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -61.3 -2.8 3.27 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.342 -0.39 . . . . 1.12 113.867 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.54 -8.77 57.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.93 0.365 . . . . 2.37 110.979 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 184' ' ' LEU . 4.4 pp -48.05 137.28 10.94 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 113.425 0.898 . . . . 3.87 113.425 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -94.92 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.553 2.835 . . . . 2.51 111.483 170.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -90.35 -64.18 1.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.836 0.309 . . . . 3.23 111.836 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.1 m -99.32 146.93 25.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 2.03 111.627 -172.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.29 65.12 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.979 0.419 . . . . 2.5 111.197 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.48 ' O ' HD12 ' A' ' 211' ' ' LEU . 33.0 m-20 -108.41 168.68 9.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.038 -1.097 . . . . 1.81 108.038 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.657 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 13.2 p90 -159.58 154.13 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.252 -0.979 . . . . 5.32 112.988 -170.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.682 ' CE3' ' HB1' ' A' ' 257' ' ' ALA . 6.9 m95 -111.84 142.17 44.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.419 -1.264 . . . . 4.55 107.747 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.0 t -121.66 113.24 19.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.548 0.69 . . . . 2.39 112.434 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -138.24 131.21 16.38 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 5.32 110.534 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.66 139.39 76.55 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.86 2.374 . . . . 2.47 112.165 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -138.36 159.17 25.17 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.142 -0.552 . . . . 2.0 113.443 -170.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 107.79 -1.189 . . . . 3.36 107.79 175.364 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.457 0.17 . . . . 3.51 110.588 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -113.47 58.34 0.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.63 0.729 . . . . 3.37 110.392 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.64 -15.43 57.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.988 -1.006 . . . . 2.47 110.519 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 40.6 t -100.65 151.28 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.714 -0.675 . . . . 1.74 110.66 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -117.57 109.35 16.59 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.734 -0.839 . . . . 2.3 108.734 174.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -74.01 100.82 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.951 -0.759 . . . . 6.37 108.951 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.59 99.6 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.688 -0.856 . . . . 2.32 108.688 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 21.5 t -86.19 111.22 20.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.202 -0.454 . . . . 2.1 109.903 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 189' ' ' ASP . 20.6 tp -72.21 120.48 17.88 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.935 -0.765 . . . . 2.35 108.935 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -66.23 -14.91 62.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.243 -0.435 . . . . 3.47 111.708 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.486 ' HG2' ' H ' ' A' ' 187' ' ' SER . 7.1 tp10 -104.71 96.49 10.6 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.573 0.225 . . . . 1.56 110.787 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 63.0 Cg_endo -77.4 144.98 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.461 2.107 . . . . 1.37 111.828 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.3 pt -88.78 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.178 -0.465 . . . . 1.85 111.291 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.4 m -94.68 126.71 40.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.663 . . . . 1.78 110.334 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.49 158.79 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.765 -0.457 . . . . 1.64 109.765 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 55.1 p -95.85 158.69 15.33 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.912 -0.315 . . . . 1.52 111.07 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.604 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 63.8 m -56.55 -39.26 73.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.935 -0.575 . . . . 1.81 110.694 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.89 -31.02 26.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 2.51 111.372 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.91 -45.1 13.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.45 . . . . 1.02 110.175 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.38 -40.71 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.916 -0.584 . . . . 1.88 111.475 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 219' ' ' SER . 89.7 mt -59.24 -35.13 73.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 1.59 111.8 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.419 ' HD2' HG11 ' A' ' 160' ' ' VAL . 66.1 mttp -70.19 -23.47 62.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.628 -0.26 . . . . 2.3 111.473 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -72.87 -25.43 61.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.22 0.533 . . . . 3.18 110.094 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -80.8 -9.89 59.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 3.55 110.603 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -86.9 -10.13 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 2.74 110.444 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.22 148.63 48.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.886 -0.597 . . . . 1.66 110.853 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.589 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 11.5 m120 -113.84 139.43 49.17 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.419 0.628 . . . . 1.13 110.331 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -76.05 -30.62 58.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.768 -1.106 . . . . 4.38 109.568 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.427 ' C ' ' HG2' ' A' ' 169' ' ' LYS . 4.5 p-10 -76.24 171.08 15.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.118 -0.947 . . . . 1.62 112.247 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.87 -179.33 38.91 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.763 -1.108 . . . . 1.16 111.288 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.65 129.17 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 3.56 110.866 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.94 4.34 48.31 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.472 -0.785 . . . . 2.23 112.547 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -116.05 153.94 48.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.249 -0.278 . . . . 2.59 110.249 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.36 131.81 48.04 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.857 2.371 . . . . 1.5 111.774 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.589 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 31.2 tt0 -53.65 115.15 1.82 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.592 0.71 . . . . 3.4 112.755 -174.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -108.82 117.86 35.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.896 -1.15 . . . . 2.47 107.896 168.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.68 125.46 25.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.678 0.275 . . . . 2.6 110.713 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.5 ttm -77.37 90.32 3.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.065 -0.717 . . . . 1.94 109.065 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 27.7 m -136.36 151.74 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.836 -0.62 . . . . 1.67 109.872 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 14.1 t70 69.67 -87.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.696 0.622 . . . . 2.18 110.588 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 48.98 15.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.364 1.246 . . . . 2.64 114.364 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -150.46 177.97 9.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.272 0.487 . . . . 5.31 110.689 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -116.75 131.56 23.85 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.204 -0.295 . . . . 6.91 110.204 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.466 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 59.7 Cg_endo -73.72 -148.34 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.83 2.354 . . . . 3.72 112.772 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.466 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -82.95 136.1 34.66 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.924 -0.485 . . . . 3.34 111.486 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -123.09 162.31 40.01 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.791 -0.64 . . . . 4.92 110.215 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.51 177.82 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.804 3.003 . . . . 4.01 114.341 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 252' ' ' ASN . 4.4 mm? -55.38 -4.7 0.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.245 1.418 . . . . 4.9 113.306 178.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 75.0 mmtt -54.11 49.4 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.489 1.515 . . . . 5.68 114.975 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 3.3 t30 132.67 62.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.911 2.084 . . . . 5.11 111.968 175.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.454 ' HB3' ' H ' ' A' ' 254' ' ' GLN . 29.8 mtm180 88.29 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.418 -1.265 . . . . 6.74 112.689 153.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.454 ' H ' ' HB3' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -157.83 163.7 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.645 -0.872 . . . . 3.08 108.645 -171.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.66 125.17 62.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.818 0.342 . . . . 3.06 111.461 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -106.8 177.14 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 3.01 109.896 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.682 ' HB1' ' CE3' ' A' ' 191' ' ' TRP . . . -136.67 171.78 13.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.772 0.32 . . . . 1.99 111.487 -170.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.3 m -129.43 97.31 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.262 0.553 . . . . 2.47 110.157 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -153.62 138.98 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.835 -0.802 . . . . 5.03 108.835 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.366 -0.826 . . . . 4.82 111.043 -175.378 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.871 -0.789 . . . . 3.14 108.871 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.446 ' HA ' HD11 ' A' ' 255' ' ' ILE . 64.7 mt -86.29 86.83 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.494 0.664 . . . . 2.71 110.888 -171.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -94.29 101.73 13.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.681 -0.69 . . . . 2.82 109.146 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -58.62 -25.31 62.54 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.612 0.597 . . . . 2.71 112.612 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -73.87 -44.14 56.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 5.23 110.455 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 m -81.36 -21.02 39.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.459 . . . . 3.38 111.284 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.8 142.1 42.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.468 -0.333 . . . . 1.76 110.826 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -134.42 114.46 12.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.706 0.289 . . . . 4.05 110.557 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -63.18 135.67 57.28 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.559 -0.534 . . . . 4.9 109.559 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -108.37 120.59 46.12 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.358 -0.383 . . . . 2.27 110.0 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.39 -24.02 50.47 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.695 2.264 . . . . 2.45 112.982 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.0 m -77.89 -26.84 49.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.795 0.331 . . . . 4.62 111.026 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 92.1 mt -83.28 140.9 32.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 5.15 110.475 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.44 159.92 38.13 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.082 -0.508 . . . . 4.21 110.864 -174.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.78 162.91 6.14 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.235 2.623 . . . . 2.76 113.255 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.569 ' HG ' ' CE2' ' A' ' 190' ' ' TYR . 95.2 mt -71.14 132.64 45.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 2.93 111.27 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 m -100.06 97.11 7.99 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.245 -1.021 . . . . 2.46 108.245 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.72 103.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.086 -0.506 . . . . 2.17 109.853 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.5 m -99.59 89.47 4.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.302 -0.629 . . . . 1.87 109.302 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -112.2 10.13 20.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.209 -0.45 . . . . 3.97 111.207 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.84 -30.71 64.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.891 0.377 . . . . 2.48 111.547 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.5 mp0 -109.04 39.64 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.361 -0.381 . . . . 2.54 110.427 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.99 57.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.821 0.343 . . . . 1.41 111.762 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.4 m -138.55 107.11 5.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.41 110.645 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -92.47 153.61 19.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.523 -0.547 . . . . 1.84 109.523 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -116.27 -58.62 2.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.505 0.558 . . . . 1.45 112.505 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -169.17 163.19 10.99 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.357 -0.214 . . . . 3.72 110.824 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -114.45 144.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.237 -0.283 . . . . 1.35 110.237 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -132.13 144.6 50.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 1.53 110.952 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -111.54 115.86 29.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 1.49 109.909 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -110.52 72.97 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.371 0.605 . . . . 2.18 110.929 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.77 -35.25 0.48 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 114.721 -1.127 . . . . 2.0 115.146 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -150.6 -29.78 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 117.104 0.452 . . . . 4.11 111.514 -173.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.43 161.87 25.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.583 -0.525 . . . . 1.78 109.583 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -129.19 121.55 27.92 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.194 0.521 . . . . 3.48 110.354 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -111.87 139.8 47.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 1.99 110.088 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 40.8 t -100.77 117.64 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.655 -0.498 . . . . 1.75 109.655 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.81 119.34 21.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 2.02 110.37 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -108.36 150.68 27.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.644 -0.707 . . . . 2.19 109.63 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -81.87 109.88 16.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 1.33 110.803 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.84 56.36 0.81 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.564 0.697 . . . . 2.65 110.334 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -89.23 -9.07 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 2.01 111.804 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.436 ' C ' ' H ' ' A' ' 76' ' ' LYS . 11.5 pt20 -163.35 177.91 8.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.549 . . . . 2.35 109.516 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -76.41 23.47 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.257 0.348 . . . . 1.92 111.731 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 16.9 ptpt -54.08 -39.67 66.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.473 -0.331 . . . . 2.31 111.717 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -133.18 101.27 5.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.114 0.483 . . . . 1.44 110.332 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.28 166.12 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.979 -0.555 . . . . 1.82 111.087 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.92 115.06 7.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.724 . . . . 1.8 109.844 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -145.13 123.5 12.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.058 0.456 . . . . 3.02 111.315 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -73.41 175.89 45.65 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 119.092 -0.838 . . . . 1.44 111.154 164.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.08 -143.4 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 N-CA-C 115.124 0.81 . . . . 2.15 115.124 168.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 72.3 Cg_exo -49.34 120.0 5.19 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.697 1.598 . . . . 3.17 112.728 -173.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 mt -154.35 -168.08 2.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.561 -1.2 . . . . 4.55 108.798 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.93 44.13 2.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.753 0.311 . . . . 4.95 110.954 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 124' ' ' ASN . . . 129.59 -177.84 17.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.971 -0.633 . . . . 2.25 112.829 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 m -107.76 133.8 51.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.455 -0.572 . . . . 2.12 109.455 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 51.5 m-85 -108.66 114.28 27.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.958 0.408 . . . . 3.88 111.948 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 98.5 mtt180 -79.15 140.53 37.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.103 -0.499 . . . . 3.87 110.468 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.53 124.6 24.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.762 -0.458 . . . . 1.68 109.762 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 tt -117.8 -41.6 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 111.701 0.26 . . . . 2.16 111.701 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 10.0 pt20 -159.11 165.21 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.858 -0.423 . . . . 1.95 109.858 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.454 ' CB ' HD21 ' A' ' 120' ' ' LEU . 42.4 p90 -146.98 161.01 41.67 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.007 -0.277 . . . . 0.98 111.456 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 11.7 p-80 -146.56 160.22 42.43 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.914 -0.585 . . . . 1.07 109.861 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.569 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.3 m-85 -122.75 148.93 44.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.889 0.376 . . . . 3.99 111.396 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -105.55 175.89 5.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.335 -0.617 . . . . 2.2 109.335 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -172.81 114.19 0.27 Allowed 'General case' 0 N--CA 1.463 0.176 0 O-C-N 123.199 0.312 . . . . 6.08 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.655 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -79.03 154.5 39.32 Favored Glycine 0 C--O 1.226 -0.397 0 N-CA-C 111.435 -0.666 . . . . 2.19 111.435 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 t -65.11 -29.25 70.1 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.195 0.997 . . . . 3.08 110.063 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.9 mt -106.4 144.98 32.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.448 -0.797 . . . . 3.48 109.438 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.19 70.3 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.553 0.533 . . . . 3.85 111.003 176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.66 43.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 2.37 112.741 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.481 ' HA ' ' CG ' ' A' ' 113' ' ' LYS . 13.0 pt20 -173.12 164.01 4.78 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 110.1 -0.333 . . . . 2.62 110.1 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.58 -1.78 49.38 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.509 -0.853 . . . . 1.62 114.1 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 p -90.63 -26.73 19.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.825 0.676 . . . . 2.24 112.825 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.45 ' HA ' ' CD1' ' A' ' 244' ' ' TRP . 0.6 OUTLIER 71.58 -170.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.749 -1.204 . . . . 3.72 107.749 -169.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.2 m80 54.99 71.37 0.54 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.312 0.505 . . . . 4.03 110.612 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 113' ' ' LYS . 14.2 p -87.0 116.3 24.96 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.448 -0.501 . . . . 2.99 110.723 -165.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 26.4 t -82.7 93.62 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.874 -0.417 . . . . 2.88 109.874 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 58.64 54.57 5.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.457 -0.572 . . . . 2.8 109.457 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 69.51 -2.33 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.106 -0.952 . . . . 5.35 112.578 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 23.1 ttmm -86.36 124.03 32.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.081 0.467 . . . . 3.58 111.192 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.505 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -116.33 138.09 51.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.799 -0.637 . . . . 3.26 109.694 175.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -88.38 159.99 17.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.639 -0.71 . . . . 1.71 110.499 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.48 ' HA ' ' H ' ' A' ' 103' ' ' GLN . . . -64.46 -20.05 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.846 . . . . 1.57 112.372 -174.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 147' ' ' LEU . . . -166.05 168.73 15.27 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.951 -0.389 . . . . 1.3 109.951 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -154.27 142.75 20.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.596 -0.52 . . . . 1.85 109.596 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.569 HD13 ' CE2' ' A' ' 95' ' ' PHE . 15.1 tp -100.79 127.69 47.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.748 -0.66 . . . . 1.61 109.85 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.422 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.1 m170 -114.55 101.48 9.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.26 0.552 . . . . 2.25 110.831 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 48.0 mt -83.2 107.89 16.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.229 -0.896 . . . . 1.51 109.834 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.481 ' HA ' HG11 ' A' ' 142' ' ' VAL . 41.3 t -82.57 123.27 38.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.384 0.612 . . . . 1.24 111.459 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 36.6 m-70 -123.09 147.22 46.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.289 -0.868 . . . . 2.86 109.387 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.663 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 62.5 p-90 -120.53 142.58 49.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.979 0.418 . . . . 4.96 111.113 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 86' ' ' GLY . 30.2 t30 -66.58 111.91 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.3 111.288 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.663 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 12.1 t -70.58 -16.35 62.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.564 -0.743 . . . . 2.77 111.784 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -58.4 -20.82 47.4 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.224 0.453 . . . . 3.79 112.224 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.48 6.2 49.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.135 0.493 . . . . 3.34 111.265 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.82 -3.46 3.84 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.773 1.069 . . . . 2.37 115.773 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -172.75 148.45 1.88 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.696 1.248 . . . . 3.93 110.104 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.559 ' O ' HG21 ' A' ' 134' ' ' VAL . 38.4 p90 -60.67 -34.11 73.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.607 -1.179 . . . . 3.6 112.563 -173.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.41 97.88 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.013 -0.613 . . . . 2.35 112.748 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -76.7 -27.99 55.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.966 0.412 . . . . 3.75 110.473 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.683 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -62.44 -35.42 79.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 2.17 110.866 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 130' ' ' PHE . 47.4 t -65.32 -16.92 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.077 -0.51 . . . . 3.11 111.26 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.59 -13.57 57.85 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.071 -0.393 . . . . 3.55 111.144 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.401 HE21 ' HA2' ' A' ' 139' ' ' GLY . 5.7 tt0 -102.53 134.15 20.1 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.786 -0.45 . . . . 3.02 109.786 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 51.5 Cg_exo -55.37 -26.12 51.39 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.975 2.45 . . . . 1.93 112.618 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -111.98 27.24 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.07 0.462 . . . . 2.29 109.863 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -79.13 -33.6 35.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.015 -0.612 . . . . 1.5 113.729 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 85.3 mt -110.44 157.01 20.04 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.706 -0.479 . . . . 1.98 109.706 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.31 127.07 13.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.723 0.297 . . . . 1.83 110.24 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 27.9 m -116.51 139.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 120.767 0.318 . . . . 2.28 110.358 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.2 tp -99.07 109.26 22.01 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.347 -0.612 . . . . 2.89 109.347 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -91.72 111.84 4.08 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.75 -0.659 . . . . 0.95 112.298 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.7 mt -109.42 118.17 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.726 -0.472 . . . . 1.38 109.726 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -69.54 143.24 53.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.405 -0.361 . . . . 1.37 111.303 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.444 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . 10.8 mp -112.92 120.02 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.133 -0.485 . . . . 1.48 110.185 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.08 142.11 43.68 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.792 -0.818 . . . . 2.52 108.792 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.06 135.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 1.88 110.802 -174.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.01 -95.53 0.11 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.126 -0.789 . . . . 1.53 111.126 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.1 m -82.08 141.83 32.82 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.721 -0.474 . . . . 2.08 109.721 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.61 41.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.897 -0.592 . . . . 1.36 111.825 -174.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.9 tptt -117.28 102.17 52.53 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.474 . . . . 1.78 110.104 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.62 -42.41 67.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.442 2.762 . . . . 1.34 112.487 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 182' ' ' GLY . . . -59.33 -33.69 76.92 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.073 -0.584 . . . . 0.75 112.954 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.73 -30.95 22.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.152 0.501 . . . . 1.39 110.536 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -37.4 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.63 110.662 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -52.98 -49.44 66.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.204 -0.907 . . . . 3.26 112.414 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.92 -38.62 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 1.97 111.415 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.1 -39.6 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.21 0.529 . . . . 1.64 111.293 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.36 -15.76 39.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 1.22 112.284 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.34 -11.15 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.802 0.334 . . . . 2.07 111.399 -176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.87 -33.6 67.01 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.954 0.724 . . . . 1.95 112.954 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.57 -26.69 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.884 0.373 . . . . 2.31 111.524 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.7 m -80.89 -1.03 41.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.951 0.352 . . . . 1.78 111.951 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.6 pt -131.92 36.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 1.42 110.069 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.19 -33.58 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 1.98 112.669 -170.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -119.48 159.51 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.857 0.361 . . . . 1.4 111.396 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -52.6 131.73 34.72 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.594 -0.73 . . . . 2.84 112.043 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.44 -28.44 15.01 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.871 -0.68 . . . . 0.85 112.451 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.79 143.62 52.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.212 0.53 . . . . 2.22 111.188 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.7 m -134.21 150.41 51.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 1.93 109.147 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -136.87 129.79 30.77 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.176 -0.305 . . . . 1.17 110.176 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.22 137.02 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.059 0.457 . . . . 1.8 110.672 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -140.85 80.4 1.75 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.197 -0.668 . . . . 1.31 109.197 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.0 p -116.04 163.66 15.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.469 -0.332 . . . . 1.69 111.466 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 58.91 36.98 24.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.848 -0.615 . . . . 2.26 111.276 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -129.75 133.79 47.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 4.84 110.202 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 181' ' ' ARG . 4.2 p30 -109.39 145.83 32.68 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.496 -0.775 . . . . 2.51 111.067 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.0 -5.58 14.61 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.026 2.484 . . . . 1.47 112.342 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.484 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 5.6 tmm_? -57.6 -38.57 75.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.184 -0.462 . . . . 3.16 110.508 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -68.02 -7.03 48.62 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.818 -0.628 . . . . 1.12 113.361 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.94 -12.27 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.129 0.465 . . . . 2.37 111.015 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.53 129.99 55.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 3.87 110.645 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.89 -170.02 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.02 2.48 . . . . 2.51 113.404 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.93 -65.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.065 0.765 . . . . 3.23 113.065 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 12.9 m -68.95 131.61 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 2.03 111.328 -172.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.86 62.87 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 2.5 110.832 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -127.65 141.59 51.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.435 -0.95 . . . . 1.81 108.435 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.569 ' CE2' ' HG ' ' A' ' 47' ' ' LEU . 51.9 p90 -149.23 158.24 44.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.967 0.413 . . . . 5.32 111.846 -166.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.578 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 9.2 m-90 -115.51 107.36 15.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.534 -0.757 . . . . 4.55 109.077 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 5.9 t -96.31 117.2 30.32 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.828 0.677 . . . . 2.39 112.828 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -139.21 128.51 14.11 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 5.32 109.989 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 58.4 Cg_exo -53.38 136.72 63.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.191 2.594 . . . . 2.47 113.674 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.49 156.7 25.37 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.027 -0.533 . . . . 2.0 112.839 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 32.4 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.241 0.543 . . . . 3.36 109.812 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 196' ' ' SER . 43.7 tp . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.804 -0.443 . . . . 3.51 109.804 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -106.33 62.67 0.65 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.381 0.61 . . . . 3.37 110.868 -173.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 73.9 m -108.64 15.1 24.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 2.47 110.868 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 95.2 t -117.9 137.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 1.74 111.082 -177.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.8 m -98.19 104.67 16.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.475 -0.935 . . . . 2.3 108.475 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.422 ' O ' ' HA ' ' A' ' 192' ' ' THR . 0.0 OUTLIER -86.7 100.61 12.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 6.37 110.924 -174.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.562 HG22 ' CD1' ' A' ' 190' ' ' TYR . 75.1 mt -96.42 100.02 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 2.32 109.479 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.3 m -99.6 125.64 53.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.183 0.515 . . . . 2.1 110.603 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.2 tp -87.44 137.3 32.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.634 -0.712 . . . . 2.35 109.595 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 20.5 pttp -72.44 -11.2 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.035 0.383 . . . . 3.47 112.035 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.2 tp10 -101.11 105.98 42.14 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.655 0.264 . . . . 1.56 110.944 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 5.9 Cg_exo -75.47 149.69 35.17 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.886 2.391 . . . . 1.37 111.771 175.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.9 pt -99.82 147.25 7.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.001 -0.37 . . . . 1.85 110.001 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 42.7 m -92.35 123.79 35.94 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.567 -0.531 . . . . 1.78 109.567 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.14 163.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.886 -0.597 . . . . 1.64 110.265 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 41.3 t -90.25 147.38 23.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.125 0.488 . . . . 1.52 110.226 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.698 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 7.5 p -56.49 -35.36 67.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 1.81 110.653 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -70.06 -21.84 63.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.678 -0.692 . . . . 2.51 111.188 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -80.17 -51.74 8.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.393 . . . . 1.02 110.132 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.603 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 13.0 m -64.84 -29.21 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.455 0.539 . . . . 1.88 112.455 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.9 mt -66.05 -27.36 68.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 1.59 111.01 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.457 ' HA ' ' CG ' ' A' ' 227' ' ' LYS . 68.6 mttm -74.6 -21.0 59.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.267 -0.424 . . . . 2.3 110.959 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 26.2 m-85 -66.89 -19.06 65.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.106 0.479 . . . . 3.18 110.178 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -103.68 9.43 37.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 3.55 110.257 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.457 ' CG ' ' HA ' ' A' ' 224' ' ' LYS . 12.5 mmmm -91.0 1.46 57.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 2.74 111.028 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.24 133.77 35.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.206 -0.664 . . . . 1.66 109.206 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -159.19 -178.72 7.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.931 0.345 . . . . 1.13 111.931 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 35.0 t80 52.94 81.14 0.09 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.094 -0.957 . . . . 4.38 112.48 174.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.599 ' CG ' ' H ' ' A' ' 232' ' ' GLY . 0.0 OUTLIER -54.41 -87.65 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.051 -0.522 . . . . 1.62 111.61 171.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 231' ' ' ASN . . . -125.08 -158.7 10.1 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.839 -0.696 . . . . 1.16 112.26 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.09 145.32 24.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.148 -0.315 . . . . 3.56 110.148 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.95 14.61 82.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.77 . . . . 2.23 112.288 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -148.72 107.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.59 108.64 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.11 114.32 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 120.722 0.948 . . . . 1.5 111.116 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -139.37 104.08 4.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.51 -0.768 . . . . 3.4 111.442 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.27 94.96 1.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.714 0.768 . . . . 2.47 109.951 157.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.25 99.63 4.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.237 -0.892 . . . . 2.6 109.501 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -118.4 82.87 1.92 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.965 -1.124 . . . . 1.94 107.965 172.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.8 m -156.57 133.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.906 -1.043 . . . . 1.67 110.141 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.655 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER 63.52 -79.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.239 0.962 . . . . 2.18 112.481 173.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 48.4 47.57 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.318 0.386 . . . . 2.64 110.681 -171.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 106' ' ' GLU . 85.9 t90 -105.12 134.02 48.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.916 0.389 . . . . 5.31 110.792 -172.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -105.32 132.23 21.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.986 -0.552 . . . . 6.91 110.416 176.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.436 ' HA ' ' CH2' ' A' ' 244' ' ' TRP . 62.5 Cg_exo -53.97 128.0 27.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.163 2.576 . . . . 3.72 112.676 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.39 159.76 33.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.684 -0.689 . . . . 3.34 111.983 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -108.73 149.85 40.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 4.92 110.673 -173.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 36.7 Cg_endo -63.7 147.3 92.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.641 2.894 . . . . 4.01 114.075 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 67.5 mt -68.23 -12.42 60.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.86 -1.063 . . . . 4.9 113.364 -171.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 61.6 pttt -61.08 42.84 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.382 1.623 . . . . 5.68 115.382 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.667 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 1.5 p30 125.42 -4.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.378 1.871 . . . . 5.11 109.926 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 30.7 mmt180 -116.69 82.67 1.83 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.438 -1.319 . . . . 6.74 107.438 168.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -134.69 158.1 44.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.102 -0.333 . . . . 3.08 110.102 -166.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.446 HD11 ' HA ' ' A' ' 33' ' ' ILE . 5.1 pt -102.62 125.9 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.808 0.67 . . . . 3.06 112.808 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 81.7 mttt -101.64 144.2 30.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.396 -0.82 . . . . 3.01 109.028 165.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 190' ' ' TYR . . . -106.65 148.17 28.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.248 -0.649 . . . . 1.99 109.248 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 190' ' ' TYR . 5.4 m -131.64 95.1 3.65 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.887 -0.725 . . . . 2.47 111.864 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -156.95 133.48 9.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.967 -1.015 . . . . 5.03 108.674 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.569 -0.729 . . . . 4.82 110.363 -173.196 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' HD21 ' A' ' 250' ' ' LEU . 1.4 m-20 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 122.048 0.928 . . . . 3.14 111.956 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.0 127.56 38.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.219 -1.355 . . . . 2.71 110.015 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.29 99.27 10.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.169 -0.468 . . . . 2.82 109.985 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -54.25 -29.32 46.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 2.71 111.568 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -75.33 -28.64 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 5.23 110.675 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 m -81.69 -28.77 33.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.874 0.369 . . . . 3.38 110.487 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -67.05 108.71 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.532 . . . . 1.76 111.593 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -85.31 138.18 32.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.6 -0.727 . . . . 4.05 110.484 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 30.1 p90 -78.57 130.71 36.26 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.393 -0.595 . . . . 4.9 109.393 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -109.11 109.79 60.71 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.337 -0.392 . . . . 2.27 110.11 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.41 -17.36 57.26 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.031 2.488 . . . . 2.45 112.49 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 83' ' ' PRO . 49.1 m -75.58 -9.04 58.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 4.62 110.858 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -96.55 139.26 32.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.286 -0.415 . . . . 5.15 110.283 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.9 161.14 37.73 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.468 -0.567 . . . . 4.21 109.468 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.55 157.15 23.78 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.748 2.299 . . . . 2.76 112.816 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 190' ' ' TYR . 91.9 mt -85.64 138.78 31.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 2.93 111.146 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -101.33 120.57 40.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.652 -0.87 . . . . 2.46 108.652 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.46 103.06 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.76 0.315 . . . . 2.17 110.659 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 91.25 3.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.264 -0.643 . . . . 1.87 109.264 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 p90 -137.95 20.01 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.923 0.392 . . . . 3.97 111.45 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.39 -18.8 64.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.304 -0.407 . . . . 2.48 111.21 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -103.18 10.74 37.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.534 -0.303 . . . . 2.54 110.737 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.66 125.74 24.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.863 0.363 . . . . 1.41 111.627 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.3 m -115.42 109.23 17.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.963 -0.562 . . . . 1.41 111.243 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -78.12 149.66 33.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.552 -0.536 . . . . 1.84 109.552 174.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -121.59 -54.97 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.974 0.416 . . . . 1.45 111.466 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.408 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 14.7 ptm180 -140.6 152.23 45.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.362 -0.381 . . . . 3.72 110.698 -175.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.0 tt -127.61 133.92 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.585 -0.895 . . . . 1.35 108.585 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.68 162.88 36.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 1.53 111.777 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.449 ' CB ' ' HA ' ' A' ' 169' ' ' LYS . 5.9 m-20 -101.3 109.87 21.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.926 -1.034 . . . . 1.49 109.237 176.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.55 ' HB3' ' OD1' ' A' ' 67' ' ' ASN . 42.5 t30 -126.57 129.37 48.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.112 -0.495 . . . . 2.18 111.06 -174.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 26.4 -74.59 0.0 OUTLIER Glycine 0 N--CA 1.47 0.96 0 N-CA-C 117.45 1.74 . . . . 2.0 117.45 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' ASN . 25.7 m80 -83.14 -19.79 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.983 0.364 . . . . 4.11 111.983 -167.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 175.38 -141.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.966 -0.383 . . . . 1.78 109.966 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -118.12 143.79 46.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.072 -1.085 . . . . 3.48 108.072 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 13.5 m120 -128.24 128.62 45.03 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.086 -0.339 . . . . 1.99 110.086 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.97 121.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.209 0.528 . . . . 1.75 109.851 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 58' ' ' ARG . 55.7 mm-40 -90.07 138.98 31.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 2.02 111.433 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.92 157.26 22.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.493 -0.776 . . . . 2.19 109.235 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.77 108.37 13.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.216 -0.661 . . . . 1.33 109.216 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -108.51 58.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.663 0.744 . . . . 2.65 110.607 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -100.85 -13.58 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.573 -0.74 . . . . 2.01 111.416 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.446 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -152.09 177.59 10.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.103 -0.499 . . . . 2.35 109.942 -170.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -82.01 65.96 7.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 1.92 110.987 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 58.6 mttm -90.59 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.946 -0.57 . . . . 2.31 109.838 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -114.39 99.03 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 1.44 110.267 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.88 145.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.94 -0.573 . . . . 1.82 110.51 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 tp -137.58 112.08 8.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 1.8 109.725 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 22.1 pttm -153.8 126.13 8.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 3.02 111.743 175.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.87 177.93 46.64 Favored Glycine 0 C--O 1.221 -0.707 0 CA-C-N 115.462 -0.79 . . . . 1.44 112.753 173.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.91 -132.76 0.0 OUTLIER Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.73 1.157 . . . . 2.15 115.764 167.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HG2' ' O ' ' A' ' 43' ' ' SER . 78.9 Cg_exo -44.12 170.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.179 3.253 . . . . 3.17 114.43 -171.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.3 tp -32.37 75.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.553 1.316 . . . . 4.55 114.553 -145.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 15.1 p-10 -76.73 -71.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.314 -1.766 . . . . 4.95 112.635 173.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 82.06 127.45 0.99 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.384 -1.086 . . . . 2.25 110.384 -165.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.9 m -63.48 103.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.103 0.452 . . . . 2.12 111.734 -174.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 63.6 m-85 -95.04 126.99 40.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.867 -0.606 . . . . 3.88 111.026 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -103.85 143.97 32.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.312 -0.403 . . . . 3.87 110.243 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 34.4 tp -81.52 132.01 35.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 1.68 110.86 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.7 tt -109.21 -35.0 2.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.183 -0.462 . . . . 2.16 110.784 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 172.25 8.42 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.341 -0.39 . . . . 1.95 110.316 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.408 ' CD2' HD11 ' A' ' 118' ' ' LEU . 9.4 p90 -151.4 153.36 34.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.98 110.347 169.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 13.5 p-80 -148.16 157.64 43.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.559 -0.746 . . . . 1.07 109.62 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -139.7 123.06 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.773 -0.771 . . . . 3.99 111.374 168.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -94.73 146.24 24.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.099 -0.955 . . . . 2.2 110.353 171.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -132.7 170.81 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.603 -0.518 . . . . 6.08 109.603 -176.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -95.89 173.83 31.0 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.488 -0.863 . . . . 2.19 112.777 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.5 t -68.26 -28.0 66.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.283 0.563 . . . . 3.08 109.957 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.63 141.14 47.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.589 -0.732 . . . . 3.48 109.091 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.426 ' HB2' HG23 ' A' ' 149' ' ' VAL . 4.8 p-10 -68.26 -5.88 20.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.168 0.432 . . . . 3.85 112.168 -174.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.79 10.06 57.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.807 -0.711 . . . . 2.37 113.047 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.41 170.28 16.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.892 0.346 . . . . 2.62 110.916 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 113.41 -14.59 22.86 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.502 -0.856 . . . . 1.62 112.518 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.3 t -75.59 -34.59 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.411 0.148 . . . . 2.24 111.203 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' HG2' ' NE1' ' A' ' 244' ' ' TRP . 0.0 OUTLIER 66.35 -172.19 0.19 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.6 0.563 . . . . 3.72 110.036 -171.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.5 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 17.3 m80 52.44 44.69 29.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.66 0.743 . . . . 4.03 109.62 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.471 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -79.29 117.47 20.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.034 . . . . 2.99 111.397 -172.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.04 95.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.692 -1.14 . . . . 2.88 110.504 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 58.66 60.04 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.844 -1.071 . . . . 2.8 110.824 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm 69.71 11.51 7.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.73 -0.668 . . . . 5.35 112.527 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -96.23 97.19 9.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.826 0.346 . . . . 3.58 110.644 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.471 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 98.6 mttt -96.11 148.38 22.74 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.261 -0.644 . . . . 3.26 109.261 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -106.6 -176.6 3.12 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.6 -0.519 . . . . 1.71 109.6 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.4 -43.55 66.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.803 0.335 . . . . 1.57 111.19 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.52 164.04 37.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 1.3 110.269 -174.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.5 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 29.6 tt0 -130.38 124.16 31.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 1.85 109.792 176.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 94' ' ' HIS . 56.7 tp -91.04 114.97 27.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.797 . . . . 1.61 110.214 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.477 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 22.5 m170 -102.91 106.55 17.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.159 -0.473 . . . . 2.25 110.615 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.74 108.09 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.256 -0.646 . . . . 1.51 109.256 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -81.91 126.34 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.339 -0.392 . . . . 1.24 110.822 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 58.5 m80 -125.56 145.17 50.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.834 -0.432 . . . . 2.86 109.834 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -124.6 143.91 50.45 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.83 -0.804 . . . . 4.96 108.83 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 87' ' ' THR . 35.8 p30 -83.52 139.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.859 0.837 . . . . 2.3 111.687 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -66.08 -16.01 63.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.095 -0.957 . . . . 2.77 110.567 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -50.63 -44.35 57.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 3.79 112.097 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -93.6 6.95 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.513 -0.475 . . . . 3.34 111.092 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.47 1.52 1.77 Allowed Glycine 0 C--N 1.335 0.472 0 N-CA-C 115.523 0.969 . . . . 2.37 115.523 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 132' ' ' LYS . 16.6 t70 -169.14 137.04 1.9 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.739 0.769 . . . . 3.93 109.658 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.597 ' O ' HG22 ' A' ' 134' ' ' VAL . 26.5 p90 -60.22 -43.27 96.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.714 -0.676 . . . . 3.6 110.984 -177.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -35.52 90.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.274 -0.489 . . . . 2.35 112.599 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -68.36 -37.59 80.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.773 -0.455 . . . . 3.75 109.773 177.152 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.88 -29.27 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 2.17 110.705 178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -65.57 -20.03 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 3.11 111.315 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -88.53 -1.74 58.22 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.762 -0.586 . . . . 3.55 111.614 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -126.21 143.17 44.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.868 0.366 . . . . 3.02 110.483 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 26.6 Cg_endo -62.0 -24.63 76.97 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.431 2.754 . . . . 1.93 113.493 -175.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -110.41 27.03 10.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.904 -0.406 . . . . 2.29 109.904 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -81.25 -48.53 5.95 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.946 -0.645 . . . . 1.5 113.788 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 134' ' ' VAL . 85.8 mt -107.79 161.13 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.085 0.469 . . . . 1.98 111.316 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.3 104.9 4.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.624 -0.716 . . . . 1.83 110.33 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.4 t -97.66 115.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.236 -0.438 . . . . 2.28 109.858 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 63.5 tp -88.11 111.54 21.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.867 -0.606 . . . . 2.89 109.684 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.79 108.85 3.61 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.189 -0.529 . . . . 0.95 111.935 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 mt -102.07 130.77 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.158 -0.312 . . . . 1.38 110.158 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 69.9 m-85 -75.55 145.75 41.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.663 -0.244 . . . . 1.37 110.527 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.35 117.68 30.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.695 -0.483 . . . . 1.48 109.695 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 216' ' ' SER . 20.5 ptmt -114.72 152.42 32.05 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.283 -0.636 . . . . 2.52 109.283 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 29.3 t -92.26 131.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 1.88 110.861 -176.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.86 -105.55 0.21 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.627 -0.989 . . . . 1.53 110.627 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.5 m -70.03 160.61 31.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.506 -0.553 . . . . 2.08 109.506 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.61 159.22 15.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.573 -0.285 . . . . 1.36 111.193 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 216' ' ' SER . 12.4 mmmm -111.03 99.89 44.68 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.573 -0.899 . . . . 1.78 108.573 172.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.75 -21.05 61.7 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.984 2.456 . . . . 1.34 113.355 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.19 -13.34 81.01 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.654 -0.784 . . . . 0.75 112.919 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.9 tp -87.13 -17.96 31.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 1.39 111.004 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -60.41 -39.5 87.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.63 112.265 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 162' ' ' VAL . 30.7 mmmt -58.29 -40.92 83.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.618 0.247 . . . . 3.26 111.02 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.87 -46.9 84.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.262 0.553 . . . . 1.97 110.166 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 46.9 t -67.19 -27.68 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 1.64 111.295 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.02 -34.57 66.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 1.22 111.562 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 158' ' ' LYS . 87.7 t -82.54 -23.39 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.417 -0.356 . . . . 2.07 111.781 -174.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.7 pp -69.56 -12.84 61.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.018 0.437 . . . . 1.95 111.428 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.31 -26.5 68.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.088 0.47 . . . . 2.31 110.444 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.1 t -81.31 0.74 35.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 1.78 111.432 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.14 43.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.268 -0.641 . . . . 1.42 109.268 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.4 -38.37 66.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.084 -0.962 . . . . 1.98 112.622 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.8 p -105.52 149.9 25.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.631 0.253 . . . . 1.4 110.945 -177.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 61.7 pttt -66.54 141.14 57.96 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.973 -0.38 . . . . 2.84 109.973 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.34 -22.44 30.91 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.43 -0.89 . . . . 0.85 111.681 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -82.57 156.17 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 2.22 110.488 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -145.96 153.57 40.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.208 -0.451 . . . . 1.93 109.986 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.12 154.35 45.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.827 -0.435 . . . . 1.17 109.827 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.29 135.42 39.62 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.845 -0.428 . . . . 1.8 109.845 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.56 80.39 1.77 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.728 -0.841 . . . . 1.31 108.728 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.5 p -113.41 165.12 12.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.703 -0.68 . . . . 1.69 112.065 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.2 t30 54.9 57.84 5.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.5 -0.773 . . . . 2.26 111.113 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -135.1 131.75 37.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.835 -0.62 . . . . 4.84 109.824 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 13.0 m-20 -106.19 118.48 54.77 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.851 -0.425 . . . . 2.51 109.851 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 2.7 Cg_exo -76.21 -4.57 15.26 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.943 2.429 . . . . 1.47 112.898 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -59.05 -42.85 91.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.32 . . . . 3.16 111.548 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.05 -3.04 9.64 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.208 -0.52 . . . . 1.12 113.601 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.57 -1.29 35.87 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.66 -0.318 . . . . 2.37 111.117 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 184' ' ' LEU . 4.0 pp -54.69 150.13 19.32 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 112.742 0.645 . . . . 3.87 112.742 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -91.05 -176.17 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.453 2.769 . . . . 2.51 111.467 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -85.69 -64.68 1.11 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.523 -0.471 . . . . 3.23 111.56 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.5 m -87.22 135.15 33.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.817 0.341 . . . . 2.03 111.495 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.21 62.89 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.404 0.621 . . . . 2.5 110.295 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 211' ' ' LEU . 6.4 m-20 -116.37 170.05 8.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.944 -1.132 . . . . 1.81 107.944 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 46.6 p90 -168.04 161.73 12.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.793 1.035 . . . . 5.32 113.793 -166.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.442 ' HD1' ' O ' ' A' ' 210' ' ' VAL . 2.9 m95 -101.09 138.73 37.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.724 -1.584 . . . . 4.55 106.724 167.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.1 t -137.7 105.22 5.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.61 0.719 . . . . 2.39 112.031 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 194' ' ' PRO . 25.9 t80 -139.3 149.6 61.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.264 -0.643 . . . . 5.32 109.264 173.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 193' ' ' TYR . 93.6 Cg_exo -46.88 129.91 15.18 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.456 2.104 . . . . 2.47 111.652 172.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -138.57 161.29 25.74 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.444 -0.798 . . . . 2.0 113.177 -166.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 108.831 -0.803 . . . . 3.36 108.831 176.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 37.4 tp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.716 0.293 . . . . 3.51 110.459 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 10.5 pt-20 -92.99 40.07 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.923 -0.581 . . . . 3.37 111.584 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 25.6 p -86.96 -4.49 59.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.293 0.568 . . . . 2.47 110.557 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 27.4 t -112.18 150.03 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.637 -0.71 . . . . 1.74 111.14 -173.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.9 m -107.21 103.5 12.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.332 -1.358 . . . . 2.3 107.332 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.416 ' HB2' ' HA3' ' A' ' 195' ' ' GLY . 1.1 t90 -75.52 102.29 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.033 0.444 . . . . 6.37 110.107 -172.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 42.3 mm -95.68 100.42 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.537 -0.756 . . . . 2.32 109.364 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' A' ' 191' ' ' TRP . 32.4 t -94.03 119.03 41.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.42 -0.585 . . . . 2.1 109.42 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 189' ' ' ASP . 17.1 tp -73.95 122.45 22.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.949 0.404 . . . . 2.35 110.389 -174.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -61.59 -21.91 64.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 3.47 111.995 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -95.14 111.87 56.41 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.642 -0.254 . . . . 1.56 110.537 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 98.4 Cg_endo -82.73 134.14 7.25 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.511 2.14 . . . . 1.37 111.752 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.7 pt -88.79 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 1.85 109.487 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.593 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 24.6 t -103.83 125.66 50.42 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.978 0.418 . . . . 1.78 110.763 -175.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.1 m -116.75 155.07 18.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 1.64 109.486 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.4 t -102.93 161.78 13.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.918 -0.313 . . . . 1.52 110.782 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.63 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 t -49.62 -54.06 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.668 0.605 . . . . 1.81 111.849 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 36.6 tt0 -52.56 -39.23 61.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.751 0.31 . . . . 2.51 111.781 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.4 -50.58 69.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.468 -0.333 . . . . 1.02 110.556 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.27 -19.95 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.429 -0.351 . . . . 1.88 111.587 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.2 mt -73.65 -44.26 57.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 1.59 110.558 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 52.5 mtpt -65.35 -25.86 67.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 2.3 110.562 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -75.29 -28.1 59.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.455 0.645 . . . . 3.18 109.744 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 56.1 ttp180 -71.8 -0.94 12.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.325 -0.852 . . . . 3.55 110.928 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -84.22 -14.14 50.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.982 0.42 . . . . 2.74 110.115 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.412 HD22 HD22 ' A' ' 61' ' ' ASN . 68.2 mt -69.65 144.83 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.49 0.662 . . . . 1.66 111.257 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.3 m120 -108.56 139.58 43.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.325 -0.852 . . . . 1.13 109.645 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.512 ' O ' ' HD3' ' A' ' 169' ' ' LYS . 65.8 t80 -79.14 -30.81 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.744 . . . . 4.38 109.956 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -68.85 163.46 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 1.62 111.5 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.11 48.29 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.474 -1.05 . . . . 1.16 110.474 174.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.1 135.06 47.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.501 0.65 . . . . 3.56 110.553 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.29 41.71 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.749 . . . . 2.23 112.797 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.66 162.34 43.33 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.968 0.384 . . . . 2.59 110.017 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.15 127.55 26.78 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.221 1.947 . . . . 1.5 111.361 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.67 120.38 12.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.408 0.623 . . . . 3.4 111.776 -174.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 13.2 pt-20 -128.47 153.46 47.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.305 -0.861 . . . . 2.47 108.828 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.23 135.95 33.29 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.649 0.261 . . . . 2.6 110.761 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.9 ttm -80.1 88.43 5.41 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.832 -0.803 . . . . 1.94 108.832 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.5 m -142.55 144.17 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.834 -0.802 . . . . 1.67 108.834 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.44 -78.19 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.734 0.646 . . . . 2.18 110.397 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.1 t30 42.5 40.56 1.96 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.901 0.75 . . . . 2.64 112.176 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.452 ' NE1' ' HG2' ' A' ' 106' ' ' GLU . 38.6 t-105 -141.59 160.67 39.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.067 0.461 . . . . 5.31 111.341 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 245' ' ' ARG . 25.0 mmt180 -128.38 83.4 66.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.143 -1.058 . . . . 6.91 108.143 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 38.6 Cg_exo -55.52 -87.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 124.053 3.169 . . . . 3.72 116.487 -160.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.419 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -81.08 102.3 10.15 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.293 1.22 . . . . 3.34 114.293 -162.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 12.0 mm100 -80.31 -178.0 1.05 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.243 -1.021 . . . . 4.92 108.243 160.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 34.1 Cg_exo -40.76 112.14 0.17 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 121.867 1.711 . . . . 4.01 112.355 175.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -60.05 -51.45 69.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 4.9 112.452 -164.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -60.83 -9.97 4.88 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.901 1.445 . . . . 5.68 114.901 -174.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 253' ' ' ARG . 8.5 p30 38.09 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 118.749 2.87 . . . . 5.11 118.749 167.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.596 ' NE ' ' HA ' ' A' ' 253' ' ' ARG . 0.4 OUTLIER 171.4 -156.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.324 1.049 . . . . 6.74 109.201 -165.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -131.72 130.15 41.6 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.726 -1.583 . . . . 3.08 106.726 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 43.8 mt -111.92 145.46 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.809 0.338 . . . . 3.06 111.416 -166.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -123.34 162.08 23.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 3.01 109.935 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -159.16 170.74 21.29 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.385 -0.598 . . . . 1.99 109.385 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 8.6 t -148.23 113.41 5.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.744 -0.382 . . . . 2.47 110.441 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -117.85 95.33 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 5.03 109.54 173.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.529 -0.748 . . . . 4.82 110.146 -178.366 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.495 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 23.9 t0 . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 108.317 -0.994 . . . . 3.14 108.317 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mt -102.82 105.87 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.461 -0.495 . . . . 2.71 111.105 -173.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.56 107.37 18.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.093 -1.077 . . . . 2.82 108.093 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -54.8 -31.44 59.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 2.71 112.411 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -77.82 -44.69 26.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.737 0.304 . . . . 5.23 110.944 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 m -73.83 -28.06 61.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.545 -0.298 . . . . 3.38 111.372 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.6 129.85 42.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.011 0.434 . . . . 1.76 111.608 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -91.16 124.47 35.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.876 -0.602 . . . . 4.05 110.942 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -75.34 127.68 33.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.975 -0.557 . . . . 4.9 109.569 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.87 134.04 20.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.608 -0.515 . . . . 2.27 109.608 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.43 56.83 2.8 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.857 2.371 . . . . 2.45 112.656 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 45' ' ' LYS . 39.4 t -74.72 -56.85 4.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.053 -0.521 . . . . 4.62 110.204 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 mt 64.09 -25.31 0.08 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.389 0.885 . . . . 5.15 113.389 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 43' ' ' SER . 62.8 mttp -70.48 142.75 89.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.949 0.404 . . . . 4.21 111.691 -175.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.56 158.82 7.89 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.078 2.519 . . . . 2.76 112.486 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.429 HD21 ' HA3' ' A' ' 81' ' ' GLY . 79.0 mt -86.81 132.81 33.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 2.93 109.717 174.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 t -90.88 109.98 21.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.714 -0.847 . . . . 2.46 108.714 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.4 t -119.63 97.41 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.893 -0.41 . . . . 2.17 109.893 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 23.5 m -89.37 89.15 7.76 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.223 -0.658 . . . . 1.87 109.223 177.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -100.1 -6.39 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 3.97 111.383 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.508 ' HA ' ' NH2' ' A' ' 181' ' ' ARG . 32.3 t70 -61.32 -24.85 66.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.682 0.277 . . . . 2.48 111.529 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 1.5 mp0 -101.04 5.0 42.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.55 -0.296 . . . . 2.54 110.997 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.1 27.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 1.41 111.462 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 m -120.04 119.51 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.983 -0.553 . . . . 1.41 110.609 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 p -88.13 153.26 21.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.125 -0.488 . . . . 1.84 110.19 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.09 -56.67 1.82 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 1.45 111.725 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -152.34 159.42 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.053 0.454 . . . . 3.72 111.819 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.494 HD13 ' HB2' ' A' ' 66' ' ' PHE . 13.9 tt -115.18 134.81 57.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.34 -0.845 . . . . 1.35 109.54 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -133.68 142.79 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.802 0.334 . . . . 1.53 111.637 -171.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -101.48 88.95 3.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.767 -0.827 . . . . 1.49 108.767 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -142.32 90.32 2.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.384 0.512 . . . . 2.18 112.384 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . 139.45 -54.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.271 -0.966 . . . . 2.0 110.778 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 28.8 p80 174.07 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.652 -0.774 . . . . 4.11 111.153 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.515 ' CB ' ' H ' ' A' ' 95' ' ' PHE . . . -165.77 -170.15 1.71 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.205 0.526 . . . . 1.78 111.461 -173.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.494 ' HB2' HD13 ' A' ' 59' ' ' ILE . 2.4 p90 -106.63 87.23 2.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.787 -1.097 . . . . 3.48 109.417 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 3.0 m-20 -71.44 100.26 2.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.663 -1.153 . . . . 1.99 110.324 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 72.8 t -85.41 113.39 23.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.035 0.445 . . . . 1.75 110.197 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.93 122.69 27.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.327 -0.851 . . . . 2.02 110.379 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -101.7 157.67 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.656 -0.498 . . . . 2.19 109.656 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.1 115.58 20.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.831 0.348 . . . . 1.33 110.661 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -127.01 56.03 1.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.786 0.803 . . . . 2.65 109.96 175.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -91.59 -11.77 36.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.806 0.812 . . . . 2.01 109.164 170.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 162.8 39.5 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.643 -1.162 . . . . 2.35 108.886 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -75.61 77.26 2.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.224 0.535 . . . . 1.92 111.169 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 98.2 mttt -92.94 -50.75 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.429 -0.805 . . . . 2.31 110.646 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -111.9 100.14 8.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.822 -0.626 . . . . 1.44 109.682 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -110.19 131.75 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.008 -0.542 . . . . 1.82 111.843 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.56 119.28 31.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.756 -0.656 . . . . 1.8 109.993 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -160.26 122.15 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.591 -0.522 . . . . 3.02 109.591 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.429 ' HA3' HD21 ' A' ' 47' ' ' LEU . . . -129.1 -177.97 15.14 Favored Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.923 -0.932 . . . . 1.44 111.118 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.39 -130.0 0.0 OUTLIER Glycine 0 CA--C 1.543 1.818 0 O-C-N 124.771 0.924 . . . . 2.15 115.398 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -44.05 170.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.632 2.888 . . . . 3.17 114.178 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.2 pt? -30.67 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.964 1.364 . . . . 4.55 114.231 -146.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.637 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 12.3 p-10 -110.9 -112.23 0.33 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.231 -1.804 . . . . 4.95 113.042 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.637 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 97.47 155.11 29.99 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.53 -1.428 . . . . 2.25 109.53 -163.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.9 m -77.72 102.14 6.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.777 0.789 . . . . 2.12 110.934 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 74.0 m-85 -97.55 117.71 32.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.039 -0.356 . . . . 3.88 110.039 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.84 145.41 26.61 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.845 -0.428 . . . . 3.87 109.845 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.7 tp -74.59 120.22 19.85 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.376 -0.601 . . . . 1.68 109.376 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 tt -113.12 -42.12 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.713 0.292 . . . . 2.16 111.329 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.0 pt20 -167.74 168.88 12.15 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.322 -0.622 . . . . 1.95 109.322 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.554 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 4.1 p90 -134.89 164.23 28.05 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.35 -0.54 . . . . 0.98 111.418 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -138.37 160.3 39.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.653 -0.869 . . . . 1.07 108.653 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.515 ' H ' ' CB ' ' A' ' 65' ' ' ALA . 79.1 t80 -130.25 144.14 51.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.484 0.183 . . . . 3.99 111.185 -172.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.61 146.95 40.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.988 0.423 . . . . 2.2 110.558 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -161.05 150.99 17.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 6.08 108.557 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -90.11 155.87 24.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.906 . . . . 2.19 112.672 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -60.56 -28.11 68.2 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.133 0.492 . . . . 3.08 110.477 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.55 -154.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.679 -0.691 . . . . 3.48 110.516 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -136.61 48.29 2.13 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.433 -0.951 . . . . 3.85 108.433 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.24 41.97 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.196 -0.911 . . . . 2.37 112.136 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -159.21 169.76 23.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.713 -0.477 . . . . 2.62 109.713 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.67 10.37 86.26 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.882 -0.675 . . . . 1.62 112.888 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.45 -2.7 57.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.489 0.552 . . . . 2.24 112.489 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.553 ' HG2' ' H ' ' A' ' 107' ' ' HIS . 18.2 tt0 67.35 178.96 0.23 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.642 -0.503 . . . . 3.72 109.642 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.553 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 29.6 m80 48.57 45.05 21.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.396 0.679 . . . . 4.03 112.11 174.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.0 t -81.0 127.6 32.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.731 0.777 . . . . 2.99 111.672 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.04 115.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.755 -1.111 . . . . 2.88 110.503 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.24 37.21 23.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.846 0.831 . . . . 2.8 109.591 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.18 14.72 8.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.529 -1.214 . . . . 5.35 111.619 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -89.32 114.48 25.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.147 -0.686 . . . . 3.58 109.147 172.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -107.06 173.62 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 3.26 110.186 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.4 172.95 7.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.979 -0.555 . . . . 1.71 109.895 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.51 77.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.75 0.278 . . . . 1.57 111.75 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 95' ' ' PHE . . . -167.43 170.56 11.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.017 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -150.06 141.87 23.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 1.85 110.67 174.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 93' ' ' PHE . 50.3 tp -105.26 125.74 51.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.598 -0.728 . . . . 1.61 109.052 174.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.502 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -114.76 102.43 10.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 2.25 110.341 -172.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.554 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 5.8 mp -90.27 111.26 22.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.359 0.599 . . . . 1.51 110.781 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -77.82 119.82 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.466 -0.788 . . . . 1.24 111.099 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 73.9 m80 -106.57 137.64 44.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.485 -0.779 . . . . 2.86 109.347 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -110.38 128.07 55.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.123 -0.489 . . . . 4.96 111.205 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -69.98 105.29 2.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.03 -0.532 . . . . 2.3 109.907 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.0 t -62.73 -17.49 60.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.544 . . . . 2.77 111.735 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.47 -29.79 70.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.45 -0.341 . . . . 3.79 111.799 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -90.35 -1.24 57.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.36 . . . . 3.34 111.069 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.84 23.73 2.63 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 115.826 1.09 . . . . 2.37 115.826 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.573 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 32.2 t70 -176.87 126.8 0.16 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.986 0.893 . . . . 3.93 109.801 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -64.31 -37.87 89.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.685 -0.689 . . . . 3.6 111.715 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -28.61 70.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.103 -0.57 . . . . 2.35 112.578 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 39.6 mmtm -80.49 -41.02 25.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.505 -0.554 . . . . 3.75 109.505 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.592 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.33 -38.84 88.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.452 -0.795 . . . . 2.17 112.152 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.7 -15.11 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.789 0.328 . . . . 3.11 111.168 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.53 13.33 26.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.287 -0.415 . . . . 3.55 110.432 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 17.4 mm100 -121.03 135.35 24.77 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.78 -0.452 . . . . 3.02 109.78 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.505 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 11.3 Cg_endo -56.09 -29.85 76.36 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.355 2.703 . . . . 1.93 113.798 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -111.37 25.57 11.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.922 0.391 . . . . 2.29 110.208 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -62.05 -48.72 81.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.247 0.859 . . . . 1.5 115.247 -172.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 206' ' ' VAL . 40.0 mt -133.92 170.31 15.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.835 0.817 . . . . 1.98 111.138 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.94 105.36 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.513 -0.767 . . . . 1.83 109.851 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.636 ' O ' ' HB ' ' A' ' 209' ' ' ILE . 4.7 m -88.83 111.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 2.28 111.36 -176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -86.27 100.43 12.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.774 -0.648 . . . . 2.89 110.287 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.64 118.5 5.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.161 -0.542 . . . . 0.95 112.558 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.57 118.37 58.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.781 -0.452 . . . . 1.38 109.781 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -71.04 147.57 48.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.998 0.428 . . . . 1.37 111.586 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.6 mp -116.75 131.82 56.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.656 -0.702 . . . . 1.48 110.271 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -126.4 144.33 50.87 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.789 -0.819 . . . . 2.52 108.789 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.03 130.94 35.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.454 0.645 . . . . 1.88 111.353 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 177.06 -105.25 0.2 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.114 -0.948 . . . . 1.53 110.921 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.9 t -71.53 142.95 50.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.424 -0.584 . . . . 2.08 109.424 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.53 156.58 39.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 1.36 111.202 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -118.08 95.04 47.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.596 -0.52 . . . . 1.78 109.596 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.65 -37.15 91.23 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.146 2.564 . . . . 1.34 112.49 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.05 -31.01 79.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.75 112.619 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 160' ' ' VAL . 53.3 tp -88.78 -31.68 18.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.517 -0.402 . . . . 1.39 109.948 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -39.33 63.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.711 -0.677 . . . . 1.63 110.151 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -49.39 -47.91 47.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.676 -0.693 . . . . 3.26 111.016 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 162' ' ' VAL . 21.3 t -76.68 -43.18 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 1.97 111.065 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 156' ' ' LEU . 19.3 t -61.76 -35.47 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.184 0.516 . . . . 1.64 111.147 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.36 -30.46 67.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.309 -0.405 . . . . 1.22 111.589 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 175' ' ' PHE . 9.6 p -92.9 -18.51 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.829 -0.348 . . . . 2.07 111.875 -173.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -67.73 -13.01 61.75 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.988 0.423 . . . . 1.95 111.092 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.54 -19.72 65.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.31 110.498 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.0 t -85.47 0.58 51.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.02 -0.536 . . . . 1.78 111.423 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 41.1 pt -135.83 46.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.581 0.705 . . . . 1.42 109.585 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.23 -32.47 71.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.079 -0.964 . . . . 1.98 111.264 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.5 p -112.66 145.21 40.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.895 0.378 . . . . 1.4 110.937 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.48 138.55 58.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 2.84 110.542 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.57 -20.89 33.67 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.624 -0.798 . . . . 0.85 112.473 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.72 152.3 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.109 0.48 . . . . 2.22 111.188 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 m -132.43 157.82 43.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.93 109.642 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.57 151.02 39.69 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.394 -0.595 . . . . 1.17 109.394 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.16 132.76 43.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.192 0.52 . . . . 1.8 110.406 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 162' ' ' VAL . 48.9 t80 -141.48 79.23 1.67 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 1.31 108.295 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 56' ' ' SER . 6.2 m -111.87 156.82 21.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.608 . . . . 1.69 111.558 -174.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 56.4 58.22 4.38 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.357 0.663 . . . . 2.26 112.384 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.45 134.68 41.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 4.84 109.632 172.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.549 ' CG ' ' HE ' ' A' ' 181' ' ' ARG . 10.2 t70 -108.22 129.62 23.84 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 2.51 111.111 -173.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 19.3 Cg_exo -66.65 -3.74 9.76 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.637 2.892 . . . . 1.47 114.704 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.549 ' HE ' ' CG ' ' A' ' 179' ' ' ASP . 18.5 ptp180 -59.93 -26.27 65.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.745 0.307 . . . . 3.16 111.401 -178.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -79.74 7.14 56.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.92 -0.657 . . . . 1.12 112.299 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.4 mt -115.28 -27.52 7.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 2.37 110.312 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.34 131.63 80.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.799 -0.637 . . . . 3.87 111.428 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.1 -177.07 3.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.97 2.446 . . . . 2.51 112.873 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.79 -55.21 6.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.884 0.327 . . . . 3.23 111.884 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 4.5 m -85.21 130.3 34.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.27 -0.27 . . . . 2.03 110.27 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 tp -111.75 82.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.329 -0.396 . . . . 2.5 110.448 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -118.19 177.4 4.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.56 -0.533 . . . . 1.81 109.56 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -162.93 145.48 10.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.929 0.714 . . . . 5.32 112.929 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.418 ' CD1' ' HB ' ' A' ' 210' ' ' VAL . 7.4 m0 -116.17 145.47 43.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.496 -1.298 . . . . 4.55 107.496 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -142.44 102.83 4.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.779 1.029 . . . . 2.39 113.779 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.532 ' HB2' ' HA ' ' A' ' 255' ' ' ILE . 48.8 t80 -142.41 128.43 10.67 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 5.32 110.031 168.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.74 127.74 23.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.817 2.344 . . . . 2.47 113.618 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -141.76 161.54 27.07 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.248 -0.887 . . . . 2.0 112.283 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 29.6 t . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 109.683 -0.488 . . . . 3.36 109.683 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.508 ' HB3' ' SG ' ' A' ' 205' ' ' CYS . 97.0 mt . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.032 0.444 . . . . 3.51 110.174 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -86.82 78.24 9.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.647 -0.706 . . . . 3.37 109.757 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 203' ' ' LEU . 60.0 m -121.08 -15.4 8.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 2.47 111.992 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 140' ' ' LEU . 47.1 t -145.13 102.65 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 C-N-CA 119.641 -0.823 . . . . 1.74 112.333 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 193' ' ' TYR . 82.3 m -155.73 88.8 1.14 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 2.3 111.508 166.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' TRP . . . . . 0.734 ' O ' HG12 ' A' ' 209' ' ' ILE . 1.1 p90 -150.05 87.06 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.163 -1.015 . . . . 6.37 112.449 160.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 208' ' ' TRP . 9.4 mm -166.89 113.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 123.999 0.92 . . . . 2.32 109.122 157.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 191' ' ' TRP . 95.5 t -125.23 99.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.656 -0.498 . . . . 2.1 109.656 166.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -66.81 107.5 2.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 2.35 110.719 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -53.71 -23.07 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 3.47 111.408 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.5 tp10 -105.17 113.63 64.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.273 -0.422 . . . . 1.56 110.841 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -82.88 152.2 14.57 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.579 2.186 . . . . 1.37 111.707 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.1 pt -100.59 152.17 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.006 -0.368 . . . . 1.85 110.006 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 62.8 m -94.78 129.27 41.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.28 -0.418 . . . . 1.78 109.96 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.33 162.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.065 -0.516 . . . . 1.64 109.853 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' SER . . . . . 0.416 ' HB3' ' HG3' ' A' ' 221' ' ' GLN . 48.3 t -88.21 146.03 25.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.183 -0.462 . . . . 1.52 109.823 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.706 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.3 t -57.44 -33.87 68.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.626 -0.715 . . . . 1.81 110.329 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.44 -20.71 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 2.51 111.095 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.416 ' HG3' ' HB3' ' A' ' 218' ' ' SER . 55.9 mt-30 -78.67 -45.89 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.283 -0.417 . . . . 1.02 110.015 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.659 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 24.9 m -70.41 -24.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.52 -0.309 . . . . 1.88 111.369 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.4 mt -62.38 -36.55 82.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.774 0.321 . . . . 1.59 110.556 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -73.22 -25.4 60.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 2.3 111.488 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.3 m-85 -67.5 -30.87 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.345 0.593 . . . . 3.18 109.657 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -81.54 1.5 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.247 -0.888 . . . . 3.55 110.601 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.29 -13.02 19.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.167 0.508 . . . . 2.74 109.806 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.1 155.19 37.36 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.759 -0.655 . . . . 1.66 110.482 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.5 m120 -115.53 150.14 37.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.82 -0.627 . . . . 1.13 109.837 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -88.29 -27.34 21.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.45 -0.796 . . . . 4.38 109.953 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.8 p-10 -76.54 168.52 19.92 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.272 -0.877 . . . . 1.62 111.395 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.26 167.71 30.46 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.19 -1.164 . . . . 1.16 110.19 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.17 142.54 51.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 3.56 110.199 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.33 51.06 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.738 -0.744 . . . . 2.23 112.77 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.68 153.57 77.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.33 -0.619 . . . . 2.59 109.33 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.31 122.89 12.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.188 1.925 . . . . 1.5 110.582 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.569 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 9.7 pt-20 -67.42 129.98 41.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.792 0.806 . . . . 3.4 112.47 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.0 mt-10 -115.13 120.18 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.666 -1.152 . . . . 2.47 109.002 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.71 132.88 47.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.994 0.426 . . . . 2.6 110.834 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.1 tpp -71.94 91.65 1.22 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.441 -0.799 . . . . 1.94 111.067 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.16 147.54 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.549 0.214 . . . . 1.67 110.941 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.479 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER 66.79 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.584 0.754 . . . . 2.18 111.886 179.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 47.58 34.18 3.4 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.58 0.352 . . . . 2.64 111.838 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' TRP . . . . . 0.527 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 21.5 t90 -129.61 150.04 51.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 5.31 110.721 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -113.71 132.58 22.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.604 -0.517 . . . . 6.91 109.604 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -46.47 151.8 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.717 2.944 . . . . 3.72 113.76 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -70.58 158.28 36.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.939 . . . . 3.34 111.598 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLN . . . . . 0.407 ' CD ' ' HD2' ' A' ' 249' ' ' PRO . 56.2 tp60 -121.55 128.37 25.67 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.399 -0.364 . . . . 4.92 110.148 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.407 ' HD2' ' CD ' ' A' ' 248' ' ' GLN . 10.3 Cg_endo -50.26 169.92 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.452 3.434 . . . . 4.01 115.449 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 3.2 mm? -62.16 -12.55 20.39 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.828 -1.533 . . . . 4.9 113.071 -169.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.563 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 19.0 ptpt -60.11 41.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.377 1.621 . . . . 5.68 115.377 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 7.4 p30 130.29 -3.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 126.099 1.76 . . . . 5.11 111.023 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 57.5 mmt-85 -130.32 95.42 3.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.106 0.479 . . . . 6.74 110.205 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -137.34 104.25 5.33 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 3.08 108.483 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 193' ' ' TYR . 2.0 mp -84.78 132.57 31.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.189 -0.46 . . . . 3.06 111.191 -169.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -80.63 150.34 29.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 3.01 109.851 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -112.6 140.79 47.07 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.113 -0.328 . . . . 1.99 110.113 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 48.9 m -152.0 96.76 2.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.342 0.591 . . . . 2.47 110.499 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.05 123.15 19.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.213 0.53 . . . . 5.03 110.997 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 pttm . . . . . 0 C--O 1.248 1.001 0 CA-C-N 114.98 -1.009 . . . . 4.82 111.887 177.178 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 120.701 0.286 . . . . 17.73 110.336 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m 58.92 23.13 11.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.742 -0.663 . . . . 15.49 111.895 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -148.66 94.91 2.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 16.29 110.677 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -93.21 -23.28 18.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.695 0.76 . . . . 14.68 109.01 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -146.62 135.97 22.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.537 -1.21 . . . . 15.53 109.354 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.02 139.36 9.23 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.152 -0.779 . . . . 10.81 111.152 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.479 ' CE2' ' HA ' ' A' ' 243' ' ' ASN . 10.5 t80 -79.7 99.52 7.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.363 0.601 . . . . 11.61 109.542 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.36 -86.11 0.18 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.41 -1.476 . . . . 9.0 109.41 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -92.5 134.84 34.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.616 -1.253 . . . . 10.04 107.616 166.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -50.67 -48.21 58.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.126 0.787 . . . . 11.67 113.126 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -103.87 24.67 10.92 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.555 -0.458 . . . . 11.18 111.505 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.84 122.96 4.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.742 . . . . 8.9 111.946 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.24 121.88 7.89 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.804 1.669 . . . . 8.2 112.783 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -82.25 -40.81 21.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.372 -0.831 . . . . 10.62 110.58 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -61.57 -38.57 88.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.695 -0.684 . . . . 10.41 110.724 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -49.33 -52.3 28.83 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.965 0.358 . . . . 9.19 111.965 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -63.74 -31.33 72.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.732 0.301 . . . . 7.71 111.299 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -90.24 -11.47 40.84 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.775 -0.37 . . . . 10.03 111.669 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -89.54 -27.87 19.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.21 0.528 . . . . 7.89 110.036 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.41 ' HB3' HG21 ' A' ' 22' ' ' ILE . 85.6 m-85 -107.62 99.68 30.45 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.541 -0.754 . . . . 7.65 109.484 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.64 -32.74 55.87 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.427 2.751 . . . . 8.15 112.751 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.41 HG21 ' HB3' ' A' ' 20' ' ' PHE . 11.0 tp -54.05 -9.69 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.959 0.725 . . . . 6.15 112.959 175.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.39 -14.77 53.79 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.058 0.456 . . . . 5.72 110.439 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -50.55 -22.05 1.8 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.566 -0.743 . . . . 8.17 111.853 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.56 -175.05 32.54 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.029 -0.828 . . . . 5.05 111.029 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -117.7 107.45 14.2 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 117.484 -1.686 . . . . 7.09 109.81 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.8 ptt-85 -166.41 127.01 1.68 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.48 -0.563 . . . . 5.44 109.48 160.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -116.27 -52.0 2.6 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 118.48 -1.288 . . . . 7.33 112.809 162.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -94.63 155.98 38.88 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.632 -0.258 . . . . 4.35 110.435 -169.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.539 ' HB3' ' OG1' ' A' ' 198' ' ' THR . 26.5 Cg_endo -64.79 -41.84 17.08 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.757 1.638 . . . . 4.96 112.623 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.4 p -162.15 163.48 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.43 0.633 . . . . 5.07 112.121 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 53.2 t0 -159.68 115.15 2.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.625 -1.17 . . . . 3.14 107.848 172.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.522 ' HA ' HG13 ' A' ' 255' ' ' ILE . 36.5 mt -113.01 140.41 33.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 120.854 0.359 . . . . 2.71 111.415 -167.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -135.31 137.18 42.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.316 -0.994 . . . . 2.82 108.316 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -47.87 -39.34 18.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.042 0.449 . . . . 2.71 111.855 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -81.32 -28.74 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.076 -0.511 . . . . 5.23 111.075 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -96.78 20.39 11.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.472 0.653 . . . . 3.38 110.906 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.48 130.68 53.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.466 -0.568 . . . . 1.76 109.466 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 256' ' ' LYS . 75.6 mmtt -109.52 122.27 47.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.918 0.39 . . . . 4.05 110.513 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -70.56 139.98 51.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.969 -0.56 . . . . 4.9 111.121 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.47 147.25 36.31 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.523 -0.762 . . . . 2.27 109.602 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 44' ' ' LEU . 14.0 Cg_endo -54.99 144.88 66.12 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.549 2.833 . . . . 2.45 113.71 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.44 ' HB2' ' HA ' ' A' ' 260' ' ' LYS . 14.1 t -46.32 45.26 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.111 1.523 . . . . 4.62 115.111 166.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' ' C ' ' A' ' 42' ' ' PRO . 3.7 pp -59.59 171.36 0.86 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.009 -0.541 . . . . 5.15 110.084 168.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 34.9 mmtp -53.69 123.23 37.19 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.806 0.336 . . . . 4.21 111.756 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.59 171.46 3.45 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.581 2.854 . . . . 2.76 113.27 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.483 HD21 ' HA3' ' A' ' 81' ' ' GLY . 68.0 mt -82.14 111.69 18.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 2.93 109.555 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 m -78.14 108.73 11.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.046 -0.353 . . . . 2.46 110.046 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -101.93 113.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.281 0.563 . . . . 2.17 110.573 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -126.55 92.29 3.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.988 -0.551 . . . . 1.87 109.851 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 7.7 p90 -129.04 23.16 5.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.944 -0.571 . . . . 3.97 110.961 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.95 -22.4 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.11 0.481 . . . . 2.48 110.093 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -99.47 7.75 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.72 -0.673 . . . . 2.54 110.646 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.68 121.27 14.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.142 -0.481 . . . . 1.41 111.182 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 m -109.12 106.84 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.847 -0.615 . . . . 1.41 110.435 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 p -78.58 147.22 33.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.84 109.478 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.67 -57.13 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.979 0.418 . . . . 1.45 111.766 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -147.23 156.48 42.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 3.72 110.911 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.93 134.06 67.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.196 -0.668 . . . . 1.35 109.196 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 172' ' ' SER . 66.8 tp -136.22 144.08 44.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 1.53 111.249 -170.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -105.29 118.54 36.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.568 -0.742 . . . . 1.49 109.296 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.03 66.33 0.97 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.29 -0.564 . . . . 2.18 111.09 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . 66.73 -52.93 0.22 Allowed Glycine 0 CA--C 1.523 0.568 0 CA-C-N 114.487 -1.233 . . . . 2.0 115.289 165.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -96.34 -26.62 15.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.898 0.38 . . . . 4.11 110.208 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.32 178.62 8.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 1.78 110.095 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -126.61 123.81 38.48 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.921 -0.77 . . . . 3.48 108.921 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -117.08 143.44 45.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.947 0.403 . . . . 1.99 111.36 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -114.75 123.46 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.542 -0.54 . . . . 1.75 109.542 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 2.02 111.329 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.57 152.65 27.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 2.19 109.17 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -83.63 135.04 34.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.787 0.327 . . . . 1.33 110.383 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -133.49 59.35 1.74 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.985 0.897 . . . . 2.65 109.576 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -87.07 -11.32 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 2.01 109.634 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -144.66 177.35 8.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.415 -1.328 . . . . 2.35 107.415 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.07 71.57 4.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.734 0.778 . . . . 1.92 110.423 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -82.75 -61.06 1.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.175 -0.92 . . . . 2.31 110.738 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -112.78 98.06 6.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 1.44 110.024 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.12 138.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.915 -0.584 . . . . 1.82 111.166 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.7 tp -136.67 113.47 10.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.048 -0.524 . . . . 1.8 110.152 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.65 124.15 7.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.466 0.65 . . . . 3.02 111.553 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.483 ' HA3' HD21 ' A' ' 47' ' ' LEU . . . -87.53 178.33 47.36 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.167 -0.924 . . . . 1.44 111.478 169.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -38.62 -142.13 0.0 OUTLIER Glycine 0 CA--C 1.535 1.299 0 O-C-N 124.669 0.864 . . . . 2.15 114.974 167.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -49.65 120.41 5.84 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 121.59 1.527 . . . . 3.17 112.152 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.5 mt -159.43 -169.48 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.706 -1.134 . . . . 4.55 109.173 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -126.78 41.8 3.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.717 0.294 . . . . 4.95 110.779 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.91 176.14 14.21 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.632 -0.794 . . . . 2.25 113.172 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 125' ' ' THR . 76.4 m -102.09 122.05 43.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.771 -0.455 . . . . 2.12 109.771 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 38.2 m-85 -104.01 106.42 16.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.019 0.437 . . . . 3.88 110.928 -175.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.453 ' NH2' ' HZ3' ' A' ' 123' ' ' TRP . 18.4 mtm180 -85.61 149.59 25.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 3.87 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.85 124.73 28.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 1.68 110.239 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 92' ' ' GLN . 7.2 tt -109.16 -34.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.464 -0.334 . . . . 2.16 111.392 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HG2' HG22 ' A' ' 91' ' ' ILE . 27.6 pt20 -169.98 169.17 8.27 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.865 -0.152 . . . . 1.95 110.718 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.457 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 11.3 p90 -153.66 160.39 42.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.98 110.845 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -147.55 162.27 39.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.6 -0.727 . . . . 1.07 109.55 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 118' ' ' LEU . 85.4 m-85 -106.2 152.3 23.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 3.99 111.278 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.492 ' CE1' ' HB2' ' A' ' 119' ' ' HIS . 13.6 m170 -108.72 142.85 38.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.814 -1.18 . . . . 2.2 107.814 173.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.579 ' HE1' ' HB ' ' A' ' 222' ' ' VAL . 6.4 t90 -152.61 116.67 4.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.529 -0.468 . . . . 6.08 110.74 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.74 154.75 31.25 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.953 -0.641 . . . . 2.19 112.003 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -67.58 -32.37 73.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.223 0.511 . . . . 3.08 110.617 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -106.56 140.36 39.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.943 -0.762 . . . . 3.48 108.943 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -64.05 -4.38 3.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.896 0.702 . . . . 3.85 112.896 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.17 21.4 24.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.439 -0.886 . . . . 2.37 112.847 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.6 pt20 -158.87 165.57 33.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.13 0.465 . . . . 2.62 110.415 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.95 -34.66 3.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.26 -0.971 . . . . 1.62 114.246 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.8 p -73.4 -34.76 65.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.388 0.594 . . . . 2.24 111.873 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.28 -163.86 0.16 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.445 -0.946 . . . . 3.72 108.445 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 50.62 55.4 9.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.485 0.66 . . . . 4.03 109.889 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.8 p -77.94 117.56 19.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.273 -0.876 . . . . 2.99 110.981 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 29.9 t -88.51 92.58 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.88 109.947 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.35 -67.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.652 1.22 . . . . 2.8 111.723 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -127.22 -3.53 6.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.337 -0.392 . . . . 5.35 111.503 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HB2' ' H ' ' A' ' 109' ' ' VAL . 64.3 mttm -69.56 178.17 2.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.041 -0.264 . . . . 3.58 110.479 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.8 pttt 147.77 109.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.746 0.819 . . . . 3.26 108.926 -160.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -121.39 166.66 13.78 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.146 -0.346 . . . . 1.71 110.073 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 103' ' ' GLN . . . -79.55 -17.89 52.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 1.57 112.441 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.448 ' HB2' ' CD1' ' A' ' 97' ' ' TRP . . . -156.65 164.36 38.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.932 0.396 . . . . 1.3 111.513 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.84 151.54 20.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.508 -0.769 . . . . 1.85 110.402 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 95' ' ' PHE . 39.7 tp -104.23 127.44 51.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.675 -0.491 . . . . 1.61 109.675 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 96' ' ' HIS . 22.6 t-160 -118.19 105.84 12.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.372 -0.376 . . . . 2.25 110.227 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.2 mp -100.23 125.92 46.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 1.51 110.689 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.444 ' HA ' HG11 ' A' ' 142' ' ' VAL . 46.4 t -98.5 125.18 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.926 0.393 . . . . 1.24 111.235 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -116.26 144.03 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.489 . . . . 2.86 109.681 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.469 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 11.2 t90 -117.9 137.93 52.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.16 -0.473 . . . . 4.96 111.294 -175.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 30.6 t30 -70.72 104.58 2.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.34 0.59 . . . . 2.3 111.238 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 87' ' ' THR . 7.7 t -67.62 -25.62 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.835 1.05 . . . . 2.77 113.835 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 64.8 pttt -68.39 -5.12 17.29 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.277 0.843 . . . . 3.79 113.277 -171.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -107.44 -0.78 22.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.049 -0.407 . . . . 3.34 111.638 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.88 30.3 4.89 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.149 -0.932 . . . . 2.37 115.148 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.469 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 14.9 t70 -163.27 121.27 1.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.931 0.865 . . . . 3.93 109.388 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 134' ' ' VAL . 55.3 p90 -66.44 -40.08 89.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 3.6 111.951 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -32.47 81.8 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.816 -0.707 . . . . 2.35 112.451 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 42.2 mmtm -66.34 -34.57 78.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.79 0.328 . . . . 3.75 110.215 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.34 -34.03 74.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.971 -0.558 . . . . 2.17 110.767 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 130' ' ' PHE . 63.3 t -65.06 -25.75 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 3.11 110.571 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.61 16.78 6.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 3.55 110.977 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 21.6 mt-30 -131.69 135.33 26.65 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 3.02 109.687 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 37.7 Cg_exo -60.59 -26.4 82.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.655 2.237 . . . . 1.93 112.725 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -113.92 19.18 16.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 2.29 111.07 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.15 -29.44 73.35 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.888 -0.672 . . . . 1.5 114.127 -172.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.8 158.61 34.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.066 0.433 . . . . 1.98 110.982 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -144.49 126.96 15.94 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.952 -0.759 . . . . 1.83 108.952 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 121' ' ' VAL . 32.2 m -125.49 149.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.933 0.397 . . . . 2.28 111.38 -173.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.53 122.7 47.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.614 -0.721 . . . . 2.89 110.187 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.8 109.76 2.89 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.29 -0.724 . . . . 0.95 111.29 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.7 mt -111.28 113.9 45.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.243 -0.28 . . . . 1.38 110.243 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -66.6 145.32 55.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.788 0.328 . . . . 1.37 111.01 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.48 124.09 51.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.779 -0.452 . . . . 1.48 109.779 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.2 141.97 47.44 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.559 -0.534 . . . . 2.52 109.559 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 45.1 t -85.45 132.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.061 0.457 . . . . 1.88 110.866 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.3 -105.08 0.21 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.997 -0.841 . . . . 1.53 110.997 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.7 t -71.19 142.33 50.65 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.301 -0.629 . . . . 2.08 109.301 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.68 151.86 45.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.558 -0.292 . . . . 1.36 111.059 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.0 tptt -108.48 99.11 31.32 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.657 -0.497 . . . . 1.78 109.657 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.54 -36.89 89.99 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.965 2.443 . . . . 1.34 112.742 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.07 75.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.991 -0.624 . . . . 0.75 113.115 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 26.2 tp -83.92 -17.23 41.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.224 0.512 . . . . 1.39 110.373 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -41.56 63.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 1.63 110.768 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HE3' ' OD1' ' A' ' 179' ' ' ASP . 65.3 mttm -49.2 -49.09 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.557 . . . . 3.26 112.415 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.5 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 14.8 p -79.99 -35.9 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.708 -0.397 . . . . 1.97 110.832 -177.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.438 ' HA ' ' CD1' ' A' ' 163' ' ' LEU . 78.2 t -59.8 -35.77 62.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.363 0.601 . . . . 1.64 110.452 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.52 -33.99 76.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.198 -0.91 . . . . 1.22 111.963 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.9 p -99.25 -3.66 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 111.793 0.294 . . . . 2.07 111.793 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 92.8 mt -55.6 -42.49 74.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.848 0.356 . . . . 1.95 111.916 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.99 -20.94 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.422 -0.353 . . . . 2.31 111.662 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 72.6 m -92.66 0.4 57.42 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.219 0.452 . . . . 1.78 112.219 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.09 34.52 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.578 -0.527 . . . . 1.42 109.578 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.447 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 82.6 tttt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.262 -0.881 . . . . 1.98 112.152 -172.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 171' ' ' LYS . 37.9 p -102.69 152.15 21.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.696 0.284 . . . . 1.4 111.118 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -71.62 146.6 48.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.885 0.374 . . . . 2.84 110.662 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.15 9.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.529 -0.843 . . . . 0.85 112.5 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 168' ' ' THR . 21.5 ptmt -90.87 155.58 18.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 2.22 110.914 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 60' ' ' LEU . 16.5 p -128.07 160.41 32.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.518 -0.765 . . . . 1.93 110.548 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -144.66 145.86 31.96 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.047 -0.353 . . . . 1.17 110.047 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.15 131.74 40.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.829 -0.434 . . . . 1.8 109.829 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -139.97 79.93 1.74 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.992 -0.744 . . . . 1.31 108.992 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 p -104.65 162.7 13.06 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.462 -0.79 . . . . 1.69 111.477 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 58.12 45.97 16.83 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.788 0.662 . . . . 2.26 112.788 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -99.06 135.46 40.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.974 -0.38 . . . . 4.84 109.974 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.426 ' OD1' ' HE3' ' A' ' 158' ' ' LYS . 6.3 p-10 -110.61 119.28 46.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 121.13 0.49 . . . . 2.51 110.675 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.86 -7.28 19.12 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.817 2.345 . . . . 1.47 112.639 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -63.36 -28.58 70.09 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.877 0.37 . . . . 3.16 110.688 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.75 59.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.172 -0.537 . . . . 1.12 112.977 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 74.9 mt -102.32 -7.06 22.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.583 0.23 . . . . 2.37 111.396 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.82 130.27 88.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.622 0.601 . . . . 3.87 112.622 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.82 -171.59 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.892 2.395 . . . . 2.51 111.369 173.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.75 -62.47 1.68 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.959 0.409 . . . . 3.23 110.613 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.501 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.3 m -91.05 144.77 25.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 2.03 110.279 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 44.3 tp -109.81 63.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.362 0.601 . . . . 2.5 110.549 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 4.2 m-20 -97.8 162.82 13.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.81 108.484 174.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.6 p90 -167.16 156.01 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.159 -0.616 . . . . 5.32 112.474 -174.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.424 ' NE1' ' HG2' ' A' ' 212' ' ' LYS . 12.1 m95 -107.25 149.16 28.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.875 -1.157 . . . . 4.55 107.875 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.8 t -131.28 103.46 6.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.472 0.653 . . . . 2.39 111.589 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.525 ' OH ' ' HA ' ' A' ' 253' ' ' ARG . 45.3 t80 -138.75 132.42 16.23 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 5.32 111.018 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.466 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 43.3 Cg_exo -58.3 130.07 35.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.596 2.198 . . . . 2.47 111.876 172.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -108.23 155.71 16.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.209 -0.519 . . . . 2.0 113.068 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 198' ' ' THR . 22.7 t -82.97 -137.8 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.431 0.692 . . . . 3.36 112.256 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.603 ' C ' ' H ' ' A' ' 199' ' ' THR . 32.0 tp -39.95 13.32 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 128.289 2.636 . . . . 5.18 117.46 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.539 ' OG1' ' HB3' ' A' ' 30' ' ' PRO . 3.8 m -67.7 24.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.617 -1.302 . . . . 5.53 111.333 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.603 ' H ' ' C ' ' A' ' 197' ' ' LEU . 1.1 p -149.35 164.45 20.98 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 123.556 0.742 . . . . 5.89 109.029 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.467 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 59.7 Cg_exo -48.27 -50.49 12.0 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.306 2.004 . . . . 6.31 113.992 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 7.4 Cg_endo -88.92 147.71 5.71 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.224 1.95 . . . . 5.26 112.381 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.17 78.97 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 4.29 110.595 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.81 174.05 12.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.533 -0.303 . . . . 3.51 110.63 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 8.5 pt-20 -112.88 71.99 0.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.227 0.537 . . . . 3.37 110.746 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.461 ' SG ' HG21 ' A' ' 199' ' ' THR . 28.7 p -96.87 -9.6 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.47 110.645 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.89 141.06 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.782 -0.645 . . . . 1.74 111.395 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.3 m -113.18 108.8 17.78 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.002 -0.74 . . . . 2.3 109.002 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.425 ' O ' ' HA ' ' A' ' 192' ' ' THR . 33.6 m95 -82.31 119.22 23.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.936 0.398 . . . . 6.37 111.985 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 48.5 mm -108.78 99.55 8.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.379 -0.971 . . . . 2.32 108.379 170.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.6 t -101.65 119.36 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.316 -0.402 . . . . 2.1 110.386 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 40.1 mt -74.68 137.92 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.829 0.347 . . . . 2.35 110.254 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 85.2 mttt -83.06 -8.64 59.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 3.47 110.68 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.501 ' HG2' ' H ' ' A' ' 187' ' ' SER . 8.4 tp10 -105.26 101.38 30.61 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.255 -0.43 . . . . 1.56 110.501 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 15.7 Cg_exo -69.23 141.48 47.5 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.757 2.305 . . . . 1.37 111.713 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.46 150.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.907 -0.405 . . . . 1.85 109.907 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 12.9 m -90.44 122.03 32.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.074 -0.512 . . . . 1.78 110.526 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.4 m -125.09 151.22 30.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.238 -0.653 . . . . 1.64 109.238 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 60.8 p -91.1 160.05 15.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.488 -0.485 . . . . 1.52 111.525 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.479 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.3 m -54.27 -45.56 72.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 1.81 110.803 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -55.74 -32.5 63.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 2.51 111.434 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -76.87 -52.09 10.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.479 -0.328 . . . . 1.02 110.846 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.579 ' HB ' ' HE1' ' A' ' 97' ' ' TRP . 15.7 m -64.04 -34.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.081 0.4 . . . . 1.88 112.081 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.4 mt -63.39 -30.68 71.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.689 0.281 . . . . 1.59 111.385 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -78.8 -20.18 50.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.313 . . . . 2.3 111.621 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -71.96 -24.48 61.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.275 0.559 . . . . 3.18 109.866 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -80.69 1.28 30.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.59 -0.732 . . . . 3.55 110.533 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -91.61 -9.03 45.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 2.74 110.635 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.06 153.98 39.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.092 0.472 . . . . 1.66 110.638 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.3 m120 -119.31 150.87 39.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.958 -0.564 . . . . 1.13 110.928 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 240' ' ' MET . 33.4 m-85 -77.46 -34.75 54.33 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.377 -0.972 . . . . 4.38 108.377 170.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.9 p-10 -74.31 163.84 27.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.078 -1.419 . . . . 1.62 112.39 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.72 -170.75 47.16 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.614 -1.175 . . . . 1.16 110.993 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.0 126.72 31.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.957 -0.386 . . . . 3.56 109.957 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.9 29.49 31.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.844 -0.694 . . . . 2.23 112.068 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 20.0 mm-40 -127.43 159.13 67.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.138 -0.319 . . . . 2.59 110.138 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.21 121.86 10.15 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 1.5 112.518 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.21 119.36 7.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.573 -0.74 . . . . 3.4 112.534 -174.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.3 mt-10 -131.72 146.74 52.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 2.47 109.206 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.44 125.3 42.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.394 -0.224 . . . . 2.6 110.394 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.548 ' HA ' ' CE2' ' A' ' 230' ' ' PHE . 55.5 ttm -69.45 90.79 0.54 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.515 0.51 . . . . 1.94 110.176 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.42 157.26 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 1.67 110.979 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 12.9 t70 68.47 -85.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.114 -0.948 . . . . 2.18 111.066 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.479 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 56.2 m-80 50.06 35.47 10.02 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.911 0.708 . . . . 2.64 112.911 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -137.36 158.97 43.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.424 0.63 . . . . 5.31 111.6 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -111.22 146.87 35.44 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.181 -0.918 . . . . 6.91 110.357 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.89 151.26 20.69 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.926 2.417 . . . . 3.72 112.892 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -78.31 159.74 28.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.439 -0.8 . . . . 3.34 110.681 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -113.79 153.69 45.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.42 . . . . 4.92 111.404 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.84 178.57 2.74 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.762 2.975 . . . . 4.01 113.39 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.562 ' C ' ' H ' ' A' ' 252' ' ' ASN . 4.2 mm? -51.11 -11.15 0.09 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.056 0.942 . . . . 4.9 113.021 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -59.49 41.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.092 0.957 . . . . 5.68 113.492 170.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 250' ' ' LEU . 2.9 t30 119.07 41.91 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.584 1.954 . . . . 5.11 112.296 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.64 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 7.4 ppt_? -145.52 121.44 10.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 6.74 110.896 160.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -137.48 122.4 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.656 -1.238 . . . . 3.08 107.656 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.522 HG13 ' HA ' ' A' ' 33' ' ' ILE . 29.4 mm -91.49 144.1 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 3.06 112.416 -165.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 67.6 mttm -127.97 146.6 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 3.01 109.101 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -138.17 103.85 5.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.572 0.225 . . . . 1.99 110.785 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 p -92.77 98.52 11.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.013 0.435 . . . . 2.47 111.014 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.86 154.3 27.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.248 -0.433 . . . . 5.03 110.018 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 43' ' ' SER . 49.2 pttt . . . . . 0 C--O 1.246 0.895 0 O-C-N 123.613 0.571 . . . . 4.82 111.335 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.478 0.965 0 CA-C-O 120.554 0.216 . . . . 17.73 111.138 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 p -132.81 122.22 24.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 15.49 111.548 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -125.47 163.79 21.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.302 -0.408 . . . . 16.29 110.155 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.432 ' CD2' ' HG2' ' A' ' 9' ' ' LYS . 44.9 m80 -105.6 112.33 25.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.945 -0.57 . . . . 14.68 110.252 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -117.12 66.03 0.73 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.2 0.524 . . . . 15.53 110.859 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.21 158.58 12.45 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.783 -0.927 . . . . 10.81 110.783 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -78.22 97.41 5.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.248 0.547 . . . . 11.61 109.8 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.41 122.15 4.99 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.846 -0.901 . . . . 9.0 110.846 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 4' ' ' HIS . 87.8 mttt -60.28 119.45 7.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.419 0.155 . . . . 10.04 111.419 -176.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.7 m170 44.66 -87.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.06 0.944 . . . . 11.67 113.026 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -97.0 21.17 10.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 11.18 110.724 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -102.18 2.84 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.086 -1.206 . . . . 8.9 110.086 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.72 123.03 3.6 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.899 1.733 . . . . 8.2 110.559 166.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.7 -37.72 16.46 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.728 0.299 . . . . 10.62 110.984 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -80.54 -4.38 53.73 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.828 -0.349 . . . . 10.41 110.946 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -93.11 -46.97 7.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 9.19 110.209 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -67.63 -4.64 12.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.963 0.357 . . . . 7.71 111.963 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -66.63 -37.53 85.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.467 0.651 . . . . 10.03 109.429 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.97 -26.27 25.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.11 -0.95 . . . . 7.89 110.627 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -129.88 91.83 38.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 7.65 110.236 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.514 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 24.9 Cg_exo -63.86 -25.73 67.54 Favored 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 123.299 2.666 . . . . 8.15 113.953 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.9 pt -61.72 -10.54 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 113.174 0.805 . . . . 6.15 113.174 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.67 -22.51 66.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.659 0.266 . . . . 5.72 111.48 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 22.3 pttp -102.77 23.84 11.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 8.17 110.601 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.48 -111.1 3.57 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 111.021 -0.832 . . . . 5.05 111.021 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -80.02 123.83 28.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.585 -1.265 . . . . 7.09 107.585 168.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.556 ' HG2' ' HB2' ' A' ' 252' ' ' ASN . 9.9 mpt_? -84.64 153.81 22.93 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.019 0.914 . . . . 5.44 111.878 -175.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 196' ' ' SER . 0.0 OUTLIER -149.73 24.21 0.87 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.926 -1.488 . . . . 7.33 109.374 -168.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.466 ' HB2' HG13 ' A' ' 31' ' ' VAL . 14.9 m -97.51 159.8 30.25 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 113.219 0.822 . . . . 4.35 113.219 -161.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.505 ' HA ' ' CE1' ' A' ' 107' ' ' HIS . 13.4 Cg_endo -54.61 35.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.174 1 C-N-CA 126.747 4.964 . . . . 4.96 115.742 174.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG13 ' HB2' ' A' ' 29' ' ' SER . 13.1 m -85.95 -176.31 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 118.401 0.546 . . . . 5.07 111.987 -162.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -90.17 135.23 33.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.16 -0.927 . . . . 3.14 110.668 -164.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 41.1 mt -97.18 126.54 49.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.985 -0.552 . . . . 2.71 110.562 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 16.7 t70 -112.73 117.41 32.13 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.379 -0.6 . . . . 2.82 109.379 171.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 p -56.05 -27.67 54.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.945 -0.57 . . . . 2.71 112.458 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.506 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 43.5 m80 -74.29 -18.04 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.185 0.517 . . . . 5.23 110.318 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -117.87 18.9 13.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.497 -0.774 . . . . 3.38 109.851 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.63 85.33 2.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.394 -0.595 . . . . 1.76 109.394 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -75.8 121.93 23.31 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.453 -0.794 . . . . 4.05 111.535 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 40.4 p90 -84.2 143.45 29.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.297 -0.411 . . . . 4.9 110.318 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -109.7 119.36 48.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.177 -0.465 . . . . 2.27 110.43 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.13 -15.24 46.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.758 2.305 . . . . 2.45 111.587 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.9 m -75.98 -19.21 58.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 4.62 110.746 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 89.5 mt -83.1 137.87 33.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.093 0.473 . . . . 5.15 110.259 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -118.54 135.19 23.53 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 4.21 110.73 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.99 158.09 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.94 3.094 . . . . 2.76 113.303 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.15 155.61 19.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 2.93 111.423 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 80' ' ' LYS . 34.7 p -129.1 136.04 49.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 2.46 108.984 173.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.31 136.78 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.383 -0.372 . . . . 2.17 110.981 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -119.29 89.34 3.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.508 -0.553 . . . . 1.87 109.508 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -103.1 5.72 38.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.786 -0.643 . . . . 3.97 110.254 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -51.88 -40.08 60.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 2.48 111.555 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -111.66 23.67 13.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.266 -0.425 . . . . 2.54 111.343 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.18 111.17 6.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.86 0.362 . . . . 1.41 111.014 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -106.22 108.47 20.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.282 -0.417 . . . . 1.41 110.863 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 176' ' ' THR . 17.3 m -77.43 148.74 35.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.223 -0.658 . . . . 1.84 109.223 174.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.44 -56.99 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.681 0.252 . . . . 1.45 111.681 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -154.18 164.9 37.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.161 0.505 . . . . 3.72 111.49 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.77 138.3 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.338 -0.846 . . . . 1.35 109.779 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.5 tp -130.29 139.57 50.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.593 -0.276 . . . . 1.53 111.09 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -91.46 117.02 29.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.195 0.521 . . . . 1.49 110.743 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 64' ' ' HIS . 15.7 m120 -115.59 150.05 37.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.182 -1.414 . . . . 2.18 107.182 170.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.71 38.2 0.49 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.65 -0.786 . . . . 2.0 114.536 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' ASN . 84.8 m-70 -132.61 -39.7 0.99 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.188 -0.671 . . . . 4.11 109.188 169.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.24 -170.31 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.311 -0.996 . . . . 1.78 108.311 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -108.63 135.53 49.73 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.128 -0.694 . . . . 3.48 109.128 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.67 111.61 24.18 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.289 -0.414 . . . . 1.99 110.71 -176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.77 113.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.114 -0.698 . . . . 1.75 109.114 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.52 134.04 35.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.983 0.421 . . . . 2.02 111.032 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -103.28 155.61 18.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.504 -0.771 . . . . 2.19 109.33 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.13 119.82 22.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.809 0.338 . . . . 1.33 110.139 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.35 56.18 1.12 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.718 0.771 . . . . 2.65 109.988 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -87.2 -16.57 34.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.473 -0.785 . . . . 2.01 109.881 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -153.13 176.55 11.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.966 -1.015 . . . . 2.35 108.673 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.69 73.57 7.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.234 0.54 . . . . 1.92 111.012 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 81.4 mttt -97.47 -65.15 0.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 2.31 112.481 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.49 101.51 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 1.44 110.223 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.1 t -119.56 143.4 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.993 0.425 . . . . 1.82 112.088 -169.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 tp -118.59 129.95 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.176 -0.675 . . . . 1.8 109.176 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 95.3 mttt -125.55 137.63 53.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.841 -0.429 . . . . 3.02 109.841 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.0 170.2 24.65 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.976 -0.557 . . . . 1.44 111.959 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.4 -147.88 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.817 0.363 . . . . 2.15 113.245 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 51.9 Cg_exo -52.19 119.7 6.18 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 121.904 1.736 . . . . 3.17 112.253 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 72.4 mt -155.03 -171.7 3.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.781 -1.1 . . . . 4.55 108.676 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.02 51.76 1.52 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 4.95 110.639 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.02 -173.78 19.74 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.531 -0.843 . . . . 2.25 112.902 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -108.48 127.6 54.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.015 -0.365 . . . . 2.12 110.015 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 124' ' ' ASN . 71.9 m-85 -103.66 101.77 11.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.404 0.621 . . . . 3.88 111.449 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -79.09 144.0 34.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.481 -0.781 . . . . 3.87 110.427 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.76 120.79 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.501 -0.555 . . . . 1.68 109.501 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.18 -36.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.319 . . . . 2.16 111.698 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -172.11 167.76 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.252 -0.647 . . . . 1.95 109.252 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.45 ' CD2' HD11 ' A' ' 118' ' ' LEU . 35.9 p90 -140.01 167.81 21.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.278 -0.569 . . . . 0.98 112.17 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -147.36 160.94 41.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.826 -1.176 . . . . 1.07 107.826 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.95 172.0 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.652 0.66 . . . . 3.99 111.032 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -129.45 146.03 51.35 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.697 -0.853 . . . . 2.2 108.697 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -157.32 133.38 9.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.164 0.506 . . . . 6.08 110.667 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 78.94 165.28 28.85 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.635 -0.793 . . . . 2.19 112.673 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.532 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 33.3 t 156.42 -96.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.661 -1.237 . . . . 3.08 107.661 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 75.6 mt -83.14 -153.84 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.713 -0.676 . . . . 3.48 109.303 167.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -45.81 -33.54 3.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.038 0.535 . . . . 3.85 112.124 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 113' ' ' LYS . . . 176.91 89.92 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.9 -0.667 . . . . 2.37 112.129 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 27.5 mt-30 -127.37 -177.69 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.376 . . . . 2.62 111.183 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.6 -29.56 2.76 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 109.048 -1.621 . . . . 1.62 109.048 -172.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 117' ' ' GLU . 3.3 t -68.66 67.58 0.14 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.296 -1.452 . . . . 2.24 112.474 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.467 ' CA ' ' HE1' ' A' ' 244' ' ' TRP . 28.8 tt0 -56.62 155.05 7.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 110.117 -0.327 . . . . 3.72 110.117 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.505 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 44.4 m-70 58.89 64.61 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.994 -0.743 . . . . 4.03 108.994 -173.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.58 133.47 36.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.242 -0.89 . . . . 2.99 112.033 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.546 ' H ' ' HB3' ' A' ' 112' ' ' LYS . 40.6 t -78.61 90.61 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 114.922 -1.036 . . . . 2.88 108.894 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.48 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 33.7 t70 64.23 -71.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.135 0.897 . . . . 2.8 110.724 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.48 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 54.9 mttp -138.46 30.23 2.38 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.512 0.19 . . . . 5.35 111.512 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HB3' ' H ' ' A' ' 109' ' ' VAL . 25.4 ttpp -70.16 71.57 0.42 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.189 0.519 . . . . 3.58 110.086 174.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 102' ' ' GLY . 51.3 mtmt -99.77 96.45 7.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.45 . . . . 3.26 110.987 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -91.57 156.56 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.492 -0.929 . . . . 1.71 108.492 170.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.71 -9.69 55.4 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.481 0.488 . . . . 1.57 112.025 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.39 163.96 17.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.412 0.445 . . . . 1.3 110.322 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 105' ' ' SER . 33.2 tt0 -158.71 138.6 12.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.673 -0.694 . . . . 1.85 109.657 176.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.546 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 57.7 tp -102.51 132.86 48.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.024 -0.535 . . . . 1.61 110.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -119.86 102.41 8.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.188 0.518 . . . . 2.25 110.261 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.437 HD23 ' CB ' ' A' ' 93' ' ' PHE . 24.5 mt -83.96 116.98 23.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 1.51 110.581 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.54 127.23 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.34 0.59 . . . . 1.24 110.591 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 31.7 m-70 -124.45 144.11 50.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.898 -0.592 . . . . 2.86 110.062 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -111.42 131.23 55.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.891 -0.595 . . . . 4.96 110.755 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 88' ' ' TYR . 22.0 t30 -72.84 110.43 7.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.202 0.525 . . . . 2.3 110.742 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.9 p -66.34 -21.47 66.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 2.77 112.165 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -53.51 -27.49 25.93 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.384 0.513 . . . . 3.79 112.384 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.93 8.88 44.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.128 0.418 . . . . 3.34 112.128 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.09 -1.22 0.64 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.175 1.23 . . . . 2.37 116.175 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -168.79 136.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.416 1.108 . . . . 3.93 109.715 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.535 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.2 p90 -66.41 -38.63 87.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 3.6 111.687 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.16 97.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.838 -0.696 . . . . 2.35 111.904 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -70.72 -31.9 68.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.486 . . . . 3.75 110.241 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.621 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -65.59 -25.74 67.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.777 -0.647 . . . . 2.17 110.887 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -63.72 -19.62 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 3.11 110.993 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.39 -11.91 59.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.96 -0.463 . . . . 3.55 110.996 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 7.3 tt0 -111.14 136.39 20.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.637 -0.256 . . . . 3.02 110.623 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.8 Cg_exo -55.9 -27.15 61.73 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.34 2.694 . . . . 1.93 113.351 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 3.7 m-20 -111.5 27.07 10.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.109 0.48 . . . . 2.29 110.064 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.06 -36.49 31.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 1.5 113.503 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.8 mt -121.56 163.35 19.03 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.475 -0.427 . . . . 1.98 110.375 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.44 147.67 34.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.154 -0.475 . . . . 1.83 110.179 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.15 113.57 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.906 -0.405 . . . . 2.28 109.906 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.611 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 48.7 tp -93.4 108.32 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.092 -0.504 . . . . 2.89 110.079 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -93.92 148.35 18.97 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.932 -0.576 . . . . 0.95 112.99 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 mt -137.41 125.28 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.598 -0.519 . . . . 1.38 109.598 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 18.0 m-85 -71.06 139.12 50.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.474 -0.195 . . . . 1.37 110.474 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.7 mp -113.29 110.65 20.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.468 . . . . 1.48 110.701 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 19.4 ptpt -98.94 152.3 19.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.157 -0.683 . . . . 2.52 109.157 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.61 121.07 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.018 0.437 . . . . 1.88 110.495 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.01 -114.49 0.35 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.503 -0.639 . . . . 1.53 111.503 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.4 t -66.93 147.25 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.88 -0.415 . . . . 2.08 109.88 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.84 34.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.91 0.386 . . . . 1.36 111.669 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 216' ' ' SER . 56.7 mmtt -114.58 96.48 43.78 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.824 -0.625 . . . . 1.78 109.433 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.49 -33.92 93.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.687 2.258 . . . . 1.34 111.873 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.41 71.12 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.743 -0.662 . . . . 0.75 112.357 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 160' ' ' VAL . 62.0 tp -86.53 -26.35 24.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.216 0.532 . . . . 1.39 109.616 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -37.25 69.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.201 -0.909 . . . . 1.63 110.184 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -59.4 -37.69 78.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 3.26 111.279 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.616 ' O ' HG11 ' A' ' 162' ' ' VAL . 42.2 t -72.82 -43.39 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.154 0.502 . . . . 1.97 110.314 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 156' ' ' LEU . 33.9 t -59.77 -34.24 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 1.64 110.756 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.26 -31.05 72.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 1.22 112.014 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.616 HG11 ' O ' ' A' ' 159' ' ' VAL . 5.2 p -86.32 -4.73 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 2.07 111.012 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.52 -25.72 67.46 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.355 -0.384 . . . . 1.95 111.236 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.17 -32.31 72.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 2.31 111.279 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 m -88.5 -3.25 58.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.989 0.366 . . . . 1.78 111.989 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.58 41.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.327 0.584 . . . . 1.42 110.269 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.14 -31.24 70.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 1.98 111.421 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.9 p -117.43 158.17 24.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.785 -0.189 . . . . 1.4 111.174 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -55.03 147.0 16.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.351 0.596 . . . . 2.84 112.345 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.28 -22.01 31.89 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.331 -0.85 . . . . 0.85 112.25 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -72.84 139.84 47.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.116 0.484 . . . . 2.22 110.873 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.8 p -133.54 157.6 45.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.408 -0.814 . . . . 1.93 109.549 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.71 143.75 28.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.76 -0.459 . . . . 1.17 109.76 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.8 133.45 46.54 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.245 -0.65 . . . . 1.8 109.245 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -142.34 81.21 1.74 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.81 -0.632 . . . . 1.31 109.483 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 56' ' ' SER . 5.2 m -108.44 164.27 12.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.256 -0.429 . . . . 1.69 110.936 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.44 64.54 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.731 0.644 . . . . 2.26 111.773 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 53.2 t80 -115.22 144.65 43.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 4.84 110.145 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.61 102.33 25.59 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 2.51 111.348 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 16.0 Cg_exo -69.18 -12.16 33.33 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.917 2.412 . . . . 1.47 112.238 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -62.88 -24.48 67.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.393 -0.367 . . . . 3.16 110.957 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.62 68.28 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.601 -0.809 . . . . 1.12 111.797 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 83.5 mt -118.22 -38.01 3.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.646 -0.502 . . . . 2.37 109.646 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.07 131.71 83.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 3.87 110.566 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.84 -178.86 4.41 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.7 2.267 . . . . 2.51 112.727 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.65 -62.39 1.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.097 -0.501 . . . . 3.23 111.35 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.7 m -71.09 131.93 44.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 2.03 110.885 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.3 mt -111.32 63.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.079 0.466 . . . . 2.5 111.597 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 19.5 m-20 -105.6 173.23 6.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.741 -1.207 . . . . 1.81 107.741 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 46.9 p90 -164.65 150.24 10.15 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.325 -0.95 . . . . 5.32 113.235 -171.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.47 ' CE3' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m95 -109.35 151.27 26.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.817 -1.549 . . . . 4.55 106.817 166.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.7 t -139.5 130.86 26.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.603 0.716 . . . . 2.39 112.55 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.418 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 51.3 t80 -138.76 142.22 33.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.214 -0.903 . . . . 5.32 109.205 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.418 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 76.8 Cg_exo -52.0 149.07 21.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.429 2.086 . . . . 2.47 112.006 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -117.9 125.12 6.34 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.839 -0.696 . . . . 2.0 112.968 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 28' ' ' GLN . 11.9 t -85.16 -137.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.557 0.743 . . . . 3.36 111.112 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.643 ' C ' ' H ' ' A' ' 199' ' ' THR . 2.7 pt? -42.58 12.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.727 2.121 . . . . 5.18 116.727 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 196' ' ' SER . 2.1 m -68.21 25.51 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.011 0.823 . . . . 5.53 110.733 172.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.643 ' H ' ' C ' ' A' ' 197' ' ' LEU . 1.8 p -149.41 167.72 12.45 Favored Pre-proline 0 C--N 1.324 -0.534 0 C-N-CA 124.502 1.121 . . . . 5.89 108.531 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.515 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 53.9 Cg_exo -47.45 -48.86 14.33 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.854 1.703 . . . . 6.31 113.167 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 83.0 Cg_endo -98.63 145.37 0.54 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.239 1.96 . . . . 5.26 112.585 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.15 89.83 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.881 -0.785 . . . . 4.29 108.881 171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 tt -143.05 155.49 44.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.458 -0.792 . . . . 3.51 109.359 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.4 OUTLIER -88.77 43.96 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.927 0.394 . . . . 3.37 110.857 -176.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 2.1 p -86.37 -9.05 57.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.257 0.466 . . . . 2.47 112.257 -174.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.14 148.15 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.012 0.434 . . . . 1.74 111.077 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.3 m -117.5 108.22 15.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.026 -0.731 . . . . 2.3 109.026 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 210' ' ' VAL . 59.2 t90 -84.98 124.3 31.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.114 0.483 . . . . 6.37 110.013 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 73.2 mt -130.93 120.49 47.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.018 -0.734 . . . . 2.32 109.018 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 14.5 p -115.92 131.51 68.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.577 -0.449 . . . . 2.1 110.962 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 92.7 mt -71.98 129.09 37.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.125 -0.488 . . . . 2.35 110.208 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 0.7 OUTLIER -56.91 -24.05 49.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.116 -0.947 . . . . 3.47 111.435 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.93 115.05 65.98 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 1.56 110.68 -170.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.507 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 12.2 Cg_exo -71.89 157.76 54.25 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.639 2.226 . . . . 1.37 111.925 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 45.2 pt -114.09 151.43 15.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.172 -0.677 . . . . 1.85 109.172 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.568 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 2.6 p -101.53 126.6 48.37 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.847 0.356 . . . . 1.78 111.215 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.73 155.03 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.533 -0.758 . . . . 1.64 109.206 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.6 t -87.88 152.85 21.77 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.607 -0.437 . . . . 1.52 110.803 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.484 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 15.8 m -51.13 -48.13 61.84 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.287 0.367 . . . . 1.81 111.57 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 2.7 mp0 -53.94 -42.64 69.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 2.51 110.755 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.77 -45.48 92.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.657 . . . . 1.02 110.312 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.69 -37.44 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.562 . . . . 1.88 110.565 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 219' ' ' SER . 97.7 mt -67.31 -34.01 76.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.63 . . . . 1.59 110.916 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 98.5 mttt -71.07 -22.83 62.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.326 . . . . 2.3 111.161 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -72.58 -31.0 64.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 3.18 109.189 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -78.26 -4.26 46.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.325 -0.852 . . . . 3.55 110.336 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 93.3 mttt -94.06 -0.15 55.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 2.74 110.094 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -73.75 150.99 40.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.798 -0.637 . . . . 1.66 109.66 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.506 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.5 m120 -111.97 125.26 53.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.601 0.715 . . . . 1.13 111.248 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -64.74 -32.23 73.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.41 -1.268 . . . . 4.38 110.018 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -70.03 160.8 31.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 1.62 111.719 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.11 179.37 52.87 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.895 -0.882 . . . . 1.16 110.895 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.58 137.2 42.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.858 0.829 . . . . 3.56 110.434 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 80.8 20.31 65.97 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.027 -0.606 . . . . 2.23 112.059 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -121.95 155.79 60.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 122.399 0.279 . . . . 2.59 110.263 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.76 125.14 18.13 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.916 2.41 . . . . 1.5 111.358 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -58.25 133.2 55.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.748 0.785 . . . . 3.4 112.59 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.13 120.19 18.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.62 -1.173 . . . . 2.47 108.508 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.5 116.91 7.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.739 0.304 . . . . 2.6 110.228 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 51.7 ttm -70.52 95.29 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.697 -0.683 . . . . 1.94 109.525 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.27 169.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.315 -0.402 . . . . 1.67 110.607 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.4 t70 71.35 -100.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.931 0.77 . . . . 2.18 109.983 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 45.55 32.58 1.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.489 . . . . 2.64 110.833 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.467 ' HE1' ' CA ' ' A' ' 106' ' ' GLU . 78.6 t90 -115.23 137.11 52.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.992 -0.373 . . . . 5.31 109.992 -171.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 82.5 mtm180 -90.55 127.04 54.19 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.546 -0.297 . . . . 6.91 111.043 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 245' ' ' ARG . 34.8 Cg_exo -61.14 150.77 82.84 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.262 2.642 . . . . 3.72 113.363 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 30' ' ' PRO . . . -96.58 95.43 7.97 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.663 -0.698 . . . . 3.34 111.762 -176.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -56.92 157.33 11.06 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.699 . . . . 4.92 112.104 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.79 177.84 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.747 2.964 . . . . 4.01 113.488 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 252' ' ' ASN . 87.4 mt -63.68 -10.96 21.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.982 -1.008 . . . . 4.9 111.397 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -52.86 49.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.626 1.713 . . . . 5.68 115.626 168.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.556 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER 139.91 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.759 2.024 . . . . 5.11 113.193 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.474 ' CG ' ' H ' ' A' ' 254' ' ' GLN . 5.5 ttp180 97.37 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.186 -1.825 . . . . 6.74 110.839 156.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.474 ' H ' ' CG ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -157.95 162.1 38.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.874 -0.788 . . . . 3.08 108.874 -167.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 33' ' ' ILE . 9.5 mt -100.06 129.03 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.866 0.365 . . . . 3.06 110.667 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -81.95 152.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.426 -0.583 . . . . 3.01 109.426 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.73 166.27 14.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.278 -0.419 . . . . 1.99 110.975 -172.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 27.8 p -149.36 97.82 2.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.543 0.687 . . . . 2.47 110.724 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -132.53 104.93 6.93 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.151 -0.931 . . . . 5.03 108.728 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.599 -0.715 . . . . 4.82 109.96 -178.139 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 120.707 0.289 . . . . 17.73 110.342 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 m 59.1 55.92 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.862 -0.608 . . . . 15.49 110.799 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -98.6 118.02 34.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.962 -0.563 . . . . 16.29 110.629 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -144.85 130.14 18.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.694 -0.684 . . . . 14.68 110.364 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -138.39 137.2 37.05 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.026 -0.533 . . . . 15.53 110.174 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.54 -178.05 46.0 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.271 -0.731 . . . . 10.81 111.271 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -88.63 109.86 20.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.764 0.316 . . . . 11.61 110.723 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 12' ' ' GLY . . . 62.77 -172.76 9.95 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.88 -0.6 . . . . 9.0 113.961 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -88.22 128.77 35.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.471 -0.365 . . . . 10.04 110.344 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.6 m80 59.95 -85.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.62 -0.718 . . . . 11.67 112.261 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -108.09 -5.74 16.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.861 0.319 . . . . 11.18 111.861 -173.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.505 ' O ' ' HA3' ' A' ' 8' ' ' GLY . . . 148.15 -41.24 0.91 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 119.429 -1.367 . . . . 8.9 115.204 -178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -43.98 140.68 4.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.899 2.4 . . . . 8.2 114.24 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -71.64 5.47 2.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.401 -0.818 . . . . 10.62 112.791 -177.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -67.42 10.59 0.16 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.152 0.501 . . . . 10.41 111.442 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' GLU . 20.1 t-105 -73.26 -2.22 21.02 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.834 0.854 . . . . 9.19 110.244 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -58.32 -10.43 2.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.544 -0.753 . . . . 7.71 112.596 -168.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -74.32 -28.62 61.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.015 0.436 . . . . 10.03 110.732 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -84.92 -17.97 36.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.946 -0.57 . . . . 7.89 110.525 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.67 95.51 44.65 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.56 -0.746 . . . . 7.65 109.716 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 56.6 Cg_exo -51.71 -45.46 37.95 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.321 2.681 . . . . 8.15 112.985 -175.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -6.35 7.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.417 0.525 . . . . 6.15 112.417 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -80.64 -3.32 50.08 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.141 -0.35 . . . . 5.72 111.81 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -71.69 36.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.424 0.527 . . . . 8.17 112.424 176.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 23' ' ' ALA . . . -96.84 -175.63 35.14 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.747 -0.74 . . . . 5.05 111.339 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -114.69 113.25 24.07 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.52 -0.872 . . . . 7.09 109.017 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.576 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 5.2 tpp180 -152.33 -179.71 7.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.509 -0.477 . . . . 5.44 110.164 171.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.576 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 51.6 tt0 -34.14 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.668 1.187 . . . . 7.33 112.911 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 31' ' ' VAL . 53.3 m -104.04 169.35 7.39 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 107.995 -1.113 . . . . 4.35 107.995 173.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.39 28.92 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.405 0 C-N-CA 124.01 3.14 . . . . 4.96 115.165 171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.598 HG13 ' H ' ' A' ' 32' ' ' ASP . 11.3 t -95.22 -175.59 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.772 0.829 . . . . 5.07 108.89 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.598 ' H ' HG13 ' A' ' 31' ' ' VAL . 29.3 m-20 -116.23 141.11 48.58 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.009 -0.432 . . . . 3.14 110.943 -171.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' HB ' ' CG ' ' A' ' 248' ' ' GLN . 0.4 OUTLIER -96.2 144.27 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 2.71 110.875 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -114.86 111.08 20.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 2.82 109.907 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -10.87 57.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.267 0.469 . . . . 2.71 112.267 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -59.77 -26.73 65.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.884 0.373 . . . . 5.23 110.934 175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -81.63 -15.42 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 3.38 111.357 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -62.19 109.84 1.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.472 0.654 . . . . 1.76 112.742 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -107.23 120.61 42.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.748 -1.115 . . . . 4.05 109.405 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -85.12 130.68 34.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.762 -0.654 . . . . 4.9 109.805 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 43' ' ' SER . 16.4 t70 -110.33 125.63 30.57 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.375 -0.375 . . . . 2.27 110.727 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.08 -9.73 23.76 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.951 2.434 . . . . 2.45 113.831 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.5 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . 43.4 t -78.88 -26.36 43.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.305 -0.628 . . . . 4.62 109.305 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.64 125.89 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 5.15 109.663 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -118.68 133.38 23.6 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.441 -0.8 . . . . 4.21 110.568 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.73 123.66 6.14 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.008 2.472 . . . . 2.76 111.539 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.5 mt -59.19 144.39 46.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 2.93 111.523 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.8 t -93.49 114.42 26.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.014 -1.106 . . . . 2.46 108.014 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.76 133.11 64.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.987 -0.552 . . . . 2.17 111.85 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 20.0 m -120.54 90.88 3.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.912 -0.585 . . . . 1.87 109.601 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -108.42 -2.26 19.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.06 -0.518 . . . . 3.97 111.403 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.37 -30.29 63.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.044 0.449 . . . . 2.48 110.228 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 19.6 mt-30 -76.16 -21.77 56.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 2.54 110.435 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 77' ' ' ALA . . . -69.33 150.69 47.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.755 -0.657 . . . . 1.41 111.501 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.743 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 77.9 m -141.41 128.82 21.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.867 -0.606 . . . . 1.41 110.274 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 176' ' ' THR . 22.9 m -74.91 147.76 40.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 1.84 110.056 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.2 mt -115.04 -52.32 2.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.421 -0.354 . . . . 1.45 110.985 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -163.99 164.69 23.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 3.72 111.33 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 tt -126.6 139.18 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.64 -0.709 . . . . 1.35 109.548 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.4 tp -126.56 137.19 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 1.53 111.344 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -92.32 107.88 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.329 -0.989 . . . . 1.49 108.329 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -113.34 68.06 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.02 -0.672 . . . . 2.18 109.969 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.64 -57.26 0.08 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 113.961 -1.472 . . . . 2.0 115.097 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -107.97 -22.79 12.28 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.389 0.276 . . . . 4.11 111.436 -169.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.42 178.29 10.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.662 0.268 . . . . 1.78 110.466 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.437 ' CZ ' HD11 ' A' ' 228' ' ' LEU . 96.8 m-85 -111.04 143.46 41.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.367 -0.379 . . . . 3.48 110.168 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -122.08 108.51 13.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.637 -0.256 . . . . 1.99 110.816 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 22.0 t -94.92 112.07 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.528 -0.545 . . . . 1.75 109.528 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.2 132.16 39.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.018 0.437 . . . . 2.02 111.866 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -103.83 157.73 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 2.19 109.249 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.743 ' OD1' ' HB ' ' A' ' 55' ' ' THR . 1.6 p-10 -91.09 125.54 35.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.15 0.5 . . . . 1.33 109.846 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 6.9 t70 -152.96 63.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.464 0.649 . . . . 2.65 110.313 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -76.68 1.81 15.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.065 0.935 . . . . 2.01 109.088 167.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -163.72 140.28 6.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.55 -1.648 . . . . 2.35 106.55 -177.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.15 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.713 0.768 . . . . 1.92 112.801 -168.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 70.8 mmtt -101.16 -47.25 4.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.314 -0.857 . . . . 2.31 110.199 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -105.5 99.42 9.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.762 -0.654 . . . . 1.44 110.268 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.34 127.64 65.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.042 -0.526 . . . . 1.82 111.554 -171.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.2 tp -119.56 117.37 28.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 1.8 109.783 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -160.82 122.68 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.173 -0.306 . . . . 3.02 110.173 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.83 -179.52 16.51 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-O 119.587 -0.563 . . . . 1.44 112.315 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -34.87 -135.43 0.0 OUTLIER Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.43 0.932 . . . . 2.15 115.43 166.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.69 167.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 123.365 2.71 . . . . 3.17 113.802 -172.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.4 pt? -33.51 82.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.622 1.341 . . . . 4.55 114.622 -146.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 21.7 p-10 -81.67 -77.3 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.437 -1.71 . . . . 4.95 112.543 175.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.22 131.93 0.81 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.723 -1.351 . . . . 2.25 109.723 -165.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.7 m -73.6 115.54 13.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.086 0.943 . . . . 2.12 111.769 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.6 m-85 -104.85 145.84 29.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.659 -0.7 . . . . 3.88 109.74 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.545 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 80.2 mtm180 -107.72 138.31 44.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.551 0.215 . . . . 3.87 110.777 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 tt -88.73 112.45 23.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.921 -0.77 . . . . 1.68 108.921 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.554 HD12 ' CE3' ' A' ' 123' ' ' TRP . 54.7 mt -125.54 -23.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.518 -0.473 . . . . 2.16 111.567 -174.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.1 pt20 -156.49 159.56 38.73 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.101 -0.374 . . . . 1.95 110.715 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.536 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 31.9 p90 -150.82 164.23 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.98 110.285 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.529 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 4.2 p-80 -137.98 158.53 44.13 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.656 0.597 . . . . 1.07 110.58 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -136.0 168.83 18.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.954 -0.387 . . . . 3.99 109.954 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -165.43 146.31 7.15 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.951 -0.389 . . . . 2.2 109.951 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.465 ' CZ3' ' HB2' ' A' ' 226' ' ' ARG . 83.1 t90 -140.22 147.97 40.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.233 -0.44 . . . . 6.08 109.833 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 84.76 165.61 40.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.682 -0.771 . . . . 2.19 113.164 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . 40.5 t 160.58 -89.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.115 0.966 . . . . 3.08 108.551 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.52 -156.55 0.55 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.983 -0.553 . . . . 3.48 110.027 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.79 -42.06 62.15 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.491 0.495 . . . . 3.85 111.361 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.28 46.63 0.56 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.351 -0.7 . . . . 2.37 111.351 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 104' ' ' GLY . 4.6 tt0 -116.74 -174.87 2.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.026 -0.731 . . . . 2.62 109.026 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 103' ' ' GLN . . . 131.39 -25.21 4.08 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.397 -0.906 . . . . 1.62 112.737 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 62.4 p -67.34 -36.58 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.68 0.622 . . . . 2.24 112.68 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 245' ' ' ARG . 34.5 tt0 82.41 174.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.282 -1.377 . . . . 3.72 107.282 -166.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.528 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 98.2 m-70 55.66 58.86 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 4.03 111.605 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -82.26 122.2 27.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.249 0.547 . . . . 2.99 110.311 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 23.1 t -89.04 91.84 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.764 -0.653 . . . . 2.88 109.682 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.472 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 27.2 t70 64.84 -70.14 0.09 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.015 0.822 . . . . 2.8 110.65 -174.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.472 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 0.3 OUTLIER -142.21 11.81 1.97 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.013 -0.539 . . . . 5.35 111.094 174.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 40.1 ttmt -81.19 84.9 6.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.068 0.461 . . . . 3.58 109.795 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 17.6 pttp -110.87 132.97 53.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 3.26 110.82 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -107.07 167.42 9.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.471 -0.331 . . . . 1.71 110.307 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB1' ' NE1' ' A' ' 97' ' ' TRP . . . -65.16 -36.14 83.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.373 -0.376 . . . . 1.57 111.885 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.87 165.48 35.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.637 0.256 . . . . 1.3 110.998 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -146.67 141.88 27.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.068 -0.716 . . . . 1.85 109.068 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 93' ' ' PHE . 48.7 tp -101.57 116.41 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.936 -0.574 . . . . 1.61 109.496 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.529 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 18.8 m170 -107.42 105.44 15.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 2.25 110.69 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.536 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.7 mp -94.18 125.72 38.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.861 -0.609 . . . . 1.51 110.461 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -92.41 137.51 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 1.24 110.43 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 36.3 m80 -131.64 140.44 49.37 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.133 -0.692 . . . . 2.86 109.133 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.554 ' CE3' HD12 ' A' ' 91' ' ' ILE . 47.1 m0 -110.44 129.99 55.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.121 0.263 . . . . 4.96 110.492 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -63.21 114.72 3.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.084 0.469 . . . . 2.3 110.748 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -80.5 -26.79 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.842 -0.617 . . . . 2.77 111.642 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -59.1 -24.45 62.96 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.753 0.279 . . . . 3.79 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -91.06 9.77 29.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.323 0.583 . . . . 3.34 110.721 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . 67.72 -4.09 4.46 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.221 -0.899 . . . . 2.37 115.333 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 21.8 t70 175.21 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.131 0.966 . . . . 3.93 109.936 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.432 ' O ' HG11 ' A' ' 134' ' ' VAL . 35.4 p90 -58.08 -34.94 70.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.036 -0.529 . . . . 3.6 111.053 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.54 -38.73 88.82 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.201 -0.523 . . . . 2.35 112.706 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 8.9 mmpt? -78.39 -37.32 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.131 0.491 . . . . 3.75 109.98 175.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.595 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -64.88 -34.36 78.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.365 -0.834 . . . . 2.17 112.312 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 130' ' ' PHE . 27.9 m -67.94 -9.18 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.848 0.314 . . . . 3.11 111.848 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -93.06 -6.16 48.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.26 0.552 . . . . 3.55 110.309 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.518 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 5.9 tt0 -107.29 131.63 21.56 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 3.02 109.317 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 50.9 Cg_exo -55.03 -22.07 29.54 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.968 2.445 . . . . 1.93 112.879 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.518 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.9 m-20 -111.56 28.6 8.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 2.29 110.605 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -80.85 -40.29 12.25 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.086 -0.578 . . . . 1.5 114.524 -173.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.94 158.38 18.28 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.218 -0.578 . . . . 1.98 109.95 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -143.67 117.84 9.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.855 0.36 . . . . 1.83 110.716 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.75 121.38 61.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.141 -0.482 . . . . 2.28 110.06 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 209' ' ' ILE . 60.9 tp -93.83 119.42 32.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.486 -0.561 . . . . 2.89 109.486 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.75 111.35 3.76 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.977 -0.63 . . . . 0.95 112.615 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.7 mt -110.96 107.57 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 110.221 -0.288 . . . . 1.38 110.221 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 96.8 m-85 -63.15 149.46 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.37 111.323 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mp -113.83 131.26 56.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.589 . . . . 1.48 110.121 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 216' ' ' SER . 17.4 ptpt -122.16 136.82 54.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.562 -0.532 . . . . 2.52 109.562 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 3.6 m -99.82 79.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.313 0.577 . . . . 1.88 112.262 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.583 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -157.89 60.05 0.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.684 -0.77 . . . . 1.53 112.024 168.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.583 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 7.7 t 158.78 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.64 -1.244 . . . . 2.08 107.64 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -76.43 139.07 40.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.815 0.34 . . . . 1.36 110.739 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 216' ' ' SER . 16.9 tptm -110.62 96.62 28.83 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.14 -0.482 . . . . 1.78 109.968 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.42 -36.18 97.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.971 2.448 . . . . 1.34 112.453 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.55 -6.68 66.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.196 -0.526 . . . . 0.75 113.597 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.1 tp -90.06 -21.18 22.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.773 0.787 . . . . 1.39 110.743 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.409 ' HA ' ' HB ' ' A' ' 160' ' ' VAL . 7.9 tp-100 -57.28 -34.77 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 1.63 111.648 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -47.37 -50.6 21.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.296 0.48 . . . . 3.26 112.296 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -81.05 -30.07 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.703 -0.399 . . . . 1.97 110.814 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.582 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 82.1 t -63.83 -35.62 73.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.2 0.524 . . . . 1.64 111.204 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.88 -22.51 60.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.293 -0.412 . . . . 1.22 111.516 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.55 -13.89 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.372 0.508 . . . . 2.07 112.372 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.589 HD11 ' N ' ' A' ' 164' ' ' ASP . 3.9 pp -60.13 -27.51 67.12 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.912 0.708 . . . . 1.95 112.912 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.589 ' N ' HD11 ' A' ' 163' ' ' LEU . 14.7 t70 -70.97 -25.03 62.54 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.954 -0.466 . . . . 2.31 110.664 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.3 m -76.69 -3.52 38.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.063 0.459 . . . . 1.78 111.136 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.2 pt -137.36 36.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.341 -0.615 . . . . 1.42 109.341 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -74.85 -25.36 58.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.665 -0.698 . . . . 1.98 111.255 -171.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 231' ' ' ASN . 0.1 OUTLIER -119.54 148.55 43.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.936 0.398 . . . . 1.4 111.139 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -55.09 126.08 23.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 2.84 112.017 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.93 -16.51 36.26 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.69 -0.767 . . . . 0.85 112.077 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -88.69 152.74 21.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.321 0.581 . . . . 2.22 110.796 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 t -143.78 159.19 42.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.466 -0.788 . . . . 1.93 109.078 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.96 130.86 20.39 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.855 -0.424 . . . . 1.17 109.855 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.28 132.94 55.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.369 -0.604 . . . . 1.8 109.369 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -140.69 77.94 1.63 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.019 -1.104 . . . . 1.31 108.019 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 56' ' ' SER . 4.9 m -106.73 156.98 18.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 1.69 111.757 -173.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.16 60.28 2.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.916 0.886 . . . . 2.26 112.254 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -131.58 130.46 42.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.649 -1.159 . . . . 4.84 108.829 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.46 140.75 21.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.01 0.433 . . . . 2.51 111.462 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.84 -6.52 14.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.918 2.412 . . . . 1.47 111.617 172.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -58.65 -42.41 88.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.305 -0.861 . . . . 3.16 111.568 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.06 -15.29 69.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.953 -0.641 . . . . 1.12 112.995 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.45 -10.58 48.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.502 0.192 . . . . 2.37 111.45 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.11 141.35 40.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.83 0.348 . . . . 3.87 111.018 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.87 -175.58 2.83 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.915 2.41 . . . . 2.51 112.722 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.64 -59.94 2.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.337 -0.392 . . . . 3.23 111.044 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 m -83.8 137.35 33.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 2.03 111.264 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.1 tp -109.18 64.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.352 0.596 . . . . 2.5 110.351 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 211' ' ' LEU . 19.1 m-20 -108.01 166.16 10.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.807 -0.812 . . . . 1.81 108.807 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -164.89 163.89 20.94 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.156 -0.618 . . . . 5.32 112.224 -167.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.34 130.99 55.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.05 -0.977 . . . . 4.55 108.375 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.2 p -95.32 106.22 18.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 2.39 111.393 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.432 ' OH ' ' HB2' ' A' ' 28' ' ' GLN . 54.1 t80 -135.99 125.43 16.02 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 5.32 111.882 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.38 132.55 5.15 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.694 2.263 . . . . 2.47 112.531 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -110.42 157.14 15.19 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.959 -0.564 . . . . 2.0 112.006 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 60.1 m -132.82 -160.62 1.06 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.595 -0.356 . . . . 3.36 111.206 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 1.8 pp -71.93 6.68 1.94 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.51 0.93 . . . . 5.18 113.51 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 27' ' ' ARG . 76.4 p -86.71 21.13 2.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.269 0.557 . . . . 5.53 110.532 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 18.3 p -125.32 179.74 1.07 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.879 -0.786 . . . . 5.89 108.879 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 199' ' ' THR . 2.8 Cg_exo -33.77 -51.56 0.53 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.512 2.808 . . . . 6.31 114.364 171.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 203' ' ' LEU . 95.6 Cg_endo -82.59 126.91 4.82 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.475 1.45 . . . . 5.26 112.264 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.82 23.07 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 4.29 111.517 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 201' ' ' PRO . 95.7 mt -118.29 132.72 56.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.241 -0.436 . . . . 3.51 110.171 175.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 8.1 pt-20 -80.51 65.29 5.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.193 0.521 . . . . 3.37 110.989 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.4 p -128.53 13.9 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.44 0.904 . . . . 2.47 113.44 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.18 138.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.43 0.633 . . . . 1.74 112.181 -171.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 24.6 m -111.28 113.43 25.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.277 -1.009 . . . . 2.3 108.277 168.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -97.47 113.89 25.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.271 0.558 . . . . 6.37 110.331 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.468 ' O ' HD13 ' A' ' 143' ' ' LEU . 48.7 mm -103.49 102.99 14.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.587 -0.733 . . . . 2.32 109.277 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.06 125.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.412 -0.588 . . . . 2.1 109.412 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 189' ' ' ASP . 15.8 tp -80.09 116.85 20.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.058 -0.349 . . . . 2.35 110.058 -176.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -61.82 -33.38 74.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.95 -0.568 . . . . 3.47 110.401 -177.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -95.75 103.07 11.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 1.56 110.165 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 14.7 Cg_exo -71.23 171.58 15.74 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.725 2.283 . . . . 1.37 112.135 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.9 pt -112.44 149.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.566 . . . . 1.85 109.945 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 5.5 p -105.18 132.2 51.69 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.03 -0.532 . . . . 1.78 110.641 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 26.9 m -128.47 165.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.976 -0.556 . . . . 1.64 110.181 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 21.0 t -94.34 153.0 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.669 -0.241 . . . . 1.52 110.682 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.554 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 17.1 p -54.54 -48.14 72.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.49 0.186 . . . . 1.81 111.272 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -54.79 -29.41 54.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.392 -0.367 . . . . 2.51 111.63 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.88 -45.91 33.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.064 -0.516 . . . . 1.02 110.362 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.562 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 34.7 m -78.56 -21.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 1.88 111.91 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 219' ' ' SER . 77.1 mt -65.06 -31.62 72.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.411 . . . . 1.59 110.489 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -74.61 -22.02 59.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.125 -0.489 . . . . 2.3 110.78 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.4 m-85 -77.48 -27.37 51.95 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.6 -0.889 . . . . 3.18 108.6 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.465 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 67.0 ttt180 -72.32 -20.06 61.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.535 -1.211 . . . . 3.55 110.651 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.16 -6.7 34.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 2.74 111.313 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.437 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 93.2 mt -65.22 154.78 37.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.916 0.389 . . . . 1.66 110.647 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -116.71 134.71 54.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.312 0.577 . . . . 1.13 110.713 -175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -78.72 -35.68 44.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.868 -1.06 . . . . 4.38 109.774 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.414 ' O ' HG22 ' A' ' 168' ' ' THR . 4.3 p-10 -72.64 169.35 16.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.049 -0.978 . . . . 1.62 111.888 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.01 177.25 38.19 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.303 -0.862 . . . . 1.16 111.177 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.37 125.37 25.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 3.56 110.487 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.14 7.74 42.99 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.728 -0.669 . . . . 2.23 113.397 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 44.3 mt-10 -112.32 157.54 39.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 117.393 0.597 . . . . 2.59 109.67 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.66 125.33 18.38 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.289 1.992 . . . . 1.5 110.613 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.43 118.48 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.84 0.829 . . . . 3.4 112.564 -171.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.99 116.37 31.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.583 -1.19 . . . . 2.47 107.901 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.97 125.14 25.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.063 0.459 . . . . 2.6 110.584 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 60.7 ttm -78.94 89.78 4.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 1.94 110.59 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.01 167.6 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.766 -0.827 . . . . 1.67 108.766 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 19.5 t70 66.48 -88.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.764 0.665 . . . . 2.18 110.056 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 63.09 -11.26 0.09 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.354 0.872 . . . . 2.64 113.354 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.44 ' CZ3' ' HG3' ' A' ' 200' ' ' PRO . 98.0 m95 -153.77 175.11 13.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.142 -0.688 . . . . 5.31 109.142 -169.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 106' ' ' GLU . 39.0 mtp85 -129.39 147.54 65.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.212 -0.292 . . . . 6.91 110.212 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.99 82.48 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.748 2.298 . . . . 3.72 111.561 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.445 ' HB2' HE21 ' A' ' 28' ' ' GLN . . . -98.78 118.18 34.94 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.049 -0.523 . . . . 3.34 111.315 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.502 ' CG ' ' HB ' ' A' ' 33' ' ' ILE . 16.2 mm-40 -124.16 156.31 66.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 4.92 109.465 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 1.1 Cg_endo -43.18 129.54 6.03 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.404 2.736 . . . . 4.01 113.095 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -43.45 -57.21 3.19 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 124.121 0.888 . . . . 4.9 112.231 -171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 54.6 pttt -106.34 0.2 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.554 0.216 . . . . 5.68 111.422 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER 75.89 -47.97 0.58 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.601 0.761 . . . . 5.11 111.465 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 70.64 -108.81 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.607 -0.886 . . . . 6.74 108.607 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -140.93 136.75 32.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.231 -1.396 . . . . 3.08 107.231 165.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 75.6 mt -84.6 121.85 37.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.302 -0.559 . . . . 3.06 109.671 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.35 134.85 42.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.899 -0.778 . . . . 3.01 108.899 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.25 172.9 12.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.257 -0.429 . . . . 1.99 110.019 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.7 m -128.33 94.69 3.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.292 -0.563 . . . . 2.47 110.968 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -146.37 126.66 13.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.733 -0.839 . . . . 5.03 108.733 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 18.8 pttp . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.244 -0.884 . . . . 4.82 110.336 -179.42 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptm . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.707 0.289 . . . . 17.73 110.333 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -77.91 -24.54 48.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.356 0.598 . . . . 15.49 109.652 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -109.61 117.23 33.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.427 -0.806 . . . . 16.29 109.351 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -89.32 -8.15 53.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.386 -0.598 . . . . 14.68 109.386 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 70.12 -67.28 0.24 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.951 -1.022 . . . . 15.53 110.727 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' A' ' 12' ' ' GLY . . . -119.23 128.84 7.8 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.658 -0.782 . . . . 10.81 111.503 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.479 ' CE2' ' HG3' ' A' ' 245' ' ' ARG . 55.3 m-85 -81.13 103.03 10.65 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.608 0.718 . . . . 11.61 110.776 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.04 -84.83 0.19 Allowed Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.658 -1.155 . . . . 9.0 110.33 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 13' ' ' PRO . 67.2 mttm -92.57 147.86 22.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.894 -0.78 . . . . 10.04 108.894 170.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -62.55 -24.17 67.39 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.043 0.386 . . . . 11.67 112.043 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -104.03 -2.25 26.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.394 0.616 . . . . 11.18 110.509 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 6' ' ' GLY . . . 95.31 120.47 3.53 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.674 -0.774 . . . . 8.9 111.333 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.434 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 68.5 Cg_endo -74.92 122.49 7.28 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.852 1.701 . . . . 8.2 112.933 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -92.28 -19.1 22.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.351 -0.84 . . . . 10.62 110.753 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -114.37 22.94 13.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 10.41 111.072 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.401 ' CD1' HD22 ' A' ' 202' ' ' LEU . 25.1 t-105 -66.8 -22.66 66.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.597 0.713 . . . . 9.19 109.748 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.535 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 30.6 p-80 -64.15 -9.82 19.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.542 -0.754 . . . . 7.71 111.762 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -78.23 -11.84 59.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.667 0.27 . . . . 10.03 111.353 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -123.66 -17.73 6.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 7.89 110.054 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 13.3 m-85 -140.55 89.77 10.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.08 -0.509 . . . . 7.65 109.646 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 74.9 Cg_exo -51.2 -35.11 51.24 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.121 2.548 . . . . 8.15 113.145 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.9 pt -57.65 -2.65 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 113.845 1.054 . . . . 6.15 113.845 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.14 -17.04 64.68 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.18 -0.325 . . . . 5.72 110.53 172.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 21' ' ' PRO . 61.7 mttp -45.1 -21.28 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.109 0.781 . . . . 8.17 113.109 169.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.95 -161.98 36.52 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.788 -0.925 . . . . 5.05 110.788 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -116.55 104.54 11.51 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 118.058 -1.457 . . . . 7.09 109.366 172.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 27' ' ' ARG . 5.3 ttm180 -165.73 129.77 2.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 118.305 -0.855 . . . . 5.44 108.813 164.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -111.47 -52.52 2.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 120.861 1.664 . . . . 7.33 111.423 159.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 m -100.52 162.38 20.98 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 110.125 -0.324 . . . . 4.35 110.125 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD3' ' OG1' ' A' ' 199' ' ' THR . 88.3 Cg_endo -99.4 -2.92 0.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.786 2.324 . . . . 4.96 114.579 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 247' ' ' ALA . 4.1 p -160.09 140.08 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 114.585 1.328 . . . . 5.07 114.585 -174.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -164.53 117.07 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.067 -1.457 . . . . 3.14 107.067 158.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 55.5 mt -93.96 90.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.237 0.541 . . . . 2.71 111.116 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -77.15 106.23 8.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.604 -0.726 . . . . 2.82 109.849 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -40.61 30.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.402 -0.817 . . . . 2.71 112.777 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -70.48 -33.75 71.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 5.23 110.885 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 m -89.34 -30.26 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.459 -0.337 . . . . 3.38 111.252 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.87 89.93 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.043 0.449 . . . . 1.76 112.035 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -97.97 138.75 34.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.944 -0.571 . . . . 4.05 110.145 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.761 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 48.0 p90 -84.26 123.4 30.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.928 0.394 . . . . 4.9 110.65 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.97 139.0 23.07 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.32 -0.4 . . . . 2.27 110.076 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -90.17 22.82 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.812 2.341 . . . . 2.45 112.324 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 m -89.35 -18.8 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 4.62 110.65 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.444 HD21 ' OG ' ' A' ' 258' ' ' SER . 3.4 pp -97.55 156.91 16.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 5.15 110.255 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -99.03 144.22 27.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.432 -0.349 . . . . 4.21 110.954 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 31.1 Cg_endo -64.37 165.35 20.23 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.128 2.552 . . . . 2.76 112.184 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.6 146.23 24.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 2.93 111.743 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -110.61 107.15 16.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.678 -0.86 . . . . 2.46 108.678 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -90.76 102.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.411 -0.359 . . . . 2.17 110.873 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -119.26 89.47 3.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.119 0.485 . . . . 1.87 110.423 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.06 21.71 1.58 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.54 0.686 . . . . 3.97 110.423 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.31 -17.92 64.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.38 -0.827 . . . . 2.48 110.021 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.02 -5.02 38.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.729 -0.669 . . . . 2.54 109.811 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.61 158.76 35.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.707 -0.678 . . . . 1.41 111.838 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -150.16 143.38 25.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.199 -0.91 . . . . 1.41 109.076 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 176' ' ' THR . 14.5 m -91.1 165.37 13.54 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.14 -0.689 . . . . 1.84 109.14 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -119.36 -50.34 2.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.018 0.437 . . . . 1.45 111.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -157.9 152.58 25.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.256 -0.429 . . . . 3.72 111.072 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.475 HG12 HD11 ' A' ' 166' ' ' ILE . 14.6 tt -115.55 138.48 45.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.034 -0.728 . . . . 1.35 109.034 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.2 tp -135.82 141.17 44.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.207 0.527 . . . . 1.53 112.229 -170.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -100.16 105.6 17.22 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.797 -1.186 . . . . 1.49 107.797 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -138.56 73.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.158 0.504 . . . . 2.18 112.09 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.59 -52.71 0.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.838 -1.173 . . . . 2.0 111.997 161.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -147.41 -51.24 0.19 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.98 0.419 . . . . 4.11 110.094 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.58 169.77 8.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 1.78 111.491 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CZ ' HD11 ' A' ' 228' ' ' LEU . 34.4 m-85 -110.24 100.25 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.502 -0.772 . . . . 3.48 109.247 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -89.33 118.58 29.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 1.99 111.622 -170.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.454 HG23 HG13 ' A' ' 59' ' ' ILE . 21.3 t -100.71 114.07 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.65 -0.5 . . . . 1.75 109.65 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -80.26 138.77 36.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.038 0.385 . . . . 2.02 112.038 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.453 ' CE2' ' HD1' ' A' ' 93' ' ' PHE . 65.9 m-85 -105.32 163.32 12.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.691 -0.686 . . . . 2.19 109.747 170.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.58 113.53 25.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.894 -0.41 . . . . 1.33 109.894 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -124.55 57.87 1.24 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.868 0.842 . . . . 2.65 111.034 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -87.71 -9.26 54.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.082 0.944 . . . . 2.01 108.926 167.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.25 171.3 19.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.445 -1.252 . . . . 2.35 108.057 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.28 73.15 2.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.38 0.609 . . . . 1.92 110.857 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -92.35 -56.48 3.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.815 . . . . 2.31 109.67 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.21 101.71 11.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.719 -0.673 . . . . 1.44 109.722 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.31 135.23 63.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.191 0.52 . . . . 1.82 110.746 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 tp -140.07 110.56 6.69 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.342 -0.985 . . . . 1.8 108.342 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -148.89 125.62 11.13 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.006 -0.678 . . . . 3.02 112.683 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . -66.22 173.86 23.18 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.354 -0.839 . . . . 1.44 111.663 159.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 84' ' ' LEU . . . -41.83 -143.93 0.0 OUTLIER Glycine 0 CA--C 1.538 1.485 0 N-CA-C 114.996 0.758 . . . . 2.15 114.996 169.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.88 122.69 9.45 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.955 1.77 . . . . 3.17 112.447 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 82' ' ' GLY . 82.1 mt -138.77 -168.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.899 -1.046 . . . . 4.55 110.216 -174.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.64 57.17 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.022 0.379 . . . . 4.95 112.022 -167.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.51 -116.94 2.26 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.024 -1.084 . . . . 2.25 113.995 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 m -127.36 111.78 14.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.65 -0.5 . . . . 2.12 109.65 -171.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.71 ' HA ' ' CD2' ' A' ' 122' ' ' HIS . 9.8 m-85 -99.03 91.12 4.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.518 0.675 . . . . 3.88 112.3 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.57 146.77 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.016 -0.993 . . . . 3.87 109.532 172.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.4 tp -89.61 130.33 35.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.633 -0.506 . . . . 1.68 109.633 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.5 tt -106.31 -32.78 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.677 0.275 . . . . 2.16 111.481 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.437 ' HG2' HG23 ' A' ' 91' ' ' ILE . 3.8 pt20 -163.04 171.95 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 1.95 110.352 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' HD1' ' CE2' ' A' ' 70' ' ' PHE . 26.8 p90 -144.41 146.98 32.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.98 109.347 169.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.414 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 5.2 p-80 -134.28 160.16 38.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.8 -0.444 . . . . 1.07 109.8 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.17 167.91 19.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.948 0.404 . . . . 3.99 110.95 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.13 167.78 29.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.93 -0.767 . . . . 2.2 108.93 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.4 ' CZ3' ' HA ' ' A' ' 226' ' ' ARG . 82.0 t90 -151.2 151.11 31.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.15 0.282 . . . . 6.08 110.245 -170.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.547 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -113.37 159.71 13.53 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.838 -0.696 . . . . 2.19 112.164 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 -39.76 79.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.869 0.366 . . . . 3.08 111.857 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 102' ' ' GLY . 87.1 mt -111.27 146.02 37.75 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.809 -0.812 . . . . 3.48 108.809 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.26 12.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.684 0.624 . . . . 3.85 112.684 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 100' ' ' LEU . . . -118.66 17.83 10.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 2.37 111.97 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.433 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 14.0 pt20 -158.15 159.51 36.24 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.115 -0.328 . . . . 2.62 110.115 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.46 6.74 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 1.62 112.246 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.4 t -69.41 -45.81 68.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.748 0.309 . . . . 2.24 111.069 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.585 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 2.6 tp10 65.05 -162.64 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.528 -0.76 . . . . 3.72 109.093 -169.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.585 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 33.7 m80 53.27 49.28 20.19 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.171 0.986 . . . . 4.03 108.53 -167.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 112' ' ' LYS . 13.0 t -79.72 131.58 35.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.815 -1.539 . . . . 2.99 112.171 -168.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 28.4 t -98.98 107.55 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 114.359 -1.291 . . . . 2.88 109.633 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.36 42.95 20.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.56 0.695 . . . . 2.8 110.096 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm 61.15 20.71 11.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.887 -1.051 . . . . 5.35 112.497 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' C ' ' HG1' ' A' ' 108' ' ' THR . 51.5 tttp -94.01 112.34 24.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.59 -0.522 . . . . 3.58 109.59 169.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 50.7 mttp -98.55 168.03 10.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.18 0.514 . . . . 3.26 111.174 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -119.53 176.55 5.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.3 -0.863 . . . . 1.71 109.453 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.91 94.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.1 0.407 . . . . 1.57 112.1 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.8 168.5 25.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.267 -0.424 . . . . 1.3 109.961 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -142.52 140.37 31.8 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.599 -0.519 . . . . 1.85 109.599 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.421 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 36.8 tp -103.3 125.75 50.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.323 -0.621 . . . . 1.61 109.323 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 12.3 m170 -118.76 109.93 16.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.1 0.476 . . . . 2.25 112.1 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 120' ' ' LEU . 5.0 mp -94.33 116.43 28.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.701 -0.681 . . . . 1.51 109.484 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.3 124.24 48.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.105 0.478 . . . . 1.24 112.013 -171.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.71 ' CD2' ' HA ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -89.62 140.96 29.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 2.86 111.005 175.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -112.64 141.53 46.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 4.96 109.542 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -93.22 96.01 9.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 2.3 110.927 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.9 m -68.01 -16.94 64.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.934 -0.576 . . . . 2.77 111.251 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -52.63 -33.12 45.22 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.71 0.404 . . . . 3.79 111.804 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -107.85 -6.51 16.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.367 0.603 . . . . 3.34 110.484 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.52 38.55 9.5 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.232 -1.349 . . . . 2.37 113.785 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.556 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 22.8 t70 -166.31 110.48 0.79 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.634 -0.506 . . . . 3.93 109.634 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -57.26 -32.94 67.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 3.6 111.19 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.15 81.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.056 -0.593 . . . . 2.35 112.761 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.556 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 38.0 mmtm -88.29 -28.8 20.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 3.75 110.375 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.475 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -63.91 -36.28 83.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.021 -0.536 . . . . 2.17 110.685 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.488 ' O ' HD23 ' A' ' 203' ' ' LEU . 34.9 m -77.99 -2.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.372 -0.376 . . . . 3.11 111.236 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -109.01 19.23 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.278 0.561 . . . . 3.55 110.449 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -129.02 128.3 23.38 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.269 -1.011 . . . . 3.02 108.269 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.88 -31.59 73.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.097 2.532 . . . . 1.93 113.2 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -111.13 24.26 13.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 2.29 109.997 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -66.01 -50.23 53.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.016 -0.538 . . . . 1.5 112.497 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 79.4 mt -109.28 151.98 25.83 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.418 -0.586 . . . . 1.98 109.418 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -145.99 123.91 12.02 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.748 -0.834 . . . . 1.83 108.748 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.55 116.83 53.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.879 -0.328 . . . . 2.28 110.899 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 38.0 tp -83.38 115.69 22.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.668 -0.696 . . . . 2.89 109.696 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -106.16 128.88 9.52 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.038 -0.601 . . . . 0.95 112.623 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.7 122.61 70.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.387 -0.597 . . . . 1.38 109.387 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -69.75 146.39 51.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 1.37 110.301 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.34 130.46 56.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.413 -0.358 . . . . 1.48 110.149 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 216' ' ' SER . 26.2 pttm -125.32 151.59 45.84 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.457 -0.571 . . . . 2.52 109.457 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 40.7 t -84.84 121.42 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.094 0.473 . . . . 1.88 110.62 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.48 -114.72 0.33 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.504 -0.771 . . . . 1.53 111.201 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.3 p -74.01 156.3 37.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.206 -0.294 . . . . 2.08 110.206 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.22 148.88 37.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.808 0.337 . . . . 1.36 111.04 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 216' ' ' SER . 46.3 tptt -113.68 100.04 51.2 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.29 -0.414 . . . . 1.78 110.033 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.32 -31.33 73.42 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.663 2.242 . . . . 1.34 112.543 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.94 -19.34 71.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.063 -0.589 . . . . 0.75 112.979 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.478 ' O ' HG22 ' A' ' 160' ' ' VAL . 37.0 tp -112.07 -12.04 13.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.054 0.454 . . . . 1.39 110.792 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -40.52 79.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.909 -0.587 . . . . 1.63 111.142 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.98 -26.86 62.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.972 0.415 . . . . 3.26 110.314 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 162' ' ' VAL . 59.0 t -72.3 -44.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 1.97 109.504 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 41.6 t -62.58 -34.31 64.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.691 . . . . 1.64 110.361 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.2 -28.74 68.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.443 -0.798 . . . . 1.22 111.562 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 159' ' ' VAL . 8.8 p -97.73 -14.57 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.794 -0.363 . . . . 2.07 111.883 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.4 pp -70.75 -20.42 62.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.618 -0.433 . . . . 1.95 111.891 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 30.7 t70 -67.39 -24.42 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.235 0.54 . . . . 2.31 110.398 176.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.0 m -79.81 1.16 27.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 1.78 111.229 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.475 HD11 HG12 ' A' ' 59' ' ' ILE . 40.5 pt -137.28 37.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.779 -0.823 . . . . 1.42 108.779 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 87.1 tttt -58.45 -32.01 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.861 -1.063 . . . . 1.98 111.854 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -119.92 154.17 34.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.31 -0.404 . . . . 1.4 110.485 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.46 135.37 57.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 2.84 110.663 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.7 38.18 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.71 -0.757 . . . . 0.85 111.715 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -89.77 143.47 26.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 2.22 110.711 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.3 p -139.88 156.59 46.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.033 -0.53 . . . . 1.93 109.659 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.6 140.37 40.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.118 -0.327 . . . . 1.17 110.118 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.92 130.8 44.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.553 -0.536 . . . . 1.8 109.553 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.38 79.79 1.68 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.797 -0.446 . . . . 1.31 109.797 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' SER . 21.7 p -106.76 164.98 11.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 1.69 111.148 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 56.65 71.32 0.58 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.432 0.457 . . . . 2.26 111.255 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 55.1 t80 -123.59 142.37 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.754 0.311 . . . . 4.84 110.293 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.47 102.3 14.11 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.823 -0.626 . . . . 2.51 110.061 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 2.9 Cg_exo -75.83 -19.83 15.82 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.637 2.224 . . . . 1.47 111.688 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -56.6 -38.55 72.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.287 -0.87 . . . . 3.16 111.663 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.08 6.94 2.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.125 -0.489 . . . . 1.12 113.863 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.57 -13.61 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.272 0.536 . . . . 2.37 110.352 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.3 130.43 87.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.591 . . . . 3.87 111.356 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.62 -171.95 1.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.443 2.095 . . . . 2.51 111.384 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.91 -62.37 1.67 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.936 0.398 . . . . 3.23 110.203 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.4 m -75.06 123.1 24.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 2.03 110.936 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.3 tp -101.52 64.1 0.98 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.625 0.726 . . . . 2.5 109.47 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.593 ' HB3' ' O ' ' A' ' 258' ' ' SER . 12.3 m-20 -124.91 147.64 48.73 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.398 -0.964 . . . . 1.81 108.398 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 53.1 p90 -144.43 158.71 43.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.562 0.949 . . . . 5.32 113.562 -166.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -93.02 140.08 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.42 -1.326 . . . . 4.55 107.42 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 9.3 t -136.57 116.72 13.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.713 0.688 . . . . 2.39 112.684 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -140.31 132.38 14.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 5.32 110.632 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.18 125.4 10.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.598 1.532 . . . . 2.47 110.575 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.34 160.13 26.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.035 -0.602 . . . . 2.0 113.249 -168.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.664 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 14.0 m -63.4 152.83 37.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.65 -0.5 . . . . 3.36 109.65 173.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.414 ' H ' HD11 ' A' ' 197' ' ' LEU . 5.7 mp -61.99 -50.86 70.37 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.18 -0.608 . . . . 5.18 112.055 -169.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.474 ' OG1' ' HD2' ' A' ' 200' ' ' PRO . 23.5 p -122.47 -44.93 2.22 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.0 -0.28 . . . . 5.53 111.54 175.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.512 ' HB ' ' HD3' ' A' ' 200' ' ' PRO . 1.9 m 157.71 -57.34 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 125.579 1.552 . . . . 5.89 109.118 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.512 ' HD3' ' HB ' ' A' ' 199' ' ' THR . 53.4 Cg_exo -51.09 -43.55 47.55 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.326 2.018 . . . . 6.31 113.948 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.578 ' O ' ' HB3' ' A' ' 196' ' ' SER . 3.0 Cg_endo -83.37 109.11 1.58 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.034 1.823 . . . . 5.26 111.144 172.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.401 HD22 ' CD1' ' A' ' 16' ' ' TRP . 1.8 mm? -78.58 50.42 0.96 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.439 0.638 . . . . 4.29 110.29 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 196' ' ' SER . 30.9 tp -116.18 120.34 38.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.359 -0.837 . . . . 3.51 108.905 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -98.89 51.55 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.381 0.61 . . . . 3.37 110.897 -171.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.7 p -91.89 -5.72 52.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.926 -0.579 . . . . 2.47 110.859 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 133.18 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.064 0.459 . . . . 1.74 110.575 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 21.7 m -105.91 103.51 13.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.126 -0.694 . . . . 2.3 109.126 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.577 ' O ' ' HA ' ' A' ' 192' ' ' THR . 96.3 m95 -76.16 110.39 10.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.301 -0.409 . . . . 6.37 110.43 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 74.3 mt -115.38 101.18 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.201 -0.666 . . . . 2.32 109.201 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 41.3 t -113.44 126.03 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 121.035 -0.266 . . . . 2.1 110.852 -171.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 137.25 41.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.291 0.567 . . . . 2.35 111.306 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -68.38 -10.35 54.46 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.346 -0.843 . . . . 3.47 112.376 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -114.61 107.75 50.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.815 -0.354 . . . . 1.56 111.198 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.81 143.49 50.77 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.133 2.555 . . . . 1.37 112.417 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -96.43 158.86 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.29 -0.633 . . . . 1.85 109.29 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 6.6 m -106.91 139.36 41.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.967 0.413 . . . . 1.78 111.425 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -124.18 148.42 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.64 109.024 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.7 t -94.98 164.78 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.149 -0.315 . . . . 1.52 110.149 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.492 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 m -47.23 -48.09 24.43 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.775 0.658 . . . . 1.81 112.775 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.55 -33.98 56.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 2.51 111.413 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -78.38 -43.32 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.262 -0.426 . . . . 1.02 110.049 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.72 -38.93 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 1.88 110.929 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.4 mt -57.63 -36.03 71.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.766 -0.652 . . . . 1.59 111.303 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -77.2 -24.33 51.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.318 -0.401 . . . . 2.3 110.961 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -72.13 -34.04 68.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 3.18 109.491 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.4 ' HA ' ' CZ3' ' A' ' 97' ' ' TRP . 43.2 ttm180 -70.87 -11.1 60.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.093 -0.958 . . . . 3.55 110.987 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.445 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 99.6 mttt -89.96 -19.36 24.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.3 -0.409 . . . . 2.74 111.338 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.427 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 95.7 mt -64.61 146.03 55.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.321 0.582 . . . . 1.66 112.199 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.09 149.2 37.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.408 -0.815 . . . . 1.13 109.901 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -86.4 -32.12 21.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.464 -0.789 . . . . 4.38 110.027 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.95 166.49 22.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.085 -0.962 . . . . 1.62 111.959 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.99 -177.8 36.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.548 -0.751 . . . . 1.16 111.433 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.05 130.76 46.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.838 0.352 . . . . 3.56 110.743 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.6 33.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.808 -0.71 . . . . 2.23 112.919 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.84 160.48 66.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.37 -0.604 . . . . 2.59 109.37 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -53.06 123.02 12.18 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.476 2.117 . . . . 1.5 111.46 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -68.65 112.74 5.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 3.4 111.413 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -116.42 121.42 41.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.05 -0.977 . . . . 2.47 109.268 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -67.54 148.42 51.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 2.6 111.06 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 57.0 tpp -76.68 97.38 4.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.233 -0.894 . . . . 1.94 109.202 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.16 135.12 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.955 0.354 . . . . 1.67 111.955 -171.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.547 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 38.9 t70 70.59 -59.98 0.51 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.242 1.017 . . . . 2.18 111.037 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 84.24 -28.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.976 -1.011 . . . . 2.64 113.023 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -165.04 152.66 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.264 0.484 . . . . 5.31 112.07 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.479 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 31.6 tpt180 -139.72 71.99 36.19 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.408 -0.815 . . . . 6.91 109.565 173.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.412 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 31.2 Cg_endo -120.25 57.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 123.498 2.798 . . . . 3.72 115.378 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 31' ' ' VAL . . . -115.26 122.31 45.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.634 1.106 . . . . 3.34 110.827 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.405 ' HB2' ' HG2' ' A' ' 253' ' ' ARG . 16.5 mm-40 -122.91 162.7 37.56 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 111.697 0.258 . . . . 4.92 111.697 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.24 174.02 11.38 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.976 2.451 . . . . 4.01 113.512 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 252' ' ' ASN . 3.3 mm? -60.68 -11.01 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.591 -1.186 . . . . 4.9 113.451 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 252' ' ' ASN . 19.6 ptpt -59.44 41.25 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.611 1.338 . . . . 5.68 114.611 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 250' ' ' LEU . 6.3 t-20 118.48 -33.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.539 1.935 . . . . 5.11 110.069 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.554 ' N ' ' HD3' ' A' ' 253' ' ' ARG . 0.5 OUTLIER -90.69 89.6 7.59 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.586 0.708 . . . . 6.74 110.107 -177.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -155.39 154.1 31.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.92 -1.141 . . . . 3.08 107.92 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.474 HG21 ' O ' ' A' ' 256' ' ' LYS . 14.9 mt -124.84 136.82 59.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.602 -0.439 . . . . 3.06 110.766 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.474 ' O ' HG21 ' A' ' 255' ' ' ILE . 40.5 mtmt -76.99 165.53 24.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 3.01 109.472 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.761 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.48 159.01 27.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.532 -0.544 . . . . 1.99 109.532 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 41.8 m -151.91 97.64 2.36 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.884 -0.413 . . . . 2.47 109.884 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.38 110.46 10.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.651 -0.704 . . . . 5.03 109.249 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.438 -0.792 . . . . 4.82 110.165 178.759 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 121.137 0.494 . . . . 17.73 110.148 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 t -94.19 156.38 16.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.657 -0.701 . . . . 15.49 110.036 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -111.03 0.99 17.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.255 -0.646 . . . . 16.29 109.255 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -79.23 -61.36 2.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.825 -0.625 . . . . 14.68 109.758 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 -93.51 132.83 37.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.163 0.506 . . . . 15.53 110.746 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.42 142.92 3.69 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.563 -1.015 . . . . 10.81 110.563 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -57.68 133.27 55.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.049 0.452 . . . . 11.61 110.592 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.23 -26.98 18.74 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.691 -0.686 . . . . 9.0 113.39 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 3.5 mptp? -79.73 139.11 37.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.294 0.547 . . . . 10.04 112.215 -173.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.6 m170 69.38 -82.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.097 -0.956 . . . . 11.67 111.808 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.25 -7.82 12.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.232 0.539 . . . . 11.18 110.087 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.02 -121.08 2.78 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.955 -1.258 . . . . 8.9 109.955 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.63 124.21 5.65 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.36 1.373 . . . . 8.2 110.697 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -90.28 -33.18 16.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.852 0.358 . . . . 10.62 110.52 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -71.66 -38.01 70.72 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.953 -0.758 . . . . 10.41 108.953 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -75.56 -11.94 60.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.501 -0.772 . . . . 9.19 110.614 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -75.95 -27.7 57.65 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.53 -0.544 . . . . 7.71 109.53 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -83.17 -29.09 28.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.131 -0.486 . . . . 10.03 110.262 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -77.53 -28.93 52.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.067 -0.515 . . . . 7.89 110.168 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -131.38 80.7 67.04 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.68 -0.691 . . . . 7.65 109.44 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -57.7 -25.96 70.68 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.167 2.578 . . . . 8.15 113.617 -176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.606 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 9.7 tp -81.04 7.64 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.886 0.374 . . . . 6.15 111.608 -176.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.08 14.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.666 0.617 . . . . 5.72 112.666 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -88.95 59.83 5.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.937 0.398 . . . . 8.17 111.043 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.42 -38.45 3.01 Favored Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 111.134 -0.786 . . . . 5.05 111.134 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 28.9 mm-40 -51.49 129.79 26.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.903 -0.648 . . . . 7.09 109.341 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.537 ' CD ' ' HB3' ' A' ' 252' ' ' ASN . 7.8 mtm180 -81.38 130.27 34.97 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.448 0.642 . . . . 5.44 112.582 -167.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.416 ' H ' ' HG3' ' A' ' 248' ' ' GLN . 41.1 tt0 -136.0 -16.42 1.69 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.976 -1.011 . . . . 7.33 110.1 170.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.436 ' HG ' ' HG2' ' A' ' 248' ' ' GLN . 6.4 p -102.01 165.55 13.71 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 108.912 -0.773 . . . . 4.35 108.912 -173.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.588 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 20.4 Cg_exo -67.22 -49.51 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 CA-C-N 119.748 0.946 . . . . 4.96 112.474 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.421 HG22 HG13 ' A' ' 255' ' ' ILE . 12.9 p -170.94 143.01 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.55 0.574 . . . . 5.07 112.55 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.17 116.68 24.52 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.212 -1.033 . . . . 3.14 108.212 157.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 61.3 mt -90.57 102.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 2.71 111.794 -167.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.08 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 2.82 109.944 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -60.1 -32.55 71.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.367 0.877 . . . . 2.71 113.367 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -68.85 -45.14 71.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.73 0.3 . . . . 5.23 111.083 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -82.09 -19.65 39.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.365 -0.38 . . . . 3.38 111.004 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.3 134.74 50.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.989 0.423 . . . . 1.76 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.76 116.31 28.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 4.05 110.401 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.51 124.4 26.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 4.9 109.82 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 258' ' ' SER . 29.9 t70 -118.9 143.37 33.6 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.128 -0.942 . . . . 2.27 110.137 -170.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' A' ' 44' ' ' LEU . 21.1 Cg_exo -67.36 119.13 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.157 1.905 . . . . 2.45 111.815 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 m -53.38 43.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.025 1.12 . . . . 4.62 114.025 169.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 45' ' ' LYS . 2.0 pt? -14.32 -66.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.304 1.842 . . . . 5.15 114.044 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' H ' ' HG ' ' A' ' 44' ' ' LEU . 27.5 mmtp -117.16 148.6 42.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 121.717 -0.615 . . . . 4.21 109.807 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.23 137.66 31.68 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.747 2.298 . . . . 2.76 112.696 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 190' ' ' TYR . 95.1 mt -66.61 127.41 32.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 2.93 111.06 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 22.7 t -84.12 115.16 22.25 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.652 -0.87 . . . . 2.46 108.652 174.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.9 107.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.521 . . . . 2.17 110.092 -173.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.5 t -133.63 91.74 2.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.142 0.496 . . . . 1.87 110.834 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.796 ' HH ' ' NE2' ' A' ' 122' ' ' HIS . 65.5 m-85 -108.98 0.53 20.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.795 -0.639 . . . . 3.97 110.192 172.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.474 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . 4.1 m-20 -69.29 -30.88 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 2.48 111.816 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.474 ' NE2' ' HB2' ' A' ' 52' ' ' ASP . 1.0 OUTLIER -98.67 -2.58 37.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.716 -0.394 . . . . 2.54 110.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.13 130.15 40.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.054 -0.521 . . . . 1.41 111.785 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -106.33 106.88 17.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 1.41 110.975 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.47 143.0 44.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.277 -0.419 . . . . 1.84 110.109 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.4 mt -114.71 -57.26 2.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.825 0.345 . . . . 1.45 111.85 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -155.41 159.28 39.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 3.72 111.052 -170.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 66' ' ' PHE . 13.2 tt -126.1 137.11 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.2 -0.667 . . . . 1.35 109.2 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.426 HD13 ' OG ' ' A' ' 172' ' ' SER . 27.3 tp -140.87 110.83 6.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.827 0.346 . . . . 1.53 111.809 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 66' ' ' PHE . 40.8 t30 -75.73 117.74 17.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.898 -0.778 . . . . 1.49 108.898 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -140.3 69.39 1.35 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.244 -0.583 . . . . 2.18 111.301 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.52 -67.3 0.51 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.497 -0.859 . . . . 2.0 112.798 165.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 243' ' ' ASN . 49.8 t60 -101.11 -29.53 12.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 4.11 111.1 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.79 -171.75 1.68 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.942 -0.572 . . . . 1.78 109.757 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 30.9 p90 -118.16 123.17 44.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 3.48 109.712 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -94.43 114.96 27.07 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.539 -0.755 . . . . 1.99 110.364 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 59.8 t -90.6 105.88 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 1.75 109.597 173.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.9 137.77 32.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.994 0.426 . . . . 2.02 111.472 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.99 170.07 8.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 2.19 110.681 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -97.45 101.43 12.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.831 -0.622 . . . . 1.33 109.345 174.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' OD1' ' HB3' ' A' ' 90' ' ' LEU . 16.0 m-20 -120.9 60.62 0.9 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.65 111.038 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.7 t -108.82 1.1 20.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.487 -0.779 . . . . 2.01 111.195 173.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.24 172.59 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.673 0.273 . . . . 2.35 111.03 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.41 65.7 5.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.891 -0.595 . . . . 1.92 110.989 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -130.77 1.92 4.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.532 . . . . 2.31 110.587 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.01 84.49 1.15 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.272 -0.64 . . . . 1.44 109.272 -168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.54 149.17 22.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.375 0.607 . . . . 1.82 112.539 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 48' ' ' SER . 40.0 tp -148.56 112.36 5.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.864 -1.062 . . . . 1.8 108.826 170.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HD3' ' OG1' ' A' ' 87' ' ' THR . 45.3 pttt -150.13 141.0 22.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.483 0.549 . . . . 3.02 112.483 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -57.68 172.68 2.87 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 115.628 -0.715 . . . . 1.44 111.928 156.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.94 -143.99 0.0 OUTLIER Glycine 0 CA--C 1.54 1.649 0 N-CA-C 117.793 1.877 . . . . 2.15 117.793 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.17 124.36 7.48 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.185 2.59 . . . . 3.17 114.174 -163.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 12.3 tp -142.13 -168.15 2.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.748 -1.569 . . . . 4.55 107.142 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.49 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 p-10 -148.82 89.08 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.13 0.877 . . . . 4.95 109.181 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 99.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.589 -0.815 . . . . 2.25 111.098 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.45 ' OG1' ' HD3' ' A' ' 80' ' ' LYS . 46.2 m -104.61 103.2 12.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.62 0.724 . . . . 2.12 112.494 -172.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.0 m-85 -126.34 98.26 5.37 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.203 -1.036 . . . . 3.88 108.203 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 27.5 mmt180 -141.69 89.03 2.17 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 112.192 0.441 . . . . 3.87 112.192 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 40.6 tp -156.82 158.89 37.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.745 -1.576 . . . . 1.68 106.745 160.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.504 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 6.1 tp -161.88 -46.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.816 1.189 . . . . 2.16 112.287 169.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 8.6 pt20 -158.8 172.2 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 1.95 111.479 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -146.57 144.05 29.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.118 -0.697 . . . . 0.98 109.118 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.6 p-80 -142.32 159.89 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.267 -0.424 . . . . 1.07 110.48 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 118' ' ' LEU . 81.3 m-85 -117.73 168.11 10.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 3.99 110.646 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.416 ' CE1' ' HE2' ' A' ' 64' ' ' HIS . 17.1 m-70 -122.91 170.99 9.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.085 -0.709 . . . . 2.2 109.085 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -156.24 129.37 8.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.868 0.366 . . . . 6.08 110.131 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 103' ' ' GLN . . . -89.59 -50.86 3.03 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.769 -0.65 . . . . 2.19 113.14 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 26.3 t 149.06 -50.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.348 1.059 . . . . 3.08 108.74 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.69 160.88 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 3.48 109.398 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 115' ' ' ALA . 35.0 t70 -71.71 67.16 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.423 0.63 . . . . 3.85 110.607 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.46 42.91 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.701 -0.761 . . . . 2.37 112.941 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.642 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 12.9 pt20 -172.27 143.03 1.41 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.018 0.409 . . . . 2.62 110.423 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.21 81.84 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 120.786 -0.721 . . . . 1.62 112.35 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 41.6 t -89.14 -8.34 53.93 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.12 0.415 . . . . 2.24 112.12 -177.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.564 ' HA ' ' NE1' ' A' ' 244' ' ' TRP . 7.7 tp10 72.3 157.46 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.287 0.367 . . . . 3.72 110.471 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.702 ' CD2' ' HH ' ' A' ' 193' ' ' TYR . 29.6 m170 54.61 67.31 1.03 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.074 0.464 . . . . 4.03 111.863 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -80.21 127.25 32.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.892 0.853 . . . . 2.99 111.016 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 38.1 t -103.29 105.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.58 -1.191 . . . . 2.88 110.157 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.03 45.43 21.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 2.8 110.293 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 64.27 14.29 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.685 -1.143 . . . . 5.35 112.077 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -89.03 126.16 35.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.69 -0.485 . . . . 3.58 109.69 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.61 155.08 21.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.046 -0.724 . . . . 3.26 109.046 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -109.51 -170.24 1.62 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.344 -0.389 . . . . 1.71 110.287 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -46.6 18.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.374 . . . . 1.57 110.916 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.09 163.95 38.42 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.945 -0.571 . . . . 1.3 110.448 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -129.11 145.56 51.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 1.85 110.046 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.585 HD11 ' CZ ' ' A' ' 95' ' ' PHE . 24.6 tp -111.73 112.2 23.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.246 -0.434 . . . . 1.61 109.861 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.422 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 46.9 m170 -110.93 105.27 14.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.15 -0.477 . . . . 2.25 111.335 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.01 110.77 22.03 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.053 -0.721 . . . . 1.51 109.053 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.5 t -86.9 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.047 0.451 . . . . 1.24 110.195 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.796 ' NE2' ' HH ' ' A' ' 51' ' ' TYR . 38.6 m80 -131.22 125.31 32.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.905 -0.588 . . . . 2.86 109.838 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.504 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -111.02 151.53 27.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.052 -0.721 . . . . 4.96 109.052 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.579 ' ND2' ' HA ' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -93.2 101.53 13.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.787 0.803 . . . . 2.3 111.244 178.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -64.49 -10.02 22.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.39 -0.823 . . . . 2.77 112.813 -173.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -69.65 -47.94 61.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.842 0.353 . . . . 3.79 110.468 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -84.4 -21.11 30.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.375 0.607 . . . . 3.34 110.493 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.46 -2.28 64.97 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.813 -1.315 . . . . 2.37 109.813 -171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.579 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 12.0 t70 73.3 -87.0 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.0 -1.1 . . . . 3.93 112.957 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -46.38 -40.12 11.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.069 0.766 . . . . 3.6 113.069 -168.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.454 ' O ' HG21 ' A' ' 134' ' ' VAL . . . -55.22 -61.12 7.73 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.022 -0.609 . . . . 2.35 112.324 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -73.69 -28.19 61.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.742 0.275 . . . . 3.75 111.742 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.63 62.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.473 0.546 . . . . 2.17 112.473 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 131' ' ' GLY . 34.4 m -64.92 -31.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.857 -0.337 . . . . 3.11 111.157 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -100.66 -28.3 12.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 3.55 110.855 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 8.9 tt0 -76.05 119.85 79.03 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 3.02 110.848 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.95 -17.1 54.96 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 1.93 111.365 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.458 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 m-20 -105.31 27.07 8.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.159 -0.928 . . . . 2.29 109.418 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.09 -82.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.382 0 CA-C-N 116.115 -0.493 . . . . 1.5 112.554 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.43 148.9 25.35 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.21 0.529 . . . . 1.98 110.661 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.46 104.51 7.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.486 -0.779 . . . . 1.83 109.177 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.59 129.29 60.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.314 -0.403 . . . . 2.28 111.28 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 34.4 tp -97.47 127.27 43.3 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.173 -0.677 . . . . 2.89 109.173 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -111.23 131.18 10.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.783 -0.722 . . . . 0.95 112.736 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.4 mt -137.69 106.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 1.38 109.508 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -62.93 156.43 24.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.936 0.398 . . . . 1.37 111.889 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.75 123.2 49.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 1.48 110.097 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.3 ptmm? -115.64 138.39 51.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.817 -0.629 . . . . 2.52 109.823 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 47.8 t -88.1 133.97 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.711 0.291 . . . . 1.88 110.991 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.614 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . 126.64 58.63 0.14 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.847 -0.692 . . . . 1.53 113.361 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 3.2 t 160.26 122.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.26 -1.015 . . . . 2.08 108.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.31 134.64 39.68 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.941 -0.304 . . . . 1.36 110.271 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -114.91 95.85 42.85 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.303 -0.408 . . . . 1.78 110.462 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.84 -39.25 92.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.152 2.568 . . . . 1.34 112.341 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.459 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -66.66 -21.05 70.67 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.926 -0.654 . . . . 0.75 112.82 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 160' ' ' VAL . 60.7 tp -91.88 -31.27 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 1.39 110.412 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.454 ' NE2' ' HG2' ' A' ' 221' ' ' GLN . 8.7 tp-100 -53.37 -40.98 65.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 1.63 112.27 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.5 pttt -55.41 -37.45 67.65 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.642 0.608 . . . . 3.26 112.642 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.453 ' O ' HG11 ' A' ' 162' ' ' VAL . 12.0 p -85.16 -32.64 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.434 -0.507 . . . . 1.97 110.959 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 44.1 t -64.96 -38.97 84.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 1.64 110.909 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.97 -35.3 79.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.78 -0.646 . . . . 1.22 111.429 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.466 HG12 ' CE2' ' A' ' 175' ' ' PHE . 8.3 p -88.04 -17.35 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.777 0.288 . . . . 2.07 111.777 -172.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.1 pp -74.42 -15.23 60.92 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.31 -0.556 . . . . 1.95 110.512 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.43 -24.62 64.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 2.31 110.434 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.2 m -84.47 1.85 43.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 1.78 111.359 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.4 pt -138.56 38.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.973 -0.751 . . . . 1.42 108.973 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -53.14 -41.54 65.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.837 -1.074 . . . . 1.98 111.947 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.6 p -102.69 149.83 24.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.426 -0.352 . . . . 1.4 110.434 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.16 137.4 57.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 2.84 110.31 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.64 -24.55 17.07 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.556 -0.831 . . . . 0.85 111.664 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.09 132.33 37.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.138 0.494 . . . . 2.22 110.734 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.426 ' OG ' HD13 ' A' ' 60' ' ' LEU . 4.0 m -117.71 154.11 32.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.845 -0.798 . . . . 1.93 108.845 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -145.21 137.5 25.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.869 -0.419 . . . . 1.17 109.869 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.88 131.99 47.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.543 -0.539 . . . . 1.8 109.543 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 162' ' ' VAL . 20.2 t80 -138.46 78.1 1.66 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.178 -1.045 . . . . 1.31 108.178 -176.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 13.0 m -97.45 139.81 32.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.508 -0.769 . . . . 1.69 112.817 -173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 24.7 m120 42.61 73.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.834 -1.075 . . . . 2.26 113.516 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.27 101.4 7.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.723 -0.671 . . . . 4.84 109.575 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -55.88 119.42 25.93 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 2.51 111.895 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.65 -5.46 17.11 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.682 2.254 . . . . 1.47 111.165 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.436 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 57.1 ttp180 -57.76 -37.17 73.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 3.16 111.272 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.15 -24.11 60.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.257 -0.497 . . . . 1.12 112.969 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.8 mt -81.12 -24.3 37.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.835 0.35 . . . . 2.37 111.01 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.37 128.37 92.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 3.87 111.089 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.48 -170.16 0.77 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.992 2.462 . . . . 2.51 113.375 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -75.5 -64.16 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.18 0.437 . . . . 3.23 112.18 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.548 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 3.5 m -80.26 134.32 36.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 2.03 111.17 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 95.0 mt -108.3 64.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.197 0.522 . . . . 2.5 110.96 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.46 ' HB2' ' HE3' ' A' ' 212' ' ' LYS . 55.9 m-20 -123.74 144.16 49.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.723 -1.214 . . . . 1.81 107.723 173.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.448 ' CD2' HD13 ' A' ' 47' ' ' LEU . 30.4 p90 -133.39 144.94 49.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.979 1.103 . . . . 5.32 113.979 -163.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 17.5 m95 -90.24 131.6 35.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.45 -1.25 . . . . 4.55 107.675 168.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.9 t -128.05 118.13 22.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.436 0.636 . . . . 2.39 111.737 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.702 ' HH ' ' CD2' ' A' ' 107' ' ' HIS . 20.0 p90 -139.75 153.84 70.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 5.32 110.678 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -72.39 136.43 26.34 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.813 2.342 . . . . 2.47 110.937 172.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.726 ' HA3' ' CD1' ' A' ' 208' ' ' TRP . . . -137.99 158.78 24.86 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.364 -0.922 . . . . 2.0 113.062 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 t -97.04 153.07 18.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.12 0.486 . . . . 3.36 111.005 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -81.97 14.92 2.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.031 -0.986 . . . . 5.18 110.387 178.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.4 t -64.57 25.25 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.856 1.428 . . . . 5.53 114.856 -161.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.575 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.1 OUTLIER -85.55 -64.7 0.22 Allowed Pre-proline 0 C--N 1.319 -0.742 0 O-C-N 121.334 -0.854 . . . . 5.89 109.042 172.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 199' ' ' THR . 1.2 Cg_endo -83.71 -68.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.665 0 C-N-CA 121.629 1.553 . . . . 6.31 113.101 166.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 97.9 Cg_endo -104.47 157.63 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.436 2.091 . . . . 5.26 112.74 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 23.7 tp -90.81 68.04 6.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.499 0.666 . . . . 4.29 110.696 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 134' ' ' VAL . 56.9 tp -108.39 122.0 46.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.517 -0.765 . . . . 3.51 110.847 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -92.24 77.72 5.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.559 . . . . 3.37 111.186 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 85.2 m -147.81 43.29 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 2.47 110.349 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.25 146.07 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 1.74 110.956 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 48.9 m -114.28 121.45 43.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.302 -0.629 . . . . 2.3 109.302 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.726 ' CD1' ' HA3' ' A' ' 195' ' ' GLY . 36.9 m95 -106.4 130.13 54.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 6.37 110.977 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 49.1 mm -121.71 116.06 48.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.85 . . . . 2.32 109.54 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 98.0 t -111.29 133.88 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.302 -0.259 . . . . 2.1 110.302 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.37 143.93 27.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.234 0.54 . . . . 2.35 110.751 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 189' ' ' ASP . 26.8 ttmt -53.24 -23.02 7.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.945 -1.025 . . . . 3.47 112.231 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.548 ' HG3' ' H ' ' A' ' 187' ' ' SER . 68.7 mm-40 -110.55 121.03 42.38 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.424 -0.353 . . . . 1.56 111.068 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -84.02 171.62 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.61 2.207 . . . . 1.37 111.246 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 31.0 pt -111.48 147.25 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.964 0.411 . . . . 1.85 109.963 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 23.0 p -100.17 146.42 26.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.334 0.588 . . . . 1.78 111.234 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -140.66 146.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.208 -0.905 . . . . 1.64 109.418 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 222' ' ' VAL . 59.5 m -101.86 168.22 9.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.887 -0.325 . . . . 1.52 111.372 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.544 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 49.1 m -48.49 -51.0 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.092 0.775 . . . . 1.81 113.092 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.7 -48.06 82.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.698 0.285 . . . . 2.51 111.275 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.454 ' HG2' ' NE2' ' A' ' 157' ' ' GLN . 18.1 mt-30 -59.3 -44.63 92.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.764 -0.458 . . . . 1.02 109.764 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 226' ' ' ARG . 95.9 t -60.51 -40.69 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.721 -0.672 . . . . 1.88 110.874 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.6 mt -60.43 -37.03 79.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 1.59 111.027 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -66.62 -33.86 76.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.472 -0.331 . . . . 2.3 110.887 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -67.46 -30.8 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.328 0.585 . . . . 3.18 109.751 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 222' ' ' VAL . 23.6 mtp180 -79.14 -3.93 47.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.487 -0.779 . . . . 3.55 111.294 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 47.3 mmtm -87.82 -19.49 27.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.104 -0.332 . . . . 2.74 110.104 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.25 139.82 57.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.921 -0.581 . . . . 1.66 111.434 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.419 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.93 149.32 38.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 1.13 110.315 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -79.57 -31.77 41.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 4.38 109.749 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 4.5 p-10 -73.95 165.16 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.129 -0.941 . . . . 1.62 112.397 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.77 171.23 42.89 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.506 -1.225 . . . . 1.16 110.834 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.01 141.58 57.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.216 0.508 . . . . 3.56 110.688 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.76 3.88 73.47 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.701 -0.761 . . . . 2.23 111.908 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -114.01 157.67 41.42 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.369 -0.234 . . . . 2.59 110.369 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 127.62 26.81 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.89 2.394 . . . . 1.5 111.785 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.42 116.93 5.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 3.4 111.547 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -121.68 119.75 32.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.577 -0.738 . . . . 2.47 109.127 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 226' ' ' ARG . 83.9 mt -67.1 149.5 50.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 2.6 111.861 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 55.7 tpp -75.36 103.76 5.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.084 -0.962 . . . . 1.94 108.903 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.23 139.16 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 1.67 112.121 -171.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.83 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.648 -1.16 . . . . 2.18 111.31 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.503 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 33.1 m-80 55.76 31.37 17.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.044 0.537 . . . . 2.64 111.945 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.564 ' NE1' ' HA ' ' A' ' 106' ' ' GLU . 30.6 t90 -134.17 144.53 48.56 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.199 -0.313 . . . . 5.31 110.414 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.568 ' O ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -111.12 149.05 39.93 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.424 -0.213 . . . . 6.91 110.424 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.73 132.91 3.95 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 124.33 3.353 . . . . 3.72 114.246 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.38 151.0 46.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.223 -0.899 . . . . 3.34 110.926 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 27' ' ' ARG . 77.0 mm-40 -123.81 150.09 61.24 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 4.92 110.466 -174.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.37 175.26 10.29 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.598 2.865 . . . . 4.01 115.261 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 82.7 mt -63.53 -8.81 10.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.368 -1.742 . . . . 4.9 113.432 -173.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 16.9 ttmm -58.17 44.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.467 1.284 . . . . 5.68 114.467 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.537 ' HB3' ' CD ' ' A' ' 27' ' ' ARG . 7.5 t-20 119.21 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 127.017 2.127 . . . . 5.11 109.52 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 30' ' ' PRO . 42.8 mmt-85 -126.2 84.87 2.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.413 -0.958 . . . . 6.74 108.413 168.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -115.9 142.4 46.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 3.08 110.012 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.421 HG13 HG22 ' A' ' 31' ' ' VAL . 3.1 mp -103.76 122.99 57.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 3.06 111.064 -174.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 1.0 OUTLIER -97.86 145.13 26.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.523 -0.917 . . . . 3.01 108.523 167.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -123.64 93.01 3.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.512 -0.551 . . . . 1.99 109.512 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 54.1 m -80.18 97.41 6.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.628 0.728 . . . . 2.47 110.924 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -135.12 103.72 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.375 -1.284 . . . . 5.03 109.253 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 C--O 1.248 1.01 0 CA-C-N 116.154 -0.476 . . . . 4.82 110.67 178.49 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.115 0.483 . . . . 17.73 110.055 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 t -138.82 40.7 2.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.419 0.628 . . . . 15.49 109.341 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -139.32 33.44 2.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.54 0.686 . . . . 16.29 109.66 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -110.27 -38.74 5.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.107 -0.952 . . . . 14.68 109.464 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -96.1 81.63 3.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.4 -0.818 . . . . 15.53 109.819 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.432 ' HA3' ' HA3' ' A' ' 12' ' ' GLY . . . -159.32 135.21 4.06 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.463 -0.875 . . . . 10.81 112.2 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -104.66 100.07 9.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.066 0.46 . . . . 11.61 111.35 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.65 158.04 33.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.707 -0.758 . . . . 9.0 113.392 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -45.7 134.99 7.08 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.285 -0.458 . . . . 10.04 111.736 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 81.66 -25.28 0.16 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.886 -1.052 . . . . 11.67 111.699 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -102.51 -14.49 16.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.175 0.512 . . . . 11.18 110.43 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA3' ' HA3' ' A' ' 6' ' ' GLY . . . -179.74 -152.45 10.79 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.844 -0.902 . . . . 8.9 110.844 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.16 129.19 11.97 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.695 2.264 . . . . 8.2 111.52 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -82.27 -21.26 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.004 0.431 . . . . 10.62 110.359 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 18' ' ' LYS . 41.8 m80 -112.16 22.78 14.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.434 0.635 . . . . 10.41 109.379 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -54.18 -26.2 26.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.889 -1.051 . . . . 9.19 112.231 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -77.19 -6.13 51.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.879 0.371 . . . . 7.71 110.649 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HD3' ' HB3' ' A' ' 15' ' ' HIS . 56.5 mtpt -89.12 -41.93 11.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.424 -0.353 . . . . 10.03 110.487 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -68.72 -27.65 66.12 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.116 0.484 . . . . 7.89 110.336 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.452 ' HB3' HG21 ' A' ' 22' ' ' ILE . 20.7 m-85 -108.16 92.68 9.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.676 -0.693 . . . . 7.65 110.749 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.52 -21.05 53.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.71 2.273 . . . . 8.15 111.996 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 20' ' ' PHE . 7.7 tp -42.89 -29.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.565 -0.743 . . . . 6.15 112.649 173.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -39.75 -37.18 0.5 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.765 0.654 . . . . 5.72 112.765 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -71.71 34.24 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.407 -0.36 . . . . 8.17 111.775 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 23' ' ' ALA . . . -167.48 -65.03 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.169 -0.772 . . . . 5.05 111.169 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.44 ' CB ' ' HB3' ' A' ' 204' ' ' GLU . 0.0 OUTLIER -45.25 169.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.067 0.937 . . . . 7.09 113.277 171.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -149.19 170.57 18.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.614 -2.365 . . . . 5.44 104.614 -165.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.714 ' NE2' ' HA ' ' A' ' 252' ' ' ASN . 1.1 mp0 -53.79 152.83 5.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 120.4 1.455 . . . . 7.33 113.233 175.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.444 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -48.08 167.04 0.2 Allowed Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 113.951 -1.477 . . . . 4.35 114.568 176.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.541 ' HA ' ' CE2' ' A' ' 208' ' ' TRP . 54.5 Cg_exo -43.24 35.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 1 C-N-CA 127.164 5.243 . . . . 4.96 117.006 169.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG21 ' H ' ' A' ' 32' ' ' ASP . 4.1 p -89.82 -174.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 118.557 0.617 . . . . 5.07 110.184 -170.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.626 ' H ' HG21 ' A' ' 31' ' ' VAL . 95.3 m-20 -51.94 141.53 17.58 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.776 1.028 . . . . 3.14 113.776 -169.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.764 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 58.8 mt -98.97 139.66 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.372 -1.285 . . . . 2.71 110.981 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' H ' ' CD1' ' A' ' 255' ' ' ILE . 24.3 t70 -112.14 118.31 34.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.833 -0.432 . . . . 2.82 109.833 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -43.79 73.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.397 -0.82 . . . . 2.71 113.138 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.77 -42.1 91.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 5.23 110.792 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 255' ' ' ILE . 22.9 m -72.67 -28.11 62.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.019 -0.537 . . . . 3.38 110.904 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 255' ' ' ILE . . . -75.22 93.59 2.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.264 0.554 . . . . 1.76 110.95 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.94 142.19 28.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.475 -0.784 . . . . 4.05 110.665 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.5 m-85 -58.07 122.48 13.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.472 -0.785 . . . . 4.9 110.975 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.63 133.96 27.26 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.764 . . . . 2.27 109.857 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.15 59.75 3.06 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.971 2.447 . . . . 2.45 112.497 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.9 t -69.72 -53.59 17.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 4.62 110.121 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp 72.04 -54.66 0.68 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.31 -0.859 . . . . 5.15 111.733 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 43.7 mmtm -75.62 132.64 74.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 4.21 110.371 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.29 167.02 26.6 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.641 2.227 . . . . 2.76 112.273 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.406 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 61.3 tp -93.54 116.9 29.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.942 -0.572 . . . . 2.93 109.842 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 32.1 t -86.87 121.65 29.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.427 -0.583 . . . . 2.46 109.427 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.75 134.82 57.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.973 0.416 . . . . 2.17 110.716 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 28.4 t -128.54 91.03 3.16 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.309 0.576 . . . . 1.87 109.652 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.85 9.02 32.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 3.97 109.647 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -55.49 -39.1 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.404 -0.816 . . . . 2.48 111.201 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.2 mp0 -99.44 15.59 25.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 2.54 111.238 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 121.72 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 1.41 111.374 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -114.37 106.98 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.12 -0.491 . . . . 1.41 110.519 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.0 m -76.14 146.68 39.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.354 -0.61 . . . . 1.84 109.354 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.28 -56.69 1.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 1.45 111.925 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.45 155.8 32.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.724 0.297 . . . . 3.72 111.282 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -122.02 138.5 52.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.116 -0.493 . . . . 1.35 109.906 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 172' ' ' SER . 38.2 tp -134.63 138.48 44.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.013 0.435 . . . . 1.53 111.905 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.05 114.49 26.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.267 -0.879 . . . . 1.49 109.13 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -115.26 70.15 0.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 2.18 110.308 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.2 -59.04 0.16 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.164 -1.38 . . . . 2.0 115.531 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -110.91 -17.02 13.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.842 0.353 . . . . 4.11 111.089 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.38 174.66 14.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.981 -0.748 . . . . 1.78 108.981 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -138.4 135.47 35.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.637 -0.505 . . . . 3.48 109.637 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 94' ' ' HIS . 15.5 m120 -126.58 152.39 46.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.214 -0.448 . . . . 1.99 110.508 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.49 129.07 67.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.079 -0.51 . . . . 1.75 109.751 174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.79 131.63 34.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.081 -0.509 . . . . 2.02 111.433 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.84 153.21 21.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.634 -0.712 . . . . 2.19 109.674 172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 33.0 t70 -72.15 92.65 1.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.084 -0.507 . . . . 1.33 110.137 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -108.4 56.47 0.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.657 0.742 . . . . 2.65 111.206 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -103.16 -3.39 25.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.749 -0.66 . . . . 2.01 111.317 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.466 ' CG ' ' HE3' ' A' ' 76' ' ' LYS . 9.5 pt20 -148.66 165.0 32.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.215 -0.448 . . . . 2.35 110.122 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -81.1 73.28 8.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.189 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HD2' ' O ' ' A' ' 71' ' ' ASP . 15.2 ptpt -102.39 -41.18 6.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.591 -0.731 . . . . 2.31 110.998 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -113.2 96.9 6.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.676 -0.49 . . . . 1.44 109.676 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 95.3 t -124.16 150.91 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.768 -0.651 . . . . 1.82 110.856 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 79' ' ' LEU . 2.5 pt? -149.19 115.74 5.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.772 0.32 . . . . 1.8 110.523 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -139.04 125.09 19.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 3.02 110.62 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 85' ' ' ASP . . . -133.95 -178.19 15.44 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.521 -1.432 . . . . 1.44 109.521 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -26.51 -127.93 0.0 OUTLIER Glycine 0 N--CA 1.486 2.024 0 C-N-CA 125.089 1.328 . . . . 2.15 115.991 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.66 170.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.075 2.517 . . . . 3.17 112.99 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.7 pt? -31.9 114.14 0.14 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.389 1.255 . . . . 4.55 114.389 -144.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 9.8 p-10 -128.27 -128.09 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 113.424 -1.717 . . . . 4.95 112.284 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 106.05 161.3 22.73 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.193 -1.163 . . . . 2.25 110.193 -166.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.552 ' O ' HG23 ' A' ' 125' ' ' THR . 20.1 m -73.66 102.99 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.987 0.893 . . . . 2.12 110.715 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 68.2 m-85 -100.78 133.5 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 3.88 110.544 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HD2' ' CZ2' ' A' ' 123' ' ' TRP . 99.7 mtt180 -102.49 142.78 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.225 -0.443 . . . . 3.87 110.42 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.3 tp -77.64 125.15 28.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.618 -0.512 . . . . 1.68 109.618 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.52 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.4 tt -111.73 -40.72 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.834 0.35 . . . . 2.16 110.886 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -165.15 169.36 16.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.714 -0.476 . . . . 1.95 109.714 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HB3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 p90 -143.81 158.23 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.356 -0.238 . . . . 0.98 110.356 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.536 ' HB3' ' ND2' ' A' ' 67' ' ' ASN . 5.4 p-80 -132.34 158.91 40.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.616 -0.513 . . . . 1.07 109.616 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.82 149.93 28.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 3.99 110.375 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.469 ' ND1' ' HB3' ' A' ' 117' ' ' GLU . 13.4 m170 -100.48 153.05 19.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.504 -0.924 . . . . 2.2 108.504 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.418 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 75.0 t-105 -161.73 125.61 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.023 -0.362 . . . . 6.08 110.023 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -87.42 -171.51 47.27 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 111.319 -0.712 . . . . 2.19 111.319 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.429 ' HA ' ' HB ' ' A' ' 241' ' ' VAL . 11.2 t -78.52 -46.94 18.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.736 0.768 . . . . 3.08 109.995 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 102' ' ' GLY . 92.6 mt -83.95 146.61 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.429 . . . . 3.48 110.135 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.21 32.59 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.765 0.654 . . . . 3.85 112.765 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 100' ' ' LEU . . . -155.4 21.93 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.921 -0.656 . . . . 2.37 112.344 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -150.46 169.58 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.211 -0.292 . . . . 2.62 110.211 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.412 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 86.95 17.41 59.58 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.668 -0.777 . . . . 1.62 113.111 169.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 77.8 p -80.58 -8.86 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.963 0.382 . . . . 2.24 111.701 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 66.48 164.68 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.101 -0.703 . . . . 3.72 109.101 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.408 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 29.4 m80 58.11 46.73 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 4.03 110.704 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.5 m -78.4 117.71 19.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 2.99 110.097 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 46.2 t -84.22 99.67 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 114.549 -1.205 . . . . 2.88 110.887 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 69.58 -72.27 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.709 0.631 . . . . 2.8 110.599 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -146.06 5.56 0.99 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.814 -0.439 . . . . 5.35 109.814 173.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.06 97.15 11.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.973 -0.558 . . . . 3.58 110.085 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -110.89 145.22 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 3.26 109.512 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -105.06 179.03 4.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.303 -0.408 . . . . 1.71 110.203 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.02 53.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.026 0.441 . . . . 1.57 110.668 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.35 23.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.795 -0.639 . . . . 1.3 110.049 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 31.0 tt0 -147.73 146.38 29.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.97 -0.559 . . . . 1.85 110.255 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -99.45 107.3 19.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.548 -0.751 . . . . 1.61 109.604 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -109.52 102.41 11.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.11 0.481 . . . . 2.25 110.176 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 93' ' ' PHE . 5.0 mp -87.49 128.1 35.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.74 -0.664 . . . . 1.51 111.158 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.428 ' HA ' HG13 ' A' ' 142' ' ' VAL . 45.2 t -96.45 127.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.965 -0.561 . . . . 1.24 110.393 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 20.9 m80 -126.77 138.11 53.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.608 -0.516 . . . . 2.86 109.608 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.581 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 44.9 p-90 -112.52 144.78 41.43 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.545 0.528 . . . . 4.96 110.592 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.667 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 41.8 t-20 -75.38 109.89 9.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 2.3 110.752 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.581 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 8.9 t -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.068 0.766 . . . . 2.77 113.068 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.667 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 21.3 ptmt -71.3 -7.68 48.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.166 0.432 . . . . 3.79 112.166 -172.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.09 -17.59 6.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.349 0.595 . . . . 3.34 110.459 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.45 -4.95 85.64 Favored Glycine 0 C--N 1.325 -0.042 0 N-CA-C 109.734 -1.347 . . . . 2.37 109.734 -167.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 123' ' ' TRP . 13.1 t70 71.55 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.193 -1.504 . . . . 3.93 112.224 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 134' ' ' VAL . 95.7 m-85 -45.27 -31.4 1.53 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.256 1.206 . . . . 3.6 114.256 -168.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.53 -65.03 2.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.344 -0.932 . . . . 2.35 111.803 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -72.23 -30.78 65.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.979 0.363 . . . . 3.75 111.979 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -26.34 49.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.141 0.422 . . . . 2.17 112.141 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 130' ' ' PHE . 59.7 t -60.66 -34.75 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 3.11 110.71 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -119.9 18.77 12.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.479 -0.328 . . . . 3.55 111.466 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -132.16 113.83 14.79 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.755 -0.461 . . . . 3.02 109.755 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.506 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 38.0 Cg_exo -60.69 -14.63 32.54 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.023 2.482 . . . . 1.93 113.785 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.77 27.15 9.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.303 . . . . 2.29 110.552 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.443 ' O ' ' HE1' ' A' ' 88' ' ' TYR . . . -66.61 -86.84 0.07 OUTLIER Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.947 -0.57 . . . . 1.5 114.211 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.76 161.21 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.562 0.696 . . . . 1.98 112.708 -168.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.43 110.58 5.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.939 . . . . 1.83 110.177 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.428 HG13 ' HA ' ' A' ' 121' ' ' VAL . 21.2 m -107.32 152.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.812 -0.44 . . . . 2.28 109.812 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 10.2 tt -131.92 125.25 31.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.315 -0.254 . . . . 2.89 110.315 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.86 131.9 10.22 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.843 -0.694 . . . . 0.95 113.025 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -119.57 122.87 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.208 -0.293 . . . . 1.38 110.208 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -68.38 146.95 52.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.466 -0.334 . . . . 1.37 111.628 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.417 HD21 ' HB ' ' A' ' 215' ' ' ILE . 80.2 mt -124.47 114.52 19.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 1.48 110.219 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -107.24 153.73 22.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.71 -0.478 . . . . 2.52 109.71 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 44.1 t -90.08 127.64 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.987 0.423 . . . . 1.88 110.848 -175.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.07 -105.12 0.19 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.217 -0.753 . . . . 1.53 111.217 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.0 m -76.23 146.58 38.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.04 -0.356 . . . . 2.08 110.04 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.485 ' CA ' ' HB2' ' A' ' 218' ' ' SER . . . -70.0 146.99 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 1.36 111.298 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 216' ' ' SER . 51.6 tptt -112.89 99.76 49.2 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.603 -0.726 . . . . 1.78 109.67 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 11.1 Cg_endo -55.55 -36.34 94.26 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.735 2.29 . . . . 1.34 111.919 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.12 -28.89 72.88 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.8 -0.636 . . . . 0.75 113.06 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.4 tp -93.82 -19.85 20.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.226 -0.573 . . . . 1.39 110.153 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -46.01 91.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.174 -0.466 . . . . 1.63 110.461 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.9 pttp -57.42 -40.7 78.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.677 0.621 . . . . 3.26 112.677 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.68 -36.01 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.263 -0.575 . . . . 1.97 110.73 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 75.8 t -64.03 -36.45 76.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.125 0.488 . . . . 1.64 110.757 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.39 -31.34 70.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.04 -0.527 . . . . 1.22 110.465 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 158' ' ' LYS . 73.0 t -83.55 -27.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 2.07 111.476 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.3 pp -70.77 -13.39 62.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.222 0.534 . . . . 1.95 110.31 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.42 -24.8 65.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.85 -0.613 . . . . 2.31 110.211 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.3 m -83.41 -1.64 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.31 . . . . 1.78 111.556 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 163' ' ' LEU . 47.2 pt -139.67 26.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 1.42 109.962 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 229' ' ' ASN . 48.9 pttt -74.89 16.15 0.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.038 -0.528 . . . . 1.98 112.334 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.76 140.23 46.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.902 0.382 . . . . 1.4 110.408 174.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.32 120.16 7.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 2.84 111.876 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.49 30.72 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.631 -0.795 . . . . 0.85 112.462 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -88.17 148.98 24.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.908 0.385 . . . . 2.22 110.687 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 11.6 p -145.57 157.28 44.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.874 -0.603 . . . . 1.93 110.158 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -147.61 149.43 32.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.67 0.271 . . . . 1.17 110.52 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.97 136.79 46.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.017 0.437 . . . . 1.8 110.268 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -140.55 79.91 1.73 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.797 -0.816 . . . . 1.31 108.797 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.3 p -109.44 159.86 16.68 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.275 0.472 . . . . 1.69 112.275 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.35 47.16 21.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.509 -0.769 . . . . 2.26 112.345 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.13 98.29 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.891 0.377 . . . . 4.84 110.186 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.08 136.25 82.19 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.884 -0.598 . . . . 2.51 111.136 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.03 -4.27 13.18 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.123 2.549 . . . . 1.47 112.226 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -55.07 -42.68 73.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.872 -0.604 . . . . 3.16 112.136 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -58.97 -13.55 19.87 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 116.176 -0.465 . . . . 1.12 113.675 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.21 -7.65 44.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.852 0.326 . . . . 2.37 111.168 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.62 128.78 68.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 3.87 110.595 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.07 -178.39 4.15 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.827 2.351 . . . . 2.51 112.527 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.81 -63.21 1.46 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.561 0.219 . . . . 3.23 110.749 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.0 m -70.41 130.42 41.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 2.03 110.712 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.04 62.55 0.6 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.255 0.55 . . . . 2.5 110.107 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -94.21 128.28 40.56 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.329 -0.989 . . . . 1.81 108.329 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 52.6 p90 -139.66 147.45 41.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.067 0.766 . . . . 5.32 113.067 -169.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 28.6 m-90 -86.76 135.84 33.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.286 -0.87 . . . . 4.55 108.928 169.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 192' ' ' THR . 7.1 t -119.69 103.26 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.641 0.734 . . . . 2.39 110.346 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.473 ' HB3' ' CE2' ' A' ' 208' ' ' TRP . 4.6 t80 -137.48 137.08 21.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.098 -0.501 . . . . 5.32 110.783 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -89.56 128.83 1.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.745 2.297 . . . . 2.47 112.279 173.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.09 157.65 25.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.276 -0.487 . . . . 2.0 112.696 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 201' ' ' PRO . 1.7 m -65.41 148.41 51.75 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.395 -0.594 . . . . 3.36 109.395 174.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.52 HD13 ' SG ' ' A' ' 205' ' ' CYS . 8.2 mp -56.4 -53.29 59.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.285 0.476 . . . . 5.18 112.285 -168.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 18.0 m -125.58 -45.98 1.76 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.95 0.405 . . . . 5.53 110.13 166.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.73 -55.7 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.103 -0.953 . . . . 5.89 111.177 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.485 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 52.3 Cg_exo -53.12 -44.49 48.44 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.276 1.984 . . . . 6.31 113.581 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 12.2 Cg_exo -73.9 78.53 2.48 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.559 1.506 . . . . 5.26 110.398 169.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 65.0 mt -51.56 -27.24 10.37 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.348 1.03 . . . . 4.29 113.327 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 196' ' ' SER . 42.9 tp -53.54 145.25 15.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.29 0.567 . . . . 3.51 110.967 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.44 ' HB3' ' CB ' ' A' ' 26' ' ' GLU . 12.2 pt-20 -95.96 41.46 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 3.37 109.57 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 197' ' ' LEU . 4.6 p -84.11 2.49 39.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 2.47 112.362 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.433 ' CG2' ' HG ' ' A' ' 197' ' ' LEU . 73.7 t -105.03 129.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 120.95 0.405 . . . . 1.74 109.943 175.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.3 m -107.76 100.83 10.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.715 -0.846 . . . . 2.3 108.715 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.541 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 4.4 p-90 -90.24 100.96 13.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.914 0.864 . . . . 6.37 111.72 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 51.3 mm -88.85 105.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.065 -1.425 . . . . 2.32 109.671 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.1 t -106.78 128.99 61.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.965 -0.294 . . . . 2.1 110.544 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -85.89 140.85 30.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.419 0.628 . . . . 2.35 111.448 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -83.86 -21.71 31.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.149 -0.932 . . . . 3.47 110.92 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -88.33 113.38 55.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.271 -0.422 . . . . 1.56 109.873 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.93 155.81 15.25 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.668 2.245 . . . . 1.37 113.11 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.417 ' HB ' HD21 ' A' ' 147' ' ' LEU . 26.8 mm -106.19 146.44 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.771 -0.649 . . . . 1.85 109.609 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 15.1 m -99.57 127.93 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.451 -0.34 . . . . 1.78 111.322 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.9 m -122.48 151.51 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.921 -0.77 . . . . 1.64 108.921 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.485 ' HB2' ' CA ' ' A' ' 152' ' ' ALA . 8.0 t -97.1 163.82 12.77 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.277 -0.569 . . . . 1.52 111.159 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.528 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 24.9 m -50.82 -50.62 56.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 1.81 111.886 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -50.98 -36.29 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.934 0.397 . . . . 2.51 111.573 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.95 -48.32 54.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.146 -0.479 . . . . 1.02 110.894 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.418 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 29.4 m -74.92 -22.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 1.88 111.277 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 219' ' ' SER . 94.7 mt -68.28 -45.2 73.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.032 -0.359 . . . . 1.59 110.032 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -67.8 -29.46 68.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 2.3 110.659 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.49 -42.49 82.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 3.18 110.041 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 67.0 ttt180 -73.93 10.88 1.01 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.72 -0.673 . . . . 3.55 111.011 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.46 -8.6 38.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.06 -0.348 . . . . 2.74 110.06 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.81 132.45 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.08 -0.509 . . . . 1.66 111.039 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 167' ' ' LYS . 0.9 OUTLIER -101.53 140.41 35.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.907 -0.588 . . . . 1.13 110.218 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -78.86 -34.94 44.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.781 -1.099 . . . . 4.38 109.668 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.6 p-10 -70.8 163.86 26.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.84 -1.073 . . . . 1.62 111.875 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.92 174.4 51.25 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.231 -0.895 . . . . 1.16 111.197 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.55 127.5 32.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.95 0.375 . . . . 3.56 110.062 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.22 -2.58 56.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.859 -0.686 . . . . 2.23 112.635 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 41.3 mt-10 -102.2 159.97 27.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.065 -0.346 . . . . 2.59 110.065 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.96 128.68 30.89 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.181 . . . . 1.5 111.519 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -59.38 125.63 24.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 3.4 112.734 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 44.8 mt-10 -130.57 150.24 51.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.091 -1.078 . . . . 2.47 108.091 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.7 mt -90.97 133.38 35.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.525 -0.47 . . . . 2.6 110.866 -175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 ttm -76.83 89.3 3.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.359 -0.978 . . . . 1.94 108.359 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 99' ' ' SER . 21.7 m -133.55 153.24 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 1.67 110.198 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.4 t70 67.36 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.004 0.815 . . . . 2.18 110.356 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 43.39 32.22 0.48 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.555 0.534 . . . . 2.64 111.743 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -104.5 136.66 43.65 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.082 0.468 . . . . 5.31 110.597 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.528 ' H ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -70.3 144.3 91.93 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.267 -0.879 . . . . 6.91 110.434 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.63 131.93 43.49 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.792 2.328 . . . . 3.72 111.965 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.99 132.37 49.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 3.34 111.584 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.474 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 66.8 mm-40 -85.17 172.79 8.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.854 -0.795 . . . . 4.92 108.854 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.549 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 73.4 Cg_exo -43.06 110.51 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.406 2.071 . . . . 4.01 112.03 174.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -58.42 4.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.443 -1.253 . . . . 4.9 113.586 -167.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -69.59 -7.0 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.624 0.972 . . . . 5.68 113.624 -173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.714 ' HA ' ' NE2' ' A' ' 28' ' ' GLN . 7.7 p30 36.33 54.27 1.03 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.718 1.007 . . . . 5.11 113.718 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 252' ' ' ASN . 13.4 mmt180 76.11 -89.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.391 -0.596 . . . . 6.74 109.391 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.47 136.52 21.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.975 -1.12 . . . . 3.08 107.975 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 38' ' ' ALA . 17.0 mt -94.24 150.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.691 0.281 . . . . 3.06 111.033 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -104.55 131.44 51.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 3.01 110.558 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.31 97.55 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.256 -0.429 . . . . 1.99 110.164 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.3 p -95.73 96.46 9.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.367 -0.533 . . . . 2.47 111.609 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 257' ' ' ALA . 24.8 p90 -166.71 154.4 9.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 5.03 110.047 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.491 ' HZ1' ' HB3' ' A' ' 260' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.997 -0.547 . . . . 4.82 110.605 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.999 -0.371 . . . . 17.73 109.999 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.1 t 68.17 98.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.505 0.669 . . . . 15.49 111.57 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -98.93 23.53 8.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.254 -0.647 . . . . 16.29 109.254 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -87.97 94.51 9.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.596 -0.729 . . . . 14.68 110.709 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -84.4 86.1 7.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.34 0.591 . . . . 15.53 109.933 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.26 154.33 23.39 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.097 -0.801 . . . . 10.81 111.097 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -92.24 97.08 10.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.764 0.792 . . . . 11.61 110.622 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.93 -87.08 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.251 -1.34 . . . . 9.0 110.649 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -74.81 117.86 17.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.581 -0.896 . . . . 10.04 108.581 172.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.2 m80 56.65 174.81 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.335 0.588 . . . . 11.67 111.184 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 245' ' ' ARG . 7.2 m120 -113.18 13.55 19.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.64 0.733 . . . . 11.18 110.024 174.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.33 160.16 28.21 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.261 -1.536 . . . . 8.9 109.261 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.89 121.14 9.08 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 CA-C-N 119.302 1.551 . . . . 8.2 111.804 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.35 2.4 50.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.913 -0.585 . . . . 10.62 112.116 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -114.91 -26.32 7.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.97 0.414 . . . . 10.41 110.949 -176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -76.89 -15.06 59.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.13 -0.487 . . . . 9.19 111.059 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.26 -15.66 62.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 7.71 110.459 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -87.69 -30.65 20.22 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.129 0.49 . . . . 10.03 109.893 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.57 -32.22 65.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.766 -0.652 . . . . 7.89 110.389 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.434 ' HB3' HG23 ' A' ' 22' ' ' ILE . 95.9 m-85 -124.65 98.18 37.78 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.425 -0.807 . . . . 7.65 109.862 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 50.0 Cg_exo -54.93 -29.13 62.54 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.387 2.725 . . . . 8.15 112.92 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' A' ' 20' ' ' PHE . 14.5 tt -44.82 -28.17 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 113.073 0.768 . . . . 6.15 113.073 175.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.48 -10.12 7.1 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.83 0.678 . . . . 5.72 112.83 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 34.1 mmtp -59.82 -16.16 26.29 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 122.154 -0.341 . . . . 8.17 111.293 168.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.67 -73.48 0.92 Allowed Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.321 -0.712 . . . . 5.05 111.321 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.49 168.73 1.06 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 122.753 0.421 . . . . 7.09 110.022 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 165.42 29.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 104.878 -2.267 . . . . 5.44 104.878 -165.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -55.97 -50.0 72.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.753 1.161 . . . . 7.33 112.342 -166.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 248' ' ' GLN . 70.3 m -94.44 145.34 29.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.424 -0.353 . . . . 4.35 110.327 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.555 ' HA ' ' OG ' ' A' ' 196' ' ' SER . 74.4 Cg_endo -75.72 -41.88 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.032 2.488 . . . . 4.96 115.588 -166.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 193' ' ' TYR . 7.4 p -161.54 157.09 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.715 -0.394 . . . . 5.07 111.846 -174.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.464 ' CB ' ' HG2' ' A' ' 248' ' ' GLN . 32.2 t70 -163.01 132.9 4.35 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.109 -0.7 . . . . 3.14 109.109 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 54.2 mt -101.98 103.57 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.904 0.705 . . . . 2.71 112.904 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -93.69 102.14 14.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.053 -0.721 . . . . 2.82 109.053 165.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 m -56.99 -28.46 62.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 2.71 112.353 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -69.84 -34.27 73.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.563 0.221 . . . . 5.23 111.281 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -85.7 -23.29 27.46 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.955 -0.298 . . . . 3.38 111.126 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -61.54 105.28 0.51 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.283 0.563 . . . . 1.76 111.716 174.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.28 138.05 36.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.526 -0.761 . . . . 4.05 111.235 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 99.2 m-85 -73.93 132.41 42.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.529 . . . . 4.9 110.112 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -120.81 124.09 27.67 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.427 -0.351 . . . . 2.27 110.725 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.35 -23.22 44.72 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.767 2.312 . . . . 2.45 112.036 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 m -65.7 -27.81 68.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.524 . . . . 4.62 111.396 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.7 mt -70.52 119.26 14.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.028 0.442 . . . . 5.15 111.01 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 59.0 tttm -99.29 131.43 25.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.407 -0.815 . . . . 4.21 109.294 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.3 154.44 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.862 3.041 . . . . 2.76 114.034 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.64 125.21 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.066 -0.97 . . . . 2.93 110.729 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 m -96.87 98.42 10.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.239 -0.652 . . . . 2.46 109.239 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.414 HG23 ' HG ' ' A' ' 79' ' ' LEU . 8.9 t -102.9 127.98 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.912 -0.585 . . . . 2.17 110.649 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -129.58 91.4 3.15 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.82 -0.437 . . . . 1.87 109.82 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.517 ' HH ' ' HB2' ' A' ' 181' ' ' ARG . 7.8 p90 -106.35 11.63 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.864 0.364 . . . . 3.97 110.92 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 2.48 111.067 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 48.9 mt-30 -94.33 6.17 49.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.987 -0.552 . . . . 2.54 111.964 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.51 133.72 49.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 1.41 111.603 -172.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -113.38 106.24 14.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 1.41 110.467 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 m -72.34 138.05 47.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.162 -0.472 . . . . 1.84 109.832 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 71' ' ' ASP . 82.6 mt -113.74 -58.21 2.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 1.45 112.427 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -158.9 161.44 36.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.868 0.366 . . . . 3.72 111.448 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -121.17 133.2 68.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.651 -0.87 . . . . 1.35 108.651 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 57.9 tp -137.3 119.05 15.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.56 0.578 . . . . 1.53 112.56 -171.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -79.18 114.06 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.102 -1.073 . . . . 1.49 108.102 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.434 ' HA ' ' HG3' ' A' ' 169' ' ' LYS . 53.8 t30 -140.34 70.59 1.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.654 -0.819 . . . . 2.18 112.423 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 103.27 -67.01 0.33 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.137 -1.03 . . . . 2.0 113.132 162.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.477 ' HB3' ' OD1' ' A' ' 243' ' ' ASN . 51.7 m80 -103.82 -27.55 12.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.048 0.452 . . . . 4.11 110.895 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.96 -169.98 2.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.755 -0.657 . . . . 1.78 110.159 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 95' ' ' PHE . 34.8 p90 -133.8 134.03 42.37 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.271 -1.011 . . . . 3.48 108.271 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 8.3 p30 -132.71 151.87 51.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.055 0.455 . . . . 1.99 111.398 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 98.2 t -106.46 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 1.75 109.84 176.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.39 138.38 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.464 . . . . 2.02 111.417 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.82 150.69 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.339 -0.846 . . . . 2.19 109.135 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.429 ' HB2' HD21 ' A' ' 57' ' ' LEU . 22.4 t70 -75.2 124.44 27.06 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.009 -0.367 . . . . 1.33 110.009 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -125.81 58.31 1.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.08 0.943 . . . . 2.65 110.448 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 p -96.41 -5.25 40.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.51 -0.768 . . . . 2.01 109.75 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -143.17 157.69 44.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.834 -1.075 . . . . 2.35 108.813 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.58 70.25 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.549 0.69 . . . . 1.92 109.769 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 68.5 mttm -92.75 -54.64 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.287 -0.869 . . . . 2.31 111.538 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.5 110.42 21.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.282 -0.417 . . . . 1.44 110.283 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.75 144.24 34.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.392 -0.367 . . . . 1.82 110.613 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 49' ' ' VAL . 9.6 tt -149.9 113.04 4.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.707 -0.849 . . . . 1.8 108.707 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -151.43 127.44 10.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.156 0.503 . . . . 3.02 111.385 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -67.89 174.01 30.01 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.784 -0.644 . . . . 1.44 111.635 164.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 45' ' ' LYS . . . -39.2 -142.73 0.0 OUTLIER Glycine 0 N--CA 1.472 1.076 0 N-CA-C 115.813 1.085 . . . . 2.15 115.813 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.52 121.32 6.95 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 121.856 1.704 . . . . 3.17 112.37 -173.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.521 ' HB3' ' HH ' ' A' ' 88' ' ' TYR . 70.8 mt -147.81 -168.17 3.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.528 -1.214 . . . . 4.55 108.713 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.707 ' H ' ' HH ' ' A' ' 88' ' ' TYR . 7.1 m-20 -129.24 70.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.444 0.535 . . . . 4.95 112.444 -174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 131.19 -125.56 4.5 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.794 -1.193 . . . . 2.25 115.072 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.77 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 85.6 m -131.51 115.68 16.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.692 -0.754 . . . . 2.12 109.755 -169.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.707 ' HH ' ' H ' ' A' ' 85' ' ' ASP . 78.7 m-85 -115.01 91.36 3.59 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.037 -0.665 . . . . 3.88 111.739 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.29 142.49 34.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 3.87 110.109 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -73.77 121.86 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 1.68 110.331 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.455 HG22 ' HG2' ' A' ' 92' ' ' GLN . 5.2 tp -107.92 -38.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 2.16 111.088 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 8.7 pt20 -170.25 168.06 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.625 -0.262 . . . . 1.95 110.498 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 41.6 p90 -141.31 145.89 36.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.648 -0.501 . . . . 0.98 109.648 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.8 p-80 -128.9 159.81 34.63 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.329 0.393 . . . . 1.07 110.695 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 t80 -135.74 158.13 45.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.959 -0.386 . . . . 3.99 109.959 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -162.65 171.12 17.37 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.734 0.302 . . . . 2.2 111.713 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.506 ' CZ2' ' HB ' ' A' ' 222' ' ' VAL . 23.1 m95 -138.99 148.74 43.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.588 -0.733 . . . . 6.08 110.459 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' N ' ' HA3' ' A' ' 104' ' ' GLY . . . -79.18 -37.38 25.02 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 116.022 -0.535 . . . . 2.19 113.499 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.503 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 47.1 t 162.93 -70.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.57 0.748 . . . . 3.08 109.35 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.38 158.33 26.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.359 -0.837 . . . . 3.48 109.68 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.22 62.05 0.13 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.558 0.536 . . . . 3.85 111.463 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.23 32.31 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.649 -0.786 . . . . 2.37 113.029 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.503 ' NE2' ' HB3' ' A' ' 99' ' ' SER . 13.6 pt20 -161.29 157.21 25.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.898 0.349 . . . . 2.62 110.485 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.485 ' HA3' ' N ' ' A' ' 98' ' ' GLY . . . 99.11 45.92 2.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.867 -0.682 . . . . 1.62 112.482 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 45.2 t -103.88 -28.4 11.62 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.284 -0.166 . . . . 2.24 111.264 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 105' ' ' SER . 8.5 tp10 68.07 169.3 0.27 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.196 -0.668 . . . . 3.72 109.196 -167.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.6 m170 60.59 35.13 20.07 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.482 0.658 . . . . 4.03 110.414 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.468 ' CG2' ' HA ' ' A' ' 113' ' ' LYS . 73.2 p -82.73 119.59 24.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.167 -0.924 . . . . 2.99 111.637 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 87.9 t -76.42 117.0 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.214 -0.903 . . . . 2.88 109.878 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.71 35.42 16.93 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.128 -0.693 . . . . 2.8 109.128 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.7 mttp 59.91 27.49 16.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.073 -0.967 . . . . 5.35 112.342 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -77.3 86.87 3.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.114 -0.328 . . . . 3.58 110.114 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 98.9 mttt -61.69 113.05 2.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.066 0.46 . . . . 3.26 111.477 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -83.88 177.34 8.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.551 -0.75 . . . . 1.71 109.108 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.86 -53.7 54.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.914 0.338 . . . . 1.57 111.914 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.2 169.56 4.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.124 -0.325 . . . . 1.3 110.124 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -148.94 141.81 24.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.987 -0.375 . . . . 1.85 109.987 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 34.5 tp -99.74 125.89 45.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.871 -0.604 . . . . 1.61 109.493 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.447 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.4 m170 -110.69 107.9 17.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 2.25 111.516 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 5.4 mp -93.39 113.35 25.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.786 -0.643 . . . . 1.51 110.19 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.04 127.65 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.294 0.569 . . . . 1.24 111.527 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.9 139.88 50.5 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.017 -1.105 . . . . 2.86 108.017 172.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.94 154.36 46.64 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.57 -0.452 . . . . 4.96 111.559 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.77 ' HA ' ' O ' ' A' ' 87' ' ' THR . 53.1 t30 -76.43 89.58 3.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 2.3 110.988 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.9 p -73.45 -9.2 58.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.538 0.94 . . . . 2.77 113.538 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 13.5 ptmm? -71.52 -46.02 60.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.963 -0.695 . . . . 3.79 109.736 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.496 ' CG ' ' HG3' ' A' ' 132' ' ' LYS . 67.6 m-85 -94.19 -15.56 24.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 3.34 111.138 173.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 129' ' ' ASP . . . 101.23 -1.04 54.2 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.835 -0.698 . . . . 2.37 111.57 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 128' ' ' GLY . 32.8 t70 81.52 -78.16 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.834 0.854 . . . . 3.93 112.185 172.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -56.3 -19.87 16.26 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.438 0.903 . . . . 3.6 113.438 -168.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.09 -67.52 1.62 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.723 -0.751 . . . . 2.35 112.165 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.496 ' HG3' ' CG ' ' A' ' 127' ' ' TYR . 45.0 mmtm -72.13 -21.25 61.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.416 0.524 . . . . 3.75 112.416 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.63 56.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 2.17 111.427 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.62 -36.29 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 3.11 110.418 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -106.4 -24.66 12.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.661 0.267 . . . . 3.55 111.283 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -95.47 105.13 18.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 3.02 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 72.4 Cg_endo -76.52 -0.46 10.45 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.424 2.083 . . . . 1.93 112.419 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.53 27.07 10.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.425 -0.352 . . . . 2.29 110.39 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.87 -53.92 8.96 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 120.808 -0.711 . . . . 1.5 112.849 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 91.5 mt -89.32 151.0 22.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 1.98 110.784 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.47 106.63 5.75 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.485 -0.78 . . . . 1.83 109.286 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 44.4 t -107.3 117.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.457 -0.338 . . . . 2.28 110.803 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.99 126.18 33.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.833 -0.621 . . . . 2.89 109.62 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.19 115.43 4.45 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.737 -0.744 . . . . 0.95 112.638 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.6 mt -104.91 111.48 34.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.137 -0.319 . . . . 1.38 110.137 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -67.99 144.61 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.695 0.283 . . . . 1.37 110.981 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.2 mp -115.71 131.94 56.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.43 -0.35 . . . . 1.48 110.315 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -121.5 143.91 49.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.147 -0.686 . . . . 2.52 109.147 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 42.5 t -88.43 129.6 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 1.88 111.374 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.59 -104.12 0.18 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.532 -0.758 . . . . 1.53 111.279 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 p -81.66 146.73 29.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.197 -0.297 . . . . 2.08 110.197 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.33 148.86 47.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.086 0.469 . . . . 1.36 111.621 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 216' ' ' SER . 49.3 tptt -111.5 103.76 55.39 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 1.78 109.444 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.83 -38.11 94.89 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.002 2.468 . . . . 1.34 112.299 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.46 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -62.13 -29.21 72.18 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 116.031 -0.531 . . . . 0.75 113.035 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.5 tp -94.48 -17.58 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.271 0.535 . . . . 1.39 110.392 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -43.78 92.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.828 -0.624 . . . . 1.63 110.233 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.0 pttt -56.87 -32.39 65.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 3.26 111.853 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.6 t -77.07 -41.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 1.97 110.47 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 156' ' ' LEU . 72.4 t -57.57 -36.93 55.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.745 -0.662 . . . . 1.64 111.331 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.02 -20.6 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.56 . . . . 1.22 112.405 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.0 t -96.6 -7.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.902 0.382 . . . . 2.07 111.332 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 84.6 mt -57.66 -42.1 82.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.854 0.687 . . . . 1.95 112.854 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.94 -24.81 66.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.81 0.338 . . . . 2.31 111.386 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.0 m -81.15 -8.98 59.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.476 -0.329 . . . . 1.78 111.26 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -134.21 36.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.364 0.602 . . . . 1.42 109.739 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.58 -32.92 74.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 1.98 111.451 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.9 p -116.93 155.73 28.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.888 0.375 . . . . 1.4 111.528 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.434 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 42.5 tttm -59.73 132.42 53.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.868 -0.605 . . . . 2.84 110.611 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.36 -17.14 40.73 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.756 -0.735 . . . . 0.85 111.555 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -75.28 107.83 7.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.941 0.4 . . . . 2.22 110.602 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.0 m -98.95 140.74 32.65 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.262 -0.644 . . . . 1.93 109.262 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.28 129.35 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.825 -0.435 . . . . 1.17 109.825 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.45 134.13 56.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 1.8 109.825 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.41 79.85 1.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.833 . . . . 1.31 108.752 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.0 p -105.27 152.87 22.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 1.69 112.095 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.27 62.98 2.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.724 -0.671 . . . . 2.26 112.131 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -134.67 98.1 3.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 4.84 110.768 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.15 140.44 88.15 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.822 -0.626 . . . . 2.51 111.112 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.16 -3.48 13.15 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.178 2.585 . . . . 1.47 112.17 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.517 ' HB2' ' HH ' ' A' ' 51' ' ' TYR . 40.0 ttp180 -55.5 -42.59 74.67 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.863 -0.608 . . . . 3.16 112.302 -175.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -63.0 -16.95 58.1 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.046 -0.597 . . . . 1.12 113.285 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.75 -16.26 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 2.37 110.948 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.05 133.8 36.42 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.456 . . . . 3.87 110.896 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.61 -170.47 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.921 2.414 . . . . 2.51 112.426 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.63 -49.87 60.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.621 0.248 . . . . 3.23 111.601 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.6 m -94.73 141.19 28.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 2.03 110.732 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.5 64.09 0.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.534 0.683 . . . . 2.5 109.735 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.434 ' O ' HD13 ' A' ' 211' ' ' LEU . 0.9 OUTLIER -80.45 163.59 23.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.514 -0.766 . . . . 1.81 109.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.704 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 30.6 p90 -165.57 142.88 5.68 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.679 -0.408 . . . . 5.32 110.872 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -123.91 106.64 10.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.026 -1.102 . . . . 4.55 108.026 170.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -82.61 121.48 26.87 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.811 0.671 . . . . 2.39 112.811 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.446 ' CD1' HG22 ' A' ' 31' ' ' VAL . 83.7 t80 -137.21 131.9 17.82 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.773 . . . . 5.32 110.387 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.77 129.36 20.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.738 2.292 . . . . 2.47 112.379 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.499 ' HA3' ' NE1' ' A' ' 208' ' ' TRP . . . -119.8 157.03 15.69 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.389 -0.434 . . . . 2.0 113.006 -174.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.555 ' OG ' ' HA ' ' A' ' 30' ' ' PRO . 22.7 p -107.15 143.68 34.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.41 0.624 . . . . 3.36 111.801 -175.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 203' ' ' LEU . 55.5 mt -90.77 19.56 5.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.224 -0.898 . . . . 5.18 110.704 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.93 27.31 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.6 1.704 . . . . 5.53 115.6 -161.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.693 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 46.2 p -80.25 -154.29 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 107.182 -1.414 . . . . 5.89 107.182 166.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.693 ' CD ' ' HB ' ' A' ' 199' ' ' THR . 84.3 Cg_exo -48.02 -44.76 27.07 Favored 'Trans proline' 0 C--N 1.364 1.361 0 CA-C-N 122.512 1.933 . . . . 6.31 114.069 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 2.7 Cg_exo -78.51 79.0 3.45 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.125 1.883 . . . . 5.26 111.689 172.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.13 80.48 0.96 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.847 -0.615 . . . . 4.29 112.079 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 30.9 tp -152.05 120.5 6.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.815 -0.175 . . . . 3.51 111.335 172.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 5.6 pt-20 -80.83 109.79 15.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.543 0.687 . . . . 3.37 111.03 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 23.5 p -140.67 21.96 2.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.944 0.402 . . . . 2.47 110.668 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -104.8 138.12 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.005 0.431 . . . . 1.74 111.185 -176.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.6 m -112.84 111.83 22.88 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.074 -0.713 . . . . 2.3 109.074 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.499 ' NE1' ' HA3' ' A' ' 195' ' ' GLY . 97.4 m95 -81.97 116.78 21.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.648 0.261 . . . . 6.37 110.476 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 38.4 mm -101.73 98.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.695 -0.854 . . . . 2.32 108.695 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 38.1 t -85.67 116.99 29.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 2.1 111.937 -174.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 189' ' ' ASP . 56.0 tp -80.23 113.89 18.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.846 -0.427 . . . . 2.35 109.846 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 6.2 tmmm? -60.99 -21.62 63.72 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.399 0.518 . . . . 3.47 112.399 -176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -99.64 106.07 37.83 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 111.874 0.324 . . . . 1.56 111.874 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 10.1 Cg_exo -73.77 138.55 26.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.059 2.506 . . . . 1.37 111.689 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -91.58 152.12 3.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.839 0.352 . . . . 1.85 110.334 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 3.1 p -96.08 122.29 38.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.959 -0.564 . . . . 1.78 111.147 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.5 m -123.75 153.18 29.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 1.64 109.791 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 t -88.19 158.97 18.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.592 0.234 . . . . 1.52 111.23 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.476 ' HA ' HG21 ' A' ' 222' ' ' VAL . 29.6 t -54.6 -42.85 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 1.81 110.513 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -56.31 -27.3 55.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.51 111.78 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.2 -49.75 9.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.343 -0.389 . . . . 1.02 110.15 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.506 ' HB ' ' CZ2' ' A' ' 97' ' ' TRP . 35.1 m -66.51 -31.13 52.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 1.88 111.27 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.644 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 89.6 mt -60.52 -39.77 89.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 1.59 110.673 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -74.46 -25.03 59.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.12 -0.491 . . . . 2.3 111.157 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.69 -28.86 61.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.201 0.524 . . . . 3.18 109.749 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -86.29 -3.35 58.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.92 -0.582 . . . . 3.55 110.279 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.5 mmtt -88.05 -9.3 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 2.74 109.948 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.37 150.14 45.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.659 -0.7 . . . . 1.66 110.722 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -108.26 142.93 37.81 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.532 0.682 . . . . 1.13 110.393 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -78.49 -32.19 48.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.592 -1.185 . . . . 4.38 109.166 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -76.98 169.98 17.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.93 -1.032 . . . . 1.62 111.987 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 169' ' ' LYS . . . -96.34 179.05 34.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.006 -0.997 . . . . 1.16 111.204 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.52 137.67 57.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 3.56 110.426 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.17 62.69 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 2.23 112.894 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.49 153.26 69.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 117.085 0.443 . . . . 2.59 109.838 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.8 125.1 17.96 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.348 2.032 . . . . 1.5 111.187 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.422 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.8 pt-20 -64.16 127.57 32.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.577 0.703 . . . . 3.4 112.325 -172.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.79 124.05 38.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.768 -1.106 . . . . 2.47 108.365 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.14 145.89 55.28 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.956 0.408 . . . . 2.6 111.159 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 30.6 mtt -65.81 102.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.647 -0.706 . . . . 1.94 110.074 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.35 142.04 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.567 -0.742 . . . . 1.67 110.436 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 244' ' ' TRP . 38.9 t70 68.35 -90.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.326 -0.852 . . . . 2.18 110.487 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.477 ' OD1' ' HB3' ' A' ' 64' ' ' HIS . 47.8 t30 65.75 -23.46 0.09 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.313 0.857 . . . . 2.64 113.313 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.438 ' H ' ' C ' ' A' ' 242' ' ' ASP . 63.3 t-105 -146.85 134.04 20.52 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.674 -0.641 . . . . 5.31 111.323 -169.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.489 ' CD ' ' H ' ' A' ' 245' ' ' ARG . 0.1 OUTLIER -93.22 102.57 7.54 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.222 -0.899 . . . . 6.91 108.975 174.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 245' ' ' ARG . 4.2 Cg_exo -74.83 -91.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.888 2.392 . . . . 3.72 115.101 -166.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.24 129.88 38.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.873 0.694 . . . . 3.34 112.873 -159.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 29' ' ' SER . 24.5 pt20 -82.53 179.16 2.04 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.575 -0.739 . . . . 4.92 110.176 171.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 248' ' ' GLN . 69.0 Cg_exo -53.83 132.79 51.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.829 1.686 . . . . 4.01 111.58 170.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.9 -39.68 19.62 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.666 -1.152 . . . . 4.9 112.606 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 253' ' ' ARG . 22.3 ptmt -61.29 -12.19 12.63 Favored 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 115.654 1.724 . . . . 5.68 115.654 -176.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 9.2 p30 37.82 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 118.806 2.891 . . . . 5.11 118.806 165.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 252' ' ' ASN . 35.2 ttm180 142.98 -118.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.399 1.88 . . . . 6.74 105.964 -163.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' A' ' 253' ' ' ARG . 19.5 tt0 -146.27 128.74 15.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.246 -1.39 . . . . 3.08 107.246 161.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 60.8 mt -91.04 146.37 6.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.783 -0.451 . . . . 3.06 109.783 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -116.61 137.03 52.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 3.01 110.499 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.25 160.64 24.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.19 -0.914 . . . . 1.99 109.503 -176.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 32.9 t -143.17 98.02 3.19 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.053 -0.659 . . . . 2.47 111.502 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -132.87 90.88 2.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.916 . . . . 5.03 108.584 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.243 0.736 0 CA-C-O 118.364 -0.827 . . . . 4.82 110.518 -176.699 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 246' ' ' PRO . 66.6 mtt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.747 0.308 . . . . 17.73 110.754 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -70.9 129.82 40.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.033 0.444 . . . . 15.49 111.146 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -133.25 49.16 2.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.994 -0.548 . . . . 16.29 109.59 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -67.15 112.93 4.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 14.68 110.094 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.2 t-105 71.05 -60.96 0.5 Allowed 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.989 0.806 . . . . 15.53 111.408 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.98 129.93 10.06 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.758 -0.735 . . . . 10.81 111.964 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -91.06 96.4 10.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.121 0.486 . . . . 11.61 110.463 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.35 -71.06 0.51 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.407 -1.077 . . . . 9.0 110.407 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' PRO . 54.1 mtpt -91.47 170.26 10.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.547 -0.908 . . . . 10.04 108.547 170.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -59.83 -51.86 67.93 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.776 -0.37 . . . . 11.67 110.347 177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -83.81 -15.87 46.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.402 0.62 . . . . 11.18 110.387 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.444 ' HA2' ' HD3' ' A' ' 13' ' ' PRO . . . 110.84 137.46 7.46 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.635 -0.712 . . . . 8.9 111.581 -176.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.444 ' HD3' ' HA2' ' A' ' 12' ' ' GLY . 5.1 Cg_exo -77.95 128.26 9.07 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.563 2.175 . . . . 8.2 111.781 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.43 -19.86 61.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.515 0.674 . . . . 10.62 109.89 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -109.66 27.61 9.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.054 -0.975 . . . . 10.41 110.038 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -64.15 -22.44 66.94 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.816 0.817 . . . . 9.19 109.108 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -48.48 -48.9 37.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.246 -1.343 . . . . 7.71 109.753 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -93.07 -42.2 9.54 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.159 0.429 . . . . 10.03 112.159 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.68 16.95 0.59 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.001 1.112 . . . . 7.89 114.001 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -152.67 105.83 2.71 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.758 -0.83 . . . . 7.65 108.758 -170.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.434 ' O ' HG23 ' A' ' 22' ' ' ILE . 88.2 Cg_exo -41.98 126.19 3.42 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.013 2.476 . . . . 8.15 113.133 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 21' ' ' PRO . 10.5 tp 53.8 44.52 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.936 1.294 . . . . 6.15 112.474 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.15 6.03 32.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.544 . . . . 5.72 111.376 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 24' ' ' LYS . 3.2 mmmp? -85.67 -6.98 59.07 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.954 -0.758 . . . . 8.17 108.954 173.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 170.42 78.03 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.651 -1.38 . . . . 5.05 109.651 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -48.55 149.2 1.73 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.028 0.751 . . . . 7.09 113.028 -172.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -136.9 176.1 9.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.898 -1.046 . . . . 5.44 110.052 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.491 ' H ' ' NE2' ' A' ' 28' ' ' GLN . 2.2 mp0 -48.1 105.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.935 0.874 . . . . 7.33 111.895 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.458 ' H ' ' HG2' ' A' ' 253' ' ' ARG . 18.8 m -102.74 162.45 20.13 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 113.977 -1.465 . . . . 4.35 112.007 -175.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HG2' ' HG2' ' A' ' 245' ' ' ARG . 34.5 Cg_exo -43.06 39.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 1 C-N-CA 127.116 5.21 . . . . 4.96 116.564 165.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 248' ' ' GLN . 15.7 m -88.64 -175.14 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.326 0.584 . . . . 5.07 111.247 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.662 ' HA ' ' OG1' ' A' ' 108' ' ' THR . 31.7 t70 -98.56 108.35 21.02 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.978 -0.749 . . . . 3.14 108.978 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 110' ' ' ASP . 72.4 mt -67.47 126.95 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.807 -0.633 . . . . 2.71 110.917 -173.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.8 114.6 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.93 -0.577 . . . . 2.82 110.489 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -63.69 -31.54 72.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.71 111.728 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -76.19 -4.4 41.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.815 0.34 . . . . 5.23 111.533 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.0 m -102.41 -8.22 21.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.464 0.649 . . . . 3.38 109.929 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -78.2 120.39 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 1.76 110.758 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -95.41 132.34 40.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.252 -0.431 . . . . 4.05 110.232 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.72 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 27.4 m-85 -82.46 130.28 35.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.486 0.66 . . . . 4.9 111.883 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 258' ' ' SER . 25.3 t70 -125.2 140.55 36.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 2.27 109.248 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.96 90.94 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.801 2.334 . . . . 2.45 113.295 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.1 t -60.28 -38.18 82.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.933 -0.576 . . . . 4.62 110.392 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt 72.21 -67.1 0.27 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.464 -0.789 . . . . 5.15 111.996 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -101.44 128.08 30.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.51 0.195 . . . . 4.21 110.979 -175.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.55 160.91 26.13 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.048 2.499 . . . . 2.76 111.874 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 11.0 mp -80.0 143.76 33.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.368 0.507 . . . . 2.93 112.368 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -106.86 99.41 8.98 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.317 -0.856 . . . . 2.46 108.723 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 t -117.0 108.1 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.028 -0.533 . . . . 2.17 110.268 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.6 m -102.12 89.46 3.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.077 -0.51 . . . . 1.87 109.705 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -101.57 3.43 40.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.94 -0.763 . . . . 3.97 108.94 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.58 -33.06 69.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.45 -1.25 . . . . 2.48 111.859 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -103.6 13.14 33.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.693 0.257 . . . . 2.54 111.693 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.83 122.94 17.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 1.41 111.496 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 23.1 m -103.26 111.96 24.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.938 -0.573 . . . . 1.41 110.386 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -76.73 141.84 40.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.735 -0.468 . . . . 1.84 109.735 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.8 mt -118.54 -57.29 2.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.277 0.473 . . . . 1.45 112.277 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -156.49 148.1 22.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.643 -0.253 . . . . 3.72 110.722 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -108.92 137.21 42.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.608 -0.516 . . . . 1.35 109.608 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.8 tp -128.4 145.47 51.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.299 -0.41 . . . . 1.53 110.395 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.538 ' OD1' ' HE1' ' A' ' 240' ' ' MET . 52.1 t30 -117.16 124.18 48.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.933 0.397 . . . . 1.49 111.196 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.23 153.03 46.62 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.184 -1.043 . . . . 2.18 108.184 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.576 ' HA2' ' SD ' ' A' ' 240' ' ' MET . . . -69.91 33.08 0.39 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 115.478 0.951 . . . . 2.0 115.478 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -131.95 -36.96 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.521 -0.548 . . . . 4.11 109.521 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -171.01 -179.62 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.399 -0.963 . . . . 1.78 108.399 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -117.2 144.9 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.797 -1.186 . . . . 3.48 107.797 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 4.6 p30 -131.33 141.33 49.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.02 0.438 . . . . 1.99 111.468 -172.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.7 t -106.15 116.48 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.787 -0.642 . . . . 1.75 109.903 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.85 128.47 33.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.654 -0.703 . . . . 2.02 110.901 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -105.8 159.26 16.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.847 -0.615 . . . . 2.19 110.458 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 26.1 t70 -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.847 -0.615 . . . . 1.33 109.613 174.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.47 60.96 1.65 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.036 0.922 . . . . 2.65 110.334 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 m -92.2 -5.75 51.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.575 -0.739 . . . . 2.01 110.203 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 74' ' ' GLN . 1.6 mp0 -145.7 176.44 9.64 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.405 -0.961 . . . . 2.35 108.405 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 89' ' ' ARG . 18.1 m-20 -75.33 65.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.158 0.504 . . . . 1.92 110.675 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -84.8 -59.0 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 2.31 110.223 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -114.59 97.3 6.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.518 -0.764 . . . . 1.44 109.749 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.52 146.5 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.168 -0.469 . . . . 1.82 110.083 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tt -137.22 113.4 9.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 1.8 109.463 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.455 ' HD2' HG23 ' A' ' 87' ' ' THR . 12.6 ptmm? -148.09 124.23 10.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.258 0.552 . . . . 3.02 110.959 172.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -86.12 175.64 48.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.981 -0.848 . . . . 1.44 110.981 167.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.59 -142.92 0.0 OUTLIER Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.304 0.649 . . . . 2.15 114.508 165.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.49 120.6 5.95 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.518 1.478 . . . . 3.17 112.19 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -158.62 -168.23 2.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.838 -1.074 . . . . 4.55 108.883 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -125.34 45.71 2.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 121.181 -0.208 . . . . 4.95 110.989 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.74 158.79 7.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.43 -0.89 . . . . 2.25 113.123 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.455 HG23 ' HD2' ' A' ' 80' ' ' LYS . 92.1 m -98.23 114.74 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 2.12 109.814 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 65.6 m-85 -102.25 132.92 47.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.19 0.441 . . . . 3.88 112.19 -171.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.401 HH21 ' CG ' ' A' ' 75' ' ' ASP . 98.2 mtt180 -103.59 147.09 27.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 3.87 109.86 173.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 121' ' ' VAL . 48.4 tp -77.44 130.14 36.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.559 -0.291 . . . . 1.68 110.949 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -110.28 -40.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.376 . . . . 2.16 110.954 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -170.53 168.07 7.84 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.821 -0.437 . . . . 1.95 109.821 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 19.4 p90 -135.88 157.51 46.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.174 -0.21 . . . . 0.98 110.688 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -143.09 158.94 43.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.54 -0.541 . . . . 1.07 109.54 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.649 ' CE2' ' HG ' ' A' ' 118' ' ' LEU . 42.1 m-85 -111.76 166.16 11.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.589 0.233 . . . . 3.99 110.654 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 2.0 m80 -122.39 139.14 54.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.029 -0.73 . . . . 2.2 109.029 171.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.419 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 39.6 p90 -159.39 142.71 14.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.782 -0.451 . . . . 6.08 109.782 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB ' ' A' ' 241' ' ' VAL . . . 174.69 -168.04 40.53 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.181 -1.009 . . . . 2.19 112.913 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t 43.77 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.465 1.106 . . . . 3.08 112.312 -173.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' GLY . 89.3 mt -85.26 -159.32 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 3.48 109.647 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.61 66.48 9.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.91 0.386 . . . . 3.85 110.071 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 97' ' ' TRP . . . 82.29 120.39 0.6 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.889 -0.672 . . . . 2.37 112.595 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? 178.94 157.21 0.51 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.753 0.421 . . . . 2.62 110.491 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 96' ' ' HIS . . . 128.6 109.84 1.48 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.378 -0.915 . . . . 1.62 113.918 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.468 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 30.5 t -91.64 -47.23 7.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.604 -0.887 . . . . 2.24 108.604 169.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -119.17 48.14 1.55 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.744 -1.947 . . . . 3.72 105.744 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 78.2 t60 64.69 2.05 1.55 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.455 -1.702 . . . . 4.03 111.616 -171.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.662 ' OG1' ' HA ' ' A' ' 32' ' ' ASP . 21.2 p -144.27 179.41 7.25 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.765 -0.828 . . . . 2.99 108.765 158.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.0 t -142.31 92.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.332 0.515 . . . . 2.88 111.559 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 36.5 t70 42.36 44.11 3.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.394 0.678 . . . . 2.8 112.513 172.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 67.51 -43.29 0.46 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.291 0.636 . . . . 5.35 111.368 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 110' ' ' ASP . 9.2 mmmm -79.23 71.66 5.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.492 0.317 . . . . 3.58 110.389 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -52.54 120.81 6.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.39 -0.368 . . . . 3.26 110.389 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -104.84 -164.67 1.06 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 1.71 110.44 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.61 67.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.712 0.634 . . . . 1.57 112.712 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.4 172.41 6.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.31 -0.255 . . . . 1.3 110.31 -172.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.77 135.75 34.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.352 -0.61 . . . . 1.85 109.352 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.649 ' HG ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 tt -108.47 118.45 36.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 1.61 110.284 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.588 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -110.97 100.36 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.904 0.383 . . . . 2.25 110.837 -176.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.9 mp -88.03 108.62 19.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.269 -0.423 . . . . 1.51 110.451 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.413 ' O ' HD13 ' A' ' 90' ' ' LEU . 33.2 t -79.3 123.15 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 1.24 111.187 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 61.3 m80 -118.25 156.98 27.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.326 -0.62 . . . . 2.86 109.326 175.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.63 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 52.3 p-90 -133.9 144.04 48.63 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.264 -0.273 . . . . 4.96 110.264 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -65.82 107.64 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 2.3 111.069 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.63 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 9.5 t -69.46 -14.84 63.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 2.77 112.12 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.18 -14.1 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 3.79 111.231 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.69 3.72 53.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 3.34 110.617 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 62.42 -1.3 1.58 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.503 0.961 . . . . 2.37 115.503 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -169.6 139.46 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.141 0.97 . . . . 3.93 110.116 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.39 -44.06 88.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.919 -0.582 . . . . 3.6 111.294 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.401 ' O ' HG11 ' A' ' 134' ' ' VAL . . . -61.65 -34.91 90.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.106 -0.568 . . . . 2.35 112.156 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -72.47 -38.86 68.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.857 0.361 . . . . 3.75 110.656 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.582 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.07 -38.42 82.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 2.17 111.825 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 131' ' ' GLY . 8.9 p -67.41 -11.9 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.24 0.543 . . . . 3.11 111.285 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.6 15.06 10.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.987 0.422 . . . . 3.55 110.91 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -126.15 138.57 32.46 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.6 -32.04 62.42 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.361 2.708 . . . . 1.93 113.439 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.7 28.97 8.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.068 0.461 . . . . 2.29 110.252 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.99 -36.32 28.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.018 -0.61 . . . . 1.5 113.263 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.0 mt -108.34 157.63 18.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.769 0.319 . . . . 1.98 110.643 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -142.5 107.43 4.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.082 0.468 . . . . 1.83 110.522 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.588 ' HB ' ' CD2' ' A' ' 119' ' ' HIS . 7.8 m -94.02 119.67 42.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.188 0.518 . . . . 2.28 110.857 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 46.5 tp -89.1 112.5 23.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.889 -0.596 . . . . 2.89 109.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA3' ' HE1' ' A' ' 208' ' ' TRP . . . -99.49 132.18 10.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.812 -0.709 . . . . 0.95 112.321 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.8 mt -129.54 124.27 59.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.666 -0.494 . . . . 1.38 109.666 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.89 140.62 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.752 0.31 . . . . 1.37 110.709 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.6 128.55 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.429 -0.582 . . . . 1.48 109.429 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 15.6 ptpt -122.71 151.09 41.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.062 -0.348 . . . . 2.52 110.062 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.748 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 14.2 m -70.44 107.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.472 0.654 . . . . 1.88 111.716 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -155.16 -135.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.495 -0.775 . . . . 1.53 111.272 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.0 m -70.28 121.68 18.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.656 -0.498 . . . . 2.08 109.656 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.569 ' HB2' ' CB ' ' A' ' 218' ' ' SER . . . -83.64 104.53 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.337 -0.246 . . . . 1.36 110.337 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -70.68 126.43 92.2 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.031 -0.359 . . . . 1.78 110.031 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.28 -14.02 31.88 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.04 2.494 . . . . 1.34 112.556 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.526 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -58.64 -25.53 58.66 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.98 -0.555 . . . . 0.75 112.936 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 159' ' ' VAL . 48.0 tp -91.95 -32.05 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.189 0.519 . . . . 1.39 110.406 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -52.49 -38.93 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 1.63 112.142 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 41.6 pttt -61.27 -33.86 74.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.499 0.555 . . . . 3.26 112.499 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 162' ' ' VAL . 13.3 p -84.58 -36.81 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.581 -0.448 . . . . 1.97 110.775 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 156' ' ' LEU . 19.5 t -65.16 -39.18 84.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 1.64 110.72 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.2 -28.03 66.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.519 -0.764 . . . . 1.22 112.695 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 159' ' ' VAL . 10.0 p -92.2 -2.76 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.978 0.418 . . . . 2.07 111.136 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.29 -28.03 67.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.333 -0.394 . . . . 1.95 111.529 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -67.34 -25.21 65.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.497 -0.319 . . . . 2.31 111.431 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.7 t -84.4 -1.76 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 1.78 110.811 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.41 33.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.356 -0.979 . . . . 1.42 108.356 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -55.62 -35.55 66.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.479 -1.237 . . . . 1.98 111.787 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.1 p -106.72 152.62 23.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.082 0.468 . . . . 1.4 111.163 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -57.94 136.67 57.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 2.84 111.296 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.46 -15.04 57.75 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.734 -0.746 . . . . 0.85 112.917 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -86.81 151.23 23.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 2.22 111.34 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.5 p -142.2 151.43 42.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.394 -0.821 . . . . 1.93 109.816 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.65 148.51 44.13 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.911 -0.403 . . . . 1.17 109.911 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 135.53 51.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.791 0.329 . . . . 1.8 110.125 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -138.61 80.17 1.78 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.734 -0.839 . . . . 1.31 108.734 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.5 p -124.13 169.09 12.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.796 -0.638 . . . . 1.69 111.232 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.56 38.68 22.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.019 -0.537 . . . . 2.26 111.313 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -120.98 137.72 54.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.291 -0.413 . . . . 4.84 110.363 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -80.76 118.85 74.23 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.757 -0.656 . . . . 2.51 110.752 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.89 -21.66 27.92 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.929 2.419 . . . . 1.47 112.766 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -77.27 -2.52 35.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 3.16 111.05 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.11 -17.92 46.59 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 116.168 -0.469 . . . . 1.12 113.262 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.33 -38.09 65.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.63 0.215 . . . . 2.37 110.531 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 79.9 mt 54.69 85.17 0.2 Allowed Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.755 . . . . 3.87 112.778 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.33 136.76 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.296 2.664 . . . . 2.51 112.133 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -107.84 27.34 9.31 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.365 0.666 . . . . 3.23 110.501 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.0 t -153.51 103.14 2.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.661 -0.496 . . . . 2.03 109.661 -159.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.16 59.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.594 -0.443 . . . . 2.5 110.839 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -125.88 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.033 -1.099 . . . . 1.81 108.033 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 5.6 p90 -162.47 144.94 11.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.855 -0.738 . . . . 5.32 111.816 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.507 ' HB3' ' O ' ' A' ' 256' ' ' LYS . 48.6 m0 -92.63 129.07 38.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.778 -0.823 . . . . 4.55 108.778 168.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.4 t -84.67 94.04 8.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.12 0.962 . . . . 2.39 110.432 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.63 119.16 18.15 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 5.32 109.349 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.418 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 26.7 Cg_exo -62.24 150.21 87.75 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.008 1.805 . . . . 2.47 111.218 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.86 123.27 5.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.475 -0.869 . . . . 2.0 112.824 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 198' ' ' THR . 22.0 t -95.53 -135.34 0.21 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.273 -0.64 . . . . 3.36 109.273 175.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 199' ' ' THR . 2.5 pt? -46.55 11.4 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.604 1.705 . . . . 5.18 115.604 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.542 ' H ' ' C ' ' A' ' 196' ' ' SER . 20.1 p -66.5 27.73 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.784 0.802 . . . . 5.53 111.679 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.63 ' H ' ' C ' ' A' ' 197' ' ' LEU . 1.3 p -165.43 170.14 6.45 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.002 -1.454 . . . . 5.89 108.726 -170.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.459 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 74.0 Cg_exo -48.01 -48.51 16.19 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 121.928 1.752 . . . . 6.31 113.254 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 5.2 Cg_exo -80.9 136.14 10.36 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.222 1.948 . . . . 5.26 112.31 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.445 HD12 ' HB3' ' A' ' 197' ' ' LEU . 40.7 tp -68.74 -40.36 79.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.97 -1.014 . . . . 4.29 111.584 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 203' ' ' LEU . 2.7 pp -56.06 147.43 20.12 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.477 0.656 . . . . 3.51 111.988 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 204' ' ' GLU . 0.0 OUTLIER -77.78 73.74 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.172 -0.922 . . . . 3.37 111.584 -172.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 7.8 p -99.52 7.24 45.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.441 -0.799 . . . . 2.47 110.702 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 t -118.86 151.05 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.292 0.568 . . . . 1.74 112.079 -169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 13.4 m -121.75 121.73 37.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.194 -1.039 . . . . 2.3 108.194 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.503 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.3 t90 -86.73 125.97 34.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.105 0.479 . . . . 6.37 110.214 -175.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.486 ' O ' HD13 ' A' ' 143' ' ' LEU . 44.4 mm -109.69 100.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.438 -0.801 . . . . 2.32 108.965 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 3.9 t -92.91 129.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.844 -0.342 . . . . 2.1 111.556 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.958 -0.756 . . . . 2.35 108.958 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.23 2.12 37.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.042 0.756 . . . . 3.47 113.042 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -111.65 105.31 56.66 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 121.072 -0.251 . . . . 1.56 110.915 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.423 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 19.6 Cg_exo -67.67 141.14 53.75 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.856 2.371 . . . . 1.37 112.326 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.0 pt -96.98 153.59 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.322 -0.399 . . . . 1.85 110.188 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.5 m -89.4 128.16 35.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.226 -0.443 . . . . 1.78 111.59 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.748 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 35.5 m -137.83 137.95 44.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.606 -0.725 . . . . 1.64 109.11 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.569 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 8.5 t -87.8 159.87 18.25 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.278 -0.569 . . . . 1.52 111.804 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.541 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.4 m -48.26 -46.02 35.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.615 -0.72 . . . . 1.81 111.586 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.86 -26.29 46.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.961 -0.563 . . . . 2.51 112.33 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -80.86 -48.36 12.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.582 -0.525 . . . . 1.02 109.582 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.99 -39.1 83.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.221 -0.899 . . . . 1.88 111.477 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.8 mt -62.05 -25.92 67.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 1.59 111.72 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -76.71 -19.67 57.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.584 -0.28 . . . . 2.3 111.337 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -68.92 -34.44 75.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.439 0.638 . . . . 3.18 110.072 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 28.2 ttm180 -76.23 -2.92 33.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.374 -0.83 . . . . 3.55 110.948 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -86.7 -3.75 59.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.392 . . . . 2.74 110.299 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.91 145.29 34.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.865 -0.607 . . . . 1.66 110.568 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.59 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.08 127.62 55.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 1.13 111.071 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.94 -34.37 74.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.914 -1.039 . . . . 4.38 110.874 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.59 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -69.49 162.38 27.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.674 -0.694 . . . . 1.62 111.933 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.84 166.4 42.96 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.677 -0.969 . . . . 1.16 110.677 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.79 133.43 50.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 3.56 110.803 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 95.51 6.71 59.59 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 2.23 111.87 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -119.01 158.04 49.04 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.518 -0.549 . . . . 2.59 109.518 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.08 122.99 12.11 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.919 2.413 . . . . 1.5 112.134 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.32 126.3 26.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 3.4 112.178 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 10.6 tp10 -124.55 134.53 52.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.288 -0.869 . . . . 2.47 110.221 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.81 107.97 2.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.575 . . . . 2.6 110.083 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.576 ' SD ' ' HA2' ' A' ' 63' ' ' GLY . 51.1 ttp -74.33 91.24 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 1.94 109.374 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.451 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 27.6 m -135.38 157.71 39.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.628 -0.715 . . . . 1.67 111.293 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 70.42 -81.47 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 124.129 0.893 . . . . 2.18 110.939 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.485 HD22 ' HG2' ' A' ' 240' ' ' MET . 73.4 m-20 50.43 29.18 3.74 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.753 0.649 . . . . 2.64 112.753 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -148.07 152.76 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 5.31 108.876 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.4 ' HG2' ' HG2' ' A' ' 30' ' ' PRO . 17.1 ptp180 -80.38 148.94 67.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.609 -0.145 . . . . 6.91 110.609 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.458 ' HG2' ' O ' ' A' ' 1' ' ' MET . 80.6 Cg_exo -48.89 164.11 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.485 2.79 . . . . 3.72 113.598 177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . . . -68.77 98.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.596 -0.729 . . . . 3.34 112.504 -170.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.501 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 27.0 mm-40 -61.25 163.83 9.94 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.537 -0.756 . . . . 4.92 110.586 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.603 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 72.0 Cg_endo -75.09 161.1 39.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 4.01 113.366 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -8.83 34.59 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.2 -0.909 . . . . 4.9 112.315 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.668 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 47.9 mmtm -55.29 49.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.571 1.693 . . . . 5.68 115.571 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER 124.91 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.979 2.112 . . . . 5.11 110.149 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.603 ' HD3' ' O ' ' A' ' 249' ' ' PRO . 4.3 mpt_? -138.42 100.25 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.336 -0.987 . . . . 6.74 108.336 167.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -128.84 148.43 50.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.581 -0.526 . . . . 3.08 109.581 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 21.6 mm -102.0 147.66 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.341 -0.391 . . . . 3.06 110.517 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 191' ' ' TRP . 45.3 mttp -135.71 166.39 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.637 -0.875 . . . . 3.01 108.637 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.72 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -144.28 114.89 7.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.634 -0.136 . . . . 1.99 110.634 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 21.3 m -97.2 100.71 12.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.283 0.563 . . . . 2.47 110.702 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -145.13 131.64 19.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.588 -0.733 . . . . 5.03 110.242 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.782 -0.627 . . . . 4.82 109.759 178.218 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.962 -0.384 . . . . 17.73 109.962 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 m -76.36 84.61 3.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 15.49 111.057 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -99.99 -11.81 20.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.587 -0.733 . . . . 16.29 109.225 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -79.12 123.0 26.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.458 -0.792 . . . . 14.68 109.433 170.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.15 112.67 25.88 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.421 -0.585 . . . . 15.53 109.421 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.04 134.22 11.8 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.615 -0.802 . . . . 10.81 112.317 -176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -69.84 105.59 2.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.911 0.386 . . . . 11.61 110.174 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.53 -160.43 43.61 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.624 -0.717 . . . . 9.0 111.835 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -59.88 120.71 10.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.466 -0.198 . . . . 10.04 110.466 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 177.55 -66.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.691 0.619 . . . . 11.67 109.747 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -126.61 30.6 5.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.04 0.448 . . . . 11.18 110.47 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.28 106.62 1.5 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.915 -0.659 . . . . 8.9 111.574 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.87 125.91 14.46 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.497 2.131 . . . . 8.2 112.603 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -87.03 -30.46 21.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.258 -1.016 . . . . 10.62 108.258 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -87.55 26.34 1.29 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.977 -1.465 . . . . 10.41 109.483 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -45.95 -39.2 8.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.736 0.814 . . . . 9.19 112.923 -173.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -74.9 -38.07 61.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.855 0.36 . . . . 7.71 110.862 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -70.6 -17.52 62.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.927 -0.579 . . . . 10.03 110.649 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.7 11.18 7.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.773 0.796 . . . . 7.89 109.828 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -131.14 103.26 15.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.202 -0.908 . . . . 7.65 108.677 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.56 86.05 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.717 2.278 . . . . 8.15 112.754 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 27' ' ' ARG . 10.4 tp 43.26 51.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.207 1.003 . . . . 6.15 111.72 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.93 23.44 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.739 -0.664 . . . . 5.72 112.665 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -103.98 17.47 24.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.911 0.862 . . . . 8.17 109.098 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.03 89.31 0.45 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 108.996 -1.642 . . . . 5.05 108.996 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.44 ' HA ' HG23 ' A' ' 22' ' ' ILE . 2.4 mp0 -62.19 122.3 15.24 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.752 0.787 . . . . 7.09 112.344 -164.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.513 ' O ' HG22 ' A' ' 22' ' ' ILE . 56.8 mtt180 -148.34 126.97 12.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.179 -1.373 . . . . 5.44 107.446 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' OE1' HD11 ' A' ' 197' ' ' LEU . 9.2 tt0 -147.45 -91.84 0.08 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.727 -0.472 . . . . 7.33 109.727 172.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.8 m -71.99 104.54 1.02 Allowed Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 108.983 -0.747 . . . . 4.35 108.983 171.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HG3' ' HD2' ' A' ' 194' ' ' PRO . 54.7 Cg_endo -67.67 -42.6 6.59 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.315 2.01 . . . . 4.96 113.773 -165.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 248' ' ' GLN . 0.1 OUTLIER -160.6 169.73 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.13 0.491 . . . . 5.07 111.402 -175.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.42 143.58 26.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.073 -0.967 . . . . 3.14 108.856 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 49.8 mt -88.34 91.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.372 0.606 . . . . 2.71 109.796 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.97 119.45 39.5 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.766 -0.652 . . . . 2.82 109.444 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -55.34 -33.41 63.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.797 . . . . 2.71 112.812 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -76.73 -34.83 58.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.12 0.486 . . . . 5.23 110.705 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -88.01 18.06 4.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.599 -0.728 . . . . 3.38 110.438 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.16 150.26 36.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 1.76 109.2 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -119.35 122.78 42.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.039 0.447 . . . . 4.05 110.472 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -82.59 126.22 32.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.673 -0.694 . . . . 4.9 109.952 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -145.8 97.74 4.55 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.773 -0.454 . . . . 2.27 109.773 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.04 28.89 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.657 2.238 . . . . 2.45 112.677 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -99.9 -5.92 27.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.289 -0.414 . . . . 4.62 110.827 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.66 152.1 21.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.545 -0.539 . . . . 5.15 109.545 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.25 135.72 20.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.681 -0.236 . . . . 4.21 110.723 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.35 136.94 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 2.76 111.364 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.65 131.6 43.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.857 0.361 . . . . 2.93 111.208 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -66.47 122.95 18.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.639 -0.71 . . . . 2.46 109.677 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 79' ' ' LEU . 3.0 t -109.38 103.0 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.237 -0.438 . . . . 2.17 110.141 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.697 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 6.7 m -105.18 89.33 3.1 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.81 -0.811 . . . . 1.87 108.81 177.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.3 p90 -124.46 6.43 8.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.906 0.384 . . . . 3.97 111.461 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.7 -19.27 65.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.409 -0.359 . . . . 2.48 111.418 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.9 mp0 -98.64 6.55 46.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.575 -0.284 . . . . 2.54 110.403 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.15 133.82 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 1.41 111.675 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.5 m -120.75 106.37 11.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.888 -0.596 . . . . 1.41 110.186 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.9 p -79.4 150.81 31.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.685 -0.487 . . . . 1.84 109.685 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.9 mt -122.07 -55.4 1.88 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.832 0.349 . . . . 1.45 111.616 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 58' ' ' ARG . 11.6 ptm85 -154.8 152.37 29.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.452 -0.34 . . . . 3.72 111.016 -172.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 tt -115.15 137.39 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.559 -0.534 . . . . 1.35 109.559 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.5 tp -134.07 142.32 47.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.726 0.298 . . . . 1.53 111.11 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -111.09 108.04 17.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.876 -0.787 . . . . 1.49 108.876 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -142.51 72.59 1.38 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.685 0.624 . . . . 2.18 112.685 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.14 -71.41 0.4 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.437 -1.363 . . . . 2.0 113.569 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -142.55 0.04 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.775 0.321 . . . . 4.11 111.585 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.44 174.75 13.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.803 -0.814 . . . . 1.78 108.803 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 95' ' ' PHE . 49.7 p90 -115.38 121.97 44.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 3.48 109.465 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -96.53 116.22 28.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.751 . . . . 1.99 110.46 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 42.0 t -93.05 106.1 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.584 -0.524 . . . . 1.75 109.584 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.62 129.26 37.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.887 -0.597 . . . . 2.02 111.589 -174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -111.52 153.98 25.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.347 -0.842 . . . . 2.19 110.265 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -76.54 110.95 11.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.922 -0.581 . . . . 1.33 110.626 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.455 ' HB2' ' CD ' ' A' ' 89' ' ' ARG . 6.2 p-10 -116.26 55.53 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.298 0.571 . . . . 2.65 111.392 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -104.91 -6.5 20.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.483 . . . . 2.01 111.025 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 76' ' ' LYS . 46.1 mt-30 -137.94 176.56 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.206 -0.664 . . . . 2.35 109.206 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -82.14 41.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.18 0.514 . . . . 1.92 110.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 34.9 mmtp -51.32 -60.69 2.85 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.897 -1.047 . . . . 2.31 110.673 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.697 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -130.87 96.75 4.15 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.285 -0.871 . . . . 1.44 110.159 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.5 m -111.95 147.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.404 0.621 . . . . 1.82 111.605 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.449 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.9 tp -129.29 119.43 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.857 -1.065 . . . . 1.8 108.466 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' A' ' 87' ' ' THR . 57.3 pttt -158.97 121.14 3.51 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.5 -0.48 . . . . 3.02 111.764 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.62 176.9 40.15 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 114.337 0.495 . . . . 1.44 114.337 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.33 -137.43 0.0 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.156 1.36 . . . . 2.15 115.755 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.8 148.76 3.58 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.081 2.521 . . . . 3.17 113.166 -168.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.1 pt? -39.95 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.038 1.866 . . . . 4.55 116.038 -157.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -85.94 -48.55 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.519 -0.764 . . . . 4.95 109.663 162.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 123.79 163.48 11.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.167 -0.54 . . . . 2.25 112.223 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.434 ' HA ' ' HB3' ' A' ' 80' ' ' LYS . 49.1 m -94.69 103.15 15.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 2.12 110.04 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -95.76 102.1 13.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.286 -0.416 . . . . 3.88 110.081 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.455 ' CD ' ' HB2' ' A' ' 72' ' ' ASP . 16.0 ptp180 -82.03 152.36 26.68 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.211 -0.306 . . . . 3.87 110.183 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.3 tp -76.47 122.86 25.15 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.737 -0.468 . . . . 1.68 109.737 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -108.38 -32.81 2.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.906 0.384 . . . . 2.16 110.164 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.3 pt20 -171.64 169.66 5.93 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.691 -0.485 . . . . 1.95 109.691 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -140.72 158.43 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.412 -0.588 . . . . 0.98 109.412 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -147.41 158.73 44.09 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.19 0.306 . . . . 1.07 110.73 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.672 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 66.5 m-85 -123.08 165.55 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 3.99 110.773 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -172.6 126.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.266 0.626 . . . . 2.2 109.661 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.473 ' CE3' ' HB2' ' A' ' 116' ' ' ALA . 14.8 p90 -161.8 -174.51 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.591 -0.277 . . . . 6.08 110.375 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.438 ' O ' ' HB ' ' A' ' 241' ' ' VAL . . . 89.92 99.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.512 -0.851 . . . . 2.19 111.681 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.7 t -143.08 -82.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.711 -0.848 . . . . 3.08 108.711 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.419 HD12 ' OE1' ' A' ' 103' ' ' GLN . 84.2 mt -95.75 -155.18 0.46 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.143 -0.688 . . . . 3.48 109.143 169.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.82 -48.31 67.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.077 0.399 . . . . 3.85 112.077 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.71 63.68 0.36 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.602 -0.808 . . . . 2.37 111.448 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 114' ' ' TYR . 13.1 pt20 -150.65 -172.11 4.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 2.62 110.761 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.29 8.71 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.62 111.474 -168.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.433 ' HB2' ' N ' ' A' ' 116' ' ' ALA . 48.2 t -78.46 -33.5 48.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.338 0.495 . . . . 2.24 112.338 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.501 ' CG ' ' H ' ' A' ' 107' ' ' HIS . 0.9 OUTLIER 69.85 -156.32 0.15 Allowed 'General case' 0 C--N 1.343 0.316 0 N-CA-C 107.363 -1.347 . . . . 3.72 107.363 -173.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.501 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 4.3 m-70 53.04 69.79 0.66 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.161 0.437 . . . . 4.03 110.046 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.3 t -98.71 117.43 33.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 120.024 -0.671 . . . . 2.99 110.136 -165.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 14.7 m -92.18 103.44 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.161 0.505 . . . . 2.88 110.785 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.2 t70 54.01 58.83 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.555 -0.748 . . . . 2.8 109.735 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 67.23 4.83 3.85 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.866 -1.061 . . . . 5.35 113.19 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -90.36 111.68 22.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.949 -0.389 . . . . 3.58 109.949 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -93.08 146.6 23.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.569 -0.9 . . . . 3.26 108.569 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 96.8 m-85 -95.93 176.44 6.11 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.601 -0.439 . . . . 1.71 109.935 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.0 -39.03 20.18 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.664 0.616 . . . . 1.57 112.664 -171.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 147' ' ' LEU . . . -145.34 149.97 35.76 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.606 -0.438 . . . . 1.3 111.801 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -110.88 141.55 44.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.055 -0.52 . . . . 1.85 110.563 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.672 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 13.0 tp -121.73 121.86 38.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.771 -0.649 . . . . 1.61 110.045 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.35 104.34 10.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 2.25 111.446 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -89.81 111.01 21.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.031 -0.531 . . . . 1.51 109.589 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.75 123.62 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.316 0.579 . . . . 1.24 110.766 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -115.74 145.53 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.64 -0.709 . . . . 2.86 109.912 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.454 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 9.1 t90 -112.0 133.47 54.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.973 -0.558 . . . . 4.96 110.719 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -78.17 111.84 14.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.084 -0.507 . . . . 2.3 110.231 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 t -58.34 -21.66 50.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.719 -0.673 . . . . 2.77 112.111 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -46.79 -32.18 3.51 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.557 0.947 . . . . 3.79 113.557 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.42 ' HE2' ' OE1' ' A' ' 136' ' ' GLN . 4.8 m-85 -97.38 -4.62 38.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.648 0.61 . . . . 3.34 112.648 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.87 14.9 2.91 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.575 0.59 . . . . 2.37 114.575 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.454 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 18.1 t70 -172.11 117.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.853 -0.795 . . . . 3.93 108.853 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -65.52 -33.14 75.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 3.6 111.819 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 134' ' ' VAL . . . -61.45 -33.66 85.51 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.881 -0.676 . . . . 2.35 112.133 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 69.9 mmtt -83.79 -24.98 30.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.797 0.332 . . . . 3.75 110.979 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.459 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.49 -21.85 63.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.358 -0.383 . . . . 2.17 111.912 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 131' ' ' GLY . 31.3 m -73.05 3.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 3.11 112.381 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 2.5 pt20 -97.15 -11.0 24.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 3.55 110.182 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.42 ' OE1' ' HE2' ' A' ' 127' ' ' TYR . 29.9 tt0 -101.81 136.48 19.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 3.02 109.867 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.65 -28.39 86.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.28 2.654 . . . . 1.93 112.656 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.415 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.8 p-10 -112.24 27.71 9.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 2.29 109.447 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.36 -37.64 86.29 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.725 -0.67 . . . . 1.5 111.747 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.416 ' HB2' HG22 ' A' ' 206' ' ' VAL . 86.8 mt -122.37 158.01 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.018 -0.734 . . . . 1.98 109.018 173.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.52 122.69 12.93 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.2 -0.296 . . . . 1.83 110.2 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.91 126.87 69.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.015 0.436 . . . . 2.28 110.697 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 49.0 tp -93.04 117.83 30.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.621 -0.718 . . . . 2.89 109.777 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -104.4 127.61 9.16 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.275 -0.488 . . . . 0.95 112.132 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.88 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.756 -0.461 . . . . 1.38 109.756 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.7 141.9 49.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.798 -0.183 . . . . 1.37 110.556 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 9.7 mp -121.27 135.32 55.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.118 0.485 . . . . 1.48 110.676 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 216' ' ' SER . 54.6 pttt -123.54 156.3 35.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.839 -0.8 . . . . 2.52 108.839 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 46.6 t -94.34 126.62 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.875 0.369 . . . . 1.88 110.568 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.22 -105.89 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.634 -0.586 . . . . 1.53 111.634 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.8 m -67.04 154.99 39.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.655 0.264 . . . . 2.08 110.315 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.33 157.27 16.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.015 -0.365 . . . . 1.36 110.015 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 216' ' ' SER . 28.2 mtpp -128.06 103.0 21.14 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.069 -0.345 . . . . 1.78 110.069 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.65 -33.93 61.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.362 2.708 . . . . 1.34 112.612 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.85 -28.64 73.67 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.75 112.502 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.7 tp -102.64 -23.64 13.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 1.39 110.543 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -38.43 70.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 1.63 110.047 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.3 -29.73 70.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.935 -0.575 . . . . 3.26 111.235 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.24 -48.54 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.21 0.528 . . . . 1.97 110.15 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 221' ' ' GLN . 43.2 t -65.33 -36.0 76.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.698 -0.683 . . . . 1.64 111.205 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.58 -28.22 69.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 1.22 112.231 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.52 -1.37 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.73 -0.388 . . . . 2.07 111.482 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.99 -22.21 60.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 1.95 111.778 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -66.6 -28.83 68.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.445 0.164 . . . . 2.31 111.366 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.4 p -83.26 -0.54 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.301 . . . . 1.78 111.739 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.29 34.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 1.42 108.883 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -67.73 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.87 -1.059 . . . . 1.98 111.883 -169.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.66 148.77 49.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 1.4 110.706 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -59.61 126.34 27.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.351 -0.84 . . . . 2.84 111.084 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 114.51 -21.46 14.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.819 -0.705 . . . . 0.85 112.693 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -88.67 153.15 21.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 2.22 111.26 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 42.6 p -144.21 161.62 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 1.93 110.732 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.47 151.63 37.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.148 -0.478 . . . . 1.17 109.816 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.64 131.95 41.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.815 -0.439 . . . . 1.8 109.815 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -141.53 81.77 1.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.085 -0.507 . . . . 1.31 109.839 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 46.0 p -98.85 166.54 11.25 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.278 -0.419 . . . . 1.69 111.363 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 66.17 32.2 8.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.814 -0.63 . . . . 2.26 112.418 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.616 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 68.3 t80 -66.63 132.3 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.331 -0.248 . . . . 4.84 110.331 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.22 100.25 0.68 Allowed Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 123.621 0.575 . . . . 2.51 110.567 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 11.1 Cg_exo -71.16 -36.24 7.54 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.71 2.274 . . . . 1.47 112.445 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.3 -9.96 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 3.16 110.637 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -70.93 0.97 26.64 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.063 -0.517 . . . . 1.12 113.14 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 86.4 mt -91.68 -14.58 29.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.197 -0.297 . . . . 2.37 110.197 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.5 mt 42.84 73.7 0.89 Allowed Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 113.462 0.912 . . . . 3.87 113.462 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.39 119.11 1.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.148 2.565 . . . . 2.51 111.127 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.3 mt-10 -112.39 25.08 11.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.778 0.431 . . . . 3.23 111.346 -171.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 213' ' ' GLU . 0.3 OUTLIER -168.3 90.06 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.047 -0.661 . . . . 2.03 110.605 -160.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.68 63.91 0.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.008 -1.108 . . . . 2.5 108.008 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 258' ' ' SER . 8.6 m-20 -87.71 -51.18 6.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.652 0.982 . . . . 1.81 113.652 -166.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -146.85 144.62 29.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.267 -0.573 . . . . 5.32 111.955 -172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -136.72 129.01 29.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.682 -0.69 . . . . 4.55 110.595 174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 192' ' ' THR . 7.6 t -171.91 74.01 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.93 0.872 . . . . 2.39 111.134 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -139.36 137.33 18.85 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.123 -0.489 . . . . 5.32 111.092 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 30' ' ' PRO . 97.7 Cg_endo -84.83 132.21 4.68 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.829 2.353 . . . . 2.47 111.812 175.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' HA3' ' HB ' ' A' ' 206' ' ' VAL . . . -99.22 106.27 3.19 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.532 -0.842 . . . . 2.0 112.61 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 198' ' ' THR . 22.9 t -84.21 -138.03 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 122.922 0.489 . . . . 3.36 111.752 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.597 ' C ' ' H ' ' A' ' 199' ' ' THR . 4.4 pp -45.25 8.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 117.252 2.316 . . . . 5.18 117.252 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 196' ' ' SER . 7.1 m -73.86 25.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.116 -0.99 . . . . 5.53 109.619 171.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.606 HG22 ' SG ' ' A' ' 205' ' ' CYS . 9.4 t -144.9 151.07 48.27 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 114.737 -1.12 . . . . 5.89 108.966 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.446 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 72.8 Cg_exo -46.9 -53.46 6.22 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 122.805 2.337 . . . . 6.31 114.9 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 68.3 Cg_endo -82.84 20.59 1.12 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.017 1.811 . . . . 5.26 114.611 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 62.64 -60.73 0.13 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.488 0.921 . . . . 4.29 113.488 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 pp -43.23 153.47 0.1 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.809 0.844 . . . . 3.51 112.945 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.78 88.74 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.469 -0.787 . . . . 3.37 111.458 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.606 ' SG ' HG22 ' A' ' 199' ' ' THR . 3.3 p -118.15 16.46 14.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.097 -0.956 . . . . 2.47 109.561 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 199' ' ' THR . 51.0 t -117.57 149.71 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.835 -1.075 . . . . 1.74 109.744 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 87.3 m -117.19 117.13 28.73 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.374 -0.602 . . . . 2.3 109.374 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -84.98 133.05 34.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.375 0.607 . . . . 6.37 110.7 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 67.4 mt -121.29 141.78 40.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.363 -0.977 . . . . 2.32 108.363 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.42 146.33 31.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.201 0.524 . . . . 2.1 111.681 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.83 131.45 55.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.928 -0.768 . . . . 2.35 108.928 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.499 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 53.9 tttm -69.12 -7.6 37.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 3.47 111.644 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 187' ' ' SER . 10.1 tp10 -94.04 112.32 56.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.436 -0.347 . . . . 1.56 111.177 -175.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 4.9 Cg_exo -78.65 130.51 9.8 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.658 2.239 . . . . 1.37 111.09 171.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 34.1 pt -99.22 154.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.447 -0.575 . . . . 1.85 109.447 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 27.4 p -103.68 126.76 51.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.703 0.287 . . . . 1.78 111.711 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -114.83 147.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.15 -0.685 . . . . 1.64 109.15 173.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -93.6 166.55 12.18 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.532 -0.467 . . . . 1.52 110.78 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.561 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 44.0 m -50.19 -47.92 54.4 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.438 0.461 . . . . 1.81 112.209 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.69 -38.14 69.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.588 0.232 . . . . 2.51 111.391 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.408 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.1 mt-30 -67.38 -43.11 82.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 1.02 110.176 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.0 -41.78 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 1.88 111.031 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 219' ' ' SER . 90.2 mt -67.84 -44.1 77.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 1.59 111.689 -176.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -65.88 -24.42 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.912 0.338 . . . . 2.3 111.912 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.407 ' C ' ' H ' ' A' ' 227' ' ' LYS . 79.7 t80 -71.64 -36.03 70.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.033 0.444 . . . . 3.18 110.15 176.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -78.56 17.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.658 0.742 . . . . 3.55 110.439 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 225' ' ' PHE . 97.5 mttt -97.57 -19.22 18.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.196 -0.668 . . . . 2.74 109.196 171.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.05 134.51 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.603 -0.726 . . . . 1.66 111.236 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.515 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 12.4 m120 -96.92 144.23 27.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 1.13 110.147 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -79.79 -28.92 40.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.778 -1.101 . . . . 4.38 108.79 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -83.4 174.81 10.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 1.62 111.585 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.73 179.1 27.65 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.04 -0.982 . . . . 1.16 111.545 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.8 125.46 23.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.988 0.423 . . . . 3.56 111.579 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.72 20.1 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.845 -0.616 . . . . 2.23 113.507 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -133.14 157.22 78.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.898 0.349 . . . . 2.59 110.079 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.98 122.69 12.26 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.557 2.171 . . . . 1.5 111.692 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.515 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 38.5 tt0 -57.25 117.94 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.235 0.828 . . . . 3.4 113.235 -173.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 60.0 mm-40 -115.27 142.12 47.11 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.583 -1.189 . . . . 2.47 108.042 169.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.11 127.05 38.51 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.968 -0.293 . . . . 2.6 110.214 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 52.6 ttp -81.23 94.96 6.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.16 0.505 . . . . 1.94 110.07 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 98' ' ' GLY . 21.8 m -137.95 156.41 31.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.673 -0.694 . . . . 1.67 110.752 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.39 -80.23 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.914 0.758 . . . . 2.18 110.953 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 47.37 32.16 2.14 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.176 0.591 . . . . 2.64 112.193 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -146.89 174.55 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.232 0.539 . . . . 5.31 111.657 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -127.68 145.7 55.86 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.598 -0.728 . . . . 6.91 110.261 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.17 174.16 3.48 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.548 2.166 . . . . 3.72 112.48 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.86 158.86 34.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.785 -0.643 . . . . 3.34 112.33 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 52.2 mt-30 -114.45 170.5 5.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.491 -0.777 . . . . 4.92 109.601 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.83 175.77 9.88 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.859 2.373 . . . . 4.01 113.489 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.8 -7.39 1.61 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.788 1.235 . . . . 4.9 112.88 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -55.87 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.517 2.043 . . . . 5.68 116.517 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.561 ' C ' HD21 ' A' ' 252' ' ' ASN . 0.2 OUTLIER 131.04 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 126.665 1.986 . . . . 5.11 113.298 177.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -172.71 133.93 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.022 0.439 . . . . 6.74 111.574 166.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -114.16 150.61 33.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.394 -0.821 . . . . 3.08 109.486 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.8 mm -85.91 113.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.827 0.346 . . . . 3.06 110.573 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.42 ' HB3' HG22 ' A' ' 192' ' ' THR . 41.8 ttmt -109.34 143.41 38.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.058 -0.719 . . . . 3.01 109.058 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.95 164.0 29.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.724 0.297 . . . . 1.99 110.924 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 36.0 m -151.12 97.41 2.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.996 0.427 . . . . 2.47 109.985 175.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.84 95.95 4.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.215 -0.661 . . . . 5.03 109.215 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.718 -0.658 . . . . 4.82 110.399 -177.132 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.908 0.385 . . . . 17.73 110.723 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.2 p -107.76 18.36 21.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.298 -0.41 . . . . 15.49 111.523 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -99.28 127.78 45.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.782 0.325 . . . . 16.29 110.44 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 5' ' ' TRP . 18.0 m-70 -81.71 93.86 6.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.195 -0.457 . . . . 14.68 109.924 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 92.6 m95 74.66 155.3 0.16 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.324 1.015 . . . . 15.53 110.964 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.19 170.59 40.54 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.438 -0.887 . . . . 10.81 112.182 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CG ' ' HA ' ' A' ' 243' ' ' ASN . 6.1 p90 -88.44 100.2 12.86 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.377 0.608 . . . . 11.61 110.841 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.41 -117.64 0.81 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.79 -0.719 . . . . 9.0 111.899 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -92.13 119.5 31.85 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.434 -0.58 . . . . 10.04 109.434 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 44.47 -94.5 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.408 0.892 . . . . 11.67 113.408 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 12.2 m120 -111.31 20.41 17.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.275 0.56 . . . . 11.18 110.68 -173.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.71 128.46 2.65 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.845 -0.902 . . . . 8.9 110.845 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.15 119.97 6.51 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.483 1.455 . . . . 8.2 112.415 -175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 74.3 mm-40 -88.1 -28.91 21.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.537 -0.756 . . . . 10.62 112.328 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -66.12 -40.28 90.57 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.705 -0.398 . . . . 10.41 110.07 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -50.79 -52.62 39.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.147 -0.479 . . . . 9.19 111.835 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -58.46 -34.05 70.42 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.56 0.219 . . . . 7.71 111.104 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 75.6 mmtt -66.73 -49.11 67.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 10.03 110.677 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -70.87 -29.22 65.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.319 -0.4 . . . . 7.89 111.826 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.66 81.16 40.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.786 0.327 . . . . 7.65 110.283 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.63 -12.44 33.73 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.597 2.198 . . . . 8.15 112.205 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.7 tt -60.16 -12.04 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.043 0.449 . . . . 6.15 110.906 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.94 63.44 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.328 -0.396 . . . . 5.72 110.577 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -59.01 -8.15 1.33 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.122 -0.49 . . . . 8.17 112.287 170.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.5 179.23 41.77 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.275 -1.13 . . . . 5.05 110.275 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.8 106.82 14.28 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 117.433 -1.707 . . . . 7.09 110.881 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.18 124.47 1.49 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 119.205 -0.426 . . . . 5.44 110.18 158.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -148.99 -58.04 0.21 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.377 0.99 . . . . 7.33 110.283 150.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 247' ' ' ALA . 4.3 p -107.53 99.77 30.57 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.257 -1.338 . . . . 4.35 107.479 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.85 -48.25 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 121.078 1.185 . . . . 4.96 114.314 -166.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -160.08 148.26 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.801 0.334 . . . . 5.07 110.552 -175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -90.09 109.13 20.2 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.479 -0.934 . . . . 3.14 108.479 168.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 108' ' ' THR . 75.5 mt -67.55 125.25 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.59 0.709 . . . . 2.71 111.645 -173.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.88 122.91 29.57 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.935 -1.029 . . . . 2.82 108.81 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.6 p -57.22 -24.86 57.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.936 0.717 . . . . 2.71 112.936 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -81.34 -27.19 35.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 5.23 111.263 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 m -95.39 -28.7 14.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.422 . . . . 3.38 111.14 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.31 121.18 13.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 1.76 110.651 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.13 116.24 22.25 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.817 -0.438 . . . . 4.05 109.817 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -65.41 136.83 56.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 4.9 110.402 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 258' ' ' SER . 19.0 t70 -130.63 132.79 24.18 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.745 -0.661 . . . . 2.27 110.23 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.578 ' O ' HD22 ' A' ' 44' ' ' LEU . 23.3 Cg_exo -65.17 108.98 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.213 1.942 . . . . 2.45 112.55 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.682 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -53.08 -18.39 2.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.699 -0.682 . . . . 4.62 111.468 171.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER 50.65 -84.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.94 1.296 . . . . 5.15 113.177 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' H ' ' CG ' ' A' ' 44' ' ' LEU . 88.4 tttt -89.69 133.05 35.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.141 -0.318 . . . . 4.21 110.141 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.47 136.98 57.39 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.636 2.224 . . . . 2.76 111.519 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.03 141.66 43.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 2.93 110.096 -177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -102.48 97.19 7.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.898 -0.778 . . . . 2.46 108.898 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.26 108.7 23.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.589 -0.732 . . . . 2.17 109.175 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 61.5 m -108.31 91.51 3.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.982 0.42 . . . . 1.87 110.356 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -102.85 8.95 39.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.922 -0.581 . . . . 3.97 109.542 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.09 -29.59 57.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.963 -1.017 . . . . 2.48 111.156 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 53' ' ' GLN . 5.9 mt-30 -113.31 23.04 13.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.659 -0.7 . . . . 2.54 110.997 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.3 114.02 9.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.035 0.445 . . . . 1.41 110.54 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -115.56 112.26 21.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.41 110.617 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 p -77.96 156.18 30.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.077 -0.511 . . . . 1.84 110.246 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.4 mt -121.63 -56.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.612 -0.267 . . . . 1.45 111.449 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.73 156.67 23.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 3.72 111.515 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 166' ' ' ILE . 12.0 tt -107.12 137.73 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.515 -0.766 . . . . 1.35 109.7 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.0 tp -135.4 150.55 49.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.203 0.525 . . . . 1.53 111.683 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.501 ' HB2' ' HB ' ' A' ' 166' ' ' ILE . 49.0 t-20 -113.33 111.87 22.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.254 -1.387 . . . . 1.49 107.254 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -135.64 71.41 1.43 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.811 -0.756 . . . . 2.18 111.875 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.03 -83.67 0.62 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 119.917 -1.135 . . . . 2.0 112.918 160.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -112.29 -7.29 14.01 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.156 -0.218 . . . . 4.11 111.381 -173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.4 167.26 24.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 1.78 111.612 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 46.1 m-85 -110.34 105.53 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.632 -0.877 . . . . 3.48 108.632 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -99.0 124.82 44.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.469 -0.332 . . . . 1.99 111.764 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.68 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.074 -0.713 . . . . 1.75 109.074 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.29 163.29 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.705 0.764 . . . . 2.02 112.581 -170.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.57 164.64 27.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.424 -1.262 . . . . 2.19 108.372 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 106.15 14.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.689 -0.485 . . . . 1.33 109.689 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -112.24 57.05 0.65 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.575 0.702 . . . . 2.65 110.102 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.1 p -95.83 -20.85 18.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.953 -0.567 . . . . 2.01 111.425 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 7.9 pt20 -145.8 177.97 8.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 2.35 110.784 -171.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.21 63.44 0.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.556 -0.747 . . . . 1.92 110.586 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 74' ' ' GLN . 48.0 mttm -86.0 -69.02 0.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.956 -0.565 . . . . 2.31 111.356 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -115.21 102.48 9.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 1.44 109.61 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.05 142.74 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.186 -0.461 . . . . 1.82 111.788 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 tp -123.31 121.24 35.33 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 1.8 109.324 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -159.96 121.17 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.193 0.52 . . . . 3.02 110.696 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.7 28.55 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 119.606 -0.552 . . . . 1.44 112.033 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -41.01 -140.27 0.0 OUTLIER Glycine 0 CA--C 1.534 1.236 0 O-C-N 124.606 0.827 . . . . 2.15 114.373 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.09 122.94 8.05 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 121.918 1.745 . . . . 3.17 111.525 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 13.2 tp -175.2 -168.27 0.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.367 -1.345 . . . . 4.55 107.367 -165.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.521 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 20.8 t70 -135.9 72.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.798 0.726 . . . . 4.95 110.294 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 164.47 20.26 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 2.25 113.094 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.3 m -105.77 129.44 53.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.529 -0.545 . . . . 2.12 109.529 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -115.3 109.99 18.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.392 . . . . 3.88 111.09 -171.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.8 mtt180 -83.65 155.87 22.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.782 -0.451 . . . . 3.87 109.782 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.5 tp -83.21 131.61 35.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.132 -0.322 . . . . 1.68 110.132 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.666 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.8 tt -116.64 -47.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 2.16 111.375 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -166.56 165.11 16.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.732 -0.47 . . . . 1.95 109.732 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.538 ' CD2' HD11 ' A' ' 118' ' ' LEU . 15.5 p90 -133.84 167.2 21.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.945 -0.302 . . . . 0.98 110.418 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 66' ' ' PHE . 8.2 p-80 -147.51 158.6 44.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.164 -0.68 . . . . 1.07 109.164 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.74 163.65 23.86 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.376 -0.231 . . . . 3.99 110.376 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.541 ' HD1' ' HB3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -124.03 165.24 17.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.694 -0.854 . . . . 2.2 108.694 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.622 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 65.6 t-105 -133.03 140.54 47.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.412 . . . . 6.08 110.626 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.56 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -91.46 -71.17 1.2 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.726 -0.67 . . . . 2.19 112.732 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 24.7 t 165.48 -65.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.277 -1.009 . . . . 3.08 108.277 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.4 mt -111.36 168.02 9.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.312 -0.858 . . . . 3.48 108.869 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.71 61.78 3.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.564 0.697 . . . . 3.85 110.943 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -154.95 -24.35 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.505 -0.855 . . . . 2.37 113.537 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -152.15 176.51 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.304 0.552 . . . . 2.62 110.581 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.56 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 97.04 -33.15 5.97 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.788 -0.72 . . . . 1.62 113.003 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.3 p -71.1 -27.77 63.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.119 0.485 . . . . 2.24 110.76 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 3.6 tp10 58.81 -158.07 0.31 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.958 -1.127 . . . . 3.72 107.958 -166.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.513 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 19.3 m-70 54.76 65.21 1.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.817 -0.809 . . . . 4.03 108.817 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.501 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -93.05 133.61 36.03 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 2.99 109.953 -168.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -109.48 104.61 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.015 -0.365 . . . . 2.88 110.015 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.97 53.74 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.429 -0.805 . . . . 2.8 110.449 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 77.97 -11.22 1.23 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.201 -0.908 . . . . 5.35 111.826 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -93.97 108.82 20.59 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.432 . . . . 3.58 112.168 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 64.0 mttp -81.69 176.44 9.63 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.752 -0.833 . . . . 3.26 108.752 166.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -124.11 -173.19 2.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.243 -0.183 . . . . 1.71 111.094 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.6 -35.43 58.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.938 0.348 . . . . 1.57 111.938 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.77 168.65 26.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.37 -0.377 . . . . 1.3 110.165 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HB3' ' HD1' ' A' ' 96' ' ' HIS . 1.7 tm-20 -145.3 147.3 32.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.067 -0.716 . . . . 1.85 109.067 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.538 HD11 ' CD2' ' A' ' 93' ' ' PHE . 39.5 tp -126.02 122.03 34.69 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.291 0.369 . . . . 1.61 111.047 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -108.69 109.74 20.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.431 -0.35 . . . . 2.25 110.669 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.491 HD21 ' CB ' ' A' ' 93' ' ' PHE . 18.4 mt -93.67 105.21 17.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.935 -0.394 . . . . 1.51 109.935 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.6 118.34 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.334 0.587 . . . . 1.24 112.054 -173.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 52.0 m-70 -110.36 134.09 52.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.472 -0.785 . . . . 2.86 109.482 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.666 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 25.3 p-90 -111.18 148.05 33.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.476 . . . . 4.96 111.885 -172.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.9 110.2 1.27 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.41 -0.814 . . . . 2.3 111.181 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -60.46 -30.4 69.64 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.314 0.857 . . . . 2.77 113.314 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -80.3 -56.84 3.92 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.331 0.493 . . . . 3.79 112.331 -171.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.34 -19.24 56.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 3.34 111.719 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.41 72.68 Favored Glycine 0 C--N 1.318 -0.419 0 N-CA-C 110.314 -1.114 . . . . 2.37 110.314 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.617 ' OD2' ' HG ' ' A' ' 140' ' ' LEU . 22.7 t70 78.48 -78.07 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.95 -1.125 . . . . 3.93 113.162 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -50.33 -21.12 1.28 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.055 1.131 . . . . 3.6 114.055 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.99 -69.14 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.954 -1.117 . . . . 2.35 112.555 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 72.4 mmtt -89.15 -40.14 13.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.533 0.568 . . . . 3.75 112.533 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.8 -29.91 69.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.035 0.383 . . . . 2.17 112.035 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.16 -6.41 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.279 0.562 . . . . 3.11 110.848 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -114.6 19.1 16.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 3.55 110.311 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 22.9 mt-30 -131.25 127.2 21.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 108.782 -0.822 . . . . 3.02 108.782 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.23 -29.93 48.96 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.108 2.539 . . . . 1.93 113.688 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.96 24.26 12.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.728 0.299 . . . . 2.29 110.459 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.97 -70.41 1.07 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.073 -0.512 . . . . 1.5 113.829 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.617 ' HG ' ' OD2' ' A' ' 129' ' ' ASP . 6.5 mp -89.05 171.29 9.95 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.832 0.349 . . . . 1.98 110.801 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -141.39 104.11 4.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.618 -0.512 . . . . 1.83 109.618 172.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.67 111.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.799 -0.445 . . . . 2.28 109.799 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 57.8 tp -82.73 104.86 13.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 2.89 110.345 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -84.86 151.33 26.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.847 -0.692 . . . . 0.95 112.145 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.03 129.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.102 -0.332 . . . . 1.38 110.102 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 107' ' ' HIS . 3.2 m-85 -70.75 137.82 49.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.419 -0.355 . . . . 1.37 110.641 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.93 108.08 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.0 0.429 . . . . 1.48 110.445 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -106.02 164.5 11.92 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 2.52 108.863 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.8 m -106.3 138.42 31.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 1.88 111.847 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.24 -96.83 0.1 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.092 -0.958 . . . . 1.53 110.952 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -87.88 153.78 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.776 -0.453 . . . . 2.08 109.776 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.77 158.37 36.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.194 0.521 . . . . 1.36 112.113 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 216' ' ' SER . 30.5 mmmt -112.31 100.13 48.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.4 -0.818 . . . . 1.78 109.01 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.05 -40.4 59.31 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.089 2.526 . . . . 1.34 112.251 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.81 74.89 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.091 -0.576 . . . . 0.75 113.143 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.2 tp -92.41 -26.23 18.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.46 0.63 . . . . 1.39 110.2 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -35.66 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.63 109.638 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.47 -39.65 84.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.538 -0.755 . . . . 3.26 110.995 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.1 t -71.98 -48.04 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.184 0.516 . . . . 1.97 110.146 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.619 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 67.3 t -58.93 -32.62 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 1.64 110.971 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.41 -21.51 64.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.569 -0.741 . . . . 1.22 111.891 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.29 -12.92 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.505 0.558 . . . . 2.07 112.505 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -57.48 -21.49 37.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.718 0.636 . . . . 1.95 112.718 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.508 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.9 p-10 -64.61 -18.99 65.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 2.31 111.086 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -88.7 -5.99 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.855 0.36 . . . . 1.78 110.9 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 61' ' ' ASN . 14.3 pt -126.64 39.19 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.526 0.679 . . . . 1.42 109.983 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.66 -28.18 69.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.547 -0.751 . . . . 1.98 111.184 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.7 p -130.96 147.66 52.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.362 -0.381 . . . . 1.4 110.709 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -58.57 140.37 54.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.842 -0.617 . . . . 2.84 111.005 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.09 -10.77 55.34 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.951 -0.642 . . . . 0.85 112.131 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.9 144.58 31.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.449 . . . . 2.22 111.041 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.7 p -141.82 156.47 45.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.627 -0.715 . . . . 1.93 110.181 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.63 136.37 35.86 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.482 -0.327 . . . . 1.17 110.282 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.02 129.36 41.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.143 -0.481 . . . . 1.8 110.762 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -138.94 77.86 1.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.004 -1.11 . . . . 1.31 108.004 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.98 156.11 21.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.672 -0.694 . . . . 1.69 111.261 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 54.78 56.33 6.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.123 0.487 . . . . 2.26 112.003 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.536 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 73.0 m-85 -124.75 143.62 50.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.932 -0.576 . . . . 4.84 109.852 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 181' ' ' ARG . 6.4 m-20 -93.12 107.31 24.26 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 2.51 111.844 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 19.4 Cg_exo -69.1 -13.52 36.48 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.934 2.423 . . . . 1.47 112.001 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 179' ' ' ASP . 16.7 ptt180 -66.09 -16.85 64.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.375 . . . . 3.16 110.48 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.49 6.84 67.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.853 -0.612 . . . . 1.12 111.822 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 67.1 mt -110.96 -32.0 6.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.286 0.565 . . . . 2.37 109.557 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.06 127.11 73.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.41 -0.814 . . . . 3.87 111.339 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.37 -174.57 1.46 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.244 2.629 . . . . 2.51 113.099 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.77 -58.72 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.834 0.679 . . . . 3.23 112.834 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 19.7 m -61.52 125.06 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.801 0.334 . . . . 2.03 111.008 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.0 tp -104.22 62.67 0.74 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.588 0.708 . . . . 2.5 109.87 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.456 ' O ' HD12 ' A' ' 211' ' ' LEU . 24.2 m-20 -133.67 -177.86 4.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.994 -1.113 . . . . 1.81 107.994 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.2 p90 -163.01 155.03 18.14 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.308 -0.957 . . . . 5.32 112.625 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.467 ' CE2' ' HG3' ' A' ' 212' ' ' LYS . 57.4 m95 -96.35 142.31 28.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.752 -1.113 . . . . 4.55 109.331 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 256' ' ' LYS . 19.1 m -74.81 79.23 2.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.081 0.467 . . . . 2.39 109.786 173.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.404 ' HB3' ' CG2' ' A' ' 210' ' ' VAL . 41.0 t80 -117.89 103.08 50.7 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.629 . . . . 5.32 109.967 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.65 146.36 76.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.255 2.637 . . . . 2.47 113.087 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.666 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -139.66 153.15 22.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.508 -0.853 . . . . 2.0 112.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.8 t -107.38 137.03 46.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.882 0.372 . . . . 3.36 110.154 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 199' ' ' THR . 2.0 pp -76.73 -34.6 58.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.9 -0.591 . . . . 5.18 111.004 -176.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.436 ' HB ' ' HG ' ' A' ' 202' ' ' LEU . 1.4 m -82.48 29.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.423 0.63 . . . . 5.53 109.57 176.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 15.8 p 68.53 156.68 0.15 Allowed Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 113.829 -1.532 . . . . 5.89 109.905 -168.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 199' ' ' THR . 11.0 Cg_exo -27.86 -58.99 0.1 Allowed 'Trans proline' 0 CA--C 1.545 1.062 1 C-N-CA 125.379 4.052 . . . . 6.31 116.578 -174.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.08 66.54 7.82 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.558 1.506 . . . . 5.26 113.501 -170.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.436 ' HG ' ' HB ' ' A' ' 198' ' ' THR . 0.2 OUTLIER -148.53 -85.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.589 -0.444 . . . . 4.29 111.668 174.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.96 163.94 29.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 3.51 112.022 -172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.41 67.12 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.732 0.777 . . . . 3.37 110.281 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.9 m -118.24 24.71 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.223 -0.899 . . . . 2.47 110.491 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 70.7 t -120.38 134.39 64.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.65 -0.705 . . . . 1.74 110.159 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.2 m -73.63 121.7 21.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.597 -0.729 . . . . 2.3 109.629 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.424 ' CE3' HG22 ' A' ' 192' ' ' THR . 0.0 OUTLIER -64.48 99.49 0.31 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.072 -0.967 . . . . 6.37 111.981 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 58.3 mt -142.43 100.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.326 -0.397 . . . . 2.32 110.368 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 73.3 t -117.25 119.14 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.286 -0.264 . . . . 2.1 110.286 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 189' ' ' ASP . 9.8 tp -62.06 123.2 17.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.228 -0.286 . . . . 2.35 110.228 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 191' ' ' TRP . 29.2 ttpp -65.59 -8.31 19.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.716 1.376 . . . . 3.47 114.716 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 36.3 tt0 -105.93 110.06 63.74 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 119.776 -0.77 . . . . 1.56 111.096 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 25.7 Cg_exo -64.49 137.66 56.18 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.776 2.317 . . . . 1.37 111.578 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -97.49 149.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.745 -0.465 . . . . 1.85 109.745 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.58 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 17.0 t -103.34 120.7 41.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.207 -0.664 . . . . 1.78 109.207 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.47 162.95 8.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.996 -0.372 . . . . 1.64 109.996 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 16.2 t -81.92 151.09 27.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.121 -0.325 . . . . 1.52 110.121 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.635 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 13.9 m -55.67 -43.17 76.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.405 -0.361 . . . . 1.81 110.83 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 12.3 tp10 -59.42 -32.51 70.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 2.51 111.019 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -67.18 -49.92 62.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 1.02 110.741 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.622 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 31.2 m -71.0 -29.75 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.351 . . . . 1.88 111.944 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 219' ' ' SER . 91.1 mt -63.9 -26.54 68.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 1.59 110.84 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 58.1 mtpt -82.68 -22.67 34.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 2.3 110.86 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.6 m-85 -70.12 -34.05 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.514 -0.55 . . . . 3.18 109.514 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.92 -14.62 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 3.55 111.042 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -95.61 -3.12 46.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.406 -0.361 . . . . 2.74 111.528 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.69 154.6 21.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.226 0.536 . . . . 1.66 111.224 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.45 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.3 m120 -119.81 159.48 24.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.266 -0.642 . . . . 1.13 109.266 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -105.62 -4.64 20.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 4.38 110.424 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.8 p-10 -85.1 176.14 8.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 1.62 110.091 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -104.09 169.12 17.37 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.143 -0.783 . . . . 1.16 111.143 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -55.24 143.58 27.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 3.56 110.647 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.76 23.83 54.8 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.052 -0.594 . . . . 2.23 112.923 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.4 153.33 76.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 117.247 0.523 . . . . 2.59 109.851 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.06 127.74 23.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.531 2.154 . . . . 1.5 111.01 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.0 118.68 4.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.623 0.725 . . . . 3.4 112.783 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -114.13 110.39 19.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.855 -1.066 . . . . 2.47 109.121 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.55 139.64 47.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.336 -0.393 . . . . 2.6 111.077 -176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.6 ttm -87.52 91.52 8.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.391 -0.596 . . . . 1.94 109.391 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.69 154.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.203 -0.453 . . . . 1.67 111.356 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.5 t70 69.06 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.077 0.861 . . . . 2.18 110.524 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.407 ' HA ' ' CG ' ' A' ' 7' ' ' TYR . 58.9 t30 56.3 20.38 4.59 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.177 0.806 . . . . 2.64 113.177 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -151.32 167.44 27.87 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.056 -0.403 . . . . 5.31 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -125.09 147.7 57.91 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 115.802 -0.635 . . . . 6.91 110.675 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -43.9 146.54 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.051 2.501 . . . . 3.72 112.553 168.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 29' ' ' SER . . . -72.94 142.65 47.84 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.196 1.184 . . . . 3.34 114.196 -166.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -74.76 159.55 82.89 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.675 -1.148 . . . . 4.92 110.303 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.57 174.48 8.76 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.454 2.77 . . . . 4.01 113.729 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.635 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 89.2 mt -66.14 -9.5 32.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.81 -1.086 . . . . 4.9 112.081 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 74.3 mmtt -58.67 46.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.623 1.342 . . . . 5.68 114.623 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 51.5 t30 120.19 6.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.559 1.944 . . . . 5.11 110.721 176.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 1.2 mpt_? -132.98 104.02 6.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.716 -0.674 . . . . 6.74 109.298 171.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -114.5 145.63 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.757 0.313 . . . . 3.08 111.099 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.3 mm -100.88 126.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.027 -0.533 . . . . 3.06 110.35 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.544 ' HB2' ' OG1' ' A' ' 192' ' ' THR . 96.4 mttt -117.19 150.78 38.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.703 -0.851 . . . . 3.01 108.703 172.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -115.94 95.8 5.28 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.705 -0.479 . . . . 1.99 109.705 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 68.6 m -80.69 94.66 6.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.728 -0.789 . . . . 2.47 110.506 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -140.19 111.02 6.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.3 -1.318 . . . . 5.03 108.833 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-N 116.053 -0.521 . . . . 4.82 110.956 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.295 -0.261 . . . . 17.73 110.295 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m 65.13 -175.44 0.18 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.656 0.597 . . . . 15.49 111.263 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 56.14 65.25 1.48 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.386 0.613 . . . . 16.29 110.502 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -101.34 132.79 46.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.044 -0.525 . . . . 14.68 110.537 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 60.46 -164.0 0.24 Allowed 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.919 0.762 . . . . 15.53 111.051 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.16 -174.84 43.64 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.882 -0.887 . . . . 10.81 110.882 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.02 98.56 4.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.189 0.519 . . . . 11.61 109.696 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.19 144.77 10.35 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.523 -0.762 . . . . 9.0 111.783 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -47.83 129.45 14.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.531 0.681 . . . . 10.04 112.555 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -155.51 -58.33 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.164 -0.925 . . . . 11.67 108.734 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -117.89 30.69 7.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.289 -0.869 . . . . 11.18 109.477 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.6 116.29 1.01 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.002 -0.839 . . . . 8.9 111.002 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.6 124.74 9.53 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.065 1.843 . . . . 8.2 112.037 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.46 -20.28 25.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.215 0.531 . . . . 10.62 110.371 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.4 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 33.7 m170 -114.22 24.47 11.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.634 -0.712 . . . . 10.41 111.62 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -45.03 -53.35 7.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.757 0.651 . . . . 9.19 112.757 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -74.47 -9.63 58.78 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.504 -0.478 . . . . 7.71 111.241 -174.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 15' ' ' HIS . 28.0 ttpt -67.62 -18.08 64.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.372 0.606 . . . . 10.03 110.071 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -77.74 -9.85 59.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.736 -0.666 . . . . 7.89 111.001 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.46 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . 61.1 m-85 -110.93 102.91 53.89 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.293 -0.632 . . . . 7.65 109.293 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -52.53 -21.41 14.12 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.832 3.021 . . . . 8.15 114.932 -172.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 22' ' ' ILE . 9.9 tp -146.1 51.74 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 122.1 0.952 . . . . 6.15 110.761 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 20' ' ' PHE . . . -65.04 -32.37 74.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.594 -0.73 . . . . 5.72 111.59 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -138.98 -45.86 0.47 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.306 0.574 . . . . 8.17 110.835 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.79 -44.73 0.24 Allowed Glycine 0 CA--C 1.504 -0.616 0 N-CA-C 109.16 -1.576 . . . . 5.05 109.16 -175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 202' ' ' LEU . 6.9 pt-20 -48.55 154.62 0.63 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.55 -0.825 . . . . 7.09 110.071 165.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.47 165.8 35.28 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.653 -1.98 . . . . 5.44 105.653 -168.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.62 -59.85 4.34 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.003 1.274 . . . . 7.33 112.612 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 29.6 t -103.66 150.44 38.13 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.984 -1.117 . . . . 4.35 107.984 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.499 ' HG3' ' CZ3' ' A' ' 208' ' ' TRP . 20.5 Cg_endo -60.73 -48.16 11.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 CA-C-N 120.402 1.179 . . . . 4.96 111.885 -176.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG11 HD12 ' A' ' 255' ' ' ILE . 10.7 p -169.5 143.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 111.799 0.296 . . . . 5.07 111.799 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.33 117.32 28.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.252 -1.018 . . . . 3.14 108.252 162.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -97.67 126.15 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.732 0.301 . . . . 2.71 111.757 -170.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.85 117.48 34.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.426 -0.352 . . . . 2.82 110.239 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -30.42 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.782 -0.645 . . . . 2.71 112.148 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -83.14 -15.61 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.589 -0.278 . . . . 5.23 111.495 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.443 HG21 ' CD1' ' A' ' 250' ' ' LEU . 88.5 m -98.23 -29.35 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.655 0.264 . . . . 3.38 111.26 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 130.62 44.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.76 111.259 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.39 124.31 45.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 4.05 109.93 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.14 113.33 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.488 -0.56 . . . . 4.9 109.488 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -118.62 118.72 33.32 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 2.27 109.669 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -53.82 91.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 123.583 2.855 . . . . 2.45 113.599 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 p -58.89 -30.85 68.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.743 -0.662 . . . . 4.62 110.844 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt 71.28 -64.92 0.36 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.323 -0.853 . . . . 5.15 111.65 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -76.0 130.63 77.74 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.737 0.303 . . . . 4.21 110.729 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.58 158.58 32.23 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.723 2.282 . . . . 2.76 111.925 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 48' ' ' SER . 6.5 tt -91.52 140.29 29.89 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.333 -0.617 . . . . 2.93 109.333 -178.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.488 ' N ' HD22 ' A' ' 47' ' ' LEU . 2.0 t -144.6 139.33 28.02 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.848 -0.797 . . . . 2.46 108.848 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.33 128.88 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.048 0.452 . . . . 2.17 111.929 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.5 t -118.94 90.04 3.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.079 -0.711 . . . . 1.87 109.079 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.76 13.84 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 3.97 110.421 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.69 -31.65 68.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 2.48 111.213 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 13.9 mt-30 -109.35 17.35 21.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 2.54 110.736 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.24 114.48 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.37 . . . . 1.41 110.922 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 m -101.35 106.24 17.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.049 -0.523 . . . . 1.41 110.734 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -85.42 151.49 23.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.799 -0.637 . . . . 1.84 109.712 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.24 -57.54 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 1.45 111.545 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -167.34 159.63 12.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.64 0.257 . . . . 3.72 111.036 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 14.1 tt -104.99 140.6 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.317 -0.623 . . . . 1.35 109.317 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -130.29 140.53 50.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.115 0.483 . . . . 1.53 111.555 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.22 108.6 20.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.732 -1.211 . . . . 1.49 107.732 170.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -137.83 71.55 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.572 -0.851 . . . . 2.18 111.791 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.62 -75.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 119.941 -1.123 . . . . 2.0 112.851 159.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.447 ' NE2' ' HB3' ' A' ' 243' ' ' ASN . 52.4 t-80 -112.59 -12.85 13.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.056 0.391 . . . . 4.11 112.056 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -154.2 175.99 12.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.997 0.427 . . . . 1.78 111.748 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.79 103.8 9.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.414 -0.958 . . . . 3.48 108.414 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.94 134.97 47.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.155 0.502 . . . . 1.99 111.87 -170.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 48.4 t -100.25 112.13 31.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.309 -0.626 . . . . 1.75 109.309 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.48 130.87 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 2.02 112.198 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -111.87 163.7 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.397 -0.964 . . . . 2.19 108.397 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.05 121.49 27.09 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.614 -0.434 . . . . 1.33 111.372 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.609 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 10.0 t0 -114.72 60.42 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.884 0.849 . . . . 2.65 109.75 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 t -116.47 -15.49 10.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 2.01 110.134 165.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -137.6 160.79 38.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.496 -0.557 . . . . 2.35 109.496 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -82.33 64.71 7.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.27 0.557 . . . . 1.92 110.207 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.553 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 67.6 mttm -79.18 -51.22 9.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.434 -0.803 . . . . 2.31 110.003 -177.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.88 105.2 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 1.44 109.215 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.14 139.98 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.046 0.451 . . . . 1.82 110.914 -172.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 14.7 tp -109.55 148.89 30.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.819 -0.628 . . . . 1.8 110.969 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 93.5 mttt -116.55 141.51 48.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.024 -1.102 . . . . 3.02 108.024 164.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.2 168.73 31.42 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.271 -0.966 . . . . 1.44 112.229 -165.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.513 ' HA3' ' HH ' ' A' ' 190' ' ' TYR . . . -60.63 -146.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 112.263 -0.335 . . . . 2.15 112.263 169.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.43 121.66 9.42 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.09 1.86 . . . . 3.17 112.095 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.423 HD22 ' CD1' ' A' ' 88' ' ' TYR . 8.3 tp -179.63 157.57 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.024 -1.102 . . . . 4.55 108.024 -175.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.57 111.32 13.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.987 1.106 . . . . 4.95 113.987 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.1 -101.66 0.96 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.441 -0.885 . . . . 2.25 114.858 161.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 89' ' ' ARG . 33.4 m -130.95 103.92 6.83 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.487 -0.56 . . . . 2.12 109.487 -167.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.501 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 1.3 m-85 -95.44 91.52 6.24 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.608 -0.437 . . . . 3.88 110.044 -172.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 55.9 mtt180 -107.27 146.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.717 0.294 . . . . 3.87 110.568 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 57.8 tp -77.84 123.86 27.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.552 -0.536 . . . . 1.68 109.552 171.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.1 -40.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.176 -0.465 . . . . 2.16 110.02 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -174.89 168.51 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.764 -0.653 . . . . 1.95 109.715 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.28 150.01 47.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.199 -0.667 . . . . 0.98 109.199 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 7.6 p-80 -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.632 0.254 . . . . 1.07 110.863 -172.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -134.37 158.89 42.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 3.99 110.347 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -165.13 179.39 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.644 0.259 . . . . 2.2 111.36 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.636 ' CD1' ' HA ' ' A' ' 242' ' ' ASP . 2.9 t90 74.0 -100.46 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.066 0.946 . . . . 6.08 110.407 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 53.02 15.58 3.57 Favored Glycine 0 N--CA 1.475 1.241 0 N-CA-C 115.278 0.871 . . . . 2.19 115.278 174.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.498 ' H ' ' HD1' ' A' ' 97' ' ' TRP . 48.3 p -45.7 -53.92 8.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.896 0.702 . . . . 3.08 112.896 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.7 mt -128.53 146.86 50.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.477 -0.564 . . . . 3.48 109.477 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.69 -13.23 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 3.85 111.613 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.55 -10.26 41.59 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.347 -0.93 . . . . 2.37 113.017 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.39 119.27 2.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.579 0.704 . . . . 2.62 111.725 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.28 41.32 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.658 -0.701 . . . . 1.62 111.794 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.4 p -105.8 -14.09 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 2.24 112.298 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.76 174.23 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.463 -0.569 . . . . 3.72 109.463 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.589 ' HE2' ' CD ' ' A' ' 117' ' ' GLU . 14.9 p80 44.09 68.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.312 1.053 . . . . 4.03 111.426 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.6 t -75.97 130.41 38.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.515 -1.22 . . . . 2.99 110.681 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 23.3 t -101.76 105.69 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 114.378 -1.283 . . . . 2.88 110.171 -172.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 55.31 50.76 14.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.568 -0.742 . . . . 2.8 109.472 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 68.33 1.14 2.77 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.238 -0.892 . . . . 5.35 112.607 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 47.8 tptt -89.75 123.72 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 3.58 110.968 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.69 155.96 27.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.809 -0.632 . . . . 3.26 110.31 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.69 168.89 9.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.101 -0.703 . . . . 1.71 109.101 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.43 79.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.274 0.472 . . . . 1.57 112.274 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.46 171.32 7.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.219 -0.66 . . . . 1.3 109.219 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.589 ' CD ' ' HE2' ' A' ' 107' ' ' HIS . 28.8 tt0 -142.24 138.43 31.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.067 0.461 . . . . 1.85 110.509 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.3 tp -102.43 126.49 49.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.43 -0.804 . . . . 1.61 109.448 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.402 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 42.4 m170 -107.98 110.27 21.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 2.25 111.147 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 6.8 mp -94.68 103.44 15.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.678 -0.49 . . . . 1.51 109.678 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.419 HG23 HG11 ' A' ' 142' ' ' VAL . 19.3 t -76.85 100.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.008 -0.542 . . . . 1.24 110.436 -176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 90' ' ' LEU . 3.2 p80 -138.97 76.19 1.56 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.755 1.021 . . . . 2.86 113.755 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.0 t90 178.91 99.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.345 0.658 . . . . 4.96 109.856 149.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.558 ' ND2' ' HB3' ' A' ' 133' ' ' ALA . 24.8 t-20 -124.62 90.48 3.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 118.612 -0.708 . . . . 2.3 111.561 157.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.5 m -81.28 -51.98 7.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 120.819 1.645 . . . . 2.77 111.492 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -43.57 -32.77 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 114.549 1.314 . . . . 3.79 114.549 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.98 -16.35 6.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.133 -0.627 . . . . 3.34 111.851 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.38 38.91 51.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.583 -0.607 . . . . 2.37 111.583 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 12.3 t70 -169.33 110.48 0.47 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.675 -0.861 . . . . 3.93 108.675 -171.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -63.44 -32.12 73.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.943 0.349 . . . . 3.6 111.943 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.71 98.64 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.921 -0.657 . . . . 2.35 112.818 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.457 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 31.7 mmmt -74.32 -20.99 59.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.276 0.56 . . . . 3.75 110.311 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.558 ' HB3' ' ND2' ' A' ' 124' ' ' ASN . . . -74.75 -20.95 59.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 2.17 111.988 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.6 t -61.11 -22.08 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.152 -0.476 . . . . 3.11 111.566 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -98.18 8.09 45.32 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.158 -0.339 . . . . 3.55 111.572 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.481 ' NE2' ' HD2' ' A' ' 137' ' ' PRO . 12.9 mm100 -122.86 127.47 25.72 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.662 0.267 . . . . 3.02 111.161 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.481 ' HD2' ' NE2' ' A' ' 136' ' ' GLN . 11.2 Cg_endo -55.3 -32.96 83.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.604 2.869 . . . . 1.93 113.465 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.61 28.42 8.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.796 -0.446 . . . . 2.29 109.796 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.19 -27.91 73.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.048 -0.596 . . . . 1.5 114.319 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.8 mt -137.19 170.29 16.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.459 . . . . 1.98 111.564 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.14 118.58 6.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 1.83 109.472 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 33.8 m -113.4 142.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 2.28 111.064 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.0 tp -95.46 103.85 15.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.786 . . . . 2.89 108.879 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.6 3.66 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.044 -0.598 . . . . 0.95 112.223 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 32.3 mt -102.62 124.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.866 -0.42 . . . . 1.38 109.866 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 48.8 m-85 -68.2 148.2 51.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 1.37 110.898 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.6 mp -118.56 138.3 52.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.498 -0.556 . . . . 1.48 109.498 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -143.23 146.55 33.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.891 -0.781 . . . . 2.52 108.891 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 95.7 t -83.79 130.87 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.099 0.476 . . . . 1.88 111.663 -171.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.45 -110.14 0.24 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.872 -0.891 . . . . 1.53 110.872 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 t -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.313 -0.625 . . . . 2.08 109.313 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.0 158.27 23.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.608 0.242 . . . . 1.36 110.987 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -115.94 106.2 50.06 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.922 -0.399 . . . . 1.78 109.922 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 51.1 Cg_exo -54.96 -35.77 90.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.08 2.52 . . . . 1.34 112.362 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.58 71.98 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.992 -0.623 . . . . 0.75 112.645 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.433 ' HB3' HE22 ' A' ' 221' ' ' GLN . 19.1 tp -88.05 -20.25 26.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.47 -0.567 . . . . 1.39 109.47 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 19.8 mm-40 -52.82 -37.34 59.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.546 -0.752 . . . . 1.63 110.647 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 175' ' ' PHE . 57.3 mttp -54.01 -54.27 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.458 0.474 . . . . 3.26 111.601 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.438 ' HA ' HG11 ' A' ' 162' ' ' VAL . 11.4 p -74.62 -37.26 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.91 0.386 . . . . 1.97 110.762 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 80.6 t -64.94 -34.97 74.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.419 0.628 . . . . 1.64 110.808 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.66 -32.84 71.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.063 -0.517 . . . . 1.22 111.317 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 159' ' ' VAL . 9.3 p -89.58 -20.74 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.17 0.433 . . . . 2.07 112.17 -173.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 228' ' ' LEU . 3.0 pp -67.84 -16.92 64.33 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.071 0.463 . . . . 1.95 111.161 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.452 ' N ' HD11 ' A' ' 163' ' ' LEU . 9.8 t70 -65.04 -23.35 67.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 2.31 110.325 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.7 m -89.73 1.71 55.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 1.78 111.935 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.96 39.23 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.513 0.673 . . . . 1.42 110.078 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 89.0 tttt -59.62 -22.59 62.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.146 -0.933 . . . . 1.98 111.666 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.1 p -120.18 137.56 54.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.51 -0.314 . . . . 1.4 110.812 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.514 ' HD2' ' O ' ' A' ' 230' ' ' PHE . 15.0 ptmm? -56.07 137.09 51.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.053 -0.521 . . . . 2.84 111.348 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.33 -30.46 8.23 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.976 -0.63 . . . . 0.85 111.816 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -81.8 153.79 26.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.06 0.457 . . . . 2.22 110.91 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.9 t -145.84 151.84 38.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.622 -0.717 . . . . 1.93 109.499 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -133.58 126.29 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.604 -0.271 . . . . 1.17 110.312 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.38 131.15 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 1.8 110.495 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -144.55 86.09 1.8 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 1.31 110.523 -176.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.6 p -95.99 160.92 14.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.703 0.287 . . . . 1.69 111.485 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 21.1 m120 65.19 29.8 11.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.774 -0.648 . . . . 2.26 112.331 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -87.47 119.9 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.464 -0.569 . . . . 4.84 109.464 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.74 112.7 63.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.995 0.426 . . . . 2.51 111.024 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.49 -17.83 60.92 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.82 2.347 . . . . 1.47 111.723 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -53.95 -40.07 66.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.554 -0.748 . . . . 3.16 110.861 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -64.89 -18.33 64.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.666 -0.697 . . . . 1.12 113.704 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.8 mt -96.83 -11.96 24.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.261 0.53 . . . . 2.37 111.701 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 96.7 mt -63.85 123.72 82.64 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.727 0.299 . . . . 3.87 111.563 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.46 ' HB2' ' HG2' ' A' ' 213' ' ' GLU . 2.5 Cg_endo -82.49 -170.04 0.86 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.221 2.614 . . . . 2.51 112.154 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.47 -66.19 0.92 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.159 0.8 . . . . 3.23 113.159 -174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 20.1 m -65.48 114.66 5.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.15 0.5 . . . . 2.03 111.357 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 17.8 tp -103.15 70.57 1.07 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 2.5 110.744 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 211' ' ' LEU . 3.0 m-20 -130.33 174.32 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.39 -0.967 . . . . 1.81 108.39 176.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.693 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 38.4 p90 -166.36 154.7 10.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.559 0.948 . . . . 5.32 113.559 -164.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.613 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 4.1 m95 -107.78 149.74 27.84 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.239 -1.393 . . . . 4.55 107.239 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.7 t -138.38 103.03 4.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.97 0.804 . . . . 2.39 112.799 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.39 157.84 69.88 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.924 -0.58 . . . . 5.32 110.492 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.04 137.21 78.28 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.731 2.288 . . . . 2.47 112.366 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -134.25 156.97 22.66 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.303 -0.475 . . . . 2.0 113.563 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.8 t -94.77 143.12 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.642 0.377 . . . . 3.36 110.04 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 62.1 tp -94.99 -46.06 6.99 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.854 0.687 . . . . 5.18 112.854 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.653 ' O ' ' HD2' ' A' ' 200' ' ' PRO . 13.7 m -116.37 -43.09 2.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.881 -0.328 . . . . 5.53 110.812 -175.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.41 ' CB ' ' O ' ' A' ' 198' ' ' THR . 53.0 m 105.42 -63.01 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.804 0 O-C-N 124.956 1.41 . . . . 5.89 113.193 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 198' ' ' THR . 5.8 Cg_exo -39.71 -55.47 1.65 Allowed 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.194 2.596 . . . . 6.31 115.387 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.95 -9.37 18.05 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 121.456 1.437 . . . . 5.26 112.374 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . 68.1 mt 64.95 66.16 0.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.269 -1.332 . . . . 4.29 110.813 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.2 mt -116.21 121.92 43.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.24 -0.436 . . . . 3.51 110.53 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.4 66.77 0.89 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.861 0.838 . . . . 3.37 109.581 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.0 11.76 30.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.774 -1.103 . . . . 2.47 111.026 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.73 149.63 22.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.077 0.465 . . . . 1.74 111.414 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.4 m -103.03 107.86 18.82 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 2.3 107.989 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.499 ' CZ3' ' HG3' ' A' ' 30' ' ' PRO . 1.3 t-105 -80.89 100.08 8.68 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.737 -0.468 . . . . 6.37 109.737 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 55.3 mt -99.91 100.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.01 -0.541 . . . . 2.32 109.742 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 45.4 t -85.11 119.35 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.251 -0.432 . . . . 2.1 110.852 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 189' ' ' ASP . 46.2 tp -80.41 122.43 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.439 . . . . 2.35 110.612 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -48.44 -28.74 3.46 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.082 1.142 . . . . 3.47 114.082 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.46 ' HG2' ' HB2' ' A' ' 185' ' ' PRO . 5.7 tp10 -102.98 114.42 65.25 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.396 -0.522 . . . . 1.56 110.926 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.436 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 90.5 Cg_endo -80.01 148.61 19.6 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.803 2.335 . . . . 1.37 111.893 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 34.4 pt -101.88 149.44 6.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 1.85 110.559 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.7 p -101.93 117.53 35.02 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.462 -0.79 . . . . 1.78 110.098 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 32.6 m -115.76 168.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.137 -0.483 . . . . 1.64 110.049 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.3 t -90.65 148.78 22.41 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.741 -0.384 . . . . 1.52 110.417 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.55 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 10.6 p -53.66 -45.0 70.11 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.507 0.505 . . . . 1.81 111.502 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.0 -31.53 71.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.647 -0.251 . . . . 2.51 111.306 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.433 HE22 ' HB3' ' A' ' 156' ' ' LEU . 54.5 mt-30 -62.51 -51.09 68.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.7 0.286 . . . . 1.02 110.628 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.65 -26.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.933 -0.307 . . . . 1.88 111.156 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 219' ' ' SER . 88.3 mt -69.44 -36.07 76.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 1.59 110.883 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -66.11 -31.44 72.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.064 0.459 . . . . 2.3 110.764 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -69.7 -39.32 76.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.594 -0.73 . . . . 3.18 109.754 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -72.0 -3.62 23.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.24 -0.891 . . . . 3.55 111.011 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 98.5 mttt -94.34 -1.38 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 2.74 110.665 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 163' ' ' LEU . 55.6 mt -90.41 155.08 19.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.037 -0.529 . . . . 1.66 110.775 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -112.36 155.7 23.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.51 -0.314 . . . . 1.13 110.354 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.514 ' O ' ' HD2' ' A' ' 169' ' ' LYS . 50.4 p90 -111.52 -18.42 12.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.215 -0.448 . . . . 4.38 110.293 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.509 HD21 ' HB2' ' A' ' 235' ' ' GLU . 6.2 p-10 -71.51 -31.83 67.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.62 111.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.455 ' CA ' ' HG2' ' A' ' 169' ' ' LYS . . . 97.99 -159.71 20.79 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.564 -0.827 . . . . 1.16 113.018 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.17 150.38 20.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.686 0.279 . . . . 3.56 110.34 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.19 4.22 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.01 -0.615 . . . . 2.23 112.685 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.509 ' HB2' HD21 ' A' ' 231' ' ' ASN . 41.6 mt-10 -134.92 159.55 71.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.447 -0.575 . . . . 2.59 109.447 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.91 129.92 37.87 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.772 2.315 . . . . 1.5 112.005 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.64 114.35 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 3.4 111.839 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.71 117.82 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.393 -0.595 . . . . 2.47 109.393 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.21 136.24 55.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.789 -0.642 . . . . 2.6 111.206 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.5 ttm -81.32 89.94 6.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.668 -0.697 . . . . 1.94 109.49 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.73 153.59 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 1.67 109.804 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.636 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 13.6 t70 64.75 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.885 0.741 . . . . 2.18 110.607 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.447 ' HB3' ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER 52.23 27.33 4.61 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.56 0.948 . . . . 2.64 113.56 179.027 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.444 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 73.8 m95 -139.84 169.32 17.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.902 0.382 . . . . 5.31 110.81 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 29' ' ' SER . 24.1 mmt180 -117.35 148.91 43.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 6.91 111.573 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -33.23 138.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.921 3.747 . . . . 3.72 115.014 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.565 ' HA ' ' CB ' ' A' ' 29' ' ' SER . . . -54.91 143.82 24.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.683 -1.144 . . . . 3.34 112.209 -175.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.446 ' HG2' ' H ' ' A' ' 29' ' ' SER . 28.4 mm-40 -107.97 130.36 22.9 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 4.92 110.894 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 248' ' ' GLN . 27.4 Cg_exo -63.23 175.17 2.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.52 2.813 . . . . 4.01 113.956 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 37' ' ' THR . 49.8 mt -62.17 -11.19 13.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.207 -1.361 . . . . 4.9 113.402 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 18.5 ptpt -57.79 47.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.234 1.938 . . . . 5.68 116.234 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 7.5 t30 127.4 25.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 126.372 1.869 . . . . 5.11 111.106 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 252' ' ' ASN . 0.0 OUTLIER -141.94 110.76 6.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.083 -0.71 . . . . 6.74 109.083 166.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.02 121.81 45.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.072 -0.714 . . . . 3.08 109.072 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.402 HD12 HG11 ' A' ' 31' ' ' VAL . 47.6 mm -82.95 115.58 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.181 0.515 . . . . 3.06 112.262 -174.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.56 127.5 40.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.639 -0.71 . . . . 3.01 109.555 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -116.37 146.09 42.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.717 -0.475 . . . . 1.99 109.717 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 19.5 m -142.41 96.43 2.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.426 0.631 . . . . 2.47 110.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.418 ' HA ' ' OD1' ' A' ' 189' ' ' ASP . 86.5 t80 -126.54 90.69 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.548 -0.908 . . . . 5.03 108.548 166.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.375 -0.821 . . . . 4.82 109.823 -177.54 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttp . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.748 0.309 . . . . 17.73 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 p -68.02 -47.14 69.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 15.49 111.573 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -102.67 44.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.429 0.633 . . . . 16.29 111.462 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -98.02 94.22 6.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.362 -0.977 . . . . 14.68 108.362 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -81.84 141.95 32.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.077 0.465 . . . . 15.53 111.573 -172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 11' ' ' ASN . . . 169.08 177.62 39.95 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.623 -0.717 . . . . 10.81 111.442 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -92.8 105.08 17.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.85 0.357 . . . . 11.61 111.032 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.44 176.7 51.51 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.874 -0.603 . . . . 9.0 112.84 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.538 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 3.4 mppt? -58.62 153.93 15.41 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.412 -0.218 . . . . 10.04 110.412 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 98.7 m-70 74.81 -54.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.523 0.729 . . . . 11.67 111.424 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 15.9 m120 -78.74 -16.75 56.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.149 0.499 . . . . 11.18 109.822 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.69 -139.56 3.67 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.904 -0.878 . . . . 8.9 110.904 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.06 135.18 10.91 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.631 2.221 . . . . 8.2 110.852 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -78.78 -9.93 59.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.526 0.679 . . . . 10.62 110.01 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -123.75 23.69 8.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.579 -0.737 . . . . 10.41 110.017 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -65.39 -21.59 66.69 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.874 -0.603 . . . . 9.19 110.514 -175.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -58.82 -29.53 66.95 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.364 -0.38 . . . . 7.71 111.39 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -89.4 -40.8 12.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.63 0.252 . . . . 10.03 111.252 -176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.52 -8.61 58.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.165 0.507 . . . . 7.89 110.893 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -137.59 103.93 8.47 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.295 -1.002 . . . . 7.65 108.295 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.12 70.47 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.187 2.591 . . . . 8.15 113.726 -172.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.44 ' HA ' ' CG ' ' A' ' 26' ' ' GLU . 1.9 mp -106.56 -44.03 7.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.293 0.568 . . . . 6.15 110.17 172.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.0 -2.68 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.71 -0.677 . . . . 5.72 112.172 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -88.51 10.33 20.67 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.626 0.232 . . . . 8.17 111.626 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.73 49.39 0.85 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.438 -0.887 . . . . 5.05 112.903 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.44 ' CG ' ' HA ' ' A' ' 22' ' ' ILE . 23.6 mm-40 -106.43 121.77 44.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.769 0.318 . . . . 7.09 110.655 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -76.72 138.4 39.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.672 0.748 . . . . 5.44 111.562 174.259 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -131.53 -150.64 0.43 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.695 -1.139 . . . . 7.33 112.059 -171.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.3 m -47.65 160.48 0.38 Allowed Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 115.653 1.723 . . . . 4.35 115.653 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -63.11 34.46 0.08 OUTLIER 'Trans proline' 0 N--CA 1.484 0.956 1 C-N-CA 125.979 4.453 . . . . 4.96 114.662 173.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 m -87.92 -168.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 119.295 -0.383 . . . . 5.07 110.37 -170.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -47.31 123.12 5.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.465 0.913 . . . . 3.14 113.465 -159.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 26.2 mm -101.6 134.37 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.718 -1.128 . . . . 2.71 111.2 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.408 ' HB3' ' OG1' ' A' ' 37' ' ' THR . 16.2 t70 -107.32 113.45 26.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.963 -0.384 . . . . 2.82 109.963 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -56.67 -33.11 66.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.319 0.859 . . . . 2.71 113.319 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -75.07 -41.29 59.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.876 -0.329 . . . . 5.23 111.109 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 7.3 p -72.55 -27.53 62.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.801 0.334 . . . . 3.38 110.532 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -69.89 84.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.277 0.56 . . . . 1.76 110.443 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -79.73 134.43 36.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.692 -0.685 . . . . 4.05 109.656 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 2.5 p90 -81.68 124.52 29.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.194 0.521 . . . . 4.9 110.297 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -118.0 119.9 33.12 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 2.27 109.621 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.32 24.57 0.31 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.999 2.466 . . . . 2.45 113.728 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.8 p -95.86 -17.21 21.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.268 0.556 . . . . 4.62 109.51 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.77 124.51 30.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.493 -0.776 . . . . 5.15 109.768 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -115.15 136.57 22.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.122 -0.49 . . . . 4.21 110.922 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.07 122.84 12.42 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.825 2.35 . . . . 2.76 112.049 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 6.2 mp -78.62 132.96 37.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 2.93 110.904 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.6 t -84.56 138.04 32.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.466 -0.568 . . . . 2.46 109.466 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.0 t -118.37 121.78 67.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.192 -0.458 . . . . 2.17 110.832 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.3 p -111.55 89.91 3.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.438 -0.578 . . . . 1.87 109.438 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' HH ' ' HG3' ' A' ' 181' ' ' ARG . 30.4 p90 -109.84 10.01 24.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.687 -0.688 . . . . 3.97 110.098 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.8 -34.72 65.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.386 -0.825 . . . . 2.48 111.544 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.7 13.66 29.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.278 0.473 . . . . 2.54 112.278 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.29 113.57 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 1.41 111.923 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.8 m -107.33 109.83 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.847 -0.615 . . . . 1.41 110.547 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 178' ' ' PHE . 18.1 m -78.57 145.51 34.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.404 -0.362 . . . . 1.84 110.617 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -115.64 -55.77 2.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 1.45 111.718 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 58' ' ' ARG . 12.3 ptm180 -166.6 159.09 13.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 3.72 111.271 -173.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 tt -112.16 137.5 44.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 1.35 109.934 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -129.39 135.76 49.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.894 0.378 . . . . 1.53 111.681 -173.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.99 117.99 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.375 -0.972 . . . . 1.49 108.375 172.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -137.48 71.02 1.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.662 -0.815 . . . . 2.18 112.311 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 230' ' ' PHE . . . 99.53 -58.84 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.342 -0.932 . . . . 2.0 113.885 157.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -125.56 -9.1 6.83 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.691 -0.403 . . . . 4.11 111.82 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -160.49 177.74 10.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.804 -0.443 . . . . 1.78 109.804 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -139.3 136.72 35.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.256 -1.016 . . . . 3.48 108.256 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.01 151.93 48.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.063 0.459 . . . . 1.99 111.941 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.8 127.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.381 -0.827 . . . . 1.75 109.51 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.82 137.03 33.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 2.02 110.984 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -112.95 170.1 8.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.356 -0.838 . . . . 2.19 109.475 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 14.3 t70 -98.89 132.16 44.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.005 0.431 . . . . 1.33 110.92 174.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.509 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 22.6 t70 -137.1 62.29 1.6 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.227 -0.897 . . . . 2.65 109.118 170.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -80.67 -4.52 54.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.116 0.96 . . . . 2.01 108.626 166.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.546 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -163.63 148.98 11.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.026 -1.842 . . . . 2.35 106.026 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -61.68 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.138 0.97 . . . . 1.92 111.783 -171.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 61.7 mttm -91.9 -53.2 4.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.906 -1.043 . . . . 2.31 111.021 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.39 104.61 10.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.994 -0.548 . . . . 1.44 109.638 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.6 t -117.44 153.03 19.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.75 -0.463 . . . . 1.82 109.75 -176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tt -147.7 112.65 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 1.8 109.561 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.95 132.52 8.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.642 0.734 . . . . 3.02 111.622 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 47' ' ' LEU . . . -76.48 174.36 53.78 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 114.899 -1.046 . . . . 1.44 112.152 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.66 -142.88 0.0 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 124.259 0.623 . . . . 2.15 113.942 168.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.66 122.37 8.75 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 121.456 1.438 . . . . 3.17 111.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.476 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 7.9 tp -157.53 -167.66 2.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.947 -1.024 . . . . 4.55 108.428 -166.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.476 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 16.4 m-20 -123.64 32.67 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.741 0.305 . . . . 4.95 110.65 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.02 145.53 4.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.692 -0.766 . . . . 2.25 113.081 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.3 m -93.1 113.73 26.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.322 -0.622 . . . . 2.12 109.322 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 70.2 m-85 -101.33 127.91 47.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.155 0.503 . . . . 3.88 111.72 -171.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 123' ' ' TRP . 22.8 ptt180 -99.76 142.31 31.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.886 -0.597 . . . . 3.87 110.786 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 tt -92.42 120.09 32.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.371 -0.603 . . . . 1.68 109.371 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.633 HD12 ' CE3' ' A' ' 123' ' ' TRP . 36.8 mt -121.97 -15.65 6.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.42 -0.354 . . . . 2.16 111.099 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -166.54 162.71 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.167 -0.333 . . . . 1.95 110.227 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.454 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 41.4 p90 -140.49 140.5 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.22 -0.659 . . . . 0.98 109.22 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.473 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.4 p-80 -118.51 158.05 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.329 . . . . 1.07 110.227 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -133.69 156.97 46.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.143 -0.48 . . . . 3.99 109.967 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -152.07 139.4 19.43 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.753 -0.462 . . . . 2.2 109.753 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.618 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 68.9 t-105 -104.01 137.61 41.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.944 -0.571 . . . . 6.08 110.006 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -70.02 -60.97 4.55 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.962 -0.563 . . . . 2.19 113.165 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 29.0 t 162.23 -64.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 3.08 108.166 -176.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.0 mt -110.31 164.79 12.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.082 -0.963 . . . . 3.48 109.151 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -83.04 56.02 3.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.673 0.749 . . . . 3.85 110.86 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.75 -2.66 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.645 -0.707 . . . . 2.37 113.105 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.11 155.98 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.076 0.438 . . . . 2.62 110.385 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 100.67 -13.98 59.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.801 -0.714 . . . . 1.62 112.643 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.9 t -75.01 -32.84 61.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.49 . . . . 2.24 109.927 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 58.83 -159.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.55 -0.75 . . . . 3.72 110.122 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m80 58.37 30.72 20.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.428 -1.323 . . . . 4.03 107.428 -168.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.32 129.33 34.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.882 -1.508 . . . . 2.99 111.781 -166.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.2 m -100.15 111.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.825 -1.08 . . . . 2.88 110.606 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.63 43.21 12.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.964 -1.016 . . . . 2.8 110.406 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 68.3 20.95 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.125 -0.943 . . . . 5.35 112.078 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HE3' ' CZ ' ' A' ' 114' ' ' TYR . 4.4 tmmm? -102.81 89.55 3.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.985 0.422 . . . . 3.58 109.926 173.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -79.22 157.36 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 3.26 110.028 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.452 ' CZ ' ' HE3' ' A' ' 112' ' ' LYS . 82.2 m-85 -102.68 178.92 4.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.614 -0.266 . . . . 1.71 110.75 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.14 -47.22 68.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 1.57 111.381 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.415 ' HB3' ' CE3' ' A' ' 97' ' ' TRP . . . -155.77 168.16 28.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.041 -0.527 . . . . 1.3 110.539 -173.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -134.94 135.32 41.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 1.85 109.896 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.35 126.76 55.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.591 -0.522 . . . . 1.61 109.591 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.473 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -122.12 109.6 14.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.077 0.465 . . . . 2.25 111.695 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.3 mp -91.55 117.84 30.07 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.88 -0.785 . . . . 1.51 108.88 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.62 143.79 11.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.438 -0.346 . . . . 1.24 110.698 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 53.7 m-70 -138.81 134.7 33.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.633 -0.877 . . . . 2.86 108.633 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.633 ' CE3' HD12 ' A' ' 91' ' ' ILE . 37.5 m0 -111.23 140.99 45.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.457 -0.571 . . . . 4.96 109.457 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.79 112.97 2.03 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.889 -0.412 . . . . 2.3 109.889 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 t -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 2.77 110.828 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -63.35 -16.88 61.76 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.948 0.351 . . . . 3.79 111.948 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.96 -6.28 35.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.728 0.299 . . . . 3.34 110.711 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.77 18.84 0.76 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.16 -0.927 . . . . 2.37 115.189 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.511 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 21.7 t70 -170.59 125.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.652 0.726 . . . . 3.93 110.386 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.615 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.5 p90 -57.07 -40.72 77.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.98 -1.009 . . . . 3.6 111.054 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.01 -37.41 79.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.256 -0.497 . . . . 2.35 112.893 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.511 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 41.5 mmtm -76.9 -28.76 55.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 3.75 110.333 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -75.36 -35.04 61.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 2.17 111.133 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 130' ' ' PHE . 77.2 t -65.01 -25.87 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 3.11 110.37 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -95.38 17.94 13.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.053 0.454 . . . . 3.55 110.668 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 139' ' ' GLY . 4.3 tp-100 -131.24 121.77 18.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.168 -0.469 . . . . 3.02 109.952 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.79 -36.03 14.39 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.017 3.144 . . . . 1.93 113.619 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -110.74 27.65 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.965 0.412 . . . . 2.29 109.961 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -84.68 -42.65 7.19 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.159 -0.543 . . . . 1.5 113.541 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 69.0 mt -104.03 153.54 20.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.38 0.59 . . . . 1.98 110.469 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 122' ' ' HIS . . . -142.88 147.12 34.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.829 -0.623 . . . . 1.83 109.954 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.4 t -133.76 137.69 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.153 -0.476 . . . . 2.28 109.954 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -106.07 121.74 44.74 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.702 -0.481 . . . . 2.89 109.702 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.74 128.46 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.867 -0.682 . . . . 0.95 113.041 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.76 115.52 31.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.914 -0.402 . . . . 1.38 109.914 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -77.99 149.97 33.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.931 0.396 . . . . 1.37 111.168 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.04 134.94 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.835 -0.62 . . . . 1.48 110.361 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -127.16 144.52 51.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.471 -0.566 . . . . 2.52 109.471 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 19.6 m -86.75 130.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.389 0.614 . . . . 1.88 111.742 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.32 -104.54 0.18 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.224 -0.898 . . . . 1.53 111.391 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -81.19 150.98 28.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 2.08 109.919 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.31 149.84 45.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.224 -0.444 . . . . 1.36 111.229 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 216' ' ' SER . 22.5 tptm -119.45 96.14 49.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.003 -0.544 . . . . 1.78 109.904 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.56 -37.94 83.34 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.22 2.613 . . . . 1.34 112.524 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.94 -37.88 86.75 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.75 113.172 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 160' ' ' VAL . 61.9 tp -93.05 -22.43 19.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.082 0.441 . . . . 1.39 110.456 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -34.22 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 1.63 111.316 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -56.49 -41.75 77.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 3.26 110.904 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.58 -41.86 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 1.97 110.249 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 25.8 t -61.88 -33.81 59.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.374 0.606 . . . . 1.64 110.588 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.99 -37.06 78.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.797 -0.638 . . . . 1.22 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.91 -18.88 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 111.913 0.338 . . . . 2.07 111.913 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -66.32 -17.13 64.57 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.738 -0.385 . . . . 1.95 111.91 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.7 -24.06 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 2.31 110.881 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.5 m -84.8 0.43 50.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.264 -0.426 . . . . 1.78 111.427 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 163' ' ' LEU . 44.7 pt -137.4 44.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.345 0.593 . . . . 1.42 109.627 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.79 -36.98 80.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.436 -0.802 . . . . 1.98 111.697 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -114.51 151.93 32.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.708 -0.224 . . . . 1.4 110.734 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 21.4 pttm -63.56 140.85 58.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.046 0.45 . . . . 2.84 110.611 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.13 47.71 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.753 -0.737 . . . . 0.85 111.42 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.61 147.72 22.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.128 0.49 . . . . 2.22 111.144 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.3 p -144.11 150.42 38.08 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.502 -0.772 . . . . 1.93 109.49 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -135.43 133.71 38.88 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.737 -0.468 . . . . 1.17 109.737 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.07 129.83 43.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.156 0.503 . . . . 1.8 110.065 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -141.44 79.91 1.71 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.678 -0.86 . . . . 1.31 108.678 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.5 m -99.29 153.99 18.53 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.273 -0.876 . . . . 1.69 110.984 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.4 m120 54.78 77.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.188 0.595 . . . . 2.26 111.959 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.43 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 71.3 t80 -131.42 140.63 49.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.9 -0.591 . . . . 4.84 109.494 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.41 120.89 51.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.198 0.523 . . . . 2.51 110.639 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.27 -5.57 16.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.025 2.483 . . . . 1.47 111.948 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.414 ' HG3' ' HH ' ' A' ' 51' ' ' TYR . 42.1 ttp-105 -55.54 -36.95 67.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.773 -0.649 . . . . 3.16 110.975 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.05 8.08 61.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.968 -0.634 . . . . 1.12 112.417 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.6 mt -117.28 -38.95 3.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.984 0.421 . . . . 2.37 109.989 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.3 mt -73.1 131.44 83.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.727 -0.669 . . . . 3.87 111.101 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 5.8 Cg_exo -77.65 179.73 6.23 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.002 2.468 . . . . 2.51 112.361 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -84.76 -63.8 1.27 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.26 0.467 . . . . 3.23 112.26 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.3 t -78.06 134.7 37.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.653 0.263 . . . . 2.03 110.964 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.8 mt -113.21 60.84 0.64 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.946 0.403 . . . . 2.5 110.288 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 212' ' ' LYS . 4.5 m-20 -140.22 144.42 36.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.41 -0.959 . . . . 1.81 108.41 173.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.613 ' CD2' ' HA ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER 171.85 -171.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.415 -0.587 . . . . 5.32 109.415 -173.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 257' ' ' ALA . 25.7 p90 -81.3 151.24 28.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.487 -0.485 . . . . 4.55 110.127 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.442 ' OG1' HD13 ' A' ' 209' ' ' ILE . 4.7 t -167.29 116.92 0.84 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.573 0.702 . . . . 2.39 110.827 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.617 ' CD1' ' HD2' ' A' ' 251' ' ' LYS . 6.2 t80 -139.87 147.82 52.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.869 -0.789 . . . . 5.32 108.869 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 99.2 Cg_exo -47.64 151.19 3.51 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.628 2.219 . . . . 2.47 112.875 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.93 159.45 24.6 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.327 -0.851 . . . . 2.0 112.453 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.8 t -115.68 152.81 32.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.977 0.418 . . . . 3.36 110.166 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.526 ' O ' ' HD2' ' A' ' 201' ' ' PRO . 65.7 mt -88.9 11.61 17.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.634 -0.712 . . . . 5.18 110.574 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 201' ' ' PRO . 11.9 t -66.81 23.19 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.027 1.121 . . . . 5.53 114.027 -168.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.575 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.1 OUTLIER -76.36 -63.9 0.55 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 O-C-N 121.642 -0.661 . . . . 5.89 109.238 169.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 199' ' ' THR . 1.9 Cg_endo -82.96 -67.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.556 1.62 0 C-N-CA 121.847 1.698 . . . . 6.31 113.496 166.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 200' ' ' PRO . 51.9 Cg_endo -100.72 141.77 0.27 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.15 1.9 . . . . 5.26 113.22 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.5 tp -74.71 66.92 1.52 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.2 0.524 . . . . 4.29 110.999 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.8 tp -128.95 129.97 46.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 3.51 110.988 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.86 93.23 4.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.177 -0.465 . . . . 3.37 111.707 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 5.7 p -139.25 24.49 2.51 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.779 0.659 . . . . 2.47 112.779 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.15 143.2 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.74 111.964 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.5 m -126.35 104.52 8.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.331 -0.618 . . . . 2.3 109.331 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -101.64 134.95 43.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.476 0.655 . . . . 6.37 112.144 -175.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.442 HD13 ' OG1' ' A' ' 192' ' ' THR . 7.9 mm -116.13 128.32 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.779 -1.1 . . . . 2.32 109.173 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 t -108.17 150.28 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.341 -0.614 . . . . 2.1 109.341 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -109.57 146.43 34.7 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.98 -0.288 . . . . 2.35 111.325 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 190' ' ' TYR . 37.5 ttmt -52.99 -60.28 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.765 0.654 . . . . 3.47 112.765 -176.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.86 114.88 34.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.696 -0.684 . . . . 1.56 111.68 -171.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.37 147.32 22.77 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.156 1.904 . . . . 1.37 110.5 174.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 pt -89.4 140.08 16.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.459 -0.496 . . . . 1.85 110.21 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 18.4 t -97.32 127.48 43.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.052 -0.522 . . . . 1.78 109.734 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 29.8 m -127.0 156.39 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.729 -0.668 . . . . 1.64 109.737 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.5 t -85.83 154.58 21.46 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.179 -0.304 . . . . 1.52 110.179 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.55 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 46.2 m -53.46 -42.35 67.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.001 0.188 . . . . 1.81 111.398 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 9.9 pt-20 -56.94 -27.77 61.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.605 -0.27 . . . . 2.51 111.634 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -77.08 -46.91 21.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.028 -0.36 . . . . 1.02 110.028 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.71 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 26.7 m -70.83 -28.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.88 111.228 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.7 mt -64.48 -33.57 76.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.298 -0.41 . . . . 1.59 110.558 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 65.2 mttp -74.97 -24.22 58.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 2.3 111.238 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.3 m-85 -67.0 -35.13 79.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.202 0.525 . . . . 3.18 109.851 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -84.45 13.96 4.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.696 -0.684 . . . . 3.55 110.578 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.0 mmtt -100.63 -14.96 17.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.79 -0.448 . . . . 2.74 109.79 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.9 mt -77.64 152.75 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 1.66 111.546 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.486 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 11.6 m120 -117.58 154.31 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 1.13 109.273 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 45.5 p90 -102.97 -11.55 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.492 -0.483 . . . . 4.38 110.252 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -75.26 169.5 17.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.821 -0.627 . . . . 1.62 111.022 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -85.89 171.72 45.15 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.867 -0.606 . . . . 1.16 111.889 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.64 128.58 36.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.961 0.41 . . . . 3.56 110.779 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 98.58 9.43 52.92 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.671 -0.695 . . . . 2.23 112.191 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -111.54 160.87 27.83 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.088 -0.338 . . . . 2.59 110.088 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.23 127.81 27.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.485 2.124 . . . . 1.5 111.165 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.09 110.3 1.02 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 3.4 111.517 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -117.28 115.23 24.86 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.001 -0.74 . . . . 2.47 109.001 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.3 135.0 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.267 0.556 . . . . 2.6 111.73 -172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.9 ttm -81.66 90.21 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.994 -1.003 . . . . 1.94 108.955 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.62 153.38 38.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.182 -0.463 . . . . 1.67 110.667 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.44 ' O ' ' HD1' ' A' ' 244' ' ' TRP . 16.7 t70 66.27 -88.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.36 1.037 . . . . 2.18 111.369 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.1 t30 47.67 43.19 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.55 0.531 . . . . 2.64 111.301 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.44 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 20.5 m95 -144.08 159.7 42.17 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.6 -0.687 . . . . 5.31 110.03 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.449 ' NH1' ' HA ' ' A' ' 199' ' ' THR . 6.3 ptp180 -113.36 116.82 46.08 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.569 -0.53 . . . . 6.91 109.569 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -52.96 -86.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.177 2.585 . . . . 3.72 114.826 -167.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -108.29 99.49 8.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.239 0.542 . . . . 3.34 112.188 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -110.65 173.64 2.78 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 107.869 -1.16 . . . . 4.92 107.869 169.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.25 94.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.798 1.666 . . . . 4.01 111.129 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' A' ' 251' ' ' LYS . 1.6 pt? -64.34 -56.96 10.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.764 -0.653 . . . . 4.9 111.452 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.617 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 62.6 mmtt -122.46 -10.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.934 -0.306 . . . . 5.68 111.229 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.93 -48.19 0.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.152 0.981 . . . . 5.11 111.844 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 253' ' ' ARG . 67.3 mtt180 -89.17 -80.78 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 6.74 110.246 176.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -157.53 156.55 32.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.513 -0.551 . . . . 3.08 109.513 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 11.5 tt -112.8 148.72 15.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.637 0.256 . . . . 3.06 110.432 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.1 153.47 20.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.222 0.534 . . . . 3.01 111.158 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -131.01 171.44 13.23 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.153 -0.93 . . . . 1.99 109.032 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.5 p -163.46 98.8 0.91 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.985 0.421 . . . . 2.47 110.783 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.03 102.43 6.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.732 0.777 . . . . 5.03 109.963 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 17.1 pttm . . . . . 0 C--O 1.248 0.982 0 CA-C-N 115.007 -0.997 . . . . 4.82 110.226 -174.558 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 109.896 -0.409 . . . . 17.73 109.896 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 t -79.52 131.86 36.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.068 0.461 . . . . 15.49 110.741 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -116.72 13.19 15.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.841 -0.618 . . . . 16.29 109.684 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.401 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 5.5 p80 -134.44 146.26 49.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.311 -0.859 . . . . 14.68 110.411 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' H ' ' HA ' ' A' ' 13' ' ' PRO . 95.4 m95 60.77 25.98 15.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.853 0.835 . . . . 15.53 109.802 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.688 ' O ' ' HA2' ' A' ' 12' ' ' GLY . . . -164.58 -170.68 29.86 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 109.565 -1.414 . . . . 10.81 109.565 -177.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 243' ' ' ASN . 57.0 m-85 -71.84 97.72 1.86 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.346 0.573 . . . . 11.61 109.783 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.15 -105.21 0.2 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.888 -0.672 . . . . 9.0 112.357 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.01 150.73 23.25 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.254 0.464 . . . . 10.04 112.254 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 58.49 -100.61 0.11 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.332 -0.849 . . . . 11.67 111.33 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.419 ' HB3' ' CG ' ' A' ' 200' ' ' PRO . 10.3 p30 -126.16 -1.35 7.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.133 0.492 . . . . 11.18 110.111 176.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.688 ' HA2' ' O ' ' A' ' 6' ' ' GLY . . . 156.38 -78.66 0.19 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.287 -0.87 . . . . 8.9 111.01 -172.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HA ' ' H ' ' A' ' 5' ' ' TRP . 5.9 Cg_exo -80.25 125.1 5.65 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.488 2.126 . . . . 8.2 111.265 172.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' HG2' ' HB3' ' A' ' 4' ' ' HIS . 10.6 pt-20 -80.38 0.58 32.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.398 . . . . 10.62 111.499 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -119.48 22.3 11.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.903 0.859 . . . . 10.41 108.712 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.1 t90 -66.3 -25.49 66.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.404 -1.271 . . . . 9.19 110.163 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 19.4 p80 -66.76 -4.88 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.583 -0.735 . . . . 7.71 112.194 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -88.38 -30.9 19.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.878 0.371 . . . . 10.03 110.22 173.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -92.62 -38.2 12.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 7.89 110.142 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -144.56 75.55 14.79 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.164 -0.925 . . . . 7.65 108.881 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 22' ' ' ILE . 70.9 Cg_exo -39.45 -82.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.269 3.313 . . . . 8.15 114.833 -169.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 21' ' ' PRO . 7.8 tp 51.52 9.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.235 1.014 . . . . 6.15 112.605 -176.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -76.03 -16.54 59.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.196 0.522 . . . . 5.72 110.465 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -85.42 16.44 3.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.722 -0.672 . . . . 8.17 110.265 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.38 31.7 0.12 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.594 -0.812 . . . . 5.05 113.222 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.71 168.52 9.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.989 0.395 . . . . 7.09 110.031 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.435 ' CZ ' ' HE2' ' A' ' 251' ' ' LYS . 2.4 ptp180 -156.0 125.9 6.47 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.237 -1.023 . . . . 5.44 108.237 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -150.21 65.96 0.96 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.462 -0.495 . . . . 7.33 111.921 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 248' ' ' GLN . 14.4 m -47.66 113.26 2.51 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.2 0.445 . . . . 4.35 112.2 171.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.2 28.78 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.742 2.961 . . . . 4.96 111.375 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.46 -174.22 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.197 -0.91 . . . . 5.07 111.338 -166.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -83.77 140.73 31.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.094 -0.503 . . . . 3.14 109.821 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 108' ' ' THR . 24.7 mm -71.41 128.24 34.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.981 0.896 . . . . 2.71 111.895 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.652 ' C ' ' H ' ' A' ' 36' ' ' HIS . 23.0 t70 -43.98 156.13 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.367 -1.742 . . . . 2.82 114.083 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' THR . 13.3 t -55.69 19.35 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.618 1.967 . . . . 2.71 113.434 172.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.652 ' H ' ' C ' ' A' ' 34' ' ' ASP . 33.5 p-80 -47.33 1.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.171 1.789 . . . . 5.23 114.663 -176.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' THR . 2.6 m -72.28 27.81 0.05 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.613 0.765 . . . . 3.38 109.086 163.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 36' ' ' HIS . . . -56.79 164.85 1.36 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.733 1.213 . . . . 1.76 112.884 -163.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.94 139.92 50.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.805 -1.088 . . . . 4.05 110.845 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.42 ' HB2' ' H ' ' A' ' 259' ' ' PHE . 7.9 p90 -59.93 123.76 18.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.141 -0.936 . . . . 4.9 112.241 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -86.72 133.16 40.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 2.27 110.618 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.84 -14.17 11.31 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.803 2.336 . . . . 2.45 114.354 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.9 p -93.11 -2.46 55.44 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.577 -0.449 . . . . 4.62 111.063 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.29 154.53 17.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.237 -0.438 . . . . 5.15 110.3 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -115.44 106.89 50.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 4.21 109.935 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.461 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 52.8 Cg_exo -56.1 120.07 7.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.614 2.21 . . . . 2.76 112.089 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 46' ' ' PRO . 12.7 mt -169.99 116.92 0.55 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.432 0.901 . . . . 2.93 113.432 -173.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 m -157.75 79.55 0.86 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.562 -0.903 . . . . 2.46 108.562 152.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.72 95.12 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.354 0.872 . . . . 2.17 113.354 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 39.7 m -142.23 85.44 1.92 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 121.439 1.927 . . . . 1.87 109.267 155.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.885 ' HH ' ' HE2' ' A' ' 122' ' ' HIS . 58.2 m-85 -134.18 19.14 3.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.208 -0.308 . . . . 3.97 111.052 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.73 -28.61 68.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 2.48 111.381 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -110.0 13.7 23.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.354 . . . . 2.54 111.634 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.1 127.01 29.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 1.41 111.383 -174.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -116.09 115.24 25.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.213 -0.449 . . . . 1.41 110.875 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 176' ' ' THR . 5.6 m -84.34 153.54 23.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.196 -0.456 . . . . 1.84 109.795 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -117.73 -57.23 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 1.45 111.926 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -170.01 164.63 9.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 3.72 111.436 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.2 tt -127.08 143.84 39.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.436 -0.802 . . . . 1.35 109.874 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 172' ' ' SER . 20.6 tp -144.75 121.14 10.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.955 0.354 . . . . 1.53 111.955 -173.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -68.5 109.1 3.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.967 -0.56 . . . . 1.49 109.495 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -141.4 70.63 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.786 -0.766 . . . . 2.18 112.766 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.67 -65.1 0.33 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.765 -1.207 . . . . 2.0 112.879 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -128.39 -11.92 5.08 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.948 -0.301 . . . . 4.11 111.473 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.96 -173.2 3.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 1.78 110.986 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.52 88.41 2.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 3.48 108.881 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.09 114.39 15.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.473 -0.785 . . . . 1.99 110.285 -171.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 5.5 p -94.1 124.13 46.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.887 -0.597 . . . . 1.75 110.184 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.87 132.62 40.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.867 -0.606 . . . . 2.02 111.604 -174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.25 152.63 22.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.184 -0.916 . . . . 2.19 109.784 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.76 129.4 45.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 1.33 109.828 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.09 63.97 1.4 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.89 -1.05 . . . . 2.65 109.961 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 p -79.91 -3.21 47.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.368 -0.833 . . . . 2.01 110.54 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.477 ' OE1' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -154.28 177.69 10.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.053 -1.462 . . . . 2.35 107.053 175.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.9 79.06 0.21 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.247 0.476 . . . . 1.92 111.5 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HE2' ' OE1' ' A' ' 74' ' ' GLN . 61.4 mttm -102.49 -66.13 0.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.597 -0.274 . . . . 2.31 110.682 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.01 84.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.391 0.615 . . . . 1.44 110.06 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' SER . 17.8 m -115.25 150.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 1.82 110.467 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.6 tp -100.6 124.6 46.4 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.978 -0.555 . . . . 1.8 110.413 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -125.67 133.4 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.718 -0.845 . . . . 3.02 108.718 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' CB ' ' A' ' 47' ' ' LEU . . . -149.93 170.79 30.0 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 119.477 -0.624 . . . . 1.44 111.666 -170.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.36 -146.69 0.0 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 123.859 0.388 . . . . 2.15 113.161 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.39 119.81 6.43 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 121.564 1.51 . . . . 3.17 111.781 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.1 mt -157.01 -178.07 7.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.454 -0.794 . . . . 4.55 109.843 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -127.45 67.2 1.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.338 -0.392 . . . . 4.95 111.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.2 -170.59 14.23 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.635 -0.793 . . . . 2.25 112.904 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.531 ' O ' HG22 ' A' ' 125' ' ' THR . 30.7 m -105.65 134.97 47.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 2.12 110.162 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.523 ' CE1' ' HA3' ' A' ' 139' ' ' GLY . 33.1 m-85 -114.87 119.37 36.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 3.88 110.428 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HD3' ' CB ' ' A' ' 125' ' ' THR . 39.6 mtp180 -91.93 143.33 26.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.376 -0.375 . . . . 3.87 111.085 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 tt -88.61 128.84 35.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.642 -0.503 . . . . 1.68 109.642 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.1 tt -113.62 -34.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 2.16 110.509 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.539 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 5.3 pt20 -165.44 174.86 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 1.95 109.54 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -155.32 156.64 35.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.98 110.712 169.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -147.2 161.15 41.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 1.07 109.346 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CE2' HD12 ' A' ' 118' ' ' LEU . 69.1 m-85 -107.06 166.7 10.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 3.99 111.002 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -128.99 146.62 50.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.464 -1.68 . . . . 2.2 106.464 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.652 ' O ' ' HA ' ' A' ' 242' ' ' ASP . 8.3 m-90 -133.53 -169.66 2.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.434 0.561 . . . . 6.08 111.388 -170.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.42 24.99 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.721 -1.351 . . . . 2.19 109.721 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.1 t -70.89 -15.07 62.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.128 0.964 . . . . 3.08 110.478 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.2 mt -128.86 150.49 50.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.881 -0.785 . . . . 3.48 108.881 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.82 6.36 2.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.285 0.476 . . . . 3.85 112.285 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.35 24.78 6.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.509 -0.853 . . . . 2.37 112.455 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 18.0 pt20 -158.67 162.76 37.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.995 -0.372 . . . . 2.62 109.995 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.7 -18.91 16.7 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.316 -0.945 . . . . 1.62 112.281 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 99.2 p -69.02 -34.6 75.5 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.258 -0.177 . . . . 2.24 111.275 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 107' ' ' HIS . 1.0 OUTLIER 71.03 -173.13 0.17 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.426 -0.953 . . . . 3.72 108.426 -175.109 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.599 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 1.8 m-70 57.86 37.75 27.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.647 0.736 . . . . 4.03 109.723 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.594 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.3 123.46 29.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.669 -1.151 . . . . 2.99 112.404 -173.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.65 102.37 13.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.237 -0.892 . . . . 2.88 110.469 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.86 55.08 5.62 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.673 -0.694 . . . . 2.8 109.663 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 68.27 24.31 7.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.035 -0.984 . . . . 5.35 112.22 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -93.21 90.49 6.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 3.58 110.53 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.59 146.74 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 3.26 110.437 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 94.5 m-85 -100.77 -168.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.381 -0.372 . . . . 1.71 110.107 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.16 34.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.723 0.297 . . . . 1.57 111.725 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.84 168.24 21.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.387 -0.369 . . . . 1.3 110.5 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -124.29 151.89 43.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 1.85 109.485 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.52 HD12 ' CE2' ' A' ' 95' ' ' PHE . 57.3 tp -115.61 147.72 40.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.233 -0.284 . . . . 1.61 110.233 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -121.75 114.91 21.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.393 -0.595 . . . . 2.25 109.393 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.58 91.58 4.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.843 0.354 . . . . 1.51 110.12 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 46.6 t -65.68 117.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.365 0.602 . . . . 1.24 111.701 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.885 ' HE2' ' HH ' ' A' ' 51' ' ' TYR . 76.8 m80 -138.66 125.58 21.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.089 -1.078 . . . . 2.86 108.089 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.662 ' CD1' ' HB2' ' A' ' 130' ' ' PHE . 88.4 m95 -110.82 144.91 39.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.622 -0.431 . . . . 4.96 111.258 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.443 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 56.4 t30 -62.69 100.79 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.419 -0.81 . . . . 2.3 110.317 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 87' ' ' THR . 10.3 t -70.63 -24.34 62.71 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.065 0.765 . . . . 2.77 113.065 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -68.14 -5.14 16.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.429 0.529 . . . . 3.79 112.429 -174.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -95.42 17.49 14.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.788 0.804 . . . . 3.34 109.543 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.22 -3.58 10.45 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.491 -1.231 . . . . 2.37 115.786 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -173.5 145.19 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.577 1.189 . . . . 3.93 109.949 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.662 ' HB2' ' CD1' ' A' ' 123' ' ' TRP . 25.1 p90 -67.95 -43.12 79.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.854 -0.612 . . . . 3.6 111.705 -176.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.15 -28.81 73.43 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.072 -0.585 . . . . 2.35 112.182 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -81.27 -34.75 31.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.496 -0.557 . . . . 3.75 109.496 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.39 66.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.745 -0.661 . . . . 2.17 111.63 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.05 -19.39 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.297 0.57 . . . . 3.11 110.764 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.34 16.73 22.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 3.55 110.655 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.83 118.49 44.68 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.815 0.341 . . . . 3.02 111.133 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.587 ' HA ' ' SG ' ' A' ' 205' ' ' CYS . 25.0 Cg_exo -64.18 -20.61 67.31 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.691 2.261 . . . . 1.93 111.965 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.04 28.39 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.992 0.738 . . . . 2.29 112.992 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . 128.34 94.49 0.8 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.827 -1.654 . . . . 1.5 114.609 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 20.8 mt -97.0 -175.85 3.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.914 -0.772 . . . . 1.98 108.914 167.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' HIS . . . -71.2 124.85 25.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.581 0.705 . . . . 1.83 110.372 -167.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.1 m -77.93 164.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.506 -1.225 . . . . 2.28 112.331 -167.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.7 tp -85.54 143.86 28.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.665 -1.152 . . . . 2.89 111.264 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 170.94 42.69 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.782 -1.099 . . . . 0.95 112.186 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.4 HG23 ' HA ' ' A' ' 214' ' ' PRO . 11.2 mt -86.63 142.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.572 0.225 . . . . 1.38 110.76 -176.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -63.13 157.09 23.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 1.37 111.532 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.4 mp -113.01 137.46 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 1.48 110.686 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -129.76 143.41 50.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.95 -0.759 . . . . 2.52 108.95 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 24.1 t -108.66 81.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.312 -0.555 . . . . 1.88 112.281 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -165.95 67.17 0.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.377 -0.916 . . . . 1.53 112.342 165.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.537 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 19.3 t 157.95 126.43 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.541 -1.281 . . . . 2.08 107.541 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 138.45 41.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.74 -0.384 . . . . 1.36 110.671 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -104.89 98.41 15.31 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.474 -0.565 . . . . 1.78 109.474 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.59 -24.44 69.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.599 2.199 . . . . 1.34 112.719 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.2 6.55 79.14 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.865 -0.683 . . . . 0.75 113.104 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -110.67 -13.99 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 1.39 110.904 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.76 -36.53 76.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 1.63 111.518 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -49.18 -44.19 42.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.713 0.292 . . . . 3.26 111.165 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.21 -42.01 37.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 1.97 110.437 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.719 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 48.7 t -63.74 -39.58 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.813 -0.631 . . . . 1.64 111.576 -176.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -69.98 -24.31 63.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.712 0.291 . . . . 1.22 111.698 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.87 -11.91 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.001 0.371 . . . . 2.07 112.001 -174.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -65.74 -17.07 64.36 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.963 -0.46 . . . . 1.95 111.559 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.409 ' N ' HD11 ' A' ' 163' ' ' LEU . 16.7 m-20 -66.42 -28.06 68.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 2.31 110.727 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.2 m -84.36 0.14 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.387 -0.369 . . . . 1.78 111.387 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.447 ' CG1' ' HA ' ' A' ' 163' ' ' LEU . 18.6 pt -137.97 57.1 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 1.42 109.337 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -74.71 -40.23 61.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.828 -0.623 . . . . 1.98 111.367 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.7 p -115.97 158.0 23.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.982 0.42 . . . . 1.4 111.647 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.21 132.76 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 2.84 110.484 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.52 -22.28 26.76 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.551 -0.833 . . . . 0.85 111.726 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -87.62 142.04 28.15 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.197 0.522 . . . . 2.22 110.736 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.406 ' HB3' HD11 ' A' ' 60' ' ' LEU . 6.7 p -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.227 -0.897 . . . . 1.93 110.368 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.26 134.32 32.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.548 -0.538 . . . . 1.17 109.548 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.28 133.68 44.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.069 0.462 . . . . 1.8 109.918 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -142.07 81.36 1.75 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.572 -0.74 . . . . 1.31 109.36 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' SER . 7.1 m -104.97 162.22 13.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.468 -0.333 . . . . 1.69 111.317 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.7 57.16 3.3 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.42 0.688 . . . . 2.26 111.989 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -126.76 132.25 51.12 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.531 -0.544 . . . . 4.84 109.531 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 5.3 p-10 -107.87 126.89 28.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.442 -0.345 . . . . 2.51 110.365 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 22.4 Cg_exo -66.42 -3.84 9.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.417 2.745 . . . . 1.47 113.333 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -58.98 -31.82 69.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 3.16 111.04 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.6 -30.58 72.97 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.141 -0.552 . . . . 1.12 112.361 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.3 mt -72.7 -34.33 67.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.014 0.435 . . . . 2.37 110.334 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.3 mt -71.43 118.75 68.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 3.87 110.51 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.9 -165.19 0.24 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.028 2.485 . . . . 2.51 113.289 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.92 -61.97 1.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.278 0.473 . . . . 3.23 112.278 -173.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.453 ' HB2' ' CG ' ' A' ' 213' ' ' GLU . 34.7 m -75.45 129.43 37.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 2.03 110.514 -176.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 46' ' ' PRO . 39.6 tp -105.43 63.43 0.69 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.016 -0.538 . . . . 2.5 110.082 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 21.9 m-20 -109.95 145.64 36.57 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.374 -0.973 . . . . 1.81 108.374 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -136.47 149.27 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.607 -0.837 . . . . 5.32 112.936 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.559 ' HB3' ' CG2' ' A' ' 255' ' ' ILE . 6.8 m-90 -93.78 141.68 28.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.49 -1.232 . . . . 4.55 108.445 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.9 t -136.8 109.92 7.76 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.456 0.646 . . . . 2.39 112.498 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.841 ' HH ' ' H ' ' A' ' 253' ' ' ARG . 54.9 t80 -139.22 138.21 20.42 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.627 -0.715 . . . . 5.32 110.506 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 48.7 Cg_exo -57.47 128.49 29.61 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.315 2.01 . . . . 2.47 111.494 172.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 208' ' ' TRP . . . -122.52 157.22 17.14 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.961 -0.637 . . . . 2.0 113.456 -171.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 13.5 m -92.63 119.05 31.66 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 3.36 109.733 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.99 -44.49 63.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.284 -0.416 . . . . 5.18 111.187 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 199' ' ' THR . 7.1 p -113.37 -40.11 3.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.433 -0.349 . . . . 5.53 111.027 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.537 ' O ' HD21 ' A' ' 202' ' ' LEU . 87.3 m 106.43 -60.13 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 124.874 1.359 . . . . 5.89 113.107 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 199' ' ' THR . 51.7 Cg_exo -52.8 -51.53 10.91 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.053 1.835 . . . . 6.31 115.037 -176.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.53 -7.86 22.09 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.377 1.385 . . . . 5.26 112.358 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 199' ' ' THR . 67.2 mt 65.78 56.75 0.88 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.829 -1.078 . . . . 4.29 110.628 175.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 196' ' ' SER . 16.2 tp -95.66 118.02 31.57 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.616 -0.513 . . . . 3.51 109.616 -176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.85 28.11 8.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.193 0.521 . . . . 3.37 111.076 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' ' 137' ' ' PRO . 68.3 m -80.06 -4.8 54.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.822 -0.626 . . . . 2.47 111.446 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.444 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 48.4 t -90.18 137.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.383 -0.229 . . . . 1.74 110.383 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.2 m -105.5 102.59 12.05 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.885 -0.413 . . . . 2.3 109.885 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.529 ' O ' ' HA ' ' A' ' 192' ' ' THR . 43.2 m0 -72.19 100.84 2.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.245 -0.28 . . . . 6.37 110.245 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 65.6 mt -105.51 99.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.211 -0.663 . . . . 2.32 109.211 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.6 t -111.21 122.46 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.244 -0.435 . . . . 2.1 110.67 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 3.7 mm? -69.28 134.09 48.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.328 0.585 . . . . 2.35 110.127 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.547 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 32.6 ttpt -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.676 -1.147 . . . . 3.47 111.509 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.453 ' CG ' ' HB2' ' A' ' 187' ' ' SER . 22.2 mm-40 -76.27 110.92 12.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 1.56 110.795 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.4 ' HA ' HG23 ' A' ' 145' ' ' ILE . 61.3 Cg_endo -74.91 154.19 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.623 2.216 . . . . 1.37 112.025 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.15 110.94 10.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.103 -0.499 . . . . 1.85 109.902 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 79.2 p -93.18 118.66 31.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.741 -0.466 . . . . 1.78 109.741 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 30.8 m -120.98 157.78 23.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.64 110.539 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.3 t -90.58 157.96 17.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.071 -0.513 . . . . 1.52 109.978 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.66 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 20.3 m -55.09 -46.59 75.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 1.81 110.732 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -52.65 -34.87 53.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 2.51 111.603 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -71.14 -50.11 36.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 1.02 110.203 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -71.88 -22.48 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.839 0.311 . . . . 1.88 111.839 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 219' ' ' SER . 83.0 mt -64.48 -43.83 92.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.81 -0.441 . . . . 1.59 109.81 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -68.72 -29.56 68.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 2.3 111.382 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.62 -30.37 64.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.53 . . . . 3.18 109.907 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -80.06 -2.68 45.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.741 -0.663 . . . . 3.55 110.346 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 33.4 mmtp -90.41 -6.52 54.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 2.74 110.064 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.61 146.68 26.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.887 -0.597 . . . . 1.66 110.807 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.579 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.8 m120 -118.79 125.83 50.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.659 -0.701 . . . . 1.13 109.521 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -78.76 -7.74 58.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 4.38 111.38 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.579 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.2 p-10 -77.58 162.71 26.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.831 0.348 . . . . 1.62 110.236 171.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.8 159.89 36.73 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.098 -0.801 . . . . 1.16 111.098 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.86 134.27 56.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 3.56 110.957 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.67 11.61 70.77 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.776 -0.647 . . . . 2.23 112.922 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -112.93 158.61 37.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.69 -0.485 . . . . 2.59 109.69 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.55 122.81 11.5 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.593 2.196 . . . . 1.5 111.819 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 120.18 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.381 -0.827 . . . . 3.4 112.383 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -127.82 136.55 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.329 -0.989 . . . . 2.47 108.329 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.12 133.38 33.63 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.758 -0.46 . . . . 2.6 109.758 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 51.8 ttm -75.12 88.28 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.099 0.476 . . . . 1.94 109.757 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.15 167.36 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.861 -0.792 . . . . 1.67 108.861 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.652 ' HA ' ' O ' ' A' ' 97' ' ' TRP . 0.7 OUTLIER 61.75 -90.85 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.402 0.439 . . . . 2.18 110.814 -174.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.438 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 54.4 m-80 43.13 45.8 4.82 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.271 0.558 . . . . 2.64 111.923 -175.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.415 ' O ' ' HB3' ' A' ' 7' ' ' TYR . 60.9 t-105 -153.14 153.06 32.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.331 -0.85 . . . . 5.31 108.979 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -100.58 130.35 25.75 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.089 -0.337 . . . . 6.91 110.089 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.27 53.33 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.769 2.313 . . . . 3.72 111.937 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -114.14 121.79 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.401 -0.818 . . . . 3.34 109.978 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 29' ' ' SER . 27.9 mp0 -90.3 152.43 45.69 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.226 -0.443 . . . . 4.92 110.84 -176.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.69 141.67 15.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.598 2.866 . . . . 4.01 112.807 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 251' ' ' LYS . 0.6 OUTLIER -40.59 -55.78 2.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.976 -1.011 . . . . 4.9 113.699 -171.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.546 ' N ' HD13 ' A' ' 250' ' ' LEU . 69.6 mmtt -114.33 -4.96 12.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.95 0.352 . . . . 5.68 111.95 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.1 p30 34.22 65.52 0.31 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.132 0.895 . . . . 5.11 112.345 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.841 ' H ' ' HH ' ' A' ' 193' ' ' TYR . 69.9 mtt180 -70.85 -90.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.85 -0.34 . . . . 6.74 111.08 -173.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -159.64 154.97 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.178 -0.675 . . . . 3.08 109.178 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.559 ' CG2' ' HB3' ' A' ' 191' ' ' TRP . 13.7 mt -118.78 113.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.159 -0.311 . . . . 3.06 110.159 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -76.85 165.76 24.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 3.01 110.706 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 191' ' ' TRP . . . -126.0 168.54 13.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 1.99 109.975 -175.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.9 p -138.07 95.99 3.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.201 0.524 . . . . 2.47 111.242 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.42 ' H ' ' HB2' ' A' ' 40' ' ' TYR . 49.9 t80 -136.91 119.06 15.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 5.03 110.304 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.526 ' HZ3' ' HB2' ' A' ' 260' ' ' LYS . 9.8 mtmp? . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.612 -0.708 . . . . 4.82 109.577 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.63 0.252 . . . . 17.73 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.8 t -138.35 156.96 47.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.904 0.383 . . . . 15.49 110.628 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -126.07 71.64 1.26 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.096 0.474 . . . . 16.29 110.536 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -132.87 100.69 4.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 14.68 109.686 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -132.47 154.13 50.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.171 -0.468 . . . . 15.53 110.759 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.74 -170.33 29.55 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 109.908 -1.277 . . . . 10.81 109.908 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.673 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 86.5 t80 -70.19 96.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.073 0.936 . . . . 11.61 108.571 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 12' ' ' GLY . . . 87.21 151.35 20.54 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.849 -0.9 . . . . 9.0 110.849 -172.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 56.9 mttp -45.87 124.2 5.1 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.986 0.735 . . . . 10.04 112.986 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.3 t60 66.79 -78.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.021 -1.445 . . . . 11.67 112.238 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -124.04 -12.89 7.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.953 -0.299 . . . . 11.18 111.53 -172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 7' ' ' TYR . . . 165.26 -67.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.389 -1.386 . . . . 8.9 113.989 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.63 121.97 9.3 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.571 1.514 . . . . 8.2 111.897 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 36.2 tt0 -86.04 -41.98 14.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 10.62 110.36 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -116.95 -31.0 5.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.155 -0.475 . . . . 10.41 111.156 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -51.96 -35.65 46.82 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.895 0.702 . . . . 9.19 112.895 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -67.64 -13.91 62.49 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.677 -0.409 . . . . 7.71 111.095 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -83.27 -46.89 12.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.195 -0.457 . . . . 10.03 110.267 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.18 -22.27 59.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.036 -0.529 . . . . 7.89 110.634 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.69 88.9 17.22 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.656 -0.868 . . . . 7.65 108.656 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.66 -14.36 35.41 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.12 2.547 . . . . 8.15 113.418 -174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.463 ' O ' HG12 ' A' ' 22' ' ' ILE . 12.3 tt -108.13 22.62 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.852 0.834 . . . . 6.15 110.415 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -73.61 -8.1 54.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.055 -0.52 . . . . 5.72 111.113 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -73.75 20.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.094 0.473 . . . . 8.17 111.256 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 23' ' ' ALA . . . -145.55 43.38 0.93 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.942 -0.863 . . . . 5.05 110.942 177.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' HA ' HD22 ' A' ' 197' ' ' LEU . 40.8 mt-10 -56.65 141.82 42.14 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.187 0.518 . . . . 7.09 111.935 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -151.82 129.85 11.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.069 -0.969 . . . . 5.44 110.126 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.452 ' HB3' ' CZ3' ' A' ' 244' ' ' TRP . 23.2 mm-40 -143.37 -83.55 0.16 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.322 -0.992 . . . . 7.33 108.322 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.3 m -78.97 104.92 2.46 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.54 -0.911 . . . . 4.35 108.54 164.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 28' ' ' GLN . 52.1 Cg_endo -71.29 -31.34 14.42 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.246 1.964 . . . . 4.96 112.474 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.32 161.81 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.376 0.608 . . . . 5.07 111.305 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -82.93 140.63 32.71 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.951 -1.129 . . . . 3.14 107.951 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 59.9 mt -82.99 85.1 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.543 0.687 . . . . 2.71 109.381 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -102.08 112.19 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.188 -0.914 . . . . 2.82 110.397 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m -54.85 -31.67 59.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 2.71 112.643 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -74.67 -38.6 62.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.126 0.488 . . . . 5.23 110.421 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 m -79.13 -29.26 43.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.737 -0.665 . . . . 3.38 111.083 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.22 116.2 6.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.76 110.695 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -92.42 129.49 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.146 -0.479 . . . . 4.05 109.921 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.725 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.3 p90 -63.2 121.91 14.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 4.9 110.256 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -105.65 125.78 32.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.54 -0.755 . . . . 2.27 109.397 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 15.5 Cg_exo -69.82 60.1 1.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.64 2.227 . . . . 2.45 111.789 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 m -63.5 -17.45 62.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 4.62 111.713 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 42' ' ' PRO . 80.5 mt 61.56 -86.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.394 0.677 . . . . 5.15 112.386 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 46' ' ' PRO . 85.7 tttt -65.66 130.79 94.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.916 0.389 . . . . 4.21 111.517 -175.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.434 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 56.9 Cg_endo -71.2 171.01 16.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.819 2.346 . . . . 2.76 111.23 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.78 131.43 40.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.734 -0.469 . . . . 2.93 109.734 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.4 m -108.78 115.12 29.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.949 -0.389 . . . . 2.46 109.949 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 22.0 t -123.0 110.77 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 2.17 110.286 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.636 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.0 m -92.18 90.28 7.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.525 -0.546 . . . . 1.87 109.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.0 9.84 38.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 3.97 111.556 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.05 -37.03 81.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 2.48 111.047 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -97.26 27.05 4.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.107 -0.497 . . . . 2.54 111.293 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.33 56.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.146 0.498 . . . . 1.41 112.057 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -146.87 106.03 3.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.828 -0.624 . . . . 1.41 110.178 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.3 p -89.01 158.8 17.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.488 -0.56 . . . . 1.84 109.488 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.17 -56.68 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.178 0.436 . . . . 1.45 112.178 -173.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.57 157.75 32.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.909 -0.317 . . . . 3.72 110.728 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -114.26 136.99 49.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 1.35 109.348 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' A' ' 172' ' ' SER . 64.9 tp -132.55 146.55 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.171 0.51 . . . . 1.53 111.306 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.1 111.54 24.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.591 -0.732 . . . . 1.49 109.354 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -109.44 67.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.385 -0.526 . . . . 2.18 110.487 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.91 -51.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.752 0 O-C-N 124.808 1.317 . . . . 2.0 115.477 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -106.44 -26.46 11.43 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 122.487 0.315 . . . . 4.11 110.623 -172.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.68 171.38 16.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.562 -0.29 . . . . 1.78 110.51 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 95' ' ' PHE . 13.1 p90 -130.24 114.55 15.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.143 -0.688 . . . . 3.48 109.143 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -116.89 145.6 43.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.99 111.562 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.13 119.33 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 1.75 109.445 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.93 125.64 29.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.804 -0.634 . . . . 2.02 110.049 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -105.69 151.2 24.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.703 -0.68 . . . . 2.19 109.242 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -83.49 106.35 15.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.745 0.307 . . . . 1.33 110.33 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -124.36 57.44 1.24 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.982 0.896 . . . . 2.65 110.594 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -92.98 -5.28 51.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.185 -0.916 . . . . 2.01 109.327 169.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.41 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -158.72 169.82 23.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.878 -1.056 . . . . 2.35 108.757 -178.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -78.17 72.71 4.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 1.92 111.17 -174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 65.6 mttm -81.1 -53.25 6.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.986 -0.552 . . . . 2.31 110.458 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -119.75 112.18 18.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.096 -0.502 . . . . 1.44 110.09 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 91.8 t -113.4 137.04 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.632 -0.713 . . . . 1.82 110.496 -176.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tt -129.19 113.6 15.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.134 -0.321 . . . . 1.8 110.134 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -147.84 125.01 11.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 3.02 110.457 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.93 -177.77 19.62 Favored Glycine 0 C--O 1.219 -0.793 0 CA-C-O 118.937 -0.924 . . . . 1.44 111.151 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.83 -130.18 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 O-C-N 124.971 1.041 . . . . 2.15 115.498 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.506 ' HD2' ' HH ' ' A' ' 190' ' ' TYR . 81.3 Cg_exo -44.61 169.49 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.68 2.92 . . . . 3.17 114.217 -170.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -31.07 102.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.268 1.509 . . . . 4.55 114.879 -147.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.598 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 8.4 p-10 -107.03 -100.9 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.19 -1.823 . . . . 4.95 112.793 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.598 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 94.05 152.73 29.62 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.385 -1.086 . . . . 2.25 110.385 -165.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.622 ' HB ' ' OG1' ' A' ' 125' ' ' THR . 14.5 m -69.67 113.9 7.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.932 0.866 . . . . 2.12 110.819 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.58 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 55.8 m-85 -110.19 107.12 16.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.365 . . . . 3.88 111.654 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.47 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 97.5 mtt180 -75.91 137.88 40.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 3.87 110.992 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.75 125.55 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.505 -0.554 . . . . 1.68 109.505 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.428 HG23 ' HG2' ' A' ' 92' ' ' GLN . 4.5 tt -111.57 -38.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.952 0.406 . . . . 2.16 110.973 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.428 ' HG2' HG23 ' A' ' 91' ' ' ILE . 24.8 pt20 -164.98 158.34 16.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.7 -0.482 . . . . 1.95 109.7 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.86 140.69 24.79 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.163 -0.31 . . . . 0.98 110.163 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -135.21 157.63 46.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.412 -0.358 . . . . 1.07 110.654 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 54.6 m-85 -113.77 169.16 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 3.99 110.495 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.401 ' CG ' ' HE1' ' A' ' 244' ' ' TRP . 0.3 OUTLIER -137.63 173.1 12.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.087 -0.708 . . . . 2.2 109.087 174.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.47 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 30.8 t-105 -151.33 127.03 10.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.857 -0.423 . . . . 6.08 109.857 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -94.24 140.85 15.25 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.093 -0.575 . . . . 2.19 112.255 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 t -46.82 -43.51 18.53 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.641 0.376 . . . . 3.08 111.863 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 103' ' ' GLN . 45.1 mt -122.78 152.71 40.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.532 -0.544 . . . . 3.48 109.532 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.05 -7.4 3.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.818 -0.628 . . . . 3.85 112.187 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.76 29.56 2.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.76 . . . . 2.37 112.505 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 7.6 tp60 -159.44 139.88 12.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.925 0.363 . . . . 2.62 110.873 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 244' ' ' TRP . . . 94.57 -28.99 9.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.861 -0.685 . . . . 1.62 112.402 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.451 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 1.2 m -89.55 -17.9 27.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.469 0.176 . . . . 2.24 111.127 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 60.02 -156.75 0.34 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.388 -0.369 . . . . 3.72 110.689 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.464 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 62.6 m80 63.33 69.37 0.57 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.381 -0.6 . . . . 4.03 109.381 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 5.6 t -104.09 118.38 36.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.113 0.482 . . . . 2.99 110.53 -167.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.0 t -85.54 105.65 14.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.365 -0.976 . . . . 2.88 108.365 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 66.88 -71.53 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.67 0.606 . . . . 2.8 110.652 -171.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -152.05 19.12 0.67 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 5.35 110.605 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 108' ' ' THR . 13.9 mmmm -107.75 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.018 -0.537 . . . . 3.58 111.553 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -80.31 156.19 26.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.91 . . . . 3.26 108.544 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -93.43 -171.29 2.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.8 0.333 . . . . 1.71 111.189 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.41 -27.36 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 1.57 111.752 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 147' ' ' LEU . . . -153.25 168.74 25.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.617 0.246 . . . . 1.3 110.533 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HG2' ' CE1' ' A' ' 107' ' ' HIS . 13.7 tp10 -151.8 152.6 32.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.372 -0.603 . . . . 1.85 109.372 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.501 HD12 ' CE2' ' A' ' 95' ' ' PHE . 38.2 tp -125.79 131.38 52.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.712 0.291 . . . . 1.61 110.963 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 107.72 14.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 2.25 110.705 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -102.22 109.55 21.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.105 -0.332 . . . . 1.51 110.105 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.02 129.22 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.188 -0.46 . . . . 1.24 111.49 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 19.0 m-70 -127.39 156.32 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 2.86 109.63 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -127.49 150.51 49.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 4.96 111.554 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.57 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 19.6 t30 -69.21 116.45 9.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.064 -0.971 . . . . 2.3 111.811 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.622 ' OG1' ' HB ' ' A' ' 87' ' ' THR . 53.2 p -63.16 -32.79 74.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.655 0.983 . . . . 2.77 113.655 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.57 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 60.9 pttt -74.28 -4.56 36.88 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.338 -0.545 . . . . 3.79 111.923 -173.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -91.42 -5.65 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.34 0.59 . . . . 3.34 109.546 170.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.9 19.32 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 115.569 0.987 . . . . 2.37 115.569 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -177.91 133.13 0.16 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.883 0.841 . . . . 3.93 109.802 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.601 ' O ' HG22 ' A' ' 134' ' ' VAL . 40.3 p90 -66.33 -42.97 87.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.633 . . . . 3.6 111.345 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.27 -33.25 86.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.108 -0.568 . . . . 2.35 112.231 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 127' ' ' TYR . 98.1 mttt -74.28 -34.11 63.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.027 -0.36 . . . . 3.75 110.027 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.35 66.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 2.17 110.765 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 130' ' ' PHE . 42.0 t -63.53 -18.25 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.203 0.525 . . . . 3.11 110.761 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.68 -9.62 53.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.126 -0.359 . . . . 3.55 111.178 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 205' ' ' CYS . 7.6 tt0 -104.41 126.44 31.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.232 -0.284 . . . . 3.02 110.232 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 73.1 Cg_exo -52.79 -31.2 50.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.548 2.832 . . . . 1.93 113.12 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.14 28.15 9.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.185 0.517 . . . . 2.29 109.848 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.03 -30.91 24.55 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.826 -0.625 . . . . 1.5 113.408 -172.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HB2' HG23 ' A' ' 206' ' ' VAL . 91.3 mt -112.21 157.58 20.72 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.574 -0.368 . . . . 1.98 110.3 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.57 123.16 10.45 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.814 -0.439 . . . . 1.83 109.814 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.88 129.88 71.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 116.292 -0.413 . . . . 2.28 110.012 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 209' ' ' ILE . 35.8 tp -90.99 134.24 34.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 2.89 109.835 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -115.41 145.77 18.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.069 -0.586 . . . . 0.95 112.018 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.4 mt -142.48 122.75 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.528 -0.545 . . . . 1.38 109.528 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.451 ' CZ ' HG12 ' A' ' 210' ' ' VAL . 44.2 m-85 -73.99 141.07 45.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.694 0.283 . . . . 1.37 111.032 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . 9.0 mp -119.2 121.22 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 1.48 110.041 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.82 147.74 41.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.109 -0.496 . . . . 2.52 109.798 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 62.1 t -87.07 130.16 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.901 0.381 . . . . 1.88 110.863 -174.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.11 -105.29 0.19 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.291 -0.724 . . . . 1.53 111.291 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.2 t -81.89 146.18 29.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 2.08 109.521 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.446 ' CA ' ' HB2' ' A' ' 218' ' ' SER . . . -66.62 152.12 45.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.183 0.515 . . . . 1.36 112.222 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -109.39 102.99 51.56 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.335 -0.848 . . . . 1.78 108.735 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.55 -32.93 65.99 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 123.095 2.53 . . . . 1.34 112.835 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.18 -15.95 72.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.094 -0.574 . . . . 0.75 113.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.3 tp -99.62 -9.03 23.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.346 0.593 . . . . 1.39 110.298 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -45.49 88.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.502 -0.772 . . . . 1.63 112.19 -173.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.476 ' O ' HG22 ' A' ' 162' ' ' VAL . 13.0 ptmm? -76.68 -27.89 55.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.433 -0.507 . . . . 3.26 111.813 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.37 -40.34 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.495 -0.482 . . . . 1.97 111.316 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.49 ' HA ' ' HG ' ' A' ' 163' ' ' LEU . 34.5 m -62.45 -28.74 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.197 0.522 . . . . 1.64 110.671 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.83 -30.55 71.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.556 -0.747 . . . . 1.22 111.173 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 158' ' ' LYS . 41.2 t -89.31 -16.33 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 2.07 111.269 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 77.0 mt -56.05 -31.8 63.49 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.229 0.455 . . . . 1.95 112.229 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.88 -30.12 70.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.78 0.324 . . . . 2.31 111.476 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.9 m -84.46 -3.15 58.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.567 -0.288 . . . . 1.78 111.769 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 44.5 pt -132.89 29.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.528 0.68 . . . . 1.42 109.312 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -60.06 -27.66 67.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.95 -1.023 . . . . 1.98 112.075 -172.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.8 p -119.54 152.97 36.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 1.4 111.598 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -54.39 127.94 29.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.064 -0.971 . . . . 2.84 111.648 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.18 -22.27 31.57 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.588 -0.815 . . . . 0.85 112.849 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -78.56 139.76 38.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.159 0.504 . . . . 2.22 111.307 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.415 ' HB2' HD13 ' A' ' 60' ' ' LEU . 27.4 t -127.06 146.56 50.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.178 -0.919 . . . . 1.93 109.39 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.38 127.08 23.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.438 -0.346 . . . . 1.17 110.08 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.7 132.03 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.501 . . . . 1.8 110.45 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.89 80.99 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.845 -0.616 . . . . 1.31 109.596 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 p -102.81 161.16 13.97 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.116 -0.493 . . . . 1.69 111.824 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 12.9 m120 57.04 66.71 1.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.569 -0.742 . . . . 2.26 111.546 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -119.86 139.18 52.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 4.84 110.191 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 181' ' ' ARG . 17.1 t0 -102.0 106.77 49.45 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 2.51 110.938 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.469 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 23.6 Cg_exo -64.81 -15.08 48.5 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.008 2.472 . . . . 1.47 111.924 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.493 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 29.2 ttp180 -68.78 -21.88 64.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.655 -0.702 . . . . 3.16 110.345 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -77.67 -8.8 87.18 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.774 -0.726 . . . . 1.12 111.855 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 97.0 mt -106.11 -18.26 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.997 0.427 . . . . 2.37 109.884 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 83.3 mt -73.28 126.34 90.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 3.87 110.028 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 59.8 Cg_endo -69.73 -176.28 1.43 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.438 2.758 . . . . 2.51 113.637 -173.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.77 -50.48 64.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.297 -0.411 . . . . 3.23 111.879 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 15.4 m -88.68 136.79 32.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.75 0.31 . . . . 2.03 110.367 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.2 tp -106.09 64.73 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.706 . . . . 2.5 109.893 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.41 -176.32 3.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.953 -1.128 . . . . 1.81 107.953 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.506 ' HH ' ' HD2' ' A' ' 83' ' ' PRO . 44.7 p90 -163.52 154.33 16.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.886 0.766 . . . . 5.32 112.855 -169.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -115.29 146.6 41.34 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.827 -1.175 . . . . 4.55 107.827 170.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -108.71 126.84 53.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.096 0.474 . . . . 2.39 111.126 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -133.17 154.08 81.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 5.32 109.989 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.31 129.82 15.45 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.404 2.069 . . . . 2.47 111.77 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -101.79 97.48 1.61 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.792 -0.718 . . . . 2.0 111.455 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 198' ' ' THR . 15.7 m -83.17 -140.48 0.06 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.91 0.707 . . . . 3.36 112.91 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.612 ' C ' ' H ' ' A' ' 199' ' ' THR . 4.6 pp -50.24 12.73 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 117.029 2.233 . . . . 5.18 117.029 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 196' ' ' SER . 9.8 t -66.79 29.91 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.0 0.905 . . . . 5.53 111.039 174.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.612 ' H ' ' C ' ' A' ' 197' ' ' LEU . 24.2 p -124.18 156.5 66.42 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-N 114.823 -1.08 . . . . 5.89 110.159 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.413 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 52.1 Cg_exo -52.5 -54.51 5.05 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.222 1.948 . . . . 6.31 114.032 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 3.4 Cg_endo -87.58 26.08 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.548 2.165 . . . . 5.26 113.442 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.2 tt 47.25 78.65 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.631 0.772 . . . . 4.29 111.758 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.633 HD11 ' SG ' ' A' ' 205' ' ' CYS . 1.9 pp -152.49 150.06 29.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.176 -0.466 . . . . 3.51 111.659 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 7.9 pt-20 -87.79 92.67 9.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.555 0.693 . . . . 3.37 111.083 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.633 ' SG ' HD11 ' A' ' 203' ' ' LEU . 93.9 m -138.83 32.84 2.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.804 -0.635 . . . . 2.47 110.709 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 140' ' ' LEU . 95.3 t -125.63 149.05 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.732 -0.667 . . . . 1.74 111.187 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.1 m -111.68 107.12 16.12 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.083 -1.08 . . . . 2.3 108.083 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -89.23 115.65 26.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.153 0.501 . . . . 6.37 110.333 -174.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.513 ' O ' HD13 ' A' ' 143' ' ' LEU . 63.5 mt -114.57 116.59 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.603 -0.726 . . . . 2.32 109.68 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.451 HG12 ' CZ ' ' A' ' 146' ' ' PHE . 24.3 t -109.71 129.8 63.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.253 -0.277 . . . . 2.1 110.253 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.73 126.44 29.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.818 0.342 . . . . 2.35 110.555 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -47.5 -24.16 0.78 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.561 0.948 . . . . 3.47 113.561 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 8.6 tp10 -106.81 123.7 37.76 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.644 0.259 . . . . 1.56 110.569 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.437 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 89.9 Cg_endo -81.77 158.63 18.77 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.671 2.248 . . . . 1.37 112.01 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 41.7 pt -113.97 154.35 15.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.844 0.354 . . . . 1.85 110.326 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.3 m -104.17 130.43 51.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.78 110.844 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 18.6 m -125.34 151.17 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.058 -0.719 . . . . 1.64 109.058 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.446 ' HB2' ' CA ' ' A' ' 152' ' ' ALA . 7.5 t -95.2 161.23 14.2 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.449 -0.501 . . . . 1.52 111.164 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.677 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 3.1 p -52.55 -47.18 66.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.32 -0.4 . . . . 1.81 111.658 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -52.6 -33.93 48.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.983 0.421 . . . . 2.51 111.382 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -78.48 -50.68 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 1.02 110.517 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.47 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 27.2 m -67.67 -23.53 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 1.88 111.653 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 219' ' ' SER . 84.7 mt -61.31 -33.39 73.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 1.59 110.717 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -74.76 -23.26 58.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 2.3 110.843 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 29.5 m-85 -68.88 -39.58 79.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.231 0.539 . . . . 3.18 109.802 174.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -76.08 -2.03 28.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.419 -0.81 . . . . 3.55 110.825 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 34.3 mmtp -91.88 -12.62 33.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.409 -0.359 . . . . 2.74 110.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.03 151.4 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 1.66 110.731 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.575 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 9.4 m120 -123.69 127.26 47.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.821 -0.627 . . . . 1.13 110.259 -175.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 65.4 m-85 -57.94 -33.62 69.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.767 -0.652 . . . . 4.38 111.004 173.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.575 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -72.69 164.19 26.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 1.62 111.884 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.73 171.75 43.56 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.536 -0.756 . . . . 1.16 111.309 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.91 123.27 17.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.994 0.426 . . . . 3.56 110.645 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 91.05 25.1 25.4 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.807 -0.633 . . . . 2.23 112.52 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 62.2 mt-10 -124.55 161.85 45.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.036 -0.357 . . . . 2.59 110.036 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 9.9 Cg_endo -52.15 123.06 11.74 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.164 2.576 . . . . 1.5 112.411 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.15 113.72 1.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.477 -0.783 . . . . 3.4 112.275 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -115.99 102.88 10.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.804 -0.813 . . . . 2.47 108.804 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.34 138.02 56.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.166 0.508 . . . . 2.6 111.332 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.629 ' HA ' ' CE1' ' A' ' 230' ' ' PHE . 50.4 ttm -79.1 90.77 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.166 -0.925 . . . . 1.94 110.54 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.9 m -124.44 153.31 30.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 1.67 110.19 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 76.7 m-20 72.04 -80.24 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.133 0.896 . . . . 2.18 109.678 -176.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 56.34 27.72 12.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.073 0.463 . . . . 2.64 111.393 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.561 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 26.8 m95 -142.37 156.67 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 5.31 110.597 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.652 ' NH2' ' HA3' ' A' ' 12' ' ' GLY . 16.1 mmm180 -106.4 137.75 19.52 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.477 -0.783 . . . . 6.91 109.803 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.86 146.14 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.069 3.179 . . . . 3.72 113.667 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.36 151.48 46.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.068 -0.969 . . . . 3.34 110.781 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 86.9 mm-40 -94.76 170.6 7.8 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.473 -0.785 . . . . 4.92 110.079 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 74.8 Cg_exo -44.05 143.21 3.4 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.415 2.076 . . . . 4.01 112.461 176.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.54 -38.45 55.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.03 -0.986 . . . . 4.9 109.749 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 253' ' ' ARG . 21.0 pttm -64.88 -14.8 60.79 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 115.209 1.559 . . . . 5.68 115.209 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.5 t30 24.58 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.783 2.512 . . . . 5.11 117.783 151.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 251' ' ' LYS . 15.5 tpp180 166.28 -125.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.912 -1.514 . . . . 6.74 106.912 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -127.48 133.95 49.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 3.08 109.88 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.6 131.06 35.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.83 -0.433 . . . . 3.06 109.83 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -120.7 133.21 55.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.115 -0.493 . . . . 3.01 110.898 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.725 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -143.82 129.41 19.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.246 -0.649 . . . . 1.99 109.246 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 p -92.23 97.6 10.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.827 -0.749 . . . . 2.47 111.172 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -126.01 92.4 3.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.683 0.754 . . . . 5.03 110.259 167.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.346 -0.843 . . . . 4.82 110.259 178.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.958 0.409 . . . . 17.73 110.572 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p -120.16 122.4 40.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.855 -0.611 . . . . 15.49 110.304 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -114.94 96.44 5.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.087 -0.506 . . . . 16.29 110.193 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -155.37 177.6 11.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.013 -0.539 . . . . 14.68 109.994 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 63.41 119.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.846 0.716 . . . . 15.53 111.796 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' HA3' ' HA2' ' A' ' 12' ' ' GLY . . . -172.92 155.17 22.38 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.578 -0.82 . . . . 10.81 112.215 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -82.11 102.04 10.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.499 0.666 . . . . 11.61 110.479 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.16 -88.02 0.18 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.933 -1.031 . . . . 9.0 110.618 -175.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 18.4 tptm -90.5 158.81 16.84 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.725 -1.213 . . . . 10.04 107.725 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -72.22 -5.57 36.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.839 0.352 . . . . 11.67 111.661 -173.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -124.69 15.84 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.9 -0.591 . . . . 11.18 109.538 174.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' HA2' ' HA3' ' A' ' 6' ' ' GLY . . . 91.98 131.82 5.51 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.405 -1.078 . . . . 8.9 110.405 -172.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 20.5 Cg_endo -62.4 118.77 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 CA-C-N 119.069 1.434 . . . . 8.2 111.932 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 36.9 mt-10 -89.08 -3.59 58.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.223 -0.899 . . . . 10.62 110.828 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -59.65 -38.21 80.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 10.41 110.224 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -45.16 -54.47 6.82 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.814 -0.63 . . . . 9.19 112.207 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -78.54 -34.25 47.29 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.19 -0.319 . . . . 7.71 111.741 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 57.8 mtpt -62.02 -42.04 98.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.84 0.352 . . . . 10.03 111.227 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.34 -25.23 17.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.33 -0.395 . . . . 7.89 111.577 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -131.42 93.88 28.0 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.819 0.342 . . . . 7.65 110.33 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 -25.95 51.22 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.926 2.417 . . . . 8.15 112.213 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.23 -17.64 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 115.421 -0.809 . . . . 6.15 111.936 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.411 ' HB1' HD23 ' A' ' 202' ' ' LEU . . . -56.51 -30.07 62.59 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.167 0.432 . . . . 5.72 112.167 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -91.44 26.82 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.704 0.288 . . . . 8.17 111.44 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.44 158.31 51.16 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.621 -0.992 . . . . 5.05 110.621 172.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 33.4 tt0 -107.9 112.67 25.4 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.243 -0.983 . . . . 7.09 110.707 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 26' ' ' GLU . 29.7 mmt180 -142.28 177.09 8.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.736 -1.209 . . . . 5.44 107.736 167.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.447 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . 29.0 tt0 -66.11 87.54 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.307 0.575 . . . . 7.33 109.593 172.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 31' ' ' VAL . 23.3 t -47.33 144.66 4.32 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.542 -1.208 . . . . 4.35 111.956 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.47 25.69 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.022 3.148 . . . . 4.96 113.761 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 33' ' ' ILE . 34.5 m -94.91 -173.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.252 -0.431 . . . . 5.07 110.363 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB3' HD11 ' A' ' 250' ' ' LEU . 24.2 t70 -52.59 114.2 1.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.054 0.93 . . . . 3.14 111.647 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 31' ' ' VAL . 85.4 mt -102.82 141.79 18.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.33 -1.305 . . . . 2.71 109.918 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 19.3 t70 -120.93 121.62 38.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.827 0.346 . . . . 2.82 110.166 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -69.07 -28.77 66.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 2.71 112.054 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 35.1 m80 -60.54 -43.35 97.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.324 0.583 . . . . 5.23 110.314 173.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -71.98 -21.42 61.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.288 -0.869 . . . . 3.38 110.007 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.82 98.78 3.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.5 -0.773 . . . . 1.76 110.55 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -72.11 126.33 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.941 -0.572 . . . . 4.05 109.653 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 51.1 p90 -82.64 131.49 35.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 4.9 110.336 -172.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.14 138.74 26.57 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.821 -0.627 . . . . 2.27 110.005 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.81 13.2 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.223 2.615 . . . . 2.45 114.064 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -60.45 -52.48 65.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 4.62 109.899 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.1 mt 53.08 13.78 0.41 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.583 0.957 . . . . 5.15 113.583 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -56.72 111.55 3.44 Favored Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 123.408 0.443 . . . . 4.21 111.887 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -87.33 157.3 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.919 2.413 . . . . 2.76 111.99 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -83.1 154.48 24.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.047 -0.524 . . . . 2.93 110.369 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 38.5 t -129.62 131.02 46.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.295 -0.631 . . . . 2.46 109.295 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.89 137.37 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 2.17 111.433 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 47.7 m -127.75 90.94 3.19 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.033 -0.728 . . . . 1.87 109.033 171.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CD1' ' HB2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -133.03 16.42 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.879 -0.328 . . . . 3.97 111.883 -176.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.14 -22.04 64.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.966 0.413 . . . . 2.48 110.951 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.03 3.72 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 2.54 111.228 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.84 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.187 0.517 . . . . 1.41 111.853 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.8 m -98.62 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.064 -0.516 . . . . 1.41 110.506 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -81.24 149.67 28.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 1.84 110.494 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.1 mt -115.85 -49.71 2.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.071 0.462 . . . . 1.45 110.844 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -160.59 161.96 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.026 -0.534 . . . . 3.72 110.726 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.09 133.75 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.941 -0.762 . . . . 1.35 108.941 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.3 tp -129.34 131.21 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.975 0.417 . . . . 1.53 111.408 -172.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -80.81 109.3 15.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.742 -0.663 . . . . 1.49 109.355 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.91 68.89 0.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.968 0.413 . . . . 2.18 110.166 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 240' ' ' MET . . . 64.33 -53.58 0.09 OUTLIER Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.279 -1.328 . . . . 2.0 115.208 171.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -110.1 -19.86 12.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.788 0.328 . . . . 4.11 111.32 -169.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.96 177.61 10.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 1.78 110.247 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.681 ' CE1' HD13 ' A' ' 228' ' ' LEU . 29.2 m-85 -117.38 112.84 21.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.304 -0.628 . . . . 3.48 109.304 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.4 m120 -90.72 105.2 17.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.47 . . . . 1.99 110.783 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 60.1 t -82.26 105.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.752 -0.833 . . . . 1.75 108.752 171.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.12 132.47 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.016 -0.538 . . . . 2.02 111.084 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -112.02 155.74 23.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.462 -0.79 . . . . 2.19 109.032 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.14 110.39 15.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.933 0.397 . . . . 1.33 110.559 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -107.06 55.18 0.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.712 0.768 . . . . 2.65 109.939 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -96.94 -5.85 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.758 . . . . 2.01 110.771 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.447 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -154.03 166.63 32.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.372 -0.831 . . . . 2.35 109.18 178.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.91 36.74 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.36 0.504 . . . . 1.92 112.36 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 92.6 mttt -55.48 -63.58 1.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.246 -0.434 . . . . 2.31 110.656 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -103.55 115.96 31.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.872 -0.604 . . . . 1.44 110.341 -177.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.9 t -134.51 141.96 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 1.82 110.808 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . 58.6 tp -105.61 128.33 53.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.338 -0.616 . . . . 1.8 109.338 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 55.8 mtpt -119.92 124.76 46.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.244 0.545 . . . . 3.02 110.24 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.77 170.99 19.83 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.789 -0.924 . . . . 1.44 110.789 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.71 -148.95 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 O-C-N 123.657 0.269 . . . . 2.15 113.539 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.43 119.03 5.26 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 121.569 1.512 . . . . 3.17 112.451 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.629 ' HB3' ' HH ' ' A' ' 88' ' ' TYR . 59.2 mt -159.66 -171.14 3.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.078 -0.965 . . . . 4.55 108.938 -176.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -132.89 76.95 1.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.751 -0.38 . . . . 4.95 111.714 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.7 -178.68 17.29 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.247 -0.977 . . . . 2.25 114.206 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 m -105.76 120.1 40.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.859 -0.671 . . . . 2.12 109.363 176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.629 ' HH ' ' HB3' ' A' ' 84' ' ' LEU . 32.2 m-85 -105.41 104.79 14.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 3.88 111.436 -171.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 99.4 mtt180 -75.37 152.62 38.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.099 -0.5 . . . . 3.87 110.314 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.9 120.43 24.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.974 -0.38 . . . . 1.68 109.974 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.0 tt -110.26 -34.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.447 -0.342 . . . . 2.16 111.02 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 7.2 pt20 -173.86 174.52 3.04 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.661 -0.496 . . . . 1.95 109.661 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.525 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 20.4 p90 -147.09 161.65 40.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.861 -0.336 . . . . 0.98 111.02 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.463 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.7 p-80 -147.46 160.11 42.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.053 -0.721 . . . . 1.07 109.053 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -125.11 172.79 9.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.774 0.321 . . . . 3.99 110.899 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -127.24 117.14 21.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.712 -1.218 . . . . 2.2 107.712 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.56 ' NE1' ' HA ' ' A' ' 99' ' ' SER . 60.3 t-105 -101.49 112.33 24.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.778 0.323 . . . . 6.08 110.694 -173.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -63.32 -39.07 97.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.629 -0.714 . . . . 2.19 112.497 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.56 ' HA ' ' NE1' ' A' ' 97' ' ' TRP . 32.5 t 91.56 -17.92 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.266 1.026 . . . . 3.08 110.178 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.57 137.85 50.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.134 -1.062 . . . . 3.48 108.134 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.21 -24.96 65.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.652 0.982 . . . . 3.85 113.652 -168.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.99 7.53 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.914 -1.136 . . . . 2.37 113.863 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.99 152.58 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.383 0.591 . . . . 2.62 111.023 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 122.89 -27.27 5.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.64 -0.791 . . . . 1.62 112.692 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.2 t -71.29 -46.98 59.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.464 0.172 . . . . 2.24 111.464 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 61.46 -172.66 0.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.937 0.347 . . . . 3.72 111.937 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.9 m80 56.48 30.21 16.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.957 0.884 . . . . 4.03 108.664 -166.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.587 ' HG1' ' C ' ' A' ' 112' ' ' LYS . 2.0 t -83.13 153.6 24.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.997 -1.456 . . . . 2.99 113.122 -169.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.0 m -101.52 93.45 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.397 -0.82 . . . . 2.88 111.382 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.64 71.55 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.039 -0.982 . . . . 2.8 111.329 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 59.41 21.29 9.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.091 -0.958 . . . . 5.35 113.417 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.587 ' C ' ' HG1' ' A' ' 108' ' ' THR . 22.7 tptm -97.82 73.55 2.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.332 -0.618 . . . . 3.58 109.332 172.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.48 ' HZ1' HG22 ' A' ' 108' ' ' THR . 67.2 mttm -86.9 150.9 23.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.279 -0.418 . . . . 3.26 109.97 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 76.6 m-85 -110.71 -173.79 2.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.751 -0.462 . . . . 1.71 109.751 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.9 -38.97 69.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.623 0.601 . . . . 1.57 112.623 -172.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.53 169.02 17.65 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.929 -0.308 . . . . 1.3 111.527 -170.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -136.17 140.07 43.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.612 -0.722 . . . . 1.85 109.107 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.5 tp -109.63 133.67 52.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 1.61 110.245 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 39.8 m170 -120.38 106.1 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 2.25 110.684 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 5.3 mp -86.83 114.92 23.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.757 -0.46 . . . . 1.51 109.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.03 134.14 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.225 0.536 . . . . 1.24 110.571 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.55 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 74.4 m-70 -119.68 150.82 39.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 2.86 111.521 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -110.17 123.84 50.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.819 -1.082 . . . . 4.96 110.008 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.591 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 40.5 t-20 -79.37 117.99 20.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.113 -0.494 . . . . 2.3 110.426 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -73.93 -32.21 63.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.17 -0.468 . . . . 2.77 112.193 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.591 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 19.6 ptmt -63.24 -25.19 68.21 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.112 0.412 . . . . 3.79 112.112 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.539 ' HH ' ' NE2' ' A' ' 136' ' ' GLN . 37.2 m-85 -93.38 -11.87 31.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.906 0.384 . . . . 3.34 111.136 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.74 26.11 3.85 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.123 -0.944 . . . . 2.37 113.687 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -176.31 115.29 0.12 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.793 -0.447 . . . . 3.93 109.793 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.616 ' O ' HG21 ' A' ' 134' ' ' VAL . 50.8 p90 -57.81 -36.24 71.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 3.6 111.677 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.55 -44.9 96.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.875 -0.678 . . . . 2.35 112.444 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -64.4 -36.21 83.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.21 0.529 . . . . 3.75 109.984 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' GLY . . . -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 2.17 111.303 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 130' ' ' PHE . 72.0 t -61.73 -22.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.028 0.442 . . . . 3.11 111.083 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -77.0 -0.81 25.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 3.55 111.414 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.539 ' NE2' ' HH ' ' A' ' 127' ' ' TYR . 6.2 tt0 -126.26 131.77 24.07 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.79 -0.448 . . . . 3.02 109.79 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.17 -18.19 50.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.897 2.398 . . . . 1.93 112.76 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.439 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 13.1 m-20 -113.91 17.63 17.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.174 -0.676 . . . . 2.29 109.174 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -83.24 -11.23 81.11 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.437 -0.802 . . . . 1.5 113.934 -168.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.583 ' C ' HG11 ' A' ' 206' ' ' VAL . 80.1 mt -146.48 172.19 13.91 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.269 -0.271 . . . . 1.98 110.269 -175.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -156.94 121.34 4.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.363 -0.38 . . . . 1.83 110.671 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.582 ' O ' HG23 ' A' ' 209' ' ' ILE . 33.6 m -97.95 165.86 2.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 N-CA-C 108.637 -0.875 . . . . 2.28 108.637 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.5 tp -116.45 114.71 24.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.774 -0.454 . . . . 2.89 109.774 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -97.16 117.27 5.73 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.047 -0.597 . . . . 0.95 112.689 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.9 mt -118.87 127.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.306 -0.257 . . . . 1.38 110.306 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -78.4 147.22 34.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.366 -0.235 . . . . 1.37 110.366 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 8.1 mp -117.7 124.47 48.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 1.48 111.145 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -116.56 144.91 43.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.322 -0.622 . . . . 2.52 109.322 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 11.2 t -88.05 130.38 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.894 0.378 . . . . 1.88 110.356 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.09 -114.88 0.4 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.414 -0.674 . . . . 1.53 111.414 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.3 t -81.99 156.37 24.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.489 -0.56 . . . . 2.08 109.489 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.408 ' N ' ' HB2' ' A' ' 218' ' ' SER . . . -78.02 148.6 34.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 1.36 111.098 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 183' ' ' LEU . 82.5 tttt -113.19 110.4 51.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.771 -0.455 . . . . 1.78 109.771 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.5 -38.66 90.05 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.708 2.939 . . . . 1.34 113.565 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.3 -19.84 64.65 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.115 -0.564 . . . . 0.75 112.899 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.507 ' O ' HG22 ' A' ' 160' ' ' VAL . 55.5 tp -95.56 -16.56 22.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.025 0.44 . . . . 1.39 110.336 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -46.12 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.761 -0.654 . . . . 1.63 111.162 -173.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.29 -36.73 66.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.873 0.323 . . . . 3.26 111.873 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.12 -42.67 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.077 0.465 . . . . 1.97 110.556 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 156' ' ' LEU . 24.4 t -67.27 -29.73 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 1.64 110.811 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.21 -35.82 61.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.224 -0.444 . . . . 1.22 111.698 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.93 -19.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.654 0.264 . . . . 2.07 111.546 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.436 HD11 HD23 ' A' ' 228' ' ' LEU . 3.4 pp -74.71 -12.79 60.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.947 -0.301 . . . . 1.95 111.501 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.06 -31.08 69.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.947 0.403 . . . . 2.31 111.081 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.3 m -87.57 1.55 53.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.328 0.492 . . . . 1.78 112.328 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.6 pt -139.74 39.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.563 0.697 . . . . 1.42 110.598 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.601 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 84.8 tttt -54.0 -31.68 51.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.672 -1.149 . . . . 1.98 112.688 -176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -111.65 150.17 30.51 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.196 0.522 . . . . 1.4 111.959 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -58.31 128.16 35.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.388 -0.824 . . . . 2.84 111.502 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.65 -18.83 19.6 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.578 -0.82 . . . . 0.85 112.537 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -87.52 149.12 24.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.362 0.601 . . . . 2.22 111.215 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.5 p -134.96 157.26 47.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.053 -0.976 . . . . 1.93 109.702 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.81 139.05 29.13 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.153 -0.314 . . . . 1.17 110.153 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.55 135.04 48.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.623 -0.51 . . . . 1.8 109.623 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.409 ' CE1' ' HB2' ' A' ' 178' ' ' PHE . 22.8 t80 -136.23 81.46 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.242 0.544 . . . . 1.31 109.812 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.0 m -79.97 138.6 37.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.664 -0.698 . . . . 1.69 112.32 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 52.34 76.09 0.2 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.105 -0.952 . . . . 2.26 113.281 169.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.582 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 52.0 t80 -92.13 137.52 32.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.758 -0.46 . . . . 4.84 109.758 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -105.09 94.58 8.0 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.4 0.619 . . . . 2.51 110.94 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 12.3 Cg_exo -71.83 -9.49 24.88 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.653 2.235 . . . . 1.47 112.321 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -49.81 -39.54 38.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.196 0.522 . . . . 3.16 110.87 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -56.23 -26.98 51.57 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.281 -0.872 . . . . 1.12 113.061 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.412 ' HA ' ' HE2' ' A' ' 153' ' ' LYS . 90.2 mt -76.63 -29.65 56.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 2.37 112.571 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 185' ' ' PRO . 85.9 mt -33.14 -47.73 0.58 Allowed Pre-proline 0 N--CA 1.483 1.185 0 N-CA-C 116.237 1.939 . . . . 3.87 116.237 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 184' ' ' LEU . 14.1 Cg_exo -71.73 48.89 1.12 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.556 1.504 . . . . 2.51 114.029 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 187' ' ' SER . 0.0 OUTLIER -109.45 -6.19 15.53 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.998 -0.439 . . . . 3.23 111.766 173.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.456 ' OG ' ' HE2' ' A' ' 212' ' ' LYS . 46.1 t 72.84 128.43 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.782 0.676 . . . . 2.03 111.038 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.472 ' HA ' HD21 ' A' ' 211' ' ' LEU . 96.0 mt -113.81 59.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.395 -0.366 . . . . 2.5 110.174 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -144.43 153.08 41.54 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.997 -0.742 . . . . 1.81 108.997 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.448 ' HB3' ' HB ' ' A' ' 210' ' ' VAL . 0.1 OUTLIER 171.58 -168.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.121 -1.066 . . . . 5.32 108.121 -178.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.561 ' HB3' ' HA ' ' A' ' 257' ' ' ALA . 1.5 p90 -75.87 147.97 38.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.09 0.472 . . . . 4.55 110.265 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.3 t -107.28 75.91 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.8 0.81 . . . . 2.39 110.811 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 28' ' ' GLN . 20.8 t80 -138.43 138.5 22.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.635 -0.711 . . . . 5.32 110.057 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.511 ' HA ' ' OG1' ' A' ' 207' ' ' THR . 33.0 Cg_endo -64.7 130.29 25.91 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.728 2.285 . . . . 2.47 112.832 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -125.29 142.85 14.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.862 -0.608 . . . . 2.0 112.12 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m -65.3 130.81 44.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.579 0.704 . . . . 3.36 112.405 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.92 16.86 16.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.523 -1.217 . . . . 5.18 109.857 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.7 p -62.95 32.55 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.279 1.432 . . . . 5.53 114.47 -170.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.58 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 6.6 p -77.46 -177.71 0.86 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 118.838 -0.601 . . . . 5.89 109.472 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.58 ' HD2' ' HB ' ' A' ' 199' ' ' THR . 2.7 Cg_exo -37.31 -46.41 1.62 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.704 2.269 . . . . 6.31 113.174 169.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 8.3 Cg_exo -76.4 95.56 1.05 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.516 1.477 . . . . 5.26 109.388 161.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.411 HD23 ' HB1' ' A' ' 23' ' ' ALA . 18.3 tp -87.08 43.46 1.1 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 4.29 111.943 -166.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.5 117.51 26.34 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.573 -0.451 . . . . 3.51 110.744 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -104.25 51.3 0.78 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 3.37 110.352 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 62.2 m -135.69 11.74 3.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.436 -0.802 . . . . 2.47 110.412 -176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.583 HG11 ' C ' ' A' ' 140' ' ' LEU . 15.9 m -136.23 100.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 1.74 110.46 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.511 ' OG1' ' HA ' ' A' ' 194' ' ' PRO . 1.4 t -151.21 89.8 1.54 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 115.358 1.614 . . . . 2.3 115.358 170.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.592 ' O ' HG21 ' A' ' 209' ' ' ILE . 0.1 OUTLIER -151.96 85.5 1.29 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.569 -0.707 . . . . 6.37 109.322 143.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.592 HG21 ' O ' ' A' ' 208' ' ' TRP . 0.1 OUTLIER -163.16 98.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.177 0.436 . . . . 2.32 112.177 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.502 HG23 ' CD1' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.11 136.61 59.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.469 -0.769 . . . . 2.1 109.893 165.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 188' ' ' LEU . 51.6 mt -114.1 123.19 49.05 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 2.35 110.631 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.456 ' HE2' ' OG ' ' A' ' 187' ' ' SER . 62.3 pttt -67.62 -36.77 81.44 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.122 0.415 . . . . 3.47 112.122 -174.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.411 ' HG2' ' HG3' ' A' ' 212' ' ' LYS . 25.0 mm-40 -99.14 117.21 64.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 1.56 111.166 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.65 148.25 58.89 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.525 2.15 . . . . 1.37 111.134 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -79.45 147.26 6.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 1.85 109.62 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.1 t -89.9 116.4 27.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.003 -0.544 . . . . 1.78 110.577 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -119.37 135.69 58.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.586 -0.894 . . . . 1.64 108.586 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 152' ' ' ALA . 13.2 t -96.95 170.43 9.16 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.992 -0.442 . . . . 1.52 111.502 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.567 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 11.0 p -51.48 -53.03 41.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.367 0.506 . . . . 1.81 112.367 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.47 -40.14 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 2.51 111.099 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -68.87 -51.08 44.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.966 -0.561 . . . . 1.02 110.071 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.9 m -69.25 -20.71 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 111.912 0.338 . . . . 1.88 111.912 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 219' ' ' SER . 57.9 mt -61.87 -42.41 99.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.019 0.437 . . . . 1.59 109.907 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.676 ' O ' ' HG ' ' A' ' 228' ' ' LEU . 62.5 mttm -66.62 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.511 -0.768 . . . . 2.3 110.865 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -73.23 -31.14 63.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.216 0.532 . . . . 3.18 110.496 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -83.35 -13.86 54.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.684 -0.689 . . . . 3.55 110.89 -174.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.531 ' HB2' ' HZ2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -100.62 -2.35 32.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.205 -0.452 . . . . 2.74 111.294 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.681 HD13 ' CE1' ' A' ' 66' ' ' PHE . 90.7 mt -73.62 152.43 40.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.064 0.459 . . . . 1.66 110.952 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.601 ' OD1' ' HE2' ' A' ' 167' ' ' LYS . 11.9 m120 -111.22 141.48 44.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.408 0.623 . . . . 1.13 111.037 -174.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.77 -31.47 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.731 -1.122 . . . . 4.38 108.815 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.8 p-10 -72.83 165.21 25.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.506 -1.224 . . . . 1.62 112.208 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.09 174.41 45.61 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.915 -1.039 . . . . 1.16 110.814 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.5 133.07 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.832 -0.433 . . . . 3.56 109.832 -176.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.26 3.84 88.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.694 -0.765 . . . . 2.23 113.27 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 32.6 mt-10 -98.66 164.34 17.18 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.657 -0.498 . . . . 2.59 109.657 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.44 126.51 22.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 1.5 111.571 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.51 109.34 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.647 -0.706 . . . . 3.4 111.763 -172.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -125.59 122.15 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.41 -0.814 . . . . 2.47 110.193 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.58 149.42 49.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.773 -0.649 . . . . 2.6 111.116 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.413 ' HE2' ' O ' ' A' ' 63' ' ' GLY . 53.5 mtt -73.0 102.55 3.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 1.94 109.352 175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.87 133.47 68.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 1.67 111.505 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.461 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 17.6 t70 63.62 -80.02 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.3 -0.864 . . . . 2.18 111.211 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 56.36 33.68 22.8 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.818 0.447 . . . . 2.64 111.804 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -125.35 144.75 50.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.468 -0.568 . . . . 5.31 109.468 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.575 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 0.1 OUTLIER -67.62 147.25 98.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.044 -0.525 . . . . 6.91 111.358 -178.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 61.1 Cg_exo -53.17 153.26 16.8 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.443 2.762 . . . . 3.72 112.348 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 118.57 16.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.317 -0.401 . . . . 3.34 111.585 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.531 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 48.6 mt-30 -68.89 171.44 6.37 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.771 -0.65 . . . . 4.92 109.684 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 66.1 Cg_exo -42.26 123.2 2.57 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.386 2.058 . . . . 4.01 111.853 173.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -55.96 -52.87 62.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.571 -0.74 . . . . 4.9 111.836 -163.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 253' ' ' ARG . 18.8 ptpt -62.21 -10.95 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.865 1.061 . . . . 5.68 113.865 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 10.4 p30 48.9 -42.59 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.887 2.551 . . . . 5.11 117.887 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 251' ' ' LYS . 20.0 ttt180 168.74 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.485 -0.931 . . . . 6.74 108.485 -164.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -129.33 136.12 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.063 -0.717 . . . . 3.08 109.063 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.1 mt -99.66 142.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.246 -0.279 . . . . 3.06 110.246 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -132.46 159.1 40.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.596 -0.275 . . . . 3.01 110.348 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 191' ' ' TRP . . . -130.57 157.7 42.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 1.99 110.971 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 191' ' ' TRP . 14.0 p -163.91 98.31 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.387 . . . . 2.47 110.275 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -162.08 150.13 14.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.39 -0.368 . . . . 5.03 110.374 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.38 -0.819 . . . . 4.82 109.673 -177.817 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.627 0.251 . . . . 17.73 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 p -89.19 -30.78 18.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.969 0.414 . . . . 15.49 110.872 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -97.54 175.87 6.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.17 -0.468 . . . . 16.29 110.279 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -135.92 4.81 3.04 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.272 0.471 . . . . 14.68 112.272 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -176.01 134.12 0.26 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.227 0.536 . . . . 15.53 111.642 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.533 ' O ' ' HA2' ' A' ' 12' ' ' GLY . . . -146.64 128.86 3.13 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.309 -1.116 . . . . 10.81 110.309 170.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -68.73 117.9 11.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.883 0.342 . . . . 11.61 110.951 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.65 -113.26 0.29 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.884 -0.674 . . . . 9.0 112.513 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HB2' ' HZ2' ' A' ' 9' ' ' LYS . 10.4 mtmp? -79.55 138.5 37.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.763 0.316 . . . . 10.04 111.091 -176.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 65.23 -100.45 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.435 -0.802 . . . . 11.67 110.087 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -126.8 -15.15 5.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.116 0.484 . . . . 11.18 110.652 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 6' ' ' GLY . . . 179.16 -112.05 0.35 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.954 -0.641 . . . . 8.9 111.977 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.572 ' O ' ' HE3' ' A' ' 16' ' ' TRP . 6.2 Cg_exo -78.58 157.49 28.53 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.622 2.215 . . . . 8.2 111.543 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.89 -17.44 35.53 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.605 0.717 . . . . 10.62 109.461 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -90.27 29.92 1.19 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.754 -1.112 . . . . 10.41 109.724 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.572 ' HE3' ' O ' ' A' ' 13' ' ' PRO . 7.2 p90 -61.03 -12.01 10.23 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.815 -0.63 . . . . 9.19 112.015 -170.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -66.05 -48.66 70.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.096 -0.502 . . . . 7.71 109.82 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.8 ttmm -92.33 -52.57 4.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.107 -0.497 . . . . 10.03 111.327 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -81.21 16.42 1.59 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.553 1.316 . . . . 7.89 114.553 -168.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -152.42 91.18 3.62 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 119.156 -1.018 . . . . 7.65 109.435 -171.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' O ' HD23 ' A' ' 202' ' ' LEU . 58.0 Cg_endo -71.48 64.77 2.92 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.031 2.488 . . . . 8.15 113.538 -173.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 tp -173.08 -32.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.068 -0.515 . . . . 6.15 110.926 173.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.72 33.23 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 5.72 111.542 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -95.64 -26.66 15.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.705 0.764 . . . . 8.17 109.007 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.39 176.79 19.66 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 109.531 -1.428 . . . . 5.05 109.531 170.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -111.73 111.23 22.06 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 118.59 -1.244 . . . . 7.09 109.548 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HG3' ' CB ' ' A' ' 204' ' ' GLU . 24.6 mmt180 -149.51 176.33 10.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.351 -0.611 . . . . 5.44 109.351 168.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.528 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . 27.3 tt0 -45.93 103.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.617 0.722 . . . . 7.33 112.045 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 31' ' ' VAL . 49.7 m -93.02 166.63 15.95 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.844 -1.071 . . . . 4.35 109.939 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 29' ' ' SER . 10.0 Cg_endo -52.7 31.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 125.198 3.932 . . . . 4.96 115.042 170.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 248' ' ' GLN . 3.8 m -93.81 -171.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 122.971 0.508 . . . . 5.07 109.756 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -110.54 140.33 44.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.547 0.213 . . . . 3.14 111.007 -167.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.8 mt -85.49 135.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 116.353 -0.385 . . . . 2.71 110.626 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -105.82 111.46 24.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.744 -0.465 . . . . 2.82 109.744 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.5 p -60.61 -27.24 67.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.037 -0.529 . . . . 2.71 112.321 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -66.56 -45.7 78.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 5.23 110.818 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 m -78.74 -25.9 44.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 3.38 110.667 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.12 116.93 3.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.129 0.49 . . . . 1.76 111.248 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -94.24 128.7 40.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 4.05 110.918 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.1 p90 -76.69 140.05 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.262 -0.426 . . . . 4.9 110.18 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.34 98.46 13.92 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.899 0.381 . . . . 2.27 110.007 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.18 -10.5 27.41 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.181 2.587 . . . . 2.45 113.14 -175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.6 p -78.96 -1.92 37.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.023 0.439 . . . . 4.62 110.565 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.501 HD12 ' OG ' ' A' ' 258' ' ' SER . 78.4 mt -89.54 138.27 31.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.387 -0.597 . . . . 5.15 109.387 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.36 140.25 26.3 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 4.21 110.879 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.44 138.07 84.44 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.128 2.552 . . . . 2.76 111.649 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 mt -72.94 138.3 46.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 2.93 110.457 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -91.81 120.52 32.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.009 -1.108 . . . . 2.46 108.009 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 79' ' ' LEU . 1.9 t -116.45 110.93 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.522 -0.308 . . . . 2.17 110.624 -172.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.9 t -94.91 88.38 5.27 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.034 -0.728 . . . . 1.87 109.034 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CE1' ' HG2' ' A' ' 181' ' ' ARG . 1.4 p90 -107.25 1.1 23.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.892 -0.594 . . . . 3.97 111.36 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.35 -32.83 65.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.242 -0.435 . . . . 2.48 111.557 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.471 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 1.2 mp0 -101.5 6.89 42.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.54 111.138 -176.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.63 128.1 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.812 0.339 . . . . 1.41 111.537 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -112.31 107.03 15.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.954 -0.566 . . . . 1.41 110.721 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 t -79.67 150.51 30.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 1.84 108.95 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.7 mt -117.79 -54.52 2.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 1.45 111.825 -173.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -161.91 159.58 26.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.322 -0.399 . . . . 3.72 110.841 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.1 tt -115.31 141.5 32.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.312 -0.625 . . . . 1.35 109.312 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 171' ' ' LYS . 61.5 tp -127.6 138.26 52.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.37 . . . . 1.53 110.89 -173.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -92.99 119.78 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.063 0.459 . . . . 1.49 110.547 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 49.0 m-80 -127.74 146.53 50.55 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.339 -0.985 . . . . 2.18 108.339 170.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.22 6.34 7.6 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.976 -0.631 . . . . 2.0 113.932 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -114.33 -54.29 2.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.165 0.482 . . . . 4.11 109.713 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 62' ' ' ASN . . . -140.53 163.22 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.336 -0.393 . . . . 1.78 110.416 174.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -111.47 99.77 8.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.805 -0.443 . . . . 3.48 109.805 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -86.55 138.83 31.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 1.99 111.72 -171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.3 t -114.59 113.25 43.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.476 -0.784 . . . . 1.75 108.977 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -72.66 140.53 47.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.913 -0.585 . . . . 2.02 112.076 -172.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -125.68 144.32 50.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 2.19 110.1 172.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.65 139.5 30.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.148 -0.478 . . . . 1.33 111.068 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.02 64.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.033 -0.985 . . . . 2.65 109.868 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -77.82 -11.06 59.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.982 0.896 . . . . 2.01 108.65 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.25 160.05 43.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.927 -1.488 . . . . 2.35 107.824 -176.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.97 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.688 0.618 . . . . 1.92 111.865 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 53' ' ' GLN . 90.0 mttt -109.54 -59.41 1.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.65 0.611 . . . . 2.31 112.65 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.84 102.15 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.06 0.457 . . . . 1.44 111.258 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.59 145.41 24.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.205 -0.452 . . . . 1.82 111.206 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.421 ' CD1' HG23 ' A' ' 49' ' ' VAL . 31.8 tp -134.39 112.88 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.935 -0.395 . . . . 1.8 109.935 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -150.98 123.23 8.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 3.02 111.538 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -97.17 176.06 31.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.762 -1.021 . . . . 1.44 110.905 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.17 -141.28 0.0 OUTLIER Glycine 0 CA--C 1.541 1.71 0 N-CA-C 115.331 0.892 . . . . 2.15 115.331 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.64 122.21 8.47 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.227 1.952 . . . . 3.17 112.329 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.563 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 14.1 tp -165.44 -170.3 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.976 -1.12 . . . . 4.55 107.976 -171.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.563 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 27.0 t70 -122.23 41.72 3.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.294 0.497 . . . . 4.95 110.997 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.77 174.91 13.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.858 -1.163 . . . . 2.25 114.229 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.0 m -101.86 124.18 47.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.073 -0.564 . . . . 2.12 110.12 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -114.07 113.16 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.071 0.463 . . . . 3.88 111.55 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.79 153.93 20.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.372 -0.376 . . . . 3.87 110.431 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.89 124.33 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.819 0.342 . . . . 1.68 110.615 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.536 ' HB ' ' CE3' ' A' ' 123' ' ' TRP . 14.2 tt -105.62 -34.02 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.918 0.389 . . . . 2.16 110.117 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -173.93 164.67 4.24 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.854 -0.795 . . . . 1.95 108.854 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -136.71 154.66 50.54 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.566 -0.902 . . . . 0.98 108.566 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.47 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.7 p-80 -139.78 158.8 43.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.943 0.401 . . . . 1.07 110.962 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.12 166.84 20.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 3.99 109.426 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.433 ' HE1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -144.46 157.69 44.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.451 -0.574 . . . . 2.2 109.451 175.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.598 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 73.1 t-105 -128.51 139.5 52.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 6.08 110.228 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 241' ' ' VAL . . . -95.06 -59.42 1.11 Allowed Glycine 0 C--O 1.218 -0.844 0 C-N-CA 120.837 -0.697 . . . . 2.19 112.74 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 28.8 p 163.07 -57.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.365 0.603 . . . . 3.08 110.648 -172.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.81 153.26 23.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.307 -0.86 . . . . 3.48 110.4 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.38 51.69 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.666 0.746 . . . . 3.85 110.243 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -176.02 1.64 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.151 -0.931 . . . . 2.37 112.434 -175.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -160.35 155.24 24.33 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.887 -0.782 . . . . 2.62 108.887 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 116.19 -27.12 8.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.192 -1.004 . . . . 1.62 111.873 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 t -70.39 -46.73 63.44 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.011 -0.366 . . . . 2.24 110.011 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 113' ' ' LYS . 8.1 mm-40 58.89 177.39 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.044 -0.525 . . . . 3.72 111.808 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.44 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 24.6 m80 59.76 14.45 4.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.962 -0.563 . . . . 4.03 111.286 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 113' ' ' LYS . 7.3 t -82.38 -178.8 7.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.11 -0.95 . . . . 2.99 113.088 -172.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.0 m -103.61 123.94 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.582 -1.19 . . . . 2.88 111.965 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 61.17 39.14 16.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.38 -1.282 . . . . 2.8 111.413 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 67.81 8.54 6.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.758 -0.656 . . . . 5.35 112.163 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.43 73.91 6.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.694 0.283 . . . . 3.58 110.707 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.515 ' HD3' ' OE1' ' A' ' 106' ' ' GLU . 91.9 mttt -69.07 150.25 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.222 0.534 . . . . 3.26 111.641 -176.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 81.4 m-85 -101.12 -177.26 3.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.174 -0.921 . . . . 1.71 109.848 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.63 67.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.917 0.389 . . . . 1.57 111.704 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.32 163.75 39.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.457 . . . . 1.3 110.224 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.44 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 44.3 tt0 -129.99 135.2 48.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.732 -0.47 . . . . 1.85 109.732 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.493 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 42.9 tp -110.78 132.5 54.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.066 -0.515 . . . . 1.61 109.907 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -128.09 111.34 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.792 0.33 . . . . 2.25 111.628 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 6.6 mp -92.71 113.46 25.74 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.151 -0.315 . . . . 1.51 110.151 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.73 122.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.162 0.506 . . . . 1.24 111.37 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -120.92 146.64 46.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.95 -0.568 . . . . 2.86 109.513 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.536 ' CE3' ' HB ' ' A' ' 91' ' ' ILE . 2.1 p90 -119.56 148.83 42.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.615 -0.513 . . . . 4.96 109.615 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -68.99 114.73 7.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.278 0.561 . . . . 2.3 110.37 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -68.19 -21.87 64.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.235 -0.893 . . . . 2.77 112.101 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.87 -21.6 64.83 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.861 0.363 . . . . 3.79 111.506 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.3 -3.17 34.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.003 0.43 . . . . 3.34 110.125 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.79 30.22 6.67 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 114.714 -1.13 . . . . 2.37 114.98 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.479 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 30.5 t70 -173.42 129.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.037 0.918 . . . . 3.93 110.214 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.598 ' O ' HG21 ' A' ' 134' ' ' VAL . 85.8 t80 -60.0 -46.4 89.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.961 -1.018 . . . . 3.6 110.842 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.66 99.24 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.227 -0.511 . . . . 2.35 112.832 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.479 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 73.6 mmtt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.07 0.462 . . . . 3.75 110.316 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.68 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.66 -0.7 . . . . 2.17 110.738 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.598 HG21 ' O ' ' A' ' 130' ' ' PHE . 99.6 t -64.83 -26.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.022 -0.535 . . . . 3.11 111.493 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -83.87 -4.66 58.85 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.023 -0.423 . . . . 3.55 111.451 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' A' ' 136' ' ' GLN . 3.1 tt0 -107.28 132.36 21.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.885 -0.413 . . . . 3.02 109.885 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 74.4 Cg_exo -52.46 -30.37 43.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.426 2.751 . . . . 1.93 113.499 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.91 25.18 12.05 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.646 0.26 . . . . 2.29 110.472 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.68 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -70.87 -33.63 65.99 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.579 -0.819 . . . . 1.5 113.394 -172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.7 mt -114.71 156.9 23.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.999 0.428 . . . . 1.98 110.069 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.0 106.57 6.14 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.284 -0.635 . . . . 1.83 109.284 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 91.3 t -103.94 116.45 47.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.093 -0.503 . . . . 2.28 110.353 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 44.5 tp -88.8 112.85 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.631 -0.713 . . . . 2.89 109.329 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -101.64 141.9 15.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.906 -0.664 . . . . 0.95 112.337 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.6 mt -133.64 131.75 57.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.453 -0.573 . . . . 1.38 109.453 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.4 148.99 25.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.921 -0.4 . . . . 1.37 109.921 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.9 mp -116.79 124.01 48.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 1.48 110.973 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 18.9 ptpt -108.1 150.52 27.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.271 -0.64 . . . . 2.52 109.271 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 92.3 t -95.01 130.55 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.133 0.492 . . . . 1.88 110.83 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.59 -103.61 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.794 -0.639 . . . . 1.53 111.731 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 p -71.07 147.22 48.71 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.839 0.352 . . . . 2.08 110.385 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.2 149.58 33.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.263 -0.426 . . . . 1.36 110.606 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.0 100.4 53.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.053 -0.521 . . . . 1.78 110.303 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.46 -35.02 64.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.41 2.74 . . . . 1.34 112.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.44 -21.36 64.47 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.347 -0.454 . . . . 0.75 113.524 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.501 ' HB3' ' NE2' ' A' ' 221' ' ' GLN . 27.1 tp -98.04 -6.25 32.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.3 0.55 . . . . 1.39 110.802 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.01 -41.24 74.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 1.63 111.805 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -66.04 -34.66 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.728 0.299 . . . . 3.26 111.085 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 162' ' ' VAL . 67.4 t -71.55 -50.29 40.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 1.97 110.823 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.406 ' HB ' ' HD2' ' A' ' 224' ' ' LYS . 32.9 m -65.61 -24.89 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 1.64 111.255 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.74 -34.1 58.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.499 . . . . 1.22 111.495 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 159' ' ' VAL . 6.0 p -81.89 -8.77 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 2.07 110.749 -175.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.34 -27.22 63.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.966 -0.561 . . . . 1.95 111.391 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.15 -34.66 73.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 2.31 111.413 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.3 t -89.25 -1.55 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.664 -0.244 . . . . 1.78 111.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 38.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.05 0.452 . . . . 1.42 110.374 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.9 -35.33 72.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 1.98 111.023 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 p -106.39 149.02 27.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.396 0.617 . . . . 1.4 111.52 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -57.41 126.94 29.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.901 -1.045 . . . . 2.84 111.18 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.5 -22.24 20.2 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.748 -0.739 . . . . 0.85 112.642 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.425 ' O ' HD11 ' A' ' 60' ' ' LEU . 64.8 mttm -79.62 150.28 31.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.167 0.508 . . . . 2.22 111.472 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 8.5 t -140.75 151.34 44.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.402 -0.817 . . . . 1.93 109.279 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -140.51 134.85 31.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.07 -0.344 . . . . 1.17 110.07 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.43 132.41 53.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.249 0.547 . . . . 1.8 110.402 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -141.51 80.79 1.75 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.611 -0.722 . . . . 1.31 109.585 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 32.0 p -101.34 160.9 14.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.274 0.472 . . . . 1.69 112.274 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.1 42.16 10.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.263 -0.88 . . . . 2.26 111.755 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.46 130.57 45.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 4.84 110.828 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 3.2 p30 -105.72 133.18 20.31 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 2.51 109.92 176.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 3.3 Cg_exo -77.93 -11.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.536 2.157 . . . . 1.47 111.439 173.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.511 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 18.4 mtm180 -57.68 -44.0 85.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.616 -0.72 . . . . 3.16 111.498 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.86 -6.48 56.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.83 -0.7 . . . . 1.12 112.978 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.42 ' O ' HG21 ' A' ' 215' ' ' ILE . 6.7 mp -108.7 -9.23 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.582 -0.364 . . . . 2.37 111.002 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 95.3 mt -70.75 140.83 86.81 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.913 0.387 . . . . 3.87 111.621 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.52 -167.98 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.273 2.648 . . . . 2.51 113.308 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.7 -59.74 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 3.23 111.309 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.51 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 9.7 m -91.05 140.44 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 2.03 110.949 -174.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 35.1 tp -106.02 62.78 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.549 0.69 . . . . 2.5 109.657 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 258' ' ' SER . 6.9 m-20 -122.45 171.79 8.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.829 -1.175 . . . . 1.81 107.829 176.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 51.7 p90 -167.71 163.5 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.831 1.049 . . . . 5.32 113.831 -163.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.565 ' CZ2' ' HG3' ' A' ' 212' ' ' LYS . 13.4 m-90 -105.37 141.94 36.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.223 -1.399 . . . . 4.55 107.223 164.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.4 t -138.86 109.13 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.409 0.623 . . . . 2.39 112.558 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 28' ' ' GLN . 8.9 t80 -139.88 129.03 13.6 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 5.32 109.671 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.51 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 89.0 Cg_exo -48.9 134.92 29.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.058 2.505 . . . . 2.47 112.92 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 28' ' ' GLN . . . -107.48 153.39 16.83 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.82 -0.627 . . . . 2.0 113.659 -170.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 198' ' ' THR . 72.9 p -92.7 -134.45 0.15 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.68 0.792 . . . . 3.36 111.243 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.662 ' C ' ' H ' ' A' ' 199' ' ' THR . 40.4 tp -45.57 10.11 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.387 1.875 . . . . 5.18 116.03 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 196' ' ' SER . 1.4 p -68.01 26.0 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.789 -1.195 . . . . 5.53 110.898 166.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.662 ' H ' ' C ' ' A' ' 197' ' ' LEU . 9.7 t -148.48 149.69 32.07 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 114.658 -1.156 . . . . 5.89 108.449 -175.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.477 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 77.6 Cg_exo -44.19 -51.35 6.81 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.066 2.511 . . . . 6.31 115.245 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 11.1 Cg_endo -91.16 158.69 3.83 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.307 2.005 . . . . 5.26 112.61 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -75.43 74.59 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.292 0.568 . . . . 4.29 110.206 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp -151.81 174.55 13.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.663 -0.699 . . . . 3.51 110.727 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -112.78 85.94 2.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.563 0.697 . . . . 3.37 110.502 -177.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.5 p -111.93 3.43 17.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.167 -0.47 . . . . 2.47 111.07 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.04 134.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.281 0.563 . . . . 1.74 111.819 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.5 m -102.9 97.85 7.92 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.079 -1.452 . . . . 2.3 107.079 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -88.77 120.35 30.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.076 0.465 . . . . 6.37 110.815 -169.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 71.3 mt -126.18 118.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 2.32 109.356 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 191' ' ' TRP . 3.4 p -120.32 126.26 75.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.808 0.337 . . . . 2.1 110.602 -174.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.22 137.02 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.079 -0.51 . . . . 2.35 110.596 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.565 ' HG3' ' CZ2' ' A' ' 191' ' ' TRP . 33.6 ttmt -81.53 -1.36 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 3.47 110.756 -177.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -111.8 91.65 15.56 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.3 -0.63 . . . . 1.56 109.3 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 18.9 Cg_exo -66.61 147.44 81.81 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.775 2.317 . . . . 1.37 112.031 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.42 HG21 ' O ' ' A' ' 183' ' ' LEU . 38.8 pt -94.61 154.35 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 1.85 110.751 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.9 m -99.92 137.92 37.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.961 -0.563 . . . . 1.78 110.975 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 12.6 m -134.63 155.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.634 -0.712 . . . . 1.64 109.193 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 44.9 t -83.44 154.8 23.77 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.941 -0.303 . . . . 1.52 110.602 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.638 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 6.3 p -54.91 -45.56 74.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.583 -0.28 . . . . 1.81 110.531 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 43.5 mt-10 -55.69 -27.76 51.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.204 -0.453 . . . . 2.51 111.5 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.501 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 52.9 mt-30 -80.27 -47.39 14.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 1.02 110.454 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.598 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 35.1 m -71.91 -26.69 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 1.88 111.499 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.7 mt -66.72 -30.3 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.79 0.329 . . . . 1.59 110.445 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 96.1 mttt -69.43 -24.29 63.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 2.3 110.765 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 21.9 m-85 -75.73 -25.01 56.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 3.18 109.774 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -79.29 -10.94 59.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 3.55 110.189 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -90.29 -8.78 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 2.74 110.35 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.26 150.48 48.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 1.66 110.425 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.7 m120 -110.21 136.35 49.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.409 0.623 . . . . 1.13 110.613 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -76.93 -30.5 56.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.758 -1.11 . . . . 4.38 109.739 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.6 p-10 -73.61 164.38 26.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.128 -0.942 . . . . 1.62 112.132 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.83 174.32 46.0 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.073 -0.967 . . . . 1.16 111.079 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.11 135.84 55.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.243 0.521 . . . . 3.56 110.511 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 90.69 7.91 66.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.859 -0.686 . . . . 2.23 112.434 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -112.53 159.24 34.88 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.244 -0.28 . . . . 2.59 110.244 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.26 124.0 15.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.453 2.102 . . . . 1.5 110.911 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.435 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.9 pt-20 -62.01 123.93 19.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.819 0.819 . . . . 3.4 111.909 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 43.5 mt-10 -116.97 125.27 51.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.843 -1.071 . . . . 2.47 108.486 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -70.05 147.57 49.88 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.117 -0.492 . . . . 2.6 110.619 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 11.9 tpt -73.94 92.13 2.07 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.528 -0.916 . . . . 1.94 108.528 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.0 m -140.21 142.12 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 1.67 110.674 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 30.1 t70 66.42 -95.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.226 -0.897 . . . . 2.18 109.497 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 m120 53.25 19.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.483 0.549 . . . . 2.64 112.483 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -150.08 164.31 35.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.792 0.33 . . . . 5.31 110.406 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.414 ' HE ' ' NE2' ' A' ' 248' ' ' GLN . 12.6 ptm180 -107.78 148.12 36.74 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.926 -0.579 . . . . 6.91 110.898 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.97 161.98 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.625 2.883 . . . . 3.72 113.623 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.2 143.66 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.334 -0.848 . . . . 3.34 110.695 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.543 ' HB2' HG11 ' A' ' 31' ' ' VAL . 41.9 mt-30 -124.69 170.54 8.79 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.867 -0.606 . . . . 4.92 111.1 -169.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.415 ' CD ' ' HB3' ' A' ' 248' ' ' GLN . 6.5 Cg_exo -76.09 174.94 11.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.401 2.734 . . . . 4.01 115.031 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.42 -8.7 57.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 113.879 -1.51 . . . . 4.9 113.069 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 18.4 pttp -55.21 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.319 2.34 . . . . 5.68 117.319 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 3.3 p-10 134.62 28.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.976 1.71 . . . . 5.11 112.065 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.424 ' NE ' HD11 ' A' ' 255' ' ' ILE . 56.3 ttt180 -147.94 120.05 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.924 -0.399 . . . . 6.74 109.924 162.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -146.79 122.39 10.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.429 -1.322 . . . . 3.08 107.429 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.444 HD12 HG23 ' A' ' 255' ' ' ILE . 14.8 mt -124.85 145.83 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.006 0.432 . . . . 3.06 111.803 -168.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.46 143.55 48.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 3.01 110.041 169.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -118.59 92.72 3.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.157 -0.474 . . . . 1.99 110.097 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 69.0 m -105.55 100.67 10.23 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.288 -0.565 . . . . 2.47 111.724 -172.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -126.27 100.43 6.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.136 -1.061 . . . . 5.03 108.136 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.503 -0.761 . . . . 4.82 110.808 -173.279 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.702 0.287 . . . . 17.73 110.829 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 p -97.2 -24.97 15.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.148 -0.221 . . . . 15.49 111.465 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -86.55 25.02 1.3 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.074 0.464 . . . . 16.29 111.211 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -77.82 95.47 4.72 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.727 -0.842 . . . . 14.68 108.727 174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -88.31 139.6 30.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.817 0.341 . . . . 15.53 110.57 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.71 163.7 30.86 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.431 -0.667 . . . . 10.81 111.431 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -86.99 99.3 11.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.536 0.208 . . . . 11.61 110.607 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.65 157.11 21.29 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.705 -0.76 . . . . 9.0 112.367 175.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 56.0 tttp -58.29 148.46 27.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.241 -0.281 . . . . 10.04 110.241 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 91.1 m-70 73.72 -46.56 0.63 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.64 0.776 . . . . 11.67 111.354 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -78.26 -16.2 58.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.485 0.659 . . . . 11.18 109.596 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.73 -127.08 2.46 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.331 -0.85 . . . . 8.9 111.351 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.89 131.88 17.62 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.355 2.037 . . . . 8.2 111.895 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -87.69 -41.21 13.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.721 -0.672 . . . . 10.62 110.916 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -107.04 26.39 10.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.996 -0.547 . . . . 10.41 110.505 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -46.78 -41.94 16.17 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.61 -0.723 . . . . 9.19 112.053 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.418 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 31.9 m-70 -70.67 -23.47 62.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.895 0.379 . . . . 7.71 111.153 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.45 -35.12 18.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 10.03 110.437 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.07 -24.97 59.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.895 -0.593 . . . . 7.89 110.655 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -114.67 93.45 33.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.731 -0.668 . . . . 7.65 109.749 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.43 -31.19 46.91 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.344 2.696 . . . . 8.15 113.14 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -51.19 -27.58 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.46 0.541 . . . . 6.15 112.46 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' A' ' 202' ' ' LEU . . . -64.36 -29.5 70.57 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.735 0.302 . . . . 5.72 111.348 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 17' ' ' HIS . 31.5 mmtp -68.42 -11.73 60.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.268 0.556 . . . . 8.17 110.47 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.37 36.38 2.59 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.591 -1.004 . . . . 5.05 110.591 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -62.92 152.76 35.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.257 -0.471 . . . . 7.09 112.031 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -147.95 127.26 13.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.763 -0.828 . . . . 5.44 108.763 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.644 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 33.6 tt0 -142.68 170.58 15.44 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.558 -0.905 . . . . 7.33 108.558 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.554 ' N ' ' HG2' ' A' ' 28' ' ' GLN . 16.0 m -88.94 100.06 1.89 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.092 -0.707 . . . . 4.35 109.092 170.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 28' ' ' GLN . 74.4 Cg_endo -101.08 -17.4 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.004 2.469 . . . . 4.96 113.605 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.535 HG11 ' O ' ' A' ' 253' ' ' ARG . 27.7 m -95.63 172.93 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.046 0.45 . . . . 5.07 111.697 -168.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -127.55 145.38 50.88 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.053 -1.091 . . . . 3.14 108.053 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 57.1 mt -65.62 103.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.41 0.624 . . . . 2.71 111.191 -169.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' THR . 20.9 m-20 -83.44 102.66 12.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.929 -1.032 . . . . 2.82 108.947 176.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -55.02 -35.65 64.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.405 0.52 . . . . 2.71 112.405 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -84.66 -28.58 26.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.092 0.404 . . . . 5.23 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 5.7 m -89.12 -15.81 32.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.285 0.564 . . . . 3.38 110.91 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.02 142.16 56.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 1.76 110.747 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -104.32 116.45 32.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.376 -0.602 . . . . 4.05 109.376 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -87.59 87.18 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 4.9 110.835 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' OD2' ' HG ' ' A' ' 44' ' ' LEU . 19.6 t70 -73.93 119.72 77.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 2.27 110.91 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.57 -16.71 9.09 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.876 2.384 . . . . 2.45 112.918 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 m -70.25 -46.22 64.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.636 -0.505 . . . . 4.62 109.636 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.417 ' HG ' ' OD2' ' A' ' 41' ' ' ASP . 95.9 mt -54.29 144.52 20.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.417 -0.811 . . . . 5.15 111.008 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -117.1 124.07 29.49 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.672 -0.695 . . . . 4.21 109.835 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HA ' ' CE2' ' A' ' 190' ' ' TYR . 73.3 Cg_exo -51.52 122.76 10.81 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.258 1.972 . . . . 2.76 111.623 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.95 126.87 30.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.539 -0.755 . . . . 2.93 110.606 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.451 ' O ' HD11 ' A' ' 79' ' ' LEU . 53.7 p -67.35 136.19 54.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.706 -0.479 . . . . 2.46 109.706 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.46 97.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.818 -0.438 . . . . 2.17 109.818 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 9.8 m -97.14 88.62 4.53 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.478 -0.564 . . . . 1.87 109.478 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 181' ' ' ARG . 1.0 OUTLIER -129.23 18.09 5.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.5 0.667 . . . . 3.97 109.896 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.06 -28.83 69.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.016 -0.993 . . . . 2.48 110.216 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.2 7.84 45.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 2.54 111.256 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.71 133.64 55.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.738 0.304 . . . . 1.41 111.717 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.578 ' OG1' ' HE2' ' A' ' 76' ' ' LYS . 10.7 m -121.1 119.13 31.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.085 -0.507 . . . . 1.41 110.532 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 t -83.92 150.25 25.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.308 -0.405 . . . . 1.84 110.431 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.0 mt -116.71 -55.44 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 1.45 111.424 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -169.75 160.83 8.93 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.425 -0.352 . . . . 3.72 110.942 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 17.4 tt -109.32 144.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 1.35 109.281 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.6 tp -135.68 136.93 41.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.313 0.578 . . . . 1.53 111.779 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.445 ' CB ' ' HA ' ' A' ' 169' ' ' LYS . 4.2 m-20 -88.43 106.03 17.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.943 -1.026 . . . . 1.49 109.32 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 64' ' ' HIS . 44.6 m-80 -100.04 75.19 1.84 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.382 -0.372 . . . . 2.18 111.4 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 65.93 -26.15 0.15 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 115.56 0.984 . . . . 2.0 115.56 174.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 62' ' ' ASN . 25.5 p80 -163.76 -25.82 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.76 0.314 . . . . 4.11 111.533 -172.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.74 157.93 19.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.12 -0.326 . . . . 1.78 110.12 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -131.7 96.37 3.94 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.51 -0.922 . . . . 3.48 108.51 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -115.86 145.59 42.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.23 -0.896 . . . . 1.99 111.437 -170.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 58.8 t -93.71 121.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.781 -0.645 . . . . 1.75 110.049 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -86.52 125.05 33.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.69 -0.686 . . . . 2.02 109.787 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -103.83 164.38 11.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.919 0.39 . . . . 2.19 110.674 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.64 116.16 28.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.879 -0.6 . . . . 1.33 109.824 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -127.77 59.99 1.45 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.925 0.869 . . . . 2.65 110.795 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -75.9 -5.29 45.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.435 -0.802 . . . . 2.01 110.614 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -157.61 176.94 11.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 2.35 109.218 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.65 30.38 0.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.385 -0.371 . . . . 1.92 111.194 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.578 ' HE2' ' OG1' ' A' ' 55' ' ' THR . 2.4 ptpp? -50.77 -44.94 58.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.75 -0.659 . . . . 2.31 111.628 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.15 99.54 6.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.367 . . . . 1.44 110.119 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.2 m -129.0 168.36 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.386 0.613 . . . . 1.82 111.739 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 48' ' ' SER . 38.7 tp -137.19 111.45 8.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.04 -0.982 . . . . 1.8 108.416 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -150.45 126.34 10.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 3.02 111.419 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 173.94 24.28 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.965 -0.561 . . . . 1.44 113.347 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.78 -134.11 0.0 OUTLIER Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.349 0.976 . . . . 2.15 114.545 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -44.9 169.92 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.226 2.618 . . . . 3.17 112.712 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -35.8 150.34 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.472 1.286 . . . . 4.55 114.472 -154.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 13.8 p-10 174.58 -66.61 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.797 -1.092 . . . . 4.95 111.227 -156.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.6 141.8 2.44 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.371 -0.691 . . . . 2.25 111.371 -170.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.3 m -88.51 125.69 34.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.695 0.747 . . . . 2.12 111.033 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.501 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.2 m-85 -118.65 126.36 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.325 -0.398 . . . . 3.88 111.24 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.4 mtt180 -83.0 135.63 34.79 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.55 -0.295 . . . . 3.87 111.024 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.45 117.02 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.48 -0.563 . . . . 1.68 109.48 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.421 HG23 ' HG2' ' A' ' 92' ' ' GLN . 6.9 tt -110.12 -36.34 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.335 -0.393 . . . . 2.16 111.241 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 20.6 pt20 -162.86 168.31 21.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.339 -0.245 . . . . 1.95 110.339 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -141.1 149.31 41.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.921 -0.4 . . . . 0.98 109.921 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -140.4 158.02 44.64 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.151 0.282 . . . . 1.07 110.714 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.7 m-85 -108.86 153.2 23.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.407 -0.36 . . . . 3.99 110.108 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -105.52 153.55 21.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 2.2 111.903 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.634 ' CB ' ' HA2' ' A' ' 104' ' ' GLY . 0.7 OUTLIER 69.37 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.738 -1.119 . . . . 6.08 111.984 170.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 241' ' ' VAL . . . 69.69 118.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.161 -0.542 . . . . 2.19 112.055 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 23.1 t 176.16 -89.53 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.03 0.415 . . . . 3.08 111.435 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.72 170.82 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 3.48 111.382 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.05 45.14 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.409 -0.814 . . . . 3.85 111.341 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -176.56 20.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.905 . . . . 2.37 112.828 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -155.86 120.03 4.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 2.62 110.043 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.634 ' HA2' ' CB ' ' A' ' 97' ' ' TRP . . . 157.71 -26.52 0.45 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.817 -0.706 . . . . 1.62 111.551 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 114' ' ' TYR . 43.2 m -81.35 64.73 6.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.098 0.559 . . . . 2.24 110.283 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.15 143.06 55.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.75 -0.463 . . . . 3.72 109.75 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.447 ' O ' HG13 ' A' ' 33' ' ' ILE . 34.7 m80 61.65 25.64 15.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.984 0.421 . . . . 4.03 111.618 174.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.4 t -82.68 -175.54 5.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.5 . . . . 2.99 111.512 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 15.0 m -71.07 106.81 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 2.88 111.715 -166.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.0 t70 58.2 31.11 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.991 -1.459 . . . . 2.8 109.724 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.5 mttp 66.81 28.67 8.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.984 -1.007 . . . . 5.35 112.479 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -69.24 72.31 0.29 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.168 0.509 . . . . 3.58 110.488 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.75 114.29 2.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.415 -0.811 . . . . 3.26 112.584 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.5 ' H ' ' HB2' ' A' ' 105' ' ' SER . 67.2 m-85 -106.31 -163.16 0.9 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.343 -0.844 . . . . 1.71 109.276 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.61 95.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.13 0.789 . . . . 1.57 113.13 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.11 169.66 15.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.456 0.539 . . . . 1.3 112.456 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -122.59 135.01 54.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.501 -1.227 . . . . 1.85 108.25 171.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.488 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.3 tp -116.06 116.41 27.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.243 -0.28 . . . . 1.61 110.243 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -106.25 110.3 22.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 2.25 111.314 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.2 mp -88.21 102.71 15.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.601 -0.888 . . . . 1.51 108.601 173.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.31 120.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.727 -0.67 . . . . 1.24 110.783 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 12.7 m-70 -117.1 141.99 47.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.984 -0.747 . . . . 2.86 108.984 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.502 ' CZ2' ' HD2' ' A' ' 89' ' ' ARG . 61.5 p-90 -111.87 141.22 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.801 0.334 . . . . 4.96 110.854 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.448 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 44.4 t30 -62.12 110.63 1.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.473 0.654 . . . . 2.3 111.519 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.3 t -61.5 -33.45 73.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.934 -1.03 . . . . 2.77 112.872 -170.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 21.4 pttm -72.02 -6.81 44.96 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.239 0.829 . . . . 3.79 113.239 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.412 ' CZ ' ' HG3' ' A' ' 136' ' ' GLN . 43.4 m-85 -97.93 -4.23 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.568 -0.453 . . . . 3.34 110.836 172.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.5 26.55 5.24 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.074 -0.966 . . . . 2.37 114.779 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.37 122.91 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.547 0.673 . . . . 3.93 109.669 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.545 ' O ' HG22 ' A' ' 134' ' ' VAL . 46.3 p90 -69.37 -31.98 70.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 3.6 111.521 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.24 -37.23 92.66 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.751 -0.738 . . . . 2.35 112.007 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -70.49 -32.88 70.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.35 0.595 . . . . 3.75 109.61 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.73 -25.27 64.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 2.17 111.085 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 130' ' ' PHE . 93.8 t -68.5 -25.89 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 3.11 110.394 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -81.58 -13.82 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 3.55 110.774 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 127' ' ' TYR . 14.2 mm100 -111.18 135.91 20.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.051 -0.522 . . . . 3.02 110.1 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.11 -21.41 55.88 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.671 2.248 . . . . 1.93 112.796 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -113.0 25.45 11.39 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.931 -0.396 . . . . 2.29 109.931 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.76 -30.04 49.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.693 . . . . 1.5 113.892 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 88.1 mt -123.67 158.62 31.15 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.352 -0.499 . . . . 1.98 110.546 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.7 121.05 7.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 1.83 110.031 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 m -110.52 119.65 59.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.022 0.439 . . . . 2.28 110.418 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.2 tp -83.41 104.87 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.467 -0.568 . . . . 2.89 109.467 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -90.36 114.92 4.49 Favored Glycine 0 N--CA 1.446 -0.65 0 O-C-N 123.652 0.595 . . . . 0.95 112.363 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.7 mt -117.06 105.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.389 -0.597 . . . . 1.38 109.389 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 86.6 m-85 -66.24 154.47 39.78 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.122 0.487 . . . . 1.37 111.712 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.68 112.75 24.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.544 -0.753 . . . . 1.48 110.071 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -96.72 147.17 24.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.157 -0.683 . . . . 2.52 109.157 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.82 126.41 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 1.88 110.92 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.23 -106.79 0.22 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.421 -0.672 . . . . 1.53 111.421 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.7 m -69.13 140.64 54.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.824 -0.436 . . . . 2.08 109.824 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.43 152.62 45.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.562 -0.29 . . . . 1.36 110.805 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -108.6 95.29 16.01 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.941 -0.762 . . . . 1.78 108.941 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.02 -35.9 99.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.994 2.463 . . . . 1.34 112.966 -173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.43 -18.4 79.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.913 -0.66 . . . . 0.75 113.061 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.4 tp -90.15 -20.8 22.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.921 0.391 . . . . 1.39 110.805 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.647 HE21 ' HA ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -55.82 -34.25 65.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.947 -0.569 . . . . 1.63 112.154 -175.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -51.75 -41.1 61.34 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 112.534 0.568 . . . . 3.26 112.534 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.5 p -85.56 -38.96 13.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.347 -0.541 . . . . 1.97 111.018 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.419 HG11 ' HD2' ' A' ' 224' ' ' LYS . 31.4 t -63.22 -47.22 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 1.64 111.765 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -18.35 62.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.065 0.394 . . . . 1.22 112.065 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 162' ' ' VAL . 44.4 t -96.22 -1.59 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 121.197 0.523 . . . . 2.07 111.013 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.8 -24.97 66.22 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.901 0.381 . . . . 1.95 111.304 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.9 -31.68 71.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.46 -0.336 . . . . 2.31 110.717 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 44.5 m -76.9 -5.07 47.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 1.78 111.628 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.5 pt -137.78 45.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 1.42 109.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -67.05 -28.97 68.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.418 -0.81 . . . . 1.98 110.986 -175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 p -116.38 149.05 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.724 0.297 . . . . 1.4 110.723 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 61' ' ' ASN . 56.3 pttt -65.25 148.88 50.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.457 -0.338 . . . . 2.84 110.104 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.55 33.84 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.457 -0.878 . . . . 0.85 111.37 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -82.22 157.58 23.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.419 0.628 . . . . 2.22 111.146 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.2 p -141.72 154.04 45.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 1.93 109.122 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.13 122.95 20.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.969 -0.382 . . . . 1.17 109.969 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.25 144.66 56.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.967 -0.561 . . . . 1.8 111.314 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.36 81.2 1.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 1.31 110.327 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 p -112.25 159.12 18.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.495 -0.32 . . . . 1.69 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.6 43.59 25.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.06 -0.518 . . . . 2.26 111.386 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.08 140.35 52.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.401 -0.363 . . . . 4.84 110.23 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -92.15 110.33 43.59 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.392 -0.367 . . . . 2.51 110.467 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.23 -14.85 13.07 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.463 2.109 . . . . 1.47 112.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.545 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . 9.4 ttp180 -71.93 -24.15 61.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 3.16 111.267 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -61.3 -2.8 3.27 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.342 -0.39 . . . . 1.12 113.867 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.54 -8.77 57.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.93 0.365 . . . . 2.37 110.979 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 184' ' ' LEU . 4.4 pp -48.05 137.28 10.94 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 113.425 0.898 . . . . 3.87 113.425 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -94.92 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.553 2.835 . . . . 2.51 111.483 170.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -90.35 -64.18 1.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.836 0.309 . . . . 3.23 111.836 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.1 m -99.32 146.93 25.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 2.03 111.627 -172.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.29 65.12 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.979 0.419 . . . . 2.5 111.197 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.48 ' O ' HD12 ' A' ' 211' ' ' LEU . 33.0 m-20 -108.41 168.68 9.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.038 -1.097 . . . . 1.81 108.038 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.657 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 13.2 p90 -159.58 154.13 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.252 -0.979 . . . . 5.32 112.988 -170.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.682 ' CE3' ' HB1' ' A' ' 257' ' ' ALA . 6.9 m95 -111.84 142.17 44.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.419 -1.264 . . . . 4.55 107.747 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.0 t -121.66 113.24 19.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.548 0.69 . . . . 2.39 112.434 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -138.24 131.21 16.38 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 5.32 110.534 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.66 139.39 76.55 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.86 2.374 . . . . 2.47 112.165 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.455 ' HA2' ' OG ' ' A' ' 29' ' ' SER . . . -138.36 159.17 25.17 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.142 -0.552 . . . . 2.0 113.443 -170.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.6 t -114.08 129.82 56.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.79 -1.189 . . . . 3.36 107.79 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.47 -47.74 66.3 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.419 0.896 . . . . 5.18 113.419 -161.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.475 HG22 ' HD2' ' A' ' 200' ' ' PRO . 1.3 t -121.81 -46.92 2.21 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.863 -0.735 . . . . 5.53 112.723 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.708 ' OG1' ' HD3' ' A' ' 200' ' ' PRO . 0.3 OUTLIER 156.08 -66.33 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 124.73 1.212 . . . . 5.89 111.455 -176.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.708 ' HD3' ' OG1' ' A' ' 199' ' ' THR . 52.5 Cg_exo -55.49 -41.28 79.51 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.339 2.693 . . . . 6.31 116.337 -170.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.73 -24.48 55.32 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 121.636 1.557 . . . . 5.26 112.961 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 200' ' ' PRO . 94.8 mt 53.98 23.55 4.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.952 -1.022 . . . . 4.29 112.922 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.01 172.47 8.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.703 -0.226 . . . . 3.51 110.588 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -113.47 58.34 0.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.63 0.729 . . . . 3.37 110.392 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.64 -15.43 57.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.988 -1.006 . . . . 2.47 110.519 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 40.6 t -100.65 151.28 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.714 -0.675 . . . . 1.74 110.66 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -117.57 109.35 16.59 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.734 -0.839 . . . . 2.3 108.734 174.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -74.01 100.82 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.951 -0.759 . . . . 6.37 108.951 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.59 99.6 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.688 -0.856 . . . . 2.32 108.688 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 21.5 t -86.19 111.22 20.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.202 -0.454 . . . . 2.1 109.903 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 189' ' ' ASP . 20.6 tp -72.21 120.48 17.88 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.935 -0.765 . . . . 2.35 108.935 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -66.23 -14.91 62.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.243 -0.435 . . . . 3.47 111.708 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.486 ' HG2' ' H ' ' A' ' 187' ' ' SER . 7.1 tp10 -104.71 96.49 10.6 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.573 0.225 . . . . 1.56 110.787 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 63.0 Cg_endo -77.4 144.98 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.461 2.107 . . . . 1.37 111.828 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.3 pt -88.78 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.178 -0.465 . . . . 1.85 111.291 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.4 m -94.68 126.71 40.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.663 . . . . 1.78 110.334 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.49 158.79 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.765 -0.457 . . . . 1.64 109.765 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 55.1 p -95.85 158.69 15.33 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.912 -0.315 . . . . 1.52 111.07 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.604 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 63.8 m -56.55 -39.26 73.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.935 -0.575 . . . . 1.81 110.694 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.89 -31.02 26.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 2.51 111.372 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.91 -45.1 13.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.45 . . . . 1.02 110.175 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.38 -40.71 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.916 -0.584 . . . . 1.88 111.475 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 219' ' ' SER . 89.7 mt -59.24 -35.13 73.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 1.59 111.8 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.419 ' HD2' HG11 ' A' ' 160' ' ' VAL . 66.1 mttp -70.19 -23.47 62.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.628 -0.26 . . . . 2.3 111.473 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -72.87 -25.43 61.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.22 0.533 . . . . 3.18 110.094 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -80.8 -9.89 59.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 3.55 110.603 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -86.9 -10.13 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 2.74 110.444 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.22 148.63 48.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.886 -0.597 . . . . 1.66 110.853 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.589 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 11.5 m120 -113.84 139.43 49.17 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.419 0.628 . . . . 1.13 110.331 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -76.05 -30.62 58.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.768 -1.106 . . . . 4.38 109.568 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.427 ' C ' ' HG2' ' A' ' 169' ' ' LYS . 4.5 p-10 -76.24 171.08 15.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.118 -0.947 . . . . 1.62 112.247 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.87 -179.33 38.91 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.763 -1.108 . . . . 1.16 111.288 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.65 129.17 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 3.56 110.866 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.94 4.34 48.31 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.472 -0.785 . . . . 2.23 112.547 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -116.05 153.94 48.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.249 -0.278 . . . . 2.59 110.249 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.36 131.81 48.04 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.857 2.371 . . . . 1.5 111.774 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.589 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 31.2 tt0 -53.65 115.15 1.82 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.592 0.71 . . . . 3.4 112.755 -174.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -108.82 117.86 35.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.896 -1.15 . . . . 2.47 107.896 168.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.68 125.46 25.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.678 0.275 . . . . 2.6 110.713 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.5 ttm -77.37 90.32 3.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.065 -0.717 . . . . 1.94 109.065 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 27.7 m -136.36 151.74 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.836 -0.62 . . . . 1.67 109.872 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 14.1 t70 69.67 -87.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.696 0.622 . . . . 2.18 110.588 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 48.98 15.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.364 1.246 . . . . 2.64 114.364 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -150.46 177.97 9.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.272 0.487 . . . . 5.31 110.689 -172.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -116.75 131.56 23.85 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.204 -0.295 . . . . 6.91 110.204 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.466 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 59.7 Cg_endo -73.72 -148.34 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.83 2.354 . . . . 3.72 112.772 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.466 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -82.95 136.1 34.66 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.924 -0.485 . . . . 3.34 111.486 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 73.6 mm-40 -123.09 162.31 40.01 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.791 -0.64 . . . . 4.92 110.215 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.51 177.82 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.804 3.003 . . . . 4.01 114.341 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 252' ' ' ASN . 4.4 mm? -55.38 -4.7 0.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.245 1.418 . . . . 4.9 113.306 178.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 75.0 mmtt -54.11 49.4 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.489 1.515 . . . . 5.68 114.975 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 3.3 t30 132.67 62.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.911 2.084 . . . . 5.11 111.968 175.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.535 ' O ' HG11 ' A' ' 31' ' ' VAL . 29.8 mtm180 88.29 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.418 -1.265 . . . . 6.74 112.689 153.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.454 ' H ' ' HB3' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -157.83 163.7 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.645 -0.872 . . . . 3.08 108.645 -171.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.66 125.17 62.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.818 0.342 . . . . 3.06 111.461 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -106.8 177.14 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 3.01 109.896 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.682 ' HB1' ' CE3' ' A' ' 191' ' ' TRP . . . -136.67 171.78 13.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.772 0.32 . . . . 1.99 111.487 -170.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.3 m -129.43 97.31 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.262 0.553 . . . . 2.47 110.157 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -153.62 138.98 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.835 -0.802 . . . . 5.03 108.835 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.366 -0.826 . . . . 4.82 111.043 -175.378 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.97 0.414 . . . . 17.73 110.557 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 m -155.98 92.18 1.34 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.735 -0.839 . . . . 15.49 108.735 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -75.62 -84.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.036 -0.529 . . . . 16.29 110.641 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -166.36 -75.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.348 -0.612 . . . . 14.68 109.348 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -110.42 -176.89 3.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.047 -0.524 . . . . 15.53 109.779 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.11 134.38 3.24 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.196 -1.002 . . . . 10.81 112.692 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -90.45 99.6 12.59 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.869 -0.419 . . . . 11.61 109.869 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.01 -62.22 0.5 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.758 -0.734 . . . . 9.0 111.739 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -49.88 127.11 15.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.274 -0.269 . . . . 10.04 110.274 173.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -69.97 2.05 3.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.115 -0.493 . . . . 11.67 111.599 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.582 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 9.6 t30 -116.84 -15.23 10.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.282 -0.417 . . . . 11.18 110.337 174.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.95 -97.17 1.89 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.839 -0.696 . . . . 8.9 111.934 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 11' ' ' ASN . 17.8 Cg_endo -60.48 160.83 22.45 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.134 2.556 . . . . 8.2 113.039 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.22 3.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.619 1.168 . . . . 10.62 113.902 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.462 ' H ' ' C ' ' A' ' 13' ' ' PRO . 38.5 t-80 -68.09 -19.66 64.87 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.92 0.867 . . . . 10.41 108.988 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.402 ' CE3' ' HB2' ' A' ' 11' ' ' ASN . 5.7 t-105 -62.75 -8.59 7.05 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.18 -1.373 . . . . 9.19 111.813 175.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 20' ' ' PHE . 8.7 p-80 -59.48 -3.5 0.46 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.056 1.132 . . . . 7.71 114.056 -172.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -52.59 -29.37 25.44 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.484 0.55 . . . . 10.03 112.484 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -123.49 12.49 9.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.185 0.517 . . . . 7.89 111.037 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 22' ' ' ILE . 78.6 m-85 -124.88 106.3 29.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.701 -0.681 . . . . 7.65 110.114 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.04 -26.91 19.98 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.588 2.858 . . . . 8.15 114.226 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.5 tt -14.0 -47.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 114.544 1.313 . . . . 6.15 114.544 169.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.32 -24.52 4.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.756 0.651 . . . . 5.72 112.756 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -117.79 -10.77 10.43 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.077 0.399 . . . . 8.17 112.077 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.96 -87.29 0.06 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 119.979 -1.105 . . . . 5.05 113.416 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.632 ' HA ' ' OE2' ' A' ' 204' ' ' GLU . 1.2 mp0 -40.83 168.8 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.893 1.072 . . . . 7.09 113.893 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.474 HH21 ' CD ' ' A' ' 204' ' ' GLU . 14.4 ptp180 -151.61 138.2 18.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.32 -0.993 . . . . 5.44 108.32 -153.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -73.26 -62.64 1.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.457 0.572 . . . . 7.33 110.9 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.6 m -105.91 155.05 38.98 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 107.307 -1.368 . . . . 4.35 107.307 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' ' HB3' ' A' ' 253' ' ' ARG . 1.6 Cg_endo -82.18 -50.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.249 0 CA-C-N 120.114 1.076 . . . . 4.96 112.468 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 32' ' ' ASP . 6.3 p -169.1 143.25 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.726 -0.39 . . . . 5.07 111.632 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 31' ' ' VAL . 1.1 p-10 -84.62 139.74 31.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.871 -0.789 . . . . 3.14 108.871 164.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.446 ' HA ' HD11 ' A' ' 255' ' ' ILE . 64.7 mt -86.29 86.83 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.494 0.664 . . . . 2.71 110.888 -171.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -94.29 101.73 13.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.681 -0.69 . . . . 2.82 109.146 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -58.62 -25.31 62.54 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.612 0.597 . . . . 2.71 112.612 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -73.87 -44.14 56.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 5.23 110.455 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 m -81.36 -21.02 39.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.459 . . . . 3.38 111.284 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.8 142.1 42.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.468 -0.333 . . . . 1.76 110.826 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -134.42 114.46 12.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.706 0.289 . . . . 4.05 110.557 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -63.18 135.67 57.28 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.559 -0.534 . . . . 4.9 109.559 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -108.37 120.59 46.12 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.358 -0.383 . . . . 2.27 110.0 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.39 -24.02 50.47 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.695 2.264 . . . . 2.45 112.982 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.0 m -77.89 -26.84 49.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.795 0.331 . . . . 4.62 111.026 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 92.1 mt -83.28 140.9 32.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 5.15 110.475 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.44 159.92 38.13 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.082 -0.508 . . . . 4.21 110.864 -174.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.78 162.91 6.14 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.235 2.623 . . . . 2.76 113.255 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.569 ' HG ' ' CE2' ' A' ' 190' ' ' TYR . 95.2 mt -71.14 132.64 45.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 2.93 111.27 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 m -100.06 97.11 7.99 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.245 -1.021 . . . . 2.46 108.245 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.72 103.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.086 -0.506 . . . . 2.17 109.853 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.5 m -99.59 89.47 4.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.302 -0.629 . . . . 1.87 109.302 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -112.2 10.13 20.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.209 -0.45 . . . . 3.97 111.207 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.84 -30.71 64.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.891 0.377 . . . . 2.48 111.547 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.5 mp0 -109.04 39.64 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.361 -0.381 . . . . 2.54 110.427 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.99 57.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.821 0.343 . . . . 1.41 111.762 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.4 m -138.55 107.11 5.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.41 110.645 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -92.47 153.61 19.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.523 -0.547 . . . . 1.84 109.523 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -116.27 -58.62 2.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.505 0.558 . . . . 1.45 112.505 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -169.17 163.19 10.99 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.357 -0.214 . . . . 3.72 110.824 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -114.45 144.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.237 -0.283 . . . . 1.35 110.237 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -132.13 144.6 50.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 1.53 110.952 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -111.54 115.86 29.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 1.49 109.909 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -110.52 72.97 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.371 0.605 . . . . 2.18 110.929 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.77 -35.25 0.48 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 114.721 -1.127 . . . . 2.0 115.146 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -150.6 -29.78 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 117.104 0.452 . . . . 4.11 111.514 -173.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.43 161.87 25.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.583 -0.525 . . . . 1.78 109.583 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -129.19 121.55 27.92 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.194 0.521 . . . . 3.48 110.354 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -111.87 139.8 47.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 1.99 110.088 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 40.8 t -100.77 117.64 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.655 -0.498 . . . . 1.75 109.655 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.81 119.34 21.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 2.02 110.37 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -108.36 150.68 27.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.644 -0.707 . . . . 2.19 109.63 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -81.87 109.88 16.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 1.33 110.803 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.84 56.36 0.81 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.564 0.697 . . . . 2.65 110.334 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -89.23 -9.07 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 2.01 111.804 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.436 ' C ' ' H ' ' A' ' 76' ' ' LYS . 11.5 pt20 -163.35 177.91 8.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.549 . . . . 2.35 109.516 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -76.41 23.47 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.257 0.348 . . . . 1.92 111.731 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 16.9 ptpt -54.08 -39.67 66.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.473 -0.331 . . . . 2.31 111.717 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -133.18 101.27 5.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.114 0.483 . . . . 1.44 110.332 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.28 166.12 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.979 -0.555 . . . . 1.82 111.087 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.92 115.06 7.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.724 . . . . 1.8 109.844 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -145.13 123.5 12.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.058 0.456 . . . . 3.02 111.315 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -73.41 175.89 45.65 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 119.092 -0.838 . . . . 1.44 111.154 164.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.08 -143.4 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 N-CA-C 115.124 0.81 . . . . 2.15 115.124 168.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 72.3 Cg_exo -49.34 120.0 5.19 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.697 1.598 . . . . 3.17 112.728 -173.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 mt -154.35 -168.08 2.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.561 -1.2 . . . . 4.55 108.798 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.93 44.13 2.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.753 0.311 . . . . 4.95 110.954 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 124' ' ' ASN . . . 129.59 -177.84 17.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.971 -0.633 . . . . 2.25 112.829 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 m -107.76 133.8 51.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.455 -0.572 . . . . 2.12 109.455 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 51.5 m-85 -108.66 114.28 27.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.958 0.408 . . . . 3.88 111.948 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 98.5 mtt180 -79.15 140.53 37.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.103 -0.499 . . . . 3.87 110.468 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.53 124.6 24.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.762 -0.458 . . . . 1.68 109.762 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 tt -117.8 -41.6 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 111.701 0.26 . . . . 2.16 111.701 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 10.0 pt20 -159.11 165.21 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.858 -0.423 . . . . 1.95 109.858 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.454 ' CB ' HD21 ' A' ' 120' ' ' LEU . 42.4 p90 -146.98 161.01 41.67 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.007 -0.277 . . . . 0.98 111.456 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 11.7 p-80 -146.56 160.22 42.43 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.914 -0.585 . . . . 1.07 109.861 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.569 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.3 m-85 -122.75 148.93 44.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.889 0.376 . . . . 3.99 111.396 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -105.55 175.89 5.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.335 -0.617 . . . . 2.2 109.335 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -172.81 114.19 0.27 Allowed 'General case' 0 N--CA 1.463 0.176 0 O-C-N 123.199 0.312 . . . . 6.08 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.655 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -79.03 154.5 39.32 Favored Glycine 0 C--O 1.226 -0.397 0 N-CA-C 111.435 -0.666 . . . . 2.19 111.435 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 t -65.11 -29.25 70.1 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.195 0.997 . . . . 3.08 110.063 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.9 mt -106.4 144.98 32.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.448 -0.797 . . . . 3.48 109.438 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.19 70.3 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.553 0.533 . . . . 3.85 111.003 176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.66 43.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 2.37 112.741 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' HA ' ' CG ' ' A' ' 113' ' ' LYS . 13.0 pt20 -173.12 164.01 4.78 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 110.1 -0.333 . . . . 2.62 110.1 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.58 -1.78 49.38 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.509 -0.853 . . . . 1.62 114.1 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 p -90.63 -26.73 19.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.825 0.676 . . . . 2.24 112.825 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.45 ' HA ' ' CD1' ' A' ' 244' ' ' TRP . 0.6 OUTLIER 71.58 -170.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.749 -1.204 . . . . 3.72 107.749 -169.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.2 m80 54.99 71.37 0.54 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.312 0.505 . . . . 4.03 110.612 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 113' ' ' LYS . 14.2 p -87.0 116.3 24.96 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.448 -0.501 . . . . 2.99 110.723 -165.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 26.4 t -82.7 93.62 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.874 -0.417 . . . . 2.88 109.874 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 58.64 54.57 5.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.457 -0.572 . . . . 2.8 109.457 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 69.51 -2.33 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.106 -0.952 . . . . 5.35 112.578 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 23.1 ttmm -86.36 124.03 32.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.081 0.467 . . . . 3.58 111.192 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.505 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -116.33 138.09 51.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.799 -0.637 . . . . 3.26 109.694 175.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -88.38 159.99 17.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.639 -0.71 . . . . 1.71 110.499 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.48 ' HA ' ' H ' ' A' ' 103' ' ' GLN . . . -64.46 -20.05 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.846 . . . . 1.57 112.372 -174.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 147' ' ' LEU . . . -166.05 168.73 15.27 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.951 -0.389 . . . . 1.3 109.951 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -154.27 142.75 20.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.596 -0.52 . . . . 1.85 109.596 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.569 HD13 ' CE2' ' A' ' 95' ' ' PHE . 15.1 tp -100.79 127.69 47.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.748 -0.66 . . . . 1.61 109.85 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.422 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.1 m170 -114.55 101.48 9.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.26 0.552 . . . . 2.25 110.831 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 48.0 mt -83.2 107.89 16.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.229 -0.896 . . . . 1.51 109.834 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.481 ' HA ' HG11 ' A' ' 142' ' ' VAL . 41.3 t -82.57 123.27 38.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.384 0.612 . . . . 1.24 111.459 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 36.6 m-70 -123.09 147.22 46.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.289 -0.868 . . . . 2.86 109.387 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.663 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 62.5 p-90 -120.53 142.58 49.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.979 0.418 . . . . 4.96 111.113 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 86' ' ' GLY . 30.2 t30 -66.58 111.91 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.3 111.288 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.663 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 12.1 t -70.58 -16.35 62.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.564 -0.743 . . . . 2.77 111.784 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -58.4 -20.82 47.4 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.224 0.453 . . . . 3.79 112.224 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.48 6.2 49.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.135 0.493 . . . . 3.34 111.265 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.82 -3.46 3.84 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.773 1.069 . . . . 2.37 115.773 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -172.75 148.45 1.88 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.696 1.248 . . . . 3.93 110.104 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.559 ' O ' HG21 ' A' ' 134' ' ' VAL . 38.4 p90 -60.67 -34.11 73.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.607 -1.179 . . . . 3.6 112.563 -173.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.41 97.88 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.013 -0.613 . . . . 2.35 112.748 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -76.7 -27.99 55.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.966 0.412 . . . . 3.75 110.473 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.683 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -62.44 -35.42 79.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 2.17 110.866 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 130' ' ' PHE . 47.4 t -65.32 -16.92 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.077 -0.51 . . . . 3.11 111.26 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.59 -13.57 57.85 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.071 -0.393 . . . . 3.55 111.144 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.401 HE21 ' HA2' ' A' ' 139' ' ' GLY . 5.7 tt0 -102.53 134.15 20.1 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.786 -0.45 . . . . 3.02 109.786 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 51.5 Cg_exo -55.37 -26.12 51.39 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.975 2.45 . . . . 1.93 112.618 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -111.98 27.24 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.07 0.462 . . . . 2.29 109.863 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -79.13 -33.6 35.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.015 -0.612 . . . . 1.5 113.729 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 85.3 mt -110.44 157.01 20.04 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.706 -0.479 . . . . 1.98 109.706 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.31 127.07 13.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.723 0.297 . . . . 1.83 110.24 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 27.9 m -116.51 139.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 120.767 0.318 . . . . 2.28 110.358 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.2 tp -99.07 109.26 22.01 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.347 -0.612 . . . . 2.89 109.347 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -91.72 111.84 4.08 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.75 -0.659 . . . . 0.95 112.298 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.7 mt -109.42 118.17 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.726 -0.472 . . . . 1.38 109.726 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -69.54 143.24 53.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.405 -0.361 . . . . 1.37 111.303 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.444 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . 10.8 mp -112.92 120.02 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.133 -0.485 . . . . 1.48 110.185 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.08 142.11 43.68 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.792 -0.818 . . . . 2.52 108.792 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.06 135.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 1.88 110.802 -174.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.01 -95.53 0.11 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.126 -0.789 . . . . 1.53 111.126 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.1 m -82.08 141.83 32.82 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.721 -0.474 . . . . 2.08 109.721 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.61 41.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.897 -0.592 . . . . 1.36 111.825 -174.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.9 tptt -117.28 102.17 52.53 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.474 . . . . 1.78 110.104 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.62 -42.41 67.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.442 2.762 . . . . 1.34 112.487 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 182' ' ' GLY . . . -59.33 -33.69 76.92 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.073 -0.584 . . . . 0.75 112.954 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.73 -30.95 22.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.152 0.501 . . . . 1.39 110.536 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -37.4 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.63 110.662 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -52.98 -49.44 66.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.204 -0.907 . . . . 3.26 112.414 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.92 -38.62 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 1.97 111.415 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.1 -39.6 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.21 0.529 . . . . 1.64 111.293 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.36 -15.76 39.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 1.22 112.284 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.34 -11.15 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.802 0.334 . . . . 2.07 111.399 -176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.87 -33.6 67.01 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.954 0.724 . . . . 1.95 112.954 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.57 -26.69 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.884 0.373 . . . . 2.31 111.524 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.7 m -80.89 -1.03 41.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.951 0.352 . . . . 1.78 111.951 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.6 pt -131.92 36.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 1.42 110.069 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.19 -33.58 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 1.98 112.669 -170.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -119.48 159.51 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.857 0.361 . . . . 1.4 111.396 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -52.6 131.73 34.72 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.594 -0.73 . . . . 2.84 112.043 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.44 -28.44 15.01 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.871 -0.68 . . . . 0.85 112.451 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.79 143.62 52.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.212 0.53 . . . . 2.22 111.188 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.7 m -134.21 150.41 51.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 1.93 109.147 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -136.87 129.79 30.77 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.176 -0.305 . . . . 1.17 110.176 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.22 137.02 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.059 0.457 . . . . 1.8 110.672 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -140.85 80.4 1.75 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.197 -0.668 . . . . 1.31 109.197 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.0 p -116.04 163.66 15.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.469 -0.332 . . . . 1.69 111.466 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 58.91 36.98 24.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.848 -0.615 . . . . 2.26 111.276 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -129.75 133.79 47.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 4.84 110.202 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 181' ' ' ARG . 4.2 p30 -109.39 145.83 32.68 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.496 -0.775 . . . . 2.51 111.067 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.0 -5.58 14.61 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.026 2.484 . . . . 1.47 112.342 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.484 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 5.6 tmm_? -57.6 -38.57 75.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.184 -0.462 . . . . 3.16 110.508 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -68.02 -7.03 48.62 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.818 -0.628 . . . . 1.12 113.361 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.94 -12.27 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.129 0.465 . . . . 2.37 111.015 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.53 129.99 55.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 3.87 110.645 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.89 -170.02 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.02 2.48 . . . . 2.51 113.404 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.93 -65.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.065 0.765 . . . . 3.23 113.065 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 12.9 m -68.95 131.61 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 2.03 111.328 -172.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.86 62.87 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 2.5 110.832 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -127.65 141.59 51.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.435 -0.95 . . . . 1.81 108.435 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.569 ' CE2' ' HG ' ' A' ' 47' ' ' LEU . 51.9 p90 -149.23 158.24 44.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.967 0.413 . . . . 5.32 111.846 -166.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.578 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 9.2 m-90 -115.51 107.36 15.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.534 -0.757 . . . . 4.55 109.077 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 5.9 t -96.31 117.2 30.32 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.828 0.677 . . . . 2.39 112.828 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -139.21 128.51 14.11 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 5.32 109.989 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 58.4 Cg_exo -53.38 136.72 63.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.191 2.594 . . . . 2.47 113.674 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.49 156.7 25.37 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.027 -0.533 . . . . 2.0 112.839 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 32.4 t -65.61 126.08 27.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.241 0.543 . . . . 3.36 109.812 173.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 206' ' ' VAL . 2.3 pt? -59.67 -47.05 87.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.968 -1.015 . . . . 5.18 113.646 -168.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 197' ' ' LEU . 3.5 t -121.1 -25.4 5.32 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.918 -0.313 . . . . 5.53 111.54 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 32.5 m 105.67 -57.59 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.087 1.355 . . . . 5.89 113.647 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.461 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 82.1 Cg_exo -42.61 -51.41 5.19 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.603 2.202 . . . . 6.31 115.701 -177.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 71.6 Cg_endo -76.34 -15.98 17.58 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.709 1.606 . . . . 5.26 112.124 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.412 HD23 HD11 ' A' ' 22' ' ' ILE . 88.0 mt 55.61 70.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.746 -0.661 . . . . 4.29 110.988 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 196' ' ' SER . 43.7 tp -131.15 132.15 44.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.513 -0.767 . . . . 3.51 109.804 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.632 ' OE2' ' HA ' ' A' ' 26' ' ' GLU . 8.2 pt-20 -106.33 62.67 0.65 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.381 0.61 . . . . 3.37 110.868 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 73.9 m -108.64 15.1 24.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 2.47 110.868 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 95.2 t -117.9 137.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 1.74 111.082 -177.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.8 m -98.19 104.67 16.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.475 -0.935 . . . . 2.3 108.475 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.422 ' O ' ' HA ' ' A' ' 192' ' ' THR . 0.0 OUTLIER -86.7 100.61 12.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 6.37 110.924 -174.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.562 HG22 ' CD1' ' A' ' 190' ' ' TYR . 75.1 mt -96.42 100.02 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 2.32 109.479 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.3 m -99.6 125.64 53.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.183 0.515 . . . . 2.1 110.603 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.2 tp -87.44 137.3 32.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.634 -0.712 . . . . 2.35 109.595 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 20.5 pttp -72.44 -11.2 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.035 0.383 . . . . 3.47 112.035 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.2 tp10 -101.11 105.98 42.14 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.655 0.264 . . . . 1.56 110.944 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 5.9 Cg_exo -75.47 149.69 35.17 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.886 2.391 . . . . 1.37 111.771 175.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.9 pt -99.82 147.25 7.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.001 -0.37 . . . . 1.85 110.001 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 42.7 m -92.35 123.79 35.94 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.567 -0.531 . . . . 1.78 109.567 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.14 163.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.886 -0.597 . . . . 1.64 110.265 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 41.3 t -90.25 147.38 23.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.125 0.488 . . . . 1.52 110.226 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.698 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 7.5 p -56.49 -35.36 67.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 1.81 110.653 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -70.06 -21.84 63.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.678 -0.692 . . . . 2.51 111.188 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -80.17 -51.74 8.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.393 . . . . 1.02 110.132 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.603 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 13.0 m -64.84 -29.21 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.455 0.539 . . . . 1.88 112.455 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.9 mt -66.05 -27.36 68.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 1.59 111.01 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.457 ' HA ' ' CG ' ' A' ' 227' ' ' LYS . 68.6 mttm -74.6 -21.0 59.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.267 -0.424 . . . . 2.3 110.959 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 26.2 m-85 -66.89 -19.06 65.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.106 0.479 . . . . 3.18 110.178 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -103.68 9.43 37.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 3.55 110.257 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.457 ' CG ' ' HA ' ' A' ' 224' ' ' LYS . 12.5 mmmm -91.0 1.46 57.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 2.74 111.028 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.24 133.77 35.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.206 -0.664 . . . . 1.66 109.206 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -159.19 -178.72 7.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.931 0.345 . . . . 1.13 111.931 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 35.0 t80 52.94 81.14 0.09 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.094 -0.957 . . . . 4.38 112.48 174.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.599 ' CG ' ' H ' ' A' ' 232' ' ' GLY . 0.0 OUTLIER -54.41 -87.65 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.051 -0.522 . . . . 1.62 111.61 171.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 231' ' ' ASN . . . -125.08 -158.7 10.1 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.839 -0.696 . . . . 1.16 112.26 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.09 145.32 24.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.148 -0.315 . . . . 3.56 110.148 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.95 14.61 82.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.77 . . . . 2.23 112.288 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -148.72 107.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.59 108.64 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.11 114.32 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 120.722 0.948 . . . . 1.5 111.116 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -139.37 104.08 4.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.51 -0.768 . . . . 3.4 111.442 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.27 94.96 1.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.714 0.768 . . . . 2.47 109.951 157.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.25 99.63 4.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.237 -0.892 . . . . 2.6 109.501 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -118.4 82.87 1.92 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.965 -1.124 . . . . 1.94 107.965 172.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.8 m -156.57 133.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.906 -1.043 . . . . 1.67 110.141 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.655 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER 63.52 -79.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.239 0.962 . . . . 2.18 112.481 173.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 48.4 47.57 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.318 0.386 . . . . 2.64 110.681 -171.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 106' ' ' GLU . 85.9 t90 -105.12 134.02 48.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.916 0.389 . . . . 5.31 110.792 -172.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -105.32 132.23 21.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.986 -0.552 . . . . 6.91 110.416 176.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.436 ' HA ' ' CH2' ' A' ' 244' ' ' TRP . 62.5 Cg_exo -53.97 128.0 27.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.163 2.576 . . . . 3.72 112.676 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.39 159.76 33.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.684 -0.689 . . . . 3.34 111.983 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -108.73 149.85 40.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 4.92 110.673 -173.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 36.7 Cg_endo -63.7 147.3 92.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.641 2.894 . . . . 4.01 114.075 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 67.5 mt -68.23 -12.42 60.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.86 -1.063 . . . . 4.9 113.364 -171.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 61.6 pttt -61.08 42.84 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.382 1.623 . . . . 5.68 115.382 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.667 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 1.5 p30 125.42 -4.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.378 1.871 . . . . 5.11 109.926 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 30.7 mmt180 -116.69 82.67 1.83 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.438 -1.319 . . . . 6.74 107.438 168.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -134.69 158.1 44.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.102 -0.333 . . . . 3.08 110.102 -166.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.446 HD11 ' HA ' ' A' ' 33' ' ' ILE . 5.1 pt -102.62 125.9 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.808 0.67 . . . . 3.06 112.808 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 81.7 mttt -101.64 144.2 30.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.396 -0.82 . . . . 3.01 109.028 165.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 190' ' ' TYR . . . -106.65 148.17 28.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.248 -0.649 . . . . 1.99 109.248 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 190' ' ' TYR . 5.4 m -131.64 95.1 3.65 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.887 -0.725 . . . . 2.47 111.864 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -156.95 133.48 9.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.967 -1.015 . . . . 5.03 108.674 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.569 -0.729 . . . . 4.82 110.363 -173.196 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttp . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.962 0.41 . . . . 17.73 110.464 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 p -162.63 -81.71 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 15.49 110.103 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -141.79 -55.9 0.46 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.22 -0.659 . . . . 16.29 109.22 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -142.22 161.83 37.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.35 -0.841 . . . . 14.68 110.008 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -90.55 135.23 33.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.348 -0.387 . . . . 15.53 110.342 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.09 176.89 38.47 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.735 -0.946 . . . . 10.81 110.735 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 9.1 p90 -80.05 110.63 15.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.332 0.566 . . . . 11.61 109.977 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.8 148.08 7.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.8 -0.714 . . . . 9.0 112.017 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 16' ' ' TRP . 13.2 mptt -53.14 123.18 11.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.017 0.437 . . . . 10.04 111.782 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.647 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 6.1 t-160 61.37 -88.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.009 0.923 . . . . 11.67 112.349 175.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -95.12 -14.76 23.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.785 0.326 . . . . 11.18 110.777 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 7' ' ' TYR . . . 135.45 -59.72 0.65 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.644 -0.789 . . . . 8.9 112.037 -174.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.98 126.12 18.79 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.213 1.942 . . . . 8.2 111.846 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' A' ' 9' ' ' LYS . 6.0 mm-40 -64.17 0.05 1.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.698 -0.683 . . . . 10.62 112.64 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -63.99 -4.3 3.3 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.163 0.506 . . . . 10.41 111.445 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.647 ' CD1' ' HB2' ' A' ' 10' ' ' HIS . 73.9 t-105 -87.13 -2.69 58.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.413 0.625 . . . . 9.19 109.866 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -56.53 -6.28 0.28 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.111 -0.95 . . . . 7.71 112.888 -170.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -58.91 -37.0 75.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.041 0.448 . . . . 10.03 110.768 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.444 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 31.5 t70 -68.0 -19.83 64.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.651 -0.704 . . . . 7.89 110.885 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -109.69 93.22 13.8 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.034 -0.53 . . . . 7.65 109.673 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 19' ' ' ASP . 50.1 Cg_exo -53.81 -45.35 41.64 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.889 2.393 . . . . 8.15 112.731 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.5 tt -59.16 -18.14 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.773 0.657 . . . . 6.15 112.773 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.06 -17.5 63.24 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.818 0.342 . . . . 5.72 110.973 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -72.02 3.74 4.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 8.17 111.182 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.82 168.12 46.99 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 111.375 -0.69 . . . . 5.05 111.375 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -115.32 115.77 27.18 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.173 -0.611 . . . . 7.09 109.97 -176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 1.8 mpt_? -136.61 169.31 17.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.385 0.539 . . . . 5.44 110.914 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -45.4 112.31 0.44 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 124.093 0.87 . . . . 7.33 110.398 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 31' ' ' VAL . 40.9 m -98.88 145.61 30.26 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 115.545 -0.752 . . . . 4.35 110.48 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' A' ' 107' ' ' HIS . 59.1 Cg_endo -71.92 25.6 0.25 Allowed 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 123.488 2.792 . . . . 4.96 113.112 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 29' ' ' SER . 23.0 m -96.36 -175.47 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.4 -0.364 . . . . 5.07 111.201 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' HD21 ' A' ' 250' ' ' LEU . 1.4 m-20 -51.44 104.73 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 122.048 0.928 . . . . 3.14 111.956 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.0 127.56 38.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.219 -1.355 . . . . 2.71 110.015 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.29 99.27 10.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.169 -0.468 . . . . 2.82 109.985 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -54.25 -29.32 46.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 2.71 111.568 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -75.33 -28.64 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 5.23 110.675 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 m -81.69 -28.77 33.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.874 0.369 . . . . 3.38 110.487 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -67.05 108.71 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.532 . . . . 1.76 111.593 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -85.31 138.18 32.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.6 -0.727 . . . . 4.05 110.484 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 30.1 p90 -78.57 130.71 36.26 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.393 -0.595 . . . . 4.9 109.393 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -109.11 109.79 60.71 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.337 -0.392 . . . . 2.27 110.11 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.41 -17.36 57.26 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.031 2.488 . . . . 2.45 112.49 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 83' ' ' PRO . 49.1 m -75.58 -9.04 58.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 4.62 110.858 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -96.55 139.26 32.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.286 -0.415 . . . . 5.15 110.283 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.9 161.14 37.73 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.468 -0.567 . . . . 4.21 109.468 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.55 157.15 23.78 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.748 2.299 . . . . 2.76 112.816 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 190' ' ' TYR . 91.9 mt -85.64 138.78 31.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 2.93 111.146 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -101.33 120.57 40.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.652 -0.87 . . . . 2.46 108.652 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.46 103.06 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.76 0.315 . . . . 2.17 110.659 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 91.25 3.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.264 -0.643 . . . . 1.87 109.264 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 p90 -137.95 20.01 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.923 0.392 . . . . 3.97 111.45 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.39 -18.8 64.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.304 -0.407 . . . . 2.48 111.21 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -103.18 10.74 37.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.534 -0.303 . . . . 2.54 110.737 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.66 125.74 24.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.863 0.363 . . . . 1.41 111.627 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.3 m -115.42 109.23 17.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.963 -0.562 . . . . 1.41 111.243 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -78.12 149.66 33.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.552 -0.536 . . . . 1.84 109.552 174.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -121.59 -54.97 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.974 0.416 . . . . 1.45 111.466 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.408 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 14.7 ptm180 -140.6 152.23 45.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.362 -0.381 . . . . 3.72 110.698 -175.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.0 tt -127.61 133.92 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.585 -0.895 . . . . 1.35 108.585 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.68 162.88 36.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 1.53 111.777 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.449 ' CB ' ' HA ' ' A' ' 169' ' ' LYS . 5.9 m-20 -101.3 109.87 21.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.926 -1.034 . . . . 1.49 109.237 176.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.55 ' HB3' ' OD1' ' A' ' 67' ' ' ASN . 42.5 t30 -126.57 129.37 48.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.112 -0.495 . . . . 2.18 111.06 -174.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 26.4 -74.59 0.0 OUTLIER Glycine 0 N--CA 1.47 0.96 0 N-CA-C 117.45 1.74 . . . . 2.0 117.45 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' ASN . 25.7 m80 -83.14 -19.79 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.983 0.364 . . . . 4.11 111.983 -167.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 175.38 -141.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.966 -0.383 . . . . 1.78 109.966 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -118.12 143.79 46.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.072 -1.085 . . . . 3.48 108.072 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 13.5 m120 -128.24 128.62 45.03 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.086 -0.339 . . . . 1.99 110.086 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.97 121.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.209 0.528 . . . . 1.75 109.851 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 58' ' ' ARG . 55.7 mm-40 -90.07 138.98 31.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 2.02 111.433 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.92 157.26 22.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.493 -0.776 . . . . 2.19 109.235 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.77 108.37 13.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.216 -0.661 . . . . 1.33 109.216 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -108.51 58.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.663 0.744 . . . . 2.65 110.607 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -100.85 -13.58 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.573 -0.74 . . . . 2.01 111.416 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.446 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -152.09 177.59 10.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.103 -0.499 . . . . 2.35 109.942 -170.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -82.01 65.96 7.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 1.92 110.987 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 58.6 mttm -90.59 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.946 -0.57 . . . . 2.31 109.838 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -114.39 99.03 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 1.44 110.267 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.88 145.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.94 -0.573 . . . . 1.82 110.51 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 tp -137.58 112.08 8.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 1.8 109.725 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 22.1 pttm -153.8 126.13 8.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 3.02 111.743 175.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.87 177.93 46.64 Favored Glycine 0 C--O 1.221 -0.707 0 CA-C-N 115.462 -0.79 . . . . 1.44 112.753 173.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.91 -132.76 0.0 OUTLIER Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.73 1.157 . . . . 2.15 115.764 167.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HG2' ' O ' ' A' ' 43' ' ' SER . 78.9 Cg_exo -44.12 170.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.179 3.253 . . . . 3.17 114.43 -171.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.3 tp -32.37 75.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.553 1.316 . . . . 4.55 114.553 -145.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 15.1 p-10 -76.73 -71.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.314 -1.766 . . . . 4.95 112.635 173.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 82.06 127.45 0.99 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.384 -1.086 . . . . 2.25 110.384 -165.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.9 m -63.48 103.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.103 0.452 . . . . 2.12 111.734 -174.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 63.6 m-85 -95.04 126.99 40.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.867 -0.606 . . . . 3.88 111.026 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -103.85 143.97 32.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.312 -0.403 . . . . 3.87 110.243 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 34.4 tp -81.52 132.01 35.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 1.68 110.86 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.7 tt -109.21 -35.0 2.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.183 -0.462 . . . . 2.16 110.784 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 172.25 8.42 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.341 -0.39 . . . . 1.95 110.316 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' CD2' HD11 ' A' ' 118' ' ' LEU . 9.4 p90 -151.4 153.36 34.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.98 110.347 169.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 13.5 p-80 -148.16 157.64 43.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.559 -0.746 . . . . 1.07 109.62 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -139.7 123.06 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.773 -0.771 . . . . 3.99 111.374 168.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -94.73 146.24 24.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.099 -0.955 . . . . 2.2 110.353 171.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -132.7 170.81 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.603 -0.518 . . . . 6.08 109.603 -176.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -95.89 173.83 31.0 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.488 -0.863 . . . . 2.19 112.777 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.5 t -68.26 -28.0 66.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.283 0.563 . . . . 3.08 109.957 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.63 141.14 47.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.589 -0.732 . . . . 3.48 109.091 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.426 ' HB2' HG23 ' A' ' 149' ' ' VAL . 4.8 p-10 -68.26 -5.88 20.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.168 0.432 . . . . 3.85 112.168 -174.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.79 10.06 57.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.807 -0.711 . . . . 2.37 113.047 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.41 170.28 16.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.892 0.346 . . . . 2.62 110.916 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 113.41 -14.59 22.86 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.502 -0.856 . . . . 1.62 112.518 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.3 t -75.59 -34.59 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.411 0.148 . . . . 2.24 111.203 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' HG2' ' NE1' ' A' ' 244' ' ' TRP . 0.0 OUTLIER 66.35 -172.19 0.19 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.6 0.563 . . . . 3.72 110.036 -171.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.546 ' CD2' ' HA ' ' A' ' 30' ' ' PRO . 17.3 m80 52.44 44.69 29.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.66 0.743 . . . . 4.03 109.62 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.471 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -79.29 117.47 20.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.034 . . . . 2.99 111.397 -172.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.04 95.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.692 -1.14 . . . . 2.88 110.504 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 58.66 60.04 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.844 -1.071 . . . . 2.8 110.824 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm 69.71 11.51 7.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.73 -0.668 . . . . 5.35 112.527 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -96.23 97.19 9.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.826 0.346 . . . . 3.58 110.644 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.471 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 98.6 mttt -96.11 148.38 22.74 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.261 -0.644 . . . . 3.26 109.261 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -106.6 -176.6 3.12 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.6 -0.519 . . . . 1.71 109.6 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.4 -43.55 66.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.803 0.335 . . . . 1.57 111.19 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.52 164.04 37.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 1.3 110.269 -174.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.5 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 29.6 tt0 -130.38 124.16 31.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 1.85 109.792 176.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 94' ' ' HIS . 56.7 tp -91.04 114.97 27.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.797 . . . . 1.61 110.214 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.477 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 22.5 m170 -102.91 106.55 17.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.159 -0.473 . . . . 2.25 110.615 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.74 108.09 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.256 -0.646 . . . . 1.51 109.256 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -81.91 126.34 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.339 -0.392 . . . . 1.24 110.822 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 58.5 m80 -125.56 145.17 50.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.834 -0.432 . . . . 2.86 109.834 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -124.6 143.91 50.45 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.83 -0.804 . . . . 4.96 108.83 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 87' ' ' THR . 35.8 p30 -83.52 139.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.859 0.837 . . . . 2.3 111.687 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -66.08 -16.01 63.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.095 -0.957 . . . . 2.77 110.567 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -50.63 -44.35 57.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 3.79 112.097 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -93.6 6.95 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.513 -0.475 . . . . 3.34 111.092 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.47 1.52 1.77 Allowed Glycine 0 C--N 1.335 0.472 0 N-CA-C 115.523 0.969 . . . . 2.37 115.523 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 132' ' ' LYS . 16.6 t70 -169.14 137.04 1.9 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.739 0.769 . . . . 3.93 109.658 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.597 ' O ' HG22 ' A' ' 134' ' ' VAL . 26.5 p90 -60.22 -43.27 96.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.714 -0.676 . . . . 3.6 110.984 -177.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -35.52 90.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.274 -0.489 . . . . 2.35 112.599 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -68.36 -37.59 80.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.773 -0.455 . . . . 3.75 109.773 177.152 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.88 -29.27 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 2.17 110.705 178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -65.57 -20.03 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 3.11 111.315 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -88.53 -1.74 58.22 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.762 -0.586 . . . . 3.55 111.614 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -126.21 143.17 44.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.868 0.366 . . . . 3.02 110.483 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 26.6 Cg_endo -62.0 -24.63 76.97 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.431 2.754 . . . . 1.93 113.493 -175.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -110.41 27.03 10.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.904 -0.406 . . . . 2.29 109.904 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -81.25 -48.53 5.95 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.946 -0.645 . . . . 1.5 113.788 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 134' ' ' VAL . 85.8 mt -107.79 161.13 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.085 0.469 . . . . 1.98 111.316 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.3 104.9 4.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.624 -0.716 . . . . 1.83 110.33 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.4 t -97.66 115.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.236 -0.438 . . . . 2.28 109.858 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 63.5 tp -88.11 111.54 21.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.867 -0.606 . . . . 2.89 109.684 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.79 108.85 3.61 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.189 -0.529 . . . . 0.95 111.935 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 mt -102.07 130.77 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.158 -0.312 . . . . 1.38 110.158 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 69.9 m-85 -75.55 145.75 41.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.663 -0.244 . . . . 1.37 110.527 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.35 117.68 30.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.695 -0.483 . . . . 1.48 109.695 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 216' ' ' SER . 20.5 ptmt -114.72 152.42 32.05 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.283 -0.636 . . . . 2.52 109.283 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 29.3 t -92.26 131.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 1.88 110.861 -176.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.86 -105.55 0.21 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.627 -0.989 . . . . 1.53 110.627 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.5 m -70.03 160.61 31.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.506 -0.553 . . . . 2.08 109.506 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.61 159.22 15.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.573 -0.285 . . . . 1.36 111.193 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 216' ' ' SER . 12.4 mmmm -111.03 99.89 44.68 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.573 -0.899 . . . . 1.78 108.573 172.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.75 -21.05 61.7 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.984 2.456 . . . . 1.34 113.355 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.19 -13.34 81.01 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.654 -0.784 . . . . 0.75 112.919 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.9 tp -87.13 -17.96 31.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 1.39 111.004 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -60.41 -39.5 87.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.63 112.265 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 162' ' ' VAL . 30.7 mmmt -58.29 -40.92 83.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.618 0.247 . . . . 3.26 111.02 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.87 -46.9 84.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.262 0.553 . . . . 1.97 110.166 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 46.9 t -67.19 -27.68 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 1.64 111.295 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.02 -34.57 66.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 1.22 111.562 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 158' ' ' LYS . 87.7 t -82.54 -23.39 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.417 -0.356 . . . . 2.07 111.781 -174.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.7 pp -69.56 -12.84 61.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.018 0.437 . . . . 1.95 111.428 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.31 -26.5 68.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.088 0.47 . . . . 2.31 110.444 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.1 t -81.31 0.74 35.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 1.78 111.432 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.14 43.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.268 -0.641 . . . . 1.42 109.268 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.4 -38.37 66.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.084 -0.962 . . . . 1.98 112.622 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.8 p -105.52 149.9 25.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.631 0.253 . . . . 1.4 110.945 -177.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 61.7 pttt -66.54 141.14 57.96 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.973 -0.38 . . . . 2.84 109.973 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.34 -22.44 30.91 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.43 -0.89 . . . . 0.85 111.681 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -82.57 156.17 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 2.22 110.488 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -145.96 153.57 40.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.208 -0.451 . . . . 1.93 109.986 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.12 154.35 45.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.827 -0.435 . . . . 1.17 109.827 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.29 135.42 39.62 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.845 -0.428 . . . . 1.8 109.845 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.56 80.39 1.77 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.728 -0.841 . . . . 1.31 108.728 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.5 p -113.41 165.12 12.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.703 -0.68 . . . . 1.69 112.065 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.2 t30 54.9 57.84 5.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.5 -0.773 . . . . 2.26 111.113 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -135.1 131.75 37.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.835 -0.62 . . . . 4.84 109.824 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 13.0 m-20 -106.19 118.48 54.77 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.851 -0.425 . . . . 2.51 109.851 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 2.7 Cg_exo -76.21 -4.57 15.26 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.943 2.429 . . . . 1.47 112.898 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -59.05 -42.85 91.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.32 . . . . 3.16 111.548 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.05 -3.04 9.64 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.208 -0.52 . . . . 1.12 113.601 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.57 -1.29 35.87 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.66 -0.318 . . . . 2.37 111.117 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 184' ' ' LEU . 4.0 pp -54.69 150.13 19.32 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 112.742 0.645 . . . . 3.87 112.742 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -91.05 -176.17 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.453 2.769 . . . . 2.51 111.467 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -85.69 -64.68 1.11 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.523 -0.471 . . . . 3.23 111.56 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.5 m -87.22 135.15 33.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.817 0.341 . . . . 2.03 111.495 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.21 62.89 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.404 0.621 . . . . 2.5 110.295 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 211' ' ' LEU . 6.4 m-20 -116.37 170.05 8.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.944 -1.132 . . . . 1.81 107.944 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 46.6 p90 -168.04 161.73 12.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.793 1.035 . . . . 5.32 113.793 -166.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.442 ' HD1' ' O ' ' A' ' 210' ' ' VAL . 2.9 m95 -101.09 138.73 37.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.724 -1.584 . . . . 4.55 106.724 167.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.1 t -137.7 105.22 5.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.61 0.719 . . . . 2.39 112.031 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 194' ' ' PRO . 25.9 t80 -139.3 149.6 61.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.264 -0.643 . . . . 5.32 109.264 173.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 193' ' ' TYR . 93.6 Cg_exo -46.88 129.91 15.18 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.456 2.104 . . . . 2.47 111.652 172.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -138.57 161.29 25.74 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.444 -0.798 . . . . 2.0 113.177 -166.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -99.59 131.66 45.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.831 -0.803 . . . . 3.36 108.831 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 197' ' ' LEU . 2.1 pt? -56.11 -48.21 76.61 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.673 1.36 . . . . 5.18 114.673 -163.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.403 ' N ' ' HG ' ' A' ' 197' ' ' LEU . 20.6 m -121.02 -44.08 2.42 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.065 -0.654 . . . . 5.53 112.344 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 50.0 p -104.9 162.19 20.51 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.4 -0.818 . . . . 5.89 111.471 -173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.456 ' HB3' ' HD2' ' A' ' 201' ' ' PRO . 74.6 Cg_exo -52.03 169.79 0.26 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.921 2.414 . . . . 6.31 111.767 169.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 200' ' ' PRO . 24.6 Cg_exo -16.98 111.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 1 C-N-CA 125.339 4.026 . . . . 5.26 115.849 -171.044 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -151.59 -83.82 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.86 -1.063 . . . . 4.29 109.711 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 37.4 tp -118.45 131.97 56.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.293 . . . . 3.51 110.459 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 10.5 pt-20 -92.99 40.07 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.923 -0.581 . . . . 3.37 111.584 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 25.6 p -86.96 -4.49 59.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.293 0.568 . . . . 2.47 110.557 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 27.4 t -112.18 150.03 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.637 -0.71 . . . . 1.74 111.14 -173.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.9 m -107.21 103.5 12.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.332 -1.358 . . . . 2.3 107.332 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.416 ' HB2' ' HA3' ' A' ' 195' ' ' GLY . 1.1 t90 -75.52 102.29 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.033 0.444 . . . . 6.37 110.107 -172.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 42.3 mm -95.68 100.42 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.537 -0.756 . . . . 2.32 109.364 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' A' ' 191' ' ' TRP . 32.4 t -94.03 119.03 41.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.42 -0.585 . . . . 2.1 109.42 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 189' ' ' ASP . 17.1 tp -73.95 122.45 22.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.949 0.404 . . . . 2.35 110.389 -174.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -61.59 -21.91 64.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 3.47 111.995 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -95.14 111.87 56.41 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.642 -0.254 . . . . 1.56 110.537 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 98.4 Cg_endo -82.73 134.14 7.25 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.511 2.14 . . . . 1.37 111.752 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.7 pt -88.79 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 1.85 109.487 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.593 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 24.6 t -103.83 125.66 50.42 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.978 0.418 . . . . 1.78 110.763 -175.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.1 m -116.75 155.07 18.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 1.64 109.486 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.4 t -102.93 161.78 13.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.918 -0.313 . . . . 1.52 110.782 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.63 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 t -49.62 -54.06 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.668 0.605 . . . . 1.81 111.849 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 36.6 tt0 -52.56 -39.23 61.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.751 0.31 . . . . 2.51 111.781 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.4 -50.58 69.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.468 -0.333 . . . . 1.02 110.556 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.27 -19.95 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.429 -0.351 . . . . 1.88 111.587 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.2 mt -73.65 -44.26 57.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 1.59 110.558 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 52.5 mtpt -65.35 -25.86 67.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 2.3 110.562 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -75.29 -28.1 59.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.455 0.645 . . . . 3.18 109.744 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 56.1 ttp180 -71.8 -0.94 12.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.325 -0.852 . . . . 3.55 110.928 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -84.22 -14.14 50.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.982 0.42 . . . . 2.74 110.115 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.412 HD22 HD22 ' A' ' 61' ' ' ASN . 68.2 mt -69.65 144.83 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.49 0.662 . . . . 1.66 111.257 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.3 m120 -108.56 139.58 43.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.325 -0.852 . . . . 1.13 109.645 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.512 ' O ' ' HD3' ' A' ' 169' ' ' LYS . 65.8 t80 -79.14 -30.81 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.744 . . . . 4.38 109.956 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -68.85 163.46 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 1.62 111.5 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.11 48.29 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.474 -1.05 . . . . 1.16 110.474 174.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.1 135.06 47.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.501 0.65 . . . . 3.56 110.553 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.29 41.71 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.749 . . . . 2.23 112.797 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.66 162.34 43.33 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.968 0.384 . . . . 2.59 110.017 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.15 127.55 26.78 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.221 1.947 . . . . 1.5 111.361 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.67 120.38 12.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.408 0.623 . . . . 3.4 111.776 -174.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 13.2 pt-20 -128.47 153.46 47.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.305 -0.861 . . . . 2.47 108.828 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.23 135.95 33.29 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.649 0.261 . . . . 2.6 110.761 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.9 ttm -80.1 88.43 5.41 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.832 -0.803 . . . . 1.94 108.832 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.5 m -142.55 144.17 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.834 -0.802 . . . . 1.67 108.834 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.44 -78.19 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.734 0.646 . . . . 2.18 110.397 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.1 t30 42.5 40.56 1.96 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.901 0.75 . . . . 2.64 112.176 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.452 ' NE1' ' HG2' ' A' ' 106' ' ' GLU . 38.6 t-105 -141.59 160.67 39.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.067 0.461 . . . . 5.31 111.341 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 245' ' ' ARG . 25.0 mmt180 -128.38 83.4 66.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.143 -1.058 . . . . 6.91 108.143 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 38.6 Cg_exo -55.52 -87.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 124.053 3.169 . . . . 3.72 116.487 -160.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.419 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -81.08 102.3 10.15 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.293 1.22 . . . . 3.34 114.293 -162.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 12.0 mm100 -80.31 -178.0 1.05 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.243 -1.021 . . . . 4.92 108.243 160.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 34.1 Cg_exo -40.76 112.14 0.17 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 121.867 1.711 . . . . 4.01 112.355 175.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -60.05 -51.45 69.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 4.9 112.452 -164.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -60.83 -9.97 4.88 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.901 1.445 . . . . 5.68 114.901 -174.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 253' ' ' ARG . 8.5 p30 38.09 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 118.749 2.87 . . . . 5.11 118.749 167.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.596 ' NE ' ' HA ' ' A' ' 253' ' ' ARG . 0.4 OUTLIER 171.4 -156.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.324 1.049 . . . . 6.74 109.201 -165.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -131.72 130.15 41.6 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.726 -1.583 . . . . 3.08 106.726 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 43.8 mt -111.92 145.46 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.809 0.338 . . . . 3.06 111.416 -166.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -123.34 162.08 23.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 3.01 109.935 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -159.16 170.74 21.29 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.385 -0.598 . . . . 1.99 109.385 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 8.6 t -148.23 113.41 5.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.744 -0.382 . . . . 2.47 110.441 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -117.85 95.33 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 5.03 109.54 173.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.529 -0.748 . . . . 4.82 110.146 -178.366 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.002 0.43 . . . . 17.73 110.429 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 p -152.81 162.08 41.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.267 -0.424 . . . . 15.49 110.596 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -121.41 175.49 6.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.978 -0.555 . . . . 16.29 110.292 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -144.64 95.48 2.71 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.294 -0.632 . . . . 14.68 109.294 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -107.79 174.06 6.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.036 0.446 . . . . 15.53 111.317 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.42 -171.6 35.23 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.562 -1.015 . . . . 10.81 110.562 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -83.98 98.11 9.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 117.28 0.54 . . . . 11.61 110.779 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.81 -148.42 31.6 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.373 -0.831 . . . . 9.0 113.33 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.66 167.76 19.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 10.04 110.059 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 69.09 -66.6 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.717 0.636 . . . . 11.67 111.378 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.49 -15.05 56.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.945 0.402 . . . . 11.18 110.695 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -135.27 -168.08 11.52 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.813 -0.708 . . . . 8.9 111.811 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' O ' ' HE3' ' A' ' 16' ' ' TRP . 96.6 Cg_endo -80.27 135.74 10.97 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.511 2.141 . . . . 8.2 111.829 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.73 3.48 25.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.016 -0.538 . . . . 10.62 110.588 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -111.2 22.51 15.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.803 -0.635 . . . . 10.41 110.36 -172.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.521 ' HE3' ' O ' ' A' ' 13' ' ' PRO . 15.1 p90 -64.1 -18.58 64.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.608 -0.269 . . . . 9.19 111.557 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -68.01 -19.94 64.96 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.839 -0.43 . . . . 7.71 109.839 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -85.13 -36.13 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 10.03 110.69 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.63 -29.75 25.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 7.89 111.054 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -107.44 102.46 44.31 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.223 -0.444 . . . . 7.65 110.562 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.16 -40.39 77.02 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.826 2.351 . . . . 8.15 112.273 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mt -54.76 -27.19 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.232 -0.44 . . . . 6.15 112.058 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.88 -33.56 71.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 5.72 110.476 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -80.05 -5.53 55.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 8.17 111.08 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.85 -101.05 2.35 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.399 -0.68 . . . . 5.05 111.399 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.02 140.03 9.61 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.253 0.549 . . . . 7.09 110.827 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 8.3 mpt_? -87.61 131.45 34.42 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.113 -0.494 . . . . 5.44 110.439 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 199' ' ' THR . 4.1 pt20 -83.63 37.21 0.57 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.946 0.879 . . . . 7.33 110.54 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 27' ' ' ARG . 3.2 p -100.45 115.88 64.94 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 114.678 -1.146 . . . . 4.35 109.466 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.48 -44.95 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.293 1.328 . . . . 4.96 112.379 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 107' ' ' HIS . 7.2 p -165.42 143.02 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 112.336 0.495 . . . . 5.07 112.336 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 23.9 t0 -147.05 107.85 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.317 -0.994 . . . . 3.14 108.317 164.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mt -102.82 105.87 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.461 -0.495 . . . . 2.71 111.105 -173.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.56 107.37 18.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.093 -1.077 . . . . 2.82 108.093 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -54.8 -31.44 59.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 2.71 112.411 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -77.82 -44.69 26.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.737 0.304 . . . . 5.23 110.944 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 m -73.83 -28.06 61.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.545 -0.298 . . . . 3.38 111.372 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.6 129.85 42.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.011 0.434 . . . . 1.76 111.608 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -91.16 124.47 35.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.876 -0.602 . . . . 4.05 110.942 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -75.34 127.68 33.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.975 -0.557 . . . . 4.9 109.569 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.87 134.04 20.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.608 -0.515 . . . . 2.27 109.608 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.43 56.83 2.8 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.857 2.371 . . . . 2.45 112.656 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 45' ' ' LYS . 39.4 t -74.72 -56.85 4.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.053 -0.521 . . . . 4.62 110.204 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 mt 64.09 -25.31 0.08 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.389 0.885 . . . . 5.15 113.389 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 43' ' ' SER . 62.8 mttp -70.48 142.75 89.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.949 0.404 . . . . 4.21 111.691 -175.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.56 158.82 7.89 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.078 2.519 . . . . 2.76 112.486 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.429 HD21 ' HA3' ' A' ' 81' ' ' GLY . 79.0 mt -86.81 132.81 33.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 2.93 109.717 174.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 t -90.88 109.98 21.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.714 -0.847 . . . . 2.46 108.714 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.4 t -119.63 97.41 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.893 -0.41 . . . . 2.17 109.893 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 23.5 m -89.37 89.15 7.76 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.223 -0.658 . . . . 1.87 109.223 177.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -100.1 -6.39 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 3.97 111.383 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.508 ' HA ' ' NH2' ' A' ' 181' ' ' ARG . 32.3 t70 -61.32 -24.85 66.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.682 0.277 . . . . 2.48 111.529 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 1.5 mp0 -101.04 5.0 42.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.55 -0.296 . . . . 2.54 110.997 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.1 27.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 1.41 111.462 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 m -120.04 119.51 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.983 -0.553 . . . . 1.41 110.609 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 p -88.13 153.26 21.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.125 -0.488 . . . . 1.84 110.19 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.09 -56.67 1.82 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 1.45 111.725 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -152.34 159.42 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.053 0.454 . . . . 3.72 111.819 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.494 HD13 ' HB2' ' A' ' 66' ' ' PHE . 13.9 tt -115.18 134.81 57.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.34 -0.845 . . . . 1.35 109.54 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -133.68 142.79 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.802 0.334 . . . . 1.53 111.637 -171.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -101.48 88.95 3.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.767 -0.827 . . . . 1.49 108.767 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -142.32 90.32 2.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.384 0.512 . . . . 2.18 112.384 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . 139.45 -54.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.271 -0.966 . . . . 2.0 110.778 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 28.8 p80 174.07 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.652 -0.774 . . . . 4.11 111.153 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.515 ' CB ' ' H ' ' A' ' 95' ' ' PHE . . . -165.77 -170.15 1.71 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.205 0.526 . . . . 1.78 111.461 -173.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.494 ' HB2' HD13 ' A' ' 59' ' ' ILE . 2.4 p90 -106.63 87.23 2.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.787 -1.097 . . . . 3.48 109.417 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 3.0 m-20 -71.44 100.26 2.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.663 -1.153 . . . . 1.99 110.324 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 72.8 t -85.41 113.39 23.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.035 0.445 . . . . 1.75 110.197 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.93 122.69 27.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.327 -0.851 . . . . 2.02 110.379 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -101.7 157.67 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.656 -0.498 . . . . 2.19 109.656 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.1 115.58 20.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.831 0.348 . . . . 1.33 110.661 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -127.01 56.03 1.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.786 0.803 . . . . 2.65 109.96 175.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -91.59 -11.77 36.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.806 0.812 . . . . 2.01 109.164 170.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 162.8 39.5 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.643 -1.162 . . . . 2.35 108.886 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -75.61 77.26 2.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.224 0.535 . . . . 1.92 111.169 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 98.2 mttt -92.94 -50.75 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.429 -0.805 . . . . 2.31 110.646 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -111.9 100.14 8.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.822 -0.626 . . . . 1.44 109.682 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -110.19 131.75 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.008 -0.542 . . . . 1.82 111.843 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.56 119.28 31.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.756 -0.656 . . . . 1.8 109.993 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -160.26 122.15 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.591 -0.522 . . . . 3.02 109.591 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.429 ' HA3' HD21 ' A' ' 47' ' ' LEU . . . -129.1 -177.97 15.14 Favored Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.923 -0.932 . . . . 1.44 111.118 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.39 -130.0 0.0 OUTLIER Glycine 0 CA--C 1.543 1.818 0 O-C-N 124.771 0.924 . . . . 2.15 115.398 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -44.05 170.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.632 2.888 . . . . 3.17 114.178 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.2 pt? -30.67 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.964 1.364 . . . . 4.55 114.231 -146.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.637 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 12.3 p-10 -110.9 -112.23 0.33 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.231 -1.804 . . . . 4.95 113.042 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.637 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 97.47 155.11 29.99 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.53 -1.428 . . . . 2.25 109.53 -163.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.9 m -77.72 102.14 6.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.777 0.789 . . . . 2.12 110.934 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 74.0 m-85 -97.55 117.71 32.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.039 -0.356 . . . . 3.88 110.039 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.84 145.41 26.61 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.845 -0.428 . . . . 3.87 109.845 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.7 tp -74.59 120.22 19.85 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.376 -0.601 . . . . 1.68 109.376 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 tt -113.12 -42.12 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.713 0.292 . . . . 2.16 111.329 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.0 pt20 -167.74 168.88 12.15 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.322 -0.622 . . . . 1.95 109.322 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.554 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 4.1 p90 -134.89 164.23 28.05 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.35 -0.54 . . . . 0.98 111.418 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -138.37 160.3 39.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.653 -0.869 . . . . 1.07 108.653 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.515 ' H ' ' CB ' ' A' ' 65' ' ' ALA . 79.1 t80 -130.25 144.14 51.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.484 0.183 . . . . 3.99 111.185 -172.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.61 146.95 40.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.988 0.423 . . . . 2.2 110.558 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -161.05 150.99 17.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 6.08 108.557 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -90.11 155.87 24.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.906 . . . . 2.19 112.672 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -60.56 -28.11 68.2 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.133 0.492 . . . . 3.08 110.477 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.55 -154.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.679 -0.691 . . . . 3.48 110.516 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -136.61 48.29 2.13 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.433 -0.951 . . . . 3.85 108.433 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.24 41.97 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.196 -0.911 . . . . 2.37 112.136 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -159.21 169.76 23.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.713 -0.477 . . . . 2.62 109.713 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.67 10.37 86.26 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.882 -0.675 . . . . 1.62 112.888 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.45 -2.7 57.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.489 0.552 . . . . 2.24 112.489 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.553 ' HG2' ' H ' ' A' ' 107' ' ' HIS . 18.2 tt0 67.35 178.96 0.23 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.642 -0.503 . . . . 3.72 109.642 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.553 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 29.6 m80 48.57 45.05 21.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.396 0.679 . . . . 4.03 112.11 174.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.0 t -81.0 127.6 32.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.731 0.777 . . . . 2.99 111.672 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.04 115.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.755 -1.111 . . . . 2.88 110.503 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.24 37.21 23.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.846 0.831 . . . . 2.8 109.591 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.18 14.72 8.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.529 -1.214 . . . . 5.35 111.619 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -89.32 114.48 25.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.147 -0.686 . . . . 3.58 109.147 172.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -107.06 173.62 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 3.26 110.186 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.4 172.95 7.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.979 -0.555 . . . . 1.71 109.895 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.51 77.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.75 0.278 . . . . 1.57 111.75 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 95' ' ' PHE . . . -167.43 170.56 11.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.017 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -150.06 141.87 23.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 1.85 110.67 174.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 93' ' ' PHE . 50.3 tp -105.26 125.74 51.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.598 -0.728 . . . . 1.61 109.052 174.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.502 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -114.76 102.43 10.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 2.25 110.341 -172.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.554 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 5.8 mp -90.27 111.26 22.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.359 0.599 . . . . 1.51 110.781 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -77.82 119.82 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.466 -0.788 . . . . 1.24 111.099 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 73.9 m80 -106.57 137.64 44.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.485 -0.779 . . . . 2.86 109.347 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -110.38 128.07 55.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.123 -0.489 . . . . 4.96 111.205 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -69.98 105.29 2.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.03 -0.532 . . . . 2.3 109.907 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.0 t -62.73 -17.49 60.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.544 . . . . 2.77 111.735 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.47 -29.79 70.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.45 -0.341 . . . . 3.79 111.799 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -90.35 -1.24 57.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.36 . . . . 3.34 111.069 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.84 23.73 2.63 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 115.826 1.09 . . . . 2.37 115.826 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.573 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 32.2 t70 -176.87 126.8 0.16 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.986 0.893 . . . . 3.93 109.801 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -64.31 -37.87 89.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.685 -0.689 . . . . 3.6 111.715 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -28.61 70.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.103 -0.57 . . . . 2.35 112.578 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 39.6 mmtm -80.49 -41.02 25.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.505 -0.554 . . . . 3.75 109.505 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.592 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.33 -38.84 88.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.452 -0.795 . . . . 2.17 112.152 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.7 -15.11 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.789 0.328 . . . . 3.11 111.168 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.53 13.33 26.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.287 -0.415 . . . . 3.55 110.432 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 17.4 mm100 -121.03 135.35 24.77 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.78 -0.452 . . . . 3.02 109.78 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.505 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 11.3 Cg_endo -56.09 -29.85 76.36 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.355 2.703 . . . . 1.93 113.798 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -111.37 25.57 11.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.922 0.391 . . . . 2.29 110.208 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -62.05 -48.72 81.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.247 0.859 . . . . 1.5 115.247 -172.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 206' ' ' VAL . 40.0 mt -133.92 170.31 15.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.835 0.817 . . . . 1.98 111.138 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.94 105.36 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.513 -0.767 . . . . 1.83 109.851 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.636 ' O ' ' HB ' ' A' ' 209' ' ' ILE . 4.7 m -88.83 111.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 2.28 111.36 -176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -86.27 100.43 12.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.774 -0.648 . . . . 2.89 110.287 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.64 118.5 5.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.161 -0.542 . . . . 0.95 112.558 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.57 118.37 58.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.781 -0.452 . . . . 1.38 109.781 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -71.04 147.57 48.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.998 0.428 . . . . 1.37 111.586 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.6 mp -116.75 131.82 56.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.656 -0.702 . . . . 1.48 110.271 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -126.4 144.33 50.87 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.789 -0.819 . . . . 2.52 108.789 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.03 130.94 35.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.454 0.645 . . . . 1.88 111.353 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 177.06 -105.25 0.2 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.114 -0.948 . . . . 1.53 110.921 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.9 t -71.53 142.95 50.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.424 -0.584 . . . . 2.08 109.424 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.53 156.58 39.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 1.36 111.202 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -118.08 95.04 47.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.596 -0.52 . . . . 1.78 109.596 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.65 -37.15 91.23 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.146 2.564 . . . . 1.34 112.49 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.05 -31.01 79.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.75 112.619 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 160' ' ' VAL . 53.3 tp -88.78 -31.68 18.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.517 -0.402 . . . . 1.39 109.948 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -39.33 63.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.711 -0.677 . . . . 1.63 110.151 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -49.39 -47.91 47.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.676 -0.693 . . . . 3.26 111.016 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 162' ' ' VAL . 21.3 t -76.68 -43.18 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 1.97 111.065 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 156' ' ' LEU . 19.3 t -61.76 -35.47 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.184 0.516 . . . . 1.64 111.147 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.36 -30.46 67.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.309 -0.405 . . . . 1.22 111.589 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 175' ' ' PHE . 9.6 p -92.9 -18.51 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.829 -0.348 . . . . 2.07 111.875 -173.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -67.73 -13.01 61.75 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.988 0.423 . . . . 1.95 111.092 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.54 -19.72 65.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.31 110.498 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.0 t -85.47 0.58 51.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.02 -0.536 . . . . 1.78 111.423 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 41.1 pt -135.83 46.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.581 0.705 . . . . 1.42 109.585 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.23 -32.47 71.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.079 -0.964 . . . . 1.98 111.264 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.5 p -112.66 145.21 40.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.895 0.378 . . . . 1.4 110.937 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.48 138.55 58.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 2.84 110.542 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.57 -20.89 33.67 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.624 -0.798 . . . . 0.85 112.473 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.72 152.3 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.109 0.48 . . . . 2.22 111.188 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 m -132.43 157.82 43.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.93 109.642 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.57 151.02 39.69 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.394 -0.595 . . . . 1.17 109.394 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.16 132.76 43.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.192 0.52 . . . . 1.8 110.406 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 162' ' ' VAL . 48.9 t80 -141.48 79.23 1.67 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 1.31 108.295 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 56' ' ' SER . 6.2 m -111.87 156.82 21.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.608 . . . . 1.69 111.558 -174.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 56.4 58.22 4.38 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.357 0.663 . . . . 2.26 112.384 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.45 134.68 41.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 4.84 109.632 172.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.549 ' CG ' ' HE ' ' A' ' 181' ' ' ARG . 10.2 t70 -108.22 129.62 23.84 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 2.51 111.111 -173.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 19.3 Cg_exo -66.65 -3.74 9.76 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.637 2.892 . . . . 1.47 114.704 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.549 ' HE ' ' CG ' ' A' ' 179' ' ' ASP . 18.5 ptp180 -59.93 -26.27 65.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.745 0.307 . . . . 3.16 111.401 -178.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -79.74 7.14 56.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.92 -0.657 . . . . 1.12 112.299 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.4 mt -115.28 -27.52 7.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 2.37 110.312 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.34 131.63 80.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.799 -0.637 . . . . 3.87 111.428 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.1 -177.07 3.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.97 2.446 . . . . 2.51 112.873 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.79 -55.21 6.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.884 0.327 . . . . 3.23 111.884 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 4.5 m -85.21 130.3 34.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.27 -0.27 . . . . 2.03 110.27 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 tp -111.75 82.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.329 -0.396 . . . . 2.5 110.448 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -118.19 177.4 4.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.56 -0.533 . . . . 1.81 109.56 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -162.93 145.48 10.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.929 0.714 . . . . 5.32 112.929 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.418 ' CD1' ' HB ' ' A' ' 210' ' ' VAL . 7.4 m0 -116.17 145.47 43.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.496 -1.298 . . . . 4.55 107.496 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -142.44 102.83 4.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.779 1.029 . . . . 2.39 113.779 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.532 ' HB2' ' HA ' ' A' ' 255' ' ' ILE . 48.8 t80 -142.41 128.43 10.67 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 5.32 110.031 168.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.74 127.74 23.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.817 2.344 . . . . 2.47 113.618 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -141.76 161.54 27.07 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.248 -0.887 . . . . 2.0 112.283 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 29.6 t -61.31 144.56 53.69 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.683 -0.488 . . . . 3.36 109.683 173.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.94 -53.41 58.24 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.988 0.366 . . . . 5.18 111.988 -164.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.519 HG21 ' HD2' ' A' ' 200' ' ' PRO . 1.7 t -127.56 -46.4 1.45 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.783 -0.367 . . . . 5.53 111.471 167.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 1.8 m 169.18 -60.39 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.774 1.229 . . . . 5.89 110.275 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.544 ' HD3' ' HB ' ' A' ' 199' ' ' THR . 48.8 Cg_exo -55.35 -46.36 33.1 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 121.861 1.707 . . . . 6.31 113.901 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 24.1 Cg_exo -65.3 106.92 0.9 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.374 1.383 . . . . 5.26 110.608 172.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 54.3 mt -77.62 46.03 0.52 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.788 -0.642 . . . . 4.29 111.806 -172.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.508 ' HB3' ' SG ' ' A' ' 205' ' ' CYS . 97.0 mt -127.03 118.78 25.14 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.032 0.444 . . . . 3.51 110.174 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -86.82 78.24 9.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.647 -0.706 . . . . 3.37 109.757 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 203' ' ' LEU . 60.0 m -121.08 -15.4 8.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 2.47 111.992 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 140' ' ' LEU . 47.1 t -145.13 102.65 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 C-N-CA 119.641 -0.823 . . . . 1.74 112.333 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 193' ' ' TYR . 82.3 m -155.73 88.8 1.14 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 2.3 111.508 166.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' TRP . . . . . 0.734 ' O ' HG12 ' A' ' 209' ' ' ILE . 1.1 p90 -150.05 87.06 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.163 -1.015 . . . . 6.37 112.449 160.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 208' ' ' TRP . 9.4 mm -166.89 113.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 123.999 0.92 . . . . 2.32 109.122 157.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 191' ' ' TRP . 95.5 t -125.23 99.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.656 -0.498 . . . . 2.1 109.656 166.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -66.81 107.5 2.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 2.35 110.719 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -53.71 -23.07 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 3.47 111.408 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.5 tp10 -105.17 113.63 64.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.273 -0.422 . . . . 1.56 110.841 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -82.88 152.2 14.57 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.579 2.186 . . . . 1.37 111.707 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.1 pt -100.59 152.17 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.006 -0.368 . . . . 1.85 110.006 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 62.8 m -94.78 129.27 41.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.28 -0.418 . . . . 1.78 109.96 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.33 162.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.065 -0.516 . . . . 1.64 109.853 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.416 ' HB3' ' HG3' ' A' ' 221' ' ' GLN . 48.3 t -88.21 146.03 25.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.183 -0.462 . . . . 1.52 109.823 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.706 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.3 t -57.44 -33.87 68.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.626 -0.715 . . . . 1.81 110.329 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.44 -20.71 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 2.51 111.095 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.416 ' HG3' ' HB3' ' A' ' 218' ' ' SER . 55.9 mt-30 -78.67 -45.89 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.283 -0.417 . . . . 1.02 110.015 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.659 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 24.9 m -70.41 -24.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.52 -0.309 . . . . 1.88 111.369 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.4 mt -62.38 -36.55 82.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.774 0.321 . . . . 1.59 110.556 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -73.22 -25.4 60.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 2.3 111.488 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.3 m-85 -67.5 -30.87 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.345 0.593 . . . . 3.18 109.657 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -81.54 1.5 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.247 -0.888 . . . . 3.55 110.601 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.29 -13.02 19.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.167 0.508 . . . . 2.74 109.806 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.1 155.19 37.36 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.759 -0.655 . . . . 1.66 110.482 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.5 m120 -115.53 150.14 37.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.82 -0.627 . . . . 1.13 109.837 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -88.29 -27.34 21.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.45 -0.796 . . . . 4.38 109.953 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.8 p-10 -76.54 168.52 19.92 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.272 -0.877 . . . . 1.62 111.395 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.26 167.71 30.46 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.19 -1.164 . . . . 1.16 110.19 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.17 142.54 51.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 3.56 110.199 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.33 51.06 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.738 -0.744 . . . . 2.23 112.77 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.68 153.57 77.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.33 -0.619 . . . . 2.59 109.33 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.31 122.89 12.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.188 1.925 . . . . 1.5 110.582 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.569 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 9.7 pt-20 -67.42 129.98 41.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.792 0.806 . . . . 3.4 112.47 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.0 mt-10 -115.13 120.18 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.666 -1.152 . . . . 2.47 109.002 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.71 132.88 47.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.994 0.426 . . . . 2.6 110.834 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.1 tpp -71.94 91.65 1.22 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.441 -0.799 . . . . 1.94 111.067 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.16 147.54 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.549 0.214 . . . . 1.67 110.941 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.479 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER 66.79 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.584 0.754 . . . . 2.18 111.886 179.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 47.58 34.18 3.4 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.58 0.352 . . . . 2.64 111.838 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' TRP . . . . . 0.527 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 21.5 t90 -129.61 150.04 51.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 5.31 110.721 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -113.71 132.58 22.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.604 -0.517 . . . . 6.91 109.604 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -46.47 151.8 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.717 2.944 . . . . 3.72 113.76 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -70.58 158.28 36.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.939 . . . . 3.34 111.598 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLN . . . . . 0.407 ' CD ' ' HD2' ' A' ' 249' ' ' PRO . 56.2 tp60 -121.55 128.37 25.67 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.399 -0.364 . . . . 4.92 110.148 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.407 ' HD2' ' CD ' ' A' ' 248' ' ' GLN . 10.3 Cg_endo -50.26 169.92 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.452 3.434 . . . . 4.01 115.449 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 3.2 mm? -62.16 -12.55 20.39 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.828 -1.533 . . . . 4.9 113.071 -169.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.563 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 19.0 ptpt -60.11 41.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.377 1.621 . . . . 5.68 115.377 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 7.4 p30 130.29 -3.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 126.099 1.76 . . . . 5.11 111.023 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 57.5 mmt-85 -130.32 95.42 3.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.106 0.479 . . . . 6.74 110.205 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -137.34 104.25 5.33 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 3.08 108.483 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 193' ' ' TYR . 2.0 mp -84.78 132.57 31.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.189 -0.46 . . . . 3.06 111.191 -169.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -80.63 150.34 29.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 3.01 109.851 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -112.6 140.79 47.07 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.113 -0.328 . . . . 1.99 110.113 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 48.9 m -152.0 96.76 2.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.342 0.591 . . . . 2.47 110.499 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.05 123.15 19.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.213 0.53 . . . . 5.03 110.997 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 pttm . . . . . 0 C--O 1.248 1.001 0 CA-C-N 114.98 -1.009 . . . . 4.82 111.887 177.178 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 53.2 t0 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 107.848 -1.168 . . . . 2.88 107.848 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.542 ' HA ' HG13 ' A' ' 255' ' ' ILE . 36.5 mt -113.01 140.41 33.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 120.854 0.359 . . . . 2.32 111.415 -167.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -135.31 137.18 42.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.316 -0.994 . . . . 2.82 108.316 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -47.87 -39.34 18.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.042 0.449 . . . . 2.24 111.855 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -81.32 -28.74 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.076 -0.511 . . . . 4.54 111.075 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -96.78 20.39 11.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.472 0.653 . . . . 3.06 110.906 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.48 130.68 53.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.466 -0.568 . . . . 1.72 109.466 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 256' ' ' LYS . 75.6 mmtt -109.52 122.27 47.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.918 0.39 . . . . 3.69 110.513 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -70.56 139.98 51.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.969 -0.56 . . . . 4.64 111.121 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.47 147.25 36.31 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.523 -0.762 . . . . 2.27 109.602 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 44' ' ' LEU . 14.0 Cg_endo -54.99 144.88 66.12 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.549 2.833 . . . . 2.15 113.71 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.441 ' HB2' ' HA ' ' A' ' 260' ' ' LYS . 14.1 t -46.32 45.26 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.111 1.523 . . . . 4.29 115.111 166.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 42' ' ' PRO . 3.7 pp -59.59 171.36 0.86 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.009 -0.541 . . . . 4.74 110.084 168.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 34.9 mmtp -53.69 123.23 37.19 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.806 0.336 . . . . 3.77 111.756 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 36.3 Cg_exo -60.59 171.46 3.45 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.581 2.854 . . . . 2.36 113.27 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.511 HD23 ' HA3' ' A' ' 81' ' ' GLY . 68.0 mt -82.14 111.69 18.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 2.55 109.555 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 m -78.14 108.73 11.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.046 -0.353 . . . . 2.38 110.046 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -101.93 113.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.281 0.563 . . . . 1.59 110.573 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -126.55 92.29 3.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.988 -0.551 . . . . 1.45 109.851 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 7.7 p90 -129.04 23.16 5.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.944 -0.571 . . . . 3.62 110.961 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.95 -22.4 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.11 0.481 . . . . 2.48 110.093 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -99.47 7.75 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.72 -0.673 . . . . 2.24 110.646 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.68 121.27 14.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.142 -0.481 . . . . 0.8 111.182 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 m -109.12 106.84 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.847 -0.615 . . . . 1.06 110.435 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 p -78.58 147.22 33.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.26 109.478 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.67 -57.13 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.979 0.418 . . . . 0.74 111.766 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -147.23 156.48 42.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 3.17 110.911 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.93 134.06 67.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.196 -0.668 . . . . 0.64 109.196 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 172' ' ' SER . 66.8 tp -136.22 144.08 44.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.96 111.249 -170.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -105.29 118.54 36.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.568 -0.742 . . . . 1.49 109.296 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.03 66.33 0.97 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.29 -0.564 . . . . 1.83 111.09 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . 66.73 -52.93 0.22 Allowed Glycine 0 CA--C 1.523 0.568 0 CA-C-N 114.487 -1.233 . . . . 1.64 115.289 165.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -96.34 -26.62 15.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.898 0.38 . . . . 3.33 110.208 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.32 178.62 8.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 1.38 110.095 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -126.61 123.81 38.48 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.921 -0.77 . . . . 2.74 108.921 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -117.08 143.44 45.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.947 0.403 . . . . 1.76 111.36 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -114.75 123.46 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.542 -0.54 . . . . 1.15 109.542 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 2.02 111.329 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.57 152.65 27.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 1.66 109.17 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -83.63 135.04 34.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.787 0.327 . . . . 1.33 110.383 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -133.49 59.35 1.74 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.985 0.897 . . . . 2.65 109.576 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -87.07 -11.32 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 1.61 109.634 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -144.66 177.35 8.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.415 -1.328 . . . . 2.35 107.415 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.07 71.57 4.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.734 0.778 . . . . 1.92 110.423 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -82.75 -61.06 1.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.175 -0.92 . . . . 1.77 110.738 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -112.78 98.06 6.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.76 110.024 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.12 138.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.915 -0.584 . . . . 1.27 111.166 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.7 tp -136.67 113.47 10.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.152 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.65 124.15 7.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.466 0.65 . . . . 2.54 111.553 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -87.53 178.33 47.36 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.167 -0.924 . . . . 1.31 111.478 169.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -38.62 -142.13 0.0 OUTLIER Glycine 0 CA--C 1.535 1.299 0 O-C-N 124.669 0.864 . . . . 1.9 114.974 167.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -49.65 120.41 5.84 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 121.59 1.527 . . . . 2.91 112.152 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.5 mt -159.43 -169.48 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.706 -1.134 . . . . 4.11 109.173 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -126.78 41.8 3.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.717 0.294 . . . . 4.95 110.779 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.91 176.14 14.21 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.632 -0.794 . . . . 2.25 113.172 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 125' ' ' THR . 76.4 m -102.09 122.05 43.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.771 -0.455 . . . . 1.91 109.771 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 38.2 m-85 -104.01 106.42 16.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.019 0.437 . . . . 3.7 110.928 -175.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' NH2' ' HZ3' ' A' ' 123' ' ' TRP . 18.4 mtm180 -85.61 149.59 25.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 3.54 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.85 124.73 28.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 1.14 110.239 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.471 HG23 ' HG2' ' A' ' 92' ' ' GLN . 7.2 tt -109.16 -34.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.464 -0.334 . . . . 1.68 111.392 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' HG23 ' A' ' 91' ' ' ILE . 27.6 pt20 -169.98 169.17 8.27 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.865 -0.152 . . . . 1.55 110.718 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 11.3 p90 -153.66 160.39 42.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.86 110.845 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -147.55 162.27 39.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.6 -0.727 . . . . 0.93 109.55 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 85.4 m-85 -106.2 152.3 23.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 3.17 111.278 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 119' ' ' HIS . 13.6 m170 -108.72 142.85 38.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.814 -1.18 . . . . 1.68 107.814 173.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.597 ' HE1' ' HB ' ' A' ' 222' ' ' VAL . 6.4 t90 -152.61 116.67 4.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.529 -0.468 . . . . 5.18 110.74 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.74 154.75 31.25 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.953 -0.641 . . . . 2.13 112.003 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -67.58 -32.37 73.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.223 0.511 . . . . 2.9 110.617 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -106.56 140.36 39.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.943 -0.762 . . . . 3.03 108.943 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -64.05 -4.38 3.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.896 0.702 . . . . 3.85 112.896 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.17 21.4 24.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.439 -0.886 . . . . 1.94 112.847 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.6 pt20 -158.87 165.57 33.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.13 0.465 . . . . 2.45 110.415 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.95 -34.66 3.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.26 -0.971 . . . . 1.47 114.246 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.8 p -73.4 -34.76 65.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.388 0.594 . . . . 2.0 111.873 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.28 -163.86 0.16 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.445 -0.946 . . . . 3.72 108.445 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 50.62 55.4 9.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.485 0.66 . . . . 3.52 109.889 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.8 p -77.94 117.56 19.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.273 -0.876 . . . . 2.52 110.981 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.541 ' H ' ' HB2' ' A' ' 112' ' ' LYS . 29.9 t -88.51 92.58 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.48 109.947 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.35 -67.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.652 1.22 . . . . 2.8 111.723 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 109' ' ' VAL . 22.3 pttp -127.22 -3.53 6.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.337 -0.392 . . . . 4.98 111.503 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HB2' ' H ' ' A' ' 109' ' ' VAL . 64.3 mttm -69.56 178.17 2.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.041 -0.264 . . . . 3.23 110.479 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.8 pttt 147.77 109.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.746 0.819 . . . . 2.82 108.926 -160.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -121.39 166.66 13.78 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.146 -0.346 . . . . 1.62 110.073 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' GLN . . . -79.55 -17.89 52.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 1.03 112.441 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 97' ' ' TRP . . . -156.65 164.36 38.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.932 0.396 . . . . 0.75 111.513 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.84 151.54 20.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.508 -0.769 . . . . 1.58 110.402 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.463 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 39.7 tp -104.23 127.44 51.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.675 -0.491 . . . . 1.07 109.675 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 96' ' ' HIS . 22.6 t-160 -118.19 105.84 12.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.372 -0.376 . . . . 1.77 110.227 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.2 mp -100.23 125.92 46.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.93 110.689 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 142' ' ' VAL . 46.4 t -98.5 125.18 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.926 0.393 . . . . 0.61 111.235 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -116.26 144.03 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.489 . . . . 2.13 109.681 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.47 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 11.2 t90 -117.9 137.93 52.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.16 -0.473 . . . . 4.26 111.294 -175.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.511 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 30.6 t30 -70.72 104.58 2.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.34 0.59 . . . . 2.02 111.238 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 87' ' ' THR . 7.7 t -67.62 -25.62 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.835 1.05 . . . . 2.34 113.835 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 64.8 pttt -68.39 -5.12 17.29 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.277 0.843 . . . . 3.35 113.277 -171.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -107.44 -0.78 22.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.049 -0.407 . . . . 3.1 111.638 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.88 30.3 4.89 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.149 -0.932 . . . . 2.37 115.148 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.47 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 14.9 t70 -163.27 121.27 1.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.931 0.865 . . . . 3.93 109.388 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.506 ' O ' HG23 ' A' ' 134' ' ' VAL . 55.3 p90 -66.44 -40.08 89.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 3.0 111.951 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -32.47 81.8 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.816 -0.707 . . . . 2.15 112.451 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 42.2 mmtm -66.34 -34.57 78.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.79 0.328 . . . . 3.43 110.215 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.34 -34.03 74.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.971 -0.558 . . . . 1.76 110.767 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 130' ' ' PHE . 63.3 t -65.06 -25.75 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 2.77 110.571 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.61 16.78 6.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 3.55 110.977 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 71.1 mt-30 -131.69 135.33 26.65 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 3.02 109.687 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 37.7 Cg_exo -60.59 -26.4 82.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.655 2.237 . . . . 1.6 112.725 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -113.92 19.18 16.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 2.29 111.07 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.15 -29.44 73.35 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.888 -0.672 . . . . 1.22 114.127 -172.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.8 158.61 34.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.066 0.433 . . . . 1.57 110.982 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -144.49 126.96 15.94 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.952 -0.759 . . . . 1.38 108.952 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 121' ' ' VAL . 32.2 m -125.49 149.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.933 0.397 . . . . 1.73 111.38 -173.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.53 122.7 47.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.614 -0.721 . . . . 2.42 110.187 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.8 109.76 2.89 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.29 -0.724 . . . . 0.86 111.29 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.415 HG12 HD12 ' A' ' 211' ' ' LEU . 23.7 mt -111.28 113.9 45.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.243 -0.28 . . . . 0.76 110.243 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -66.6 145.32 55.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.788 0.328 . . . . 1.2 111.01 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.48 124.09 51.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.779 -0.452 . . . . 0.88 109.779 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.2 141.97 47.44 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.559 -0.534 . . . . 2.03 109.559 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 45.1 t -85.45 132.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.061 0.457 . . . . 1.27 110.866 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.3 -105.08 0.21 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.997 -0.841 . . . . 1.53 110.997 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.7 t -71.19 142.33 50.65 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.301 -0.629 . . . . 1.54 109.301 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.68 151.86 45.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.558 -0.292 . . . . 0.78 111.059 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.0 tptt -108.48 99.11 31.32 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.657 -0.497 . . . . 1.22 109.657 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.54 -36.89 89.99 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.965 2.443 . . . . 1.05 112.742 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.07 75.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.991 -0.624 . . . . 0.7 113.115 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 160' ' ' VAL . 26.2 tp -83.92 -17.23 41.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.224 0.512 . . . . 0.77 110.373 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -41.56 63.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 1.41 110.768 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.434 ' HE3' ' OD1' ' A' ' 179' ' ' ASP . 65.3 mttm -49.2 -49.09 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.557 . . . . 2.86 112.415 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 14.8 p -79.99 -35.9 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.708 -0.397 . . . . 1.38 110.832 -177.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' A' ' 163' ' ' LEU . 78.2 t -59.8 -35.77 62.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.363 0.601 . . . . 1.11 110.452 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.52 -33.99 76.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.198 -0.91 . . . . 1.22 111.963 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.9 p -99.25 -3.66 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 111.793 0.294 . . . . 1.41 111.793 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 92.8 mt -55.6 -42.49 74.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.848 0.356 . . . . 1.39 111.916 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.99 -20.94 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.422 -0.353 . . . . 2.31 111.662 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 72.6 m -92.66 0.4 57.42 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.219 0.452 . . . . 1.4 112.219 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.09 34.52 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.578 -0.527 . . . . 0.85 109.578 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.449 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 82.6 tttt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.262 -0.881 . . . . 1.59 112.152 -172.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 171' ' ' LYS . 37.9 p -102.69 152.15 21.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.696 0.284 . . . . 0.77 111.118 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -71.62 146.6 48.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.885 0.374 . . . . 2.29 110.662 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.15 9.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.529 -0.843 . . . . 0.85 112.5 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 168' ' ' THR . 21.5 ptmt -90.87 155.58 18.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 1.7 110.914 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.459 ' HB3' HD13 ' A' ' 60' ' ' LEU . 16.5 p -128.07 160.41 32.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.518 -0.765 . . . . 1.37 110.548 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -144.66 145.86 31.96 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.047 -0.353 . . . . 0.61 110.047 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.15 131.74 40.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.829 -0.434 . . . . 1.8 109.829 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -139.97 79.93 1.74 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.992 -0.744 . . . . 1.04 108.992 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 p -104.65 162.7 13.06 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.462 -0.79 . . . . 1.17 111.477 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 58.12 45.97 16.83 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.788 0.662 . . . . 1.77 112.788 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -99.06 135.46 40.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.974 -0.38 . . . . 3.99 109.974 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.434 ' OD1' ' HE3' ' A' ' 158' ' ' LYS . 6.3 p-10 -110.61 119.28 46.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 121.13 0.49 . . . . 2.51 110.675 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.86 -7.28 19.12 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.817 2.345 . . . . 1.26 112.639 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -63.36 -28.58 70.09 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.877 0.37 . . . . 2.76 110.688 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.75 59.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.172 -0.537 . . . . 1.12 112.977 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 74.9 mt -102.32 -7.06 22.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.583 0.23 . . . . 1.73 111.396 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.82 130.27 88.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.622 0.601 . . . . 3.45 112.622 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.82 -171.59 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.892 2.395 . . . . 2.08 111.369 173.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.75 -62.47 1.68 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.959 0.409 . . . . 3.23 110.613 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.52 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.3 m -91.05 144.77 25.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 1.66 110.279 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 44.3 tp -109.81 63.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.362 0.601 . . . . 1.99 110.549 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 212' ' ' LYS . 4.2 m-20 -97.8 162.82 13.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.81 108.484 174.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.529 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.6 p90 -167.16 156.01 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.159 -0.616 . . . . 5.01 112.474 -174.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.436 ' NE1' ' HG2' ' A' ' 212' ' ' LYS . 12.1 m95 -107.25 149.16 28.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.875 -1.157 . . . . 3.93 107.875 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.8 t -131.28 103.46 6.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.472 0.653 . . . . 2.13 111.589 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.524 ' OH ' ' HA ' ' A' ' 253' ' ' ARG . 45.3 t80 -138.75 132.42 16.23 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 5.21 111.018 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 43.3 Cg_exo -58.3 130.07 35.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.596 2.198 . . . . 2.12 111.876 172.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -108.23 155.71 16.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.209 -0.519 . . . . 1.75 113.068 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.542 0.646 0 C-N-CA 123.431 0.692 . . . . 2.99 112.256 -177.769 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.519 0.199 . . . . 2.96 110.63 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 8.5 pt-20 -112.88 71.99 0.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.227 0.537 . . . . 3.37 110.746 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 28.7 p -96.87 -9.6 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.15 110.645 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.89 141.06 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.782 -0.645 . . . . 1.26 111.395 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.3 m -113.18 108.8 17.78 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.002 -0.74 . . . . 2.08 109.002 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 192' ' ' THR . 33.6 m95 -82.31 119.22 23.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.936 0.398 . . . . 5.53 111.985 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 48.5 mm -108.78 99.55 8.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.379 -0.971 . . . . 1.63 108.379 170.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.6 t -101.65 119.36 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.316 -0.402 . . . . 1.62 110.386 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 40.1 mt -74.68 137.92 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.829 0.347 . . . . 1.73 110.254 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 85.2 mttt -83.06 -8.64 59.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 2.98 110.68 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 187' ' ' SER . 8.4 tp10 -105.26 101.38 30.61 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.255 -0.43 . . . . 1.47 110.501 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 15.7 Cg_exo -69.23 141.48 47.5 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.757 2.305 . . . . 0.96 111.713 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.46 150.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.907 -0.405 . . . . 1.25 109.907 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 12.9 m -90.44 122.03 32.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.074 -0.512 . . . . 1.29 110.526 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.4 m -125.09 151.22 30.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.238 -0.653 . . . . 1.02 109.238 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 60.8 p -91.1 160.05 15.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.488 -0.485 . . . . 1.08 111.525 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.488 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.3 m -54.27 -45.56 72.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 1.33 110.803 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -55.74 -32.5 63.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 2.51 111.434 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -76.87 -52.09 10.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.479 -0.328 . . . . 0.7 110.846 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.597 ' HB ' ' HE1' ' A' ' 97' ' ' TRP . 15.7 m -64.04 -34.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.081 0.4 . . . . 1.36 112.081 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.4 mt -63.39 -30.68 71.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.689 0.281 . . . . 1.03 111.385 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -78.8 -20.18 50.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.313 . . . . 1.75 111.621 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -71.96 -24.48 61.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.275 0.559 . . . . 2.47 109.866 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -80.69 1.28 30.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.59 -0.732 . . . . 3.04 110.533 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -91.61 -9.03 45.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 2.31 110.635 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.06 153.98 39.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.092 0.472 . . . . 0.95 110.638 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.3 m120 -119.31 150.87 39.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.958 -0.564 . . . . 1.13 110.928 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 240' ' ' MET . 33.4 m-85 -77.46 -34.75 54.33 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.377 -0.972 . . . . 3.74 108.377 170.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.9 p-10 -74.31 163.84 27.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.078 -1.419 . . . . 1.62 112.39 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.72 -170.75 47.16 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.614 -1.175 . . . . 1.16 110.993 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.0 126.72 31.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.957 -0.386 . . . . 3.56 109.957 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.9 29.49 31.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.844 -0.694 . . . . 2.08 112.068 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 20.0 mm-40 -127.43 159.13 67.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.138 -0.319 . . . . 2.59 110.138 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.21 121.86 10.15 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 1.36 112.518 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.21 119.36 7.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.573 -0.74 . . . . 3.4 112.534 -174.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.3 mt-10 -131.72 146.74 52.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 2.47 109.206 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.44 125.3 42.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.394 -0.224 . . . . 2.14 110.394 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.562 ' HA ' ' CE2' ' A' ' 230' ' ' PHE . 55.5 ttm -69.45 90.79 0.54 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.515 0.51 . . . . 1.68 110.176 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.42 157.26 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 1.27 110.979 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 12.9 t70 68.47 -85.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.114 -0.948 . . . . 2.18 111.066 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 50.06 35.47 10.02 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.911 0.708 . . . . 2.15 112.911 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.424 ' HE1' ' CG ' ' A' ' 96' ' ' HIS . 2.3 m95 -137.36 158.97 43.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.424 0.63 . . . . 4.59 111.6 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -111.22 146.87 35.44 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.181 -0.918 . . . . 6.13 110.357 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.89 151.26 20.69 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.926 2.417 . . . . 3.28 112.892 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -78.31 159.74 28.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.439 -0.8 . . . . 2.98 110.681 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -113.79 153.69 45.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.42 . . . . 4.32 111.404 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.84 178.57 2.74 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.762 2.975 . . . . 3.48 113.39 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 252' ' ' ASN . 4.2 mm? -51.11 -11.15 0.09 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.056 0.942 . . . . 4.63 113.021 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -59.49 41.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.092 0.957 . . . . 5.34 113.492 170.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.545 ' H ' ' C ' ' A' ' 250' ' ' LEU . 2.9 t30 119.07 41.91 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.584 1.954 . . . . 4.64 112.296 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.645 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 7.4 ppt_? -145.52 121.44 10.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 6.11 110.896 160.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -137.48 122.4 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.656 -1.238 . . . . 3.08 107.656 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 33' ' ' ILE . 29.4 mm -91.49 144.1 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 2.6 112.416 -165.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 67.6 mttm -127.97 146.6 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 2.63 109.101 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.408 ' HB2' ' CE3' ' A' ' 191' ' ' TRP . . . -138.17 103.85 5.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.572 0.225 . . . . 1.71 110.785 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 p -92.77 98.52 11.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.013 0.435 . . . . 2.21 111.014 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.86 154.3 27.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.248 -0.433 . . . . 4.31 110.018 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 43' ' ' SER . 49.2 pttt . . . . . 0 C--O 1.246 0.895 0 O-C-N 123.613 0.571 . . . . 4.49 111.335 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.869 0.366 . . . . 2.88 110.668 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HB ' HG22 ' A' ' 109' ' ' VAL . 41.1 mt -97.18 126.54 49.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.985 -0.552 . . . . 2.32 110.562 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 16.7 t70 -112.73 117.41 32.13 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.379 -0.6 . . . . 2.82 109.379 171.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 p -56.05 -27.67 54.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.945 -0.57 . . . . 2.24 112.458 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.506 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 43.5 m80 -74.29 -18.04 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.185 0.517 . . . . 4.54 110.318 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -117.87 18.9 13.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.497 -0.774 . . . . 3.06 109.851 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.63 85.33 2.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.394 -0.595 . . . . 1.72 109.394 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -75.8 121.93 23.31 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.453 -0.794 . . . . 3.69 111.535 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 40.4 p90 -84.2 143.45 29.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.297 -0.411 . . . . 4.64 110.318 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' HB2' ' HG ' ' A' ' 44' ' ' LEU . 25.4 m-20 -109.7 119.36 48.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.177 -0.465 . . . . 2.27 110.43 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.13 -15.24 46.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.758 2.305 . . . . 2.15 111.587 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.9 m -75.98 -19.21 58.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 4.29 110.746 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 89.5 mt -83.1 137.87 33.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.093 0.473 . . . . 4.74 110.259 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -118.54 135.19 23.53 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 3.77 110.73 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.99 158.09 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.94 3.094 . . . . 2.36 113.303 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.15 155.61 19.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 2.55 111.423 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 80' ' ' LYS . 34.7 p -129.1 136.04 49.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 2.38 108.984 173.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.31 136.78 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.383 -0.372 . . . . 1.59 110.981 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -119.29 89.34 3.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.508 -0.553 . . . . 1.45 109.508 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -103.1 5.72 38.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.786 -0.643 . . . . 3.62 110.254 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -51.88 -40.08 60.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 2.48 111.555 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -111.66 23.67 13.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.266 -0.425 . . . . 2.24 111.343 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.18 111.17 6.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.86 0.362 . . . . 0.8 111.014 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -106.22 108.47 20.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.282 -0.417 . . . . 1.06 110.863 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 176' ' ' THR . 17.3 m -77.43 148.74 35.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.223 -0.658 . . . . 1.26 109.223 174.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.44 -56.99 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.681 0.252 . . . . 0.74 111.681 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -154.18 164.9 37.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.161 0.505 . . . . 3.17 111.49 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.77 138.3 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.338 -0.846 . . . . 0.64 109.779 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.5 tp -130.29 139.57 50.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.593 -0.276 . . . . 0.96 111.09 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -91.46 117.02 29.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.195 0.521 . . . . 1.49 110.743 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -115.59 150.05 37.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.182 -1.414 . . . . 1.83 107.182 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.71 38.2 0.49 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.65 -0.786 . . . . 1.64 114.536 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -132.61 -39.7 0.99 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.188 -0.671 . . . . 3.33 109.188 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.24 -170.31 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.311 -0.996 . . . . 1.38 108.311 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -108.63 135.53 49.73 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.128 -0.694 . . . . 2.74 109.128 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.67 111.61 24.18 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.289 -0.414 . . . . 1.76 110.71 -176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.77 113.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.114 -0.698 . . . . 1.15 109.114 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.52 134.04 35.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.983 0.421 . . . . 2.02 111.032 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -103.28 155.61 18.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.504 -0.771 . . . . 1.66 109.33 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.13 119.82 22.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.809 0.338 . . . . 1.33 110.139 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.35 56.18 1.12 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.718 0.771 . . . . 2.65 109.988 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -87.2 -16.57 34.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.473 -0.785 . . . . 1.61 109.881 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -153.13 176.55 11.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.966 -1.015 . . . . 2.35 108.673 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.69 73.57 7.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.234 0.54 . . . . 1.92 111.012 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.449 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 81.4 mttt -97.47 -65.15 0.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 1.77 112.481 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 89' ' ' ARG . . . -101.49 101.51 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.76 110.223 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.1 t -119.56 143.4 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.993 0.425 . . . . 1.27 112.088 -169.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 tp -118.59 129.95 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.176 -0.675 . . . . 1.29 109.176 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 95.3 mttt -125.55 137.63 53.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.841 -0.429 . . . . 2.54 109.841 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.0 170.2 24.65 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.976 -0.557 . . . . 1.31 111.959 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.4 -147.88 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.817 0.363 . . . . 1.9 113.245 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 51.9 Cg_exo -52.19 119.7 6.18 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 121.904 1.736 . . . . 2.91 112.253 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 72.4 mt -155.03 -171.7 3.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.781 -1.1 . . . . 4.11 108.676 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.02 51.76 1.52 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 4.95 110.639 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.02 -173.78 19.74 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.531 -0.843 . . . . 2.25 112.902 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -108.48 127.6 54.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.015 -0.365 . . . . 1.91 110.015 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 124' ' ' ASN . 71.9 m-85 -103.66 101.77 11.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.404 0.621 . . . . 3.7 111.449 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 77' ' ' ALA . 41.8 ttm180 -79.09 144.0 34.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.481 -0.781 . . . . 3.54 110.427 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.76 120.79 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.501 -0.555 . . . . 1.14 109.501 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.18 -36.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.319 . . . . 1.68 111.698 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -172.11 167.76 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.252 -0.647 . . . . 1.55 109.252 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.48 ' CB ' HD23 ' A' ' 120' ' ' LEU . 35.9 p90 -140.01 167.81 21.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.278 -0.569 . . . . 0.86 112.17 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -147.36 160.94 41.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.826 -1.176 . . . . 0.93 107.826 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.95 172.0 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.652 0.66 . . . . 3.17 111.032 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -129.45 146.03 51.35 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.697 -0.853 . . . . 1.68 108.697 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -157.32 133.38 9.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.164 0.506 . . . . 5.18 110.667 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 78.94 165.28 28.85 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.635 -0.793 . . . . 2.13 112.673 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 33.3 t 156.42 -96.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.661 -1.237 . . . . 2.9 107.661 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 75.6 mt -83.14 -153.84 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.713 -0.676 . . . . 3.03 109.303 167.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -45.81 -33.54 3.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.038 0.535 . . . . 3.85 112.124 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 113' ' ' LYS . . . 176.91 89.92 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.9 -0.667 . . . . 1.94 112.129 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 96.3 mt-30 -127.37 -177.69 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.376 . . . . 2.45 111.183 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.6 -29.56 2.76 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 109.048 -1.621 . . . . 1.47 109.048 -172.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 117' ' ' GLU . 3.3 t -68.66 67.58 0.14 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.296 -1.452 . . . . 2.0 112.474 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.495 ' CA ' ' HE1' ' A' ' 244' ' ' TRP . 28.8 tt0 -56.62 155.05 7.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 110.117 -0.327 . . . . 3.72 110.117 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 58.89 64.61 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.994 -0.743 . . . . 3.52 108.994 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.58 133.47 36.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.242 -0.89 . . . . 2.52 112.033 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 33' ' ' ILE . 40.6 t -78.61 90.61 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 114.922 -1.036 . . . . 2.48 108.894 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 33.7 t70 64.23 -71.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.135 0.897 . . . . 2.8 110.724 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.479 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 54.9 mttp -138.46 30.23 2.38 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.512 0.19 . . . . 4.98 111.512 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HB3' ' H ' ' A' ' 109' ' ' VAL . 25.4 ttpp -70.16 71.57 0.42 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.189 0.519 . . . . 3.23 110.086 174.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 102' ' ' GLY . 51.3 mtmt -99.77 96.45 7.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.45 . . . . 2.82 110.987 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.405 ' H ' ' HB2' ' A' ' 105' ' ' SER . 70.3 m-85 -91.57 156.56 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.492 -0.929 . . . . 1.62 108.492 170.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.71 -9.69 55.4 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.481 0.488 . . . . 1.03 112.025 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.39 163.96 17.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.412 0.445 . . . . 0.75 110.322 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 105' ' ' SER . 33.2 tt0 -158.71 138.6 12.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.673 -0.694 . . . . 1.58 109.657 176.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.558 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 57.7 tp -102.51 132.86 48.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.024 -0.535 . . . . 1.07 110.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -119.86 102.41 8.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.188 0.518 . . . . 1.77 110.261 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 93' ' ' PHE . 24.5 mt -83.96 116.98 23.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 0.93 110.581 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.54 127.23 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.34 0.59 . . . . 0.61 110.591 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 31.7 m-70 -124.45 144.11 50.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.898 -0.592 . . . . 2.13 110.062 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -111.42 131.23 55.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.891 -0.595 . . . . 4.26 110.755 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.508 ' HB2' ' CE1' ' A' ' 88' ' ' TYR . 22.0 t30 -72.84 110.43 7.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.202 0.525 . . . . 2.02 110.742 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.9 p -66.34 -21.47 66.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 2.34 112.165 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -53.51 -27.49 25.93 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.384 0.513 . . . . 3.35 112.384 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.93 8.88 44.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.128 0.418 . . . . 3.1 112.128 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.09 -1.22 0.64 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.175 1.23 . . . . 2.37 116.175 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -168.79 136.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.416 1.108 . . . . 3.93 109.715 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.2 p90 -66.41 -38.63 87.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 3.0 111.687 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.16 97.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.838 -0.696 . . . . 2.15 111.904 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -70.72 -31.9 68.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.486 . . . . 3.43 110.241 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.628 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -65.59 -25.74 67.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.777 -0.647 . . . . 1.76 110.887 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -63.72 -19.62 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 2.77 110.993 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.39 -11.91 59.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.96 -0.463 . . . . 3.55 110.996 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.436 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 51.1 tt0 -111.14 136.39 20.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.637 -0.256 . . . . 3.02 110.623 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.8 Cg_exo -55.9 -27.15 61.73 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.34 2.694 . . . . 1.6 113.351 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.436 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 3.7 m-20 -111.5 27.07 10.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.109 0.48 . . . . 2.29 110.064 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.06 -36.49 31.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 1.22 113.503 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.8 mt -121.56 163.35 19.03 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.475 -0.427 . . . . 1.57 110.375 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.44 147.67 34.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.154 -0.475 . . . . 1.38 110.179 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.15 113.57 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.906 -0.405 . . . . 1.73 109.906 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 48.7 tp -93.4 108.32 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.092 -0.504 . . . . 2.42 110.079 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -93.92 148.35 18.97 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.932 -0.576 . . . . 0.86 112.99 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 mt -137.41 125.28 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.598 -0.519 . . . . 0.76 109.598 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 18.0 m-85 -71.06 139.12 50.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.474 -0.195 . . . . 1.2 110.474 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.7 mp -113.29 110.65 20.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.468 . . . . 0.88 110.701 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.552 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 19.4 ptpt -98.94 152.3 19.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.157 -0.683 . . . . 2.03 109.157 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.61 121.07 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.018 0.437 . . . . 1.27 110.495 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.01 -114.49 0.35 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.503 -0.639 . . . . 1.53 111.503 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.4 t -66.93 147.25 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.88 -0.415 . . . . 1.54 109.88 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.84 34.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.91 0.386 . . . . 0.78 111.669 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 216' ' ' SER . 56.7 mmtt -114.58 96.48 43.78 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.824 -0.625 . . . . 1.22 109.433 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.49 -33.92 93.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.687 2.258 . . . . 1.05 111.873 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.41 71.12 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.743 -0.662 . . . . 0.7 112.357 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 160' ' ' VAL . 62.0 tp -86.53 -26.35 24.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.216 0.532 . . . . 0.77 109.616 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -37.25 69.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.201 -0.909 . . . . 1.41 110.184 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -59.4 -37.69 78.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 2.86 111.279 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 162' ' ' VAL . 42.2 t -72.82 -43.39 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.154 0.502 . . . . 1.38 110.314 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 156' ' ' LEU . 33.9 t -59.77 -34.24 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 1.11 110.756 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.26 -31.05 72.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 1.22 112.014 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 159' ' ' VAL . 5.2 p -86.32 -4.73 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 1.41 111.012 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.52 -25.72 67.46 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.355 -0.384 . . . . 1.39 111.236 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.17 -32.31 72.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 2.31 111.279 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 m -88.5 -3.25 58.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.989 0.366 . . . . 1.4 111.989 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.58 41.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.327 0.584 . . . . 0.85 110.269 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.14 -31.24 70.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 1.59 111.421 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.9 p -117.43 158.17 24.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.785 -0.189 . . . . 0.77 111.174 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -55.03 147.0 16.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.351 0.596 . . . . 2.29 112.345 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.28 -22.01 31.89 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.331 -0.85 . . . . 0.85 112.25 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -72.84 139.84 47.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.116 0.484 . . . . 1.7 110.873 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.8 p -133.54 157.6 45.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.408 -0.814 . . . . 1.37 109.549 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.71 143.75 28.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.76 -0.459 . . . . 0.61 109.76 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.8 133.45 46.54 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.245 -0.65 . . . . 1.8 109.245 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -142.34 81.21 1.74 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.81 -0.632 . . . . 1.04 109.483 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' SER . 5.2 m -108.44 164.27 12.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.256 -0.429 . . . . 1.17 110.936 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.44 64.54 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.731 0.644 . . . . 1.77 111.773 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 53.2 t80 -115.22 144.65 43.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 3.99 110.145 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.61 102.33 25.59 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 2.51 111.348 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 16.0 Cg_exo -69.18 -12.16 33.33 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.917 2.412 . . . . 1.26 112.238 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -62.88 -24.48 67.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.393 -0.367 . . . . 2.76 110.957 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.62 68.28 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.601 -0.809 . . . . 1.12 111.797 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 83.5 mt -118.22 -38.01 3.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.646 -0.502 . . . . 1.73 109.646 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.07 131.71 83.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 3.45 110.566 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.84 -178.86 4.41 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.7 2.267 . . . . 2.08 112.727 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.65 -62.39 1.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.097 -0.501 . . . . 3.23 111.35 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.7 m -71.09 131.93 44.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 1.66 110.885 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.3 mt -111.32 63.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.079 0.466 . . . . 1.99 111.597 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 19.5 m-20 -105.6 173.23 6.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.741 -1.207 . . . . 1.81 107.741 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 46.9 p90 -164.65 150.24 10.15 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.325 -0.95 . . . . 5.01 113.235 -171.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.452 ' CE3' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m95 -109.35 151.27 26.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.817 -1.549 . . . . 3.93 106.817 166.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.7 t -139.5 130.86 26.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.603 0.716 . . . . 2.13 112.55 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.436 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 51.3 t80 -138.76 142.22 33.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.214 -0.903 . . . . 5.21 109.205 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.436 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 76.8 Cg_exo -52.0 149.07 21.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.429 2.086 . . . . 2.12 112.006 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -117.9 125.12 6.34 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.839 -0.696 . . . . 1.75 112.968 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 123.557 0.743 . . . . 2.99 111.112 179.579 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.359 -0.608 . . . . 2.96 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.4 OUTLIER -88.77 43.96 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.927 0.394 . . . . 3.37 110.857 -176.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 2.1 p -86.37 -9.05 57.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.257 0.466 . . . . 2.15 112.257 -174.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.14 148.15 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.012 0.434 . . . . 1.26 111.077 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.3 m -117.5 108.22 15.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.026 -0.731 . . . . 2.08 109.026 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.428 ' CZ2' ' HB ' ' A' ' 210' ' ' VAL . 59.2 t90 -84.98 124.3 31.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.114 0.483 . . . . 5.53 110.013 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 73.2 mt -130.93 120.49 47.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.018 -0.734 . . . . 1.63 109.018 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 14.5 p -115.92 131.51 68.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.577 -0.449 . . . . 1.62 110.962 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 92.7 mt -71.98 129.09 37.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.125 -0.488 . . . . 1.73 110.208 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 0.7 OUTLIER -56.91 -24.05 49.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.116 -0.947 . . . . 2.98 111.435 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.93 115.05 65.98 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 1.47 110.68 -170.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.552 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 12.2 Cg_exo -71.89 157.76 54.25 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.639 2.226 . . . . 0.96 111.925 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.432 ' HB ' ' HE3' ' A' ' 153' ' ' LYS . 45.2 pt -114.09 151.43 15.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.172 -0.677 . . . . 1.25 109.172 172.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.585 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 2.6 p -101.53 126.6 48.37 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.847 0.356 . . . . 1.29 111.215 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.73 155.03 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.533 -0.758 . . . . 1.02 109.206 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.6 t -87.88 152.85 21.77 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.607 -0.437 . . . . 1.08 110.803 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 15.8 m -51.13 -48.13 61.84 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.287 0.367 . . . . 1.33 111.57 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 2.7 mp0 -53.94 -42.64 69.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 2.51 110.755 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.77 -45.48 92.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.657 . . . . 0.7 110.312 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.69 -37.44 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.562 . . . . 1.36 110.565 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 219' ' ' SER . 97.7 mt -67.31 -34.01 76.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.63 . . . . 1.03 110.916 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 98.5 mttt -71.07 -22.83 62.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.326 . . . . 1.75 111.161 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -72.58 -31.0 64.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 2.47 109.189 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -78.26 -4.26 46.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.325 -0.852 . . . . 3.04 110.336 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 93.3 mttt -94.06 -0.15 55.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 2.31 110.094 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -73.75 150.99 40.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.95 109.66 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.504 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.5 m120 -111.97 125.26 53.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.601 0.715 . . . . 1.13 111.248 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.405 ' HA ' ' HE2' ' A' ' 240' ' ' MET . 90.0 t80 -64.74 -32.23 73.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.41 -1.268 . . . . 3.74 110.018 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -70.03 160.8 31.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 1.62 111.719 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.11 179.37 52.87 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.895 -0.882 . . . . 1.16 110.895 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.58 137.2 42.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.858 0.829 . . . . 3.56 110.434 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 80.8 20.31 65.97 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.027 -0.606 . . . . 2.08 112.059 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -121.95 155.79 60.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 122.399 0.279 . . . . 2.59 110.263 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.76 125.14 18.13 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.916 2.41 . . . . 1.36 111.358 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -58.25 133.2 55.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.748 0.785 . . . . 3.4 112.59 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.13 120.19 18.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.62 -1.173 . . . . 2.47 108.508 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.5 116.91 7.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.739 0.304 . . . . 2.14 110.228 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 230' ' ' PHE . 51.7 ttm -70.52 95.29 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.697 -0.683 . . . . 1.68 109.525 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.27 169.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.315 -0.402 . . . . 1.27 110.607 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.4 t70 71.35 -100.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.931 0.77 . . . . 2.18 109.983 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 45.55 32.58 1.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.489 . . . . 2.15 110.833 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.495 ' HE1' ' CA ' ' A' ' 106' ' ' GLU . 78.6 t90 -115.23 137.11 52.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.992 -0.373 . . . . 4.59 109.992 -171.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 82.5 mtm180 -90.55 127.04 54.19 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.546 -0.297 . . . . 6.13 111.043 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 245' ' ' ARG . 34.8 Cg_exo -61.14 150.77 82.84 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.262 2.642 . . . . 3.28 113.363 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -96.58 95.43 7.97 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.663 -0.698 . . . . 2.98 111.762 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -56.92 157.33 11.06 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.699 . . . . 4.32 112.104 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.79 177.84 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.747 2.964 . . . . 3.48 113.488 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.68 -10.96 21.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.982 -1.008 . . . . 4.63 111.397 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -52.86 49.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.626 1.713 . . . . 5.34 115.626 168.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 32.0 p30 139.91 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.759 2.024 . . . . 4.64 113.193 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.479 ' CG ' ' H ' ' A' ' 254' ' ' GLN . 5.5 ttp180 97.37 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.186 -1.825 . . . . 6.11 110.839 156.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.479 ' H ' ' CG ' ' A' ' 253' ' ' ARG . 3.6 pp0? -157.95 162.1 38.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.874 -0.788 . . . . 3.08 108.874 -167.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.476 HD12 HG12 ' A' ' 33' ' ' ILE . 9.5 mt -100.06 129.03 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.866 0.365 . . . . 2.6 110.667 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -81.95 152.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.426 -0.583 . . . . 2.63 109.426 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.73 166.27 14.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.278 -0.419 . . . . 1.71 110.975 -172.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 27.8 p -149.36 97.82 2.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.543 0.687 . . . . 2.21 110.724 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -132.53 104.93 6.93 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.151 -0.931 . . . . 4.31 108.728 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.599 -0.715 . . . . 4.49 109.96 -178.139 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.906 0.384 . . . . 2.88 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.513 ' HB ' ' CG ' ' A' ' 248' ' ' GLN . 0.4 OUTLIER -96.2 144.27 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 2.32 110.875 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -114.86 111.08 20.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 2.82 109.907 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -10.87 57.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.267 0.469 . . . . 2.24 112.267 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -59.77 -26.73 65.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.884 0.373 . . . . 4.54 110.934 175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -81.63 -15.42 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 3.06 111.357 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -62.19 109.84 1.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.472 0.654 . . . . 1.72 112.742 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -107.23 120.61 42.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.748 -1.115 . . . . 3.69 109.405 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -85.12 130.68 34.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.762 -0.654 . . . . 4.64 109.805 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 43' ' ' SER . 16.4 t70 -110.33 125.63 30.57 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.375 -0.375 . . . . 2.27 110.727 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.08 -9.73 23.76 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.951 2.434 . . . . 2.15 113.831 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . 43.4 t -78.88 -26.36 43.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.305 -0.628 . . . . 4.29 109.305 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.64 125.89 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 4.74 109.663 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -118.68 133.38 23.6 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.441 -0.8 . . . . 3.77 110.568 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.73 123.66 6.14 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.008 2.472 . . . . 2.36 111.539 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 79' ' ' LEU . 47.5 mt -59.19 144.39 46.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 2.55 111.523 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.8 t -93.49 114.42 26.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.014 -1.106 . . . . 2.38 108.014 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.76 133.11 64.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.987 -0.552 . . . . 1.59 111.85 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 20.0 m -120.54 90.88 3.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.912 -0.585 . . . . 1.45 109.601 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -108.42 -2.26 19.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.06 -0.518 . . . . 3.62 111.403 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.37 -30.29 63.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.044 0.449 . . . . 2.48 110.228 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 94.1 mt-30 -76.16 -21.77 56.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 2.24 110.435 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -69.33 150.69 47.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.755 -0.657 . . . . 0.8 111.501 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.754 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 77.9 m -141.41 128.82 21.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.867 -0.606 . . . . 1.06 110.274 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 176' ' ' THR . 22.9 m -74.91 147.76 40.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 1.26 110.056 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 71' ' ' ASP . 96.2 mt -115.04 -52.32 2.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.421 -0.354 . . . . 0.74 110.985 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HA ' ' N ' ' A' ' 175' ' ' PHE . 15.9 ptp180 -163.99 164.69 23.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 3.17 111.33 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 tt -126.6 139.18 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.64 -0.709 . . . . 0.64 109.548 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.4 tp -126.56 137.19 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.96 111.344 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -92.32 107.88 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.329 -0.989 . . . . 1.49 108.329 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -113.34 68.06 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.02 -0.672 . . . . 1.83 109.969 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.64 -57.26 0.08 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 113.961 -1.472 . . . . 1.64 115.097 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -107.97 -22.79 12.28 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.389 0.276 . . . . 3.33 111.436 -169.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.42 178.29 10.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.662 0.268 . . . . 1.38 110.466 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 228' ' ' LEU . 96.8 m-85 -111.04 143.46 41.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.367 -0.379 . . . . 2.74 110.168 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -122.08 108.51 13.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.637 -0.256 . . . . 1.76 110.816 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 22.0 t -94.92 112.07 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.528 -0.545 . . . . 1.15 109.528 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.2 132.16 39.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.018 0.437 . . . . 2.02 111.866 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -103.83 157.73 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 1.66 109.249 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.754 ' OD1' ' HB ' ' A' ' 55' ' ' THR . 1.6 p-10 -91.09 125.54 35.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.15 0.5 . . . . 1.33 109.846 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.563 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 6.9 t70 -152.96 63.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.464 0.649 . . . . 2.65 110.313 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -76.68 1.81 15.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.065 0.935 . . . . 1.61 109.088 167.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -163.72 140.28 6.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.55 -1.648 . . . . 2.35 106.55 -177.091 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.15 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.713 0.768 . . . . 1.92 112.801 -168.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 70.8 mmtt -101.16 -47.25 4.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.314 -0.857 . . . . 1.77 110.199 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -105.5 99.42 9.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.762 -0.654 . . . . 0.76 110.268 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.34 127.64 65.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.042 -0.526 . . . . 1.27 111.554 -171.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 47' ' ' LEU . 48.2 tp -119.56 117.37 28.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 1.29 109.783 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -160.82 122.68 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.173 -0.306 . . . . 2.54 110.173 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -119.83 -179.52 16.51 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-O 119.587 -0.563 . . . . 1.31 112.315 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -34.87 -135.43 0.0 OUTLIER Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.43 0.932 . . . . 1.9 115.43 166.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.69 167.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 123.365 2.71 . . . . 2.91 113.802 -172.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.4 pt? -33.51 82.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.622 1.341 . . . . 4.11 114.622 -146.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 21.7 p-10 -81.67 -77.3 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.437 -1.71 . . . . 4.95 112.543 175.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.438 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.22 131.93 0.81 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.723 -1.351 . . . . 2.25 109.723 -165.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.7 m -73.6 115.54 13.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.086 0.943 . . . . 1.91 111.769 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.6 m-85 -104.85 145.84 29.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.659 -0.7 . . . . 3.7 109.74 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 80.2 mtm180 -107.72 138.31 44.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.551 0.215 . . . . 3.54 110.777 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HB3' ' HB1' ' A' ' 77' ' ' ALA . 4.4 tt -88.73 112.45 23.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.921 -0.77 . . . . 1.14 108.921 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' CE3' ' A' ' 123' ' ' TRP . 54.7 mt -125.54 -23.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.518 -0.473 . . . . 1.68 111.567 -174.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.716 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.1 pt20 -156.49 159.56 38.73 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.101 -0.374 . . . . 1.55 110.715 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 31.9 p90 -150.82 164.23 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.86 110.285 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.538 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 4.2 p-80 -137.98 158.53 44.13 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.656 0.597 . . . . 0.93 110.58 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -136.0 168.83 18.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.954 -0.387 . . . . 3.17 109.954 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -165.43 146.31 7.15 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.951 -0.389 . . . . 1.68 109.951 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.461 ' CZ3' ' HB2' ' A' ' 226' ' ' ARG . 83.1 t90 -140.22 147.97 40.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.233 -0.44 . . . . 5.18 109.833 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 84.76 165.61 40.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.682 -0.771 . . . . 2.13 113.164 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . 40.5 t 160.58 -89.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.115 0.966 . . . . 2.9 108.551 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.52 -156.55 0.55 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.983 -0.553 . . . . 3.03 110.027 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.79 -42.06 62.15 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.491 0.495 . . . . 3.85 111.361 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.28 46.63 0.56 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.351 -0.7 . . . . 1.94 111.351 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 104' ' ' GLY . 4.6 tt0 -116.74 -174.87 2.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.026 -0.731 . . . . 2.45 109.026 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 103' ' ' GLN . . . 131.39 -25.21 4.08 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.397 -0.906 . . . . 1.47 112.737 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 62.4 p -67.34 -36.58 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 245' ' ' ARG . 34.5 tt0 82.41 174.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.282 -1.377 . . . . 3.72 107.282 -166.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.533 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 98.2 m-70 55.66 58.86 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 3.52 111.605 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -82.26 122.2 27.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.249 0.547 . . . . 2.52 110.311 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 23.1 t -89.04 91.84 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.764 -0.653 . . . . 2.48 109.682 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.486 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 27.2 t70 64.84 -70.14 0.09 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.015 0.822 . . . . 2.8 110.65 -174.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.486 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 0.3 OUTLIER -142.21 11.81 1.97 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.013 -0.539 . . . . 4.98 111.094 174.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 40.1 ttmt -81.19 84.9 6.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.068 0.461 . . . . 3.23 109.795 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.493 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 17.6 pttp -110.87 132.97 53.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 2.82 110.82 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -107.07 167.42 9.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.471 -0.331 . . . . 1.62 110.307 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.439 ' HB1' ' NE1' ' A' ' 97' ' ' TRP . . . -65.16 -36.14 83.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.373 -0.376 . . . . 1.03 111.885 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.87 165.48 35.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.637 0.256 . . . . 0.75 110.998 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 105' ' ' SER . 51.9 tt0 -146.67 141.88 27.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.068 -0.716 . . . . 1.58 109.068 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' A' ' 93' ' ' PHE . 48.7 tp -101.57 116.41 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.936 -0.574 . . . . 1.07 109.496 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.538 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 18.8 m170 -107.42 105.44 15.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 1.77 110.69 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.7 mp -94.18 125.72 38.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.861 -0.609 . . . . 0.93 110.461 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -92.41 137.51 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 0.61 110.43 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 36.3 m80 -131.64 140.44 49.37 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.133 -0.692 . . . . 2.13 109.133 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.562 ' CE3' HD12 ' A' ' 91' ' ' ILE . 47.1 m0 -110.44 129.99 55.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.121 0.263 . . . . 4.26 110.492 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -63.21 114.72 3.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.084 0.469 . . . . 2.02 110.748 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -80.5 -26.79 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.842 -0.617 . . . . 2.34 111.642 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -59.1 -24.45 62.96 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.753 0.279 . . . . 3.35 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -91.06 9.77 29.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.323 0.583 . . . . 3.1 110.721 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . 67.72 -4.09 4.46 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.221 -0.899 . . . . 2.37 115.333 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 21.8 t70 175.21 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.131 0.966 . . . . 3.93 109.936 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 134' ' ' VAL . 35.4 p90 -58.08 -34.94 70.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.036 -0.529 . . . . 3.0 111.053 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.54 -38.73 88.82 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.201 -0.523 . . . . 2.15 112.706 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 8.9 mmpt? -78.39 -37.32 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.131 0.491 . . . . 3.43 109.98 175.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.608 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -64.88 -34.36 78.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.365 -0.834 . . . . 1.76 112.312 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 130' ' ' PHE . 27.9 m -67.94 -9.18 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.848 0.314 . . . . 2.77 111.848 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -93.06 -6.16 48.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.26 0.552 . . . . 3.55 110.309 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 44.7 tt0 -107.29 131.63 21.56 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 3.02 109.317 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 50.9 Cg_exo -55.03 -22.07 29.54 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.968 2.445 . . . . 1.6 112.879 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.575 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.9 m-20 -111.56 28.6 8.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 2.29 110.605 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -80.85 -40.29 12.25 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.086 -0.578 . . . . 1.22 114.524 -173.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.94 158.38 18.28 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.218 -0.578 . . . . 1.57 109.95 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -143.67 117.84 9.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.855 0.36 . . . . 1.38 110.716 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.75 121.38 61.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.141 -0.482 . . . . 1.73 110.06 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 209' ' ' ILE . 60.9 tp -93.83 119.42 32.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.486 -0.561 . . . . 2.42 109.486 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.75 111.35 3.76 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.977 -0.63 . . . . 0.86 112.615 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.7 mt -110.96 107.57 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 110.221 -0.288 . . . . 0.76 110.221 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 96.8 m-85 -63.15 149.46 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.2 111.323 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mp -113.83 131.26 56.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.589 . . . . 0.88 110.121 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 216' ' ' SER . 17.4 ptpt -122.16 136.82 54.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.562 -0.532 . . . . 2.03 109.562 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 3.6 m -99.82 79.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.313 0.577 . . . . 1.27 112.262 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -157.89 60.05 0.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.684 -0.77 . . . . 1.53 112.024 168.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.594 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 7.7 t 158.78 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.64 -1.244 . . . . 1.54 107.64 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -76.43 139.07 40.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.815 0.34 . . . . 0.78 110.739 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 216' ' ' SER . 16.9 tptm -110.62 96.62 28.83 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.14 -0.482 . . . . 1.22 109.968 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.42 -36.18 97.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.971 2.448 . . . . 1.05 112.453 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.55 -6.68 66.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.196 -0.526 . . . . 0.7 113.597 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.1 tp -90.06 -21.18 22.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.773 0.787 . . . . 0.77 110.743 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.425 ' HA ' ' HB ' ' A' ' 160' ' ' VAL . 7.9 tp-100 -57.28 -34.77 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 1.41 111.648 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -47.37 -50.6 21.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.296 0.48 . . . . 2.86 112.296 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -81.05 -30.07 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.703 -0.399 . . . . 1.38 110.814 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 82.1 t -63.83 -35.62 73.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.2 0.524 . . . . 1.11 111.204 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.88 -22.51 60.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.293 -0.412 . . . . 1.22 111.516 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.55 -13.89 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.372 0.508 . . . . 1.41 112.372 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 164' ' ' ASP . 3.9 pp -60.13 -27.51 67.12 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.912 0.708 . . . . 1.39 112.912 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.581 ' N ' HD12 ' A' ' 163' ' ' LEU . 14.7 t70 -70.97 -25.03 62.54 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.954 -0.466 . . . . 2.31 110.664 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.3 m -76.69 -3.52 38.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.063 0.459 . . . . 1.4 111.136 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.2 pt -137.36 36.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.341 -0.615 . . . . 0.85 109.341 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -74.85 -25.36 58.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.665 -0.698 . . . . 1.59 111.255 -171.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 231' ' ' ASN . 0.1 OUTLIER -119.54 148.55 43.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.936 0.398 . . . . 0.77 111.139 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -55.09 126.08 23.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 2.29 112.017 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.93 -16.51 36.26 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.69 -0.767 . . . . 0.85 112.077 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -88.69 152.74 21.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.321 0.581 . . . . 1.7 110.796 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 t -143.78 159.19 42.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.466 -0.788 . . . . 1.37 109.078 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.96 130.86 20.39 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.855 -0.424 . . . . 0.61 109.855 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.28 132.94 55.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.369 -0.604 . . . . 1.8 109.369 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.404 ' N ' ' HA ' ' A' ' 58' ' ' ARG . 27.2 t80 -140.69 77.94 1.63 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.019 -1.104 . . . . 1.04 108.019 -173.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 56' ' ' SER . 4.9 m -106.73 156.98 18.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 1.17 111.757 -173.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.16 60.28 2.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.916 0.886 . . . . 1.77 112.254 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -131.58 130.46 42.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.649 -1.159 . . . . 3.99 108.829 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.46 140.75 21.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.01 0.433 . . . . 2.51 111.462 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' A' ' 183' ' ' LEU . 73.5 Cg_endo -79.84 -6.52 14.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.918 2.412 . . . . 1.26 111.617 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -58.65 -42.41 88.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.305 -0.861 . . . . 2.76 111.568 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.06 -15.29 69.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.953 -0.641 . . . . 1.12 112.995 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 180' ' ' PRO . 3.9 mm? -88.45 -10.58 48.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.502 0.192 . . . . 1.73 111.45 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.11 141.35 40.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.83 0.348 . . . . 3.45 111.018 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.87 -175.58 2.83 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.915 2.41 . . . . 2.08 112.722 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.64 -59.94 2.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.337 -0.392 . . . . 3.23 111.044 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 m -83.8 137.35 33.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 1.66 111.264 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.1 tp -109.18 64.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.352 0.596 . . . . 1.99 110.351 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.408 ' O ' HD12 ' A' ' 211' ' ' LEU . 19.1 m-20 -108.01 166.16 10.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.807 -0.812 . . . . 1.81 108.807 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -164.89 163.89 20.94 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.156 -0.618 . . . . 5.01 112.224 -167.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.34 130.99 55.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.05 -0.977 . . . . 3.93 108.375 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.2 p -95.32 106.22 18.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 2.13 111.393 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -135.99 125.43 16.02 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 5.21 111.882 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.38 132.55 5.15 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.694 2.263 . . . . 2.12 112.531 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -110.42 157.14 15.19 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.959 -0.564 . . . . 1.75 112.006 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 60.1 m . . . . . 0 C--N 1.324 -0.539 0 O-C-N 122.595 -0.356 . . . . 2.99 111.206 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.781 0.324 . . . . 2.96 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 196' ' ' SER . 8.1 pt-20 -80.51 65.29 5.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.193 0.521 . . . . 3.37 110.989 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.4 p -128.53 13.9 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.44 0.904 . . . . 2.15 113.44 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.18 138.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.43 0.633 . . . . 1.26 112.181 -171.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 24.6 m -111.28 113.43 25.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.277 -1.009 . . . . 2.08 108.277 168.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -97.47 113.89 25.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.271 0.558 . . . . 5.53 110.331 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.478 ' O ' HD12 ' A' ' 143' ' ' LEU . 48.7 mm -103.49 102.99 14.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.587 -0.733 . . . . 1.63 109.277 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.06 125.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.412 -0.588 . . . . 1.62 109.412 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 189' ' ' ASP . 15.8 tp -80.09 116.85 20.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.058 -0.349 . . . . 1.73 110.058 -176.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -61.82 -33.38 74.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.95 -0.568 . . . . 2.98 110.401 -177.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -95.75 103.07 11.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 1.47 110.165 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 14.7 Cg_exo -71.23 171.58 15.74 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.725 2.283 . . . . 0.96 112.135 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.9 pt -112.44 149.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.566 . . . . 1.25 109.945 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 5.5 p -105.18 132.2 51.69 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.03 -0.532 . . . . 1.29 110.641 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 26.9 m -128.47 165.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.976 -0.556 . . . . 1.02 110.181 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 21.0 t -94.34 153.0 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.669 -0.241 . . . . 1.08 110.682 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.565 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 17.1 p -54.54 -48.14 72.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.49 0.186 . . . . 1.33 111.272 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -54.79 -29.41 54.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.392 -0.367 . . . . 2.51 111.63 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.88 -45.91 33.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.064 -0.516 . . . . 0.7 110.362 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 34.7 m -78.56 -21.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 1.36 111.91 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 219' ' ' SER . 77.1 mt -65.06 -31.62 72.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.411 . . . . 1.03 110.489 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 163' ' ' LEU . 53.2 mttm -74.61 -22.02 59.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.125 -0.489 . . . . 1.75 110.78 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.4 m-85 -77.48 -27.37 51.95 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.6 -0.889 . . . . 2.47 108.6 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.461 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 67.0 ttt180 -72.32 -20.06 61.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.535 -1.211 . . . . 3.04 110.651 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.16 -6.7 34.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 2.31 111.313 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.451 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 93.2 mt -65.22 154.78 37.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.916 0.389 . . . . 0.95 110.647 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -116.71 134.71 54.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.312 0.577 . . . . 1.13 110.713 -175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -78.72 -35.68 44.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.868 -1.06 . . . . 3.74 109.774 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.3 p-10 -72.64 169.35 16.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.049 -0.978 . . . . 1.62 111.888 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.01 177.25 38.19 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.303 -0.862 . . . . 1.16 111.177 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.37 125.37 25.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 3.56 110.487 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.14 7.74 42.99 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.728 -0.669 . . . . 2.08 113.397 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 44.3 mt-10 -112.32 157.54 39.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 117.393 0.597 . . . . 2.59 109.67 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.66 125.33 18.38 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.289 1.992 . . . . 1.36 110.613 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.43 118.48 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.84 0.829 . . . . 3.4 112.564 -171.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.99 116.37 31.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.583 -1.19 . . . . 2.47 107.901 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.97 125.14 25.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.063 0.459 . . . . 2.14 110.584 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 60.7 ttm -78.94 89.78 4.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 1.68 110.59 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.01 167.6 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.766 -0.827 . . . . 1.27 108.766 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 19.5 t70 66.48 -88.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.764 0.665 . . . . 2.18 110.056 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 63.09 -11.26 0.09 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.354 0.872 . . . . 2.15 113.354 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -153.77 175.11 13.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.142 -0.688 . . . . 4.59 109.142 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 106' ' ' GLU . 39.0 mtp85 -129.39 147.54 65.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.212 -0.292 . . . . 6.13 110.212 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.99 82.48 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.748 2.298 . . . . 3.28 111.561 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -98.78 118.18 34.94 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.049 -0.523 . . . . 2.98 111.315 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.513 ' CG ' ' HB ' ' A' ' 33' ' ' ILE . 16.2 mm-40 -124.16 156.31 66.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 4.32 109.465 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.18 129.54 6.03 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.404 2.736 . . . . 3.48 113.095 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -43.45 -57.21 3.19 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 124.121 0.888 . . . . 4.63 112.231 -171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 54.6 pttt -106.34 0.2 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.554 0.216 . . . . 5.34 111.422 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER 75.89 -47.97 0.58 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.601 0.761 . . . . 4.64 111.465 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 70.64 -108.81 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.607 -0.886 . . . . 6.11 108.607 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -140.93 136.75 32.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.231 -1.396 . . . . 3.08 107.231 165.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 75.6 mt -84.6 121.85 37.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.302 -0.559 . . . . 2.6 109.671 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.35 134.85 42.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.899 -0.778 . . . . 2.63 108.899 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.25 172.9 12.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.257 -0.429 . . . . 1.71 110.019 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.7 m -128.33 94.69 3.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.292 -0.563 . . . . 2.21 110.968 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -146.37 126.66 13.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.733 -0.839 . . . . 4.31 108.733 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 18.8 pttp . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.244 -0.884 . . . . 4.49 110.336 -179.42 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 107.067 -1.457 . . . . 2.88 107.067 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 55.5 mt -93.96 90.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.237 0.541 . . . . 2.32 111.116 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -77.15 106.23 8.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.604 -0.726 . . . . 2.82 109.849 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -40.61 30.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.402 -0.817 . . . . 2.24 112.777 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -70.48 -33.75 71.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 4.54 110.885 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 m -89.34 -30.26 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.459 -0.337 . . . . 3.06 111.252 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.87 89.93 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.043 0.449 . . . . 1.72 112.035 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -97.97 138.75 34.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.944 -0.571 . . . . 3.69 110.145 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.772 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 48.0 p90 -84.26 123.4 30.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.928 0.394 . . . . 4.64 110.65 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.97 139.0 23.07 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.32 -0.4 . . . . 2.27 110.076 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -90.17 22.82 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.812 2.341 . . . . 2.15 112.324 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 m -89.35 -18.8 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 4.29 110.65 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.45 HD21 ' OG ' ' A' ' 258' ' ' SER . 3.4 pp -97.55 156.91 16.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 4.74 110.255 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -99.03 144.22 27.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.432 -0.349 . . . . 3.77 110.954 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 31.1 Cg_endo -64.37 165.35 20.23 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.128 2.552 . . . . 2.36 112.184 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.6 146.23 24.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 2.55 111.743 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -110.61 107.15 16.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.678 -0.86 . . . . 2.38 108.678 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -90.76 102.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.411 -0.359 . . . . 1.59 110.873 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -119.26 89.47 3.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.119 0.485 . . . . 1.45 110.423 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.06 21.71 1.58 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.54 0.686 . . . . 3.62 110.423 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.31 -17.92 64.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.38 -0.827 . . . . 2.48 110.021 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.02 -5.02 38.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.729 -0.669 . . . . 2.24 109.811 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.61 158.76 35.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.707 -0.678 . . . . 0.8 111.838 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -150.16 143.38 25.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.199 -0.91 . . . . 1.06 109.076 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 176' ' ' THR . 14.5 m -91.1 165.37 13.54 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.14 -0.689 . . . . 1.26 109.14 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -119.36 -50.34 2.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.018 0.437 . . . . 0.74 111.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -157.9 152.58 25.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.256 -0.429 . . . . 3.17 111.072 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.551 HG13 HG22 ' A' ' 68' ' ' VAL . 14.6 tt -115.55 138.48 45.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.034 -0.728 . . . . 0.64 109.034 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 172' ' ' SER . 47.2 tp -135.82 141.17 44.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.207 0.527 . . . . 0.96 112.229 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -100.16 105.6 17.22 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.797 -1.186 . . . . 1.49 107.797 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -138.56 73.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.158 0.504 . . . . 1.83 112.09 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.59 -52.71 0.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.838 -1.173 . . . . 1.64 111.997 161.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -147.41 -51.24 0.19 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.98 0.419 . . . . 3.33 110.094 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.58 169.77 8.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 1.38 111.491 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 228' ' ' LEU . 34.4 m-85 -110.24 100.25 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.502 -0.772 . . . . 2.74 109.247 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -89.33 118.58 29.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 1.76 111.622 -170.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 59' ' ' ILE . 21.3 t -100.71 114.07 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.65 -0.5 . . . . 1.15 109.65 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -80.26 138.77 36.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.038 0.385 . . . . 2.02 112.038 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.454 ' CE2' ' HD1' ' A' ' 93' ' ' PHE . 65.9 m-85 -105.32 163.32 12.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.691 -0.686 . . . . 1.66 109.747 170.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.58 113.53 25.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.894 -0.41 . . . . 1.33 109.894 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -124.55 57.87 1.24 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.868 0.842 . . . . 2.65 111.034 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -87.71 -9.26 54.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.082 0.944 . . . . 1.61 108.926 167.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.25 171.3 19.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.445 -1.252 . . . . 2.35 108.057 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.28 73.15 2.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.38 0.609 . . . . 1.92 110.857 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -92.35 -56.48 3.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.815 . . . . 1.77 109.67 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.21 101.71 11.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.719 -0.673 . . . . 0.76 109.722 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.31 135.23 63.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.191 0.52 . . . . 1.27 110.746 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 tp -140.07 110.56 6.69 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.342 -0.985 . . . . 1.29 108.342 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -148.89 125.62 11.13 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.006 -0.678 . . . . 2.54 112.683 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . -66.22 173.86 23.18 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.354 -0.839 . . . . 1.31 111.663 159.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' O ' ' HG ' ' A' ' 84' ' ' LEU . . . -41.83 -143.93 0.0 OUTLIER Glycine 0 CA--C 1.538 1.485 0 N-CA-C 114.996 0.758 . . . . 1.9 114.996 169.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.88 122.69 9.45 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.955 1.77 . . . . 2.91 112.447 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 82' ' ' GLY . 82.1 mt -138.77 -168.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.899 -1.046 . . . . 4.11 110.216 -174.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.64 57.17 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.022 0.379 . . . . 4.95 112.022 -167.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.51 -116.94 2.26 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.024 -1.084 . . . . 2.25 113.995 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.417 HG21 ' HB ' ' A' ' 125' ' ' THR . 11.6 m -127.36 111.78 14.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.65 -0.5 . . . . 1.91 109.65 -171.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.73 ' HA ' ' CD2' ' A' ' 122' ' ' HIS . 9.8 m-85 -99.03 91.12 4.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.518 0.675 . . . . 3.7 112.3 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.57 146.77 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.016 -0.993 . . . . 3.54 109.532 172.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 120' ' ' LEU . 10.4 tp -89.61 130.33 35.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.633 -0.506 . . . . 1.14 109.633 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.5 tt -106.31 -32.78 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.677 0.275 . . . . 1.68 111.481 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 91' ' ' ILE . 3.8 pt20 -163.04 171.95 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 1.55 110.352 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.454 ' HD1' ' CE2' ' A' ' 70' ' ' PHE . 26.8 p90 -144.41 146.98 32.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.86 109.347 169.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.426 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 5.2 p-80 -134.28 160.16 38.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.8 -0.444 . . . . 0.93 109.8 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.17 167.91 19.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.948 0.404 . . . . 3.17 110.95 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.13 167.78 29.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.93 -0.767 . . . . 1.68 108.93 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -151.2 151.11 31.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.15 0.282 . . . . 5.18 110.245 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -113.37 159.71 13.53 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.838 -0.696 . . . . 2.13 112.164 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 -39.76 79.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.869 0.366 . . . . 2.9 111.857 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.27 146.02 37.75 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.809 -0.812 . . . . 3.03 108.809 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.26 12.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.684 0.624 . . . . 3.85 112.684 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.66 17.83 10.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 1.94 111.97 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.429 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 14.0 pt20 -158.15 159.51 36.24 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.115 -0.328 . . . . 2.45 110.115 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.46 6.74 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 1.47 112.246 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.4 t -69.41 -45.81 68.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.748 0.309 . . . . 2.0 111.069 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.586 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 2.6 tp10 65.05 -162.64 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.528 -0.76 . . . . 3.72 109.093 -169.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.586 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 33.7 m80 53.27 49.28 20.19 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.171 0.986 . . . . 3.52 108.53 -167.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 t -79.72 131.58 35.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.815 -1.539 . . . . 2.52 112.171 -168.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 28.4 t -98.98 107.55 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 114.359 -1.291 . . . . 2.48 109.633 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.36 42.95 20.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.56 0.695 . . . . 2.8 110.096 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm 61.15 20.71 11.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.887 -1.051 . . . . 4.98 112.497 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -94.01 112.34 24.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.59 -0.522 . . . . 3.23 109.59 169.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 50.7 mttp -98.55 168.03 10.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.18 0.514 . . . . 2.82 111.174 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -119.53 176.55 5.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.3 -0.863 . . . . 1.62 109.453 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.91 94.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.1 0.407 . . . . 1.03 112.1 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.8 168.5 25.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.267 -0.424 . . . . 0.75 109.961 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -142.52 140.37 31.8 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.599 -0.519 . . . . 1.58 109.599 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 36.8 tp -103.3 125.75 50.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.323 -0.621 . . . . 1.07 109.323 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 12.3 m170 -118.76 109.93 16.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.1 0.476 . . . . 1.77 112.1 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -94.33 116.43 28.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.701 -0.681 . . . . 0.93 109.484 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.3 124.24 48.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.105 0.478 . . . . 0.61 112.013 -171.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.73 ' CD2' ' HA ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -89.62 140.96 29.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 2.13 111.005 175.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -112.64 141.53 46.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 4.26 109.542 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -93.22 96.01 9.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 2.02 110.927 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.417 ' HB ' HG21 ' A' ' 87' ' ' THR . 2.9 m -68.01 -16.94 64.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.934 -0.576 . . . . 2.34 111.251 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -52.63 -33.12 45.22 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.71 0.404 . . . . 3.35 111.804 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -107.85 -6.51 16.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.367 0.603 . . . . 3.1 110.484 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.52 38.55 9.5 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.232 -1.349 . . . . 2.37 113.785 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.56 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 22.8 t70 -166.31 110.48 0.79 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.634 -0.506 . . . . 3.93 109.634 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -57.26 -32.94 67.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 3.0 111.19 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.15 81.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.056 -0.593 . . . . 2.15 112.761 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.56 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 38.0 mmtm -88.29 -28.8 20.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 3.43 110.375 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.482 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -63.91 -36.28 83.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.76 110.685 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.483 ' O ' HD21 ' A' ' 203' ' ' LEU . 34.9 m -77.99 -2.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.372 -0.376 . . . . 2.77 111.236 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -109.01 19.23 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.278 0.561 . . . . 3.55 110.449 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -129.02 128.3 23.38 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.269 -1.011 . . . . 3.02 108.269 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.88 -31.59 73.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.097 2.532 . . . . 1.6 113.2 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -111.13 24.26 13.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 2.29 109.997 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -66.01 -50.23 53.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.016 -0.538 . . . . 1.22 112.497 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 79.4 mt -109.28 151.98 25.83 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.418 -0.586 . . . . 1.57 109.418 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -145.99 123.91 12.02 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.748 -0.834 . . . . 1.38 108.748 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.55 116.83 53.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.879 -0.328 . . . . 1.73 110.899 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 38.0 tp -83.38 115.69 22.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.668 -0.696 . . . . 2.42 109.696 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -106.16 128.88 9.52 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.038 -0.601 . . . . 0.86 112.623 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.7 122.61 70.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.387 -0.597 . . . . 0.76 109.387 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -69.75 146.39 51.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 1.2 110.301 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.34 130.46 56.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.413 -0.358 . . . . 0.88 110.149 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 216' ' ' SER . 26.2 pttm -125.32 151.59 45.84 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.457 -0.571 . . . . 2.03 109.457 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 40.7 t -84.84 121.42 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.094 0.473 . . . . 1.27 110.62 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.48 -114.72 0.33 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.504 -0.771 . . . . 1.53 111.201 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.3 p -74.01 156.3 37.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.206 -0.294 . . . . 1.54 110.206 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.22 148.88 37.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.808 0.337 . . . . 0.78 111.04 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 216' ' ' SER . 46.3 tptt -113.68 100.04 51.2 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.29 -0.414 . . . . 1.22 110.033 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 28.4 Cg_endo -63.32 -31.33 73.42 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.663 2.242 . . . . 1.05 112.543 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.94 -19.34 71.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.063 -0.589 . . . . 0.7 112.979 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.0 tp -112.07 -12.04 13.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.054 0.454 . . . . 0.77 110.792 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -40.52 79.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.909 -0.587 . . . . 1.41 111.142 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.98 -26.86 62.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.972 0.415 . . . . 2.86 110.314 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 162' ' ' VAL . 59.0 t -72.3 -44.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 1.38 109.504 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.563 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 41.6 t -62.58 -34.31 64.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.691 . . . . 1.11 110.361 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.2 -28.74 68.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.443 -0.798 . . . . 1.22 111.562 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 159' ' ' VAL . 8.8 p -97.73 -14.57 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.794 -0.363 . . . . 1.41 111.883 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.4 pp -70.75 -20.42 62.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.618 -0.433 . . . . 1.39 111.891 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 30.7 t70 -67.39 -24.42 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.235 0.54 . . . . 2.31 110.398 176.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.0 m -79.81 1.16 27.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 1.4 111.229 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 59' ' ' ILE . 40.5 pt -137.28 37.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.779 -0.823 . . . . 0.85 108.779 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 87.1 tttt -58.45 -32.01 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.861 -1.063 . . . . 1.59 111.854 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -119.92 154.17 34.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.31 -0.404 . . . . 0.77 110.485 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.46 135.37 57.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 2.29 110.663 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.7 38.18 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.71 -0.757 . . . . 0.85 111.715 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -89.77 143.47 26.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.7 110.711 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.488 ' HB3' HD13 ' A' ' 60' ' ' LEU . 65.3 p -139.88 156.59 46.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.033 -0.53 . . . . 1.37 109.659 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.6 140.37 40.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.118 -0.327 . . . . 0.61 110.118 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.92 130.8 44.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.553 -0.536 . . . . 1.8 109.553 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.38 79.79 1.68 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.797 -0.446 . . . . 1.04 109.797 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 56' ' ' SER . 21.7 p -106.76 164.98 11.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 1.17 111.148 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 56.65 71.32 0.58 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.432 0.457 . . . . 1.77 111.255 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.473 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 55.1 t80 -123.59 142.37 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.754 0.311 . . . . 3.99 110.293 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.47 102.3 14.11 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.823 -0.626 . . . . 2.51 110.061 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 2.9 Cg_exo -75.83 -19.83 15.82 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.637 2.224 . . . . 1.26 111.688 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -56.6 -38.55 72.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.287 -0.87 . . . . 2.76 111.663 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.08 6.94 2.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.125 -0.489 . . . . 1.12 113.863 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.57 -13.61 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.272 0.536 . . . . 1.73 110.352 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.3 130.43 87.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.591 . . . . 3.45 111.356 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.62 -171.95 1.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.443 2.095 . . . . 2.08 111.384 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.91 -62.37 1.67 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.936 0.398 . . . . 3.23 110.203 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.4 m -75.06 123.1 24.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 1.66 110.936 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.3 tp -101.52 64.1 0.98 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.625 0.726 . . . . 1.99 109.47 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 258' ' ' SER . 12.3 m-20 -124.91 147.64 48.73 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.398 -0.964 . . . . 1.81 108.398 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.457 ' CD1' HG23 ' A' ' 209' ' ' ILE . 53.1 p90 -144.43 158.71 43.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.562 0.949 . . . . 5.01 113.562 -166.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -93.02 140.08 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.42 -1.326 . . . . 3.93 107.42 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 9.3 t -136.57 116.72 13.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.713 0.688 . . . . 2.13 112.684 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -140.31 132.38 14.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 5.21 110.632 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.18 125.4 10.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.598 1.532 . . . . 2.12 110.575 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.34 160.13 26.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.035 -0.602 . . . . 1.75 113.249 -168.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 14.0 m . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 109.65 -0.5 . . . . 2.99 109.65 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 196' ' ' SER . 30.9 tp . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 108.905 -0.776 . . . . 2.96 108.905 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -98.89 51.55 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.381 0.61 . . . . 3.37 110.897 -171.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.7 p -91.89 -5.72 52.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.926 -0.579 . . . . 2.15 110.859 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 133.18 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.064 0.459 . . . . 1.26 110.575 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 21.7 m -105.91 103.51 13.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.126 -0.694 . . . . 2.08 109.126 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 192' ' ' THR . 96.3 m95 -76.16 110.39 10.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.301 -0.409 . . . . 5.53 110.43 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 74.3 mt -115.38 101.18 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.201 -0.666 . . . . 1.63 109.201 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 41.3 t -113.44 126.03 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 121.035 -0.266 . . . . 1.62 110.852 -171.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 137.25 41.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.291 0.567 . . . . 1.73 111.306 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -68.38 -10.35 54.46 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.346 -0.843 . . . . 2.98 112.376 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -114.61 107.75 50.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.815 -0.354 . . . . 1.47 111.198 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.81 143.49 50.77 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.133 2.555 . . . . 0.96 112.417 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -96.43 158.86 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.29 -0.633 . . . . 1.25 109.29 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 6.6 m -106.91 139.36 41.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.967 0.413 . . . . 1.29 111.425 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -124.18 148.42 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.02 109.024 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.7 t -94.98 164.78 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.149 -0.315 . . . . 1.08 110.149 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 m -47.23 -48.09 24.43 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.775 0.658 . . . . 1.33 112.775 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.55 -33.98 56.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 2.51 111.413 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -78.38 -43.32 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.262 -0.426 . . . . 0.7 110.049 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.72 -38.93 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 1.36 110.929 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.4 mt -57.63 -36.03 71.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.766 -0.652 . . . . 1.03 111.303 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -77.2 -24.33 51.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.318 -0.401 . . . . 1.75 110.961 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -72.13 -34.04 68.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 2.47 109.491 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -70.87 -11.1 60.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.093 -0.958 . . . . 3.04 110.987 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 99.6 mttt -89.96 -19.36 24.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.3 -0.409 . . . . 2.31 111.338 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.436 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 95.7 mt -64.61 146.03 55.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.321 0.582 . . . . 0.95 112.199 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.09 149.2 37.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.408 -0.815 . . . . 1.13 109.901 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -86.4 -32.12 21.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.464 -0.789 . . . . 3.74 110.027 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -71.95 166.49 22.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.085 -0.962 . . . . 1.62 111.959 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.99 -177.8 36.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.548 -0.751 . . . . 1.16 111.433 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.05 130.76 46.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.838 0.352 . . . . 3.56 110.743 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.6 33.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.808 -0.71 . . . . 2.08 112.919 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.84 160.48 66.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.37 -0.604 . . . . 2.59 109.37 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -53.06 123.02 12.18 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.476 2.117 . . . . 1.36 111.46 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.413 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 54.1 mt-10 -68.65 112.74 5.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 3.4 111.413 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -116.42 121.42 41.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.05 -0.977 . . . . 2.47 109.268 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -67.54 148.42 51.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 2.14 111.06 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 57.0 tpp -76.68 97.38 4.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.233 -0.894 . . . . 1.68 109.202 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.16 135.12 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.955 0.354 . . . . 1.27 111.955 -171.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.595 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 38.9 t70 70.59 -59.98 0.51 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.242 1.017 . . . . 2.18 111.037 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 84.24 -28.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.976 -1.011 . . . . 2.15 113.023 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -165.04 152.66 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.264 0.484 . . . . 4.59 112.07 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -139.72 71.99 36.19 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.408 -0.815 . . . . 6.13 109.565 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 106' ' ' GLU . 31.2 Cg_endo -120.25 57.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 123.498 2.798 . . . . 3.28 115.378 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -115.26 122.31 45.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.634 1.106 . . . . 2.98 110.827 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 253' ' ' ARG . 16.5 mm-40 -122.91 162.7 37.56 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 111.697 0.258 . . . . 4.32 111.697 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.24 174.02 11.38 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.976 2.451 . . . . 3.48 113.512 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 252' ' ' ASN . 3.3 mm? -60.68 -11.01 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.591 -1.186 . . . . 4.63 113.451 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 252' ' ' ASN . 19.6 ptpt -59.44 41.25 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.611 1.338 . . . . 5.34 114.611 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 251' ' ' LYS . 6.3 t-20 118.48 -33.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.539 1.935 . . . . 4.64 110.069 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.55 ' N ' ' HD3' ' A' ' 253' ' ' ARG . 0.5 OUTLIER -90.69 89.6 7.59 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.586 0.708 . . . . 6.11 110.107 -177.313 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -155.39 154.1 31.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.92 -1.141 . . . . 3.08 107.92 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 256' ' ' LYS . 14.9 mt -124.84 136.82 59.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.602 -0.439 . . . . 2.6 110.766 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.48 ' O ' HG22 ' A' ' 255' ' ' ILE . 40.5 mtmt -76.99 165.53 24.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 2.63 109.472 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.772 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.48 159.01 27.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.532 -0.544 . . . . 1.71 109.532 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 41.8 m -151.91 97.64 2.36 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.884 -0.413 . . . . 2.21 109.884 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.38 110.46 10.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.651 -0.704 . . . . 4.31 109.249 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.438 -0.792 . . . . 4.49 110.165 178.759 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 108.212 -1.033 . . . . 2.88 108.212 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 61.3 mt -90.57 102.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 2.32 111.794 -167.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.08 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 2.82 109.944 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -60.1 -32.55 71.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.367 0.877 . . . . 2.24 113.367 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -68.85 -45.14 71.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.73 0.3 . . . . 4.54 111.083 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -82.09 -19.65 39.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.365 -0.38 . . . . 3.06 111.004 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.3 134.74 50.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.989 0.423 . . . . 1.72 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.76 116.31 28.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 3.69 110.401 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.51 124.4 26.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 4.64 109.82 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.659 ' O ' ' HA ' ' A' ' 258' ' ' SER . 29.9 t70 -118.9 143.37 33.6 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.128 -0.942 . . . . 2.27 110.137 -170.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 44' ' ' LEU . 21.1 Cg_exo -67.36 119.13 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.157 1.905 . . . . 2.15 111.815 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 m -53.38 43.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.025 1.12 . . . . 4.29 114.025 169.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' H ' ' A' ' 45' ' ' LYS . 2.0 pt? -14.32 -66.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.304 1.842 . . . . 4.74 114.044 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.613 ' H ' ' HG ' ' A' ' 44' ' ' LEU . 27.5 mmtp -117.16 148.6 42.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 121.717 -0.615 . . . . 3.77 109.807 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.23 137.66 31.68 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.747 2.298 . . . . 2.36 112.696 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.462 HD11 ' CD2' ' A' ' 190' ' ' TYR . 95.1 mt -66.61 127.41 32.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 2.55 111.06 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 22.7 t -84.12 115.16 22.25 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.652 -0.87 . . . . 2.38 108.652 174.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.9 107.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.521 . . . . 1.59 110.092 -173.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 78' ' ' VAL . 19.5 t -133.63 91.74 2.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.142 0.496 . . . . 1.45 110.834 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -108.98 0.53 20.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.795 -0.639 . . . . 3.62 110.192 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' A' ' 181' ' ' ARG . 4.1 m-20 -69.29 -30.88 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 2.48 111.816 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.67 -2.58 37.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.716 -0.394 . . . . 2.24 110.692 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.13 130.15 40.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.054 -0.521 . . . . 0.8 111.785 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -106.33 106.88 17.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 1.06 110.975 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.0 OUTLIER -74.47 143.0 44.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.277 -0.419 . . . . 1.26 110.109 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 71' ' ' ASP . 86.4 mt -114.71 -57.26 2.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.825 0.345 . . . . 0.74 111.85 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -155.41 159.28 39.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 3.17 111.052 -170.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 66' ' ' PHE . 13.2 tt -126.1 137.11 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.2 -0.667 . . . . 0.64 109.2 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' OG ' ' A' ' 172' ' ' SER . 27.3 tp -140.87 110.83 6.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.827 0.346 . . . . 0.96 111.809 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 66' ' ' PHE . 40.8 t30 -75.73 117.74 17.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.898 -0.778 . . . . 1.49 108.898 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -140.3 69.39 1.35 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.244 -0.583 . . . . 1.83 111.301 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.52 -67.3 0.51 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.497 -0.859 . . . . 1.64 112.798 165.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.517 ' CE1' ' HB3' ' A' ' 243' ' ' ASN . 49.8 t60 -101.11 -29.53 12.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 3.33 111.1 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.79 -171.75 1.68 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.942 -0.572 . . . . 1.38 109.757 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 30.9 p90 -118.16 123.17 44.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 2.74 109.712 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -94.43 114.96 27.07 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.539 -0.755 . . . . 1.76 110.364 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 59.8 t -90.6 105.88 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 1.15 109.597 173.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.9 137.77 32.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.994 0.426 . . . . 2.02 111.472 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.99 170.07 8.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 1.66 110.681 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 57' ' ' LEU . 24.3 t70 -97.45 101.43 12.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.831 -0.622 . . . . 1.33 109.345 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.549 ' OD1' ' HB3' ' A' ' 90' ' ' LEU . 16.0 m-20 -120.9 60.62 0.9 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.65 111.038 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.7 t -108.82 1.1 20.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.487 -0.779 . . . . 1.61 111.195 173.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.24 172.59 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.673 0.273 . . . . 2.35 111.03 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.41 65.7 5.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.891 -0.595 . . . . 1.92 110.989 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -130.77 1.92 4.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.532 . . . . 1.77 110.587 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HB1' ' CD2' ' A' ' 90' ' ' LEU . . . -154.01 84.49 1.15 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.272 -0.64 . . . . 0.76 109.272 -168.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 50' ' ' SER . 27.1 m -139.54 149.17 22.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.375 0.607 . . . . 1.27 112.539 -173.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 48' ' ' SER . 40.0 tp -148.56 112.36 5.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.864 -1.062 . . . . 1.29 108.826 170.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 87' ' ' THR . 45.3 pttt -150.13 141.0 22.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.483 0.549 . . . . 2.54 112.483 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -57.68 172.68 2.87 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 115.628 -0.715 . . . . 1.31 111.928 156.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.94 -143.99 0.0 OUTLIER Glycine 0 CA--C 1.54 1.649 0 N-CA-C 117.793 1.877 . . . . 1.9 117.793 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.17 124.36 7.48 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.185 2.59 . . . . 2.91 114.174 -163.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 12.3 tp -142.13 -168.15 2.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.748 -1.569 . . . . 4.11 107.142 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.511 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 p-10 -148.82 89.08 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.13 0.877 . . . . 4.95 109.181 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 99.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.589 -0.815 . . . . 2.25 111.098 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 80' ' ' LYS . 46.2 m -104.61 103.2 12.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.62 0.724 . . . . 1.91 112.494 -172.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.0 m-85 -126.34 98.26 5.37 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.203 -1.036 . . . . 3.7 108.203 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 27.5 mmt180 -141.69 89.03 2.17 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 112.192 0.441 . . . . 3.54 112.192 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.549 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 40.6 tp -156.82 158.89 37.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.745 -1.576 . . . . 1.14 106.745 160.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.511 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 6.1 tp -161.88 -46.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.816 1.189 . . . . 1.68 112.287 169.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 8.6 pt20 -158.8 172.2 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 1.55 111.479 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -146.57 144.05 29.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.118 -0.697 . . . . 0.86 109.118 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.6 p-80 -142.32 159.89 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.267 -0.424 . . . . 0.93 110.48 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.597 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 81.3 m-85 -117.73 168.11 10.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 3.17 110.646 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -122.91 170.99 9.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.085 -0.709 . . . . 1.68 109.085 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -156.24 129.37 8.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.868 0.366 . . . . 5.18 110.131 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 103' ' ' GLN . . . -89.59 -50.86 3.03 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.769 -0.65 . . . . 2.13 113.14 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.577 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 26.3 t 149.06 -50.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.348 1.059 . . . . 2.9 108.74 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.69 160.88 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 3.03 109.398 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 115' ' ' ALA . 35.0 t70 -71.71 67.16 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.423 0.63 . . . . 3.85 110.607 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.46 42.91 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.701 -0.761 . . . . 1.94 112.941 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.647 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 3.5 pt20 -172.27 143.03 1.41 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.018 0.409 . . . . 2.45 110.423 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.21 81.84 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 120.786 -0.721 . . . . 1.47 112.35 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 41.6 t -89.14 -8.34 53.93 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.12 0.415 . . . . 2.0 112.12 -177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HA ' ' NE1' ' A' ' 244' ' ' TRP . 7.7 tp10 72.3 157.46 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.287 0.367 . . . . 3.72 110.471 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.46 ' CG ' ' HG3' ' A' ' 106' ' ' GLU . 29.6 m170 54.61 67.31 1.03 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.074 0.464 . . . . 3.52 111.863 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -80.21 127.25 32.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.892 0.853 . . . . 2.52 111.016 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 38.1 t -103.29 105.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.58 -1.191 . . . . 2.48 110.157 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.03 45.43 21.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 2.8 110.293 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 64.27 14.29 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.685 -1.143 . . . . 4.98 112.077 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -89.03 126.16 35.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.69 -0.485 . . . . 3.23 109.69 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.61 155.08 21.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.046 -0.724 . . . . 2.82 109.046 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -109.51 -170.24 1.62 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.344 -0.389 . . . . 1.62 110.287 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.435 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -46.6 18.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.374 . . . . 1.03 110.916 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.09 163.95 38.42 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.945 -0.571 . . . . 0.75 110.448 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -129.11 145.56 51.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 1.58 110.046 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.597 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 24.6 tp -111.73 112.2 23.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.246 -0.434 . . . . 1.07 109.861 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.431 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 46.9 m170 -110.93 105.27 14.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.15 -0.477 . . . . 1.77 111.335 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.7 mp -91.01 110.77 22.03 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.5 t -86.9 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.61 110.195 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 89' ' ' ARG . 38.6 m80 -131.22 125.31 32.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.905 -0.588 . . . . 2.13 109.838 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.511 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -111.02 151.53 27.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.052 -0.721 . . . . 4.26 109.052 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 15.9 p30 -93.2 101.53 13.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.787 0.803 . . . . 2.02 111.244 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -64.49 -10.02 22.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.39 -0.823 . . . . 2.34 112.813 -173.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -69.65 -47.94 61.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.842 0.353 . . . . 3.35 110.468 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -84.4 -21.11 30.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.375 0.607 . . . . 3.1 110.493 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.46 -2.28 64.97 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.813 -1.315 . . . . 2.37 109.813 -171.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 123' ' ' TRP . 12.0 t70 73.3 -87.0 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.0 -1.1 . . . . 3.93 112.957 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -46.38 -40.12 11.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.069 0.766 . . . . 3.0 113.069 -168.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 134' ' ' VAL . . . -55.22 -61.12 7.73 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.022 -0.609 . . . . 2.15 112.324 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -73.69 -28.19 61.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.742 0.275 . . . . 3.43 111.742 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.63 62.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.473 0.546 . . . . 1.76 112.473 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 203' ' ' LEU . 34.4 m -64.92 -31.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.857 -0.337 . . . . 2.77 111.157 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 134' ' ' VAL . 41.6 mt-30 -100.66 -28.3 12.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 3.55 110.855 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.541 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 60.5 tt0 -76.05 119.85 79.03 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 3.02 110.848 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.95 -17.1 54.96 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 1.6 111.365 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.541 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 m-20 -105.31 27.07 8.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.159 -0.928 . . . . 2.29 109.418 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.09 -82.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.382 0 CA-C-N 116.115 -0.493 . . . . 1.22 112.554 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.43 148.9 25.35 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.21 0.529 . . . . 1.57 110.661 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.46 104.51 7.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.486 -0.779 . . . . 1.38 109.177 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.59 129.29 60.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.314 -0.403 . . . . 1.73 111.28 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 34.4 tp -97.47 127.27 43.3 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.173 -0.677 . . . . 2.42 109.173 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -111.23 131.18 10.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.783 -0.722 . . . . 0.86 112.736 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.4 mt -137.69 106.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 0.76 109.508 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -62.93 156.43 24.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.936 0.398 . . . . 1.2 111.889 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.75 123.2 49.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.88 110.097 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.3 ptmm? -115.64 138.39 51.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.817 -0.629 . . . . 2.03 109.823 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 47.8 t -88.1 133.97 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.711 0.291 . . . . 1.27 110.991 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . 126.64 58.63 0.14 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.847 -0.692 . . . . 1.53 113.361 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.624 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 3.2 t 160.26 122.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.26 -1.015 . . . . 1.54 108.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.31 134.64 39.68 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.941 -0.304 . . . . 0.78 110.271 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -114.91 95.85 42.85 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.303 -0.408 . . . . 1.22 110.462 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.84 -39.25 92.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.152 2.568 . . . . 1.05 112.341 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -66.66 -21.05 70.67 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.926 -0.654 . . . . 0.7 112.82 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 160' ' ' VAL . 60.7 tp -91.88 -31.27 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 0.77 110.412 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.462 ' NE2' ' HG2' ' A' ' 221' ' ' GLN . 8.7 tp-100 -53.37 -40.98 65.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 1.41 112.27 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.5 pttt -55.41 -37.45 67.65 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.642 0.608 . . . . 2.86 112.642 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 162' ' ' VAL . 12.0 p -85.16 -32.64 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.434 -0.507 . . . . 1.38 110.959 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.619 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 44.1 t -64.96 -38.97 84.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 1.11 110.909 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.97 -35.3 79.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.78 -0.646 . . . . 1.22 111.429 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 175' ' ' PHE . 8.3 p -88.04 -17.35 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.777 0.288 . . . . 1.41 111.777 -172.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.1 pp -74.42 -15.23 60.92 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.31 -0.556 . . . . 1.39 110.512 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.43 -24.62 64.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 2.31 110.434 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.2 m -84.47 1.85 43.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 1.4 111.359 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.4 pt -138.56 38.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.973 -0.751 . . . . 0.85 108.973 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -53.14 -41.54 65.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.837 -1.074 . . . . 1.59 111.947 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.6 p -102.69 149.83 24.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.426 -0.352 . . . . 0.77 110.434 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.16 137.4 57.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 2.29 110.31 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.64 -24.55 17.07 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.556 -0.831 . . . . 0.85 111.664 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.09 132.33 37.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.138 0.494 . . . . 1.7 110.734 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.434 ' OG ' HD13 ' A' ' 60' ' ' LEU . 4.0 m -117.71 154.11 32.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.845 -0.798 . . . . 1.37 108.845 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -145.21 137.5 25.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.869 -0.419 . . . . 0.61 109.869 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.88 131.99 47.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.543 -0.539 . . . . 1.8 109.543 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.468 ' CE2' HG11 ' A' ' 162' ' ' VAL . 20.2 t80 -138.46 78.1 1.66 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.178 -1.045 . . . . 1.04 108.178 -176.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 56' ' ' SER . 13.0 m -97.45 139.81 32.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.508 -0.769 . . . . 1.17 112.817 -173.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 24.7 m120 42.61 73.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.834 -1.075 . . . . 1.77 113.516 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.27 101.4 7.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.723 -0.671 . . . . 3.99 109.575 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -55.88 119.42 25.93 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 2.51 111.895 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.65 -5.46 17.11 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.682 2.254 . . . . 1.26 111.165 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 57.1 ttp180 -57.76 -37.17 73.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.76 111.272 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.15 -24.11 60.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.257 -0.497 . . . . 1.12 112.969 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.8 mt -81.12 -24.3 37.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.835 0.35 . . . . 1.73 111.01 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.37 128.37 92.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 3.45 111.089 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.48 -170.16 0.77 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.992 2.462 . . . . 2.08 113.375 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -75.5 -64.16 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.18 0.437 . . . . 3.23 112.18 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.633 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 3.5 m -80.26 134.32 36.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 1.66 111.17 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 95.0 mt -108.3 64.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.197 0.522 . . . . 1.99 110.96 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.495 ' HB2' ' HE3' ' A' ' 212' ' ' LYS . 55.9 m-20 -123.74 144.16 49.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.723 -1.214 . . . . 1.81 107.723 173.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.462 ' CD2' HD11 ' A' ' 47' ' ' LEU . 30.4 p90 -133.39 144.94 49.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.979 1.103 . . . . 5.01 113.979 -163.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.464 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 17.5 m95 -90.24 131.6 35.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.45 -1.25 . . . . 3.93 107.675 168.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 256' ' ' LYS . 4.9 t -128.05 118.13 22.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.436 0.636 . . . . 2.13 111.737 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 20.0 p90 -139.75 153.84 70.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 5.21 110.678 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 193' ' ' TYR . 9.7 Cg_exo -72.39 136.43 26.34 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.813 2.342 . . . . 2.12 110.937 172.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.727 ' HA3' ' CD1' ' A' ' 208' ' ' TRP . . . -137.99 158.78 24.86 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.364 -0.922 . . . . 1.75 113.062 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.12 0.486 . . . . 2.99 111.005 -177.887 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 134' ' ' VAL . 56.9 tp . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.835 0.35 . . . . 2.96 110.847 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -92.24 77.72 5.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.559 . . . . 3.37 111.186 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 85.2 m -147.81 43.29 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 2.15 110.349 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.25 146.07 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 1.26 110.956 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 48.9 m -114.28 121.45 43.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.302 -0.629 . . . . 2.08 109.302 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.727 ' CD1' ' HA3' ' A' ' 195' ' ' GLY . 36.9 m95 -106.4 130.13 54.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 5.53 110.977 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 49.1 mm -121.71 116.06 48.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.85 . . . . 1.63 109.54 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 98.0 t -111.29 133.88 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.302 -0.259 . . . . 1.62 110.302 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 143' ' ' LEU . 88.1 mt -86.37 143.93 27.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.234 0.54 . . . . 1.73 110.751 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 189' ' ' ASP . 26.8 ttmt -53.24 -23.02 7.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.945 -1.025 . . . . 2.98 112.231 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.633 ' HG3' ' H ' ' A' ' 187' ' ' SER . 68.7 mm-40 -110.55 121.03 42.38 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.424 -0.353 . . . . 1.47 111.068 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -84.02 171.62 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.61 2.207 . . . . 0.96 111.246 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 31.0 pt -111.48 147.25 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.964 0.411 . . . . 1.25 109.963 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 23.0 p -100.17 146.42 26.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.334 0.588 . . . . 1.29 111.234 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -140.66 146.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.208 -0.905 . . . . 1.02 109.418 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 222' ' ' VAL . 59.5 m -101.86 168.22 9.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.887 -0.325 . . . . 1.08 111.372 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.555 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 49.1 m -48.49 -51.0 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.092 0.775 . . . . 1.33 113.092 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.7 -48.06 82.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.698 0.285 . . . . 2.51 111.275 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.475 ' HB2' ' CG2' ' A' ' 217' ' ' VAL . 18.1 mt-30 -59.3 -44.63 92.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.764 -0.458 . . . . 0.7 109.764 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.513 ' O ' ' HG3' ' A' ' 226' ' ' ARG . 95.9 t -60.51 -40.69 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.721 -0.672 . . . . 1.36 110.874 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.6 mt -60.43 -37.03 79.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.027 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.41 ' HD2' HG12 ' A' ' 160' ' ' VAL . 93.2 mttt -66.62 -33.86 76.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.472 -0.331 . . . . 1.75 110.887 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -67.46 -30.8 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.328 0.585 . . . . 2.47 109.751 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 222' ' ' VAL . 23.6 mtp180 -79.14 -3.93 47.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.487 -0.779 . . . . 3.04 111.294 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 47.3 mmtm -87.82 -19.49 27.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.104 -0.332 . . . . 2.31 110.104 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.25 139.82 57.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.921 -0.581 . . . . 0.95 111.434 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.429 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 90.3 m-20 -115.93 149.32 38.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 1.13 110.315 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -79.57 -31.77 41.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 3.74 109.749 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 4.5 p-10 -73.95 165.16 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.129 -0.941 . . . . 1.62 112.397 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.77 171.23 42.89 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.506 -1.225 . . . . 1.16 110.834 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.01 141.58 57.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.216 0.508 . . . . 3.56 110.688 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.76 3.88 73.47 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.701 -0.761 . . . . 2.08 111.908 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -114.01 157.67 41.42 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.369 -0.234 . . . . 2.59 110.369 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 127.62 26.81 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.89 2.394 . . . . 1.36 111.785 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.42 116.93 5.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 3.4 111.547 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -121.68 119.75 32.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.577 -0.738 . . . . 2.47 109.127 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 226' ' ' ARG . 83.9 mt -67.1 149.5 50.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 2.14 111.861 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 55.7 tpp -75.36 103.76 5.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.084 -0.962 . . . . 1.68 108.903 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.23 139.16 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 1.27 112.121 -171.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.83 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.648 -1.16 . . . . 2.18 111.31 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 33.1 m-80 55.76 31.37 17.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.044 0.537 . . . . 2.15 111.945 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' A' ' 106' ' ' GLU . 30.6 t90 -134.17 144.53 48.56 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.199 -0.313 . . . . 4.59 110.414 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.569 ' O ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -111.12 149.05 39.93 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.424 -0.213 . . . . 6.13 110.424 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.73 132.91 3.95 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 124.33 3.353 . . . . 3.28 114.246 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.38 151.0 46.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.223 -0.899 . . . . 2.98 110.926 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -123.81 150.09 61.24 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 4.32 110.466 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.37 175.26 10.29 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.598 2.865 . . . . 3.48 115.261 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 82.7 mt -63.53 -8.81 10.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.368 -1.742 . . . . 4.63 113.432 -173.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 252' ' ' ASN . 16.9 ttmm -58.17 44.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.467 1.284 . . . . 5.34 114.467 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.492 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 7.5 t-20 119.21 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 127.017 2.127 . . . . 4.64 109.52 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 42.8 mmt-85 -126.2 84.87 2.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.413 -0.958 . . . . 6.11 108.413 168.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -115.9 142.4 46.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 3.08 110.012 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.76 122.99 57.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 2.6 111.064 -174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 1.0 OUTLIER -97.86 145.13 26.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.523 -0.917 . . . . 2.63 108.523 167.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -123.64 93.01 3.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.512 -0.551 . . . . 1.71 109.512 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 54.1 m -80.18 97.41 6.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.628 0.728 . . . . 2.21 110.924 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -135.12 103.72 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.375 -1.284 . . . . 4.31 109.253 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 C--O 1.248 1.01 0 CA-C-N 116.154 -0.476 . . . . 4.49 110.67 178.49 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 113.776 1.028 . . . . 2.88 113.776 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 58.8 mt -98.97 139.66 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.372 -1.285 . . . . 2.32 110.981 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.509 ' H ' ' CD1' ' A' ' 255' ' ' ILE . 24.3 t70 -112.14 118.31 34.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.833 -0.432 . . . . 2.82 109.833 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -43.79 73.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.397 -0.82 . . . . 2.24 113.138 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.77 -42.1 91.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 4.54 110.792 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 255' ' ' ILE . 22.9 m -72.67 -28.11 62.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.019 -0.537 . . . . 3.06 110.904 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 255' ' ' ILE . . . -75.22 93.59 2.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.264 0.554 . . . . 1.72 110.95 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.94 142.19 28.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.475 -0.784 . . . . 3.69 110.665 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.5 m-85 -58.07 122.48 13.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.472 -0.785 . . . . 4.64 110.975 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.63 133.96 27.26 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.764 . . . . 2.27 109.857 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.15 59.75 3.06 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.971 2.447 . . . . 2.15 112.497 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.402 ' CB ' ' HB2' ' A' ' 258' ' ' SER . 36.9 t -69.72 -53.59 17.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 4.29 110.121 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp 72.04 -54.66 0.68 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.31 -0.859 . . . . 4.74 111.733 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 43.7 mmtm -75.62 132.64 74.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 3.77 110.371 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.29 167.02 26.6 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.641 2.227 . . . . 2.36 112.273 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.44 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 61.3 tp -93.54 116.9 29.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.942 -0.572 . . . . 2.55 109.842 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 32.1 t -86.87 121.65 29.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.427 -0.583 . . . . 2.38 109.427 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.75 134.82 57.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.973 0.416 . . . . 1.59 110.716 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 28.4 t -128.54 91.03 3.16 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.309 0.576 . . . . 1.45 109.652 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.85 9.02 32.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 3.62 109.647 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 8.3 t70 -55.49 -39.1 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.404 -0.816 . . . . 2.48 111.201 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.2 mp0 -99.44 15.59 25.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 2.24 111.238 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 121.72 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.8 111.374 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -114.37 106.98 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.12 -0.491 . . . . 1.06 110.519 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.0 m -76.14 146.68 39.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.354 -0.61 . . . . 1.26 109.354 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.28 -56.69 1.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.74 111.925 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.45 155.8 32.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.724 0.297 . . . . 3.17 111.282 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.1 tt -122.02 138.5 52.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.116 -0.493 . . . . 0.64 109.906 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 172' ' ' SER . 38.2 tp -134.63 138.48 44.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.013 0.435 . . . . 0.96 111.905 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.05 114.49 26.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.267 -0.879 . . . . 1.49 109.13 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -115.26 70.15 0.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 1.83 110.308 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.2 -59.04 0.16 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.164 -1.38 . . . . 1.64 115.531 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -110.91 -17.02 13.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.842 0.353 . . . . 3.33 111.089 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.38 174.66 14.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.981 -0.748 . . . . 1.38 108.981 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -138.4 135.47 35.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.637 -0.505 . . . . 2.74 109.637 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -126.58 152.39 46.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.214 -0.448 . . . . 1.76 110.508 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 7.1 p -111.49 129.07 67.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.079 -0.51 . . . . 1.15 109.751 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.79 131.63 34.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.081 -0.509 . . . . 2.02 111.433 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.84 153.21 21.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.634 -0.712 . . . . 1.66 109.674 172.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.558 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 33.0 t70 -72.15 92.65 1.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.084 -0.507 . . . . 1.33 110.137 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -108.4 56.47 0.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.657 0.742 . . . . 2.65 111.206 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -103.16 -3.39 25.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.749 -0.66 . . . . 1.61 111.317 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.481 ' CG ' ' HE3' ' A' ' 76' ' ' LYS . 9.5 pt20 -148.66 165.0 32.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.215 -0.448 . . . . 2.35 110.122 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -81.1 73.28 8.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.189 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HD2' ' O ' ' A' ' 71' ' ' ASP . 15.2 ptpt -102.39 -41.18 6.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.591 -0.731 . . . . 1.77 110.998 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -113.2 96.9 6.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.676 -0.49 . . . . 0.76 109.676 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 95.3 t -124.16 150.91 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.768 -0.651 . . . . 1.27 110.856 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 79' ' ' LEU . 2.5 pt? -149.19 115.74 5.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.772 0.32 . . . . 1.29 110.523 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -139.04 125.09 19.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 2.54 110.62 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 47' ' ' LEU . . . -133.95 -178.19 15.44 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.521 -1.432 . . . . 1.31 109.521 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -26.51 -127.93 0.0 OUTLIER Glycine 0 N--CA 1.486 2.024 0 C-N-CA 125.089 1.328 . . . . 1.9 115.991 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.66 170.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.075 2.517 . . . . 2.91 112.99 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.7 pt? -31.9 114.14 0.14 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.389 1.255 . . . . 4.11 114.389 -144.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 9.8 p-10 -128.27 -128.09 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 113.424 -1.717 . . . . 4.95 112.284 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 106.05 161.3 22.73 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.193 -1.163 . . . . 2.25 110.193 -166.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 125' ' ' THR . 20.1 m -73.66 102.99 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.987 0.893 . . . . 1.91 110.715 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 68.2 m-85 -100.78 133.5 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 3.7 110.544 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HD2' ' CZ2' ' A' ' 123' ' ' TRP . 99.7 mtt180 -102.49 142.78 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.225 -0.443 . . . . 3.54 110.42 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.3 tp -77.64 125.15 28.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.618 -0.512 . . . . 1.14 109.618 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.4 tt -111.73 -40.72 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.834 0.35 . . . . 1.68 110.886 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -165.15 169.36 16.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.714 -0.476 . . . . 1.55 109.714 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.486 ' HB3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 p90 -143.81 158.23 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.356 -0.238 . . . . 0.86 110.356 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -132.34 158.91 40.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.616 -0.513 . . . . 0.93 109.616 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.82 149.93 28.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 3.17 110.375 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.485 ' ND1' ' HB3' ' A' ' 117' ' ' GLU . 13.4 m170 -100.48 153.05 19.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.504 -0.924 . . . . 1.68 108.504 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 75.0 t-105 -161.73 125.61 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.023 -0.362 . . . . 5.18 110.023 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -87.42 -171.51 47.27 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 111.319 -0.712 . . . . 2.13 111.319 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' A' ' 241' ' ' VAL . 11.2 t -78.52 -46.94 18.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.736 0.768 . . . . 2.9 109.995 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 102' ' ' GLY . 92.6 mt -83.95 146.61 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.429 . . . . 3.03 110.135 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.21 32.59 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.765 0.654 . . . . 3.85 112.765 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 100' ' ' LEU . . . -155.4 21.93 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.921 -0.656 . . . . 1.94 112.344 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.402 ' HG3' ' HA3' ' A' ' 98' ' ' GLY . 3.1 pt20 -150.46 169.58 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.211 -0.292 . . . . 2.45 110.211 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.422 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 86.95 17.41 59.58 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.668 -0.777 . . . . 1.47 113.111 169.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 77.8 p -80.58 -8.86 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.963 0.382 . . . . 2.0 111.701 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 66.48 164.68 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.101 -0.703 . . . . 3.72 109.101 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.426 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 29.4 m80 58.11 46.73 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 3.52 110.704 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.5 m -78.4 117.71 19.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 2.52 110.097 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 46.2 t -84.22 99.67 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 114.549 -1.205 . . . . 2.48 110.887 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 69.58 -72.27 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.709 0.631 . . . . 2.8 110.599 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -146.06 5.56 0.99 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.814 -0.439 . . . . 4.98 109.814 173.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.06 97.15 11.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.973 -0.558 . . . . 3.23 110.085 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -110.89 145.22 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 2.82 109.512 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 46.1 m-85 -105.06 179.03 4.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.303 -0.408 . . . . 1.62 110.203 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.02 53.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.026 0.441 . . . . 1.03 110.668 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.35 23.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.75 110.049 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 31.0 tt0 -147.73 146.38 29.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.97 -0.559 . . . . 1.58 110.255 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -99.45 107.3 19.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.548 -0.751 . . . . 1.07 109.604 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -109.52 102.41 11.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.11 0.481 . . . . 1.77 110.176 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 93' ' ' PHE . 5.0 mp -87.49 128.1 35.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.93 111.158 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 142' ' ' VAL . 45.2 t -96.45 127.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.965 -0.561 . . . . 0.61 110.393 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 20.9 m80 -126.77 138.11 53.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.608 -0.516 . . . . 2.13 109.608 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.586 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 44.9 p-90 -112.52 144.78 41.43 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.545 0.528 . . . . 4.26 110.592 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.672 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 41.8 t-20 -75.38 109.89 9.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 2.02 110.752 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.586 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 8.9 t -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.068 0.766 . . . . 2.34 113.068 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.672 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 21.3 ptmt -71.3 -7.68 48.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.166 0.432 . . . . 3.35 112.166 -172.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.09 -17.59 6.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.349 0.595 . . . . 3.1 110.459 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.45 -4.95 85.64 Favored Glycine 0 C--N 1.325 -0.042 0 N-CA-C 109.734 -1.347 . . . . 2.37 109.734 -167.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 123' ' ' TRP . 13.1 t70 71.55 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.193 -1.504 . . . . 3.93 112.224 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.443 ' O ' HG23 ' A' ' 134' ' ' VAL . 95.7 m-85 -45.27 -31.4 1.53 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.256 1.206 . . . . 3.0 114.256 -168.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.53 -65.03 2.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.344 -0.932 . . . . 2.15 111.803 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -72.23 -30.78 65.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.979 0.363 . . . . 3.43 111.979 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -26.34 49.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.141 0.422 . . . . 1.76 112.141 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 130' ' ' PHE . 59.7 t -60.66 -34.75 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 2.77 110.71 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -119.9 18.77 12.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.479 -0.328 . . . . 3.55 111.466 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 57.2 tt0 -132.16 113.83 14.79 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.755 -0.461 . . . . 3.02 109.755 -173.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.524 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 38.0 Cg_exo -60.69 -14.63 32.54 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.023 2.482 . . . . 1.6 113.785 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.77 27.15 9.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.303 . . . . 2.29 110.552 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.444 ' O ' ' HE1' ' A' ' 88' ' ' TYR . . . -66.61 -86.84 0.07 OUTLIER Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.947 -0.57 . . . . 1.22 114.211 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.76 161.21 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.562 0.696 . . . . 1.57 112.708 -168.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.43 110.58 5.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.939 . . . . 1.38 110.177 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 208' ' ' TRP . 21.2 m -107.32 152.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.812 -0.44 . . . . 1.73 109.812 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 10.2 tt -131.92 125.25 31.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.315 -0.254 . . . . 2.42 110.315 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.86 131.9 10.22 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.843 -0.694 . . . . 0.86 113.025 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -119.57 122.87 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.208 -0.293 . . . . 0.76 110.208 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -68.38 146.95 52.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.466 -0.334 . . . . 1.2 111.628 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.444 HD23 ' HB ' ' A' ' 215' ' ' ILE . 80.2 mt -124.47 114.52 19.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 0.88 110.219 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -107.24 153.73 22.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.71 -0.478 . . . . 2.03 109.71 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 44.1 t -90.08 127.64 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.987 0.423 . . . . 1.27 110.848 -175.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.07 -105.12 0.19 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.217 -0.753 . . . . 1.53 111.217 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.0 m -76.23 146.58 38.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.04 -0.356 . . . . 1.54 110.04 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -70.0 146.99 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.78 111.298 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 216' ' ' SER . 51.6 tptt -112.89 99.76 49.2 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.603 -0.726 . . . . 1.22 109.67 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 11.1 Cg_endo -55.55 -36.34 94.26 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.735 2.29 . . . . 1.05 111.919 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.12 -28.89 72.88 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.8 -0.636 . . . . 0.7 113.06 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.436 ' HG ' HG23 ' A' ' 160' ' ' VAL . 21.4 tp -93.82 -19.85 20.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.226 -0.573 . . . . 0.77 110.153 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -46.01 91.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.174 -0.466 . . . . 1.41 110.461 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.9 pttp -57.42 -40.7 78.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.677 0.621 . . . . 2.86 112.677 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.68 -36.01 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.263 -0.575 . . . . 1.38 110.73 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 75.8 t -64.03 -36.45 76.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.125 0.488 . . . . 1.11 110.757 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.39 -31.34 70.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.04 -0.527 . . . . 1.22 110.465 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 158' ' ' LYS . 73.0 t -83.55 -27.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.41 111.476 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.3 pp -70.77 -13.39 62.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.222 0.534 . . . . 1.39 110.31 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.42 -24.8 65.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.85 -0.613 . . . . 2.31 110.211 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.3 m -83.41 -1.64 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.31 . . . . 1.4 111.556 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 163' ' ' LEU . 47.2 pt -139.67 26.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 0.85 109.962 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 229' ' ' ASN . 48.9 pttt -74.89 16.15 0.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.038 -0.528 . . . . 1.59 112.334 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.76 140.23 46.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.902 0.382 . . . . 0.77 110.408 174.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.412 ' HB3' ' HA2' ' A' ' 232' ' ' GLY . 74.2 tttt -56.32 120.16 7.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 2.29 111.876 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.49 30.72 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.631 -0.795 . . . . 0.85 112.462 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -88.17 148.98 24.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.908 0.385 . . . . 1.7 110.687 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 60' ' ' LEU . 11.6 p -145.57 157.28 44.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.874 -0.603 . . . . 1.37 110.158 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -147.61 149.43 32.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.67 0.271 . . . . 0.61 110.52 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.97 136.79 46.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.017 0.437 . . . . 1.8 110.268 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -140.55 79.91 1.73 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.797 -0.816 . . . . 1.04 108.797 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.3 p -109.44 159.86 16.68 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.275 0.472 . . . . 1.17 112.275 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.35 47.16 21.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.509 -0.769 . . . . 1.77 112.345 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.13 98.29 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.891 0.377 . . . . 3.99 110.186 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.08 136.25 82.19 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.884 -0.598 . . . . 2.51 111.136 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.03 -4.27 13.18 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.123 2.549 . . . . 1.26 112.226 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 70.0 mtp180 -55.07 -42.68 73.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.872 -0.604 . . . . 2.76 112.136 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -58.97 -13.55 19.87 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 116.176 -0.465 . . . . 1.12 113.675 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.21 -7.65 44.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.852 0.326 . . . . 1.73 111.168 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.62 128.78 68.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 3.45 110.595 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.07 -178.39 4.15 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.827 2.351 . . . . 2.08 112.527 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.81 -63.21 1.46 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.561 0.219 . . . . 3.23 110.749 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.0 m -70.41 130.42 41.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 1.66 110.712 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.04 62.55 0.6 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.255 0.55 . . . . 1.99 110.107 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -94.21 128.28 40.56 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.329 -0.989 . . . . 1.81 108.329 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 52.6 p90 -139.66 147.45 41.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.067 0.766 . . . . 5.01 113.067 -169.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 28.6 m-90 -86.76 135.84 33.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.286 -0.87 . . . . 3.93 108.928 169.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 192' ' ' THR . 7.1 t -119.69 103.26 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.641 0.734 . . . . 2.13 110.346 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' A' ' 208' ' ' TRP . 4.6 t80 -137.48 137.08 21.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.098 -0.501 . . . . 5.21 110.783 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -89.56 128.83 1.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.745 2.297 . . . . 2.12 112.279 173.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.09 157.65 25.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.276 -0.487 . . . . 1.75 112.696 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 1.7 m . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 109.395 -0.594 . . . . 2.99 109.395 174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 196' ' ' SER . 42.9 tp . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 121.29 0.567 . . . . 2.96 110.967 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.96 41.46 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 3.37 109.57 -174.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 137' ' ' PRO . 4.6 p -84.11 2.49 39.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 2.15 112.362 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.03 129.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 120.95 0.405 . . . . 1.26 109.943 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.3 m -107.76 100.83 10.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.715 -0.846 . . . . 2.08 108.715 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 193' ' ' TYR . 4.4 p-90 -90.24 100.96 13.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.914 0.864 . . . . 5.53 111.72 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 51.3 mm -88.85 105.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.065 -1.425 . . . . 1.63 109.671 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.1 t -106.78 128.99 61.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.965 -0.294 . . . . 1.62 110.544 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -85.89 140.85 30.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.419 0.628 . . . . 1.73 111.448 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -83.86 -21.71 31.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.149 -0.932 . . . . 2.98 110.92 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.403 ' OE1' ' HD2' ' A' ' 214' ' ' PRO . 11.3 tp10 -88.33 113.38 55.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.271 -0.422 . . . . 1.47 109.873 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 83.0 Cg_endo -82.93 155.81 15.25 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.668 2.245 . . . . 0.96 113.11 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.444 ' HB ' HD23 ' A' ' 147' ' ' LEU . 26.8 mm -106.19 146.44 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.771 -0.649 . . . . 1.25 109.609 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 15.1 m -99.57 127.93 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.451 -0.34 . . . . 1.29 111.322 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.9 m -122.48 151.51 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.921 -0.77 . . . . 1.02 108.921 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 8.0 t -97.1 163.82 12.77 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.277 -0.569 . . . . 1.08 111.159 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.542 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 24.9 m -50.82 -50.62 56.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 1.33 111.886 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -50.98 -36.29 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.934 0.397 . . . . 2.51 111.573 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.95 -48.32 54.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.146 -0.479 . . . . 0.7 110.894 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.424 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 29.4 m -74.92 -22.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 1.36 111.277 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 219' ' ' SER . 94.7 mt -68.28 -45.2 73.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.032 -0.359 . . . . 1.03 110.032 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -67.8 -29.46 68.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 1.75 110.659 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.49 -42.49 82.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 2.47 110.041 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 67.0 ttt180 -73.93 10.88 1.01 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.72 -0.673 . . . . 3.04 111.011 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.46 -8.6 38.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.06 -0.348 . . . . 2.31 110.06 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.81 132.45 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.08 -0.509 . . . . 0.95 111.039 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 167' ' ' LYS . 6.3 m-20 -101.53 140.41 35.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.907 -0.588 . . . . 1.13 110.218 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -78.86 -34.94 44.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.781 -1.099 . . . . 3.74 109.668 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.6 p-10 -70.8 163.86 26.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.84 -1.073 . . . . 1.62 111.875 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 169' ' ' LYS . . . -83.92 174.4 51.25 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.231 -0.895 . . . . 1.16 111.197 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.55 127.5 32.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.95 0.375 . . . . 3.56 110.062 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.22 -2.58 56.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.859 -0.686 . . . . 2.08 112.635 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 41.3 mt-10 -102.2 159.97 27.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.065 -0.346 . . . . 2.59 110.065 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.96 128.68 30.89 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.181 . . . . 1.36 111.519 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -59.38 125.63 24.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 3.4 112.734 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 44.8 mt-10 -130.57 150.24 51.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.091 -1.078 . . . . 2.47 108.091 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.7 mt -90.97 133.38 35.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.525 -0.47 . . . . 2.14 110.866 -175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 ttm -76.83 89.3 3.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.359 -0.978 . . . . 1.68 108.359 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 99' ' ' SER . 21.7 m -133.55 153.24 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 1.27 110.198 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.4 t70 67.36 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.004 0.815 . . . . 2.18 110.356 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 22.1 m120 43.39 32.22 0.48 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.555 0.534 . . . . 2.15 111.743 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -104.5 136.66 43.65 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.082 0.468 . . . . 4.59 110.597 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.585 ' H ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -70.3 144.3 91.93 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.267 -0.879 . . . . 6.13 110.434 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.63 131.93 43.49 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.792 2.328 . . . . 3.28 111.965 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.99 132.37 49.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 2.98 111.584 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.519 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 66.8 mm-40 -85.17 172.79 8.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.854 -0.795 . . . . 4.32 108.854 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 73.4 Cg_exo -43.06 110.51 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.406 2.071 . . . . 3.48 112.03 174.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -58.42 4.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.443 -1.253 . . . . 4.63 113.586 -167.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 37' ' ' THR . 5.2 ptpp? -69.59 -7.0 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.624 0.972 . . . . 5.34 113.624 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 7.7 p30 36.33 54.27 1.03 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.718 1.007 . . . . 4.64 113.718 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 252' ' ' ASN . 13.4 mmt180 76.11 -89.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.391 -0.596 . . . . 6.11 109.391 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.47 136.52 21.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.975 -1.12 . . . . 3.08 107.975 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.515 ' H ' HG22 ' A' ' 37' ' ' THR . 17.0 mt -94.24 150.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.691 0.281 . . . . 2.6 111.033 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -104.55 131.44 51.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 2.63 110.558 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.31 97.55 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.256 -0.429 . . . . 1.71 110.164 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.402 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 22.3 p -95.73 96.46 9.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.367 -0.533 . . . . 2.21 111.609 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.486 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 24.8 p90 -166.71 154.4 9.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 4.31 110.047 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.997 -0.547 . . . . 4.49 110.605 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.498 ' HB2' ' H ' ' A' ' 248' ' ' GLN . 32.2 t70 . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 109.109 -0.7 . . . . 2.88 109.109 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 210' ' ' VAL . 54.2 mt -101.98 103.57 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.904 0.705 . . . . 2.32 112.904 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -93.69 102.14 14.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.053 -0.721 . . . . 2.82 109.053 165.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 m -56.99 -28.46 62.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 2.24 112.353 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -69.84 -34.27 73.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.563 0.221 . . . . 4.54 111.281 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -85.7 -23.29 27.46 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.955 -0.298 . . . . 3.06 111.126 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -61.54 105.28 0.51 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.283 0.563 . . . . 1.72 111.716 174.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.28 138.05 36.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.526 -0.761 . . . . 3.69 111.235 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 99.2 m-85 -73.93 132.41 42.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.529 . . . . 4.64 110.112 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -120.81 124.09 27.67 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.427 -0.351 . . . . 2.27 110.725 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.35 -23.22 44.72 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.767 2.312 . . . . 2.15 112.036 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 m -65.7 -27.81 68.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.524 . . . . 4.29 111.396 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.7 mt -70.52 119.26 14.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.028 0.442 . . . . 4.74 111.01 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.605 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 59.0 tttm -99.29 131.43 25.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.407 -0.815 . . . . 3.77 109.294 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.3 154.44 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.862 3.041 . . . . 2.36 114.034 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.64 125.21 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.066 -0.97 . . . . 2.55 110.729 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 m -96.87 98.42 10.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.239 -0.652 . . . . 2.38 109.239 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.43 HG22 ' HG ' ' A' ' 79' ' ' LEU . 8.9 t -102.9 127.98 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.912 -0.585 . . . . 1.59 110.649 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -129.58 91.4 3.15 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.82 -0.437 . . . . 1.45 109.82 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -106.35 11.63 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.864 0.364 . . . . 3.62 110.92 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 2.48 111.067 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 48.9 mt-30 -94.33 6.17 49.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.987 -0.552 . . . . 2.24 111.964 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -67.51 133.72 49.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.8 111.603 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -113.38 106.24 14.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 1.06 110.467 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 m -72.34 138.05 47.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.162 -0.472 . . . . 1.26 109.832 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 71' ' ' ASP . 82.6 mt -113.74 -58.21 2.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.74 112.427 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -158.9 161.44 36.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.868 0.366 . . . . 3.17 111.448 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -121.17 133.2 68.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.651 -0.87 . . . . 0.64 108.651 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 57.9 tp -137.3 119.05 15.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.56 0.578 . . . . 0.96 112.56 -171.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -79.18 114.06 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.102 -1.073 . . . . 1.49 108.102 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 169' ' ' LYS . 53.8 t30 -140.34 70.59 1.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.654 -0.819 . . . . 1.83 112.423 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 103.27 -67.01 0.33 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.137 -1.03 . . . . 1.64 113.132 162.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.471 ' HB3' ' OD1' ' A' ' 243' ' ' ASN . 51.7 m80 -103.82 -27.55 12.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.048 0.452 . . . . 3.33 110.895 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.96 -169.98 2.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.755 -0.657 . . . . 1.38 110.159 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 95' ' ' PHE . 34.8 p90 -133.8 134.03 42.37 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.271 -1.011 . . . . 2.74 108.271 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 8.3 p30 -132.71 151.87 51.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.055 0.455 . . . . 1.76 111.398 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 98.2 t -106.46 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 1.15 109.84 176.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.39 138.38 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.464 . . . . 2.02 111.417 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.82 150.69 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.339 -0.846 . . . . 1.66 109.135 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB2' HD21 ' A' ' 57' ' ' LEU . 22.4 t70 -75.2 124.44 27.06 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.009 -0.367 . . . . 1.33 110.009 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -125.81 58.31 1.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.08 0.943 . . . . 2.65 110.448 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 p -96.41 -5.25 40.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.51 -0.768 . . . . 1.61 109.75 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -143.17 157.69 44.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.834 -1.075 . . . . 2.35 108.813 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.58 70.25 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.549 0.69 . . . . 1.92 109.769 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 68.5 mttm -92.75 -54.64 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.287 -0.869 . . . . 1.77 111.538 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -110.5 110.42 21.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.282 -0.417 . . . . 0.76 110.283 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.75 144.24 34.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.392 -0.367 . . . . 1.27 110.613 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HG ' HG22 ' A' ' 49' ' ' VAL . 9.6 tt -149.9 113.04 4.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.707 -0.849 . . . . 1.29 108.707 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -151.43 127.44 10.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.156 0.503 . . . . 2.54 111.385 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -67.89 174.01 30.01 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.784 -0.644 . . . . 1.31 111.635 164.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 45' ' ' LYS . . . -39.2 -142.73 0.0 OUTLIER Glycine 0 N--CA 1.472 1.076 0 N-CA-C 115.813 1.085 . . . . 1.9 115.813 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.52 121.32 6.95 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 121.856 1.704 . . . . 2.91 112.37 -173.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.8 mt -147.81 -168.17 3.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.528 -1.214 . . . . 4.11 108.713 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -129.24 70.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.444 0.535 . . . . 4.95 112.444 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 131.19 -125.56 4.5 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.794 -1.193 . . . . 2.25 115.072 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.776 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 85.6 m -131.51 115.68 16.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.692 -0.754 . . . . 1.91 109.755 -169.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -115.01 91.36 3.59 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.037 -0.665 . . . . 3.7 111.739 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.29 142.49 34.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.109 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -73.77 121.86 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 1.14 110.331 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.519 HG23 ' HG2' ' A' ' 92' ' ' GLN . 5.2 tp -107.92 -38.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 1.68 111.088 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG2' HG23 ' A' ' 91' ' ' ILE . 16.4 pt20 -170.25 168.06 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.625 -0.262 . . . . 1.55 110.498 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 41.6 p90 -141.31 145.89 36.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.648 -0.501 . . . . 0.86 109.648 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.459 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.8 p-80 -128.9 159.81 34.63 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.329 0.393 . . . . 0.93 110.695 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 t80 -135.74 158.13 45.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.959 -0.386 . . . . 3.17 109.959 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -162.65 171.12 17.37 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.734 0.302 . . . . 1.68 111.713 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.506 ' CZ2' ' HB ' ' A' ' 222' ' ' VAL . 23.1 m95 -138.99 148.74 43.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.588 -0.733 . . . . 5.18 110.459 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . -79.18 -37.38 25.02 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 116.022 -0.535 . . . . 2.13 113.499 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 47.1 t 162.93 -70.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.57 0.748 . . . . 2.9 109.35 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.38 158.33 26.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.359 -0.837 . . . . 3.03 109.68 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.22 62.05 0.13 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.558 0.536 . . . . 3.85 111.463 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.23 32.31 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.649 -0.786 . . . . 1.94 113.029 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -161.29 157.21 25.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.898 0.349 . . . . 2.45 110.485 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' N ' ' A' ' 98' ' ' GLY . . . 99.11 45.92 2.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.867 -0.682 . . . . 1.47 112.482 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 45.2 t -103.88 -28.4 11.62 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.284 -0.166 . . . . 2.0 111.264 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 105' ' ' SER . 8.5 tp10 68.07 169.3 0.27 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.196 -0.668 . . . . 3.72 109.196 -167.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.6 m170 60.59 35.13 20.07 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.482 0.658 . . . . 3.52 110.414 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.476 ' CG2' ' HA ' ' A' ' 113' ' ' LYS . 73.2 p -82.73 119.59 24.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.167 -0.924 . . . . 2.52 111.637 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 87.9 t -76.42 117.0 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.214 -0.903 . . . . 2.48 109.878 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.71 35.42 16.93 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.128 -0.693 . . . . 2.8 109.128 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.7 mttp 59.91 27.49 16.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.073 -0.967 . . . . 4.98 112.342 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -77.3 86.87 3.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.114 -0.328 . . . . 3.23 110.114 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.476 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 98.9 mttt -61.69 113.05 2.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.066 0.46 . . . . 2.82 111.477 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -83.88 177.34 8.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.551 -0.75 . . . . 1.62 109.108 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.86 -53.7 54.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.914 0.338 . . . . 1.03 111.914 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.2 169.56 4.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.124 -0.325 . . . . 0.75 110.124 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.4 ' HB2' ' OG ' ' A' ' 105' ' ' SER . 26.8 tt0 -148.94 141.81 24.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.987 -0.375 . . . . 1.58 109.987 -178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 34.5 tp -99.74 125.89 45.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.871 -0.604 . . . . 1.07 109.493 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.4 m170 -110.69 107.9 17.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.77 111.516 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 120' ' ' LEU . 5.4 mp -93.39 113.35 25.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.786 -0.643 . . . . 0.93 110.19 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.04 127.65 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.294 0.569 . . . . 0.61 111.527 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.9 139.88 50.5 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.017 -1.105 . . . . 2.13 108.017 172.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.94 154.36 46.64 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.57 -0.452 . . . . 4.26 111.559 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.776 ' HA ' ' O ' ' A' ' 87' ' ' THR . 53.1 t30 -76.43 89.58 3.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 2.02 110.988 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.9 p -73.45 -9.2 58.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.538 0.94 . . . . 2.34 113.538 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 13.5 ptmm? -71.52 -46.02 60.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.963 -0.695 . . . . 3.35 109.736 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.516 ' CG ' ' HG3' ' A' ' 132' ' ' LYS . 67.6 m-85 -94.19 -15.56 24.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 3.1 111.138 173.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 129' ' ' ASP . . . 101.23 -1.04 54.2 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.835 -0.698 . . . . 2.37 111.57 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 128' ' ' GLY . 32.8 t70 81.52 -78.16 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.834 0.854 . . . . 3.93 112.185 172.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -56.3 -19.87 16.26 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.438 0.903 . . . . 3.0 113.438 -168.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.09 -67.52 1.62 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.723 -0.751 . . . . 2.15 112.165 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HG3' ' CG ' ' A' ' 127' ' ' TYR . 45.0 mmtm -72.13 -21.25 61.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.416 0.524 . . . . 3.43 112.416 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.63 56.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 1.76 111.427 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 203' ' ' LEU . 70.1 t -61.62 -36.29 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 2.77 110.418 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -106.4 -24.66 12.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.661 0.267 . . . . 3.55 111.283 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -95.47 105.13 18.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 3.02 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 72.4 Cg_endo -76.52 -0.46 10.45 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.424 2.083 . . . . 1.6 112.419 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.53 27.07 10.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.425 -0.352 . . . . 2.29 110.39 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.87 -53.92 8.96 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 120.808 -0.711 . . . . 1.22 112.849 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 91.5 mt -89.32 151.0 22.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 1.57 110.784 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.47 106.63 5.75 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.485 -0.78 . . . . 1.38 109.286 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 44.4 t -107.3 117.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.457 -0.338 . . . . 1.73 110.803 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.99 126.18 33.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.833 -0.621 . . . . 2.42 109.62 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.19 115.43 4.45 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.737 -0.744 . . . . 0.86 112.638 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.6 mt -104.91 111.48 34.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.137 -0.319 . . . . 0.76 110.137 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -67.99 144.61 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.695 0.283 . . . . 1.2 110.981 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.2 mp -115.71 131.94 56.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.43 -0.35 . . . . 0.88 110.315 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -121.5 143.91 49.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.147 -0.686 . . . . 2.03 109.147 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 42.5 t -88.43 129.6 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 1.27 111.374 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.59 -104.12 0.18 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.532 -0.758 . . . . 1.53 111.279 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 p -81.66 146.73 29.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.197 -0.297 . . . . 1.54 110.197 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.33 148.86 47.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.086 0.469 . . . . 0.78 111.621 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 216' ' ' SER . 49.3 tptt -111.5 103.76 55.39 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 1.22 109.444 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.83 -38.11 94.89 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.002 2.468 . . . . 1.05 112.299 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.466 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -62.13 -29.21 72.18 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 116.031 -0.531 . . . . 0.7 113.035 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.5 tp -94.48 -17.58 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.271 0.535 . . . . 0.77 110.392 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -43.78 92.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.828 -0.624 . . . . 1.41 110.233 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.0 pttt -56.87 -32.39 65.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 2.86 111.853 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.6 t -77.07 -41.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 1.38 110.47 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 156' ' ' LEU . 72.4 t -57.57 -36.93 55.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.745 -0.662 . . . . 1.11 111.331 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.02 -20.6 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.56 . . . . 1.22 112.405 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.0 t -96.6 -7.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.902 0.382 . . . . 1.41 111.332 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 84.6 mt -57.66 -42.1 82.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.854 0.687 . . . . 1.39 112.854 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.94 -24.81 66.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.81 0.338 . . . . 2.31 111.386 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.0 m -81.15 -8.98 59.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.476 -0.329 . . . . 1.4 111.26 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -134.21 36.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.364 0.602 . . . . 0.85 109.739 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.58 -32.92 74.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 1.59 111.451 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.9 p -116.93 155.73 28.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.888 0.375 . . . . 0.77 111.528 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 42.5 tttm -59.73 132.42 53.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.868 -0.605 . . . . 2.29 110.611 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.36 -17.14 40.73 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.756 -0.735 . . . . 0.85 111.555 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -75.28 107.83 7.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.941 0.4 . . . . 1.7 110.602 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.0 m -98.95 140.74 32.65 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.262 -0.644 . . . . 1.37 109.262 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.28 129.35 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.825 -0.435 . . . . 0.61 109.825 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.45 134.13 56.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 1.8 109.825 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.41 79.85 1.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.833 . . . . 1.04 108.752 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.0 p -105.27 152.87 22.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 1.17 112.095 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.27 62.98 2.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.724 -0.671 . . . . 1.77 112.131 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -134.67 98.1 3.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 3.99 110.768 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.15 140.44 88.15 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.822 -0.626 . . . . 2.51 111.112 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.16 -3.48 13.15 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.178 2.585 . . . . 1.26 112.17 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.5 -42.59 74.67 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.863 -0.608 . . . . 2.76 112.302 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -63.0 -16.95 58.1 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.046 -0.597 . . . . 1.12 113.285 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.75 -16.26 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 1.73 110.948 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.05 133.8 36.42 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.456 . . . . 3.45 110.896 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.61 -170.47 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.921 2.414 . . . . 2.08 112.426 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.63 -49.87 60.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.621 0.248 . . . . 3.23 111.601 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.422 ' HB2' ' HG3' ' A' ' 213' ' ' GLU . 36.6 m -94.73 141.19 28.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 1.66 110.732 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.5 64.09 0.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.534 0.683 . . . . 1.99 109.735 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.434 ' O ' HD12 ' A' ' 211' ' ' LEU . 0.9 OUTLIER -80.45 163.59 23.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.514 -0.766 . . . . 1.81 109.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.714 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 30.6 p90 -165.57 142.88 5.68 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.679 -0.408 . . . . 5.01 110.872 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -123.91 106.64 10.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.026 -1.102 . . . . 3.93 108.026 170.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.4 HG23 ' HE2' ' A' ' 256' ' ' LYS . 2.7 t -82.61 121.48 26.87 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.811 0.671 . . . . 2.13 112.811 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 83.7 t80 -137.21 131.9 17.82 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.773 . . . . 5.21 110.387 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 193' ' ' TYR . 16.8 Cg_exo -66.77 129.36 20.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.738 2.292 . . . . 2.12 112.379 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.512 ' HA3' ' NE1' ' A' ' 208' ' ' TRP . . . -119.8 157.03 15.69 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.389 -0.434 . . . . 1.75 113.006 -174.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.41 0.624 . . . . 2.99 111.801 -175.638 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 134' ' ' VAL . 30.9 tp . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 111.335 0.124 . . . . 2.96 111.335 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 5.6 pt-20 -80.83 109.79 15.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.543 0.687 . . . . 3.37 111.03 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 23.5 p -140.67 21.96 2.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.944 0.402 . . . . 2.15 110.668 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.487 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -104.8 138.12 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.005 0.431 . . . . 1.26 111.185 -176.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.6 m -112.84 111.83 22.88 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.074 -0.713 . . . . 2.08 109.074 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.512 ' NE1' ' HA3' ' A' ' 195' ' ' GLY . 97.4 m95 -81.97 116.78 21.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.648 0.261 . . . . 5.53 110.476 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 38.4 mm -101.73 98.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.695 -0.854 . . . . 1.63 108.695 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 38.1 t -85.67 116.99 29.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 1.62 111.937 -174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 189' ' ' ASP . 56.0 tp -80.23 113.89 18.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.846 -0.427 . . . . 1.73 109.846 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.562 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 6.2 tmmm? -60.99 -21.62 63.72 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.399 0.518 . . . . 2.98 112.399 -176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 187' ' ' SER . 34.5 mm-40 -99.64 106.07 37.83 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 111.874 0.324 . . . . 1.47 111.874 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 10.1 Cg_exo -73.77 138.55 26.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.059 2.506 . . . . 0.96 111.689 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -91.58 152.12 3.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.839 0.352 . . . . 1.25 110.334 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 3.1 p -96.08 122.29 38.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.959 -0.564 . . . . 1.29 111.147 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.5 m -123.75 153.18 29.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 1.02 109.791 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 t -88.19 158.97 18.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.592 0.234 . . . . 1.08 111.23 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.523 ' HA ' HG22 ' A' ' 222' ' ' VAL . 29.6 t -54.6 -42.85 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 1.33 110.513 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -56.31 -27.3 55.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.51 111.78 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.2 -49.75 9.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.343 -0.389 . . . . 0.7 110.15 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.1 m -66.51 -31.13 52.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 1.36 111.27 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 89.6 mt -60.52 -39.77 89.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 1.03 110.673 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -74.46 -25.03 59.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.12 -0.491 . . . . 1.75 111.157 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.69 -28.86 61.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.201 0.524 . . . . 2.47 109.749 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -86.29 -3.35 58.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.92 -0.582 . . . . 3.04 110.279 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.5 mmtt -88.05 -9.3 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 2.31 109.948 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.44 HD11 HD22 ' A' ' 163' ' ' LEU . 91.9 mt -71.37 150.14 45.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.659 -0.7 . . . . 0.95 110.722 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -108.26 142.93 37.81 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.532 0.682 . . . . 1.13 110.393 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -78.49 -32.19 48.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.592 -1.185 . . . . 3.74 109.166 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -76.98 169.98 17.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.93 -1.032 . . . . 1.62 111.987 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 169' ' ' LYS . . . -96.34 179.05 34.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.006 -0.997 . . . . 1.16 111.204 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.52 137.67 57.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 3.56 110.426 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.17 62.69 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 2.08 112.894 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.49 153.26 69.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 117.085 0.443 . . . . 2.59 109.838 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.8 125.1 17.96 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.348 2.032 . . . . 1.36 111.187 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.439 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.8 pt-20 -64.16 127.57 32.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.577 0.703 . . . . 3.4 112.325 -172.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.79 124.05 38.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.768 -1.106 . . . . 2.47 108.365 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.14 145.89 55.28 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.956 0.408 . . . . 2.14 111.159 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 30.6 mtt -65.81 102.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.647 -0.706 . . . . 1.68 110.074 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.35 142.04 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.567 -0.742 . . . . 1.27 110.436 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 244' ' ' TRP . 38.9 t70 68.35 -90.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.326 -0.852 . . . . 2.18 110.487 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 64' ' ' HIS . 47.8 t30 65.75 -23.46 0.09 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.313 0.857 . . . . 2.15 113.313 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.419 ' H ' ' C ' ' A' ' 242' ' ' ASP . 63.3 t-105 -146.85 134.04 20.52 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.674 -0.641 . . . . 4.59 111.323 -169.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.573 ' CD ' ' H ' ' A' ' 245' ' ' ARG . 0.1 OUTLIER -93.22 102.57 7.54 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.222 -0.899 . . . . 6.13 108.975 174.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 4.2 Cg_exo -74.83 -91.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.888 2.392 . . . . 3.28 115.101 -166.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.24 129.88 38.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.873 0.694 . . . . 2.98 112.873 -159.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.498 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 24.5 pt20 -82.53 179.16 2.04 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.575 -0.739 . . . . 4.32 110.176 171.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 248' ' ' GLN . 69.0 Cg_exo -53.83 132.79 51.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.829 1.686 . . . . 3.48 111.58 170.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.9 -39.68 19.62 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.666 -1.152 . . . . 4.63 112.606 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 253' ' ' ARG . 22.3 ptmt -61.29 -12.19 12.63 Favored 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 115.654 1.724 . . . . 5.34 115.654 -176.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 9.2 p30 37.82 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 118.806 2.891 . . . . 4.64 118.806 165.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 251' ' ' LYS . 35.2 ttm180 142.98 -118.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.399 1.88 . . . . 6.11 105.964 -163.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 253' ' ' ARG . 19.5 tt0 -146.27 128.74 15.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.246 -1.39 . . . . 3.08 107.246 161.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 60.8 mt -91.04 146.37 6.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.783 -0.451 . . . . 2.6 109.783 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.4 ' HE2' HG23 ' A' ' 192' ' ' THR . 19.3 pttm -116.61 137.03 52.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.63 110.499 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.25 160.64 24.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.19 -0.914 . . . . 1.71 109.503 -176.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 32.9 t -143.17 98.02 3.19 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.053 -0.659 . . . . 2.21 111.502 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -132.87 90.88 2.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.916 . . . . 4.31 108.584 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.243 0.736 0 CA-C-O 118.364 -0.827 . . . . 4.49 110.518 -176.699 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.678 ' HA ' ' OG1' ' A' ' 108' ' ' THR . 31.7 t70 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.978 -0.749 . . . . 2.88 108.978 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 110' ' ' ASP . 72.4 mt -67.47 126.95 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.807 -0.633 . . . . 2.32 110.917 -173.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.8 114.6 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.93 -0.577 . . . . 2.82 110.489 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -63.69 -31.54 72.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.24 111.728 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -76.19 -4.4 41.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.815 0.34 . . . . 4.54 111.533 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.0 m -102.41 -8.22 21.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.464 0.649 . . . . 3.06 109.929 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -78.2 120.39 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 1.72 110.758 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -95.41 132.34 40.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.252 -0.431 . . . . 3.69 110.232 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.736 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 27.4 m-85 -82.46 130.28 35.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.486 0.66 . . . . 4.64 111.883 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 258' ' ' SER . 25.3 t70 -125.2 140.55 36.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 2.27 109.248 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.96 90.94 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.801 2.334 . . . . 2.15 113.295 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.1 t -60.28 -38.18 82.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.933 -0.576 . . . . 4.29 110.392 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt 72.21 -67.1 0.27 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.464 -0.789 . . . . 4.74 111.996 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -101.44 128.08 30.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.51 0.195 . . . . 3.77 110.979 -175.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.55 160.91 26.13 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.048 2.499 . . . . 2.36 111.874 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.561 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 11.0 mp -80.0 143.76 33.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.368 0.507 . . . . 2.55 112.368 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -106.86 99.41 8.98 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.317 -0.856 . . . . 2.38 108.723 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 t -117.0 108.1 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.028 -0.533 . . . . 1.59 110.268 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.6 m -102.12 89.46 3.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.077 -0.51 . . . . 1.45 109.705 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -101.57 3.43 40.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.94 -0.763 . . . . 3.62 108.94 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.58 -33.06 69.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.45 -1.25 . . . . 2.48 111.859 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -103.6 13.14 33.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.693 0.257 . . . . 2.24 111.693 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -63.83 122.94 17.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.8 111.496 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 23.1 m -103.26 111.96 24.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.938 -0.573 . . . . 1.06 110.386 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -76.73 141.84 40.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.735 -0.468 . . . . 1.26 109.735 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 71' ' ' ASP . 84.8 mt -118.54 -57.29 2.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.277 0.473 . . . . 0.74 112.277 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -156.49 148.1 22.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.643 -0.253 . . . . 3.17 110.722 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -108.92 137.21 42.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.608 -0.516 . . . . 0.64 109.608 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.8 tp -128.4 145.47 51.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.299 -0.41 . . . . 0.96 110.395 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -117.16 124.18 48.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.933 0.397 . . . . 1.49 111.196 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.23 153.03 46.62 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.184 -1.043 . . . . 1.83 108.184 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.581 ' HA2' ' SD ' ' A' ' 240' ' ' MET . . . -69.91 33.08 0.39 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 115.478 0.951 . . . . 1.64 115.478 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -131.95 -36.96 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.521 -0.548 . . . . 3.33 109.521 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -171.01 -179.62 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.399 -0.963 . . . . 1.38 108.399 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -117.2 144.9 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.797 -1.186 . . . . 2.74 107.797 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 4.6 p30 -131.33 141.33 49.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.02 0.438 . . . . 1.76 111.468 -172.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.7 t -106.15 116.48 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.787 -0.642 . . . . 1.15 109.903 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.85 128.47 33.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.654 -0.703 . . . . 2.02 110.901 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -105.8 159.26 16.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.847 -0.615 . . . . 1.66 110.458 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 26.1 t70 -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.847 -0.615 . . . . 1.33 109.613 174.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.47 60.96 1.65 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.036 0.922 . . . . 2.65 110.334 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 m -92.2 -5.75 51.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.575 -0.739 . . . . 1.61 110.203 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -145.7 176.44 9.64 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.405 -0.961 . . . . 2.35 108.405 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' CG ' HH21 ' A' ' 89' ' ' ARG . 18.1 m-20 -75.33 65.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.158 0.504 . . . . 1.92 110.675 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -84.8 -59.0 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 1.77 110.223 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -114.59 97.3 6.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.518 -0.764 . . . . 0.76 109.749 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.52 146.5 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.168 -0.469 . . . . 1.27 110.083 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tt -137.22 113.4 9.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 1.29 109.463 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.609 ' HD2' HG23 ' A' ' 87' ' ' THR . 12.6 ptmm? -148.09 124.23 10.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.258 0.552 . . . . 2.54 110.959 172.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -86.12 175.64 48.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.981 -0.848 . . . . 1.31 110.981 167.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.59 -142.92 0.0 OUTLIER Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.304 0.649 . . . . 1.9 114.508 165.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.49 120.6 5.95 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.518 1.478 . . . . 2.91 112.19 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -158.62 -168.23 2.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.838 -1.074 . . . . 4.11 108.883 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -125.34 45.71 2.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 121.181 -0.208 . . . . 4.95 110.989 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.74 158.79 7.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.43 -0.89 . . . . 2.25 113.123 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.609 HG23 ' HD2' ' A' ' 80' ' ' LYS . 92.1 m -98.23 114.74 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 1.91 109.814 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 65.6 m-85 -102.25 132.92 47.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.19 0.441 . . . . 3.7 112.19 -171.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 75' ' ' ASP . 98.2 mtt180 -103.59 147.09 27.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 3.54 109.86 173.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 121' ' ' VAL . 48.4 tp -77.44 130.14 36.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.559 -0.291 . . . . 1.14 110.949 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -110.28 -40.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.376 . . . . 1.68 110.954 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -170.53 168.07 7.84 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.821 -0.437 . . . . 1.55 109.821 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 19.4 p90 -135.88 157.51 46.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.174 -0.21 . . . . 0.86 110.688 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -143.09 158.94 43.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.54 -0.541 . . . . 0.93 109.54 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.657 ' CE2' ' HG ' ' A' ' 118' ' ' LEU . 42.1 m-85 -111.76 166.16 11.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.589 0.233 . . . . 3.17 110.654 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 2.0 m80 -122.39 139.14 54.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.029 -0.73 . . . . 1.68 109.029 171.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.456 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 39.6 p90 -159.39 142.71 14.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.782 -0.451 . . . . 5.18 109.782 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.487 ' HA2' ' HB ' ' A' ' 241' ' ' VAL . . . 174.69 -168.04 40.53 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.181 -1.009 . . . . 2.13 112.913 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t 43.77 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.465 1.106 . . . . 2.9 112.312 -173.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' GLY . 89.3 mt -85.26 -159.32 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 3.03 109.647 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.61 66.48 9.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.91 0.386 . . . . 3.85 110.071 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 97' ' ' TRP . . . 82.29 120.39 0.6 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.889 -0.672 . . . . 1.94 112.595 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? 178.94 157.21 0.51 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.753 0.421 . . . . 2.45 110.491 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 96' ' ' HIS . . . 128.6 109.84 1.48 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.378 -0.915 . . . . 1.47 113.918 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.47 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 30.5 t -91.64 -47.23 7.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.604 -0.887 . . . . 2.0 108.604 169.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -119.17 48.14 1.55 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.744 -1.947 . . . . 3.72 105.744 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 64.69 2.05 1.55 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.455 -1.702 . . . . 3.52 111.616 -171.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.678 ' OG1' ' HA ' ' A' ' 32' ' ' ASP . 21.2 p -144.27 179.41 7.25 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.765 -0.828 . . . . 2.52 108.765 158.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.0 t -142.31 92.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.332 0.515 . . . . 2.48 111.559 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 36.5 t70 42.36 44.11 3.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.394 0.678 . . . . 2.8 112.513 172.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 67.51 -43.29 0.46 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.291 0.636 . . . . 4.98 111.368 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 110' ' ' ASP . 9.2 mmmm -79.23 71.66 5.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.492 0.317 . . . . 3.23 110.389 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 108' ' ' THR . 57.6 mttp -52.54 120.81 6.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.39 -0.368 . . . . 2.82 110.389 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -104.84 -164.67 1.06 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 1.62 110.44 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 222' ' ' VAL . . . -61.85 -51.61 67.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.712 0.634 . . . . 1.03 112.712 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.4 172.41 6.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.31 -0.255 . . . . 0.75 110.31 -172.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.77 135.75 34.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.352 -0.61 . . . . 1.58 109.352 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.657 ' HG ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 tt -108.47 118.45 36.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.284 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -110.97 100.36 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.904 0.383 . . . . 1.77 110.837 -176.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.9 mp -88.03 108.62 19.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.269 -0.423 . . . . 0.93 110.451 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 90' ' ' LEU . 33.2 t -79.3 123.15 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 0.61 111.187 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 61.3 m80 -118.25 156.98 27.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.326 -0.62 . . . . 2.13 109.326 175.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.641 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 52.3 p-90 -133.9 144.04 48.63 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.264 -0.273 . . . . 4.26 110.264 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -65.82 107.64 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 2.02 111.069 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.641 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 9.5 t -69.46 -14.84 63.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 2.34 112.12 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.18 -14.1 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 3.35 111.231 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.69 3.72 53.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 3.1 110.617 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 62.42 -1.3 1.58 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.503 0.961 . . . . 2.37 115.503 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -169.6 139.46 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.141 0.97 . . . . 3.93 110.116 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.39 -44.06 88.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.919 -0.582 . . . . 3.0 111.294 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.407 ' O ' HG12 ' A' ' 134' ' ' VAL . . . -61.65 -34.91 90.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.106 -0.568 . . . . 2.15 112.156 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -72.47 -38.86 68.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.857 0.361 . . . . 3.43 110.656 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.594 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.07 -38.42 82.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 1.76 111.825 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 131' ' ' GLY . 8.9 p -67.41 -11.9 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.24 0.543 . . . . 2.77 111.285 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -89.6 15.06 10.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.987 0.422 . . . . 3.55 110.91 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -126.15 138.57 32.46 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 60.9 Cg_exo -53.6 -32.04 62.42 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.361 2.708 . . . . 1.6 113.439 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.7 28.97 8.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.068 0.461 . . . . 2.29 110.252 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.99 -36.32 28.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.018 -0.61 . . . . 1.22 113.263 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.0 mt -108.34 157.63 18.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.769 0.319 . . . . 1.57 110.643 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -142.5 107.43 4.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.082 0.468 . . . . 1.38 110.522 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 119' ' ' HIS . 7.8 m -94.02 119.67 42.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.188 0.518 . . . . 1.73 110.857 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 46.5 tp -89.1 112.5 23.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.889 -0.596 . . . . 2.42 109.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.462 ' HA3' ' HE1' ' A' ' 208' ' ' TRP . . . -99.49 132.18 10.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.812 -0.709 . . . . 0.86 112.321 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.8 mt -129.54 124.27 59.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.666 -0.494 . . . . 0.76 109.666 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.89 140.62 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.752 0.31 . . . . 1.2 110.709 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.487 HD23 HG11 ' A' ' 217' ' ' VAL . 10.3 mp -118.6 128.55 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.429 -0.582 . . . . 0.88 109.429 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 15.6 ptpt -122.71 151.09 41.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.062 -0.348 . . . . 2.03 110.062 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 14.2 m -70.44 107.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.472 0.654 . . . . 1.27 111.716 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -155.16 -135.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.495 -0.775 . . . . 1.53 111.272 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.0 m -70.28 121.68 18.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.656 -0.498 . . . . 1.54 109.656 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.59 ' HB2' ' CB ' ' A' ' 218' ' ' SER . . . -83.64 104.53 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.337 -0.246 . . . . 0.78 110.337 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -70.68 126.43 92.2 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.031 -0.359 . . . . 1.22 110.031 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.28 -14.02 31.88 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.04 2.494 . . . . 1.05 112.556 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.536 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -58.64 -25.53 58.66 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.98 -0.555 . . . . 0.7 112.936 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 159' ' ' VAL . 48.0 tp -91.95 -32.05 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.189 0.519 . . . . 0.77 110.406 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -52.49 -38.93 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 1.41 112.142 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 41.6 pttt -61.27 -33.86 74.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.499 0.555 . . . . 2.86 112.499 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 162' ' ' VAL . 13.3 p -84.58 -36.81 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.581 -0.448 . . . . 1.38 110.775 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 156' ' ' LEU . 19.5 t -65.16 -39.18 84.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 1.11 110.72 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.2 -28.03 66.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.519 -0.764 . . . . 1.22 112.695 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 159' ' ' VAL . 10.0 p -92.2 -2.76 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.978 0.418 . . . . 1.41 111.136 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' HD21 ' A' ' 228' ' ' LEU . 75.3 mt -60.29 -28.03 67.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.333 -0.394 . . . . 1.39 111.529 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -67.34 -25.21 65.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.497 -0.319 . . . . 2.31 111.431 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.7 t -84.4 -1.76 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 1.4 110.811 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.41 33.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.356 -0.979 . . . . 0.85 108.356 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -55.62 -35.55 66.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.479 -1.237 . . . . 1.59 111.787 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.1 p -106.72 152.62 23.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.082 0.468 . . . . 0.77 111.163 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -57.94 136.67 57.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 2.29 111.296 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.46 -15.04 57.75 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.734 -0.746 . . . . 0.85 112.917 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -86.81 151.23 23.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 1.7 111.34 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.5 p -142.2 151.43 42.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.394 -0.821 . . . . 1.37 109.816 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.65 148.51 44.13 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.911 -0.403 . . . . 0.61 109.911 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 135.53 51.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.791 0.329 . . . . 1.8 110.125 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -138.61 80.17 1.78 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.734 -0.839 . . . . 1.04 108.734 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.5 p -124.13 169.09 12.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.796 -0.638 . . . . 1.17 111.232 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.56 38.68 22.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.019 -0.537 . . . . 1.77 111.313 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -120.98 137.72 54.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.291 -0.413 . . . . 3.99 110.363 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -80.76 118.85 74.23 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.757 -0.656 . . . . 2.51 110.752 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.89 -21.66 27.92 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.929 2.419 . . . . 1.26 112.766 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -77.27 -2.52 35.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 2.76 111.05 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.11 -17.92 46.59 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 116.168 -0.469 . . . . 1.12 113.262 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.33 -38.09 65.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.63 0.215 . . . . 1.73 110.531 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 79.9 mt 54.69 85.17 0.2 Allowed Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.755 . . . . 3.45 112.778 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.33 136.76 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.296 2.664 . . . . 2.08 112.133 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -107.84 27.34 9.31 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.365 0.666 . . . . 3.23 110.501 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 213' ' ' GLU . 35.0 t -153.51 103.14 2.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.661 -0.496 . . . . 1.66 109.661 -159.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.16 59.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.594 -0.443 . . . . 1.99 110.839 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -125.88 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.033 -1.099 . . . . 1.81 108.033 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.575 ' HB2' HG23 ' A' ' 209' ' ' ILE . 5.6 p90 -162.47 144.94 11.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.855 -0.738 . . . . 5.01 111.816 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 256' ' ' LYS . 48.6 m0 -92.63 129.07 38.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.778 -0.823 . . . . 3.93 108.778 168.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.4 t -84.67 94.04 8.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.12 0.962 . . . . 2.13 110.432 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.63 119.16 18.15 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 5.21 109.349 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.24 150.21 87.75 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.008 1.805 . . . . 2.12 111.218 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.86 123.27 5.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.475 -0.869 . . . . 1.75 112.824 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 22.0 t . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 109.273 -0.64 . . . . 2.99 109.273 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 203' ' ' LEU . 2.7 pp . . . . . 0 C--O 1.235 0.342 0 CA-C-O 121.477 0.656 . . . . 2.96 111.988 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 204' ' ' GLU . 0.0 OUTLIER -77.78 73.74 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.172 -0.922 . . . . 3.37 111.584 -172.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.8 p -99.52 7.24 45.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.441 -0.799 . . . . 2.15 110.702 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 142' ' ' VAL . 10.9 t -118.86 151.05 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.292 0.568 . . . . 1.26 112.079 -169.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 13.4 m -121.75 121.73 37.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.194 -1.039 . . . . 2.08 108.194 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.507 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.3 t90 -86.73 125.97 34.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.105 0.479 . . . . 5.53 110.214 -175.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 190' ' ' TYR . 44.4 mm -109.69 100.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.438 -0.801 . . . . 1.63 108.965 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 3.9 t -92.91 129.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.844 -0.342 . . . . 1.62 111.556 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.958 -0.756 . . . . 1.73 108.958 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.23 2.12 37.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.042 0.756 . . . . 2.98 113.042 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 187' ' ' SER . 10.9 tp10 -111.65 105.31 56.66 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 121.072 -0.251 . . . . 1.47 110.915 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 19.6 Cg_exo -67.67 141.14 53.75 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.856 2.371 . . . . 0.96 112.326 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.0 pt -96.98 153.59 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.322 -0.399 . . . . 1.25 110.188 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.5 m -89.4 128.16 35.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.226 -0.443 . . . . 1.29 111.59 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 35.5 m -137.83 137.95 44.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.606 -0.725 . . . . 1.02 109.11 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.59 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 8.5 t -87.8 159.87 18.25 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.278 -0.569 . . . . 1.08 111.804 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.552 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.4 m -48.26 -46.02 35.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.615 -0.72 . . . . 1.33 111.586 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.86 -26.29 46.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.961 -0.563 . . . . 2.51 112.33 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -80.86 -48.36 12.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.582 -0.525 . . . . 0.7 109.582 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.467 HG21 ' HB1' ' A' ' 115' ' ' ALA . 22.0 t -62.99 -39.1 83.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.221 -0.899 . . . . 1.36 111.477 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.8 mt -62.05 -25.92 67.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 1.03 111.72 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -76.71 -19.67 57.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.584 -0.28 . . . . 1.75 111.337 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -68.92 -34.44 75.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.439 0.638 . . . . 2.47 110.072 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 28.2 ttm180 -76.23 -2.92 33.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.374 -0.83 . . . . 3.04 110.948 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -86.7 -3.75 59.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.392 . . . . 2.31 110.299 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 163' ' ' LEU . 94.8 mt -78.91 145.29 34.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.865 -0.607 . . . . 0.95 110.568 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.596 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.08 127.62 55.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 1.13 111.071 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.94 -34.37 74.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.914 -1.039 . . . . 3.74 110.874 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -69.49 162.38 27.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.674 -0.694 . . . . 1.62 111.933 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.84 166.4 42.96 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.677 -0.969 . . . . 1.16 110.677 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.79 133.43 50.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 3.56 110.803 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 95.51 6.71 59.59 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 2.08 111.87 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -119.01 158.04 49.04 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.518 -0.549 . . . . 2.59 109.518 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.08 122.99 12.11 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.919 2.413 . . . . 1.36 112.134 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.417 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 10.6 pt-20 -62.32 126.3 26.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 3.4 112.178 -174.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 10.6 tp10 -124.55 134.53 52.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.288 -0.869 . . . . 2.47 110.221 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.81 107.97 2.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.575 . . . . 2.14 110.083 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.581 ' SD ' ' HA2' ' A' ' 63' ' ' GLY . 51.1 ttp -74.33 91.24 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 1.68 109.374 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.487 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 27.6 m -135.38 157.71 39.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.628 -0.715 . . . . 1.27 111.293 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 70.42 -81.47 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 124.129 0.893 . . . . 2.18 110.939 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 14.5 m120 50.43 29.18 3.74 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.753 0.649 . . . . 2.15 112.753 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -148.07 152.76 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 4.59 108.876 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -80.38 148.94 67.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.609 -0.145 . . . . 6.13 110.609 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.89 164.11 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.485 2.79 . . . . 3.28 113.598 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.77 98.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.596 -0.729 . . . . 2.98 112.504 -170.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 27.0 mm-40 -61.25 163.83 9.94 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.537 -0.756 . . . . 4.32 110.586 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.622 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 72.0 Cg_endo -75.09 161.1 39.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 3.48 113.366 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -8.83 34.59 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.2 -0.909 . . . . 4.63 112.315 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 47.9 mmtm -55.29 49.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.571 1.693 . . . . 5.34 115.571 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.682 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER 124.91 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.979 2.112 . . . . 4.64 110.149 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 249' ' ' PRO . 4.3 mpt_? -138.42 100.25 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.336 -0.987 . . . . 6.11 108.336 167.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -128.84 148.43 50.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.581 -0.526 . . . . 3.08 109.581 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 21.6 mm -102.0 147.66 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.341 -0.391 . . . . 2.6 110.517 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 191' ' ' TRP . 45.3 mttp -135.71 166.39 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.637 -0.875 . . . . 2.63 108.637 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.736 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -144.28 114.89 7.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.634 -0.136 . . . . 1.71 110.634 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 21.3 m -97.2 100.71 12.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.283 0.563 . . . . 2.21 110.702 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -145.13 131.64 19.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.588 -0.733 . . . . 4.31 110.242 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.782 -0.627 . . . . 4.49 109.759 178.218 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 108.856 -0.794 . . . . 2.88 108.856 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 49.8 mt -88.34 91.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.372 0.606 . . . . 2.32 109.796 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.97 119.45 39.5 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.766 -0.652 . . . . 2.82 109.444 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -55.34 -33.41 63.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.797 . . . . 2.24 112.812 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -76.73 -34.83 58.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.12 0.486 . . . . 4.54 110.705 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -88.01 18.06 4.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.599 -0.728 . . . . 3.06 110.438 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.16 150.26 36.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 1.72 109.2 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -119.35 122.78 42.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.039 0.447 . . . . 3.69 110.472 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -82.59 126.22 32.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.673 -0.694 . . . . 4.64 109.952 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -145.8 97.74 4.55 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.773 -0.454 . . . . 2.27 109.773 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.04 28.89 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.657 2.238 . . . . 2.15 112.677 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -99.9 -5.92 27.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.289 -0.414 . . . . 4.29 110.827 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.66 152.1 21.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.545 -0.539 . . . . 4.74 109.545 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.25 135.72 20.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.681 -0.236 . . . . 3.77 110.723 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.35 136.94 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 2.36 111.364 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.65 131.6 43.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.857 0.361 . . . . 2.55 111.208 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -66.47 122.95 18.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.639 -0.71 . . . . 2.38 109.677 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 79' ' ' LEU . 3.0 t -109.38 103.0 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.237 -0.438 . . . . 1.59 110.141 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.713 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 6.7 m -105.18 89.33 3.1 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.81 -0.811 . . . . 1.45 108.81 177.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.3 p90 -124.46 6.43 8.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.906 0.384 . . . . 3.62 111.461 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.7 -19.27 65.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.409 -0.359 . . . . 2.48 111.418 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 25.2 mp0 -98.64 6.55 46.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.575 -0.284 . . . . 2.24 110.403 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -55.15 133.82 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.8 111.675 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.5 m -120.75 106.37 11.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.888 -0.596 . . . . 1.06 110.186 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.9 p -79.4 150.81 31.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.685 -0.487 . . . . 1.26 109.685 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.9 mt -122.07 -55.4 1.88 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.832 0.349 . . . . 0.74 111.616 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -154.8 152.37 29.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.452 -0.34 . . . . 3.17 111.016 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 tt -115.15 137.39 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.559 -0.534 . . . . 0.64 109.559 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 172' ' ' SER . 39.5 tp -134.07 142.32 47.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.726 0.298 . . . . 0.96 111.11 -173.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -111.09 108.04 17.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.876 -0.787 . . . . 1.49 108.876 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -142.51 72.59 1.38 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.685 0.624 . . . . 1.83 112.685 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.14 -71.41 0.4 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.437 -1.363 . . . . 1.64 113.569 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -142.55 0.04 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.775 0.321 . . . . 3.33 111.585 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.44 174.75 13.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.803 -0.814 . . . . 1.38 108.803 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 95' ' ' PHE . 49.7 p90 -115.38 121.97 44.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 2.74 109.465 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -96.53 116.22 28.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.751 . . . . 1.76 110.46 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 42.0 t -93.05 106.1 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.584 -0.524 . . . . 1.15 109.584 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.62 129.26 37.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.887 -0.597 . . . . 2.02 111.589 -174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -111.52 153.98 25.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.347 -0.842 . . . . 1.66 110.265 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -76.54 110.95 11.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.922 -0.581 . . . . 1.33 110.626 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' CD ' ' A' ' 89' ' ' ARG . 6.2 p-10 -116.26 55.53 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.298 0.571 . . . . 2.65 111.392 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -104.91 -6.5 20.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.483 . . . . 1.61 111.025 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -137.94 176.56 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.206 -0.664 . . . . 2.35 109.206 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -82.14 41.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.18 0.514 . . . . 1.92 110.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 34.9 mmtp -51.32 -60.69 2.85 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.897 -1.047 . . . . 1.77 110.673 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -130.87 96.75 4.15 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.285 -0.871 . . . . 0.76 110.159 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 16.5 m -111.95 147.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.404 0.621 . . . . 1.27 111.605 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.9 tp -129.29 119.43 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.857 -1.065 . . . . 1.29 108.466 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 87' ' ' THR . 57.3 pttt -158.97 121.14 3.51 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.5 -0.48 . . . . 2.54 111.764 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.62 176.9 40.15 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 114.337 0.495 . . . . 1.31 114.337 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.33 -137.43 0.0 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.156 1.36 . . . . 1.9 115.755 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.8 148.76 3.58 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.081 2.521 . . . . 2.91 113.166 -168.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.1 pt? -39.95 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.038 1.866 . . . . 4.11 116.038 -157.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -85.94 -48.55 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.519 -0.764 . . . . 4.95 109.663 162.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 123.79 163.48 11.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.167 -0.54 . . . . 2.25 112.223 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.466 ' HA ' ' HB3' ' A' ' 80' ' ' LYS . 49.1 m -94.69 103.15 15.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 1.91 110.04 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 21.7 m-85 -95.76 102.1 13.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.286 -0.416 . . . . 3.7 110.081 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' CD ' ' HB2' ' A' ' 72' ' ' ASP . 16.0 ptp180 -82.03 152.36 26.68 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.211 -0.306 . . . . 3.54 110.183 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.3 tp -76.47 122.86 25.15 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.737 -0.468 . . . . 1.14 109.737 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -108.38 -32.81 2.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.906 0.384 . . . . 1.68 110.164 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.3 pt20 -171.64 169.66 5.93 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.691 -0.485 . . . . 1.55 109.691 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -140.72 158.43 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.412 -0.588 . . . . 0.86 109.412 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -147.41 158.73 44.09 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.19 0.306 . . . . 0.93 110.73 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 66.5 m-85 -123.08 165.55 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 3.17 110.773 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -172.6 126.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.266 0.626 . . . . 1.68 109.661 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.517 ' CE3' ' HB1' ' A' ' 116' ' ' ALA . 14.8 p90 -161.8 -174.51 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.591 -0.277 . . . . 5.18 110.375 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 241' ' ' VAL . . . 89.92 99.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.512 -0.851 . . . . 2.13 111.681 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.7 t -143.08 -82.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.711 -0.848 . . . . 2.9 108.711 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD12 ' OE1' ' A' ' 103' ' ' GLN . 84.2 mt -95.75 -155.18 0.46 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.143 -0.688 . . . . 3.03 109.143 169.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.82 -48.31 67.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.077 0.399 . . . . 3.85 112.077 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.71 63.68 0.36 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.602 -0.808 . . . . 1.94 111.448 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 114' ' ' TYR . 13.1 pt20 -150.65 -172.11 4.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 2.45 110.761 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.29 8.71 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.47 111.474 -168.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.444 ' HB2' ' N ' ' A' ' 116' ' ' ALA . 48.2 t -78.46 -33.5 48.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.338 0.495 . . . . 2.0 112.338 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.466 ' CG ' ' H ' ' A' ' 107' ' ' HIS . 0.9 OUTLIER 69.85 -156.32 0.15 Allowed 'General case' 0 C--N 1.343 0.316 0 N-CA-C 107.363 -1.347 . . . . 3.72 107.363 -173.13 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 4.3 m-70 53.04 69.79 0.66 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.161 0.437 . . . . 3.52 110.046 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 5.3 t -98.71 117.43 33.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 120.024 -0.671 . . . . 2.52 110.136 -165.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 14.7 m -92.18 103.44 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.161 0.505 . . . . 2.48 110.785 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.2 t70 54.01 58.83 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.555 -0.748 . . . . 2.8 109.735 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 67.23 4.83 3.85 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.866 -1.061 . . . . 4.98 113.19 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 109' ' ' VAL . 37.5 ttmt -90.36 111.68 22.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.949 -0.389 . . . . 3.23 109.949 175.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -93.08 146.6 23.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.569 -0.9 . . . . 2.82 108.569 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 96.8 m-85 -95.93 176.44 6.11 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.601 -0.439 . . . . 1.62 109.935 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.0 -39.03 20.18 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.664 0.616 . . . . 1.03 112.664 -171.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HB1' ' CE3' ' A' ' 97' ' ' TRP . . . -145.34 149.97 35.76 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.606 -0.438 . . . . 0.75 111.801 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' OE1' ' NE2' ' A' ' 107' ' ' HIS . 3.5 tp10 -110.88 141.55 44.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.055 -0.52 . . . . 1.58 110.563 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.681 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 13.0 tp -121.73 121.86 38.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.771 -0.649 . . . . 1.07 110.045 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.35 104.34 10.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 1.77 111.446 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -89.81 111.01 21.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.031 -0.531 . . . . 0.93 109.589 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.75 123.62 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.316 0.579 . . . . 0.61 110.766 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 29.8 m-70 -115.74 145.53 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.64 -0.709 . . . . 2.13 109.912 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.458 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 9.1 t90 -112.0 133.47 54.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.973 -0.558 . . . . 4.26 110.719 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -78.17 111.84 14.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.231 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 t -58.34 -21.66 50.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.719 -0.673 . . . . 2.34 112.111 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -46.79 -32.18 3.51 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.557 0.947 . . . . 3.35 113.557 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.43 ' CE2' ' HB2' ' A' ' 136' ' ' GLN . 4.8 m-85 -97.38 -4.62 38.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.648 0.61 . . . . 3.1 112.648 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.87 14.9 2.91 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.575 0.59 . . . . 2.37 114.575 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 18.1 t70 -172.11 117.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.853 -0.795 . . . . 3.93 108.853 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -65.52 -33.14 75.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 3.0 111.819 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 134' ' ' VAL . . . -61.45 -33.66 85.51 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.881 -0.676 . . . . 2.15 112.133 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 69.9 mmtt -83.79 -24.98 30.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.797 0.332 . . . . 3.43 110.979 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.475 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.49 -21.85 63.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.358 -0.383 . . . . 1.76 111.912 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 131' ' ' GLY . 31.3 m -73.05 3.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 2.77 112.381 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 12.7 pt20 -97.15 -11.0 24.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 3.55 110.182 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.456 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 29.9 tt0 -101.81 136.48 19.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 3.02 109.867 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 25.3 Cg_endo -60.65 -28.39 86.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.28 2.654 . . . . 1.6 112.656 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.456 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.8 p-10 -112.24 27.71 9.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 2.29 109.447 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.36 -37.64 86.29 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.725 -0.67 . . . . 1.22 111.747 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 206' ' ' VAL . 86.8 mt -122.37 158.01 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.018 -0.734 . . . . 1.57 109.018 173.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.52 122.69 12.93 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.2 -0.296 . . . . 1.38 110.2 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.91 126.87 69.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.015 0.436 . . . . 1.73 110.697 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 49.0 tp -93.04 117.83 30.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.621 -0.718 . . . . 2.42 109.777 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -104.4 127.61 9.16 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.275 -0.488 . . . . 0.86 112.132 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.88 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.756 -0.461 . . . . 0.76 109.756 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.7 141.9 49.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.798 -0.183 . . . . 1.2 110.556 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 9.7 mp -121.27 135.32 55.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.118 0.485 . . . . 0.88 110.676 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 216' ' ' SER . 54.6 pttt -123.54 156.3 35.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.839 -0.8 . . . . 2.03 108.839 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 46.6 t -94.34 126.62 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.875 0.369 . . . . 1.27 110.568 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.22 -105.89 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.634 -0.586 . . . . 1.53 111.634 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.8 m -67.04 154.99 39.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.655 0.264 . . . . 1.54 110.315 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.33 157.27 16.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.015 -0.365 . . . . 0.78 110.015 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 216' ' ' SER . 28.2 mtpp -128.06 103.0 21.14 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.069 -0.345 . . . . 1.22 110.069 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.65 -33.93 61.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.362 2.708 . . . . 1.05 112.612 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.85 -28.64 73.67 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.7 112.502 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.7 tp -102.64 -23.64 13.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.77 110.543 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -38.43 70.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 1.41 110.047 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.3 -29.73 70.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.935 -0.575 . . . . 2.86 111.235 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.24 -48.54 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.21 0.528 . . . . 1.38 110.15 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.441 HG11 ' HA ' ' A' ' 221' ' ' GLN . 43.2 t -65.33 -36.0 76.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.698 -0.683 . . . . 1.11 111.205 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.58 -28.22 69.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 1.22 112.231 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.52 -1.37 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.73 -0.388 . . . . 1.41 111.482 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.51 ' HB3' HD21 ' A' ' 228' ' ' LEU . 79.6 mt -58.99 -22.21 60.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 1.39 111.778 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -66.6 -28.83 68.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.445 0.164 . . . . 2.31 111.366 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.4 p -83.26 -0.54 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.301 . . . . 1.4 111.739 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.29 34.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.85 108.883 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.425 ' HA ' HD23 ' A' ' 228' ' ' LEU . 84.1 tttt -67.73 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.87 -1.059 . . . . 1.59 111.883 -169.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.66 148.77 49.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 0.77 110.706 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -59.61 126.34 27.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.351 -0.84 . . . . 2.29 111.084 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 114.51 -21.46 14.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.819 -0.705 . . . . 0.85 112.693 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -88.67 153.15 21.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 1.7 111.26 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' HD13 ' A' ' 60' ' ' LEU . 42.6 p -144.21 161.62 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 1.37 110.732 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.47 151.63 37.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.148 -0.478 . . . . 0.61 109.816 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.64 131.95 41.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.815 -0.439 . . . . 1.8 109.815 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -141.53 81.77 1.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.085 -0.507 . . . . 1.04 109.839 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 46.0 p -98.85 166.54 11.25 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.278 -0.419 . . . . 1.17 111.363 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 66.17 32.2 8.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.814 -0.63 . . . . 1.77 112.418 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.604 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 68.3 t80 -66.63 132.3 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.331 -0.248 . . . . 3.99 110.331 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.22 100.25 0.68 Allowed Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 123.621 0.575 . . . . 2.51 110.567 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 11.1 Cg_exo -71.16 -36.24 7.54 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.71 2.274 . . . . 1.26 112.445 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.3 -9.96 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 2.76 110.637 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -70.93 0.97 26.64 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.063 -0.517 . . . . 1.12 113.14 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 86.4 mt -91.68 -14.58 29.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.197 -0.297 . . . . 1.73 110.197 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.5 mt 42.84 73.7 0.89 Allowed Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 113.462 0.912 . . . . 3.45 113.462 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.39 119.11 1.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.148 2.565 . . . . 2.08 111.127 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.3 mt-10 -112.39 25.08 11.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.778 0.431 . . . . 3.23 111.346 -171.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.472 ' CB ' ' HB2' ' A' ' 213' ' ' GLU . 0.3 OUTLIER -168.3 90.06 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.047 -0.661 . . . . 1.66 110.605 -160.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.68 63.91 0.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.008 -1.108 . . . . 1.99 108.008 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 258' ' ' SER . 8.6 m-20 -87.71 -51.18 6.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.652 0.982 . . . . 1.81 113.652 -166.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 51.0 p90 -146.85 144.62 29.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.267 -0.573 . . . . 5.01 111.955 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -136.72 129.01 29.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.682 -0.69 . . . . 3.93 110.595 174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 256' ' ' LYS . 7.6 t -171.91 74.01 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.93 0.872 . . . . 2.13 111.134 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 208' ' ' TRP . 82.9 m-85 -139.36 137.33 18.85 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.123 -0.489 . . . . 5.21 111.092 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.83 132.21 4.68 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.829 2.353 . . . . 2.12 111.812 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.431 ' HA3' ' HB ' ' A' ' 206' ' ' VAL . . . -99.22 106.27 3.19 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.532 -0.842 . . . . 1.75 112.61 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.322 -0.609 0 C-N-CA 122.922 0.489 . . . . 2.99 111.752 178.707 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.945 0.72 . . . . 2.96 112.945 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.78 88.74 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.469 -0.787 . . . . 3.37 111.458 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.3 p -118.15 16.46 14.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.097 -0.956 . . . . 2.15 109.561 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 140' ' ' LEU . 51.0 t -117.57 149.71 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.835 -1.075 . . . . 1.26 109.744 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 87.3 m -117.19 117.13 28.73 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.374 -0.602 . . . . 2.08 109.374 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 193' ' ' TYR . 36.9 m0 -84.98 133.05 34.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.375 0.607 . . . . 5.53 110.7 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 67.4 mt -121.29 141.78 40.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.363 -0.977 . . . . 1.63 108.363 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.42 146.33 31.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.201 0.524 . . . . 1.62 111.681 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.83 131.45 55.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.928 -0.768 . . . . 1.73 108.928 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 53.9 tttm -69.12 -7.6 37.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 2.98 111.644 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 186' ' ' GLU . 10.1 tp10 -94.04 112.32 56.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.436 -0.347 . . . . 1.47 111.177 -175.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 4.9 Cg_exo -78.65 130.51 9.8 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.658 2.239 . . . . 0.96 111.09 171.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.404 HG13 ' HG ' ' A' ' 147' ' ' LEU . 34.1 pt -99.22 154.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.447 -0.575 . . . . 1.25 109.447 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.512 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 27.4 p -103.68 126.76 51.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.703 0.287 . . . . 1.29 111.711 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -114.83 147.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.15 -0.685 . . . . 1.02 109.15 173.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -93.6 166.55 12.18 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.532 -0.467 . . . . 1.08 110.78 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.574 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 44.0 m -50.19 -47.92 54.4 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.438 0.461 . . . . 1.33 112.209 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.69 -38.14 69.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.588 0.232 . . . . 2.51 111.391 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.441 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.1 mt-30 -67.38 -43.11 82.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 0.7 110.176 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.0 -41.78 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 1.36 111.031 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 219' ' ' SER . 90.2 mt -67.84 -44.1 77.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 1.03 111.689 -176.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -65.88 -24.42 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.912 0.338 . . . . 1.75 111.912 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -71.64 -36.03 70.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.033 0.444 . . . . 2.47 110.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -78.56 17.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.658 0.742 . . . . 3.04 110.439 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.57 -19.22 18.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.196 -0.668 . . . . 2.31 109.196 171.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 163' ' ' LEU . 88.7 mt -68.05 134.51 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.603 -0.726 . . . . 0.95 111.236 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 83.3 m-20 -96.92 144.23 27.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 1.13 110.147 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -79.79 -28.92 40.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.778 -1.101 . . . . 3.74 108.79 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -83.4 174.81 10.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 1.62 111.585 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.73 179.1 27.65 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.04 -0.982 . . . . 1.16 111.545 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.8 125.46 23.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.988 0.423 . . . . 3.56 111.579 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.72 20.1 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.845 -0.616 . . . . 2.08 113.507 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -133.14 157.22 78.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.898 0.349 . . . . 2.59 110.079 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.98 122.69 12.26 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.557 2.171 . . . . 1.36 111.692 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.25 117.94 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.235 0.828 . . . . 3.4 113.235 -173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 60.0 mm-40 -115.27 142.12 47.11 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.583 -1.189 . . . . 2.47 108.042 169.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.11 127.05 38.51 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.968 -0.293 . . . . 2.14 110.214 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 52.6 ttp -81.23 94.96 6.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.16 0.505 . . . . 1.68 110.07 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 98' ' ' GLY . 21.8 m -137.95 156.41 31.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.673 -0.694 . . . . 1.27 110.752 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.39 -80.23 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.914 0.758 . . . . 2.18 110.953 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 47.37 32.16 2.14 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.176 0.591 . . . . 2.15 112.193 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -146.89 174.55 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.232 0.539 . . . . 4.59 111.657 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -127.68 145.7 55.86 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.598 -0.728 . . . . 6.13 110.261 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.17 174.16 3.48 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.548 2.166 . . . . 3.28 112.48 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.86 158.86 34.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.785 -0.643 . . . . 2.98 112.33 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -114.45 170.5 5.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.491 -0.777 . . . . 4.32 109.601 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.83 175.77 9.88 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.859 2.373 . . . . 3.48 113.489 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.8 -7.39 1.61 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.788 1.235 . . . . 4.63 112.88 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -55.87 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.517 2.043 . . . . 5.34 116.517 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 37.3 p30 131.04 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 126.665 1.986 . . . . 4.64 113.298 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -172.71 133.93 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.022 0.439 . . . . 6.11 111.574 166.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -114.16 150.61 33.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.394 -0.821 . . . . 3.08 109.486 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.8 mm -85.91 113.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.827 0.346 . . . . 2.6 110.573 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.514 ' HB3' HG21 ' A' ' 192' ' ' THR . 41.8 ttmt -109.34 143.41 38.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.058 -0.719 . . . . 2.63 109.058 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 190' ' ' TYR . . . -136.95 164.0 29.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.724 0.297 . . . . 1.71 110.924 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 36.0 m -151.12 97.41 2.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.996 0.427 . . . . 2.21 109.985 175.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.84 95.95 4.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.215 -0.661 . . . . 4.31 109.215 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.718 -0.658 . . . . 4.49 110.399 -177.132 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 108.479 -0.934 . . . . 2.88 108.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 108' ' ' THR . 75.5 mt -67.55 125.25 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.59 0.709 . . . . 2.32 111.645 -173.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.88 122.91 29.57 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.935 -1.029 . . . . 2.82 108.81 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.6 p -57.22 -24.86 57.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.936 0.717 . . . . 2.24 112.936 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -81.34 -27.19 35.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 4.54 111.263 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 m -95.39 -28.7 14.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.422 . . . . 3.06 111.14 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.31 121.18 13.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 1.72 110.651 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.13 116.24 22.25 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.817 -0.438 . . . . 3.69 109.817 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -65.41 136.83 56.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 4.64 110.402 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 258' ' ' SER . 19.0 t70 -130.63 132.79 24.18 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.745 -0.661 . . . . 2.27 110.23 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.588 ' O ' HD23 ' A' ' 44' ' ' LEU . 23.3 Cg_exo -65.17 108.98 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.213 1.942 . . . . 2.15 112.55 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.698 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -53.08 -18.39 2.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.699 -0.682 . . . . 4.29 111.468 171.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER 50.65 -84.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.94 1.296 . . . . 4.74 113.177 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' H ' ' CG ' ' A' ' 44' ' ' LEU . 88.4 tttt -89.69 133.05 35.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.141 -0.318 . . . . 3.77 110.141 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.47 136.98 57.39 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.636 2.224 . . . . 2.36 111.519 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.03 141.66 43.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 2.55 110.096 -177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -102.48 97.19 7.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.898 -0.778 . . . . 2.38 108.898 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.26 108.7 23.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.589 -0.732 . . . . 1.59 109.175 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.695 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 61.5 m -108.31 91.51 3.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.982 0.42 . . . . 1.45 110.356 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 181' ' ' ARG . 7.8 p90 -102.85 8.95 39.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.922 -0.581 . . . . 3.62 109.542 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.09 -29.59 57.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.963 -1.017 . . . . 2.48 111.156 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 50.6 mt-30 -113.31 23.04 13.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.659 -0.7 . . . . 2.24 110.997 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HB1' ' HG2' ' A' ' 180' ' ' PRO . . . -72.3 114.02 9.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.035 0.445 . . . . 0.8 110.54 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -115.56 112.26 21.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.617 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 p -77.96 156.18 30.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.077 -0.511 . . . . 1.26 110.246 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.4 mt -121.63 -56.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.612 -0.267 . . . . 0.74 111.449 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.73 156.67 23.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 3.17 111.515 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.519 HG12 HD13 ' A' ' 166' ' ' ILE . 12.0 tt -107.12 137.73 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.515 -0.766 . . . . 0.64 109.7 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 172' ' ' SER . 24.0 tp -135.4 150.55 49.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.203 0.525 . . . . 0.96 111.683 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 166' ' ' ILE . 49.0 t-20 -113.33 111.87 22.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.254 -1.387 . . . . 1.49 107.254 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -135.64 71.41 1.43 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.811 -0.756 . . . . 1.83 111.875 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.03 -83.67 0.62 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 119.917 -1.135 . . . . 1.64 112.918 160.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -112.29 -7.29 14.01 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.156 -0.218 . . . . 3.33 111.381 -173.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.4 167.26 24.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 1.38 111.612 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 46.1 m-85 -110.34 105.53 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.632 -0.877 . . . . 2.74 108.632 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -99.0 124.82 44.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.469 -0.332 . . . . 1.76 111.764 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 59' ' ' ILE . 49.0 t -107.68 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.074 -0.713 . . . . 1.15 109.074 172.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.29 163.29 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.705 0.764 . . . . 2.02 112.581 -170.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.57 164.64 27.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.424 -1.262 . . . . 1.66 108.372 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 106.15 14.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.689 -0.485 . . . . 1.33 109.689 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -112.24 57.05 0.65 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.575 0.702 . . . . 2.65 110.102 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.1 p -95.83 -20.85 18.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.953 -0.567 . . . . 1.61 111.425 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.465 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 7.9 pt20 -145.8 177.97 8.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 2.35 110.784 -171.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' OD2' HG21 ' A' ' 78' ' ' VAL . 11.4 t70 -71.21 63.44 0.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.556 -0.747 . . . . 1.92 110.586 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' A' ' 74' ' ' GLN . 48.0 mttm -86.0 -69.02 0.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.956 -0.565 . . . . 1.77 111.356 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -115.21 102.48 9.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.76 109.61 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.405 HG21 ' OD2' ' A' ' 75' ' ' ASP . 39.0 t -117.05 142.74 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.186 -0.461 . . . . 1.27 111.788 -171.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 tp -123.31 121.24 35.33 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 1.29 109.324 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -159.96 121.17 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.193 0.52 . . . . 2.54 110.696 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.7 28.55 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 119.606 -0.552 . . . . 1.31 112.033 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -41.01 -140.27 0.0 OUTLIER Glycine 0 CA--C 1.534 1.236 0 O-C-N 124.606 0.827 . . . . 1.9 114.373 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.09 122.94 8.05 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 121.918 1.745 . . . . 2.91 111.525 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 13.2 tp -175.2 -168.27 0.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.367 -1.345 . . . . 4.11 107.367 -165.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 20.8 t70 -135.9 72.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.798 0.726 . . . . 4.95 110.294 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 164.47 20.26 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 2.25 113.094 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.3 m -105.77 129.44 53.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.529 -0.545 . . . . 1.91 109.529 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 8.5 m-85 -115.3 109.99 18.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.392 . . . . 3.7 111.09 -171.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.8 mtt180 -83.65 155.87 22.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.782 -0.451 . . . . 3.54 109.782 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 51.5 tp -83.21 131.61 35.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.132 -0.322 . . . . 1.14 110.132 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.676 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.8 tt -116.64 -47.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 1.68 111.375 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -166.56 165.11 16.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.732 -0.47 . . . . 1.55 109.732 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CD2' HD11 ' A' ' 118' ' ' LEU . 15.5 p90 -133.84 167.2 21.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.945 -0.302 . . . . 0.86 110.418 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 66' ' ' PHE . 8.2 p-80 -147.51 158.6 44.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.164 -0.68 . . . . 0.93 109.164 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.74 163.65 23.86 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.376 -0.231 . . . . 3.17 110.376 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.432 ' ND1' ' HB3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -124.03 165.24 17.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.694 -0.854 . . . . 1.68 108.694 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 65.6 t-105 -133.03 140.54 47.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.412 . . . . 5.18 110.626 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.576 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -91.46 -71.17 1.2 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.726 -0.67 . . . . 2.13 112.732 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 24.7 t 165.48 -65.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.277 -1.009 . . . . 2.9 108.277 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.4 mt -111.36 168.02 9.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.312 -0.858 . . . . 3.03 108.869 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.71 61.78 3.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.564 0.697 . . . . 3.85 110.943 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -154.95 -24.35 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.505 -0.855 . . . . 1.94 113.537 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -152.15 176.51 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.304 0.552 . . . . 2.45 110.581 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.576 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 97.04 -33.15 5.97 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.788 -0.72 . . . . 1.47 113.003 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.3 p -71.1 -27.77 63.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.119 0.485 . . . . 2.0 110.76 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 3.6 tp10 58.81 -158.07 0.31 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.958 -1.127 . . . . 3.72 107.958 -166.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.511 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 19.3 m-70 54.76 65.21 1.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.817 -0.809 . . . . 3.52 108.817 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.509 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -93.05 133.61 36.03 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 2.52 109.953 -168.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -109.48 104.61 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.015 -0.365 . . . . 2.48 110.015 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.97 53.74 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.429 -0.805 . . . . 2.8 110.449 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 77.97 -11.22 1.23 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.201 -0.908 . . . . 4.98 111.826 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -93.97 108.82 20.59 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.432 . . . . 3.23 112.168 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 64.0 mttp -81.69 176.44 9.63 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.752 -0.833 . . . . 2.82 108.752 166.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -124.11 -173.19 2.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.243 -0.183 . . . . 1.62 111.094 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.6 -35.43 58.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.938 0.348 . . . . 1.03 111.938 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.77 168.65 26.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.37 -0.377 . . . . 0.75 110.165 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.432 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 1.7 tm-20 -145.3 147.3 32.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.067 -0.716 . . . . 1.58 109.067 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 93' ' ' PHE . 39.5 tp -126.02 122.03 34.69 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.291 0.369 . . . . 1.07 111.047 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -108.69 109.74 20.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.431 -0.35 . . . . 1.77 110.669 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' CB ' ' A' ' 93' ' ' PHE . 18.4 mt -93.67 105.21 17.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.935 -0.394 . . . . 0.93 109.935 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.6 118.34 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.334 0.587 . . . . 0.61 112.054 -173.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 52.0 m-70 -110.36 134.09 52.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.472 -0.785 . . . . 2.13 109.482 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.676 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 25.3 p-90 -111.18 148.05 33.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.476 . . . . 4.26 111.885 -172.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.9 110.2 1.27 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.41 -0.814 . . . . 2.02 111.181 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -60.46 -30.4 69.64 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.314 0.857 . . . . 2.34 113.314 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -80.3 -56.84 3.92 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.331 0.493 . . . . 3.35 112.331 -171.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.34 -19.24 56.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 3.1 111.719 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.41 72.68 Favored Glycine 0 C--N 1.318 -0.419 0 N-CA-C 110.314 -1.114 . . . . 2.37 110.314 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.628 ' OD2' ' HG ' ' A' ' 140' ' ' LEU . 22.7 t70 78.48 -78.07 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.95 -1.125 . . . . 3.93 113.162 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -50.33 -21.12 1.28 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.055 1.131 . . . . 3.0 114.055 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.99 -69.14 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.954 -1.117 . . . . 2.15 112.555 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 72.4 mmtt -89.15 -40.14 13.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.533 0.568 . . . . 3.43 112.533 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . . . -66.8 -29.91 69.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.035 0.383 . . . . 1.76 112.035 -171.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.16 -6.41 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.279 0.562 . . . . 2.77 110.848 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -114.6 19.1 16.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 3.55 110.311 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 88.5 mt-30 -131.25 127.2 21.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 108.782 -0.822 . . . . 3.02 108.782 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.23 -29.93 48.96 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.108 2.539 . . . . 1.6 113.688 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.96 24.26 12.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.728 0.299 . . . . 2.29 110.459 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.97 -70.41 1.07 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.073 -0.512 . . . . 1.22 113.829 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HG ' ' OD2' ' A' ' 129' ' ' ASP . 6.5 mp -89.05 171.29 9.95 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.832 0.349 . . . . 1.57 110.801 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -141.39 104.11 4.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.618 -0.512 . . . . 1.38 109.618 172.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.67 111.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.799 -0.445 . . . . 1.73 109.799 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 57.8 tp -82.73 104.86 13.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 2.42 110.345 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -84.86 151.33 26.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.847 -0.692 . . . . 0.86 112.145 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.03 129.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.102 -0.332 . . . . 0.76 110.102 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 107' ' ' HIS . 3.2 m-85 -70.75 137.82 49.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.419 -0.355 . . . . 1.2 110.641 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.93 108.08 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.0 0.429 . . . . 0.88 110.445 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 215' ' ' ILE . 58.9 pttt -106.02 164.5 11.92 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 2.03 108.863 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.8 m -106.3 138.42 31.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 1.27 111.847 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.24 -96.83 0.1 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.092 -0.958 . . . . 1.53 110.952 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -87.88 153.78 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.776 -0.453 . . . . 1.54 109.776 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.77 158.37 36.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.194 0.521 . . . . 0.78 112.113 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 216' ' ' SER . 30.5 mmmt -112.31 100.13 48.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.4 -0.818 . . . . 1.22 109.01 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.05 -40.4 59.31 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.089 2.526 . . . . 1.05 112.251 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.81 74.89 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.091 -0.576 . . . . 0.7 113.143 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.2 tp -92.41 -26.23 18.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.46 0.63 . . . . 0.77 110.2 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -35.66 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.41 109.638 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.47 -39.65 84.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.538 -0.755 . . . . 2.86 110.995 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.1 t -71.98 -48.04 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.184 0.516 . . . . 1.38 110.146 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.618 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 67.3 t -58.93 -32.62 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 1.11 110.971 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.41 -21.51 64.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.569 -0.741 . . . . 1.22 111.891 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.29 -12.92 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.505 0.558 . . . . 1.41 112.505 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -57.48 -21.49 37.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.718 0.636 . . . . 1.39 112.718 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.503 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.9 p-10 -64.61 -18.99 65.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 2.31 111.086 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -88.7 -5.99 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.855 0.36 . . . . 1.4 110.9 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 61' ' ' ASN . 14.3 pt -126.64 39.19 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.526 0.679 . . . . 0.85 109.983 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.66 -28.18 69.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.547 -0.751 . . . . 1.59 111.184 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.7 p -130.96 147.66 52.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.362 -0.381 . . . . 0.77 110.709 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -58.57 140.37 54.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.842 -0.617 . . . . 2.29 111.005 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.09 -10.77 55.34 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.951 -0.642 . . . . 0.85 112.131 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 60' ' ' LEU . 97.8 mttt -104.9 144.58 31.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.449 . . . . 1.7 111.041 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 60' ' ' LEU . 23.7 p -141.82 156.47 45.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.627 -0.715 . . . . 1.37 110.181 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.63 136.37 35.86 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.482 -0.327 . . . . 0.61 110.282 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.02 129.36 41.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.143 -0.481 . . . . 1.8 110.762 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -138.94 77.86 1.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.004 -1.11 . . . . 1.04 108.004 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.98 156.11 21.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.672 -0.694 . . . . 1.17 111.261 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 54.78 56.33 6.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.123 0.487 . . . . 1.77 112.003 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.544 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 73.0 m-85 -124.75 143.62 50.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.932 -0.576 . . . . 3.99 109.852 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 181' ' ' ARG . 6.4 m-20 -93.12 107.31 24.26 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 2.51 111.844 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 19.4 Cg_exo -69.1 -13.52 36.48 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.934 2.423 . . . . 1.26 112.001 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.435 ' HG2' ' HB3' ' A' ' 179' ' ' ASP . 16.7 ptt180 -66.09 -16.85 64.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.375 . . . . 2.76 110.48 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.49 6.84 67.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.853 -0.612 . . . . 1.12 111.822 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 67.1 mt -110.96 -32.0 6.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.286 0.565 . . . . 1.73 109.557 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.06 127.11 73.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.41 -0.814 . . . . 3.45 111.339 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.37 -174.57 1.46 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.244 2.629 . . . . 2.08 113.099 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.77 -58.72 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.834 0.679 . . . . 3.23 112.834 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 19.7 m -61.52 125.06 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.801 0.334 . . . . 1.66 111.008 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.0 tp -104.22 62.67 0.74 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.588 0.708 . . . . 1.99 109.87 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.452 ' O ' HD12 ' A' ' 211' ' ' LEU . 24.2 m-20 -133.67 -177.86 4.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.994 -1.113 . . . . 1.81 107.994 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.2 p90 -163.01 155.03 18.14 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.308 -0.957 . . . . 5.01 112.625 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.471 ' CE2' ' HG3' ' A' ' 212' ' ' LYS . 57.4 m95 -96.35 142.31 28.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.752 -1.113 . . . . 3.93 109.331 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 256' ' ' LYS . 19.1 m -74.81 79.23 2.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.081 0.467 . . . . 2.13 109.786 173.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.413 ' HB3' ' CG2' ' A' ' 210' ' ' VAL . 41.0 t80 -117.89 103.08 50.7 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.629 . . . . 5.21 109.967 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.408 ' N ' ' HB3' ' A' ' 208' ' ' TRP . 45.1 Cg_exo -56.65 146.36 76.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.255 2.637 . . . . 2.12 113.087 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.67 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -139.66 153.15 22.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.508 -0.853 . . . . 1.75 112.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.882 0.372 . . . . 2.99 110.154 171.159 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.969 0.414 . . . . 2.96 112.022 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.41 67.12 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.732 0.777 . . . . 3.37 110.281 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.9 m -118.24 24.71 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.223 -0.899 . . . . 2.15 110.491 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 70.7 t -120.38 134.39 64.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.65 -0.705 . . . . 1.26 110.159 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.2 m -73.63 121.7 21.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.597 -0.729 . . . . 2.08 109.629 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.435 ' CE3' HG23 ' A' ' 192' ' ' THR . 0.0 OUTLIER -64.48 99.49 0.31 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.072 -0.967 . . . . 5.53 111.981 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 58.3 mt -142.43 100.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.326 -0.397 . . . . 1.63 110.368 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 73.3 t -117.25 119.14 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.286 -0.264 . . . . 1.62 110.286 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 189' ' ' ASP . 9.8 tp -62.06 123.2 17.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.228 -0.286 . . . . 1.73 110.228 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.471 ' HG3' ' CE2' ' A' ' 191' ' ' TRP . 29.2 ttpp -65.59 -8.31 19.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.716 1.376 . . . . 2.98 114.716 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 36.3 tt0 -105.93 110.06 63.74 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 119.776 -0.77 . . . . 1.47 111.096 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.448 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 25.7 Cg_exo -64.49 137.66 56.18 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.776 2.317 . . . . 0.96 111.578 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.405 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 38.6 pt -97.49 149.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.745 -0.465 . . . . 1.25 109.745 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 17.0 t -103.34 120.7 41.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.207 -0.664 . . . . 1.29 109.207 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.47 162.95 8.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.996 -0.372 . . . . 1.02 109.996 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 16.2 t -81.92 151.09 27.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.121 -0.325 . . . . 1.08 110.121 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.643 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 13.9 m -55.67 -43.17 76.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.405 -0.361 . . . . 1.33 110.83 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 12.3 tp10 -59.42 -32.51 70.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 2.51 111.019 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.421 ' HA ' HG11 ' A' ' 160' ' ' VAL . 56.2 mt-30 -67.18 -49.92 62.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.7 110.741 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.628 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 31.2 m -71.0 -29.75 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.351 . . . . 1.36 111.944 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 219' ' ' SER . 91.1 mt -63.9 -26.54 68.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 1.03 110.84 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 58.1 mtpt -82.68 -22.67 34.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 1.75 110.86 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.6 m-85 -70.12 -34.05 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.514 -0.55 . . . . 2.47 109.514 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.92 -14.62 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 3.04 111.042 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -95.61 -3.12 46.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.406 -0.361 . . . . 2.31 111.528 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.69 154.6 21.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.226 0.536 . . . . 0.95 111.224 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 39.6 m-20 -119.81 159.48 24.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.266 -0.642 . . . . 1.13 109.266 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -105.62 -4.64 20.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 3.74 110.424 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.8 p-10 -85.1 176.14 8.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 1.62 110.091 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -104.09 169.12 17.37 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.143 -0.783 . . . . 1.16 111.143 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -55.24 143.58 27.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 3.56 110.647 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.76 23.83 54.8 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.052 -0.594 . . . . 2.08 112.923 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.4 153.33 76.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 117.247 0.523 . . . . 2.59 109.851 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.06 127.74 23.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.531 2.154 . . . . 1.36 111.01 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.0 118.68 4.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.623 0.725 . . . . 3.4 112.783 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -114.13 110.39 19.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.855 -1.066 . . . . 2.47 109.121 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.55 139.64 47.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.336 -0.393 . . . . 2.14 111.077 -176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.6 ttm -87.52 91.52 8.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.391 -0.596 . . . . 1.68 109.391 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.69 154.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.203 -0.453 . . . . 1.27 111.356 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.5 t70 69.06 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.077 0.861 . . . . 2.18 110.524 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ASN . . . . . 0.416 HD22 ' HB3' ' A' ' 96' ' ' HIS . 58.9 t30 56.3 20.38 4.59 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.177 0.806 . . . . 2.15 113.177 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -151.32 167.44 27.87 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.056 -0.403 . . . . 4.59 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -125.09 147.7 57.91 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 115.802 -0.635 . . . . 6.13 110.675 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -43.9 146.54 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.051 2.501 . . . . 3.28 112.553 168.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.94 142.65 47.84 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.196 1.184 . . . . 2.98 114.196 -166.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -74.76 159.55 82.89 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.675 -1.148 . . . . 4.32 110.303 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.57 174.48 8.76 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.454 2.77 . . . . 3.48 113.729 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 89.2 mt -66.14 -9.5 32.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.81 -1.086 . . . . 4.63 112.081 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 74.3 mmtt -58.67 46.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.623 1.342 . . . . 5.34 114.623 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 51.5 t30 120.19 6.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.559 1.944 . . . . 4.64 110.721 176.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 1.2 mpt_? -132.98 104.02 6.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.716 -0.674 . . . . 6.11 109.298 171.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -114.5 145.63 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.757 0.313 . . . . 3.08 111.099 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.3 mm -100.88 126.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.027 -0.533 . . . . 2.6 110.35 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.553 ' HB2' ' OG1' ' A' ' 192' ' ' THR . 96.4 mttt -117.19 150.78 38.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.703 -0.851 . . . . 2.63 108.703 172.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -115.94 95.8 5.28 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.705 -0.479 . . . . 1.71 109.705 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 68.6 m -80.69 94.66 6.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.728 -0.789 . . . . 2.21 110.506 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -140.19 111.02 6.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.3 -1.318 . . . . 4.31 108.833 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-N 116.053 -0.521 . . . . 4.49 110.956 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 19.2 t70 . . . . . 0 C--O 1.231 0.103 0 N-CA-C 108.252 -1.018 . . . . 2.88 108.252 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -97.67 126.15 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.732 0.301 . . . . 2.32 111.757 -170.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.85 117.48 34.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.426 -0.352 . . . . 2.82 110.239 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -30.42 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.782 -0.645 . . . . 2.24 112.148 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -83.14 -15.61 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.589 -0.278 . . . . 4.54 111.495 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 250' ' ' LEU . 88.5 m -98.23 -29.35 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.655 0.264 . . . . 3.06 111.26 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 130.62 44.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.72 111.259 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.39 124.31 45.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 3.69 109.93 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.14 113.33 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.488 -0.56 . . . . 4.64 109.488 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -118.62 118.72 33.32 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 2.27 109.669 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -53.82 91.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 123.583 2.855 . . . . 2.15 113.599 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 p -58.89 -30.85 68.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.743 -0.662 . . . . 4.29 110.844 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt 71.28 -64.92 0.36 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.323 -0.853 . . . . 4.74 111.65 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -76.0 130.63 77.74 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.737 0.303 . . . . 3.77 110.729 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.58 158.58 32.23 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.723 2.282 . . . . 2.36 111.925 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 48' ' ' SER . 6.5 tt -91.52 140.29 29.89 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.333 -0.617 . . . . 2.55 109.333 -178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.502 ' N ' HD23 ' A' ' 47' ' ' LEU . 2.0 t -144.6 139.33 28.02 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.848 -0.797 . . . . 2.38 108.848 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.33 128.88 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.048 0.452 . . . . 1.59 111.929 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.5 t -118.94 90.04 3.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.079 -0.711 . . . . 1.45 109.079 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.76 13.84 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 3.62 110.421 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.69 -31.65 68.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 2.48 111.213 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 77.5 mt-30 -109.35 17.35 21.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 2.24 110.736 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.24 114.48 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.37 . . . . 0.8 110.922 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 m -101.35 106.24 17.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.049 -0.523 . . . . 1.06 110.734 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -85.42 151.49 23.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.799 -0.637 . . . . 1.26 109.712 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.24 -57.54 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.74 111.545 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -167.34 159.63 12.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.64 0.257 . . . . 3.17 111.036 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 14.1 tt -104.99 140.6 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.317 -0.623 . . . . 0.64 109.317 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -130.29 140.53 50.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.115 0.483 . . . . 0.96 111.555 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.22 108.6 20.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.732 -1.211 . . . . 1.49 107.732 170.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -137.83 71.55 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.572 -0.851 . . . . 1.83 111.791 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.62 -75.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 119.941 -1.123 . . . . 1.64 112.851 159.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 243' ' ' ASN . 52.4 t-80 -112.59 -12.85 13.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.056 0.391 . . . . 3.33 112.056 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -154.2 175.99 12.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.997 0.427 . . . . 1.38 111.748 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.79 103.8 9.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.414 -0.958 . . . . 2.74 108.414 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.94 134.97 47.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.155 0.502 . . . . 1.76 111.87 -170.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 48.4 t -100.25 112.13 31.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.309 -0.626 . . . . 1.15 109.309 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.48 130.87 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 2.02 112.198 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -111.87 163.7 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.397 -0.964 . . . . 1.66 108.397 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.05 121.49 27.09 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.614 -0.434 . . . . 1.33 111.372 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.624 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 10.0 t0 -114.72 60.42 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.884 0.849 . . . . 2.65 109.75 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 t -116.47 -15.49 10.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 1.61 110.134 165.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -137.6 160.79 38.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.496 -0.557 . . . . 2.35 109.496 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -82.33 64.71 7.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.27 0.557 . . . . 1.92 110.207 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 67.6 mttm -79.18 -51.22 9.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.434 -0.803 . . . . 1.77 110.003 -177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . . . -115.88 105.2 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.76 109.215 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.14 139.98 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.046 0.451 . . . . 1.27 110.914 -172.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.498 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 14.7 tp -109.55 148.89 30.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.819 -0.628 . . . . 1.29 110.969 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 93.5 mttt -116.55 141.51 48.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.024 -1.102 . . . . 2.54 108.024 164.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.2 168.73 31.42 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.271 -0.966 . . . . 1.31 112.229 -165.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.63 -146.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 112.263 -0.335 . . . . 1.9 112.263 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.43 121.66 9.42 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.09 1.86 . . . . 2.91 112.095 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 88' ' ' TYR . 8.3 tp -179.63 157.57 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.024 -1.102 . . . . 4.11 108.024 -175.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.57 111.32 13.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.987 1.106 . . . . 4.95 113.987 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.1 -101.66 0.96 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.441 -0.885 . . . . 2.25 114.858 161.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.469 HG22 ' HG3' ' A' ' 89' ' ' ARG . 33.4 m -130.95 103.92 6.83 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.487 -0.56 . . . . 1.91 109.487 -167.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.498 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 1.3 m-85 -95.44 91.52 6.24 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.608 -0.437 . . . . 3.7 110.044 -172.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 55.9 mtt180 -107.27 146.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.717 0.294 . . . . 3.54 110.568 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 57.8 tp -77.84 123.86 27.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.552 -0.536 . . . . 1.14 109.552 171.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.1 -40.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.176 -0.465 . . . . 1.68 110.02 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -174.89 168.51 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.764 -0.653 . . . . 1.55 109.715 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.28 150.01 47.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.199 -0.667 . . . . 0.86 109.199 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 119' ' ' HIS . 16.6 p80 -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.632 0.254 . . . . 0.93 110.863 -172.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -134.37 158.89 42.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 3.17 110.347 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -165.13 179.39 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.644 0.259 . . . . 1.68 111.36 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.632 ' CD1' ' HA ' ' A' ' 242' ' ' ASP . 2.9 t90 74.0 -100.46 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.066 0.946 . . . . 5.18 110.407 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 53.02 15.58 3.57 Favored Glycine 0 N--CA 1.475 1.241 0 N-CA-C 115.278 0.871 . . . . 2.13 115.278 174.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.585 ' H ' ' HD1' ' A' ' 97' ' ' TRP . 48.3 p -45.7 -53.92 8.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.896 0.702 . . . . 2.9 112.896 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.7 mt -128.53 146.86 50.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.477 -0.564 . . . . 3.03 109.477 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.69 -13.23 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 3.85 111.613 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.55 -10.26 41.59 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.347 -0.93 . . . . 1.94 113.017 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.39 119.27 2.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.579 0.704 . . . . 2.45 111.725 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.28 41.32 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.658 -0.701 . . . . 1.47 111.794 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.4 p -105.8 -14.09 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 2.0 112.298 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.76 174.23 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.463 -0.569 . . . . 3.72 109.463 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.613 ' HE2' ' CD ' ' A' ' 117' ' ' GLU . 14.9 p80 44.09 68.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.312 1.053 . . . . 3.52 111.426 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.6 t -75.97 130.41 38.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.515 -1.22 . . . . 2.52 110.681 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 23.3 t -101.76 105.69 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 114.378 -1.283 . . . . 2.48 110.171 -172.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 55.31 50.76 14.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.568 -0.742 . . . . 2.8 109.472 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 68.33 1.14 2.77 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.238 -0.892 . . . . 4.98 112.607 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 47.8 tptt -89.75 123.72 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 3.23 110.968 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.69 155.96 27.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.809 -0.632 . . . . 2.82 110.31 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.69 168.89 9.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.101 -0.703 . . . . 1.62 109.101 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.43 79.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.274 0.472 . . . . 1.03 112.274 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.46 171.32 7.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.219 -0.66 . . . . 0.75 109.219 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.613 ' CD ' ' HE2' ' A' ' 107' ' ' HIS . 28.8 tt0 -142.24 138.43 31.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.067 0.461 . . . . 1.58 110.509 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.3 tp -102.43 126.49 49.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.43 -0.804 . . . . 1.07 109.448 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.616 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 42.4 m170 -107.98 110.27 21.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 1.77 111.147 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 6.8 mp -94.68 103.44 15.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.678 -0.49 . . . . 0.93 109.678 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.482 HG22 HG12 ' A' ' 142' ' ' VAL . 19.3 t -76.85 100.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.008 -0.542 . . . . 0.61 110.436 -176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 90' ' ' LEU . 3.2 p80 -138.97 76.19 1.56 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.755 1.021 . . . . 2.13 113.755 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.0 t90 178.91 99.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.345 0.658 . . . . 4.26 109.856 149.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' A' ' 133' ' ' ALA . 24.8 t-20 -124.62 90.48 3.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 118.612 -0.708 . . . . 2.02 111.561 157.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.5 m -81.28 -51.98 7.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 120.819 1.645 . . . . 2.34 111.492 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HD2' ' HA2' ' A' ' 139' ' ' GLY . 13.0 ptpt -43.57 -32.77 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 114.549 1.314 . . . . 3.35 114.549 -173.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.98 -16.35 6.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.133 -0.627 . . . . 3.1 111.851 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.38 38.91 51.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.583 -0.607 . . . . 2.37 111.583 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 12.3 t70 -169.33 110.48 0.47 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.675 -0.861 . . . . 3.93 108.675 -171.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -63.44 -32.12 73.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.943 0.349 . . . . 3.0 111.943 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.71 98.64 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.921 -0.657 . . . . 2.15 112.818 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 31.7 mmmt -74.32 -20.99 59.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.276 0.56 . . . . 3.43 110.311 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.612 ' HB2' ' ND2' ' A' ' 124' ' ' ASN . . . -74.75 -20.95 59.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 1.76 111.988 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.6 t -61.11 -22.08 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.566 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -98.18 8.09 45.32 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.158 -0.339 . . . . 3.55 111.572 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -122.86 127.47 25.72 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.662 0.267 . . . . 3.02 111.161 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.3 -32.96 83.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.604 2.869 . . . . 1.6 113.465 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.61 28.42 8.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.796 -0.446 . . . . 2.29 109.796 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.404 ' HA2' ' HD2' ' A' ' 126' ' ' LYS . . . -67.19 -27.91 73.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.048 -0.596 . . . . 1.22 114.319 -175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.8 mt -137.19 170.29 16.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.459 . . . . 1.57 111.564 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.14 118.58 6.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 1.38 109.472 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 121' ' ' VAL . 33.8 m -113.4 142.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 1.73 111.064 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.0 tp -95.46 103.85 15.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.786 . . . . 2.42 108.879 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.6 3.66 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.044 -0.598 . . . . 0.86 112.223 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 32.3 mt -102.62 124.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.866 -0.42 . . . . 0.76 109.866 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 48.8 m-85 -68.2 148.2 51.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 1.2 110.898 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.6 mp -118.56 138.3 52.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.498 -0.556 . . . . 0.88 109.498 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.1 ptmm? -143.23 146.55 33.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.891 -0.781 . . . . 2.03 108.891 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 95.7 t -83.79 130.87 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.099 0.476 . . . . 1.27 111.663 -171.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.45 -110.14 0.24 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.872 -0.891 . . . . 1.53 110.872 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 t -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.313 -0.625 . . . . 1.54 109.313 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.0 158.27 23.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.608 0.242 . . . . 0.78 110.987 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -115.94 106.2 50.06 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.922 -0.399 . . . . 1.22 109.922 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 51.1 Cg_exo -54.96 -35.77 90.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.08 2.52 . . . . 1.05 112.362 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.58 71.98 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.992 -0.623 . . . . 0.7 112.645 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.485 ' HB3' HE22 ' A' ' 221' ' ' GLN . 19.1 tp -88.05 -20.25 26.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.47 -0.567 . . . . 0.77 109.47 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 13.1 mm100 -52.82 -37.34 59.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.647 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 175' ' ' PHE . 57.3 mttp -54.01 -54.27 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.458 0.474 . . . . 2.86 111.601 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 162' ' ' VAL . 11.4 p -74.62 -37.26 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.91 0.386 . . . . 1.38 110.762 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 80.6 t -64.94 -34.97 74.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.419 0.628 . . . . 1.11 110.808 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.66 -32.84 71.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.063 -0.517 . . . . 1.22 111.317 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 159' ' ' VAL . 9.3 p -89.58 -20.74 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.17 0.433 . . . . 1.41 112.17 -173.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.485 HD13 HD11 ' A' ' 228' ' ' LEU . 3.0 pp -67.84 -16.92 64.33 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.071 0.463 . . . . 1.39 111.161 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.8 t70 -65.04 -23.35 67.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 2.31 110.325 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.7 m -89.73 1.71 55.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 1.4 111.935 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.96 39.23 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.513 0.673 . . . . 0.85 110.078 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 89.0 tttt -59.62 -22.59 62.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.146 -0.933 . . . . 1.59 111.666 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.1 p -120.18 137.56 54.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.51 -0.314 . . . . 0.77 110.812 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 230' ' ' PHE . 15.0 ptmm? -56.07 137.09 51.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.053 -0.521 . . . . 2.29 111.348 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.33 -30.46 8.23 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.976 -0.63 . . . . 0.85 111.816 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -81.8 153.79 26.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.06 0.457 . . . . 1.7 110.91 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.9 t -145.84 151.84 38.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.622 -0.717 . . . . 1.37 109.499 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -133.58 126.29 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.604 -0.271 . . . . 0.61 110.312 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.38 131.15 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 1.8 110.495 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -144.55 86.09 1.8 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 1.04 110.523 -176.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.6 p -95.99 160.92 14.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.703 0.287 . . . . 1.17 111.485 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 21.1 m120 65.19 29.8 11.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.774 -0.648 . . . . 1.77 112.331 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -87.47 119.9 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.464 -0.569 . . . . 3.99 109.464 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.74 112.7 63.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.995 0.426 . . . . 2.51 111.024 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.49 -17.83 60.92 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.82 2.347 . . . . 1.26 111.723 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -53.95 -40.07 66.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.554 -0.748 . . . . 2.76 110.861 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -64.89 -18.33 64.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.666 -0.697 . . . . 1.12 113.704 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.8 mt -96.83 -11.96 24.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.261 0.53 . . . . 1.73 111.701 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 96.7 mt -63.85 123.72 82.64 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.727 0.299 . . . . 3.45 111.563 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.498 ' HB2' ' HG2' ' A' ' 213' ' ' GLU . 2.5 Cg_endo -82.49 -170.04 0.86 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.221 2.614 . . . . 2.08 112.154 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.47 -66.19 0.92 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.159 0.8 . . . . 3.23 113.159 -174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 20.1 m -65.48 114.66 5.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.15 0.5 . . . . 1.66 111.357 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 47' ' ' LEU . 17.8 tp -103.15 70.57 1.07 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 1.99 110.744 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.458 ' O ' HD12 ' A' ' 211' ' ' LEU . 3.0 m-20 -130.33 174.32 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.39 -0.967 . . . . 1.81 108.39 176.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 38.4 p90 -166.36 154.7 10.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.559 0.948 . . . . 5.01 113.559 -164.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.617 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 4.1 m95 -107.78 149.74 27.84 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.239 -1.393 . . . . 3.93 107.239 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.7 t -138.38 103.03 4.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.97 0.804 . . . . 2.13 112.799 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.39 157.84 69.88 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.924 -0.58 . . . . 5.21 110.492 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.04 137.21 78.28 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.731 2.288 . . . . 2.12 112.366 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -134.25 156.97 22.66 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.303 -0.475 . . . . 1.75 113.563 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.33 -0.254 0 C-N-CA 122.642 0.377 . . . . 2.99 110.04 179.781 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.764 0.316 . . . . 2.96 110.53 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.4 66.77 0.89 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.861 0.838 . . . . 3.37 109.581 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.0 11.76 30.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.774 -1.103 . . . . 2.15 111.026 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.73 149.63 22.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.077 0.465 . . . . 1.26 111.414 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.4 m -103.03 107.86 18.82 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 2.08 107.989 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -80.89 100.08 8.68 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.737 -0.468 . . . . 5.53 109.737 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 55.3 mt -99.91 100.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.01 -0.541 . . . . 1.63 109.742 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 45.4 t -85.11 119.35 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.251 -0.432 . . . . 1.62 110.852 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 189' ' ' ASP . 46.2 tp -80.41 122.43 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.439 . . . . 1.73 110.612 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -48.44 -28.74 3.46 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.082 1.142 . . . . 2.98 114.082 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 185' ' ' PRO . 5.7 tp10 -102.98 114.42 65.25 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.396 -0.522 . . . . 1.47 110.926 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.45 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 90.5 Cg_endo -80.01 148.61 19.6 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.803 2.335 . . . . 0.96 111.893 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 34.4 pt -101.88 149.44 6.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 1.25 110.559 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 1.7 p -101.93 117.53 35.02 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.462 -0.79 . . . . 1.29 110.098 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 32.6 m -115.76 168.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.137 -0.483 . . . . 1.02 110.049 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.3 t -90.65 148.78 22.41 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.741 -0.384 . . . . 1.08 110.417 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.56 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 10.6 p -53.66 -45.0 70.11 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.507 0.505 . . . . 1.33 111.502 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.0 -31.53 71.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.647 -0.251 . . . . 2.51 111.306 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.485 HE22 ' HB3' ' A' ' 156' ' ' LEU . 54.5 mt-30 -62.51 -51.09 68.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.7 0.286 . . . . 0.7 110.628 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.65 -26.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.933 -0.307 . . . . 1.36 111.156 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 219' ' ' SER . 88.3 mt -69.44 -36.07 76.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 1.03 110.883 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -66.11 -31.44 72.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.064 0.459 . . . . 1.75 110.764 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -69.7 -39.32 76.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.594 -0.73 . . . . 2.47 109.754 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -72.0 -3.62 23.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.24 -0.891 . . . . 3.04 111.011 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 98.5 mttt -94.34 -1.38 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 2.31 110.665 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.485 HD11 HD13 ' A' ' 163' ' ' LEU . 55.6 mt -90.41 155.08 19.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.037 -0.529 . . . . 0.95 110.775 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -112.36 155.7 23.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.51 -0.314 . . . . 1.13 110.354 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.532 ' O ' ' HD2' ' A' ' 169' ' ' LYS . 50.4 p90 -111.52 -18.42 12.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.215 -0.448 . . . . 3.74 110.293 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.573 HD22 ' HB2' ' A' ' 235' ' ' GLU . 6.2 p-10 -71.51 -31.83 67.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.62 111.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.471 ' CA ' ' HG2' ' A' ' 169' ' ' LYS . . . 97.99 -159.71 20.79 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.564 -0.827 . . . . 1.16 113.018 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.17 150.38 20.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.686 0.279 . . . . 3.56 110.34 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.19 4.22 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.01 -0.615 . . . . 2.08 112.685 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.573 ' HB2' HD22 ' A' ' 231' ' ' ASN . 41.6 mt-10 -134.92 159.55 71.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.447 -0.575 . . . . 2.59 109.447 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.91 129.92 37.87 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.772 2.315 . . . . 1.36 112.005 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.64 114.35 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 3.4 111.839 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.71 117.82 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.393 -0.595 . . . . 2.47 109.393 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.21 136.24 55.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.789 -0.642 . . . . 2.14 111.206 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.5 ttm -81.32 89.94 6.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.668 -0.697 . . . . 1.68 109.49 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.73 153.59 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 1.27 109.804 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.632 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 13.6 t70 64.75 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.885 0.741 . . . . 2.18 110.607 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ASN . . . . . 0.46 ' HB3' ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER 52.23 27.33 4.61 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.56 0.948 . . . . 2.15 113.56 179.027 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 73.8 m95 -139.84 169.32 17.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.902 0.382 . . . . 4.59 110.81 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -117.35 148.91 43.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 6.13 111.573 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -33.23 138.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.921 3.747 . . . . 3.28 115.014 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -54.91 143.82 24.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.683 -1.144 . . . . 2.98 112.209 -175.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 28.4 mm-40 -107.97 130.36 22.9 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 4.32 110.894 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 248' ' ' GLN . 27.4 Cg_exo -63.23 175.17 2.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.52 2.813 . . . . 3.48 113.956 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.491 ' CD1' HG21 ' A' ' 37' ' ' THR . 49.8 mt -62.17 -11.19 13.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.207 -1.361 . . . . 4.63 113.402 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 18.5 ptpt -57.79 47.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.234 1.938 . . . . 5.34 116.234 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 7.5 t30 127.4 25.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 126.372 1.869 . . . . 4.64 111.106 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 252' ' ' ASN . 0.0 OUTLIER -141.94 110.76 6.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.083 -0.71 . . . . 6.11 109.083 166.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.02 121.81 45.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.072 -0.714 . . . . 3.08 109.072 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.6 mm -82.95 115.58 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.181 0.515 . . . . 2.6 112.262 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.56 127.5 40.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.639 -0.71 . . . . 2.63 109.555 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -116.37 146.09 42.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.717 -0.475 . . . . 1.71 109.717 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 19.5 m -142.41 96.43 2.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.426 0.631 . . . . 2.21 110.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.435 ' HA ' ' OD1' ' A' ' 189' ' ' ASP . 86.5 t80 -126.54 90.69 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.548 -0.908 . . . . 4.31 108.548 166.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.375 -0.821 . . . . 4.49 109.823 -177.54 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 113.465 0.913 . . . . 2.88 113.465 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 26.2 mm -101.6 134.37 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.718 -1.128 . . . . 2.32 111.2 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 37' ' ' THR . 16.2 t70 -107.32 113.45 26.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.963 -0.384 . . . . 2.82 109.963 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -56.67 -33.11 66.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.319 0.859 . . . . 2.24 113.319 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -75.07 -41.29 59.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.876 -0.329 . . . . 4.54 111.109 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 7.3 p -72.55 -27.53 62.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.801 0.334 . . . . 3.06 110.532 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -69.89 84.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.277 0.56 . . . . 1.72 110.443 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -79.73 134.43 36.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.692 -0.685 . . . . 3.69 109.656 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.616 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 2.5 p90 -81.68 124.52 29.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.194 0.521 . . . . 4.64 110.297 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -118.0 119.9 33.12 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 2.27 109.621 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.32 24.57 0.31 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.999 2.466 . . . . 2.15 113.728 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.8 p -95.86 -17.21 21.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.268 0.556 . . . . 4.29 109.51 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.77 124.51 30.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.493 -0.776 . . . . 4.74 109.768 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -115.15 136.57 22.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.122 -0.49 . . . . 3.77 110.922 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.07 122.84 12.42 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.825 2.35 . . . . 2.36 112.049 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.482 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 6.2 mp -78.62 132.96 37.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 2.55 110.904 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.6 t -84.56 138.04 32.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.466 -0.568 . . . . 2.38 109.466 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.0 t -118.37 121.78 67.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.192 -0.458 . . . . 1.59 110.832 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.3 p -111.55 89.91 3.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.438 -0.578 . . . . 1.45 109.438 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -109.84 10.01 24.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.687 -0.688 . . . . 3.62 110.098 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.8 -34.72 65.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.386 -0.825 . . . . 2.48 111.544 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.7 13.66 29.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.278 0.473 . . . . 2.24 112.278 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.29 113.57 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 0.8 111.923 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.8 m -107.33 109.83 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.847 -0.615 . . . . 1.06 110.547 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 178' ' ' PHE . 18.1 m -78.57 145.51 34.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.404 -0.362 . . . . 1.26 110.617 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -115.64 -55.77 2.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.74 111.718 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -166.6 159.09 13.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 3.17 111.271 -173.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 tt -112.16 137.5 44.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 0.64 109.934 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -129.39 135.76 49.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.894 0.378 . . . . 0.96 111.681 -173.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.99 117.99 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.375 -0.972 . . . . 1.49 108.375 172.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -137.48 71.02 1.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.662 -0.815 . . . . 1.83 112.311 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 230' ' ' PHE . . . 99.53 -58.84 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.342 -0.932 . . . . 1.64 113.885 157.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -125.56 -9.1 6.83 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.691 -0.403 . . . . 3.33 111.82 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -160.49 177.74 10.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.804 -0.443 . . . . 1.38 109.804 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -139.3 136.72 35.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.256 -1.016 . . . . 2.74 108.256 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.01 151.93 48.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.063 0.459 . . . . 1.76 111.941 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.8 127.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.381 -0.827 . . . . 1.15 109.51 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.82 137.03 33.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 2.02 110.984 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -112.95 170.1 8.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.356 -0.838 . . . . 1.66 109.475 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.414 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 14.3 t70 -98.89 132.16 44.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.005 0.431 . . . . 1.33 110.92 174.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.53 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 22.6 t70 -137.1 62.29 1.6 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.227 -0.897 . . . . 2.65 109.118 170.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -80.67 -4.52 54.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.116 0.96 . . . . 1.61 108.626 166.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.63 148.98 11.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.026 -1.842 . . . . 2.35 106.026 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -61.68 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.138 0.97 . . . . 1.92 111.783 -171.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 71' ' ' ASP . 61.7 mttm -91.9 -53.2 4.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.906 -1.043 . . . . 1.77 111.021 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.39 104.61 10.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.994 -0.548 . . . . 0.76 109.638 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.6 t -117.44 153.03 19.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 -176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tt -147.7 112.65 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 1.29 109.561 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.95 132.52 8.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.642 0.734 . . . . 2.54 111.622 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 47' ' ' LEU . . . -76.48 174.36 53.78 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 114.899 -1.046 . . . . 1.31 112.152 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.66 -142.88 0.0 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 124.259 0.623 . . . . 1.9 113.942 168.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.66 122.37 8.75 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 121.456 1.438 . . . . 2.91 111.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 7.9 tp -157.53 -167.66 2.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.947 -1.024 . . . . 4.11 108.428 -166.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.483 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 16.4 m-20 -123.64 32.67 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.741 0.305 . . . . 4.95 110.65 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.02 145.53 4.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.692 -0.766 . . . . 2.25 113.081 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.3 m -93.1 113.73 26.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.322 -0.622 . . . . 1.91 109.322 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 70.2 m-85 -101.33 127.91 47.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.155 0.503 . . . . 3.7 111.72 -171.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 123' ' ' TRP . 22.8 ptt180 -99.76 142.31 31.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.886 -0.597 . . . . 3.54 110.786 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 120' ' ' LEU . 8.4 tt -92.42 120.09 32.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.371 -0.603 . . . . 1.14 109.371 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.643 HD12 ' CE3' ' A' ' 123' ' ' TRP . 36.8 mt -121.97 -15.65 6.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.42 -0.354 . . . . 1.68 111.099 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -166.54 162.71 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.167 -0.333 . . . . 1.55 110.227 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 41.4 p90 -140.49 140.5 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.22 -0.659 . . . . 0.86 109.22 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.4 p-80 -118.51 158.05 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.329 . . . . 0.93 110.227 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 116' ' ' ALA . 78.4 t80 -133.69 156.97 46.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.143 -0.48 . . . . 3.17 109.967 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -152.07 139.4 19.43 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.753 -0.462 . . . . 1.68 109.753 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 68.9 t-105 -104.01 137.61 41.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.944 -0.571 . . . . 5.18 110.006 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -70.02 -60.97 4.55 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.962 -0.563 . . . . 2.13 113.165 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 29.0 t 162.23 -64.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 2.9 108.166 -176.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.0 mt -110.31 164.79 12.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.082 -0.963 . . . . 3.03 109.151 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -83.04 56.02 3.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.673 0.749 . . . . 3.85 110.86 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.75 -2.66 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.645 -0.707 . . . . 1.94 113.105 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.11 155.98 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.076 0.438 . . . . 2.45 110.385 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 100.67 -13.98 59.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.801 -0.714 . . . . 1.47 112.643 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.9 t -75.01 -32.84 61.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.49 . . . . 2.0 109.927 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 58.83 -159.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.55 -0.75 . . . . 3.72 110.122 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m80 58.37 30.72 20.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.428 -1.323 . . . . 3.52 107.428 -168.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.32 129.33 34.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.882 -1.508 . . . . 2.52 111.781 -166.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.2 m -100.15 111.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.825 -1.08 . . . . 2.48 110.606 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.63 43.21 12.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.964 -1.016 . . . . 2.8 110.406 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 68.3 20.95 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.125 -0.943 . . . . 4.98 112.078 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HE3' ' CZ ' ' A' ' 114' ' ' TYR . 4.4 tmmm? -102.81 89.55 3.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.985 0.422 . . . . 3.23 109.926 173.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -79.22 157.36 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 2.82 110.028 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 112' ' ' LYS . 82.2 m-85 -102.68 178.92 4.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.614 -0.266 . . . . 1.62 110.75 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.14 -47.22 68.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 1.03 111.381 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB2' ' CE3' ' A' ' 97' ' ' TRP . . . -155.77 168.16 28.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.041 -0.527 . . . . 0.75 110.539 -173.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -134.94 135.32 41.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 1.58 109.896 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.35 126.76 55.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.591 -0.522 . . . . 1.07 109.591 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.483 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -122.12 109.6 14.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.077 0.465 . . . . 1.77 111.695 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.3 mp -91.55 117.84 30.07 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.88 -0.785 . . . . 0.93 108.88 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.62 143.79 11.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.438 -0.346 . . . . 0.61 110.698 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 53.7 m-70 -138.81 134.7 33.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.633 -0.877 . . . . 2.13 108.633 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.643 ' CE3' HD12 ' A' ' 91' ' ' ILE . 37.5 m0 -111.23 140.99 45.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.457 -0.571 . . . . 4.26 109.457 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.79 112.97 2.03 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.889 -0.412 . . . . 2.02 109.889 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 t -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 2.34 110.828 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -63.35 -16.88 61.76 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.948 0.351 . . . . 3.35 111.948 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.96 -6.28 35.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.728 0.299 . . . . 3.1 110.711 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.77 18.84 0.76 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.16 -0.927 . . . . 2.37 115.189 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 21.7 t70 -170.59 125.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.652 0.726 . . . . 3.93 110.386 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.625 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.5 p90 -57.07 -40.72 77.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.98 -1.009 . . . . 3.0 111.054 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.01 -37.41 79.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.256 -0.497 . . . . 2.15 112.893 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 41.5 mmtm -76.9 -28.76 55.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 3.43 110.333 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -75.36 -35.04 61.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 1.76 111.133 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 130' ' ' PHE . 77.2 t -65.01 -25.87 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 2.77 110.37 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -95.38 17.94 13.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.053 0.454 . . . . 3.55 110.668 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 139' ' ' GLY . 4.3 tp-100 -131.24 121.77 18.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.168 -0.469 . . . . 3.02 109.952 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 92.4 Cg_exo -45.79 -36.03 14.39 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.017 3.144 . . . . 1.6 113.619 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -110.74 27.65 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.965 0.412 . . . . 2.29 109.961 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 136' ' ' GLN . . . -84.68 -42.65 7.19 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.159 -0.543 . . . . 1.22 113.541 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 69.0 mt -104.03 153.54 20.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.38 0.59 . . . . 1.57 110.469 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -142.88 147.12 34.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.829 -0.623 . . . . 1.38 109.954 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.4 t -133.76 137.69 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.153 -0.476 . . . . 1.73 109.954 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -106.07 121.74 44.74 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.702 -0.481 . . . . 2.42 109.702 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.74 128.46 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.867 -0.682 . . . . 0.86 113.041 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.76 115.52 31.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.914 -0.402 . . . . 0.76 109.914 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -77.99 149.97 33.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.931 0.396 . . . . 1.2 111.168 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.04 134.94 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.835 -0.62 . . . . 0.88 110.361 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -127.16 144.52 51.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.471 -0.566 . . . . 2.03 109.471 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 19.6 m -86.75 130.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.389 0.614 . . . . 1.27 111.742 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.32 -104.54 0.18 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.224 -0.898 . . . . 1.53 111.391 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -81.19 150.98 28.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 1.54 109.919 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.31 149.84 45.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.224 -0.444 . . . . 0.78 111.229 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 216' ' ' SER . 22.5 tptm -119.45 96.14 49.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.003 -0.544 . . . . 1.22 109.904 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 54.0 Cg_exo -53.56 -37.94 83.34 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.22 2.613 . . . . 1.05 112.524 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.94 -37.88 86.75 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.7 113.172 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 160' ' ' VAL . 61.9 tp -93.05 -22.43 19.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.082 0.441 . . . . 0.77 110.456 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -57.24 -34.22 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 1.41 111.316 -178.208 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -56.49 -41.75 77.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 2.86 110.904 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.58 -41.86 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 1.38 110.249 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 25.8 t -61.88 -33.81 59.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.374 0.606 . . . . 1.11 110.588 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.99 -37.06 78.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.797 -0.638 . . . . 1.22 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.91 -18.88 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 111.913 0.338 . . . . 1.41 111.913 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -66.32 -17.13 64.57 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.738 -0.385 . . . . 1.39 111.91 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.7 -24.06 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 2.31 110.881 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.5 m -84.8 0.43 50.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.264 -0.426 . . . . 1.4 111.427 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.42 HG12 ' HA ' ' A' ' 163' ' ' LEU . 44.7 pt -137.4 44.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.345 0.593 . . . . 0.85 109.627 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.79 -36.98 80.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.436 -0.802 . . . . 1.59 111.697 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -114.51 151.93 32.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.708 -0.224 . . . . 0.77 110.734 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 21.4 pttm -63.56 140.85 58.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.046 0.45 . . . . 2.29 110.611 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.13 47.71 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.753 -0.737 . . . . 0.85 111.42 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.61 147.72 22.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.128 0.49 . . . . 1.7 111.144 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.3 p -144.11 150.42 38.08 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.502 -0.772 . . . . 1.37 109.49 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -135.43 133.71 38.88 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.737 -0.468 . . . . 0.61 109.737 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.07 129.83 43.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.156 0.503 . . . . 1.8 110.065 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -141.44 79.91 1.71 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.678 -0.86 . . . . 1.04 108.678 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.5 m -99.29 153.99 18.53 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.273 -0.876 . . . . 1.17 110.984 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.4 m120 54.78 77.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.188 0.595 . . . . 1.77 111.959 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.437 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 71.3 t80 -131.42 140.63 49.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.9 -0.591 . . . . 3.99 109.494 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.41 120.89 51.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.198 0.523 . . . . 2.51 110.639 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.27 -5.57 16.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.025 2.483 . . . . 1.26 111.948 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 181' ' ' ARG . 42.1 ttp-105 -55.54 -36.95 67.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.773 -0.649 . . . . 2.76 110.975 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.05 8.08 61.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.968 -0.634 . . . . 1.12 112.417 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.6 mt -117.28 -38.95 3.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.984 0.421 . . . . 1.73 109.989 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.518 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.3 mt -73.1 131.44 83.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.727 -0.669 . . . . 3.45 111.101 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 5.8 Cg_exo -77.65 179.73 6.23 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.002 2.468 . . . . 2.08 112.361 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -84.76 -63.8 1.27 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.26 0.467 . . . . 3.23 112.26 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.3 t -78.06 134.7 37.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.653 0.263 . . . . 1.66 110.964 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.8 mt -113.21 60.84 0.64 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.946 0.403 . . . . 1.99 110.288 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 212' ' ' LYS . 4.5 m-20 -140.22 144.42 36.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.41 -0.959 . . . . 1.81 108.41 173.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER 171.85 -171.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.415 -0.587 . . . . 5.01 109.415 -173.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 257' ' ' ALA . 25.7 p90 -81.3 151.24 28.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.487 -0.485 . . . . 3.93 110.127 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.451 ' OG1' HD13 ' A' ' 209' ' ' ILE . 4.7 t -167.29 116.92 0.84 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.573 0.702 . . . . 2.13 110.827 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.621 ' CD1' ' HD2' ' A' ' 251' ' ' LYS . 6.2 t80 -139.87 147.82 52.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.869 -0.789 . . . . 5.21 108.869 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 99.2 Cg_exo -47.64 151.19 3.51 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.628 2.219 . . . . 2.12 112.875 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.93 159.45 24.6 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.75 112.453 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 120.977 0.418 . . . . 2.99 110.166 -176.88 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.833 0.349 . . . . 2.96 110.988 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.86 93.23 4.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.177 -0.465 . . . . 3.37 111.707 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.7 p -139.25 24.49 2.51 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.779 0.659 . . . . 2.15 112.779 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.15 143.2 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.26 111.964 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 5.5 m -126.35 104.52 8.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.331 -0.618 . . . . 2.08 109.331 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -101.64 134.95 43.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.476 0.655 . . . . 5.53 112.144 -175.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.451 HD13 ' OG1' ' A' ' 192' ' ' THR . 7.9 mm -116.13 128.32 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.779 -1.1 . . . . 1.63 109.173 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 t -108.17 150.28 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.341 -0.614 . . . . 1.62 109.341 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.415 ' HB2' ' HG2' ' A' ' 185' ' ' PRO . 1.9 mm? -109.57 146.43 34.7 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.98 -0.288 . . . . 1.73 111.325 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.61 ' HA ' ' CD2' ' A' ' 190' ' ' TYR . 37.5 ttmt -52.99 -60.28 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.765 0.654 . . . . 2.98 112.765 -176.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 185' ' ' PRO . 11.4 mm-40 -72.86 114.88 34.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.696 -0.684 . . . . 1.47 111.68 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.37 147.32 22.77 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.156 1.904 . . . . 0.96 110.5 174.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 pt -89.4 140.08 16.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.459 -0.496 . . . . 1.25 110.21 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 18.4 t -97.32 127.48 43.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.052 -0.522 . . . . 1.29 109.734 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 29.8 m -127.0 156.39 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.729 -0.668 . . . . 1.02 109.737 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.5 t -85.83 154.58 21.46 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.179 -0.304 . . . . 1.08 110.179 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.561 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 46.2 m -53.46 -42.35 67.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.001 0.188 . . . . 1.33 111.398 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 9.9 pt-20 -56.94 -27.77 61.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.605 -0.27 . . . . 2.51 111.634 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -77.08 -46.91 21.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.028 -0.36 . . . . 0.7 110.028 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.723 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 26.7 m -70.83 -28.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.36 111.228 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.7 mt -64.48 -33.57 76.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.298 -0.41 . . . . 1.03 110.558 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 65.2 mttp -74.97 -24.22 58.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 1.75 111.238 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.723 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.3 m-85 -67.0 -35.13 79.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.202 0.525 . . . . 2.47 109.851 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -84.45 13.96 4.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.696 -0.684 . . . . 3.04 110.578 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.0 mmtt -100.63 -14.96 17.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.79 -0.448 . . . . 2.31 109.79 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.401 HD21 HD13 ' A' ' 163' ' ' LEU . 97.9 mt -77.64 152.75 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 0.95 111.546 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.494 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 11.6 m120 -117.58 154.31 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 1.13 109.273 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 45.5 p90 -102.97 -11.55 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.492 -0.483 . . . . 3.74 110.252 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -75.26 169.5 17.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.821 -0.627 . . . . 1.62 111.022 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -85.89 171.72 45.15 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.867 -0.606 . . . . 1.16 111.889 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.64 128.58 36.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.961 0.41 . . . . 3.56 110.779 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 98.58 9.43 52.92 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.671 -0.695 . . . . 2.08 112.191 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -111.54 160.87 27.83 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.088 -0.338 . . . . 2.59 110.088 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.23 127.81 27.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.485 2.124 . . . . 1.36 111.165 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.09 110.3 1.02 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 3.4 111.517 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -117.28 115.23 24.86 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.001 -0.74 . . . . 2.47 109.001 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.3 135.0 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.267 0.556 . . . . 2.14 111.73 -172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.9 ttm -81.66 90.21 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.994 -1.003 . . . . 1.68 108.955 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.62 153.38 38.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.182 -0.463 . . . . 1.27 110.667 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.438 ' O ' ' HD1' ' A' ' 244' ' ' TRP . 16.7 t70 66.27 -88.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.36 1.037 . . . . 2.18 111.369 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.1 t30 47.67 43.19 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.55 0.531 . . . . 2.15 111.301 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 20.5 m95 -144.08 159.7 42.17 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.6 -0.687 . . . . 4.59 110.03 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.415 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 6.3 ptp180 -113.36 116.82 46.08 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.569 -0.53 . . . . 6.13 109.569 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.452 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 45.3 Cg_exo -52.96 -86.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.177 2.585 . . . . 3.28 114.826 -167.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.452 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -108.29 99.49 8.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.239 0.542 . . . . 2.98 112.188 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 26.5 mm-40 -110.65 173.64 2.78 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 107.869 -1.16 . . . . 4.32 107.869 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 52.7 Cg_exo -57.25 94.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.798 1.666 . . . . 3.48 111.129 172.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.61 ' HG ' ' N ' ' A' ' 251' ' ' LYS . 1.6 pt? -64.34 -56.96 10.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.764 -0.653 . . . . 4.63 111.452 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.621 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 62.6 mmtt -122.46 -10.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.934 -0.306 . . . . 5.34 111.229 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.93 -48.19 0.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.152 0.981 . . . . 4.64 111.844 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -89.17 -80.78 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 6.11 110.246 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -157.53 156.55 32.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.513 -0.551 . . . . 3.08 109.513 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 11.5 tt -112.8 148.72 15.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.637 0.256 . . . . 2.6 110.432 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.1 153.47 20.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.222 0.534 . . . . 2.63 111.158 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -131.01 171.44 13.23 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.153 -0.93 . . . . 1.71 109.032 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.5 p -163.46 98.8 0.91 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.985 0.421 . . . . 2.21 110.783 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.03 102.43 6.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.732 0.777 . . . . 4.31 109.963 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 17.1 pttm . . . . . 0 C--O 1.248 0.982 0 CA-C-N 115.007 -0.997 . . . . 4.49 110.226 -174.558 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.821 -0.437 . . . . 2.88 109.821 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 108' ' ' THR . 24.7 mm -71.41 128.24 34.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.981 0.896 . . . . 2.32 111.895 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 36' ' ' HIS . 23.0 t70 -43.98 156.13 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.367 -1.742 . . . . 2.82 114.083 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' THR . 13.3 t -55.69 19.35 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.618 1.967 . . . . 2.24 113.434 172.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.613 ' H ' ' C ' ' A' ' 34' ' ' ASP . 33.5 p-80 -47.33 1.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.171 1.789 . . . . 4.54 114.663 -176.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' THR . 2.6 m -72.28 27.81 0.05 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.613 0.765 . . . . 3.06 109.086 163.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 36' ' ' HIS . . . -56.79 164.85 1.36 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.733 1.213 . . . . 1.72 112.884 -163.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.94 139.92 50.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.805 -1.088 . . . . 3.69 110.845 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.475 ' HB2' ' H ' ' A' ' 259' ' ' PHE . 7.9 p90 -59.93 123.76 18.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.141 -0.936 . . . . 4.64 112.241 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -86.72 133.16 40.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 2.27 110.618 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.84 -14.17 11.31 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.803 2.336 . . . . 2.15 114.354 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.9 p -93.11 -2.46 55.44 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.577 -0.449 . . . . 4.29 111.063 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.29 154.53 17.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.237 -0.438 . . . . 4.74 110.3 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HE3' HD11 ' A' ' 47' ' ' LEU . 61.9 tttp -115.44 106.89 50.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 3.77 109.935 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 52.8 Cg_exo -56.1 120.07 7.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.614 2.21 . . . . 2.36 112.089 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' PRO . 12.7 mt -169.99 116.92 0.55 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.432 0.901 . . . . 2.55 113.432 -173.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.411 ' HB3' HD11 ' A' ' 79' ' ' LEU . 66.6 m -157.75 79.55 0.86 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.562 -0.903 . . . . 2.38 108.562 152.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.72 95.12 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.354 0.872 . . . . 1.59 113.354 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 39.7 m -142.23 85.44 1.92 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 121.439 1.927 . . . . 1.45 109.267 155.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -134.18 19.14 3.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.208 -0.308 . . . . 3.62 111.052 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.73 -28.61 68.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 2.48 111.381 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 39.2 mt-30 -110.0 13.7 23.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.354 . . . . 2.24 111.634 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.1 127.01 29.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.8 111.383 -174.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -116.09 115.24 25.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.213 -0.449 . . . . 1.06 110.875 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 176' ' ' THR . 5.6 m -84.34 153.54 23.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.196 -0.456 . . . . 1.26 109.795 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -117.73 -57.23 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.74 111.926 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -170.01 164.63 9.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 3.17 111.436 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.2 tt -127.08 143.84 39.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.436 -0.802 . . . . 0.64 109.874 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 172' ' ' SER . 20.6 tp -144.75 121.14 10.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.955 0.354 . . . . 0.96 111.955 -173.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -68.5 109.1 3.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.967 -0.56 . . . . 1.49 109.495 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -141.4 70.63 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.786 -0.766 . . . . 1.83 112.766 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.67 -65.1 0.33 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.765 -1.207 . . . . 1.64 112.879 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -128.39 -11.92 5.08 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.948 -0.301 . . . . 3.33 111.473 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.96 -173.2 3.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 1.38 110.986 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.52 88.41 2.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 2.74 108.881 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.09 114.39 15.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.473 -0.785 . . . . 1.76 110.285 -171.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 5.5 p -94.1 124.13 46.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.887 -0.597 . . . . 1.15 110.184 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.87 132.62 40.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.867 -0.606 . . . . 2.02 111.604 -174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.25 152.63 22.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.184 -0.916 . . . . 1.66 109.784 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.76 129.4 45.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 1.33 109.828 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.09 63.97 1.4 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.89 -1.05 . . . . 2.65 109.961 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 p -79.91 -3.21 47.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.368 -0.833 . . . . 1.61 110.54 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.484 ' OE1' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -154.28 177.69 10.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.053 -1.462 . . . . 2.35 107.053 175.735 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.9 79.06 0.21 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.247 0.476 . . . . 1.92 111.5 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HE2' ' OE1' ' A' ' 74' ' ' GLN . 61.4 mttm -102.49 -66.13 0.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.597 -0.274 . . . . 1.77 110.682 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.01 84.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.391 0.615 . . . . 0.76 110.06 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 50' ' ' SER . 17.8 m -115.25 150.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 1.27 110.467 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 48' ' ' SER . 28.6 tp -100.6 124.6 46.4 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.978 -0.555 . . . . 1.29 110.413 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -125.67 133.4 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.718 -0.845 . . . . 2.54 108.718 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' CB ' ' A' ' 47' ' ' LEU . . . -149.93 170.79 30.0 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 119.477 -0.624 . . . . 1.31 111.666 -170.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.36 -146.69 0.0 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 123.859 0.388 . . . . 1.9 113.161 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.39 119.81 6.43 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 121.564 1.51 . . . . 2.91 111.781 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.1 mt -157.01 -178.07 7.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.454 -0.794 . . . . 4.11 109.843 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -127.45 67.2 1.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.338 -0.392 . . . . 4.95 111.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.2 -170.59 14.23 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.635 -0.793 . . . . 2.25 112.904 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.539 ' O ' HG22 ' A' ' 125' ' ' THR . 30.7 m -105.65 134.97 47.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 1.91 110.162 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' A' ' 139' ' ' GLY . 33.1 m-85 -114.87 119.37 36.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 3.7 110.428 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HD3' ' CB ' ' A' ' 125' ' ' THR . 39.6 mtp180 -91.93 143.33 26.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.376 -0.375 . . . . 3.54 111.085 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 tt -88.61 128.84 35.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.642 -0.503 . . . . 1.14 109.642 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.441 HG23 ' HG2' ' A' ' 92' ' ' GLN . 13.1 tt -113.62 -34.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 1.68 110.509 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.546 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 5.3 pt20 -165.44 174.86 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 1.55 109.54 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 119' ' ' HIS . 42.6 p90 -155.32 156.64 35.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.86 110.712 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -147.2 161.15 41.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.93 109.346 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' A' ' 118' ' ' LEU . 69.1 m-85 -107.06 166.7 10.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 3.17 111.002 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -128.99 146.62 50.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.464 -1.68 . . . . 1.68 106.464 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 242' ' ' ASP . 8.3 m-90 -133.53 -169.66 2.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.434 0.561 . . . . 5.18 111.388 -170.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.42 24.99 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.721 -1.351 . . . . 2.13 109.721 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.1 t -70.89 -15.07 62.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.128 0.964 . . . . 2.9 110.478 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.2 mt -128.86 150.49 50.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.881 -0.785 . . . . 3.03 108.881 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.82 6.36 2.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.285 0.476 . . . . 3.85 112.285 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.35 24.78 6.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.509 -0.853 . . . . 1.94 112.455 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 18.0 pt20 -158.67 162.76 37.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.995 -0.372 . . . . 2.45 109.995 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.7 -18.91 16.7 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.316 -0.945 . . . . 1.47 112.281 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 99.2 p -69.02 -34.6 75.5 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.258 -0.177 . . . . 2.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 107' ' ' HIS . 1.0 OUTLIER 71.03 -173.13 0.17 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.426 -0.953 . . . . 3.72 108.426 -175.109 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.593 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 1.8 m-70 57.86 37.75 27.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.647 0.736 . . . . 3.52 109.723 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.603 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.3 123.46 29.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.669 -1.151 . . . . 2.52 112.404 -173.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.65 102.37 13.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.237 -0.892 . . . . 2.48 110.469 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.86 55.08 5.62 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.673 -0.694 . . . . 2.8 109.663 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 68.27 24.31 7.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.035 -0.984 . . . . 4.98 112.22 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -93.21 90.49 6.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 3.23 110.53 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.59 146.74 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 2.82 110.437 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 94.5 m-85 -100.77 -168.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.381 -0.372 . . . . 1.62 110.107 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.16 34.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.723 0.297 . . . . 1.03 111.725 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.84 168.24 21.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.387 -0.369 . . . . 0.75 110.5 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -124.29 151.89 43.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 1.58 109.485 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.531 HD13 ' CE2' ' A' ' 95' ' ' PHE . 57.3 tp -115.61 147.72 40.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.233 -0.284 . . . . 1.07 110.233 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 93' ' ' PHE . 1.6 t-160 -121.75 114.91 21.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.393 -0.595 . . . . 1.77 109.393 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.58 91.58 4.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.843 0.354 . . . . 0.93 110.12 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.649 ' HA ' ' HB1' ' A' ' 141' ' ' ALA . 46.6 t -65.68 117.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.365 0.602 . . . . 0.61 111.701 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 76.8 m80 -138.66 125.58 21.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.089 -1.078 . . . . 2.13 108.089 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.678 ' CD1' ' HB2' ' A' ' 130' ' ' PHE . 88.4 m95 -110.82 144.91 39.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.622 -0.431 . . . . 4.26 111.258 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.449 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 56.4 t30 -62.69 100.79 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.419 -0.81 . . . . 2.02 110.317 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 87' ' ' THR . 10.3 t -70.63 -24.34 62.71 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.065 0.765 . . . . 2.34 113.065 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -68.14 -5.14 16.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.429 0.529 . . . . 3.35 112.429 -174.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -95.42 17.49 14.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.788 0.804 . . . . 3.1 109.543 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.22 -3.58 10.45 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.491 -1.231 . . . . 2.37 115.786 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -173.5 145.19 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.577 1.189 . . . . 3.93 109.949 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.678 ' HB2' ' CD1' ' A' ' 123' ' ' TRP . 25.1 p90 -67.95 -43.12 79.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.854 -0.612 . . . . 3.0 111.705 -176.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.15 -28.81 73.43 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.072 -0.585 . . . . 2.15 112.182 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -81.27 -34.75 31.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.496 -0.557 . . . . 3.43 109.496 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.39 66.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.745 -0.661 . . . . 1.76 111.63 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 130' ' ' PHE . 42.1 t -60.05 -19.39 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.297 0.57 . . . . 2.77 110.764 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -99.34 16.73 22.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 3.55 110.655 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -112.83 118.49 44.68 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.815 0.341 . . . . 3.02 111.133 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.547 ' HA ' ' SG ' ' A' ' 205' ' ' CYS . 25.0 Cg_exo -64.18 -20.61 67.31 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.691 2.261 . . . . 1.6 111.965 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.04 28.39 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.992 0.738 . . . . 2.29 112.992 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . 128.34 94.49 0.8 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.827 -1.654 . . . . 1.22 114.609 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 20.8 mt -97.0 -175.85 3.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.914 -0.772 . . . . 1.57 108.914 167.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 121' ' ' VAL . . . -71.2 124.85 25.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.581 0.705 . . . . 1.38 110.372 -167.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.1 m -77.93 164.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.506 -1.225 . . . . 1.73 112.331 -167.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.7 tp -85.54 143.86 28.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.665 -1.152 . . . . 2.42 111.264 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 170.94 42.69 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.782 -1.099 . . . . 0.86 112.186 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 214' ' ' PRO . 11.2 mt -86.63 142.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.572 0.225 . . . . 0.76 110.76 -176.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -63.13 157.09 23.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 1.2 111.532 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.4 mp -113.01 137.46 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.88 110.686 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -129.76 143.41 50.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.95 -0.759 . . . . 2.03 108.95 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 24.1 t -108.66 81.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.312 -0.555 . . . . 1.27 112.281 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -165.95 67.17 0.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.377 -0.916 . . . . 1.53 112.342 165.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 19.3 t 157.95 126.43 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.541 -1.281 . . . . 1.54 107.541 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 138.45 41.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.74 -0.384 . . . . 0.78 110.671 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -104.89 98.41 15.31 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.474 -0.565 . . . . 1.22 109.474 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.59 -24.44 69.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.599 2.199 . . . . 1.05 112.719 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.2 6.55 79.14 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.865 -0.683 . . . . 0.7 113.104 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -110.67 -13.99 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.77 110.904 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.76 -36.53 76.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 1.41 111.518 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -49.18 -44.19 42.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.713 0.292 . . . . 2.86 111.165 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.21 -42.01 37.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 1.38 110.437 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 48.7 t -63.74 -39.58 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.813 -0.631 . . . . 1.11 111.576 -176.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -69.98 -24.31 63.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.712 0.291 . . . . 1.22 111.698 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.87 -11.91 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.001 0.371 . . . . 1.41 112.001 -174.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -65.74 -17.07 64.36 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.963 -0.46 . . . . 1.39 111.559 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.403 ' N ' HD12 ' A' ' 163' ' ' LEU . 16.7 m-20 -66.42 -28.06 68.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 2.31 110.727 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.2 m -84.36 0.14 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.387 -0.369 . . . . 1.4 111.387 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.455 ' CG1' ' HA ' ' A' ' 163' ' ' LEU . 18.6 pt -137.97 57.1 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.85 109.337 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -74.71 -40.23 61.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.828 -0.623 . . . . 1.59 111.367 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.7 p -115.97 158.0 23.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.982 0.42 . . . . 0.77 111.647 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.21 132.76 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 2.29 110.484 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.52 -22.28 26.76 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.551 -0.833 . . . . 0.85 111.726 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -87.62 142.04 28.15 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.197 0.522 . . . . 1.7 110.736 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 60' ' ' LEU . 6.7 p -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.227 -0.897 . . . . 1.37 110.368 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.26 134.32 32.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.548 -0.538 . . . . 0.61 109.548 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.28 133.68 44.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.069 0.462 . . . . 1.8 109.918 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -142.07 81.36 1.75 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.572 -0.74 . . . . 1.04 109.36 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 56' ' ' SER . 7.1 m -104.97 162.22 13.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.468 -0.333 . . . . 1.17 111.317 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.7 57.16 3.3 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.42 0.688 . . . . 1.77 111.989 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -126.76 132.25 51.12 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.531 -0.544 . . . . 3.99 109.531 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 5.3 p-10 -107.87 126.89 28.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.442 -0.345 . . . . 2.51 110.365 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 22.4 Cg_exo -66.42 -3.84 9.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.417 2.745 . . . . 1.26 113.333 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -58.98 -31.82 69.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 2.76 111.04 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.6 -30.58 72.97 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.141 -0.552 . . . . 1.12 112.361 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.3 mt -72.7 -34.33 67.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.014 0.435 . . . . 1.73 110.334 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 mt -71.43 118.75 68.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 3.45 110.51 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 8.9 Cg_exo -73.9 -165.19 0.24 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.028 2.485 . . . . 2.08 113.289 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.92 -61.97 1.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.278 0.473 . . . . 3.23 112.278 -173.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.457 ' HB2' ' CG ' ' A' ' 213' ' ' GLU . 34.7 m -75.45 129.43 37.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 1.66 110.514 -176.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 46' ' ' PRO . 39.6 tp -105.43 63.43 0.69 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.016 -0.538 . . . . 1.99 110.082 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 21.9 m-20 -109.95 145.64 36.57 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.374 -0.973 . . . . 1.81 108.374 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -136.47 149.27 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.607 -0.837 . . . . 5.01 112.936 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.573 ' HB3' ' CG2' ' A' ' 255' ' ' ILE . 6.8 m-90 -93.78 141.68 28.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.49 -1.232 . . . . 3.93 108.445 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.9 t -136.8 109.92 7.76 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.456 0.646 . . . . 2.13 112.498 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.562 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 54.9 t80 -139.22 138.21 20.42 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.627 -0.715 . . . . 5.21 110.506 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 48.7 Cg_exo -57.47 128.49 29.61 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.315 2.01 . . . . 2.12 111.494 172.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 208' ' ' TRP . . . -122.52 157.22 17.14 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.961 -0.637 . . . . 1.75 113.456 -171.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 13.5 m . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 2.99 109.733 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 196' ' ' SER . 16.2 tp . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 109.616 -0.513 . . . . 2.96 109.616 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.85 28.11 8.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.193 0.521 . . . . 3.37 111.076 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 137' ' ' PRO . 68.3 m -80.06 -4.8 54.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.822 -0.626 . . . . 2.15 111.446 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 48.4 t -90.18 137.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.383 -0.229 . . . . 1.26 110.383 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.2 m -105.5 102.59 12.05 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.885 -0.413 . . . . 2.08 109.885 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.548 ' O ' ' HA ' ' A' ' 192' ' ' THR . 43.2 m0 -72.19 100.84 2.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.245 -0.28 . . . . 5.53 110.245 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 65.6 mt -105.51 99.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.211 -0.663 . . . . 1.63 109.211 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.6 t -111.21 122.46 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.244 -0.435 . . . . 1.62 110.67 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 3.7 mm? -69.28 134.09 48.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.328 0.585 . . . . 1.73 110.127 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.562 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 32.6 ttpt -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.676 -1.147 . . . . 2.98 111.509 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.457 ' CG ' ' HB2' ' A' ' 187' ' ' SER . 22.2 mm-40 -76.27 110.92 12.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 1.47 110.795 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 145' ' ' ILE . 61.3 Cg_endo -74.91 154.19 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.623 2.216 . . . . 0.96 112.025 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.15 110.94 10.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.103 -0.499 . . . . 1.25 109.902 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.525 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 79.2 p -93.18 118.66 31.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.741 -0.466 . . . . 1.29 109.741 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 30.8 m -120.98 157.78 23.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.02 110.539 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.3 t -90.58 157.96 17.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.071 -0.513 . . . . 1.08 109.978 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.672 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 20.3 m -55.09 -46.59 75.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 1.33 110.732 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -52.65 -34.87 53.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 2.51 111.603 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -71.14 -50.11 36.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.7 110.203 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -71.88 -22.48 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.839 0.311 . . . . 1.36 111.839 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 219' ' ' SER . 83.0 mt -64.48 -43.83 92.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.81 -0.441 . . . . 1.03 109.81 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.446 ' HB3' HD11 ' A' ' 163' ' ' LEU . 67.4 mttm -68.72 -29.56 68.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 1.75 111.382 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.62 -30.37 64.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.53 . . . . 2.47 109.907 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -80.06 -2.68 45.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.741 -0.663 . . . . 3.04 110.346 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 33.4 mmtp -90.41 -6.52 54.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 2.31 110.064 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.61 146.68 26.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.887 -0.597 . . . . 0.95 110.807 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.588 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.8 m120 -118.79 125.83 50.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.659 -0.701 . . . . 1.13 109.521 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -78.76 -7.74 58.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 3.74 111.38 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.588 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.2 p-10 -77.58 162.71 26.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.831 0.348 . . . . 1.62 110.236 171.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.8 159.89 36.73 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.098 -0.801 . . . . 1.16 111.098 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.86 134.27 56.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 3.56 110.957 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.67 11.61 70.77 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.776 -0.647 . . . . 2.08 112.922 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -112.93 158.61 37.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.69 -0.485 . . . . 2.59 109.69 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.55 122.81 11.5 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.593 2.196 . . . . 1.36 111.819 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 120.18 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.381 -0.827 . . . . 3.4 112.383 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -127.82 136.55 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.329 -0.989 . . . . 2.47 108.329 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.12 133.38 33.63 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.758 -0.46 . . . . 2.14 109.758 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 51.8 ttm -75.12 88.28 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.099 0.476 . . . . 1.68 109.757 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.15 167.36 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.861 -0.792 . . . . 1.27 108.861 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' TRP . 0.7 OUTLIER 61.75 -90.85 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.402 0.439 . . . . 2.18 110.814 -174.468 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 43.13 45.8 4.82 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.271 0.558 . . . . 2.15 111.923 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.442 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 60.9 t-105 -153.14 153.06 32.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.331 -0.85 . . . . 4.59 108.979 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -100.58 130.35 25.75 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.089 -0.337 . . . . 6.13 110.089 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.27 53.33 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.769 2.313 . . . . 3.28 111.937 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -114.14 121.79 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.401 -0.818 . . . . 2.98 109.978 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 33' ' ' ILE . 27.9 mp0 -90.3 152.43 45.69 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.226 -0.443 . . . . 4.32 110.84 -176.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.69 141.67 15.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.598 2.866 . . . . 3.48 112.807 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 251' ' ' LYS . 0.6 OUTLIER -40.59 -55.78 2.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.976 -1.011 . . . . 4.63 113.699 -171.092 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.546 ' N ' HD12 ' A' ' 250' ' ' LEU . 69.6 mmtt -114.33 -4.96 12.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.95 0.352 . . . . 5.34 111.95 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.1 p30 34.22 65.52 0.31 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.132 0.895 . . . . 4.64 112.345 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -70.85 -90.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.85 -0.34 . . . . 6.11 111.08 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -159.64 154.97 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.178 -0.675 . . . . 3.08 109.178 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.573 ' CG2' ' HB3' ' A' ' 191' ' ' TRP . 13.7 mt -118.78 113.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.159 -0.311 . . . . 2.6 110.159 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 62.3 pttt -76.85 165.76 24.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 2.63 110.706 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 191' ' ' TRP . . . -126.0 168.54 13.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 1.71 109.975 -175.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.9 p -138.07 95.99 3.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.201 0.524 . . . . 2.21 111.242 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.475 ' H ' ' HB2' ' A' ' 40' ' ' TYR . 49.9 t80 -136.91 119.06 15.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 4.31 110.304 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.612 -0.708 . . . . 4.49 109.577 175.601 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 107.951 -1.129 . . . . 2.88 107.951 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 59.9 mt -82.99 85.1 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.543 0.687 . . . . 2.32 109.381 -176.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -102.08 112.19 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.188 -0.914 . . . . 2.82 110.397 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m -54.85 -31.67 59.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 2.24 112.643 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -74.67 -38.6 62.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.126 0.488 . . . . 4.54 110.421 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 m -79.13 -29.26 43.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.737 -0.665 . . . . 3.06 111.083 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.22 116.2 6.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.72 110.695 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -92.42 129.49 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.146 -0.479 . . . . 3.69 109.921 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.3 p90 -63.2 121.91 14.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 4.64 110.256 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 19.7 t70 -105.65 125.78 32.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.54 -0.755 . . . . 2.27 109.397 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.448 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 15.5 Cg_exo -69.82 60.1 1.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.64 2.227 . . . . 2.15 111.789 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 m -63.5 -17.45 62.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 4.29 111.713 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 42' ' ' PRO . 80.5 mt 61.56 -86.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.394 0.677 . . . . 4.74 112.386 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 46' ' ' PRO . 85.7 tttt -65.66 130.79 94.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.916 0.389 . . . . 3.77 111.517 -175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 56.9 Cg_endo -71.2 171.01 16.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.819 2.346 . . . . 2.36 111.23 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.78 131.43 40.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.734 -0.469 . . . . 2.55 109.734 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.4 m -108.78 115.12 29.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.949 -0.389 . . . . 2.38 109.949 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 22.0 t -123.0 110.77 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 1.59 110.286 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.0 m -92.18 90.28 7.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.525 -0.546 . . . . 1.45 109.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.0 9.84 38.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 3.62 111.556 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.05 -37.03 81.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 2.48 111.047 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -97.26 27.05 4.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.293 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.33 56.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.146 0.498 . . . . 0.8 112.057 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -146.87 106.03 3.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.828 -0.624 . . . . 1.06 110.178 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.3 p -89.01 158.8 17.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.488 -0.56 . . . . 1.26 109.488 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.17 -56.68 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.178 0.436 . . . . 0.74 112.178 -173.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.57 157.75 32.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.909 -0.317 . . . . 3.17 110.728 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -114.26 136.99 49.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 0.64 109.348 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 172' ' ' SER . 64.9 tp -132.55 146.55 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.171 0.51 . . . . 0.96 111.306 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.1 111.54 24.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.591 -0.732 . . . . 1.49 109.354 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -109.44 67.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.385 -0.526 . . . . 1.83 110.487 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.91 -51.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.752 0 O-C-N 124.808 1.317 . . . . 1.64 115.477 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -106.44 -26.46 11.43 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 122.487 0.315 . . . . 3.33 110.623 -172.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.68 171.38 16.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.562 -0.29 . . . . 1.38 110.51 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 95' ' ' PHE . 13.1 p90 -130.24 114.55 15.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.143 -0.688 . . . . 2.74 109.143 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -116.89 145.6 43.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.76 111.562 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.13 119.33 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 1.15 109.445 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.93 125.64 29.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.804 -0.634 . . . . 2.02 110.049 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -105.69 151.2 24.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.703 -0.68 . . . . 1.66 109.242 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -83.49 106.35 15.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.745 0.307 . . . . 1.33 110.33 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -124.36 57.44 1.24 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.982 0.896 . . . . 2.65 110.594 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -92.98 -5.28 51.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.185 -0.916 . . . . 1.61 109.327 169.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -158.72 169.82 23.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.878 -1.056 . . . . 2.35 108.757 -178.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -78.17 72.71 4.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 1.92 111.17 -174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 65.6 mttm -81.1 -53.25 6.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.986 -0.552 . . . . 1.77 110.458 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -119.75 112.18 18.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.096 -0.502 . . . . 0.76 110.09 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 91.8 t -113.4 137.04 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.632 -0.713 . . . . 1.27 110.496 -176.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tt -129.19 113.6 15.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.134 -0.321 . . . . 1.29 110.134 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -147.84 125.01 11.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 2.54 110.457 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.93 -177.77 19.62 Favored Glycine 0 C--O 1.219 -0.793 0 CA-C-O 118.937 -0.924 . . . . 1.31 111.151 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.83 -130.18 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 O-C-N 124.971 1.041 . . . . 1.9 115.498 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.61 169.49 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.68 2.92 . . . . 2.91 114.217 -170.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -31.07 102.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.268 1.509 . . . . 4.11 114.879 -147.169 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 8.4 p-10 -107.03 -100.9 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.19 -1.823 . . . . 4.95 112.793 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.561 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 94.05 152.73 29.62 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.385 -1.086 . . . . 2.25 110.385 -165.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.629 ' HB ' ' OG1' ' A' ' 125' ' ' THR . 14.5 m -69.67 113.9 7.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.932 0.866 . . . . 1.91 110.819 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.633 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 55.8 m-85 -110.19 107.12 16.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.365 . . . . 3.7 111.654 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 97.5 mtt180 -75.91 137.88 40.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 3.54 110.992 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.75 125.55 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.505 -0.554 . . . . 1.14 109.505 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 92' ' ' GLN . 4.5 tt -111.57 -38.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.952 0.406 . . . . 1.68 110.973 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 91' ' ' ILE . 24.8 pt20 -164.98 158.34 16.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.7 -0.482 . . . . 1.55 109.7 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.86 140.69 24.79 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.163 -0.31 . . . . 0.86 110.163 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -135.21 157.63 46.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.412 -0.358 . . . . 0.93 110.654 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 54.6 m-85 -113.77 169.16 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 3.17 110.495 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.422 ' CG ' ' HE1' ' A' ' 244' ' ' TRP . 0.3 OUTLIER -137.63 173.1 12.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.087 -0.708 . . . . 1.68 109.087 174.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.475 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 30.8 t-105 -151.33 127.03 10.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.857 -0.423 . . . . 5.18 109.857 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -94.24 140.85 15.25 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.093 -0.575 . . . . 2.13 112.255 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 t -46.82 -43.51 18.53 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.641 0.376 . . . . 2.9 111.863 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 103' ' ' GLN . 45.1 mt -122.78 152.71 40.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.532 -0.544 . . . . 3.03 109.532 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.05 -7.4 3.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.818 -0.628 . . . . 3.85 112.187 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.76 29.56 2.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.76 . . . . 1.94 112.505 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 7.6 tp60 -159.44 139.88 12.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.925 0.363 . . . . 2.45 110.873 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.579 ' O ' ' HB2' ' A' ' 244' ' ' TRP . . . 94.57 -28.99 9.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.861 -0.685 . . . . 1.47 112.402 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.457 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 1.2 m -89.55 -17.9 27.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.469 0.176 . . . . 2.0 111.127 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 60.02 -156.75 0.34 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.388 -0.369 . . . . 3.72 110.689 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.458 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 62.6 m80 63.33 69.37 0.57 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.381 -0.6 . . . . 3.52 109.381 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.436 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 5.6 t -104.09 118.38 36.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.113 0.482 . . . . 2.52 110.53 -167.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 41.0 t -85.54 105.65 14.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.365 -0.976 . . . . 2.48 108.365 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 66.88 -71.53 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.67 0.606 . . . . 2.8 110.652 -171.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -152.05 19.12 0.67 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 4.98 110.605 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 108' ' ' THR . 13.9 mmmm -107.75 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.018 -0.537 . . . . 3.23 111.553 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.436 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 54.4 mttm -80.31 156.19 26.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.91 . . . . 2.82 108.544 171.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -93.43 -171.29 2.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.8 0.333 . . . . 1.62 111.189 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.41 -27.36 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 1.03 111.752 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 147' ' ' LEU . . . -153.25 168.74 25.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.617 0.246 . . . . 0.75 110.533 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HG2' ' CE1' ' A' ' 107' ' ' HIS . 13.7 tp10 -151.8 152.6 32.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.372 -0.603 . . . . 1.58 109.372 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 95' ' ' PHE . 38.2 tp -125.79 131.38 52.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.712 0.291 . . . . 1.07 110.963 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 107.72 14.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.77 110.705 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.1 mp -102.22 109.55 21.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.105 -0.332 . . . . 0.93 110.105 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.02 129.22 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.188 -0.46 . . . . 0.61 111.49 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 19.0 m-70 -127.39 156.32 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 2.13 109.63 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.415 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 66.1 p-90 -127.49 150.51 49.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 4.26 111.554 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 19.6 t30 -69.21 116.45 9.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.064 -0.971 . . . . 2.02 111.811 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.629 ' OG1' ' HB ' ' A' ' 87' ' ' THR . 53.2 p -63.16 -32.79 74.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.655 0.983 . . . . 2.34 113.655 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 60.9 pttt -74.28 -4.56 36.88 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.338 -0.545 . . . . 3.35 111.923 -173.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -91.42 -5.65 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.34 0.59 . . . . 3.1 109.546 170.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.9 19.32 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 115.569 0.987 . . . . 2.37 115.569 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -177.91 133.13 0.16 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.883 0.841 . . . . 3.93 109.802 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.601 ' O ' HG23 ' A' ' 134' ' ' VAL . 40.3 p90 -66.33 -42.97 87.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.633 . . . . 3.0 111.345 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.27 -33.25 86.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.108 -0.568 . . . . 2.15 112.231 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB3' ' CE1' ' A' ' 127' ' ' TYR . 98.1 mttt -74.28 -34.11 63.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.027 -0.36 . . . . 3.43 110.027 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.35 66.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 1.76 110.765 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 130' ' ' PHE . 42.0 t -63.53 -18.25 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.203 0.525 . . . . 2.77 110.761 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.68 -9.62 53.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.126 -0.359 . . . . 3.55 111.178 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 205' ' ' CYS . 48.9 tt0 -104.41 126.44 31.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.232 -0.284 . . . . 3.02 110.232 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 73.1 Cg_exo -52.79 -31.2 50.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.548 2.832 . . . . 1.6 113.12 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.4 m-20 -112.14 28.15 9.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.185 0.517 . . . . 2.29 109.848 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.03 -30.91 24.55 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.826 -0.625 . . . . 1.22 113.408 -172.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 206' ' ' VAL . 91.3 mt -112.21 157.58 20.72 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.574 -0.368 . . . . 1.57 110.3 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.57 123.16 10.45 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.814 -0.439 . . . . 1.38 109.814 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.88 129.88 71.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 116.292 -0.413 . . . . 1.73 110.012 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 209' ' ' ILE . 35.8 tp -90.99 134.24 34.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 2.42 109.835 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -115.41 145.77 18.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.069 -0.586 . . . . 0.86 112.018 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 118' ' ' LEU . 62.4 mt -142.48 122.75 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.528 -0.545 . . . . 0.76 109.528 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.458 ' CZ ' HG11 ' A' ' 210' ' ' VAL . 44.2 m-85 -73.99 141.07 45.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.694 0.283 . . . . 1.2 111.032 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 9.0 mp -119.2 121.22 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 0.88 110.041 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.82 147.74 41.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.109 -0.496 . . . . 2.03 109.798 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 62.1 t -87.07 130.16 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.901 0.381 . . . . 1.27 110.863 -174.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.11 -105.29 0.19 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.291 -0.724 . . . . 1.53 111.291 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.2 t -81.89 146.18 29.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 1.54 109.521 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.472 ' CA ' ' HB2' ' A' ' 218' ' ' SER . . . -66.62 152.12 45.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.183 0.515 . . . . 0.78 112.222 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -109.39 102.99 51.56 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.335 -0.848 . . . . 1.22 108.735 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.55 -32.93 65.99 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 123.095 2.53 . . . . 1.05 112.835 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.18 -15.95 72.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.094 -0.574 . . . . 0.7 113.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.3 tp -99.62 -9.03 23.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.346 0.593 . . . . 0.77 110.298 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -45.49 88.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.502 -0.772 . . . . 1.41 112.19 -173.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.0 ptmm? -76.68 -27.89 55.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.433 -0.507 . . . . 2.86 111.813 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.37 -40.34 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.495 -0.482 . . . . 1.38 111.316 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.494 ' HA ' ' HG ' ' A' ' 163' ' ' LEU . 34.5 m -62.45 -28.74 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.197 0.522 . . . . 1.11 110.671 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.83 -30.55 71.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.556 -0.747 . . . . 1.22 111.173 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 158' ' ' LYS . 41.2 t -89.31 -16.33 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.41 111.269 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 77.0 mt -56.05 -31.8 63.49 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.229 0.455 . . . . 1.39 112.229 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.88 -30.12 70.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.78 0.324 . . . . 2.31 111.476 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.9 m -84.46 -3.15 58.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.567 -0.288 . . . . 1.4 111.769 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 44.5 pt -132.89 29.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.528 0.68 . . . . 0.85 109.312 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -60.06 -27.66 67.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.95 -1.023 . . . . 1.59 112.075 -172.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.8 p -119.54 152.97 36.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.77 111.598 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -54.39 127.94 29.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.064 -0.971 . . . . 2.29 111.648 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.18 -22.27 31.57 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.588 -0.815 . . . . 0.85 112.849 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -78.56 139.76 38.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.159 0.504 . . . . 1.7 111.307 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB2' HD13 ' A' ' 60' ' ' LEU . 27.4 t -127.06 146.56 50.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.178 -0.919 . . . . 1.37 109.39 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.38 127.08 23.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.438 -0.346 . . . . 0.61 110.08 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.7 132.03 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.501 . . . . 1.8 110.45 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.89 80.99 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.845 -0.616 . . . . 1.04 109.596 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 p -102.81 161.16 13.97 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.116 -0.493 . . . . 1.17 111.824 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 12.9 m120 57.04 66.71 1.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.569 -0.742 . . . . 1.77 111.546 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -119.86 139.18 52.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 3.99 110.191 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.509 ' OD1' ' HB3' ' A' ' 181' ' ' ARG . 17.1 t0 -102.0 106.77 49.45 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 2.51 110.938 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.48 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 23.6 Cg_exo -64.81 -15.08 48.5 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.008 2.472 . . . . 1.26 111.924 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.509 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 29.2 ttp180 -68.78 -21.88 64.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.655 -0.702 . . . . 2.76 110.345 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -77.67 -8.8 87.18 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.774 -0.726 . . . . 1.12 111.855 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 97.0 mt -106.11 -18.26 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.997 0.427 . . . . 1.73 109.884 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 83.3 mt -73.28 126.34 90.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 3.45 110.028 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 59.8 Cg_endo -69.73 -176.28 1.43 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.438 2.758 . . . . 2.08 113.637 -173.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.77 -50.48 64.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.297 -0.411 . . . . 3.23 111.879 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 15.4 m -88.68 136.79 32.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.75 0.31 . . . . 1.66 110.367 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.2 tp -106.09 64.73 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.706 . . . . 1.99 109.893 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.41 -176.32 3.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.953 -1.128 . . . . 1.81 107.953 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -163.52 154.33 16.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.886 0.766 . . . . 5.01 112.855 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -115.29 146.6 41.34 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.827 -1.175 . . . . 3.93 107.827 170.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -108.71 126.84 53.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.096 0.474 . . . . 2.13 111.126 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -133.17 154.08 81.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 5.21 109.989 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.31 129.82 15.45 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.404 2.069 . . . . 2.12 111.77 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -101.79 97.48 1.61 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.792 -0.718 . . . . 1.75 111.455 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 15.7 m . . . . . 0 C--N 1.319 -0.742 0 N-CA-C 112.91 0.707 . . . . 2.99 112.91 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.653 HD13 ' SG ' ' A' ' 205' ' ' CYS . 1.9 pp . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.798 0.333 . . . . 2.96 111.659 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 196' ' ' SER . 7.9 pt-20 -87.79 92.67 9.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.555 0.693 . . . . 3.37 111.083 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.653 ' SG ' HD13 ' A' ' 203' ' ' LEU . 93.9 m -138.83 32.84 2.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.804 -0.635 . . . . 2.15 110.709 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 140' ' ' LEU . 95.3 t -125.63 149.05 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.732 -0.667 . . . . 1.26 111.187 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.1 m -111.68 107.12 16.12 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.083 -1.08 . . . . 2.08 108.083 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -89.23 115.65 26.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.153 0.501 . . . . 5.53 110.333 -174.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.524 ' O ' HD12 ' A' ' 143' ' ' LEU . 63.5 mt -114.57 116.59 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.603 -0.726 . . . . 1.63 109.68 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.458 HG11 ' CZ ' ' A' ' 146' ' ' PHE . 24.3 t -109.71 129.8 63.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.253 -0.277 . . . . 1.62 110.253 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.73 126.44 29.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.818 0.342 . . . . 1.73 110.555 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -47.5 -24.16 0.78 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.561 0.948 . . . . 2.98 113.561 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 8.6 tp10 -106.81 123.7 37.76 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.644 0.259 . . . . 1.47 110.569 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 89.9 Cg_endo -81.77 158.63 18.77 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.671 2.248 . . . . 0.96 112.01 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 41.7 pt -113.97 154.35 15.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.844 0.354 . . . . 1.25 110.326 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.3 m -104.17 130.43 51.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.844 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 18.6 m -125.34 151.17 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.058 -0.719 . . . . 1.02 109.058 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.472 ' HB2' ' CA ' ' A' ' 152' ' ' ALA . 7.5 t -95.2 161.23 14.2 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.449 -0.501 . . . . 1.08 111.164 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.69 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 3.1 p -52.55 -47.18 66.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.32 -0.4 . . . . 1.33 111.658 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -52.6 -33.93 48.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.983 0.421 . . . . 2.51 111.382 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -78.48 -50.68 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 0.7 110.517 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.475 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 27.2 m -67.67 -23.53 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 1.36 111.653 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 219' ' ' SER . 84.7 mt -61.31 -33.39 73.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 1.03 110.717 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -74.76 -23.26 58.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 1.75 110.843 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 29.5 m-85 -68.88 -39.58 79.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.231 0.539 . . . . 2.47 109.802 174.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -76.08 -2.03 28.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.419 -0.81 . . . . 3.04 110.825 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 34.3 mmtp -91.88 -12.62 33.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.409 -0.359 . . . . 2.31 110.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 163' ' ' LEU . 90.4 mt -73.03 151.4 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 0.95 110.731 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.585 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 9.4 m120 -123.69 127.26 47.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.821 -0.627 . . . . 1.13 110.259 -175.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 65.4 m-85 -57.94 -33.62 69.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.767 -0.652 . . . . 3.74 111.004 173.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -72.69 164.19 26.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 1.62 111.884 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.73 171.75 43.56 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.536 -0.756 . . . . 1.16 111.309 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.91 123.27 17.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.994 0.426 . . . . 3.56 110.645 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 91.05 25.1 25.4 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.807 -0.633 . . . . 2.08 112.52 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 62.2 mt-10 -124.55 161.85 45.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.036 -0.357 . . . . 2.59 110.036 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 9.9 Cg_endo -52.15 123.06 11.74 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.164 2.576 . . . . 1.36 112.411 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.15 113.72 1.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.477 -0.783 . . . . 3.4 112.275 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -115.99 102.88 10.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.804 -0.813 . . . . 2.47 108.804 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.34 138.02 56.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.166 0.508 . . . . 2.14 111.332 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.637 ' HA ' ' CE1' ' A' ' 230' ' ' PHE . 50.4 ttm -79.1 90.77 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.166 -0.925 . . . . 1.68 110.54 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.9 m -124.44 153.31 30.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.19 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.477 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 76.7 m-20 72.04 -80.24 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.133 0.896 . . . . 2.18 109.678 -176.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 56.34 27.72 12.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.073 0.463 . . . . 2.15 111.393 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.579 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 26.8 m95 -142.37 156.67 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 4.59 110.597 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -106.4 137.75 19.52 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.477 -0.783 . . . . 6.13 109.803 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.86 146.14 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.069 3.179 . . . . 3.28 113.667 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.36 151.48 46.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.068 -0.969 . . . . 2.98 110.781 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.542 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 86.9 mm-40 -94.76 170.6 7.8 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.473 -0.785 . . . . 4.32 110.079 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 74.8 Cg_exo -44.05 143.21 3.4 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.415 2.076 . . . . 3.48 112.461 176.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.54 -38.45 55.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.03 -0.986 . . . . 4.63 109.749 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 253' ' ' ARG . 21.0 pttm -64.88 -14.8 60.79 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 115.209 1.559 . . . . 5.34 115.209 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.5 t30 24.58 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.783 2.512 . . . . 4.64 117.783 151.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 251' ' ' LYS . 15.5 tpp180 166.28 -125.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.912 -1.514 . . . . 6.11 106.912 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -127.48 133.95 49.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 3.08 109.88 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.6 131.06 35.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.83 -0.433 . . . . 2.6 109.83 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -120.7 133.21 55.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.115 -0.493 . . . . 2.63 110.898 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -143.82 129.41 19.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.246 -0.649 . . . . 1.71 109.246 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 p -92.23 97.6 10.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.827 -0.749 . . . . 2.21 111.172 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -126.01 92.4 3.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.683 0.754 . . . . 4.31 110.259 167.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.346 -0.843 . . . . 4.49 110.259 178.931 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.564 ' HB3' HD11 ' A' ' 250' ' ' LEU . 24.2 t70 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 122.054 0.93 . . . . 2.88 111.647 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 85.4 mt -102.82 141.79 18.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.33 -1.305 . . . . 2.32 109.918 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 19.3 t70 -120.93 121.62 38.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.827 0.346 . . . . 2.82 110.166 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -69.07 -28.77 66.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 2.24 112.054 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 35.1 m80 -60.54 -43.35 97.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.324 0.583 . . . . 4.54 110.314 173.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -71.98 -21.42 61.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.288 -0.869 . . . . 3.06 110.007 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' A' ' 257' ' ' ALA . . . -74.82 98.78 3.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.5 -0.773 . . . . 1.72 110.55 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -72.11 126.33 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.941 -0.572 . . . . 3.69 109.653 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 51.1 p90 -82.64 131.49 35.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 4.64 110.336 -172.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.14 138.74 26.57 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.821 -0.627 . . . . 2.27 110.005 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.81 13.2 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.223 2.615 . . . . 2.15 114.064 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -60.45 -52.48 65.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 4.29 109.899 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.1 mt 53.08 13.78 0.41 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.583 0.957 . . . . 4.74 113.583 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HD3' ' HD2' ' A' ' 46' ' ' PRO . 16.2 tppt? -56.72 111.55 3.44 Favored Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 123.408 0.443 . . . . 3.77 111.887 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 84.9 Cg_endo -87.33 157.3 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.919 2.413 . . . . 2.36 111.99 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -83.1 154.48 24.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.047 -0.524 . . . . 2.55 110.369 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 38.5 t -129.62 131.02 46.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.295 -0.631 . . . . 2.38 109.295 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.89 137.37 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 1.59 111.433 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 47.7 m -127.75 90.94 3.19 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.033 -0.728 . . . . 1.45 109.033 171.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -133.03 16.42 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.879 -0.328 . . . . 3.62 111.883 -176.115 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.14 -22.04 64.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.966 0.413 . . . . 2.48 110.951 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.03 3.72 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 2.24 111.228 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.84 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.187 0.517 . . . . 0.8 111.853 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.8 m -98.62 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.064 -0.516 . . . . 1.06 110.506 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 5.3 p -81.24 149.67 28.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 1.26 110.494 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.1 mt -115.85 -49.71 2.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.071 0.462 . . . . 0.74 110.844 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -160.59 161.96 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.026 -0.534 . . . . 3.17 110.726 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.09 133.75 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.941 -0.762 . . . . 0.64 108.941 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 171' ' ' LYS . 53.3 tp -129.34 131.21 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.975 0.417 . . . . 0.96 111.408 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -80.81 109.3 15.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.742 -0.663 . . . . 1.49 109.355 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.91 68.89 0.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.968 0.413 . . . . 1.83 110.166 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.33 -53.58 0.09 OUTLIER Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.279 -1.328 . . . . 1.64 115.208 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -110.1 -19.86 12.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.788 0.328 . . . . 3.33 111.32 -169.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.96 177.61 10.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 1.38 110.247 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.705 ' CE1' HD13 ' A' ' 228' ' ' LEU . 29.2 m-85 -117.38 112.84 21.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.304 -0.628 . . . . 2.74 109.304 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.4 m120 -90.72 105.2 17.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.47 . . . . 1.76 110.783 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 60.1 t -82.26 105.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.752 -0.833 . . . . 1.15 108.752 171.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.12 132.47 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.016 -0.538 . . . . 2.02 111.084 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 75.8 m-85 -112.02 155.74 23.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.462 -0.79 . . . . 1.66 109.032 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.14 110.39 15.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.933 0.397 . . . . 1.33 110.559 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -107.06 55.18 0.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.712 0.768 . . . . 2.65 109.939 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -96.94 -5.85 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.758 . . . . 1.61 110.771 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -154.03 166.63 32.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.372 -0.831 . . . . 2.35 109.18 178.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.91 36.74 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.36 0.504 . . . . 1.92 112.36 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 92.6 mttt -55.48 -63.58 1.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.246 -0.434 . . . . 1.77 110.656 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -103.55 115.96 31.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.872 -0.604 . . . . 0.76 110.341 -177.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.9 t -134.51 141.96 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.808 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.6 tp -105.61 128.33 53.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.338 -0.616 . . . . 1.29 109.338 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 55.8 mtpt -119.92 124.76 46.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.244 0.545 . . . . 2.54 110.24 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.77 170.99 19.83 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.789 -0.924 . . . . 1.31 110.789 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.71 -148.95 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 O-C-N 123.657 0.269 . . . . 1.9 113.539 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.43 119.03 5.26 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 121.569 1.512 . . . . 2.91 112.451 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -159.66 -171.14 3.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.078 -0.965 . . . . 4.11 108.938 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -132.89 76.95 1.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.751 -0.38 . . . . 4.95 111.714 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.7 -178.68 17.29 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.247 -0.977 . . . . 2.25 114.206 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 m -105.76 120.1 40.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.859 -0.671 . . . . 1.91 109.363 176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 32.2 m-85 -105.41 104.79 14.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 3.7 111.436 -171.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 99.4 mtt180 -75.37 152.62 38.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.099 -0.5 . . . . 3.54 110.314 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.9 120.43 24.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.974 -0.38 . . . . 1.14 109.974 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.0 tt -110.26 -34.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.447 -0.342 . . . . 1.68 111.02 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 7.2 pt20 -173.86 174.52 3.04 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.661 -0.496 . . . . 1.55 109.661 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 20.4 p90 -147.09 161.65 40.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.861 -0.336 . . . . 0.86 111.02 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.7 p-80 -147.46 160.11 42.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -125.11 172.79 9.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.774 0.321 . . . . 3.17 110.899 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -127.24 117.14 21.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.712 -1.218 . . . . 1.68 107.712 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.58 ' NE1' ' HA ' ' A' ' 99' ' ' SER . 60.3 t-105 -101.49 112.33 24.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.778 0.323 . . . . 5.18 110.694 -173.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -63.32 -39.07 97.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.629 -0.714 . . . . 2.13 112.497 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.58 ' HA ' ' NE1' ' A' ' 97' ' ' TRP . 32.5 t 91.56 -17.92 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.266 1.026 . . . . 2.9 110.178 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 92.4 mt -112.57 137.85 50.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.134 -1.062 . . . . 3.03 108.134 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.21 -24.96 65.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.652 0.982 . . . . 3.85 113.652 -168.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.99 7.53 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.914 -1.136 . . . . 1.94 113.863 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.425 ' HG3' ' HB2' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -165.99 152.58 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.383 0.591 . . . . 2.45 111.023 176.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.484 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 122.89 -27.27 5.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.64 -0.791 . . . . 1.47 112.692 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 114' ' ' TYR . 39.2 t -71.29 -46.98 59.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.464 0.172 . . . . 2.0 111.464 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 61.46 -172.66 0.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.937 0.347 . . . . 3.72 111.937 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.9 m80 56.48 30.21 16.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.957 0.884 . . . . 3.52 108.664 -166.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 108' ' ' THR . 2.0 t -83.13 153.6 24.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.997 -1.456 . . . . 2.52 113.122 -169.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.0 m -101.52 93.45 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.397 -0.82 . . . . 2.48 111.382 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.64 71.55 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.039 -0.982 . . . . 2.8 111.329 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 59.41 21.29 9.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.091 -0.958 . . . . 4.98 113.417 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -97.82 73.55 2.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.332 -0.618 . . . . 3.23 109.332 172.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.9 150.9 23.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.279 -0.418 . . . . 2.82 109.97 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 105' ' ' SER . 76.6 m-85 -110.71 -173.79 2.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.751 -0.462 . . . . 1.62 109.751 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.9 -38.97 69.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.623 0.601 . . . . 1.03 112.623 -172.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.53 169.02 17.65 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.929 -0.308 . . . . 0.75 111.527 -170.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -136.17 140.07 43.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.612 -0.722 . . . . 1.58 109.107 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.5 tp -109.63 133.67 52.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 1.07 110.245 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.477 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 39.8 m170 -120.38 106.1 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 1.77 110.684 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.3 mp -86.83 114.92 23.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.757 -0.46 . . . . 0.93 109.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.03 134.14 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.225 0.536 . . . . 0.61 110.571 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.547 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 77.9 m80 -119.68 150.82 39.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 2.13 111.521 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -110.17 123.84 50.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.819 -1.082 . . . . 4.26 110.008 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 40.5 t-20 -79.37 117.99 20.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.113 -0.494 . . . . 2.02 110.426 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -73.93 -32.21 63.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.17 -0.468 . . . . 2.34 112.193 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 19.6 ptmt -63.24 -25.19 68.21 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.112 0.412 . . . . 3.35 112.112 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.38 -11.87 31.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.906 0.384 . . . . 3.1 111.136 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.74 26.11 3.85 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.123 -0.944 . . . . 2.37 113.687 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -176.31 115.29 0.12 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.793 -0.447 . . . . 3.93 109.793 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 134' ' ' VAL . 50.8 p90 -57.81 -36.24 71.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 3.0 111.677 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.55 -44.9 96.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.875 -0.678 . . . . 2.15 112.444 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -64.4 -36.21 83.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.21 0.529 . . . . 3.43 109.984 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 139' ' ' GLY . . . -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 1.76 111.303 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 130' ' ' PHE . 72.0 t -61.73 -22.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.028 0.442 . . . . 2.77 111.083 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -77.0 -0.81 25.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 3.55 111.414 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.492 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 46.5 tt0 -126.26 131.77 24.07 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.79 -0.448 . . . . 3.02 109.79 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.17 -18.19 50.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.897 2.398 . . . . 1.6 112.76 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.492 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 13.1 m-20 -113.91 17.63 17.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.174 -0.676 . . . . 2.29 109.174 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.412 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -83.24 -11.23 81.11 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.437 -0.802 . . . . 1.22 113.934 -168.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.594 ' C ' HG12 ' A' ' 206' ' ' VAL . 80.1 mt -146.48 172.19 13.91 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.269 -0.271 . . . . 1.57 110.269 -175.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -156.94 121.34 4.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.363 -0.38 . . . . 1.38 110.671 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.51 ' O ' HG21 ' A' ' 209' ' ' ILE . 33.6 m -97.95 165.86 2.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 N-CA-C 108.637 -0.875 . . . . 1.73 108.637 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.5 tp -116.45 114.71 24.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.774 -0.454 . . . . 2.42 109.774 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -97.16 117.27 5.73 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.047 -0.597 . . . . 0.86 112.689 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.9 mt -118.87 127.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.306 -0.257 . . . . 0.76 110.306 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -78.4 147.22 34.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.366 -0.235 . . . . 1.2 110.366 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 8.1 mp -117.7 124.47 48.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.88 111.145 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -116.56 144.91 43.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.322 -0.622 . . . . 2.03 109.322 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 11.2 t -88.05 130.38 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.894 0.378 . . . . 1.27 110.356 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.09 -114.88 0.4 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.414 -0.674 . . . . 1.53 111.414 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.3 t -81.99 156.37 24.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.489 -0.56 . . . . 1.54 109.489 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.417 ' N ' ' HB2' ' A' ' 218' ' ' SER . . . -78.02 148.6 34.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 0.78 111.098 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 183' ' ' LEU . 82.5 tttt -113.19 110.4 51.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.771 -0.455 . . . . 1.22 109.771 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.5 -38.66 90.05 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.708 2.939 . . . . 1.05 113.565 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.3 -19.84 64.65 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.115 -0.564 . . . . 0.7 112.899 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -95.56 -16.56 22.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.025 0.44 . . . . 0.77 110.336 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -46.12 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.761 -0.654 . . . . 1.41 111.162 -173.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.29 -36.73 66.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.873 0.323 . . . . 2.86 111.873 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.12 -42.67 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.077 0.465 . . . . 1.38 110.556 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 156' ' ' LEU . 24.4 t -67.27 -29.73 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 1.11 110.811 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.21 -35.82 61.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.224 -0.444 . . . . 1.22 111.698 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.93 -19.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.654 0.264 . . . . 1.41 111.546 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 228' ' ' LEU . 3.4 pp -74.71 -12.79 60.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.947 -0.301 . . . . 1.39 111.501 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.06 -31.08 69.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.947 0.403 . . . . 2.31 111.081 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.3 m -87.57 1.55 53.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.328 0.492 . . . . 1.4 112.328 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.6 pt -139.74 39.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.563 0.697 . . . . 0.85 110.598 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.606 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 84.8 tttt -54.0 -31.68 51.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.672 -1.149 . . . . 1.59 112.688 -176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -111.65 150.17 30.51 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.196 0.522 . . . . 0.77 111.959 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -58.31 128.16 35.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.388 -0.824 . . . . 2.29 111.502 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.65 -18.83 19.6 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.578 -0.82 . . . . 0.85 112.537 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.404 ' O ' HD12 ' A' ' 60' ' ' LEU . 67.4 mttm -87.52 149.12 24.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.362 0.601 . . . . 1.7 111.215 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.5 p -134.96 157.26 47.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.053 -0.976 . . . . 1.37 109.702 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.81 139.05 29.13 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.153 -0.314 . . . . 0.61 110.153 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.55 135.04 48.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.623 -0.51 . . . . 1.8 109.623 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 178' ' ' PHE . 22.8 t80 -136.23 81.46 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.242 0.544 . . . . 1.04 109.812 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.0 m -79.97 138.6 37.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.664 -0.698 . . . . 1.17 112.32 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 52.34 76.09 0.2 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.105 -0.952 . . . . 1.77 113.281 169.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 52.0 t80 -92.13 137.52 32.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.758 -0.46 . . . . 3.99 109.758 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -105.09 94.58 8.0 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.4 0.619 . . . . 2.51 110.94 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 12.3 Cg_exo -71.83 -9.49 24.88 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.653 2.235 . . . . 1.26 112.321 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -49.81 -39.54 38.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.196 0.522 . . . . 2.76 110.87 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -56.23 -26.98 51.57 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.281 -0.872 . . . . 1.12 113.061 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 153' ' ' LYS . 90.2 mt -76.63 -29.65 56.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.73 112.571 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.402 ' HB2' ' HD3' ' A' ' 185' ' ' PRO . 85.9 mt -33.14 -47.73 0.58 Allowed Pre-proline 0 N--CA 1.483 1.185 0 N-CA-C 116.237 1.939 . . . . 3.45 116.237 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 184' ' ' LEU . 14.1 Cg_exo -71.73 48.89 1.12 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.556 1.504 . . . . 2.08 114.029 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 187' ' ' SER . 0.0 OUTLIER -109.45 -6.19 15.53 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.998 -0.439 . . . . 3.23 111.766 173.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.477 ' OG ' ' HE2' ' A' ' 212' ' ' LYS . 46.1 t 72.84 128.43 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.782 0.676 . . . . 1.66 111.038 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.503 ' HA ' HD22 ' A' ' 211' ' ' LEU . 96.0 mt -113.81 59.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.395 -0.366 . . . . 1.99 110.174 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -144.43 153.08 41.54 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.997 -0.742 . . . . 1.81 108.997 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.468 ' HB3' ' HB ' ' A' ' 210' ' ' VAL . 0.1 OUTLIER 171.58 -168.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.121 -1.066 . . . . 5.01 108.121 -178.546 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.61 ' HB3' ' HA ' ' A' ' 257' ' ' ALA . 1.5 p90 -75.87 147.97 38.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.09 0.472 . . . . 3.93 110.265 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.3 t -107.28 75.91 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.8 0.81 . . . . 2.13 110.811 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.423 ' OH ' ' HD3' ' A' ' 253' ' ' ARG . 20.8 t80 -138.43 138.5 22.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.635 -0.711 . . . . 5.21 110.057 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HA ' ' OG1' ' A' ' 207' ' ' THR . 33.0 Cg_endo -64.7 130.29 25.91 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.728 2.285 . . . . 2.12 112.832 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -125.29 142.85 14.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.862 -0.608 . . . . 1.75 112.12 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 C--N 1.325 -0.478 0 CA-C-O 121.579 0.704 . . . . 2.99 112.405 -177.784 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.978 0.418 . . . . 2.96 110.744 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -104.25 51.3 0.78 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 3.37 110.352 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 62.2 m -135.69 11.74 3.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.436 -0.802 . . . . 2.15 110.412 -176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.594 HG12 ' C ' ' A' ' 140' ' ' LEU . 15.9 m -136.23 100.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 1.26 110.46 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 194' ' ' PRO . 1.4 t -151.21 89.8 1.54 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 115.358 1.614 . . . . 2.08 115.358 170.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.504 ' O ' HG23 ' A' ' 209' ' ' ILE . 0.1 OUTLIER -151.96 85.5 1.29 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.569 -0.707 . . . . 5.53 109.322 143.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -163.16 98.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.177 0.436 . . . . 1.63 112.177 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.11 136.61 59.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.469 -0.769 . . . . 1.62 109.893 165.338 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 188' ' ' LEU . 51.6 mt -114.1 123.19 49.05 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 1.73 110.631 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.477 ' HE2' ' OG ' ' A' ' 187' ' ' SER . 62.3 pttt -67.62 -36.77 81.44 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.122 0.415 . . . . 2.98 112.122 -174.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 212' ' ' LYS . 25.0 mm-40 -99.14 117.21 64.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 1.47 111.166 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.65 148.25 58.89 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.525 2.15 . . . . 0.96 111.134 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -79.45 147.26 6.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 1.25 109.62 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.1 t -89.9 116.4 27.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.003 -0.544 . . . . 1.29 110.577 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -119.37 135.69 58.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.586 -0.894 . . . . 1.02 108.586 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 152' ' ' ALA . 13.2 t -96.95 170.43 9.16 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.992 -0.442 . . . . 1.08 111.502 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.58 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 11.0 p -51.48 -53.03 41.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.367 0.506 . . . . 1.33 112.367 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.47 -40.14 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 2.51 111.099 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -68.87 -51.08 44.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.966 -0.561 . . . . 0.7 110.071 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.9 m -69.25 -20.71 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 111.912 0.338 . . . . 1.36 111.912 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 219' ' ' SER . 57.9 mt -61.87 -42.41 99.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.019 0.437 . . . . 1.03 109.907 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.683 ' O ' ' HG ' ' A' ' 228' ' ' LEU . 62.5 mttm -66.62 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.511 -0.768 . . . . 1.75 110.865 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -73.23 -31.14 63.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.216 0.532 . . . . 2.47 110.496 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.439 ' HE ' ' HB2' ' A' ' 226' ' ' ARG . 5.7 ttm180 -83.35 -13.86 54.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.684 -0.689 . . . . 3.04 110.89 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -2.35 32.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.205 -0.452 . . . . 2.31 111.294 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.705 HD13 ' CE1' ' A' ' 66' ' ' PHE . 90.7 mt -73.62 152.43 40.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.064 0.459 . . . . 0.95 110.952 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.606 ' OD1' ' HE2' ' A' ' 167' ' ' LYS . 11.9 m120 -111.22 141.48 44.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.408 0.623 . . . . 1.13 111.037 -174.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.77 -31.47 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.731 -1.122 . . . . 3.74 108.815 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.8 p-10 -72.83 165.21 25.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.506 -1.224 . . . . 1.62 112.208 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.09 174.41 45.61 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.915 -1.039 . . . . 1.16 110.814 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.5 133.07 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.832 -0.433 . . . . 3.56 109.832 -176.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.26 3.84 88.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.694 -0.765 . . . . 2.08 113.27 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 32.6 mt-10 -98.66 164.34 17.18 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.657 -0.498 . . . . 2.59 109.657 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.44 126.51 22.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 1.36 111.571 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.51 109.34 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.647 -0.706 . . . . 3.4 111.763 -172.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -125.59 122.15 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.41 -0.814 . . . . 2.47 110.193 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.58 149.42 49.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.773 -0.649 . . . . 2.14 111.116 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 mtt -73.0 102.55 3.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 1.68 109.352 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.87 133.47 68.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 1.27 111.505 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.476 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 17.6 t70 63.62 -80.02 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.3 -0.864 . . . . 2.18 111.211 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 56.36 33.68 22.8 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.818 0.447 . . . . 2.15 111.804 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -125.35 144.75 50.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.468 -0.568 . . . . 4.59 109.468 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 0.1 OUTLIER -67.62 147.25 98.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.044 -0.525 . . . . 6.13 111.358 -178.442 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.594 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 61.1 Cg_exo -53.17 153.26 16.8 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.443 2.762 . . . . 3.28 112.348 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 118.57 16.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.317 -0.401 . . . . 2.98 111.585 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.55 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 48.6 mt-30 -68.89 171.44 6.37 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.771 -0.65 . . . . 4.32 109.684 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 66.1 Cg_exo -42.26 123.2 2.57 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.386 2.058 . . . . 3.48 111.853 173.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -55.96 -52.87 62.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.571 -0.74 . . . . 4.63 111.836 -163.668 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 253' ' ' ARG . 18.8 ptpt -62.21 -10.95 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.865 1.061 . . . . 5.34 113.865 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 10.4 p30 48.9 -42.59 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.887 2.551 . . . . 4.64 117.887 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 251' ' ' LYS . 20.0 ttt180 168.74 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.485 -0.931 . . . . 6.11 108.485 -164.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -129.33 136.12 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.063 -0.717 . . . . 3.08 109.063 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.457 HD13 HG23 ' A' ' 33' ' ' ILE . 36.1 mt -99.66 142.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.246 -0.279 . . . . 2.6 110.246 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -132.46 159.1 40.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.596 -0.275 . . . . 2.63 110.348 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.61 ' HA ' ' HB3' ' A' ' 191' ' ' TRP . . . -130.57 157.7 42.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 1.71 110.971 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 191' ' ' TRP . 14.0 p -163.91 98.31 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.387 . . . . 2.21 110.275 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -162.08 150.13 14.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.39 -0.368 . . . . 4.31 110.374 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.38 -0.819 . . . . 4.49 109.673 -177.817 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 27.6 t70 . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 120.547 0.213 . . . . 2.88 111.007 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' HB ' HG12 ' A' ' 109' ' ' VAL . 50.8 mt -85.49 135.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 116.353 -0.385 . . . . 2.32 110.626 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -105.82 111.46 24.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.744 -0.465 . . . . 2.82 109.744 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.5 p -60.61 -27.24 67.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.037 -0.529 . . . . 2.24 112.321 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -66.56 -45.7 78.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 4.54 110.818 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 m -78.74 -25.9 44.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 3.06 110.667 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.12 116.93 3.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.129 0.49 . . . . 1.72 111.248 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -94.24 128.7 40.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 3.69 110.918 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.1 p90 -76.69 140.05 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.262 -0.426 . . . . 4.64 110.18 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.34 98.46 13.92 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.899 0.381 . . . . 2.27 110.007 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.18 -10.5 27.41 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.181 2.587 . . . . 2.15 113.14 -175.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.6 p -78.96 -1.92 37.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.023 0.439 . . . . 4.29 110.565 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.51 HD12 ' OG ' ' A' ' 258' ' ' SER . 78.4 mt -89.54 138.27 31.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.387 -0.597 . . . . 4.74 109.387 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.36 140.25 26.3 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 3.77 110.879 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.44 138.07 84.44 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.128 2.552 . . . . 2.36 111.649 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.409 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 57.7 mt -72.94 138.3 46.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 2.55 110.457 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -91.81 120.52 32.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.009 -1.108 . . . . 2.38 108.009 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' CD1' ' A' ' 79' ' ' LEU . 1.9 t -116.45 110.93 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.522 -0.308 . . . . 1.59 110.624 -172.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.9 t -94.91 88.38 5.27 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.034 -0.728 . . . . 1.45 109.034 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 181' ' ' ARG . 1.4 p90 -107.25 1.1 23.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.892 -0.594 . . . . 3.62 111.36 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.35 -32.83 65.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.242 -0.435 . . . . 2.48 111.557 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.466 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 1.2 mp0 -101.5 6.89 42.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.24 111.138 -176.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.63 128.1 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.812 0.339 . . . . 0.8 111.537 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -112.31 107.03 15.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.954 -0.566 . . . . 1.06 110.721 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 t -79.67 150.51 30.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 1.26 108.95 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.7 mt -117.79 -54.52 2.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.74 111.825 -173.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -161.91 159.58 26.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.322 -0.399 . . . . 3.17 110.841 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.1 tt -115.31 141.5 32.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.312 -0.625 . . . . 0.64 109.312 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 171' ' ' LYS . 61.5 tp -127.6 138.26 52.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.37 . . . . 0.96 110.89 -173.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -92.99 119.78 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.063 0.459 . . . . 1.49 110.547 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 17.5 m120 -127.74 146.53 50.55 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.339 -0.985 . . . . 1.83 108.339 170.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.22 6.34 7.6 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.976 -0.631 . . . . 1.64 113.932 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -114.33 -54.29 2.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.165 0.482 . . . . 3.33 109.713 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 62' ' ' ASN . . . -140.53 163.22 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.336 -0.393 . . . . 1.38 110.416 174.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 69.7 m-85 -111.47 99.77 8.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.805 -0.443 . . . . 2.74 109.805 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 94' ' ' HIS . 81.3 m-20 -86.55 138.83 31.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 1.76 111.72 -171.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.3 t -114.59 113.25 43.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.476 -0.784 . . . . 1.15 108.977 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -72.66 140.53 47.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.913 -0.585 . . . . 2.02 112.076 -172.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -125.68 144.32 50.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 1.66 110.1 172.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.65 139.5 30.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.148 -0.478 . . . . 1.33 111.068 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.02 64.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.033 -0.985 . . . . 2.65 109.868 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -77.82 -11.06 59.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.982 0.896 . . . . 1.61 108.65 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -149.25 160.05 43.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.927 -1.488 . . . . 2.35 107.824 -176.455 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.97 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.688 0.618 . . . . 1.92 111.865 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 53' ' ' GLN . 90.0 mttt -109.54 -59.41 1.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.65 0.611 . . . . 1.77 112.65 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.84 102.15 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.76 111.258 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.59 145.41 24.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.205 -0.452 . . . . 1.27 111.206 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 49' ' ' VAL . 31.8 tp -134.39 112.88 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.935 -0.395 . . . . 1.29 109.935 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -150.98 123.23 8.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 2.54 111.538 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -97.17 176.06 31.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.762 -1.021 . . . . 1.31 110.905 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.17 -141.28 0.0 OUTLIER Glycine 0 CA--C 1.541 1.71 0 N-CA-C 115.331 0.892 . . . . 1.9 115.331 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.64 122.21 8.47 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.227 1.952 . . . . 2.91 112.329 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 14.1 tp -165.44 -170.3 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.976 -1.12 . . . . 4.11 107.976 -171.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.583 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 27.0 t70 -122.23 41.72 3.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.294 0.497 . . . . 4.95 110.997 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.77 174.91 13.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.858 -1.163 . . . . 2.25 114.229 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.0 m -101.86 124.18 47.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.073 -0.564 . . . . 1.91 110.12 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -114.07 113.16 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.071 0.463 . . . . 3.7 111.55 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.79 153.93 20.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.372 -0.376 . . . . 3.54 110.431 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.89 124.33 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.819 0.342 . . . . 1.14 110.615 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.545 ' HB ' ' CE3' ' A' ' 123' ' ' TRP . 14.2 tt -105.62 -34.02 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.918 0.389 . . . . 1.68 110.117 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -173.93 164.67 4.24 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.854 -0.795 . . . . 1.55 108.854 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' A' ' 120' ' ' LEU . 14.9 p90 -136.71 154.66 50.54 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.566 -0.902 . . . . 0.86 108.566 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.481 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.7 p-80 -139.78 158.8 43.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.943 0.401 . . . . 0.93 110.962 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.12 166.84 20.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 3.17 109.426 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.46 157.69 44.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.451 -0.574 . . . . 1.68 109.451 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 73.1 t-105 -128.51 139.5 52.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 5.18 110.228 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -95.06 -59.42 1.11 Allowed Glycine 0 C--O 1.218 -0.844 0 C-N-CA 120.837 -0.697 . . . . 2.13 112.74 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 28.8 p 163.07 -57.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.365 0.603 . . . . 2.9 110.648 -172.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.81 153.26 23.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.307 -0.86 . . . . 3.03 110.4 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.38 51.69 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.666 0.746 . . . . 3.85 110.243 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -176.02 1.64 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.151 -0.931 . . . . 1.94 112.434 -175.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -160.35 155.24 24.33 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.887 -0.782 . . . . 2.45 108.887 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 116.19 -27.12 8.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.192 -1.004 . . . . 1.47 111.873 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 t -70.39 -46.73 63.44 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.011 -0.366 . . . . 2.0 110.011 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.524 ' OE1' ' HD3' ' A' ' 113' ' ' LYS . 8.1 mm-40 58.89 177.39 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.044 -0.525 . . . . 3.72 111.808 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.453 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 24.6 m80 59.76 14.45 4.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.962 -0.563 . . . . 3.52 111.286 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 113' ' ' LYS . 7.3 t -82.38 -178.8 7.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.11 -0.95 . . . . 2.52 113.088 -172.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 33' ' ' ILE . 17.0 m -103.61 123.94 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.582 -1.19 . . . . 2.48 111.965 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 61.17 39.14 16.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.38 -1.282 . . . . 2.8 111.413 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 67.81 8.54 6.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.758 -0.656 . . . . 4.98 112.163 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.43 73.91 6.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.694 0.283 . . . . 3.23 110.707 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.524 ' HD3' ' OE1' ' A' ' 106' ' ' GLU . 91.9 mttt -69.07 150.25 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.222 0.534 . . . . 2.82 111.641 -176.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 81.4 m-85 -101.12 -177.26 3.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.174 -0.921 . . . . 1.62 109.848 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.63 67.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.917 0.389 . . . . 1.03 111.704 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.32 163.75 39.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.457 . . . . 0.75 110.224 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 44.3 tt0 -129.99 135.2 48.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.732 -0.47 . . . . 1.58 109.732 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.5 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 42.9 tp -110.78 132.5 54.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.066 -0.515 . . . . 1.07 109.907 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.481 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -128.09 111.34 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.792 0.33 . . . . 1.77 111.628 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 93' ' ' PHE . 6.6 mp -92.71 113.46 25.74 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.151 -0.315 . . . . 0.93 110.151 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.73 122.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.162 0.506 . . . . 0.61 111.37 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -120.92 146.64 46.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.95 -0.568 . . . . 2.13 109.513 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.545 ' CE3' ' HB ' ' A' ' 91' ' ' ILE . 2.1 p90 -119.56 148.83 42.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.615 -0.513 . . . . 4.26 109.615 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -68.99 114.73 7.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.278 0.561 . . . . 2.02 110.37 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -68.19 -21.87 64.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.235 -0.893 . . . . 2.34 112.101 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.87 -21.6 64.83 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.861 0.363 . . . . 3.35 111.506 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.3 -3.17 34.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.003 0.43 . . . . 3.1 110.125 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.79 30.22 6.67 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 114.714 -1.13 . . . . 2.37 114.98 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 30.5 t70 -173.42 129.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.037 0.918 . . . . 3.93 110.214 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.608 ' O ' HG23 ' A' ' 134' ' ' VAL . 85.8 t80 -60.0 -46.4 89.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.961 -1.018 . . . . 3.0 110.842 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.66 99.24 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.227 -0.511 . . . . 2.15 112.832 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.48 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 73.6 mmtt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.07 0.462 . . . . 3.43 110.316 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.688 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.66 -0.7 . . . . 1.76 110.738 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 130' ' ' PHE . 99.6 t -64.83 -26.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.022 -0.535 . . . . 2.77 111.493 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -83.87 -4.66 58.85 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.023 -0.423 . . . . 3.55 111.451 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.455 HE21 ' HA2' ' A' ' 139' ' ' GLY . 3.1 tt0 -107.28 132.36 21.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.885 -0.413 . . . . 3.02 109.885 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 74.4 Cg_exo -52.46 -30.37 43.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.426 2.751 . . . . 1.6 113.499 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.91 25.18 12.05 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.646 0.26 . . . . 2.29 110.472 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -70.87 -33.63 65.99 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.579 -0.819 . . . . 1.22 113.394 -172.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.7 mt -114.71 156.9 23.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.999 0.428 . . . . 1.57 110.069 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.0 106.57 6.14 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.284 -0.635 . . . . 1.38 109.284 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 91.3 t -103.94 116.45 47.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.093 -0.503 . . . . 1.73 110.353 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 44.5 tp -88.8 112.85 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.329 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -101.64 141.9 15.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.906 -0.664 . . . . 0.86 112.337 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.6 mt -133.64 131.75 57.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.453 -0.573 . . . . 0.76 109.453 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.4 148.99 25.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.921 -0.4 . . . . 1.2 109.921 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.9 mp -116.79 124.01 48.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.88 110.973 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 18.9 ptpt -108.1 150.52 27.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.271 -0.64 . . . . 2.03 109.271 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 92.3 t -95.01 130.55 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.133 0.492 . . . . 1.27 110.83 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.59 -103.61 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.794 -0.639 . . . . 1.53 111.731 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 p -71.07 147.22 48.71 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.839 0.352 . . . . 1.54 110.385 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -78.2 149.58 33.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.263 -0.426 . . . . 0.78 110.606 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.0 100.4 53.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.053 -0.521 . . . . 1.22 110.303 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.46 -35.02 64.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.41 2.74 . . . . 1.05 112.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.44 -21.36 64.47 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.347 -0.454 . . . . 0.7 113.524 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.507 ' HB3' ' NE2' ' A' ' 221' ' ' GLN . 27.1 tp -98.04 -6.25 32.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.3 0.55 . . . . 0.77 110.802 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -56.01 -41.24 74.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 1.41 111.805 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -66.04 -34.66 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.728 0.299 . . . . 2.86 111.085 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 162' ' ' VAL . 67.4 t -71.55 -50.29 40.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 1.38 110.823 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 224' ' ' LYS . 32.9 m -65.61 -24.89 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 1.11 111.255 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.74 -34.1 58.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.499 . . . . 1.22 111.495 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 159' ' ' VAL . 6.0 p -81.89 -8.77 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 1.41 110.749 -175.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.34 -27.22 63.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.966 -0.561 . . . . 1.39 111.391 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.15 -34.66 73.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 2.31 111.413 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.3 t -89.25 -1.55 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.664 -0.244 . . . . 1.4 111.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 38.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.05 0.452 . . . . 0.85 110.374 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.9 -35.33 72.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 1.59 111.023 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 p -106.39 149.02 27.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.396 0.617 . . . . 0.77 111.52 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -57.41 126.94 29.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.901 -1.045 . . . . 2.29 111.18 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.5 -22.24 20.2 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.748 -0.739 . . . . 0.85 112.642 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 60' ' ' LEU . 64.8 mttm -79.62 150.28 31.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.167 0.508 . . . . 1.7 111.472 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 60' ' ' LEU . 8.5 t -140.75 151.34 44.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.402 -0.817 . . . . 1.37 109.279 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -140.51 134.85 31.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.07 -0.344 . . . . 0.61 110.07 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.43 132.41 53.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.249 0.547 . . . . 1.8 110.402 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -141.51 80.79 1.75 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.611 -0.722 . . . . 1.04 109.585 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 32.0 p -101.34 160.9 14.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.274 0.472 . . . . 1.17 112.274 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.1 42.16 10.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.263 -0.88 . . . . 1.77 111.755 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.46 130.57 45.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 3.99 110.828 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 3.2 p30 -105.72 133.18 20.31 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 2.51 109.92 176.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 3.3 Cg_exo -77.93 -11.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.536 2.157 . . . . 1.26 111.439 173.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.52 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 18.4 mtm180 -57.68 -44.0 85.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.616 -0.72 . . . . 2.76 111.498 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.86 -6.48 56.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.83 -0.7 . . . . 1.12 112.978 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.454 ' O ' HG21 ' A' ' 215' ' ' ILE . 6.7 mp -108.7 -9.23 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.582 -0.364 . . . . 1.73 111.002 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 95.3 mt -70.75 140.83 86.81 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.913 0.387 . . . . 3.45 111.621 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.52 -167.98 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.273 2.648 . . . . 2.08 113.308 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.7 -59.74 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 3.23 111.309 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.578 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 9.7 m -91.05 140.44 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 1.66 110.949 -174.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 35.1 tp -106.02 62.78 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.549 0.69 . . . . 1.99 109.657 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 258' ' ' SER . 6.9 m-20 -122.45 171.79 8.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.829 -1.175 . . . . 1.81 107.829 176.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 51.7 p90 -167.71 163.5 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.831 1.049 . . . . 5.01 113.831 -163.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.575 ' HE3' HG13 ' A' ' 210' ' ' VAL . 13.4 m-90 -105.37 141.94 36.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.223 -1.399 . . . . 3.93 107.223 164.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.4 t -138.86 109.13 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.409 0.623 . . . . 2.13 112.558 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.528 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 8.9 t80 -139.88 129.03 13.6 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 5.21 109.671 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 89.0 Cg_exo -48.9 134.92 29.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.058 2.505 . . . . 2.12 112.92 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -107.48 153.39 16.83 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.82 -0.627 . . . . 1.75 113.659 -170.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.9 p . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 123.68 0.792 . . . . 2.99 111.243 179.583 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.907 0.384 . . . . 2.96 110.727 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -112.78 85.94 2.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.563 0.697 . . . . 3.37 110.502 -177.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.5 p -111.93 3.43 17.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.167 -0.47 . . . . 2.15 111.07 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.04 134.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.281 0.563 . . . . 1.26 111.819 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.5 m -102.9 97.85 7.92 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.079 -1.452 . . . . 2.08 107.079 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.422 ' HE1' ' CD2' ' A' ' 119' ' ' HIS . 9.2 t90 -88.77 120.35 30.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.076 0.465 . . . . 5.53 110.815 -169.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 71.3 mt -126.18 118.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 1.63 109.356 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.575 HG13 ' HE3' ' A' ' 191' ' ' TRP . 3.4 p -120.32 126.26 75.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.808 0.337 . . . . 1.62 110.602 -174.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.22 137.02 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.079 -0.51 . . . . 1.73 110.596 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.573 ' HG3' ' CZ2' ' A' ' 191' ' ' TRP . 33.6 ttmt -81.53 -1.36 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 2.98 110.756 -177.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.578 ' HG3' ' H ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -111.8 91.65 15.56 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.3 -0.63 . . . . 1.47 109.3 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 18.9 Cg_exo -66.61 147.44 81.81 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.775 2.317 . . . . 0.96 112.031 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.454 HG21 ' O ' ' A' ' 183' ' ' LEU . 38.8 pt -94.61 154.35 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 1.25 110.751 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.9 m -99.92 137.92 37.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.975 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 12.6 m -134.63 155.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.634 -0.712 . . . . 1.02 109.193 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 44.9 t -83.44 154.8 23.77 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.941 -0.303 . . . . 1.08 110.602 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.649 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 6.3 p -54.91 -45.56 74.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.583 -0.28 . . . . 1.33 110.531 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 43.5 mt-10 -55.69 -27.76 51.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.204 -0.453 . . . . 2.51 111.5 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 52.9 mt-30 -80.27 -47.39 14.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.7 110.454 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.608 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 35.1 m -71.91 -26.69 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 1.36 111.499 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.7 mt -66.72 -30.3 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.79 0.329 . . . . 1.03 110.445 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 160' ' ' VAL . 96.1 mttt -69.43 -24.29 63.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 1.75 110.765 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 21.9 m-85 -75.73 -25.01 56.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 2.47 109.774 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -79.29 -10.94 59.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 3.04 110.189 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -90.29 -8.78 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 2.31 110.35 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.26 150.48 48.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.95 110.425 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.7 m120 -110.21 136.35 49.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.409 0.623 . . . . 1.13 110.613 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -76.93 -30.5 56.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.758 -1.11 . . . . 3.74 109.739 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.6 p-10 -73.61 164.38 26.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.128 -0.942 . . . . 1.62 112.132 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.83 174.32 46.0 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.073 -0.967 . . . . 1.16 111.079 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.11 135.84 55.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.243 0.521 . . . . 3.56 110.511 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 90.69 7.91 66.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.859 -0.686 . . . . 2.08 112.434 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -112.53 159.24 34.88 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.244 -0.28 . . . . 2.59 110.244 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.26 124.0 15.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.453 2.102 . . . . 1.36 110.911 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.451 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.9 pt-20 -62.01 123.93 19.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.819 0.819 . . . . 3.4 111.909 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 43.5 mt-10 -116.97 125.27 51.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.843 -1.071 . . . . 2.47 108.486 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -70.05 147.57 49.88 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.117 -0.492 . . . . 2.14 110.619 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 11.9 tpt -73.94 92.13 2.07 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.528 -0.916 . . . . 1.68 108.528 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.0 m -140.21 142.12 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.674 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 30.1 t70 66.42 -95.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.226 -0.897 . . . . 2.18 109.497 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 m120 53.25 19.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.483 0.549 . . . . 2.15 112.483 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -150.08 164.31 35.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.792 0.33 . . . . 4.59 110.406 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.432 ' HE ' ' NE2' ' A' ' 248' ' ' GLN . 12.6 ptm180 -107.78 148.12 36.74 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.926 -0.579 . . . . 6.13 110.898 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.97 161.98 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.625 2.883 . . . . 3.28 113.623 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -71.2 143.66 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.334 -0.848 . . . . 2.98 110.695 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.432 ' NE2' ' HE ' ' A' ' 245' ' ' ARG . 41.9 mt-30 -124.69 170.54 8.79 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.867 -0.606 . . . . 4.32 111.1 -169.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 248' ' ' GLN . 6.5 Cg_exo -76.09 174.94 11.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.401 2.734 . . . . 3.48 115.031 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.42 -8.7 57.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 113.879 -1.51 . . . . 4.63 113.069 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 18.4 pttp -55.21 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.319 2.34 . . . . 5.34 117.319 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 3.3 p-10 134.62 28.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.976 1.71 . . . . 4.64 112.065 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.433 ' NE ' HD11 ' A' ' 255' ' ' ILE . 56.3 ttt180 -147.94 120.05 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.924 -0.399 . . . . 6.11 109.924 162.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -146.79 122.39 10.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.429 -1.322 . . . . 3.08 107.429 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 191' ' ' TRP . 14.8 mt -124.85 145.83 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.006 0.432 . . . . 2.6 111.803 -168.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.46 143.55 48.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 2.63 110.041 169.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -118.59 92.72 3.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.157 -0.474 . . . . 1.71 110.097 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 69.0 m -105.55 100.67 10.23 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.288 -0.565 . . . . 2.21 111.724 -172.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -126.27 100.43 6.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.136 -1.061 . . . . 4.31 108.136 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.503 -0.761 . . . . 4.49 110.808 -173.279 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 108.053 -1.091 . . . . 2.88 108.053 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 57.1 mt -65.62 103.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.41 0.624 . . . . 2.32 111.191 -169.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' A' ' 37' ' ' THR . 20.9 m-20 -83.44 102.66 12.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.929 -1.032 . . . . 2.82 108.947 176.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -55.02 -35.65 64.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.405 0.52 . . . . 2.24 112.405 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -84.66 -28.58 26.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.092 0.404 . . . . 4.54 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 5.7 m -89.12 -15.81 32.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.285 0.564 . . . . 3.06 110.91 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.02 142.16 56.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 1.72 110.747 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -104.32 116.45 32.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.376 -0.602 . . . . 3.69 109.376 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -87.59 87.18 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 4.64 110.835 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' OD2' ' HG ' ' A' ' 44' ' ' LEU . 19.6 t70 -73.93 119.72 77.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 2.27 110.91 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.57 -16.71 9.09 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.876 2.384 . . . . 2.15 112.918 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 m -70.25 -46.22 64.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.636 -0.505 . . . . 4.29 109.636 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.433 ' HG ' ' OD2' ' A' ' 41' ' ' ASP . 95.9 mt -54.29 144.52 20.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.417 -0.811 . . . . 4.74 111.008 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HD3' ' HD2' ' A' ' 46' ' ' PRO . 16.6 tppt? -117.1 124.07 29.49 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.672 -0.695 . . . . 3.77 109.835 -174.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 73.3 Cg_exo -51.52 122.76 10.81 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.258 1.972 . . . . 2.36 111.623 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.95 126.87 30.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.539 -0.755 . . . . 2.55 110.606 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.461 ' O ' HD12 ' A' ' 79' ' ' LEU . 53.7 p -67.35 136.19 54.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.706 -0.479 . . . . 2.38 109.706 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.46 97.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.818 -0.438 . . . . 1.59 109.818 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 9.8 m -97.14 88.62 4.53 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.478 -0.564 . . . . 1.45 109.478 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.55 ' CE1' ' HA ' ' A' ' 181' ' ' ARG . 1.0 OUTLIER -129.23 18.09 5.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.5 0.667 . . . . 3.62 109.896 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.06 -28.83 69.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.016 -0.993 . . . . 2.48 110.216 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -96.2 7.84 45.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 2.24 111.256 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . . . -62.71 133.64 55.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.738 0.304 . . . . 0.8 111.717 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.589 ' OG1' ' HE2' ' A' ' 76' ' ' LYS . 10.7 m -121.1 119.13 31.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.085 -0.507 . . . . 1.06 110.532 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 t -83.92 150.25 25.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.308 -0.405 . . . . 1.26 110.431 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.0 mt -116.71 -55.44 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.424 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -169.75 160.83 8.93 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.425 -0.352 . . . . 3.17 110.942 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 17.4 tt -109.32 144.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.64 109.281 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.6 tp -135.68 136.93 41.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.313 0.578 . . . . 0.96 111.779 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.458 ' CB ' ' HA ' ' A' ' 169' ' ' LYS . 4.2 m-20 -88.43 106.03 17.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.943 -1.026 . . . . 1.49 109.32 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 64' ' ' HIS . 16.7 m120 -100.04 75.19 1.84 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.382 -0.372 . . . . 1.83 111.4 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 65.93 -26.15 0.15 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 115.56 0.984 . . . . 1.64 115.56 174.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' ASN . 25.5 p80 -163.76 -25.82 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.76 0.314 . . . . 3.33 111.533 -172.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.74 157.93 19.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.12 -0.326 . . . . 1.38 110.12 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -131.7 96.37 3.94 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.51 -0.922 . . . . 2.74 108.51 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.86 145.59 42.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.23 -0.896 . . . . 1.76 111.437 -170.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 58.8 t -93.71 121.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.781 -0.645 . . . . 1.15 110.049 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -86.52 125.05 33.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.69 -0.686 . . . . 2.02 109.787 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -103.83 164.38 11.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.919 0.39 . . . . 1.66 110.674 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.64 116.16 28.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.879 -0.6 . . . . 1.33 109.824 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -127.77 59.99 1.45 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.925 0.869 . . . . 2.65 110.795 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -75.9 -5.29 45.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.435 -0.802 . . . . 1.61 110.614 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -157.61 176.94 11.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 2.35 109.218 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.65 30.38 0.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.385 -0.371 . . . . 1.92 111.194 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HE2' ' OG1' ' A' ' 55' ' ' THR . 2.4 ptpp? -50.77 -44.94 58.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.75 -0.659 . . . . 1.77 111.628 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.15 99.54 6.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.367 . . . . 0.76 110.119 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.2 m -129.0 168.36 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.386 0.613 . . . . 1.27 111.739 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 48' ' ' SER . 38.7 tp -137.19 111.45 8.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.04 -0.982 . . . . 1.29 108.416 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -150.45 126.34 10.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 2.54 111.419 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 173.94 24.28 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.965 -0.561 . . . . 1.31 113.347 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.78 -134.11 0.0 OUTLIER Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.349 0.976 . . . . 1.9 114.545 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -44.9 169.92 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.226 2.618 . . . . 2.91 112.712 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -35.8 150.34 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.472 1.286 . . . . 4.11 114.472 -154.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 13.8 p-10 174.58 -66.61 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.797 -1.092 . . . . 4.95 111.227 -156.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.6 141.8 2.44 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.371 -0.691 . . . . 2.25 111.371 -170.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 125' ' ' THR . 23.3 m -88.51 125.69 34.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.695 0.747 . . . . 1.91 111.033 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.2 m-85 -118.65 126.36 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.325 -0.398 . . . . 3.7 111.24 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.4 mtt180 -83.0 135.63 34.79 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.55 -0.295 . . . . 3.54 111.024 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.45 117.02 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.48 -0.563 . . . . 1.14 109.48 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.454 HG23 ' HG2' ' A' ' 92' ' ' GLN . 6.9 tt -110.12 -36.34 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.335 -0.393 . . . . 1.68 111.241 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.454 ' HG2' HG23 ' A' ' 91' ' ' ILE . 20.6 pt20 -162.86 168.31 21.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.339 -0.245 . . . . 1.55 110.339 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 118' ' ' LEU . 23.4 p90 -141.1 149.31 41.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.921 -0.4 . . . . 0.86 109.921 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -140.4 158.02 44.64 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.151 0.282 . . . . 0.93 110.714 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.7 m-85 -108.86 153.2 23.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.407 -0.36 . . . . 3.17 110.108 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -105.52 153.55 21.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 1.68 111.903 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.655 ' CB ' ' HA2' ' A' ' 104' ' ' GLY . 0.7 OUTLIER 69.37 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.738 -1.119 . . . . 5.18 111.984 170.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 241' ' ' VAL . . . 69.69 118.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.161 -0.542 . . . . 2.13 112.055 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 23.1 t 176.16 -89.53 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.03 0.415 . . . . 2.9 111.435 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.72 170.82 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 3.03 111.382 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.05 45.14 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.409 -0.814 . . . . 3.85 111.341 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -176.56 20.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.905 . . . . 1.94 112.828 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -155.86 120.03 4.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 2.45 110.043 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.655 ' HA2' ' CB ' ' A' ' 97' ' ' TRP . . . 157.71 -26.52 0.45 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.817 -0.706 . . . . 1.47 111.551 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.526 ' HB2' ' H ' ' A' ' 114' ' ' TYR . 43.2 m -81.35 64.73 6.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.098 0.559 . . . . 2.0 110.283 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.15 143.06 55.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.75 -0.463 . . . . 3.72 109.75 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 34.7 m80 61.65 25.64 15.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.984 0.421 . . . . 3.52 111.618 174.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.4 t -82.68 -175.54 5.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.5 . . . . 2.52 111.512 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 15.0 m -71.07 106.81 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 2.48 111.715 -166.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.0 t70 58.2 31.11 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.991 -1.459 . . . . 2.8 109.724 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.5 mttp 66.81 28.67 8.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.984 -1.007 . . . . 4.98 112.479 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -69.24 72.31 0.29 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.168 0.509 . . . . 3.23 110.488 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.75 114.29 2.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.415 -0.811 . . . . 2.82 112.584 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.526 ' H ' ' HB2' ' A' ' 105' ' ' SER . 67.2 m-85 -106.31 -163.16 0.9 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.343 -0.844 . . . . 1.62 109.276 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.61 95.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.13 0.789 . . . . 1.03 113.13 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.11 169.66 15.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.456 0.539 . . . . 0.75 112.456 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -122.59 135.01 54.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.501 -1.227 . . . . 1.58 108.25 171.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.489 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.3 tp -116.06 116.41 27.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.243 -0.28 . . . . 1.07 110.243 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -106.25 110.3 22.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 1.77 111.314 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.2 mp -88.21 102.71 15.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.601 -0.888 . . . . 0.93 108.601 173.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.31 120.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.727 -0.67 . . . . 0.61 110.783 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 12.7 m-70 -117.1 141.99 47.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.984 -0.747 . . . . 2.13 108.984 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CZ2' ' HD2' ' A' ' 89' ' ' ARG . 61.5 p-90 -111.87 141.22 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.801 0.334 . . . . 4.26 110.854 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.469 HD21 ' HE2' ' A' ' 126' ' ' LYS . 44.4 t30 -62.12 110.63 1.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.473 0.654 . . . . 2.02 111.519 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.401 HG22 ' HB ' ' A' ' 87' ' ' THR . 11.3 t -61.5 -33.45 73.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.934 -1.03 . . . . 2.34 112.872 -170.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.469 ' HE2' HD21 ' A' ' 124' ' ' ASN . 21.4 pttm -72.02 -6.81 44.96 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.239 0.829 . . . . 3.35 113.239 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 136' ' ' GLN . 43.4 m-85 -97.93 -4.23 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.568 -0.453 . . . . 3.1 110.836 172.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.5 26.55 5.24 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.074 -0.966 . . . . 2.37 114.779 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.37 122.91 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.547 0.673 . . . . 3.93 109.669 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 134' ' ' VAL . 46.3 p90 -69.37 -31.98 70.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 3.0 111.521 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.24 -37.23 92.66 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.751 -0.738 . . . . 2.15 112.007 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -70.49 -32.88 70.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.35 0.595 . . . . 3.43 109.61 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.423 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.73 -25.27 64.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 1.76 111.085 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 130' ' ' PHE . 93.8 t -68.5 -25.89 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 2.77 110.394 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -81.58 -13.82 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 3.55 110.774 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 127' ' ' TYR . 75.1 mm-40 -111.18 135.91 20.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.051 -0.522 . . . . 3.02 110.1 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.11 -21.41 55.88 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.671 2.248 . . . . 1.6 112.796 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -113.0 25.45 11.39 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.931 -0.396 . . . . 2.29 109.931 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.76 -30.04 49.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.693 . . . . 1.22 113.892 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 88.1 mt -123.67 158.62 31.15 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.352 -0.499 . . . . 1.57 110.546 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.7 121.05 7.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 1.38 110.031 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 m -110.52 119.65 59.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.022 0.439 . . . . 1.73 110.418 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.2 tp -83.41 104.87 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.467 -0.568 . . . . 2.42 109.467 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -90.36 114.92 4.49 Favored Glycine 0 N--CA 1.446 -0.65 0 O-C-N 123.652 0.595 . . . . 0.86 112.363 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.7 mt -117.06 105.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.389 -0.597 . . . . 0.76 109.389 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 86.6 m-85 -66.24 154.47 39.78 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.122 0.487 . . . . 1.2 111.712 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.451 HD23 HG11 ' A' ' 217' ' ' VAL . 7.8 mp -112.68 112.75 24.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.544 -0.753 . . . . 0.88 110.071 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -96.72 147.17 24.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.157 -0.683 . . . . 2.03 109.157 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.82 126.41 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 1.27 110.92 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.23 -106.79 0.22 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.421 -0.672 . . . . 1.53 111.421 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.7 m -69.13 140.64 54.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.824 -0.436 . . . . 1.54 109.824 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.43 152.62 45.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.562 -0.29 . . . . 0.78 110.805 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 154' ' ' PRO . 47.4 tptt -108.6 95.29 16.01 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.941 -0.762 . . . . 1.22 108.941 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 15.5 Cg_endo -57.02 -35.9 99.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.994 2.463 . . . . 1.05 112.966 -173.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.43 -18.4 79.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.913 -0.66 . . . . 0.7 113.061 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.4 tp -90.15 -20.8 22.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.921 0.391 . . . . 0.77 110.805 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -55.82 -34.25 65.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.947 -0.569 . . . . 1.41 112.154 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -51.75 -41.1 61.34 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 112.534 0.568 . . . . 2.86 112.534 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.5 p -85.56 -38.96 13.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.347 -0.541 . . . . 1.38 111.018 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.5 HG12 ' HD2' ' A' ' 224' ' ' LYS . 31.4 t -63.22 -47.22 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 1.11 111.765 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -18.35 62.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.065 0.394 . . . . 1.22 112.065 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 162' ' ' VAL . 44.4 t -96.22 -1.59 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 121.197 0.523 . . . . 1.41 111.013 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.8 -24.97 66.22 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.901 0.381 . . . . 1.39 111.304 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.9 -31.68 71.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.46 -0.336 . . . . 2.31 110.717 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 44.5 m -76.9 -5.07 47.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 1.4 111.628 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.5 pt -137.78 45.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.85 109.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -67.05 -28.97 68.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.418 -0.81 . . . . 1.59 110.986 -175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 p -116.38 149.05 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.724 0.297 . . . . 0.77 110.723 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.484 ' HD2' ' HA2' ' A' ' 63' ' ' GLY . 56.3 pttt -65.25 148.88 50.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.457 -0.338 . . . . 2.29 110.104 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.55 33.84 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.457 -0.878 . . . . 0.85 111.37 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -82.22 157.58 23.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.419 0.628 . . . . 1.7 111.146 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.2 p -141.72 154.04 45.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 1.37 109.122 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.13 122.95 20.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.969 -0.382 . . . . 0.61 109.969 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.25 144.66 56.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.967 -0.561 . . . . 1.8 111.314 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.36 81.2 1.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 1.04 110.327 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 p -112.25 159.12 18.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.495 -0.32 . . . . 1.17 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.6 43.59 25.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.06 -0.518 . . . . 1.77 111.386 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.08 140.35 52.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.401 -0.363 . . . . 3.99 110.23 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -92.15 110.33 43.59 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.392 -0.367 . . . . 2.51 110.467 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.23 -14.85 13.07 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.463 2.109 . . . . 1.26 112.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.55 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . 9.4 ttp180 -71.93 -24.15 61.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 2.76 111.267 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -61.3 -2.8 3.27 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.342 -0.39 . . . . 1.12 113.867 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.54 -8.77 57.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.93 0.365 . . . . 1.73 110.979 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.4 pp -48.05 137.28 10.94 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 113.425 0.898 . . . . 3.45 113.425 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HG3' HD21 ' A' ' 211' ' ' LEU . 69.1 Cg_endo -94.92 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.553 2.835 . . . . 2.08 111.483 170.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.8 mt-10 -90.35 -64.18 1.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.836 0.309 . . . . 3.23 111.836 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.489 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.1 m -99.32 146.93 25.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 1.66 111.627 -172.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 211' ' ' LEU . 83.9 mt -111.29 65.12 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.979 0.419 . . . . 1.99 111.197 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.486 ' O ' HD12 ' A' ' 211' ' ' LEU . 33.0 m-20 -108.41 168.68 9.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.038 -1.097 . . . . 1.81 108.038 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.667 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 13.2 p90 -159.58 154.13 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.252 -0.979 . . . . 5.01 112.988 -170.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.707 ' CE3' ' HB2' ' A' ' 257' ' ' ALA . 6.9 m95 -111.84 142.17 44.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.419 -1.264 . . . . 3.93 107.747 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.0 t -121.66 113.24 19.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.548 0.69 . . . . 2.13 112.434 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 49.6 t80 -138.24 131.21 16.38 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 5.21 110.534 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 193' ' ' TYR . 10.0 Cg_endo -54.66 139.39 76.55 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.86 2.374 . . . . 2.12 112.165 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -138.36 159.17 25.17 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.142 -0.552 . . . . 1.75 113.443 -170.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 107.79 -1.189 . . . . 2.99 107.79 175.364 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.457 0.17 . . . . 2.96 110.588 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -113.47 58.34 0.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.63 0.729 . . . . 3.37 110.392 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.64 -15.43 57.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.988 -1.006 . . . . 2.15 110.519 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 40.6 t -100.65 151.28 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.714 -0.675 . . . . 1.26 110.66 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -117.57 109.35 16.59 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.734 -0.839 . . . . 2.08 108.734 174.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.41 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.7 t90 -74.01 100.82 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.951 -0.759 . . . . 5.53 108.951 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.59 99.6 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.688 -0.856 . . . . 1.63 108.688 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 21.5 t -86.19 111.22 20.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.202 -0.454 . . . . 1.62 109.903 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 189' ' ' ASP . 20.6 tp -72.21 120.48 17.88 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.935 -0.765 . . . . 1.73 108.935 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -66.23 -14.91 62.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.243 -0.435 . . . . 2.98 111.708 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 186' ' ' GLU . 7.1 tp10 -104.71 96.49 10.6 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.573 0.225 . . . . 1.47 110.787 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.443 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 63.0 Cg_endo -77.4 144.98 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.461 2.107 . . . . 0.96 111.828 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.3 pt -88.78 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.178 -0.465 . . . . 1.25 111.291 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.4 m -94.68 126.71 40.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.663 . . . . 1.29 110.334 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 147' ' ' LEU . 33.8 m -127.49 158.79 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.765 -0.457 . . . . 1.02 109.765 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 55.1 p -95.85 158.69 15.33 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.912 -0.315 . . . . 1.08 111.07 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.613 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 63.8 m -56.55 -39.26 73.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.935 -0.575 . . . . 1.33 110.694 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.89 -31.02 26.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 2.51 111.372 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.91 -45.1 13.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.45 . . . . 0.7 110.175 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.38 -40.71 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.916 -0.584 . . . . 1.36 111.475 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 219' ' ' SER . 89.7 mt -59.24 -35.13 73.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 1.03 111.8 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.5 ' HD2' HG12 ' A' ' 160' ' ' VAL . 66.1 mttp -70.19 -23.47 62.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.628 -0.26 . . . . 1.75 111.473 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -72.87 -25.43 61.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.22 0.533 . . . . 2.47 110.094 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -80.8 -9.89 59.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 3.04 110.603 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -86.9 -10.13 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 2.31 110.444 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.22 148.63 48.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.886 -0.597 . . . . 0.95 110.853 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.595 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 11.5 m120 -113.84 139.43 49.17 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.419 0.628 . . . . 1.13 110.331 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -76.05 -30.62 58.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.768 -1.106 . . . . 3.74 109.568 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.438 ' C ' ' HG2' ' A' ' 169' ' ' LYS . 4.5 p-10 -76.24 171.08 15.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.118 -0.947 . . . . 1.62 112.247 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.87 -179.33 38.91 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.763 -1.108 . . . . 1.16 111.288 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.65 129.17 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 3.56 110.866 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.94 4.34 48.31 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.472 -0.785 . . . . 2.08 112.547 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -116.05 153.94 48.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.249 -0.278 . . . . 2.59 110.249 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.36 131.81 48.04 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.857 2.371 . . . . 1.36 111.774 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.595 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 31.2 tt0 -53.65 115.15 1.82 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.592 0.71 . . . . 3.4 112.755 -174.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -108.82 117.86 35.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.896 -1.15 . . . . 2.47 107.896 168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.68 125.46 25.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.678 0.275 . . . . 2.14 110.713 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.5 ttm -77.37 90.32 3.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.065 -0.717 . . . . 1.68 109.065 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 27.7 m -136.36 151.74 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.836 -0.62 . . . . 1.27 109.872 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 14.1 t70 69.67 -87.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.696 0.622 . . . . 2.18 110.588 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 48.98 15.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.364 1.246 . . . . 2.15 114.364 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.413 ' HD1' ' H ' ' A' ' 97' ' ' TRP . 98.5 m95 -150.46 177.97 9.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.272 0.487 . . . . 4.59 110.689 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -116.75 131.56 23.85 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.204 -0.295 . . . . 6.13 110.204 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 59.7 Cg_endo -73.72 -148.34 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.83 2.354 . . . . 3.28 112.772 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -82.95 136.1 34.66 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.924 -0.485 . . . . 2.98 111.486 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -123.09 162.31 40.01 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.791 -0.64 . . . . 4.32 110.215 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.51 177.82 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.804 3.003 . . . . 3.48 114.341 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.38 -4.7 0.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.245 1.418 . . . . 4.63 113.306 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 75.0 mmtt -54.11 49.4 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.489 1.515 . . . . 5.34 114.975 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 3.3 t30 132.67 62.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.911 2.084 . . . . 4.64 111.968 175.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.403 ' HB3' ' H ' ' A' ' 254' ' ' GLN . 29.8 mtm180 88.29 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.418 -1.265 . . . . 6.11 112.689 153.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.403 ' H ' ' HB3' ' A' ' 253' ' ' ARG . 5.0 pp0? -157.83 163.7 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.645 -0.872 . . . . 3.08 108.645 -171.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.66 125.17 62.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.818 0.342 . . . . 2.6 111.461 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -106.8 177.14 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 2.63 109.896 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.707 ' HB2' ' CE3' ' A' ' 191' ' ' TRP . . . -136.67 171.78 13.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.772 0.32 . . . . 1.71 111.487 -170.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.3 m -129.43 97.31 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.262 0.553 . . . . 2.21 110.157 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -153.62 138.98 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.835 -0.802 . . . . 4.31 108.835 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.366 -0.826 . . . . 4.49 111.043 -175.378 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.871 -0.789 . . . . 2.88 108.871 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.53 ' HA ' HD13 ' A' ' 255' ' ' ILE . 64.7 mt -86.29 86.83 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.494 0.664 . . . . 2.32 110.888 -171.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -94.29 101.73 13.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.681 -0.69 . . . . 2.82 109.146 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -58.62 -25.31 62.54 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.612 0.597 . . . . 2.24 112.612 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -73.87 -44.14 56.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 4.54 110.455 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 m -81.36 -21.02 39.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.459 . . . . 3.06 111.284 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 255' ' ' ILE . . . -56.8 142.1 42.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.468 -0.333 . . . . 1.72 110.826 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -134.42 114.46 12.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.706 0.289 . . . . 3.69 110.557 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -63.18 135.67 57.28 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.559 -0.534 . . . . 4.64 109.559 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -108.37 120.59 46.12 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.358 -0.383 . . . . 2.27 110.0 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.39 -24.02 50.47 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.695 2.264 . . . . 2.15 112.982 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.0 m -77.89 -26.84 49.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.795 0.331 . . . . 4.29 111.026 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 92.1 mt -83.28 140.9 32.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 4.74 110.475 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.44 159.92 38.13 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.082 -0.508 . . . . 3.77 110.864 -174.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.78 162.91 6.14 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.235 2.623 . . . . 2.36 113.255 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.576 ' HG ' ' CE2' ' A' ' 190' ' ' TYR . 95.2 mt -71.14 132.64 45.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 2.55 111.27 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 m -100.06 97.11 7.99 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.245 -1.021 . . . . 2.38 108.245 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.72 103.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.086 -0.506 . . . . 1.59 109.853 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.5 m -99.59 89.47 4.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.302 -0.629 . . . . 1.45 109.302 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -112.2 10.13 20.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.209 -0.45 . . . . 3.62 111.207 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.84 -30.71 64.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.891 0.377 . . . . 2.48 111.547 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 24.7 mp0 -109.04 39.64 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.361 -0.381 . . . . 2.24 110.427 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.99 57.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.821 0.343 . . . . 0.8 111.762 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 63.4 m -138.55 107.11 5.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.06 110.645 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -92.47 153.61 19.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.523 -0.547 . . . . 1.26 109.523 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -116.27 -58.62 2.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.505 0.558 . . . . 0.74 112.505 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -169.17 163.19 10.99 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.357 -0.214 . . . . 3.17 110.824 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -114.45 144.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.237 -0.283 . . . . 0.64 110.237 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -132.13 144.6 50.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.96 110.952 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -111.54 115.86 29.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 1.49 109.909 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -110.52 72.97 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.371 0.605 . . . . 1.83 110.929 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.77 -35.25 0.48 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 114.721 -1.127 . . . . 1.64 115.146 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -150.6 -29.78 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 117.104 0.452 . . . . 3.33 111.514 -173.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.43 161.87 25.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.583 -0.525 . . . . 1.38 109.583 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -129.19 121.55 27.92 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.194 0.521 . . . . 2.74 110.354 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -111.87 139.8 47.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 1.76 110.088 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 40.8 t -100.77 117.64 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.655 -0.498 . . . . 1.15 109.655 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.81 119.34 21.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 2.02 110.37 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -108.36 150.68 27.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.644 -0.707 . . . . 1.66 109.63 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 9.5 t0 -81.87 109.88 16.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 1.33 110.803 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.84 56.36 0.81 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.564 0.697 . . . . 2.65 110.334 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -89.23 -9.07 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 1.61 111.804 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 76' ' ' LYS . 11.5 pt20 -163.35 177.91 8.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.549 . . . . 2.35 109.516 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -76.41 23.47 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.257 0.348 . . . . 1.92 111.731 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 16.9 ptpt -54.08 -39.67 66.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.473 -0.331 . . . . 1.77 111.717 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -133.18 101.27 5.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.114 0.483 . . . . 0.76 110.332 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 89' ' ' ARG . 11.8 m -125.28 166.12 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.979 -0.555 . . . . 1.27 111.087 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.92 115.06 7.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.724 . . . . 1.29 109.844 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -145.13 123.5 12.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.058 0.456 . . . . 2.54 111.315 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -73.41 175.89 45.65 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 119.092 -0.838 . . . . 1.31 111.154 164.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.08 -143.4 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 N-CA-C 115.124 0.81 . . . . 1.9 115.124 168.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 72.3 Cg_exo -49.34 120.0 5.19 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.697 1.598 . . . . 2.91 112.728 -173.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 mt -154.35 -168.08 2.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.561 -1.2 . . . . 4.11 108.798 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.93 44.13 2.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.753 0.311 . . . . 4.95 110.954 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.503 ' HA3' ' OD1' ' A' ' 124' ' ' ASN . . . 129.59 -177.84 17.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.971 -0.633 . . . . 2.25 112.829 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 m -107.76 133.8 51.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.455 -0.572 . . . . 1.91 109.455 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 51.5 m-85 -108.66 114.28 27.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.958 0.408 . . . . 3.7 111.948 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 98.5 mtt180 -79.15 140.53 37.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.103 -0.499 . . . . 3.54 110.468 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.53 124.6 24.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.762 -0.458 . . . . 1.14 109.762 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 tt -117.8 -41.6 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 111.701 0.26 . . . . 1.68 111.701 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 10.0 pt20 -159.11 165.21 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.858 -0.423 . . . . 1.55 109.858 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CB ' HD23 ' A' ' 120' ' ' LEU . 42.4 p90 -146.98 161.01 41.67 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.007 -0.277 . . . . 0.86 111.456 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.432 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 11.7 p-80 -146.56 160.22 42.43 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.914 -0.585 . . . . 0.93 109.861 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.3 m-85 -122.75 148.93 44.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.889 0.376 . . . . 3.17 111.396 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -105.55 175.89 5.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.335 -0.617 . . . . 1.68 109.335 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -172.81 114.19 0.27 Allowed 'General case' 0 N--CA 1.463 0.176 0 O-C-N 123.199 0.312 . . . . 5.18 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.761 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -79.03 154.5 39.32 Favored Glycine 0 C--O 1.226 -0.397 0 N-CA-C 111.435 -0.666 . . . . 2.13 111.435 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 t -65.11 -29.25 70.1 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.195 0.997 . . . . 2.9 110.063 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.9 mt -106.4 144.98 32.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.448 -0.797 . . . . 3.03 109.438 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.19 70.3 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.553 0.533 . . . . 3.85 111.003 176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.66 43.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 1.94 112.741 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' ALA . 13.0 pt20 -173.12 164.01 4.78 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 110.1 -0.333 . . . . 2.45 110.1 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.58 -1.78 49.38 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.509 -0.853 . . . . 1.47 114.1 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 p -90.63 -26.73 19.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.825 0.676 . . . . 2.0 112.825 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 244' ' ' TRP . 0.6 OUTLIER 71.58 -170.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.749 -1.204 . . . . 3.72 107.749 -169.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.2 m80 54.99 71.37 0.54 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.312 0.505 . . . . 3.52 110.612 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 113' ' ' LYS . 14.2 p -87.0 116.3 24.96 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.448 -0.501 . . . . 2.52 110.723 -165.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 26.4 t -82.7 93.62 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.874 -0.417 . . . . 2.48 109.874 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 58.64 54.57 5.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.457 -0.572 . . . . 2.8 109.457 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 69.51 -2.33 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.106 -0.952 . . . . 4.98 112.578 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 23.1 ttmm -86.36 124.03 32.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.081 0.467 . . . . 3.23 111.192 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.543 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -116.33 138.09 51.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.799 -0.637 . . . . 2.82 109.694 175.359 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -88.38 159.99 17.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.639 -0.71 . . . . 1.62 110.499 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.526 ' HA ' ' H ' ' A' ' 103' ' ' GLN . . . -64.46 -20.05 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.846 . . . . 1.03 112.372 -174.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 147' ' ' LEU . . . -166.05 168.73 15.27 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.951 -0.389 . . . . 0.75 109.951 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -154.27 142.75 20.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.596 -0.52 . . . . 1.58 109.596 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 95' ' ' PHE . 15.1 tp -100.79 127.69 47.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.748 -0.66 . . . . 1.07 109.85 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.432 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.1 m170 -114.55 101.48 9.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.26 0.552 . . . . 1.77 110.831 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 48.0 mt -83.2 107.89 16.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.229 -0.896 . . . . 0.93 109.834 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 142' ' ' VAL . 41.3 t -82.57 123.27 38.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.384 0.612 . . . . 0.61 111.459 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 52.2 m80 -123.09 147.22 46.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.289 -0.868 . . . . 2.13 109.387 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.671 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 62.5 p-90 -120.53 142.58 49.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.979 0.418 . . . . 4.26 111.113 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.503 ' OD1' ' HA3' ' A' ' 86' ' ' GLY . 30.2 t30 -66.58 111.91 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.02 111.288 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.671 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 12.1 t -70.58 -16.35 62.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.564 -0.743 . . . . 2.34 111.784 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.405 ' HB3' HD21 ' A' ' 124' ' ' ASN . 38.2 ttpt -58.4 -20.82 47.4 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.224 0.453 . . . . 3.35 112.224 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.48 6.2 49.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.135 0.493 . . . . 3.1 111.265 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.82 -3.46 3.84 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.773 1.069 . . . . 2.37 115.773 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -172.75 148.45 1.88 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.696 1.248 . . . . 3.93 110.104 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 134' ' ' VAL . 38.4 p90 -60.67 -34.11 73.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.607 -1.179 . . . . 3.0 112.563 -173.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.41 97.88 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.013 -0.613 . . . . 2.15 112.748 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -76.7 -27.99 55.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.966 0.412 . . . . 3.43 110.473 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.696 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -62.44 -35.42 79.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 1.76 110.866 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 130' ' ' PHE . 47.4 t -65.32 -16.92 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.077 -0.51 . . . . 2.77 111.26 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.59 -13.57 57.85 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.071 -0.393 . . . . 3.55 111.144 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 41.8 tt0 -102.53 134.15 20.1 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.786 -0.45 . . . . 3.02 109.786 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 51.5 Cg_exo -55.37 -26.12 51.39 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.975 2.45 . . . . 1.6 112.618 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 23.0 m-20 -111.98 27.24 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.07 0.462 . . . . 2.29 109.863 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.696 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -79.13 -33.6 35.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.015 -0.612 . . . . 1.22 113.729 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.404 ' HB2' HG22 ' A' ' 206' ' ' VAL . 85.3 mt -110.44 157.01 20.04 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.706 -0.479 . . . . 1.57 109.706 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.31 127.07 13.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.723 0.297 . . . . 1.38 110.24 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 121' ' ' VAL . 27.9 m -116.51 139.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 120.767 0.318 . . . . 1.73 110.358 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.2 tp -99.07 109.26 22.01 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.347 -0.612 . . . . 2.42 109.347 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -91.72 111.84 4.08 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.75 -0.659 . . . . 0.86 112.298 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.7 mt -109.42 118.17 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.726 -0.472 . . . . 0.76 109.726 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -69.54 143.24 53.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.405 -0.361 . . . . 1.2 111.303 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 10.8 mp -112.92 120.02 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.133 -0.485 . . . . 0.88 110.185 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.08 142.11 43.68 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.792 -0.818 . . . . 2.03 108.792 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.06 135.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 1.27 110.802 -174.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.01 -95.53 0.11 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.126 -0.789 . . . . 1.53 111.126 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.1 m -82.08 141.83 32.82 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.721 -0.474 . . . . 1.54 109.721 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.61 41.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.897 -0.592 . . . . 0.78 111.825 -174.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.9 tptt -117.28 102.17 52.53 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.474 . . . . 1.22 110.104 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.62 -42.41 67.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.442 2.762 . . . . 1.05 112.487 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 182' ' ' GLY . . . -59.33 -33.69 76.92 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.073 -0.584 . . . . 0.7 112.954 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.73 -30.95 22.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.152 0.501 . . . . 0.77 110.536 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -37.4 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.41 110.662 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -52.98 -49.44 66.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.204 -0.907 . . . . 2.86 112.414 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.92 -38.62 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 1.38 111.415 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.436 HG12 ' HD2' ' A' ' 224' ' ' LYS . 88.3 t -59.1 -39.6 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.21 0.529 . . . . 1.11 111.293 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.36 -15.76 39.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 1.22 112.284 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.34 -11.15 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.802 0.334 . . . . 1.41 111.399 -176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.87 -33.6 67.01 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.954 0.724 . . . . 1.39 112.954 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.57 -26.69 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.884 0.373 . . . . 2.31 111.524 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.7 m -80.89 -1.03 41.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.951 0.352 . . . . 1.4 111.951 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.6 pt -131.92 36.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.85 110.069 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.19 -33.58 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 1.59 112.669 -170.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 230' ' ' PHE . 18.0 p -119.48 159.51 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.857 0.361 . . . . 0.77 111.396 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -52.6 131.73 34.72 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.594 -0.73 . . . . 2.29 112.043 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.44 -28.44 15.01 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.871 -0.68 . . . . 0.85 112.451 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.79 143.62 52.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.212 0.53 . . . . 1.7 111.188 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.7 m -134.21 150.41 51.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 1.37 109.147 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -136.87 129.79 30.77 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.176 -0.305 . . . . 0.61 110.176 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.22 137.02 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.059 0.457 . . . . 1.8 110.672 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -140.85 80.4 1.75 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.197 -0.668 . . . . 1.04 109.197 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.0 p -116.04 163.66 15.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.469 -0.332 . . . . 1.17 111.466 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 58.91 36.98 24.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.848 -0.615 . . . . 1.77 111.276 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -129.75 133.79 47.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 3.99 110.202 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 181' ' ' ARG . 4.2 p30 -109.39 145.83 32.68 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.496 -0.775 . . . . 2.51 111.067 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 6.0 Cg_exo -79.0 -5.58 14.61 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.026 2.484 . . . . 1.26 112.342 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.494 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 5.6 tmm_? -57.6 -38.57 75.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.184 -0.462 . . . . 2.76 110.508 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -68.02 -7.03 48.62 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.818 -0.628 . . . . 1.12 113.361 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.94 -12.27 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.129 0.465 . . . . 1.73 111.015 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.53 129.99 55.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 3.45 110.645 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.89 -170.02 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.02 2.48 . . . . 2.08 113.404 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.93 -65.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.065 0.765 . . . . 3.23 113.065 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 12.9 m -68.95 131.61 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 1.66 111.328 -172.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.86 62.87 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 1.99 110.832 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 212' ' ' LYS . 13.9 t0 -127.65 141.59 51.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.435 -0.95 . . . . 1.81 108.435 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 47' ' ' LEU . 51.9 p90 -149.23 158.24 44.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.967 0.413 . . . . 5.01 111.846 -166.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 9.2 m-90 -115.51 107.36 15.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.534 -0.757 . . . . 3.93 109.077 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 5.9 t -96.31 117.2 30.32 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.828 0.677 . . . . 2.13 112.828 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -139.21 128.51 14.11 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 5.21 109.989 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 58.4 Cg_exo -53.38 136.72 63.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.191 2.594 . . . . 2.12 113.674 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -140.49 156.7 25.37 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.027 -0.533 . . . . 1.75 112.839 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 32.4 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.241 0.543 . . . . 2.99 109.812 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 196' ' ' SER . 43.7 tp . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.804 -0.443 . . . . 2.96 109.804 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -106.33 62.67 0.65 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.381 0.61 . . . . 3.37 110.868 -173.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 73.9 m -108.64 15.1 24.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 2.15 110.868 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 95.2 t -117.9 137.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 1.26 111.082 -177.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.8 m -98.19 104.67 16.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.475 -0.935 . . . . 2.08 108.475 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' A' ' 192' ' ' THR . 0.0 OUTLIER -86.7 100.61 12.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 5.53 110.924 -174.168 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.568 HG23 ' CD1' ' A' ' 190' ' ' TYR . 75.1 mt -96.42 100.02 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 1.63 109.479 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 191' ' ' TRP . 16.3 m -99.6 125.64 53.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.183 0.515 . . . . 1.62 110.603 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.2 tp -87.44 137.3 32.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.634 -0.712 . . . . 1.73 109.595 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 20.5 pttp -72.44 -11.2 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.035 0.383 . . . . 2.98 112.035 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.2 tp10 -101.11 105.98 42.14 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.655 0.264 . . . . 1.47 110.944 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 5.9 Cg_exo -75.47 149.69 35.17 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.886 2.391 . . . . 0.96 111.771 175.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.9 pt -99.82 147.25 7.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.001 -0.37 . . . . 1.25 110.001 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 42.7 m -92.35 123.79 35.94 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.567 -0.531 . . . . 1.29 109.567 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.14 163.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.886 -0.597 . . . . 1.02 110.265 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 41.3 t -90.25 147.38 23.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.125 0.488 . . . . 1.08 110.226 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.7 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 7.5 p -56.49 -35.36 67.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 1.33 110.653 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -70.06 -21.84 63.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.678 -0.692 . . . . 2.51 111.188 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -80.17 -51.74 8.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.393 . . . . 0.7 110.132 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.606 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 13.0 m -64.84 -29.21 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.455 0.539 . . . . 1.36 112.455 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.9 mt -66.05 -27.36 68.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 1.03 111.01 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.467 ' HA ' ' CG ' ' A' ' 227' ' ' LYS . 68.6 mttm -74.6 -21.0 59.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.267 -0.424 . . . . 1.75 110.959 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 26.2 m-85 -66.89 -19.06 65.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.106 0.479 . . . . 2.47 110.178 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -103.68 9.43 37.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 3.04 110.257 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 224' ' ' LYS . 12.5 mmmm -91.0 1.46 57.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 2.31 111.028 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.24 133.77 35.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.206 -0.664 . . . . 0.95 109.206 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 238' ' ' GLU . 3.3 p30 -159.19 -178.72 7.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.931 0.345 . . . . 1.13 111.931 -176.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.455 ' HB3' HG22 ' A' ' 168' ' ' THR . 35.0 t80 52.94 81.14 0.09 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.094 -0.957 . . . . 3.74 112.48 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.584 ' CG ' ' H ' ' A' ' 232' ' ' GLY . 29.0 p-10 -54.41 -87.65 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.051 -0.522 . . . . 1.62 111.61 171.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' A' ' 231' ' ' ASN . . . -125.08 -158.7 10.1 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.839 -0.696 . . . . 1.16 112.26 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.09 145.32 24.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.148 -0.315 . . . . 3.56 110.148 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.95 14.61 82.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.77 . . . . 2.08 112.288 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -148.72 107.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.59 108.64 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.11 114.32 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 120.722 0.948 . . . . 1.36 111.116 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -139.37 104.08 4.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.51 -0.768 . . . . 3.4 111.442 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 229' ' ' ASN . 7.3 pt-20 -154.27 94.96 1.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.714 0.768 . . . . 2.47 109.951 157.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.25 99.63 4.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.237 -0.892 . . . . 2.14 109.501 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -118.4 82.87 1.92 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.965 -1.124 . . . . 1.68 107.965 172.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.8 m -156.57 133.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.906 -1.043 . . . . 1.27 110.141 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.761 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER 63.52 -79.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.239 0.962 . . . . 2.18 112.481 173.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 48.4 47.57 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.318 0.386 . . . . 2.15 110.681 -171.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 106' ' ' GLU . 85.9 t90 -105.12 134.02 48.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.916 0.389 . . . . 4.59 110.792 -172.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 32.2 ptt180 -105.32 132.23 21.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.986 -0.552 . . . . 6.13 110.416 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.417 ' HA ' ' CH2' ' A' ' 244' ' ' TRP . 62.5 Cg_exo -53.97 128.0 27.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.163 2.576 . . . . 3.28 112.676 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.39 159.76 33.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.684 -0.689 . . . . 2.98 111.983 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -108.73 149.85 40.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 4.32 110.673 -173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 36.7 Cg_endo -63.7 147.3 92.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.641 2.894 . . . . 3.48 114.075 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 67.5 mt -68.23 -12.42 60.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.86 -1.063 . . . . 4.63 113.364 -171.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 61.6 pttt -61.08 42.84 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.382 1.623 . . . . 5.34 115.382 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 1.5 p30 125.42 -4.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.378 1.871 . . . . 4.64 109.926 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 30.7 mmt180 -116.69 82.67 1.83 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.438 -1.319 . . . . 6.11 107.438 168.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -134.69 158.1 44.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.102 -0.333 . . . . 3.08 110.102 -166.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 33' ' ' ILE . 5.1 pt -102.62 125.9 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.808 0.67 . . . . 2.6 112.808 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 81.7 mttt -101.64 144.2 30.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.396 -0.82 . . . . 2.63 109.028 165.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 190' ' ' TYR . . . -106.65 148.17 28.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.248 -0.649 . . . . 1.71 109.248 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 190' ' ' TYR . 5.4 m -131.64 95.1 3.65 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.887 -0.725 . . . . 2.21 111.864 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -156.95 133.48 9.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.967 -1.015 . . . . 4.31 108.674 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.569 -0.729 . . . . 4.49 110.363 -173.196 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.513 ' HB2' HD21 ' A' ' 250' ' ' LEU . 1.4 m-20 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 122.048 0.928 . . . . 2.88 111.956 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.0 127.56 38.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.219 -1.355 . . . . 2.32 110.015 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.29 99.27 10.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.169 -0.468 . . . . 2.82 109.985 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -54.25 -29.32 46.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 2.24 111.568 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -75.33 -28.64 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 4.54 110.675 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 m -81.69 -28.77 33.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.874 0.369 . . . . 3.06 110.487 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -67.05 108.71 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.532 . . . . 1.72 111.593 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -85.31 138.18 32.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.6 -0.727 . . . . 3.69 110.484 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 30.1 p90 -78.57 130.71 36.26 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.393 -0.595 . . . . 4.64 109.393 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -109.11 109.79 60.71 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.337 -0.392 . . . . 2.27 110.11 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.41 -17.36 57.26 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.031 2.488 . . . . 2.15 112.49 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 83' ' ' PRO . 49.1 m -75.58 -9.04 58.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 4.29 110.858 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -96.55 139.26 32.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.286 -0.415 . . . . 4.74 110.283 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.9 161.14 37.73 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.468 -0.567 . . . . 3.77 109.468 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.55 157.15 23.78 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.748 2.299 . . . . 2.36 112.816 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.419 ' HG ' ' CD2' ' A' ' 190' ' ' TYR . 91.9 mt -85.64 138.78 31.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 2.55 111.146 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -101.33 120.57 40.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.652 -0.87 . . . . 2.38 108.652 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.46 103.06 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.76 0.315 . . . . 1.59 110.659 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 91.25 3.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.264 -0.643 . . . . 1.45 109.264 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 p90 -137.95 20.01 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.923 0.392 . . . . 3.62 111.45 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.39 -18.8 64.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.304 -0.407 . . . . 2.48 111.21 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -103.18 10.74 37.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.534 -0.303 . . . . 2.24 110.737 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.66 125.74 24.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.863 0.363 . . . . 0.8 111.627 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.3 m -115.42 109.23 17.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.963 -0.562 . . . . 1.06 111.243 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -78.12 149.66 33.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.552 -0.536 . . . . 1.26 109.552 174.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -121.59 -54.97 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.974 0.416 . . . . 0.74 111.466 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 14.7 ptm180 -140.6 152.23 45.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.362 -0.381 . . . . 3.17 110.698 -175.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.0 tt -127.61 133.92 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.585 -0.895 . . . . 0.64 108.585 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.68 162.88 36.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.96 111.777 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 169' ' ' LYS . 0.9 OUTLIER -101.3 109.87 21.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.926 -1.034 . . . . 1.49 109.237 176.194 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.565 ' HB3' ' OD1' ' A' ' 67' ' ' ASN . 42.5 t30 -126.57 129.37 48.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.112 -0.495 . . . . 1.83 111.06 -174.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 26.4 -74.59 0.0 OUTLIER Glycine 0 N--CA 1.47 0.96 0 N-CA-C 117.45 1.74 . . . . 1.64 117.45 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' ASN . 25.7 m80 -83.14 -19.79 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.983 0.364 . . . . 3.33 111.983 -167.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 175.38 -141.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.966 -0.383 . . . . 1.38 109.966 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -118.12 143.79 46.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.072 -1.085 . . . . 2.74 108.072 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 13.5 m120 -128.24 128.62 45.03 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.086 -0.339 . . . . 1.76 110.086 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.97 121.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.209 0.528 . . . . 1.15 109.851 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 58' ' ' ARG . 55.7 mm-40 -90.07 138.98 31.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 2.02 111.433 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.92 157.26 22.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.493 -0.776 . . . . 1.66 109.235 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.77 108.37 13.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.216 -0.661 . . . . 1.33 109.216 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -108.51 58.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.663 0.744 . . . . 2.65 110.607 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -100.85 -13.58 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.573 -0.74 . . . . 1.61 111.416 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -152.09 177.59 10.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.103 -0.499 . . . . 2.35 109.942 -170.034 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -82.01 65.96 7.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 1.92 110.987 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 58.6 mttm -90.59 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.946 -0.57 . . . . 1.77 109.838 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -114.39 99.03 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 0.76 110.267 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.88 145.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.94 -0.573 . . . . 1.27 110.51 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 tp -137.58 112.08 8.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 1.29 109.725 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 22.1 pttm -153.8 126.13 8.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 2.54 111.743 175.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.87 177.93 46.64 Favored Glycine 0 C--O 1.221 -0.707 0 CA-C-N 115.462 -0.79 . . . . 1.31 112.753 173.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.91 -132.76 0.0 OUTLIER Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.73 1.157 . . . . 1.9 115.764 167.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 43' ' ' SER . 78.9 Cg_exo -44.12 170.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.179 3.253 . . . . 2.91 114.43 -171.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.3 tp -32.37 75.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.553 1.316 . . . . 4.11 114.553 -145.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 80' ' ' LYS . 15.1 p-10 -76.73 -71.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.314 -1.766 . . . . 4.95 112.635 173.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 82.06 127.45 0.99 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.384 -1.086 . . . . 2.25 110.384 -165.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.9 m -63.48 103.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.103 0.452 . . . . 1.91 111.734 -174.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.561 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 63.6 m-85 -95.04 126.99 40.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.867 -0.606 . . . . 3.7 111.026 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -103.85 143.97 32.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.312 -0.403 . . . . 3.54 110.243 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 34.4 tp -81.52 132.01 35.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 1.14 110.86 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.7 tt -109.21 -35.0 2.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.183 -0.462 . . . . 1.68 110.784 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 172.25 8.42 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.341 -0.39 . . . . 1.55 110.316 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 118' ' ' LEU . 9.4 p90 -151.4 153.36 34.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.86 110.347 169.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.485 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 13.5 p-80 -148.16 157.64 43.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.559 -0.746 . . . . 0.93 109.62 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB3' ' HA ' ' A' ' 118' ' ' LEU . 53.1 p90 -139.7 123.06 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.773 -0.771 . . . . 3.17 111.374 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -94.73 146.24 24.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.099 -0.955 . . . . 1.68 110.353 171.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -132.7 170.81 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.603 -0.518 . . . . 5.18 109.603 -176.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -95.89 173.83 31.0 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.488 -0.863 . . . . 2.13 112.777 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.5 t -68.26 -28.0 66.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.283 0.563 . . . . 2.9 109.957 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.63 141.14 47.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.589 -0.732 . . . . 3.03 109.091 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 149' ' ' VAL . 4.8 p-10 -68.26 -5.88 20.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.168 0.432 . . . . 3.85 112.168 -174.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.79 10.06 57.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.807 -0.711 . . . . 1.94 113.047 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -164.41 170.28 16.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.892 0.346 . . . . 2.45 110.916 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 113.41 -14.59 22.86 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.502 -0.856 . . . . 1.47 112.518 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.3 t -75.59 -34.59 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.411 0.148 . . . . 2.0 111.203 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.469 ' HG2' ' NE1' ' A' ' 244' ' ' TRP . 0.0 OUTLIER 66.35 -172.19 0.19 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.6 0.563 . . . . 3.72 110.036 -171.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.519 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 17.3 m80 52.44 44.69 29.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.66 0.743 . . . . 3.52 109.62 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -79.29 117.47 20.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.034 . . . . 2.52 111.397 -172.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.04 95.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.692 -1.14 . . . . 2.48 110.504 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 58.66 60.04 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.844 -1.071 . . . . 2.8 110.824 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm 69.71 11.51 7.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.73 -0.668 . . . . 4.98 112.527 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -96.23 97.19 9.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.826 0.346 . . . . 3.23 110.644 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.496 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 98.6 mttt -96.11 148.38 22.74 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.261 -0.644 . . . . 2.82 109.261 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -106.6 -176.6 3.12 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.6 -0.519 . . . . 1.62 109.6 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.4 -43.55 66.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.803 0.335 . . . . 1.03 111.19 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.52 164.04 37.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 0.75 110.269 -174.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.519 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 29.6 tt0 -130.38 124.16 31.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 1.58 109.792 176.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 94' ' ' HIS . 56.7 tp -91.04 114.97 27.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.797 . . . . 1.07 110.214 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.485 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 22.5 m170 -102.91 106.55 17.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.159 -0.473 . . . . 1.77 110.615 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -95.74 108.09 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.256 -0.646 . . . . 0.93 109.256 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -81.91 126.34 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.339 -0.392 . . . . 0.61 110.822 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 58.5 m80 -125.56 145.17 50.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.834 -0.432 . . . . 2.13 109.834 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -124.6 143.91 50.45 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.83 -0.804 . . . . 4.26 108.83 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 87' ' ' THR . 35.8 p30 -83.52 139.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.859 0.837 . . . . 2.02 111.687 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -66.08 -16.01 63.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.095 -0.957 . . . . 2.34 110.567 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -50.63 -44.35 57.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 3.35 112.097 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -93.6 6.95 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.513 -0.475 . . . . 3.1 111.092 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.47 1.52 1.77 Allowed Glycine 0 C--N 1.335 0.472 0 N-CA-C 115.523 0.969 . . . . 2.37 115.523 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 132' ' ' LYS . 16.6 t70 -169.14 137.04 1.9 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.739 0.769 . . . . 3.93 109.658 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.607 ' O ' HG23 ' A' ' 134' ' ' VAL . 26.5 p90 -60.22 -43.27 96.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.714 -0.676 . . . . 3.0 110.984 -177.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -35.52 90.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.274 -0.489 . . . . 2.15 112.599 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -68.36 -37.59 80.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.773 -0.455 . . . . 3.43 109.773 177.152 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.88 -29.27 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 1.76 110.705 178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -65.57 -20.03 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 2.77 111.315 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -88.53 -1.74 58.22 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.762 -0.586 . . . . 3.55 111.614 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -126.21 143.17 44.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.868 0.366 . . . . 3.02 110.483 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 26.6 Cg_endo -62.0 -24.63 76.97 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.431 2.754 . . . . 1.6 113.493 -175.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -110.41 27.03 10.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.904 -0.406 . . . . 2.29 109.904 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -81.25 -48.53 5.95 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.946 -0.645 . . . . 1.22 113.788 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.496 HD11 HG22 ' A' ' 134' ' ' VAL . 85.8 mt -107.79 161.13 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.085 0.469 . . . . 1.57 111.316 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.3 104.9 4.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.624 -0.716 . . . . 1.38 110.33 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.4 t -97.66 115.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.236 -0.438 . . . . 1.73 109.858 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 63.5 tp -88.11 111.54 21.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.867 -0.606 . . . . 2.42 109.684 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.79 108.85 3.61 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.189 -0.529 . . . . 0.86 111.935 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 mt -102.07 130.77 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.158 -0.312 . . . . 0.76 110.158 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 69.9 m-85 -75.55 145.75 41.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.663 -0.244 . . . . 1.2 110.527 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.35 117.68 30.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.695 -0.483 . . . . 0.88 109.695 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 216' ' ' SER . 20.5 ptmt -114.72 152.42 32.05 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.283 -0.636 . . . . 2.03 109.283 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 29.3 t -92.26 131.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 1.27 110.861 -176.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.86 -105.55 0.21 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.627 -0.989 . . . . 1.53 110.627 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.5 m -70.03 160.61 31.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.506 -0.553 . . . . 1.54 109.506 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.61 159.22 15.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.573 -0.285 . . . . 0.78 111.193 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 216' ' ' SER . 12.4 mmmm -111.03 99.89 44.68 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.573 -0.899 . . . . 1.22 108.573 172.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.75 -21.05 61.7 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.984 2.456 . . . . 1.05 113.355 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.19 -13.34 81.01 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.654 -0.784 . . . . 0.7 112.919 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.9 tp -87.13 -17.96 31.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.77 111.004 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -60.41 -39.5 87.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.41 112.265 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 162' ' ' VAL . 30.7 mmmt -58.29 -40.92 83.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.618 0.247 . . . . 2.86 111.02 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.87 -46.9 84.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.262 0.553 . . . . 1.38 110.166 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 46.9 t -67.19 -27.68 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 1.11 111.295 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.02 -34.57 66.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 1.22 111.562 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 158' ' ' LYS . 87.7 t -82.54 -23.39 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.417 -0.356 . . . . 1.41 111.781 -174.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.7 pp -69.56 -12.84 61.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.018 0.437 . . . . 1.39 111.428 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.31 -26.5 68.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.088 0.47 . . . . 2.31 110.444 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.1 t -81.31 0.74 35.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 1.4 111.432 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.14 43.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.268 -0.641 . . . . 0.85 109.268 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.4 -38.37 66.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.084 -0.962 . . . . 1.59 112.622 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.8 p -105.52 149.9 25.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.631 0.253 . . . . 0.77 110.945 -177.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.501 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 61.7 pttt -66.54 141.14 57.96 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.973 -0.38 . . . . 2.29 109.973 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.34 -22.44 30.91 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.43 -0.89 . . . . 0.85 111.681 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -82.57 156.17 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 1.7 110.488 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -145.96 153.57 40.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.208 -0.451 . . . . 1.37 109.986 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.12 154.35 45.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.827 -0.435 . . . . 0.61 109.827 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.29 135.42 39.62 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.845 -0.428 . . . . 1.8 109.845 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.56 80.39 1.77 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.728 -0.841 . . . . 1.04 108.728 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.5 p -113.41 165.12 12.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.703 -0.68 . . . . 1.17 112.065 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.2 t30 54.9 57.84 5.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.5 -0.773 . . . . 1.77 111.113 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -135.1 131.75 37.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.835 -0.62 . . . . 3.99 109.824 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 13.0 m-20 -106.19 118.48 54.77 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.851 -0.425 . . . . 2.51 109.851 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 2.7 Cg_exo -76.21 -4.57 15.26 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.943 2.429 . . . . 1.26 112.898 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -59.05 -42.85 91.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.32 . . . . 2.76 111.548 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.05 -3.04 9.64 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.208 -0.52 . . . . 1.12 113.601 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 180' ' ' PRO . 7.8 mp -100.57 -1.29 35.87 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.66 -0.318 . . . . 1.73 111.117 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.0 pp -54.69 150.13 19.32 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 112.742 0.645 . . . . 3.45 112.742 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -91.05 -176.17 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.453 2.769 . . . . 2.08 111.467 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -85.69 -64.68 1.11 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.523 -0.471 . . . . 3.23 111.56 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.5 m -87.22 135.15 33.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.817 0.341 . . . . 1.66 111.495 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.21 62.89 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.404 0.621 . . . . 1.99 110.295 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 6.4 m-20 -116.37 170.05 8.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.944 -1.132 . . . . 1.81 107.944 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.419 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 46.6 p90 -168.04 161.73 12.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.793 1.035 . . . . 5.01 113.793 -166.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.441 ' HD1' ' O ' ' A' ' 210' ' ' VAL . 2.9 m95 -101.09 138.73 37.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.724 -1.584 . . . . 3.93 106.724 167.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.1 t -137.7 105.22 5.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.61 0.719 . . . . 2.13 112.031 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.501 ' CG ' ' HD2' ' A' ' 194' ' ' PRO . 25.9 t80 -139.3 149.6 61.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.264 -0.643 . . . . 5.21 109.264 173.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 193' ' ' TYR . 93.6 Cg_exo -46.88 129.91 15.18 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.456 2.104 . . . . 2.12 111.652 172.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.486 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -138.57 161.29 25.74 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.444 -0.798 . . . . 1.75 113.177 -166.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 108.831 -0.803 . . . . 2.99 108.831 176.987 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 37.4 tp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.716 0.293 . . . . 2.96 110.459 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 10.5 pt-20 -92.99 40.07 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.923 -0.581 . . . . 3.37 111.584 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 25.6 p -86.96 -4.49 59.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.293 0.568 . . . . 2.15 110.557 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 27.4 t -112.18 150.03 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.637 -0.71 . . . . 1.26 111.14 -173.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.9 m -107.21 103.5 12.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.332 -1.358 . . . . 2.08 107.332 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.432 ' HB2' ' HA3' ' A' ' 195' ' ' GLY . 1.1 t90 -75.52 102.29 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.033 0.444 . . . . 5.53 110.107 -172.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 42.3 mm -95.68 100.42 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.537 -0.756 . . . . 1.63 109.364 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.441 ' O ' ' HD1' ' A' ' 191' ' ' TRP . 32.4 t -94.03 119.03 41.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.42 -0.585 . . . . 1.62 109.42 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 189' ' ' ASP . 17.1 tp -73.95 122.45 22.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.949 0.404 . . . . 1.73 110.389 -174.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 17.8 tppt? -61.59 -21.91 64.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 2.98 111.995 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -95.14 111.87 56.41 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.642 -0.254 . . . . 1.47 110.537 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.422 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 98.4 Cg_endo -82.73 134.14 7.25 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.511 2.14 . . . . 0.96 111.752 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.7 pt -88.79 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 1.25 109.487 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.613 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 24.6 t -103.83 125.66 50.42 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.978 0.418 . . . . 1.29 110.763 -175.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.1 m -116.75 155.07 18.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 1.02 109.486 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.4 t -102.93 161.78 13.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.918 -0.313 . . . . 1.08 110.782 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.641 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 t -49.62 -54.06 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.668 0.605 . . . . 1.33 111.849 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 36.6 tt0 -52.56 -39.23 61.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.751 0.31 . . . . 2.51 111.781 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.4 -50.58 69.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.468 -0.333 . . . . 0.7 110.556 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.27 -19.95 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.429 -0.351 . . . . 1.36 111.587 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.2 mt -73.65 -44.26 57.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 1.03 110.558 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 52.5 mtpt -65.35 -25.86 67.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 1.75 110.562 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -75.29 -28.1 59.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.455 0.645 . . . . 2.47 109.744 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 56.1 ttp180 -71.8 -0.94 12.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.325 -0.852 . . . . 3.04 110.928 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -84.22 -14.14 50.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.982 0.42 . . . . 2.31 110.115 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.65 144.83 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.49 0.662 . . . . 0.95 111.257 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.3 m120 -108.56 139.58 43.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.325 -0.852 . . . . 1.13 109.645 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.501 ' O ' ' HD3' ' A' ' 169' ' ' LYS . 65.8 t80 -79.14 -30.81 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.744 . . . . 3.74 109.956 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -68.85 163.46 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 1.62 111.5 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.11 48.29 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.474 -1.05 . . . . 1.16 110.474 174.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.1 135.06 47.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.501 0.65 . . . . 3.56 110.553 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.29 41.71 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.749 . . . . 2.08 112.797 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.66 162.34 43.33 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.968 0.384 . . . . 2.59 110.017 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.15 127.55 26.78 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.221 1.947 . . . . 1.36 111.361 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.67 120.38 12.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.408 0.623 . . . . 3.4 111.776 -174.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 13.2 pt-20 -128.47 153.46 47.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.305 -0.861 . . . . 2.47 108.828 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.23 135.95 33.29 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.649 0.261 . . . . 2.14 110.761 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.9 ttm -80.1 88.43 5.41 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.832 -0.803 . . . . 1.68 108.832 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.5 m -142.55 144.17 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.834 -0.802 . . . . 1.27 108.834 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.44 -78.19 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.734 0.646 . . . . 2.18 110.397 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.1 t30 42.5 40.56 1.96 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.901 0.75 . . . . 2.15 112.176 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.469 ' NE1' ' HG2' ' A' ' 106' ' ' GLU . 38.6 t-105 -141.59 160.67 39.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.067 0.461 . . . . 4.59 111.341 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 245' ' ' ARG . 25.0 mmt180 -128.38 83.4 66.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.143 -1.058 . . . . 6.13 108.143 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -55.52 -87.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 124.053 3.169 . . . . 3.28 116.487 -160.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -81.08 102.3 10.15 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.293 1.22 . . . . 2.98 114.293 -162.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.657 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 12.0 mm100 -80.31 -178.0 1.05 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.243 -1.021 . . . . 4.32 108.243 160.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.657 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 34.1 Cg_exo -40.76 112.14 0.17 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 121.867 1.711 . . . . 3.48 112.355 175.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -60.05 -51.45 69.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 4.63 112.452 -164.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -60.83 -9.97 4.88 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.901 1.445 . . . . 5.34 114.901 -174.327 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 253' ' ' ARG . 8.5 p30 38.09 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 118.749 2.87 . . . . 4.64 118.749 167.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.614 ' NE ' ' HA ' ' A' ' 253' ' ' ARG . 0.4 OUTLIER 171.4 -156.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.324 1.049 . . . . 6.11 109.201 -165.01 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -131.72 130.15 41.6 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.726 -1.583 . . . . 3.08 106.726 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 43.8 mt -111.92 145.46 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.809 0.338 . . . . 2.6 111.416 -166.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -123.34 162.08 23.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 2.63 109.935 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -159.16 170.74 21.29 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.385 -0.598 . . . . 1.71 109.385 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 8.6 t -148.23 113.41 5.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.744 -0.382 . . . . 2.21 110.441 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.413 ' CD1' ' HG2' ' A' ' 212' ' ' LYS . 88.6 t80 -117.85 95.33 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 4.31 109.54 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.529 -0.748 . . . . 4.49 110.146 -178.366 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 23.9 t0 . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 108.317 -0.994 . . . . 2.88 108.317 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mt -102.82 105.87 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.461 -0.495 . . . . 2.32 111.105 -173.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.56 107.37 18.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.093 -1.077 . . . . 2.82 108.093 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -54.8 -31.44 59.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 2.24 112.411 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -77.82 -44.69 26.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.737 0.304 . . . . 4.54 110.944 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 m -73.83 -28.06 61.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.545 -0.298 . . . . 3.06 111.372 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.6 129.85 42.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.011 0.434 . . . . 1.72 111.608 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -91.16 124.47 35.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.876 -0.602 . . . . 3.69 110.942 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -75.34 127.68 33.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.975 -0.557 . . . . 4.64 109.569 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.87 134.04 20.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.608 -0.515 . . . . 2.27 109.608 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.43 56.83 2.8 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.857 2.371 . . . . 2.15 112.656 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' LYS . 39.4 t -74.72 -56.85 4.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.053 -0.521 . . . . 4.29 110.204 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 mt 64.09 -25.31 0.08 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.389 0.885 . . . . 4.74 113.389 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' SER . 62.8 mttp -70.48 142.75 89.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.949 0.404 . . . . 3.77 111.691 -175.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.56 158.82 7.89 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.078 2.519 . . . . 2.36 112.486 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.539 HD23 ' HA3' ' A' ' 81' ' ' GLY . 79.0 mt -86.81 132.81 33.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 2.55 109.717 174.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 t -90.88 109.98 21.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.714 -0.847 . . . . 2.38 108.714 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.4 t -119.63 97.41 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.893 -0.41 . . . . 1.59 109.893 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 23.5 m -89.37 89.15 7.76 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.223 -0.658 . . . . 1.45 109.223 177.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -100.1 -6.39 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 3.62 111.383 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.516 ' HA ' ' NH2' ' A' ' 181' ' ' ARG . 32.3 t70 -61.32 -24.85 66.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.682 0.277 . . . . 2.48 111.529 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 22.9 mp0 -101.04 5.0 42.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.55 -0.296 . . . . 2.24 110.997 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.1 27.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.8 111.462 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 m -120.04 119.51 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.983 -0.553 . . . . 1.06 110.609 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 p -88.13 153.26 21.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.125 -0.488 . . . . 1.26 110.19 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.09 -56.67 1.82 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.74 111.725 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HA ' ' H ' ' A' ' 175' ' ' PHE . 32.3 ptt180 -152.34 159.42 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.053 0.454 . . . . 3.17 111.819 -175.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 66' ' ' PHE . 13.9 tt -115.18 134.81 57.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.34 -0.845 . . . . 0.64 109.54 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -133.68 142.79 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.802 0.334 . . . . 0.96 111.637 -171.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -101.48 88.95 3.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.767 -0.827 . . . . 1.49 108.767 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -142.32 90.32 2.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.384 0.512 . . . . 1.83 112.384 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . 139.45 -54.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.271 -0.966 . . . . 1.64 110.778 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 28.8 p80 174.07 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.652 -0.774 . . . . 3.33 111.153 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.569 ' CB ' ' H ' ' A' ' 95' ' ' PHE . . . -165.77 -170.15 1.71 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.205 0.526 . . . . 1.38 111.461 -173.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 59' ' ' ILE . 2.4 p90 -106.63 87.23 2.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.787 -1.097 . . . . 2.74 109.417 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 3.0 m-20 -71.44 100.26 2.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.663 -1.153 . . . . 1.76 110.324 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 72.8 t -85.41 113.39 23.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.035 0.445 . . . . 1.15 110.197 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.93 122.69 27.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.327 -0.851 . . . . 2.02 110.379 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -101.7 157.67 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.656 -0.498 . . . . 1.66 109.656 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.1 115.58 20.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.831 0.348 . . . . 1.33 110.661 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -127.01 56.03 1.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.786 0.803 . . . . 2.65 109.96 175.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -91.59 -11.77 36.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.806 0.812 . . . . 1.61 109.164 170.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 162.8 39.5 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.643 -1.162 . . . . 2.35 108.886 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -75.61 77.26 2.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.224 0.535 . . . . 1.92 111.169 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 98.2 mttt -92.94 -50.75 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.429 -0.805 . . . . 1.77 110.646 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -111.9 100.14 8.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.822 -0.626 . . . . 0.76 109.682 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.456 HG13 HG23 ' A' ' 87' ' ' THR . 55.1 t -110.19 131.75 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.008 -0.542 . . . . 1.27 111.843 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.56 119.28 31.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.756 -0.656 . . . . 1.29 109.993 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -160.26 122.15 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.591 -0.522 . . . . 2.54 109.591 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.539 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -129.1 -177.97 15.14 Favored Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.923 -0.932 . . . . 1.31 111.118 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.39 -130.0 0.0 OUTLIER Glycine 0 CA--C 1.543 1.818 0 O-C-N 124.771 0.924 . . . . 1.9 115.398 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -44.05 170.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.632 2.888 . . . . 2.91 114.178 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.2 pt? -30.67 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.964 1.364 . . . . 4.11 114.231 -146.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.587 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 12.3 p-10 -110.9 -112.23 0.33 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.231 -1.804 . . . . 4.95 113.042 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.587 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 97.47 155.11 29.99 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.53 -1.428 . . . . 2.25 109.53 -163.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.456 HG23 HG13 ' A' ' 78' ' ' VAL . 15.9 m -77.72 102.14 6.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.777 0.789 . . . . 1.91 110.934 -177.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 74.0 m-85 -97.55 117.71 32.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.039 -0.356 . . . . 3.7 110.039 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.84 145.41 26.61 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.845 -0.428 . . . . 3.54 109.845 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.7 tp -74.59 120.22 19.85 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.376 -0.601 . . . . 1.14 109.376 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 tt -113.12 -42.12 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.713 0.292 . . . . 1.68 111.329 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 28.3 pt20 -167.74 168.88 12.15 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.322 -0.622 . . . . 1.55 109.322 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.572 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 4.1 p90 -134.89 164.23 28.05 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.35 -0.54 . . . . 0.86 111.418 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -138.37 160.3 39.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.653 -0.869 . . . . 0.93 108.653 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.569 ' H ' ' CB ' ' A' ' 65' ' ' ALA . 79.1 t80 -130.25 144.14 51.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.484 0.183 . . . . 3.17 111.185 -172.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.61 146.95 40.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.988 0.423 . . . . 1.68 110.558 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -161.05 150.99 17.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 5.18 108.557 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -90.11 155.87 24.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.906 . . . . 2.13 112.672 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -60.56 -28.11 68.2 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.133 0.492 . . . . 2.9 110.477 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.55 -154.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.679 -0.691 . . . . 3.03 110.516 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -136.61 48.29 2.13 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.433 -0.951 . . . . 3.85 108.433 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.24 41.97 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.196 -0.911 . . . . 1.94 112.136 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.406 ' CG ' ' HA3' ' A' ' 98' ' ' GLY . 10.5 pt20 -159.21 169.76 23.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.713 -0.477 . . . . 2.45 109.713 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.67 10.37 86.26 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.882 -0.675 . . . . 1.47 112.888 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.45 -2.7 57.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.489 0.552 . . . . 2.0 112.489 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.572 ' HG2' ' H ' ' A' ' 107' ' ' HIS . 18.2 tt0 67.35 178.96 0.23 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.642 -0.503 . . . . 3.72 109.642 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.572 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 29.6 m80 48.57 45.05 21.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.396 0.679 . . . . 3.52 112.11 174.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.0 t -81.0 127.6 32.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.731 0.777 . . . . 2.52 111.672 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.04 115.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.755 -1.111 . . . . 2.48 110.503 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.24 37.21 23.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.846 0.831 . . . . 2.8 109.591 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.18 14.72 8.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.529 -1.214 . . . . 4.98 111.619 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -89.32 114.48 25.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.147 -0.686 . . . . 3.23 109.147 172.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -107.06 173.62 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 2.82 110.186 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.4 172.95 7.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.979 -0.555 . . . . 1.62 109.895 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.51 77.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.75 0.278 . . . . 1.03 111.75 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.431 ' HB1' ' CZ ' ' A' ' 95' ' ' PHE . . . -167.43 170.56 11.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.131 -0.486 . . . . 0.75 110.017 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -150.06 141.87 23.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 1.58 110.67 174.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.482 HD11 ' CD2' ' A' ' 93' ' ' PHE . 50.3 tp -105.26 125.74 51.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.598 -0.728 . . . . 1.07 109.052 174.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.512 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -114.76 102.43 10.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 1.77 110.341 -172.027 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.572 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 5.8 mp -90.27 111.26 22.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.359 0.599 . . . . 0.93 110.781 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -77.82 119.82 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.466 -0.788 . . . . 0.61 111.099 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 73.9 m80 -106.57 137.64 44.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.485 -0.779 . . . . 2.13 109.347 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -110.38 128.07 55.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.123 -0.489 . . . . 4.26 111.205 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -69.98 105.29 2.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.03 -0.532 . . . . 2.02 109.907 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.0 t -62.73 -17.49 60.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.544 . . . . 2.34 111.735 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.47 -29.79 70.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.45 -0.341 . . . . 3.35 111.799 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -90.35 -1.24 57.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.36 . . . . 3.1 111.069 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.84 23.73 2.63 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 115.826 1.09 . . . . 2.37 115.826 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.584 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 32.2 t70 -176.87 126.8 0.16 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.986 0.893 . . . . 3.93 109.801 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -64.31 -37.87 89.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.685 -0.689 . . . . 3.0 111.715 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -28.61 70.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.103 -0.57 . . . . 2.15 112.578 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 39.6 mmtm -80.49 -41.02 25.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.505 -0.554 . . . . 3.43 109.505 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.604 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.33 -38.84 88.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.452 -0.795 . . . . 1.76 112.152 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.7 -15.11 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.789 0.328 . . . . 2.77 111.168 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.53 13.33 26.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.287 -0.415 . . . . 3.55 110.432 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 88.2 mm-40 -121.03 135.35 24.77 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.78 -0.452 . . . . 3.02 109.78 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.504 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 11.3 Cg_endo -56.09 -29.85 76.36 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.355 2.703 . . . . 1.6 113.798 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -111.37 25.57 11.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.922 0.391 . . . . 2.29 110.208 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -62.05 -48.72 81.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.247 0.859 . . . . 1.22 115.247 -172.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 206' ' ' VAL . 40.0 mt -133.92 170.31 15.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.835 0.817 . . . . 1.57 111.138 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.94 105.36 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.513 -0.767 . . . . 1.38 109.851 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.658 ' O ' ' HB ' ' A' ' 209' ' ' ILE . 4.7 m -88.83 111.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 1.73 111.36 -176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -86.27 100.43 12.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.774 -0.648 . . . . 2.42 110.287 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.64 118.5 5.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.161 -0.542 . . . . 0.86 112.558 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.57 118.37 58.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.781 -0.452 . . . . 0.76 109.781 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -71.04 147.57 48.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.998 0.428 . . . . 1.2 111.586 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 10.6 mp -116.75 131.82 56.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.656 -0.702 . . . . 0.88 110.271 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -126.4 144.33 50.87 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.789 -0.819 . . . . 2.03 108.789 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.03 130.94 35.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.454 0.645 . . . . 1.27 111.353 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 177.06 -105.25 0.2 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.114 -0.948 . . . . 1.53 110.921 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.9 t -71.53 142.95 50.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.424 -0.584 . . . . 1.54 109.424 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.53 156.58 39.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.78 111.202 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -118.08 95.04 47.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.596 -0.52 . . . . 1.22 109.596 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.65 -37.15 91.23 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.146 2.564 . . . . 1.05 112.49 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.05 -31.01 79.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.7 112.619 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.3 tp -88.78 -31.68 18.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.517 -0.402 . . . . 0.77 109.948 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -39.33 63.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.711 -0.677 . . . . 1.41 110.151 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -49.39 -47.91 47.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.676 -0.693 . . . . 2.86 111.016 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.68 -43.18 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 1.38 111.065 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 156' ' ' LEU . 19.3 t -61.76 -35.47 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.184 0.516 . . . . 1.11 111.147 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.36 -30.46 67.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.309 -0.405 . . . . 1.22 111.589 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 175' ' ' PHE . 9.6 p -92.9 -18.51 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.829 -0.348 . . . . 1.41 111.875 -173.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -67.73 -13.01 61.75 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.988 0.423 . . . . 1.39 111.092 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.54 -19.72 65.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.31 110.498 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.0 t -85.47 0.58 51.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.02 -0.536 . . . . 1.4 111.423 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 59' ' ' ILE . 41.1 pt -135.83 46.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.581 0.705 . . . . 0.85 109.585 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.23 -32.47 71.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.079 -0.964 . . . . 1.59 111.264 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.5 p -112.66 145.21 40.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.895 0.378 . . . . 0.77 110.937 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.48 138.55 58.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 2.29 110.542 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.57 -20.89 33.67 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.624 -0.798 . . . . 0.85 112.473 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.72 152.3 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.109 0.48 . . . . 1.7 111.188 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 m -132.43 157.82 43.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.37 109.642 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.57 151.02 39.69 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.394 -0.595 . . . . 0.61 109.394 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.16 132.76 43.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.192 0.52 . . . . 1.8 110.406 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 162' ' ' VAL . 48.9 t80 -141.48 79.23 1.67 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 1.04 108.295 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' SER . 6.2 m -111.87 156.82 21.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.608 . . . . 1.17 111.558 -174.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 56.4 58.22 4.38 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.357 0.663 . . . . 1.77 112.384 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.45 134.68 41.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 3.99 109.632 172.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.578 ' CG ' ' HE ' ' A' ' 181' ' ' ARG . 10.2 t70 -108.22 129.62 23.84 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 2.51 111.111 -173.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.65 -3.74 9.76 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.637 2.892 . . . . 1.26 114.704 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.578 ' HE ' ' CG ' ' A' ' 179' ' ' ASP . 18.5 ptp180 -59.93 -26.27 65.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.745 0.307 . . . . 2.76 111.401 -178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -79.74 7.14 56.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.92 -0.657 . . . . 1.12 112.299 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.4 mt -115.28 -27.52 7.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 1.73 110.312 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.34 131.63 80.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.799 -0.637 . . . . 3.45 111.428 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.1 -177.07 3.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.97 2.446 . . . . 2.08 112.873 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.79 -55.21 6.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.884 0.327 . . . . 3.23 111.884 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 4.5 m -85.21 130.3 34.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.27 -0.27 . . . . 1.66 110.27 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 tp -111.75 82.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.329 -0.396 . . . . 1.99 110.448 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -118.19 177.4 4.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.56 -0.533 . . . . 1.81 109.56 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -162.93 145.48 10.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.929 0.714 . . . . 5.01 112.929 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.428 ' CD1' ' HB ' ' A' ' 210' ' ' VAL . 7.4 m0 -116.17 145.47 43.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.496 -1.298 . . . . 3.93 107.496 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -142.44 102.83 4.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.779 1.029 . . . . 2.13 113.779 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 255' ' ' ILE . 48.8 t80 -142.41 128.43 10.67 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 5.21 110.031 168.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.74 127.74 23.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.817 2.344 . . . . 2.12 113.618 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -141.76 161.54 27.07 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.248 -0.887 . . . . 1.75 112.283 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 29.6 t . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 109.683 -0.488 . . . . 2.99 109.683 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.522 ' HB3' ' SG ' ' A' ' 205' ' ' CYS . 97.0 mt . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.032 0.444 . . . . 2.96 110.174 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -86.82 78.24 9.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.647 -0.706 . . . . 3.37 109.757 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 203' ' ' LEU . 60.0 m -121.08 -15.4 8.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 2.15 111.992 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 140' ' ' LEU . 47.1 t -145.13 102.65 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 C-N-CA 119.641 -0.823 . . . . 1.26 112.333 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 193' ' ' TYR . 82.3 m -155.73 88.8 1.14 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 2.08 111.508 166.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' TRP . . . . . 0.724 ' O ' HG12 ' A' ' 209' ' ' ILE . 1.1 p90 -150.05 87.06 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.163 -1.015 . . . . 5.53 112.449 160.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.724 HG12 ' O ' ' A' ' 208' ' ' TRP . 9.4 mm -166.89 113.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 123.999 0.92 . . . . 1.63 109.122 157.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 191' ' ' TRP . 95.5 t -125.23 99.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.656 -0.498 . . . . 1.62 109.656 166.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -66.81 107.5 2.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 1.73 110.719 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -53.71 -23.07 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 2.98 111.408 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.5 tp10 -105.17 113.63 64.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.273 -0.422 . . . . 1.47 110.841 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -82.88 152.2 14.57 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.579 2.186 . . . . 0.96 111.707 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.1 pt -100.59 152.17 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.006 -0.368 . . . . 1.25 110.006 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 62.8 m -94.78 129.27 41.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.28 -0.418 . . . . 1.29 109.96 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.33 162.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.065 -0.516 . . . . 1.02 109.853 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.426 ' HB3' ' HG3' ' A' ' 221' ' ' GLN . 48.3 t -88.21 146.03 25.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.183 -0.462 . . . . 1.08 109.823 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.717 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.3 t -57.44 -33.87 68.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.626 -0.715 . . . . 1.33 110.329 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.44 -20.71 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 2.51 111.095 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.426 ' HG3' ' HB3' ' A' ' 218' ' ' SER . 55.9 mt-30 -78.67 -45.89 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.283 -0.417 . . . . 0.7 110.015 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.668 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 24.9 m -70.41 -24.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.52 -0.309 . . . . 1.36 111.369 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.4 mt -62.38 -36.55 82.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.774 0.321 . . . . 1.03 110.556 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -73.22 -25.4 60.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 1.75 111.488 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.668 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.3 m-85 -67.5 -30.87 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.345 0.593 . . . . 2.47 109.657 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -81.54 1.5 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.247 -0.888 . . . . 3.04 110.601 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.29 -13.02 19.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.167 0.508 . . . . 2.31 109.806 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.417 HD21 HD13 ' A' ' 163' ' ' LEU . 93.8 mt -75.1 155.19 37.36 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.759 -0.655 . . . . 0.95 110.482 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.5 m120 -115.53 150.14 37.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.82 -0.627 . . . . 1.13 109.837 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -88.29 -27.34 21.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.45 -0.796 . . . . 3.74 109.953 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.8 p-10 -76.54 168.52 19.92 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.272 -0.877 . . . . 1.62 111.395 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.26 167.71 30.46 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.19 -1.164 . . . . 1.16 110.19 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.17 142.54 51.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 3.56 110.199 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.33 51.06 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.738 -0.744 . . . . 2.08 112.77 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.68 153.57 77.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.33 -0.619 . . . . 2.59 109.33 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.31 122.89 12.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.188 1.925 . . . . 1.36 110.582 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.582 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 9.7 pt-20 -67.42 129.98 41.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.792 0.806 . . . . 3.4 112.47 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.0 mt-10 -115.13 120.18 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.666 -1.152 . . . . 2.47 109.002 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.71 132.88 47.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.994 0.426 . . . . 2.14 110.834 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.1 tpp -71.94 91.65 1.22 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.441 -0.799 . . . . 1.68 111.067 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.16 147.54 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.549 0.214 . . . . 1.27 110.941 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.501 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER 66.79 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.584 0.754 . . . . 2.18 111.886 179.01 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 47.58 34.18 3.4 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.58 0.352 . . . . 2.15 111.838 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' TRP . . . . . 0.565 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 21.5 t90 -129.61 150.04 51.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 4.59 110.721 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 2.8 tmt_? -113.71 132.58 22.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.604 -0.517 . . . . 6.13 109.604 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.405 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 94.2 Cg_exo -46.47 151.8 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.717 2.944 . . . . 3.28 113.76 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -70.58 158.28 36.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.939 . . . . 2.98 111.598 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLN . . . . . 0.404 ' CD ' ' HD2' ' A' ' 249' ' ' PRO . 56.2 tp60 -121.55 128.37 25.67 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.399 -0.364 . . . . 4.32 110.148 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.404 ' HD2' ' CD ' ' A' ' 248' ' ' GLN . 10.3 Cg_endo -50.26 169.92 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.452 3.434 . . . . 3.48 115.449 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 3.2 mm? -62.16 -12.55 20.39 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.828 -1.533 . . . . 4.63 113.071 -169.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 19.0 ptpt -60.11 41.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.377 1.621 . . . . 5.34 115.377 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 7.4 p30 130.29 -3.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 126.099 1.76 . . . . 4.64 111.023 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 57.5 mmt-85 -130.32 95.42 3.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.106 0.479 . . . . 6.11 110.205 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -137.34 104.25 5.33 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 3.08 108.483 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 193' ' ' TYR . 2.0 mp -84.78 132.57 31.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.189 -0.46 . . . . 2.6 111.191 -169.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -80.63 150.34 29.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 2.63 109.851 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -112.6 140.79 47.07 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.113 -0.328 . . . . 1.71 110.113 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 48.9 m -152.0 96.76 2.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.342 0.591 . . . . 2.21 110.499 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.05 123.15 19.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.213 0.53 . . . . 4.31 110.997 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 pttm . . . . . 0 C--O 1.248 1.001 0 CA-C-N 114.98 -1.009 . . . . 4.49 111.887 177.178 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 120.701 0.286 . . . . 17.49 110.336 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m 58.92 23.13 11.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.742 -0.663 . . . . 15.32 111.895 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -148.66 94.91 2.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 15.81 110.677 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -93.21 -23.28 18.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.695 0.76 . . . . 14.19 109.01 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -146.62 135.97 22.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.537 -1.21 . . . . 14.91 109.354 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.02 139.36 9.23 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.152 -0.779 . . . . 10.79 111.152 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 243' ' ' ASN . 10.5 t80 -79.7 99.52 7.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.363 0.601 . . . . 11.39 109.542 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.36 -86.11 0.18 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.41 -1.476 . . . . 9.0 109.41 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -92.5 134.84 34.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.616 -1.253 . . . . 9.76 107.616 166.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -50.67 -48.21 58.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.126 0.787 . . . . 11.19 113.126 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -103.87 24.67 10.92 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.555 -0.458 . . . . 10.8 111.505 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.84 122.96 4.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.742 . . . . 8.82 111.946 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.24 121.88 7.89 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.804 1.669 . . . . 7.87 112.783 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -82.25 -40.81 21.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.372 -0.831 . . . . 10.62 110.58 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -61.57 -38.57 88.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.695 -0.684 . . . . 9.87 110.724 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.433 ' HZ2' HD11 ' A' ' 197' ' ' LEU . 45.1 t-105 -49.33 -52.3 28.83 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.965 0.358 . . . . 8.48 111.965 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -63.74 -31.33 72.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.732 0.301 . . . . 7.13 111.299 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -90.24 -11.47 40.84 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.775 -0.37 . . . . 9.68 111.669 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -89.54 -27.87 19.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.21 0.528 . . . . 7.89 110.036 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.439 ' HB3' HG22 ' A' ' 22' ' ' ILE . 85.6 m-85 -107.62 99.68 30.45 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.541 -0.754 . . . . 7.17 109.484 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.64 -32.74 55.87 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.427 2.751 . . . . 7.76 112.751 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.439 HG22 ' HB3' ' A' ' 20' ' ' PHE . 11.0 tp -54.05 -9.69 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.959 0.725 . . . . 5.83 112.959 175.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.39 -14.77 53.79 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.058 0.456 . . . . 5.44 110.439 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -50.55 -22.05 1.8 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.566 -0.743 . . . . 7.78 111.853 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.56 -175.05 32.54 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.029 -0.828 . . . . 5.01 111.029 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -117.7 107.45 14.2 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 117.484 -1.686 . . . . 7.09 109.81 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.8 ptt-85 -166.41 127.01 1.68 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.48 -0.563 . . . . 5.13 109.48 160.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 29' ' ' SER . 6.3 pt20 -116.27 -52.0 2.6 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 118.48 -1.288 . . . . 7.12 112.809 162.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 28' ' ' GLN . 4.8 m -94.63 155.98 38.88 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.632 -0.258 . . . . 3.94 110.435 -169.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HB3' ' OG1' ' A' ' 198' ' ' THR . 26.5 Cg_endo -64.79 -41.84 17.08 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.757 1.638 . . . . 4.52 112.623 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.4 p -162.15 163.48 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.43 0.633 . . . . 4.54 112.121 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 53.2 t0 -159.68 115.15 2.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.625 -1.17 . . . . 2.88 107.848 172.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.542 ' HA ' HG13 ' A' ' 255' ' ' ILE . 36.5 mt -113.01 140.41 33.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 120.854 0.359 . . . . 2.32 111.415 -167.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -135.31 137.18 42.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.316 -0.994 . . . . 2.82 108.316 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -47.87 -39.34 18.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.042 0.449 . . . . 2.24 111.855 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -81.32 -28.74 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.076 -0.511 . . . . 4.54 111.075 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -96.78 20.39 11.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.472 0.653 . . . . 3.06 110.906 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.48 130.68 53.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.466 -0.568 . . . . 1.72 109.466 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 256' ' ' LYS . 75.6 mmtt -109.52 122.27 47.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.918 0.39 . . . . 3.69 110.513 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -70.56 139.98 51.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.969 -0.56 . . . . 4.64 111.121 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.47 147.25 36.31 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.523 -0.762 . . . . 2.27 109.602 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 44' ' ' LEU . 14.0 Cg_endo -54.99 144.88 66.12 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.549 2.833 . . . . 2.15 113.71 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.441 ' HB2' ' HA ' ' A' ' 260' ' ' LYS . 14.1 t -46.32 45.26 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.111 1.523 . . . . 4.29 115.111 166.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 42' ' ' PRO . 3.7 pp -59.59 171.36 0.86 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.009 -0.541 . . . . 4.74 110.084 168.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 34.9 mmtp -53.69 123.23 37.19 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.806 0.336 . . . . 3.77 111.756 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 36.3 Cg_exo -60.59 171.46 3.45 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.581 2.854 . . . . 2.36 113.27 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.511 HD23 ' HA3' ' A' ' 81' ' ' GLY . 68.0 mt -82.14 111.69 18.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 2.55 109.555 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 m -78.14 108.73 11.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.046 -0.353 . . . . 2.38 110.046 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -101.93 113.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.281 0.563 . . . . 1.59 110.573 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -126.55 92.29 3.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.988 -0.551 . . . . 1.45 109.851 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 7.7 p90 -129.04 23.16 5.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.944 -0.571 . . . . 3.62 110.961 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.95 -22.4 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.11 0.481 . . . . 2.48 110.093 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -99.47 7.75 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.72 -0.673 . . . . 2.24 110.646 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.68 121.27 14.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.142 -0.481 . . . . 0.8 111.182 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 m -109.12 106.84 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.847 -0.615 . . . . 1.06 110.435 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 p -78.58 147.22 33.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.26 109.478 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.67 -57.13 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.979 0.418 . . . . 0.74 111.766 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -147.23 156.48 42.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 3.17 110.911 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.93 134.06 67.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.196 -0.668 . . . . 0.64 109.196 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 172' ' ' SER . 66.8 tp -136.22 144.08 44.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.96 111.249 -170.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -105.29 118.54 36.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.568 -0.742 . . . . 1.49 109.296 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.03 66.33 0.97 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.29 -0.564 . . . . 1.83 111.09 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . 66.73 -52.93 0.22 Allowed Glycine 0 CA--C 1.523 0.568 0 CA-C-N 114.487 -1.233 . . . . 1.64 115.289 165.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -96.34 -26.62 15.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.898 0.38 . . . . 3.33 110.208 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.32 178.62 8.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 1.38 110.095 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -126.61 123.81 38.48 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.921 -0.77 . . . . 2.74 108.921 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -117.08 143.44 45.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.947 0.403 . . . . 1.76 111.36 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -114.75 123.46 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.542 -0.54 . . . . 1.15 109.542 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 2.02 111.329 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.57 152.65 27.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 1.66 109.17 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -83.63 135.04 34.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.787 0.327 . . . . 1.33 110.383 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -133.49 59.35 1.74 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.985 0.897 . . . . 2.65 109.576 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -87.07 -11.32 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 1.61 109.634 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -144.66 177.35 8.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.415 -1.328 . . . . 2.35 107.415 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.07 71.57 4.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.734 0.778 . . . . 1.92 110.423 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -82.75 -61.06 1.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.175 -0.92 . . . . 1.77 110.738 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -112.78 98.06 6.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.76 110.024 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.12 138.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.915 -0.584 . . . . 1.27 111.166 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.7 tp -136.67 113.47 10.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.152 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.65 124.15 7.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.466 0.65 . . . . 2.54 111.553 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -87.53 178.33 47.36 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.167 -0.924 . . . . 1.31 111.478 169.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -38.62 -142.13 0.0 OUTLIER Glycine 0 CA--C 1.535 1.299 0 O-C-N 124.669 0.864 . . . . 1.9 114.974 167.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -49.65 120.41 5.84 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 121.59 1.527 . . . . 2.91 112.152 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.5 mt -159.43 -169.48 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.706 -1.134 . . . . 4.11 109.173 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -126.78 41.8 3.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.717 0.294 . . . . 4.95 110.779 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.91 176.14 14.21 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.632 -0.794 . . . . 2.25 113.172 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 125' ' ' THR . 76.4 m -102.09 122.05 43.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.771 -0.455 . . . . 1.91 109.771 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 38.2 m-85 -104.01 106.42 16.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.019 0.437 . . . . 3.7 110.928 -175.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' NH2' ' HZ3' ' A' ' 123' ' ' TRP . 18.4 mtm180 -85.61 149.59 25.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 3.54 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.85 124.73 28.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 1.14 110.239 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.471 HG23 ' HG2' ' A' ' 92' ' ' GLN . 7.2 tt -109.16 -34.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.464 -0.334 . . . . 1.68 111.392 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' HG23 ' A' ' 91' ' ' ILE . 27.6 pt20 -169.98 169.17 8.27 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.865 -0.152 . . . . 1.55 110.718 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 11.3 p90 -153.66 160.39 42.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.86 110.845 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -147.55 162.27 39.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.6 -0.727 . . . . 0.93 109.55 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 85.4 m-85 -106.2 152.3 23.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 3.17 111.278 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 119' ' ' HIS . 13.6 m170 -108.72 142.85 38.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.814 -1.18 . . . . 1.68 107.814 173.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.597 ' HE1' ' HB ' ' A' ' 222' ' ' VAL . 6.4 t90 -152.61 116.67 4.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.529 -0.468 . . . . 5.18 110.74 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.74 154.75 31.25 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.953 -0.641 . . . . 2.13 112.003 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -67.58 -32.37 73.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.223 0.511 . . . . 2.9 110.617 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -106.56 140.36 39.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.943 -0.762 . . . . 3.03 108.943 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -64.05 -4.38 3.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.896 0.702 . . . . 3.85 112.896 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.17 21.4 24.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.439 -0.886 . . . . 1.94 112.847 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.6 pt20 -158.87 165.57 33.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.13 0.465 . . . . 2.45 110.415 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.95 -34.66 3.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.26 -0.971 . . . . 1.47 114.246 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.8 p -73.4 -34.76 65.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.388 0.594 . . . . 2.0 111.873 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.28 -163.86 0.16 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.445 -0.946 . . . . 3.72 108.445 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 50.62 55.4 9.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.485 0.66 . . . . 3.52 109.889 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.8 p -77.94 117.56 19.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.273 -0.876 . . . . 2.52 110.981 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.541 ' H ' ' HB2' ' A' ' 112' ' ' LYS . 29.9 t -88.51 92.58 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.48 109.947 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.35 -67.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.652 1.22 . . . . 2.8 111.723 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 109' ' ' VAL . 22.3 pttp -127.22 -3.53 6.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.337 -0.392 . . . . 4.98 111.503 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HB2' ' H ' ' A' ' 109' ' ' VAL . 64.3 mttm -69.56 178.17 2.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.041 -0.264 . . . . 3.23 110.479 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.8 pttt 147.77 109.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.746 0.819 . . . . 2.82 108.926 -160.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -121.39 166.66 13.78 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.146 -0.346 . . . . 1.62 110.073 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' GLN . . . -79.55 -17.89 52.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 1.03 112.441 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 97' ' ' TRP . . . -156.65 164.36 38.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.932 0.396 . . . . 0.75 111.513 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.84 151.54 20.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.508 -0.769 . . . . 1.58 110.402 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.463 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 39.7 tp -104.23 127.44 51.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.675 -0.491 . . . . 1.07 109.675 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 96' ' ' HIS . 22.6 t-160 -118.19 105.84 12.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.372 -0.376 . . . . 1.77 110.227 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.2 mp -100.23 125.92 46.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.93 110.689 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 142' ' ' VAL . 46.4 t -98.5 125.18 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.926 0.393 . . . . 0.61 111.235 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -116.26 144.03 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.489 . . . . 2.13 109.681 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.47 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 11.2 t90 -117.9 137.93 52.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.16 -0.473 . . . . 4.26 111.294 -175.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.511 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 30.6 t30 -70.72 104.58 2.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.34 0.59 . . . . 2.02 111.238 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 87' ' ' THR . 7.7 t -67.62 -25.62 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.835 1.05 . . . . 2.34 113.835 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 64.8 pttt -68.39 -5.12 17.29 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.277 0.843 . . . . 3.35 113.277 -171.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -107.44 -0.78 22.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.049 -0.407 . . . . 3.1 111.638 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.88 30.3 4.89 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.149 -0.932 . . . . 2.37 115.148 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 14.9 t70 -163.27 121.27 1.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.931 0.865 . . . . 3.93 109.388 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.506 ' O ' HG23 ' A' ' 134' ' ' VAL . 55.3 p90 -66.44 -40.08 89.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 3.0 111.951 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -32.47 81.8 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.816 -0.707 . . . . 2.15 112.451 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 42.2 mmtm -66.34 -34.57 78.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.79 0.328 . . . . 3.43 110.215 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.34 -34.03 74.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.971 -0.558 . . . . 1.76 110.767 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 130' ' ' PHE . 63.3 t -65.06 -25.75 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 2.77 110.571 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.61 16.78 6.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 3.55 110.977 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 71.1 mt-30 -131.69 135.33 26.65 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 3.02 109.687 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 37.7 Cg_exo -60.59 -26.4 82.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.655 2.237 . . . . 1.6 112.725 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -113.92 19.18 16.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 2.29 111.07 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.15 -29.44 73.35 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.888 -0.672 . . . . 1.22 114.127 -172.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.8 158.61 34.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.066 0.433 . . . . 1.57 110.982 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -144.49 126.96 15.94 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.952 -0.759 . . . . 1.38 108.952 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 121' ' ' VAL . 32.2 m -125.49 149.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.933 0.397 . . . . 1.73 111.38 -173.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.53 122.7 47.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.614 -0.721 . . . . 2.42 110.187 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.8 109.76 2.89 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.29 -0.724 . . . . 0.86 111.29 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.415 HG12 HD12 ' A' ' 211' ' ' LEU . 23.7 mt -111.28 113.9 45.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.243 -0.28 . . . . 0.76 110.243 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -66.6 145.32 55.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.788 0.328 . . . . 1.2 111.01 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.48 124.09 51.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.779 -0.452 . . . . 0.88 109.779 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.2 141.97 47.44 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.559 -0.534 . . . . 2.03 109.559 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 45.1 t -85.45 132.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.061 0.457 . . . . 1.27 110.866 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.3 -105.08 0.21 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.997 -0.841 . . . . 1.53 110.997 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.7 t -71.19 142.33 50.65 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.301 -0.629 . . . . 1.54 109.301 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.68 151.86 45.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.558 -0.292 . . . . 0.78 111.059 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.0 tptt -108.48 99.11 31.32 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.657 -0.497 . . . . 1.22 109.657 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.54 -36.89 89.99 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.965 2.443 . . . . 1.05 112.742 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.07 75.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.991 -0.624 . . . . 0.7 113.115 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 160' ' ' VAL . 26.2 tp -83.92 -17.23 41.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.224 0.512 . . . . 0.77 110.373 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -41.56 63.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 1.41 110.768 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.434 ' HE3' ' OD1' ' A' ' 179' ' ' ASP . 65.3 mttm -49.2 -49.09 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.557 . . . . 2.86 112.415 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 14.8 p -79.99 -35.9 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.708 -0.397 . . . . 1.38 110.832 -177.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' A' ' 163' ' ' LEU . 78.2 t -59.8 -35.77 62.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.363 0.601 . . . . 1.11 110.452 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.52 -33.99 76.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.198 -0.91 . . . . 1.22 111.963 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.9 p -99.25 -3.66 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 111.793 0.294 . . . . 1.41 111.793 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 92.8 mt -55.6 -42.49 74.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.848 0.356 . . . . 1.39 111.916 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.99 -20.94 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.422 -0.353 . . . . 2.31 111.662 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 72.6 m -92.66 0.4 57.42 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.219 0.452 . . . . 1.4 112.219 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.09 34.52 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.578 -0.527 . . . . 0.85 109.578 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.449 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 82.6 tttt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.262 -0.881 . . . . 1.59 112.152 -172.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 171' ' ' LYS . 37.9 p -102.69 152.15 21.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.696 0.284 . . . . 0.77 111.118 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -71.62 146.6 48.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.885 0.374 . . . . 2.29 110.662 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.15 9.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.529 -0.843 . . . . 0.85 112.5 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 168' ' ' THR . 21.5 ptmt -90.87 155.58 18.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 1.7 110.914 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.459 ' HB3' HD13 ' A' ' 60' ' ' LEU . 16.5 p -128.07 160.41 32.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.518 -0.765 . . . . 1.37 110.548 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -144.66 145.86 31.96 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.047 -0.353 . . . . 0.61 110.047 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.15 131.74 40.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.829 -0.434 . . . . 1.8 109.829 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -139.97 79.93 1.74 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.992 -0.744 . . . . 1.04 108.992 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 p -104.65 162.7 13.06 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.462 -0.79 . . . . 1.17 111.477 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 58.12 45.97 16.83 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.788 0.662 . . . . 1.77 112.788 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -99.06 135.46 40.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.974 -0.38 . . . . 3.99 109.974 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.434 ' OD1' ' HE3' ' A' ' 158' ' ' LYS . 6.3 p-10 -110.61 119.28 46.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 121.13 0.49 . . . . 2.51 110.675 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.86 -7.28 19.12 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.817 2.345 . . . . 1.26 112.639 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -63.36 -28.58 70.09 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.877 0.37 . . . . 2.76 110.688 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.75 59.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.172 -0.537 . . . . 1.12 112.977 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 74.9 mt -102.32 -7.06 22.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.583 0.23 . . . . 1.73 111.396 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.82 130.27 88.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.622 0.601 . . . . 3.45 112.622 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.82 -171.59 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.892 2.395 . . . . 2.08 111.369 173.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.75 -62.47 1.68 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.959 0.409 . . . . 3.23 110.613 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.52 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.3 m -91.05 144.77 25.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 1.66 110.279 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 44.3 tp -109.81 63.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.362 0.601 . . . . 1.99 110.549 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 212' ' ' LYS . 4.2 m-20 -97.8 162.82 13.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.81 108.484 174.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.529 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.6 p90 -167.16 156.01 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.159 -0.616 . . . . 5.01 112.474 -174.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.436 ' NE1' ' HG2' ' A' ' 212' ' ' LYS . 12.1 m95 -107.25 149.16 28.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.875 -1.157 . . . . 3.93 107.875 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.8 t -131.28 103.46 6.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.472 0.653 . . . . 2.13 111.589 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.524 ' OH ' ' HA ' ' A' ' 253' ' ' ARG . 45.3 t80 -138.75 132.42 16.23 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 5.21 111.018 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 43.3 Cg_exo -58.3 130.07 35.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.596 2.198 . . . . 2.12 111.876 172.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -108.23 155.71 16.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.209 -0.519 . . . . 1.75 113.068 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 198' ' ' THR . 22.7 t -82.97 -137.8 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.431 0.692 . . . . 2.99 112.256 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.572 ' C ' ' H ' ' A' ' 199' ' ' THR . 32.0 tp -39.95 13.32 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 128.289 2.636 . . . . 4.75 117.46 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.546 ' OG1' ' HB3' ' A' ' 30' ' ' PRO . 3.8 m -67.7 24.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.617 -1.302 . . . . 5.1 111.333 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 197' ' ' LEU . 1.1 p -149.35 164.45 20.98 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 123.556 0.742 . . . . 5.53 109.029 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.433 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 59.7 Cg_exo -48.27 -50.49 12.0 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.306 2.004 . . . . 5.83 113.992 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 7.4 Cg_endo -88.92 147.71 5.71 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.224 1.95 . . . . 4.78 112.381 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.17 78.97 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 3.84 110.595 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.81 174.05 12.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.533 -0.303 . . . . 2.96 110.63 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 8.5 pt-20 -112.88 71.99 0.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.227 0.537 . . . . 3.37 110.746 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.463 ' SG ' HG21 ' A' ' 199' ' ' THR . 28.7 p -96.87 -9.6 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.15 110.645 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.89 141.06 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.782 -0.645 . . . . 1.26 111.395 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.3 m -113.18 108.8 17.78 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.002 -0.74 . . . . 2.08 109.002 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 192' ' ' THR . 33.6 m95 -82.31 119.22 23.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.936 0.398 . . . . 5.53 111.985 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 48.5 mm -108.78 99.55 8.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.379 -0.971 . . . . 1.63 108.379 170.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.6 t -101.65 119.36 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.316 -0.402 . . . . 1.62 110.386 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 40.1 mt -74.68 137.92 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.829 0.347 . . . . 1.73 110.254 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 85.2 mttt -83.06 -8.64 59.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 2.98 110.68 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 187' ' ' SER . 8.4 tp10 -105.26 101.38 30.61 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.255 -0.43 . . . . 1.47 110.501 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 15.7 Cg_exo -69.23 141.48 47.5 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.757 2.305 . . . . 0.96 111.713 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.46 150.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.907 -0.405 . . . . 1.25 109.907 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 12.9 m -90.44 122.03 32.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.074 -0.512 . . . . 1.29 110.526 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.4 m -125.09 151.22 30.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.238 -0.653 . . . . 1.02 109.238 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 60.8 p -91.1 160.05 15.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.488 -0.485 . . . . 1.08 111.525 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.488 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.3 m -54.27 -45.56 72.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 1.33 110.803 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -55.74 -32.5 63.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 2.51 111.434 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -76.87 -52.09 10.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.479 -0.328 . . . . 0.7 110.846 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.597 ' HB ' ' HE1' ' A' ' 97' ' ' TRP . 15.7 m -64.04 -34.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.081 0.4 . . . . 1.36 112.081 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.4 mt -63.39 -30.68 71.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.689 0.281 . . . . 1.03 111.385 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -78.8 -20.18 50.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.313 . . . . 1.75 111.621 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -71.96 -24.48 61.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.275 0.559 . . . . 2.47 109.866 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -80.69 1.28 30.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.59 -0.732 . . . . 3.04 110.533 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -91.61 -9.03 45.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 2.31 110.635 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.06 153.98 39.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.092 0.472 . . . . 0.95 110.638 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.3 m120 -119.31 150.87 39.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.958 -0.564 . . . . 1.13 110.928 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 240' ' ' MET . 33.4 m-85 -77.46 -34.75 54.33 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.377 -0.972 . . . . 3.74 108.377 170.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.9 p-10 -74.31 163.84 27.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.078 -1.419 . . . . 1.62 112.39 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.72 -170.75 47.16 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.614 -1.175 . . . . 1.16 110.993 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.0 126.72 31.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.957 -0.386 . . . . 3.56 109.957 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.9 29.49 31.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.844 -0.694 . . . . 2.08 112.068 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 20.0 mm-40 -127.43 159.13 67.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.138 -0.319 . . . . 2.59 110.138 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.21 121.86 10.15 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 1.36 112.518 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.21 119.36 7.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.573 -0.74 . . . . 3.4 112.534 -174.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.3 mt-10 -131.72 146.74 52.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 2.47 109.206 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.44 125.3 42.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.394 -0.224 . . . . 2.14 110.394 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.562 ' HA ' ' CE2' ' A' ' 230' ' ' PHE . 55.5 ttm -69.45 90.79 0.54 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.515 0.51 . . . . 1.68 110.176 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.42 157.26 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 1.27 110.979 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 12.9 t70 68.47 -85.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.114 -0.948 . . . . 2.18 111.066 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.49 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 56.2 m-80 50.06 35.47 10.02 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.911 0.708 . . . . 2.15 112.911 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.424 ' HE1' ' CG ' ' A' ' 96' ' ' HIS . 2.3 m95 -137.36 158.97 43.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.424 0.63 . . . . 4.59 111.6 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -111.22 146.87 35.44 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.181 -0.918 . . . . 6.13 110.357 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.89 151.26 20.69 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.926 2.417 . . . . 3.28 112.892 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -78.31 159.74 28.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.439 -0.8 . . . . 2.98 110.681 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -113.79 153.69 45.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.42 . . . . 4.32 111.404 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.84 178.57 2.74 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.762 2.975 . . . . 3.48 113.39 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 252' ' ' ASN . 4.2 mm? -51.11 -11.15 0.09 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.056 0.942 . . . . 4.63 113.021 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -59.49 41.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.092 0.957 . . . . 5.34 113.492 170.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.545 ' H ' ' C ' ' A' ' 250' ' ' LEU . 2.9 t30 119.07 41.91 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.584 1.954 . . . . 4.64 112.296 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.645 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 7.4 ppt_? -145.52 121.44 10.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 6.11 110.896 160.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -137.48 122.4 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.656 -1.238 . . . . 3.08 107.656 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 33' ' ' ILE . 29.4 mm -91.49 144.1 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 2.6 112.416 -165.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 67.6 mttm -127.97 146.6 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 2.63 109.101 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.408 ' HB2' ' CE3' ' A' ' 191' ' ' TRP . . . -138.17 103.85 5.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.572 0.225 . . . . 1.71 110.785 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 p -92.77 98.52 11.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.013 0.435 . . . . 2.21 111.014 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.86 154.3 27.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.248 -0.433 . . . . 4.31 110.018 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 43' ' ' SER . 49.2 pttt . . . . . 0 C--O 1.246 0.895 0 O-C-N 123.613 0.571 . . . . 4.49 111.335 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.478 0.965 0 CA-C-O 120.554 0.216 . . . . 17.49 111.138 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 p -132.81 122.22 24.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 15.32 111.548 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -125.47 163.79 21.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.302 -0.408 . . . . 15.81 110.155 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -105.6 112.33 25.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.945 -0.57 . . . . 14.19 110.252 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -117.12 66.03 0.73 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.2 0.524 . . . . 14.91 110.859 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.21 158.58 12.45 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.783 -0.927 . . . . 10.79 110.783 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -78.22 97.41 5.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.248 0.547 . . . . 11.39 109.8 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.41 122.15 4.99 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.846 -0.901 . . . . 9.0 110.846 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -60.28 119.45 7.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.419 0.155 . . . . 9.76 111.419 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.7 m170 44.66 -87.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.06 0.944 . . . . 11.19 113.026 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -97.0 21.17 10.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 10.8 110.724 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -102.18 2.84 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.086 -1.206 . . . . 8.82 110.086 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HB2' ' HB2' ' A' ' 16' ' ' TRP . 2.4 Cg_endo -82.72 123.03 3.6 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.899 1.733 . . . . 7.87 110.559 166.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.7 -37.72 16.46 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.728 0.299 . . . . 10.62 110.984 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -80.54 -4.38 53.73 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.828 -0.349 . . . . 9.87 110.946 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.0 t90 -93.11 -46.97 7.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 8.48 110.209 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -67.63 -4.64 12.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.963 0.357 . . . . 7.13 111.963 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -66.63 -37.53 85.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.467 0.651 . . . . 9.68 109.429 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.97 -26.27 25.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.11 -0.95 . . . . 7.89 110.627 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -129.88 91.83 38.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 7.17 110.236 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.533 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 24.9 Cg_exo -63.86 -25.73 67.54 Favored 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 123.299 2.666 . . . . 7.76 113.953 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.9 pt -61.72 -10.54 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 113.174 0.805 . . . . 5.83 113.174 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.67 -22.51 66.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.659 0.266 . . . . 5.44 111.48 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 22.3 pttp -102.77 23.84 11.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 7.78 110.601 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.48 -111.1 3.57 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 111.021 -0.832 . . . . 5.01 111.021 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -80.02 123.83 28.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.585 -1.265 . . . . 7.09 107.585 168.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.565 ' HG2' ' HB2' ' A' ' 252' ' ' ASN . 9.9 mpt_? -84.64 153.81 22.93 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.019 0.914 . . . . 5.13 111.878 -175.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 196' ' ' SER . 0.0 OUTLIER -149.73 24.21 0.87 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.926 -1.488 . . . . 7.12 109.374 -168.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.494 ' HB2' HG13 ' A' ' 31' ' ' VAL . 14.9 m -97.51 159.8 30.25 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 113.219 0.822 . . . . 3.94 113.219 -161.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.582 ' HA ' ' CE1' ' A' ' 107' ' ' HIS . 13.4 Cg_endo -54.61 35.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.174 1 C-N-CA 126.747 4.964 . . . . 4.52 115.742 174.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 248' ' ' GLN . 13.1 m -85.95 -176.31 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 118.401 0.546 . . . . 4.54 111.987 -162.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -90.17 135.23 33.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.16 -0.927 . . . . 2.88 110.668 -164.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HB ' HG22 ' A' ' 109' ' ' VAL . 41.1 mt -97.18 126.54 49.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.985 -0.552 . . . . 2.32 110.562 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 16.7 t70 -112.73 117.41 32.13 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.379 -0.6 . . . . 2.82 109.379 171.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 p -56.05 -27.67 54.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.945 -0.57 . . . . 2.24 112.458 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.506 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 43.5 m80 -74.29 -18.04 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.185 0.517 . . . . 4.54 110.318 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -117.87 18.9 13.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.497 -0.774 . . . . 3.06 109.851 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.63 85.33 2.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.394 -0.595 . . . . 1.72 109.394 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -75.8 121.93 23.31 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.453 -0.794 . . . . 3.69 111.535 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 40.4 p90 -84.2 143.45 29.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.297 -0.411 . . . . 4.64 110.318 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' HB2' ' HG ' ' A' ' 44' ' ' LEU . 25.4 m-20 -109.7 119.36 48.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.177 -0.465 . . . . 2.27 110.43 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.13 -15.24 46.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.758 2.305 . . . . 2.15 111.587 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.9 m -75.98 -19.21 58.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 4.29 110.746 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 89.5 mt -83.1 137.87 33.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.093 0.473 . . . . 4.74 110.259 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -118.54 135.19 23.53 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 3.77 110.73 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.99 158.09 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.94 3.094 . . . . 2.36 113.303 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.15 155.61 19.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 2.55 111.423 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 80' ' ' LYS . 34.7 p -129.1 136.04 49.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 2.38 108.984 173.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.31 136.78 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.383 -0.372 . . . . 1.59 110.981 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -119.29 89.34 3.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.508 -0.553 . . . . 1.45 109.508 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -103.1 5.72 38.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.786 -0.643 . . . . 3.62 110.254 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -51.88 -40.08 60.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 2.48 111.555 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -111.66 23.67 13.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.266 -0.425 . . . . 2.24 111.343 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.18 111.17 6.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.86 0.362 . . . . 0.8 111.014 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -106.22 108.47 20.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.282 -0.417 . . . . 1.06 110.863 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 176' ' ' THR . 17.3 m -77.43 148.74 35.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.223 -0.658 . . . . 1.26 109.223 174.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.44 -56.99 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.681 0.252 . . . . 0.74 111.681 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -154.18 164.9 37.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.161 0.505 . . . . 3.17 111.49 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.77 138.3 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.338 -0.846 . . . . 0.64 109.779 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.5 tp -130.29 139.57 50.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.593 -0.276 . . . . 0.96 111.09 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -91.46 117.02 29.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.195 0.521 . . . . 1.49 110.743 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -115.59 150.05 37.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.182 -1.414 . . . . 1.83 107.182 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.71 38.2 0.49 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.65 -0.786 . . . . 1.64 114.536 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -132.61 -39.7 0.99 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.188 -0.671 . . . . 3.33 109.188 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.24 -170.31 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.311 -0.996 . . . . 1.38 108.311 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -108.63 135.53 49.73 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.128 -0.694 . . . . 2.74 109.128 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.67 111.61 24.18 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.289 -0.414 . . . . 1.76 110.71 -176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.77 113.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.114 -0.698 . . . . 1.15 109.114 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.52 134.04 35.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.983 0.421 . . . . 2.02 111.032 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -103.28 155.61 18.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.504 -0.771 . . . . 1.66 109.33 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.13 119.82 22.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.809 0.338 . . . . 1.33 110.139 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.35 56.18 1.12 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.718 0.771 . . . . 2.65 109.988 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -87.2 -16.57 34.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.473 -0.785 . . . . 1.61 109.881 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -153.13 176.55 11.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.966 -1.015 . . . . 2.35 108.673 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.69 73.57 7.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.234 0.54 . . . . 1.92 111.012 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.449 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 81.4 mttt -97.47 -65.15 0.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 1.77 112.481 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 89' ' ' ARG . . . -101.49 101.51 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.76 110.223 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.1 t -119.56 143.4 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.993 0.425 . . . . 1.27 112.088 -169.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 tp -118.59 129.95 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.176 -0.675 . . . . 1.29 109.176 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 95.3 mttt -125.55 137.63 53.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.841 -0.429 . . . . 2.54 109.841 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.0 170.2 24.65 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.976 -0.557 . . . . 1.31 111.959 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.4 -147.88 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.817 0.363 . . . . 1.9 113.245 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 51.9 Cg_exo -52.19 119.7 6.18 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 121.904 1.736 . . . . 2.91 112.253 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 72.4 mt -155.03 -171.7 3.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.781 -1.1 . . . . 4.11 108.676 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.02 51.76 1.52 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 4.95 110.639 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.02 -173.78 19.74 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.531 -0.843 . . . . 2.25 112.902 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -108.48 127.6 54.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.015 -0.365 . . . . 1.91 110.015 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 124' ' ' ASN . 71.9 m-85 -103.66 101.77 11.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.404 0.621 . . . . 3.7 111.449 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 77' ' ' ALA . 41.8 ttm180 -79.09 144.0 34.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.481 -0.781 . . . . 3.54 110.427 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.76 120.79 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.501 -0.555 . . . . 1.14 109.501 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.18 -36.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.319 . . . . 1.68 111.698 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -172.11 167.76 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.252 -0.647 . . . . 1.55 109.252 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.48 ' CB ' HD23 ' A' ' 120' ' ' LEU . 35.9 p90 -140.01 167.81 21.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.278 -0.569 . . . . 0.86 112.17 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -147.36 160.94 41.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.826 -1.176 . . . . 0.93 107.826 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.95 172.0 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.652 0.66 . . . . 3.17 111.032 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -129.45 146.03 51.35 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.697 -0.853 . . . . 1.68 108.697 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -157.32 133.38 9.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.164 0.506 . . . . 5.18 110.667 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 78.94 165.28 28.85 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.635 -0.793 . . . . 2.13 112.673 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 33.3 t 156.42 -96.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.661 -1.237 . . . . 2.9 107.661 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 75.6 mt -83.14 -153.84 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.713 -0.676 . . . . 3.03 109.303 167.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -45.81 -33.54 3.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.038 0.535 . . . . 3.85 112.124 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 113' ' ' LYS . . . 176.91 89.92 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.9 -0.667 . . . . 1.94 112.129 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 96.3 mt-30 -127.37 -177.69 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.376 . . . . 2.45 111.183 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.6 -29.56 2.76 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 109.048 -1.621 . . . . 1.47 109.048 -172.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 117' ' ' GLU . 3.3 t -68.66 67.58 0.14 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.296 -1.452 . . . . 2.0 112.474 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' CA ' ' HE1' ' A' ' 244' ' ' TRP . 28.8 tt0 -56.62 155.05 7.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 110.117 -0.327 . . . . 3.72 110.117 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 44.4 m-70 58.89 64.61 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.994 -0.743 . . . . 3.52 108.994 -173.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.58 133.47 36.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.242 -0.89 . . . . 2.52 112.033 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 33' ' ' ILE . 40.6 t -78.61 90.61 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 114.922 -1.036 . . . . 2.48 108.894 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 33.7 t70 64.23 -71.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.135 0.897 . . . . 2.8 110.724 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.479 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 54.9 mttp -138.46 30.23 2.38 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.512 0.19 . . . . 4.98 111.512 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HB3' ' H ' ' A' ' 109' ' ' VAL . 25.4 ttpp -70.16 71.57 0.42 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.189 0.519 . . . . 3.23 110.086 174.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 102' ' ' GLY . 51.3 mtmt -99.77 96.45 7.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.45 . . . . 2.82 110.987 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.405 ' H ' ' HB2' ' A' ' 105' ' ' SER . 70.3 m-85 -91.57 156.56 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.492 -0.929 . . . . 1.62 108.492 170.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.71 -9.69 55.4 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.481 0.488 . . . . 1.03 112.025 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.39 163.96 17.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.412 0.445 . . . . 0.75 110.322 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 105' ' ' SER . 33.2 tt0 -158.71 138.6 12.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.673 -0.694 . . . . 1.58 109.657 176.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.558 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 57.7 tp -102.51 132.86 48.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.024 -0.535 . . . . 1.07 110.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -119.86 102.41 8.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.188 0.518 . . . . 1.77 110.261 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 93' ' ' PHE . 24.5 mt -83.96 116.98 23.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 0.93 110.581 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.54 127.23 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.34 0.59 . . . . 0.61 110.591 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 31.7 m-70 -124.45 144.11 50.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.898 -0.592 . . . . 2.13 110.062 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -111.42 131.23 55.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.891 -0.595 . . . . 4.26 110.755 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.508 ' HB2' ' CE1' ' A' ' 88' ' ' TYR . 22.0 t30 -72.84 110.43 7.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.202 0.525 . . . . 2.02 110.742 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.9 p -66.34 -21.47 66.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 2.34 112.165 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -53.51 -27.49 25.93 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.384 0.513 . . . . 3.35 112.384 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.93 8.88 44.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.128 0.418 . . . . 3.1 112.128 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.09 -1.22 0.64 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.175 1.23 . . . . 2.37 116.175 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -168.79 136.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.416 1.108 . . . . 3.93 109.715 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.2 p90 -66.41 -38.63 87.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 3.0 111.687 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.16 97.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.838 -0.696 . . . . 2.15 111.904 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -70.72 -31.9 68.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.486 . . . . 3.43 110.241 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.628 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -65.59 -25.74 67.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.777 -0.647 . . . . 1.76 110.887 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -63.72 -19.62 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 2.77 110.993 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.39 -11.91 59.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.96 -0.463 . . . . 3.55 110.996 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.436 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 51.1 tt0 -111.14 136.39 20.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.637 -0.256 . . . . 3.02 110.623 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.8 Cg_exo -55.9 -27.15 61.73 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.34 2.694 . . . . 1.6 113.351 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.436 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 3.7 m-20 -111.5 27.07 10.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.109 0.48 . . . . 2.29 110.064 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.06 -36.49 31.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 1.22 113.503 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.8 mt -121.56 163.35 19.03 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.475 -0.427 . . . . 1.57 110.375 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.44 147.67 34.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.154 -0.475 . . . . 1.38 110.179 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.15 113.57 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.906 -0.405 . . . . 1.73 109.906 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 48.7 tp -93.4 108.32 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.092 -0.504 . . . . 2.42 110.079 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -93.92 148.35 18.97 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.932 -0.576 . . . . 0.86 112.99 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 mt -137.41 125.28 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.598 -0.519 . . . . 0.76 109.598 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 18.0 m-85 -71.06 139.12 50.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.474 -0.195 . . . . 1.2 110.474 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.7 mp -113.29 110.65 20.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.468 . . . . 0.88 110.701 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.552 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 19.4 ptpt -98.94 152.3 19.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.157 -0.683 . . . . 2.03 109.157 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.61 121.07 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.018 0.437 . . . . 1.27 110.495 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.01 -114.49 0.35 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.503 -0.639 . . . . 1.53 111.503 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.4 t -66.93 147.25 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.88 -0.415 . . . . 1.54 109.88 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.84 34.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.91 0.386 . . . . 0.78 111.669 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 216' ' ' SER . 56.7 mmtt -114.58 96.48 43.78 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.824 -0.625 . . . . 1.22 109.433 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.49 -33.92 93.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.687 2.258 . . . . 1.05 111.873 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.41 71.12 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.743 -0.662 . . . . 0.7 112.357 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 160' ' ' VAL . 62.0 tp -86.53 -26.35 24.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.216 0.532 . . . . 0.77 109.616 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -37.25 69.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.201 -0.909 . . . . 1.41 110.184 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -59.4 -37.69 78.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 2.86 111.279 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 162' ' ' VAL . 42.2 t -72.82 -43.39 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.154 0.502 . . . . 1.38 110.314 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 156' ' ' LEU . 33.9 t -59.77 -34.24 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 1.11 110.756 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.26 -31.05 72.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 1.22 112.014 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 159' ' ' VAL . 5.2 p -86.32 -4.73 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 1.41 111.012 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.52 -25.72 67.46 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.355 -0.384 . . . . 1.39 111.236 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.17 -32.31 72.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 2.31 111.279 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 m -88.5 -3.25 58.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.989 0.366 . . . . 1.4 111.989 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.58 41.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.327 0.584 . . . . 0.85 110.269 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.14 -31.24 70.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 1.59 111.421 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.9 p -117.43 158.17 24.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.785 -0.189 . . . . 0.77 111.174 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -55.03 147.0 16.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.351 0.596 . . . . 2.29 112.345 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.28 -22.01 31.89 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.331 -0.85 . . . . 0.85 112.25 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -72.84 139.84 47.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.116 0.484 . . . . 1.7 110.873 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.8 p -133.54 157.6 45.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.408 -0.814 . . . . 1.37 109.549 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.71 143.75 28.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.76 -0.459 . . . . 0.61 109.76 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.8 133.45 46.54 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.245 -0.65 . . . . 1.8 109.245 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -142.34 81.21 1.74 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.81 -0.632 . . . . 1.04 109.483 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' SER . 5.2 m -108.44 164.27 12.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.256 -0.429 . . . . 1.17 110.936 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.44 64.54 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.731 0.644 . . . . 1.77 111.773 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 53.2 t80 -115.22 144.65 43.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 3.99 110.145 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.61 102.33 25.59 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 2.51 111.348 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 16.0 Cg_exo -69.18 -12.16 33.33 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.917 2.412 . . . . 1.26 112.238 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -62.88 -24.48 67.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.393 -0.367 . . . . 2.76 110.957 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.62 68.28 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.601 -0.809 . . . . 1.12 111.797 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 83.5 mt -118.22 -38.01 3.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.646 -0.502 . . . . 1.73 109.646 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.07 131.71 83.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 3.45 110.566 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.84 -178.86 4.41 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.7 2.267 . . . . 2.08 112.727 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.65 -62.39 1.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.097 -0.501 . . . . 3.23 111.35 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.7 m -71.09 131.93 44.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 1.66 110.885 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.3 mt -111.32 63.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.079 0.466 . . . . 1.99 111.597 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 19.5 m-20 -105.6 173.23 6.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.741 -1.207 . . . . 1.81 107.741 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 46.9 p90 -164.65 150.24 10.15 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.325 -0.95 . . . . 5.01 113.235 -171.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.452 ' CE3' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m95 -109.35 151.27 26.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.817 -1.549 . . . . 3.93 106.817 166.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.7 t -139.5 130.86 26.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.603 0.716 . . . . 2.13 112.55 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.436 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 51.3 t80 -138.76 142.22 33.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.214 -0.903 . . . . 5.21 109.205 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.436 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 76.8 Cg_exo -52.0 149.07 21.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.429 2.086 . . . . 2.12 112.006 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -117.9 125.12 6.34 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.839 -0.696 . . . . 1.75 112.968 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 28' ' ' GLN . 11.9 t -85.16 -137.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.557 0.743 . . . . 2.99 111.112 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 199' ' ' THR . 2.7 pt? -42.58 12.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.727 2.121 . . . . 4.75 116.727 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 196' ' ' SER . 2.1 m -68.21 25.51 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.011 0.823 . . . . 5.1 110.733 172.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.611 ' H ' ' C ' ' A' ' 197' ' ' LEU . 1.8 p -149.41 167.72 12.45 Favored Pre-proline 0 C--N 1.324 -0.534 0 C-N-CA 124.502 1.121 . . . . 5.53 108.531 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.508 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 53.9 Cg_exo -47.45 -48.86 14.33 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.854 1.703 . . . . 5.83 113.167 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 83.0 Cg_endo -98.63 145.37 0.54 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.239 1.96 . . . . 4.78 112.585 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 197' ' ' LEU . 6.3 tt -67.15 89.83 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.881 -0.785 . . . . 3.84 108.881 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 tt -143.05 155.49 44.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.458 -0.792 . . . . 2.96 109.359 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.4 OUTLIER -88.77 43.96 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.927 0.394 . . . . 3.37 110.857 -176.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 2.1 p -86.37 -9.05 57.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.257 0.466 . . . . 2.15 112.257 -174.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.14 148.15 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.012 0.434 . . . . 1.26 111.077 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.3 m -117.5 108.22 15.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.026 -0.731 . . . . 2.08 109.026 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.428 ' CZ2' ' HB ' ' A' ' 210' ' ' VAL . 59.2 t90 -84.98 124.3 31.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.114 0.483 . . . . 5.53 110.013 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 73.2 mt -130.93 120.49 47.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.018 -0.734 . . . . 1.63 109.018 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 14.5 p -115.92 131.51 68.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.577 -0.449 . . . . 1.62 110.962 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 92.7 mt -71.98 129.09 37.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.125 -0.488 . . . . 1.73 110.208 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 0.7 OUTLIER -56.91 -24.05 49.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.116 -0.947 . . . . 2.98 111.435 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.93 115.05 65.98 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 1.47 110.68 -170.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.552 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 12.2 Cg_exo -71.89 157.76 54.25 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.639 2.226 . . . . 0.96 111.925 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.432 ' HB ' ' HE3' ' A' ' 153' ' ' LYS . 45.2 pt -114.09 151.43 15.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.172 -0.677 . . . . 1.25 109.172 172.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.585 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 2.6 p -101.53 126.6 48.37 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.847 0.356 . . . . 1.29 111.215 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.73 155.03 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.533 -0.758 . . . . 1.02 109.206 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.6 t -87.88 152.85 21.77 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.607 -0.437 . . . . 1.08 110.803 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 15.8 m -51.13 -48.13 61.84 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.287 0.367 . . . . 1.33 111.57 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 2.7 mp0 -53.94 -42.64 69.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 2.51 110.755 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.77 -45.48 92.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.657 . . . . 0.7 110.312 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.69 -37.44 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.562 . . . . 1.36 110.565 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 219' ' ' SER . 97.7 mt -67.31 -34.01 76.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.63 . . . . 1.03 110.916 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 98.5 mttt -71.07 -22.83 62.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.326 . . . . 1.75 111.161 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -72.58 -31.0 64.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 2.47 109.189 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -78.26 -4.26 46.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.325 -0.852 . . . . 3.04 110.336 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 93.3 mttt -94.06 -0.15 55.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 2.31 110.094 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -73.75 150.99 40.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.95 109.66 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.504 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.5 m120 -111.97 125.26 53.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.601 0.715 . . . . 1.13 111.248 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.405 ' HA ' ' HE2' ' A' ' 240' ' ' MET . 90.0 t80 -64.74 -32.23 73.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.41 -1.268 . . . . 3.74 110.018 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -70.03 160.8 31.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 1.62 111.719 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.11 179.37 52.87 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.895 -0.882 . . . . 1.16 110.895 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.58 137.2 42.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.858 0.829 . . . . 3.56 110.434 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 80.8 20.31 65.97 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.027 -0.606 . . . . 2.08 112.059 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -121.95 155.79 60.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 122.399 0.279 . . . . 2.59 110.263 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.76 125.14 18.13 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.916 2.41 . . . . 1.36 111.358 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -58.25 133.2 55.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.748 0.785 . . . . 3.4 112.59 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.13 120.19 18.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.62 -1.173 . . . . 2.47 108.508 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.5 116.91 7.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.739 0.304 . . . . 2.14 110.228 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 230' ' ' PHE . 51.7 ttm -70.52 95.29 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.697 -0.683 . . . . 1.68 109.525 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.27 169.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.315 -0.402 . . . . 1.27 110.607 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.4 t70 71.35 -100.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.931 0.77 . . . . 2.18 109.983 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 45.55 32.58 1.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.489 . . . . 2.15 110.833 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.495 ' HE1' ' CA ' ' A' ' 106' ' ' GLU . 78.6 t90 -115.23 137.11 52.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.992 -0.373 . . . . 4.59 109.992 -171.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 82.5 mtm180 -90.55 127.04 54.19 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.546 -0.297 . . . . 6.13 111.043 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 245' ' ' ARG . 34.8 Cg_exo -61.14 150.77 82.84 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.262 2.642 . . . . 3.28 113.363 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' PRO . . . -96.58 95.43 7.97 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.663 -0.698 . . . . 2.98 111.762 -176.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.511 ' HB2' HG12 ' A' ' 31' ' ' VAL . 41.5 mt-30 -56.92 157.33 11.06 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.699 . . . . 4.32 112.104 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.79 177.84 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.747 2.964 . . . . 3.48 113.488 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.68 -10.96 21.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.982 -1.008 . . . . 4.63 111.397 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -52.86 49.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.626 1.713 . . . . 5.34 115.626 168.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.565 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 32.0 p30 139.91 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.759 2.024 . . . . 4.64 113.193 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.479 ' CG ' ' H ' ' A' ' 254' ' ' GLN . 5.5 ttp180 97.37 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.186 -1.825 . . . . 6.11 110.839 156.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.479 ' H ' ' CG ' ' A' ' 253' ' ' ARG . 3.6 pp0? -157.95 162.1 38.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.874 -0.788 . . . . 3.08 108.874 -167.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.476 HD12 HG12 ' A' ' 33' ' ' ILE . 9.5 mt -100.06 129.03 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.866 0.365 . . . . 2.6 110.667 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -81.95 152.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.426 -0.583 . . . . 2.63 109.426 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.73 166.27 14.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.278 -0.419 . . . . 1.71 110.975 -172.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 27.8 p -149.36 97.82 2.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.543 0.687 . . . . 2.21 110.724 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -132.53 104.93 6.93 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.151 -0.931 . . . . 4.31 108.728 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.599 -0.715 . . . . 4.49 109.96 -178.139 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 120.707 0.289 . . . . 17.49 110.342 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 m 59.1 55.92 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.862 -0.608 . . . . 15.32 110.799 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -98.6 118.02 34.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.962 -0.563 . . . . 15.81 110.629 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -144.85 130.14 18.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.694 -0.684 . . . . 14.19 110.364 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -138.39 137.2 37.05 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.026 -0.533 . . . . 14.91 110.174 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.54 -178.05 46.0 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.271 -0.731 . . . . 10.79 111.271 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -88.63 109.86 20.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.764 0.316 . . . . 11.39 110.723 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 12' ' ' GLY . . . 62.77 -172.76 9.95 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.88 -0.6 . . . . 9.0 113.961 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -88.22 128.77 35.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.471 -0.365 . . . . 9.76 110.344 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.6 m80 59.95 -85.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.62 -0.718 . . . . 11.19 112.261 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -108.09 -5.74 16.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.861 0.319 . . . . 10.8 111.861 -173.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.518 ' O ' ' HA3' ' A' ' 8' ' ' GLY . . . 148.15 -41.24 0.91 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 119.429 -1.367 . . . . 8.82 115.204 -178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -43.98 140.68 4.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.899 2.4 . . . . 7.87 114.24 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -71.64 5.47 2.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.401 -0.818 . . . . 10.62 112.791 -177.154 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -67.42 10.59 0.16 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.152 0.501 . . . . 9.87 111.442 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.481 ' H ' ' C ' ' A' ' 14' ' ' GLU . 20.1 t-105 -73.26 -2.22 21.02 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.834 0.854 . . . . 8.48 110.244 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -58.32 -10.43 2.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.544 -0.753 . . . . 7.13 112.596 -168.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -74.32 -28.62 61.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.015 0.436 . . . . 9.68 110.732 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -84.92 -17.97 36.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.946 -0.57 . . . . 7.89 110.525 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.67 95.51 44.65 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.56 -0.746 . . . . 7.17 109.716 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.449 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 56.6 Cg_exo -51.71 -45.46 37.95 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.321 2.681 . . . . 7.76 112.985 -175.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.553 ' H ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -71.89 -6.35 7.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.417 0.525 . . . . 5.83 112.417 -178.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HA ' HD11 ' A' ' 197' ' ' LEU . . . -80.64 -3.32 50.08 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.141 -0.35 . . . . 5.44 111.81 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -71.69 36.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.424 0.527 . . . . 7.78 112.424 176.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 23' ' ' ALA . . . -96.84 -175.63 35.14 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.747 -0.74 . . . . 5.01 111.339 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -114.69 113.25 24.07 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.52 -0.872 . . . . 7.09 109.017 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 5.2 tpp180 -152.33 -179.71 7.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.509 -0.477 . . . . 5.13 110.164 171.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.569 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 51.6 tt0 -34.14 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.668 1.187 . . . . 7.12 112.911 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.523 ' HB2' HG23 ' A' ' 31' ' ' VAL . 53.3 m -104.04 169.35 7.39 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 107.995 -1.113 . . . . 3.94 107.995 173.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' HG3' ' A' ' 14' ' ' GLU . 78.4 Cg_exo -54.39 28.92 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.405 0 C-N-CA 124.01 3.14 . . . . 4.52 115.165 171.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 32' ' ' ASP . 11.3 t -95.22 -175.59 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.772 0.829 . . . . 4.54 108.89 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.779 ' H ' HG12 ' A' ' 31' ' ' VAL . 29.3 m-20 -116.23 141.11 48.58 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.009 -0.432 . . . . 2.88 110.943 -171.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.513 ' HB ' ' CG ' ' A' ' 248' ' ' GLN . 0.4 OUTLIER -96.2 144.27 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 2.32 110.875 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -114.86 111.08 20.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 2.82 109.907 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -10.87 57.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.267 0.469 . . . . 2.24 112.267 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -59.77 -26.73 65.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.884 0.373 . . . . 4.54 110.934 175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -81.63 -15.42 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 3.06 111.357 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -62.19 109.84 1.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.472 0.654 . . . . 1.72 112.742 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -107.23 120.61 42.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.748 -1.115 . . . . 3.69 109.405 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -85.12 130.68 34.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.762 -0.654 . . . . 4.64 109.805 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 43' ' ' SER . 16.4 t70 -110.33 125.63 30.57 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.375 -0.375 . . . . 2.27 110.727 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.08 -9.73 23.76 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.951 2.434 . . . . 2.15 113.831 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . 43.4 t -78.88 -26.36 43.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.305 -0.628 . . . . 4.29 109.305 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.64 125.89 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 4.74 109.663 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -118.68 133.38 23.6 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.441 -0.8 . . . . 3.77 110.568 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.73 123.66 6.14 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.008 2.472 . . . . 2.36 111.539 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 79' ' ' LEU . 47.5 mt -59.19 144.39 46.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 2.55 111.523 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.8 t -93.49 114.42 26.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.014 -1.106 . . . . 2.38 108.014 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.76 133.11 64.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.987 -0.552 . . . . 1.59 111.85 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 20.0 m -120.54 90.88 3.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.912 -0.585 . . . . 1.45 109.601 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -108.42 -2.26 19.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.06 -0.518 . . . . 3.62 111.403 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.37 -30.29 63.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.044 0.449 . . . . 2.48 110.228 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 94.1 mt-30 -76.16 -21.77 56.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 2.24 110.435 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -69.33 150.69 47.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.755 -0.657 . . . . 0.8 111.501 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.754 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 77.9 m -141.41 128.82 21.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.867 -0.606 . . . . 1.06 110.274 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 176' ' ' THR . 22.9 m -74.91 147.76 40.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 1.26 110.056 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 71' ' ' ASP . 96.2 mt -115.04 -52.32 2.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.421 -0.354 . . . . 0.74 110.985 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HA ' ' N ' ' A' ' 175' ' ' PHE . 15.9 ptp180 -163.99 164.69 23.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 3.17 111.33 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 tt -126.6 139.18 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.64 -0.709 . . . . 0.64 109.548 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.4 tp -126.56 137.19 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.96 111.344 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -92.32 107.88 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.329 -0.989 . . . . 1.49 108.329 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -113.34 68.06 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.02 -0.672 . . . . 1.83 109.969 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.64 -57.26 0.08 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 113.961 -1.472 . . . . 1.64 115.097 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -107.97 -22.79 12.28 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.389 0.276 . . . . 3.33 111.436 -169.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.42 178.29 10.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.662 0.268 . . . . 1.38 110.466 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 228' ' ' LEU . 96.8 m-85 -111.04 143.46 41.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.367 -0.379 . . . . 2.74 110.168 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -122.08 108.51 13.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.637 -0.256 . . . . 1.76 110.816 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 22.0 t -94.92 112.07 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.528 -0.545 . . . . 1.15 109.528 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.2 132.16 39.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.018 0.437 . . . . 2.02 111.866 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -103.83 157.73 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 1.66 109.249 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.754 ' OD1' ' HB ' ' A' ' 55' ' ' THR . 1.6 p-10 -91.09 125.54 35.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.15 0.5 . . . . 1.33 109.846 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.563 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 6.9 t70 -152.96 63.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.464 0.649 . . . . 2.65 110.313 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -76.68 1.81 15.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.065 0.935 . . . . 1.61 109.088 167.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -163.72 140.28 6.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.55 -1.648 . . . . 2.35 106.55 -177.091 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.15 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.713 0.768 . . . . 1.92 112.801 -168.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 70.8 mmtt -101.16 -47.25 4.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.314 -0.857 . . . . 1.77 110.199 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -105.5 99.42 9.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.762 -0.654 . . . . 0.76 110.268 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.34 127.64 65.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.042 -0.526 . . . . 1.27 111.554 -171.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 47' ' ' LEU . 48.2 tp -119.56 117.37 28.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 1.29 109.783 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -160.82 122.68 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.173 -0.306 . . . . 2.54 110.173 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -119.83 -179.52 16.51 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-O 119.587 -0.563 . . . . 1.31 112.315 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -34.87 -135.43 0.0 OUTLIER Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.43 0.932 . . . . 1.9 115.43 166.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.69 167.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 123.365 2.71 . . . . 2.91 113.802 -172.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.4 pt? -33.51 82.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.622 1.341 . . . . 4.11 114.622 -146.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 21.7 p-10 -81.67 -77.3 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.437 -1.71 . . . . 4.95 112.543 175.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.438 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.22 131.93 0.81 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.723 -1.351 . . . . 2.25 109.723 -165.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.7 m -73.6 115.54 13.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.086 0.943 . . . . 1.91 111.769 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.6 m-85 -104.85 145.84 29.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.659 -0.7 . . . . 3.7 109.74 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 80.2 mtm180 -107.72 138.31 44.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.551 0.215 . . . . 3.54 110.777 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HB3' ' HB1' ' A' ' 77' ' ' ALA . 4.4 tt -88.73 112.45 23.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.921 -0.77 . . . . 1.14 108.921 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' CE3' ' A' ' 123' ' ' TRP . 54.7 mt -125.54 -23.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.518 -0.473 . . . . 1.68 111.567 -174.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.716 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.1 pt20 -156.49 159.56 38.73 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.101 -0.374 . . . . 1.55 110.715 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 31.9 p90 -150.82 164.23 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.86 110.285 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.538 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 4.2 p-80 -137.98 158.53 44.13 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.656 0.597 . . . . 0.93 110.58 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -136.0 168.83 18.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.954 -0.387 . . . . 3.17 109.954 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -165.43 146.31 7.15 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.951 -0.389 . . . . 1.68 109.951 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.461 ' CZ3' ' HB2' ' A' ' 226' ' ' ARG . 83.1 t90 -140.22 147.97 40.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.233 -0.44 . . . . 5.18 109.833 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 84.76 165.61 40.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.682 -0.771 . . . . 2.13 113.164 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . 40.5 t 160.58 -89.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.115 0.966 . . . . 2.9 108.551 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.52 -156.55 0.55 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.983 -0.553 . . . . 3.03 110.027 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.79 -42.06 62.15 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.491 0.495 . . . . 3.85 111.361 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.28 46.63 0.56 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.351 -0.7 . . . . 1.94 111.351 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 104' ' ' GLY . 4.6 tt0 -116.74 -174.87 2.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.026 -0.731 . . . . 2.45 109.026 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 103' ' ' GLN . . . 131.39 -25.21 4.08 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.397 -0.906 . . . . 1.47 112.737 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 62.4 p -67.34 -36.58 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 245' ' ' ARG . 34.5 tt0 82.41 174.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.282 -1.377 . . . . 3.72 107.282 -166.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 98.2 m-70 55.66 58.86 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 3.52 111.605 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -82.26 122.2 27.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.249 0.547 . . . . 2.52 110.311 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 23.1 t -89.04 91.84 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.764 -0.653 . . . . 2.48 109.682 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.486 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 27.2 t70 64.84 -70.14 0.09 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.015 0.822 . . . . 2.8 110.65 -174.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.486 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 0.3 OUTLIER -142.21 11.81 1.97 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.013 -0.539 . . . . 4.98 111.094 174.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 40.1 ttmt -81.19 84.9 6.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.068 0.461 . . . . 3.23 109.795 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.493 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 17.6 pttp -110.87 132.97 53.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 2.82 110.82 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -107.07 167.42 9.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.471 -0.331 . . . . 1.62 110.307 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.439 ' HB1' ' NE1' ' A' ' 97' ' ' TRP . . . -65.16 -36.14 83.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.373 -0.376 . . . . 1.03 111.885 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.87 165.48 35.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.637 0.256 . . . . 0.75 110.998 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 105' ' ' SER . 51.9 tt0 -146.67 141.88 27.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.068 -0.716 . . . . 1.58 109.068 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' A' ' 93' ' ' PHE . 48.7 tp -101.57 116.41 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.936 -0.574 . . . . 1.07 109.496 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.538 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 18.8 m170 -107.42 105.44 15.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 1.77 110.69 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.7 mp -94.18 125.72 38.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.861 -0.609 . . . . 0.93 110.461 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -92.41 137.51 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 0.61 110.43 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 36.3 m80 -131.64 140.44 49.37 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.133 -0.692 . . . . 2.13 109.133 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.562 ' CE3' HD12 ' A' ' 91' ' ' ILE . 47.1 m0 -110.44 129.99 55.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.121 0.263 . . . . 4.26 110.492 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -63.21 114.72 3.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.084 0.469 . . . . 2.02 110.748 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -80.5 -26.79 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.842 -0.617 . . . . 2.34 111.642 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -59.1 -24.45 62.96 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.753 0.279 . . . . 3.35 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -91.06 9.77 29.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.323 0.583 . . . . 3.1 110.721 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . 67.72 -4.09 4.46 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.221 -0.899 . . . . 2.37 115.333 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 21.8 t70 175.21 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.131 0.966 . . . . 3.93 109.936 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 134' ' ' VAL . 35.4 p90 -58.08 -34.94 70.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.036 -0.529 . . . . 3.0 111.053 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.54 -38.73 88.82 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.201 -0.523 . . . . 2.15 112.706 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 8.9 mmpt? -78.39 -37.32 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.131 0.491 . . . . 3.43 109.98 175.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.608 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -64.88 -34.36 78.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.365 -0.834 . . . . 1.76 112.312 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 130' ' ' PHE . 27.9 m -67.94 -9.18 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.848 0.314 . . . . 2.77 111.848 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -93.06 -6.16 48.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.26 0.552 . . . . 3.55 110.309 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 44.7 tt0 -107.29 131.63 21.56 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 3.02 109.317 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 50.9 Cg_exo -55.03 -22.07 29.54 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.968 2.445 . . . . 1.6 112.879 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.575 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.9 m-20 -111.56 28.6 8.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 2.29 110.605 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -80.85 -40.29 12.25 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.086 -0.578 . . . . 1.22 114.524 -173.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.94 158.38 18.28 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.218 -0.578 . . . . 1.57 109.95 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -143.67 117.84 9.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.855 0.36 . . . . 1.38 110.716 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.75 121.38 61.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.141 -0.482 . . . . 1.73 110.06 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 209' ' ' ILE . 60.9 tp -93.83 119.42 32.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.486 -0.561 . . . . 2.42 109.486 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.75 111.35 3.76 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.977 -0.63 . . . . 0.86 112.615 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.7 mt -110.96 107.57 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 110.221 -0.288 . . . . 0.76 110.221 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 96.8 m-85 -63.15 149.46 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.2 111.323 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mp -113.83 131.26 56.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.589 . . . . 0.88 110.121 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 216' ' ' SER . 17.4 ptpt -122.16 136.82 54.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.562 -0.532 . . . . 2.03 109.562 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 3.6 m -99.82 79.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.313 0.577 . . . . 1.27 112.262 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -157.89 60.05 0.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.684 -0.77 . . . . 1.53 112.024 168.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.594 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 7.7 t 158.78 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.64 -1.244 . . . . 1.54 107.64 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -76.43 139.07 40.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.815 0.34 . . . . 0.78 110.739 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 216' ' ' SER . 16.9 tptm -110.62 96.62 28.83 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.14 -0.482 . . . . 1.22 109.968 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.42 -36.18 97.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.971 2.448 . . . . 1.05 112.453 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.55 -6.68 66.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.196 -0.526 . . . . 0.7 113.597 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.1 tp -90.06 -21.18 22.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.773 0.787 . . . . 0.77 110.743 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.425 ' HA ' ' HB ' ' A' ' 160' ' ' VAL . 7.9 tp-100 -57.28 -34.77 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 1.41 111.648 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -47.37 -50.6 21.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.296 0.48 . . . . 2.86 112.296 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -81.05 -30.07 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.703 -0.399 . . . . 1.38 110.814 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 82.1 t -63.83 -35.62 73.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.2 0.524 . . . . 1.11 111.204 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.88 -22.51 60.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.293 -0.412 . . . . 1.22 111.516 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.55 -13.89 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.372 0.508 . . . . 1.41 112.372 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 164' ' ' ASP . 3.9 pp -60.13 -27.51 67.12 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.912 0.708 . . . . 1.39 112.912 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.581 ' N ' HD12 ' A' ' 163' ' ' LEU . 14.7 t70 -70.97 -25.03 62.54 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.954 -0.466 . . . . 2.31 110.664 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.3 m -76.69 -3.52 38.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.063 0.459 . . . . 1.4 111.136 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.2 pt -137.36 36.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.341 -0.615 . . . . 0.85 109.341 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -74.85 -25.36 58.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.665 -0.698 . . . . 1.59 111.255 -171.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 231' ' ' ASN . 0.1 OUTLIER -119.54 148.55 43.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.936 0.398 . . . . 0.77 111.139 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -55.09 126.08 23.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 2.29 112.017 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.93 -16.51 36.26 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.69 -0.767 . . . . 0.85 112.077 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -88.69 152.74 21.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.321 0.581 . . . . 1.7 110.796 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 t -143.78 159.19 42.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.466 -0.788 . . . . 1.37 109.078 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.96 130.86 20.39 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.855 -0.424 . . . . 0.61 109.855 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.28 132.94 55.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.369 -0.604 . . . . 1.8 109.369 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.404 ' N ' ' HA ' ' A' ' 58' ' ' ARG . 27.2 t80 -140.69 77.94 1.63 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.019 -1.104 . . . . 1.04 108.019 -173.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 56' ' ' SER . 4.9 m -106.73 156.98 18.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 1.17 111.757 -173.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.16 60.28 2.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.916 0.886 . . . . 1.77 112.254 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -131.58 130.46 42.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.649 -1.159 . . . . 3.99 108.829 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.46 140.75 21.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.01 0.433 . . . . 2.51 111.462 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' A' ' 183' ' ' LEU . 73.5 Cg_endo -79.84 -6.52 14.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.918 2.412 . . . . 1.26 111.617 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -58.65 -42.41 88.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.305 -0.861 . . . . 2.76 111.568 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.06 -15.29 69.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.953 -0.641 . . . . 1.12 112.995 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 180' ' ' PRO . 3.9 mm? -88.45 -10.58 48.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.502 0.192 . . . . 1.73 111.45 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.11 141.35 40.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.83 0.348 . . . . 3.45 111.018 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.87 -175.58 2.83 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.915 2.41 . . . . 2.08 112.722 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.64 -59.94 2.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.337 -0.392 . . . . 3.23 111.044 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 m -83.8 137.35 33.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 1.66 111.264 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.1 tp -109.18 64.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.352 0.596 . . . . 1.99 110.351 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.408 ' O ' HD12 ' A' ' 211' ' ' LEU . 19.1 m-20 -108.01 166.16 10.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.807 -0.812 . . . . 1.81 108.807 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -164.89 163.89 20.94 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.156 -0.618 . . . . 5.01 112.224 -167.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.34 130.99 55.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.05 -0.977 . . . . 3.93 108.375 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.2 p -95.32 106.22 18.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 2.13 111.393 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.446 ' OH ' ' HB2' ' A' ' 28' ' ' GLN . 54.1 t80 -135.99 125.43 16.02 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 5.21 111.882 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.38 132.55 5.15 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.694 2.263 . . . . 2.12 112.531 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -110.42 157.14 15.19 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.959 -0.564 . . . . 1.75 112.006 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 60.1 m -132.82 -160.62 1.06 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.595 -0.356 . . . . 2.99 111.206 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 23' ' ' ALA . 1.8 pp -71.93 6.68 1.94 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.51 0.93 . . . . 4.75 113.51 -172.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 27' ' ' ARG . 76.4 p -86.71 21.13 2.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.269 0.557 . . . . 5.1 110.532 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.615 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 18.3 p -125.32 179.74 1.07 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.879 -0.786 . . . . 5.53 108.879 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.615 ' HD2' ' HB ' ' A' ' 199' ' ' THR . 2.8 Cg_exo -33.77 -51.56 0.53 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.512 2.808 . . . . 5.83 114.364 171.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.59 126.91 4.82 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.475 1.45 . . . . 4.78 112.264 174.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.82 23.07 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 3.84 111.517 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.29 132.72 56.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.241 -0.436 . . . . 2.96 110.171 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 196' ' ' SER . 8.1 pt-20 -80.51 65.29 5.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.193 0.521 . . . . 3.37 110.989 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.4 p -128.53 13.9 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.44 0.904 . . . . 2.15 113.44 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.18 138.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.43 0.633 . . . . 1.26 112.181 -171.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 24.6 m -111.28 113.43 25.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.277 -1.009 . . . . 2.08 108.277 168.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -97.47 113.89 25.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.271 0.558 . . . . 5.53 110.331 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.478 ' O ' HD12 ' A' ' 143' ' ' LEU . 48.7 mm -103.49 102.99 14.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.587 -0.733 . . . . 1.63 109.277 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.06 125.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.412 -0.588 . . . . 1.62 109.412 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 189' ' ' ASP . 15.8 tp -80.09 116.85 20.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.058 -0.349 . . . . 1.73 110.058 -176.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -61.82 -33.38 74.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.95 -0.568 . . . . 2.98 110.401 -177.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -95.75 103.07 11.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 1.47 110.165 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 14.7 Cg_exo -71.23 171.58 15.74 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.725 2.283 . . . . 0.96 112.135 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.9 pt -112.44 149.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.566 . . . . 1.25 109.945 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 5.5 p -105.18 132.2 51.69 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.03 -0.532 . . . . 1.29 110.641 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 26.9 m -128.47 165.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.976 -0.556 . . . . 1.02 110.181 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 21.0 t -94.34 153.0 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.669 -0.241 . . . . 1.08 110.682 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.565 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 17.1 p -54.54 -48.14 72.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.49 0.186 . . . . 1.33 111.272 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -54.79 -29.41 54.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.392 -0.367 . . . . 2.51 111.63 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.88 -45.91 33.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.064 -0.516 . . . . 0.7 110.362 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 34.7 m -78.56 -21.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 1.36 111.91 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 219' ' ' SER . 77.1 mt -65.06 -31.62 72.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.411 . . . . 1.03 110.489 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 163' ' ' LEU . 53.2 mttm -74.61 -22.02 59.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.125 -0.489 . . . . 1.75 110.78 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.4 m-85 -77.48 -27.37 51.95 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.6 -0.889 . . . . 2.47 108.6 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.461 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 67.0 ttt180 -72.32 -20.06 61.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.535 -1.211 . . . . 3.04 110.651 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.16 -6.7 34.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 2.31 111.313 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.451 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 93.2 mt -65.22 154.78 37.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.916 0.389 . . . . 0.95 110.647 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -116.71 134.71 54.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.312 0.577 . . . . 1.13 110.713 -175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -78.72 -35.68 44.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.868 -1.06 . . . . 3.74 109.774 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.3 p-10 -72.64 169.35 16.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.049 -0.978 . . . . 1.62 111.888 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.01 177.25 38.19 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.303 -0.862 . . . . 1.16 111.177 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.37 125.37 25.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 3.56 110.487 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.14 7.74 42.99 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.728 -0.669 . . . . 2.08 113.397 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 44.3 mt-10 -112.32 157.54 39.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 117.393 0.597 . . . . 2.59 109.67 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.66 125.33 18.38 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.289 1.992 . . . . 1.36 110.613 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.43 118.48 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.84 0.829 . . . . 3.4 112.564 -171.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.99 116.37 31.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.583 -1.19 . . . . 2.47 107.901 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.97 125.14 25.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.063 0.459 . . . . 2.14 110.584 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 60.7 ttm -78.94 89.78 4.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 1.68 110.59 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.01 167.6 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.766 -0.827 . . . . 1.27 108.766 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 19.5 t70 66.48 -88.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.764 0.665 . . . . 2.18 110.056 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 63.09 -11.26 0.09 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.354 0.872 . . . . 2.15 113.354 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.427 ' CZ3' ' HG3' ' A' ' 200' ' ' PRO . 98.0 m95 -153.77 175.11 13.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.142 -0.688 . . . . 4.59 109.142 -169.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 106' ' ' GLU . 39.0 mtp85 -129.39 147.54 65.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.212 -0.292 . . . . 6.13 110.212 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.99 82.48 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.748 2.298 . . . . 3.28 111.561 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.429 ' HB3' HE21 ' A' ' 28' ' ' GLN . . . -98.78 118.18 34.94 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.049 -0.523 . . . . 2.98 111.315 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.513 ' CG ' ' HB ' ' A' ' 33' ' ' ILE . 16.2 mm-40 -124.16 156.31 66.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 4.32 109.465 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 1.1 Cg_endo -43.18 129.54 6.03 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.404 2.736 . . . . 3.48 113.095 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -43.45 -57.21 3.19 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 124.121 0.888 . . . . 4.63 112.231 -171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 54.6 pttt -106.34 0.2 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.554 0.216 . . . . 5.34 111.422 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER 75.89 -47.97 0.58 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.601 0.761 . . . . 4.64 111.465 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 70.64 -108.81 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.607 -0.886 . . . . 6.11 108.607 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -140.93 136.75 32.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.231 -1.396 . . . . 3.08 107.231 165.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 75.6 mt -84.6 121.85 37.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.302 -0.559 . . . . 2.6 109.671 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.35 134.85 42.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.899 -0.778 . . . . 2.63 108.899 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.25 172.9 12.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.257 -0.429 . . . . 1.71 110.019 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.7 m -128.33 94.69 3.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.292 -0.563 . . . . 2.21 110.968 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -146.37 126.66 13.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.733 -0.839 . . . . 4.31 108.733 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 18.8 pttp . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.244 -0.884 . . . . 4.49 110.336 -179.42 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptm . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.707 0.289 . . . . 17.49 110.333 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -77.91 -24.54 48.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.356 0.598 . . . . 15.32 109.652 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -109.61 117.23 33.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.427 -0.806 . . . . 15.81 109.351 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -89.32 -8.15 53.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.386 -0.598 . . . . 14.19 109.386 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 70.12 -67.28 0.24 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.951 -1.022 . . . . 14.91 110.727 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' HA3' ' HA2' ' A' ' 12' ' ' GLY . . . -119.23 128.84 7.8 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.658 -0.782 . . . . 10.79 111.503 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.499 ' CE2' ' HG3' ' A' ' 245' ' ' ARG . 55.3 m-85 -81.13 103.03 10.65 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.608 0.718 . . . . 11.39 110.776 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.04 -84.83 0.19 Allowed Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.658 -1.155 . . . . 9.0 110.33 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -92.57 147.86 22.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.894 -0.78 . . . . 9.76 108.894 170.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -62.55 -24.17 67.39 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.043 0.386 . . . . 11.19 112.043 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -104.03 -2.25 26.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.394 0.616 . . . . 10.8 110.509 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' HA3' ' A' ' 6' ' ' GLY . . . 95.31 120.47 3.53 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.674 -0.774 . . . . 8.82 111.333 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.92 122.49 7.28 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.852 1.701 . . . . 7.87 112.933 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -92.28 -19.1 22.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.351 -0.84 . . . . 10.62 110.753 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -114.37 22.94 13.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 9.87 111.072 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.404 ' CD1' HD21 ' A' ' 202' ' ' LEU . 25.1 t-105 -66.8 -22.66 66.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.597 0.713 . . . . 8.48 109.748 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 30.6 p-80 -64.15 -9.82 19.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.542 -0.754 . . . . 7.13 111.762 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -78.23 -11.84 59.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.667 0.27 . . . . 9.68 111.353 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -123.66 -17.73 6.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 7.89 110.054 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 13.3 m-85 -140.55 89.77 10.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.08 -0.509 . . . . 7.17 109.646 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 74.9 Cg_exo -51.2 -35.11 51.24 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.121 2.548 . . . . 7.76 113.145 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.9 pt -57.65 -2.65 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 113.845 1.054 . . . . 5.83 113.845 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.14 -17.04 64.68 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.18 -0.325 . . . . 5.44 110.53 172.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 21' ' ' PRO . 61.7 mttp -45.1 -21.28 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.109 0.781 . . . . 7.78 113.109 169.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.95 -161.98 36.52 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.788 -0.925 . . . . 5.01 110.788 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -116.55 104.54 11.51 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 118.058 -1.457 . . . . 7.09 109.366 172.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HE ' ' HB2' ' A' ' 27' ' ' ARG . 5.3 ttm180 -165.73 129.77 2.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 118.305 -0.855 . . . . 5.13 108.813 164.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -111.47 -52.52 2.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 120.861 1.664 . . . . 7.12 111.423 159.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 m -100.52 162.38 20.98 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 110.125 -0.324 . . . . 3.94 110.125 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 246' ' ' PRO . 88.3 Cg_endo -99.4 -2.92 0.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.786 2.324 . . . . 4.52 114.579 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 107' ' ' HIS . 4.1 p -160.09 140.08 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 114.585 1.328 . . . . 4.54 114.585 -174.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -164.53 117.07 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.067 -1.457 . . . . 2.88 107.067 158.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 55.5 mt -93.96 90.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.237 0.541 . . . . 2.32 111.116 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -77.15 106.23 8.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.604 -0.726 . . . . 2.82 109.849 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -40.61 30.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.402 -0.817 . . . . 2.24 112.777 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -70.48 -33.75 71.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 4.54 110.885 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 m -89.34 -30.26 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.459 -0.337 . . . . 3.06 111.252 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.87 89.93 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.043 0.449 . . . . 1.72 112.035 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -97.97 138.75 34.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.944 -0.571 . . . . 3.69 110.145 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.772 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 48.0 p90 -84.26 123.4 30.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.928 0.394 . . . . 4.64 110.65 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.97 139.0 23.07 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.32 -0.4 . . . . 2.27 110.076 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -90.17 22.82 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.812 2.341 . . . . 2.15 112.324 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 m -89.35 -18.8 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 4.29 110.65 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.45 HD21 ' OG ' ' A' ' 258' ' ' SER . 3.4 pp -97.55 156.91 16.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 4.74 110.255 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -99.03 144.22 27.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.432 -0.349 . . . . 3.77 110.954 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 31.1 Cg_endo -64.37 165.35 20.23 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.128 2.552 . . . . 2.36 112.184 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.6 146.23 24.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 2.55 111.743 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -110.61 107.15 16.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.678 -0.86 . . . . 2.38 108.678 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -90.76 102.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.411 -0.359 . . . . 1.59 110.873 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -119.26 89.47 3.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.119 0.485 . . . . 1.45 110.423 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.06 21.71 1.58 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.54 0.686 . . . . 3.62 110.423 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.31 -17.92 64.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.38 -0.827 . . . . 2.48 110.021 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.02 -5.02 38.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.729 -0.669 . . . . 2.24 109.811 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.61 158.76 35.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.707 -0.678 . . . . 0.8 111.838 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -150.16 143.38 25.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.199 -0.91 . . . . 1.06 109.076 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 176' ' ' THR . 14.5 m -91.1 165.37 13.54 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.14 -0.689 . . . . 1.26 109.14 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -119.36 -50.34 2.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.018 0.437 . . . . 0.74 111.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -157.9 152.58 25.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.256 -0.429 . . . . 3.17 111.072 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.551 HG13 HG22 ' A' ' 68' ' ' VAL . 14.6 tt -115.55 138.48 45.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.034 -0.728 . . . . 0.64 109.034 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 172' ' ' SER . 47.2 tp -135.82 141.17 44.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.207 0.527 . . . . 0.96 112.229 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -100.16 105.6 17.22 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.797 -1.186 . . . . 1.49 107.797 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -138.56 73.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.158 0.504 . . . . 1.83 112.09 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.59 -52.71 0.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.838 -1.173 . . . . 1.64 111.997 161.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -147.41 -51.24 0.19 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.98 0.419 . . . . 3.33 110.094 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.58 169.77 8.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 1.38 111.491 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 228' ' ' LEU . 34.4 m-85 -110.24 100.25 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.502 -0.772 . . . . 2.74 109.247 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -89.33 118.58 29.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 1.76 111.622 -170.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 59' ' ' ILE . 21.3 t -100.71 114.07 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.65 -0.5 . . . . 1.15 109.65 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -80.26 138.77 36.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.038 0.385 . . . . 2.02 112.038 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.454 ' CE2' ' HD1' ' A' ' 93' ' ' PHE . 65.9 m-85 -105.32 163.32 12.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.691 -0.686 . . . . 1.66 109.747 170.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.58 113.53 25.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.894 -0.41 . . . . 1.33 109.894 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -124.55 57.87 1.24 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.868 0.842 . . . . 2.65 111.034 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -87.71 -9.26 54.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.082 0.944 . . . . 1.61 108.926 167.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.25 171.3 19.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.445 -1.252 . . . . 2.35 108.057 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.28 73.15 2.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.38 0.609 . . . . 1.92 110.857 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -92.35 -56.48 3.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.815 . . . . 1.77 109.67 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.21 101.71 11.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.719 -0.673 . . . . 0.76 109.722 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.31 135.23 63.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.191 0.52 . . . . 1.27 110.746 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 tp -140.07 110.56 6.69 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.342 -0.985 . . . . 1.29 108.342 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -148.89 125.62 11.13 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.006 -0.678 . . . . 2.54 112.683 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . -66.22 173.86 23.18 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.354 -0.839 . . . . 1.31 111.663 159.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' O ' ' HG ' ' A' ' 84' ' ' LEU . . . -41.83 -143.93 0.0 OUTLIER Glycine 0 CA--C 1.538 1.485 0 N-CA-C 114.996 0.758 . . . . 1.9 114.996 169.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.88 122.69 9.45 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.955 1.77 . . . . 2.91 112.447 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 82' ' ' GLY . 82.1 mt -138.77 -168.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.899 -1.046 . . . . 4.11 110.216 -174.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.64 57.17 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.022 0.379 . . . . 4.95 112.022 -167.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.51 -116.94 2.26 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.024 -1.084 . . . . 2.25 113.995 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.417 HG21 ' HB ' ' A' ' 125' ' ' THR . 11.6 m -127.36 111.78 14.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.65 -0.5 . . . . 1.91 109.65 -171.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.73 ' HA ' ' CD2' ' A' ' 122' ' ' HIS . 9.8 m-85 -99.03 91.12 4.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.518 0.675 . . . . 3.7 112.3 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.57 146.77 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.016 -0.993 . . . . 3.54 109.532 172.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 120' ' ' LEU . 10.4 tp -89.61 130.33 35.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.633 -0.506 . . . . 1.14 109.633 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.5 tt -106.31 -32.78 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.677 0.275 . . . . 1.68 111.481 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 91' ' ' ILE . 3.8 pt20 -163.04 171.95 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 1.55 110.352 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.454 ' HD1' ' CE2' ' A' ' 70' ' ' PHE . 26.8 p90 -144.41 146.98 32.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.86 109.347 169.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.426 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 5.2 p-80 -134.28 160.16 38.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.8 -0.444 . . . . 0.93 109.8 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.17 167.91 19.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.948 0.404 . . . . 3.17 110.95 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.13 167.78 29.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.93 -0.767 . . . . 1.68 108.93 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -151.2 151.11 31.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.15 0.282 . . . . 5.18 110.245 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -113.37 159.71 13.53 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.838 -0.696 . . . . 2.13 112.164 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 -39.76 79.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.869 0.366 . . . . 2.9 111.857 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.27 146.02 37.75 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.809 -0.812 . . . . 3.03 108.809 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.26 12.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.684 0.624 . . . . 3.85 112.684 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.66 17.83 10.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 1.94 111.97 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.429 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 14.0 pt20 -158.15 159.51 36.24 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.115 -0.328 . . . . 2.45 110.115 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.46 6.74 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 1.47 112.246 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.4 t -69.41 -45.81 68.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.748 0.309 . . . . 2.0 111.069 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.586 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 2.6 tp10 65.05 -162.64 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.528 -0.76 . . . . 3.72 109.093 -169.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.615 ' HA ' HG21 ' A' ' 31' ' ' VAL . 33.7 m80 53.27 49.28 20.19 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.171 0.986 . . . . 3.52 108.53 -167.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 t -79.72 131.58 35.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.815 -1.539 . . . . 2.52 112.171 -168.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 28.4 t -98.98 107.55 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 114.359 -1.291 . . . . 2.48 109.633 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.36 42.95 20.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.56 0.695 . . . . 2.8 110.096 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm 61.15 20.71 11.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.887 -1.051 . . . . 4.98 112.497 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -94.01 112.34 24.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.59 -0.522 . . . . 3.23 109.59 169.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 50.7 mttp -98.55 168.03 10.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.18 0.514 . . . . 2.82 111.174 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -119.53 176.55 5.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.3 -0.863 . . . . 1.62 109.453 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.91 94.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.1 0.407 . . . . 1.03 112.1 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.8 168.5 25.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.267 -0.424 . . . . 0.75 109.961 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -142.52 140.37 31.8 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.599 -0.519 . . . . 1.58 109.599 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 36.8 tp -103.3 125.75 50.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.323 -0.621 . . . . 1.07 109.323 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 12.3 m170 -118.76 109.93 16.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.1 0.476 . . . . 1.77 112.1 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -94.33 116.43 28.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.701 -0.681 . . . . 0.93 109.484 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.3 124.24 48.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.105 0.478 . . . . 0.61 112.013 -171.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.73 ' CD2' ' HA ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -89.62 140.96 29.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 2.13 111.005 175.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -112.64 141.53 46.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 4.26 109.542 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -93.22 96.01 9.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 2.02 110.927 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.417 ' HB ' HG21 ' A' ' 87' ' ' THR . 2.9 m -68.01 -16.94 64.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.934 -0.576 . . . . 2.34 111.251 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -52.63 -33.12 45.22 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.71 0.404 . . . . 3.35 111.804 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -107.85 -6.51 16.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.367 0.603 . . . . 3.1 110.484 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.52 38.55 9.5 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.232 -1.349 . . . . 2.37 113.785 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.56 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 22.8 t70 -166.31 110.48 0.79 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.634 -0.506 . . . . 3.93 109.634 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -57.26 -32.94 67.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 3.0 111.19 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.15 81.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.056 -0.593 . . . . 2.15 112.761 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.56 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 38.0 mmtm -88.29 -28.8 20.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 3.43 110.375 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.482 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -63.91 -36.28 83.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.76 110.685 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.483 ' O ' HD21 ' A' ' 203' ' ' LEU . 34.9 m -77.99 -2.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.372 -0.376 . . . . 2.77 111.236 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -109.01 19.23 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.278 0.561 . . . . 3.55 110.449 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -129.02 128.3 23.38 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.269 -1.011 . . . . 3.02 108.269 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.88 -31.59 73.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.097 2.532 . . . . 1.6 113.2 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -111.13 24.26 13.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 2.29 109.997 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -66.01 -50.23 53.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.016 -0.538 . . . . 1.22 112.497 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 79.4 mt -109.28 151.98 25.83 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.418 -0.586 . . . . 1.57 109.418 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -145.99 123.91 12.02 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.748 -0.834 . . . . 1.38 108.748 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.55 116.83 53.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.879 -0.328 . . . . 1.73 110.899 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 38.0 tp -83.38 115.69 22.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.668 -0.696 . . . . 2.42 109.696 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -106.16 128.88 9.52 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.038 -0.601 . . . . 0.86 112.623 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.7 122.61 70.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.387 -0.597 . . . . 0.76 109.387 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -69.75 146.39 51.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 1.2 110.301 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.34 130.46 56.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.413 -0.358 . . . . 0.88 110.149 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 216' ' ' SER . 26.2 pttm -125.32 151.59 45.84 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.457 -0.571 . . . . 2.03 109.457 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 40.7 t -84.84 121.42 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.094 0.473 . . . . 1.27 110.62 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.48 -114.72 0.33 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.504 -0.771 . . . . 1.53 111.201 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.3 p -74.01 156.3 37.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.206 -0.294 . . . . 1.54 110.206 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.22 148.88 37.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.808 0.337 . . . . 0.78 111.04 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 216' ' ' SER . 46.3 tptt -113.68 100.04 51.2 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.29 -0.414 . . . . 1.22 110.033 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 28.4 Cg_endo -63.32 -31.33 73.42 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.663 2.242 . . . . 1.05 112.543 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.94 -19.34 71.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.063 -0.589 . . . . 0.7 112.979 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.0 tp -112.07 -12.04 13.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.054 0.454 . . . . 0.77 110.792 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -40.52 79.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.909 -0.587 . . . . 1.41 111.142 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.98 -26.86 62.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.972 0.415 . . . . 2.86 110.314 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 162' ' ' VAL . 59.0 t -72.3 -44.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 1.38 109.504 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.563 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 41.6 t -62.58 -34.31 64.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.691 . . . . 1.11 110.361 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.2 -28.74 68.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.443 -0.798 . . . . 1.22 111.562 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 159' ' ' VAL . 8.8 p -97.73 -14.57 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.794 -0.363 . . . . 1.41 111.883 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.4 pp -70.75 -20.42 62.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.618 -0.433 . . . . 1.39 111.891 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 30.7 t70 -67.39 -24.42 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.235 0.54 . . . . 2.31 110.398 176.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.0 m -79.81 1.16 27.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 1.4 111.229 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 59' ' ' ILE . 40.5 pt -137.28 37.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.779 -0.823 . . . . 0.85 108.779 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 87.1 tttt -58.45 -32.01 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.861 -1.063 . . . . 1.59 111.854 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -119.92 154.17 34.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.31 -0.404 . . . . 0.77 110.485 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.46 135.37 57.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 2.29 110.663 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.7 38.18 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.71 -0.757 . . . . 0.85 111.715 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -89.77 143.47 26.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.7 110.711 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.488 ' HB3' HD13 ' A' ' 60' ' ' LEU . 65.3 p -139.88 156.59 46.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.033 -0.53 . . . . 1.37 109.659 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.6 140.37 40.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.118 -0.327 . . . . 0.61 110.118 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.92 130.8 44.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.553 -0.536 . . . . 1.8 109.553 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.38 79.79 1.68 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.797 -0.446 . . . . 1.04 109.797 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 56' ' ' SER . 21.7 p -106.76 164.98 11.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 1.17 111.148 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 56.65 71.32 0.58 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.432 0.457 . . . . 1.77 111.255 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.473 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 55.1 t80 -123.59 142.37 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.754 0.311 . . . . 3.99 110.293 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.47 102.3 14.11 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.823 -0.626 . . . . 2.51 110.061 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 2.9 Cg_exo -75.83 -19.83 15.82 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.637 2.224 . . . . 1.26 111.688 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -56.6 -38.55 72.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.287 -0.87 . . . . 2.76 111.663 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.08 6.94 2.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.125 -0.489 . . . . 1.12 113.863 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.57 -13.61 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.272 0.536 . . . . 1.73 110.352 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.3 130.43 87.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.591 . . . . 3.45 111.356 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.62 -171.95 1.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.443 2.095 . . . . 2.08 111.384 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.91 -62.37 1.67 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.936 0.398 . . . . 3.23 110.203 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.4 m -75.06 123.1 24.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 1.66 110.936 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.3 tp -101.52 64.1 0.98 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.625 0.726 . . . . 1.99 109.47 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 258' ' ' SER . 12.3 m-20 -124.91 147.64 48.73 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.398 -0.964 . . . . 1.81 108.398 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.457 ' CD1' HG23 ' A' ' 209' ' ' ILE . 53.1 p90 -144.43 158.71 43.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.562 0.949 . . . . 5.01 113.562 -166.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -93.02 140.08 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.42 -1.326 . . . . 3.93 107.42 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 9.3 t -136.57 116.72 13.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.713 0.688 . . . . 2.13 112.684 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -140.31 132.38 14.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 5.21 110.632 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.18 125.4 10.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.598 1.532 . . . . 2.12 110.575 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.34 160.13 26.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.035 -0.602 . . . . 1.75 113.249 -168.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 14.0 m -63.4 152.83 37.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.65 -0.5 . . . . 2.99 109.65 173.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.527 ' H ' HD12 ' A' ' 197' ' ' LEU . 5.7 mp -61.99 -50.86 70.37 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.18 -0.608 . . . . 4.75 112.055 -169.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 200' ' ' PRO . 23.5 p -122.47 -44.93 2.22 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.0 -0.28 . . . . 5.1 111.54 175.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 200' ' ' PRO . 1.9 m 157.71 -57.34 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 125.579 1.552 . . . . 5.53 109.118 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 199' ' ' THR . 53.4 Cg_exo -51.09 -43.55 47.55 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.326 2.018 . . . . 5.83 113.948 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.578 ' O ' ' HB3' ' A' ' 196' ' ' SER . 3.0 Cg_endo -83.37 109.11 1.58 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.034 1.823 . . . . 4.78 111.144 172.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 202' ' ' LEU . 1.8 mm? -78.58 50.42 0.96 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.439 0.638 . . . . 3.84 110.29 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 196' ' ' SER . 30.9 tp -116.18 120.34 38.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.359 -0.837 . . . . 2.96 108.905 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -98.89 51.55 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.381 0.61 . . . . 3.37 110.897 -171.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.7 p -91.89 -5.72 52.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.926 -0.579 . . . . 2.15 110.859 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 133.18 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.064 0.459 . . . . 1.26 110.575 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 21.7 m -105.91 103.51 13.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.126 -0.694 . . . . 2.08 109.126 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 192' ' ' THR . 96.3 m95 -76.16 110.39 10.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.301 -0.409 . . . . 5.53 110.43 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 74.3 mt -115.38 101.18 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.201 -0.666 . . . . 1.63 109.201 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 41.3 t -113.44 126.03 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 121.035 -0.266 . . . . 1.62 110.852 -171.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 137.25 41.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.291 0.567 . . . . 1.73 111.306 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -68.38 -10.35 54.46 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.346 -0.843 . . . . 2.98 112.376 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -114.61 107.75 50.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.815 -0.354 . . . . 1.47 111.198 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.81 143.49 50.77 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.133 2.555 . . . . 0.96 112.417 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -96.43 158.86 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.29 -0.633 . . . . 1.25 109.29 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 6.6 m -106.91 139.36 41.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.967 0.413 . . . . 1.29 111.425 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -124.18 148.42 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.02 109.024 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.7 t -94.98 164.78 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.149 -0.315 . . . . 1.08 110.149 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 m -47.23 -48.09 24.43 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.775 0.658 . . . . 1.33 112.775 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.55 -33.98 56.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 2.51 111.413 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -78.38 -43.32 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.262 -0.426 . . . . 0.7 110.049 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.72 -38.93 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 1.36 110.929 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.4 mt -57.63 -36.03 71.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.766 -0.652 . . . . 1.03 111.303 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -77.2 -24.33 51.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.318 -0.401 . . . . 1.75 110.961 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -72.13 -34.04 68.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 2.47 109.491 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -70.87 -11.1 60.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.093 -0.958 . . . . 3.04 110.987 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 99.6 mttt -89.96 -19.36 24.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.3 -0.409 . . . . 2.31 111.338 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.436 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 95.7 mt -64.61 146.03 55.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.321 0.582 . . . . 0.95 112.199 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.09 149.2 37.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.408 -0.815 . . . . 1.13 109.901 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -86.4 -32.12 21.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.464 -0.789 . . . . 3.74 110.027 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -71.95 166.49 22.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.085 -0.962 . . . . 1.62 111.959 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.99 -177.8 36.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.548 -0.751 . . . . 1.16 111.433 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.05 130.76 46.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.838 0.352 . . . . 3.56 110.743 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.6 33.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.808 -0.71 . . . . 2.08 112.919 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.84 160.48 66.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.37 -0.604 . . . . 2.59 109.37 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -53.06 123.02 12.18 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.476 2.117 . . . . 1.36 111.46 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.413 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 54.1 mt-10 -68.65 112.74 5.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 3.4 111.413 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -116.42 121.42 41.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.05 -0.977 . . . . 2.47 109.268 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -67.54 148.42 51.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 2.14 111.06 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 57.0 tpp -76.68 97.38 4.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.233 -0.894 . . . . 1.68 109.202 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.16 135.12 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.955 0.354 . . . . 1.27 111.955 -171.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.595 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 38.9 t70 70.59 -59.98 0.51 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.242 1.017 . . . . 2.18 111.037 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 84.24 -28.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.976 -1.011 . . . . 2.15 113.023 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -165.04 152.66 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.264 0.484 . . . . 4.59 112.07 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 31.6 tpt180 -139.72 71.99 36.19 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.408 -0.815 . . . . 6.13 109.565 173.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 31.2 Cg_endo -120.25 57.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 123.498 2.798 . . . . 3.28 115.378 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 31' ' ' VAL . . . -115.26 122.31 45.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.634 1.106 . . . . 2.98 110.827 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 253' ' ' ARG . 16.5 mm-40 -122.91 162.7 37.56 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 111.697 0.258 . . . . 4.32 111.697 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.24 174.02 11.38 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.976 2.451 . . . . 3.48 113.512 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 252' ' ' ASN . 3.3 mm? -60.68 -11.01 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.591 -1.186 . . . . 4.63 113.451 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 252' ' ' ASN . 19.6 ptpt -59.44 41.25 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.611 1.338 . . . . 5.34 114.611 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 251' ' ' LYS . 6.3 t-20 118.48 -33.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.539 1.935 . . . . 4.64 110.069 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.55 ' N ' ' HD3' ' A' ' 253' ' ' ARG . 0.5 OUTLIER -90.69 89.6 7.59 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.586 0.708 . . . . 6.11 110.107 -177.313 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -155.39 154.1 31.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.92 -1.141 . . . . 3.08 107.92 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 31' ' ' VAL . 14.9 mt -124.84 136.82 59.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.602 -0.439 . . . . 2.6 110.766 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.48 ' O ' HG22 ' A' ' 255' ' ' ILE . 40.5 mtmt -76.99 165.53 24.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 2.63 109.472 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.772 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.48 159.01 27.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.532 -0.544 . . . . 1.71 109.532 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 41.8 m -151.91 97.64 2.36 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.884 -0.413 . . . . 2.21 109.884 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.38 110.46 10.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.651 -0.704 . . . . 4.31 109.249 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.438 -0.792 . . . . 4.49 110.165 178.759 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 121.137 0.494 . . . . 17.49 110.148 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 t -94.19 156.38 16.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.657 -0.701 . . . . 15.32 110.036 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -111.03 0.99 17.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.255 -0.646 . . . . 15.81 109.255 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -79.23 -61.36 2.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.825 -0.625 . . . . 14.19 109.758 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 -93.51 132.83 37.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.163 0.506 . . . . 14.91 110.746 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.42 142.92 3.69 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.563 -1.015 . . . . 10.79 110.563 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -57.68 133.27 55.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.049 0.452 . . . . 11.39 110.592 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.23 -26.98 18.74 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.691 -0.686 . . . . 9.0 113.39 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 3.5 mptp? -79.73 139.11 37.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.294 0.547 . . . . 9.76 112.215 -173.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.6 m170 69.38 -82.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.097 -0.956 . . . . 11.19 111.808 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.25 -7.82 12.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.232 0.539 . . . . 10.8 110.087 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.02 -121.08 2.78 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.955 -1.258 . . . . 8.82 109.955 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.63 124.21 5.65 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.36 1.373 . . . . 7.87 110.697 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -90.28 -33.18 16.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.852 0.358 . . . . 10.62 110.52 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -71.66 -38.01 70.72 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.953 -0.758 . . . . 9.87 108.953 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -75.56 -11.94 60.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.501 -0.772 . . . . 8.48 110.614 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -75.95 -27.7 57.65 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.53 -0.544 . . . . 7.13 109.53 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -83.17 -29.09 28.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.131 -0.486 . . . . 9.68 110.262 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -77.53 -28.93 52.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.067 -0.515 . . . . 7.89 110.168 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -131.38 80.7 67.04 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.68 -0.691 . . . . 7.17 109.44 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -57.7 -25.96 70.68 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.167 2.578 . . . . 7.76 113.617 -176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.619 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 9.7 tp -81.04 7.64 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.886 0.374 . . . . 5.83 111.608 -176.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.08 14.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.666 0.617 . . . . 5.44 112.666 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -88.95 59.83 5.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.937 0.398 . . . . 7.78 111.043 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.42 -38.45 3.01 Favored Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 111.134 -0.786 . . . . 5.01 111.134 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 28.9 mm-40 -51.49 129.79 26.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.903 -0.648 . . . . 7.09 109.341 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.556 ' CD ' ' HB3' ' A' ' 252' ' ' ASN . 7.8 mtm180 -81.38 130.27 34.97 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.448 0.642 . . . . 5.13 112.582 -167.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' A' ' 248' ' ' GLN . 41.1 tt0 -136.0 -16.42 1.69 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.976 -1.011 . . . . 7.12 110.1 170.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.4 p -102.01 165.55 13.71 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 108.912 -0.773 . . . . 3.94 108.912 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 20.4 Cg_exo -67.22 -49.51 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 CA-C-N 119.748 0.946 . . . . 4.52 112.474 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.451 HG21 HG13 ' A' ' 255' ' ' ILE . 12.9 p -170.94 143.01 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.55 0.574 . . . . 4.54 112.55 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.17 116.68 24.52 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.212 -1.033 . . . . 2.88 108.212 157.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 61.3 mt -90.57 102.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 2.32 111.794 -167.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.08 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 2.82 109.944 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -60.1 -32.55 71.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.367 0.877 . . . . 2.24 113.367 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -68.85 -45.14 71.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.73 0.3 . . . . 4.54 111.083 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -82.09 -19.65 39.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.365 -0.38 . . . . 3.06 111.004 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.3 134.74 50.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.989 0.423 . . . . 1.72 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.76 116.31 28.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 3.69 110.401 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.51 124.4 26.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 4.64 109.82 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.659 ' O ' ' HA ' ' A' ' 258' ' ' SER . 29.9 t70 -118.9 143.37 33.6 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.128 -0.942 . . . . 2.27 110.137 -170.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 44' ' ' LEU . 21.1 Cg_exo -67.36 119.13 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.157 1.905 . . . . 2.15 111.815 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 m -53.38 43.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.025 1.12 . . . . 4.29 114.025 169.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' H ' ' A' ' 45' ' ' LYS . 2.0 pt? -14.32 -66.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.304 1.842 . . . . 4.74 114.044 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.613 ' H ' ' HG ' ' A' ' 44' ' ' LEU . 27.5 mmtp -117.16 148.6 42.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 121.717 -0.615 . . . . 3.77 109.807 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.23 137.66 31.68 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.747 2.298 . . . . 2.36 112.696 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.462 HD11 ' CD2' ' A' ' 190' ' ' TYR . 95.1 mt -66.61 127.41 32.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 2.55 111.06 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 22.7 t -84.12 115.16 22.25 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.652 -0.87 . . . . 2.38 108.652 174.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.9 107.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.521 . . . . 1.59 110.092 -173.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 78' ' ' VAL . 19.5 t -133.63 91.74 2.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.142 0.496 . . . . 1.45 110.834 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -108.98 0.53 20.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.795 -0.639 . . . . 3.62 110.192 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' A' ' 181' ' ' ARG . 4.1 m-20 -69.29 -30.88 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 2.48 111.816 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.67 -2.58 37.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.716 -0.394 . . . . 2.24 110.692 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.13 130.15 40.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.054 -0.521 . . . . 0.8 111.785 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -106.33 106.88 17.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 1.06 110.975 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.0 OUTLIER -74.47 143.0 44.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.277 -0.419 . . . . 1.26 110.109 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 71' ' ' ASP . 86.4 mt -114.71 -57.26 2.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.825 0.345 . . . . 0.74 111.85 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -155.41 159.28 39.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 3.17 111.052 -170.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 66' ' ' PHE . 13.2 tt -126.1 137.11 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.2 -0.667 . . . . 0.64 109.2 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' OG ' ' A' ' 172' ' ' SER . 27.3 tp -140.87 110.83 6.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.827 0.346 . . . . 0.96 111.809 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 66' ' ' PHE . 40.8 t30 -75.73 117.74 17.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.898 -0.778 . . . . 1.49 108.898 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -140.3 69.39 1.35 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.244 -0.583 . . . . 1.83 111.301 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.52 -67.3 0.51 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.497 -0.859 . . . . 1.64 112.798 165.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.517 ' CE1' ' HB3' ' A' ' 243' ' ' ASN . 49.8 t60 -101.11 -29.53 12.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 3.33 111.1 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.79 -171.75 1.68 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.942 -0.572 . . . . 1.38 109.757 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 30.9 p90 -118.16 123.17 44.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 2.74 109.712 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -94.43 114.96 27.07 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.539 -0.755 . . . . 1.76 110.364 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 59.8 t -90.6 105.88 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 1.15 109.597 173.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.9 137.77 32.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.994 0.426 . . . . 2.02 111.472 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.99 170.07 8.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 1.66 110.681 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 57' ' ' LEU . 24.3 t70 -97.45 101.43 12.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.831 -0.622 . . . . 1.33 109.345 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.549 ' OD1' ' HB3' ' A' ' 90' ' ' LEU . 16.0 m-20 -120.9 60.62 0.9 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.65 111.038 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.7 t -108.82 1.1 20.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.487 -0.779 . . . . 1.61 111.195 173.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.24 172.59 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.673 0.273 . . . . 2.35 111.03 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.41 65.7 5.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.891 -0.595 . . . . 1.92 110.989 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -130.77 1.92 4.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.532 . . . . 1.77 110.587 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HB1' ' CD2' ' A' ' 90' ' ' LEU . . . -154.01 84.49 1.15 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.272 -0.64 . . . . 0.76 109.272 -168.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 50' ' ' SER . 27.1 m -139.54 149.17 22.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.375 0.607 . . . . 1.27 112.539 -173.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 48' ' ' SER . 40.0 tp -148.56 112.36 5.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.864 -1.062 . . . . 1.29 108.826 170.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 87' ' ' THR . 45.3 pttt -150.13 141.0 22.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.483 0.549 . . . . 2.54 112.483 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -57.68 172.68 2.87 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 115.628 -0.715 . . . . 1.31 111.928 156.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.94 -143.99 0.0 OUTLIER Glycine 0 CA--C 1.54 1.649 0 N-CA-C 117.793 1.877 . . . . 1.9 117.793 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.17 124.36 7.48 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.185 2.59 . . . . 2.91 114.174 -163.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 12.3 tp -142.13 -168.15 2.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.748 -1.569 . . . . 4.11 107.142 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.511 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 p-10 -148.82 89.08 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.13 0.877 . . . . 4.95 109.181 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 99.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.589 -0.815 . . . . 2.25 111.098 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 80' ' ' LYS . 46.2 m -104.61 103.2 12.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.62 0.724 . . . . 1.91 112.494 -172.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.0 m-85 -126.34 98.26 5.37 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.203 -1.036 . . . . 3.7 108.203 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 27.5 mmt180 -141.69 89.03 2.17 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 112.192 0.441 . . . . 3.54 112.192 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.549 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 40.6 tp -156.82 158.89 37.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.745 -1.576 . . . . 1.14 106.745 160.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.511 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 6.1 tp -161.88 -46.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.816 1.189 . . . . 1.68 112.287 169.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 8.6 pt20 -158.8 172.2 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 1.55 111.479 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -146.57 144.05 29.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.118 -0.697 . . . . 0.86 109.118 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.6 p-80 -142.32 159.89 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.267 -0.424 . . . . 0.93 110.48 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.597 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 81.3 m-85 -117.73 168.11 10.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 3.17 110.646 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -122.91 170.99 9.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.085 -0.709 . . . . 1.68 109.085 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -156.24 129.37 8.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.868 0.366 . . . . 5.18 110.131 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 103' ' ' GLN . . . -89.59 -50.86 3.03 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.769 -0.65 . . . . 2.13 113.14 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.577 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 26.3 t 149.06 -50.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.348 1.059 . . . . 2.9 108.74 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.69 160.88 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 3.03 109.398 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 115' ' ' ALA . 35.0 t70 -71.71 67.16 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.423 0.63 . . . . 3.85 110.607 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.46 42.91 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.701 -0.761 . . . . 1.94 112.941 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.647 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 3.5 pt20 -172.27 143.03 1.41 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.018 0.409 . . . . 2.45 110.423 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.21 81.84 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 120.786 -0.721 . . . . 1.47 112.35 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 41.6 t -89.14 -8.34 53.93 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.12 0.415 . . . . 2.0 112.12 -177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HA ' ' NE1' ' A' ' 244' ' ' TRP . 7.7 tp10 72.3 157.46 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.287 0.367 . . . . 3.72 110.471 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.46 ' CG ' ' HG3' ' A' ' 106' ' ' GLU . 29.6 m170 54.61 67.31 1.03 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.074 0.464 . . . . 3.52 111.863 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -80.21 127.25 32.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.892 0.853 . . . . 2.52 111.016 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 38.1 t -103.29 105.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.58 -1.191 . . . . 2.48 110.157 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.03 45.43 21.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 2.8 110.293 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 64.27 14.29 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.685 -1.143 . . . . 4.98 112.077 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -89.03 126.16 35.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.69 -0.485 . . . . 3.23 109.69 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.61 155.08 21.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.046 -0.724 . . . . 2.82 109.046 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -109.51 -170.24 1.62 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.344 -0.389 . . . . 1.62 110.287 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.435 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -46.6 18.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.374 . . . . 1.03 110.916 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.09 163.95 38.42 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.945 -0.571 . . . . 0.75 110.448 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -129.11 145.56 51.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 1.58 110.046 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.597 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 24.6 tp -111.73 112.2 23.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.246 -0.434 . . . . 1.07 109.861 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.431 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 46.9 m170 -110.93 105.27 14.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.15 -0.477 . . . . 1.77 111.335 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.7 mp -91.01 110.77 22.03 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.5 t -86.9 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.61 110.195 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 89' ' ' ARG . 38.6 m80 -131.22 125.31 32.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.905 -0.588 . . . . 2.13 109.838 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.511 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -111.02 151.53 27.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.052 -0.721 . . . . 4.26 109.052 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 15.9 p30 -93.2 101.53 13.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.787 0.803 . . . . 2.02 111.244 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -64.49 -10.02 22.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.39 -0.823 . . . . 2.34 112.813 -173.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -69.65 -47.94 61.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.842 0.353 . . . . 3.35 110.468 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -84.4 -21.11 30.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.375 0.607 . . . . 3.1 110.493 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.46 -2.28 64.97 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.813 -1.315 . . . . 2.37 109.813 -171.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 123' ' ' TRP . 12.0 t70 73.3 -87.0 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.0 -1.1 . . . . 3.93 112.957 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -46.38 -40.12 11.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.069 0.766 . . . . 3.0 113.069 -168.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 134' ' ' VAL . . . -55.22 -61.12 7.73 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.022 -0.609 . . . . 2.15 112.324 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -73.69 -28.19 61.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.742 0.275 . . . . 3.43 111.742 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.63 62.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.473 0.546 . . . . 1.76 112.473 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 203' ' ' LEU . 34.4 m -64.92 -31.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.857 -0.337 . . . . 2.77 111.157 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 134' ' ' VAL . 41.6 mt-30 -100.66 -28.3 12.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 3.55 110.855 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.541 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 60.5 tt0 -76.05 119.85 79.03 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 3.02 110.848 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.95 -17.1 54.96 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 1.6 111.365 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.541 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 m-20 -105.31 27.07 8.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.159 -0.928 . . . . 2.29 109.418 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.09 -82.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.382 0 CA-C-N 116.115 -0.493 . . . . 1.22 112.554 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.43 148.9 25.35 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.21 0.529 . . . . 1.57 110.661 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.46 104.51 7.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.486 -0.779 . . . . 1.38 109.177 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.59 129.29 60.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.314 -0.403 . . . . 1.73 111.28 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 34.4 tp -97.47 127.27 43.3 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.173 -0.677 . . . . 2.42 109.173 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -111.23 131.18 10.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.783 -0.722 . . . . 0.86 112.736 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.4 mt -137.69 106.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 0.76 109.508 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -62.93 156.43 24.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.936 0.398 . . . . 1.2 111.889 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.75 123.2 49.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.88 110.097 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.3 ptmm? -115.64 138.39 51.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.817 -0.629 . . . . 2.03 109.823 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 47.8 t -88.1 133.97 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.711 0.291 . . . . 1.27 110.991 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . 126.64 58.63 0.14 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.847 -0.692 . . . . 1.53 113.361 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.624 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 3.2 t 160.26 122.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.26 -1.015 . . . . 1.54 108.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.31 134.64 39.68 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.941 -0.304 . . . . 0.78 110.271 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -114.91 95.85 42.85 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.303 -0.408 . . . . 1.22 110.462 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.84 -39.25 92.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.152 2.568 . . . . 1.05 112.341 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -66.66 -21.05 70.67 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.926 -0.654 . . . . 0.7 112.82 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 160' ' ' VAL . 60.7 tp -91.88 -31.27 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 0.77 110.412 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.462 ' NE2' ' HG2' ' A' ' 221' ' ' GLN . 8.7 tp-100 -53.37 -40.98 65.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 1.41 112.27 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.5 pttt -55.41 -37.45 67.65 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.642 0.608 . . . . 2.86 112.642 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 162' ' ' VAL . 12.0 p -85.16 -32.64 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.434 -0.507 . . . . 1.38 110.959 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.619 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 44.1 t -64.96 -38.97 84.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 1.11 110.909 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.97 -35.3 79.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.78 -0.646 . . . . 1.22 111.429 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 175' ' ' PHE . 8.3 p -88.04 -17.35 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.777 0.288 . . . . 1.41 111.777 -172.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.1 pp -74.42 -15.23 60.92 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.31 -0.556 . . . . 1.39 110.512 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.43 -24.62 64.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 2.31 110.434 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.2 m -84.47 1.85 43.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 1.4 111.359 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.4 pt -138.56 38.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.973 -0.751 . . . . 0.85 108.973 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -53.14 -41.54 65.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.837 -1.074 . . . . 1.59 111.947 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.6 p -102.69 149.83 24.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.426 -0.352 . . . . 0.77 110.434 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.16 137.4 57.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 2.29 110.31 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.64 -24.55 17.07 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.556 -0.831 . . . . 0.85 111.664 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.09 132.33 37.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.138 0.494 . . . . 1.7 110.734 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.434 ' OG ' HD13 ' A' ' 60' ' ' LEU . 4.0 m -117.71 154.11 32.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.845 -0.798 . . . . 1.37 108.845 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -145.21 137.5 25.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.869 -0.419 . . . . 0.61 109.869 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.88 131.99 47.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.543 -0.539 . . . . 1.8 109.543 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.468 ' CE2' HG11 ' A' ' 162' ' ' VAL . 20.2 t80 -138.46 78.1 1.66 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.178 -1.045 . . . . 1.04 108.178 -176.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 56' ' ' SER . 13.0 m -97.45 139.81 32.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.508 -0.769 . . . . 1.17 112.817 -173.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 24.7 m120 42.61 73.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.834 -1.075 . . . . 1.77 113.516 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.27 101.4 7.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.723 -0.671 . . . . 3.99 109.575 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -55.88 119.42 25.93 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 2.51 111.895 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.65 -5.46 17.11 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.682 2.254 . . . . 1.26 111.165 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 57.1 ttp180 -57.76 -37.17 73.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.76 111.272 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.15 -24.11 60.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.257 -0.497 . . . . 1.12 112.969 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.8 mt -81.12 -24.3 37.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.835 0.35 . . . . 1.73 111.01 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.37 128.37 92.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 3.45 111.089 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.48 -170.16 0.77 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.992 2.462 . . . . 2.08 113.375 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -75.5 -64.16 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.18 0.437 . . . . 3.23 112.18 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.633 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 3.5 m -80.26 134.32 36.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 1.66 111.17 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 95.0 mt -108.3 64.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.197 0.522 . . . . 1.99 110.96 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.495 ' HB2' ' HE3' ' A' ' 212' ' ' LYS . 55.9 m-20 -123.74 144.16 49.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.723 -1.214 . . . . 1.81 107.723 173.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.462 ' CD2' HD11 ' A' ' 47' ' ' LEU . 30.4 p90 -133.39 144.94 49.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.979 1.103 . . . . 5.01 113.979 -163.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.464 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 17.5 m95 -90.24 131.6 35.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.45 -1.25 . . . . 3.93 107.675 168.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 256' ' ' LYS . 4.9 t -128.05 118.13 22.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.436 0.636 . . . . 2.13 111.737 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 20.0 p90 -139.75 153.84 70.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 5.21 110.678 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 193' ' ' TYR . 9.7 Cg_exo -72.39 136.43 26.34 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.813 2.342 . . . . 2.12 110.937 172.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.727 ' HA3' ' CD1' ' A' ' 208' ' ' TRP . . . -137.99 158.78 24.86 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.364 -0.922 . . . . 1.75 113.062 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 t -97.04 153.07 18.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.12 0.486 . . . . 2.99 111.005 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -81.97 14.92 2.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.031 -0.986 . . . . 4.75 110.387 178.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.4 t -64.57 25.25 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.856 1.428 . . . . 5.1 114.856 -161.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.577 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.1 OUTLIER -85.55 -64.7 0.22 Allowed Pre-proline 0 C--N 1.319 -0.742 0 O-C-N 121.334 -0.854 . . . . 5.53 109.042 172.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 199' ' ' THR . 1.2 Cg_endo -83.71 -68.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.665 0 C-N-CA 121.629 1.553 . . . . 5.83 113.101 166.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 200' ' ' PRO . 97.9 Cg_endo -104.47 157.63 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.436 2.091 . . . . 4.78 112.74 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 23.7 tp -90.81 68.04 6.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.499 0.666 . . . . 3.84 110.696 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 134' ' ' VAL . 56.9 tp -108.39 122.0 46.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.517 -0.765 . . . . 2.96 110.847 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -92.24 77.72 5.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.559 . . . . 3.37 111.186 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 85.2 m -147.81 43.29 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 2.15 110.349 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.25 146.07 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 1.26 110.956 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 48.9 m -114.28 121.45 43.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.302 -0.629 . . . . 2.08 109.302 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.727 ' CD1' ' HA3' ' A' ' 195' ' ' GLY . 36.9 m95 -106.4 130.13 54.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 5.53 110.977 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 49.1 mm -121.71 116.06 48.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.85 . . . . 1.63 109.54 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 98.0 t -111.29 133.88 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.302 -0.259 . . . . 1.62 110.302 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 143' ' ' LEU . 88.1 mt -86.37 143.93 27.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.234 0.54 . . . . 1.73 110.751 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 189' ' ' ASP . 26.8 ttmt -53.24 -23.02 7.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.945 -1.025 . . . . 2.98 112.231 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.633 ' HG3' ' H ' ' A' ' 187' ' ' SER . 68.7 mm-40 -110.55 121.03 42.38 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.424 -0.353 . . . . 1.47 111.068 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -84.02 171.62 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.61 2.207 . . . . 0.96 111.246 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 31.0 pt -111.48 147.25 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.964 0.411 . . . . 1.25 109.963 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 23.0 p -100.17 146.42 26.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.334 0.588 . . . . 1.29 111.234 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -140.66 146.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.208 -0.905 . . . . 1.02 109.418 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 222' ' ' VAL . 59.5 m -101.86 168.22 9.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.887 -0.325 . . . . 1.08 111.372 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.555 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 49.1 m -48.49 -51.0 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.092 0.775 . . . . 1.33 113.092 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.7 -48.06 82.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.698 0.285 . . . . 2.51 111.275 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.475 ' HB2' ' CG2' ' A' ' 217' ' ' VAL . 18.1 mt-30 -59.3 -44.63 92.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.764 -0.458 . . . . 0.7 109.764 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.513 ' O ' ' HG3' ' A' ' 226' ' ' ARG . 95.9 t -60.51 -40.69 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.721 -0.672 . . . . 1.36 110.874 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.6 mt -60.43 -37.03 79.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.027 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.41 ' HD2' HG12 ' A' ' 160' ' ' VAL . 93.2 mttt -66.62 -33.86 76.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.472 -0.331 . . . . 1.75 110.887 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -67.46 -30.8 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.328 0.585 . . . . 2.47 109.751 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 222' ' ' VAL . 23.6 mtp180 -79.14 -3.93 47.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.487 -0.779 . . . . 3.04 111.294 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 47.3 mmtm -87.82 -19.49 27.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.104 -0.332 . . . . 2.31 110.104 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.25 139.82 57.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.921 -0.581 . . . . 0.95 111.434 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.429 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 90.3 m-20 -115.93 149.32 38.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 1.13 110.315 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -79.57 -31.77 41.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 3.74 109.749 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 4.5 p-10 -73.95 165.16 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.129 -0.941 . . . . 1.62 112.397 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.77 171.23 42.89 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.506 -1.225 . . . . 1.16 110.834 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.01 141.58 57.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.216 0.508 . . . . 3.56 110.688 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.76 3.88 73.47 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.701 -0.761 . . . . 2.08 111.908 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -114.01 157.67 41.42 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.369 -0.234 . . . . 2.59 110.369 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 127.62 26.81 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.89 2.394 . . . . 1.36 111.785 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.42 116.93 5.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 3.4 111.547 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -121.68 119.75 32.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.577 -0.738 . . . . 2.47 109.127 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 226' ' ' ARG . 83.9 mt -67.1 149.5 50.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 2.14 111.861 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 55.7 tpp -75.36 103.76 5.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.084 -0.962 . . . . 1.68 108.903 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.23 139.16 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 1.27 112.121 -171.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.83 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.648 -1.16 . . . . 2.18 111.31 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 33.1 m-80 55.76 31.37 17.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.044 0.537 . . . . 2.15 111.945 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' A' ' 106' ' ' GLU . 30.6 t90 -134.17 144.53 48.56 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.199 -0.313 . . . . 4.59 110.414 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.569 ' O ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -111.12 149.05 39.93 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.424 -0.213 . . . . 6.13 110.424 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.73 132.91 3.95 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 124.33 3.353 . . . . 3.28 114.246 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.38 151.0 46.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.223 -0.899 . . . . 2.98 110.926 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.507 ' HG3' ' HA ' ' A' ' 27' ' ' ARG . 77.0 mm-40 -123.81 150.09 61.24 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 4.32 110.466 -174.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.37 175.26 10.29 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.598 2.865 . . . . 3.48 115.261 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 82.7 mt -63.53 -8.81 10.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.368 -1.742 . . . . 4.63 113.432 -173.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 16.9 ttmm -58.17 44.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.467 1.284 . . . . 5.34 114.467 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.556 ' HB3' ' CD ' ' A' ' 27' ' ' ARG . 7.5 t-20 119.21 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 127.017 2.127 . . . . 4.64 109.52 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.583 ' HD2' ' O ' ' A' ' 30' ' ' PRO . 42.8 mmt-85 -126.2 84.87 2.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.413 -0.958 . . . . 6.11 108.413 168.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -115.9 142.4 46.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 3.08 110.012 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.451 HG13 HG21 ' A' ' 31' ' ' VAL . 3.1 mp -103.76 122.99 57.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 2.6 111.064 -174.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 1.0 OUTLIER -97.86 145.13 26.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.523 -0.917 . . . . 2.63 108.523 167.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -123.64 93.01 3.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.512 -0.551 . . . . 1.71 109.512 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 54.1 m -80.18 97.41 6.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.628 0.728 . . . . 2.21 110.924 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -135.12 103.72 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.375 -1.284 . . . . 4.31 109.253 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 C--O 1.248 1.01 0 CA-C-N 116.154 -0.476 . . . . 4.49 110.67 178.49 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.115 0.483 . . . . 17.49 110.055 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 t -138.82 40.7 2.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.419 0.628 . . . . 15.32 109.341 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -139.32 33.44 2.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.54 0.686 . . . . 15.81 109.66 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -110.27 -38.74 5.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.107 -0.952 . . . . 14.19 109.464 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -96.1 81.63 3.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.4 -0.818 . . . . 14.91 109.819 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' HA3' ' HA3' ' A' ' 12' ' ' GLY . . . -159.32 135.21 4.06 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.463 -0.875 . . . . 10.79 112.2 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -104.66 100.07 9.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.066 0.46 . . . . 11.39 111.35 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.65 158.04 33.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.707 -0.758 . . . . 9.0 113.392 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -45.7 134.99 7.08 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.285 -0.458 . . . . 9.76 111.736 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 81.66 -25.28 0.16 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.886 -1.052 . . . . 11.19 111.699 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -102.51 -14.49 16.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.175 0.512 . . . . 10.8 110.43 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' HA3' ' HA3' ' A' ' 6' ' ' GLY . . . -179.74 -152.45 10.79 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.844 -0.902 . . . . 8.82 110.844 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.16 129.19 11.97 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.695 2.264 . . . . 7.87 111.52 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -82.27 -21.26 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.004 0.431 . . . . 10.62 110.359 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.471 ' HB3' ' HD3' ' A' ' 18' ' ' LYS . 41.8 m80 -112.16 22.78 14.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.434 0.635 . . . . 9.87 109.379 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -54.18 -26.2 26.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.889 -1.051 . . . . 8.48 112.231 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -77.19 -6.13 51.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.879 0.371 . . . . 7.13 110.649 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 15' ' ' HIS . 56.5 mtpt -89.12 -41.93 11.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.424 -0.353 . . . . 9.68 110.487 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -68.72 -27.65 66.12 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.116 0.484 . . . . 7.89 110.336 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.47 ' HB3' HG22 ' A' ' 22' ' ' ILE . 20.7 m-85 -108.16 92.68 9.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.676 -0.693 . . . . 7.17 110.749 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.52 -21.05 53.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.71 2.273 . . . . 7.76 111.996 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 20' ' ' PHE . 7.7 tp -42.89 -29.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.565 -0.743 . . . . 5.83 112.649 173.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -39.75 -37.18 0.5 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.765 0.654 . . . . 5.44 112.765 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -71.71 34.24 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.407 -0.36 . . . . 7.78 111.775 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 23' ' ' ALA . . . -167.48 -65.03 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.169 -0.772 . . . . 5.01 111.169 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 204' ' ' GLU . 0.0 OUTLIER -45.25 169.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.067 0.937 . . . . 7.09 113.277 171.119 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -149.19 170.57 18.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.614 -2.365 . . . . 5.13 104.614 -165.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.586 ' OE1' ' HA ' ' A' ' 252' ' ' ASN . 1.5 mp0 -53.79 152.83 5.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 120.4 1.455 . . . . 7.12 113.233 175.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -48.08 167.04 0.2 Allowed Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 113.951 -1.477 . . . . 3.94 114.568 176.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HA ' ' CE2' ' A' ' 208' ' ' TRP . 54.5 Cg_exo -43.24 35.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 1 C-N-CA 127.164 5.243 . . . . 4.52 117.006 169.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 32' ' ' ASP . 4.1 p -89.82 -174.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 118.557 0.617 . . . . 4.54 110.184 -170.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.755 ' H ' HG22 ' A' ' 31' ' ' VAL . 95.3 m-20 -51.94 141.53 17.58 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.776 1.028 . . . . 2.88 113.776 -169.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 58.8 mt -98.97 139.66 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.372 -1.285 . . . . 2.32 110.981 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.509 ' H ' ' CD1' ' A' ' 255' ' ' ILE . 24.3 t70 -112.14 118.31 34.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.833 -0.432 . . . . 2.82 109.833 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -43.79 73.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.397 -0.82 . . . . 2.24 113.138 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.77 -42.1 91.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 4.54 110.792 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 255' ' ' ILE . 22.9 m -72.67 -28.11 62.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.019 -0.537 . . . . 3.06 110.904 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 255' ' ' ILE . . . -75.22 93.59 2.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.264 0.554 . . . . 1.72 110.95 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.94 142.19 28.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.475 -0.784 . . . . 3.69 110.665 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.5 m-85 -58.07 122.48 13.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.472 -0.785 . . . . 4.64 110.975 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.63 133.96 27.26 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.764 . . . . 2.27 109.857 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.15 59.75 3.06 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.971 2.447 . . . . 2.15 112.497 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.402 ' CB ' ' HB2' ' A' ' 258' ' ' SER . 36.9 t -69.72 -53.59 17.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 4.29 110.121 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp 72.04 -54.66 0.68 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.31 -0.859 . . . . 4.74 111.733 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 43.7 mmtm -75.62 132.64 74.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 3.77 110.371 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.29 167.02 26.6 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.641 2.227 . . . . 2.36 112.273 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.44 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 61.3 tp -93.54 116.9 29.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.942 -0.572 . . . . 2.55 109.842 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 32.1 t -86.87 121.65 29.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.427 -0.583 . . . . 2.38 109.427 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.75 134.82 57.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.973 0.416 . . . . 1.59 110.716 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 28.4 t -128.54 91.03 3.16 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.309 0.576 . . . . 1.45 109.652 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.85 9.02 32.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 3.62 109.647 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 8.3 t70 -55.49 -39.1 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.404 -0.816 . . . . 2.48 111.201 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.2 mp0 -99.44 15.59 25.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 2.24 111.238 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 121.72 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.8 111.374 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -114.37 106.98 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.12 -0.491 . . . . 1.06 110.519 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.0 m -76.14 146.68 39.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.354 -0.61 . . . . 1.26 109.354 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.28 -56.69 1.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.74 111.925 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.45 155.8 32.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.724 0.297 . . . . 3.17 111.282 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.1 tt -122.02 138.5 52.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.116 -0.493 . . . . 0.64 109.906 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 172' ' ' SER . 38.2 tp -134.63 138.48 44.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.013 0.435 . . . . 0.96 111.905 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.05 114.49 26.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.267 -0.879 . . . . 1.49 109.13 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -115.26 70.15 0.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 1.83 110.308 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.2 -59.04 0.16 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.164 -1.38 . . . . 1.64 115.531 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -110.91 -17.02 13.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.842 0.353 . . . . 3.33 111.089 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.38 174.66 14.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.981 -0.748 . . . . 1.38 108.981 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -138.4 135.47 35.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.637 -0.505 . . . . 2.74 109.637 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -126.58 152.39 46.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.214 -0.448 . . . . 1.76 110.508 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 7.1 p -111.49 129.07 67.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.079 -0.51 . . . . 1.15 109.751 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.79 131.63 34.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.081 -0.509 . . . . 2.02 111.433 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.84 153.21 21.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.634 -0.712 . . . . 1.66 109.674 172.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.558 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 33.0 t70 -72.15 92.65 1.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.084 -0.507 . . . . 1.33 110.137 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -108.4 56.47 0.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.657 0.742 . . . . 2.65 111.206 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -103.16 -3.39 25.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.749 -0.66 . . . . 1.61 111.317 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.481 ' CG ' ' HE3' ' A' ' 76' ' ' LYS . 9.5 pt20 -148.66 165.0 32.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.215 -0.448 . . . . 2.35 110.122 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -81.1 73.28 8.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.189 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HD2' ' O ' ' A' ' 71' ' ' ASP . 15.2 ptpt -102.39 -41.18 6.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.591 -0.731 . . . . 1.77 110.998 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -113.2 96.9 6.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.676 -0.49 . . . . 0.76 109.676 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 95.3 t -124.16 150.91 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.768 -0.651 . . . . 1.27 110.856 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 79' ' ' LEU . 2.5 pt? -149.19 115.74 5.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.772 0.32 . . . . 1.29 110.523 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -139.04 125.09 19.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 2.54 110.62 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 47' ' ' LEU . . . -133.95 -178.19 15.44 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.521 -1.432 . . . . 1.31 109.521 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -26.51 -127.93 0.0 OUTLIER Glycine 0 N--CA 1.486 2.024 0 C-N-CA 125.089 1.328 . . . . 1.9 115.991 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.66 170.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.075 2.517 . . . . 2.91 112.99 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.7 pt? -31.9 114.14 0.14 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.389 1.255 . . . . 4.11 114.389 -144.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 9.8 p-10 -128.27 -128.09 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 113.424 -1.717 . . . . 4.95 112.284 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 106.05 161.3 22.73 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.193 -1.163 . . . . 2.25 110.193 -166.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 125' ' ' THR . 20.1 m -73.66 102.99 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.987 0.893 . . . . 1.91 110.715 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 68.2 m-85 -100.78 133.5 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 3.7 110.544 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HD2' ' CZ2' ' A' ' 123' ' ' TRP . 99.7 mtt180 -102.49 142.78 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.225 -0.443 . . . . 3.54 110.42 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.3 tp -77.64 125.15 28.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.618 -0.512 . . . . 1.14 109.618 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.4 tt -111.73 -40.72 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.834 0.35 . . . . 1.68 110.886 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -165.15 169.36 16.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.714 -0.476 . . . . 1.55 109.714 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.486 ' HB3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 p90 -143.81 158.23 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.356 -0.238 . . . . 0.86 110.356 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -132.34 158.91 40.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.616 -0.513 . . . . 0.93 109.616 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.82 149.93 28.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 3.17 110.375 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.485 ' ND1' ' HB3' ' A' ' 117' ' ' GLU . 13.4 m170 -100.48 153.05 19.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.504 -0.924 . . . . 1.68 108.504 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 75.0 t-105 -161.73 125.61 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.023 -0.362 . . . . 5.18 110.023 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -87.42 -171.51 47.27 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 111.319 -0.712 . . . . 2.13 111.319 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' A' ' 241' ' ' VAL . 11.2 t -78.52 -46.94 18.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.736 0.768 . . . . 2.9 109.995 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 102' ' ' GLY . 92.6 mt -83.95 146.61 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.429 . . . . 3.03 110.135 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.21 32.59 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.765 0.654 . . . . 3.85 112.765 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 100' ' ' LEU . . . -155.4 21.93 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.921 -0.656 . . . . 1.94 112.344 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.402 ' HG3' ' HA3' ' A' ' 98' ' ' GLY . 3.1 pt20 -150.46 169.58 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.211 -0.292 . . . . 2.45 110.211 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.422 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 86.95 17.41 59.58 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.668 -0.777 . . . . 1.47 113.111 169.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 77.8 p -80.58 -8.86 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.963 0.382 . . . . 2.0 111.701 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 66.48 164.68 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.101 -0.703 . . . . 3.72 109.101 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.426 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 29.4 m80 58.11 46.73 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 3.52 110.704 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.5 m -78.4 117.71 19.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 2.52 110.097 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 46.2 t -84.22 99.67 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 114.549 -1.205 . . . . 2.48 110.887 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 69.58 -72.27 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.709 0.631 . . . . 2.8 110.599 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -146.06 5.56 0.99 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.814 -0.439 . . . . 4.98 109.814 173.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.06 97.15 11.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.973 -0.558 . . . . 3.23 110.085 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -110.89 145.22 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 2.82 109.512 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 46.1 m-85 -105.06 179.03 4.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.303 -0.408 . . . . 1.62 110.203 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.02 53.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.026 0.441 . . . . 1.03 110.668 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.35 23.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.75 110.049 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 31.0 tt0 -147.73 146.38 29.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.97 -0.559 . . . . 1.58 110.255 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -99.45 107.3 19.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.548 -0.751 . . . . 1.07 109.604 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -109.52 102.41 11.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.11 0.481 . . . . 1.77 110.176 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 93' ' ' PHE . 5.0 mp -87.49 128.1 35.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.93 111.158 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 142' ' ' VAL . 45.2 t -96.45 127.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.965 -0.561 . . . . 0.61 110.393 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 20.9 m80 -126.77 138.11 53.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.608 -0.516 . . . . 2.13 109.608 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.586 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 44.9 p-90 -112.52 144.78 41.43 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.545 0.528 . . . . 4.26 110.592 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.672 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 41.8 t-20 -75.38 109.89 9.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 2.02 110.752 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.586 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 8.9 t -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.068 0.766 . . . . 2.34 113.068 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.672 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 21.3 ptmt -71.3 -7.68 48.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.166 0.432 . . . . 3.35 112.166 -172.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.09 -17.59 6.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.349 0.595 . . . . 3.1 110.459 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.45 -4.95 85.64 Favored Glycine 0 C--N 1.325 -0.042 0 N-CA-C 109.734 -1.347 . . . . 2.37 109.734 -167.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 123' ' ' TRP . 13.1 t70 71.55 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.193 -1.504 . . . . 3.93 112.224 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.443 ' O ' HG23 ' A' ' 134' ' ' VAL . 95.7 m-85 -45.27 -31.4 1.53 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.256 1.206 . . . . 3.0 114.256 -168.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.53 -65.03 2.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.344 -0.932 . . . . 2.15 111.803 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -72.23 -30.78 65.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.979 0.363 . . . . 3.43 111.979 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -26.34 49.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.141 0.422 . . . . 1.76 112.141 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 130' ' ' PHE . 59.7 t -60.66 -34.75 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 2.77 110.71 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -119.9 18.77 12.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.479 -0.328 . . . . 3.55 111.466 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 57.2 tt0 -132.16 113.83 14.79 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.755 -0.461 . . . . 3.02 109.755 -173.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.524 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 38.0 Cg_exo -60.69 -14.63 32.54 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.023 2.482 . . . . 1.6 113.785 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.77 27.15 9.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.303 . . . . 2.29 110.552 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.444 ' O ' ' HE1' ' A' ' 88' ' ' TYR . . . -66.61 -86.84 0.07 OUTLIER Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.947 -0.57 . . . . 1.22 114.211 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.76 161.21 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.562 0.696 . . . . 1.57 112.708 -168.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.43 110.58 5.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.939 . . . . 1.38 110.177 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 208' ' ' TRP . 21.2 m -107.32 152.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.812 -0.44 . . . . 1.73 109.812 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 10.2 tt -131.92 125.25 31.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.315 -0.254 . . . . 2.42 110.315 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.86 131.9 10.22 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.843 -0.694 . . . . 0.86 113.025 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -119.57 122.87 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.208 -0.293 . . . . 0.76 110.208 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -68.38 146.95 52.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.466 -0.334 . . . . 1.2 111.628 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.444 HD23 ' HB ' ' A' ' 215' ' ' ILE . 80.2 mt -124.47 114.52 19.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 0.88 110.219 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -107.24 153.73 22.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.71 -0.478 . . . . 2.03 109.71 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 44.1 t -90.08 127.64 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.987 0.423 . . . . 1.27 110.848 -175.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.07 -105.12 0.19 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.217 -0.753 . . . . 1.53 111.217 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.0 m -76.23 146.58 38.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.04 -0.356 . . . . 1.54 110.04 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -70.0 146.99 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.78 111.298 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 216' ' ' SER . 51.6 tptt -112.89 99.76 49.2 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.603 -0.726 . . . . 1.22 109.67 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 11.1 Cg_endo -55.55 -36.34 94.26 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.735 2.29 . . . . 1.05 111.919 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.12 -28.89 72.88 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.8 -0.636 . . . . 0.7 113.06 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.436 ' HG ' HG23 ' A' ' 160' ' ' VAL . 21.4 tp -93.82 -19.85 20.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.226 -0.573 . . . . 0.77 110.153 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -46.01 91.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.174 -0.466 . . . . 1.41 110.461 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.9 pttp -57.42 -40.7 78.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.677 0.621 . . . . 2.86 112.677 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.68 -36.01 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.263 -0.575 . . . . 1.38 110.73 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 75.8 t -64.03 -36.45 76.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.125 0.488 . . . . 1.11 110.757 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.39 -31.34 70.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.04 -0.527 . . . . 1.22 110.465 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 158' ' ' LYS . 73.0 t -83.55 -27.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.41 111.476 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.3 pp -70.77 -13.39 62.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.222 0.534 . . . . 1.39 110.31 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.42 -24.8 65.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.85 -0.613 . . . . 2.31 110.211 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.3 m -83.41 -1.64 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.31 . . . . 1.4 111.556 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 163' ' ' LEU . 47.2 pt -139.67 26.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 0.85 109.962 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 229' ' ' ASN . 48.9 pttt -74.89 16.15 0.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.038 -0.528 . . . . 1.59 112.334 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.76 140.23 46.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.902 0.382 . . . . 0.77 110.408 174.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.412 ' HB3' ' HA2' ' A' ' 232' ' ' GLY . 74.2 tttt -56.32 120.16 7.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 2.29 111.876 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.49 30.72 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.631 -0.795 . . . . 0.85 112.462 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -88.17 148.98 24.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.908 0.385 . . . . 1.7 110.687 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 60' ' ' LEU . 11.6 p -145.57 157.28 44.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.874 -0.603 . . . . 1.37 110.158 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -147.61 149.43 32.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.67 0.271 . . . . 0.61 110.52 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.97 136.79 46.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.017 0.437 . . . . 1.8 110.268 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -140.55 79.91 1.73 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.797 -0.816 . . . . 1.04 108.797 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.3 p -109.44 159.86 16.68 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.275 0.472 . . . . 1.17 112.275 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.35 47.16 21.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.509 -0.769 . . . . 1.77 112.345 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.13 98.29 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.891 0.377 . . . . 3.99 110.186 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.08 136.25 82.19 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.884 -0.598 . . . . 2.51 111.136 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.03 -4.27 13.18 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.123 2.549 . . . . 1.26 112.226 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 70.0 mtp180 -55.07 -42.68 73.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.872 -0.604 . . . . 2.76 112.136 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -58.97 -13.55 19.87 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 116.176 -0.465 . . . . 1.12 113.675 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.21 -7.65 44.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.852 0.326 . . . . 1.73 111.168 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.62 128.78 68.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 3.45 110.595 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.07 -178.39 4.15 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.827 2.351 . . . . 2.08 112.527 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.81 -63.21 1.46 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.561 0.219 . . . . 3.23 110.749 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.0 m -70.41 130.42 41.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 1.66 110.712 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.04 62.55 0.6 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.255 0.55 . . . . 1.99 110.107 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -94.21 128.28 40.56 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.329 -0.989 . . . . 1.81 108.329 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 52.6 p90 -139.66 147.45 41.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.067 0.766 . . . . 5.01 113.067 -169.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 28.6 m-90 -86.76 135.84 33.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.286 -0.87 . . . . 3.93 108.928 169.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 192' ' ' THR . 7.1 t -119.69 103.26 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.641 0.734 . . . . 2.13 110.346 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' A' ' 208' ' ' TRP . 4.6 t80 -137.48 137.08 21.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.098 -0.501 . . . . 5.21 110.783 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -89.56 128.83 1.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.745 2.297 . . . . 2.12 112.279 173.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.09 157.65 25.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.276 -0.487 . . . . 1.75 112.696 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 201' ' ' PRO . 1.7 m -65.41 148.41 51.75 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.395 -0.594 . . . . 2.99 109.395 174.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 201' ' ' PRO . 8.2 mp -56.4 -53.29 59.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.285 0.476 . . . . 4.75 112.285 -168.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 18.0 m -125.58 -45.98 1.76 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.95 0.405 . . . . 5.1 110.13 166.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.73 -55.7 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.103 -0.953 . . . . 5.53 111.177 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.466 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 52.3 Cg_exo -53.12 -44.49 48.44 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.276 1.984 . . . . 5.83 113.581 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.509 ' HB2' HD13 ' A' ' 197' ' ' LEU . 12.2 Cg_exo -73.9 78.53 2.48 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.559 1.506 . . . . 4.78 110.398 169.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 65.0 mt -51.56 -27.24 10.37 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.348 1.03 . . . . 3.84 113.327 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 196' ' ' SER . 42.9 tp -53.54 145.25 15.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.29 0.567 . . . . 2.96 110.967 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.445 ' HB3' ' CB ' ' A' ' 26' ' ' GLU . 12.2 pt-20 -95.96 41.46 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 3.37 109.57 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 137' ' ' PRO . 4.6 p -84.11 2.49 39.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 2.15 112.362 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.448 ' CG2' ' HG ' ' A' ' 197' ' ' LEU . 73.7 t -105.03 129.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 120.95 0.405 . . . . 1.26 109.943 175.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.3 m -107.76 100.83 10.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.715 -0.846 . . . . 2.08 108.715 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.554 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 4.4 p-90 -90.24 100.96 13.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.914 0.864 . . . . 5.53 111.72 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 51.3 mm -88.85 105.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.065 -1.425 . . . . 1.63 109.671 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.1 t -106.78 128.99 61.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.965 -0.294 . . . . 1.62 110.544 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -85.89 140.85 30.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.419 0.628 . . . . 1.73 111.448 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -83.86 -21.71 31.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.149 -0.932 . . . . 2.98 110.92 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.403 ' OE1' ' HD2' ' A' ' 214' ' ' PRO . 11.3 tp10 -88.33 113.38 55.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.271 -0.422 . . . . 1.47 109.873 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 83.0 Cg_endo -82.93 155.81 15.25 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.668 2.245 . . . . 0.96 113.11 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.444 ' HB ' HD23 ' A' ' 147' ' ' LEU . 26.8 mm -106.19 146.44 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.771 -0.649 . . . . 1.25 109.609 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 15.1 m -99.57 127.93 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.451 -0.34 . . . . 1.29 111.322 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.9 m -122.48 151.51 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.921 -0.77 . . . . 1.02 108.921 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 8.0 t -97.1 163.82 12.77 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.277 -0.569 . . . . 1.08 111.159 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.542 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 24.9 m -50.82 -50.62 56.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 1.33 111.886 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -50.98 -36.29 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.934 0.397 . . . . 2.51 111.573 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.95 -48.32 54.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.146 -0.479 . . . . 0.7 110.894 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.424 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 29.4 m -74.92 -22.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 1.36 111.277 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 219' ' ' SER . 94.7 mt -68.28 -45.2 73.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.032 -0.359 . . . . 1.03 110.032 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -67.8 -29.46 68.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 1.75 110.659 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.49 -42.49 82.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 2.47 110.041 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 67.0 ttt180 -73.93 10.88 1.01 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.72 -0.673 . . . . 3.04 111.011 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.46 -8.6 38.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.06 -0.348 . . . . 2.31 110.06 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.81 132.45 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.08 -0.509 . . . . 0.95 111.039 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 167' ' ' LYS . 6.3 m-20 -101.53 140.41 35.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.907 -0.588 . . . . 1.13 110.218 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -78.86 -34.94 44.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.781 -1.099 . . . . 3.74 109.668 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.6 p-10 -70.8 163.86 26.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.84 -1.073 . . . . 1.62 111.875 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 169' ' ' LYS . . . -83.92 174.4 51.25 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.231 -0.895 . . . . 1.16 111.197 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.55 127.5 32.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.95 0.375 . . . . 3.56 110.062 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.22 -2.58 56.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.859 -0.686 . . . . 2.08 112.635 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 41.3 mt-10 -102.2 159.97 27.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.065 -0.346 . . . . 2.59 110.065 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.96 128.68 30.89 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.181 . . . . 1.36 111.519 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -59.38 125.63 24.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 3.4 112.734 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 44.8 mt-10 -130.57 150.24 51.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.091 -1.078 . . . . 2.47 108.091 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.7 mt -90.97 133.38 35.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.525 -0.47 . . . . 2.14 110.866 -175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 ttm -76.83 89.3 3.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.359 -0.978 . . . . 1.68 108.359 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 99' ' ' SER . 21.7 m -133.55 153.24 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 1.27 110.198 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.4 t70 67.36 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.004 0.815 . . . . 2.18 110.356 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 22.1 m120 43.39 32.22 0.48 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.555 0.534 . . . . 2.15 111.743 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -104.5 136.66 43.65 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.082 0.468 . . . . 4.59 110.597 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.585 ' H ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -70.3 144.3 91.93 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.267 -0.879 . . . . 6.13 110.434 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.63 131.93 43.49 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.792 2.328 . . . . 3.28 111.965 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.99 132.37 49.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 2.98 111.584 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.519 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 66.8 mm-40 -85.17 172.79 8.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.854 -0.795 . . . . 4.32 108.854 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 73.4 Cg_exo -43.06 110.51 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.406 2.071 . . . . 3.48 112.03 174.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -58.42 4.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.443 -1.253 . . . . 4.63 113.586 -167.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 37' ' ' THR . 5.2 ptpp? -69.59 -7.0 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.624 0.972 . . . . 5.34 113.624 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.586 ' HA ' ' OE1' ' A' ' 28' ' ' GLN . 7.7 p30 36.33 54.27 1.03 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.718 1.007 . . . . 4.64 113.718 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 252' ' ' ASN . 13.4 mmt180 76.11 -89.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.391 -0.596 . . . . 6.11 109.391 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.47 136.52 21.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.975 -1.12 . . . . 3.08 107.975 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.515 ' H ' HG22 ' A' ' 37' ' ' THR . 17.0 mt -94.24 150.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.691 0.281 . . . . 2.6 111.033 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -104.55 131.44 51.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 2.63 110.558 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.31 97.55 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.256 -0.429 . . . . 1.71 110.164 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.402 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 22.3 p -95.73 96.46 9.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.367 -0.533 . . . . 2.21 111.609 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.486 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 24.8 p90 -166.71 154.4 9.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 4.31 110.047 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.997 -0.547 . . . . 4.49 110.605 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.999 -0.371 . . . . 17.49 109.999 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.1 t 68.17 98.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.505 0.669 . . . . 15.32 111.57 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -98.93 23.53 8.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.254 -0.647 . . . . 15.81 109.254 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -87.97 94.51 9.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.596 -0.729 . . . . 14.19 110.709 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -84.4 86.1 7.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.34 0.591 . . . . 14.91 109.933 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.26 154.33 23.39 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.097 -0.801 . . . . 10.79 111.097 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -92.24 97.08 10.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.764 0.792 . . . . 11.39 110.622 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.93 -87.08 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.251 -1.34 . . . . 9.0 110.649 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -74.81 117.86 17.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.581 -0.896 . . . . 9.76 108.581 172.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.2 m80 56.65 174.81 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.335 0.588 . . . . 11.19 111.184 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 245' ' ' ARG . 79.3 m-20 -113.18 13.55 19.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.64 0.733 . . . . 10.8 110.024 174.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.33 160.16 28.21 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.261 -1.536 . . . . 8.82 109.261 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.89 121.14 9.08 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 CA-C-N 119.302 1.551 . . . . 7.87 111.804 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.35 2.4 50.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.913 -0.585 . . . . 10.62 112.116 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -114.91 -26.32 7.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.97 0.414 . . . . 9.87 110.949 -176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -76.89 -15.06 59.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.13 -0.487 . . . . 8.48 111.059 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -70.26 -15.66 62.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 7.13 110.459 176.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -87.69 -30.65 20.22 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.129 0.49 . . . . 9.68 109.893 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.57 -32.22 65.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.766 -0.652 . . . . 7.89 110.389 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.471 ' HB3' HG22 ' A' ' 22' ' ' ILE . 95.9 m-85 -124.65 98.18 37.78 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.425 -0.807 . . . . 7.17 109.862 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 50.0 Cg_exo -54.93 -29.13 62.54 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.387 2.725 . . . . 7.76 112.92 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' A' ' 20' ' ' PHE . 14.5 tt -44.82 -28.17 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 113.073 0.768 . . . . 5.83 113.073 175.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 17' ' ' HIS . . . -61.48 -10.12 7.1 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.83 0.678 . . . . 5.44 112.83 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 34.1 mmtp -59.82 -16.16 26.29 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 122.154 -0.341 . . . . 7.78 111.293 168.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.67 -73.48 0.92 Allowed Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.321 -0.712 . . . . 5.01 111.321 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.49 168.73 1.06 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 122.753 0.421 . . . . 7.09 110.022 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 165.42 29.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 104.878 -2.267 . . . . 5.13 104.878 -165.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -55.97 -50.0 72.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.753 1.161 . . . . 7.12 112.342 -166.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.536 ' HB2' ' HA ' ' A' ' 248' ' ' GLN . 70.3 m -94.44 145.34 29.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.424 -0.353 . . . . 3.94 110.327 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HA ' ' OG ' ' A' ' 196' ' ' SER . 74.4 Cg_endo -75.72 -41.88 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.032 2.488 . . . . 4.52 115.588 -166.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG23 ' CD1' ' A' ' 193' ' ' TYR . 7.4 p -161.54 157.09 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.715 -0.394 . . . . 4.54 111.846 -174.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.498 ' HB2' ' H ' ' A' ' 248' ' ' GLN . 32.2 t70 -163.01 132.9 4.35 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.109 -0.7 . . . . 2.88 109.109 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 210' ' ' VAL . 54.2 mt -101.98 103.57 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.904 0.705 . . . . 2.32 112.904 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -93.69 102.14 14.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.053 -0.721 . . . . 2.82 109.053 165.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 m -56.99 -28.46 62.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 2.24 112.353 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -69.84 -34.27 73.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.563 0.221 . . . . 4.54 111.281 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -85.7 -23.29 27.46 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.955 -0.298 . . . . 3.06 111.126 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -61.54 105.28 0.51 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.283 0.563 . . . . 1.72 111.716 174.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.28 138.05 36.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.526 -0.761 . . . . 3.69 111.235 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 99.2 m-85 -73.93 132.41 42.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.529 . . . . 4.64 110.112 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -120.81 124.09 27.67 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.427 -0.351 . . . . 2.27 110.725 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.35 -23.22 44.72 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.767 2.312 . . . . 2.15 112.036 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 m -65.7 -27.81 68.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.524 . . . . 4.29 111.396 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.7 mt -70.52 119.26 14.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.028 0.442 . . . . 4.74 111.01 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.605 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 59.0 tttm -99.29 131.43 25.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.407 -0.815 . . . . 3.77 109.294 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.3 154.44 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.862 3.041 . . . . 2.36 114.034 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.64 125.21 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.066 -0.97 . . . . 2.55 110.729 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 m -96.87 98.42 10.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.239 -0.652 . . . . 2.38 109.239 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.43 HG22 ' HG ' ' A' ' 79' ' ' LEU . 8.9 t -102.9 127.98 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.912 -0.585 . . . . 1.59 110.649 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -129.58 91.4 3.15 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.82 -0.437 . . . . 1.45 109.82 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -106.35 11.63 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.864 0.364 . . . . 3.62 110.92 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 2.48 111.067 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 48.9 mt-30 -94.33 6.17 49.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.987 -0.552 . . . . 2.24 111.964 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -67.51 133.72 49.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.8 111.603 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -113.38 106.24 14.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 1.06 110.467 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 m -72.34 138.05 47.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.162 -0.472 . . . . 1.26 109.832 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 71' ' ' ASP . 82.6 mt -113.74 -58.21 2.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.74 112.427 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -158.9 161.44 36.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.868 0.366 . . . . 3.17 111.448 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -121.17 133.2 68.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.651 -0.87 . . . . 0.64 108.651 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 57.9 tp -137.3 119.05 15.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.56 0.578 . . . . 0.96 112.56 -171.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -79.18 114.06 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.102 -1.073 . . . . 1.49 108.102 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 169' ' ' LYS . 53.8 t30 -140.34 70.59 1.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.654 -0.819 . . . . 1.83 112.423 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 103.27 -67.01 0.33 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.137 -1.03 . . . . 1.64 113.132 162.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.471 ' HB3' ' OD1' ' A' ' 243' ' ' ASN . 51.7 m80 -103.82 -27.55 12.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.048 0.452 . . . . 3.33 110.895 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.96 -169.98 2.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.755 -0.657 . . . . 1.38 110.159 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 95' ' ' PHE . 34.8 p90 -133.8 134.03 42.37 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.271 -1.011 . . . . 2.74 108.271 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 8.3 p30 -132.71 151.87 51.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.055 0.455 . . . . 1.76 111.398 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 98.2 t -106.46 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 1.15 109.84 176.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.39 138.38 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.464 . . . . 2.02 111.417 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.82 150.69 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.339 -0.846 . . . . 1.66 109.135 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB2' HD21 ' A' ' 57' ' ' LEU . 22.4 t70 -75.2 124.44 27.06 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.009 -0.367 . . . . 1.33 110.009 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -125.81 58.31 1.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.08 0.943 . . . . 2.65 110.448 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 p -96.41 -5.25 40.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.51 -0.768 . . . . 1.61 109.75 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -143.17 157.69 44.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.834 -1.075 . . . . 2.35 108.813 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.58 70.25 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.549 0.69 . . . . 1.92 109.769 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 68.5 mttm -92.75 -54.64 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.287 -0.869 . . . . 1.77 111.538 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -110.5 110.42 21.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.282 -0.417 . . . . 0.76 110.283 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.75 144.24 34.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.392 -0.367 . . . . 1.27 110.613 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HG ' HG22 ' A' ' 49' ' ' VAL . 9.6 tt -149.9 113.04 4.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.707 -0.849 . . . . 1.29 108.707 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -151.43 127.44 10.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.156 0.503 . . . . 2.54 111.385 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -67.89 174.01 30.01 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.784 -0.644 . . . . 1.31 111.635 164.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 45' ' ' LYS . . . -39.2 -142.73 0.0 OUTLIER Glycine 0 N--CA 1.472 1.076 0 N-CA-C 115.813 1.085 . . . . 1.9 115.813 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.52 121.32 6.95 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 121.856 1.704 . . . . 2.91 112.37 -173.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.8 mt -147.81 -168.17 3.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.528 -1.214 . . . . 4.11 108.713 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -129.24 70.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.444 0.535 . . . . 4.95 112.444 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 131.19 -125.56 4.5 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.794 -1.193 . . . . 2.25 115.072 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.776 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 85.6 m -131.51 115.68 16.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.692 -0.754 . . . . 1.91 109.755 -169.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -115.01 91.36 3.59 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.037 -0.665 . . . . 3.7 111.739 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.29 142.49 34.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.109 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -73.77 121.86 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 1.14 110.331 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.519 HG23 ' HG2' ' A' ' 92' ' ' GLN . 5.2 tp -107.92 -38.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 1.68 111.088 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG2' HG23 ' A' ' 91' ' ' ILE . 16.4 pt20 -170.25 168.06 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.625 -0.262 . . . . 1.55 110.498 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 41.6 p90 -141.31 145.89 36.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.648 -0.501 . . . . 0.86 109.648 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.459 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.8 p-80 -128.9 159.81 34.63 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.329 0.393 . . . . 0.93 110.695 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 t80 -135.74 158.13 45.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.959 -0.386 . . . . 3.17 109.959 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -162.65 171.12 17.37 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.734 0.302 . . . . 1.68 111.713 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.506 ' CZ2' ' HB ' ' A' ' 222' ' ' VAL . 23.1 m95 -138.99 148.74 43.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.588 -0.733 . . . . 5.18 110.459 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . -79.18 -37.38 25.02 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 116.022 -0.535 . . . . 2.13 113.499 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 47.1 t 162.93 -70.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.57 0.748 . . . . 2.9 109.35 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.38 158.33 26.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.359 -0.837 . . . . 3.03 109.68 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.22 62.05 0.13 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.558 0.536 . . . . 3.85 111.463 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.23 32.31 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.649 -0.786 . . . . 1.94 113.029 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -161.29 157.21 25.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.898 0.349 . . . . 2.45 110.485 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' N ' ' A' ' 98' ' ' GLY . . . 99.11 45.92 2.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.867 -0.682 . . . . 1.47 112.482 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 45.2 t -103.88 -28.4 11.62 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.284 -0.166 . . . . 2.0 111.264 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 105' ' ' SER . 8.5 tp10 68.07 169.3 0.27 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.196 -0.668 . . . . 3.72 109.196 -167.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.6 m170 60.59 35.13 20.07 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.482 0.658 . . . . 3.52 110.414 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.476 ' CG2' ' HA ' ' A' ' 113' ' ' LYS . 73.2 p -82.73 119.59 24.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.167 -0.924 . . . . 2.52 111.637 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 87.9 t -76.42 117.0 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.214 -0.903 . . . . 2.48 109.878 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.71 35.42 16.93 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.128 -0.693 . . . . 2.8 109.128 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.7 mttp 59.91 27.49 16.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.073 -0.967 . . . . 4.98 112.342 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -77.3 86.87 3.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.114 -0.328 . . . . 3.23 110.114 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.476 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 98.9 mttt -61.69 113.05 2.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.066 0.46 . . . . 2.82 111.477 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -83.88 177.34 8.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.551 -0.75 . . . . 1.62 109.108 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.86 -53.7 54.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.914 0.338 . . . . 1.03 111.914 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.2 169.56 4.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.124 -0.325 . . . . 0.75 110.124 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.4 ' HB2' ' OG ' ' A' ' 105' ' ' SER . 26.8 tt0 -148.94 141.81 24.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.987 -0.375 . . . . 1.58 109.987 -178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 34.5 tp -99.74 125.89 45.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.871 -0.604 . . . . 1.07 109.493 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.4 m170 -110.69 107.9 17.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.77 111.516 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 120' ' ' LEU . 5.4 mp -93.39 113.35 25.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.786 -0.643 . . . . 0.93 110.19 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.04 127.65 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.294 0.569 . . . . 0.61 111.527 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.9 139.88 50.5 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.017 -1.105 . . . . 2.13 108.017 172.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.94 154.36 46.64 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.57 -0.452 . . . . 4.26 111.559 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.776 ' HA ' ' O ' ' A' ' 87' ' ' THR . 53.1 t30 -76.43 89.58 3.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 2.02 110.988 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.9 p -73.45 -9.2 58.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.538 0.94 . . . . 2.34 113.538 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 13.5 ptmm? -71.52 -46.02 60.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.963 -0.695 . . . . 3.35 109.736 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.516 ' CG ' ' HG3' ' A' ' 132' ' ' LYS . 67.6 m-85 -94.19 -15.56 24.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 3.1 111.138 173.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 129' ' ' ASP . . . 101.23 -1.04 54.2 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.835 -0.698 . . . . 2.37 111.57 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 128' ' ' GLY . 32.8 t70 81.52 -78.16 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.834 0.854 . . . . 3.93 112.185 172.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -56.3 -19.87 16.26 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.438 0.903 . . . . 3.0 113.438 -168.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.09 -67.52 1.62 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.723 -0.751 . . . . 2.15 112.165 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HG3' ' CG ' ' A' ' 127' ' ' TYR . 45.0 mmtm -72.13 -21.25 61.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.416 0.524 . . . . 3.43 112.416 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.63 56.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 1.76 111.427 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 203' ' ' LEU . 70.1 t -61.62 -36.29 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 2.77 110.418 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -106.4 -24.66 12.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.661 0.267 . . . . 3.55 111.283 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -95.47 105.13 18.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 3.02 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 72.4 Cg_endo -76.52 -0.46 10.45 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.424 2.083 . . . . 1.6 112.419 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.53 27.07 10.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.425 -0.352 . . . . 2.29 110.39 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.87 -53.92 8.96 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 120.808 -0.711 . . . . 1.22 112.849 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 91.5 mt -89.32 151.0 22.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 1.57 110.784 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.47 106.63 5.75 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.485 -0.78 . . . . 1.38 109.286 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 44.4 t -107.3 117.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.457 -0.338 . . . . 1.73 110.803 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.99 126.18 33.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.833 -0.621 . . . . 2.42 109.62 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.19 115.43 4.45 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.737 -0.744 . . . . 0.86 112.638 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.6 mt -104.91 111.48 34.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.137 -0.319 . . . . 0.76 110.137 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -67.99 144.61 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.695 0.283 . . . . 1.2 110.981 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.2 mp -115.71 131.94 56.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.43 -0.35 . . . . 0.88 110.315 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -121.5 143.91 49.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.147 -0.686 . . . . 2.03 109.147 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 42.5 t -88.43 129.6 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 1.27 111.374 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.59 -104.12 0.18 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.532 -0.758 . . . . 1.53 111.279 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 p -81.66 146.73 29.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.197 -0.297 . . . . 1.54 110.197 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.33 148.86 47.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.086 0.469 . . . . 0.78 111.621 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 216' ' ' SER . 49.3 tptt -111.5 103.76 55.39 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 1.22 109.444 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.83 -38.11 94.89 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.002 2.468 . . . . 1.05 112.299 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.466 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -62.13 -29.21 72.18 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 116.031 -0.531 . . . . 0.7 113.035 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.5 tp -94.48 -17.58 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.271 0.535 . . . . 0.77 110.392 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -43.78 92.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.828 -0.624 . . . . 1.41 110.233 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.0 pttt -56.87 -32.39 65.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 2.86 111.853 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.6 t -77.07 -41.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 1.38 110.47 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 156' ' ' LEU . 72.4 t -57.57 -36.93 55.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.745 -0.662 . . . . 1.11 111.331 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.02 -20.6 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.56 . . . . 1.22 112.405 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.0 t -96.6 -7.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.902 0.382 . . . . 1.41 111.332 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 84.6 mt -57.66 -42.1 82.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.854 0.687 . . . . 1.39 112.854 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.94 -24.81 66.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.81 0.338 . . . . 2.31 111.386 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.0 m -81.15 -8.98 59.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.476 -0.329 . . . . 1.4 111.26 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -134.21 36.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.364 0.602 . . . . 0.85 109.739 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.58 -32.92 74.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 1.59 111.451 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.9 p -116.93 155.73 28.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.888 0.375 . . . . 0.77 111.528 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 42.5 tttm -59.73 132.42 53.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.868 -0.605 . . . . 2.29 110.611 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.36 -17.14 40.73 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.756 -0.735 . . . . 0.85 111.555 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -75.28 107.83 7.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.941 0.4 . . . . 1.7 110.602 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.0 m -98.95 140.74 32.65 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.262 -0.644 . . . . 1.37 109.262 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.28 129.35 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.825 -0.435 . . . . 0.61 109.825 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.45 134.13 56.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 1.8 109.825 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.41 79.85 1.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.833 . . . . 1.04 108.752 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.0 p -105.27 152.87 22.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 1.17 112.095 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.27 62.98 2.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.724 -0.671 . . . . 1.77 112.131 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -134.67 98.1 3.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 3.99 110.768 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.15 140.44 88.15 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.822 -0.626 . . . . 2.51 111.112 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.16 -3.48 13.15 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.178 2.585 . . . . 1.26 112.17 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.5 -42.59 74.67 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.863 -0.608 . . . . 2.76 112.302 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -63.0 -16.95 58.1 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.046 -0.597 . . . . 1.12 113.285 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.75 -16.26 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 1.73 110.948 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.05 133.8 36.42 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.456 . . . . 3.45 110.896 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.61 -170.47 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.921 2.414 . . . . 2.08 112.426 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.63 -49.87 60.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.621 0.248 . . . . 3.23 111.601 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.422 ' HB2' ' HG3' ' A' ' 213' ' ' GLU . 36.6 m -94.73 141.19 28.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 1.66 110.732 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.5 64.09 0.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.534 0.683 . . . . 1.99 109.735 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.434 ' O ' HD12 ' A' ' 211' ' ' LEU . 0.9 OUTLIER -80.45 163.59 23.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.514 -0.766 . . . . 1.81 109.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.714 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 30.6 p90 -165.57 142.88 5.68 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.679 -0.408 . . . . 5.01 110.872 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -123.91 106.64 10.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.026 -1.102 . . . . 3.93 108.026 170.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.4 HG23 ' HE2' ' A' ' 256' ' ' LYS . 2.7 t -82.61 121.48 26.87 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.811 0.671 . . . . 2.13 112.811 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.488 ' CD1' HG23 ' A' ' 31' ' ' VAL . 83.7 t80 -137.21 131.9 17.82 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.773 . . . . 5.21 110.387 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 193' ' ' TYR . 16.8 Cg_exo -66.77 129.36 20.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.738 2.292 . . . . 2.12 112.379 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.512 ' HA3' ' NE1' ' A' ' 208' ' ' TRP . . . -119.8 157.03 15.69 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.389 -0.434 . . . . 1.75 113.006 -174.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' A' ' 30' ' ' PRO . 22.7 p -107.15 143.68 34.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.41 0.624 . . . . 2.99 111.801 -175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 203' ' ' LEU . 55.5 mt -90.77 19.56 5.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.224 -0.898 . . . . 4.75 110.704 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 196' ' ' SER . 1.0 OUTLIER -61.93 27.31 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.6 1.704 . . . . 5.1 115.6 -161.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.712 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 46.2 p -80.25 -154.29 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 107.182 -1.414 . . . . 5.53 107.182 166.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.712 ' CD ' ' HB ' ' A' ' 199' ' ' THR . 84.3 Cg_exo -48.02 -44.76 27.07 Favored 'Trans proline' 0 C--N 1.364 1.361 0 CA-C-N 122.512 1.933 . . . . 5.83 114.069 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.465 ' HD2' ' OG1' ' A' ' 199' ' ' THR . 2.7 Cg_exo -78.51 79.0 3.45 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.125 1.883 . . . . 4.78 111.689 172.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.13 80.48 0.96 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.847 -0.615 . . . . 3.84 112.079 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 30.9 tp -152.05 120.5 6.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.815 -0.175 . . . . 2.96 111.335 172.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 5.6 pt-20 -80.83 109.79 15.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.543 0.687 . . . . 3.37 111.03 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 23.5 p -140.67 21.96 2.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.944 0.402 . . . . 2.15 110.668 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.487 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -104.8 138.12 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.005 0.431 . . . . 1.26 111.185 -176.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.6 m -112.84 111.83 22.88 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.074 -0.713 . . . . 2.08 109.074 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.512 ' NE1' ' HA3' ' A' ' 195' ' ' GLY . 97.4 m95 -81.97 116.78 21.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.648 0.261 . . . . 5.53 110.476 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 38.4 mm -101.73 98.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.695 -0.854 . . . . 1.63 108.695 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 38.1 t -85.67 116.99 29.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 1.62 111.937 -174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 189' ' ' ASP . 56.0 tp -80.23 113.89 18.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.846 -0.427 . . . . 1.73 109.846 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.562 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 6.2 tmmm? -60.99 -21.62 63.72 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.399 0.518 . . . . 2.98 112.399 -176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 187' ' ' SER . 34.5 mm-40 -99.64 106.07 37.83 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 111.874 0.324 . . . . 1.47 111.874 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 10.1 Cg_exo -73.77 138.55 26.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.059 2.506 . . . . 0.96 111.689 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -91.58 152.12 3.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.839 0.352 . . . . 1.25 110.334 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 3.1 p -96.08 122.29 38.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.959 -0.564 . . . . 1.29 111.147 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.5 m -123.75 153.18 29.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 1.02 109.791 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 t -88.19 158.97 18.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.592 0.234 . . . . 1.08 111.23 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.523 ' HA ' HG22 ' A' ' 222' ' ' VAL . 29.6 t -54.6 -42.85 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 1.33 110.513 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -56.31 -27.3 55.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.51 111.78 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.2 -49.75 9.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.343 -0.389 . . . . 0.7 110.15 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.1 m -66.51 -31.13 52.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 1.36 111.27 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 89.6 mt -60.52 -39.77 89.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 1.03 110.673 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -74.46 -25.03 59.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.12 -0.491 . . . . 1.75 111.157 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.69 -28.86 61.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.201 0.524 . . . . 2.47 109.749 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -86.29 -3.35 58.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.92 -0.582 . . . . 3.04 110.279 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.5 mmtt -88.05 -9.3 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 2.31 109.948 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.44 HD11 HD22 ' A' ' 163' ' ' LEU . 91.9 mt -71.37 150.14 45.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.659 -0.7 . . . . 0.95 110.722 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -108.26 142.93 37.81 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.532 0.682 . . . . 1.13 110.393 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -78.49 -32.19 48.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.592 -1.185 . . . . 3.74 109.166 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -76.98 169.98 17.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.93 -1.032 . . . . 1.62 111.987 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 169' ' ' LYS . . . -96.34 179.05 34.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.006 -0.997 . . . . 1.16 111.204 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.52 137.67 57.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 3.56 110.426 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.17 62.69 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 2.08 112.894 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.49 153.26 69.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 117.085 0.443 . . . . 2.59 109.838 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.8 125.1 17.96 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.348 2.032 . . . . 1.36 111.187 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.439 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.8 pt-20 -64.16 127.57 32.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.577 0.703 . . . . 3.4 112.325 -172.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.79 124.05 38.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.768 -1.106 . . . . 2.47 108.365 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.14 145.89 55.28 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.956 0.408 . . . . 2.14 111.159 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 30.6 mtt -65.81 102.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.647 -0.706 . . . . 1.68 110.074 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.35 142.04 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.567 -0.742 . . . . 1.27 110.436 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 244' ' ' TRP . 38.9 t70 68.35 -90.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.326 -0.852 . . . . 2.18 110.487 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 64' ' ' HIS . 47.8 t30 65.75 -23.46 0.09 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.313 0.857 . . . . 2.15 113.313 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.419 ' H ' ' C ' ' A' ' 242' ' ' ASP . 63.3 t-105 -146.85 134.04 20.52 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.674 -0.641 . . . . 4.59 111.323 -169.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.573 ' CD ' ' H ' ' A' ' 245' ' ' ARG . 0.1 OUTLIER -93.22 102.57 7.54 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.222 -0.899 . . . . 6.13 108.975 174.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 4.2 Cg_exo -74.83 -91.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.888 2.392 . . . . 3.28 115.101 -166.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.24 129.88 38.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.873 0.694 . . . . 2.98 112.873 -159.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.536 ' HA ' ' HB2' ' A' ' 29' ' ' SER . 24.5 pt20 -82.53 179.16 2.04 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.575 -0.739 . . . . 4.32 110.176 171.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 248' ' ' GLN . 69.0 Cg_exo -53.83 132.79 51.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.829 1.686 . . . . 3.48 111.58 170.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.9 -39.68 19.62 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.666 -1.152 . . . . 4.63 112.606 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 253' ' ' ARG . 22.3 ptmt -61.29 -12.19 12.63 Favored 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 115.654 1.724 . . . . 5.34 115.654 -176.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 9.2 p30 37.82 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 118.806 2.891 . . . . 4.64 118.806 165.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 251' ' ' LYS . 35.2 ttm180 142.98 -118.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.399 1.88 . . . . 6.11 105.964 -163.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 253' ' ' ARG . 19.5 tt0 -146.27 128.74 15.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.246 -1.39 . . . . 3.08 107.246 161.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 60.8 mt -91.04 146.37 6.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.783 -0.451 . . . . 2.6 109.783 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.4 ' HE2' HG23 ' A' ' 192' ' ' THR . 19.3 pttm -116.61 137.03 52.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.63 110.499 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.25 160.64 24.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.19 -0.914 . . . . 1.71 109.503 -176.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 32.9 t -143.17 98.02 3.19 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.053 -0.659 . . . . 2.21 111.502 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -132.87 90.88 2.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.916 . . . . 4.31 108.584 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.243 0.736 0 CA-C-O 118.364 -0.827 . . . . 4.49 110.518 -176.699 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 246' ' ' PRO . 66.6 mtt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.747 0.308 . . . . 17.49 110.754 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -70.9 129.82 40.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.033 0.444 . . . . 15.32 111.146 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -133.25 49.16 2.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.994 -0.548 . . . . 15.81 109.59 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -67.15 112.93 4.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 14.19 110.094 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.2 t-105 71.05 -60.96 0.5 Allowed 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.989 0.806 . . . . 14.91 111.408 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.98 129.93 10.06 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.758 -0.735 . . . . 10.79 111.964 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -91.06 96.4 10.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.121 0.486 . . . . 11.39 110.463 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.35 -71.06 0.51 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.407 -1.077 . . . . 9.0 110.407 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' PRO . 54.1 mtpt -91.47 170.26 10.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.547 -0.908 . . . . 9.76 108.547 170.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -59.83 -51.86 67.93 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.776 -0.37 . . . . 11.19 110.347 177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -83.81 -15.87 46.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.402 0.62 . . . . 10.8 110.387 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' HA2' ' HD3' ' A' ' 13' ' ' PRO . . . 110.84 137.46 7.46 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.635 -0.712 . . . . 8.82 111.581 -176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD3' ' HA2' ' A' ' 12' ' ' GLY . 5.1 Cg_exo -77.95 128.26 9.07 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.563 2.175 . . . . 7.87 111.781 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.43 -19.86 61.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.515 0.674 . . . . 10.62 109.89 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -109.66 27.61 9.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.054 -0.975 . . . . 9.87 110.038 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -64.15 -22.44 66.94 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.816 0.817 . . . . 8.48 109.108 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -48.48 -48.9 37.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.246 -1.343 . . . . 7.13 109.753 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -93.07 -42.2 9.54 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.159 0.429 . . . . 9.68 112.159 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.68 16.95 0.59 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.001 1.112 . . . . 7.89 114.001 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -152.67 105.83 2.71 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.758 -0.83 . . . . 7.17 108.758 -170.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.441 ' O ' HG22 ' A' ' 22' ' ' ILE . 88.2 Cg_exo -41.98 126.19 3.42 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.013 2.476 . . . . 7.76 113.133 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 21' ' ' PRO . 10.5 tp 53.8 44.52 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.936 1.294 . . . . 5.83 112.474 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.15 6.03 32.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.544 . . . . 5.44 111.376 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 24' ' ' LYS . 3.2 mmmp? -85.67 -6.98 59.07 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.954 -0.758 . . . . 7.78 108.954 173.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 170.42 78.03 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.651 -1.38 . . . . 5.01 109.651 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -48.55 149.2 1.73 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.028 0.751 . . . . 7.09 113.028 -172.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -136.9 176.1 9.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.898 -1.046 . . . . 5.13 110.052 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 196' ' ' SER . 28.1 mp0 -48.1 105.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.935 0.874 . . . . 7.12 111.895 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.56 ' H ' ' HG2' ' A' ' 253' ' ' ARG . 18.8 m -102.74 162.45 20.13 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 113.977 -1.465 . . . . 3.94 112.007 -175.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -43.06 39.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 1 C-N-CA 127.116 5.21 . . . . 4.52 116.564 165.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 248' ' ' GLN . 15.7 m -88.64 -175.14 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.326 0.584 . . . . 4.54 111.247 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.678 ' HA ' ' OG1' ' A' ' 108' ' ' THR . 31.7 t70 -98.56 108.35 21.02 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.978 -0.749 . . . . 2.88 108.978 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 110' ' ' ASP . 72.4 mt -67.47 126.95 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.807 -0.633 . . . . 2.32 110.917 -173.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.8 114.6 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.93 -0.577 . . . . 2.82 110.489 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -63.69 -31.54 72.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.24 111.728 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -76.19 -4.4 41.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.815 0.34 . . . . 4.54 111.533 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.0 m -102.41 -8.22 21.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.464 0.649 . . . . 3.06 109.929 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -78.2 120.39 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 1.72 110.758 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -95.41 132.34 40.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.252 -0.431 . . . . 3.69 110.232 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.736 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 27.4 m-85 -82.46 130.28 35.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.486 0.66 . . . . 4.64 111.883 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 258' ' ' SER . 25.3 t70 -125.2 140.55 36.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 2.27 109.248 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.96 90.94 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.801 2.334 . . . . 2.15 113.295 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.1 t -60.28 -38.18 82.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.933 -0.576 . . . . 4.29 110.392 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt 72.21 -67.1 0.27 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.464 -0.789 . . . . 4.74 111.996 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -101.44 128.08 30.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.51 0.195 . . . . 3.77 110.979 -175.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.55 160.91 26.13 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.048 2.499 . . . . 2.36 111.874 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.561 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 11.0 mp -80.0 143.76 33.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.368 0.507 . . . . 2.55 112.368 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -106.86 99.41 8.98 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.317 -0.856 . . . . 2.38 108.723 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 t -117.0 108.1 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.028 -0.533 . . . . 1.59 110.268 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.6 m -102.12 89.46 3.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.077 -0.51 . . . . 1.45 109.705 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -101.57 3.43 40.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.94 -0.763 . . . . 3.62 108.94 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.58 -33.06 69.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.45 -1.25 . . . . 2.48 111.859 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -103.6 13.14 33.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.693 0.257 . . . . 2.24 111.693 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -63.83 122.94 17.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.8 111.496 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 23.1 m -103.26 111.96 24.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.938 -0.573 . . . . 1.06 110.386 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -76.73 141.84 40.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.735 -0.468 . . . . 1.26 109.735 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 71' ' ' ASP . 84.8 mt -118.54 -57.29 2.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.277 0.473 . . . . 0.74 112.277 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -156.49 148.1 22.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.643 -0.253 . . . . 3.17 110.722 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -108.92 137.21 42.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.608 -0.516 . . . . 0.64 109.608 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.8 tp -128.4 145.47 51.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.299 -0.41 . . . . 0.96 110.395 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -117.16 124.18 48.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.933 0.397 . . . . 1.49 111.196 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.23 153.03 46.62 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.184 -1.043 . . . . 1.83 108.184 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.581 ' HA2' ' SD ' ' A' ' 240' ' ' MET . . . -69.91 33.08 0.39 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 115.478 0.951 . . . . 1.64 115.478 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -131.95 -36.96 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.521 -0.548 . . . . 3.33 109.521 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -171.01 -179.62 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.399 -0.963 . . . . 1.38 108.399 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -117.2 144.9 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.797 -1.186 . . . . 2.74 107.797 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 4.6 p30 -131.33 141.33 49.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.02 0.438 . . . . 1.76 111.468 -172.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.7 t -106.15 116.48 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.787 -0.642 . . . . 1.15 109.903 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.85 128.47 33.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.654 -0.703 . . . . 2.02 110.901 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -105.8 159.26 16.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.847 -0.615 . . . . 1.66 110.458 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 26.1 t70 -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.847 -0.615 . . . . 1.33 109.613 174.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.47 60.96 1.65 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.036 0.922 . . . . 2.65 110.334 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 m -92.2 -5.75 51.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.575 -0.739 . . . . 1.61 110.203 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -145.7 176.44 9.64 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.405 -0.961 . . . . 2.35 108.405 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' CG ' HH21 ' A' ' 89' ' ' ARG . 18.1 m-20 -75.33 65.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.158 0.504 . . . . 1.92 110.675 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -84.8 -59.0 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 1.77 110.223 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -114.59 97.3 6.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.518 -0.764 . . . . 0.76 109.749 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.52 146.5 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.168 -0.469 . . . . 1.27 110.083 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tt -137.22 113.4 9.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 1.29 109.463 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.609 ' HD2' HG23 ' A' ' 87' ' ' THR . 12.6 ptmm? -148.09 124.23 10.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.258 0.552 . . . . 2.54 110.959 172.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -86.12 175.64 48.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.981 -0.848 . . . . 1.31 110.981 167.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.59 -142.92 0.0 OUTLIER Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.304 0.649 . . . . 1.9 114.508 165.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.49 120.6 5.95 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.518 1.478 . . . . 2.91 112.19 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -158.62 -168.23 2.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.838 -1.074 . . . . 4.11 108.883 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -125.34 45.71 2.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 121.181 -0.208 . . . . 4.95 110.989 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.74 158.79 7.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.43 -0.89 . . . . 2.25 113.123 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.609 HG23 ' HD2' ' A' ' 80' ' ' LYS . 92.1 m -98.23 114.74 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 1.91 109.814 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 65.6 m-85 -102.25 132.92 47.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.19 0.441 . . . . 3.7 112.19 -171.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 75' ' ' ASP . 98.2 mtt180 -103.59 147.09 27.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 3.54 109.86 173.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 121' ' ' VAL . 48.4 tp -77.44 130.14 36.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.559 -0.291 . . . . 1.14 110.949 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -110.28 -40.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.376 . . . . 1.68 110.954 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -170.53 168.07 7.84 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.821 -0.437 . . . . 1.55 109.821 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 19.4 p90 -135.88 157.51 46.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.174 -0.21 . . . . 0.86 110.688 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -143.09 158.94 43.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.54 -0.541 . . . . 0.93 109.54 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.657 ' CE2' ' HG ' ' A' ' 118' ' ' LEU . 42.1 m-85 -111.76 166.16 11.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.589 0.233 . . . . 3.17 110.654 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 2.0 m80 -122.39 139.14 54.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.029 -0.73 . . . . 1.68 109.029 171.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.456 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 39.6 p90 -159.39 142.71 14.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.782 -0.451 . . . . 5.18 109.782 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.487 ' HA2' ' HB ' ' A' ' 241' ' ' VAL . . . 174.69 -168.04 40.53 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.181 -1.009 . . . . 2.13 112.913 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t 43.77 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.465 1.106 . . . . 2.9 112.312 -173.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' GLY . 89.3 mt -85.26 -159.32 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 3.03 109.647 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.61 66.48 9.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.91 0.386 . . . . 3.85 110.071 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 97' ' ' TRP . . . 82.29 120.39 0.6 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.889 -0.672 . . . . 1.94 112.595 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? 178.94 157.21 0.51 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.753 0.421 . . . . 2.45 110.491 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 96' ' ' HIS . . . 128.6 109.84 1.48 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.378 -0.915 . . . . 1.47 113.918 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.47 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 30.5 t -91.64 -47.23 7.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.604 -0.887 . . . . 2.0 108.604 169.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -119.17 48.14 1.55 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.744 -1.947 . . . . 3.72 105.744 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 64.69 2.05 1.55 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.455 -1.702 . . . . 3.52 111.616 -171.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.678 ' OG1' ' HA ' ' A' ' 32' ' ' ASP . 21.2 p -144.27 179.41 7.25 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.765 -0.828 . . . . 2.52 108.765 158.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.0 t -142.31 92.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.332 0.515 . . . . 2.48 111.559 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 36.5 t70 42.36 44.11 3.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.394 0.678 . . . . 2.8 112.513 172.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 67.51 -43.29 0.46 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.291 0.636 . . . . 4.98 111.368 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 110' ' ' ASP . 9.2 mmmm -79.23 71.66 5.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.492 0.317 . . . . 3.23 110.389 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 108' ' ' THR . 57.6 mttp -52.54 120.81 6.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.39 -0.368 . . . . 2.82 110.389 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -104.84 -164.67 1.06 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 1.62 110.44 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 222' ' ' VAL . . . -61.85 -51.61 67.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.712 0.634 . . . . 1.03 112.712 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.4 172.41 6.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.31 -0.255 . . . . 0.75 110.31 -172.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HB3' ' HD1' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -138.77 135.75 34.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.352 -0.61 . . . . 1.58 109.352 175.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.657 ' HG ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 tt -108.47 118.45 36.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.284 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.599 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -110.97 100.36 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.904 0.383 . . . . 1.77 110.837 -176.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.9 mp -88.03 108.62 19.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.269 -0.423 . . . . 0.93 110.451 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 90' ' ' LEU . 33.2 t -79.3 123.15 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 0.61 111.187 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 61.3 m80 -118.25 156.98 27.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.326 -0.62 . . . . 2.13 109.326 175.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.641 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 52.3 p-90 -133.9 144.04 48.63 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.264 -0.273 . . . . 4.26 110.264 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -65.82 107.64 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 2.02 111.069 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.641 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 9.5 t -69.46 -14.84 63.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 2.34 112.12 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.18 -14.1 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 3.35 111.231 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.69 3.72 53.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 3.1 110.617 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 62.42 -1.3 1.58 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.503 0.961 . . . . 2.37 115.503 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -169.6 139.46 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.141 0.97 . . . . 3.93 110.116 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.39 -44.06 88.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.919 -0.582 . . . . 3.0 111.294 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.407 ' O ' HG12 ' A' ' 134' ' ' VAL . . . -61.65 -34.91 90.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.106 -0.568 . . . . 2.15 112.156 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -72.47 -38.86 68.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.857 0.361 . . . . 3.43 110.656 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.594 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.07 -38.42 82.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 1.76 111.825 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 131' ' ' GLY . 8.9 p -67.41 -11.9 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.24 0.543 . . . . 2.77 111.285 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -89.6 15.06 10.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.987 0.422 . . . . 3.55 110.91 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -126.15 138.57 32.46 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 60.9 Cg_exo -53.6 -32.04 62.42 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.361 2.708 . . . . 1.6 113.439 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.7 28.97 8.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.068 0.461 . . . . 2.29 110.252 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.99 -36.32 28.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.018 -0.61 . . . . 1.22 113.263 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.0 mt -108.34 157.63 18.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.769 0.319 . . . . 1.57 110.643 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -142.5 107.43 4.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.082 0.468 . . . . 1.38 110.522 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 119' ' ' HIS . 7.8 m -94.02 119.67 42.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.188 0.518 . . . . 1.73 110.857 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 46.5 tp -89.1 112.5 23.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.889 -0.596 . . . . 2.42 109.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.462 ' HA3' ' HE1' ' A' ' 208' ' ' TRP . . . -99.49 132.18 10.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.812 -0.709 . . . . 0.86 112.321 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.8 mt -129.54 124.27 59.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.666 -0.494 . . . . 0.76 109.666 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.89 140.62 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.752 0.31 . . . . 1.2 110.709 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.487 HD23 HG11 ' A' ' 217' ' ' VAL . 10.3 mp -118.6 128.55 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.429 -0.582 . . . . 0.88 109.429 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 15.6 ptpt -122.71 151.09 41.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.062 -0.348 . . . . 2.03 110.062 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 14.2 m -70.44 107.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.472 0.654 . . . . 1.27 111.716 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -155.16 -135.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.495 -0.775 . . . . 1.53 111.272 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.0 m -70.28 121.68 18.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.656 -0.498 . . . . 1.54 109.656 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.59 ' HB2' ' CB ' ' A' ' 218' ' ' SER . . . -83.64 104.53 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.337 -0.246 . . . . 0.78 110.337 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -70.68 126.43 92.2 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.031 -0.359 . . . . 1.22 110.031 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.28 -14.02 31.88 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.04 2.494 . . . . 1.05 112.556 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.536 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -58.64 -25.53 58.66 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.98 -0.555 . . . . 0.7 112.936 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 159' ' ' VAL . 48.0 tp -91.95 -32.05 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.189 0.519 . . . . 0.77 110.406 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -52.49 -38.93 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 1.41 112.142 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 41.6 pttt -61.27 -33.86 74.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.499 0.555 . . . . 2.86 112.499 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 162' ' ' VAL . 13.3 p -84.58 -36.81 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.581 -0.448 . . . . 1.38 110.775 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 156' ' ' LEU . 19.5 t -65.16 -39.18 84.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 1.11 110.72 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.2 -28.03 66.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.519 -0.764 . . . . 1.22 112.695 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 159' ' ' VAL . 10.0 p -92.2 -2.76 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.978 0.418 . . . . 1.41 111.136 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' HD21 ' A' ' 228' ' ' LEU . 75.3 mt -60.29 -28.03 67.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.333 -0.394 . . . . 1.39 111.529 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -67.34 -25.21 65.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.497 -0.319 . . . . 2.31 111.431 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.7 t -84.4 -1.76 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 1.4 110.811 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.41 33.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.356 -0.979 . . . . 0.85 108.356 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -55.62 -35.55 66.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.479 -1.237 . . . . 1.59 111.787 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.1 p -106.72 152.62 23.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.082 0.468 . . . . 0.77 111.163 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -57.94 136.67 57.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 2.29 111.296 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.46 -15.04 57.75 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.734 -0.746 . . . . 0.85 112.917 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -86.81 151.23 23.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 1.7 111.34 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.5 p -142.2 151.43 42.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.394 -0.821 . . . . 1.37 109.816 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.65 148.51 44.13 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.911 -0.403 . . . . 0.61 109.911 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 135.53 51.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.791 0.329 . . . . 1.8 110.125 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -138.61 80.17 1.78 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.734 -0.839 . . . . 1.04 108.734 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.5 p -124.13 169.09 12.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.796 -0.638 . . . . 1.17 111.232 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.56 38.68 22.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.019 -0.537 . . . . 1.77 111.313 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -120.98 137.72 54.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.291 -0.413 . . . . 3.99 110.363 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -80.76 118.85 74.23 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.757 -0.656 . . . . 2.51 110.752 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.89 -21.66 27.92 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.929 2.419 . . . . 1.26 112.766 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -77.27 -2.52 35.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 2.76 111.05 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.11 -17.92 46.59 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 116.168 -0.469 . . . . 1.12 113.262 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.33 -38.09 65.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.63 0.215 . . . . 1.73 110.531 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 79.9 mt 54.69 85.17 0.2 Allowed Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.755 . . . . 3.45 112.778 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.33 136.76 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.296 2.664 . . . . 2.08 112.133 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -107.84 27.34 9.31 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.365 0.666 . . . . 3.23 110.501 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 213' ' ' GLU . 35.0 t -153.51 103.14 2.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.661 -0.496 . . . . 1.66 109.661 -159.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.16 59.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.594 -0.443 . . . . 1.99 110.839 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -125.88 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.033 -1.099 . . . . 1.81 108.033 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.575 ' HB2' HG23 ' A' ' 209' ' ' ILE . 5.6 p90 -162.47 144.94 11.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.855 -0.738 . . . . 5.01 111.816 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 256' ' ' LYS . 48.6 m0 -92.63 129.07 38.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.778 -0.823 . . . . 3.93 108.778 168.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.4 t -84.67 94.04 8.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.12 0.962 . . . . 2.13 110.432 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.63 119.16 18.15 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 5.21 109.349 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 26.7 Cg_exo -62.24 150.21 87.75 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.008 1.805 . . . . 2.12 111.218 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.86 123.27 5.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.475 -0.869 . . . . 1.75 112.824 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 198' ' ' THR . 22.0 t -95.53 -135.34 0.21 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.273 -0.64 . . . . 2.99 109.273 175.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.612 ' C ' ' H ' ' A' ' 199' ' ' THR . 2.5 pt? -46.55 11.4 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.604 1.705 . . . . 4.75 115.604 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.517 ' H ' ' C ' ' A' ' 196' ' ' SER . 20.1 p -66.5 27.73 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.784 0.802 . . . . 5.1 111.679 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.612 ' H ' ' C ' ' A' ' 197' ' ' LEU . 1.3 p -165.43 170.14 6.45 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.002 -1.454 . . . . 5.53 108.726 -170.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.431 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 74.0 Cg_exo -48.01 -48.51 16.19 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 121.928 1.752 . . . . 5.83 113.254 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 5.2 Cg_exo -80.9 136.14 10.36 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.222 1.948 . . . . 4.78 112.31 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 197' ' ' LEU . 40.7 tp -68.74 -40.36 79.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.97 -1.014 . . . . 3.84 111.584 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 203' ' ' LEU . 2.7 pp -56.06 147.43 20.12 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.477 0.656 . . . . 2.96 111.988 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 204' ' ' GLU . 0.0 OUTLIER -77.78 73.74 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.172 -0.922 . . . . 3.37 111.584 -172.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.8 p -99.52 7.24 45.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.441 -0.799 . . . . 2.15 110.702 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 142' ' ' VAL . 10.9 t -118.86 151.05 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.292 0.568 . . . . 1.26 112.079 -169.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 13.4 m -121.75 121.73 37.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.194 -1.039 . . . . 2.08 108.194 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.507 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.3 t90 -86.73 125.97 34.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.105 0.479 . . . . 5.53 110.214 -175.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 190' ' ' TYR . 44.4 mm -109.69 100.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.438 -0.801 . . . . 1.63 108.965 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 3.9 t -92.91 129.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.844 -0.342 . . . . 1.62 111.556 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.958 -0.756 . . . . 1.73 108.958 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.23 2.12 37.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.042 0.756 . . . . 2.98 113.042 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 187' ' ' SER . 10.9 tp10 -111.65 105.31 56.66 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 121.072 -0.251 . . . . 1.47 110.915 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 19.6 Cg_exo -67.67 141.14 53.75 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.856 2.371 . . . . 0.96 112.326 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.0 pt -96.98 153.59 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.322 -0.399 . . . . 1.25 110.188 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.5 m -89.4 128.16 35.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.226 -0.443 . . . . 1.29 111.59 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 35.5 m -137.83 137.95 44.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.606 -0.725 . . . . 1.02 109.11 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.59 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 8.5 t -87.8 159.87 18.25 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.278 -0.569 . . . . 1.08 111.804 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.552 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.4 m -48.26 -46.02 35.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.615 -0.72 . . . . 1.33 111.586 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.86 -26.29 46.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.961 -0.563 . . . . 2.51 112.33 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -80.86 -48.36 12.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.582 -0.525 . . . . 0.7 109.582 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.467 HG21 ' HB1' ' A' ' 115' ' ' ALA . 22.0 t -62.99 -39.1 83.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.221 -0.899 . . . . 1.36 111.477 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.8 mt -62.05 -25.92 67.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 1.03 111.72 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -76.71 -19.67 57.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.584 -0.28 . . . . 1.75 111.337 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -68.92 -34.44 75.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.439 0.638 . . . . 2.47 110.072 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 28.2 ttm180 -76.23 -2.92 33.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.374 -0.83 . . . . 3.04 110.948 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -86.7 -3.75 59.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.392 . . . . 2.31 110.299 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 163' ' ' LEU . 94.8 mt -78.91 145.29 34.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.865 -0.607 . . . . 0.95 110.568 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.596 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.08 127.62 55.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 1.13 111.071 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.94 -34.37 74.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.914 -1.039 . . . . 3.74 110.874 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -69.49 162.38 27.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.674 -0.694 . . . . 1.62 111.933 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.84 166.4 42.96 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.677 -0.969 . . . . 1.16 110.677 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.79 133.43 50.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 3.56 110.803 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 95.51 6.71 59.59 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 2.08 111.87 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -119.01 158.04 49.04 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.518 -0.549 . . . . 2.59 109.518 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.08 122.99 12.11 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.919 2.413 . . . . 1.36 112.134 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.417 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 10.6 pt-20 -62.32 126.3 26.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 3.4 112.178 -174.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 10.6 tp10 -124.55 134.53 52.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.288 -0.869 . . . . 2.47 110.221 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.81 107.97 2.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.575 . . . . 2.14 110.083 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.581 ' SD ' ' HA2' ' A' ' 63' ' ' GLY . 51.1 ttp -74.33 91.24 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 1.68 109.374 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.487 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 27.6 m -135.38 157.71 39.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.628 -0.715 . . . . 1.27 111.293 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 70.42 -81.47 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 124.129 0.893 . . . . 2.18 110.939 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 14.5 m120 50.43 29.18 3.74 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.753 0.649 . . . . 2.15 112.753 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -148.07 152.76 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 4.59 108.876 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.415 HH12 ' HB2' ' A' ' 21' ' ' PRO . 17.1 ptp180 -80.38 148.94 67.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.609 -0.145 . . . . 6.13 110.609 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.475 ' HG2' ' O ' ' A' ' 1' ' ' MET . 80.6 Cg_exo -48.89 164.11 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.485 2.79 . . . . 3.28 113.598 177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . . . -68.77 98.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.596 -0.729 . . . . 2.98 112.504 -170.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 27.0 mm-40 -61.25 163.83 9.94 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.537 -0.756 . . . . 4.32 110.586 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.622 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 72.0 Cg_endo -75.09 161.1 39.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 3.48 113.366 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -8.83 34.59 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.2 -0.909 . . . . 4.63 112.315 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 47.9 mmtm -55.29 49.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.571 1.693 . . . . 5.34 115.571 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.682 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER 124.91 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.979 2.112 . . . . 4.64 110.149 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 249' ' ' PRO . 4.3 mpt_? -138.42 100.25 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.336 -0.987 . . . . 6.11 108.336 167.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -128.84 148.43 50.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.581 -0.526 . . . . 3.08 109.581 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 21.6 mm -102.0 147.66 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.341 -0.391 . . . . 2.6 110.517 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 191' ' ' TRP . 45.3 mttp -135.71 166.39 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.637 -0.875 . . . . 2.63 108.637 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.736 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -144.28 114.89 7.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.634 -0.136 . . . . 1.71 110.634 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 21.3 m -97.2 100.71 12.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.283 0.563 . . . . 2.21 110.702 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -145.13 131.64 19.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.588 -0.733 . . . . 4.31 110.242 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.782 -0.627 . . . . 4.49 109.759 178.218 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.962 -0.384 . . . . 17.49 109.962 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 m -76.36 84.61 3.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 15.32 111.057 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -99.99 -11.81 20.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.587 -0.733 . . . . 15.81 109.225 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -79.12 123.0 26.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.458 -0.792 . . . . 14.19 109.433 170.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.15 112.67 25.88 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.421 -0.585 . . . . 14.91 109.421 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.04 134.22 11.8 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.615 -0.802 . . . . 10.79 112.317 -176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -69.84 105.59 2.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.911 0.386 . . . . 11.39 110.174 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.53 -160.43 43.61 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.624 -0.717 . . . . 9.0 111.835 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -59.88 120.71 10.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.466 -0.198 . . . . 9.76 110.466 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 177.55 -66.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.691 0.619 . . . . 11.19 109.747 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -126.61 30.6 5.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.04 0.448 . . . . 10.8 110.47 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.28 106.62 1.5 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.915 -0.659 . . . . 8.82 111.574 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.87 125.91 14.46 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.497 2.131 . . . . 7.87 112.603 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -87.03 -30.46 21.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.258 -1.016 . . . . 10.62 108.258 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -87.55 26.34 1.29 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.977 -1.465 . . . . 9.87 109.483 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -45.95 -39.2 8.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.736 0.814 . . . . 8.48 112.923 -173.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -74.9 -38.07 61.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.855 0.36 . . . . 7.13 110.862 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -70.6 -17.52 62.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.927 -0.579 . . . . 9.68 110.649 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.7 11.18 7.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.773 0.796 . . . . 7.89 109.828 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -131.14 103.26 15.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.202 -0.908 . . . . 7.17 108.677 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.56 86.05 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.717 2.278 . . . . 7.76 112.754 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 27' ' ' ARG . 10.4 tp 43.26 51.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.207 1.003 . . . . 5.83 111.72 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.93 23.44 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.739 -0.664 . . . . 5.44 112.665 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -103.98 17.47 24.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.911 0.862 . . . . 7.78 109.098 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.03 89.31 0.45 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 108.996 -1.642 . . . . 5.01 108.996 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' HG23 ' A' ' 22' ' ' ILE . 2.4 mp0 -62.19 122.3 15.24 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.752 0.787 . . . . 7.09 112.344 -164.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.526 ' O ' HG21 ' A' ' 22' ' ' ILE . 56.8 mtt180 -148.34 126.97 12.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.179 -1.373 . . . . 5.13 107.446 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' OE1' HD11 ' A' ' 197' ' ' LEU . 9.2 tt0 -147.45 -91.84 0.08 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.727 -0.472 . . . . 7.12 109.727 172.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.8 m -71.99 104.54 1.02 Allowed Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 108.983 -0.747 . . . . 3.94 108.983 171.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.474 ' HG3' ' HD2' ' A' ' 194' ' ' PRO . 54.7 Cg_endo -67.67 -42.6 6.59 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.315 2.01 . . . . 4.52 113.773 -165.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 248' ' ' GLN . 0.1 OUTLIER -160.6 169.73 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.13 0.491 . . . . 4.54 111.402 -175.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.42 143.58 26.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.073 -0.967 . . . . 2.88 108.856 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 49.8 mt -88.34 91.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.372 0.606 . . . . 2.32 109.796 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.97 119.45 39.5 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.766 -0.652 . . . . 2.82 109.444 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -55.34 -33.41 63.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.797 . . . . 2.24 112.812 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -76.73 -34.83 58.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.12 0.486 . . . . 4.54 110.705 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -88.01 18.06 4.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.599 -0.728 . . . . 3.06 110.438 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.16 150.26 36.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 1.72 109.2 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -119.35 122.78 42.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.039 0.447 . . . . 3.69 110.472 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -82.59 126.22 32.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.673 -0.694 . . . . 4.64 109.952 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -145.8 97.74 4.55 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.773 -0.454 . . . . 2.27 109.773 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.04 28.89 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.657 2.238 . . . . 2.15 112.677 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -99.9 -5.92 27.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.289 -0.414 . . . . 4.29 110.827 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.66 152.1 21.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.545 -0.539 . . . . 4.74 109.545 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.25 135.72 20.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.681 -0.236 . . . . 3.77 110.723 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.35 136.94 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 2.36 111.364 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.65 131.6 43.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.857 0.361 . . . . 2.55 111.208 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -66.47 122.95 18.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.639 -0.71 . . . . 2.38 109.677 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 79' ' ' LEU . 3.0 t -109.38 103.0 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.237 -0.438 . . . . 1.59 110.141 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.713 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 6.7 m -105.18 89.33 3.1 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.81 -0.811 . . . . 1.45 108.81 177.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.3 p90 -124.46 6.43 8.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.906 0.384 . . . . 3.62 111.461 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.7 -19.27 65.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.409 -0.359 . . . . 2.48 111.418 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 25.2 mp0 -98.64 6.55 46.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.575 -0.284 . . . . 2.24 110.403 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -55.15 133.82 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.8 111.675 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.5 m -120.75 106.37 11.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.888 -0.596 . . . . 1.06 110.186 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.9 p -79.4 150.81 31.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.685 -0.487 . . . . 1.26 109.685 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.9 mt -122.07 -55.4 1.88 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.832 0.349 . . . . 0.74 111.616 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -154.8 152.37 29.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.452 -0.34 . . . . 3.17 111.016 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 tt -115.15 137.39 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.559 -0.534 . . . . 0.64 109.559 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 172' ' ' SER . 39.5 tp -134.07 142.32 47.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.726 0.298 . . . . 0.96 111.11 -173.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -111.09 108.04 17.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.876 -0.787 . . . . 1.49 108.876 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -142.51 72.59 1.38 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.685 0.624 . . . . 1.83 112.685 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.14 -71.41 0.4 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.437 -1.363 . . . . 1.64 113.569 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -142.55 0.04 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.775 0.321 . . . . 3.33 111.585 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.44 174.75 13.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.803 -0.814 . . . . 1.38 108.803 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 95' ' ' PHE . 49.7 p90 -115.38 121.97 44.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 2.74 109.465 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -96.53 116.22 28.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.751 . . . . 1.76 110.46 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 42.0 t -93.05 106.1 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.584 -0.524 . . . . 1.15 109.584 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.62 129.26 37.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.887 -0.597 . . . . 2.02 111.589 -174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -111.52 153.98 25.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.347 -0.842 . . . . 1.66 110.265 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -76.54 110.95 11.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.922 -0.581 . . . . 1.33 110.626 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' CD ' ' A' ' 89' ' ' ARG . 6.2 p-10 -116.26 55.53 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.298 0.571 . . . . 2.65 111.392 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -104.91 -6.5 20.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.483 . . . . 1.61 111.025 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -137.94 176.56 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.206 -0.664 . . . . 2.35 109.206 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -82.14 41.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.18 0.514 . . . . 1.92 110.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 34.9 mmtp -51.32 -60.69 2.85 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.897 -1.047 . . . . 1.77 110.673 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -130.87 96.75 4.15 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.285 -0.871 . . . . 0.76 110.159 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 16.5 m -111.95 147.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.404 0.621 . . . . 1.27 111.605 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.9 tp -129.29 119.43 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.857 -1.065 . . . . 1.29 108.466 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 87' ' ' THR . 57.3 pttt -158.97 121.14 3.51 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.5 -0.48 . . . . 2.54 111.764 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.62 176.9 40.15 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 114.337 0.495 . . . . 1.31 114.337 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.33 -137.43 0.0 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.156 1.36 . . . . 1.9 115.755 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.8 148.76 3.58 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.081 2.521 . . . . 2.91 113.166 -168.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.1 pt? -39.95 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.038 1.866 . . . . 4.11 116.038 -157.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -85.94 -48.55 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.519 -0.764 . . . . 4.95 109.663 162.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 123.79 163.48 11.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.167 -0.54 . . . . 2.25 112.223 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.466 ' HA ' ' HB3' ' A' ' 80' ' ' LYS . 49.1 m -94.69 103.15 15.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 1.91 110.04 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 21.7 m-85 -95.76 102.1 13.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.286 -0.416 . . . . 3.7 110.081 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' CD ' ' HB2' ' A' ' 72' ' ' ASP . 16.0 ptp180 -82.03 152.36 26.68 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.211 -0.306 . . . . 3.54 110.183 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.3 tp -76.47 122.86 25.15 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.737 -0.468 . . . . 1.14 109.737 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -108.38 -32.81 2.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.906 0.384 . . . . 1.68 110.164 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.3 pt20 -171.64 169.66 5.93 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.691 -0.485 . . . . 1.55 109.691 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -140.72 158.43 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.412 -0.588 . . . . 0.86 109.412 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -147.41 158.73 44.09 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.19 0.306 . . . . 0.93 110.73 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 66.5 m-85 -123.08 165.55 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 3.17 110.773 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -172.6 126.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.266 0.626 . . . . 1.68 109.661 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.517 ' CE3' ' HB1' ' A' ' 116' ' ' ALA . 14.8 p90 -161.8 -174.51 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.591 -0.277 . . . . 5.18 110.375 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 241' ' ' VAL . . . 89.92 99.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.512 -0.851 . . . . 2.13 111.681 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.7 t -143.08 -82.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.711 -0.848 . . . . 2.9 108.711 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD12 ' OE1' ' A' ' 103' ' ' GLN . 84.2 mt -95.75 -155.18 0.46 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.143 -0.688 . . . . 3.03 109.143 169.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.82 -48.31 67.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.077 0.399 . . . . 3.85 112.077 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.71 63.68 0.36 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.602 -0.808 . . . . 1.94 111.448 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 114' ' ' TYR . 13.1 pt20 -150.65 -172.11 4.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 2.45 110.761 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.29 8.71 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.47 111.474 -168.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.444 ' HB2' ' N ' ' A' ' 116' ' ' ALA . 48.2 t -78.46 -33.5 48.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.338 0.495 . . . . 2.0 112.338 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.466 ' CG ' ' H ' ' A' ' 107' ' ' HIS . 0.9 OUTLIER 69.85 -156.32 0.15 Allowed 'General case' 0 C--N 1.343 0.316 0 N-CA-C 107.363 -1.347 . . . . 3.72 107.363 -173.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 4.3 m-70 53.04 69.79 0.66 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.161 0.437 . . . . 3.52 110.046 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 5.3 t -98.71 117.43 33.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 120.024 -0.671 . . . . 2.52 110.136 -165.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 14.7 m -92.18 103.44 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.161 0.505 . . . . 2.48 110.785 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.2 t70 54.01 58.83 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.555 -0.748 . . . . 2.8 109.735 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 67.23 4.83 3.85 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.866 -1.061 . . . . 4.98 113.19 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 109' ' ' VAL . 37.5 ttmt -90.36 111.68 22.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.949 -0.389 . . . . 3.23 109.949 175.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -93.08 146.6 23.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.569 -0.9 . . . . 2.82 108.569 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 96.8 m-85 -95.93 176.44 6.11 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.601 -0.439 . . . . 1.62 109.935 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.0 -39.03 20.18 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.664 0.616 . . . . 1.03 112.664 -171.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HB1' ' CE3' ' A' ' 97' ' ' TRP . . . -145.34 149.97 35.76 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.606 -0.438 . . . . 0.75 111.801 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' OE1' ' NE2' ' A' ' 107' ' ' HIS . 3.5 tp10 -110.88 141.55 44.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.055 -0.52 . . . . 1.58 110.563 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.681 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 13.0 tp -121.73 121.86 38.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.771 -0.649 . . . . 1.07 110.045 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.35 104.34 10.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 1.77 111.446 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -89.81 111.01 21.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.031 -0.531 . . . . 0.93 109.589 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.75 123.62 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.316 0.579 . . . . 0.61 110.766 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 29.8 m-70 -115.74 145.53 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.64 -0.709 . . . . 2.13 109.912 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.458 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 9.1 t90 -112.0 133.47 54.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.973 -0.558 . . . . 4.26 110.719 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -78.17 111.84 14.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.231 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 t -58.34 -21.66 50.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.719 -0.673 . . . . 2.34 112.111 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -46.79 -32.18 3.51 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.557 0.947 . . . . 3.35 113.557 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.43 ' CE2' ' HB2' ' A' ' 136' ' ' GLN . 4.8 m-85 -97.38 -4.62 38.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.648 0.61 . . . . 3.1 112.648 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.87 14.9 2.91 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.575 0.59 . . . . 2.37 114.575 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 18.1 t70 -172.11 117.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.853 -0.795 . . . . 3.93 108.853 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -65.52 -33.14 75.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 3.0 111.819 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 134' ' ' VAL . . . -61.45 -33.66 85.51 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.881 -0.676 . . . . 2.15 112.133 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 69.9 mmtt -83.79 -24.98 30.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.797 0.332 . . . . 3.43 110.979 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.475 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.49 -21.85 63.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.358 -0.383 . . . . 1.76 111.912 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 131' ' ' GLY . 31.3 m -73.05 3.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 2.77 112.381 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 12.7 pt20 -97.15 -11.0 24.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 3.55 110.182 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.456 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 29.9 tt0 -101.81 136.48 19.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 3.02 109.867 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 25.3 Cg_endo -60.65 -28.39 86.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.28 2.654 . . . . 1.6 112.656 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.456 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.8 p-10 -112.24 27.71 9.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 2.29 109.447 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.36 -37.64 86.29 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.725 -0.67 . . . . 1.22 111.747 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 206' ' ' VAL . 86.8 mt -122.37 158.01 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.018 -0.734 . . . . 1.57 109.018 173.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.52 122.69 12.93 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.2 -0.296 . . . . 1.38 110.2 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.91 126.87 69.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.015 0.436 . . . . 1.73 110.697 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 49.0 tp -93.04 117.83 30.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.621 -0.718 . . . . 2.42 109.777 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -104.4 127.61 9.16 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.275 -0.488 . . . . 0.86 112.132 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.88 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.756 -0.461 . . . . 0.76 109.756 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.7 141.9 49.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.798 -0.183 . . . . 1.2 110.556 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 9.7 mp -121.27 135.32 55.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.118 0.485 . . . . 0.88 110.676 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 216' ' ' SER . 54.6 pttt -123.54 156.3 35.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.839 -0.8 . . . . 2.03 108.839 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 46.6 t -94.34 126.62 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.875 0.369 . . . . 1.27 110.568 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.22 -105.89 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.634 -0.586 . . . . 1.53 111.634 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.8 m -67.04 154.99 39.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.655 0.264 . . . . 1.54 110.315 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.33 157.27 16.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.015 -0.365 . . . . 0.78 110.015 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 216' ' ' SER . 28.2 mtpp -128.06 103.0 21.14 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.069 -0.345 . . . . 1.22 110.069 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.65 -33.93 61.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.362 2.708 . . . . 1.05 112.612 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.85 -28.64 73.67 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.7 112.502 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.7 tp -102.64 -23.64 13.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.77 110.543 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -38.43 70.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 1.41 110.047 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.3 -29.73 70.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.935 -0.575 . . . . 2.86 111.235 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.24 -48.54 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.21 0.528 . . . . 1.38 110.15 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.441 HG11 ' HA ' ' A' ' 221' ' ' GLN . 43.2 t -65.33 -36.0 76.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.698 -0.683 . . . . 1.11 111.205 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.58 -28.22 69.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 1.22 112.231 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.52 -1.37 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.73 -0.388 . . . . 1.41 111.482 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.51 ' HB3' HD21 ' A' ' 228' ' ' LEU . 79.6 mt -58.99 -22.21 60.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 1.39 111.778 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -66.6 -28.83 68.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.445 0.164 . . . . 2.31 111.366 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.4 p -83.26 -0.54 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.301 . . . . 1.4 111.739 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.29 34.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.85 108.883 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.425 ' HA ' HD23 ' A' ' 228' ' ' LEU . 84.1 tttt -67.73 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.87 -1.059 . . . . 1.59 111.883 -169.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.66 148.77 49.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 0.77 110.706 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -59.61 126.34 27.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.351 -0.84 . . . . 2.29 111.084 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 114.51 -21.46 14.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.819 -0.705 . . . . 0.85 112.693 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -88.67 153.15 21.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 1.7 111.26 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' HD13 ' A' ' 60' ' ' LEU . 42.6 p -144.21 161.62 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 1.37 110.732 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.47 151.63 37.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.148 -0.478 . . . . 0.61 109.816 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.64 131.95 41.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.815 -0.439 . . . . 1.8 109.815 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -141.53 81.77 1.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.085 -0.507 . . . . 1.04 109.839 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 46.0 p -98.85 166.54 11.25 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.278 -0.419 . . . . 1.17 111.363 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 66.17 32.2 8.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.814 -0.63 . . . . 1.77 112.418 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.604 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 68.3 t80 -66.63 132.3 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.331 -0.248 . . . . 3.99 110.331 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.22 100.25 0.68 Allowed Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 123.621 0.575 . . . . 2.51 110.567 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 11.1 Cg_exo -71.16 -36.24 7.54 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.71 2.274 . . . . 1.26 112.445 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.3 -9.96 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 2.76 110.637 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -70.93 0.97 26.64 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.063 -0.517 . . . . 1.12 113.14 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 86.4 mt -91.68 -14.58 29.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.197 -0.297 . . . . 1.73 110.197 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.5 mt 42.84 73.7 0.89 Allowed Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 113.462 0.912 . . . . 3.45 113.462 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.39 119.11 1.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.148 2.565 . . . . 2.08 111.127 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.3 mt-10 -112.39 25.08 11.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.778 0.431 . . . . 3.23 111.346 -171.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.472 ' CB ' ' HB2' ' A' ' 213' ' ' GLU . 0.3 OUTLIER -168.3 90.06 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.047 -0.661 . . . . 1.66 110.605 -160.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.68 63.91 0.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.008 -1.108 . . . . 1.99 108.008 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 258' ' ' SER . 8.6 m-20 -87.71 -51.18 6.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.652 0.982 . . . . 1.81 113.652 -166.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 51.0 p90 -146.85 144.62 29.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.267 -0.573 . . . . 5.01 111.955 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -136.72 129.01 29.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.682 -0.69 . . . . 3.93 110.595 174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 256' ' ' LYS . 7.6 t -171.91 74.01 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.93 0.872 . . . . 2.13 111.134 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 208' ' ' TRP . 82.9 m-85 -139.36 137.33 18.85 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.123 -0.489 . . . . 5.21 111.092 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 30' ' ' PRO . 97.7 Cg_endo -84.83 132.21 4.68 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.829 2.353 . . . . 2.12 111.812 175.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.431 ' HA3' ' HB ' ' A' ' 206' ' ' VAL . . . -99.22 106.27 3.19 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.532 -0.842 . . . . 1.75 112.61 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 198' ' ' THR . 22.9 t -84.21 -138.03 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 122.922 0.489 . . . . 2.99 111.752 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.591 ' C ' ' H ' ' A' ' 199' ' ' THR . 4.4 pp -45.25 8.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 117.252 2.316 . . . . 4.75 117.252 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 196' ' ' SER . 7.1 m -73.86 25.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.116 -0.99 . . . . 5.1 109.619 171.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.598 HG21 ' SG ' ' A' ' 205' ' ' CYS . 9.4 t -144.9 151.07 48.27 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 114.737 -1.12 . . . . 5.53 108.966 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.434 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 72.8 Cg_exo -46.9 -53.46 6.22 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 122.805 2.337 . . . . 5.83 114.9 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 68.3 Cg_endo -82.84 20.59 1.12 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.017 1.811 . . . . 4.78 114.611 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 62.64 -60.73 0.13 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.488 0.921 . . . . 3.84 113.488 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 pp -43.23 153.47 0.1 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.809 0.844 . . . . 2.96 112.945 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.78 88.74 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.469 -0.787 . . . . 3.37 111.458 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.598 ' SG ' HG21 ' A' ' 199' ' ' THR . 3.3 p -118.15 16.46 14.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.097 -0.956 . . . . 2.15 109.561 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 140' ' ' LEU . 51.0 t -117.57 149.71 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.835 -1.075 . . . . 1.26 109.744 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 87.3 m -117.19 117.13 28.73 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.374 -0.602 . . . . 2.08 109.374 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 193' ' ' TYR . 36.9 m0 -84.98 133.05 34.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.375 0.607 . . . . 5.53 110.7 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 67.4 mt -121.29 141.78 40.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.363 -0.977 . . . . 1.63 108.363 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.42 146.33 31.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.201 0.524 . . . . 1.62 111.681 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.83 131.45 55.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.928 -0.768 . . . . 1.73 108.928 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 53.9 tttm -69.12 -7.6 37.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 2.98 111.644 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 186' ' ' GLU . 10.1 tp10 -94.04 112.32 56.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.436 -0.347 . . . . 1.47 111.177 -175.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 4.9 Cg_exo -78.65 130.51 9.8 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.658 2.239 . . . . 0.96 111.09 171.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.404 HG13 ' HG ' ' A' ' 147' ' ' LEU . 34.1 pt -99.22 154.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.447 -0.575 . . . . 1.25 109.447 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.512 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 27.4 p -103.68 126.76 51.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.703 0.287 . . . . 1.29 111.711 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -114.83 147.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.15 -0.685 . . . . 1.02 109.15 173.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -93.6 166.55 12.18 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.532 -0.467 . . . . 1.08 110.78 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.574 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 44.0 m -50.19 -47.92 54.4 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.438 0.461 . . . . 1.33 112.209 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.69 -38.14 69.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.588 0.232 . . . . 2.51 111.391 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.441 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.1 mt-30 -67.38 -43.11 82.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 0.7 110.176 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.0 -41.78 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 1.36 111.031 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 219' ' ' SER . 90.2 mt -67.84 -44.1 77.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 1.03 111.689 -176.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -65.88 -24.42 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.912 0.338 . . . . 1.75 111.912 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -71.64 -36.03 70.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.033 0.444 . . . . 2.47 110.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -78.56 17.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.658 0.742 . . . . 3.04 110.439 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.57 -19.22 18.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.196 -0.668 . . . . 2.31 109.196 171.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 163' ' ' LEU . 88.7 mt -68.05 134.51 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.603 -0.726 . . . . 0.95 111.236 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 83.3 m-20 -96.92 144.23 27.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 1.13 110.147 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -79.79 -28.92 40.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.778 -1.101 . . . . 3.74 108.79 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -83.4 174.81 10.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 1.62 111.585 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.73 179.1 27.65 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.04 -0.982 . . . . 1.16 111.545 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.8 125.46 23.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.988 0.423 . . . . 3.56 111.579 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.72 20.1 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.845 -0.616 . . . . 2.08 113.507 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -133.14 157.22 78.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.898 0.349 . . . . 2.59 110.079 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.98 122.69 12.26 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.557 2.171 . . . . 1.36 111.692 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.25 117.94 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.235 0.828 . . . . 3.4 113.235 -173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 60.0 mm-40 -115.27 142.12 47.11 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.583 -1.189 . . . . 2.47 108.042 169.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.11 127.05 38.51 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.968 -0.293 . . . . 2.14 110.214 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 52.6 ttp -81.23 94.96 6.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.16 0.505 . . . . 1.68 110.07 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 98' ' ' GLY . 21.8 m -137.95 156.41 31.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.673 -0.694 . . . . 1.27 110.752 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.39 -80.23 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.914 0.758 . . . . 2.18 110.953 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 47.37 32.16 2.14 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.176 0.591 . . . . 2.15 112.193 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -146.89 174.55 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.232 0.539 . . . . 4.59 111.657 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -127.68 145.7 55.86 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.598 -0.728 . . . . 6.13 110.261 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.17 174.16 3.48 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.548 2.166 . . . . 3.28 112.48 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.86 158.86 34.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.785 -0.643 . . . . 2.98 112.33 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 52.2 mt-30 -114.45 170.5 5.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.491 -0.777 . . . . 4.32 109.601 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.83 175.77 9.88 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.859 2.373 . . . . 3.48 113.489 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.8 -7.39 1.61 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.788 1.235 . . . . 4.63 112.88 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -55.87 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.517 2.043 . . . . 5.34 116.517 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 37.3 p30 131.04 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 126.665 1.986 . . . . 4.64 113.298 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.418 ' CB ' ' HB2' ' A' ' 30' ' ' PRO . 5.9 tpp180 -172.71 133.93 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.022 0.439 . . . . 6.11 111.574 166.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -114.16 150.61 33.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.394 -0.821 . . . . 3.08 109.486 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.8 mm -85.91 113.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.827 0.346 . . . . 2.6 110.573 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.514 ' HB3' HG21 ' A' ' 192' ' ' THR . 41.8 ttmt -109.34 143.41 38.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.058 -0.719 . . . . 2.63 109.058 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 190' ' ' TYR . . . -136.95 164.0 29.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.724 0.297 . . . . 1.71 110.924 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 36.0 m -151.12 97.41 2.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.996 0.427 . . . . 2.21 109.985 175.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.84 95.95 4.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.215 -0.661 . . . . 4.31 109.215 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.718 -0.658 . . . . 4.49 110.399 -177.132 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.908 0.385 . . . . 17.49 110.723 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.2 p -107.76 18.36 21.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.298 -0.41 . . . . 15.32 111.523 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -99.28 127.78 45.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.782 0.325 . . . . 15.81 110.44 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 5' ' ' TRP . 18.0 m-70 -81.71 93.86 6.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.195 -0.457 . . . . 14.19 109.924 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 92.6 m95 74.66 155.3 0.16 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.324 1.015 . . . . 14.91 110.964 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.19 170.59 40.54 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.438 -0.887 . . . . 10.79 112.182 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.436 ' CG ' ' HA ' ' A' ' 243' ' ' ASN . 6.1 p90 -88.44 100.2 12.86 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.377 0.608 . . . . 11.39 110.841 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.41 -117.64 0.81 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.79 -0.719 . . . . 9.0 111.899 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 17.0 tppt? -92.13 119.5 31.85 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.434 -0.58 . . . . 9.76 109.434 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 44.47 -94.5 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.408 0.892 . . . . 11.19 113.408 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 12.2 m120 -111.31 20.41 17.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.275 0.56 . . . . 10.8 110.68 -173.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.71 128.46 2.65 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.845 -0.902 . . . . 8.82 110.845 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 9' ' ' LYS . 57.0 Cg_endo -72.15 119.97 6.51 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.483 1.455 . . . . 7.87 112.415 -175.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 74.3 mm-40 -88.1 -28.91 21.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.537 -0.756 . . . . 10.62 112.328 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -66.12 -40.28 90.57 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.705 -0.398 . . . . 9.87 110.07 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -50.79 -52.62 39.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.147 -0.479 . . . . 8.48 111.835 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -58.46 -34.05 70.42 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.56 0.219 . . . . 7.13 111.104 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 75.6 mmtt -66.73 -49.11 67.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 9.68 110.677 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -70.87 -29.22 65.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.319 -0.4 . . . . 7.89 111.826 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.66 81.16 40.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.786 0.327 . . . . 7.17 110.283 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.63 -12.44 33.73 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.597 2.198 . . . . 7.76 112.205 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.7 tt -60.16 -12.04 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.043 0.449 . . . . 5.83 110.906 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.94 63.44 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.328 -0.396 . . . . 5.44 110.577 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -59.01 -8.15 1.33 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.122 -0.49 . . . . 7.78 112.287 170.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.5 179.23 41.77 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.275 -1.13 . . . . 5.01 110.275 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.8 106.82 14.28 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 117.433 -1.707 . . . . 7.09 110.881 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 202' ' ' LEU . 0.2 OUTLIER -166.18 124.47 1.49 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 119.205 -0.426 . . . . 5.13 110.18 158.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.497 ' HG3' ' H ' ' A' ' 29' ' ' SER . 2.8 pt20 -148.99 -58.04 0.21 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.377 0.99 . . . . 7.12 110.283 150.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.497 ' H ' ' HG3' ' A' ' 28' ' ' GLN . 4.3 p -107.53 99.77 30.57 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.257 -1.338 . . . . 3.94 107.479 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.85 -48.25 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 121.078 1.185 . . . . 4.52 114.314 -166.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -160.08 148.26 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.801 0.334 . . . . 4.54 110.552 -175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -90.09 109.13 20.2 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.479 -0.934 . . . . 2.88 108.479 168.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 108' ' ' THR . 75.5 mt -67.55 125.25 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.59 0.709 . . . . 2.32 111.645 -173.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.88 122.91 29.57 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.935 -1.029 . . . . 2.82 108.81 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.6 p -57.22 -24.86 57.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.936 0.717 . . . . 2.24 112.936 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -81.34 -27.19 35.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 4.54 111.263 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 m -95.39 -28.7 14.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.422 . . . . 3.06 111.14 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.31 121.18 13.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 1.72 110.651 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.13 116.24 22.25 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.817 -0.438 . . . . 3.69 109.817 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -65.41 136.83 56.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 4.64 110.402 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 258' ' ' SER . 19.0 t70 -130.63 132.79 24.18 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.745 -0.661 . . . . 2.27 110.23 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.588 ' O ' HD23 ' A' ' 44' ' ' LEU . 23.3 Cg_exo -65.17 108.98 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.213 1.942 . . . . 2.15 112.55 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.698 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -53.08 -18.39 2.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.699 -0.682 . . . . 4.29 111.468 171.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER 50.65 -84.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.94 1.296 . . . . 4.74 113.177 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' H ' ' CG ' ' A' ' 44' ' ' LEU . 88.4 tttt -89.69 133.05 35.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.141 -0.318 . . . . 3.77 110.141 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.47 136.98 57.39 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.636 2.224 . . . . 2.36 111.519 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.03 141.66 43.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 2.55 110.096 -177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -102.48 97.19 7.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.898 -0.778 . . . . 2.38 108.898 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.26 108.7 23.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.589 -0.732 . . . . 1.59 109.175 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.695 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 61.5 m -108.31 91.51 3.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.982 0.42 . . . . 1.45 110.356 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 181' ' ' ARG . 7.8 p90 -102.85 8.95 39.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.922 -0.581 . . . . 3.62 109.542 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.09 -29.59 57.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.963 -1.017 . . . . 2.48 111.156 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 50.6 mt-30 -113.31 23.04 13.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.659 -0.7 . . . . 2.24 110.997 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HB1' ' HG2' ' A' ' 180' ' ' PRO . . . -72.3 114.02 9.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.035 0.445 . . . . 0.8 110.54 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -115.56 112.26 21.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.617 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 p -77.96 156.18 30.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.077 -0.511 . . . . 1.26 110.246 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.4 mt -121.63 -56.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.612 -0.267 . . . . 0.74 111.449 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.73 156.67 23.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 3.17 111.515 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.519 HG12 HD13 ' A' ' 166' ' ' ILE . 12.0 tt -107.12 137.73 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.515 -0.766 . . . . 0.64 109.7 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 172' ' ' SER . 24.0 tp -135.4 150.55 49.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.203 0.525 . . . . 0.96 111.683 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 166' ' ' ILE . 49.0 t-20 -113.33 111.87 22.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.254 -1.387 . . . . 1.49 107.254 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -135.64 71.41 1.43 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.811 -0.756 . . . . 1.83 111.875 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.03 -83.67 0.62 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 119.917 -1.135 . . . . 1.64 112.918 160.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -112.29 -7.29 14.01 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.156 -0.218 . . . . 3.33 111.381 -173.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.4 167.26 24.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 1.38 111.612 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 46.1 m-85 -110.34 105.53 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.632 -0.877 . . . . 2.74 108.632 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -99.0 124.82 44.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.469 -0.332 . . . . 1.76 111.764 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 59' ' ' ILE . 49.0 t -107.68 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.074 -0.713 . . . . 1.15 109.074 172.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.29 163.29 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.705 0.764 . . . . 2.02 112.581 -170.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.57 164.64 27.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.424 -1.262 . . . . 1.66 108.372 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 106.15 14.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.689 -0.485 . . . . 1.33 109.689 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -112.24 57.05 0.65 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.575 0.702 . . . . 2.65 110.102 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.1 p -95.83 -20.85 18.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.953 -0.567 . . . . 1.61 111.425 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.465 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 7.9 pt20 -145.8 177.97 8.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 2.35 110.784 -171.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' OD2' HG21 ' A' ' 78' ' ' VAL . 11.4 t70 -71.21 63.44 0.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.556 -0.747 . . . . 1.92 110.586 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' A' ' 74' ' ' GLN . 48.0 mttm -86.0 -69.02 0.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.956 -0.565 . . . . 1.77 111.356 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -115.21 102.48 9.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.76 109.61 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.405 HG21 ' OD2' ' A' ' 75' ' ' ASP . 39.0 t -117.05 142.74 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.186 -0.461 . . . . 1.27 111.788 -171.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 tp -123.31 121.24 35.33 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 1.29 109.324 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -159.96 121.17 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.193 0.52 . . . . 2.54 110.696 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.7 28.55 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 119.606 -0.552 . . . . 1.31 112.033 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -41.01 -140.27 0.0 OUTLIER Glycine 0 CA--C 1.534 1.236 0 O-C-N 124.606 0.827 . . . . 1.9 114.373 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.09 122.94 8.05 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 121.918 1.745 . . . . 2.91 111.525 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 13.2 tp -175.2 -168.27 0.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.367 -1.345 . . . . 4.11 107.367 -165.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 20.8 t70 -135.9 72.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.798 0.726 . . . . 4.95 110.294 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 164.47 20.26 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 2.25 113.094 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.3 m -105.77 129.44 53.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.529 -0.545 . . . . 1.91 109.529 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 8.5 m-85 -115.3 109.99 18.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.392 . . . . 3.7 111.09 -171.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.8 mtt180 -83.65 155.87 22.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.782 -0.451 . . . . 3.54 109.782 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 51.5 tp -83.21 131.61 35.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.132 -0.322 . . . . 1.14 110.132 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.676 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.8 tt -116.64 -47.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 1.68 111.375 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -166.56 165.11 16.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.732 -0.47 . . . . 1.55 109.732 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CD2' HD11 ' A' ' 118' ' ' LEU . 15.5 p90 -133.84 167.2 21.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.945 -0.302 . . . . 0.86 110.418 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 66' ' ' PHE . 8.2 p-80 -147.51 158.6 44.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.164 -0.68 . . . . 0.93 109.164 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.74 163.65 23.86 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.376 -0.231 . . . . 3.17 110.376 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.583 ' HD1' ' HB3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -124.03 165.24 17.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.694 -0.854 . . . . 1.68 108.694 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 65.6 t-105 -133.03 140.54 47.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.412 . . . . 5.18 110.626 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.576 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -91.46 -71.17 1.2 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.726 -0.67 . . . . 2.13 112.732 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 24.7 t 165.48 -65.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.277 -1.009 . . . . 2.9 108.277 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.4 mt -111.36 168.02 9.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.312 -0.858 . . . . 3.03 108.869 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.71 61.78 3.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.564 0.697 . . . . 3.85 110.943 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -154.95 -24.35 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.505 -0.855 . . . . 1.94 113.537 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -152.15 176.51 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.304 0.552 . . . . 2.45 110.581 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.576 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 97.04 -33.15 5.97 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.788 -0.72 . . . . 1.47 113.003 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.3 p -71.1 -27.77 63.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.119 0.485 . . . . 2.0 110.76 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 3.6 tp10 58.81 -158.07 0.31 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.958 -1.127 . . . . 3.72 107.958 -166.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.511 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 19.3 m-70 54.76 65.21 1.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.817 -0.809 . . . . 3.52 108.817 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.509 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -93.05 133.61 36.03 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 2.52 109.953 -168.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -109.48 104.61 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.015 -0.365 . . . . 2.48 110.015 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.97 53.74 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.429 -0.805 . . . . 2.8 110.449 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 77.97 -11.22 1.23 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.201 -0.908 . . . . 4.98 111.826 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -93.97 108.82 20.59 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.432 . . . . 3.23 112.168 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 64.0 mttp -81.69 176.44 9.63 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.752 -0.833 . . . . 2.82 108.752 166.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -124.11 -173.19 2.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.243 -0.183 . . . . 1.62 111.094 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.6 -35.43 58.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.938 0.348 . . . . 1.03 111.938 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.77 168.65 26.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.37 -0.377 . . . . 0.75 110.165 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.583 ' HB3' ' HD1' ' A' ' 96' ' ' HIS . 1.7 tm-20 -145.3 147.3 32.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.067 -0.716 . . . . 1.58 109.067 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 93' ' ' PHE . 39.5 tp -126.02 122.03 34.69 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.291 0.369 . . . . 1.07 111.047 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -108.69 109.74 20.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.431 -0.35 . . . . 1.77 110.669 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' CB ' ' A' ' 93' ' ' PHE . 18.4 mt -93.67 105.21 17.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.935 -0.394 . . . . 0.93 109.935 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.6 118.34 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.334 0.587 . . . . 0.61 112.054 -173.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 52.0 m-70 -110.36 134.09 52.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.472 -0.785 . . . . 2.13 109.482 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.676 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 25.3 p-90 -111.18 148.05 33.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.476 . . . . 4.26 111.885 -172.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.9 110.2 1.27 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.41 -0.814 . . . . 2.02 111.181 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -60.46 -30.4 69.64 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.314 0.857 . . . . 2.34 113.314 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -80.3 -56.84 3.92 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.331 0.493 . . . . 3.35 112.331 -171.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.34 -19.24 56.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 3.1 111.719 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.41 72.68 Favored Glycine 0 C--N 1.318 -0.419 0 N-CA-C 110.314 -1.114 . . . . 2.37 110.314 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.628 ' OD2' ' HG ' ' A' ' 140' ' ' LEU . 22.7 t70 78.48 -78.07 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.95 -1.125 . . . . 3.93 113.162 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -50.33 -21.12 1.28 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.055 1.131 . . . . 3.0 114.055 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.99 -69.14 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.954 -1.117 . . . . 2.15 112.555 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 72.4 mmtt -89.15 -40.14 13.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.533 0.568 . . . . 3.43 112.533 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . . . -66.8 -29.91 69.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.035 0.383 . . . . 1.76 112.035 -171.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.16 -6.41 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.279 0.562 . . . . 2.77 110.848 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -114.6 19.1 16.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 3.55 110.311 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 88.5 mt-30 -131.25 127.2 21.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 108.782 -0.822 . . . . 3.02 108.782 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.23 -29.93 48.96 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.108 2.539 . . . . 1.6 113.688 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.96 24.26 12.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.728 0.299 . . . . 2.29 110.459 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.97 -70.41 1.07 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.073 -0.512 . . . . 1.22 113.829 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HG ' ' OD2' ' A' ' 129' ' ' ASP . 6.5 mp -89.05 171.29 9.95 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.832 0.349 . . . . 1.57 110.801 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -141.39 104.11 4.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.618 -0.512 . . . . 1.38 109.618 172.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.67 111.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.799 -0.445 . . . . 1.73 109.799 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 57.8 tp -82.73 104.86 13.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 2.42 110.345 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -84.86 151.33 26.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.847 -0.692 . . . . 0.86 112.145 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.03 129.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.102 -0.332 . . . . 0.76 110.102 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 107' ' ' HIS . 3.2 m-85 -70.75 137.82 49.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.419 -0.355 . . . . 1.2 110.641 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.93 108.08 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.0 0.429 . . . . 0.88 110.445 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 215' ' ' ILE . 58.9 pttt -106.02 164.5 11.92 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 2.03 108.863 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.8 m -106.3 138.42 31.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 1.27 111.847 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.24 -96.83 0.1 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.092 -0.958 . . . . 1.53 110.952 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -87.88 153.78 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.776 -0.453 . . . . 1.54 109.776 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.77 158.37 36.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.194 0.521 . . . . 0.78 112.113 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 216' ' ' SER . 30.5 mmmt -112.31 100.13 48.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.4 -0.818 . . . . 1.22 109.01 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.05 -40.4 59.31 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.089 2.526 . . . . 1.05 112.251 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.81 74.89 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.091 -0.576 . . . . 0.7 113.143 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.2 tp -92.41 -26.23 18.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.46 0.63 . . . . 0.77 110.2 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -35.66 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.41 109.638 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.47 -39.65 84.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.538 -0.755 . . . . 2.86 110.995 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.1 t -71.98 -48.04 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.184 0.516 . . . . 1.38 110.146 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.618 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 67.3 t -58.93 -32.62 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 1.11 110.971 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.41 -21.51 64.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.569 -0.741 . . . . 1.22 111.891 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.29 -12.92 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.505 0.558 . . . . 1.41 112.505 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -57.48 -21.49 37.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.718 0.636 . . . . 1.39 112.718 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.503 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.9 p-10 -64.61 -18.99 65.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 2.31 111.086 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -88.7 -5.99 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.855 0.36 . . . . 1.4 110.9 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 61' ' ' ASN . 14.3 pt -126.64 39.19 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.526 0.679 . . . . 0.85 109.983 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.66 -28.18 69.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.547 -0.751 . . . . 1.59 111.184 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.7 p -130.96 147.66 52.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.362 -0.381 . . . . 0.77 110.709 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -58.57 140.37 54.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.842 -0.617 . . . . 2.29 111.005 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.09 -10.77 55.34 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.951 -0.642 . . . . 0.85 112.131 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 60' ' ' LEU . 97.8 mttt -104.9 144.58 31.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.449 . . . . 1.7 111.041 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 60' ' ' LEU . 23.7 p -141.82 156.47 45.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.627 -0.715 . . . . 1.37 110.181 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.63 136.37 35.86 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.482 -0.327 . . . . 0.61 110.282 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.02 129.36 41.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.143 -0.481 . . . . 1.8 110.762 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -138.94 77.86 1.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.004 -1.11 . . . . 1.04 108.004 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.98 156.11 21.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.672 -0.694 . . . . 1.17 111.261 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 54.78 56.33 6.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.123 0.487 . . . . 1.77 112.003 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.544 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 73.0 m-85 -124.75 143.62 50.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.932 -0.576 . . . . 3.99 109.852 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 181' ' ' ARG . 6.4 m-20 -93.12 107.31 24.26 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 2.51 111.844 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 19.4 Cg_exo -69.1 -13.52 36.48 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.934 2.423 . . . . 1.26 112.001 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.435 ' HG2' ' HB3' ' A' ' 179' ' ' ASP . 16.7 ptt180 -66.09 -16.85 64.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.375 . . . . 2.76 110.48 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.49 6.84 67.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.853 -0.612 . . . . 1.12 111.822 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 67.1 mt -110.96 -32.0 6.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.286 0.565 . . . . 1.73 109.557 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.06 127.11 73.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.41 -0.814 . . . . 3.45 111.339 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.37 -174.57 1.46 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.244 2.629 . . . . 2.08 113.099 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.77 -58.72 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.834 0.679 . . . . 3.23 112.834 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 19.7 m -61.52 125.06 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.801 0.334 . . . . 1.66 111.008 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.0 tp -104.22 62.67 0.74 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.588 0.708 . . . . 1.99 109.87 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.452 ' O ' HD12 ' A' ' 211' ' ' LEU . 24.2 m-20 -133.67 -177.86 4.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.994 -1.113 . . . . 1.81 107.994 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.2 p90 -163.01 155.03 18.14 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.308 -0.957 . . . . 5.01 112.625 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.471 ' CE2' ' HG3' ' A' ' 212' ' ' LYS . 57.4 m95 -96.35 142.31 28.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.752 -1.113 . . . . 3.93 109.331 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 256' ' ' LYS . 19.1 m -74.81 79.23 2.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.081 0.467 . . . . 2.13 109.786 173.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.413 ' HB3' ' CG2' ' A' ' 210' ' ' VAL . 41.0 t80 -117.89 103.08 50.7 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.629 . . . . 5.21 109.967 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.408 ' N ' ' HB3' ' A' ' 208' ' ' TRP . 45.1 Cg_exo -56.65 146.36 76.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.255 2.637 . . . . 2.12 113.087 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.67 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -139.66 153.15 22.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.508 -0.853 . . . . 1.75 112.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.8 t -107.38 137.03 46.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.882 0.372 . . . . 2.99 110.154 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 199' ' ' THR . 2.0 pp -76.73 -34.6 58.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.9 -0.591 . . . . 4.75 111.004 -176.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.458 ' HB ' ' HG ' ' A' ' 202' ' ' LEU . 1.4 m -82.48 29.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.423 0.63 . . . . 5.1 109.57 176.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 15.8 p 68.53 156.68 0.15 Allowed Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 113.829 -1.532 . . . . 5.53 109.905 -168.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' A' ' 199' ' ' THR . 11.0 Cg_exo -27.86 -58.99 0.1 Allowed 'Trans proline' 0 CA--C 1.545 1.062 1 C-N-CA 125.379 4.052 . . . . 5.83 116.578 -174.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.08 66.54 7.82 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.558 1.506 . . . . 4.78 113.501 -170.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.458 ' HG ' ' HB ' ' A' ' 198' ' ' THR . 0.2 OUTLIER -148.53 -85.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.589 -0.444 . . . . 3.84 111.668 174.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.96 163.94 29.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 2.96 112.022 -172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.41 67.12 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.732 0.777 . . . . 3.37 110.281 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.9 m -118.24 24.71 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.223 -0.899 . . . . 2.15 110.491 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 70.7 t -120.38 134.39 64.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.65 -0.705 . . . . 1.26 110.159 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.2 m -73.63 121.7 21.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.597 -0.729 . . . . 2.08 109.629 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.435 ' CE3' HG23 ' A' ' 192' ' ' THR . 0.0 OUTLIER -64.48 99.49 0.31 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.072 -0.967 . . . . 5.53 111.981 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 58.3 mt -142.43 100.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.326 -0.397 . . . . 1.63 110.368 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 73.3 t -117.25 119.14 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.286 -0.264 . . . . 1.62 110.286 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 189' ' ' ASP . 9.8 tp -62.06 123.2 17.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.228 -0.286 . . . . 1.73 110.228 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.471 ' HG3' ' CE2' ' A' ' 191' ' ' TRP . 29.2 ttpp -65.59 -8.31 19.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.716 1.376 . . . . 2.98 114.716 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 36.3 tt0 -105.93 110.06 63.74 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 119.776 -0.77 . . . . 1.47 111.096 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.448 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 25.7 Cg_exo -64.49 137.66 56.18 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.776 2.317 . . . . 0.96 111.578 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.405 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 38.6 pt -97.49 149.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.745 -0.465 . . . . 1.25 109.745 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 17.0 t -103.34 120.7 41.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.207 -0.664 . . . . 1.29 109.207 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.47 162.95 8.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.996 -0.372 . . . . 1.02 109.996 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 16.2 t -81.92 151.09 27.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.121 -0.325 . . . . 1.08 110.121 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.643 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 13.9 m -55.67 -43.17 76.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.405 -0.361 . . . . 1.33 110.83 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 12.3 tp10 -59.42 -32.51 70.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 2.51 111.019 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.421 ' HA ' HG11 ' A' ' 160' ' ' VAL . 56.2 mt-30 -67.18 -49.92 62.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.7 110.741 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.628 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 31.2 m -71.0 -29.75 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.351 . . . . 1.36 111.944 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 219' ' ' SER . 91.1 mt -63.9 -26.54 68.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 1.03 110.84 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 58.1 mtpt -82.68 -22.67 34.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 1.75 110.86 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.6 m-85 -70.12 -34.05 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.514 -0.55 . . . . 2.47 109.514 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.92 -14.62 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 3.04 111.042 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -95.61 -3.12 46.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.406 -0.361 . . . . 2.31 111.528 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.69 154.6 21.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.226 0.536 . . . . 0.95 111.224 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 39.6 m-20 -119.81 159.48 24.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.266 -0.642 . . . . 1.13 109.266 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -105.62 -4.64 20.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 3.74 110.424 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.8 p-10 -85.1 176.14 8.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 1.62 110.091 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -104.09 169.12 17.37 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.143 -0.783 . . . . 1.16 111.143 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -55.24 143.58 27.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 3.56 110.647 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.76 23.83 54.8 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.052 -0.594 . . . . 2.08 112.923 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.4 153.33 76.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 117.247 0.523 . . . . 2.59 109.851 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.06 127.74 23.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.531 2.154 . . . . 1.36 111.01 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.0 118.68 4.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.623 0.725 . . . . 3.4 112.783 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -114.13 110.39 19.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.855 -1.066 . . . . 2.47 109.121 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.55 139.64 47.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.336 -0.393 . . . . 2.14 111.077 -176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.6 ttm -87.52 91.52 8.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.391 -0.596 . . . . 1.68 109.391 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.69 154.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.203 -0.453 . . . . 1.27 111.356 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.5 t70 69.06 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.077 0.861 . . . . 2.18 110.524 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.436 ' HA ' ' CG ' ' A' ' 7' ' ' TYR . 58.9 t30 56.3 20.38 4.59 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.177 0.806 . . . . 2.15 113.177 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -151.32 167.44 27.87 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.056 -0.403 . . . . 4.59 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -125.09 147.7 57.91 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 115.802 -0.635 . . . . 6.13 110.675 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -43.9 146.54 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.051 2.501 . . . . 3.28 112.553 168.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 29' ' ' SER . . . -72.94 142.65 47.84 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.196 1.184 . . . . 2.98 114.196 -166.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -74.76 159.55 82.89 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.675 -1.148 . . . . 4.32 110.303 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.57 174.48 8.76 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.454 2.77 . . . . 3.48 113.729 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 89.2 mt -66.14 -9.5 32.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.81 -1.086 . . . . 4.63 112.081 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 74.3 mmtt -58.67 46.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.623 1.342 . . . . 5.34 114.623 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 51.5 t30 120.19 6.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.559 1.944 . . . . 4.64 110.721 176.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 1.2 mpt_? -132.98 104.02 6.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.716 -0.674 . . . . 6.11 109.298 171.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -114.5 145.63 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.757 0.313 . . . . 3.08 111.099 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.3 mm -100.88 126.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.027 -0.533 . . . . 2.6 110.35 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.553 ' HB2' ' OG1' ' A' ' 192' ' ' THR . 96.4 mttt -117.19 150.78 38.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.703 -0.851 . . . . 2.63 108.703 172.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -115.94 95.8 5.28 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.705 -0.479 . . . . 1.71 109.705 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 68.6 m -80.69 94.66 6.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.728 -0.789 . . . . 2.21 110.506 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -140.19 111.02 6.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.3 -1.318 . . . . 4.31 108.833 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-N 116.053 -0.521 . . . . 4.49 110.956 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.295 -0.261 . . . . 17.49 110.295 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m 65.13 -175.44 0.18 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.656 0.597 . . . . 15.32 111.263 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 56.14 65.25 1.48 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.386 0.613 . . . . 15.81 110.502 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -101.34 132.79 46.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.044 -0.525 . . . . 14.19 110.537 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 60.46 -164.0 0.24 Allowed 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.919 0.762 . . . . 14.91 111.051 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.16 -174.84 43.64 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.882 -0.887 . . . . 10.79 110.882 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.02 98.56 4.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.189 0.519 . . . . 11.39 109.696 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.19 144.77 10.35 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.523 -0.762 . . . . 9.0 111.783 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -47.83 129.45 14.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.531 0.681 . . . . 9.76 112.555 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -155.51 -58.33 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.164 -0.925 . . . . 11.19 108.734 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -117.89 30.69 7.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.289 -0.869 . . . . 10.8 109.477 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.6 116.29 1.01 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.002 -0.839 . . . . 8.82 111.002 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.6 124.74 9.53 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.065 1.843 . . . . 7.87 112.037 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.46 -20.28 25.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.215 0.531 . . . . 10.62 110.371 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 33.7 m170 -114.22 24.47 11.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.634 -0.712 . . . . 9.87 111.62 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -45.03 -53.35 7.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.757 0.651 . . . . 8.48 112.757 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -74.47 -9.63 58.78 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.504 -0.478 . . . . 7.13 111.241 -174.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HA ' HD11 ' A' ' 202' ' ' LEU . 28.0 ttpt -67.62 -18.08 64.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.372 0.606 . . . . 9.68 110.071 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -77.74 -9.85 59.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.736 -0.666 . . . . 7.89 111.001 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 61.1 m-85 -110.93 102.91 53.89 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.293 -0.632 . . . . 7.17 109.293 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -52.53 -21.41 14.12 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.832 3.021 . . . . 7.76 114.932 -172.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 22' ' ' ILE . 9.9 tp -146.1 51.74 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 122.1 0.952 . . . . 5.83 110.761 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 20' ' ' PHE . . . -65.04 -32.37 74.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.594 -0.73 . . . . 5.44 111.59 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -138.98 -45.86 0.47 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.306 0.574 . . . . 7.78 110.835 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.79 -44.73 0.24 Allowed Glycine 0 CA--C 1.504 -0.616 0 N-CA-C 109.16 -1.576 . . . . 5.01 109.16 -175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 202' ' ' LEU . 6.9 pt-20 -48.55 154.62 0.63 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.55 -0.825 . . . . 7.09 110.071 165.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.47 165.8 35.28 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.653 -1.98 . . . . 5.13 105.653 -168.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.62 -59.85 4.34 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.003 1.274 . . . . 7.12 112.612 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.594 ' CB ' ' HA ' ' A' ' 247' ' ' ALA . 29.6 t -103.66 150.44 38.13 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.984 -1.117 . . . . 3.94 107.984 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.497 ' HG3' ' CZ3' ' A' ' 208' ' ' TRP . 20.5 Cg_endo -60.73 -48.16 11.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 CA-C-N 120.402 1.179 . . . . 4.52 111.885 -176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 255' ' ' ILE . 10.7 p -169.5 143.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 111.799 0.296 . . . . 4.54 111.799 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 19.2 t70 -89.33 117.32 28.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.252 -1.018 . . . . 2.88 108.252 162.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -97.67 126.15 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.732 0.301 . . . . 2.32 111.757 -170.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.85 117.48 34.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.426 -0.352 . . . . 2.82 110.239 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -30.42 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.782 -0.645 . . . . 2.24 112.148 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -83.14 -15.61 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.589 -0.278 . . . . 4.54 111.495 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 250' ' ' LEU . 88.5 m -98.23 -29.35 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.655 0.264 . . . . 3.06 111.26 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 130.62 44.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.72 111.259 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.39 124.31 45.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 3.69 109.93 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.14 113.33 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.488 -0.56 . . . . 4.64 109.488 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -118.62 118.72 33.32 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 2.27 109.669 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -53.82 91.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 123.583 2.855 . . . . 2.15 113.599 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 p -58.89 -30.85 68.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.743 -0.662 . . . . 4.29 110.844 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt 71.28 -64.92 0.36 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.323 -0.853 . . . . 4.74 111.65 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -76.0 130.63 77.74 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.737 0.303 . . . . 3.77 110.729 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.58 158.58 32.23 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.723 2.282 . . . . 2.36 111.925 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 48' ' ' SER . 6.5 tt -91.52 140.29 29.89 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.333 -0.617 . . . . 2.55 109.333 -178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.502 ' N ' HD23 ' A' ' 47' ' ' LEU . 2.0 t -144.6 139.33 28.02 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.848 -0.797 . . . . 2.38 108.848 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.33 128.88 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.048 0.452 . . . . 1.59 111.929 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.5 t -118.94 90.04 3.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.079 -0.711 . . . . 1.45 109.079 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.76 13.84 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 3.62 110.421 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.69 -31.65 68.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 2.48 111.213 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 77.5 mt-30 -109.35 17.35 21.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 2.24 110.736 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.24 114.48 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.37 . . . . 0.8 110.922 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 m -101.35 106.24 17.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.049 -0.523 . . . . 1.06 110.734 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -85.42 151.49 23.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.799 -0.637 . . . . 1.26 109.712 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.24 -57.54 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.74 111.545 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -167.34 159.63 12.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.64 0.257 . . . . 3.17 111.036 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 14.1 tt -104.99 140.6 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.317 -0.623 . . . . 0.64 109.317 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -130.29 140.53 50.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.115 0.483 . . . . 0.96 111.555 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.22 108.6 20.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.732 -1.211 . . . . 1.49 107.732 170.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -137.83 71.55 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.572 -0.851 . . . . 1.83 111.791 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.62 -75.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 119.941 -1.123 . . . . 1.64 112.851 159.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 243' ' ' ASN . 52.4 t-80 -112.59 -12.85 13.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.056 0.391 . . . . 3.33 112.056 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -154.2 175.99 12.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.997 0.427 . . . . 1.38 111.748 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.79 103.8 9.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.414 -0.958 . . . . 2.74 108.414 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.94 134.97 47.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.155 0.502 . . . . 1.76 111.87 -170.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 48.4 t -100.25 112.13 31.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.309 -0.626 . . . . 1.15 109.309 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.48 130.87 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 2.02 112.198 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -111.87 163.7 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.397 -0.964 . . . . 1.66 108.397 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.05 121.49 27.09 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.614 -0.434 . . . . 1.33 111.372 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.624 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 10.0 t0 -114.72 60.42 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.884 0.849 . . . . 2.65 109.75 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 t -116.47 -15.49 10.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 1.61 110.134 165.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -137.6 160.79 38.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.496 -0.557 . . . . 2.35 109.496 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -82.33 64.71 7.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.27 0.557 . . . . 1.92 110.207 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 67.6 mttm -79.18 -51.22 9.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.434 -0.803 . . . . 1.77 110.003 -177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . . . -115.88 105.2 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.76 109.215 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.14 139.98 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.046 0.451 . . . . 1.27 110.914 -172.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.498 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 14.7 tp -109.55 148.89 30.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.819 -0.628 . . . . 1.29 110.969 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 93.5 mttt -116.55 141.51 48.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.024 -1.102 . . . . 2.54 108.024 164.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.2 168.73 31.42 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.271 -0.966 . . . . 1.31 112.229 -165.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.63 -146.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 112.263 -0.335 . . . . 1.9 112.263 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.43 121.66 9.42 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.09 1.86 . . . . 2.91 112.095 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 88' ' ' TYR . 8.3 tp -179.63 157.57 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.024 -1.102 . . . . 4.11 108.024 -175.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.57 111.32 13.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.987 1.106 . . . . 4.95 113.987 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.1 -101.66 0.96 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.441 -0.885 . . . . 2.25 114.858 161.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.469 HG22 ' HG3' ' A' ' 89' ' ' ARG . 33.4 m -130.95 103.92 6.83 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.487 -0.56 . . . . 1.91 109.487 -167.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.498 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 1.3 m-85 -95.44 91.52 6.24 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.608 -0.437 . . . . 3.7 110.044 -172.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 55.9 mtt180 -107.27 146.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.717 0.294 . . . . 3.54 110.568 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 57.8 tp -77.84 123.86 27.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.552 -0.536 . . . . 1.14 109.552 171.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.1 -40.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.176 -0.465 . . . . 1.68 110.02 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -174.89 168.51 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.764 -0.653 . . . . 1.55 109.715 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.28 150.01 47.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.199 -0.667 . . . . 0.86 109.199 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 7.6 p-80 -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.632 0.254 . . . . 0.93 110.863 -172.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -134.37 158.89 42.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 3.17 110.347 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -165.13 179.39 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.644 0.259 . . . . 1.68 111.36 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.632 ' CD1' ' HA ' ' A' ' 242' ' ' ASP . 2.9 t90 74.0 -100.46 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.066 0.946 . . . . 5.18 110.407 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 53.02 15.58 3.57 Favored Glycine 0 N--CA 1.475 1.241 0 N-CA-C 115.278 0.871 . . . . 2.13 115.278 174.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.585 ' H ' ' HD1' ' A' ' 97' ' ' TRP . 48.3 p -45.7 -53.92 8.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.896 0.702 . . . . 2.9 112.896 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.7 mt -128.53 146.86 50.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.477 -0.564 . . . . 3.03 109.477 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.69 -13.23 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 3.85 111.613 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.55 -10.26 41.59 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.347 -0.93 . . . . 1.94 113.017 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.39 119.27 2.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.579 0.704 . . . . 2.45 111.725 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.28 41.32 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.658 -0.701 . . . . 1.47 111.794 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.4 p -105.8 -14.09 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 2.0 112.298 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.76 174.23 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.463 -0.569 . . . . 3.72 109.463 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.613 ' HE2' ' CD ' ' A' ' 117' ' ' GLU . 14.9 p80 44.09 68.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.312 1.053 . . . . 3.52 111.426 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.6 t -75.97 130.41 38.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.515 -1.22 . . . . 2.52 110.681 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 23.3 t -101.76 105.69 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 114.378 -1.283 . . . . 2.48 110.171 -172.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 55.31 50.76 14.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.568 -0.742 . . . . 2.8 109.472 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 68.33 1.14 2.77 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.238 -0.892 . . . . 4.98 112.607 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 47.8 tptt -89.75 123.72 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 3.23 110.968 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.69 155.96 27.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.809 -0.632 . . . . 2.82 110.31 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.69 168.89 9.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.101 -0.703 . . . . 1.62 109.101 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.43 79.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.274 0.472 . . . . 1.03 112.274 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.46 171.32 7.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.219 -0.66 . . . . 0.75 109.219 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.613 ' CD ' ' HE2' ' A' ' 107' ' ' HIS . 28.8 tt0 -142.24 138.43 31.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.067 0.461 . . . . 1.58 110.509 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.3 tp -102.43 126.49 49.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.43 -0.804 . . . . 1.07 109.448 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.413 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 42.4 m170 -107.98 110.27 21.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 1.77 111.147 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 6.8 mp -94.68 103.44 15.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.678 -0.49 . . . . 0.93 109.678 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.482 HG22 HG12 ' A' ' 142' ' ' VAL . 19.3 t -76.85 100.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.008 -0.542 . . . . 0.61 110.436 -176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 90' ' ' LEU . 3.2 p80 -138.97 76.19 1.56 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.755 1.021 . . . . 2.13 113.755 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.0 t90 178.91 99.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.345 0.658 . . . . 4.26 109.856 149.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' A' ' 133' ' ' ALA . 24.8 t-20 -124.62 90.48 3.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 118.612 -0.708 . . . . 2.02 111.561 157.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.5 m -81.28 -51.98 7.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 120.819 1.645 . . . . 2.34 111.492 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HD2' ' HA2' ' A' ' 139' ' ' GLY . 13.0 ptpt -43.57 -32.77 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 114.549 1.314 . . . . 3.35 114.549 -173.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.98 -16.35 6.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.133 -0.627 . . . . 3.1 111.851 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.38 38.91 51.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.583 -0.607 . . . . 2.37 111.583 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 12.3 t70 -169.33 110.48 0.47 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.675 -0.861 . . . . 3.93 108.675 -171.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -63.44 -32.12 73.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.943 0.349 . . . . 3.0 111.943 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.71 98.64 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.921 -0.657 . . . . 2.15 112.818 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 31.7 mmmt -74.32 -20.99 59.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.276 0.56 . . . . 3.43 110.311 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.612 ' HB2' ' ND2' ' A' ' 124' ' ' ASN . . . -74.75 -20.95 59.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 1.76 111.988 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.6 t -61.11 -22.08 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.566 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -98.18 8.09 45.32 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.158 -0.339 . . . . 3.55 111.572 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -122.86 127.47 25.72 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.662 0.267 . . . . 3.02 111.161 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.3 -32.96 83.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.604 2.869 . . . . 1.6 113.465 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.61 28.42 8.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.796 -0.446 . . . . 2.29 109.796 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.404 ' HA2' ' HD2' ' A' ' 126' ' ' LYS . . . -67.19 -27.91 73.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.048 -0.596 . . . . 1.22 114.319 -175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.8 mt -137.19 170.29 16.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.459 . . . . 1.57 111.564 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.14 118.58 6.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 1.38 109.472 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 121' ' ' VAL . 33.8 m -113.4 142.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 1.73 111.064 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.0 tp -95.46 103.85 15.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.786 . . . . 2.42 108.879 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.6 3.66 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.044 -0.598 . . . . 0.86 112.223 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 32.3 mt -102.62 124.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.866 -0.42 . . . . 0.76 109.866 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 48.8 m-85 -68.2 148.2 51.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 1.2 110.898 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.6 mp -118.56 138.3 52.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.498 -0.556 . . . . 0.88 109.498 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.1 ptmm? -143.23 146.55 33.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.891 -0.781 . . . . 2.03 108.891 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 95.7 t -83.79 130.87 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.099 0.476 . . . . 1.27 111.663 -171.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.45 -110.14 0.24 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.872 -0.891 . . . . 1.53 110.872 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 t -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.313 -0.625 . . . . 1.54 109.313 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.0 158.27 23.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.608 0.242 . . . . 0.78 110.987 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -115.94 106.2 50.06 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.922 -0.399 . . . . 1.22 109.922 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 51.1 Cg_exo -54.96 -35.77 90.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.08 2.52 . . . . 1.05 112.362 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.58 71.98 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.992 -0.623 . . . . 0.7 112.645 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.485 ' HB3' HE22 ' A' ' 221' ' ' GLN . 19.1 tp -88.05 -20.25 26.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.47 -0.567 . . . . 0.77 109.47 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 13.1 mm100 -52.82 -37.34 59.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.647 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 175' ' ' PHE . 57.3 mttp -54.01 -54.27 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.458 0.474 . . . . 2.86 111.601 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 162' ' ' VAL . 11.4 p -74.62 -37.26 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.91 0.386 . . . . 1.38 110.762 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 80.6 t -64.94 -34.97 74.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.419 0.628 . . . . 1.11 110.808 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.66 -32.84 71.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.063 -0.517 . . . . 1.22 111.317 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 159' ' ' VAL . 9.3 p -89.58 -20.74 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.17 0.433 . . . . 1.41 112.17 -173.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.485 HD13 HD11 ' A' ' 228' ' ' LEU . 3.0 pp -67.84 -16.92 64.33 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.071 0.463 . . . . 1.39 111.161 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.8 t70 -65.04 -23.35 67.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 2.31 110.325 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.7 m -89.73 1.71 55.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 1.4 111.935 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.96 39.23 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.513 0.673 . . . . 0.85 110.078 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 89.0 tttt -59.62 -22.59 62.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.146 -0.933 . . . . 1.59 111.666 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.1 p -120.18 137.56 54.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.51 -0.314 . . . . 0.77 110.812 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 230' ' ' PHE . 15.0 ptmm? -56.07 137.09 51.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.053 -0.521 . . . . 2.29 111.348 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.33 -30.46 8.23 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.976 -0.63 . . . . 0.85 111.816 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -81.8 153.79 26.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.06 0.457 . . . . 1.7 110.91 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.9 t -145.84 151.84 38.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.622 -0.717 . . . . 1.37 109.499 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -133.58 126.29 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.604 -0.271 . . . . 0.61 110.312 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.38 131.15 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 1.8 110.495 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -144.55 86.09 1.8 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 1.04 110.523 -176.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.6 p -95.99 160.92 14.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.703 0.287 . . . . 1.17 111.485 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 21.1 m120 65.19 29.8 11.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.774 -0.648 . . . . 1.77 112.331 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -87.47 119.9 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.464 -0.569 . . . . 3.99 109.464 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.74 112.7 63.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.995 0.426 . . . . 2.51 111.024 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.49 -17.83 60.92 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.82 2.347 . . . . 1.26 111.723 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -53.95 -40.07 66.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.554 -0.748 . . . . 2.76 110.861 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -64.89 -18.33 64.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.666 -0.697 . . . . 1.12 113.704 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.8 mt -96.83 -11.96 24.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.261 0.53 . . . . 1.73 111.701 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 96.7 mt -63.85 123.72 82.64 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.727 0.299 . . . . 3.45 111.563 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.498 ' HB2' ' HG2' ' A' ' 213' ' ' GLU . 2.5 Cg_endo -82.49 -170.04 0.86 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.221 2.614 . . . . 2.08 112.154 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.47 -66.19 0.92 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.159 0.8 . . . . 3.23 113.159 -174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 20.1 m -65.48 114.66 5.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.15 0.5 . . . . 1.66 111.357 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 47' ' ' LEU . 17.8 tp -103.15 70.57 1.07 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 1.99 110.744 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.458 ' O ' HD12 ' A' ' 211' ' ' LEU . 3.0 m-20 -130.33 174.32 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.39 -0.967 . . . . 1.81 108.39 176.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 38.4 p90 -166.36 154.7 10.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.559 0.948 . . . . 5.01 113.559 -164.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.617 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 4.1 m95 -107.78 149.74 27.84 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.239 -1.393 . . . . 3.93 107.239 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.7 t -138.38 103.03 4.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.97 0.804 . . . . 2.13 112.799 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.39 157.84 69.88 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.924 -0.58 . . . . 5.21 110.492 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.04 137.21 78.28 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.731 2.288 . . . . 2.12 112.366 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -134.25 156.97 22.66 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.303 -0.475 . . . . 1.75 113.563 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.8 t -94.77 143.12 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.642 0.377 . . . . 2.99 110.04 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 62.1 tp -94.99 -46.06 6.99 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.854 0.687 . . . . 4.75 112.854 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.68 ' O ' ' HD2' ' A' ' 200' ' ' PRO . 13.7 m -116.37 -43.09 2.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.881 -0.328 . . . . 5.1 110.812 -175.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.41 ' CB ' ' O ' ' A' ' 198' ' ' THR . 53.0 m 105.42 -63.01 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.804 0 O-C-N 124.956 1.41 . . . . 5.53 113.193 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 198' ' ' THR . 5.8 Cg_exo -39.71 -55.47 1.65 Allowed 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.194 2.596 . . . . 5.83 115.387 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.95 -9.37 18.05 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 121.456 1.437 . . . . 4.78 112.374 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . 68.1 mt 64.95 66.16 0.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.269 -1.332 . . . . 3.84 110.813 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.2 mt -116.21 121.92 43.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.24 -0.436 . . . . 2.96 110.53 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.4 66.77 0.89 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.861 0.838 . . . . 3.37 109.581 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.0 11.76 30.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.774 -1.103 . . . . 2.15 111.026 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.73 149.63 22.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.077 0.465 . . . . 1.26 111.414 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.4 m -103.03 107.86 18.82 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 2.08 107.989 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.497 ' CZ3' ' HG3' ' A' ' 30' ' ' PRO . 1.3 t-105 -80.89 100.08 8.68 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.737 -0.468 . . . . 5.53 109.737 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 55.3 mt -99.91 100.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.01 -0.541 . . . . 1.63 109.742 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 45.4 t -85.11 119.35 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.251 -0.432 . . . . 1.62 110.852 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 189' ' ' ASP . 46.2 tp -80.41 122.43 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.439 . . . . 1.73 110.612 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -48.44 -28.74 3.46 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.082 1.142 . . . . 2.98 114.082 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 185' ' ' PRO . 5.7 tp10 -102.98 114.42 65.25 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.396 -0.522 . . . . 1.47 110.926 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.45 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 90.5 Cg_endo -80.01 148.61 19.6 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.803 2.335 . . . . 0.96 111.893 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 34.4 pt -101.88 149.44 6.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 1.25 110.559 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 1.7 p -101.93 117.53 35.02 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.462 -0.79 . . . . 1.29 110.098 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 32.6 m -115.76 168.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.137 -0.483 . . . . 1.02 110.049 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.3 t -90.65 148.78 22.41 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.741 -0.384 . . . . 1.08 110.417 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.56 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 10.6 p -53.66 -45.0 70.11 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.507 0.505 . . . . 1.33 111.502 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.0 -31.53 71.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.647 -0.251 . . . . 2.51 111.306 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.485 HE22 ' HB3' ' A' ' 156' ' ' LEU . 54.5 mt-30 -62.51 -51.09 68.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.7 0.286 . . . . 0.7 110.628 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.65 -26.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.933 -0.307 . . . . 1.36 111.156 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 219' ' ' SER . 88.3 mt -69.44 -36.07 76.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 1.03 110.883 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -66.11 -31.44 72.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.064 0.459 . . . . 1.75 110.764 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -69.7 -39.32 76.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.594 -0.73 . . . . 2.47 109.754 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -72.0 -3.62 23.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.24 -0.891 . . . . 3.04 111.011 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 98.5 mttt -94.34 -1.38 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 2.31 110.665 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.485 HD11 HD13 ' A' ' 163' ' ' LEU . 55.6 mt -90.41 155.08 19.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.037 -0.529 . . . . 0.95 110.775 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -112.36 155.7 23.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.51 -0.314 . . . . 1.13 110.354 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.532 ' O ' ' HD2' ' A' ' 169' ' ' LYS . 50.4 p90 -111.52 -18.42 12.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.215 -0.448 . . . . 3.74 110.293 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.573 HD22 ' HB2' ' A' ' 235' ' ' GLU . 6.2 p-10 -71.51 -31.83 67.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.62 111.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.471 ' CA ' ' HG2' ' A' ' 169' ' ' LYS . . . 97.99 -159.71 20.79 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.564 -0.827 . . . . 1.16 113.018 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.17 150.38 20.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.686 0.279 . . . . 3.56 110.34 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.19 4.22 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.01 -0.615 . . . . 2.08 112.685 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.573 ' HB2' HD22 ' A' ' 231' ' ' ASN . 41.6 mt-10 -134.92 159.55 71.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.447 -0.575 . . . . 2.59 109.447 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.91 129.92 37.87 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.772 2.315 . . . . 1.36 112.005 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.64 114.35 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 3.4 111.839 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.71 117.82 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.393 -0.595 . . . . 2.47 109.393 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.21 136.24 55.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.789 -0.642 . . . . 2.14 111.206 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.5 ttm -81.32 89.94 6.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.668 -0.697 . . . . 1.68 109.49 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.73 153.59 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 1.27 109.804 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.632 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 13.6 t70 64.75 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.885 0.741 . . . . 2.18 110.607 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.46 ' HB3' ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER 52.23 27.33 4.61 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.56 0.948 . . . . 2.15 113.56 179.027 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.453 ' CZ3' ' HD3' ' A' ' 30' ' ' PRO . 73.8 m95 -139.84 169.32 17.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.902 0.382 . . . . 4.59 110.81 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 29' ' ' SER . 24.1 mmt180 -117.35 148.91 43.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 6.13 111.573 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -33.23 138.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.921 3.747 . . . . 3.28 115.014 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' A' ' 29' ' ' SER . . . -54.91 143.82 24.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.683 -1.144 . . . . 2.98 112.209 -175.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' A' ' 29' ' ' SER . 28.4 mm-40 -107.97 130.36 22.9 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 4.32 110.894 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 248' ' ' GLN . 27.4 Cg_exo -63.23 175.17 2.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.52 2.813 . . . . 3.48 113.956 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.491 ' CD1' HG21 ' A' ' 37' ' ' THR . 49.8 mt -62.17 -11.19 13.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.207 -1.361 . . . . 4.63 113.402 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 18.5 ptpt -57.79 47.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.234 1.938 . . . . 5.34 116.234 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 7.5 t30 127.4 25.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 126.372 1.869 . . . . 4.64 111.106 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 252' ' ' ASN . 0.0 OUTLIER -141.94 110.76 6.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.083 -0.71 . . . . 6.11 109.083 166.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.02 121.81 45.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.072 -0.714 . . . . 3.08 109.072 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.615 HD11 HG21 ' A' ' 31' ' ' VAL . 47.6 mm -82.95 115.58 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.181 0.515 . . . . 2.6 112.262 -174.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.56 127.5 40.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.639 -0.71 . . . . 2.63 109.555 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -116.37 146.09 42.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.717 -0.475 . . . . 1.71 109.717 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 19.5 m -142.41 96.43 2.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.426 0.631 . . . . 2.21 110.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.435 ' HA ' ' OD1' ' A' ' 189' ' ' ASP . 86.5 t80 -126.54 90.69 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.548 -0.908 . . . . 4.31 108.548 166.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.375 -0.821 . . . . 4.49 109.823 -177.54 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttp . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.748 0.309 . . . . 17.49 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 p -68.02 -47.14 69.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 15.32 111.573 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -102.67 44.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.429 0.633 . . . . 15.81 111.462 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -98.02 94.22 6.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.362 -0.977 . . . . 14.19 108.362 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -81.84 141.95 32.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.077 0.465 . . . . 14.91 111.573 -172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 11' ' ' ASN . . . 169.08 177.62 39.95 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.623 -0.717 . . . . 10.79 111.442 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -92.8 105.08 17.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.85 0.357 . . . . 11.39 111.032 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.44 176.7 51.51 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.874 -0.603 . . . . 9.0 112.84 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.575 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 3.4 mppt? -58.62 153.93 15.41 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.412 -0.218 . . . . 9.76 110.412 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 74.81 -54.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.523 0.729 . . . . 11.19 111.424 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 15.9 m120 -78.74 -16.75 56.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.149 0.499 . . . . 10.8 109.822 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.69 -139.56 3.67 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.904 -0.878 . . . . 8.82 110.904 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.06 135.18 10.91 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.631 2.221 . . . . 7.87 110.852 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 41.3 tt0 -78.78 -9.93 59.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.526 0.679 . . . . 10.62 110.01 -176.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -123.75 23.69 8.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.579 -0.737 . . . . 9.87 110.017 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -65.39 -21.59 66.69 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.874 -0.603 . . . . 8.48 110.514 -175.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -58.82 -29.53 66.95 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.364 -0.38 . . . . 7.13 111.39 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -89.4 -40.8 12.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.63 0.252 . . . . 9.68 111.252 -176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.52 -8.61 58.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.165 0.507 . . . . 7.89 110.893 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -137.59 103.93 8.47 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.295 -1.002 . . . . 7.17 108.295 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.12 70.47 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.187 2.591 . . . . 7.76 113.726 -172.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.445 ' HA ' ' HG3' ' A' ' 26' ' ' GLU . 1.9 mp -106.56 -44.03 7.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.293 0.568 . . . . 5.83 110.17 172.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.0 -2.68 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.71 -0.677 . . . . 5.44 112.172 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -88.51 10.33 20.67 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.626 0.232 . . . . 7.78 111.626 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.73 49.39 0.85 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.438 -0.887 . . . . 5.01 112.903 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 22' ' ' ILE . 23.6 mm-40 -106.43 121.77 44.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.769 0.318 . . . . 7.09 110.655 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -76.72 138.4 39.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.672 0.748 . . . . 5.13 111.562 174.259 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' HB3' ' H ' ' A' ' 29' ' ' SER . 28.2 mt-30 -131.53 -150.64 0.43 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.695 -1.139 . . . . 7.12 112.059 -171.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 8.3 m -47.65 160.48 0.38 Allowed Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 115.653 1.723 . . . . 3.94 115.653 -172.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 29' ' ' SER . 38.5 Cg_exo -63.11 34.46 0.08 OUTLIER 'Trans proline' 0 N--CA 1.484 0.956 1 C-N-CA 125.979 4.453 . . . . 4.52 114.662 173.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 m -87.92 -168.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 119.295 -0.383 . . . . 4.54 110.37 -170.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -47.31 123.12 5.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.465 0.913 . . . . 2.88 113.465 -159.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 26.2 mm -101.6 134.37 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.718 -1.128 . . . . 2.32 111.2 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 37' ' ' THR . 16.2 t70 -107.32 113.45 26.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.963 -0.384 . . . . 2.82 109.963 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -56.67 -33.11 66.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.319 0.859 . . . . 2.24 113.319 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -75.07 -41.29 59.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.876 -0.329 . . . . 4.54 111.109 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 7.3 p -72.55 -27.53 62.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.801 0.334 . . . . 3.06 110.532 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -69.89 84.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.277 0.56 . . . . 1.72 110.443 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -79.73 134.43 36.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.692 -0.685 . . . . 3.69 109.656 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.616 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 2.5 p90 -81.68 124.52 29.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.194 0.521 . . . . 4.64 110.297 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -118.0 119.9 33.12 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 2.27 109.621 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.32 24.57 0.31 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.999 2.466 . . . . 2.15 113.728 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.8 p -95.86 -17.21 21.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.268 0.556 . . . . 4.29 109.51 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.77 124.51 30.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.493 -0.776 . . . . 4.74 109.768 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -115.15 136.57 22.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.122 -0.49 . . . . 3.77 110.922 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.07 122.84 12.42 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.825 2.35 . . . . 2.36 112.049 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.482 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 6.2 mp -78.62 132.96 37.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 2.55 110.904 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.6 t -84.56 138.04 32.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.466 -0.568 . . . . 2.38 109.466 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.0 t -118.37 121.78 67.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.192 -0.458 . . . . 1.59 110.832 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.3 p -111.55 89.91 3.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.438 -0.578 . . . . 1.45 109.438 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -109.84 10.01 24.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.687 -0.688 . . . . 3.62 110.098 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.8 -34.72 65.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.386 -0.825 . . . . 2.48 111.544 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.7 13.66 29.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.278 0.473 . . . . 2.24 112.278 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.29 113.57 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 0.8 111.923 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.8 m -107.33 109.83 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.847 -0.615 . . . . 1.06 110.547 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 178' ' ' PHE . 18.1 m -78.57 145.51 34.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.404 -0.362 . . . . 1.26 110.617 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -115.64 -55.77 2.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.74 111.718 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -166.6 159.09 13.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 3.17 111.271 -173.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 tt -112.16 137.5 44.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 0.64 109.934 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -129.39 135.76 49.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.894 0.378 . . . . 0.96 111.681 -173.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.99 117.99 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.375 -0.972 . . . . 1.49 108.375 172.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -137.48 71.02 1.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.662 -0.815 . . . . 1.83 112.311 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 230' ' ' PHE . . . 99.53 -58.84 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.342 -0.932 . . . . 1.64 113.885 157.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -125.56 -9.1 6.83 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.691 -0.403 . . . . 3.33 111.82 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -160.49 177.74 10.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.804 -0.443 . . . . 1.38 109.804 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -139.3 136.72 35.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.256 -1.016 . . . . 2.74 108.256 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.01 151.93 48.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.063 0.459 . . . . 1.76 111.941 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.8 127.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.381 -0.827 . . . . 1.15 109.51 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.82 137.03 33.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 2.02 110.984 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -112.95 170.1 8.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.356 -0.838 . . . . 1.66 109.475 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.414 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 14.3 t70 -98.89 132.16 44.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.005 0.431 . . . . 1.33 110.92 174.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.53 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 22.6 t70 -137.1 62.29 1.6 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.227 -0.897 . . . . 2.65 109.118 170.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -80.67 -4.52 54.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.116 0.96 . . . . 1.61 108.626 166.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.63 148.98 11.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.026 -1.842 . . . . 2.35 106.026 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -61.68 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.138 0.97 . . . . 1.92 111.783 -171.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 71' ' ' ASP . 61.7 mttm -91.9 -53.2 4.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.906 -1.043 . . . . 1.77 111.021 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.39 104.61 10.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.994 -0.548 . . . . 0.76 109.638 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.6 t -117.44 153.03 19.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 -176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tt -147.7 112.65 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 1.29 109.561 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.95 132.52 8.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.642 0.734 . . . . 2.54 111.622 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 47' ' ' LEU . . . -76.48 174.36 53.78 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 114.899 -1.046 . . . . 1.31 112.152 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.66 -142.88 0.0 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 124.259 0.623 . . . . 1.9 113.942 168.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.66 122.37 8.75 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 121.456 1.438 . . . . 2.91 111.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 7.9 tp -157.53 -167.66 2.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.947 -1.024 . . . . 4.11 108.428 -166.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.483 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 16.4 m-20 -123.64 32.67 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.741 0.305 . . . . 4.95 110.65 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.02 145.53 4.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.692 -0.766 . . . . 2.25 113.081 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.3 m -93.1 113.73 26.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.322 -0.622 . . . . 1.91 109.322 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 70.2 m-85 -101.33 127.91 47.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.155 0.503 . . . . 3.7 111.72 -171.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 123' ' ' TRP . 22.8 ptt180 -99.76 142.31 31.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.886 -0.597 . . . . 3.54 110.786 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 120' ' ' LEU . 8.4 tt -92.42 120.09 32.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.371 -0.603 . . . . 1.14 109.371 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.643 HD12 ' CE3' ' A' ' 123' ' ' TRP . 36.8 mt -121.97 -15.65 6.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.42 -0.354 . . . . 1.68 111.099 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -166.54 162.71 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.167 -0.333 . . . . 1.55 110.227 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 41.4 p90 -140.49 140.5 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.22 -0.659 . . . . 0.86 109.22 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.4 p-80 -118.51 158.05 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.329 . . . . 0.93 110.227 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 116' ' ' ALA . 78.4 t80 -133.69 156.97 46.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.143 -0.48 . . . . 3.17 109.967 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -152.07 139.4 19.43 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.753 -0.462 . . . . 1.68 109.753 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 68.9 t-105 -104.01 137.61 41.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.944 -0.571 . . . . 5.18 110.006 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -70.02 -60.97 4.55 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.962 -0.563 . . . . 2.13 113.165 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 29.0 t 162.23 -64.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 2.9 108.166 -176.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.0 mt -110.31 164.79 12.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.082 -0.963 . . . . 3.03 109.151 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -83.04 56.02 3.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.673 0.749 . . . . 3.85 110.86 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.75 -2.66 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.645 -0.707 . . . . 1.94 113.105 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.11 155.98 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.076 0.438 . . . . 2.45 110.385 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 100.67 -13.98 59.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.801 -0.714 . . . . 1.47 112.643 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.9 t -75.01 -32.84 61.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.49 . . . . 2.0 109.927 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 58.83 -159.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.55 -0.75 . . . . 3.72 110.122 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m80 58.37 30.72 20.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.428 -1.323 . . . . 3.52 107.428 -168.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.32 129.33 34.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.882 -1.508 . . . . 2.52 111.781 -166.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.2 m -100.15 111.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.825 -1.08 . . . . 2.48 110.606 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.63 43.21 12.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.964 -1.016 . . . . 2.8 110.406 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 68.3 20.95 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.125 -0.943 . . . . 4.98 112.078 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HE3' ' CZ ' ' A' ' 114' ' ' TYR . 4.4 tmmm? -102.81 89.55 3.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.985 0.422 . . . . 3.23 109.926 173.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -79.22 157.36 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 2.82 110.028 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 112' ' ' LYS . 82.2 m-85 -102.68 178.92 4.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.614 -0.266 . . . . 1.62 110.75 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.14 -47.22 68.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 1.03 111.381 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB2' ' CE3' ' A' ' 97' ' ' TRP . . . -155.77 168.16 28.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.041 -0.527 . . . . 0.75 110.539 -173.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -134.94 135.32 41.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 1.58 109.896 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.35 126.76 55.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.591 -0.522 . . . . 1.07 109.591 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.483 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -122.12 109.6 14.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.077 0.465 . . . . 1.77 111.695 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.3 mp -91.55 117.84 30.07 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.88 -0.785 . . . . 0.93 108.88 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.62 143.79 11.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.438 -0.346 . . . . 0.61 110.698 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 53.7 m-70 -138.81 134.7 33.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.633 -0.877 . . . . 2.13 108.633 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.643 ' CE3' HD12 ' A' ' 91' ' ' ILE . 37.5 m0 -111.23 140.99 45.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.457 -0.571 . . . . 4.26 109.457 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.79 112.97 2.03 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.889 -0.412 . . . . 2.02 109.889 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 t -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 2.34 110.828 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -63.35 -16.88 61.76 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.948 0.351 . . . . 3.35 111.948 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.96 -6.28 35.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.728 0.299 . . . . 3.1 110.711 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.77 18.84 0.76 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.16 -0.927 . . . . 2.37 115.189 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 21.7 t70 -170.59 125.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.652 0.726 . . . . 3.93 110.386 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.625 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.5 p90 -57.07 -40.72 77.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.98 -1.009 . . . . 3.0 111.054 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.01 -37.41 79.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.256 -0.497 . . . . 2.15 112.893 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 41.5 mmtm -76.9 -28.76 55.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 3.43 110.333 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -75.36 -35.04 61.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 1.76 111.133 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 130' ' ' PHE . 77.2 t -65.01 -25.87 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 2.77 110.37 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -95.38 17.94 13.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.053 0.454 . . . . 3.55 110.668 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 139' ' ' GLY . 4.3 tp-100 -131.24 121.77 18.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.168 -0.469 . . . . 3.02 109.952 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 92.4 Cg_exo -45.79 -36.03 14.39 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.017 3.144 . . . . 1.6 113.619 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -110.74 27.65 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.965 0.412 . . . . 2.29 109.961 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 136' ' ' GLN . . . -84.68 -42.65 7.19 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.159 -0.543 . . . . 1.22 113.541 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 69.0 mt -104.03 153.54 20.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.38 0.59 . . . . 1.57 110.469 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -142.88 147.12 34.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.829 -0.623 . . . . 1.38 109.954 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.4 t -133.76 137.69 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.153 -0.476 . . . . 1.73 109.954 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -106.07 121.74 44.74 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.702 -0.481 . . . . 2.42 109.702 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.74 128.46 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.867 -0.682 . . . . 0.86 113.041 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.76 115.52 31.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.914 -0.402 . . . . 0.76 109.914 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -77.99 149.97 33.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.931 0.396 . . . . 1.2 111.168 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.04 134.94 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.835 -0.62 . . . . 0.88 110.361 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -127.16 144.52 51.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.471 -0.566 . . . . 2.03 109.471 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 19.6 m -86.75 130.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.389 0.614 . . . . 1.27 111.742 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.32 -104.54 0.18 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.224 -0.898 . . . . 1.53 111.391 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -81.19 150.98 28.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 1.54 109.919 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.31 149.84 45.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.224 -0.444 . . . . 0.78 111.229 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 216' ' ' SER . 22.5 tptm -119.45 96.14 49.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.003 -0.544 . . . . 1.22 109.904 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 54.0 Cg_exo -53.56 -37.94 83.34 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.22 2.613 . . . . 1.05 112.524 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.94 -37.88 86.75 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.7 113.172 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 160' ' ' VAL . 61.9 tp -93.05 -22.43 19.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.082 0.441 . . . . 0.77 110.456 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -57.24 -34.22 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 1.41 111.316 -178.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -56.49 -41.75 77.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 2.86 110.904 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.58 -41.86 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 1.38 110.249 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 25.8 t -61.88 -33.81 59.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.374 0.606 . . . . 1.11 110.588 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.99 -37.06 78.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.797 -0.638 . . . . 1.22 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.91 -18.88 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 111.913 0.338 . . . . 1.41 111.913 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -66.32 -17.13 64.57 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.738 -0.385 . . . . 1.39 111.91 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.7 -24.06 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 2.31 110.881 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.5 m -84.8 0.43 50.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.264 -0.426 . . . . 1.4 111.427 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.42 HG12 ' HA ' ' A' ' 163' ' ' LEU . 44.7 pt -137.4 44.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.345 0.593 . . . . 0.85 109.627 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.79 -36.98 80.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.436 -0.802 . . . . 1.59 111.697 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -114.51 151.93 32.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.708 -0.224 . . . . 0.77 110.734 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 21.4 pttm -63.56 140.85 58.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.046 0.45 . . . . 2.29 110.611 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.13 47.71 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.753 -0.737 . . . . 0.85 111.42 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.61 147.72 22.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.128 0.49 . . . . 1.7 111.144 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.3 p -144.11 150.42 38.08 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.502 -0.772 . . . . 1.37 109.49 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -135.43 133.71 38.88 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.737 -0.468 . . . . 0.61 109.737 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.07 129.83 43.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.156 0.503 . . . . 1.8 110.065 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -141.44 79.91 1.71 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.678 -0.86 . . . . 1.04 108.678 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.5 m -99.29 153.99 18.53 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.273 -0.876 . . . . 1.17 110.984 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.4 m120 54.78 77.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.188 0.595 . . . . 1.77 111.959 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.437 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 71.3 t80 -131.42 140.63 49.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.9 -0.591 . . . . 3.99 109.494 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.41 120.89 51.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.198 0.523 . . . . 2.51 110.639 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.27 -5.57 16.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.025 2.483 . . . . 1.26 111.948 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 181' ' ' ARG . 42.1 ttp-105 -55.54 -36.95 67.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.773 -0.649 . . . . 2.76 110.975 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.05 8.08 61.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.968 -0.634 . . . . 1.12 112.417 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.6 mt -117.28 -38.95 3.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.984 0.421 . . . . 1.73 109.989 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.518 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.3 mt -73.1 131.44 83.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.727 -0.669 . . . . 3.45 111.101 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 5.8 Cg_exo -77.65 179.73 6.23 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.002 2.468 . . . . 2.08 112.361 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -84.76 -63.8 1.27 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.26 0.467 . . . . 3.23 112.26 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.3 t -78.06 134.7 37.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.653 0.263 . . . . 1.66 110.964 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.8 mt -113.21 60.84 0.64 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.946 0.403 . . . . 1.99 110.288 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 212' ' ' LYS . 4.5 m-20 -140.22 144.42 36.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.41 -0.959 . . . . 1.81 108.41 173.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER 171.85 -171.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.415 -0.587 . . . . 5.01 109.415 -173.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 257' ' ' ALA . 25.7 p90 -81.3 151.24 28.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.487 -0.485 . . . . 3.93 110.127 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.451 ' OG1' HD13 ' A' ' 209' ' ' ILE . 4.7 t -167.29 116.92 0.84 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.573 0.702 . . . . 2.13 110.827 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.621 ' CD1' ' HD2' ' A' ' 251' ' ' LYS . 6.2 t80 -139.87 147.82 52.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.869 -0.789 . . . . 5.21 108.869 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 99.2 Cg_exo -47.64 151.19 3.51 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.628 2.219 . . . . 2.12 112.875 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.93 159.45 24.6 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.75 112.453 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.8 t -115.68 152.81 32.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.977 0.418 . . . . 2.99 110.166 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.541 ' O ' ' HD2' ' A' ' 201' ' ' PRO . 65.7 mt -88.9 11.61 17.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.634 -0.712 . . . . 4.75 110.574 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 201' ' ' PRO . 11.9 t -66.81 23.19 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.027 1.121 . . . . 5.1 114.027 -168.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.583 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.1 OUTLIER -76.36 -63.9 0.55 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 O-C-N 121.642 -0.661 . . . . 5.53 109.238 169.589 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 199' ' ' THR . 1.9 Cg_endo -82.96 -67.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.556 1.62 0 C-N-CA 121.847 1.698 . . . . 5.83 113.496 166.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' A' ' 198' ' ' THR . 51.9 Cg_endo -100.72 141.77 0.27 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.15 1.9 . . . . 4.78 113.22 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.5 tp -74.71 66.92 1.52 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.2 0.524 . . . . 3.84 110.999 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.8 tp -128.95 129.97 46.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 2.96 110.988 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.86 93.23 4.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.177 -0.465 . . . . 3.37 111.707 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.7 p -139.25 24.49 2.51 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.779 0.659 . . . . 2.15 112.779 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.15 143.2 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.26 111.964 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 5.5 m -126.35 104.52 8.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.331 -0.618 . . . . 2.08 109.331 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -101.64 134.95 43.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.476 0.655 . . . . 5.53 112.144 -175.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.451 HD13 ' OG1' ' A' ' 192' ' ' THR . 7.9 mm -116.13 128.32 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.779 -1.1 . . . . 1.63 109.173 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 t -108.17 150.28 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.341 -0.614 . . . . 1.62 109.341 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.415 ' HB2' ' HG2' ' A' ' 185' ' ' PRO . 1.9 mm? -109.57 146.43 34.7 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.98 -0.288 . . . . 1.73 111.325 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.61 ' HA ' ' CD2' ' A' ' 190' ' ' TYR . 37.5 ttmt -52.99 -60.28 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.765 0.654 . . . . 2.98 112.765 -176.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 185' ' ' PRO . 11.4 mm-40 -72.86 114.88 34.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.696 -0.684 . . . . 1.47 111.68 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.37 147.32 22.77 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.156 1.904 . . . . 0.96 110.5 174.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 pt -89.4 140.08 16.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.459 -0.496 . . . . 1.25 110.21 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 18.4 t -97.32 127.48 43.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.052 -0.522 . . . . 1.29 109.734 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 29.8 m -127.0 156.39 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.729 -0.668 . . . . 1.02 109.737 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.5 t -85.83 154.58 21.46 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.179 -0.304 . . . . 1.08 110.179 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.561 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 46.2 m -53.46 -42.35 67.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.001 0.188 . . . . 1.33 111.398 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 9.9 pt-20 -56.94 -27.77 61.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.605 -0.27 . . . . 2.51 111.634 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -77.08 -46.91 21.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.028 -0.36 . . . . 0.7 110.028 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.723 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 26.7 m -70.83 -28.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.36 111.228 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.7 mt -64.48 -33.57 76.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.298 -0.41 . . . . 1.03 110.558 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 65.2 mttp -74.97 -24.22 58.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 1.75 111.238 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.723 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.3 m-85 -67.0 -35.13 79.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.202 0.525 . . . . 2.47 109.851 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -84.45 13.96 4.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.696 -0.684 . . . . 3.04 110.578 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.0 mmtt -100.63 -14.96 17.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.79 -0.448 . . . . 2.31 109.79 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.401 HD21 HD13 ' A' ' 163' ' ' LEU . 97.9 mt -77.64 152.75 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 0.95 111.546 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.494 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 11.6 m120 -117.58 154.31 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 1.13 109.273 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 45.5 p90 -102.97 -11.55 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.492 -0.483 . . . . 3.74 110.252 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -75.26 169.5 17.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.821 -0.627 . . . . 1.62 111.022 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -85.89 171.72 45.15 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.867 -0.606 . . . . 1.16 111.889 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.64 128.58 36.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.961 0.41 . . . . 3.56 110.779 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 98.58 9.43 52.92 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.671 -0.695 . . . . 2.08 112.191 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -111.54 160.87 27.83 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.088 -0.338 . . . . 2.59 110.088 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.23 127.81 27.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.485 2.124 . . . . 1.36 111.165 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.09 110.3 1.02 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 3.4 111.517 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -117.28 115.23 24.86 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.001 -0.74 . . . . 2.47 109.001 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.3 135.0 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.267 0.556 . . . . 2.14 111.73 -172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.9 ttm -81.66 90.21 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.994 -1.003 . . . . 1.68 108.955 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.62 153.38 38.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.182 -0.463 . . . . 1.27 110.667 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.438 ' O ' ' HD1' ' A' ' 244' ' ' TRP . 16.7 t70 66.27 -88.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.36 1.037 . . . . 2.18 111.369 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.1 t30 47.67 43.19 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.55 0.531 . . . . 2.15 111.301 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 20.5 m95 -144.08 159.7 42.17 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.6 -0.687 . . . . 4.59 110.03 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.446 ' NH1' ' HA ' ' A' ' 199' ' ' THR . 6.3 ptp180 -113.36 116.82 46.08 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.569 -0.53 . . . . 6.13 109.569 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.452 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 45.3 Cg_exo -52.96 -86.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.177 2.585 . . . . 3.28 114.826 -167.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.452 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -108.29 99.49 8.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.239 0.542 . . . . 2.98 112.188 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 26.5 mm-40 -110.65 173.64 2.78 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 107.869 -1.16 . . . . 4.32 107.869 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 52.7 Cg_exo -57.25 94.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.798 1.666 . . . . 3.48 111.129 172.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.61 ' HG ' ' N ' ' A' ' 251' ' ' LYS . 1.6 pt? -64.34 -56.96 10.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.764 -0.653 . . . . 4.63 111.452 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.621 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 62.6 mmtt -122.46 -10.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.934 -0.306 . . . . 5.34 111.229 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.93 -48.19 0.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.152 0.981 . . . . 4.64 111.844 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -89.17 -80.78 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 6.11 110.246 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -157.53 156.55 32.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.513 -0.551 . . . . 3.08 109.513 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 11.5 tt -112.8 148.72 15.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.637 0.256 . . . . 2.6 110.432 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.1 153.47 20.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.222 0.534 . . . . 2.63 111.158 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -131.01 171.44 13.23 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.153 -0.93 . . . . 1.71 109.032 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.5 p -163.46 98.8 0.91 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.985 0.421 . . . . 2.21 110.783 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.03 102.43 6.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.732 0.777 . . . . 4.31 109.963 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 17.1 pttm . . . . . 0 C--O 1.248 0.982 0 CA-C-N 115.007 -0.997 . . . . 4.49 110.226 -174.558 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 109.896 -0.409 . . . . 17.49 109.896 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 t -79.52 131.86 36.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.068 0.461 . . . . 15.32 110.741 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -116.72 13.19 15.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.841 -0.618 . . . . 15.81 109.684 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.425 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 5.5 p80 -134.44 146.26 49.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.311 -0.859 . . . . 14.19 110.411 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.464 ' H ' ' HA ' ' A' ' 13' ' ' PRO . 95.4 m95 60.77 25.98 15.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.853 0.835 . . . . 14.91 109.802 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.697 ' O ' ' HA2' ' A' ' 12' ' ' GLY . . . -164.58 -170.68 29.86 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 109.565 -1.414 . . . . 10.79 109.565 -177.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 243' ' ' ASN . 57.0 m-85 -71.84 97.72 1.86 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.346 0.573 . . . . 11.39 109.783 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.15 -105.21 0.2 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.888 -0.672 . . . . 9.0 112.357 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 97.1 mttt -88.01 150.73 23.25 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.254 0.464 . . . . 9.76 112.254 -175.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 58.49 -100.61 0.11 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.332 -0.849 . . . . 11.19 111.33 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.428 ' HB3' ' CG ' ' A' ' 200' ' ' PRO . 10.3 p30 -126.16 -1.35 7.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.133 0.492 . . . . 10.8 110.111 176.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 6' ' ' GLY . . . 156.38 -78.66 0.19 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.287 -0.87 . . . . 8.82 111.01 -172.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HA ' ' H ' ' A' ' 5' ' ' TRP . 5.9 Cg_exo -80.25 125.1 5.65 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.488 2.126 . . . . 7.87 111.265 172.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 4' ' ' HIS . 10.6 pt-20 -80.38 0.58 32.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.398 . . . . 10.62 111.499 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -119.48 22.3 11.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.903 0.859 . . . . 9.87 108.712 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.1 t90 -66.3 -25.49 66.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.404 -1.271 . . . . 8.48 110.163 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 19.4 p80 -66.76 -4.88 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.583 -0.735 . . . . 7.13 112.194 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -88.38 -30.9 19.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.878 0.371 . . . . 9.68 110.22 173.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -92.62 -38.2 12.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 7.89 110.142 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -144.56 75.55 14.79 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.164 -0.925 . . . . 7.17 108.881 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.503 ' O ' HG22 ' A' ' 22' ' ' ILE . 70.9 Cg_exo -39.45 -82.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.269 3.313 . . . . 7.76 114.833 -169.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 21' ' ' PRO . 7.8 tp 51.52 9.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.235 1.014 . . . . 5.83 112.605 -176.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.03 -16.54 59.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.196 0.522 . . . . 5.44 110.465 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -85.42 16.44 3.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.722 -0.672 . . . . 7.78 110.265 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.38 31.7 0.12 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.594 -0.812 . . . . 5.01 113.222 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.71 168.52 9.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.989 0.395 . . . . 7.09 110.031 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' CZ ' ' HE2' ' A' ' 251' ' ' LYS . 2.4 ptp180 -156.0 125.9 6.47 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.237 -1.023 . . . . 5.13 108.237 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.411 HE21 HG21 ' A' ' 199' ' ' THR . 35.0 tt0 -150.21 65.96 0.96 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.462 -0.495 . . . . 7.12 111.921 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 248' ' ' GLN . 14.4 m -47.66 113.26 2.51 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.2 0.445 . . . . 3.94 112.2 171.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.2 28.78 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.742 2.961 . . . . 4.52 111.375 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.46 -174.22 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.197 -0.91 . . . . 4.54 111.338 -166.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -83.77 140.73 31.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.094 -0.503 . . . . 2.88 109.821 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 108' ' ' THR . 24.7 mm -71.41 128.24 34.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.981 0.896 . . . . 2.32 111.895 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 36' ' ' HIS . 23.0 t70 -43.98 156.13 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.367 -1.742 . . . . 2.82 114.083 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' THR . 13.3 t -55.69 19.35 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.618 1.967 . . . . 2.24 113.434 172.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.613 ' H ' ' C ' ' A' ' 34' ' ' ASP . 33.5 p-80 -47.33 1.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.171 1.789 . . . . 4.54 114.663 -176.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' THR . 2.6 m -72.28 27.81 0.05 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.613 0.765 . . . . 3.06 109.086 163.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 36' ' ' HIS . . . -56.79 164.85 1.36 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.733 1.213 . . . . 1.72 112.884 -163.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.94 139.92 50.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.805 -1.088 . . . . 3.69 110.845 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' HB2' ' H ' ' A' ' 259' ' ' PHE . 7.9 p90 -59.93 123.76 18.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.141 -0.936 . . . . 4.64 112.241 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -86.72 133.16 40.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 2.27 110.618 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.84 -14.17 11.31 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.803 2.336 . . . . 2.15 114.354 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.9 p -93.11 -2.46 55.44 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.577 -0.449 . . . . 4.29 111.063 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.29 154.53 17.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.237 -0.438 . . . . 4.74 110.3 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HE3' HD11 ' A' ' 47' ' ' LEU . 61.9 tttp -115.44 106.89 50.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 3.77 109.935 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 52.8 Cg_exo -56.1 120.07 7.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.614 2.21 . . . . 2.36 112.089 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' PRO . 12.7 mt -169.99 116.92 0.55 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.432 0.901 . . . . 2.55 113.432 -173.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.411 ' HB3' HD11 ' A' ' 79' ' ' LEU . 66.6 m -157.75 79.55 0.86 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.562 -0.903 . . . . 2.38 108.562 152.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.72 95.12 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.354 0.872 . . . . 1.59 113.354 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 39.7 m -142.23 85.44 1.92 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 121.439 1.927 . . . . 1.45 109.267 155.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -134.18 19.14 3.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.208 -0.308 . . . . 3.62 111.052 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.73 -28.61 68.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 2.48 111.381 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 39.2 mt-30 -110.0 13.7 23.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.354 . . . . 2.24 111.634 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.1 127.01 29.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.8 111.383 -174.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -116.09 115.24 25.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.213 -0.449 . . . . 1.06 110.875 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 176' ' ' THR . 5.6 m -84.34 153.54 23.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.196 -0.456 . . . . 1.26 109.795 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -117.73 -57.23 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.74 111.926 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -170.01 164.63 9.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 3.17 111.436 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.2 tt -127.08 143.84 39.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.436 -0.802 . . . . 0.64 109.874 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 172' ' ' SER . 20.6 tp -144.75 121.14 10.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.955 0.354 . . . . 0.96 111.955 -173.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -68.5 109.1 3.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.967 -0.56 . . . . 1.49 109.495 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -141.4 70.63 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.786 -0.766 . . . . 1.83 112.766 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.67 -65.1 0.33 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.765 -1.207 . . . . 1.64 112.879 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -128.39 -11.92 5.08 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.948 -0.301 . . . . 3.33 111.473 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.96 -173.2 3.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 1.38 110.986 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.52 88.41 2.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 2.74 108.881 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.09 114.39 15.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.473 -0.785 . . . . 1.76 110.285 -171.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 5.5 p -94.1 124.13 46.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.887 -0.597 . . . . 1.15 110.184 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.87 132.62 40.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.867 -0.606 . . . . 2.02 111.604 -174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.25 152.63 22.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.184 -0.916 . . . . 1.66 109.784 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.76 129.4 45.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 1.33 109.828 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.09 63.97 1.4 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.89 -1.05 . . . . 2.65 109.961 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 p -79.91 -3.21 47.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.368 -0.833 . . . . 1.61 110.54 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.484 ' OE1' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -154.28 177.69 10.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.053 -1.462 . . . . 2.35 107.053 175.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.9 79.06 0.21 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.247 0.476 . . . . 1.92 111.5 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HE2' ' OE1' ' A' ' 74' ' ' GLN . 61.4 mttm -102.49 -66.13 0.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.597 -0.274 . . . . 1.77 110.682 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.01 84.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.391 0.615 . . . . 0.76 110.06 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 50' ' ' SER . 17.8 m -115.25 150.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 1.27 110.467 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 48' ' ' SER . 28.6 tp -100.6 124.6 46.4 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.978 -0.555 . . . . 1.29 110.413 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -125.67 133.4 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.718 -0.845 . . . . 2.54 108.718 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' CB ' ' A' ' 47' ' ' LEU . . . -149.93 170.79 30.0 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 119.477 -0.624 . . . . 1.31 111.666 -170.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.36 -146.69 0.0 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 123.859 0.388 . . . . 1.9 113.161 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.39 119.81 6.43 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 121.564 1.51 . . . . 2.91 111.781 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.1 mt -157.01 -178.07 7.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.454 -0.794 . . . . 4.11 109.843 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -127.45 67.2 1.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.338 -0.392 . . . . 4.95 111.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.2 -170.59 14.23 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.635 -0.793 . . . . 2.25 112.904 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.539 ' O ' HG22 ' A' ' 125' ' ' THR . 30.7 m -105.65 134.97 47.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 1.91 110.162 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' A' ' 139' ' ' GLY . 33.1 m-85 -114.87 119.37 36.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 3.7 110.428 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HD3' ' CB ' ' A' ' 125' ' ' THR . 39.6 mtp180 -91.93 143.33 26.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.376 -0.375 . . . . 3.54 111.085 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 tt -88.61 128.84 35.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.642 -0.503 . . . . 1.14 109.642 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.441 HG23 ' HG2' ' A' ' 92' ' ' GLN . 13.1 tt -113.62 -34.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 1.68 110.509 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.546 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 5.3 pt20 -165.44 174.86 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 1.55 109.54 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 119' ' ' HIS . 42.6 p90 -155.32 156.64 35.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.86 110.712 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -147.2 161.15 41.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.93 109.346 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' A' ' 118' ' ' LEU . 69.1 m-85 -107.06 166.7 10.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 3.17 111.002 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.41 ' HD1' ' CG ' ' A' ' 117' ' ' GLU . 4.6 m80 -128.99 146.62 50.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.464 -1.68 . . . . 1.68 106.464 172.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 242' ' ' ASP . 8.3 m-90 -133.53 -169.66 2.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.434 0.561 . . . . 5.18 111.388 -170.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.42 24.99 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.721 -1.351 . . . . 2.13 109.721 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.1 t -70.89 -15.07 62.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.128 0.964 . . . . 2.9 110.478 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.2 mt -128.86 150.49 50.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.881 -0.785 . . . . 3.03 108.881 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.82 6.36 2.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.285 0.476 . . . . 3.85 112.285 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.35 24.78 6.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.509 -0.853 . . . . 1.94 112.455 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 18.0 pt20 -158.67 162.76 37.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.995 -0.372 . . . . 2.45 109.995 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.7 -18.91 16.7 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.316 -0.945 . . . . 1.47 112.281 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 99.2 p -69.02 -34.6 75.5 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.258 -0.177 . . . . 2.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 107' ' ' HIS . 1.0 OUTLIER 71.03 -173.13 0.17 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.426 -0.953 . . . . 3.72 108.426 -175.109 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.593 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 1.8 m-70 57.86 37.75 27.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.647 0.736 . . . . 3.52 109.723 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.603 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.3 123.46 29.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.669 -1.151 . . . . 2.52 112.404 -173.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.65 102.37 13.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.237 -0.892 . . . . 2.48 110.469 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.86 55.08 5.62 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.673 -0.694 . . . . 2.8 109.663 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 68.27 24.31 7.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.035 -0.984 . . . . 4.98 112.22 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -93.21 90.49 6.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 3.23 110.53 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.59 146.74 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 2.82 110.437 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 94.5 m-85 -100.77 -168.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.381 -0.372 . . . . 1.62 110.107 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.16 34.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.723 0.297 . . . . 1.03 111.725 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.84 168.24 21.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.387 -0.369 . . . . 0.75 110.5 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.41 ' CG ' ' HD1' ' A' ' 96' ' ' HIS . 5.4 tp10 -124.29 151.89 43.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 1.58 109.485 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.531 HD13 ' CE2' ' A' ' 95' ' ' PHE . 57.3 tp -115.61 147.72 40.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.233 -0.284 . . . . 1.07 110.233 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 93' ' ' PHE . 1.6 t-160 -121.75 114.91 21.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.393 -0.595 . . . . 1.77 109.393 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.58 91.58 4.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.843 0.354 . . . . 0.93 110.12 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.649 ' HA ' ' HB1' ' A' ' 141' ' ' ALA . 46.6 t -65.68 117.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.365 0.602 . . . . 0.61 111.701 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 76.8 m80 -138.66 125.58 21.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.089 -1.078 . . . . 2.13 108.089 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.678 ' CD1' ' HB2' ' A' ' 130' ' ' PHE . 88.4 m95 -110.82 144.91 39.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.622 -0.431 . . . . 4.26 111.258 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.449 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 56.4 t30 -62.69 100.79 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.419 -0.81 . . . . 2.02 110.317 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 87' ' ' THR . 10.3 t -70.63 -24.34 62.71 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.065 0.765 . . . . 2.34 113.065 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -68.14 -5.14 16.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.429 0.529 . . . . 3.35 112.429 -174.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -95.42 17.49 14.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.788 0.804 . . . . 3.1 109.543 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.22 -3.58 10.45 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.491 -1.231 . . . . 2.37 115.786 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -173.5 145.19 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.577 1.189 . . . . 3.93 109.949 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.678 ' HB2' ' CD1' ' A' ' 123' ' ' TRP . 25.1 p90 -67.95 -43.12 79.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.854 -0.612 . . . . 3.0 111.705 -176.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.15 -28.81 73.43 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.072 -0.585 . . . . 2.15 112.182 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -81.27 -34.75 31.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.496 -0.557 . . . . 3.43 109.496 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.39 66.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.745 -0.661 . . . . 1.76 111.63 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 130' ' ' PHE . 42.1 t -60.05 -19.39 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.297 0.57 . . . . 2.77 110.764 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -99.34 16.73 22.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 3.55 110.655 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -112.83 118.49 44.68 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.815 0.341 . . . . 3.02 111.133 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.547 ' HA ' ' SG ' ' A' ' 205' ' ' CYS . 25.0 Cg_exo -64.18 -20.61 67.31 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.691 2.261 . . . . 1.6 111.965 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.04 28.39 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.992 0.738 . . . . 2.29 112.992 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . 128.34 94.49 0.8 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.827 -1.654 . . . . 1.22 114.609 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 20.8 mt -97.0 -175.85 3.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.914 -0.772 . . . . 1.57 108.914 167.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 121' ' ' VAL . . . -71.2 124.85 25.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.581 0.705 . . . . 1.38 110.372 -167.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.1 m -77.93 164.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.506 -1.225 . . . . 1.73 112.331 -167.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.7 tp -85.54 143.86 28.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.665 -1.152 . . . . 2.42 111.264 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 170.94 42.69 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.782 -1.099 . . . . 0.86 112.186 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 214' ' ' PRO . 11.2 mt -86.63 142.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.572 0.225 . . . . 0.76 110.76 -176.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -63.13 157.09 23.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 1.2 111.532 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.4 mp -113.01 137.46 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.88 110.686 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -129.76 143.41 50.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.95 -0.759 . . . . 2.03 108.95 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 24.1 t -108.66 81.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.312 -0.555 . . . . 1.27 112.281 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -165.95 67.17 0.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.377 -0.916 . . . . 1.53 112.342 165.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 19.3 t 157.95 126.43 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.541 -1.281 . . . . 1.54 107.541 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 138.45 41.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.74 -0.384 . . . . 0.78 110.671 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -104.89 98.41 15.31 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.474 -0.565 . . . . 1.22 109.474 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.59 -24.44 69.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.599 2.199 . . . . 1.05 112.719 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.2 6.55 79.14 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.865 -0.683 . . . . 0.7 113.104 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -110.67 -13.99 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.77 110.904 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.76 -36.53 76.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 1.41 111.518 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -49.18 -44.19 42.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.713 0.292 . . . . 2.86 111.165 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.21 -42.01 37.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 1.38 110.437 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 48.7 t -63.74 -39.58 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.813 -0.631 . . . . 1.11 111.576 -176.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -69.98 -24.31 63.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.712 0.291 . . . . 1.22 111.698 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.87 -11.91 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.001 0.371 . . . . 1.41 112.001 -174.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -65.74 -17.07 64.36 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.963 -0.46 . . . . 1.39 111.559 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.403 ' N ' HD12 ' A' ' 163' ' ' LEU . 16.7 m-20 -66.42 -28.06 68.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 2.31 110.727 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.2 m -84.36 0.14 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.387 -0.369 . . . . 1.4 111.387 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.455 ' CG1' ' HA ' ' A' ' 163' ' ' LEU . 18.6 pt -137.97 57.1 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.85 109.337 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -74.71 -40.23 61.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.828 -0.623 . . . . 1.59 111.367 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.7 p -115.97 158.0 23.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.982 0.42 . . . . 0.77 111.647 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.21 132.76 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 2.29 110.484 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.52 -22.28 26.76 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.551 -0.833 . . . . 0.85 111.726 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -87.62 142.04 28.15 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.197 0.522 . . . . 1.7 110.736 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 60' ' ' LEU . 6.7 p -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.227 -0.897 . . . . 1.37 110.368 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.26 134.32 32.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.548 -0.538 . . . . 0.61 109.548 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.28 133.68 44.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.069 0.462 . . . . 1.8 109.918 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -142.07 81.36 1.75 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.572 -0.74 . . . . 1.04 109.36 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 56' ' ' SER . 7.1 m -104.97 162.22 13.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.468 -0.333 . . . . 1.17 111.317 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.7 57.16 3.3 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.42 0.688 . . . . 1.77 111.989 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -126.76 132.25 51.12 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.531 -0.544 . . . . 3.99 109.531 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 5.3 p-10 -107.87 126.89 28.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.442 -0.345 . . . . 2.51 110.365 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 22.4 Cg_exo -66.42 -3.84 9.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.417 2.745 . . . . 1.26 113.333 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -58.98 -31.82 69.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 2.76 111.04 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.6 -30.58 72.97 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.141 -0.552 . . . . 1.12 112.361 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.3 mt -72.7 -34.33 67.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.014 0.435 . . . . 1.73 110.334 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 mt -71.43 118.75 68.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 3.45 110.51 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 8.9 Cg_exo -73.9 -165.19 0.24 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.028 2.485 . . . . 2.08 113.289 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.92 -61.97 1.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.278 0.473 . . . . 3.23 112.278 -173.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.457 ' HB2' ' CG ' ' A' ' 213' ' ' GLU . 34.7 m -75.45 129.43 37.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 1.66 110.514 -176.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 46' ' ' PRO . 39.6 tp -105.43 63.43 0.69 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.016 -0.538 . . . . 1.99 110.082 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 21.9 m-20 -109.95 145.64 36.57 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.374 -0.973 . . . . 1.81 108.374 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -136.47 149.27 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.607 -0.837 . . . . 5.01 112.936 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.573 ' HB3' ' CG2' ' A' ' 255' ' ' ILE . 6.8 m-90 -93.78 141.68 28.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.49 -1.232 . . . . 3.93 108.445 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.9 t -136.8 109.92 7.76 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.456 0.646 . . . . 2.13 112.498 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.562 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 54.9 t80 -139.22 138.21 20.42 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.627 -0.715 . . . . 5.21 110.506 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 48.7 Cg_exo -57.47 128.49 29.61 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.315 2.01 . . . . 2.12 111.494 172.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 208' ' ' TRP . . . -122.52 157.22 17.14 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.961 -0.637 . . . . 1.75 113.456 -171.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 13.5 m -92.63 119.05 31.66 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 2.99 109.733 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.99 -44.49 63.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.284 -0.416 . . . . 4.75 111.187 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.41 ' O ' ' HB ' ' A' ' 199' ' ' THR . 7.1 p -113.37 -40.11 3.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.433 -0.349 . . . . 5.1 111.027 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.547 ' O ' HD23 ' A' ' 202' ' ' LEU . 87.3 m 106.43 -60.13 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 124.874 1.359 . . . . 5.53 113.107 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 199' ' ' THR . 51.7 Cg_exo -52.8 -51.53 10.91 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.053 1.835 . . . . 5.83 115.037 -176.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.53 -7.86 22.09 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.377 1.385 . . . . 4.78 112.358 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 199' ' ' THR . 67.2 mt 65.78 56.75 0.88 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.829 -1.078 . . . . 3.84 110.628 175.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 196' ' ' SER . 16.2 tp -95.66 118.02 31.57 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.616 -0.513 . . . . 2.96 109.616 -176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.85 28.11 8.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.193 0.521 . . . . 3.37 111.076 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 137' ' ' PRO . 68.3 m -80.06 -4.8 54.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.822 -0.626 . . . . 2.15 111.446 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 48.4 t -90.18 137.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.383 -0.229 . . . . 1.26 110.383 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.2 m -105.5 102.59 12.05 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.885 -0.413 . . . . 2.08 109.885 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.548 ' O ' ' HA ' ' A' ' 192' ' ' THR . 43.2 m0 -72.19 100.84 2.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.245 -0.28 . . . . 5.53 110.245 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 65.6 mt -105.51 99.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.211 -0.663 . . . . 1.63 109.211 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.6 t -111.21 122.46 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.244 -0.435 . . . . 1.62 110.67 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 3.7 mm? -69.28 134.09 48.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.328 0.585 . . . . 1.73 110.127 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.562 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 32.6 ttpt -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.676 -1.147 . . . . 2.98 111.509 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.457 ' CG ' ' HB2' ' A' ' 187' ' ' SER . 22.2 mm-40 -76.27 110.92 12.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 1.47 110.795 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 145' ' ' ILE . 61.3 Cg_endo -74.91 154.19 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.623 2.216 . . . . 0.96 112.025 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.15 110.94 10.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.103 -0.499 . . . . 1.25 109.902 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.525 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 79.2 p -93.18 118.66 31.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.741 -0.466 . . . . 1.29 109.741 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 30.8 m -120.98 157.78 23.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.02 110.539 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.3 t -90.58 157.96 17.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.071 -0.513 . . . . 1.08 109.978 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.672 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 20.3 m -55.09 -46.59 75.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 1.33 110.732 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -52.65 -34.87 53.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 2.51 111.603 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -71.14 -50.11 36.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.7 110.203 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -71.88 -22.48 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.839 0.311 . . . . 1.36 111.839 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 219' ' ' SER . 83.0 mt -64.48 -43.83 92.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.81 -0.441 . . . . 1.03 109.81 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.446 ' HB3' HD11 ' A' ' 163' ' ' LEU . 67.4 mttm -68.72 -29.56 68.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 1.75 111.382 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.62 -30.37 64.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.53 . . . . 2.47 109.907 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -80.06 -2.68 45.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.741 -0.663 . . . . 3.04 110.346 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 33.4 mmtp -90.41 -6.52 54.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 2.31 110.064 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.61 146.68 26.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.887 -0.597 . . . . 0.95 110.807 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.588 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.8 m120 -118.79 125.83 50.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.659 -0.701 . . . . 1.13 109.521 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -78.76 -7.74 58.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 3.74 111.38 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.588 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.2 p-10 -77.58 162.71 26.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.831 0.348 . . . . 1.62 110.236 171.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.8 159.89 36.73 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.098 -0.801 . . . . 1.16 111.098 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.86 134.27 56.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 3.56 110.957 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.67 11.61 70.77 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.776 -0.647 . . . . 2.08 112.922 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -112.93 158.61 37.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.69 -0.485 . . . . 2.59 109.69 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.55 122.81 11.5 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.593 2.196 . . . . 1.36 111.819 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 120.18 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.381 -0.827 . . . . 3.4 112.383 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -127.82 136.55 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.329 -0.989 . . . . 2.47 108.329 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.12 133.38 33.63 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.758 -0.46 . . . . 2.14 109.758 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 51.8 ttm -75.12 88.28 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.099 0.476 . . . . 1.68 109.757 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.15 167.36 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.861 -0.792 . . . . 1.27 108.861 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' TRP . 0.7 OUTLIER 61.75 -90.85 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.402 0.439 . . . . 2.18 110.814 -174.468 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 54.4 m-80 43.13 45.8 4.82 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.271 0.558 . . . . 2.15 111.923 -175.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.442 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 60.9 t-105 -153.14 153.06 32.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.331 -0.85 . . . . 4.59 108.979 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -100.58 130.35 25.75 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.089 -0.337 . . . . 6.13 110.089 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.27 53.33 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.769 2.313 . . . . 3.28 111.937 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -114.14 121.79 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.401 -0.818 . . . . 2.98 109.978 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 33' ' ' ILE . 27.9 mp0 -90.3 152.43 45.69 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.226 -0.443 . . . . 4.32 110.84 -176.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.69 141.67 15.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.598 2.866 . . . . 3.48 112.807 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 251' ' ' LYS . 0.6 OUTLIER -40.59 -55.78 2.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.976 -1.011 . . . . 4.63 113.699 -171.092 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.546 ' N ' HD12 ' A' ' 250' ' ' LEU . 69.6 mmtt -114.33 -4.96 12.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.95 0.352 . . . . 5.34 111.95 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.1 p30 34.22 65.52 0.31 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.132 0.895 . . . . 4.64 112.345 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -70.85 -90.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.85 -0.34 . . . . 6.11 111.08 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -159.64 154.97 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.178 -0.675 . . . . 3.08 109.178 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.573 ' CG2' ' HB3' ' A' ' 191' ' ' TRP . 13.7 mt -118.78 113.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.159 -0.311 . . . . 2.6 110.159 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 62.3 pttt -76.85 165.76 24.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 2.63 110.706 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 191' ' ' TRP . . . -126.0 168.54 13.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 1.71 109.975 -175.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.9 p -138.07 95.99 3.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.201 0.524 . . . . 2.21 111.242 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.475 ' H ' ' HB2' ' A' ' 40' ' ' TYR . 49.9 t80 -136.91 119.06 15.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 4.31 110.304 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.612 -0.708 . . . . 4.49 109.577 175.601 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.63 0.252 . . . . 17.49 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.8 t -138.35 156.96 47.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.904 0.383 . . . . 15.32 110.628 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -126.07 71.64 1.26 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.096 0.474 . . . . 15.81 110.536 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -132.87 100.69 4.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 14.19 109.686 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -132.47 154.13 50.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.171 -0.468 . . . . 14.91 110.759 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.74 -170.33 29.55 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 109.908 -1.277 . . . . 10.79 109.908 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 86.5 t80 -70.19 96.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.073 0.936 . . . . 11.39 108.571 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 12' ' ' GLY . . . 87.21 151.35 20.54 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.849 -0.9 . . . . 9.0 110.849 -172.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 56.9 mttp -45.87 124.2 5.1 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.986 0.735 . . . . 9.76 112.986 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.3 t60 66.79 -78.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.021 -1.445 . . . . 11.19 112.238 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -124.04 -12.89 7.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.953 -0.299 . . . . 10.8 111.53 -172.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' A' ' 7' ' ' TYR . . . 165.26 -67.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.389 -1.386 . . . . 8.82 113.989 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HB3' ' HB2' ' A' ' 16' ' ' TRP . 37.9 Cg_endo -66.63 121.97 9.3 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.571 1.514 . . . . 7.87 111.897 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 36.2 tt0 -86.04 -41.98 14.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 10.62 110.36 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -116.95 -31.0 5.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.155 -0.475 . . . . 9.87 111.156 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 13' ' ' PRO . 9.2 m0 -51.96 -35.65 46.82 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.895 0.702 . . . . 8.48 112.895 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -67.64 -13.91 62.49 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.677 -0.409 . . . . 7.13 111.095 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -83.27 -46.89 12.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.195 -0.457 . . . . 9.68 110.267 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.18 -22.27 59.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.036 -0.529 . . . . 7.89 110.634 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.69 88.9 17.22 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.656 -0.868 . . . . 7.17 108.656 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.66 -14.36 35.41 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.12 2.547 . . . . 7.76 113.418 -174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 22' ' ' ILE . 12.3 tt -108.13 22.62 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.852 0.834 . . . . 5.83 110.415 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -73.61 -8.1 54.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.055 -0.52 . . . . 5.44 111.113 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -73.75 20.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.094 0.473 . . . . 7.78 111.256 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 23' ' ' ALA . . . -145.55 43.38 0.93 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.942 -0.863 . . . . 5.01 110.942 177.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HA ' HD21 ' A' ' 197' ' ' LEU . 40.8 mt-10 -56.65 141.82 42.14 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.187 0.518 . . . . 7.09 111.935 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -151.82 129.85 11.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.069 -0.969 . . . . 5.13 110.126 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 244' ' ' TRP . 23.2 mm-40 -143.37 -83.55 0.16 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.322 -0.992 . . . . 7.12 108.322 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.3 m -78.97 104.92 2.46 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.54 -0.911 . . . . 3.94 108.54 164.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 28' ' ' GLN . 52.1 Cg_endo -71.29 -31.34 14.42 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.246 1.964 . . . . 4.52 112.474 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.32 161.81 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.376 0.608 . . . . 4.54 111.305 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.458 ' H ' HD23 ' A' ' 250' ' ' LEU . 5.9 m-20 -82.93 140.63 32.71 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.951 -1.129 . . . . 2.88 107.951 168.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 59.9 mt -82.99 85.1 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.543 0.687 . . . . 2.32 109.381 -176.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -102.08 112.19 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.188 -0.914 . . . . 2.82 110.397 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m -54.85 -31.67 59.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 2.24 112.643 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -74.67 -38.6 62.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.126 0.488 . . . . 4.54 110.421 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 m -79.13 -29.26 43.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.737 -0.665 . . . . 3.06 111.083 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.22 116.2 6.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.72 110.695 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -92.42 129.49 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.146 -0.479 . . . . 3.69 109.921 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.3 p90 -63.2 121.91 14.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 4.64 110.256 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 19.7 t70 -105.65 125.78 32.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.54 -0.755 . . . . 2.27 109.397 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.448 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 15.5 Cg_exo -69.82 60.1 1.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.64 2.227 . . . . 2.15 111.789 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 m -63.5 -17.45 62.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 4.29 111.713 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 42' ' ' PRO . 80.5 mt 61.56 -86.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.394 0.677 . . . . 4.74 112.386 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 46' ' ' PRO . 85.7 tttt -65.66 130.79 94.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.916 0.389 . . . . 3.77 111.517 -175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 56.9 Cg_endo -71.2 171.01 16.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.819 2.346 . . . . 2.36 111.23 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.78 131.43 40.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.734 -0.469 . . . . 2.55 109.734 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.4 m -108.78 115.12 29.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.949 -0.389 . . . . 2.38 109.949 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 22.0 t -123.0 110.77 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 1.59 110.286 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.0 m -92.18 90.28 7.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.525 -0.546 . . . . 1.45 109.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.0 9.84 38.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 3.62 111.556 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.05 -37.03 81.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 2.48 111.047 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -97.26 27.05 4.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.293 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.33 56.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.146 0.498 . . . . 0.8 112.057 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -146.87 106.03 3.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.828 -0.624 . . . . 1.06 110.178 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.3 p -89.01 158.8 17.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.488 -0.56 . . . . 1.26 109.488 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.17 -56.68 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.178 0.436 . . . . 0.74 112.178 -173.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.57 157.75 32.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.909 -0.317 . . . . 3.17 110.728 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -114.26 136.99 49.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 0.64 109.348 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 172' ' ' SER . 64.9 tp -132.55 146.55 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.171 0.51 . . . . 0.96 111.306 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.1 111.54 24.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.591 -0.732 . . . . 1.49 109.354 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -109.44 67.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.385 -0.526 . . . . 1.83 110.487 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.91 -51.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.752 0 O-C-N 124.808 1.317 . . . . 1.64 115.477 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -106.44 -26.46 11.43 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 122.487 0.315 . . . . 3.33 110.623 -172.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.68 171.38 16.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.562 -0.29 . . . . 1.38 110.51 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 95' ' ' PHE . 13.1 p90 -130.24 114.55 15.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.143 -0.688 . . . . 2.74 109.143 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -116.89 145.6 43.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.76 111.562 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.13 119.33 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 1.15 109.445 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.93 125.64 29.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.804 -0.634 . . . . 2.02 110.049 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -105.69 151.2 24.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.703 -0.68 . . . . 1.66 109.242 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -83.49 106.35 15.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.745 0.307 . . . . 1.33 110.33 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -124.36 57.44 1.24 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.982 0.896 . . . . 2.65 110.594 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -92.98 -5.28 51.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.185 -0.916 . . . . 1.61 109.327 169.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -158.72 169.82 23.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.878 -1.056 . . . . 2.35 108.757 -178.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -78.17 72.71 4.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 1.92 111.17 -174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 65.6 mttm -81.1 -53.25 6.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.986 -0.552 . . . . 1.77 110.458 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -119.75 112.18 18.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.096 -0.502 . . . . 0.76 110.09 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 91.8 t -113.4 137.04 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.632 -0.713 . . . . 1.27 110.496 -176.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tt -129.19 113.6 15.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.134 -0.321 . . . . 1.29 110.134 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -147.84 125.01 11.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 2.54 110.457 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.93 -177.77 19.62 Favored Glycine 0 C--O 1.219 -0.793 0 CA-C-O 118.937 -0.924 . . . . 1.31 111.151 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.83 -130.18 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 O-C-N 124.971 1.041 . . . . 1.9 115.498 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.61 169.49 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.68 2.92 . . . . 2.91 114.217 -170.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -31.07 102.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.268 1.509 . . . . 4.11 114.879 -147.169 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 8.4 p-10 -107.03 -100.9 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.19 -1.823 . . . . 4.95 112.793 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.561 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 94.05 152.73 29.62 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.385 -1.086 . . . . 2.25 110.385 -165.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.629 ' HB ' ' OG1' ' A' ' 125' ' ' THR . 14.5 m -69.67 113.9 7.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.932 0.866 . . . . 1.91 110.819 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.633 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 55.8 m-85 -110.19 107.12 16.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.365 . . . . 3.7 111.654 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 97.5 mtt180 -75.91 137.88 40.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 3.54 110.992 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.75 125.55 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.505 -0.554 . . . . 1.14 109.505 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 92' ' ' GLN . 4.5 tt -111.57 -38.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.952 0.406 . . . . 1.68 110.973 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 91' ' ' ILE . 24.8 pt20 -164.98 158.34 16.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.7 -0.482 . . . . 1.55 109.7 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.86 140.69 24.79 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.163 -0.31 . . . . 0.86 110.163 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -135.21 157.63 46.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.412 -0.358 . . . . 0.93 110.654 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 54.6 m-85 -113.77 169.16 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 3.17 110.495 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.422 ' CG ' ' HE1' ' A' ' 244' ' ' TRP . 0.3 OUTLIER -137.63 173.1 12.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.087 -0.708 . . . . 1.68 109.087 174.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.475 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 30.8 t-105 -151.33 127.03 10.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.857 -0.423 . . . . 5.18 109.857 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -94.24 140.85 15.25 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.093 -0.575 . . . . 2.13 112.255 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 t -46.82 -43.51 18.53 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.641 0.376 . . . . 2.9 111.863 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 103' ' ' GLN . 45.1 mt -122.78 152.71 40.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.532 -0.544 . . . . 3.03 109.532 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.05 -7.4 3.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.818 -0.628 . . . . 3.85 112.187 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.76 29.56 2.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.76 . . . . 1.94 112.505 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 7.6 tp60 -159.44 139.88 12.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.925 0.363 . . . . 2.45 110.873 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.579 ' O ' ' HB2' ' A' ' 244' ' ' TRP . . . 94.57 -28.99 9.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.861 -0.685 . . . . 1.47 112.402 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.457 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 1.2 m -89.55 -17.9 27.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.469 0.176 . . . . 2.0 111.127 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 60.02 -156.75 0.34 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.388 -0.369 . . . . 3.72 110.689 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.458 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 62.6 m80 63.33 69.37 0.57 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.381 -0.6 . . . . 3.52 109.381 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.436 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 5.6 t -104.09 118.38 36.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.113 0.482 . . . . 2.52 110.53 -167.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 41.0 t -85.54 105.65 14.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.365 -0.976 . . . . 2.48 108.365 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 66.88 -71.53 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.67 0.606 . . . . 2.8 110.652 -171.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -152.05 19.12 0.67 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 4.98 110.605 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 108' ' ' THR . 13.9 mmmm -107.75 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.018 -0.537 . . . . 3.23 111.553 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.436 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 54.4 mttm -80.31 156.19 26.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.91 . . . . 2.82 108.544 171.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -93.43 -171.29 2.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.8 0.333 . . . . 1.62 111.189 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.41 -27.36 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 1.03 111.752 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 147' ' ' LEU . . . -153.25 168.74 25.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.617 0.246 . . . . 0.75 110.533 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HG2' ' CE1' ' A' ' 107' ' ' HIS . 13.7 tp10 -151.8 152.6 32.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.372 -0.603 . . . . 1.58 109.372 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 95' ' ' PHE . 38.2 tp -125.79 131.38 52.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.712 0.291 . . . . 1.07 110.963 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 107.72 14.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.77 110.705 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.1 mp -102.22 109.55 21.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.105 -0.332 . . . . 0.93 110.105 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.02 129.22 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.188 -0.46 . . . . 0.61 111.49 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 19.0 m-70 -127.39 156.32 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 2.13 109.63 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.415 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 66.1 p-90 -127.49 150.51 49.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 4.26 111.554 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 19.6 t30 -69.21 116.45 9.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.064 -0.971 . . . . 2.02 111.811 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.629 ' OG1' ' HB ' ' A' ' 87' ' ' THR . 53.2 p -63.16 -32.79 74.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.655 0.983 . . . . 2.34 113.655 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 60.9 pttt -74.28 -4.56 36.88 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.338 -0.545 . . . . 3.35 111.923 -173.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -91.42 -5.65 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.34 0.59 . . . . 3.1 109.546 170.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.9 19.32 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 115.569 0.987 . . . . 2.37 115.569 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -177.91 133.13 0.16 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.883 0.841 . . . . 3.93 109.802 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.601 ' O ' HG23 ' A' ' 134' ' ' VAL . 40.3 p90 -66.33 -42.97 87.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.633 . . . . 3.0 111.345 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.27 -33.25 86.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.108 -0.568 . . . . 2.15 112.231 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB3' ' CE1' ' A' ' 127' ' ' TYR . 98.1 mttt -74.28 -34.11 63.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.027 -0.36 . . . . 3.43 110.027 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.35 66.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 1.76 110.765 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 130' ' ' PHE . 42.0 t -63.53 -18.25 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.203 0.525 . . . . 2.77 110.761 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.68 -9.62 53.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.126 -0.359 . . . . 3.55 111.178 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 205' ' ' CYS . 48.9 tt0 -104.41 126.44 31.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.232 -0.284 . . . . 3.02 110.232 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 73.1 Cg_exo -52.79 -31.2 50.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.548 2.832 . . . . 1.6 113.12 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.4 m-20 -112.14 28.15 9.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.185 0.517 . . . . 2.29 109.848 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.03 -30.91 24.55 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.826 -0.625 . . . . 1.22 113.408 -172.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 206' ' ' VAL . 91.3 mt -112.21 157.58 20.72 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.574 -0.368 . . . . 1.57 110.3 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.57 123.16 10.45 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.814 -0.439 . . . . 1.38 109.814 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.88 129.88 71.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 116.292 -0.413 . . . . 1.73 110.012 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 209' ' ' ILE . 35.8 tp -90.99 134.24 34.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 2.42 109.835 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -115.41 145.77 18.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.069 -0.586 . . . . 0.86 112.018 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 118' ' ' LEU . 62.4 mt -142.48 122.75 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.528 -0.545 . . . . 0.76 109.528 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.458 ' CZ ' HG11 ' A' ' 210' ' ' VAL . 44.2 m-85 -73.99 141.07 45.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.694 0.283 . . . . 1.2 111.032 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 9.0 mp -119.2 121.22 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 0.88 110.041 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.82 147.74 41.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.109 -0.496 . . . . 2.03 109.798 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 62.1 t -87.07 130.16 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.901 0.381 . . . . 1.27 110.863 -174.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.11 -105.29 0.19 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.291 -0.724 . . . . 1.53 111.291 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.2 t -81.89 146.18 29.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 1.54 109.521 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.472 ' CA ' ' HB2' ' A' ' 218' ' ' SER . . . -66.62 152.12 45.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.183 0.515 . . . . 0.78 112.222 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -109.39 102.99 51.56 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.335 -0.848 . . . . 1.22 108.735 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.55 -32.93 65.99 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 123.095 2.53 . . . . 1.05 112.835 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.18 -15.95 72.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.094 -0.574 . . . . 0.7 113.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.3 tp -99.62 -9.03 23.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.346 0.593 . . . . 0.77 110.298 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -45.49 88.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.502 -0.772 . . . . 1.41 112.19 -173.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.0 ptmm? -76.68 -27.89 55.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.433 -0.507 . . . . 2.86 111.813 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.37 -40.34 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.495 -0.482 . . . . 1.38 111.316 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.494 ' HA ' ' HG ' ' A' ' 163' ' ' LEU . 34.5 m -62.45 -28.74 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.197 0.522 . . . . 1.11 110.671 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.83 -30.55 71.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.556 -0.747 . . . . 1.22 111.173 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 158' ' ' LYS . 41.2 t -89.31 -16.33 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.41 111.269 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 77.0 mt -56.05 -31.8 63.49 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.229 0.455 . . . . 1.39 112.229 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.88 -30.12 70.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.78 0.324 . . . . 2.31 111.476 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.9 m -84.46 -3.15 58.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.567 -0.288 . . . . 1.4 111.769 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 44.5 pt -132.89 29.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.528 0.68 . . . . 0.85 109.312 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -60.06 -27.66 67.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.95 -1.023 . . . . 1.59 112.075 -172.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.8 p -119.54 152.97 36.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.77 111.598 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -54.39 127.94 29.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.064 -0.971 . . . . 2.29 111.648 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.18 -22.27 31.57 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.588 -0.815 . . . . 0.85 112.849 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -78.56 139.76 38.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.159 0.504 . . . . 1.7 111.307 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB2' HD13 ' A' ' 60' ' ' LEU . 27.4 t -127.06 146.56 50.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.178 -0.919 . . . . 1.37 109.39 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.38 127.08 23.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.438 -0.346 . . . . 0.61 110.08 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.7 132.03 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.501 . . . . 1.8 110.45 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.89 80.99 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.845 -0.616 . . . . 1.04 109.596 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 p -102.81 161.16 13.97 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.116 -0.493 . . . . 1.17 111.824 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 12.9 m120 57.04 66.71 1.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.569 -0.742 . . . . 1.77 111.546 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -119.86 139.18 52.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 3.99 110.191 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.509 ' OD1' ' HB3' ' A' ' 181' ' ' ARG . 17.1 t0 -102.0 106.77 49.45 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 2.51 110.938 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.48 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 23.6 Cg_exo -64.81 -15.08 48.5 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.008 2.472 . . . . 1.26 111.924 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.509 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 29.2 ttp180 -68.78 -21.88 64.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.655 -0.702 . . . . 2.76 110.345 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -77.67 -8.8 87.18 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.774 -0.726 . . . . 1.12 111.855 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 97.0 mt -106.11 -18.26 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.997 0.427 . . . . 1.73 109.884 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 83.3 mt -73.28 126.34 90.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 3.45 110.028 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 59.8 Cg_endo -69.73 -176.28 1.43 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.438 2.758 . . . . 2.08 113.637 -173.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.77 -50.48 64.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.297 -0.411 . . . . 3.23 111.879 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 15.4 m -88.68 136.79 32.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.75 0.31 . . . . 1.66 110.367 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.2 tp -106.09 64.73 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.706 . . . . 1.99 109.893 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.41 -176.32 3.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.953 -1.128 . . . . 1.81 107.953 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -163.52 154.33 16.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.886 0.766 . . . . 5.01 112.855 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -115.29 146.6 41.34 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.827 -1.175 . . . . 3.93 107.827 170.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -108.71 126.84 53.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.096 0.474 . . . . 2.13 111.126 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -133.17 154.08 81.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 5.21 109.989 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.31 129.82 15.45 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.404 2.069 . . . . 2.12 111.77 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -101.79 97.48 1.61 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.792 -0.718 . . . . 1.75 111.455 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 15.7 m -83.17 -140.48 0.06 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.91 0.707 . . . . 2.99 112.91 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.588 ' C ' ' H ' ' A' ' 199' ' ' THR . 4.6 pp -50.24 12.73 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 117.029 2.233 . . . . 4.75 117.029 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.411 HG23 HG21 ' A' ' 206' ' ' VAL . 9.8 t -66.79 29.91 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.0 0.905 . . . . 5.1 111.039 174.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.588 ' H ' ' C ' ' A' ' 197' ' ' LEU . 24.2 p -124.18 156.5 66.42 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-N 114.823 -1.08 . . . . 5.53 110.159 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.5 -54.51 5.05 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.222 1.948 . . . . 5.83 114.032 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.58 26.08 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.548 2.165 . . . . 4.78 113.442 -174.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.2 tt 47.25 78.65 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.631 0.772 . . . . 3.84 111.758 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.653 HD13 ' SG ' ' A' ' 205' ' ' CYS . 1.9 pp -152.49 150.06 29.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.176 -0.466 . . . . 2.96 111.659 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 196' ' ' SER . 7.9 pt-20 -87.79 92.67 9.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.555 0.693 . . . . 3.37 111.083 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.653 ' SG ' HD13 ' A' ' 203' ' ' LEU . 93.9 m -138.83 32.84 2.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.804 -0.635 . . . . 2.15 110.709 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 140' ' ' LEU . 95.3 t -125.63 149.05 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.732 -0.667 . . . . 1.26 111.187 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.1 m -111.68 107.12 16.12 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.083 -1.08 . . . . 2.08 108.083 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -89.23 115.65 26.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.153 0.501 . . . . 5.53 110.333 -174.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.524 ' O ' HD12 ' A' ' 143' ' ' LEU . 63.5 mt -114.57 116.59 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.603 -0.726 . . . . 1.63 109.68 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.458 HG11 ' CZ ' ' A' ' 146' ' ' PHE . 24.3 t -109.71 129.8 63.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.253 -0.277 . . . . 1.62 110.253 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.73 126.44 29.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.818 0.342 . . . . 1.73 110.555 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -47.5 -24.16 0.78 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.561 0.948 . . . . 2.98 113.561 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 8.6 tp10 -106.81 123.7 37.76 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.644 0.259 . . . . 1.47 110.569 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 89.9 Cg_endo -81.77 158.63 18.77 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.671 2.248 . . . . 0.96 112.01 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 41.7 pt -113.97 154.35 15.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.844 0.354 . . . . 1.25 110.326 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.3 m -104.17 130.43 51.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.844 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 18.6 m -125.34 151.17 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.058 -0.719 . . . . 1.02 109.058 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.472 ' HB2' ' CA ' ' A' ' 152' ' ' ALA . 7.5 t -95.2 161.23 14.2 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.449 -0.501 . . . . 1.08 111.164 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.69 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 3.1 p -52.55 -47.18 66.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.32 -0.4 . . . . 1.33 111.658 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -52.6 -33.93 48.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.983 0.421 . . . . 2.51 111.382 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -78.48 -50.68 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 0.7 110.517 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.475 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 27.2 m -67.67 -23.53 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 1.36 111.653 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 219' ' ' SER . 84.7 mt -61.31 -33.39 73.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 1.03 110.717 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -74.76 -23.26 58.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 1.75 110.843 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 29.5 m-85 -68.88 -39.58 79.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.231 0.539 . . . . 2.47 109.802 174.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -76.08 -2.03 28.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.419 -0.81 . . . . 3.04 110.825 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 34.3 mmtp -91.88 -12.62 33.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.409 -0.359 . . . . 2.31 110.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 163' ' ' LEU . 90.4 mt -73.03 151.4 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 0.95 110.731 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.585 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 9.4 m120 -123.69 127.26 47.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.821 -0.627 . . . . 1.13 110.259 -175.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 65.4 m-85 -57.94 -33.62 69.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.767 -0.652 . . . . 3.74 111.004 173.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -72.69 164.19 26.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 1.62 111.884 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.73 171.75 43.56 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.536 -0.756 . . . . 1.16 111.309 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.91 123.27 17.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.994 0.426 . . . . 3.56 110.645 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 91.05 25.1 25.4 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.807 -0.633 . . . . 2.08 112.52 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 62.2 mt-10 -124.55 161.85 45.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.036 -0.357 . . . . 2.59 110.036 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 9.9 Cg_endo -52.15 123.06 11.74 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.164 2.576 . . . . 1.36 112.411 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.15 113.72 1.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.477 -0.783 . . . . 3.4 112.275 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -115.99 102.88 10.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.804 -0.813 . . . . 2.47 108.804 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.34 138.02 56.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.166 0.508 . . . . 2.14 111.332 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.637 ' HA ' ' CE1' ' A' ' 230' ' ' PHE . 50.4 ttm -79.1 90.77 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.166 -0.925 . . . . 1.68 110.54 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.9 m -124.44 153.31 30.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.19 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.477 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 76.7 m-20 72.04 -80.24 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.133 0.896 . . . . 2.18 109.678 -176.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 56.34 27.72 12.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.073 0.463 . . . . 2.15 111.393 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.579 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 26.8 m95 -142.37 156.67 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 4.59 110.597 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.658 ' NH2' ' HA3' ' A' ' 12' ' ' GLY . 16.1 mmm180 -106.4 137.75 19.52 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.477 -0.783 . . . . 6.13 109.803 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.86 146.14 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.069 3.179 . . . . 3.28 113.667 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.36 151.48 46.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.068 -0.969 . . . . 2.98 110.781 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.542 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 86.9 mm-40 -94.76 170.6 7.8 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.473 -0.785 . . . . 4.32 110.079 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 74.8 Cg_exo -44.05 143.21 3.4 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.415 2.076 . . . . 3.48 112.461 176.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 32' ' ' ASP . 3.3 tm? -76.54 -38.45 55.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.03 -0.986 . . . . 4.63 109.749 -169.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 253' ' ' ARG . 21.0 pttm -64.88 -14.8 60.79 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 115.209 1.559 . . . . 5.34 115.209 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.5 t30 24.58 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.783 2.512 . . . . 4.64 117.783 151.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 251' ' ' LYS . 15.5 tpp180 166.28 -125.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.912 -1.514 . . . . 6.11 106.912 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -127.48 133.95 49.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 3.08 109.88 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.6 131.06 35.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.83 -0.433 . . . . 2.6 109.83 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -120.7 133.21 55.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.115 -0.493 . . . . 2.63 110.898 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -143.82 129.41 19.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.246 -0.649 . . . . 1.71 109.246 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 p -92.23 97.6 10.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.827 -0.749 . . . . 2.21 111.172 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -126.01 92.4 3.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.683 0.754 . . . . 4.31 110.259 167.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.346 -0.843 . . . . 4.49 110.259 178.931 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.958 0.409 . . . . 17.49 110.572 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p -120.16 122.4 40.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.855 -0.611 . . . . 15.32 110.304 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -114.94 96.44 5.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.087 -0.506 . . . . 15.81 110.193 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -155.37 177.6 11.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.013 -0.539 . . . . 14.19 109.994 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 63.41 119.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.846 0.716 . . . . 14.91 111.796 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 12' ' ' GLY . . . -172.92 155.17 22.38 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.578 -0.82 . . . . 10.79 112.215 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -82.11 102.04 10.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.499 0.666 . . . . 11.39 110.479 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.16 -88.02 0.18 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.933 -1.031 . . . . 9.0 110.618 -175.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 18.4 tptm -90.5 158.81 16.84 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.725 -1.213 . . . . 9.76 107.725 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -72.22 -5.57 36.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.839 0.352 . . . . 11.19 111.661 -173.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -124.69 15.84 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.9 -0.591 . . . . 10.8 109.538 174.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 6' ' ' GLY . . . 91.98 131.82 5.51 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.405 -1.078 . . . . 8.82 110.405 -172.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 20.5 Cg_endo -62.4 118.77 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 CA-C-N 119.069 1.434 . . . . 7.87 111.932 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 36.9 mt-10 -89.08 -3.59 58.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.223 -0.899 . . . . 10.62 110.828 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -59.65 -38.21 80.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 9.87 110.224 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -45.16 -54.47 6.82 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.814 -0.63 . . . . 8.48 112.207 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -78.54 -34.25 47.29 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.19 -0.319 . . . . 7.13 111.741 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 57.8 mtpt -62.02 -42.04 98.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.84 0.352 . . . . 9.68 111.227 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.34 -25.23 17.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.33 -0.395 . . . . 7.89 111.577 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' HB3' HG22 ' A' ' 22' ' ' ILE . 79.2 m-85 -131.42 93.88 28.0 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.819 0.342 . . . . 7.17 110.33 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 -25.95 51.22 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.926 2.417 . . . . 7.76 112.213 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.411 HG22 ' HB3' ' A' ' 20' ' ' PHE . 14.4 tt -60.23 -17.64 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 115.421 -0.809 . . . . 5.83 111.936 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 202' ' ' LEU . . . -56.51 -30.07 62.59 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.167 0.432 . . . . 5.44 112.167 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -91.44 26.82 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.704 0.288 . . . . 7.78 111.44 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.44 158.31 51.16 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.621 -0.992 . . . . 5.01 110.621 172.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 33.4 tt0 -107.9 112.67 25.4 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.243 -0.983 . . . . 7.09 110.707 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 26' ' ' GLU . 29.7 mmt180 -142.28 177.09 8.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.736 -1.209 . . . . 5.13 107.736 167.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . 29.0 tt0 -66.11 87.54 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.307 0.575 . . . . 7.12 109.593 172.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 31' ' ' VAL . 23.3 t -47.33 144.66 4.32 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.542 -1.208 . . . . 3.94 111.956 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 46.0 Cg_endo -67.47 25.69 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.022 3.148 . . . . 4.52 113.761 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 33' ' ' ILE . 34.5 m -94.91 -173.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.252 -0.431 . . . . 4.54 110.363 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.564 ' HB3' HD11 ' A' ' 250' ' ' LEU . 24.2 t70 -52.59 114.2 1.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.054 0.93 . . . . 2.88 111.647 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 31' ' ' VAL . 85.4 mt -102.82 141.79 18.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.33 -1.305 . . . . 2.32 109.918 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 19.3 t70 -120.93 121.62 38.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.827 0.346 . . . . 2.82 110.166 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -69.07 -28.77 66.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 2.24 112.054 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 35.1 m80 -60.54 -43.35 97.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.324 0.583 . . . . 4.54 110.314 173.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -71.98 -21.42 61.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.288 -0.869 . . . . 3.06 110.007 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' A' ' 257' ' ' ALA . . . -74.82 98.78 3.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.5 -0.773 . . . . 1.72 110.55 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -72.11 126.33 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.941 -0.572 . . . . 3.69 109.653 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 51.1 p90 -82.64 131.49 35.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 4.64 110.336 -172.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.14 138.74 26.57 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.821 -0.627 . . . . 2.27 110.005 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.81 13.2 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.223 2.615 . . . . 2.15 114.064 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -60.45 -52.48 65.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 4.29 109.899 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.1 mt 53.08 13.78 0.41 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.583 0.957 . . . . 4.74 113.583 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HD3' ' HD2' ' A' ' 46' ' ' PRO . 16.2 tppt? -56.72 111.55 3.44 Favored Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 123.408 0.443 . . . . 3.77 111.887 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 84.9 Cg_endo -87.33 157.3 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.919 2.413 . . . . 2.36 111.99 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -83.1 154.48 24.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.047 -0.524 . . . . 2.55 110.369 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 38.5 t -129.62 131.02 46.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.295 -0.631 . . . . 2.38 109.295 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.89 137.37 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 1.59 111.433 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 47.7 m -127.75 90.94 3.19 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.033 -0.728 . . . . 1.45 109.033 171.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -133.03 16.42 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.879 -0.328 . . . . 3.62 111.883 -176.115 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.14 -22.04 64.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.966 0.413 . . . . 2.48 110.951 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.03 3.72 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 2.24 111.228 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.84 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.187 0.517 . . . . 0.8 111.853 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.8 m -98.62 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.064 -0.516 . . . . 1.06 110.506 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 5.3 p -81.24 149.67 28.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 1.26 110.494 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.1 mt -115.85 -49.71 2.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.071 0.462 . . . . 0.74 110.844 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -160.59 161.96 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.026 -0.534 . . . . 3.17 110.726 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.09 133.75 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.941 -0.762 . . . . 0.64 108.941 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 171' ' ' LYS . 53.3 tp -129.34 131.21 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.975 0.417 . . . . 0.96 111.408 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -80.81 109.3 15.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.742 -0.663 . . . . 1.49 109.355 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.91 68.89 0.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.968 0.413 . . . . 1.83 110.166 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.33 -53.58 0.09 OUTLIER Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.279 -1.328 . . . . 1.64 115.208 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -110.1 -19.86 12.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.788 0.328 . . . . 3.33 111.32 -169.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.96 177.61 10.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 1.38 110.247 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.705 ' CE1' HD13 ' A' ' 228' ' ' LEU . 29.2 m-85 -117.38 112.84 21.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.304 -0.628 . . . . 2.74 109.304 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.4 m120 -90.72 105.2 17.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.47 . . . . 1.76 110.783 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 60.1 t -82.26 105.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.752 -0.833 . . . . 1.15 108.752 171.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.12 132.47 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.016 -0.538 . . . . 2.02 111.084 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 75.8 m-85 -112.02 155.74 23.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.462 -0.79 . . . . 1.66 109.032 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.14 110.39 15.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.933 0.397 . . . . 1.33 110.559 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -107.06 55.18 0.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.712 0.768 . . . . 2.65 109.939 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -96.94 -5.85 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.758 . . . . 1.61 110.771 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -154.03 166.63 32.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.372 -0.831 . . . . 2.35 109.18 178.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.91 36.74 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.36 0.504 . . . . 1.92 112.36 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 92.6 mttt -55.48 -63.58 1.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.246 -0.434 . . . . 1.77 110.656 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -103.55 115.96 31.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.872 -0.604 . . . . 0.76 110.341 -177.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.9 t -134.51 141.96 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.808 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.6 tp -105.61 128.33 53.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.338 -0.616 . . . . 1.29 109.338 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 55.8 mtpt -119.92 124.76 46.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.244 0.545 . . . . 2.54 110.24 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.77 170.99 19.83 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.789 -0.924 . . . . 1.31 110.789 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.71 -148.95 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 O-C-N 123.657 0.269 . . . . 1.9 113.539 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.43 119.03 5.26 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 121.569 1.512 . . . . 2.91 112.451 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -159.66 -171.14 3.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.078 -0.965 . . . . 4.11 108.938 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -132.89 76.95 1.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.751 -0.38 . . . . 4.95 111.714 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.7 -178.68 17.29 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.247 -0.977 . . . . 2.25 114.206 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 m -105.76 120.1 40.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.859 -0.671 . . . . 1.91 109.363 176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 32.2 m-85 -105.41 104.79 14.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 3.7 111.436 -171.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 99.4 mtt180 -75.37 152.62 38.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.099 -0.5 . . . . 3.54 110.314 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.9 120.43 24.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.974 -0.38 . . . . 1.14 109.974 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.0 tt -110.26 -34.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.447 -0.342 . . . . 1.68 111.02 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 7.2 pt20 -173.86 174.52 3.04 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.661 -0.496 . . . . 1.55 109.661 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 20.4 p90 -147.09 161.65 40.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.861 -0.336 . . . . 0.86 111.02 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.7 p-80 -147.46 160.11 42.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -125.11 172.79 9.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.774 0.321 . . . . 3.17 110.899 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -127.24 117.14 21.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.712 -1.218 . . . . 1.68 107.712 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.58 ' NE1' ' HA ' ' A' ' 99' ' ' SER . 60.3 t-105 -101.49 112.33 24.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.778 0.323 . . . . 5.18 110.694 -173.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -63.32 -39.07 97.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.629 -0.714 . . . . 2.13 112.497 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.58 ' HA ' ' NE1' ' A' ' 97' ' ' TRP . 32.5 t 91.56 -17.92 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.266 1.026 . . . . 2.9 110.178 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 92.4 mt -112.57 137.85 50.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.134 -1.062 . . . . 3.03 108.134 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.21 -24.96 65.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.652 0.982 . . . . 3.85 113.652 -168.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.99 7.53 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.914 -1.136 . . . . 1.94 113.863 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.425 ' HG3' ' HB2' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -165.99 152.58 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.383 0.591 . . . . 2.45 111.023 176.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.484 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 122.89 -27.27 5.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.64 -0.791 . . . . 1.47 112.692 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 114' ' ' TYR . 39.2 t -71.29 -46.98 59.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.464 0.172 . . . . 2.0 111.464 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 11.1 mm-40 61.46 -172.66 0.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.937 0.347 . . . . 3.72 111.937 -177.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.9 m80 56.48 30.21 16.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.957 0.884 . . . . 3.52 108.664 -166.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 108' ' ' THR . 2.0 t -83.13 153.6 24.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.997 -1.456 . . . . 2.52 113.122 -169.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.0 m -101.52 93.45 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.397 -0.82 . . . . 2.48 111.382 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.64 71.55 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.039 -0.982 . . . . 2.8 111.329 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 59.41 21.29 9.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.091 -0.958 . . . . 4.98 113.417 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -97.82 73.55 2.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.332 -0.618 . . . . 3.23 109.332 172.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.9 150.9 23.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.279 -0.418 . . . . 2.82 109.97 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 105' ' ' SER . 76.6 m-85 -110.71 -173.79 2.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.751 -0.462 . . . . 1.62 109.751 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.9 -38.97 69.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.623 0.601 . . . . 1.03 112.623 -172.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.53 169.02 17.65 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.929 -0.308 . . . . 0.75 111.527 -170.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -136.17 140.07 43.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.612 -0.722 . . . . 1.58 109.107 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.5 tp -109.63 133.67 52.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 1.07 110.245 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.477 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 39.8 m170 -120.38 106.1 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 1.77 110.684 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.3 mp -86.83 114.92 23.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.757 -0.46 . . . . 0.93 109.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.03 134.14 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.225 0.536 . . . . 0.61 110.571 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.547 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 77.9 m80 -119.68 150.82 39.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 2.13 111.521 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -110.17 123.84 50.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.819 -1.082 . . . . 4.26 110.008 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 40.5 t-20 -79.37 117.99 20.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.113 -0.494 . . . . 2.02 110.426 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -73.93 -32.21 63.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.17 -0.468 . . . . 2.34 112.193 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 19.6 ptmt -63.24 -25.19 68.21 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.112 0.412 . . . . 3.35 112.112 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.38 -11.87 31.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.906 0.384 . . . . 3.1 111.136 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.74 26.11 3.85 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.123 -0.944 . . . . 2.37 113.687 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -176.31 115.29 0.12 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.793 -0.447 . . . . 3.93 109.793 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 134' ' ' VAL . 50.8 p90 -57.81 -36.24 71.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 3.0 111.677 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.55 -44.9 96.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.875 -0.678 . . . . 2.15 112.444 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -64.4 -36.21 83.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.21 0.529 . . . . 3.43 109.984 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 139' ' ' GLY . . . -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 1.76 111.303 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 130' ' ' PHE . 72.0 t -61.73 -22.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.028 0.442 . . . . 2.77 111.083 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -77.0 -0.81 25.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 3.55 111.414 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.492 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 46.5 tt0 -126.26 131.77 24.07 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.79 -0.448 . . . . 3.02 109.79 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.17 -18.19 50.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.897 2.398 . . . . 1.6 112.76 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.492 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 13.1 m-20 -113.91 17.63 17.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.174 -0.676 . . . . 2.29 109.174 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.412 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -83.24 -11.23 81.11 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.437 -0.802 . . . . 1.22 113.934 -168.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.594 ' C ' HG12 ' A' ' 206' ' ' VAL . 80.1 mt -146.48 172.19 13.91 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.269 -0.271 . . . . 1.57 110.269 -175.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -156.94 121.34 4.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.363 -0.38 . . . . 1.38 110.671 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.51 ' O ' HG21 ' A' ' 209' ' ' ILE . 33.6 m -97.95 165.86 2.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 N-CA-C 108.637 -0.875 . . . . 1.73 108.637 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.5 tp -116.45 114.71 24.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.774 -0.454 . . . . 2.42 109.774 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -97.16 117.27 5.73 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.047 -0.597 . . . . 0.86 112.689 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.9 mt -118.87 127.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.306 -0.257 . . . . 0.76 110.306 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -78.4 147.22 34.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.366 -0.235 . . . . 1.2 110.366 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 8.1 mp -117.7 124.47 48.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.88 111.145 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -116.56 144.91 43.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.322 -0.622 . . . . 2.03 109.322 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 11.2 t -88.05 130.38 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.894 0.378 . . . . 1.27 110.356 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.09 -114.88 0.4 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.414 -0.674 . . . . 1.53 111.414 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.3 t -81.99 156.37 24.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.489 -0.56 . . . . 1.54 109.489 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.417 ' N ' ' HB2' ' A' ' 218' ' ' SER . . . -78.02 148.6 34.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 0.78 111.098 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 183' ' ' LEU . 82.5 tttt -113.19 110.4 51.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.771 -0.455 . . . . 1.22 109.771 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.5 -38.66 90.05 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.708 2.939 . . . . 1.05 113.565 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.3 -19.84 64.65 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.115 -0.564 . . . . 0.7 112.899 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -95.56 -16.56 22.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.025 0.44 . . . . 0.77 110.336 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -46.12 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.761 -0.654 . . . . 1.41 111.162 -173.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.29 -36.73 66.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.873 0.323 . . . . 2.86 111.873 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.12 -42.67 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.077 0.465 . . . . 1.38 110.556 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 156' ' ' LEU . 24.4 t -67.27 -29.73 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 1.11 110.811 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.21 -35.82 61.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.224 -0.444 . . . . 1.22 111.698 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.93 -19.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.654 0.264 . . . . 1.41 111.546 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 228' ' ' LEU . 3.4 pp -74.71 -12.79 60.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.947 -0.301 . . . . 1.39 111.501 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.06 -31.08 69.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.947 0.403 . . . . 2.31 111.081 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.3 m -87.57 1.55 53.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.328 0.492 . . . . 1.4 112.328 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.6 pt -139.74 39.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.563 0.697 . . . . 0.85 110.598 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.606 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 84.8 tttt -54.0 -31.68 51.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.672 -1.149 . . . . 1.59 112.688 -176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -111.65 150.17 30.51 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.196 0.522 . . . . 0.77 111.959 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -58.31 128.16 35.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.388 -0.824 . . . . 2.29 111.502 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.65 -18.83 19.6 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.578 -0.82 . . . . 0.85 112.537 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.404 ' O ' HD12 ' A' ' 60' ' ' LEU . 67.4 mttm -87.52 149.12 24.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.362 0.601 . . . . 1.7 111.215 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.5 p -134.96 157.26 47.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.053 -0.976 . . . . 1.37 109.702 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.81 139.05 29.13 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.153 -0.314 . . . . 0.61 110.153 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.55 135.04 48.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.623 -0.51 . . . . 1.8 109.623 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 178' ' ' PHE . 22.8 t80 -136.23 81.46 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.242 0.544 . . . . 1.04 109.812 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.0 m -79.97 138.6 37.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.664 -0.698 . . . . 1.17 112.32 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 52.34 76.09 0.2 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.105 -0.952 . . . . 1.77 113.281 169.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 52.0 t80 -92.13 137.52 32.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.758 -0.46 . . . . 3.99 109.758 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -105.09 94.58 8.0 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.4 0.619 . . . . 2.51 110.94 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 12.3 Cg_exo -71.83 -9.49 24.88 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.653 2.235 . . . . 1.26 112.321 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -49.81 -39.54 38.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.196 0.522 . . . . 2.76 110.87 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -56.23 -26.98 51.57 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.281 -0.872 . . . . 1.12 113.061 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 153' ' ' LYS . 90.2 mt -76.63 -29.65 56.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.73 112.571 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.402 ' HB2' ' HD3' ' A' ' 185' ' ' PRO . 85.9 mt -33.14 -47.73 0.58 Allowed Pre-proline 0 N--CA 1.483 1.185 0 N-CA-C 116.237 1.939 . . . . 3.45 116.237 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 184' ' ' LEU . 14.1 Cg_exo -71.73 48.89 1.12 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.556 1.504 . . . . 2.08 114.029 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 187' ' ' SER . 0.0 OUTLIER -109.45 -6.19 15.53 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.998 -0.439 . . . . 3.23 111.766 173.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.477 ' OG ' ' HE2' ' A' ' 212' ' ' LYS . 46.1 t 72.84 128.43 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.782 0.676 . . . . 1.66 111.038 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.503 ' HA ' HD22 ' A' ' 211' ' ' LEU . 96.0 mt -113.81 59.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.395 -0.366 . . . . 1.99 110.174 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -144.43 153.08 41.54 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.997 -0.742 . . . . 1.81 108.997 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.468 ' HB3' ' HB ' ' A' ' 210' ' ' VAL . 0.1 OUTLIER 171.58 -168.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.121 -1.066 . . . . 5.01 108.121 -178.546 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.61 ' HB3' ' HA ' ' A' ' 257' ' ' ALA . 1.5 p90 -75.87 147.97 38.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.09 0.472 . . . . 3.93 110.265 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.3 t -107.28 75.91 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.8 0.81 . . . . 2.13 110.811 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.471 ' CD1' ' HB2' ' A' ' 28' ' ' GLN . 20.8 t80 -138.43 138.5 22.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.635 -0.711 . . . . 5.21 110.057 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HA ' ' OG1' ' A' ' 207' ' ' THR . 33.0 Cg_endo -64.7 130.29 25.91 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.728 2.285 . . . . 2.12 112.832 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -125.29 142.85 14.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.862 -0.608 . . . . 1.75 112.12 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m -65.3 130.81 44.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.579 0.704 . . . . 2.99 112.405 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.451 ' HG ' HG23 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -95.92 16.86 16.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.523 -1.217 . . . . 4.75 109.857 176.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.7 p -62.95 32.55 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.279 1.432 . . . . 5.1 114.47 -170.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.592 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 6.6 p -77.46 -177.71 0.86 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 118.838 -0.601 . . . . 5.53 109.472 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.592 ' HD2' ' HB ' ' A' ' 199' ' ' THR . 2.7 Cg_exo -37.31 -46.41 1.62 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.704 2.269 . . . . 5.83 113.174 169.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 8.3 Cg_exo -76.4 95.56 1.05 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.516 1.477 . . . . 4.78 109.388 161.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 23' ' ' ALA . 18.3 tp -87.08 43.46 1.1 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 3.84 111.943 -166.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 52.9 tp -87.5 117.51 26.34 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.573 -0.451 . . . . 2.96 110.744 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -104.25 51.3 0.78 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 3.37 110.352 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 62.2 m -135.69 11.74 3.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.436 -0.802 . . . . 2.15 110.412 -176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.594 HG12 ' C ' ' A' ' 140' ' ' LEU . 15.9 m -136.23 100.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 1.26 110.46 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 194' ' ' PRO . 1.4 t -151.21 89.8 1.54 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 115.358 1.614 . . . . 2.08 115.358 170.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.504 ' O ' HG23 ' A' ' 209' ' ' ILE . 0.1 OUTLIER -151.96 85.5 1.29 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.569 -0.707 . . . . 5.53 109.322 143.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -163.16 98.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.177 0.436 . . . . 1.63 112.177 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.11 136.61 59.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.469 -0.769 . . . . 1.62 109.893 165.338 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 188' ' ' LEU . 51.6 mt -114.1 123.19 49.05 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 1.73 110.631 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.477 ' HE2' ' OG ' ' A' ' 187' ' ' SER . 62.3 pttt -67.62 -36.77 81.44 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.122 0.415 . . . . 2.98 112.122 -174.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 212' ' ' LYS . 25.0 mm-40 -99.14 117.21 64.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 1.47 111.166 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.65 148.25 58.89 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.525 2.15 . . . . 0.96 111.134 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -79.45 147.26 6.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 1.25 109.62 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.1 t -89.9 116.4 27.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.003 -0.544 . . . . 1.29 110.577 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -119.37 135.69 58.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.586 -0.894 . . . . 1.02 108.586 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 152' ' ' ALA . 13.2 t -96.95 170.43 9.16 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.992 -0.442 . . . . 1.08 111.502 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.58 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 11.0 p -51.48 -53.03 41.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.367 0.506 . . . . 1.33 112.367 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.47 -40.14 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 2.51 111.099 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -68.87 -51.08 44.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.966 -0.561 . . . . 0.7 110.071 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.9 m -69.25 -20.71 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 111.912 0.338 . . . . 1.36 111.912 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 219' ' ' SER . 57.9 mt -61.87 -42.41 99.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.019 0.437 . . . . 1.03 109.907 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.683 ' O ' ' HG ' ' A' ' 228' ' ' LEU . 62.5 mttm -66.62 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.511 -0.768 . . . . 1.75 110.865 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -73.23 -31.14 63.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.216 0.532 . . . . 2.47 110.496 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.439 ' HE ' ' HB2' ' A' ' 226' ' ' ARG . 5.7 ttm180 -83.35 -13.86 54.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.684 -0.689 . . . . 3.04 110.89 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -2.35 32.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.205 -0.452 . . . . 2.31 111.294 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.705 HD13 ' CE1' ' A' ' 66' ' ' PHE . 90.7 mt -73.62 152.43 40.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.064 0.459 . . . . 0.95 110.952 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.606 ' OD1' ' HE2' ' A' ' 167' ' ' LYS . 11.9 m120 -111.22 141.48 44.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.408 0.623 . . . . 1.13 111.037 -174.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.77 -31.47 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.731 -1.122 . . . . 3.74 108.815 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.8 p-10 -72.83 165.21 25.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.506 -1.224 . . . . 1.62 112.208 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.09 174.41 45.61 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.915 -1.039 . . . . 1.16 110.814 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.5 133.07 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.832 -0.433 . . . . 3.56 109.832 -176.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.26 3.84 88.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.694 -0.765 . . . . 2.08 113.27 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 32.6 mt-10 -98.66 164.34 17.18 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.657 -0.498 . . . . 2.59 109.657 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.44 126.51 22.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 1.36 111.571 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.51 109.34 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.647 -0.706 . . . . 3.4 111.763 -172.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -125.59 122.15 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.41 -0.814 . . . . 2.47 110.193 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.58 149.42 49.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.773 -0.649 . . . . 2.14 111.116 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 mtt -73.0 102.55 3.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 1.68 109.352 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.87 133.47 68.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 1.27 111.505 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.476 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 17.6 t70 63.62 -80.02 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.3 -0.864 . . . . 2.18 111.211 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 56.36 33.68 22.8 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.818 0.447 . . . . 2.15 111.804 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -125.35 144.75 50.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.468 -0.568 . . . . 4.59 109.468 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 0.1 OUTLIER -67.62 147.25 98.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.044 -0.525 . . . . 6.13 111.358 -178.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.594 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 61.1 Cg_exo -53.17 153.26 16.8 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.443 2.762 . . . . 3.28 112.348 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 118.57 16.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.317 -0.401 . . . . 2.98 111.585 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.55 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 48.6 mt-30 -68.89 171.44 6.37 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.771 -0.65 . . . . 4.32 109.684 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 66.1 Cg_exo -42.26 123.2 2.57 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.386 2.058 . . . . 3.48 111.853 173.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -55.96 -52.87 62.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.571 -0.74 . . . . 4.63 111.836 -163.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 253' ' ' ARG . 18.8 ptpt -62.21 -10.95 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.865 1.061 . . . . 5.34 113.865 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 10.4 p30 48.9 -42.59 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.887 2.551 . . . . 4.64 117.887 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 251' ' ' LYS . 20.0 ttt180 168.74 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.485 -0.931 . . . . 6.11 108.485 -164.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -129.33 136.12 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.063 -0.717 . . . . 3.08 109.063 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.457 HD13 HG23 ' A' ' 33' ' ' ILE . 36.1 mt -99.66 142.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.246 -0.279 . . . . 2.6 110.246 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -132.46 159.1 40.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.596 -0.275 . . . . 2.63 110.348 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.61 ' HA ' ' HB3' ' A' ' 191' ' ' TRP . . . -130.57 157.7 42.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 1.71 110.971 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 191' ' ' TRP . 14.0 p -163.91 98.31 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.387 . . . . 2.21 110.275 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -162.08 150.13 14.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.39 -0.368 . . . . 4.31 110.374 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.38 -0.819 . . . . 4.49 109.673 -177.817 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.627 0.251 . . . . 17.49 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 p -89.19 -30.78 18.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.969 0.414 . . . . 15.32 110.872 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -97.54 175.87 6.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.17 -0.468 . . . . 15.81 110.279 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -135.92 4.81 3.04 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.272 0.471 . . . . 14.19 112.272 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -176.01 134.12 0.26 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.227 0.536 . . . . 14.91 111.642 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.549 ' O ' ' HA2' ' A' ' 12' ' ' GLY . . . -146.64 128.86 3.13 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.309 -1.116 . . . . 10.79 110.309 170.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -68.73 117.9 11.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.883 0.342 . . . . 11.39 110.951 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.65 -113.26 0.29 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.884 -0.674 . . . . 9.0 112.513 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -79.55 138.5 37.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.763 0.316 . . . . 9.76 111.091 -176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 65.23 -100.45 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.435 -0.802 . . . . 11.19 110.087 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -126.8 -15.15 5.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.116 0.484 . . . . 10.8 110.652 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 6' ' ' GLY . . . 179.16 -112.05 0.35 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.954 -0.641 . . . . 8.82 111.977 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' O ' ' HE3' ' A' ' 16' ' ' TRP . 6.2 Cg_exo -78.58 157.49 28.53 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.622 2.215 . . . . 7.87 111.543 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.89 -17.44 35.53 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.605 0.717 . . . . 10.62 109.461 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -90.27 29.92 1.19 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.754 -1.112 . . . . 9.87 109.724 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' HE3' ' O ' ' A' ' 13' ' ' PRO . 7.2 p90 -61.03 -12.01 10.23 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.815 -0.63 . . . . 8.48 112.015 -170.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -66.05 -48.66 70.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.096 -0.502 . . . . 7.13 109.82 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.8 ttmm -92.33 -52.57 4.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.107 -0.497 . . . . 9.68 111.327 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -81.21 16.42 1.59 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.553 1.316 . . . . 7.89 114.553 -168.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -152.42 91.18 3.62 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 119.156 -1.018 . . . . 7.17 109.435 -171.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' O ' HD21 ' A' ' 202' ' ' LEU . 58.0 Cg_endo -71.48 64.77 2.92 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.031 2.488 . . . . 7.76 113.538 -173.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 tp -173.08 -32.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.068 -0.515 . . . . 5.83 110.926 173.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.72 33.23 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 5.44 111.542 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -95.64 -26.66 15.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.705 0.764 . . . . 7.78 109.007 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.39 176.79 19.66 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 109.531 -1.428 . . . . 5.01 109.531 170.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -111.73 111.23 22.06 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 118.59 -1.244 . . . . 7.09 109.548 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HG3' ' CB ' ' A' ' 204' ' ' GLU . 24.6 mmt180 -149.51 176.33 10.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.351 -0.611 . . . . 5.13 109.351 168.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.536 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . 27.3 tt0 -45.93 103.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.617 0.722 . . . . 7.12 112.045 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.603 ' HB2' HG13 ' A' ' 31' ' ' VAL . 49.7 m -93.02 166.63 15.95 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.844 -1.071 . . . . 3.94 109.939 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HG2' HE22 ' A' ' 248' ' ' GLN . 10.0 Cg_endo -52.7 31.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 125.198 3.932 . . . . 4.52 115.042 170.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.659 HG12 ' HB2' ' A' ' 248' ' ' GLN . 3.8 m -93.81 -171.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 122.971 0.508 . . . . 4.54 109.756 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 27.6 t70 -110.54 140.33 44.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.547 0.213 . . . . 2.88 111.007 -167.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' HB ' HG12 ' A' ' 109' ' ' VAL . 50.8 mt -85.49 135.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 116.353 -0.385 . . . . 2.32 110.626 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -105.82 111.46 24.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.744 -0.465 . . . . 2.82 109.744 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.5 p -60.61 -27.24 67.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.037 -0.529 . . . . 2.24 112.321 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -66.56 -45.7 78.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 4.54 110.818 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 m -78.74 -25.9 44.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 3.06 110.667 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.12 116.93 3.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.129 0.49 . . . . 1.72 111.248 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -94.24 128.7 40.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 3.69 110.918 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.1 p90 -76.69 140.05 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.262 -0.426 . . . . 4.64 110.18 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.34 98.46 13.92 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.899 0.381 . . . . 2.27 110.007 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.18 -10.5 27.41 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.181 2.587 . . . . 2.15 113.14 -175.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.6 p -78.96 -1.92 37.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.023 0.439 . . . . 4.29 110.565 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.51 HD12 ' OG ' ' A' ' 258' ' ' SER . 78.4 mt -89.54 138.27 31.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.387 -0.597 . . . . 4.74 109.387 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.36 140.25 26.3 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 3.77 110.879 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.44 138.07 84.44 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.128 2.552 . . . . 2.36 111.649 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.409 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 57.7 mt -72.94 138.3 46.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 2.55 110.457 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -91.81 120.52 32.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.009 -1.108 . . . . 2.38 108.009 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' CD1' ' A' ' 79' ' ' LEU . 1.9 t -116.45 110.93 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.522 -0.308 . . . . 1.59 110.624 -172.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.9 t -94.91 88.38 5.27 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.034 -0.728 . . . . 1.45 109.034 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 181' ' ' ARG . 1.4 p90 -107.25 1.1 23.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.892 -0.594 . . . . 3.62 111.36 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.35 -32.83 65.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.242 -0.435 . . . . 2.48 111.557 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.466 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 1.2 mp0 -101.5 6.89 42.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.24 111.138 -176.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.63 128.1 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.812 0.339 . . . . 0.8 111.537 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -112.31 107.03 15.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.954 -0.566 . . . . 1.06 110.721 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 t -79.67 150.51 30.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 1.26 108.95 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.7 mt -117.79 -54.52 2.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.74 111.825 -173.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -161.91 159.58 26.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.322 -0.399 . . . . 3.17 110.841 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.1 tt -115.31 141.5 32.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.312 -0.625 . . . . 0.64 109.312 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 171' ' ' LYS . 61.5 tp -127.6 138.26 52.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.37 . . . . 0.96 110.89 -173.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -92.99 119.78 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.063 0.459 . . . . 1.49 110.547 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 17.5 m120 -127.74 146.53 50.55 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.339 -0.985 . . . . 1.83 108.339 170.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.22 6.34 7.6 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.976 -0.631 . . . . 1.64 113.932 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -114.33 -54.29 2.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.165 0.482 . . . . 3.33 109.713 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 62' ' ' ASN . . . -140.53 163.22 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.336 -0.393 . . . . 1.38 110.416 174.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 69.7 m-85 -111.47 99.77 8.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.805 -0.443 . . . . 2.74 109.805 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 94' ' ' HIS . 81.3 m-20 -86.55 138.83 31.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 1.76 111.72 -171.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.3 t -114.59 113.25 43.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.476 -0.784 . . . . 1.15 108.977 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -72.66 140.53 47.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.913 -0.585 . . . . 2.02 112.076 -172.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -125.68 144.32 50.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 1.66 110.1 172.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.65 139.5 30.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.148 -0.478 . . . . 1.33 111.068 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.02 64.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.033 -0.985 . . . . 2.65 109.868 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -77.82 -11.06 59.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.982 0.896 . . . . 1.61 108.65 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -149.25 160.05 43.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.927 -1.488 . . . . 2.35 107.824 -176.455 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.97 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.688 0.618 . . . . 1.92 111.865 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 53' ' ' GLN . 90.0 mttt -109.54 -59.41 1.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.65 0.611 . . . . 1.77 112.65 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.84 102.15 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.76 111.258 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.59 145.41 24.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.205 -0.452 . . . . 1.27 111.206 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 49' ' ' VAL . 31.8 tp -134.39 112.88 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.935 -0.395 . . . . 1.29 109.935 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -150.98 123.23 8.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 2.54 111.538 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -97.17 176.06 31.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.762 -1.021 . . . . 1.31 110.905 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.17 -141.28 0.0 OUTLIER Glycine 0 CA--C 1.541 1.71 0 N-CA-C 115.331 0.892 . . . . 1.9 115.331 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.64 122.21 8.47 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.227 1.952 . . . . 2.91 112.329 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 14.1 tp -165.44 -170.3 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.976 -1.12 . . . . 4.11 107.976 -171.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.583 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 27.0 t70 -122.23 41.72 3.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.294 0.497 . . . . 4.95 110.997 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.77 174.91 13.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.858 -1.163 . . . . 2.25 114.229 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.0 m -101.86 124.18 47.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.073 -0.564 . . . . 1.91 110.12 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -114.07 113.16 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.071 0.463 . . . . 3.7 111.55 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.79 153.93 20.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.372 -0.376 . . . . 3.54 110.431 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.89 124.33 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.819 0.342 . . . . 1.14 110.615 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.545 ' HB ' ' CE3' ' A' ' 123' ' ' TRP . 14.2 tt -105.62 -34.02 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.918 0.389 . . . . 1.68 110.117 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -173.93 164.67 4.24 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.854 -0.795 . . . . 1.55 108.854 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' A' ' 120' ' ' LEU . 14.9 p90 -136.71 154.66 50.54 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.566 -0.902 . . . . 0.86 108.566 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.481 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.7 p-80 -139.78 158.8 43.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.943 0.401 . . . . 0.93 110.962 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.12 166.84 20.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 3.17 109.426 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' HE1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -144.46 157.69 44.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.451 -0.574 . . . . 1.68 109.451 175.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 73.1 t-105 -128.51 139.5 52.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 5.18 110.228 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -95.06 -59.42 1.11 Allowed Glycine 0 C--O 1.218 -0.844 0 C-N-CA 120.837 -0.697 . . . . 2.13 112.74 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 28.8 p 163.07 -57.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.365 0.603 . . . . 2.9 110.648 -172.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.81 153.26 23.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.307 -0.86 . . . . 3.03 110.4 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.38 51.69 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.666 0.746 . . . . 3.85 110.243 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -176.02 1.64 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.151 -0.931 . . . . 1.94 112.434 -175.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -160.35 155.24 24.33 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.887 -0.782 . . . . 2.45 108.887 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 116.19 -27.12 8.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.192 -1.004 . . . . 1.47 111.873 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 t -70.39 -46.73 63.44 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.011 -0.366 . . . . 2.0 110.011 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.524 ' OE1' ' HD3' ' A' ' 113' ' ' LYS . 8.1 mm-40 58.89 177.39 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.044 -0.525 . . . . 3.72 111.808 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.453 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 24.6 m80 59.76 14.45 4.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.962 -0.563 . . . . 3.52 111.286 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 113' ' ' LYS . 7.3 t -82.38 -178.8 7.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.11 -0.95 . . . . 2.52 113.088 -172.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 33' ' ' ILE . 17.0 m -103.61 123.94 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.582 -1.19 . . . . 2.48 111.965 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 61.17 39.14 16.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.38 -1.282 . . . . 2.8 111.413 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 67.81 8.54 6.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.758 -0.656 . . . . 4.98 112.163 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.43 73.91 6.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.694 0.283 . . . . 3.23 110.707 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.524 ' HD3' ' OE1' ' A' ' 106' ' ' GLU . 91.9 mttt -69.07 150.25 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.222 0.534 . . . . 2.82 111.641 -176.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 81.4 m-85 -101.12 -177.26 3.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.174 -0.921 . . . . 1.62 109.848 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.63 67.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.917 0.389 . . . . 1.03 111.704 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.32 163.75 39.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.457 . . . . 0.75 110.224 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 44.3 tt0 -129.99 135.2 48.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.732 -0.47 . . . . 1.58 109.732 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.5 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 42.9 tp -110.78 132.5 54.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.066 -0.515 . . . . 1.07 109.907 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.481 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -128.09 111.34 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.792 0.33 . . . . 1.77 111.628 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 93' ' ' PHE . 6.6 mp -92.71 113.46 25.74 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.151 -0.315 . . . . 0.93 110.151 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.73 122.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.162 0.506 . . . . 0.61 111.37 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -120.92 146.64 46.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.95 -0.568 . . . . 2.13 109.513 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.545 ' CE3' ' HB ' ' A' ' 91' ' ' ILE . 2.1 p90 -119.56 148.83 42.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.615 -0.513 . . . . 4.26 109.615 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -68.99 114.73 7.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.278 0.561 . . . . 2.02 110.37 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -68.19 -21.87 64.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.235 -0.893 . . . . 2.34 112.101 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.87 -21.6 64.83 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.861 0.363 . . . . 3.35 111.506 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.3 -3.17 34.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.003 0.43 . . . . 3.1 110.125 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.79 30.22 6.67 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 114.714 -1.13 . . . . 2.37 114.98 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 30.5 t70 -173.42 129.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.037 0.918 . . . . 3.93 110.214 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.608 ' O ' HG23 ' A' ' 134' ' ' VAL . 85.8 t80 -60.0 -46.4 89.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.961 -1.018 . . . . 3.0 110.842 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.66 99.24 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.227 -0.511 . . . . 2.15 112.832 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.48 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 73.6 mmtt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.07 0.462 . . . . 3.43 110.316 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.688 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.66 -0.7 . . . . 1.76 110.738 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 130' ' ' PHE . 99.6 t -64.83 -26.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.022 -0.535 . . . . 2.77 111.493 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -83.87 -4.66 58.85 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.023 -0.423 . . . . 3.55 111.451 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.455 HE21 ' HA2' ' A' ' 139' ' ' GLY . 3.1 tt0 -107.28 132.36 21.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.885 -0.413 . . . . 3.02 109.885 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 74.4 Cg_exo -52.46 -30.37 43.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.426 2.751 . . . . 1.6 113.499 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.91 25.18 12.05 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.646 0.26 . . . . 2.29 110.472 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -70.87 -33.63 65.99 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.579 -0.819 . . . . 1.22 113.394 -172.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.7 mt -114.71 156.9 23.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.999 0.428 . . . . 1.57 110.069 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.0 106.57 6.14 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.284 -0.635 . . . . 1.38 109.284 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 91.3 t -103.94 116.45 47.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.093 -0.503 . . . . 1.73 110.353 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 44.5 tp -88.8 112.85 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.329 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -101.64 141.9 15.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.906 -0.664 . . . . 0.86 112.337 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.6 mt -133.64 131.75 57.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.453 -0.573 . . . . 0.76 109.453 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.4 148.99 25.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.921 -0.4 . . . . 1.2 109.921 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.9 mp -116.79 124.01 48.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.88 110.973 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 18.9 ptpt -108.1 150.52 27.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.271 -0.64 . . . . 2.03 109.271 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 92.3 t -95.01 130.55 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.133 0.492 . . . . 1.27 110.83 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.59 -103.61 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.794 -0.639 . . . . 1.53 111.731 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 p -71.07 147.22 48.71 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.839 0.352 . . . . 1.54 110.385 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -78.2 149.58 33.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.263 -0.426 . . . . 0.78 110.606 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.0 100.4 53.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.053 -0.521 . . . . 1.22 110.303 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.46 -35.02 64.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.41 2.74 . . . . 1.05 112.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.44 -21.36 64.47 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.347 -0.454 . . . . 0.7 113.524 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.507 ' HB3' ' NE2' ' A' ' 221' ' ' GLN . 27.1 tp -98.04 -6.25 32.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.3 0.55 . . . . 0.77 110.802 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -56.01 -41.24 74.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 1.41 111.805 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -66.04 -34.66 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.728 0.299 . . . . 2.86 111.085 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 162' ' ' VAL . 67.4 t -71.55 -50.29 40.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 1.38 110.823 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 224' ' ' LYS . 32.9 m -65.61 -24.89 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 1.11 111.255 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.74 -34.1 58.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.499 . . . . 1.22 111.495 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 159' ' ' VAL . 6.0 p -81.89 -8.77 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 1.41 110.749 -175.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.34 -27.22 63.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.966 -0.561 . . . . 1.39 111.391 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.15 -34.66 73.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 2.31 111.413 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.3 t -89.25 -1.55 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.664 -0.244 . . . . 1.4 111.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 38.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.05 0.452 . . . . 0.85 110.374 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.9 -35.33 72.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 1.59 111.023 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 p -106.39 149.02 27.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.396 0.617 . . . . 0.77 111.52 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -57.41 126.94 29.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.901 -1.045 . . . . 2.29 111.18 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.5 -22.24 20.2 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.748 -0.739 . . . . 0.85 112.642 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 60' ' ' LEU . 64.8 mttm -79.62 150.28 31.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.167 0.508 . . . . 1.7 111.472 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 60' ' ' LEU . 8.5 t -140.75 151.34 44.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.402 -0.817 . . . . 1.37 109.279 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -140.51 134.85 31.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.07 -0.344 . . . . 0.61 110.07 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.43 132.41 53.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.249 0.547 . . . . 1.8 110.402 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -141.51 80.79 1.75 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.611 -0.722 . . . . 1.04 109.585 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 32.0 p -101.34 160.9 14.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.274 0.472 . . . . 1.17 112.274 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.1 42.16 10.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.263 -0.88 . . . . 1.77 111.755 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.46 130.57 45.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 3.99 110.828 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 3.2 p30 -105.72 133.18 20.31 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 2.51 109.92 176.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 3.3 Cg_exo -77.93 -11.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.536 2.157 . . . . 1.26 111.439 173.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.52 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 18.4 mtm180 -57.68 -44.0 85.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.616 -0.72 . . . . 2.76 111.498 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.86 -6.48 56.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.83 -0.7 . . . . 1.12 112.978 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.454 ' O ' HG21 ' A' ' 215' ' ' ILE . 6.7 mp -108.7 -9.23 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.582 -0.364 . . . . 1.73 111.002 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 95.3 mt -70.75 140.83 86.81 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.913 0.387 . . . . 3.45 111.621 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.52 -167.98 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.273 2.648 . . . . 2.08 113.308 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.7 -59.74 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 3.23 111.309 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.578 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 9.7 m -91.05 140.44 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 1.66 110.949 -174.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 35.1 tp -106.02 62.78 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.549 0.69 . . . . 1.99 109.657 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 258' ' ' SER . 6.9 m-20 -122.45 171.79 8.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.829 -1.175 . . . . 1.81 107.829 176.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 51.7 p90 -167.71 163.5 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.831 1.049 . . . . 5.01 113.831 -163.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.575 ' HE3' HG13 ' A' ' 210' ' ' VAL . 13.4 m-90 -105.37 141.94 36.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.223 -1.399 . . . . 3.93 107.223 164.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.4 t -138.86 109.13 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.409 0.623 . . . . 2.13 112.558 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.536 ' CD1' ' HB2' ' A' ' 28' ' ' GLN . 8.9 t80 -139.88 129.03 13.6 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 5.21 109.671 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 89.0 Cg_exo -48.9 134.92 29.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.058 2.505 . . . . 2.12 112.92 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 28' ' ' GLN . . . -107.48 153.39 16.83 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.82 -0.627 . . . . 1.75 113.659 -170.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 198' ' ' THR . 72.9 p -92.7 -134.45 0.15 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.68 0.792 . . . . 2.99 111.243 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.639 ' C ' ' H ' ' A' ' 199' ' ' THR . 40.4 tp -45.57 10.11 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.387 1.875 . . . . 4.75 116.03 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 196' ' ' SER . 1.4 p -68.01 26.0 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.789 -1.195 . . . . 5.1 110.898 166.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.639 ' H ' ' C ' ' A' ' 197' ' ' LEU . 9.7 t -148.48 149.69 32.07 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 114.658 -1.156 . . . . 5.53 108.449 -175.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.442 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 77.6 Cg_exo -44.19 -51.35 6.81 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.066 2.511 . . . . 5.83 115.245 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 11.1 Cg_endo -91.16 158.69 3.83 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.307 2.005 . . . . 4.78 112.61 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 202' ' ' LEU . 0.7 OUTLIER -75.43 74.59 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.292 0.568 . . . . 3.84 110.206 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp -151.81 174.55 13.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.663 -0.699 . . . . 2.96 110.727 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -112.78 85.94 2.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.563 0.697 . . . . 3.37 110.502 -177.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.5 p -111.93 3.43 17.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.167 -0.47 . . . . 2.15 111.07 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.04 134.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.281 0.563 . . . . 1.26 111.819 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.5 m -102.9 97.85 7.92 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.079 -1.452 . . . . 2.08 107.079 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.422 ' HE1' ' CD2' ' A' ' 119' ' ' HIS . 9.2 t90 -88.77 120.35 30.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.076 0.465 . . . . 5.53 110.815 -169.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 71.3 mt -126.18 118.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 1.63 109.356 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.575 HG13 ' HE3' ' A' ' 191' ' ' TRP . 3.4 p -120.32 126.26 75.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.808 0.337 . . . . 1.62 110.602 -174.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.22 137.02 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.079 -0.51 . . . . 1.73 110.596 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.573 ' HG3' ' CZ2' ' A' ' 191' ' ' TRP . 33.6 ttmt -81.53 -1.36 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 2.98 110.756 -177.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.578 ' HG3' ' H ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -111.8 91.65 15.56 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.3 -0.63 . . . . 1.47 109.3 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 18.9 Cg_exo -66.61 147.44 81.81 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.775 2.317 . . . . 0.96 112.031 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.454 HG21 ' O ' ' A' ' 183' ' ' LEU . 38.8 pt -94.61 154.35 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 1.25 110.751 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.9 m -99.92 137.92 37.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.975 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 12.6 m -134.63 155.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.634 -0.712 . . . . 1.02 109.193 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 44.9 t -83.44 154.8 23.77 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.941 -0.303 . . . . 1.08 110.602 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.649 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 6.3 p -54.91 -45.56 74.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.583 -0.28 . . . . 1.33 110.531 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 43.5 mt-10 -55.69 -27.76 51.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.204 -0.453 . . . . 2.51 111.5 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 52.9 mt-30 -80.27 -47.39 14.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.7 110.454 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.608 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 35.1 m -71.91 -26.69 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 1.36 111.499 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.7 mt -66.72 -30.3 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.79 0.329 . . . . 1.03 110.445 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 160' ' ' VAL . 96.1 mttt -69.43 -24.29 63.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 1.75 110.765 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 21.9 m-85 -75.73 -25.01 56.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 2.47 109.774 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -79.29 -10.94 59.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 3.04 110.189 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -90.29 -8.78 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 2.31 110.35 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.26 150.48 48.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.95 110.425 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.7 m120 -110.21 136.35 49.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.409 0.623 . . . . 1.13 110.613 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -76.93 -30.5 56.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.758 -1.11 . . . . 3.74 109.739 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.6 p-10 -73.61 164.38 26.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.128 -0.942 . . . . 1.62 112.132 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.83 174.32 46.0 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.073 -0.967 . . . . 1.16 111.079 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.11 135.84 55.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.243 0.521 . . . . 3.56 110.511 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 90.69 7.91 66.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.859 -0.686 . . . . 2.08 112.434 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -112.53 159.24 34.88 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.244 -0.28 . . . . 2.59 110.244 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.26 124.0 15.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.453 2.102 . . . . 1.36 110.911 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.451 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.9 pt-20 -62.01 123.93 19.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.819 0.819 . . . . 3.4 111.909 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 43.5 mt-10 -116.97 125.27 51.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.843 -1.071 . . . . 2.47 108.486 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -70.05 147.57 49.88 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.117 -0.492 . . . . 2.14 110.619 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 11.9 tpt -73.94 92.13 2.07 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.528 -0.916 . . . . 1.68 108.528 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.0 m -140.21 142.12 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.674 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 30.1 t70 66.42 -95.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.226 -0.897 . . . . 2.18 109.497 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 m120 53.25 19.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.483 0.549 . . . . 2.15 112.483 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -150.08 164.31 35.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.792 0.33 . . . . 4.59 110.406 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.432 ' HE ' ' NE2' ' A' ' 248' ' ' GLN . 12.6 ptm180 -107.78 148.12 36.74 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.926 -0.579 . . . . 6.13 110.898 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.97 161.98 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.625 2.883 . . . . 3.28 113.623 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -71.2 143.66 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.334 -0.848 . . . . 2.98 110.695 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.659 ' HB2' HG12 ' A' ' 31' ' ' VAL . 41.9 mt-30 -124.69 170.54 8.79 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.867 -0.606 . . . . 4.32 111.1 -169.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 248' ' ' GLN . 6.5 Cg_exo -76.09 174.94 11.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.401 2.734 . . . . 3.48 115.031 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.42 -8.7 57.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 113.879 -1.51 . . . . 4.63 113.069 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 18.4 pttp -55.21 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.319 2.34 . . . . 5.34 117.319 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 3.3 p-10 134.62 28.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.976 1.71 . . . . 4.64 112.065 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.433 ' NE ' HD11 ' A' ' 255' ' ' ILE . 56.3 ttt180 -147.94 120.05 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.924 -0.399 . . . . 6.11 109.924 162.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -146.79 122.39 10.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.429 -1.322 . . . . 3.08 107.429 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 191' ' ' TRP . 14.8 mt -124.85 145.83 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.006 0.432 . . . . 2.6 111.803 -168.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.46 143.55 48.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 2.63 110.041 169.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -118.59 92.72 3.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.157 -0.474 . . . . 1.71 110.097 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 69.0 m -105.55 100.67 10.23 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.288 -0.565 . . . . 2.21 111.724 -172.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -126.27 100.43 6.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.136 -1.061 . . . . 4.31 108.136 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.503 -0.761 . . . . 4.49 110.808 -173.279 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.702 0.287 . . . . 17.49 110.829 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 p -97.2 -24.97 15.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.148 -0.221 . . . . 15.32 111.465 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -86.55 25.02 1.3 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.074 0.464 . . . . 15.81 111.211 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -77.82 95.47 4.72 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.727 -0.842 . . . . 14.19 108.727 174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -88.31 139.6 30.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.817 0.341 . . . . 14.91 110.57 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.71 163.7 30.86 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.431 -0.667 . . . . 10.79 111.431 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -86.99 99.3 11.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.536 0.208 . . . . 11.39 110.607 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.65 157.11 21.29 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.705 -0.76 . . . . 9.0 112.367 175.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 56.0 tttp -58.29 148.46 27.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.241 -0.281 . . . . 9.76 110.241 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 91.1 m-70 73.72 -46.56 0.63 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.64 0.776 . . . . 11.19 111.354 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -78.26 -16.2 58.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.485 0.659 . . . . 10.8 109.596 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.73 -127.08 2.46 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.331 -0.85 . . . . 8.82 111.351 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 16' ' ' TRP . 57.9 Cg_endo -72.89 131.88 17.62 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.355 2.037 . . . . 7.87 111.895 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -87.69 -41.21 13.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.721 -0.672 . . . . 10.62 110.916 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -107.04 26.39 10.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.996 -0.547 . . . . 9.87 110.505 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 74.1 t90 -46.78 -41.94 16.17 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.61 -0.723 . . . . 8.48 112.053 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.435 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 31.9 m-70 -70.67 -23.47 62.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.895 0.379 . . . . 7.13 111.153 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.45 -35.12 18.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 9.68 110.437 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.07 -24.97 59.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.895 -0.593 . . . . 7.89 110.655 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -114.67 93.45 33.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.731 -0.668 . . . . 7.17 109.749 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.43 -31.19 46.91 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.344 2.696 . . . . 7.76 113.14 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -51.19 -27.58 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.46 0.541 . . . . 5.83 112.46 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HA ' HD13 ' A' ' 202' ' ' LEU . . . -64.36 -29.5 70.57 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.735 0.302 . . . . 5.44 111.348 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 17' ' ' HIS . 31.5 mmtp -68.42 -11.73 60.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.268 0.556 . . . . 7.78 110.47 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.37 36.38 2.59 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.591 -1.004 . . . . 5.01 110.591 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -62.92 152.76 35.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.257 -0.471 . . . . 7.09 112.031 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -147.95 127.26 13.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.763 -0.828 . . . . 5.13 108.763 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.643 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 33.6 tt0 -142.68 170.58 15.44 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.558 -0.905 . . . . 7.12 108.558 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.567 ' N ' ' HG2' ' A' ' 28' ' ' GLN . 16.0 m -88.94 100.06 1.89 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.092 -0.707 . . . . 3.94 109.092 170.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.643 ' HD3' ' O ' ' A' ' 28' ' ' GLN . 74.4 Cg_endo -101.08 -17.4 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.004 2.469 . . . . 4.52 113.605 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 253' ' ' ARG . 27.7 m -95.63 172.93 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.046 0.45 . . . . 4.54 111.697 -168.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -127.55 145.38 50.88 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.053 -1.091 . . . . 2.88 108.053 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 57.1 mt -65.62 103.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.41 0.624 . . . . 2.32 111.191 -169.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' A' ' 37' ' ' THR . 20.9 m-20 -83.44 102.66 12.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.929 -1.032 . . . . 2.82 108.947 176.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -55.02 -35.65 64.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.405 0.52 . . . . 2.24 112.405 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -84.66 -28.58 26.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.092 0.404 . . . . 4.54 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 5.7 m -89.12 -15.81 32.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.285 0.564 . . . . 3.06 110.91 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.02 142.16 56.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 1.72 110.747 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -104.32 116.45 32.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.376 -0.602 . . . . 3.69 109.376 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -87.59 87.18 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 4.64 110.835 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' OD2' ' HG ' ' A' ' 44' ' ' LEU . 19.6 t70 -73.93 119.72 77.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 2.27 110.91 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.57 -16.71 9.09 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.876 2.384 . . . . 2.15 112.918 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 m -70.25 -46.22 64.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.636 -0.505 . . . . 4.29 109.636 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.433 ' HG ' ' OD2' ' A' ' 41' ' ' ASP . 95.9 mt -54.29 144.52 20.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.417 -0.811 . . . . 4.74 111.008 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HD3' ' HD2' ' A' ' 46' ' ' PRO . 16.6 tppt? -117.1 124.07 29.49 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.672 -0.695 . . . . 3.77 109.835 -174.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 73.3 Cg_exo -51.52 122.76 10.81 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.258 1.972 . . . . 2.36 111.623 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.95 126.87 30.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.539 -0.755 . . . . 2.55 110.606 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.461 ' O ' HD12 ' A' ' 79' ' ' LEU . 53.7 p -67.35 136.19 54.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.706 -0.479 . . . . 2.38 109.706 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.46 97.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.818 -0.438 . . . . 1.59 109.818 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 9.8 m -97.14 88.62 4.53 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.478 -0.564 . . . . 1.45 109.478 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.55 ' CE1' ' HA ' ' A' ' 181' ' ' ARG . 1.0 OUTLIER -129.23 18.09 5.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.5 0.667 . . . . 3.62 109.896 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.06 -28.83 69.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.016 -0.993 . . . . 2.48 110.216 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -96.2 7.84 45.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 2.24 111.256 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . . . -62.71 133.64 55.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.738 0.304 . . . . 0.8 111.717 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.589 ' OG1' ' HE2' ' A' ' 76' ' ' LYS . 10.7 m -121.1 119.13 31.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.085 -0.507 . . . . 1.06 110.532 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 t -83.92 150.25 25.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.308 -0.405 . . . . 1.26 110.431 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.0 mt -116.71 -55.44 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.424 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -169.75 160.83 8.93 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.425 -0.352 . . . . 3.17 110.942 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 17.4 tt -109.32 144.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.64 109.281 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.6 tp -135.68 136.93 41.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.313 0.578 . . . . 0.96 111.779 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.458 ' CB ' ' HA ' ' A' ' 169' ' ' LYS . 4.2 m-20 -88.43 106.03 17.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.943 -1.026 . . . . 1.49 109.32 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 64' ' ' HIS . 16.7 m120 -100.04 75.19 1.84 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.382 -0.372 . . . . 1.83 111.4 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 65.93 -26.15 0.15 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 115.56 0.984 . . . . 1.64 115.56 174.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' ASN . 25.5 p80 -163.76 -25.82 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.76 0.314 . . . . 3.33 111.533 -172.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.74 157.93 19.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.12 -0.326 . . . . 1.38 110.12 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -131.7 96.37 3.94 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.51 -0.922 . . . . 2.74 108.51 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.86 145.59 42.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.23 -0.896 . . . . 1.76 111.437 -170.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 58.8 t -93.71 121.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.781 -0.645 . . . . 1.15 110.049 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -86.52 125.05 33.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.69 -0.686 . . . . 2.02 109.787 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -103.83 164.38 11.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.919 0.39 . . . . 1.66 110.674 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.64 116.16 28.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.879 -0.6 . . . . 1.33 109.824 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -127.77 59.99 1.45 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.925 0.869 . . . . 2.65 110.795 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -75.9 -5.29 45.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.435 -0.802 . . . . 1.61 110.614 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -157.61 176.94 11.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 2.35 109.218 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.65 30.38 0.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.385 -0.371 . . . . 1.92 111.194 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HE2' ' OG1' ' A' ' 55' ' ' THR . 2.4 ptpp? -50.77 -44.94 58.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.75 -0.659 . . . . 1.77 111.628 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.15 99.54 6.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.367 . . . . 0.76 110.119 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.2 m -129.0 168.36 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.386 0.613 . . . . 1.27 111.739 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 48' ' ' SER . 38.7 tp -137.19 111.45 8.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.04 -0.982 . . . . 1.29 108.416 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -150.45 126.34 10.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 2.54 111.419 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 173.94 24.28 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.965 -0.561 . . . . 1.31 113.347 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.78 -134.11 0.0 OUTLIER Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.349 0.976 . . . . 1.9 114.545 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -44.9 169.92 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.226 2.618 . . . . 2.91 112.712 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -35.8 150.34 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.472 1.286 . . . . 4.11 114.472 -154.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 13.8 p-10 174.58 -66.61 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.797 -1.092 . . . . 4.95 111.227 -156.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.6 141.8 2.44 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.371 -0.691 . . . . 2.25 111.371 -170.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 125' ' ' THR . 23.3 m -88.51 125.69 34.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.695 0.747 . . . . 1.91 111.033 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.2 m-85 -118.65 126.36 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.325 -0.398 . . . . 3.7 111.24 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.4 mtt180 -83.0 135.63 34.79 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.55 -0.295 . . . . 3.54 111.024 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.45 117.02 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.48 -0.563 . . . . 1.14 109.48 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.454 HG23 ' HG2' ' A' ' 92' ' ' GLN . 6.9 tt -110.12 -36.34 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.335 -0.393 . . . . 1.68 111.241 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.454 ' HG2' HG23 ' A' ' 91' ' ' ILE . 20.6 pt20 -162.86 168.31 21.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.339 -0.245 . . . . 1.55 110.339 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 118' ' ' LEU . 23.4 p90 -141.1 149.31 41.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.921 -0.4 . . . . 0.86 109.921 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -140.4 158.02 44.64 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.151 0.282 . . . . 0.93 110.714 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.7 m-85 -108.86 153.2 23.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.407 -0.36 . . . . 3.17 110.108 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -105.52 153.55 21.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 1.68 111.903 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.655 ' CB ' ' HA2' ' A' ' 104' ' ' GLY . 0.7 OUTLIER 69.37 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.738 -1.119 . . . . 5.18 111.984 170.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 241' ' ' VAL . . . 69.69 118.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.161 -0.542 . . . . 2.13 112.055 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 23.1 t 176.16 -89.53 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.03 0.415 . . . . 2.9 111.435 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.72 170.82 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 3.03 111.382 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.05 45.14 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.409 -0.814 . . . . 3.85 111.341 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -176.56 20.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.905 . . . . 1.94 112.828 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -155.86 120.03 4.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 2.45 110.043 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.655 ' HA2' ' CB ' ' A' ' 97' ' ' TRP . . . 157.71 -26.52 0.45 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.817 -0.706 . . . . 1.47 111.551 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.526 ' HB2' ' H ' ' A' ' 114' ' ' TYR . 43.2 m -81.35 64.73 6.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.098 0.559 . . . . 2.0 110.283 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.15 143.06 55.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.75 -0.463 . . . . 3.72 109.75 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 34.7 m80 61.65 25.64 15.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.984 0.421 . . . . 3.52 111.618 174.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.4 t -82.68 -175.54 5.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.5 . . . . 2.52 111.512 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 15.0 m -71.07 106.81 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 2.48 111.715 -166.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.0 t70 58.2 31.11 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.991 -1.459 . . . . 2.8 109.724 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.5 mttp 66.81 28.67 8.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.984 -1.007 . . . . 4.98 112.479 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -69.24 72.31 0.29 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.168 0.509 . . . . 3.23 110.488 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.75 114.29 2.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.415 -0.811 . . . . 2.82 112.584 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.526 ' H ' ' HB2' ' A' ' 105' ' ' SER . 67.2 m-85 -106.31 -163.16 0.9 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.343 -0.844 . . . . 1.62 109.276 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.61 95.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.13 0.789 . . . . 1.03 113.13 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.11 169.66 15.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.456 0.539 . . . . 0.75 112.456 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -122.59 135.01 54.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.501 -1.227 . . . . 1.58 108.25 171.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.489 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.3 tp -116.06 116.41 27.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.243 -0.28 . . . . 1.07 110.243 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -106.25 110.3 22.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 1.77 111.314 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.2 mp -88.21 102.71 15.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.601 -0.888 . . . . 0.93 108.601 173.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.31 120.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.727 -0.67 . . . . 0.61 110.783 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 12.7 m-70 -117.1 141.99 47.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.984 -0.747 . . . . 2.13 108.984 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CZ2' ' HD2' ' A' ' 89' ' ' ARG . 61.5 p-90 -111.87 141.22 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.801 0.334 . . . . 4.26 110.854 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.469 HD21 ' HE2' ' A' ' 126' ' ' LYS . 44.4 t30 -62.12 110.63 1.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.473 0.654 . . . . 2.02 111.519 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.401 HG22 ' HB ' ' A' ' 87' ' ' THR . 11.3 t -61.5 -33.45 73.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.934 -1.03 . . . . 2.34 112.872 -170.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.469 ' HE2' HD21 ' A' ' 124' ' ' ASN . 21.4 pttm -72.02 -6.81 44.96 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.239 0.829 . . . . 3.35 113.239 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 136' ' ' GLN . 43.4 m-85 -97.93 -4.23 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.568 -0.453 . . . . 3.1 110.836 172.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.5 26.55 5.24 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.074 -0.966 . . . . 2.37 114.779 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.37 122.91 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.547 0.673 . . . . 3.93 109.669 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 134' ' ' VAL . 46.3 p90 -69.37 -31.98 70.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 3.0 111.521 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.24 -37.23 92.66 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.751 -0.738 . . . . 2.15 112.007 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -70.49 -32.88 70.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.35 0.595 . . . . 3.43 109.61 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.423 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.73 -25.27 64.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 1.76 111.085 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 130' ' ' PHE . 93.8 t -68.5 -25.89 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 2.77 110.394 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -81.58 -13.82 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 3.55 110.774 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 127' ' ' TYR . 75.1 mm-40 -111.18 135.91 20.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.051 -0.522 . . . . 3.02 110.1 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.11 -21.41 55.88 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.671 2.248 . . . . 1.6 112.796 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -113.0 25.45 11.39 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.931 -0.396 . . . . 2.29 109.931 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.76 -30.04 49.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.693 . . . . 1.22 113.892 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 88.1 mt -123.67 158.62 31.15 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.352 -0.499 . . . . 1.57 110.546 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.7 121.05 7.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 1.38 110.031 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 m -110.52 119.65 59.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.022 0.439 . . . . 1.73 110.418 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.2 tp -83.41 104.87 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.467 -0.568 . . . . 2.42 109.467 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -90.36 114.92 4.49 Favored Glycine 0 N--CA 1.446 -0.65 0 O-C-N 123.652 0.595 . . . . 0.86 112.363 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.7 mt -117.06 105.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.389 -0.597 . . . . 0.76 109.389 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 86.6 m-85 -66.24 154.47 39.78 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.122 0.487 . . . . 1.2 111.712 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.451 HD23 HG11 ' A' ' 217' ' ' VAL . 7.8 mp -112.68 112.75 24.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.544 -0.753 . . . . 0.88 110.071 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -96.72 147.17 24.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.157 -0.683 . . . . 2.03 109.157 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.82 126.41 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 1.27 110.92 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.23 -106.79 0.22 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.421 -0.672 . . . . 1.53 111.421 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.7 m -69.13 140.64 54.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.824 -0.436 . . . . 1.54 109.824 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.43 152.62 45.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.562 -0.29 . . . . 0.78 110.805 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 154' ' ' PRO . 47.4 tptt -108.6 95.29 16.01 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.941 -0.762 . . . . 1.22 108.941 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 15.5 Cg_endo -57.02 -35.9 99.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.994 2.463 . . . . 1.05 112.966 -173.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.43 -18.4 79.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.913 -0.66 . . . . 0.7 113.061 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.4 tp -90.15 -20.8 22.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.921 0.391 . . . . 0.77 110.805 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -55.82 -34.25 65.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.947 -0.569 . . . . 1.41 112.154 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -51.75 -41.1 61.34 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 112.534 0.568 . . . . 2.86 112.534 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.5 p -85.56 -38.96 13.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.347 -0.541 . . . . 1.38 111.018 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.5 HG12 ' HD2' ' A' ' 224' ' ' LYS . 31.4 t -63.22 -47.22 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 1.11 111.765 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -18.35 62.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.065 0.394 . . . . 1.22 112.065 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 162' ' ' VAL . 44.4 t -96.22 -1.59 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 121.197 0.523 . . . . 1.41 111.013 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.8 -24.97 66.22 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.901 0.381 . . . . 1.39 111.304 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.9 -31.68 71.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.46 -0.336 . . . . 2.31 110.717 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 44.5 m -76.9 -5.07 47.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 1.4 111.628 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.5 pt -137.78 45.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.85 109.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -67.05 -28.97 68.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.418 -0.81 . . . . 1.59 110.986 -175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 p -116.38 149.05 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.724 0.297 . . . . 0.77 110.723 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.484 ' HD2' ' HA2' ' A' ' 63' ' ' GLY . 56.3 pttt -65.25 148.88 50.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.457 -0.338 . . . . 2.29 110.104 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.55 33.84 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.457 -0.878 . . . . 0.85 111.37 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -82.22 157.58 23.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.419 0.628 . . . . 1.7 111.146 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.2 p -141.72 154.04 45.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 1.37 109.122 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.13 122.95 20.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.969 -0.382 . . . . 0.61 109.969 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.25 144.66 56.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.967 -0.561 . . . . 1.8 111.314 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.36 81.2 1.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 1.04 110.327 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 p -112.25 159.12 18.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.495 -0.32 . . . . 1.17 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.6 43.59 25.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.06 -0.518 . . . . 1.77 111.386 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.08 140.35 52.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.401 -0.363 . . . . 3.99 110.23 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -92.15 110.33 43.59 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.392 -0.367 . . . . 2.51 110.467 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.23 -14.85 13.07 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.463 2.109 . . . . 1.26 112.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.55 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . 9.4 ttp180 -71.93 -24.15 61.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 2.76 111.267 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -61.3 -2.8 3.27 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.342 -0.39 . . . . 1.12 113.867 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.54 -8.77 57.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.93 0.365 . . . . 1.73 110.979 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.4 pp -48.05 137.28 10.94 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 113.425 0.898 . . . . 3.45 113.425 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HG3' HD21 ' A' ' 211' ' ' LEU . 69.1 Cg_endo -94.92 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.553 2.835 . . . . 2.08 111.483 170.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.8 mt-10 -90.35 -64.18 1.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.836 0.309 . . . . 3.23 111.836 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.489 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.1 m -99.32 146.93 25.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 1.66 111.627 -172.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 211' ' ' LEU . 83.9 mt -111.29 65.12 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.979 0.419 . . . . 1.99 111.197 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.486 ' O ' HD12 ' A' ' 211' ' ' LEU . 33.0 m-20 -108.41 168.68 9.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.038 -1.097 . . . . 1.81 108.038 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.667 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 13.2 p90 -159.58 154.13 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.252 -0.979 . . . . 5.01 112.988 -170.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.707 ' CE3' ' HB2' ' A' ' 257' ' ' ALA . 6.9 m95 -111.84 142.17 44.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.419 -1.264 . . . . 3.93 107.747 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.0 t -121.66 113.24 19.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.548 0.69 . . . . 2.13 112.434 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 49.6 t80 -138.24 131.21 16.38 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 5.21 110.534 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 193' ' ' TYR . 10.0 Cg_endo -54.66 139.39 76.55 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.86 2.374 . . . . 2.12 112.165 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.472 ' HA2' ' OG ' ' A' ' 29' ' ' SER . . . -138.36 159.17 25.17 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.142 -0.552 . . . . 1.75 113.443 -170.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.6 t -114.08 129.82 56.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.79 -1.189 . . . . 2.99 107.79 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.47 -47.74 66.3 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.419 0.896 . . . . 4.75 113.419 -161.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 200' ' ' PRO . 1.3 t -121.81 -46.92 2.21 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.863 -0.735 . . . . 5.1 112.723 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.721 ' OG1' ' HD3' ' A' ' 200' ' ' PRO . 0.3 OUTLIER 156.08 -66.33 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 124.73 1.212 . . . . 5.53 111.455 -176.198 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.721 ' HD3' ' OG1' ' A' ' 199' ' ' THR . 52.5 Cg_exo -55.49 -41.28 79.51 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.339 2.693 . . . . 5.83 116.337 -170.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.73 -24.48 55.32 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 121.636 1.557 . . . . 4.78 112.961 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 200' ' ' PRO . 94.8 mt 53.98 23.55 4.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.952 -1.022 . . . . 3.84 112.922 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.01 172.47 8.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.703 -0.226 . . . . 2.96 110.588 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -113.47 58.34 0.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.63 0.729 . . . . 3.37 110.392 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.64 -15.43 57.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.988 -1.006 . . . . 2.15 110.519 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 40.6 t -100.65 151.28 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.714 -0.675 . . . . 1.26 110.66 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -117.57 109.35 16.59 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.734 -0.839 . . . . 2.08 108.734 174.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.41 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.7 t90 -74.01 100.82 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.951 -0.759 . . . . 5.53 108.951 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.59 99.6 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.688 -0.856 . . . . 1.63 108.688 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 21.5 t -86.19 111.22 20.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.202 -0.454 . . . . 1.62 109.903 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 189' ' ' ASP . 20.6 tp -72.21 120.48 17.88 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.935 -0.765 . . . . 1.73 108.935 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -66.23 -14.91 62.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.243 -0.435 . . . . 2.98 111.708 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 186' ' ' GLU . 7.1 tp10 -104.71 96.49 10.6 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.573 0.225 . . . . 1.47 110.787 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.443 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 63.0 Cg_endo -77.4 144.98 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.461 2.107 . . . . 0.96 111.828 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.3 pt -88.78 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.178 -0.465 . . . . 1.25 111.291 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.4 m -94.68 126.71 40.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.663 . . . . 1.29 110.334 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 147' ' ' LEU . 33.8 m -127.49 158.79 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.765 -0.457 . . . . 1.02 109.765 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 55.1 p -95.85 158.69 15.33 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.912 -0.315 . . . . 1.08 111.07 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.613 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 63.8 m -56.55 -39.26 73.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.935 -0.575 . . . . 1.33 110.694 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.89 -31.02 26.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 2.51 111.372 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.91 -45.1 13.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.45 . . . . 0.7 110.175 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.38 -40.71 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.916 -0.584 . . . . 1.36 111.475 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 219' ' ' SER . 89.7 mt -59.24 -35.13 73.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 1.03 111.8 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.5 ' HD2' HG12 ' A' ' 160' ' ' VAL . 66.1 mttp -70.19 -23.47 62.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.628 -0.26 . . . . 1.75 111.473 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -72.87 -25.43 61.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.22 0.533 . . . . 2.47 110.094 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -80.8 -9.89 59.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 3.04 110.603 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -86.9 -10.13 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 2.31 110.444 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.22 148.63 48.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.886 -0.597 . . . . 0.95 110.853 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.595 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 11.5 m120 -113.84 139.43 49.17 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.419 0.628 . . . . 1.13 110.331 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -76.05 -30.62 58.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.768 -1.106 . . . . 3.74 109.568 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.438 ' C ' ' HG2' ' A' ' 169' ' ' LYS . 4.5 p-10 -76.24 171.08 15.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.118 -0.947 . . . . 1.62 112.247 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.87 -179.33 38.91 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.763 -1.108 . . . . 1.16 111.288 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.65 129.17 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 3.56 110.866 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.94 4.34 48.31 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.472 -0.785 . . . . 2.08 112.547 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -116.05 153.94 48.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.249 -0.278 . . . . 2.59 110.249 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.36 131.81 48.04 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.857 2.371 . . . . 1.36 111.774 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.595 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 31.2 tt0 -53.65 115.15 1.82 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.592 0.71 . . . . 3.4 112.755 -174.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -108.82 117.86 35.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.896 -1.15 . . . . 2.47 107.896 168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.68 125.46 25.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.678 0.275 . . . . 2.14 110.713 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.5 ttm -77.37 90.32 3.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.065 -0.717 . . . . 1.68 109.065 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 27.7 m -136.36 151.74 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.836 -0.62 . . . . 1.27 109.872 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 14.1 t70 69.67 -87.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.696 0.622 . . . . 2.18 110.588 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 48.98 15.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.364 1.246 . . . . 2.15 114.364 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.413 ' HD1' ' H ' ' A' ' 97' ' ' TRP . 98.5 m95 -150.46 177.97 9.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.272 0.487 . . . . 4.59 110.689 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -116.75 131.56 23.85 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.204 -0.295 . . . . 6.13 110.204 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 59.7 Cg_endo -73.72 -148.34 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.83 2.354 . . . . 3.28 112.772 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -82.95 136.1 34.66 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.924 -0.485 . . . . 2.98 111.486 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 73.6 mm-40 -123.09 162.31 40.01 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.791 -0.64 . . . . 4.32 110.215 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.51 177.82 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.804 3.003 . . . . 3.48 114.341 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.38 -4.7 0.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.245 1.418 . . . . 4.63 113.306 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 75.0 mmtt -54.11 49.4 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.489 1.515 . . . . 5.34 114.975 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 3.3 t30 132.67 62.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.911 2.084 . . . . 4.64 111.968 175.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.546 ' O ' HG11 ' A' ' 31' ' ' VAL . 29.8 mtm180 88.29 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.418 -1.265 . . . . 6.11 112.689 153.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.403 ' H ' ' HB3' ' A' ' 253' ' ' ARG . 5.0 pp0? -157.83 163.7 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.645 -0.872 . . . . 3.08 108.645 -171.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.66 125.17 62.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.818 0.342 . . . . 2.6 111.461 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -106.8 177.14 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 2.63 109.896 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.707 ' HB2' ' CE3' ' A' ' 191' ' ' TRP . . . -136.67 171.78 13.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.772 0.32 . . . . 1.71 111.487 -170.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.3 m -129.43 97.31 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.262 0.553 . . . . 2.21 110.157 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -153.62 138.98 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.835 -0.802 . . . . 4.31 108.835 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.366 -0.826 . . . . 4.49 111.043 -175.378 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.97 0.414 . . . . 17.49 110.557 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 m -155.98 92.18 1.34 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.735 -0.839 . . . . 15.32 108.735 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.402 ' HB3' ' H ' ' A' ' 4' ' ' HIS . 4.6 t60 -75.62 -84.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.036 -0.529 . . . . 15.81 110.641 -174.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.402 ' H ' ' HB3' ' A' ' 3' ' ' HIS . 2.4 m80 -166.36 -75.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.348 -0.612 . . . . 14.19 109.348 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -110.42 -176.89 3.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.047 -0.524 . . . . 14.91 109.779 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.11 134.38 3.24 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.196 -1.002 . . . . 10.79 112.692 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -90.45 99.6 12.59 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.869 -0.419 . . . . 11.39 109.869 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.01 -62.22 0.5 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.758 -0.734 . . . . 9.0 111.739 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.563 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -49.88 127.11 15.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.274 -0.269 . . . . 9.76 110.274 173.357 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -69.97 2.05 3.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.115 -0.493 . . . . 11.19 111.599 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.589 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 9.6 t30 -116.84 -15.23 10.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.282 -0.417 . . . . 10.8 110.337 174.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.95 -97.17 1.89 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.839 -0.696 . . . . 8.82 111.934 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 11' ' ' ASN . 17.8 Cg_endo -60.48 160.83 22.45 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.134 2.556 . . . . 7.87 113.039 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.22 3.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.619 1.168 . . . . 10.62 113.902 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -68.09 -19.66 64.87 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.92 0.867 . . . . 9.87 108.988 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.42 ' CE3' ' HB2' ' A' ' 11' ' ' ASN . 5.7 t-105 -62.75 -8.59 7.05 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.18 -1.373 . . . . 8.48 111.813 175.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 20' ' ' PHE . 8.7 p-80 -59.48 -3.5 0.46 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.056 1.132 . . . . 7.13 114.056 -172.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -52.59 -29.37 25.44 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.484 0.55 . . . . 9.68 112.484 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -123.49 12.49 9.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.185 0.517 . . . . 7.89 111.037 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 22' ' ' ILE . 78.6 m-85 -124.88 106.3 29.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.701 -0.681 . . . . 7.17 110.114 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.04 -26.91 19.98 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.588 2.858 . . . . 7.76 114.226 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.58 HD12 HD22 ' A' ' 202' ' ' LEU . 4.5 tt -14.0 -47.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 114.544 1.313 . . . . 5.83 114.544 169.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.32 -24.52 4.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.756 0.651 . . . . 5.44 112.756 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -117.79 -10.77 10.43 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.077 0.399 . . . . 7.78 112.077 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.96 -87.29 0.06 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 119.979 -1.105 . . . . 5.01 113.416 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.657 ' HA ' ' OE2' ' A' ' 204' ' ' GLU . 1.2 mp0 -40.83 168.8 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.893 1.072 . . . . 7.09 113.893 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.486 HH21 ' CD ' ' A' ' 204' ' ' GLU . 14.4 ptp180 -151.61 138.2 18.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.32 -0.993 . . . . 5.13 108.32 -153.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -73.26 -62.64 1.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.457 0.572 . . . . 7.12 110.9 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.6 m -105.91 155.05 38.98 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 107.307 -1.368 . . . . 3.94 107.307 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 253' ' ' ARG . 1.6 Cg_endo -82.18 -50.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.249 0 CA-C-N 120.114 1.076 . . . . 4.52 112.468 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 255' ' ' ILE . 6.3 p -169.1 143.25 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.726 -0.39 . . . . 4.54 111.632 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 31' ' ' VAL . 1.1 p-10 -84.62 139.74 31.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.871 -0.789 . . . . 2.88 108.871 164.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.53 ' HA ' HD13 ' A' ' 255' ' ' ILE . 64.7 mt -86.29 86.83 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.494 0.664 . . . . 2.32 110.888 -171.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -94.29 101.73 13.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.681 -0.69 . . . . 2.82 109.146 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -58.62 -25.31 62.54 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.612 0.597 . . . . 2.24 112.612 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -73.87 -44.14 56.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 4.54 110.455 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 m -81.36 -21.02 39.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.459 . . . . 3.06 111.284 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 255' ' ' ILE . . . -56.8 142.1 42.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.468 -0.333 . . . . 1.72 110.826 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -134.42 114.46 12.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.706 0.289 . . . . 3.69 110.557 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -63.18 135.67 57.28 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.559 -0.534 . . . . 4.64 109.559 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -108.37 120.59 46.12 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.358 -0.383 . . . . 2.27 110.0 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.39 -24.02 50.47 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.695 2.264 . . . . 2.15 112.982 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.0 m -77.89 -26.84 49.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.795 0.331 . . . . 4.29 111.026 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 92.1 mt -83.28 140.9 32.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 4.74 110.475 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.44 159.92 38.13 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.082 -0.508 . . . . 3.77 110.864 -174.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.78 162.91 6.14 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.235 2.623 . . . . 2.36 113.255 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.576 ' HG ' ' CE2' ' A' ' 190' ' ' TYR . 95.2 mt -71.14 132.64 45.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 2.55 111.27 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 m -100.06 97.11 7.99 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.245 -1.021 . . . . 2.38 108.245 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.72 103.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.086 -0.506 . . . . 1.59 109.853 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.5 m -99.59 89.47 4.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.302 -0.629 . . . . 1.45 109.302 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -112.2 10.13 20.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.209 -0.45 . . . . 3.62 111.207 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.84 -30.71 64.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.891 0.377 . . . . 2.48 111.547 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 24.7 mp0 -109.04 39.64 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.361 -0.381 . . . . 2.24 110.427 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.99 57.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.821 0.343 . . . . 0.8 111.762 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 63.4 m -138.55 107.11 5.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.06 110.645 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -92.47 153.61 19.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.523 -0.547 . . . . 1.26 109.523 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -116.27 -58.62 2.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.505 0.558 . . . . 0.74 112.505 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -169.17 163.19 10.99 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.357 -0.214 . . . . 3.17 110.824 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -114.45 144.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.237 -0.283 . . . . 0.64 110.237 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -132.13 144.6 50.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.96 110.952 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -111.54 115.86 29.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 1.49 109.909 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -110.52 72.97 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.371 0.605 . . . . 1.83 110.929 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.77 -35.25 0.48 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 114.721 -1.127 . . . . 1.64 115.146 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -150.6 -29.78 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 117.104 0.452 . . . . 3.33 111.514 -173.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.43 161.87 25.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.583 -0.525 . . . . 1.38 109.583 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -129.19 121.55 27.92 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.194 0.521 . . . . 2.74 110.354 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -111.87 139.8 47.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 1.76 110.088 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 40.8 t -100.77 117.64 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.655 -0.498 . . . . 1.15 109.655 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.81 119.34 21.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 2.02 110.37 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -108.36 150.68 27.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.644 -0.707 . . . . 1.66 109.63 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 9.5 t0 -81.87 109.88 16.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 1.33 110.803 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.84 56.36 0.81 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.564 0.697 . . . . 2.65 110.334 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -89.23 -9.07 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 1.61 111.804 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 76' ' ' LYS . 11.5 pt20 -163.35 177.91 8.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.549 . . . . 2.35 109.516 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -76.41 23.47 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.257 0.348 . . . . 1.92 111.731 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 16.9 ptpt -54.08 -39.67 66.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.473 -0.331 . . . . 1.77 111.717 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -133.18 101.27 5.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.114 0.483 . . . . 0.76 110.332 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 89' ' ' ARG . 11.8 m -125.28 166.12 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.979 -0.555 . . . . 1.27 111.087 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.92 115.06 7.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.724 . . . . 1.29 109.844 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -145.13 123.5 12.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.058 0.456 . . . . 2.54 111.315 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -73.41 175.89 45.65 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 119.092 -0.838 . . . . 1.31 111.154 164.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.08 -143.4 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 N-CA-C 115.124 0.81 . . . . 1.9 115.124 168.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 72.3 Cg_exo -49.34 120.0 5.19 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.697 1.598 . . . . 2.91 112.728 -173.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 mt -154.35 -168.08 2.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.561 -1.2 . . . . 4.11 108.798 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.93 44.13 2.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.753 0.311 . . . . 4.95 110.954 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.503 ' HA3' ' OD1' ' A' ' 124' ' ' ASN . . . 129.59 -177.84 17.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.971 -0.633 . . . . 2.25 112.829 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 m -107.76 133.8 51.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.455 -0.572 . . . . 1.91 109.455 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 51.5 m-85 -108.66 114.28 27.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.958 0.408 . . . . 3.7 111.948 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 98.5 mtt180 -79.15 140.53 37.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.103 -0.499 . . . . 3.54 110.468 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.53 124.6 24.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.762 -0.458 . . . . 1.14 109.762 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 tt -117.8 -41.6 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 111.701 0.26 . . . . 1.68 111.701 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 10.0 pt20 -159.11 165.21 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.858 -0.423 . . . . 1.55 109.858 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CB ' HD23 ' A' ' 120' ' ' LEU . 42.4 p90 -146.98 161.01 41.67 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.007 -0.277 . . . . 0.86 111.456 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.432 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 11.7 p-80 -146.56 160.22 42.43 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.914 -0.585 . . . . 0.93 109.861 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.3 m-85 -122.75 148.93 44.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.889 0.376 . . . . 3.17 111.396 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -105.55 175.89 5.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.335 -0.617 . . . . 1.68 109.335 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -172.81 114.19 0.27 Allowed 'General case' 0 N--CA 1.463 0.176 0 O-C-N 123.199 0.312 . . . . 5.18 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.761 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -79.03 154.5 39.32 Favored Glycine 0 C--O 1.226 -0.397 0 N-CA-C 111.435 -0.666 . . . . 2.13 111.435 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 t -65.11 -29.25 70.1 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.195 0.997 . . . . 2.9 110.063 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.9 mt -106.4 144.98 32.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.448 -0.797 . . . . 3.03 109.438 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.19 70.3 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.553 0.533 . . . . 3.85 111.003 176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.66 43.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 1.94 112.741 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' ALA . 13.0 pt20 -173.12 164.01 4.78 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 110.1 -0.333 . . . . 2.45 110.1 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.58 -1.78 49.38 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.509 -0.853 . . . . 1.47 114.1 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 p -90.63 -26.73 19.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.825 0.676 . . . . 2.0 112.825 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 244' ' ' TRP . 0.6 OUTLIER 71.58 -170.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.749 -1.204 . . . . 3.72 107.749 -169.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.2 m80 54.99 71.37 0.54 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.312 0.505 . . . . 3.52 110.612 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 113' ' ' LYS . 14.2 p -87.0 116.3 24.96 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.448 -0.501 . . . . 2.52 110.723 -165.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 26.4 t -82.7 93.62 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.874 -0.417 . . . . 2.48 109.874 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 58.64 54.57 5.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.457 -0.572 . . . . 2.8 109.457 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 69.51 -2.33 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.106 -0.952 . . . . 4.98 112.578 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 23.1 ttmm -86.36 124.03 32.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.081 0.467 . . . . 3.23 111.192 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.543 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -116.33 138.09 51.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.799 -0.637 . . . . 2.82 109.694 175.359 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -88.38 159.99 17.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.639 -0.71 . . . . 1.62 110.499 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.526 ' HA ' ' H ' ' A' ' 103' ' ' GLN . . . -64.46 -20.05 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.846 . . . . 1.03 112.372 -174.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 147' ' ' LEU . . . -166.05 168.73 15.27 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.951 -0.389 . . . . 0.75 109.951 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -154.27 142.75 20.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.596 -0.52 . . . . 1.58 109.596 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 95' ' ' PHE . 15.1 tp -100.79 127.69 47.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.748 -0.66 . . . . 1.07 109.85 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.432 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.1 m170 -114.55 101.48 9.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.26 0.552 . . . . 1.77 110.831 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 48.0 mt -83.2 107.89 16.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.229 -0.896 . . . . 0.93 109.834 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 142' ' ' VAL . 41.3 t -82.57 123.27 38.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.384 0.612 . . . . 0.61 111.459 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 52.2 m80 -123.09 147.22 46.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.289 -0.868 . . . . 2.13 109.387 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.671 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 62.5 p-90 -120.53 142.58 49.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.979 0.418 . . . . 4.26 111.113 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.503 ' OD1' ' HA3' ' A' ' 86' ' ' GLY . 30.2 t30 -66.58 111.91 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.02 111.288 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.671 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 12.1 t -70.58 -16.35 62.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.564 -0.743 . . . . 2.34 111.784 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.405 ' HB3' HD21 ' A' ' 124' ' ' ASN . 38.2 ttpt -58.4 -20.82 47.4 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.224 0.453 . . . . 3.35 112.224 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.48 6.2 49.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.135 0.493 . . . . 3.1 111.265 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.82 -3.46 3.84 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.773 1.069 . . . . 2.37 115.773 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -172.75 148.45 1.88 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.696 1.248 . . . . 3.93 110.104 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 134' ' ' VAL . 38.4 p90 -60.67 -34.11 73.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.607 -1.179 . . . . 3.0 112.563 -173.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.41 97.88 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.013 -0.613 . . . . 2.15 112.748 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -76.7 -27.99 55.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.966 0.412 . . . . 3.43 110.473 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.696 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -62.44 -35.42 79.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 1.76 110.866 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 130' ' ' PHE . 47.4 t -65.32 -16.92 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.077 -0.51 . . . . 2.77 111.26 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.59 -13.57 57.85 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.071 -0.393 . . . . 3.55 111.144 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 41.8 tt0 -102.53 134.15 20.1 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.786 -0.45 . . . . 3.02 109.786 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 51.5 Cg_exo -55.37 -26.12 51.39 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.975 2.45 . . . . 1.6 112.618 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 23.0 m-20 -111.98 27.24 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.07 0.462 . . . . 2.29 109.863 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.696 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -79.13 -33.6 35.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.015 -0.612 . . . . 1.22 113.729 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.404 ' HB2' HG22 ' A' ' 206' ' ' VAL . 85.3 mt -110.44 157.01 20.04 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.706 -0.479 . . . . 1.57 109.706 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.31 127.07 13.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.723 0.297 . . . . 1.38 110.24 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 121' ' ' VAL . 27.9 m -116.51 139.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 120.767 0.318 . . . . 1.73 110.358 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.2 tp -99.07 109.26 22.01 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.347 -0.612 . . . . 2.42 109.347 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -91.72 111.84 4.08 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.75 -0.659 . . . . 0.86 112.298 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.7 mt -109.42 118.17 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.726 -0.472 . . . . 0.76 109.726 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -69.54 143.24 53.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.405 -0.361 . . . . 1.2 111.303 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 10.8 mp -112.92 120.02 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.133 -0.485 . . . . 0.88 110.185 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.08 142.11 43.68 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.792 -0.818 . . . . 2.03 108.792 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.06 135.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 1.27 110.802 -174.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.01 -95.53 0.11 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.126 -0.789 . . . . 1.53 111.126 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.1 m -82.08 141.83 32.82 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.721 -0.474 . . . . 1.54 109.721 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.61 41.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.897 -0.592 . . . . 0.78 111.825 -174.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.9 tptt -117.28 102.17 52.53 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.474 . . . . 1.22 110.104 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.62 -42.41 67.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.442 2.762 . . . . 1.05 112.487 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 182' ' ' GLY . . . -59.33 -33.69 76.92 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.073 -0.584 . . . . 0.7 112.954 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.73 -30.95 22.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.152 0.501 . . . . 0.77 110.536 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -37.4 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.41 110.662 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -52.98 -49.44 66.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.204 -0.907 . . . . 2.86 112.414 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.92 -38.62 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 1.38 111.415 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.436 HG12 ' HD2' ' A' ' 224' ' ' LYS . 88.3 t -59.1 -39.6 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.21 0.529 . . . . 1.11 111.293 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.36 -15.76 39.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 1.22 112.284 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.34 -11.15 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.802 0.334 . . . . 1.41 111.399 -176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.87 -33.6 67.01 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.954 0.724 . . . . 1.39 112.954 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.57 -26.69 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.884 0.373 . . . . 2.31 111.524 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.7 m -80.89 -1.03 41.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.951 0.352 . . . . 1.4 111.951 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.6 pt -131.92 36.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.85 110.069 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.19 -33.58 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 1.59 112.669 -170.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 230' ' ' PHE . 18.0 p -119.48 159.51 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.857 0.361 . . . . 0.77 111.396 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -52.6 131.73 34.72 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.594 -0.73 . . . . 2.29 112.043 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.44 -28.44 15.01 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.871 -0.68 . . . . 0.85 112.451 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.79 143.62 52.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.212 0.53 . . . . 1.7 111.188 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.7 m -134.21 150.41 51.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 1.37 109.147 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -136.87 129.79 30.77 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.176 -0.305 . . . . 0.61 110.176 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.22 137.02 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.059 0.457 . . . . 1.8 110.672 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -140.85 80.4 1.75 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.197 -0.668 . . . . 1.04 109.197 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.0 p -116.04 163.66 15.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.469 -0.332 . . . . 1.17 111.466 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 58.91 36.98 24.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.848 -0.615 . . . . 1.77 111.276 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -129.75 133.79 47.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 3.99 110.202 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 181' ' ' ARG . 4.2 p30 -109.39 145.83 32.68 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.496 -0.775 . . . . 2.51 111.067 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 6.0 Cg_exo -79.0 -5.58 14.61 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.026 2.484 . . . . 1.26 112.342 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.494 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 5.6 tmm_? -57.6 -38.57 75.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.184 -0.462 . . . . 2.76 110.508 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -68.02 -7.03 48.62 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.818 -0.628 . . . . 1.12 113.361 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.94 -12.27 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.129 0.465 . . . . 1.73 111.015 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.53 129.99 55.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 3.45 110.645 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.89 -170.02 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.02 2.48 . . . . 2.08 113.404 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.93 -65.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.065 0.765 . . . . 3.23 113.065 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 12.9 m -68.95 131.61 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 1.66 111.328 -172.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.86 62.87 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 1.99 110.832 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 212' ' ' LYS . 13.9 t0 -127.65 141.59 51.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.435 -0.95 . . . . 1.81 108.435 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 47' ' ' LEU . 51.9 p90 -149.23 158.24 44.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.967 0.413 . . . . 5.01 111.846 -166.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 9.2 m-90 -115.51 107.36 15.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.534 -0.757 . . . . 3.93 109.077 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 5.9 t -96.31 117.2 30.32 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.828 0.677 . . . . 2.13 112.828 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -139.21 128.51 14.11 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 5.21 109.989 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 58.4 Cg_exo -53.38 136.72 63.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.191 2.594 . . . . 2.12 113.674 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -140.49 156.7 25.37 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.027 -0.533 . . . . 1.75 112.839 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 32.4 t -65.61 126.08 27.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.241 0.543 . . . . 2.99 109.812 173.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 197' ' ' LEU . 2.3 pt? -59.67 -47.05 87.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.968 -1.015 . . . . 4.75 113.646 -168.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.465 ' N ' ' HG ' ' A' ' 197' ' ' LEU . 3.5 t -121.1 -25.4 5.32 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.918 -0.313 . . . . 5.1 111.54 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.43 ' HB ' ' HD3' ' A' ' 200' ' ' PRO . 32.5 m 105.67 -57.59 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.087 1.355 . . . . 5.53 113.647 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 82.1 Cg_exo -42.61 -51.41 5.19 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.603 2.202 . . . . 5.83 115.701 -177.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 71.6 Cg_endo -76.34 -15.98 17.58 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.709 1.606 . . . . 4.78 112.124 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.58 HD22 HD12 ' A' ' 22' ' ' ILE . 88.0 mt 55.61 70.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.746 -0.661 . . . . 3.84 110.988 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 196' ' ' SER . 43.7 tp -131.15 132.15 44.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.513 -0.767 . . . . 2.96 109.804 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.657 ' OE2' ' HA ' ' A' ' 26' ' ' GLU . 8.2 pt-20 -106.33 62.67 0.65 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.381 0.61 . . . . 3.37 110.868 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 73.9 m -108.64 15.1 24.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 2.15 110.868 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 95.2 t -117.9 137.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 1.26 111.082 -177.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.8 m -98.19 104.67 16.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.475 -0.935 . . . . 2.08 108.475 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' A' ' 192' ' ' THR . 0.0 OUTLIER -86.7 100.61 12.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 5.53 110.924 -174.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.568 HG23 ' CD1' ' A' ' 190' ' ' TYR . 75.1 mt -96.42 100.02 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 1.63 109.479 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 191' ' ' TRP . 16.3 m -99.6 125.64 53.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.183 0.515 . . . . 1.62 110.603 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.2 tp -87.44 137.3 32.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.634 -0.712 . . . . 1.73 109.595 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 20.5 pttp -72.44 -11.2 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.035 0.383 . . . . 2.98 112.035 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.2 tp10 -101.11 105.98 42.14 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.655 0.264 . . . . 1.47 110.944 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 5.9 Cg_exo -75.47 149.69 35.17 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.886 2.391 . . . . 0.96 111.771 175.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.9 pt -99.82 147.25 7.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.001 -0.37 . . . . 1.25 110.001 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 42.7 m -92.35 123.79 35.94 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.567 -0.531 . . . . 1.29 109.567 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.14 163.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.886 -0.597 . . . . 1.02 110.265 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 41.3 t -90.25 147.38 23.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.125 0.488 . . . . 1.08 110.226 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.7 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 7.5 p -56.49 -35.36 67.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 1.33 110.653 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -70.06 -21.84 63.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.678 -0.692 . . . . 2.51 111.188 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -80.17 -51.74 8.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.393 . . . . 0.7 110.132 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.606 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 13.0 m -64.84 -29.21 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.455 0.539 . . . . 1.36 112.455 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.9 mt -66.05 -27.36 68.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 1.03 111.01 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.467 ' HA ' ' CG ' ' A' ' 227' ' ' LYS . 68.6 mttm -74.6 -21.0 59.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.267 -0.424 . . . . 1.75 110.959 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 26.2 m-85 -66.89 -19.06 65.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.106 0.479 . . . . 2.47 110.178 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -103.68 9.43 37.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 3.04 110.257 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 224' ' ' LYS . 12.5 mmmm -91.0 1.46 57.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 2.31 111.028 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.24 133.77 35.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.206 -0.664 . . . . 0.95 109.206 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 238' ' ' GLU . 3.3 p30 -159.19 -178.72 7.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.931 0.345 . . . . 1.13 111.931 -176.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.455 ' HB3' HG22 ' A' ' 168' ' ' THR . 35.0 t80 52.94 81.14 0.09 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.094 -0.957 . . . . 3.74 112.48 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.584 ' CG ' ' H ' ' A' ' 232' ' ' GLY . 29.0 p-10 -54.41 -87.65 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.051 -0.522 . . . . 1.62 111.61 171.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' A' ' 231' ' ' ASN . . . -125.08 -158.7 10.1 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.839 -0.696 . . . . 1.16 112.26 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.09 145.32 24.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.148 -0.315 . . . . 3.56 110.148 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.95 14.61 82.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.77 . . . . 2.08 112.288 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -148.72 107.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.59 108.64 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.11 114.32 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 120.722 0.948 . . . . 1.36 111.116 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -139.37 104.08 4.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.51 -0.768 . . . . 3.4 111.442 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 229' ' ' ASN . 7.3 pt-20 -154.27 94.96 1.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.714 0.768 . . . . 2.47 109.951 157.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.25 99.63 4.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.237 -0.892 . . . . 2.14 109.501 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -118.4 82.87 1.92 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.965 -1.124 . . . . 1.68 107.965 172.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.8 m -156.57 133.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.906 -1.043 . . . . 1.27 110.141 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.761 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER 63.52 -79.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.239 0.962 . . . . 2.18 112.481 173.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 48.4 47.57 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.318 0.386 . . . . 2.15 110.681 -171.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 106' ' ' GLU . 85.9 t90 -105.12 134.02 48.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.916 0.389 . . . . 4.59 110.792 -172.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 32.2 ptt180 -105.32 132.23 21.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.986 -0.552 . . . . 6.13 110.416 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.417 ' HA ' ' CH2' ' A' ' 244' ' ' TRP . 62.5 Cg_exo -53.97 128.0 27.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.163 2.576 . . . . 3.28 112.676 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.39 159.76 33.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.684 -0.689 . . . . 2.98 111.983 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -108.73 149.85 40.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 4.32 110.673 -173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 36.7 Cg_endo -63.7 147.3 92.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.641 2.894 . . . . 3.48 114.075 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 67.5 mt -68.23 -12.42 60.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.86 -1.063 . . . . 4.63 113.364 -171.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 61.6 pttt -61.08 42.84 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.382 1.623 . . . . 5.34 115.382 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 1.5 p30 125.42 -4.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.378 1.871 . . . . 4.64 109.926 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 30.7 mmt180 -116.69 82.67 1.83 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.438 -1.319 . . . . 6.11 107.438 168.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -134.69 158.1 44.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.102 -0.333 . . . . 3.08 110.102 -166.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 33' ' ' ILE . 5.1 pt -102.62 125.9 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.808 0.67 . . . . 2.6 112.808 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 81.7 mttt -101.64 144.2 30.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.396 -0.82 . . . . 2.63 109.028 165.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 190' ' ' TYR . . . -106.65 148.17 28.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.248 -0.649 . . . . 1.71 109.248 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 190' ' ' TYR . 5.4 m -131.64 95.1 3.65 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.887 -0.725 . . . . 2.21 111.864 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -156.95 133.48 9.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.967 -1.015 . . . . 4.31 108.674 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.569 -0.729 . . . . 4.49 110.363 -173.196 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttp . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.962 0.41 . . . . 17.49 110.464 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 p -162.63 -81.71 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 15.32 110.103 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -141.79 -55.9 0.46 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.22 -0.659 . . . . 15.81 109.22 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -142.22 161.83 37.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.35 -0.841 . . . . 14.19 110.008 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -90.55 135.23 33.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.348 -0.387 . . . . 14.91 110.342 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.09 176.89 38.47 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.735 -0.946 . . . . 10.79 110.735 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 9.1 p90 -80.05 110.63 15.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.332 0.566 . . . . 11.39 109.977 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.8 148.08 7.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.8 -0.714 . . . . 9.0 112.017 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 16' ' ' TRP . 13.2 mptt -53.14 123.18 11.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.017 0.437 . . . . 9.76 111.782 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.665 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 6.1 t-160 61.37 -88.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.009 0.923 . . . . 11.19 112.349 175.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -95.12 -14.76 23.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.785 0.326 . . . . 10.8 110.777 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 7' ' ' TYR . . . 135.45 -59.72 0.65 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.644 -0.789 . . . . 8.82 112.037 -174.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.98 126.12 18.79 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.213 1.942 . . . . 7.87 111.846 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' OE2' ' HD3' ' A' ' 9' ' ' LYS . 6.0 mm-40 -64.17 0.05 1.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.698 -0.683 . . . . 10.62 112.64 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -63.99 -4.3 3.3 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.163 0.506 . . . . 9.87 111.445 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.665 ' CD1' ' HB2' ' A' ' 10' ' ' HIS . 73.9 t-105 -87.13 -2.69 58.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.413 0.625 . . . . 8.48 109.866 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -56.53 -6.28 0.28 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.111 -0.95 . . . . 7.13 112.888 -170.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -58.91 -37.0 75.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.041 0.448 . . . . 9.68 110.768 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 31.5 t70 -68.0 -19.83 64.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.651 -0.704 . . . . 7.89 110.885 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -109.69 93.22 13.8 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.034 -0.53 . . . . 7.17 109.673 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 19' ' ' ASP . 50.1 Cg_exo -53.81 -45.35 41.64 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.889 2.393 . . . . 7.76 112.731 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.5 tt -59.16 -18.14 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.773 0.657 . . . . 5.83 112.773 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.06 -17.5 63.24 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.818 0.342 . . . . 5.44 110.973 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -72.02 3.74 4.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 7.78 111.182 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.82 168.12 46.99 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 111.375 -0.69 . . . . 5.01 111.375 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -115.32 115.77 27.18 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.173 -0.611 . . . . 7.09 109.97 -176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 1.8 mpt_? -136.61 169.31 17.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.385 0.539 . . . . 5.13 110.914 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.451 HE21 HD13 ' A' ' 255' ' ' ILE . 7.4 tm0? -45.4 112.31 0.44 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 124.093 0.87 . . . . 7.12 110.398 173.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 31' ' ' VAL . 40.9 m -98.88 145.61 30.26 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 115.545 -0.752 . . . . 3.94 110.48 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HA ' ' CD2' ' A' ' 107' ' ' HIS . 59.1 Cg_endo -71.92 25.6 0.25 Allowed 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 123.488 2.792 . . . . 4.52 113.112 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 247' ' ' ALA . 23.0 m -96.36 -175.47 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.4 -0.364 . . . . 4.54 111.201 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.513 ' HB2' HD21 ' A' ' 250' ' ' LEU . 1.4 m-20 -51.44 104.73 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 122.048 0.928 . . . . 2.88 111.956 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.0 127.56 38.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.219 -1.355 . . . . 2.32 110.015 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.29 99.27 10.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.169 -0.468 . . . . 2.82 109.985 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -54.25 -29.32 46.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 2.24 111.568 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -75.33 -28.64 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 4.54 110.675 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 m -81.69 -28.77 33.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.874 0.369 . . . . 3.06 110.487 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -67.05 108.71 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.532 . . . . 1.72 111.593 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -85.31 138.18 32.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.6 -0.727 . . . . 3.69 110.484 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 30.1 p90 -78.57 130.71 36.26 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.393 -0.595 . . . . 4.64 109.393 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -109.11 109.79 60.71 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.337 -0.392 . . . . 2.27 110.11 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.41 -17.36 57.26 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.031 2.488 . . . . 2.15 112.49 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 83' ' ' PRO . 49.1 m -75.58 -9.04 58.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 4.29 110.858 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -96.55 139.26 32.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.286 -0.415 . . . . 4.74 110.283 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.9 161.14 37.73 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.468 -0.567 . . . . 3.77 109.468 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.55 157.15 23.78 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.748 2.299 . . . . 2.36 112.816 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.419 ' HG ' ' CD2' ' A' ' 190' ' ' TYR . 91.9 mt -85.64 138.78 31.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 2.55 111.146 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -101.33 120.57 40.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.652 -0.87 . . . . 2.38 108.652 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.46 103.06 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.76 0.315 . . . . 1.59 110.659 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 91.25 3.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.264 -0.643 . . . . 1.45 109.264 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 p90 -137.95 20.01 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.923 0.392 . . . . 3.62 111.45 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.39 -18.8 64.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.304 -0.407 . . . . 2.48 111.21 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -103.18 10.74 37.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.534 -0.303 . . . . 2.24 110.737 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.66 125.74 24.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.863 0.363 . . . . 0.8 111.627 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.3 m -115.42 109.23 17.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.963 -0.562 . . . . 1.06 111.243 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -78.12 149.66 33.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.552 -0.536 . . . . 1.26 109.552 174.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -121.59 -54.97 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.974 0.416 . . . . 0.74 111.466 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 14.7 ptm180 -140.6 152.23 45.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.362 -0.381 . . . . 3.17 110.698 -175.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.0 tt -127.61 133.92 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.585 -0.895 . . . . 0.64 108.585 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.68 162.88 36.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.96 111.777 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 169' ' ' LYS . 0.9 OUTLIER -101.3 109.87 21.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.926 -1.034 . . . . 1.49 109.237 176.194 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.565 ' HB3' ' OD1' ' A' ' 67' ' ' ASN . 42.5 t30 -126.57 129.37 48.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.112 -0.495 . . . . 1.83 111.06 -174.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 26.4 -74.59 0.0 OUTLIER Glycine 0 N--CA 1.47 0.96 0 N-CA-C 117.45 1.74 . . . . 1.64 117.45 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' ASN . 25.7 m80 -83.14 -19.79 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.983 0.364 . . . . 3.33 111.983 -167.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 175.38 -141.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.966 -0.383 . . . . 1.38 109.966 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -118.12 143.79 46.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.072 -1.085 . . . . 2.74 108.072 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 13.5 m120 -128.24 128.62 45.03 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.086 -0.339 . . . . 1.76 110.086 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.97 121.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.209 0.528 . . . . 1.15 109.851 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 58' ' ' ARG . 55.7 mm-40 -90.07 138.98 31.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 2.02 111.433 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.92 157.26 22.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.493 -0.776 . . . . 1.66 109.235 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.77 108.37 13.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.216 -0.661 . . . . 1.33 109.216 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -108.51 58.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.663 0.744 . . . . 2.65 110.607 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -100.85 -13.58 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.573 -0.74 . . . . 1.61 111.416 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -152.09 177.59 10.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.103 -0.499 . . . . 2.35 109.942 -170.034 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -82.01 65.96 7.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 1.92 110.987 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 58.6 mttm -90.59 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.946 -0.57 . . . . 1.77 109.838 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -114.39 99.03 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 0.76 110.267 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.88 145.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.94 -0.573 . . . . 1.27 110.51 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 tp -137.58 112.08 8.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 1.29 109.725 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 22.1 pttm -153.8 126.13 8.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 2.54 111.743 175.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.87 177.93 46.64 Favored Glycine 0 C--O 1.221 -0.707 0 CA-C-N 115.462 -0.79 . . . . 1.31 112.753 173.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.91 -132.76 0.0 OUTLIER Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.73 1.157 . . . . 1.9 115.764 167.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 43' ' ' SER . 78.9 Cg_exo -44.12 170.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.179 3.253 . . . . 2.91 114.43 -171.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.3 tp -32.37 75.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.553 1.316 . . . . 4.11 114.553 -145.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 80' ' ' LYS . 15.1 p-10 -76.73 -71.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.314 -1.766 . . . . 4.95 112.635 173.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 82.06 127.45 0.99 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.384 -1.086 . . . . 2.25 110.384 -165.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.9 m -63.48 103.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.103 0.452 . . . . 1.91 111.734 -174.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.561 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 63.6 m-85 -95.04 126.99 40.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.867 -0.606 . . . . 3.7 111.026 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -103.85 143.97 32.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.312 -0.403 . . . . 3.54 110.243 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 34.4 tp -81.52 132.01 35.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 1.14 110.86 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.7 tt -109.21 -35.0 2.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.183 -0.462 . . . . 1.68 110.784 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 172.25 8.42 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.341 -0.39 . . . . 1.55 110.316 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 118' ' ' LEU . 9.4 p90 -151.4 153.36 34.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.86 110.347 169.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.485 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 13.5 p-80 -148.16 157.64 43.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.559 -0.746 . . . . 0.93 109.62 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB3' ' HA ' ' A' ' 118' ' ' LEU . 53.1 p90 -139.7 123.06 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.773 -0.771 . . . . 3.17 111.374 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -94.73 146.24 24.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.099 -0.955 . . . . 1.68 110.353 171.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -132.7 170.81 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.603 -0.518 . . . . 5.18 109.603 -176.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -95.89 173.83 31.0 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.488 -0.863 . . . . 2.13 112.777 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.5 t -68.26 -28.0 66.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.283 0.563 . . . . 2.9 109.957 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.63 141.14 47.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.589 -0.732 . . . . 3.03 109.091 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 149' ' ' VAL . 4.8 p-10 -68.26 -5.88 20.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.168 0.432 . . . . 3.85 112.168 -174.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.79 10.06 57.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.807 -0.711 . . . . 1.94 113.047 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -164.41 170.28 16.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.892 0.346 . . . . 2.45 110.916 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 113.41 -14.59 22.86 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.502 -0.856 . . . . 1.47 112.518 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.3 t -75.59 -34.59 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.411 0.148 . . . . 2.0 111.203 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.469 ' HG2' ' NE1' ' A' ' 244' ' ' TRP . 0.0 OUTLIER 66.35 -172.19 0.19 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.6 0.563 . . . . 3.72 110.036 -171.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.561 ' CD2' ' HA ' ' A' ' 30' ' ' PRO . 17.3 m80 52.44 44.69 29.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.66 0.743 . . . . 3.52 109.62 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -79.29 117.47 20.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.034 . . . . 2.52 111.397 -172.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.04 95.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.692 -1.14 . . . . 2.48 110.504 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 58.66 60.04 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.844 -1.071 . . . . 2.8 110.824 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm 69.71 11.51 7.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.73 -0.668 . . . . 4.98 112.527 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -96.23 97.19 9.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.826 0.346 . . . . 3.23 110.644 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.496 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 98.6 mttt -96.11 148.38 22.74 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.261 -0.644 . . . . 2.82 109.261 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -106.6 -176.6 3.12 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.6 -0.519 . . . . 1.62 109.6 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.4 -43.55 66.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.803 0.335 . . . . 1.03 111.19 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.52 164.04 37.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 0.75 110.269 -174.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.519 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 29.6 tt0 -130.38 124.16 31.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 1.58 109.792 176.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 94' ' ' HIS . 56.7 tp -91.04 114.97 27.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.797 . . . . 1.07 110.214 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.485 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 22.5 m170 -102.91 106.55 17.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.159 -0.473 . . . . 1.77 110.615 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -95.74 108.09 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.256 -0.646 . . . . 0.93 109.256 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -81.91 126.34 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.339 -0.392 . . . . 0.61 110.822 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 58.5 m80 -125.56 145.17 50.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.834 -0.432 . . . . 2.13 109.834 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -124.6 143.91 50.45 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.83 -0.804 . . . . 4.26 108.83 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 87' ' ' THR . 35.8 p30 -83.52 139.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.859 0.837 . . . . 2.02 111.687 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -66.08 -16.01 63.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.095 -0.957 . . . . 2.34 110.567 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -50.63 -44.35 57.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 3.35 112.097 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -93.6 6.95 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.513 -0.475 . . . . 3.1 111.092 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.47 1.52 1.77 Allowed Glycine 0 C--N 1.335 0.472 0 N-CA-C 115.523 0.969 . . . . 2.37 115.523 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 132' ' ' LYS . 16.6 t70 -169.14 137.04 1.9 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.739 0.769 . . . . 3.93 109.658 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.607 ' O ' HG23 ' A' ' 134' ' ' VAL . 26.5 p90 -60.22 -43.27 96.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.714 -0.676 . . . . 3.0 110.984 -177.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -35.52 90.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.274 -0.489 . . . . 2.15 112.599 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -68.36 -37.59 80.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.773 -0.455 . . . . 3.43 109.773 177.152 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.88 -29.27 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 1.76 110.705 178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -65.57 -20.03 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 2.77 111.315 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -88.53 -1.74 58.22 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.762 -0.586 . . . . 3.55 111.614 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -126.21 143.17 44.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.868 0.366 . . . . 3.02 110.483 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 26.6 Cg_endo -62.0 -24.63 76.97 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.431 2.754 . . . . 1.6 113.493 -175.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -110.41 27.03 10.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.904 -0.406 . . . . 2.29 109.904 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -81.25 -48.53 5.95 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.946 -0.645 . . . . 1.22 113.788 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.496 HD11 HG22 ' A' ' 134' ' ' VAL . 85.8 mt -107.79 161.13 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.085 0.469 . . . . 1.57 111.316 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.3 104.9 4.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.624 -0.716 . . . . 1.38 110.33 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.4 t -97.66 115.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.236 -0.438 . . . . 1.73 109.858 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 63.5 tp -88.11 111.54 21.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.867 -0.606 . . . . 2.42 109.684 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.79 108.85 3.61 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.189 -0.529 . . . . 0.86 111.935 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 mt -102.07 130.77 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.158 -0.312 . . . . 0.76 110.158 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 69.9 m-85 -75.55 145.75 41.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.663 -0.244 . . . . 1.2 110.527 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.35 117.68 30.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.695 -0.483 . . . . 0.88 109.695 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 216' ' ' SER . 20.5 ptmt -114.72 152.42 32.05 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.283 -0.636 . . . . 2.03 109.283 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 29.3 t -92.26 131.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 1.27 110.861 -176.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.86 -105.55 0.21 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.627 -0.989 . . . . 1.53 110.627 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.5 m -70.03 160.61 31.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.506 -0.553 . . . . 1.54 109.506 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.61 159.22 15.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.573 -0.285 . . . . 0.78 111.193 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 216' ' ' SER . 12.4 mmmm -111.03 99.89 44.68 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.573 -0.899 . . . . 1.22 108.573 172.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.75 -21.05 61.7 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.984 2.456 . . . . 1.05 113.355 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.19 -13.34 81.01 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.654 -0.784 . . . . 0.7 112.919 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.9 tp -87.13 -17.96 31.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.77 111.004 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -60.41 -39.5 87.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.41 112.265 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 162' ' ' VAL . 30.7 mmmt -58.29 -40.92 83.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.618 0.247 . . . . 2.86 111.02 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.87 -46.9 84.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.262 0.553 . . . . 1.38 110.166 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 46.9 t -67.19 -27.68 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 1.11 111.295 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.02 -34.57 66.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 1.22 111.562 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 158' ' ' LYS . 87.7 t -82.54 -23.39 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.417 -0.356 . . . . 1.41 111.781 -174.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.7 pp -69.56 -12.84 61.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.018 0.437 . . . . 1.39 111.428 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.31 -26.5 68.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.088 0.47 . . . . 2.31 110.444 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.1 t -81.31 0.74 35.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 1.4 111.432 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.14 43.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.268 -0.641 . . . . 0.85 109.268 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.4 -38.37 66.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.084 -0.962 . . . . 1.59 112.622 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.8 p -105.52 149.9 25.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.631 0.253 . . . . 0.77 110.945 -177.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.501 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 61.7 pttt -66.54 141.14 57.96 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.973 -0.38 . . . . 2.29 109.973 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.34 -22.44 30.91 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.43 -0.89 . . . . 0.85 111.681 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -82.57 156.17 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 1.7 110.488 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -145.96 153.57 40.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.208 -0.451 . . . . 1.37 109.986 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.12 154.35 45.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.827 -0.435 . . . . 0.61 109.827 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.29 135.42 39.62 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.845 -0.428 . . . . 1.8 109.845 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.56 80.39 1.77 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.728 -0.841 . . . . 1.04 108.728 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.5 p -113.41 165.12 12.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.703 -0.68 . . . . 1.17 112.065 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.2 t30 54.9 57.84 5.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.5 -0.773 . . . . 1.77 111.113 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -135.1 131.75 37.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.835 -0.62 . . . . 3.99 109.824 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 13.0 m-20 -106.19 118.48 54.77 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.851 -0.425 . . . . 2.51 109.851 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 2.7 Cg_exo -76.21 -4.57 15.26 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.943 2.429 . . . . 1.26 112.898 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -59.05 -42.85 91.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.32 . . . . 2.76 111.548 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.05 -3.04 9.64 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.208 -0.52 . . . . 1.12 113.601 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 180' ' ' PRO . 7.8 mp -100.57 -1.29 35.87 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.66 -0.318 . . . . 1.73 111.117 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.0 pp -54.69 150.13 19.32 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 112.742 0.645 . . . . 3.45 112.742 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -91.05 -176.17 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.453 2.769 . . . . 2.08 111.467 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -85.69 -64.68 1.11 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.523 -0.471 . . . . 3.23 111.56 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.5 m -87.22 135.15 33.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.817 0.341 . . . . 1.66 111.495 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.21 62.89 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.404 0.621 . . . . 1.99 110.295 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 6.4 m-20 -116.37 170.05 8.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.944 -1.132 . . . . 1.81 107.944 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.419 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 46.6 p90 -168.04 161.73 12.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.793 1.035 . . . . 5.01 113.793 -166.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.441 ' HD1' ' O ' ' A' ' 210' ' ' VAL . 2.9 m95 -101.09 138.73 37.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.724 -1.584 . . . . 3.93 106.724 167.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.1 t -137.7 105.22 5.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.61 0.719 . . . . 2.13 112.031 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.501 ' CG ' ' HD2' ' A' ' 194' ' ' PRO . 25.9 t80 -139.3 149.6 61.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.264 -0.643 . . . . 5.21 109.264 173.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 193' ' ' TYR . 93.6 Cg_exo -46.88 129.91 15.18 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.456 2.104 . . . . 2.12 111.652 172.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.486 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -138.57 161.29 25.74 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.444 -0.798 . . . . 1.75 113.177 -166.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -99.59 131.66 45.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.831 -0.803 . . . . 2.99 108.831 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 197' ' ' LEU . 2.1 pt? -56.11 -48.21 76.61 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.673 1.36 . . . . 4.75 114.673 -163.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 197' ' ' LEU . 20.6 m -121.02 -44.08 2.42 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.065 -0.654 . . . . 5.1 112.344 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.401 ' HB ' ' OE1' ' A' ' 14' ' ' GLU . 50.0 p -104.9 162.19 20.51 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.4 -0.818 . . . . 5.53 111.471 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.463 ' HB3' ' HD2' ' A' ' 201' ' ' PRO . 74.6 Cg_exo -52.03 169.79 0.26 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.921 2.414 . . . . 5.83 111.767 169.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 200' ' ' PRO . 24.6 Cg_exo -16.98 111.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 1 C-N-CA 125.339 4.026 . . . . 4.78 115.849 -171.044 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 202' ' ' LEU . 2.0 tm? -151.59 -83.82 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.86 -1.063 . . . . 3.84 109.711 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 37.4 tp -118.45 131.97 56.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.293 . . . . 2.96 110.459 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 10.5 pt-20 -92.99 40.07 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.923 -0.581 . . . . 3.37 111.584 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 25.6 p -86.96 -4.49 59.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.293 0.568 . . . . 2.15 110.557 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 27.4 t -112.18 150.03 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.637 -0.71 . . . . 1.26 111.14 -173.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.9 m -107.21 103.5 12.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.332 -1.358 . . . . 2.08 107.332 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.432 ' HB2' ' HA3' ' A' ' 195' ' ' GLY . 1.1 t90 -75.52 102.29 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.033 0.444 . . . . 5.53 110.107 -172.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 42.3 mm -95.68 100.42 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.537 -0.756 . . . . 1.63 109.364 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.441 ' O ' ' HD1' ' A' ' 191' ' ' TRP . 32.4 t -94.03 119.03 41.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.42 -0.585 . . . . 1.62 109.42 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 189' ' ' ASP . 17.1 tp -73.95 122.45 22.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.949 0.404 . . . . 1.73 110.389 -174.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 17.8 tppt? -61.59 -21.91 64.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 2.98 111.995 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -95.14 111.87 56.41 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.642 -0.254 . . . . 1.47 110.537 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.422 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 98.4 Cg_endo -82.73 134.14 7.25 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.511 2.14 . . . . 0.96 111.752 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.7 pt -88.79 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 1.25 109.487 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.613 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 24.6 t -103.83 125.66 50.42 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.978 0.418 . . . . 1.29 110.763 -175.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.1 m -116.75 155.07 18.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 1.02 109.486 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.4 t -102.93 161.78 13.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.918 -0.313 . . . . 1.08 110.782 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.641 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 t -49.62 -54.06 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.668 0.605 . . . . 1.33 111.849 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 36.6 tt0 -52.56 -39.23 61.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.751 0.31 . . . . 2.51 111.781 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.4 -50.58 69.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.468 -0.333 . . . . 0.7 110.556 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.27 -19.95 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.429 -0.351 . . . . 1.36 111.587 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.2 mt -73.65 -44.26 57.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 1.03 110.558 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 52.5 mtpt -65.35 -25.86 67.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 1.75 110.562 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -75.29 -28.1 59.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.455 0.645 . . . . 2.47 109.744 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 56.1 ttp180 -71.8 -0.94 12.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.325 -0.852 . . . . 3.04 110.928 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -84.22 -14.14 50.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.982 0.42 . . . . 2.31 110.115 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.65 144.83 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.49 0.662 . . . . 0.95 111.257 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.3 m120 -108.56 139.58 43.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.325 -0.852 . . . . 1.13 109.645 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.501 ' O ' ' HD3' ' A' ' 169' ' ' LYS . 65.8 t80 -79.14 -30.81 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.744 . . . . 3.74 109.956 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -68.85 163.46 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 1.62 111.5 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.11 48.29 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.474 -1.05 . . . . 1.16 110.474 174.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.1 135.06 47.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.501 0.65 . . . . 3.56 110.553 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.29 41.71 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.749 . . . . 2.08 112.797 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.66 162.34 43.33 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.968 0.384 . . . . 2.59 110.017 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.15 127.55 26.78 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.221 1.947 . . . . 1.36 111.361 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.67 120.38 12.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.408 0.623 . . . . 3.4 111.776 -174.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 13.2 pt-20 -128.47 153.46 47.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.305 -0.861 . . . . 2.47 108.828 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.23 135.95 33.29 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.649 0.261 . . . . 2.14 110.761 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.9 ttm -80.1 88.43 5.41 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.832 -0.803 . . . . 1.68 108.832 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.5 m -142.55 144.17 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.834 -0.802 . . . . 1.27 108.834 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.44 -78.19 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.734 0.646 . . . . 2.18 110.397 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.1 t30 42.5 40.56 1.96 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.901 0.75 . . . . 2.15 112.176 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.469 ' NE1' ' HG2' ' A' ' 106' ' ' GLU . 38.6 t-105 -141.59 160.67 39.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.067 0.461 . . . . 4.59 111.341 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 245' ' ' ARG . 25.0 mmt180 -128.38 83.4 66.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.143 -1.058 . . . . 6.13 108.143 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -55.52 -87.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 124.053 3.169 . . . . 3.28 116.487 -160.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -81.08 102.3 10.15 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.293 1.22 . . . . 2.98 114.293 -162.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.657 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 12.0 mm100 -80.31 -178.0 1.05 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.243 -1.021 . . . . 4.32 108.243 160.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.657 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 34.1 Cg_exo -40.76 112.14 0.17 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 121.867 1.711 . . . . 3.48 112.355 175.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -60.05 -51.45 69.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 4.63 112.452 -164.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -60.83 -9.97 4.88 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.901 1.445 . . . . 5.34 114.901 -174.327 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 253' ' ' ARG . 8.5 p30 38.09 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 118.749 2.87 . . . . 4.64 118.749 167.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.614 ' NE ' ' HA ' ' A' ' 253' ' ' ARG . 0.4 OUTLIER 171.4 -156.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.324 1.049 . . . . 6.11 109.201 -165.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -131.72 130.15 41.6 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.726 -1.583 . . . . 3.08 106.726 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 43.8 mt -111.92 145.46 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.809 0.338 . . . . 2.6 111.416 -166.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -123.34 162.08 23.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 2.63 109.935 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -159.16 170.74 21.29 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.385 -0.598 . . . . 1.71 109.385 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 8.6 t -148.23 113.41 5.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.744 -0.382 . . . . 2.21 110.441 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.413 ' CD1' ' HG2' ' A' ' 212' ' ' LYS . 88.6 t80 -117.85 95.33 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 4.31 109.54 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.529 -0.748 . . . . 4.49 110.146 -178.366 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.002 0.43 . . . . 17.49 110.429 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 p -152.81 162.08 41.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.267 -0.424 . . . . 15.32 110.596 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -121.41 175.49 6.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.978 -0.555 . . . . 15.81 110.292 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -144.64 95.48 2.71 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.294 -0.632 . . . . 14.19 109.294 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -107.79 174.06 6.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.036 0.446 . . . . 14.91 111.317 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.42 -171.6 35.23 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.562 -1.015 . . . . 10.79 110.562 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -83.98 98.11 9.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 117.28 0.54 . . . . 11.39 110.779 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.81 -148.42 31.6 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.373 -0.831 . . . . 9.0 113.33 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.66 167.76 19.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 9.76 110.059 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 69.09 -66.6 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.717 0.636 . . . . 11.19 111.378 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.49 -15.05 56.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.945 0.402 . . . . 10.8 110.695 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -135.27 -168.08 11.52 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.813 -0.708 . . . . 8.82 111.811 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.519 ' O ' ' HE3' ' A' ' 16' ' ' TRP . 96.6 Cg_endo -80.27 135.74 10.97 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.511 2.141 . . . . 7.87 111.829 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.73 3.48 25.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.016 -0.538 . . . . 10.62 110.588 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -111.2 22.51 15.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.803 -0.635 . . . . 9.87 110.36 -172.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.519 ' HE3' ' O ' ' A' ' 13' ' ' PRO . 15.1 p90 -64.1 -18.58 64.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.608 -0.269 . . . . 8.48 111.557 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -68.01 -19.94 64.96 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.839 -0.43 . . . . 7.13 109.839 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -85.13 -36.13 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 9.68 110.69 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 74.8 m-20 -84.63 -29.75 25.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 7.89 111.054 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -107.44 102.46 44.31 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.223 -0.444 . . . . 7.17 110.562 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 19' ' ' ASP . 32.1 Cg_exo -58.16 -40.39 77.02 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.826 2.351 . . . . 7.76 112.273 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mt -54.76 -27.19 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.232 -0.44 . . . . 5.83 112.058 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' N ' HD13 ' A' ' 202' ' ' LEU . . . -59.88 -33.56 71.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 5.44 110.476 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -80.05 -5.53 55.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 7.78 111.08 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.85 -101.05 2.35 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.399 -0.68 . . . . 5.01 111.399 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.02 140.03 9.61 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.253 0.549 . . . . 7.09 110.827 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 8.3 mpt_? -87.61 131.45 34.42 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.113 -0.494 . . . . 5.13 110.439 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 199' ' ' THR . 4.1 pt20 -83.63 37.21 0.57 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.946 0.879 . . . . 7.12 110.54 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 p -100.45 115.88 64.94 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 114.678 -1.146 . . . . 3.94 109.466 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.48 -44.95 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.293 1.328 . . . . 4.52 112.379 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG11 ' H ' ' A' ' 107' ' ' HIS . 7.2 p -165.42 143.02 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 112.336 0.495 . . . . 4.54 112.336 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 23.9 t0 -147.05 107.85 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.317 -0.994 . . . . 2.88 108.317 164.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mt -102.82 105.87 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.461 -0.495 . . . . 2.32 111.105 -173.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.56 107.37 18.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.093 -1.077 . . . . 2.82 108.093 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -54.8 -31.44 59.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 2.24 112.411 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -77.82 -44.69 26.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.737 0.304 . . . . 4.54 110.944 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 m -73.83 -28.06 61.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.545 -0.298 . . . . 3.06 111.372 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.6 129.85 42.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.011 0.434 . . . . 1.72 111.608 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -91.16 124.47 35.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.876 -0.602 . . . . 3.69 110.942 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -75.34 127.68 33.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.975 -0.557 . . . . 4.64 109.569 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.87 134.04 20.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.608 -0.515 . . . . 2.27 109.608 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.43 56.83 2.8 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.857 2.371 . . . . 2.15 112.656 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' LYS . 39.4 t -74.72 -56.85 4.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.053 -0.521 . . . . 4.29 110.204 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 mt 64.09 -25.31 0.08 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.389 0.885 . . . . 4.74 113.389 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' SER . 62.8 mttp -70.48 142.75 89.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.949 0.404 . . . . 3.77 111.691 -175.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.56 158.82 7.89 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.078 2.519 . . . . 2.36 112.486 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.539 HD23 ' HA3' ' A' ' 81' ' ' GLY . 79.0 mt -86.81 132.81 33.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 2.55 109.717 174.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 t -90.88 109.98 21.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.714 -0.847 . . . . 2.38 108.714 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.4 t -119.63 97.41 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.893 -0.41 . . . . 1.59 109.893 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 23.5 m -89.37 89.15 7.76 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.223 -0.658 . . . . 1.45 109.223 177.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -100.1 -6.39 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 3.62 111.383 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.516 ' HA ' ' NH2' ' A' ' 181' ' ' ARG . 32.3 t70 -61.32 -24.85 66.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.682 0.277 . . . . 2.48 111.529 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 22.9 mp0 -101.04 5.0 42.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.55 -0.296 . . . . 2.24 110.997 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.1 27.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.8 111.462 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 m -120.04 119.51 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.983 -0.553 . . . . 1.06 110.609 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 p -88.13 153.26 21.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.125 -0.488 . . . . 1.26 110.19 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.09 -56.67 1.82 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.74 111.725 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HA ' ' H ' ' A' ' 175' ' ' PHE . 32.3 ptt180 -152.34 159.42 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.053 0.454 . . . . 3.17 111.819 -175.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 66' ' ' PHE . 13.9 tt -115.18 134.81 57.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.34 -0.845 . . . . 0.64 109.54 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -133.68 142.79 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.802 0.334 . . . . 0.96 111.637 -171.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -101.48 88.95 3.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.767 -0.827 . . . . 1.49 108.767 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -142.32 90.32 2.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.384 0.512 . . . . 1.83 112.384 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . 139.45 -54.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.271 -0.966 . . . . 1.64 110.778 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 28.8 p80 174.07 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.652 -0.774 . . . . 3.33 111.153 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.569 ' CB ' ' H ' ' A' ' 95' ' ' PHE . . . -165.77 -170.15 1.71 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.205 0.526 . . . . 1.38 111.461 -173.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 59' ' ' ILE . 2.4 p90 -106.63 87.23 2.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.787 -1.097 . . . . 2.74 109.417 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 3.0 m-20 -71.44 100.26 2.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.663 -1.153 . . . . 1.76 110.324 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 72.8 t -85.41 113.39 23.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.035 0.445 . . . . 1.15 110.197 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.93 122.69 27.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.327 -0.851 . . . . 2.02 110.379 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -101.7 157.67 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.656 -0.498 . . . . 1.66 109.656 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.1 115.58 20.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.831 0.348 . . . . 1.33 110.661 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -127.01 56.03 1.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.786 0.803 . . . . 2.65 109.96 175.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -91.59 -11.77 36.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.806 0.812 . . . . 1.61 109.164 170.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 162.8 39.5 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.643 -1.162 . . . . 2.35 108.886 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -75.61 77.26 2.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.224 0.535 . . . . 1.92 111.169 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 98.2 mttt -92.94 -50.75 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.429 -0.805 . . . . 1.77 110.646 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -111.9 100.14 8.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.822 -0.626 . . . . 0.76 109.682 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.456 HG13 HG23 ' A' ' 87' ' ' THR . 55.1 t -110.19 131.75 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.008 -0.542 . . . . 1.27 111.843 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.56 119.28 31.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.756 -0.656 . . . . 1.29 109.993 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -160.26 122.15 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.591 -0.522 . . . . 2.54 109.591 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.539 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -129.1 -177.97 15.14 Favored Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.923 -0.932 . . . . 1.31 111.118 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.39 -130.0 0.0 OUTLIER Glycine 0 CA--C 1.543 1.818 0 O-C-N 124.771 0.924 . . . . 1.9 115.398 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -44.05 170.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.632 2.888 . . . . 2.91 114.178 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.2 pt? -30.67 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.964 1.364 . . . . 4.11 114.231 -146.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.587 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 12.3 p-10 -110.9 -112.23 0.33 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.231 -1.804 . . . . 4.95 113.042 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.587 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 97.47 155.11 29.99 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.53 -1.428 . . . . 2.25 109.53 -163.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.456 HG23 HG13 ' A' ' 78' ' ' VAL . 15.9 m -77.72 102.14 6.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.777 0.789 . . . . 1.91 110.934 -177.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 74.0 m-85 -97.55 117.71 32.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.039 -0.356 . . . . 3.7 110.039 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.84 145.41 26.61 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.845 -0.428 . . . . 3.54 109.845 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.7 tp -74.59 120.22 19.85 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.376 -0.601 . . . . 1.14 109.376 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 tt -113.12 -42.12 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.713 0.292 . . . . 1.68 111.329 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 28.3 pt20 -167.74 168.88 12.15 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.322 -0.622 . . . . 1.55 109.322 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.572 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 4.1 p90 -134.89 164.23 28.05 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.35 -0.54 . . . . 0.86 111.418 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -138.37 160.3 39.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.653 -0.869 . . . . 0.93 108.653 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.569 ' H ' ' CB ' ' A' ' 65' ' ' ALA . 79.1 t80 -130.25 144.14 51.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.484 0.183 . . . . 3.17 111.185 -172.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.61 146.95 40.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.988 0.423 . . . . 1.68 110.558 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -161.05 150.99 17.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 5.18 108.557 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -90.11 155.87 24.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.906 . . . . 2.13 112.672 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -60.56 -28.11 68.2 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.133 0.492 . . . . 2.9 110.477 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.55 -154.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.679 -0.691 . . . . 3.03 110.516 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -136.61 48.29 2.13 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.433 -0.951 . . . . 3.85 108.433 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.24 41.97 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.196 -0.911 . . . . 1.94 112.136 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.406 ' CG ' ' HA3' ' A' ' 98' ' ' GLY . 10.5 pt20 -159.21 169.76 23.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.713 -0.477 . . . . 2.45 109.713 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.67 10.37 86.26 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.882 -0.675 . . . . 1.47 112.888 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.45 -2.7 57.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.489 0.552 . . . . 2.0 112.489 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.572 ' HG2' ' H ' ' A' ' 107' ' ' HIS . 18.2 tt0 67.35 178.96 0.23 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.642 -0.503 . . . . 3.72 109.642 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.572 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 29.6 m80 48.57 45.05 21.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.396 0.679 . . . . 3.52 112.11 174.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.0 t -81.0 127.6 32.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.731 0.777 . . . . 2.52 111.672 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.04 115.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.755 -1.111 . . . . 2.48 110.503 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.24 37.21 23.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.846 0.831 . . . . 2.8 109.591 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.18 14.72 8.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.529 -1.214 . . . . 4.98 111.619 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -89.32 114.48 25.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.147 -0.686 . . . . 3.23 109.147 172.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -107.06 173.62 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 2.82 110.186 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.4 172.95 7.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.979 -0.555 . . . . 1.62 109.895 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.51 77.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.75 0.278 . . . . 1.03 111.75 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.431 ' HB1' ' CZ ' ' A' ' 95' ' ' PHE . . . -167.43 170.56 11.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.131 -0.486 . . . . 0.75 110.017 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -150.06 141.87 23.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 1.58 110.67 174.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.482 HD11 ' CD2' ' A' ' 93' ' ' PHE . 50.3 tp -105.26 125.74 51.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.598 -0.728 . . . . 1.07 109.052 174.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.512 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -114.76 102.43 10.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 1.77 110.341 -172.027 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.572 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 5.8 mp -90.27 111.26 22.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.359 0.599 . . . . 0.93 110.781 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -77.82 119.82 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.466 -0.788 . . . . 0.61 111.099 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 73.9 m80 -106.57 137.64 44.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.485 -0.779 . . . . 2.13 109.347 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -110.38 128.07 55.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.123 -0.489 . . . . 4.26 111.205 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -69.98 105.29 2.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.03 -0.532 . . . . 2.02 109.907 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.0 t -62.73 -17.49 60.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.544 . . . . 2.34 111.735 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.47 -29.79 70.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.45 -0.341 . . . . 3.35 111.799 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -90.35 -1.24 57.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.36 . . . . 3.1 111.069 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.84 23.73 2.63 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 115.826 1.09 . . . . 2.37 115.826 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.584 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 32.2 t70 -176.87 126.8 0.16 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.986 0.893 . . . . 3.93 109.801 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -64.31 -37.87 89.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.685 -0.689 . . . . 3.0 111.715 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -28.61 70.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.103 -0.57 . . . . 2.15 112.578 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 39.6 mmtm -80.49 -41.02 25.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.505 -0.554 . . . . 3.43 109.505 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.604 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.33 -38.84 88.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.452 -0.795 . . . . 1.76 112.152 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.7 -15.11 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.789 0.328 . . . . 2.77 111.168 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.53 13.33 26.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.287 -0.415 . . . . 3.55 110.432 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 88.2 mm-40 -121.03 135.35 24.77 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.78 -0.452 . . . . 3.02 109.78 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.504 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 11.3 Cg_endo -56.09 -29.85 76.36 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.355 2.703 . . . . 1.6 113.798 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -111.37 25.57 11.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.922 0.391 . . . . 2.29 110.208 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -62.05 -48.72 81.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.247 0.859 . . . . 1.22 115.247 -172.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 206' ' ' VAL . 40.0 mt -133.92 170.31 15.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.835 0.817 . . . . 1.57 111.138 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.94 105.36 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.513 -0.767 . . . . 1.38 109.851 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.658 ' O ' ' HB ' ' A' ' 209' ' ' ILE . 4.7 m -88.83 111.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 1.73 111.36 -176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -86.27 100.43 12.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.774 -0.648 . . . . 2.42 110.287 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.64 118.5 5.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.161 -0.542 . . . . 0.86 112.558 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.57 118.37 58.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.781 -0.452 . . . . 0.76 109.781 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -71.04 147.57 48.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.998 0.428 . . . . 1.2 111.586 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 10.6 mp -116.75 131.82 56.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.656 -0.702 . . . . 0.88 110.271 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -126.4 144.33 50.87 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.789 -0.819 . . . . 2.03 108.789 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.03 130.94 35.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.454 0.645 . . . . 1.27 111.353 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 177.06 -105.25 0.2 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.114 -0.948 . . . . 1.53 110.921 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.9 t -71.53 142.95 50.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.424 -0.584 . . . . 1.54 109.424 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.53 156.58 39.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.78 111.202 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -118.08 95.04 47.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.596 -0.52 . . . . 1.22 109.596 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.65 -37.15 91.23 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.146 2.564 . . . . 1.05 112.49 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.05 -31.01 79.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.7 112.619 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.3 tp -88.78 -31.68 18.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.517 -0.402 . . . . 0.77 109.948 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -39.33 63.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.711 -0.677 . . . . 1.41 110.151 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -49.39 -47.91 47.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.676 -0.693 . . . . 2.86 111.016 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.68 -43.18 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 1.38 111.065 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 156' ' ' LEU . 19.3 t -61.76 -35.47 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.184 0.516 . . . . 1.11 111.147 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.36 -30.46 67.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.309 -0.405 . . . . 1.22 111.589 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 175' ' ' PHE . 9.6 p -92.9 -18.51 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.829 -0.348 . . . . 1.41 111.875 -173.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -67.73 -13.01 61.75 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.988 0.423 . . . . 1.39 111.092 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.54 -19.72 65.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.31 110.498 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.0 t -85.47 0.58 51.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.02 -0.536 . . . . 1.4 111.423 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 59' ' ' ILE . 41.1 pt -135.83 46.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.581 0.705 . . . . 0.85 109.585 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.23 -32.47 71.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.079 -0.964 . . . . 1.59 111.264 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.5 p -112.66 145.21 40.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.895 0.378 . . . . 0.77 110.937 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.48 138.55 58.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 2.29 110.542 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.57 -20.89 33.67 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.624 -0.798 . . . . 0.85 112.473 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.72 152.3 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.109 0.48 . . . . 1.7 111.188 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 m -132.43 157.82 43.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.37 109.642 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.57 151.02 39.69 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.394 -0.595 . . . . 0.61 109.394 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.16 132.76 43.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.192 0.52 . . . . 1.8 110.406 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 162' ' ' VAL . 48.9 t80 -141.48 79.23 1.67 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 1.04 108.295 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' SER . 6.2 m -111.87 156.82 21.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.608 . . . . 1.17 111.558 -174.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 56.4 58.22 4.38 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.357 0.663 . . . . 1.77 112.384 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.45 134.68 41.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 3.99 109.632 172.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.578 ' CG ' ' HE ' ' A' ' 181' ' ' ARG . 10.2 t70 -108.22 129.62 23.84 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 2.51 111.111 -173.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.65 -3.74 9.76 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.637 2.892 . . . . 1.26 114.704 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.578 ' HE ' ' CG ' ' A' ' 179' ' ' ASP . 18.5 ptp180 -59.93 -26.27 65.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.745 0.307 . . . . 2.76 111.401 -178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -79.74 7.14 56.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.92 -0.657 . . . . 1.12 112.299 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.4 mt -115.28 -27.52 7.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 1.73 110.312 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.34 131.63 80.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.799 -0.637 . . . . 3.45 111.428 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.1 -177.07 3.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.97 2.446 . . . . 2.08 112.873 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.79 -55.21 6.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.884 0.327 . . . . 3.23 111.884 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 4.5 m -85.21 130.3 34.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.27 -0.27 . . . . 1.66 110.27 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 tp -111.75 82.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.329 -0.396 . . . . 1.99 110.448 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -118.19 177.4 4.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.56 -0.533 . . . . 1.81 109.56 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -162.93 145.48 10.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.929 0.714 . . . . 5.01 112.929 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.428 ' CD1' ' HB ' ' A' ' 210' ' ' VAL . 7.4 m0 -116.17 145.47 43.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.496 -1.298 . . . . 3.93 107.496 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -142.44 102.83 4.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.779 1.029 . . . . 2.13 113.779 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 255' ' ' ILE . 48.8 t80 -142.41 128.43 10.67 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 5.21 110.031 168.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.74 127.74 23.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.817 2.344 . . . . 2.12 113.618 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -141.76 161.54 27.07 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.248 -0.887 . . . . 1.75 112.283 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 29.6 t -61.31 144.56 53.69 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.683 -0.488 . . . . 2.99 109.683 173.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.94 -53.41 58.24 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.988 0.366 . . . . 4.75 111.988 -164.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.651 HG23 ' HD2' ' A' ' 200' ' ' PRO . 1.7 t -127.56 -46.4 1.45 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.783 -0.367 . . . . 5.1 111.471 167.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.602 ' HB ' ' HD3' ' A' ' 200' ' ' PRO . 1.8 m 169.18 -60.39 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.774 1.229 . . . . 5.53 110.275 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.651 ' HD2' HG23 ' A' ' 198' ' ' THR . 48.8 Cg_exo -55.35 -46.36 33.1 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 121.861 1.707 . . . . 5.83 113.901 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 24.1 Cg_exo -65.3 106.92 0.9 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.374 1.383 . . . . 4.78 110.608 172.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.415 ' CD2' ' HB3' ' A' ' 28' ' ' GLN . 54.3 mt -77.62 46.03 0.52 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.788 -0.642 . . . . 3.84 111.806 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.522 ' HB3' ' SG ' ' A' ' 205' ' ' CYS . 97.0 mt -127.03 118.78 25.14 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.032 0.444 . . . . 2.96 110.174 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -86.82 78.24 9.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.647 -0.706 . . . . 3.37 109.757 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 203' ' ' LEU . 60.0 m -121.08 -15.4 8.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 2.15 111.992 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 140' ' ' LEU . 47.1 t -145.13 102.65 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 C-N-CA 119.641 -0.823 . . . . 1.26 112.333 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 193' ' ' TYR . 82.3 m -155.73 88.8 1.14 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 2.08 111.508 166.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' TRP . . . . . 0.724 ' O ' HG12 ' A' ' 209' ' ' ILE . 1.1 p90 -150.05 87.06 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.163 -1.015 . . . . 5.53 112.449 160.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.724 HG12 ' O ' ' A' ' 208' ' ' TRP . 9.4 mm -166.89 113.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 123.999 0.92 . . . . 1.63 109.122 157.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 191' ' ' TRP . 95.5 t -125.23 99.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.656 -0.498 . . . . 1.62 109.656 166.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -66.81 107.5 2.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 1.73 110.719 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -53.71 -23.07 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 2.98 111.408 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.5 tp10 -105.17 113.63 64.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.273 -0.422 . . . . 1.47 110.841 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -82.88 152.2 14.57 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.579 2.186 . . . . 0.96 111.707 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.1 pt -100.59 152.17 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.006 -0.368 . . . . 1.25 110.006 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 62.8 m -94.78 129.27 41.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.28 -0.418 . . . . 1.29 109.96 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.33 162.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.065 -0.516 . . . . 1.02 109.853 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.426 ' HB3' ' HG3' ' A' ' 221' ' ' GLN . 48.3 t -88.21 146.03 25.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.183 -0.462 . . . . 1.08 109.823 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.717 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.3 t -57.44 -33.87 68.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.626 -0.715 . . . . 1.33 110.329 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.44 -20.71 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 2.51 111.095 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.426 ' HG3' ' HB3' ' A' ' 218' ' ' SER . 55.9 mt-30 -78.67 -45.89 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.283 -0.417 . . . . 0.7 110.015 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.668 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 24.9 m -70.41 -24.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.52 -0.309 . . . . 1.36 111.369 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.4 mt -62.38 -36.55 82.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.774 0.321 . . . . 1.03 110.556 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -73.22 -25.4 60.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 1.75 111.488 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.668 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.3 m-85 -67.5 -30.87 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.345 0.593 . . . . 2.47 109.657 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -81.54 1.5 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.247 -0.888 . . . . 3.04 110.601 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.29 -13.02 19.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.167 0.508 . . . . 2.31 109.806 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.417 HD21 HD13 ' A' ' 163' ' ' LEU . 93.8 mt -75.1 155.19 37.36 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.759 -0.655 . . . . 0.95 110.482 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.5 m120 -115.53 150.14 37.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.82 -0.627 . . . . 1.13 109.837 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -88.29 -27.34 21.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.45 -0.796 . . . . 3.74 109.953 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.8 p-10 -76.54 168.52 19.92 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.272 -0.877 . . . . 1.62 111.395 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.26 167.71 30.46 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.19 -1.164 . . . . 1.16 110.19 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.17 142.54 51.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 3.56 110.199 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.33 51.06 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.738 -0.744 . . . . 2.08 112.77 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.68 153.57 77.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.33 -0.619 . . . . 2.59 109.33 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.31 122.89 12.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.188 1.925 . . . . 1.36 110.582 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.582 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 9.7 pt-20 -67.42 129.98 41.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.792 0.806 . . . . 3.4 112.47 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.0 mt-10 -115.13 120.18 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.666 -1.152 . . . . 2.47 109.002 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.71 132.88 47.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.994 0.426 . . . . 2.14 110.834 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.1 tpp -71.94 91.65 1.22 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.441 -0.799 . . . . 1.68 111.067 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.16 147.54 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.549 0.214 . . . . 1.27 110.941 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.501 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER 66.79 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.584 0.754 . . . . 2.18 111.886 179.01 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 47.58 34.18 3.4 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.58 0.352 . . . . 2.15 111.838 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' TRP . . . . . 0.565 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 21.5 t90 -129.61 150.04 51.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 4.59 110.721 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 2.8 tmt_? -113.71 132.58 22.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.604 -0.517 . . . . 6.13 109.604 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.405 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 94.2 Cg_exo -46.47 151.8 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.717 2.944 . . . . 3.28 113.76 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -70.58 158.28 36.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.939 . . . . 2.98 111.598 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLN . . . . . 0.404 ' CD ' ' HD2' ' A' ' 249' ' ' PRO . 56.2 tp60 -121.55 128.37 25.67 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.399 -0.364 . . . . 4.32 110.148 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.404 ' HD2' ' CD ' ' A' ' 248' ' ' GLN . 10.3 Cg_endo -50.26 169.92 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.452 3.434 . . . . 3.48 115.449 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 3.2 mm? -62.16 -12.55 20.39 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.828 -1.533 . . . . 4.63 113.071 -169.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 19.0 ptpt -60.11 41.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.377 1.621 . . . . 5.34 115.377 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 7.4 p30 130.29 -3.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 126.099 1.76 . . . . 4.64 111.023 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 57.5 mmt-85 -130.32 95.42 3.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.106 0.479 . . . . 6.11 110.205 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -137.34 104.25 5.33 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 3.08 108.483 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 193' ' ' TYR . 2.0 mp -84.78 132.57 31.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.189 -0.46 . . . . 2.6 111.191 -169.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -80.63 150.34 29.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 2.63 109.851 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -112.6 140.79 47.07 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.113 -0.328 . . . . 1.71 110.113 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 48.9 m -152.0 96.76 2.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.342 0.591 . . . . 2.21 110.499 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.05 123.15 19.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.213 0.53 . . . . 4.31 110.997 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 pttm . . . . . 0 C--O 1.248 1.001 0 CA-C-N 114.98 -1.009 . . . . 4.49 111.887 177.178 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 53.2 t0 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 107.848 -1.168 . . . . 2.88 107.848 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.542 ' HA ' HG13 ' A' ' 255' ' ' ILE . 36.5 mt -113.01 140.41 33.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 120.854 0.359 . . . . 2.32 111.415 -167.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -135.31 137.18 42.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.316 -0.994 . . . . 2.82 108.316 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -47.87 -39.34 18.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.042 0.449 . . . . 2.24 111.855 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -81.32 -28.74 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.076 -0.511 . . . . 4.54 111.075 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -96.78 20.39 11.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.472 0.653 . . . . 3.06 110.906 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.48 130.68 53.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.466 -0.568 . . . . 1.72 109.466 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 256' ' ' LYS . 75.6 mmtt -109.52 122.27 47.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.918 0.39 . . . . 3.69 110.513 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -70.56 139.98 51.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.969 -0.56 . . . . 4.64 111.121 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.47 147.25 36.31 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.523 -0.762 . . . . 2.27 109.602 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 44' ' ' LEU . 14.0 Cg_endo -54.99 144.88 66.12 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.549 2.833 . . . . 2.15 113.71 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.441 ' HB2' ' HA ' ' A' ' 260' ' ' LYS . 14.1 t -46.32 45.26 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.111 1.523 . . . . 4.29 115.111 166.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 42' ' ' PRO . 3.7 pp -59.59 171.36 0.86 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.009 -0.541 . . . . 4.74 110.084 168.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 34.9 mmtp -53.69 123.23 37.19 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.806 0.336 . . . . 3.77 111.756 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 36.3 Cg_exo -60.59 171.46 3.45 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.581 2.854 . . . . 2.36 113.27 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.511 HD23 ' HA3' ' A' ' 81' ' ' GLY . 68.0 mt -82.14 111.69 18.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 2.55 109.555 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 m -78.14 108.73 11.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.046 -0.353 . . . . 2.38 110.046 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -101.93 113.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.281 0.563 . . . . 1.59 110.573 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -126.55 92.29 3.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.988 -0.551 . . . . 1.45 109.851 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 7.7 p90 -129.04 23.16 5.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.944 -0.571 . . . . 3.62 110.961 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.95 -22.4 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.11 0.481 . . . . 2.48 110.093 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -99.47 7.75 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.72 -0.673 . . . . 2.24 110.646 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.68 121.27 14.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.142 -0.481 . . . . 0.8 111.182 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 m -109.12 106.84 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.847 -0.615 . . . . 1.06 110.435 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 p -78.58 147.22 33.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.26 109.478 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.67 -57.13 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.979 0.418 . . . . 0.74 111.766 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -147.23 156.48 42.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 3.17 110.911 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.93 134.06 67.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.196 -0.668 . . . . 0.64 109.196 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 172' ' ' SER . 66.8 tp -136.22 144.08 44.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.96 111.249 -170.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -105.29 118.54 36.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.568 -0.742 . . . . 1.49 109.296 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.03 66.33 0.97 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.29 -0.564 . . . . 1.83 111.09 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . 66.73 -52.93 0.22 Allowed Glycine 0 CA--C 1.523 0.568 0 CA-C-N 114.487 -1.233 . . . . 1.64 115.289 165.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -96.34 -26.62 15.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.898 0.38 . . . . 3.33 110.208 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.32 178.62 8.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 1.38 110.095 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -126.61 123.81 38.48 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.921 -0.77 . . . . 2.74 108.921 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -117.08 143.44 45.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.947 0.403 . . . . 1.76 111.36 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -114.75 123.46 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.542 -0.54 . . . . 1.15 109.542 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 2.02 111.329 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.57 152.65 27.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 1.66 109.17 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -83.63 135.04 34.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.787 0.327 . . . . 1.33 110.383 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -133.49 59.35 1.74 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.985 0.897 . . . . 2.65 109.576 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -87.07 -11.32 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 1.61 109.634 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -144.66 177.35 8.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.415 -1.328 . . . . 2.35 107.415 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.07 71.57 4.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.734 0.778 . . . . 1.92 110.423 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -82.75 -61.06 1.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.175 -0.92 . . . . 1.77 110.738 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -112.78 98.06 6.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.76 110.024 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.12 138.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.915 -0.584 . . . . 1.27 111.166 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.7 tp -136.67 113.47 10.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.152 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.65 124.15 7.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.466 0.65 . . . . 2.54 111.553 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -87.53 178.33 47.36 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.167 -0.924 . . . . 1.31 111.478 169.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -38.62 -142.13 0.0 OUTLIER Glycine 0 CA--C 1.535 1.299 0 O-C-N 124.669 0.864 . . . . 1.9 114.974 167.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -49.65 120.41 5.84 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 121.59 1.527 . . . . 2.91 112.152 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.5 mt -159.43 -169.48 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.706 -1.134 . . . . 4.11 109.173 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -126.78 41.8 3.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.717 0.294 . . . . 4.95 110.779 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.91 176.14 14.21 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.632 -0.794 . . . . 2.25 113.172 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 125' ' ' THR . 76.4 m -102.09 122.05 43.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.771 -0.455 . . . . 1.91 109.771 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 38.2 m-85 -104.01 106.42 16.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.019 0.437 . . . . 3.7 110.928 -175.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' NH2' ' HZ3' ' A' ' 123' ' ' TRP . 18.4 mtm180 -85.61 149.59 25.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 3.54 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.85 124.73 28.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 1.14 110.239 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.471 HG23 ' HG2' ' A' ' 92' ' ' GLN . 7.2 tt -109.16 -34.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.464 -0.334 . . . . 1.68 111.392 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' HG23 ' A' ' 91' ' ' ILE . 27.6 pt20 -169.98 169.17 8.27 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.865 -0.152 . . . . 1.55 110.718 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 11.3 p90 -153.66 160.39 42.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.86 110.845 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -147.55 162.27 39.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.6 -0.727 . . . . 0.93 109.55 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 85.4 m-85 -106.2 152.3 23.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 3.17 111.278 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 119' ' ' HIS . 13.6 m170 -108.72 142.85 38.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.814 -1.18 . . . . 1.68 107.814 173.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.597 ' HE1' ' HB ' ' A' ' 222' ' ' VAL . 6.4 t90 -152.61 116.67 4.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.529 -0.468 . . . . 5.18 110.74 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.74 154.75 31.25 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.953 -0.641 . . . . 2.13 112.003 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -67.58 -32.37 73.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.223 0.511 . . . . 2.9 110.617 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -106.56 140.36 39.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.943 -0.762 . . . . 3.03 108.943 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -64.05 -4.38 3.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.896 0.702 . . . . 3.85 112.896 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.17 21.4 24.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.439 -0.886 . . . . 1.94 112.847 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.6 pt20 -158.87 165.57 33.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.13 0.465 . . . . 2.45 110.415 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.95 -34.66 3.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.26 -0.971 . . . . 1.47 114.246 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.8 p -73.4 -34.76 65.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.388 0.594 . . . . 2.0 111.873 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.28 -163.86 0.16 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.445 -0.946 . . . . 3.72 108.445 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 50.62 55.4 9.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.485 0.66 . . . . 3.52 109.889 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.8 p -77.94 117.56 19.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.273 -0.876 . . . . 2.52 110.981 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.541 ' H ' ' HB2' ' A' ' 112' ' ' LYS . 29.9 t -88.51 92.58 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.48 109.947 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.35 -67.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.652 1.22 . . . . 2.8 111.723 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 109' ' ' VAL . 22.3 pttp -127.22 -3.53 6.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.337 -0.392 . . . . 4.98 111.503 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HB2' ' H ' ' A' ' 109' ' ' VAL . 64.3 mttm -69.56 178.17 2.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.041 -0.264 . . . . 3.23 110.479 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.8 pttt 147.77 109.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.746 0.819 . . . . 2.82 108.926 -160.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -121.39 166.66 13.78 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.146 -0.346 . . . . 1.62 110.073 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' GLN . . . -79.55 -17.89 52.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 1.03 112.441 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 97' ' ' TRP . . . -156.65 164.36 38.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.932 0.396 . . . . 0.75 111.513 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.84 151.54 20.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.508 -0.769 . . . . 1.58 110.402 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.463 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 39.7 tp -104.23 127.44 51.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.675 -0.491 . . . . 1.07 109.675 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 96' ' ' HIS . 22.6 t-160 -118.19 105.84 12.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.372 -0.376 . . . . 1.77 110.227 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.2 mp -100.23 125.92 46.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.93 110.689 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 142' ' ' VAL . 46.4 t -98.5 125.18 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.926 0.393 . . . . 0.61 111.235 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -116.26 144.03 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.489 . . . . 2.13 109.681 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.47 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 11.2 t90 -117.9 137.93 52.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.16 -0.473 . . . . 4.26 111.294 -175.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.511 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 30.6 t30 -70.72 104.58 2.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.34 0.59 . . . . 2.02 111.238 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 87' ' ' THR . 7.7 t -67.62 -25.62 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.835 1.05 . . . . 2.34 113.835 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 64.8 pttt -68.39 -5.12 17.29 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.277 0.843 . . . . 3.35 113.277 -171.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -107.44 -0.78 22.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.049 -0.407 . . . . 3.1 111.638 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.88 30.3 4.89 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.149 -0.932 . . . . 2.37 115.148 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.47 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 14.9 t70 -163.27 121.27 1.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.931 0.865 . . . . 3.93 109.388 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.506 ' O ' HG23 ' A' ' 134' ' ' VAL . 55.3 p90 -66.44 -40.08 89.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 3.0 111.951 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -32.47 81.8 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.816 -0.707 . . . . 2.15 112.451 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 42.2 mmtm -66.34 -34.57 78.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.79 0.328 . . . . 3.43 110.215 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.34 -34.03 74.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.971 -0.558 . . . . 1.76 110.767 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 130' ' ' PHE . 63.3 t -65.06 -25.75 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 2.77 110.571 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.61 16.78 6.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 3.55 110.977 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 21.6 mt-30 -131.69 135.33 26.65 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 3.02 109.687 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 37.7 Cg_exo -60.59 -26.4 82.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.655 2.237 . . . . 1.6 112.725 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -113.92 19.18 16.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 2.29 111.07 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.15 -29.44 73.35 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.888 -0.672 . . . . 1.22 114.127 -172.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.8 158.61 34.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.066 0.433 . . . . 1.57 110.982 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -144.49 126.96 15.94 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.952 -0.759 . . . . 1.38 108.952 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 121' ' ' VAL . 32.2 m -125.49 149.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.933 0.397 . . . . 1.73 111.38 -173.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.53 122.7 47.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.614 -0.721 . . . . 2.42 110.187 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.8 109.76 2.89 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.29 -0.724 . . . . 0.86 111.29 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.415 HG12 HD12 ' A' ' 211' ' ' LEU . 23.7 mt -111.28 113.9 45.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.243 -0.28 . . . . 0.76 110.243 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -66.6 145.32 55.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.788 0.328 . . . . 1.2 111.01 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.48 124.09 51.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.779 -0.452 . . . . 0.88 109.779 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.2 141.97 47.44 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.559 -0.534 . . . . 2.03 109.559 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 45.1 t -85.45 132.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.061 0.457 . . . . 1.27 110.866 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.3 -105.08 0.21 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.997 -0.841 . . . . 1.53 110.997 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.7 t -71.19 142.33 50.65 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.301 -0.629 . . . . 1.54 109.301 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.68 151.86 45.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.558 -0.292 . . . . 0.78 111.059 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.0 tptt -108.48 99.11 31.32 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.657 -0.497 . . . . 1.22 109.657 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.54 -36.89 89.99 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.965 2.443 . . . . 1.05 112.742 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.07 75.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.991 -0.624 . . . . 0.7 113.115 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 160' ' ' VAL . 26.2 tp -83.92 -17.23 41.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.224 0.512 . . . . 0.77 110.373 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -41.56 63.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 1.41 110.768 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.434 ' HE3' ' OD1' ' A' ' 179' ' ' ASP . 65.3 mttm -49.2 -49.09 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.557 . . . . 2.86 112.415 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 14.8 p -79.99 -35.9 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.708 -0.397 . . . . 1.38 110.832 -177.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' A' ' 163' ' ' LEU . 78.2 t -59.8 -35.77 62.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.363 0.601 . . . . 1.11 110.452 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.52 -33.99 76.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.198 -0.91 . . . . 1.22 111.963 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.9 p -99.25 -3.66 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 111.793 0.294 . . . . 1.41 111.793 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 92.8 mt -55.6 -42.49 74.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.848 0.356 . . . . 1.39 111.916 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.99 -20.94 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.422 -0.353 . . . . 2.31 111.662 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 72.6 m -92.66 0.4 57.42 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.219 0.452 . . . . 1.4 112.219 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.09 34.52 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.578 -0.527 . . . . 0.85 109.578 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.449 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 82.6 tttt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.262 -0.881 . . . . 1.59 112.152 -172.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 171' ' ' LYS . 37.9 p -102.69 152.15 21.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.696 0.284 . . . . 0.77 111.118 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -71.62 146.6 48.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.885 0.374 . . . . 2.29 110.662 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.15 9.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.529 -0.843 . . . . 0.85 112.5 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 168' ' ' THR . 21.5 ptmt -90.87 155.58 18.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 1.7 110.914 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.459 ' HB3' HD13 ' A' ' 60' ' ' LEU . 16.5 p -128.07 160.41 32.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.518 -0.765 . . . . 1.37 110.548 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -144.66 145.86 31.96 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.047 -0.353 . . . . 0.61 110.047 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.15 131.74 40.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.829 -0.434 . . . . 1.8 109.829 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -139.97 79.93 1.74 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.992 -0.744 . . . . 1.04 108.992 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 p -104.65 162.7 13.06 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.462 -0.79 . . . . 1.17 111.477 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 58.12 45.97 16.83 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.788 0.662 . . . . 1.77 112.788 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -99.06 135.46 40.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.974 -0.38 . . . . 3.99 109.974 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.434 ' OD1' ' HE3' ' A' ' 158' ' ' LYS . 6.3 p-10 -110.61 119.28 46.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 121.13 0.49 . . . . 2.51 110.675 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.86 -7.28 19.12 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.817 2.345 . . . . 1.26 112.639 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -63.36 -28.58 70.09 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.877 0.37 . . . . 2.76 110.688 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.75 59.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.172 -0.537 . . . . 1.12 112.977 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 74.9 mt -102.32 -7.06 22.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.583 0.23 . . . . 1.73 111.396 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.82 130.27 88.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.622 0.601 . . . . 3.45 112.622 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.82 -171.59 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.892 2.395 . . . . 2.08 111.369 173.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.75 -62.47 1.68 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.959 0.409 . . . . 3.23 110.613 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.52 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.3 m -91.05 144.77 25.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 1.66 110.279 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 44.3 tp -109.81 63.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.362 0.601 . . . . 1.99 110.549 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 212' ' ' LYS . 4.2 m-20 -97.8 162.82 13.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.81 108.484 174.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.529 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.6 p90 -167.16 156.01 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.159 -0.616 . . . . 5.01 112.474 -174.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.436 ' NE1' ' HG2' ' A' ' 212' ' ' LYS . 12.1 m95 -107.25 149.16 28.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.875 -1.157 . . . . 3.93 107.875 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.8 t -131.28 103.46 6.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.472 0.653 . . . . 2.13 111.589 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.524 ' OH ' ' HA ' ' A' ' 253' ' ' ARG . 45.3 t80 -138.75 132.42 16.23 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 5.21 111.018 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 43.3 Cg_exo -58.3 130.07 35.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.596 2.198 . . . . 2.12 111.876 172.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -108.23 155.71 16.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.209 -0.519 . . . . 1.75 113.068 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.542 0.646 0 C-N-CA 123.431 0.692 . . . . 2.99 112.256 -177.769 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.519 0.199 . . . . 2.96 110.63 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 8.5 pt-20 -112.88 71.99 0.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.227 0.537 . . . . 3.37 110.746 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 28.7 p -96.87 -9.6 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.15 110.645 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.89 141.06 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.782 -0.645 . . . . 1.26 111.395 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.3 m -113.18 108.8 17.78 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.002 -0.74 . . . . 2.08 109.002 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 192' ' ' THR . 33.6 m95 -82.31 119.22 23.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.936 0.398 . . . . 5.53 111.985 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 48.5 mm -108.78 99.55 8.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.379 -0.971 . . . . 1.63 108.379 170.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.6 t -101.65 119.36 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.316 -0.402 . . . . 1.62 110.386 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 40.1 mt -74.68 137.92 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.829 0.347 . . . . 1.73 110.254 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 85.2 mttt -83.06 -8.64 59.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 2.98 110.68 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 187' ' ' SER . 8.4 tp10 -105.26 101.38 30.61 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.255 -0.43 . . . . 1.47 110.501 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 15.7 Cg_exo -69.23 141.48 47.5 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.757 2.305 . . . . 0.96 111.713 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.46 150.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.907 -0.405 . . . . 1.25 109.907 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 12.9 m -90.44 122.03 32.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.074 -0.512 . . . . 1.29 110.526 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.4 m -125.09 151.22 30.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.238 -0.653 . . . . 1.02 109.238 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 60.8 p -91.1 160.05 15.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.488 -0.485 . . . . 1.08 111.525 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.488 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.3 m -54.27 -45.56 72.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 1.33 110.803 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -55.74 -32.5 63.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 2.51 111.434 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -76.87 -52.09 10.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.479 -0.328 . . . . 0.7 110.846 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.597 ' HB ' ' HE1' ' A' ' 97' ' ' TRP . 15.7 m -64.04 -34.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.081 0.4 . . . . 1.36 112.081 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.4 mt -63.39 -30.68 71.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.689 0.281 . . . . 1.03 111.385 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -78.8 -20.18 50.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.313 . . . . 1.75 111.621 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -71.96 -24.48 61.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.275 0.559 . . . . 2.47 109.866 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -80.69 1.28 30.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.59 -0.732 . . . . 3.04 110.533 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -91.61 -9.03 45.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 2.31 110.635 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.06 153.98 39.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.092 0.472 . . . . 0.95 110.638 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.3 m120 -119.31 150.87 39.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.958 -0.564 . . . . 1.13 110.928 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 240' ' ' MET . 33.4 m-85 -77.46 -34.75 54.33 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.377 -0.972 . . . . 3.74 108.377 170.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.9 p-10 -74.31 163.84 27.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.078 -1.419 . . . . 1.62 112.39 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.72 -170.75 47.16 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.614 -1.175 . . . . 1.16 110.993 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.0 126.72 31.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.957 -0.386 . . . . 3.56 109.957 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.9 29.49 31.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.844 -0.694 . . . . 2.08 112.068 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 20.0 mm-40 -127.43 159.13 67.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.138 -0.319 . . . . 2.59 110.138 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.21 121.86 10.15 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 1.36 112.518 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.21 119.36 7.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.573 -0.74 . . . . 3.4 112.534 -174.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.3 mt-10 -131.72 146.74 52.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 2.47 109.206 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.44 125.3 42.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.394 -0.224 . . . . 2.14 110.394 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.562 ' HA ' ' CE2' ' A' ' 230' ' ' PHE . 55.5 ttm -69.45 90.79 0.54 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.515 0.51 . . . . 1.68 110.176 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.42 157.26 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 1.27 110.979 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 12.9 t70 68.47 -85.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.114 -0.948 . . . . 2.18 111.066 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 50.06 35.47 10.02 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.911 0.708 . . . . 2.15 112.911 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.424 ' HE1' ' CG ' ' A' ' 96' ' ' HIS . 2.3 m95 -137.36 158.97 43.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.424 0.63 . . . . 4.59 111.6 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -111.22 146.87 35.44 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.181 -0.918 . . . . 6.13 110.357 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.89 151.26 20.69 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.926 2.417 . . . . 3.28 112.892 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -78.31 159.74 28.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.439 -0.8 . . . . 2.98 110.681 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -113.79 153.69 45.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.42 . . . . 4.32 111.404 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.84 178.57 2.74 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.762 2.975 . . . . 3.48 113.39 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 252' ' ' ASN . 4.2 mm? -51.11 -11.15 0.09 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.056 0.942 . . . . 4.63 113.021 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -59.49 41.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.092 0.957 . . . . 5.34 113.492 170.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.545 ' H ' ' C ' ' A' ' 250' ' ' LEU . 2.9 t30 119.07 41.91 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.584 1.954 . . . . 4.64 112.296 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.645 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 7.4 ppt_? -145.52 121.44 10.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 6.11 110.896 160.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -137.48 122.4 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.656 -1.238 . . . . 3.08 107.656 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 33' ' ' ILE . 29.4 mm -91.49 144.1 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 2.6 112.416 -165.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 67.6 mttm -127.97 146.6 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 2.63 109.101 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.408 ' HB2' ' CE3' ' A' ' 191' ' ' TRP . . . -138.17 103.85 5.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.572 0.225 . . . . 1.71 110.785 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 p -92.77 98.52 11.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.013 0.435 . . . . 2.21 111.014 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.86 154.3 27.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.248 -0.433 . . . . 4.31 110.018 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 43' ' ' SER . 49.2 pttt . . . . . 0 C--O 1.246 0.895 0 O-C-N 123.613 0.571 . . . . 4.49 111.335 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.869 0.366 . . . . 2.88 110.668 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HB ' HG22 ' A' ' 109' ' ' VAL . 41.1 mt -97.18 126.54 49.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.985 -0.552 . . . . 2.32 110.562 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 16.7 t70 -112.73 117.41 32.13 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.379 -0.6 . . . . 2.82 109.379 171.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 p -56.05 -27.67 54.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.945 -0.57 . . . . 2.24 112.458 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.506 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 43.5 m80 -74.29 -18.04 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.185 0.517 . . . . 4.54 110.318 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -117.87 18.9 13.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.497 -0.774 . . . . 3.06 109.851 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.63 85.33 2.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.394 -0.595 . . . . 1.72 109.394 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -75.8 121.93 23.31 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.453 -0.794 . . . . 3.69 111.535 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 40.4 p90 -84.2 143.45 29.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.297 -0.411 . . . . 4.64 110.318 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' HB2' ' HG ' ' A' ' 44' ' ' LEU . 25.4 m-20 -109.7 119.36 48.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.177 -0.465 . . . . 2.27 110.43 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.13 -15.24 46.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.758 2.305 . . . . 2.15 111.587 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.9 m -75.98 -19.21 58.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 4.29 110.746 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 89.5 mt -83.1 137.87 33.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.093 0.473 . . . . 4.74 110.259 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -118.54 135.19 23.53 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 3.77 110.73 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.99 158.09 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.94 3.094 . . . . 2.36 113.303 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.15 155.61 19.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 2.55 111.423 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 80' ' ' LYS . 34.7 p -129.1 136.04 49.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 2.38 108.984 173.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.31 136.78 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.383 -0.372 . . . . 1.59 110.981 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -119.29 89.34 3.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.508 -0.553 . . . . 1.45 109.508 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -103.1 5.72 38.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.786 -0.643 . . . . 3.62 110.254 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -51.88 -40.08 60.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 2.48 111.555 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -111.66 23.67 13.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.266 -0.425 . . . . 2.24 111.343 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.18 111.17 6.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.86 0.362 . . . . 0.8 111.014 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -106.22 108.47 20.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.282 -0.417 . . . . 1.06 110.863 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 176' ' ' THR . 17.3 m -77.43 148.74 35.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.223 -0.658 . . . . 1.26 109.223 174.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.44 -56.99 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.681 0.252 . . . . 0.74 111.681 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -154.18 164.9 37.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.161 0.505 . . . . 3.17 111.49 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.77 138.3 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.338 -0.846 . . . . 0.64 109.779 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.5 tp -130.29 139.57 50.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.593 -0.276 . . . . 0.96 111.09 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -91.46 117.02 29.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.195 0.521 . . . . 1.49 110.743 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -115.59 150.05 37.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.182 -1.414 . . . . 1.83 107.182 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.71 38.2 0.49 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.65 -0.786 . . . . 1.64 114.536 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -132.61 -39.7 0.99 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.188 -0.671 . . . . 3.33 109.188 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.24 -170.31 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.311 -0.996 . . . . 1.38 108.311 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -108.63 135.53 49.73 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.128 -0.694 . . . . 2.74 109.128 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.67 111.61 24.18 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.289 -0.414 . . . . 1.76 110.71 -176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.77 113.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.114 -0.698 . . . . 1.15 109.114 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.52 134.04 35.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.983 0.421 . . . . 2.02 111.032 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -103.28 155.61 18.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.504 -0.771 . . . . 1.66 109.33 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.13 119.82 22.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.809 0.338 . . . . 1.33 110.139 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.35 56.18 1.12 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.718 0.771 . . . . 2.65 109.988 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -87.2 -16.57 34.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.473 -0.785 . . . . 1.61 109.881 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -153.13 176.55 11.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.966 -1.015 . . . . 2.35 108.673 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.69 73.57 7.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.234 0.54 . . . . 1.92 111.012 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.449 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 81.4 mttt -97.47 -65.15 0.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 1.77 112.481 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 89' ' ' ARG . . . -101.49 101.51 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.76 110.223 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.1 t -119.56 143.4 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.993 0.425 . . . . 1.27 112.088 -169.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 tp -118.59 129.95 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.176 -0.675 . . . . 1.29 109.176 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 95.3 mttt -125.55 137.63 53.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.841 -0.429 . . . . 2.54 109.841 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.0 170.2 24.65 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.976 -0.557 . . . . 1.31 111.959 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.4 -147.88 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.817 0.363 . . . . 1.9 113.245 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 51.9 Cg_exo -52.19 119.7 6.18 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 121.904 1.736 . . . . 2.91 112.253 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 72.4 mt -155.03 -171.7 3.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.781 -1.1 . . . . 4.11 108.676 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.02 51.76 1.52 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 4.95 110.639 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.02 -173.78 19.74 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.531 -0.843 . . . . 2.25 112.902 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -108.48 127.6 54.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.015 -0.365 . . . . 1.91 110.015 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 124' ' ' ASN . 71.9 m-85 -103.66 101.77 11.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.404 0.621 . . . . 3.7 111.449 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 77' ' ' ALA . 41.8 ttm180 -79.09 144.0 34.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.481 -0.781 . . . . 3.54 110.427 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.76 120.79 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.501 -0.555 . . . . 1.14 109.501 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.18 -36.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.319 . . . . 1.68 111.698 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -172.11 167.76 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.252 -0.647 . . . . 1.55 109.252 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.48 ' CB ' HD23 ' A' ' 120' ' ' LEU . 35.9 p90 -140.01 167.81 21.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.278 -0.569 . . . . 0.86 112.17 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -147.36 160.94 41.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.826 -1.176 . . . . 0.93 107.826 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.95 172.0 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.652 0.66 . . . . 3.17 111.032 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -129.45 146.03 51.35 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.697 -0.853 . . . . 1.68 108.697 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -157.32 133.38 9.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.164 0.506 . . . . 5.18 110.667 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 78.94 165.28 28.85 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.635 -0.793 . . . . 2.13 112.673 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 33.3 t 156.42 -96.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.661 -1.237 . . . . 2.9 107.661 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 75.6 mt -83.14 -153.84 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.713 -0.676 . . . . 3.03 109.303 167.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -45.81 -33.54 3.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.038 0.535 . . . . 3.85 112.124 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 113' ' ' LYS . . . 176.91 89.92 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.9 -0.667 . . . . 1.94 112.129 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 27.5 mt-30 -127.37 -177.69 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.376 . . . . 2.45 111.183 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.6 -29.56 2.76 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 109.048 -1.621 . . . . 1.47 109.048 -172.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 117' ' ' GLU . 3.3 t -68.66 67.58 0.14 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.296 -1.452 . . . . 2.0 112.474 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.495 ' CA ' ' HE1' ' A' ' 244' ' ' TRP . 28.8 tt0 -56.62 155.05 7.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 110.117 -0.327 . . . . 3.72 110.117 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 58.89 64.61 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.994 -0.743 . . . . 3.52 108.994 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.58 133.47 36.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.242 -0.89 . . . . 2.52 112.033 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 33' ' ' ILE . 40.6 t -78.61 90.61 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 114.922 -1.036 . . . . 2.48 108.894 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 33.7 t70 64.23 -71.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.135 0.897 . . . . 2.8 110.724 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.479 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 54.9 mttp -138.46 30.23 2.38 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.512 0.19 . . . . 4.98 111.512 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HB3' ' H ' ' A' ' 109' ' ' VAL . 25.4 ttpp -70.16 71.57 0.42 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.189 0.519 . . . . 3.23 110.086 174.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 102' ' ' GLY . 51.3 mtmt -99.77 96.45 7.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.45 . . . . 2.82 110.987 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.405 ' H ' ' HB2' ' A' ' 105' ' ' SER . 70.3 m-85 -91.57 156.56 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.492 -0.929 . . . . 1.62 108.492 170.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.71 -9.69 55.4 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.481 0.488 . . . . 1.03 112.025 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.39 163.96 17.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.412 0.445 . . . . 0.75 110.322 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 105' ' ' SER . 33.2 tt0 -158.71 138.6 12.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.673 -0.694 . . . . 1.58 109.657 176.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.558 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 57.7 tp -102.51 132.86 48.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.024 -0.535 . . . . 1.07 110.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -119.86 102.41 8.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.188 0.518 . . . . 1.77 110.261 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 93' ' ' PHE . 24.5 mt -83.96 116.98 23.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 0.93 110.581 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.54 127.23 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.34 0.59 . . . . 0.61 110.591 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 31.7 m-70 -124.45 144.11 50.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.898 -0.592 . . . . 2.13 110.062 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -111.42 131.23 55.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.891 -0.595 . . . . 4.26 110.755 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.508 ' HB2' ' CE1' ' A' ' 88' ' ' TYR . 22.0 t30 -72.84 110.43 7.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.202 0.525 . . . . 2.02 110.742 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.9 p -66.34 -21.47 66.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 2.34 112.165 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -53.51 -27.49 25.93 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.384 0.513 . . . . 3.35 112.384 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.93 8.88 44.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.128 0.418 . . . . 3.1 112.128 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.09 -1.22 0.64 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.175 1.23 . . . . 2.37 116.175 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -168.79 136.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.416 1.108 . . . . 3.93 109.715 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.2 p90 -66.41 -38.63 87.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 3.0 111.687 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.16 97.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.838 -0.696 . . . . 2.15 111.904 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -70.72 -31.9 68.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.486 . . . . 3.43 110.241 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.628 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -65.59 -25.74 67.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.777 -0.647 . . . . 1.76 110.887 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -63.72 -19.62 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 2.77 110.993 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.39 -11.91 59.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.96 -0.463 . . . . 3.55 110.996 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.436 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 7.3 tt0 -111.14 136.39 20.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.637 -0.256 . . . . 3.02 110.623 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.8 Cg_exo -55.9 -27.15 61.73 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.34 2.694 . . . . 1.6 113.351 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.436 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 3.7 m-20 -111.5 27.07 10.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.109 0.48 . . . . 2.29 110.064 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.06 -36.49 31.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 1.22 113.503 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.8 mt -121.56 163.35 19.03 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.475 -0.427 . . . . 1.57 110.375 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.44 147.67 34.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.154 -0.475 . . . . 1.38 110.179 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.15 113.57 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.906 -0.405 . . . . 1.73 109.906 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 48.7 tp -93.4 108.32 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.092 -0.504 . . . . 2.42 110.079 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -93.92 148.35 18.97 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.932 -0.576 . . . . 0.86 112.99 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 mt -137.41 125.28 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.598 -0.519 . . . . 0.76 109.598 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 18.0 m-85 -71.06 139.12 50.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.474 -0.195 . . . . 1.2 110.474 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.7 mp -113.29 110.65 20.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.468 . . . . 0.88 110.701 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.552 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 19.4 ptpt -98.94 152.3 19.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.157 -0.683 . . . . 2.03 109.157 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.61 121.07 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.018 0.437 . . . . 1.27 110.495 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.01 -114.49 0.35 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.503 -0.639 . . . . 1.53 111.503 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.4 t -66.93 147.25 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.88 -0.415 . . . . 1.54 109.88 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.84 34.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.91 0.386 . . . . 0.78 111.669 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 216' ' ' SER . 56.7 mmtt -114.58 96.48 43.78 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.824 -0.625 . . . . 1.22 109.433 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.49 -33.92 93.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.687 2.258 . . . . 1.05 111.873 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.41 71.12 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.743 -0.662 . . . . 0.7 112.357 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 160' ' ' VAL . 62.0 tp -86.53 -26.35 24.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.216 0.532 . . . . 0.77 109.616 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -37.25 69.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.201 -0.909 . . . . 1.41 110.184 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -59.4 -37.69 78.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 2.86 111.279 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 162' ' ' VAL . 42.2 t -72.82 -43.39 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.154 0.502 . . . . 1.38 110.314 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 156' ' ' LEU . 33.9 t -59.77 -34.24 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 1.11 110.756 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.26 -31.05 72.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 1.22 112.014 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 159' ' ' VAL . 5.2 p -86.32 -4.73 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 1.41 111.012 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.52 -25.72 67.46 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.355 -0.384 . . . . 1.39 111.236 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.17 -32.31 72.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 2.31 111.279 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 m -88.5 -3.25 58.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.989 0.366 . . . . 1.4 111.989 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.58 41.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.327 0.584 . . . . 0.85 110.269 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.14 -31.24 70.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 1.59 111.421 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.9 p -117.43 158.17 24.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.785 -0.189 . . . . 0.77 111.174 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -55.03 147.0 16.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.351 0.596 . . . . 2.29 112.345 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.28 -22.01 31.89 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.331 -0.85 . . . . 0.85 112.25 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -72.84 139.84 47.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.116 0.484 . . . . 1.7 110.873 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.8 p -133.54 157.6 45.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.408 -0.814 . . . . 1.37 109.549 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.71 143.75 28.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.76 -0.459 . . . . 0.61 109.76 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.8 133.45 46.54 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.245 -0.65 . . . . 1.8 109.245 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -142.34 81.21 1.74 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.81 -0.632 . . . . 1.04 109.483 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' SER . 5.2 m -108.44 164.27 12.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.256 -0.429 . . . . 1.17 110.936 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.44 64.54 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.731 0.644 . . . . 1.77 111.773 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 53.2 t80 -115.22 144.65 43.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 3.99 110.145 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.61 102.33 25.59 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 2.51 111.348 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 16.0 Cg_exo -69.18 -12.16 33.33 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.917 2.412 . . . . 1.26 112.238 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -62.88 -24.48 67.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.393 -0.367 . . . . 2.76 110.957 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.62 68.28 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.601 -0.809 . . . . 1.12 111.797 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 83.5 mt -118.22 -38.01 3.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.646 -0.502 . . . . 1.73 109.646 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.07 131.71 83.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 3.45 110.566 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.84 -178.86 4.41 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.7 2.267 . . . . 2.08 112.727 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.65 -62.39 1.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.097 -0.501 . . . . 3.23 111.35 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.7 m -71.09 131.93 44.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 1.66 110.885 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.3 mt -111.32 63.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.079 0.466 . . . . 1.99 111.597 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 19.5 m-20 -105.6 173.23 6.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.741 -1.207 . . . . 1.81 107.741 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 46.9 p90 -164.65 150.24 10.15 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.325 -0.95 . . . . 5.01 113.235 -171.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.452 ' CE3' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m95 -109.35 151.27 26.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.817 -1.549 . . . . 3.93 106.817 166.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.7 t -139.5 130.86 26.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.603 0.716 . . . . 2.13 112.55 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.436 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 51.3 t80 -138.76 142.22 33.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.214 -0.903 . . . . 5.21 109.205 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.436 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 76.8 Cg_exo -52.0 149.07 21.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.429 2.086 . . . . 2.12 112.006 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -117.9 125.12 6.34 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.839 -0.696 . . . . 1.75 112.968 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 123.557 0.743 . . . . 2.99 111.112 179.579 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.359 -0.608 . . . . 2.96 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.4 OUTLIER -88.77 43.96 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.927 0.394 . . . . 3.37 110.857 -176.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 2.1 p -86.37 -9.05 57.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.257 0.466 . . . . 2.15 112.257 -174.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.14 148.15 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.012 0.434 . . . . 1.26 111.077 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.3 m -117.5 108.22 15.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.026 -0.731 . . . . 2.08 109.026 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.428 ' CZ2' ' HB ' ' A' ' 210' ' ' VAL . 59.2 t90 -84.98 124.3 31.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.114 0.483 . . . . 5.53 110.013 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 73.2 mt -130.93 120.49 47.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.018 -0.734 . . . . 1.63 109.018 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 14.5 p -115.92 131.51 68.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.577 -0.449 . . . . 1.62 110.962 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 92.7 mt -71.98 129.09 37.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.125 -0.488 . . . . 1.73 110.208 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 0.7 OUTLIER -56.91 -24.05 49.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.116 -0.947 . . . . 2.98 111.435 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.93 115.05 65.98 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 1.47 110.68 -170.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.552 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 12.2 Cg_exo -71.89 157.76 54.25 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.639 2.226 . . . . 0.96 111.925 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.432 ' HB ' ' HE3' ' A' ' 153' ' ' LYS . 45.2 pt -114.09 151.43 15.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.172 -0.677 . . . . 1.25 109.172 172.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.585 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 2.6 p -101.53 126.6 48.37 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.847 0.356 . . . . 1.29 111.215 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.73 155.03 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.533 -0.758 . . . . 1.02 109.206 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.6 t -87.88 152.85 21.77 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.607 -0.437 . . . . 1.08 110.803 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 15.8 m -51.13 -48.13 61.84 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.287 0.367 . . . . 1.33 111.57 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 2.7 mp0 -53.94 -42.64 69.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 2.51 110.755 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.77 -45.48 92.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.657 . . . . 0.7 110.312 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.69 -37.44 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.562 . . . . 1.36 110.565 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 219' ' ' SER . 97.7 mt -67.31 -34.01 76.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.63 . . . . 1.03 110.916 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 98.5 mttt -71.07 -22.83 62.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.326 . . . . 1.75 111.161 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -72.58 -31.0 64.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 2.47 109.189 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -78.26 -4.26 46.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.325 -0.852 . . . . 3.04 110.336 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 93.3 mttt -94.06 -0.15 55.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 2.31 110.094 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -73.75 150.99 40.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.95 109.66 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.504 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.5 m120 -111.97 125.26 53.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.601 0.715 . . . . 1.13 111.248 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.405 ' HA ' ' HE2' ' A' ' 240' ' ' MET . 90.0 t80 -64.74 -32.23 73.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.41 -1.268 . . . . 3.74 110.018 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -70.03 160.8 31.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 1.62 111.719 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.11 179.37 52.87 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.895 -0.882 . . . . 1.16 110.895 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.58 137.2 42.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.858 0.829 . . . . 3.56 110.434 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 80.8 20.31 65.97 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.027 -0.606 . . . . 2.08 112.059 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -121.95 155.79 60.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 122.399 0.279 . . . . 2.59 110.263 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.76 125.14 18.13 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.916 2.41 . . . . 1.36 111.358 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -58.25 133.2 55.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.748 0.785 . . . . 3.4 112.59 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.13 120.19 18.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.62 -1.173 . . . . 2.47 108.508 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.5 116.91 7.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.739 0.304 . . . . 2.14 110.228 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 230' ' ' PHE . 51.7 ttm -70.52 95.29 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.697 -0.683 . . . . 1.68 109.525 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.27 169.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.315 -0.402 . . . . 1.27 110.607 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.4 t70 71.35 -100.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.931 0.77 . . . . 2.18 109.983 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 45.55 32.58 1.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.489 . . . . 2.15 110.833 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.495 ' HE1' ' CA ' ' A' ' 106' ' ' GLU . 78.6 t90 -115.23 137.11 52.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.992 -0.373 . . . . 4.59 109.992 -171.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 82.5 mtm180 -90.55 127.04 54.19 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.546 -0.297 . . . . 6.13 111.043 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 245' ' ' ARG . 34.8 Cg_exo -61.14 150.77 82.84 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.262 2.642 . . . . 3.28 113.363 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -96.58 95.43 7.97 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.663 -0.698 . . . . 2.98 111.762 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -56.92 157.33 11.06 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.699 . . . . 4.32 112.104 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.79 177.84 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.747 2.964 . . . . 3.48 113.488 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.68 -10.96 21.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.982 -1.008 . . . . 4.63 111.397 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -52.86 49.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.626 1.713 . . . . 5.34 115.626 168.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.428 HD22 ' C ' ' A' ' 252' ' ' ASN . 0.2 OUTLIER 139.91 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.759 2.024 . . . . 4.64 113.193 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.479 ' CG ' ' H ' ' A' ' 254' ' ' GLN . 5.5 ttp180 97.37 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.186 -1.825 . . . . 6.11 110.839 156.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.479 ' H ' ' CG ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -157.95 162.1 38.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.874 -0.788 . . . . 3.08 108.874 -167.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.476 HD12 HG12 ' A' ' 33' ' ' ILE . 9.5 mt -100.06 129.03 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.866 0.365 . . . . 2.6 110.667 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -81.95 152.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.426 -0.583 . . . . 2.63 109.426 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.73 166.27 14.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.278 -0.419 . . . . 1.71 110.975 -172.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 27.8 p -149.36 97.82 2.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.543 0.687 . . . . 2.21 110.724 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -132.53 104.93 6.93 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.151 -0.931 . . . . 4.31 108.728 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.599 -0.715 . . . . 4.49 109.96 -178.139 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.906 0.384 . . . . 2.88 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.513 ' HB ' ' CG ' ' A' ' 248' ' ' GLN . 0.4 OUTLIER -96.2 144.27 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 2.32 110.875 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -114.86 111.08 20.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 2.82 109.907 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -10.87 57.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.267 0.469 . . . . 2.24 112.267 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -59.77 -26.73 65.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.884 0.373 . . . . 4.54 110.934 175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -81.63 -15.42 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 3.06 111.357 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -62.19 109.84 1.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.472 0.654 . . . . 1.72 112.742 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -107.23 120.61 42.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.748 -1.115 . . . . 3.69 109.405 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -85.12 130.68 34.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.762 -0.654 . . . . 4.64 109.805 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 43' ' ' SER . 16.4 t70 -110.33 125.63 30.57 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.375 -0.375 . . . . 2.27 110.727 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.08 -9.73 23.76 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.951 2.434 . . . . 2.15 113.831 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . 43.4 t -78.88 -26.36 43.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.305 -0.628 . . . . 4.29 109.305 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.64 125.89 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 4.74 109.663 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -118.68 133.38 23.6 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.441 -0.8 . . . . 3.77 110.568 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.73 123.66 6.14 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.008 2.472 . . . . 2.36 111.539 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 79' ' ' LEU . 47.5 mt -59.19 144.39 46.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 2.55 111.523 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.8 t -93.49 114.42 26.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.014 -1.106 . . . . 2.38 108.014 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.76 133.11 64.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.987 -0.552 . . . . 1.59 111.85 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 20.0 m -120.54 90.88 3.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.912 -0.585 . . . . 1.45 109.601 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -108.42 -2.26 19.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.06 -0.518 . . . . 3.62 111.403 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.37 -30.29 63.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.044 0.449 . . . . 2.48 110.228 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 19.6 mt-30 -76.16 -21.77 56.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 2.24 110.435 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -69.33 150.69 47.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.755 -0.657 . . . . 0.8 111.501 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.754 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 77.9 m -141.41 128.82 21.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.867 -0.606 . . . . 1.06 110.274 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 176' ' ' THR . 22.9 m -74.91 147.76 40.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 1.26 110.056 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 71' ' ' ASP . 96.2 mt -115.04 -52.32 2.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.421 -0.354 . . . . 0.74 110.985 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HA ' ' N ' ' A' ' 175' ' ' PHE . 15.9 ptp180 -163.99 164.69 23.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 3.17 111.33 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 tt -126.6 139.18 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.64 -0.709 . . . . 0.64 109.548 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.4 tp -126.56 137.19 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.96 111.344 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -92.32 107.88 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.329 -0.989 . . . . 1.49 108.329 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -113.34 68.06 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.02 -0.672 . . . . 1.83 109.969 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.64 -57.26 0.08 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 113.961 -1.472 . . . . 1.64 115.097 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -107.97 -22.79 12.28 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.389 0.276 . . . . 3.33 111.436 -169.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.42 178.29 10.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.662 0.268 . . . . 1.38 110.466 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 228' ' ' LEU . 96.8 m-85 -111.04 143.46 41.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.367 -0.379 . . . . 2.74 110.168 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -122.08 108.51 13.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.637 -0.256 . . . . 1.76 110.816 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 22.0 t -94.92 112.07 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.528 -0.545 . . . . 1.15 109.528 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.2 132.16 39.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.018 0.437 . . . . 2.02 111.866 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -103.83 157.73 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 1.66 109.249 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.754 ' OD1' ' HB ' ' A' ' 55' ' ' THR . 1.6 p-10 -91.09 125.54 35.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.15 0.5 . . . . 1.33 109.846 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.563 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 6.9 t70 -152.96 63.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.464 0.649 . . . . 2.65 110.313 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -76.68 1.81 15.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.065 0.935 . . . . 1.61 109.088 167.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -163.72 140.28 6.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.55 -1.648 . . . . 2.35 106.55 -177.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.15 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.713 0.768 . . . . 1.92 112.801 -168.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 70.8 mmtt -101.16 -47.25 4.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.314 -0.857 . . . . 1.77 110.199 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -105.5 99.42 9.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.762 -0.654 . . . . 0.76 110.268 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.34 127.64 65.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.042 -0.526 . . . . 1.27 111.554 -171.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 47' ' ' LEU . 48.2 tp -119.56 117.37 28.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 1.29 109.783 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -160.82 122.68 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.173 -0.306 . . . . 2.54 110.173 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -119.83 -179.52 16.51 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-O 119.587 -0.563 . . . . 1.31 112.315 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -34.87 -135.43 0.0 OUTLIER Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.43 0.932 . . . . 1.9 115.43 166.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.69 167.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 123.365 2.71 . . . . 2.91 113.802 -172.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.4 pt? -33.51 82.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.622 1.341 . . . . 4.11 114.622 -146.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 21.7 p-10 -81.67 -77.3 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.437 -1.71 . . . . 4.95 112.543 175.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.438 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.22 131.93 0.81 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.723 -1.351 . . . . 2.25 109.723 -165.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.7 m -73.6 115.54 13.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.086 0.943 . . . . 1.91 111.769 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.6 m-85 -104.85 145.84 29.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.659 -0.7 . . . . 3.7 109.74 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 80.2 mtm180 -107.72 138.31 44.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.551 0.215 . . . . 3.54 110.777 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HB3' ' HB1' ' A' ' 77' ' ' ALA . 4.4 tt -88.73 112.45 23.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.921 -0.77 . . . . 1.14 108.921 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' CE3' ' A' ' 123' ' ' TRP . 54.7 mt -125.54 -23.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.518 -0.473 . . . . 1.68 111.567 -174.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.716 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.1 pt20 -156.49 159.56 38.73 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.101 -0.374 . . . . 1.55 110.715 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 31.9 p90 -150.82 164.23 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.86 110.285 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.538 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 4.2 p-80 -137.98 158.53 44.13 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.656 0.597 . . . . 0.93 110.58 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -136.0 168.83 18.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.954 -0.387 . . . . 3.17 109.954 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -165.43 146.31 7.15 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.951 -0.389 . . . . 1.68 109.951 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.461 ' CZ3' ' HB2' ' A' ' 226' ' ' ARG . 83.1 t90 -140.22 147.97 40.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.233 -0.44 . . . . 5.18 109.833 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 84.76 165.61 40.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.682 -0.771 . . . . 2.13 113.164 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . 40.5 t 160.58 -89.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.115 0.966 . . . . 2.9 108.551 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.52 -156.55 0.55 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.983 -0.553 . . . . 3.03 110.027 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.79 -42.06 62.15 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.491 0.495 . . . . 3.85 111.361 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.28 46.63 0.56 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.351 -0.7 . . . . 1.94 111.351 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 104' ' ' GLY . 4.6 tt0 -116.74 -174.87 2.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.026 -0.731 . . . . 2.45 109.026 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 103' ' ' GLN . . . 131.39 -25.21 4.08 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.397 -0.906 . . . . 1.47 112.737 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 62.4 p -67.34 -36.58 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 245' ' ' ARG . 34.5 tt0 82.41 174.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.282 -1.377 . . . . 3.72 107.282 -166.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.533 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 98.2 m-70 55.66 58.86 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 3.52 111.605 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -82.26 122.2 27.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.249 0.547 . . . . 2.52 110.311 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 23.1 t -89.04 91.84 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.764 -0.653 . . . . 2.48 109.682 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.486 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 27.2 t70 64.84 -70.14 0.09 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.015 0.822 . . . . 2.8 110.65 -174.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.486 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 0.3 OUTLIER -142.21 11.81 1.97 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.013 -0.539 . . . . 4.98 111.094 174.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 40.1 ttmt -81.19 84.9 6.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.068 0.461 . . . . 3.23 109.795 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.493 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 17.6 pttp -110.87 132.97 53.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 2.82 110.82 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -107.07 167.42 9.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.471 -0.331 . . . . 1.62 110.307 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.439 ' HB1' ' NE1' ' A' ' 97' ' ' TRP . . . -65.16 -36.14 83.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.373 -0.376 . . . . 1.03 111.885 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.87 165.48 35.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.637 0.256 . . . . 0.75 110.998 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 105' ' ' SER . 51.9 tt0 -146.67 141.88 27.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.068 -0.716 . . . . 1.58 109.068 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' A' ' 93' ' ' PHE . 48.7 tp -101.57 116.41 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.936 -0.574 . . . . 1.07 109.496 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.538 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 18.8 m170 -107.42 105.44 15.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 1.77 110.69 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.7 mp -94.18 125.72 38.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.861 -0.609 . . . . 0.93 110.461 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -92.41 137.51 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 0.61 110.43 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 36.3 m80 -131.64 140.44 49.37 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.133 -0.692 . . . . 2.13 109.133 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.562 ' CE3' HD12 ' A' ' 91' ' ' ILE . 47.1 m0 -110.44 129.99 55.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.121 0.263 . . . . 4.26 110.492 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -63.21 114.72 3.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.084 0.469 . . . . 2.02 110.748 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -80.5 -26.79 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.842 -0.617 . . . . 2.34 111.642 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -59.1 -24.45 62.96 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.753 0.279 . . . . 3.35 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -91.06 9.77 29.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.323 0.583 . . . . 3.1 110.721 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . 67.72 -4.09 4.46 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.221 -0.899 . . . . 2.37 115.333 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 21.8 t70 175.21 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.131 0.966 . . . . 3.93 109.936 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 134' ' ' VAL . 35.4 p90 -58.08 -34.94 70.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.036 -0.529 . . . . 3.0 111.053 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.54 -38.73 88.82 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.201 -0.523 . . . . 2.15 112.706 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 8.9 mmpt? -78.39 -37.32 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.131 0.491 . . . . 3.43 109.98 175.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.608 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -64.88 -34.36 78.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.365 -0.834 . . . . 1.76 112.312 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 130' ' ' PHE . 27.9 m -67.94 -9.18 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.848 0.314 . . . . 2.77 111.848 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -93.06 -6.16 48.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.26 0.552 . . . . 3.55 110.309 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 5.9 tt0 -107.29 131.63 21.56 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 3.02 109.317 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 50.9 Cg_exo -55.03 -22.07 29.54 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.968 2.445 . . . . 1.6 112.879 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.575 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.9 m-20 -111.56 28.6 8.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 2.29 110.605 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -80.85 -40.29 12.25 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.086 -0.578 . . . . 1.22 114.524 -173.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.94 158.38 18.28 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.218 -0.578 . . . . 1.57 109.95 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -143.67 117.84 9.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.855 0.36 . . . . 1.38 110.716 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.75 121.38 61.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.141 -0.482 . . . . 1.73 110.06 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 209' ' ' ILE . 60.9 tp -93.83 119.42 32.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.486 -0.561 . . . . 2.42 109.486 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.75 111.35 3.76 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.977 -0.63 . . . . 0.86 112.615 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.7 mt -110.96 107.57 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 110.221 -0.288 . . . . 0.76 110.221 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 96.8 m-85 -63.15 149.46 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.2 111.323 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mp -113.83 131.26 56.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.589 . . . . 0.88 110.121 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 216' ' ' SER . 17.4 ptpt -122.16 136.82 54.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.562 -0.532 . . . . 2.03 109.562 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 3.6 m -99.82 79.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.313 0.577 . . . . 1.27 112.262 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -157.89 60.05 0.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.684 -0.77 . . . . 1.53 112.024 168.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.594 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 7.7 t 158.78 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.64 -1.244 . . . . 1.54 107.64 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -76.43 139.07 40.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.815 0.34 . . . . 0.78 110.739 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 216' ' ' SER . 16.9 tptm -110.62 96.62 28.83 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.14 -0.482 . . . . 1.22 109.968 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.42 -36.18 97.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.971 2.448 . . . . 1.05 112.453 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.55 -6.68 66.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.196 -0.526 . . . . 0.7 113.597 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.1 tp -90.06 -21.18 22.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.773 0.787 . . . . 0.77 110.743 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.425 ' HA ' ' HB ' ' A' ' 160' ' ' VAL . 7.9 tp-100 -57.28 -34.77 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 1.41 111.648 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -47.37 -50.6 21.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.296 0.48 . . . . 2.86 112.296 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -81.05 -30.07 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.703 -0.399 . . . . 1.38 110.814 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 82.1 t -63.83 -35.62 73.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.2 0.524 . . . . 1.11 111.204 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.88 -22.51 60.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.293 -0.412 . . . . 1.22 111.516 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.55 -13.89 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.372 0.508 . . . . 1.41 112.372 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 164' ' ' ASP . 3.9 pp -60.13 -27.51 67.12 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.912 0.708 . . . . 1.39 112.912 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.581 ' N ' HD12 ' A' ' 163' ' ' LEU . 14.7 t70 -70.97 -25.03 62.54 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.954 -0.466 . . . . 2.31 110.664 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.3 m -76.69 -3.52 38.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.063 0.459 . . . . 1.4 111.136 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.2 pt -137.36 36.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.341 -0.615 . . . . 0.85 109.341 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -74.85 -25.36 58.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.665 -0.698 . . . . 1.59 111.255 -171.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 231' ' ' ASN . 0.1 OUTLIER -119.54 148.55 43.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.936 0.398 . . . . 0.77 111.139 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -55.09 126.08 23.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 2.29 112.017 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.93 -16.51 36.26 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.69 -0.767 . . . . 0.85 112.077 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -88.69 152.74 21.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.321 0.581 . . . . 1.7 110.796 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 t -143.78 159.19 42.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.466 -0.788 . . . . 1.37 109.078 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.96 130.86 20.39 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.855 -0.424 . . . . 0.61 109.855 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.28 132.94 55.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.369 -0.604 . . . . 1.8 109.369 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.404 ' N ' ' HA ' ' A' ' 58' ' ' ARG . 27.2 t80 -140.69 77.94 1.63 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.019 -1.104 . . . . 1.04 108.019 -173.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 56' ' ' SER . 4.9 m -106.73 156.98 18.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 1.17 111.757 -173.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.16 60.28 2.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.916 0.886 . . . . 1.77 112.254 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -131.58 130.46 42.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.649 -1.159 . . . . 3.99 108.829 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.46 140.75 21.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.01 0.433 . . . . 2.51 111.462 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' A' ' 183' ' ' LEU . 73.5 Cg_endo -79.84 -6.52 14.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.918 2.412 . . . . 1.26 111.617 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -58.65 -42.41 88.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.305 -0.861 . . . . 2.76 111.568 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.06 -15.29 69.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.953 -0.641 . . . . 1.12 112.995 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 180' ' ' PRO . 3.9 mm? -88.45 -10.58 48.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.502 0.192 . . . . 1.73 111.45 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.11 141.35 40.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.83 0.348 . . . . 3.45 111.018 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.87 -175.58 2.83 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.915 2.41 . . . . 2.08 112.722 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.64 -59.94 2.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.337 -0.392 . . . . 3.23 111.044 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 m -83.8 137.35 33.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 1.66 111.264 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.1 tp -109.18 64.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.352 0.596 . . . . 1.99 110.351 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.408 ' O ' HD12 ' A' ' 211' ' ' LEU . 19.1 m-20 -108.01 166.16 10.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.807 -0.812 . . . . 1.81 108.807 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -164.89 163.89 20.94 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.156 -0.618 . . . . 5.01 112.224 -167.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.34 130.99 55.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.05 -0.977 . . . . 3.93 108.375 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.2 p -95.32 106.22 18.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 2.13 111.393 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -135.99 125.43 16.02 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 5.21 111.882 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.38 132.55 5.15 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.694 2.263 . . . . 2.12 112.531 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -110.42 157.14 15.19 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.959 -0.564 . . . . 1.75 112.006 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 60.1 m . . . . . 0 C--N 1.324 -0.539 0 O-C-N 122.595 -0.356 . . . . 2.99 111.206 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.781 0.324 . . . . 2.96 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 196' ' ' SER . 8.1 pt-20 -80.51 65.29 5.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.193 0.521 . . . . 3.37 110.989 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.4 p -128.53 13.9 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.44 0.904 . . . . 2.15 113.44 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.18 138.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.43 0.633 . . . . 1.26 112.181 -171.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 24.6 m -111.28 113.43 25.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.277 -1.009 . . . . 2.08 108.277 168.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -97.47 113.89 25.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.271 0.558 . . . . 5.53 110.331 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.478 ' O ' HD12 ' A' ' 143' ' ' LEU . 48.7 mm -103.49 102.99 14.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.587 -0.733 . . . . 1.63 109.277 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.06 125.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.412 -0.588 . . . . 1.62 109.412 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 189' ' ' ASP . 15.8 tp -80.09 116.85 20.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.058 -0.349 . . . . 1.73 110.058 -176.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -61.82 -33.38 74.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.95 -0.568 . . . . 2.98 110.401 -177.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -95.75 103.07 11.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 1.47 110.165 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 14.7 Cg_exo -71.23 171.58 15.74 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.725 2.283 . . . . 0.96 112.135 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.9 pt -112.44 149.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.566 . . . . 1.25 109.945 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 5.5 p -105.18 132.2 51.69 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.03 -0.532 . . . . 1.29 110.641 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 26.9 m -128.47 165.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.976 -0.556 . . . . 1.02 110.181 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 21.0 t -94.34 153.0 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.669 -0.241 . . . . 1.08 110.682 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.565 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 17.1 p -54.54 -48.14 72.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.49 0.186 . . . . 1.33 111.272 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -54.79 -29.41 54.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.392 -0.367 . . . . 2.51 111.63 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.88 -45.91 33.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.064 -0.516 . . . . 0.7 110.362 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 34.7 m -78.56 -21.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 1.36 111.91 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 219' ' ' SER . 77.1 mt -65.06 -31.62 72.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.411 . . . . 1.03 110.489 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 163' ' ' LEU . 53.2 mttm -74.61 -22.02 59.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.125 -0.489 . . . . 1.75 110.78 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.4 m-85 -77.48 -27.37 51.95 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.6 -0.889 . . . . 2.47 108.6 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.461 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 67.0 ttt180 -72.32 -20.06 61.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.535 -1.211 . . . . 3.04 110.651 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.16 -6.7 34.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 2.31 111.313 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.451 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 93.2 mt -65.22 154.78 37.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.916 0.389 . . . . 0.95 110.647 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -116.71 134.71 54.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.312 0.577 . . . . 1.13 110.713 -175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -78.72 -35.68 44.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.868 -1.06 . . . . 3.74 109.774 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.3 p-10 -72.64 169.35 16.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.049 -0.978 . . . . 1.62 111.888 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.01 177.25 38.19 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.303 -0.862 . . . . 1.16 111.177 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.37 125.37 25.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 3.56 110.487 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.14 7.74 42.99 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.728 -0.669 . . . . 2.08 113.397 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 44.3 mt-10 -112.32 157.54 39.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 117.393 0.597 . . . . 2.59 109.67 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.66 125.33 18.38 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.289 1.992 . . . . 1.36 110.613 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.43 118.48 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.84 0.829 . . . . 3.4 112.564 -171.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.99 116.37 31.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.583 -1.19 . . . . 2.47 107.901 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.97 125.14 25.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.063 0.459 . . . . 2.14 110.584 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 60.7 ttm -78.94 89.78 4.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 1.68 110.59 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.01 167.6 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.766 -0.827 . . . . 1.27 108.766 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 19.5 t70 66.48 -88.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.764 0.665 . . . . 2.18 110.056 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 63.09 -11.26 0.09 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.354 0.872 . . . . 2.15 113.354 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -153.77 175.11 13.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.142 -0.688 . . . . 4.59 109.142 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 106' ' ' GLU . 39.0 mtp85 -129.39 147.54 65.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.212 -0.292 . . . . 6.13 110.212 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.99 82.48 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.748 2.298 . . . . 3.28 111.561 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -98.78 118.18 34.94 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.049 -0.523 . . . . 2.98 111.315 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.513 ' CG ' ' HB ' ' A' ' 33' ' ' ILE . 16.2 mm-40 -124.16 156.31 66.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 4.32 109.465 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.18 129.54 6.03 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.404 2.736 . . . . 3.48 113.095 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -43.45 -57.21 3.19 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 124.121 0.888 . . . . 4.63 112.231 -171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 54.6 pttt -106.34 0.2 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.554 0.216 . . . . 5.34 111.422 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER 75.89 -47.97 0.58 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.601 0.761 . . . . 4.64 111.465 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 70.64 -108.81 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.607 -0.886 . . . . 6.11 108.607 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -140.93 136.75 32.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.231 -1.396 . . . . 3.08 107.231 165.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 75.6 mt -84.6 121.85 37.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.302 -0.559 . . . . 2.6 109.671 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.35 134.85 42.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.899 -0.778 . . . . 2.63 108.899 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.25 172.9 12.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.257 -0.429 . . . . 1.71 110.019 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.7 m -128.33 94.69 3.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.292 -0.563 . . . . 2.21 110.968 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -146.37 126.66 13.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.733 -0.839 . . . . 4.31 108.733 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 18.8 pttp . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.244 -0.884 . . . . 4.49 110.336 -179.42 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 107.067 -1.457 . . . . 2.88 107.067 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 55.5 mt -93.96 90.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.237 0.541 . . . . 2.32 111.116 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -77.15 106.23 8.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.604 -0.726 . . . . 2.82 109.849 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -40.61 30.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.402 -0.817 . . . . 2.24 112.777 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -70.48 -33.75 71.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 4.54 110.885 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 m -89.34 -30.26 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.459 -0.337 . . . . 3.06 111.252 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.87 89.93 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.043 0.449 . . . . 1.72 112.035 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -97.97 138.75 34.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.944 -0.571 . . . . 3.69 110.145 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.772 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 48.0 p90 -84.26 123.4 30.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.928 0.394 . . . . 4.64 110.65 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.97 139.0 23.07 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.32 -0.4 . . . . 2.27 110.076 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -90.17 22.82 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.812 2.341 . . . . 2.15 112.324 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 m -89.35 -18.8 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 4.29 110.65 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.45 HD21 ' OG ' ' A' ' 258' ' ' SER . 3.4 pp -97.55 156.91 16.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 4.74 110.255 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -99.03 144.22 27.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.432 -0.349 . . . . 3.77 110.954 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 31.1 Cg_endo -64.37 165.35 20.23 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.128 2.552 . . . . 2.36 112.184 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.6 146.23 24.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 2.55 111.743 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -110.61 107.15 16.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.678 -0.86 . . . . 2.38 108.678 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -90.76 102.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.411 -0.359 . . . . 1.59 110.873 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -119.26 89.47 3.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.119 0.485 . . . . 1.45 110.423 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.06 21.71 1.58 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.54 0.686 . . . . 3.62 110.423 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.31 -17.92 64.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.38 -0.827 . . . . 2.48 110.021 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.02 -5.02 38.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.729 -0.669 . . . . 2.24 109.811 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.61 158.76 35.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.707 -0.678 . . . . 0.8 111.838 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -150.16 143.38 25.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.199 -0.91 . . . . 1.06 109.076 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 176' ' ' THR . 14.5 m -91.1 165.37 13.54 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.14 -0.689 . . . . 1.26 109.14 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -119.36 -50.34 2.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.018 0.437 . . . . 0.74 111.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -157.9 152.58 25.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.256 -0.429 . . . . 3.17 111.072 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.551 HG13 HG22 ' A' ' 68' ' ' VAL . 14.6 tt -115.55 138.48 45.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.034 -0.728 . . . . 0.64 109.034 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 172' ' ' SER . 47.2 tp -135.82 141.17 44.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.207 0.527 . . . . 0.96 112.229 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -100.16 105.6 17.22 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.797 -1.186 . . . . 1.49 107.797 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -138.56 73.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.158 0.504 . . . . 1.83 112.09 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.59 -52.71 0.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.838 -1.173 . . . . 1.64 111.997 161.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -147.41 -51.24 0.19 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.98 0.419 . . . . 3.33 110.094 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.58 169.77 8.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 1.38 111.491 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 228' ' ' LEU . 34.4 m-85 -110.24 100.25 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.502 -0.772 . . . . 2.74 109.247 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -89.33 118.58 29.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 1.76 111.622 -170.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 59' ' ' ILE . 21.3 t -100.71 114.07 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.65 -0.5 . . . . 1.15 109.65 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -80.26 138.77 36.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.038 0.385 . . . . 2.02 112.038 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.454 ' CE2' ' HD1' ' A' ' 93' ' ' PHE . 65.9 m-85 -105.32 163.32 12.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.691 -0.686 . . . . 1.66 109.747 170.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.58 113.53 25.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.894 -0.41 . . . . 1.33 109.894 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -124.55 57.87 1.24 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.868 0.842 . . . . 2.65 111.034 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -87.71 -9.26 54.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.082 0.944 . . . . 1.61 108.926 167.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.25 171.3 19.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.445 -1.252 . . . . 2.35 108.057 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.28 73.15 2.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.38 0.609 . . . . 1.92 110.857 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -92.35 -56.48 3.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.815 . . . . 1.77 109.67 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.21 101.71 11.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.719 -0.673 . . . . 0.76 109.722 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.31 135.23 63.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.191 0.52 . . . . 1.27 110.746 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 tp -140.07 110.56 6.69 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.342 -0.985 . . . . 1.29 108.342 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -148.89 125.62 11.13 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.006 -0.678 . . . . 2.54 112.683 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . -66.22 173.86 23.18 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.354 -0.839 . . . . 1.31 111.663 159.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' O ' ' HG ' ' A' ' 84' ' ' LEU . . . -41.83 -143.93 0.0 OUTLIER Glycine 0 CA--C 1.538 1.485 0 N-CA-C 114.996 0.758 . . . . 1.9 114.996 169.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.88 122.69 9.45 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.955 1.77 . . . . 2.91 112.447 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 82' ' ' GLY . 82.1 mt -138.77 -168.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.899 -1.046 . . . . 4.11 110.216 -174.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.64 57.17 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.022 0.379 . . . . 4.95 112.022 -167.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.51 -116.94 2.26 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.024 -1.084 . . . . 2.25 113.995 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.417 HG21 ' HB ' ' A' ' 125' ' ' THR . 11.6 m -127.36 111.78 14.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.65 -0.5 . . . . 1.91 109.65 -171.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.73 ' HA ' ' CD2' ' A' ' 122' ' ' HIS . 9.8 m-85 -99.03 91.12 4.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.518 0.675 . . . . 3.7 112.3 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.57 146.77 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.016 -0.993 . . . . 3.54 109.532 172.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 120' ' ' LEU . 10.4 tp -89.61 130.33 35.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.633 -0.506 . . . . 1.14 109.633 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.5 tt -106.31 -32.78 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.677 0.275 . . . . 1.68 111.481 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 91' ' ' ILE . 3.8 pt20 -163.04 171.95 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 1.55 110.352 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.454 ' HD1' ' CE2' ' A' ' 70' ' ' PHE . 26.8 p90 -144.41 146.98 32.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.86 109.347 169.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.426 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 5.2 p-80 -134.28 160.16 38.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.8 -0.444 . . . . 0.93 109.8 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.17 167.91 19.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.948 0.404 . . . . 3.17 110.95 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.13 167.78 29.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.93 -0.767 . . . . 1.68 108.93 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -151.2 151.11 31.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.15 0.282 . . . . 5.18 110.245 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -113.37 159.71 13.53 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.838 -0.696 . . . . 2.13 112.164 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 -39.76 79.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.869 0.366 . . . . 2.9 111.857 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.27 146.02 37.75 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.809 -0.812 . . . . 3.03 108.809 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.26 12.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.684 0.624 . . . . 3.85 112.684 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.66 17.83 10.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 1.94 111.97 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.429 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 14.0 pt20 -158.15 159.51 36.24 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.115 -0.328 . . . . 2.45 110.115 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.46 6.74 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 1.47 112.246 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.4 t -69.41 -45.81 68.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.748 0.309 . . . . 2.0 111.069 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.586 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 2.6 tp10 65.05 -162.64 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.528 -0.76 . . . . 3.72 109.093 -169.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.586 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 33.7 m80 53.27 49.28 20.19 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.171 0.986 . . . . 3.52 108.53 -167.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 t -79.72 131.58 35.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.815 -1.539 . . . . 2.52 112.171 -168.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 28.4 t -98.98 107.55 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 114.359 -1.291 . . . . 2.48 109.633 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.36 42.95 20.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.56 0.695 . . . . 2.8 110.096 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm 61.15 20.71 11.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.887 -1.051 . . . . 4.98 112.497 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -94.01 112.34 24.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.59 -0.522 . . . . 3.23 109.59 169.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 50.7 mttp -98.55 168.03 10.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.18 0.514 . . . . 2.82 111.174 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -119.53 176.55 5.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.3 -0.863 . . . . 1.62 109.453 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.91 94.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.1 0.407 . . . . 1.03 112.1 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.8 168.5 25.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.267 -0.424 . . . . 0.75 109.961 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -142.52 140.37 31.8 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.599 -0.519 . . . . 1.58 109.599 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 36.8 tp -103.3 125.75 50.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.323 -0.621 . . . . 1.07 109.323 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 12.3 m170 -118.76 109.93 16.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.1 0.476 . . . . 1.77 112.1 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -94.33 116.43 28.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.701 -0.681 . . . . 0.93 109.484 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.3 124.24 48.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.105 0.478 . . . . 0.61 112.013 -171.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.73 ' CD2' ' HA ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -89.62 140.96 29.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 2.13 111.005 175.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -112.64 141.53 46.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 4.26 109.542 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -93.22 96.01 9.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 2.02 110.927 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.417 ' HB ' HG21 ' A' ' 87' ' ' THR . 2.9 m -68.01 -16.94 64.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.934 -0.576 . . . . 2.34 111.251 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -52.63 -33.12 45.22 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.71 0.404 . . . . 3.35 111.804 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -107.85 -6.51 16.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.367 0.603 . . . . 3.1 110.484 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.52 38.55 9.5 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.232 -1.349 . . . . 2.37 113.785 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.56 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 22.8 t70 -166.31 110.48 0.79 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.634 -0.506 . . . . 3.93 109.634 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -57.26 -32.94 67.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 3.0 111.19 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.15 81.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.056 -0.593 . . . . 2.15 112.761 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.56 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 38.0 mmtm -88.29 -28.8 20.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 3.43 110.375 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.482 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -63.91 -36.28 83.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.76 110.685 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.483 ' O ' HD21 ' A' ' 203' ' ' LEU . 34.9 m -77.99 -2.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.372 -0.376 . . . . 2.77 111.236 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -109.01 19.23 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.278 0.561 . . . . 3.55 110.449 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -129.02 128.3 23.38 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.269 -1.011 . . . . 3.02 108.269 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.88 -31.59 73.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.097 2.532 . . . . 1.6 113.2 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -111.13 24.26 13.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 2.29 109.997 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -66.01 -50.23 53.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.016 -0.538 . . . . 1.22 112.497 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 79.4 mt -109.28 151.98 25.83 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.418 -0.586 . . . . 1.57 109.418 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -145.99 123.91 12.02 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.748 -0.834 . . . . 1.38 108.748 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.55 116.83 53.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.879 -0.328 . . . . 1.73 110.899 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 38.0 tp -83.38 115.69 22.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.668 -0.696 . . . . 2.42 109.696 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -106.16 128.88 9.52 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.038 -0.601 . . . . 0.86 112.623 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.7 122.61 70.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.387 -0.597 . . . . 0.76 109.387 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -69.75 146.39 51.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 1.2 110.301 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.34 130.46 56.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.413 -0.358 . . . . 0.88 110.149 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 216' ' ' SER . 26.2 pttm -125.32 151.59 45.84 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.457 -0.571 . . . . 2.03 109.457 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 40.7 t -84.84 121.42 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.094 0.473 . . . . 1.27 110.62 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.48 -114.72 0.33 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.504 -0.771 . . . . 1.53 111.201 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.3 p -74.01 156.3 37.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.206 -0.294 . . . . 1.54 110.206 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.22 148.88 37.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.808 0.337 . . . . 0.78 111.04 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 216' ' ' SER . 46.3 tptt -113.68 100.04 51.2 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.29 -0.414 . . . . 1.22 110.033 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 28.4 Cg_endo -63.32 -31.33 73.42 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.663 2.242 . . . . 1.05 112.543 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.94 -19.34 71.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.063 -0.589 . . . . 0.7 112.979 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.0 tp -112.07 -12.04 13.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.054 0.454 . . . . 0.77 110.792 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -40.52 79.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.909 -0.587 . . . . 1.41 111.142 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.98 -26.86 62.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.972 0.415 . . . . 2.86 110.314 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 162' ' ' VAL . 59.0 t -72.3 -44.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 1.38 109.504 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.563 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 41.6 t -62.58 -34.31 64.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.691 . . . . 1.11 110.361 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.2 -28.74 68.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.443 -0.798 . . . . 1.22 111.562 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 159' ' ' VAL . 8.8 p -97.73 -14.57 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.794 -0.363 . . . . 1.41 111.883 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.4 pp -70.75 -20.42 62.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.618 -0.433 . . . . 1.39 111.891 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 30.7 t70 -67.39 -24.42 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.235 0.54 . . . . 2.31 110.398 176.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.0 m -79.81 1.16 27.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 1.4 111.229 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 59' ' ' ILE . 40.5 pt -137.28 37.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.779 -0.823 . . . . 0.85 108.779 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 87.1 tttt -58.45 -32.01 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.861 -1.063 . . . . 1.59 111.854 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -119.92 154.17 34.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.31 -0.404 . . . . 0.77 110.485 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.46 135.37 57.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 2.29 110.663 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.7 38.18 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.71 -0.757 . . . . 0.85 111.715 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -89.77 143.47 26.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.7 110.711 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.488 ' HB3' HD13 ' A' ' 60' ' ' LEU . 65.3 p -139.88 156.59 46.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.033 -0.53 . . . . 1.37 109.659 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.6 140.37 40.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.118 -0.327 . . . . 0.61 110.118 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.92 130.8 44.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.553 -0.536 . . . . 1.8 109.553 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.38 79.79 1.68 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.797 -0.446 . . . . 1.04 109.797 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 56' ' ' SER . 21.7 p -106.76 164.98 11.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 1.17 111.148 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 56.65 71.32 0.58 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.432 0.457 . . . . 1.77 111.255 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.473 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 55.1 t80 -123.59 142.37 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.754 0.311 . . . . 3.99 110.293 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.47 102.3 14.11 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.823 -0.626 . . . . 2.51 110.061 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 2.9 Cg_exo -75.83 -19.83 15.82 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.637 2.224 . . . . 1.26 111.688 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -56.6 -38.55 72.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.287 -0.87 . . . . 2.76 111.663 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.08 6.94 2.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.125 -0.489 . . . . 1.12 113.863 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.57 -13.61 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.272 0.536 . . . . 1.73 110.352 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.3 130.43 87.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.591 . . . . 3.45 111.356 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.62 -171.95 1.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.443 2.095 . . . . 2.08 111.384 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.91 -62.37 1.67 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.936 0.398 . . . . 3.23 110.203 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.4 m -75.06 123.1 24.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 1.66 110.936 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.3 tp -101.52 64.1 0.98 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.625 0.726 . . . . 1.99 109.47 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 258' ' ' SER . 12.3 m-20 -124.91 147.64 48.73 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.398 -0.964 . . . . 1.81 108.398 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.457 ' CD1' HG23 ' A' ' 209' ' ' ILE . 53.1 p90 -144.43 158.71 43.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.562 0.949 . . . . 5.01 113.562 -166.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -93.02 140.08 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.42 -1.326 . . . . 3.93 107.42 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 9.3 t -136.57 116.72 13.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.713 0.688 . . . . 2.13 112.684 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -140.31 132.38 14.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 5.21 110.632 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.18 125.4 10.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.598 1.532 . . . . 2.12 110.575 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.34 160.13 26.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.035 -0.602 . . . . 1.75 113.249 -168.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 14.0 m . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 109.65 -0.5 . . . . 2.99 109.65 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 196' ' ' SER . 30.9 tp . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 108.905 -0.776 . . . . 2.96 108.905 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -98.89 51.55 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.381 0.61 . . . . 3.37 110.897 -171.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.7 p -91.89 -5.72 52.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.926 -0.579 . . . . 2.15 110.859 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 133.18 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.064 0.459 . . . . 1.26 110.575 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 21.7 m -105.91 103.51 13.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.126 -0.694 . . . . 2.08 109.126 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 192' ' ' THR . 96.3 m95 -76.16 110.39 10.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.301 -0.409 . . . . 5.53 110.43 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 74.3 mt -115.38 101.18 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.201 -0.666 . . . . 1.63 109.201 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 41.3 t -113.44 126.03 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 121.035 -0.266 . . . . 1.62 110.852 -171.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 137.25 41.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.291 0.567 . . . . 1.73 111.306 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -68.38 -10.35 54.46 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.346 -0.843 . . . . 2.98 112.376 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -114.61 107.75 50.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.815 -0.354 . . . . 1.47 111.198 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.81 143.49 50.77 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.133 2.555 . . . . 0.96 112.417 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -96.43 158.86 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.29 -0.633 . . . . 1.25 109.29 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 6.6 m -106.91 139.36 41.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.967 0.413 . . . . 1.29 111.425 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -124.18 148.42 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.02 109.024 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.7 t -94.98 164.78 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.149 -0.315 . . . . 1.08 110.149 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 m -47.23 -48.09 24.43 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.775 0.658 . . . . 1.33 112.775 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.55 -33.98 56.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 2.51 111.413 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -78.38 -43.32 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.262 -0.426 . . . . 0.7 110.049 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.72 -38.93 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 1.36 110.929 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.4 mt -57.63 -36.03 71.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.766 -0.652 . . . . 1.03 111.303 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -77.2 -24.33 51.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.318 -0.401 . . . . 1.75 110.961 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -72.13 -34.04 68.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 2.47 109.491 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -70.87 -11.1 60.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.093 -0.958 . . . . 3.04 110.987 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 99.6 mttt -89.96 -19.36 24.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.3 -0.409 . . . . 2.31 111.338 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.436 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 95.7 mt -64.61 146.03 55.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.321 0.582 . . . . 0.95 112.199 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.09 149.2 37.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.408 -0.815 . . . . 1.13 109.901 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -86.4 -32.12 21.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.464 -0.789 . . . . 3.74 110.027 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -71.95 166.49 22.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.085 -0.962 . . . . 1.62 111.959 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.99 -177.8 36.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.548 -0.751 . . . . 1.16 111.433 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.05 130.76 46.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.838 0.352 . . . . 3.56 110.743 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.6 33.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.808 -0.71 . . . . 2.08 112.919 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.84 160.48 66.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.37 -0.604 . . . . 2.59 109.37 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -53.06 123.02 12.18 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.476 2.117 . . . . 1.36 111.46 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.413 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 54.1 mt-10 -68.65 112.74 5.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 3.4 111.413 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -116.42 121.42 41.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.05 -0.977 . . . . 2.47 109.268 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -67.54 148.42 51.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 2.14 111.06 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 57.0 tpp -76.68 97.38 4.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.233 -0.894 . . . . 1.68 109.202 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.16 135.12 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.955 0.354 . . . . 1.27 111.955 -171.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.595 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 38.9 t70 70.59 -59.98 0.51 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.242 1.017 . . . . 2.18 111.037 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 84.24 -28.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.976 -1.011 . . . . 2.15 113.023 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -165.04 152.66 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.264 0.484 . . . . 4.59 112.07 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -139.72 71.99 36.19 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.408 -0.815 . . . . 6.13 109.565 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 106' ' ' GLU . 31.2 Cg_endo -120.25 57.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 123.498 2.798 . . . . 3.28 115.378 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -115.26 122.31 45.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.634 1.106 . . . . 2.98 110.827 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 253' ' ' ARG . 16.5 mm-40 -122.91 162.7 37.56 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 111.697 0.258 . . . . 4.32 111.697 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.24 174.02 11.38 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.976 2.451 . . . . 3.48 113.512 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 252' ' ' ASN . 3.3 mm? -60.68 -11.01 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.591 -1.186 . . . . 4.63 113.451 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 252' ' ' ASN . 19.6 ptpt -59.44 41.25 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.611 1.338 . . . . 5.34 114.611 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 251' ' ' LYS . 6.3 t-20 118.48 -33.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.539 1.935 . . . . 4.64 110.069 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.55 ' N ' ' HD3' ' A' ' 253' ' ' ARG . 0.5 OUTLIER -90.69 89.6 7.59 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.586 0.708 . . . . 6.11 110.107 -177.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -155.39 154.1 31.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.92 -1.141 . . . . 3.08 107.92 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 256' ' ' LYS . 14.9 mt -124.84 136.82 59.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.602 -0.439 . . . . 2.6 110.766 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.48 ' O ' HG22 ' A' ' 255' ' ' ILE . 40.5 mtmt -76.99 165.53 24.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 2.63 109.472 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.772 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.48 159.01 27.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.532 -0.544 . . . . 1.71 109.532 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 41.8 m -151.91 97.64 2.36 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.884 -0.413 . . . . 2.21 109.884 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.38 110.46 10.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.651 -0.704 . . . . 4.31 109.249 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.438 -0.792 . . . . 4.49 110.165 178.759 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 108.212 -1.033 . . . . 2.88 108.212 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 61.3 mt -90.57 102.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 2.32 111.794 -167.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.08 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 2.82 109.944 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -60.1 -32.55 71.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.367 0.877 . . . . 2.24 113.367 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -68.85 -45.14 71.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.73 0.3 . . . . 4.54 111.083 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -82.09 -19.65 39.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.365 -0.38 . . . . 3.06 111.004 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.3 134.74 50.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.989 0.423 . . . . 1.72 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.76 116.31 28.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 3.69 110.401 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.51 124.4 26.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 4.64 109.82 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.659 ' O ' ' HA ' ' A' ' 258' ' ' SER . 29.9 t70 -118.9 143.37 33.6 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.128 -0.942 . . . . 2.27 110.137 -170.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 44' ' ' LEU . 21.1 Cg_exo -67.36 119.13 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.157 1.905 . . . . 2.15 111.815 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 m -53.38 43.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.025 1.12 . . . . 4.29 114.025 169.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' H ' ' A' ' 45' ' ' LYS . 2.0 pt? -14.32 -66.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.304 1.842 . . . . 4.74 114.044 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.613 ' H ' ' HG ' ' A' ' 44' ' ' LEU . 27.5 mmtp -117.16 148.6 42.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 121.717 -0.615 . . . . 3.77 109.807 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.23 137.66 31.68 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.747 2.298 . . . . 2.36 112.696 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.462 HD11 ' CD2' ' A' ' 190' ' ' TYR . 95.1 mt -66.61 127.41 32.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 2.55 111.06 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 22.7 t -84.12 115.16 22.25 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.652 -0.87 . . . . 2.38 108.652 174.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.9 107.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.521 . . . . 1.59 110.092 -173.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 78' ' ' VAL . 19.5 t -133.63 91.74 2.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.142 0.496 . . . . 1.45 110.834 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -108.98 0.53 20.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.795 -0.639 . . . . 3.62 110.192 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.495 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . 4.1 m-20 -69.29 -30.88 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 2.48 111.816 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.495 ' NE2' ' HB2' ' A' ' 52' ' ' ASP . 1.0 OUTLIER -98.67 -2.58 37.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.716 -0.394 . . . . 2.24 110.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.13 130.15 40.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.054 -0.521 . . . . 0.8 111.785 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -106.33 106.88 17.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 1.06 110.975 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.0 OUTLIER -74.47 143.0 44.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.277 -0.419 . . . . 1.26 110.109 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 71' ' ' ASP . 86.4 mt -114.71 -57.26 2.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.825 0.345 . . . . 0.74 111.85 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -155.41 159.28 39.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 3.17 111.052 -170.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 66' ' ' PHE . 13.2 tt -126.1 137.11 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.2 -0.667 . . . . 0.64 109.2 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' OG ' ' A' ' 172' ' ' SER . 27.3 tp -140.87 110.83 6.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.827 0.346 . . . . 0.96 111.809 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 66' ' ' PHE . 40.8 t30 -75.73 117.74 17.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.898 -0.778 . . . . 1.49 108.898 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -140.3 69.39 1.35 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.244 -0.583 . . . . 1.83 111.301 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.52 -67.3 0.51 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.497 -0.859 . . . . 1.64 112.798 165.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.517 ' CE1' ' HB3' ' A' ' 243' ' ' ASN . 49.8 t60 -101.11 -29.53 12.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 3.33 111.1 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.79 -171.75 1.68 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.942 -0.572 . . . . 1.38 109.757 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 30.9 p90 -118.16 123.17 44.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 2.74 109.712 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -94.43 114.96 27.07 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.539 -0.755 . . . . 1.76 110.364 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 59.8 t -90.6 105.88 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 1.15 109.597 173.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.9 137.77 32.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.994 0.426 . . . . 2.02 111.472 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.99 170.07 8.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 1.66 110.681 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 57' ' ' LEU . 24.3 t70 -97.45 101.43 12.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.831 -0.622 . . . . 1.33 109.345 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.549 ' OD1' ' HB3' ' A' ' 90' ' ' LEU . 16.0 m-20 -120.9 60.62 0.9 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.65 111.038 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.7 t -108.82 1.1 20.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.487 -0.779 . . . . 1.61 111.195 173.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.24 172.59 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.673 0.273 . . . . 2.35 111.03 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.41 65.7 5.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.891 -0.595 . . . . 1.92 110.989 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -130.77 1.92 4.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.532 . . . . 1.77 110.587 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HB1' ' CD2' ' A' ' 90' ' ' LEU . . . -154.01 84.49 1.15 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.272 -0.64 . . . . 0.76 109.272 -168.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 50' ' ' SER . 27.1 m -139.54 149.17 22.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.375 0.607 . . . . 1.27 112.539 -173.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 48' ' ' SER . 40.0 tp -148.56 112.36 5.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.864 -1.062 . . . . 1.29 108.826 170.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 87' ' ' THR . 45.3 pttt -150.13 141.0 22.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.483 0.549 . . . . 2.54 112.483 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -57.68 172.68 2.87 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 115.628 -0.715 . . . . 1.31 111.928 156.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.94 -143.99 0.0 OUTLIER Glycine 0 CA--C 1.54 1.649 0 N-CA-C 117.793 1.877 . . . . 1.9 117.793 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.17 124.36 7.48 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.185 2.59 . . . . 2.91 114.174 -163.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 12.3 tp -142.13 -168.15 2.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.748 -1.569 . . . . 4.11 107.142 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.511 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 p-10 -148.82 89.08 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.13 0.877 . . . . 4.95 109.181 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 99.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.589 -0.815 . . . . 2.25 111.098 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 80' ' ' LYS . 46.2 m -104.61 103.2 12.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.62 0.724 . . . . 1.91 112.494 -172.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.0 m-85 -126.34 98.26 5.37 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.203 -1.036 . . . . 3.7 108.203 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 27.5 mmt180 -141.69 89.03 2.17 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 112.192 0.441 . . . . 3.54 112.192 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.549 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 40.6 tp -156.82 158.89 37.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.745 -1.576 . . . . 1.14 106.745 160.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.511 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 6.1 tp -161.88 -46.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.816 1.189 . . . . 1.68 112.287 169.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 8.6 pt20 -158.8 172.2 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 1.55 111.479 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -146.57 144.05 29.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.118 -0.697 . . . . 0.86 109.118 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.6 p-80 -142.32 159.89 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.267 -0.424 . . . . 0.93 110.48 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.597 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 81.3 m-85 -117.73 168.11 10.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 3.17 110.646 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -122.91 170.99 9.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.085 -0.709 . . . . 1.68 109.085 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -156.24 129.37 8.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.868 0.366 . . . . 5.18 110.131 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 103' ' ' GLN . . . -89.59 -50.86 3.03 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.769 -0.65 . . . . 2.13 113.14 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.577 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 26.3 t 149.06 -50.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.348 1.059 . . . . 2.9 108.74 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.69 160.88 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 3.03 109.398 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 115' ' ' ALA . 35.0 t70 -71.71 67.16 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.423 0.63 . . . . 3.85 110.607 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.46 42.91 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.701 -0.761 . . . . 1.94 112.941 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.647 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 12.9 pt20 -172.27 143.03 1.41 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.018 0.409 . . . . 2.45 110.423 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.21 81.84 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 120.786 -0.721 . . . . 1.47 112.35 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 41.6 t -89.14 -8.34 53.93 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.12 0.415 . . . . 2.0 112.12 -177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HA ' ' NE1' ' A' ' 244' ' ' TRP . 7.7 tp10 72.3 157.46 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.287 0.367 . . . . 3.72 110.471 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.46 ' CG ' ' HG3' ' A' ' 106' ' ' GLU . 29.6 m170 54.61 67.31 1.03 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.074 0.464 . . . . 3.52 111.863 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -80.21 127.25 32.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.892 0.853 . . . . 2.52 111.016 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 38.1 t -103.29 105.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.58 -1.191 . . . . 2.48 110.157 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.03 45.43 21.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 2.8 110.293 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 64.27 14.29 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.685 -1.143 . . . . 4.98 112.077 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -89.03 126.16 35.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.69 -0.485 . . . . 3.23 109.69 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.61 155.08 21.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.046 -0.724 . . . . 2.82 109.046 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -109.51 -170.24 1.62 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.344 -0.389 . . . . 1.62 110.287 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.435 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -46.6 18.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.374 . . . . 1.03 110.916 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.09 163.95 38.42 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.945 -0.571 . . . . 0.75 110.448 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -129.11 145.56 51.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 1.58 110.046 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.597 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 24.6 tp -111.73 112.2 23.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.246 -0.434 . . . . 1.07 109.861 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.431 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 46.9 m170 -110.93 105.27 14.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.15 -0.477 . . . . 1.77 111.335 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.7 mp -91.01 110.77 22.03 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.5 t -86.9 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.61 110.195 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 89' ' ' ARG . 38.6 m80 -131.22 125.31 32.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.905 -0.588 . . . . 2.13 109.838 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.511 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -111.02 151.53 27.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.052 -0.721 . . . . 4.26 109.052 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.585 ' ND2' ' HA ' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -93.2 101.53 13.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.787 0.803 . . . . 2.02 111.244 178.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -64.49 -10.02 22.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.39 -0.823 . . . . 2.34 112.813 -173.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -69.65 -47.94 61.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.842 0.353 . . . . 3.35 110.468 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -84.4 -21.11 30.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.375 0.607 . . . . 3.1 110.493 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.46 -2.28 64.97 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.813 -1.315 . . . . 2.37 109.813 -171.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.585 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 12.0 t70 73.3 -87.0 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.0 -1.1 . . . . 3.93 112.957 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -46.38 -40.12 11.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.069 0.766 . . . . 3.0 113.069 -168.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 134' ' ' VAL . . . -55.22 -61.12 7.73 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.022 -0.609 . . . . 2.15 112.324 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -73.69 -28.19 61.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.742 0.275 . . . . 3.43 111.742 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.63 62.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.473 0.546 . . . . 1.76 112.473 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 203' ' ' LEU . 34.4 m -64.92 -31.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.857 -0.337 . . . . 2.77 111.157 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 134' ' ' VAL . 41.6 mt-30 -100.66 -28.3 12.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 3.55 110.855 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.541 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 8.9 tt0 -76.05 119.85 79.03 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 3.02 110.848 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.95 -17.1 54.96 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 1.6 111.365 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.541 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 m-20 -105.31 27.07 8.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.159 -0.928 . . . . 2.29 109.418 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.09 -82.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.382 0 CA-C-N 116.115 -0.493 . . . . 1.22 112.554 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.43 148.9 25.35 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.21 0.529 . . . . 1.57 110.661 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.46 104.51 7.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.486 -0.779 . . . . 1.38 109.177 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.59 129.29 60.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.314 -0.403 . . . . 1.73 111.28 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 34.4 tp -97.47 127.27 43.3 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.173 -0.677 . . . . 2.42 109.173 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -111.23 131.18 10.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.783 -0.722 . . . . 0.86 112.736 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.4 mt -137.69 106.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 0.76 109.508 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -62.93 156.43 24.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.936 0.398 . . . . 1.2 111.889 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.75 123.2 49.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.88 110.097 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.3 ptmm? -115.64 138.39 51.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.817 -0.629 . . . . 2.03 109.823 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 47.8 t -88.1 133.97 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.711 0.291 . . . . 1.27 110.991 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . 126.64 58.63 0.14 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.847 -0.692 . . . . 1.53 113.361 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.624 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 3.2 t 160.26 122.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.26 -1.015 . . . . 1.54 108.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.31 134.64 39.68 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.941 -0.304 . . . . 0.78 110.271 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -114.91 95.85 42.85 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.303 -0.408 . . . . 1.22 110.462 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.84 -39.25 92.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.152 2.568 . . . . 1.05 112.341 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -66.66 -21.05 70.67 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.926 -0.654 . . . . 0.7 112.82 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 160' ' ' VAL . 60.7 tp -91.88 -31.27 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 0.77 110.412 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.462 ' NE2' ' HG2' ' A' ' 221' ' ' GLN . 8.7 tp-100 -53.37 -40.98 65.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 1.41 112.27 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.5 pttt -55.41 -37.45 67.65 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.642 0.608 . . . . 2.86 112.642 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 162' ' ' VAL . 12.0 p -85.16 -32.64 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.434 -0.507 . . . . 1.38 110.959 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.619 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 44.1 t -64.96 -38.97 84.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 1.11 110.909 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.97 -35.3 79.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.78 -0.646 . . . . 1.22 111.429 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 175' ' ' PHE . 8.3 p -88.04 -17.35 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.777 0.288 . . . . 1.41 111.777 -172.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.1 pp -74.42 -15.23 60.92 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.31 -0.556 . . . . 1.39 110.512 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.43 -24.62 64.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 2.31 110.434 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.2 m -84.47 1.85 43.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 1.4 111.359 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.4 pt -138.56 38.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.973 -0.751 . . . . 0.85 108.973 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -53.14 -41.54 65.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.837 -1.074 . . . . 1.59 111.947 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.6 p -102.69 149.83 24.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.426 -0.352 . . . . 0.77 110.434 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.16 137.4 57.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 2.29 110.31 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.64 -24.55 17.07 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.556 -0.831 . . . . 0.85 111.664 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.09 132.33 37.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.138 0.494 . . . . 1.7 110.734 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.434 ' OG ' HD13 ' A' ' 60' ' ' LEU . 4.0 m -117.71 154.11 32.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.845 -0.798 . . . . 1.37 108.845 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -145.21 137.5 25.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.869 -0.419 . . . . 0.61 109.869 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.88 131.99 47.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.543 -0.539 . . . . 1.8 109.543 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.468 ' CE2' HG11 ' A' ' 162' ' ' VAL . 20.2 t80 -138.46 78.1 1.66 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.178 -1.045 . . . . 1.04 108.178 -176.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 56' ' ' SER . 13.0 m -97.45 139.81 32.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.508 -0.769 . . . . 1.17 112.817 -173.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 24.7 m120 42.61 73.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.834 -1.075 . . . . 1.77 113.516 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.27 101.4 7.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.723 -0.671 . . . . 3.99 109.575 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -55.88 119.42 25.93 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 2.51 111.895 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.65 -5.46 17.11 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.682 2.254 . . . . 1.26 111.165 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 57.1 ttp180 -57.76 -37.17 73.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.76 111.272 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.15 -24.11 60.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.257 -0.497 . . . . 1.12 112.969 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.8 mt -81.12 -24.3 37.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.835 0.35 . . . . 1.73 111.01 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.37 128.37 92.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 3.45 111.089 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.48 -170.16 0.77 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.992 2.462 . . . . 2.08 113.375 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -75.5 -64.16 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.18 0.437 . . . . 3.23 112.18 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.633 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 3.5 m -80.26 134.32 36.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 1.66 111.17 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 95.0 mt -108.3 64.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.197 0.522 . . . . 1.99 110.96 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.495 ' HB2' ' HE3' ' A' ' 212' ' ' LYS . 55.9 m-20 -123.74 144.16 49.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.723 -1.214 . . . . 1.81 107.723 173.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.462 ' CD2' HD11 ' A' ' 47' ' ' LEU . 30.4 p90 -133.39 144.94 49.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.979 1.103 . . . . 5.01 113.979 -163.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.464 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 17.5 m95 -90.24 131.6 35.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.45 -1.25 . . . . 3.93 107.675 168.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 256' ' ' LYS . 4.9 t -128.05 118.13 22.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.436 0.636 . . . . 2.13 111.737 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 20.0 p90 -139.75 153.84 70.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 5.21 110.678 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 193' ' ' TYR . 9.7 Cg_exo -72.39 136.43 26.34 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.813 2.342 . . . . 2.12 110.937 172.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.727 ' HA3' ' CD1' ' A' ' 208' ' ' TRP . . . -137.99 158.78 24.86 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.364 -0.922 . . . . 1.75 113.062 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.12 0.486 . . . . 2.99 111.005 -177.887 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 134' ' ' VAL . 56.9 tp . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.835 0.35 . . . . 2.96 110.847 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -92.24 77.72 5.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.559 . . . . 3.37 111.186 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 85.2 m -147.81 43.29 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 2.15 110.349 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.25 146.07 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 1.26 110.956 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 48.9 m -114.28 121.45 43.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.302 -0.629 . . . . 2.08 109.302 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.727 ' CD1' ' HA3' ' A' ' 195' ' ' GLY . 36.9 m95 -106.4 130.13 54.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 5.53 110.977 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 49.1 mm -121.71 116.06 48.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.85 . . . . 1.63 109.54 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 98.0 t -111.29 133.88 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.302 -0.259 . . . . 1.62 110.302 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 143' ' ' LEU . 88.1 mt -86.37 143.93 27.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.234 0.54 . . . . 1.73 110.751 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 189' ' ' ASP . 26.8 ttmt -53.24 -23.02 7.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.945 -1.025 . . . . 2.98 112.231 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.633 ' HG3' ' H ' ' A' ' 187' ' ' SER . 68.7 mm-40 -110.55 121.03 42.38 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.424 -0.353 . . . . 1.47 111.068 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -84.02 171.62 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.61 2.207 . . . . 0.96 111.246 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 31.0 pt -111.48 147.25 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.964 0.411 . . . . 1.25 109.963 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 23.0 p -100.17 146.42 26.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.334 0.588 . . . . 1.29 111.234 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -140.66 146.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.208 -0.905 . . . . 1.02 109.418 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 222' ' ' VAL . 59.5 m -101.86 168.22 9.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.887 -0.325 . . . . 1.08 111.372 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.555 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 49.1 m -48.49 -51.0 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.092 0.775 . . . . 1.33 113.092 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.7 -48.06 82.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.698 0.285 . . . . 2.51 111.275 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.475 ' HB2' ' CG2' ' A' ' 217' ' ' VAL . 18.1 mt-30 -59.3 -44.63 92.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.764 -0.458 . . . . 0.7 109.764 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.513 ' O ' ' HG3' ' A' ' 226' ' ' ARG . 95.9 t -60.51 -40.69 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.721 -0.672 . . . . 1.36 110.874 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.6 mt -60.43 -37.03 79.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.027 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.41 ' HD2' HG12 ' A' ' 160' ' ' VAL . 93.2 mttt -66.62 -33.86 76.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.472 -0.331 . . . . 1.75 110.887 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -67.46 -30.8 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.328 0.585 . . . . 2.47 109.751 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 222' ' ' VAL . 23.6 mtp180 -79.14 -3.93 47.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.487 -0.779 . . . . 3.04 111.294 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 47.3 mmtm -87.82 -19.49 27.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.104 -0.332 . . . . 2.31 110.104 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.25 139.82 57.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.921 -0.581 . . . . 0.95 111.434 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.429 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.93 149.32 38.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 1.13 110.315 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -79.57 -31.77 41.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 3.74 109.749 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 4.5 p-10 -73.95 165.16 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.129 -0.941 . . . . 1.62 112.397 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.77 171.23 42.89 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.506 -1.225 . . . . 1.16 110.834 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.01 141.58 57.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.216 0.508 . . . . 3.56 110.688 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.76 3.88 73.47 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.701 -0.761 . . . . 2.08 111.908 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -114.01 157.67 41.42 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.369 -0.234 . . . . 2.59 110.369 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 127.62 26.81 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.89 2.394 . . . . 1.36 111.785 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.42 116.93 5.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 3.4 111.547 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -121.68 119.75 32.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.577 -0.738 . . . . 2.47 109.127 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 226' ' ' ARG . 83.9 mt -67.1 149.5 50.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 2.14 111.861 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 55.7 tpp -75.36 103.76 5.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.084 -0.962 . . . . 1.68 108.903 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.23 139.16 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 1.27 112.121 -171.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.83 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.648 -1.16 . . . . 2.18 111.31 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 33.1 m-80 55.76 31.37 17.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.044 0.537 . . . . 2.15 111.945 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' A' ' 106' ' ' GLU . 30.6 t90 -134.17 144.53 48.56 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.199 -0.313 . . . . 4.59 110.414 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.569 ' O ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -111.12 149.05 39.93 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.424 -0.213 . . . . 6.13 110.424 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.73 132.91 3.95 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 124.33 3.353 . . . . 3.28 114.246 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.38 151.0 46.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.223 -0.899 . . . . 2.98 110.926 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -123.81 150.09 61.24 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 4.32 110.466 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.37 175.26 10.29 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.598 2.865 . . . . 3.48 115.261 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 82.7 mt -63.53 -8.81 10.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.368 -1.742 . . . . 4.63 113.432 -173.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 252' ' ' ASN . 16.9 ttmm -58.17 44.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.467 1.284 . . . . 5.34 114.467 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.492 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 7.5 t-20 119.21 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 127.017 2.127 . . . . 4.64 109.52 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 42.8 mmt-85 -126.2 84.87 2.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.413 -0.958 . . . . 6.11 108.413 168.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -115.9 142.4 46.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 3.08 110.012 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.76 122.99 57.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 2.6 111.064 -174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 1.0 OUTLIER -97.86 145.13 26.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.523 -0.917 . . . . 2.63 108.523 167.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -123.64 93.01 3.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.512 -0.551 . . . . 1.71 109.512 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 54.1 m -80.18 97.41 6.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.628 0.728 . . . . 2.21 110.924 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -135.12 103.72 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.375 -1.284 . . . . 4.31 109.253 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 C--O 1.248 1.01 0 CA-C-N 116.154 -0.476 . . . . 4.49 110.67 178.49 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 113.776 1.028 . . . . 2.88 113.776 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 58.8 mt -98.97 139.66 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.372 -1.285 . . . . 2.32 110.981 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.509 ' H ' ' CD1' ' A' ' 255' ' ' ILE . 24.3 t70 -112.14 118.31 34.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.833 -0.432 . . . . 2.82 109.833 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -43.79 73.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.397 -0.82 . . . . 2.24 113.138 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.77 -42.1 91.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 4.54 110.792 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 255' ' ' ILE . 22.9 m -72.67 -28.11 62.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.019 -0.537 . . . . 3.06 110.904 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 255' ' ' ILE . . . -75.22 93.59 2.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.264 0.554 . . . . 1.72 110.95 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.94 142.19 28.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.475 -0.784 . . . . 3.69 110.665 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.5 m-85 -58.07 122.48 13.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.472 -0.785 . . . . 4.64 110.975 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.63 133.96 27.26 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.764 . . . . 2.27 109.857 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.15 59.75 3.06 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.971 2.447 . . . . 2.15 112.497 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.402 ' CB ' ' HB2' ' A' ' 258' ' ' SER . 36.9 t -69.72 -53.59 17.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 4.29 110.121 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp 72.04 -54.66 0.68 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.31 -0.859 . . . . 4.74 111.733 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 43.7 mmtm -75.62 132.64 74.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 3.77 110.371 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.29 167.02 26.6 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.641 2.227 . . . . 2.36 112.273 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.44 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 61.3 tp -93.54 116.9 29.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.942 -0.572 . . . . 2.55 109.842 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 32.1 t -86.87 121.65 29.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.427 -0.583 . . . . 2.38 109.427 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.75 134.82 57.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.973 0.416 . . . . 1.59 110.716 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 28.4 t -128.54 91.03 3.16 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.309 0.576 . . . . 1.45 109.652 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.85 9.02 32.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 3.62 109.647 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 8.3 t70 -55.49 -39.1 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.404 -0.816 . . . . 2.48 111.201 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.2 mp0 -99.44 15.59 25.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 2.24 111.238 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 121.72 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.8 111.374 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -114.37 106.98 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.12 -0.491 . . . . 1.06 110.519 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.0 m -76.14 146.68 39.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.354 -0.61 . . . . 1.26 109.354 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.28 -56.69 1.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.74 111.925 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.45 155.8 32.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.724 0.297 . . . . 3.17 111.282 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.1 tt -122.02 138.5 52.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.116 -0.493 . . . . 0.64 109.906 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 172' ' ' SER . 38.2 tp -134.63 138.48 44.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.013 0.435 . . . . 0.96 111.905 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.05 114.49 26.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.267 -0.879 . . . . 1.49 109.13 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -115.26 70.15 0.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 1.83 110.308 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.2 -59.04 0.16 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.164 -1.38 . . . . 1.64 115.531 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -110.91 -17.02 13.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.842 0.353 . . . . 3.33 111.089 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.38 174.66 14.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.981 -0.748 . . . . 1.38 108.981 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -138.4 135.47 35.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.637 -0.505 . . . . 2.74 109.637 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' A' ' 94' ' ' HIS . 15.5 m120 -126.58 152.39 46.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.214 -0.448 . . . . 1.76 110.508 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 7.1 p -111.49 129.07 67.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.079 -0.51 . . . . 1.15 109.751 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.79 131.63 34.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.081 -0.509 . . . . 2.02 111.433 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.84 153.21 21.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.634 -0.712 . . . . 1.66 109.674 172.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.558 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 33.0 t70 -72.15 92.65 1.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.084 -0.507 . . . . 1.33 110.137 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -108.4 56.47 0.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.657 0.742 . . . . 2.65 111.206 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -103.16 -3.39 25.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.749 -0.66 . . . . 1.61 111.317 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.481 ' CG ' ' HE3' ' A' ' 76' ' ' LYS . 9.5 pt20 -148.66 165.0 32.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.215 -0.448 . . . . 2.35 110.122 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -81.1 73.28 8.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.189 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HD2' ' O ' ' A' ' 71' ' ' ASP . 15.2 ptpt -102.39 -41.18 6.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.591 -0.731 . . . . 1.77 110.998 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -113.2 96.9 6.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.676 -0.49 . . . . 0.76 109.676 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 95.3 t -124.16 150.91 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.768 -0.651 . . . . 1.27 110.856 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 79' ' ' LEU . 2.5 pt? -149.19 115.74 5.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.772 0.32 . . . . 1.29 110.523 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -139.04 125.09 19.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 2.54 110.62 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 47' ' ' LEU . . . -133.95 -178.19 15.44 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.521 -1.432 . . . . 1.31 109.521 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -26.51 -127.93 0.0 OUTLIER Glycine 0 N--CA 1.486 2.024 0 C-N-CA 125.089 1.328 . . . . 1.9 115.991 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.66 170.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.075 2.517 . . . . 2.91 112.99 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.7 pt? -31.9 114.14 0.14 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.389 1.255 . . . . 4.11 114.389 -144.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 9.8 p-10 -128.27 -128.09 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 113.424 -1.717 . . . . 4.95 112.284 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 106.05 161.3 22.73 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.193 -1.163 . . . . 2.25 110.193 -166.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 125' ' ' THR . 20.1 m -73.66 102.99 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.987 0.893 . . . . 1.91 110.715 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 68.2 m-85 -100.78 133.5 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 3.7 110.544 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HD2' ' CZ2' ' A' ' 123' ' ' TRP . 99.7 mtt180 -102.49 142.78 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.225 -0.443 . . . . 3.54 110.42 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.3 tp -77.64 125.15 28.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.618 -0.512 . . . . 1.14 109.618 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.4 tt -111.73 -40.72 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.834 0.35 . . . . 1.68 110.886 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -165.15 169.36 16.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.714 -0.476 . . . . 1.55 109.714 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.486 ' HB3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 p90 -143.81 158.23 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.356 -0.238 . . . . 0.86 110.356 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.546 ' HB3' ' ND2' ' A' ' 67' ' ' ASN . 5.4 p-80 -132.34 158.91 40.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.616 -0.513 . . . . 0.93 109.616 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.82 149.93 28.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 3.17 110.375 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.485 ' ND1' ' HB3' ' A' ' 117' ' ' GLU . 13.4 m170 -100.48 153.05 19.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.504 -0.924 . . . . 1.68 108.504 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 75.0 t-105 -161.73 125.61 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.023 -0.362 . . . . 5.18 110.023 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -87.42 -171.51 47.27 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 111.319 -0.712 . . . . 2.13 111.319 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' A' ' 241' ' ' VAL . 11.2 t -78.52 -46.94 18.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.736 0.768 . . . . 2.9 109.995 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 102' ' ' GLY . 92.6 mt -83.95 146.61 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.429 . . . . 3.03 110.135 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.21 32.59 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.765 0.654 . . . . 3.85 112.765 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 100' ' ' LEU . . . -155.4 21.93 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.921 -0.656 . . . . 1.94 112.344 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.402 ' HG3' ' HA3' ' A' ' 98' ' ' GLY . 3.1 pt20 -150.46 169.58 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.211 -0.292 . . . . 2.45 110.211 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.422 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 86.95 17.41 59.58 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.668 -0.777 . . . . 1.47 113.111 169.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 77.8 p -80.58 -8.86 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.963 0.382 . . . . 2.0 111.701 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 66.48 164.68 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.101 -0.703 . . . . 3.72 109.101 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.426 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 29.4 m80 58.11 46.73 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 3.52 110.704 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.5 m -78.4 117.71 19.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 2.52 110.097 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 46.2 t -84.22 99.67 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 114.549 -1.205 . . . . 2.48 110.887 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 69.58 -72.27 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.709 0.631 . . . . 2.8 110.599 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -146.06 5.56 0.99 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.814 -0.439 . . . . 4.98 109.814 173.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.06 97.15 11.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.973 -0.558 . . . . 3.23 110.085 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -110.89 145.22 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 2.82 109.512 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 46.1 m-85 -105.06 179.03 4.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.303 -0.408 . . . . 1.62 110.203 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.02 53.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.026 0.441 . . . . 1.03 110.668 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.35 23.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.75 110.049 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 31.0 tt0 -147.73 146.38 29.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.97 -0.559 . . . . 1.58 110.255 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -99.45 107.3 19.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.548 -0.751 . . . . 1.07 109.604 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -109.52 102.41 11.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.11 0.481 . . . . 1.77 110.176 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 93' ' ' PHE . 5.0 mp -87.49 128.1 35.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.93 111.158 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 142' ' ' VAL . 45.2 t -96.45 127.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.965 -0.561 . . . . 0.61 110.393 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 20.9 m80 -126.77 138.11 53.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.608 -0.516 . . . . 2.13 109.608 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.586 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 44.9 p-90 -112.52 144.78 41.43 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.545 0.528 . . . . 4.26 110.592 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.672 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 41.8 t-20 -75.38 109.89 9.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 2.02 110.752 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.586 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 8.9 t -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.068 0.766 . . . . 2.34 113.068 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.672 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 21.3 ptmt -71.3 -7.68 48.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.166 0.432 . . . . 3.35 112.166 -172.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.09 -17.59 6.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.349 0.595 . . . . 3.1 110.459 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.45 -4.95 85.64 Favored Glycine 0 C--N 1.325 -0.042 0 N-CA-C 109.734 -1.347 . . . . 2.37 109.734 -167.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 123' ' ' TRP . 13.1 t70 71.55 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.193 -1.504 . . . . 3.93 112.224 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.443 ' O ' HG23 ' A' ' 134' ' ' VAL . 95.7 m-85 -45.27 -31.4 1.53 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.256 1.206 . . . . 3.0 114.256 -168.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.53 -65.03 2.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.344 -0.932 . . . . 2.15 111.803 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -72.23 -30.78 65.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.979 0.363 . . . . 3.43 111.979 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -26.34 49.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.141 0.422 . . . . 1.76 112.141 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 130' ' ' PHE . 59.7 t -60.66 -34.75 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 2.77 110.71 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -119.9 18.77 12.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.479 -0.328 . . . . 3.55 111.466 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 7.9 tt0 -132.16 113.83 14.79 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.755 -0.461 . . . . 3.02 109.755 -173.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.524 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 38.0 Cg_exo -60.69 -14.63 32.54 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.023 2.482 . . . . 1.6 113.785 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.77 27.15 9.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.303 . . . . 2.29 110.552 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.444 ' O ' ' HE1' ' A' ' 88' ' ' TYR . . . -66.61 -86.84 0.07 OUTLIER Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.947 -0.57 . . . . 1.22 114.211 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.76 161.21 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.562 0.696 . . . . 1.57 112.708 -168.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.43 110.58 5.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.939 . . . . 1.38 110.177 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 208' ' ' TRP . 21.2 m -107.32 152.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.812 -0.44 . . . . 1.73 109.812 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 10.2 tt -131.92 125.25 31.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.315 -0.254 . . . . 2.42 110.315 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.86 131.9 10.22 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.843 -0.694 . . . . 0.86 113.025 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -119.57 122.87 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.208 -0.293 . . . . 0.76 110.208 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -68.38 146.95 52.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.466 -0.334 . . . . 1.2 111.628 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.444 HD23 ' HB ' ' A' ' 215' ' ' ILE . 80.2 mt -124.47 114.52 19.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 0.88 110.219 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -107.24 153.73 22.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.71 -0.478 . . . . 2.03 109.71 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 44.1 t -90.08 127.64 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.987 0.423 . . . . 1.27 110.848 -175.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.07 -105.12 0.19 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.217 -0.753 . . . . 1.53 111.217 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.0 m -76.23 146.58 38.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.04 -0.356 . . . . 1.54 110.04 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -70.0 146.99 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.78 111.298 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 216' ' ' SER . 51.6 tptt -112.89 99.76 49.2 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.603 -0.726 . . . . 1.22 109.67 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 11.1 Cg_endo -55.55 -36.34 94.26 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.735 2.29 . . . . 1.05 111.919 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.12 -28.89 72.88 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.8 -0.636 . . . . 0.7 113.06 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.436 ' HG ' HG23 ' A' ' 160' ' ' VAL . 21.4 tp -93.82 -19.85 20.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.226 -0.573 . . . . 0.77 110.153 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -46.01 91.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.174 -0.466 . . . . 1.41 110.461 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.9 pttp -57.42 -40.7 78.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.677 0.621 . . . . 2.86 112.677 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.68 -36.01 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.263 -0.575 . . . . 1.38 110.73 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 75.8 t -64.03 -36.45 76.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.125 0.488 . . . . 1.11 110.757 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.39 -31.34 70.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.04 -0.527 . . . . 1.22 110.465 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 158' ' ' LYS . 73.0 t -83.55 -27.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.41 111.476 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.3 pp -70.77 -13.39 62.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.222 0.534 . . . . 1.39 110.31 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.42 -24.8 65.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.85 -0.613 . . . . 2.31 110.211 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.3 m -83.41 -1.64 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.31 . . . . 1.4 111.556 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 163' ' ' LEU . 47.2 pt -139.67 26.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 0.85 109.962 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 229' ' ' ASN . 48.9 pttt -74.89 16.15 0.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.038 -0.528 . . . . 1.59 112.334 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.76 140.23 46.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.902 0.382 . . . . 0.77 110.408 174.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.412 ' HB3' ' HA2' ' A' ' 232' ' ' GLY . 74.2 tttt -56.32 120.16 7.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 2.29 111.876 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.49 30.72 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.631 -0.795 . . . . 0.85 112.462 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -88.17 148.98 24.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.908 0.385 . . . . 1.7 110.687 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 60' ' ' LEU . 11.6 p -145.57 157.28 44.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.874 -0.603 . . . . 1.37 110.158 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -147.61 149.43 32.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.67 0.271 . . . . 0.61 110.52 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.97 136.79 46.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.017 0.437 . . . . 1.8 110.268 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -140.55 79.91 1.73 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.797 -0.816 . . . . 1.04 108.797 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.3 p -109.44 159.86 16.68 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.275 0.472 . . . . 1.17 112.275 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.35 47.16 21.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.509 -0.769 . . . . 1.77 112.345 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.13 98.29 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.891 0.377 . . . . 3.99 110.186 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.08 136.25 82.19 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.884 -0.598 . . . . 2.51 111.136 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.03 -4.27 13.18 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.123 2.549 . . . . 1.26 112.226 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 70.0 mtp180 -55.07 -42.68 73.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.872 -0.604 . . . . 2.76 112.136 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -58.97 -13.55 19.87 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 116.176 -0.465 . . . . 1.12 113.675 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.21 -7.65 44.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.852 0.326 . . . . 1.73 111.168 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.62 128.78 68.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 3.45 110.595 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.07 -178.39 4.15 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.827 2.351 . . . . 2.08 112.527 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.81 -63.21 1.46 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.561 0.219 . . . . 3.23 110.749 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.0 m -70.41 130.42 41.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 1.66 110.712 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.04 62.55 0.6 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.255 0.55 . . . . 1.99 110.107 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -94.21 128.28 40.56 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.329 -0.989 . . . . 1.81 108.329 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 52.6 p90 -139.66 147.45 41.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.067 0.766 . . . . 5.01 113.067 -169.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 28.6 m-90 -86.76 135.84 33.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.286 -0.87 . . . . 3.93 108.928 169.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 192' ' ' THR . 7.1 t -119.69 103.26 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.641 0.734 . . . . 2.13 110.346 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' A' ' 208' ' ' TRP . 4.6 t80 -137.48 137.08 21.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.098 -0.501 . . . . 5.21 110.783 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -89.56 128.83 1.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.745 2.297 . . . . 2.12 112.279 173.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.09 157.65 25.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.276 -0.487 . . . . 1.75 112.696 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 1.7 m . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 109.395 -0.594 . . . . 2.99 109.395 174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 196' ' ' SER . 42.9 tp . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 121.29 0.567 . . . . 2.96 110.967 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -95.96 41.46 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 3.37 109.57 -174.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 137' ' ' PRO . 4.6 p -84.11 2.49 39.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 2.15 112.362 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.03 129.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 120.95 0.405 . . . . 1.26 109.943 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.3 m -107.76 100.83 10.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.715 -0.846 . . . . 2.08 108.715 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 193' ' ' TYR . 4.4 p-90 -90.24 100.96 13.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.914 0.864 . . . . 5.53 111.72 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 51.3 mm -88.85 105.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.065 -1.425 . . . . 1.63 109.671 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.1 t -106.78 128.99 61.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.965 -0.294 . . . . 1.62 110.544 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -85.89 140.85 30.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.419 0.628 . . . . 1.73 111.448 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -83.86 -21.71 31.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.149 -0.932 . . . . 2.98 110.92 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.403 ' OE1' ' HD2' ' A' ' 214' ' ' PRO . 11.3 tp10 -88.33 113.38 55.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.271 -0.422 . . . . 1.47 109.873 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 83.0 Cg_endo -82.93 155.81 15.25 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.668 2.245 . . . . 0.96 113.11 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.444 ' HB ' HD23 ' A' ' 147' ' ' LEU . 26.8 mm -106.19 146.44 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.771 -0.649 . . . . 1.25 109.609 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 15.1 m -99.57 127.93 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.451 -0.34 . . . . 1.29 111.322 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.9 m -122.48 151.51 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.921 -0.77 . . . . 1.02 108.921 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 8.0 t -97.1 163.82 12.77 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.277 -0.569 . . . . 1.08 111.159 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.542 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 24.9 m -50.82 -50.62 56.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 1.33 111.886 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -50.98 -36.29 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.934 0.397 . . . . 2.51 111.573 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.95 -48.32 54.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.146 -0.479 . . . . 0.7 110.894 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.424 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 29.4 m -74.92 -22.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 1.36 111.277 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 219' ' ' SER . 94.7 mt -68.28 -45.2 73.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.032 -0.359 . . . . 1.03 110.032 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -67.8 -29.46 68.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 1.75 110.659 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.49 -42.49 82.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 2.47 110.041 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 67.0 ttt180 -73.93 10.88 1.01 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.72 -0.673 . . . . 3.04 111.011 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.46 -8.6 38.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.06 -0.348 . . . . 2.31 110.06 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.81 132.45 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.08 -0.509 . . . . 0.95 111.039 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 167' ' ' LYS . 0.9 OUTLIER -101.53 140.41 35.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.907 -0.588 . . . . 1.13 110.218 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -78.86 -34.94 44.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.781 -1.099 . . . . 3.74 109.668 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.6 p-10 -70.8 163.86 26.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.84 -1.073 . . . . 1.62 111.875 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 169' ' ' LYS . . . -83.92 174.4 51.25 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.231 -0.895 . . . . 1.16 111.197 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.55 127.5 32.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.95 0.375 . . . . 3.56 110.062 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.22 -2.58 56.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.859 -0.686 . . . . 2.08 112.635 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 41.3 mt-10 -102.2 159.97 27.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.065 -0.346 . . . . 2.59 110.065 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.96 128.68 30.89 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.181 . . . . 1.36 111.519 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -59.38 125.63 24.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 3.4 112.734 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 44.8 mt-10 -130.57 150.24 51.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.091 -1.078 . . . . 2.47 108.091 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.7 mt -90.97 133.38 35.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.525 -0.47 . . . . 2.14 110.866 -175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 ttm -76.83 89.3 3.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.359 -0.978 . . . . 1.68 108.359 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 99' ' ' SER . 21.7 m -133.55 153.24 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 1.27 110.198 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.4 t70 67.36 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.004 0.815 . . . . 2.18 110.356 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 43.39 32.22 0.48 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.555 0.534 . . . . 2.15 111.743 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -104.5 136.66 43.65 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.082 0.468 . . . . 4.59 110.597 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.585 ' H ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -70.3 144.3 91.93 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.267 -0.879 . . . . 6.13 110.434 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.63 131.93 43.49 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.792 2.328 . . . . 3.28 111.965 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.99 132.37 49.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 2.98 111.584 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.519 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 66.8 mm-40 -85.17 172.79 8.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.854 -0.795 . . . . 4.32 108.854 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 73.4 Cg_exo -43.06 110.51 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.406 2.071 . . . . 3.48 112.03 174.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -58.42 4.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.443 -1.253 . . . . 4.63 113.586 -167.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 37' ' ' THR . 5.2 ptpp? -69.59 -7.0 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.624 0.972 . . . . 5.34 113.624 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 7.7 p30 36.33 54.27 1.03 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.718 1.007 . . . . 4.64 113.718 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 252' ' ' ASN . 13.4 mmt180 76.11 -89.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.391 -0.596 . . . . 6.11 109.391 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.47 136.52 21.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.975 -1.12 . . . . 3.08 107.975 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.515 ' H ' HG22 ' A' ' 37' ' ' THR . 17.0 mt -94.24 150.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.691 0.281 . . . . 2.6 111.033 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -104.55 131.44 51.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 2.63 110.558 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.31 97.55 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.256 -0.429 . . . . 1.71 110.164 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.402 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 22.3 p -95.73 96.46 9.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.367 -0.533 . . . . 2.21 111.609 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.486 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 24.8 p90 -166.71 154.4 9.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 4.31 110.047 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.997 -0.547 . . . . 4.49 110.605 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.498 ' HB2' ' H ' ' A' ' 248' ' ' GLN . 32.2 t70 . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 109.109 -0.7 . . . . 2.88 109.109 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 210' ' ' VAL . 54.2 mt -101.98 103.57 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.904 0.705 . . . . 2.32 112.904 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -93.69 102.14 14.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.053 -0.721 . . . . 2.82 109.053 165.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 m -56.99 -28.46 62.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 2.24 112.353 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -69.84 -34.27 73.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.563 0.221 . . . . 4.54 111.281 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -85.7 -23.29 27.46 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.955 -0.298 . . . . 3.06 111.126 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -61.54 105.28 0.51 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.283 0.563 . . . . 1.72 111.716 174.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.28 138.05 36.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.526 -0.761 . . . . 3.69 111.235 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 99.2 m-85 -73.93 132.41 42.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.529 . . . . 4.64 110.112 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -120.81 124.09 27.67 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.427 -0.351 . . . . 2.27 110.725 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.35 -23.22 44.72 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.767 2.312 . . . . 2.15 112.036 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 m -65.7 -27.81 68.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.524 . . . . 4.29 111.396 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.7 mt -70.52 119.26 14.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.028 0.442 . . . . 4.74 111.01 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.605 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 59.0 tttm -99.29 131.43 25.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.407 -0.815 . . . . 3.77 109.294 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.3 154.44 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.862 3.041 . . . . 2.36 114.034 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.64 125.21 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.066 -0.97 . . . . 2.55 110.729 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 m -96.87 98.42 10.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.239 -0.652 . . . . 2.38 109.239 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.43 HG22 ' HG ' ' A' ' 79' ' ' LEU . 8.9 t -102.9 127.98 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.912 -0.585 . . . . 1.59 110.649 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -129.58 91.4 3.15 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.82 -0.437 . . . . 1.45 109.82 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -106.35 11.63 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.864 0.364 . . . . 3.62 110.92 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 2.48 111.067 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 48.9 mt-30 -94.33 6.17 49.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.987 -0.552 . . . . 2.24 111.964 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -67.51 133.72 49.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.8 111.603 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -113.38 106.24 14.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 1.06 110.467 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 m -72.34 138.05 47.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.162 -0.472 . . . . 1.26 109.832 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 71' ' ' ASP . 82.6 mt -113.74 -58.21 2.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.74 112.427 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -158.9 161.44 36.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.868 0.366 . . . . 3.17 111.448 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -121.17 133.2 68.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.651 -0.87 . . . . 0.64 108.651 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 57.9 tp -137.3 119.05 15.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.56 0.578 . . . . 0.96 112.56 -171.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -79.18 114.06 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.102 -1.073 . . . . 1.49 108.102 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 169' ' ' LYS . 53.8 t30 -140.34 70.59 1.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.654 -0.819 . . . . 1.83 112.423 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 103.27 -67.01 0.33 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.137 -1.03 . . . . 1.64 113.132 162.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.471 ' HB3' ' OD1' ' A' ' 243' ' ' ASN . 51.7 m80 -103.82 -27.55 12.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.048 0.452 . . . . 3.33 110.895 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.96 -169.98 2.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.755 -0.657 . . . . 1.38 110.159 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 95' ' ' PHE . 34.8 p90 -133.8 134.03 42.37 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.271 -1.011 . . . . 2.74 108.271 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 8.3 p30 -132.71 151.87 51.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.055 0.455 . . . . 1.76 111.398 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 98.2 t -106.46 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 1.15 109.84 176.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.39 138.38 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.464 . . . . 2.02 111.417 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.82 150.69 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.339 -0.846 . . . . 1.66 109.135 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB2' HD21 ' A' ' 57' ' ' LEU . 22.4 t70 -75.2 124.44 27.06 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.009 -0.367 . . . . 1.33 110.009 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -125.81 58.31 1.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.08 0.943 . . . . 2.65 110.448 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 p -96.41 -5.25 40.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.51 -0.768 . . . . 1.61 109.75 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -143.17 157.69 44.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.834 -1.075 . . . . 2.35 108.813 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.58 70.25 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.549 0.69 . . . . 1.92 109.769 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 68.5 mttm -92.75 -54.64 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.287 -0.869 . . . . 1.77 111.538 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -110.5 110.42 21.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.282 -0.417 . . . . 0.76 110.283 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.75 144.24 34.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.392 -0.367 . . . . 1.27 110.613 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HG ' HG22 ' A' ' 49' ' ' VAL . 9.6 tt -149.9 113.04 4.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.707 -0.849 . . . . 1.29 108.707 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -151.43 127.44 10.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.156 0.503 . . . . 2.54 111.385 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -67.89 174.01 30.01 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.784 -0.644 . . . . 1.31 111.635 164.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 45' ' ' LYS . . . -39.2 -142.73 0.0 OUTLIER Glycine 0 N--CA 1.472 1.076 0 N-CA-C 115.813 1.085 . . . . 1.9 115.813 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.52 121.32 6.95 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 121.856 1.704 . . . . 2.91 112.37 -173.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.8 mt -147.81 -168.17 3.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.528 -1.214 . . . . 4.11 108.713 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -129.24 70.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.444 0.535 . . . . 4.95 112.444 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 131.19 -125.56 4.5 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.794 -1.193 . . . . 2.25 115.072 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.776 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 85.6 m -131.51 115.68 16.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.692 -0.754 . . . . 1.91 109.755 -169.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -115.01 91.36 3.59 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.037 -0.665 . . . . 3.7 111.739 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.29 142.49 34.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.109 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -73.77 121.86 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 1.14 110.331 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.519 HG23 ' HG2' ' A' ' 92' ' ' GLN . 5.2 tp -107.92 -38.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 1.68 111.088 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG2' HG23 ' A' ' 91' ' ' ILE . 8.7 pt20 -170.25 168.06 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.625 -0.262 . . . . 1.55 110.498 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 41.6 p90 -141.31 145.89 36.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.648 -0.501 . . . . 0.86 109.648 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.459 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.8 p-80 -128.9 159.81 34.63 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.329 0.393 . . . . 0.93 110.695 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 t80 -135.74 158.13 45.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.959 -0.386 . . . . 3.17 109.959 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -162.65 171.12 17.37 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.734 0.302 . . . . 1.68 111.713 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.506 ' CZ2' ' HB ' ' A' ' 222' ' ' VAL . 23.1 m95 -138.99 148.74 43.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.588 -0.733 . . . . 5.18 110.459 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . -79.18 -37.38 25.02 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 116.022 -0.535 . . . . 2.13 113.499 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 47.1 t 162.93 -70.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.57 0.748 . . . . 2.9 109.35 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.38 158.33 26.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.359 -0.837 . . . . 3.03 109.68 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.22 62.05 0.13 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.558 0.536 . . . . 3.85 111.463 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.23 32.31 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.649 -0.786 . . . . 1.94 113.029 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.522 ' NE2' ' HB3' ' A' ' 99' ' ' SER . 13.6 pt20 -161.29 157.21 25.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.898 0.349 . . . . 2.45 110.485 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' N ' ' A' ' 98' ' ' GLY . . . 99.11 45.92 2.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.867 -0.682 . . . . 1.47 112.482 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 45.2 t -103.88 -28.4 11.62 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.284 -0.166 . . . . 2.0 111.264 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 105' ' ' SER . 8.5 tp10 68.07 169.3 0.27 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.196 -0.668 . . . . 3.72 109.196 -167.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.6 m170 60.59 35.13 20.07 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.482 0.658 . . . . 3.52 110.414 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.476 ' CG2' ' HA ' ' A' ' 113' ' ' LYS . 73.2 p -82.73 119.59 24.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.167 -0.924 . . . . 2.52 111.637 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 87.9 t -76.42 117.0 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.214 -0.903 . . . . 2.48 109.878 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.71 35.42 16.93 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.128 -0.693 . . . . 2.8 109.128 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.7 mttp 59.91 27.49 16.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.073 -0.967 . . . . 4.98 112.342 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -77.3 86.87 3.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.114 -0.328 . . . . 3.23 110.114 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.476 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 98.9 mttt -61.69 113.05 2.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.066 0.46 . . . . 2.82 111.477 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -83.88 177.34 8.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.551 -0.75 . . . . 1.62 109.108 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.86 -53.7 54.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.914 0.338 . . . . 1.03 111.914 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.2 169.56 4.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.124 -0.325 . . . . 0.75 110.124 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.4 ' HB2' ' OG ' ' A' ' 105' ' ' SER . 26.8 tt0 -148.94 141.81 24.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.987 -0.375 . . . . 1.58 109.987 -178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 34.5 tp -99.74 125.89 45.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.871 -0.604 . . . . 1.07 109.493 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.4 m170 -110.69 107.9 17.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.77 111.516 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 120' ' ' LEU . 5.4 mp -93.39 113.35 25.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.786 -0.643 . . . . 0.93 110.19 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.04 127.65 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.294 0.569 . . . . 0.61 111.527 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.9 139.88 50.5 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.017 -1.105 . . . . 2.13 108.017 172.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.94 154.36 46.64 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.57 -0.452 . . . . 4.26 111.559 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.776 ' HA ' ' O ' ' A' ' 87' ' ' THR . 53.1 t30 -76.43 89.58 3.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 2.02 110.988 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.9 p -73.45 -9.2 58.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.538 0.94 . . . . 2.34 113.538 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 13.5 ptmm? -71.52 -46.02 60.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.963 -0.695 . . . . 3.35 109.736 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.516 ' CG ' ' HG3' ' A' ' 132' ' ' LYS . 67.6 m-85 -94.19 -15.56 24.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 3.1 111.138 173.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 129' ' ' ASP . . . 101.23 -1.04 54.2 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.835 -0.698 . . . . 2.37 111.57 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 128' ' ' GLY . 32.8 t70 81.52 -78.16 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.834 0.854 . . . . 3.93 112.185 172.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -56.3 -19.87 16.26 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.438 0.903 . . . . 3.0 113.438 -168.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.09 -67.52 1.62 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.723 -0.751 . . . . 2.15 112.165 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HG3' ' CG ' ' A' ' 127' ' ' TYR . 45.0 mmtm -72.13 -21.25 61.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.416 0.524 . . . . 3.43 112.416 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.63 56.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 1.76 111.427 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 203' ' ' LEU . 70.1 t -61.62 -36.29 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 2.77 110.418 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -106.4 -24.66 12.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.661 0.267 . . . . 3.55 111.283 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -95.47 105.13 18.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 3.02 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 72.4 Cg_endo -76.52 -0.46 10.45 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.424 2.083 . . . . 1.6 112.419 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.53 27.07 10.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.425 -0.352 . . . . 2.29 110.39 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.87 -53.92 8.96 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 120.808 -0.711 . . . . 1.22 112.849 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 91.5 mt -89.32 151.0 22.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 1.57 110.784 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.47 106.63 5.75 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.485 -0.78 . . . . 1.38 109.286 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 44.4 t -107.3 117.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.457 -0.338 . . . . 1.73 110.803 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.99 126.18 33.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.833 -0.621 . . . . 2.42 109.62 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.19 115.43 4.45 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.737 -0.744 . . . . 0.86 112.638 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.6 mt -104.91 111.48 34.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.137 -0.319 . . . . 0.76 110.137 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -67.99 144.61 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.695 0.283 . . . . 1.2 110.981 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.2 mp -115.71 131.94 56.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.43 -0.35 . . . . 0.88 110.315 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -121.5 143.91 49.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.147 -0.686 . . . . 2.03 109.147 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 42.5 t -88.43 129.6 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 1.27 111.374 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.59 -104.12 0.18 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.532 -0.758 . . . . 1.53 111.279 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 p -81.66 146.73 29.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.197 -0.297 . . . . 1.54 110.197 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.33 148.86 47.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.086 0.469 . . . . 0.78 111.621 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 216' ' ' SER . 49.3 tptt -111.5 103.76 55.39 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 1.22 109.444 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.83 -38.11 94.89 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.002 2.468 . . . . 1.05 112.299 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.466 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -62.13 -29.21 72.18 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 116.031 -0.531 . . . . 0.7 113.035 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.5 tp -94.48 -17.58 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.271 0.535 . . . . 0.77 110.392 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -43.78 92.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.828 -0.624 . . . . 1.41 110.233 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.0 pttt -56.87 -32.39 65.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 2.86 111.853 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.6 t -77.07 -41.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 1.38 110.47 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 156' ' ' LEU . 72.4 t -57.57 -36.93 55.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.745 -0.662 . . . . 1.11 111.331 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.02 -20.6 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.56 . . . . 1.22 112.405 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.0 t -96.6 -7.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.902 0.382 . . . . 1.41 111.332 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 84.6 mt -57.66 -42.1 82.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.854 0.687 . . . . 1.39 112.854 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.94 -24.81 66.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.81 0.338 . . . . 2.31 111.386 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.0 m -81.15 -8.98 59.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.476 -0.329 . . . . 1.4 111.26 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -134.21 36.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.364 0.602 . . . . 0.85 109.739 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.58 -32.92 74.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 1.59 111.451 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.9 p -116.93 155.73 28.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.888 0.375 . . . . 0.77 111.528 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 42.5 tttm -59.73 132.42 53.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.868 -0.605 . . . . 2.29 110.611 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.36 -17.14 40.73 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.756 -0.735 . . . . 0.85 111.555 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -75.28 107.83 7.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.941 0.4 . . . . 1.7 110.602 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.0 m -98.95 140.74 32.65 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.262 -0.644 . . . . 1.37 109.262 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.28 129.35 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.825 -0.435 . . . . 0.61 109.825 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.45 134.13 56.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 1.8 109.825 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.41 79.85 1.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.833 . . . . 1.04 108.752 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.0 p -105.27 152.87 22.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 1.17 112.095 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.27 62.98 2.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.724 -0.671 . . . . 1.77 112.131 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -134.67 98.1 3.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 3.99 110.768 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.15 140.44 88.15 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.822 -0.626 . . . . 2.51 111.112 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.16 -3.48 13.15 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.178 2.585 . . . . 1.26 112.17 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.5 -42.59 74.67 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.863 -0.608 . . . . 2.76 112.302 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -63.0 -16.95 58.1 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.046 -0.597 . . . . 1.12 113.285 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.75 -16.26 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 1.73 110.948 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.05 133.8 36.42 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.456 . . . . 3.45 110.896 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.61 -170.47 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.921 2.414 . . . . 2.08 112.426 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.63 -49.87 60.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.621 0.248 . . . . 3.23 111.601 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.422 ' HB2' ' HG3' ' A' ' 213' ' ' GLU . 36.6 m -94.73 141.19 28.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 1.66 110.732 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.5 64.09 0.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.534 0.683 . . . . 1.99 109.735 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.434 ' O ' HD12 ' A' ' 211' ' ' LEU . 0.9 OUTLIER -80.45 163.59 23.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.514 -0.766 . . . . 1.81 109.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.714 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 30.6 p90 -165.57 142.88 5.68 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.679 -0.408 . . . . 5.01 110.872 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -123.91 106.64 10.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.026 -1.102 . . . . 3.93 108.026 170.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.4 HG23 ' HE2' ' A' ' 256' ' ' LYS . 2.7 t -82.61 121.48 26.87 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.811 0.671 . . . . 2.13 112.811 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 83.7 t80 -137.21 131.9 17.82 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.773 . . . . 5.21 110.387 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 193' ' ' TYR . 16.8 Cg_exo -66.77 129.36 20.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.738 2.292 . . . . 2.12 112.379 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.512 ' HA3' ' NE1' ' A' ' 208' ' ' TRP . . . -119.8 157.03 15.69 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.389 -0.434 . . . . 1.75 113.006 -174.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.41 0.624 . . . . 2.99 111.801 -175.638 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 134' ' ' VAL . 30.9 tp . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 111.335 0.124 . . . . 2.96 111.335 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 5.6 pt-20 -80.83 109.79 15.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.543 0.687 . . . . 3.37 111.03 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 23.5 p -140.67 21.96 2.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.944 0.402 . . . . 2.15 110.668 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.487 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -104.8 138.12 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.005 0.431 . . . . 1.26 111.185 -176.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.6 m -112.84 111.83 22.88 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.074 -0.713 . . . . 2.08 109.074 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.512 ' NE1' ' HA3' ' A' ' 195' ' ' GLY . 97.4 m95 -81.97 116.78 21.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.648 0.261 . . . . 5.53 110.476 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 38.4 mm -101.73 98.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.695 -0.854 . . . . 1.63 108.695 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 38.1 t -85.67 116.99 29.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 1.62 111.937 -174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 189' ' ' ASP . 56.0 tp -80.23 113.89 18.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.846 -0.427 . . . . 1.73 109.846 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.562 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 6.2 tmmm? -60.99 -21.62 63.72 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.399 0.518 . . . . 2.98 112.399 -176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 187' ' ' SER . 34.5 mm-40 -99.64 106.07 37.83 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 111.874 0.324 . . . . 1.47 111.874 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 10.1 Cg_exo -73.77 138.55 26.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.059 2.506 . . . . 0.96 111.689 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -91.58 152.12 3.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.839 0.352 . . . . 1.25 110.334 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 3.1 p -96.08 122.29 38.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.959 -0.564 . . . . 1.29 111.147 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.5 m -123.75 153.18 29.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 1.02 109.791 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 t -88.19 158.97 18.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.592 0.234 . . . . 1.08 111.23 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.523 ' HA ' HG22 ' A' ' 222' ' ' VAL . 29.6 t -54.6 -42.85 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 1.33 110.513 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -56.31 -27.3 55.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.51 111.78 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.2 -49.75 9.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.343 -0.389 . . . . 0.7 110.15 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.1 m -66.51 -31.13 52.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 1.36 111.27 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 89.6 mt -60.52 -39.77 89.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 1.03 110.673 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -74.46 -25.03 59.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.12 -0.491 . . . . 1.75 111.157 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.69 -28.86 61.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.201 0.524 . . . . 2.47 109.749 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -86.29 -3.35 58.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.92 -0.582 . . . . 3.04 110.279 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.5 mmtt -88.05 -9.3 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 2.31 109.948 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.44 HD11 HD22 ' A' ' 163' ' ' LEU . 91.9 mt -71.37 150.14 45.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.659 -0.7 . . . . 0.95 110.722 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -108.26 142.93 37.81 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.532 0.682 . . . . 1.13 110.393 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -78.49 -32.19 48.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.592 -1.185 . . . . 3.74 109.166 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -76.98 169.98 17.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.93 -1.032 . . . . 1.62 111.987 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 169' ' ' LYS . . . -96.34 179.05 34.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.006 -0.997 . . . . 1.16 111.204 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.52 137.67 57.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 3.56 110.426 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.17 62.69 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 2.08 112.894 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.49 153.26 69.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 117.085 0.443 . . . . 2.59 109.838 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.8 125.1 17.96 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.348 2.032 . . . . 1.36 111.187 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.439 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.8 pt-20 -64.16 127.57 32.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.577 0.703 . . . . 3.4 112.325 -172.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.79 124.05 38.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.768 -1.106 . . . . 2.47 108.365 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.14 145.89 55.28 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.956 0.408 . . . . 2.14 111.159 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 30.6 mtt -65.81 102.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.647 -0.706 . . . . 1.68 110.074 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.35 142.04 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.567 -0.742 . . . . 1.27 110.436 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 244' ' ' TRP . 38.9 t70 68.35 -90.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.326 -0.852 . . . . 2.18 110.487 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 64' ' ' HIS . 47.8 t30 65.75 -23.46 0.09 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.313 0.857 . . . . 2.15 113.313 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.419 ' H ' ' C ' ' A' ' 242' ' ' ASP . 63.3 t-105 -146.85 134.04 20.52 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.674 -0.641 . . . . 4.59 111.323 -169.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.573 ' CD ' ' H ' ' A' ' 245' ' ' ARG . 0.1 OUTLIER -93.22 102.57 7.54 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.222 -0.899 . . . . 6.13 108.975 174.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 4.2 Cg_exo -74.83 -91.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.888 2.392 . . . . 3.28 115.101 -166.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.24 129.88 38.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.873 0.694 . . . . 2.98 112.873 -159.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.498 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 24.5 pt20 -82.53 179.16 2.04 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.575 -0.739 . . . . 4.32 110.176 171.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 248' ' ' GLN . 69.0 Cg_exo -53.83 132.79 51.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.829 1.686 . . . . 3.48 111.58 170.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.9 -39.68 19.62 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.666 -1.152 . . . . 4.63 112.606 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 253' ' ' ARG . 22.3 ptmt -61.29 -12.19 12.63 Favored 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 115.654 1.724 . . . . 5.34 115.654 -176.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 9.2 p30 37.82 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 118.806 2.891 . . . . 4.64 118.806 165.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 251' ' ' LYS . 35.2 ttm180 142.98 -118.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.399 1.88 . . . . 6.11 105.964 -163.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 253' ' ' ARG . 19.5 tt0 -146.27 128.74 15.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.246 -1.39 . . . . 3.08 107.246 161.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 60.8 mt -91.04 146.37 6.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.783 -0.451 . . . . 2.6 109.783 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.4 ' HE2' HG23 ' A' ' 192' ' ' THR . 19.3 pttm -116.61 137.03 52.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.63 110.499 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.25 160.64 24.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.19 -0.914 . . . . 1.71 109.503 -176.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 32.9 t -143.17 98.02 3.19 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.053 -0.659 . . . . 2.21 111.502 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -132.87 90.88 2.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.916 . . . . 4.31 108.584 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.243 0.736 0 CA-C-O 118.364 -0.827 . . . . 4.49 110.518 -176.699 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.678 ' HA ' ' OG1' ' A' ' 108' ' ' THR . 31.7 t70 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.978 -0.749 . . . . 2.88 108.978 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 110' ' ' ASP . 72.4 mt -67.47 126.95 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.807 -0.633 . . . . 2.32 110.917 -173.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.8 114.6 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.93 -0.577 . . . . 2.82 110.489 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -63.69 -31.54 72.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.24 111.728 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -76.19 -4.4 41.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.815 0.34 . . . . 4.54 111.533 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.0 m -102.41 -8.22 21.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.464 0.649 . . . . 3.06 109.929 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -78.2 120.39 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 1.72 110.758 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -95.41 132.34 40.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.252 -0.431 . . . . 3.69 110.232 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.736 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 27.4 m-85 -82.46 130.28 35.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.486 0.66 . . . . 4.64 111.883 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 258' ' ' SER . 25.3 t70 -125.2 140.55 36.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 2.27 109.248 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.96 90.94 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.801 2.334 . . . . 2.15 113.295 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.1 t -60.28 -38.18 82.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.933 -0.576 . . . . 4.29 110.392 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt 72.21 -67.1 0.27 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.464 -0.789 . . . . 4.74 111.996 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -101.44 128.08 30.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.51 0.195 . . . . 3.77 110.979 -175.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.55 160.91 26.13 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.048 2.499 . . . . 2.36 111.874 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.561 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 11.0 mp -80.0 143.76 33.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.368 0.507 . . . . 2.55 112.368 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -106.86 99.41 8.98 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.317 -0.856 . . . . 2.38 108.723 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 t -117.0 108.1 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.028 -0.533 . . . . 1.59 110.268 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.6 m -102.12 89.46 3.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.077 -0.51 . . . . 1.45 109.705 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -101.57 3.43 40.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.94 -0.763 . . . . 3.62 108.94 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.58 -33.06 69.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.45 -1.25 . . . . 2.48 111.859 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -103.6 13.14 33.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.693 0.257 . . . . 2.24 111.693 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -63.83 122.94 17.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.8 111.496 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 23.1 m -103.26 111.96 24.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.938 -0.573 . . . . 1.06 110.386 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -76.73 141.84 40.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.735 -0.468 . . . . 1.26 109.735 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 71' ' ' ASP . 84.8 mt -118.54 -57.29 2.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.277 0.473 . . . . 0.74 112.277 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -156.49 148.1 22.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.643 -0.253 . . . . 3.17 110.722 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -108.92 137.21 42.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.608 -0.516 . . . . 0.64 109.608 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.8 tp -128.4 145.47 51.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.299 -0.41 . . . . 0.96 110.395 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -117.16 124.18 48.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.933 0.397 . . . . 1.49 111.196 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.23 153.03 46.62 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.184 -1.043 . . . . 1.83 108.184 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.581 ' HA2' ' SD ' ' A' ' 240' ' ' MET . . . -69.91 33.08 0.39 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 115.478 0.951 . . . . 1.64 115.478 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -131.95 -36.96 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.521 -0.548 . . . . 3.33 109.521 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -171.01 -179.62 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.399 -0.963 . . . . 1.38 108.399 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -117.2 144.9 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.797 -1.186 . . . . 2.74 107.797 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 4.6 p30 -131.33 141.33 49.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.02 0.438 . . . . 1.76 111.468 -172.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.7 t -106.15 116.48 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.787 -0.642 . . . . 1.15 109.903 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.85 128.47 33.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.654 -0.703 . . . . 2.02 110.901 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -105.8 159.26 16.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.847 -0.615 . . . . 1.66 110.458 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 26.1 t70 -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.847 -0.615 . . . . 1.33 109.613 174.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.47 60.96 1.65 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.036 0.922 . . . . 2.65 110.334 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 m -92.2 -5.75 51.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.575 -0.739 . . . . 1.61 110.203 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 74' ' ' GLN . 1.6 mp0 -145.7 176.44 9.64 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.405 -0.961 . . . . 2.35 108.405 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' CG ' HH21 ' A' ' 89' ' ' ARG . 18.1 m-20 -75.33 65.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.158 0.504 . . . . 1.92 110.675 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -84.8 -59.0 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 1.77 110.223 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -114.59 97.3 6.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.518 -0.764 . . . . 0.76 109.749 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.52 146.5 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.168 -0.469 . . . . 1.27 110.083 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tt -137.22 113.4 9.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 1.29 109.463 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.609 ' HD2' HG23 ' A' ' 87' ' ' THR . 12.6 ptmm? -148.09 124.23 10.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.258 0.552 . . . . 2.54 110.959 172.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -86.12 175.64 48.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.981 -0.848 . . . . 1.31 110.981 167.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.59 -142.92 0.0 OUTLIER Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.304 0.649 . . . . 1.9 114.508 165.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.49 120.6 5.95 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.518 1.478 . . . . 2.91 112.19 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -158.62 -168.23 2.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.838 -1.074 . . . . 4.11 108.883 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -125.34 45.71 2.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 121.181 -0.208 . . . . 4.95 110.989 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.74 158.79 7.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.43 -0.89 . . . . 2.25 113.123 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.609 HG23 ' HD2' ' A' ' 80' ' ' LYS . 92.1 m -98.23 114.74 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 1.91 109.814 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 65.6 m-85 -102.25 132.92 47.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.19 0.441 . . . . 3.7 112.19 -171.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 75' ' ' ASP . 98.2 mtt180 -103.59 147.09 27.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 3.54 109.86 173.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 121' ' ' VAL . 48.4 tp -77.44 130.14 36.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.559 -0.291 . . . . 1.14 110.949 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -110.28 -40.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.376 . . . . 1.68 110.954 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -170.53 168.07 7.84 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.821 -0.437 . . . . 1.55 109.821 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 19.4 p90 -135.88 157.51 46.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.174 -0.21 . . . . 0.86 110.688 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -143.09 158.94 43.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.54 -0.541 . . . . 0.93 109.54 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.657 ' CE2' ' HG ' ' A' ' 118' ' ' LEU . 42.1 m-85 -111.76 166.16 11.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.589 0.233 . . . . 3.17 110.654 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 2.0 m80 -122.39 139.14 54.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.029 -0.73 . . . . 1.68 109.029 171.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.456 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 39.6 p90 -159.39 142.71 14.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.782 -0.451 . . . . 5.18 109.782 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.487 ' HA2' ' HB ' ' A' ' 241' ' ' VAL . . . 174.69 -168.04 40.53 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.181 -1.009 . . . . 2.13 112.913 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t 43.77 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.465 1.106 . . . . 2.9 112.312 -173.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' GLY . 89.3 mt -85.26 -159.32 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 3.03 109.647 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.61 66.48 9.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.91 0.386 . . . . 3.85 110.071 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 97' ' ' TRP . . . 82.29 120.39 0.6 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.889 -0.672 . . . . 1.94 112.595 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? 178.94 157.21 0.51 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.753 0.421 . . . . 2.45 110.491 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 96' ' ' HIS . . . 128.6 109.84 1.48 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.378 -0.915 . . . . 1.47 113.918 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.47 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 30.5 t -91.64 -47.23 7.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.604 -0.887 . . . . 2.0 108.604 169.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -119.17 48.14 1.55 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.744 -1.947 . . . . 3.72 105.744 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 78.2 t60 64.69 2.05 1.55 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.455 -1.702 . . . . 3.52 111.616 -171.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.678 ' OG1' ' HA ' ' A' ' 32' ' ' ASP . 21.2 p -144.27 179.41 7.25 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.765 -0.828 . . . . 2.52 108.765 158.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.0 t -142.31 92.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.332 0.515 . . . . 2.48 111.559 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 36.5 t70 42.36 44.11 3.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.394 0.678 . . . . 2.8 112.513 172.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 67.51 -43.29 0.46 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.291 0.636 . . . . 4.98 111.368 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 110' ' ' ASP . 9.2 mmmm -79.23 71.66 5.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.492 0.317 . . . . 3.23 110.389 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 108' ' ' THR . 57.6 mttp -52.54 120.81 6.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.39 -0.368 . . . . 2.82 110.389 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -104.84 -164.67 1.06 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 1.62 110.44 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 222' ' ' VAL . . . -61.85 -51.61 67.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.712 0.634 . . . . 1.03 112.712 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.4 172.41 6.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.31 -0.255 . . . . 0.75 110.31 -172.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.77 135.75 34.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.352 -0.61 . . . . 1.58 109.352 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.657 ' HG ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 tt -108.47 118.45 36.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.284 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -110.97 100.36 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.904 0.383 . . . . 1.77 110.837 -176.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.9 mp -88.03 108.62 19.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.269 -0.423 . . . . 0.93 110.451 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 90' ' ' LEU . 33.2 t -79.3 123.15 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 0.61 111.187 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 61.3 m80 -118.25 156.98 27.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.326 -0.62 . . . . 2.13 109.326 175.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.641 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 52.3 p-90 -133.9 144.04 48.63 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.264 -0.273 . . . . 4.26 110.264 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -65.82 107.64 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 2.02 111.069 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.641 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 9.5 t -69.46 -14.84 63.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 2.34 112.12 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.18 -14.1 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 3.35 111.231 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.69 3.72 53.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 3.1 110.617 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 62.42 -1.3 1.58 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.503 0.961 . . . . 2.37 115.503 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -169.6 139.46 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.141 0.97 . . . . 3.93 110.116 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.39 -44.06 88.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.919 -0.582 . . . . 3.0 111.294 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.407 ' O ' HG12 ' A' ' 134' ' ' VAL . . . -61.65 -34.91 90.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.106 -0.568 . . . . 2.15 112.156 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -72.47 -38.86 68.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.857 0.361 . . . . 3.43 110.656 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.594 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.07 -38.42 82.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 1.76 111.825 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 131' ' ' GLY . 8.9 p -67.41 -11.9 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.24 0.543 . . . . 2.77 111.285 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.6 15.06 10.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.987 0.422 . . . . 3.55 110.91 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -126.15 138.57 32.46 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 60.9 Cg_exo -53.6 -32.04 62.42 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.361 2.708 . . . . 1.6 113.439 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.7 28.97 8.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.068 0.461 . . . . 2.29 110.252 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.99 -36.32 28.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.018 -0.61 . . . . 1.22 113.263 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.0 mt -108.34 157.63 18.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.769 0.319 . . . . 1.57 110.643 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -142.5 107.43 4.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.082 0.468 . . . . 1.38 110.522 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 119' ' ' HIS . 7.8 m -94.02 119.67 42.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.188 0.518 . . . . 1.73 110.857 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 46.5 tp -89.1 112.5 23.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.889 -0.596 . . . . 2.42 109.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.462 ' HA3' ' HE1' ' A' ' 208' ' ' TRP . . . -99.49 132.18 10.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.812 -0.709 . . . . 0.86 112.321 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.8 mt -129.54 124.27 59.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.666 -0.494 . . . . 0.76 109.666 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.89 140.62 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.752 0.31 . . . . 1.2 110.709 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.487 HD23 HG11 ' A' ' 217' ' ' VAL . 10.3 mp -118.6 128.55 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.429 -0.582 . . . . 0.88 109.429 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 15.6 ptpt -122.71 151.09 41.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.062 -0.348 . . . . 2.03 110.062 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 14.2 m -70.44 107.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.472 0.654 . . . . 1.27 111.716 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -155.16 -135.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.495 -0.775 . . . . 1.53 111.272 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.0 m -70.28 121.68 18.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.656 -0.498 . . . . 1.54 109.656 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.59 ' HB2' ' CB ' ' A' ' 218' ' ' SER . . . -83.64 104.53 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.337 -0.246 . . . . 0.78 110.337 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -70.68 126.43 92.2 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.031 -0.359 . . . . 1.22 110.031 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.28 -14.02 31.88 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.04 2.494 . . . . 1.05 112.556 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.536 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -58.64 -25.53 58.66 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.98 -0.555 . . . . 0.7 112.936 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 159' ' ' VAL . 48.0 tp -91.95 -32.05 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.189 0.519 . . . . 0.77 110.406 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -52.49 -38.93 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 1.41 112.142 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 41.6 pttt -61.27 -33.86 74.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.499 0.555 . . . . 2.86 112.499 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 162' ' ' VAL . 13.3 p -84.58 -36.81 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.581 -0.448 . . . . 1.38 110.775 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 156' ' ' LEU . 19.5 t -65.16 -39.18 84.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 1.11 110.72 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.2 -28.03 66.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.519 -0.764 . . . . 1.22 112.695 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 159' ' ' VAL . 10.0 p -92.2 -2.76 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.978 0.418 . . . . 1.41 111.136 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' HD21 ' A' ' 228' ' ' LEU . 75.3 mt -60.29 -28.03 67.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.333 -0.394 . . . . 1.39 111.529 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -67.34 -25.21 65.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.497 -0.319 . . . . 2.31 111.431 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.7 t -84.4 -1.76 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 1.4 110.811 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.41 33.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.356 -0.979 . . . . 0.85 108.356 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -55.62 -35.55 66.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.479 -1.237 . . . . 1.59 111.787 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.1 p -106.72 152.62 23.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.082 0.468 . . . . 0.77 111.163 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -57.94 136.67 57.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 2.29 111.296 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.46 -15.04 57.75 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.734 -0.746 . . . . 0.85 112.917 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -86.81 151.23 23.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 1.7 111.34 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.5 p -142.2 151.43 42.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.394 -0.821 . . . . 1.37 109.816 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.65 148.51 44.13 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.911 -0.403 . . . . 0.61 109.911 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 135.53 51.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.791 0.329 . . . . 1.8 110.125 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -138.61 80.17 1.78 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.734 -0.839 . . . . 1.04 108.734 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.5 p -124.13 169.09 12.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.796 -0.638 . . . . 1.17 111.232 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.56 38.68 22.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.019 -0.537 . . . . 1.77 111.313 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -120.98 137.72 54.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.291 -0.413 . . . . 3.99 110.363 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -80.76 118.85 74.23 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.757 -0.656 . . . . 2.51 110.752 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.89 -21.66 27.92 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.929 2.419 . . . . 1.26 112.766 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -77.27 -2.52 35.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 2.76 111.05 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.11 -17.92 46.59 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 116.168 -0.469 . . . . 1.12 113.262 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.33 -38.09 65.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.63 0.215 . . . . 1.73 110.531 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 79.9 mt 54.69 85.17 0.2 Allowed Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.755 . . . . 3.45 112.778 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.33 136.76 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.296 2.664 . . . . 2.08 112.133 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -107.84 27.34 9.31 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.365 0.666 . . . . 3.23 110.501 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 213' ' ' GLU . 35.0 t -153.51 103.14 2.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.661 -0.496 . . . . 1.66 109.661 -159.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.16 59.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.594 -0.443 . . . . 1.99 110.839 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -125.88 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.033 -1.099 . . . . 1.81 108.033 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.575 ' HB2' HG23 ' A' ' 209' ' ' ILE . 5.6 p90 -162.47 144.94 11.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.855 -0.738 . . . . 5.01 111.816 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 256' ' ' LYS . 48.6 m0 -92.63 129.07 38.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.778 -0.823 . . . . 3.93 108.778 168.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.4 t -84.67 94.04 8.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.12 0.962 . . . . 2.13 110.432 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.63 119.16 18.15 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 5.21 109.349 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.24 150.21 87.75 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.008 1.805 . . . . 2.12 111.218 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.86 123.27 5.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.475 -0.869 . . . . 1.75 112.824 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 22.0 t . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 109.273 -0.64 . . . . 2.99 109.273 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 203' ' ' LEU . 2.7 pp . . . . . 0 C--O 1.235 0.342 0 CA-C-O 121.477 0.656 . . . . 2.96 111.988 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 204' ' ' GLU . 0.0 OUTLIER -77.78 73.74 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.172 -0.922 . . . . 3.37 111.584 -172.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.8 p -99.52 7.24 45.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.441 -0.799 . . . . 2.15 110.702 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 142' ' ' VAL . 10.9 t -118.86 151.05 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.292 0.568 . . . . 1.26 112.079 -169.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 13.4 m -121.75 121.73 37.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.194 -1.039 . . . . 2.08 108.194 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.507 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.3 t90 -86.73 125.97 34.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.105 0.479 . . . . 5.53 110.214 -175.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 190' ' ' TYR . 44.4 mm -109.69 100.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.438 -0.801 . . . . 1.63 108.965 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 3.9 t -92.91 129.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.844 -0.342 . . . . 1.62 111.556 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.958 -0.756 . . . . 1.73 108.958 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.23 2.12 37.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.042 0.756 . . . . 2.98 113.042 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 187' ' ' SER . 10.9 tp10 -111.65 105.31 56.66 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 121.072 -0.251 . . . . 1.47 110.915 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 19.6 Cg_exo -67.67 141.14 53.75 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.856 2.371 . . . . 0.96 112.326 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.0 pt -96.98 153.59 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.322 -0.399 . . . . 1.25 110.188 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.5 m -89.4 128.16 35.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.226 -0.443 . . . . 1.29 111.59 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 35.5 m -137.83 137.95 44.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.606 -0.725 . . . . 1.02 109.11 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.59 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 8.5 t -87.8 159.87 18.25 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.278 -0.569 . . . . 1.08 111.804 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.552 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.4 m -48.26 -46.02 35.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.615 -0.72 . . . . 1.33 111.586 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.86 -26.29 46.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.961 -0.563 . . . . 2.51 112.33 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -80.86 -48.36 12.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.582 -0.525 . . . . 0.7 109.582 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.467 HG21 ' HB1' ' A' ' 115' ' ' ALA . 22.0 t -62.99 -39.1 83.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.221 -0.899 . . . . 1.36 111.477 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.8 mt -62.05 -25.92 67.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 1.03 111.72 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -76.71 -19.67 57.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.584 -0.28 . . . . 1.75 111.337 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -68.92 -34.44 75.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.439 0.638 . . . . 2.47 110.072 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 28.2 ttm180 -76.23 -2.92 33.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.374 -0.83 . . . . 3.04 110.948 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -86.7 -3.75 59.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.392 . . . . 2.31 110.299 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 163' ' ' LEU . 94.8 mt -78.91 145.29 34.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.865 -0.607 . . . . 0.95 110.568 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.596 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.08 127.62 55.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 1.13 111.071 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.94 -34.37 74.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.914 -1.039 . . . . 3.74 110.874 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -69.49 162.38 27.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.674 -0.694 . . . . 1.62 111.933 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.84 166.4 42.96 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.677 -0.969 . . . . 1.16 110.677 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.79 133.43 50.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 3.56 110.803 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 95.51 6.71 59.59 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 2.08 111.87 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -119.01 158.04 49.04 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.518 -0.549 . . . . 2.59 109.518 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.08 122.99 12.11 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.919 2.413 . . . . 1.36 112.134 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.417 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 10.6 pt-20 -62.32 126.3 26.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 3.4 112.178 -174.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 10.6 tp10 -124.55 134.53 52.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.288 -0.869 . . . . 2.47 110.221 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.81 107.97 2.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.575 . . . . 2.14 110.083 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.581 ' SD ' ' HA2' ' A' ' 63' ' ' GLY . 51.1 ttp -74.33 91.24 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 1.68 109.374 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.487 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 27.6 m -135.38 157.71 39.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.628 -0.715 . . . . 1.27 111.293 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 70.42 -81.47 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 124.129 0.893 . . . . 2.18 110.939 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . 0.564 HD21 ' HG2' ' A' ' 240' ' ' MET . 73.4 m-20 50.43 29.18 3.74 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.753 0.649 . . . . 2.15 112.753 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -148.07 152.76 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 4.59 108.876 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -80.38 148.94 67.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.609 -0.145 . . . . 6.13 110.609 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.89 164.11 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.485 2.79 . . . . 3.28 113.598 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.77 98.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.596 -0.729 . . . . 2.98 112.504 -170.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 27.0 mm-40 -61.25 163.83 9.94 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.537 -0.756 . . . . 4.32 110.586 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.622 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 72.0 Cg_endo -75.09 161.1 39.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 3.48 113.366 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -8.83 34.59 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.2 -0.909 . . . . 4.63 112.315 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 47.9 mmtm -55.29 49.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.571 1.693 . . . . 5.34 115.571 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.682 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER 124.91 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.979 2.112 . . . . 4.64 110.149 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 249' ' ' PRO . 4.3 mpt_? -138.42 100.25 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.336 -0.987 . . . . 6.11 108.336 167.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -128.84 148.43 50.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.581 -0.526 . . . . 3.08 109.581 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 21.6 mm -102.0 147.66 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.341 -0.391 . . . . 2.6 110.517 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 191' ' ' TRP . 45.3 mttp -135.71 166.39 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.637 -0.875 . . . . 2.63 108.637 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.736 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -144.28 114.89 7.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.634 -0.136 . . . . 1.71 110.634 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 21.3 m -97.2 100.71 12.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.283 0.563 . . . . 2.21 110.702 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -145.13 131.64 19.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.588 -0.733 . . . . 4.31 110.242 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.782 -0.627 . . . . 4.49 109.759 178.218 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 108.856 -0.794 . . . . 2.88 108.856 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 49.8 mt -88.34 91.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.372 0.606 . . . . 2.32 109.796 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.97 119.45 39.5 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.766 -0.652 . . . . 2.82 109.444 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -55.34 -33.41 63.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.797 . . . . 2.24 112.812 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -76.73 -34.83 58.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.12 0.486 . . . . 4.54 110.705 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -88.01 18.06 4.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.599 -0.728 . . . . 3.06 110.438 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.16 150.26 36.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 1.72 109.2 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -119.35 122.78 42.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.039 0.447 . . . . 3.69 110.472 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -82.59 126.22 32.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.673 -0.694 . . . . 4.64 109.952 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -145.8 97.74 4.55 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.773 -0.454 . . . . 2.27 109.773 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.04 28.89 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.657 2.238 . . . . 2.15 112.677 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -99.9 -5.92 27.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.289 -0.414 . . . . 4.29 110.827 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.66 152.1 21.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.545 -0.539 . . . . 4.74 109.545 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.25 135.72 20.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.681 -0.236 . . . . 3.77 110.723 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.35 136.94 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 2.36 111.364 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.65 131.6 43.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.857 0.361 . . . . 2.55 111.208 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -66.47 122.95 18.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.639 -0.71 . . . . 2.38 109.677 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 79' ' ' LEU . 3.0 t -109.38 103.0 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.237 -0.438 . . . . 1.59 110.141 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.713 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 6.7 m -105.18 89.33 3.1 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.81 -0.811 . . . . 1.45 108.81 177.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.3 p90 -124.46 6.43 8.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.906 0.384 . . . . 3.62 111.461 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.7 -19.27 65.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.409 -0.359 . . . . 2.48 111.418 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.9 mp0 -98.64 6.55 46.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.575 -0.284 . . . . 2.24 110.403 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -55.15 133.82 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.8 111.675 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.5 m -120.75 106.37 11.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.888 -0.596 . . . . 1.06 110.186 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.9 p -79.4 150.81 31.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.685 -0.487 . . . . 1.26 109.685 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.9 mt -122.07 -55.4 1.88 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.832 0.349 . . . . 0.74 111.616 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -154.8 152.37 29.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.452 -0.34 . . . . 3.17 111.016 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 tt -115.15 137.39 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.559 -0.534 . . . . 0.64 109.559 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 172' ' ' SER . 39.5 tp -134.07 142.32 47.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.726 0.298 . . . . 0.96 111.11 -173.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -111.09 108.04 17.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.876 -0.787 . . . . 1.49 108.876 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -142.51 72.59 1.38 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.685 0.624 . . . . 1.83 112.685 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.14 -71.41 0.4 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.437 -1.363 . . . . 1.64 113.569 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -142.55 0.04 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.775 0.321 . . . . 3.33 111.585 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.44 174.75 13.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.803 -0.814 . . . . 1.38 108.803 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 95' ' ' PHE . 49.7 p90 -115.38 121.97 44.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 2.74 109.465 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -96.53 116.22 28.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.751 . . . . 1.76 110.46 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 42.0 t -93.05 106.1 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.584 -0.524 . . . . 1.15 109.584 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.62 129.26 37.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.887 -0.597 . . . . 2.02 111.589 -174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -111.52 153.98 25.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.347 -0.842 . . . . 1.66 110.265 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -76.54 110.95 11.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.922 -0.581 . . . . 1.33 110.626 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' CD ' ' A' ' 89' ' ' ARG . 6.2 p-10 -116.26 55.53 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.298 0.571 . . . . 2.65 111.392 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -104.91 -6.5 20.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.483 . . . . 1.61 111.025 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -137.94 176.56 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.206 -0.664 . . . . 2.35 109.206 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -82.14 41.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.18 0.514 . . . . 1.92 110.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 34.9 mmtp -51.32 -60.69 2.85 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.897 -1.047 . . . . 1.77 110.673 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -130.87 96.75 4.15 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.285 -0.871 . . . . 0.76 110.159 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 16.5 m -111.95 147.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.404 0.621 . . . . 1.27 111.605 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.9 tp -129.29 119.43 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.857 -1.065 . . . . 1.29 108.466 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 87' ' ' THR . 57.3 pttt -158.97 121.14 3.51 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.5 -0.48 . . . . 2.54 111.764 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.62 176.9 40.15 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 114.337 0.495 . . . . 1.31 114.337 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.33 -137.43 0.0 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.156 1.36 . . . . 1.9 115.755 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.8 148.76 3.58 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.081 2.521 . . . . 2.91 113.166 -168.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.1 pt? -39.95 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.038 1.866 . . . . 4.11 116.038 -157.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -85.94 -48.55 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.519 -0.764 . . . . 4.95 109.663 162.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 123.79 163.48 11.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.167 -0.54 . . . . 2.25 112.223 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.466 ' HA ' ' HB3' ' A' ' 80' ' ' LYS . 49.1 m -94.69 103.15 15.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 1.91 110.04 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 21.7 m-85 -95.76 102.1 13.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.286 -0.416 . . . . 3.7 110.081 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' CD ' ' HB2' ' A' ' 72' ' ' ASP . 16.0 ptp180 -82.03 152.36 26.68 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.211 -0.306 . . . . 3.54 110.183 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.3 tp -76.47 122.86 25.15 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.737 -0.468 . . . . 1.14 109.737 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -108.38 -32.81 2.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.906 0.384 . . . . 1.68 110.164 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.3 pt20 -171.64 169.66 5.93 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.691 -0.485 . . . . 1.55 109.691 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -140.72 158.43 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.412 -0.588 . . . . 0.86 109.412 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -147.41 158.73 44.09 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.19 0.306 . . . . 0.93 110.73 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 66.5 m-85 -123.08 165.55 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 3.17 110.773 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -172.6 126.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.266 0.626 . . . . 1.68 109.661 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.517 ' CE3' ' HB1' ' A' ' 116' ' ' ALA . 14.8 p90 -161.8 -174.51 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.591 -0.277 . . . . 5.18 110.375 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 241' ' ' VAL . . . 89.92 99.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.512 -0.851 . . . . 2.13 111.681 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.7 t -143.08 -82.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.711 -0.848 . . . . 2.9 108.711 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD12 ' OE1' ' A' ' 103' ' ' GLN . 84.2 mt -95.75 -155.18 0.46 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.143 -0.688 . . . . 3.03 109.143 169.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.82 -48.31 67.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.077 0.399 . . . . 3.85 112.077 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.71 63.68 0.36 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.602 -0.808 . . . . 1.94 111.448 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 114' ' ' TYR . 13.1 pt20 -150.65 -172.11 4.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 2.45 110.761 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.29 8.71 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.47 111.474 -168.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.444 ' HB2' ' N ' ' A' ' 116' ' ' ALA . 48.2 t -78.46 -33.5 48.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.338 0.495 . . . . 2.0 112.338 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.466 ' CG ' ' H ' ' A' ' 107' ' ' HIS . 0.9 OUTLIER 69.85 -156.32 0.15 Allowed 'General case' 0 C--N 1.343 0.316 0 N-CA-C 107.363 -1.347 . . . . 3.72 107.363 -173.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 4.3 m-70 53.04 69.79 0.66 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.161 0.437 . . . . 3.52 110.046 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 5.3 t -98.71 117.43 33.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 120.024 -0.671 . . . . 2.52 110.136 -165.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 14.7 m -92.18 103.44 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.161 0.505 . . . . 2.48 110.785 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.2 t70 54.01 58.83 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.555 -0.748 . . . . 2.8 109.735 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 67.23 4.83 3.85 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.866 -1.061 . . . . 4.98 113.19 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 109' ' ' VAL . 37.5 ttmt -90.36 111.68 22.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.949 -0.389 . . . . 3.23 109.949 175.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -93.08 146.6 23.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.569 -0.9 . . . . 2.82 108.569 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 96.8 m-85 -95.93 176.44 6.11 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.601 -0.439 . . . . 1.62 109.935 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.0 -39.03 20.18 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.664 0.616 . . . . 1.03 112.664 -171.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HB1' ' CE3' ' A' ' 97' ' ' TRP . . . -145.34 149.97 35.76 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.606 -0.438 . . . . 0.75 111.801 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.436 ' OE1' ' NE2' ' A' ' 107' ' ' HIS . 3.5 tp10 -110.88 141.55 44.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.055 -0.52 . . . . 1.58 110.563 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.681 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 13.0 tp -121.73 121.86 38.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.771 -0.649 . . . . 1.07 110.045 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.35 104.34 10.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 1.77 111.446 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -89.81 111.01 21.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.031 -0.531 . . . . 0.93 109.589 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.75 123.62 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.316 0.579 . . . . 0.61 110.766 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 29.8 m-70 -115.74 145.53 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.64 -0.709 . . . . 2.13 109.912 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.458 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 9.1 t90 -112.0 133.47 54.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.973 -0.558 . . . . 4.26 110.719 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -78.17 111.84 14.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.231 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 t -58.34 -21.66 50.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.719 -0.673 . . . . 2.34 112.111 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -46.79 -32.18 3.51 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.557 0.947 . . . . 3.35 113.557 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.43 ' CE2' ' HB2' ' A' ' 136' ' ' GLN . 4.8 m-85 -97.38 -4.62 38.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.648 0.61 . . . . 3.1 112.648 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.87 14.9 2.91 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.575 0.59 . . . . 2.37 114.575 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 18.1 t70 -172.11 117.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.853 -0.795 . . . . 3.93 108.853 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -65.52 -33.14 75.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 3.0 111.819 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 134' ' ' VAL . . . -61.45 -33.66 85.51 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.881 -0.676 . . . . 2.15 112.133 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 69.9 mmtt -83.79 -24.98 30.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.797 0.332 . . . . 3.43 110.979 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.475 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.49 -21.85 63.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.358 -0.383 . . . . 1.76 111.912 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 131' ' ' GLY . 31.3 m -73.05 3.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 2.77 112.381 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 2.5 pt20 -97.15 -11.0 24.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 3.55 110.182 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.456 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 29.9 tt0 -101.81 136.48 19.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 3.02 109.867 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 25.3 Cg_endo -60.65 -28.39 86.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.28 2.654 . . . . 1.6 112.656 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.456 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.8 p-10 -112.24 27.71 9.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 2.29 109.447 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.36 -37.64 86.29 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.725 -0.67 . . . . 1.22 111.747 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 206' ' ' VAL . 86.8 mt -122.37 158.01 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.018 -0.734 . . . . 1.57 109.018 173.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.52 122.69 12.93 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.2 -0.296 . . . . 1.38 110.2 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.91 126.87 69.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.015 0.436 . . . . 1.73 110.697 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 49.0 tp -93.04 117.83 30.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.621 -0.718 . . . . 2.42 109.777 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -104.4 127.61 9.16 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.275 -0.488 . . . . 0.86 112.132 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.88 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.756 -0.461 . . . . 0.76 109.756 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.7 141.9 49.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.798 -0.183 . . . . 1.2 110.556 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 9.7 mp -121.27 135.32 55.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.118 0.485 . . . . 0.88 110.676 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 216' ' ' SER . 54.6 pttt -123.54 156.3 35.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.839 -0.8 . . . . 2.03 108.839 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 46.6 t -94.34 126.62 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.875 0.369 . . . . 1.27 110.568 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.22 -105.89 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.634 -0.586 . . . . 1.53 111.634 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.8 m -67.04 154.99 39.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.655 0.264 . . . . 1.54 110.315 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.33 157.27 16.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.015 -0.365 . . . . 0.78 110.015 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 216' ' ' SER . 28.2 mtpp -128.06 103.0 21.14 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.069 -0.345 . . . . 1.22 110.069 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.65 -33.93 61.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.362 2.708 . . . . 1.05 112.612 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.85 -28.64 73.67 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.7 112.502 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.7 tp -102.64 -23.64 13.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.77 110.543 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -38.43 70.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 1.41 110.047 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.3 -29.73 70.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.935 -0.575 . . . . 2.86 111.235 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.24 -48.54 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.21 0.528 . . . . 1.38 110.15 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.441 HG11 ' HA ' ' A' ' 221' ' ' GLN . 43.2 t -65.33 -36.0 76.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.698 -0.683 . . . . 1.11 111.205 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.58 -28.22 69.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 1.22 112.231 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.52 -1.37 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.73 -0.388 . . . . 1.41 111.482 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.51 ' HB3' HD21 ' A' ' 228' ' ' LEU . 79.6 mt -58.99 -22.21 60.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 1.39 111.778 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -66.6 -28.83 68.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.445 0.164 . . . . 2.31 111.366 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.4 p -83.26 -0.54 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.301 . . . . 1.4 111.739 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.29 34.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.85 108.883 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.425 ' HA ' HD23 ' A' ' 228' ' ' LEU . 84.1 tttt -67.73 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.87 -1.059 . . . . 1.59 111.883 -169.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.66 148.77 49.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 0.77 110.706 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -59.61 126.34 27.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.351 -0.84 . . . . 2.29 111.084 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 114.51 -21.46 14.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.819 -0.705 . . . . 0.85 112.693 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -88.67 153.15 21.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 1.7 111.26 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' HD13 ' A' ' 60' ' ' LEU . 42.6 p -144.21 161.62 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 1.37 110.732 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.47 151.63 37.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.148 -0.478 . . . . 0.61 109.816 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.64 131.95 41.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.815 -0.439 . . . . 1.8 109.815 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -141.53 81.77 1.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.085 -0.507 . . . . 1.04 109.839 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 46.0 p -98.85 166.54 11.25 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.278 -0.419 . . . . 1.17 111.363 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 66.17 32.2 8.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.814 -0.63 . . . . 1.77 112.418 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.604 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 68.3 t80 -66.63 132.3 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.331 -0.248 . . . . 3.99 110.331 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.22 100.25 0.68 Allowed Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 123.621 0.575 . . . . 2.51 110.567 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 11.1 Cg_exo -71.16 -36.24 7.54 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.71 2.274 . . . . 1.26 112.445 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.3 -9.96 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 2.76 110.637 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -70.93 0.97 26.64 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.063 -0.517 . . . . 1.12 113.14 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 86.4 mt -91.68 -14.58 29.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.197 -0.297 . . . . 1.73 110.197 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.5 mt 42.84 73.7 0.89 Allowed Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 113.462 0.912 . . . . 3.45 113.462 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.39 119.11 1.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.148 2.565 . . . . 2.08 111.127 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.3 mt-10 -112.39 25.08 11.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.778 0.431 . . . . 3.23 111.346 -171.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.472 ' CB ' ' HB2' ' A' ' 213' ' ' GLU . 0.3 OUTLIER -168.3 90.06 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.047 -0.661 . . . . 1.66 110.605 -160.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.68 63.91 0.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.008 -1.108 . . . . 1.99 108.008 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 258' ' ' SER . 8.6 m-20 -87.71 -51.18 6.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.652 0.982 . . . . 1.81 113.652 -166.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 51.0 p90 -146.85 144.62 29.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.267 -0.573 . . . . 5.01 111.955 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -136.72 129.01 29.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.682 -0.69 . . . . 3.93 110.595 174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 256' ' ' LYS . 7.6 t -171.91 74.01 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.93 0.872 . . . . 2.13 111.134 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 208' ' ' TRP . 82.9 m-85 -139.36 137.33 18.85 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.123 -0.489 . . . . 5.21 111.092 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.83 132.21 4.68 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.829 2.353 . . . . 2.12 111.812 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.431 ' HA3' ' HB ' ' A' ' 206' ' ' VAL . . . -99.22 106.27 3.19 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.532 -0.842 . . . . 1.75 112.61 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.322 -0.609 0 C-N-CA 122.922 0.489 . . . . 2.99 111.752 178.707 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.945 0.72 . . . . 2.96 112.945 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.78 88.74 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.469 -0.787 . . . . 3.37 111.458 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.3 p -118.15 16.46 14.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.097 -0.956 . . . . 2.15 109.561 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 140' ' ' LEU . 51.0 t -117.57 149.71 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.835 -1.075 . . . . 1.26 109.744 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 87.3 m -117.19 117.13 28.73 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.374 -0.602 . . . . 2.08 109.374 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 193' ' ' TYR . 36.9 m0 -84.98 133.05 34.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.375 0.607 . . . . 5.53 110.7 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 67.4 mt -121.29 141.78 40.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.363 -0.977 . . . . 1.63 108.363 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.42 146.33 31.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.201 0.524 . . . . 1.62 111.681 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.83 131.45 55.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.928 -0.768 . . . . 1.73 108.928 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 53.9 tttm -69.12 -7.6 37.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 2.98 111.644 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 186' ' ' GLU . 10.1 tp10 -94.04 112.32 56.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.436 -0.347 . . . . 1.47 111.177 -175.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 4.9 Cg_exo -78.65 130.51 9.8 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.658 2.239 . . . . 0.96 111.09 171.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.404 HG13 ' HG ' ' A' ' 147' ' ' LEU . 34.1 pt -99.22 154.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.447 -0.575 . . . . 1.25 109.447 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.512 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 27.4 p -103.68 126.76 51.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.703 0.287 . . . . 1.29 111.711 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -114.83 147.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.15 -0.685 . . . . 1.02 109.15 173.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -93.6 166.55 12.18 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.532 -0.467 . . . . 1.08 110.78 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.574 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 44.0 m -50.19 -47.92 54.4 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.438 0.461 . . . . 1.33 112.209 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.69 -38.14 69.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.588 0.232 . . . . 2.51 111.391 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.441 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.1 mt-30 -67.38 -43.11 82.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 0.7 110.176 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.0 -41.78 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 1.36 111.031 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 219' ' ' SER . 90.2 mt -67.84 -44.1 77.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 1.03 111.689 -176.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -65.88 -24.42 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.912 0.338 . . . . 1.75 111.912 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -71.64 -36.03 70.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.033 0.444 . . . . 2.47 110.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -78.56 17.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.658 0.742 . . . . 3.04 110.439 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.57 -19.22 18.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.196 -0.668 . . . . 2.31 109.196 171.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 163' ' ' LEU . 88.7 mt -68.05 134.51 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.603 -0.726 . . . . 0.95 111.236 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 12.4 m120 -96.92 144.23 27.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 1.13 110.147 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -79.79 -28.92 40.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.778 -1.101 . . . . 3.74 108.79 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -83.4 174.81 10.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 1.62 111.585 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.73 179.1 27.65 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.04 -0.982 . . . . 1.16 111.545 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.8 125.46 23.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.988 0.423 . . . . 3.56 111.579 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.72 20.1 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.845 -0.616 . . . . 2.08 113.507 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -133.14 157.22 78.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.898 0.349 . . . . 2.59 110.079 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.98 122.69 12.26 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.557 2.171 . . . . 1.36 111.692 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.521 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 38.5 tt0 -57.25 117.94 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.235 0.828 . . . . 3.4 113.235 -173.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 60.0 mm-40 -115.27 142.12 47.11 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.583 -1.189 . . . . 2.47 108.042 169.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.11 127.05 38.51 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.968 -0.293 . . . . 2.14 110.214 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 52.6 ttp -81.23 94.96 6.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.16 0.505 . . . . 1.68 110.07 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 98' ' ' GLY . 21.8 m -137.95 156.41 31.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.673 -0.694 . . . . 1.27 110.752 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.39 -80.23 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.914 0.758 . . . . 2.18 110.953 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 47.37 32.16 2.14 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.176 0.591 . . . . 2.15 112.193 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -146.89 174.55 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.232 0.539 . . . . 4.59 111.657 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -127.68 145.7 55.86 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.598 -0.728 . . . . 6.13 110.261 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.17 174.16 3.48 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.548 2.166 . . . . 3.28 112.48 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.86 158.86 34.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.785 -0.643 . . . . 2.98 112.33 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -114.45 170.5 5.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.491 -0.777 . . . . 4.32 109.601 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.83 175.77 9.88 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.859 2.373 . . . . 3.48 113.489 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.8 -7.39 1.61 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.788 1.235 . . . . 4.63 112.88 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -55.87 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.517 2.043 . . . . 5.34 116.517 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.574 HD22 ' C ' ' A' ' 252' ' ' ASN . 0.2 OUTLIER 131.04 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 126.665 1.986 . . . . 4.64 113.298 177.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -172.71 133.93 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.022 0.439 . . . . 6.11 111.574 166.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -114.16 150.61 33.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.394 -0.821 . . . . 3.08 109.486 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.8 mm -85.91 113.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.827 0.346 . . . . 2.6 110.573 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.514 ' HB3' HG21 ' A' ' 192' ' ' THR . 41.8 ttmt -109.34 143.41 38.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.058 -0.719 . . . . 2.63 109.058 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 190' ' ' TYR . . . -136.95 164.0 29.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.724 0.297 . . . . 1.71 110.924 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 36.0 m -151.12 97.41 2.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.996 0.427 . . . . 2.21 109.985 175.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.84 95.95 4.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.215 -0.661 . . . . 4.31 109.215 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.718 -0.658 . . . . 4.49 110.399 -177.132 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 108.479 -0.934 . . . . 2.88 108.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 108' ' ' THR . 75.5 mt -67.55 125.25 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.59 0.709 . . . . 2.32 111.645 -173.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.88 122.91 29.57 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.935 -1.029 . . . . 2.82 108.81 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.6 p -57.22 -24.86 57.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.936 0.717 . . . . 2.24 112.936 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -81.34 -27.19 35.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 4.54 111.263 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 m -95.39 -28.7 14.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.422 . . . . 3.06 111.14 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.31 121.18 13.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 1.72 110.651 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.13 116.24 22.25 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.817 -0.438 . . . . 3.69 109.817 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -65.41 136.83 56.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 4.64 110.402 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 258' ' ' SER . 19.0 t70 -130.63 132.79 24.18 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.745 -0.661 . . . . 2.27 110.23 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.588 ' O ' HD23 ' A' ' 44' ' ' LEU . 23.3 Cg_exo -65.17 108.98 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.213 1.942 . . . . 2.15 112.55 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.698 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -53.08 -18.39 2.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.699 -0.682 . . . . 4.29 111.468 171.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER 50.65 -84.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.94 1.296 . . . . 4.74 113.177 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' H ' ' CG ' ' A' ' 44' ' ' LEU . 88.4 tttt -89.69 133.05 35.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.141 -0.318 . . . . 3.77 110.141 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.47 136.98 57.39 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.636 2.224 . . . . 2.36 111.519 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.03 141.66 43.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 2.55 110.096 -177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -102.48 97.19 7.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.898 -0.778 . . . . 2.38 108.898 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.26 108.7 23.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.589 -0.732 . . . . 1.59 109.175 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.695 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 61.5 m -108.31 91.51 3.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.982 0.42 . . . . 1.45 110.356 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 181' ' ' ARG . 7.8 p90 -102.85 8.95 39.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.922 -0.581 . . . . 3.62 109.542 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.09 -29.59 57.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.963 -1.017 . . . . 2.48 111.156 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' A' ' 53' ' ' GLN . 5.9 mt-30 -113.31 23.04 13.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.659 -0.7 . . . . 2.24 110.997 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HB1' ' HG2' ' A' ' 180' ' ' PRO . . . -72.3 114.02 9.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.035 0.445 . . . . 0.8 110.54 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -115.56 112.26 21.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.617 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 p -77.96 156.18 30.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.077 -0.511 . . . . 1.26 110.246 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.4 mt -121.63 -56.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.612 -0.267 . . . . 0.74 111.449 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.73 156.67 23.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 3.17 111.515 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.519 HG12 HD13 ' A' ' 166' ' ' ILE . 12.0 tt -107.12 137.73 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.515 -0.766 . . . . 0.64 109.7 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 172' ' ' SER . 24.0 tp -135.4 150.55 49.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.203 0.525 . . . . 0.96 111.683 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 166' ' ' ILE . 49.0 t-20 -113.33 111.87 22.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.254 -1.387 . . . . 1.49 107.254 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -135.64 71.41 1.43 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.811 -0.756 . . . . 1.83 111.875 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.03 -83.67 0.62 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 119.917 -1.135 . . . . 1.64 112.918 160.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -112.29 -7.29 14.01 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.156 -0.218 . . . . 3.33 111.381 -173.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.4 167.26 24.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 1.38 111.612 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 46.1 m-85 -110.34 105.53 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.632 -0.877 . . . . 2.74 108.632 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -99.0 124.82 44.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.469 -0.332 . . . . 1.76 111.764 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 59' ' ' ILE . 49.0 t -107.68 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.074 -0.713 . . . . 1.15 109.074 172.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.29 163.29 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.705 0.764 . . . . 2.02 112.581 -170.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.57 164.64 27.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.424 -1.262 . . . . 1.66 108.372 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 106.15 14.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.689 -0.485 . . . . 1.33 109.689 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -112.24 57.05 0.65 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.575 0.702 . . . . 2.65 110.102 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.1 p -95.83 -20.85 18.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.953 -0.567 . . . . 1.61 111.425 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.465 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 7.9 pt20 -145.8 177.97 8.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 2.35 110.784 -171.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' OD2' HG21 ' A' ' 78' ' ' VAL . 11.4 t70 -71.21 63.44 0.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.556 -0.747 . . . . 1.92 110.586 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' A' ' 74' ' ' GLN . 48.0 mttm -86.0 -69.02 0.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.956 -0.565 . . . . 1.77 111.356 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -115.21 102.48 9.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.76 109.61 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.405 HG21 ' OD2' ' A' ' 75' ' ' ASP . 39.0 t -117.05 142.74 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.186 -0.461 . . . . 1.27 111.788 -171.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 tp -123.31 121.24 35.33 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 1.29 109.324 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -159.96 121.17 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.193 0.52 . . . . 2.54 110.696 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.7 28.55 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 119.606 -0.552 . . . . 1.31 112.033 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -41.01 -140.27 0.0 OUTLIER Glycine 0 CA--C 1.534 1.236 0 O-C-N 124.606 0.827 . . . . 1.9 114.373 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.09 122.94 8.05 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 121.918 1.745 . . . . 2.91 111.525 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 13.2 tp -175.2 -168.27 0.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.367 -1.345 . . . . 4.11 107.367 -165.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 20.8 t70 -135.9 72.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.798 0.726 . . . . 4.95 110.294 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 164.47 20.26 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 2.25 113.094 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.3 m -105.77 129.44 53.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.529 -0.545 . . . . 1.91 109.529 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 8.5 m-85 -115.3 109.99 18.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.392 . . . . 3.7 111.09 -171.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.8 mtt180 -83.65 155.87 22.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.782 -0.451 . . . . 3.54 109.782 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 51.5 tp -83.21 131.61 35.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.132 -0.322 . . . . 1.14 110.132 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.676 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.8 tt -116.64 -47.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 1.68 111.375 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -166.56 165.11 16.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.732 -0.47 . . . . 1.55 109.732 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CD2' HD11 ' A' ' 118' ' ' LEU . 15.5 p90 -133.84 167.2 21.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.945 -0.302 . . . . 0.86 110.418 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 66' ' ' PHE . 8.2 p-80 -147.51 158.6 44.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.164 -0.68 . . . . 0.93 109.164 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.74 163.65 23.86 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.376 -0.231 . . . . 3.17 110.376 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.432 ' ND1' ' HB3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -124.03 165.24 17.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.694 -0.854 . . . . 1.68 108.694 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 65.6 t-105 -133.03 140.54 47.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.412 . . . . 5.18 110.626 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.576 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -91.46 -71.17 1.2 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.726 -0.67 . . . . 2.13 112.732 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 24.7 t 165.48 -65.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.277 -1.009 . . . . 2.9 108.277 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.4 mt -111.36 168.02 9.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.312 -0.858 . . . . 3.03 108.869 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.71 61.78 3.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.564 0.697 . . . . 3.85 110.943 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -154.95 -24.35 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.505 -0.855 . . . . 1.94 113.537 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -152.15 176.51 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.304 0.552 . . . . 2.45 110.581 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.576 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 97.04 -33.15 5.97 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.788 -0.72 . . . . 1.47 113.003 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.3 p -71.1 -27.77 63.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.119 0.485 . . . . 2.0 110.76 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 3.6 tp10 58.81 -158.07 0.31 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.958 -1.127 . . . . 3.72 107.958 -166.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.511 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 19.3 m-70 54.76 65.21 1.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.817 -0.809 . . . . 3.52 108.817 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.509 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -93.05 133.61 36.03 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 2.52 109.953 -168.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -109.48 104.61 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.015 -0.365 . . . . 2.48 110.015 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.97 53.74 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.429 -0.805 . . . . 2.8 110.449 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 77.97 -11.22 1.23 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.201 -0.908 . . . . 4.98 111.826 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -93.97 108.82 20.59 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.432 . . . . 3.23 112.168 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 64.0 mttp -81.69 176.44 9.63 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.752 -0.833 . . . . 2.82 108.752 166.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -124.11 -173.19 2.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.243 -0.183 . . . . 1.62 111.094 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.6 -35.43 58.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.938 0.348 . . . . 1.03 111.938 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.77 168.65 26.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.37 -0.377 . . . . 0.75 110.165 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.432 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 1.7 tm-20 -145.3 147.3 32.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.067 -0.716 . . . . 1.58 109.067 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 93' ' ' PHE . 39.5 tp -126.02 122.03 34.69 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.291 0.369 . . . . 1.07 111.047 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -108.69 109.74 20.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.431 -0.35 . . . . 1.77 110.669 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' CB ' ' A' ' 93' ' ' PHE . 18.4 mt -93.67 105.21 17.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.935 -0.394 . . . . 0.93 109.935 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.6 118.34 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.334 0.587 . . . . 0.61 112.054 -173.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 52.0 m-70 -110.36 134.09 52.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.472 -0.785 . . . . 2.13 109.482 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.676 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 25.3 p-90 -111.18 148.05 33.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.476 . . . . 4.26 111.885 -172.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.9 110.2 1.27 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.41 -0.814 . . . . 2.02 111.181 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -60.46 -30.4 69.64 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.314 0.857 . . . . 2.34 113.314 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -80.3 -56.84 3.92 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.331 0.493 . . . . 3.35 112.331 -171.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.34 -19.24 56.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 3.1 111.719 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.41 72.68 Favored Glycine 0 C--N 1.318 -0.419 0 N-CA-C 110.314 -1.114 . . . . 2.37 110.314 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.628 ' OD2' ' HG ' ' A' ' 140' ' ' LEU . 22.7 t70 78.48 -78.07 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.95 -1.125 . . . . 3.93 113.162 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -50.33 -21.12 1.28 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.055 1.131 . . . . 3.0 114.055 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.99 -69.14 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.954 -1.117 . . . . 2.15 112.555 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 72.4 mmtt -89.15 -40.14 13.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.533 0.568 . . . . 3.43 112.533 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . . . -66.8 -29.91 69.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.035 0.383 . . . . 1.76 112.035 -171.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.16 -6.41 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.279 0.562 . . . . 2.77 110.848 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -114.6 19.1 16.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 3.55 110.311 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 22.9 mt-30 -131.25 127.2 21.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 108.782 -0.822 . . . . 3.02 108.782 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.23 -29.93 48.96 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.108 2.539 . . . . 1.6 113.688 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.96 24.26 12.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.728 0.299 . . . . 2.29 110.459 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.97 -70.41 1.07 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.073 -0.512 . . . . 1.22 113.829 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HG ' ' OD2' ' A' ' 129' ' ' ASP . 6.5 mp -89.05 171.29 9.95 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.832 0.349 . . . . 1.57 110.801 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -141.39 104.11 4.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.618 -0.512 . . . . 1.38 109.618 172.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.67 111.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.799 -0.445 . . . . 1.73 109.799 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 57.8 tp -82.73 104.86 13.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 2.42 110.345 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -84.86 151.33 26.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.847 -0.692 . . . . 0.86 112.145 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.03 129.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.102 -0.332 . . . . 0.76 110.102 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 107' ' ' HIS . 3.2 m-85 -70.75 137.82 49.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.419 -0.355 . . . . 1.2 110.641 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.93 108.08 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.0 0.429 . . . . 0.88 110.445 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 215' ' ' ILE . 58.9 pttt -106.02 164.5 11.92 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 2.03 108.863 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.8 m -106.3 138.42 31.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 1.27 111.847 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.24 -96.83 0.1 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.092 -0.958 . . . . 1.53 110.952 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -87.88 153.78 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.776 -0.453 . . . . 1.54 109.776 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.77 158.37 36.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.194 0.521 . . . . 0.78 112.113 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 216' ' ' SER . 30.5 mmmt -112.31 100.13 48.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.4 -0.818 . . . . 1.22 109.01 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.05 -40.4 59.31 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.089 2.526 . . . . 1.05 112.251 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.81 74.89 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.091 -0.576 . . . . 0.7 113.143 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.2 tp -92.41 -26.23 18.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.46 0.63 . . . . 0.77 110.2 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -35.66 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.41 109.638 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.47 -39.65 84.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.538 -0.755 . . . . 2.86 110.995 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.1 t -71.98 -48.04 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.184 0.516 . . . . 1.38 110.146 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.618 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 67.3 t -58.93 -32.62 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 1.11 110.971 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.41 -21.51 64.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.569 -0.741 . . . . 1.22 111.891 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.29 -12.92 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.505 0.558 . . . . 1.41 112.505 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -57.48 -21.49 37.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.718 0.636 . . . . 1.39 112.718 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.503 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.9 p-10 -64.61 -18.99 65.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 2.31 111.086 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -88.7 -5.99 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.855 0.36 . . . . 1.4 110.9 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 61' ' ' ASN . 14.3 pt -126.64 39.19 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.526 0.679 . . . . 0.85 109.983 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.66 -28.18 69.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.547 -0.751 . . . . 1.59 111.184 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.7 p -130.96 147.66 52.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.362 -0.381 . . . . 0.77 110.709 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -58.57 140.37 54.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.842 -0.617 . . . . 2.29 111.005 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.09 -10.77 55.34 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.951 -0.642 . . . . 0.85 112.131 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 60' ' ' LEU . 97.8 mttt -104.9 144.58 31.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.449 . . . . 1.7 111.041 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 60' ' ' LEU . 23.7 p -141.82 156.47 45.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.627 -0.715 . . . . 1.37 110.181 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.63 136.37 35.86 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.482 -0.327 . . . . 0.61 110.282 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.02 129.36 41.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.143 -0.481 . . . . 1.8 110.762 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -138.94 77.86 1.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.004 -1.11 . . . . 1.04 108.004 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.98 156.11 21.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.672 -0.694 . . . . 1.17 111.261 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 54.78 56.33 6.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.123 0.487 . . . . 1.77 112.003 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.544 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 73.0 m-85 -124.75 143.62 50.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.932 -0.576 . . . . 3.99 109.852 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 181' ' ' ARG . 6.4 m-20 -93.12 107.31 24.26 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 2.51 111.844 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 19.4 Cg_exo -69.1 -13.52 36.48 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.934 2.423 . . . . 1.26 112.001 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.435 ' HG2' ' HB3' ' A' ' 179' ' ' ASP . 16.7 ptt180 -66.09 -16.85 64.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.375 . . . . 2.76 110.48 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.49 6.84 67.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.853 -0.612 . . . . 1.12 111.822 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 67.1 mt -110.96 -32.0 6.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.286 0.565 . . . . 1.73 109.557 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.06 127.11 73.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.41 -0.814 . . . . 3.45 111.339 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.37 -174.57 1.46 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.244 2.629 . . . . 2.08 113.099 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.77 -58.72 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.834 0.679 . . . . 3.23 112.834 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 19.7 m -61.52 125.06 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.801 0.334 . . . . 1.66 111.008 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.0 tp -104.22 62.67 0.74 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.588 0.708 . . . . 1.99 109.87 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.452 ' O ' HD12 ' A' ' 211' ' ' LEU . 24.2 m-20 -133.67 -177.86 4.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.994 -1.113 . . . . 1.81 107.994 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.2 p90 -163.01 155.03 18.14 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.308 -0.957 . . . . 5.01 112.625 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.471 ' CE2' ' HG3' ' A' ' 212' ' ' LYS . 57.4 m95 -96.35 142.31 28.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.752 -1.113 . . . . 3.93 109.331 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 256' ' ' LYS . 19.1 m -74.81 79.23 2.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.081 0.467 . . . . 2.13 109.786 173.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.413 ' HB3' ' CG2' ' A' ' 210' ' ' VAL . 41.0 t80 -117.89 103.08 50.7 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.629 . . . . 5.21 109.967 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.408 ' N ' ' HB3' ' A' ' 208' ' ' TRP . 45.1 Cg_exo -56.65 146.36 76.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.255 2.637 . . . . 2.12 113.087 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.67 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -139.66 153.15 22.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.508 -0.853 . . . . 1.75 112.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.882 0.372 . . . . 2.99 110.154 171.159 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.969 0.414 . . . . 2.96 112.022 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.41 67.12 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.732 0.777 . . . . 3.37 110.281 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.9 m -118.24 24.71 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.223 -0.899 . . . . 2.15 110.491 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 70.7 t -120.38 134.39 64.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.65 -0.705 . . . . 1.26 110.159 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.2 m -73.63 121.7 21.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.597 -0.729 . . . . 2.08 109.629 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.435 ' CE3' HG23 ' A' ' 192' ' ' THR . 0.0 OUTLIER -64.48 99.49 0.31 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.072 -0.967 . . . . 5.53 111.981 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 58.3 mt -142.43 100.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.326 -0.397 . . . . 1.63 110.368 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 73.3 t -117.25 119.14 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.286 -0.264 . . . . 1.62 110.286 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 189' ' ' ASP . 9.8 tp -62.06 123.2 17.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.228 -0.286 . . . . 1.73 110.228 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.471 ' HG3' ' CE2' ' A' ' 191' ' ' TRP . 29.2 ttpp -65.59 -8.31 19.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.716 1.376 . . . . 2.98 114.716 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 36.3 tt0 -105.93 110.06 63.74 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 119.776 -0.77 . . . . 1.47 111.096 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.448 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 25.7 Cg_exo -64.49 137.66 56.18 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.776 2.317 . . . . 0.96 111.578 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.405 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 38.6 pt -97.49 149.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.745 -0.465 . . . . 1.25 109.745 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 17.0 t -103.34 120.7 41.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.207 -0.664 . . . . 1.29 109.207 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.47 162.95 8.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.996 -0.372 . . . . 1.02 109.996 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 16.2 t -81.92 151.09 27.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.121 -0.325 . . . . 1.08 110.121 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.643 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 13.9 m -55.67 -43.17 76.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.405 -0.361 . . . . 1.33 110.83 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 12.3 tp10 -59.42 -32.51 70.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 2.51 111.019 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.421 ' HA ' HG11 ' A' ' 160' ' ' VAL . 56.2 mt-30 -67.18 -49.92 62.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.7 110.741 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.628 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 31.2 m -71.0 -29.75 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.351 . . . . 1.36 111.944 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 219' ' ' SER . 91.1 mt -63.9 -26.54 68.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 1.03 110.84 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 58.1 mtpt -82.68 -22.67 34.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 1.75 110.86 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.6 m-85 -70.12 -34.05 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.514 -0.55 . . . . 2.47 109.514 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.92 -14.62 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 3.04 111.042 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -95.61 -3.12 46.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.406 -0.361 . . . . 2.31 111.528 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.69 154.6 21.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.226 0.536 . . . . 0.95 111.224 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.3 m120 -119.81 159.48 24.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.266 -0.642 . . . . 1.13 109.266 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -105.62 -4.64 20.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 3.74 110.424 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.8 p-10 -85.1 176.14 8.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 1.62 110.091 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -104.09 169.12 17.37 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.143 -0.783 . . . . 1.16 111.143 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -55.24 143.58 27.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 3.56 110.647 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.76 23.83 54.8 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.052 -0.594 . . . . 2.08 112.923 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.4 153.33 76.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 117.247 0.523 . . . . 2.59 109.851 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.06 127.74 23.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.531 2.154 . . . . 1.36 111.01 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.0 118.68 4.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.623 0.725 . . . . 3.4 112.783 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -114.13 110.39 19.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.855 -1.066 . . . . 2.47 109.121 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.55 139.64 47.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.336 -0.393 . . . . 2.14 111.077 -176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.6 ttm -87.52 91.52 8.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.391 -0.596 . . . . 1.68 109.391 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.69 154.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.203 -0.453 . . . . 1.27 111.356 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.5 t70 69.06 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.077 0.861 . . . . 2.18 110.524 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . 0.416 HD22 ' HB3' ' A' ' 96' ' ' HIS . 58.9 t30 56.3 20.38 4.59 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.177 0.806 . . . . 2.15 113.177 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -151.32 167.44 27.87 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.056 -0.403 . . . . 4.59 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -125.09 147.7 57.91 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 115.802 -0.635 . . . . 6.13 110.675 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -43.9 146.54 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.051 2.501 . . . . 3.28 112.553 168.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.94 142.65 47.84 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.196 1.184 . . . . 2.98 114.196 -166.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -74.76 159.55 82.89 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.675 -1.148 . . . . 4.32 110.303 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.57 174.48 8.76 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.454 2.77 . . . . 3.48 113.729 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 89.2 mt -66.14 -9.5 32.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.81 -1.086 . . . . 4.63 112.081 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 74.3 mmtt -58.67 46.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.623 1.342 . . . . 5.34 114.623 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 51.5 t30 120.19 6.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.559 1.944 . . . . 4.64 110.721 176.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 1.2 mpt_? -132.98 104.02 6.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.716 -0.674 . . . . 6.11 109.298 171.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -114.5 145.63 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.757 0.313 . . . . 3.08 111.099 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.3 mm -100.88 126.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.027 -0.533 . . . . 2.6 110.35 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.553 ' HB2' ' OG1' ' A' ' 192' ' ' THR . 96.4 mttt -117.19 150.78 38.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.703 -0.851 . . . . 2.63 108.703 172.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -115.94 95.8 5.28 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.705 -0.479 . . . . 1.71 109.705 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 68.6 m -80.69 94.66 6.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.728 -0.789 . . . . 2.21 110.506 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -140.19 111.02 6.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.3 -1.318 . . . . 4.31 108.833 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-N 116.053 -0.521 . . . . 4.49 110.956 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 19.2 t70 . . . . . 0 C--O 1.231 0.103 0 N-CA-C 108.252 -1.018 . . . . 2.88 108.252 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -97.67 126.15 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.732 0.301 . . . . 2.32 111.757 -170.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.85 117.48 34.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.426 -0.352 . . . . 2.82 110.239 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -30.42 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.782 -0.645 . . . . 2.24 112.148 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -83.14 -15.61 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.589 -0.278 . . . . 4.54 111.495 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 250' ' ' LEU . 88.5 m -98.23 -29.35 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.655 0.264 . . . . 3.06 111.26 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 130.62 44.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.72 111.259 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.39 124.31 45.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 3.69 109.93 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.14 113.33 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.488 -0.56 . . . . 4.64 109.488 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -118.62 118.72 33.32 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 2.27 109.669 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -53.82 91.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 123.583 2.855 . . . . 2.15 113.599 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 p -58.89 -30.85 68.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.743 -0.662 . . . . 4.29 110.844 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt 71.28 -64.92 0.36 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.323 -0.853 . . . . 4.74 111.65 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -76.0 130.63 77.74 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.737 0.303 . . . . 3.77 110.729 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.58 158.58 32.23 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.723 2.282 . . . . 2.36 111.925 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 48' ' ' SER . 6.5 tt -91.52 140.29 29.89 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.333 -0.617 . . . . 2.55 109.333 -178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.502 ' N ' HD23 ' A' ' 47' ' ' LEU . 2.0 t -144.6 139.33 28.02 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.848 -0.797 . . . . 2.38 108.848 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.33 128.88 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.048 0.452 . . . . 1.59 111.929 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.5 t -118.94 90.04 3.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.079 -0.711 . . . . 1.45 109.079 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.76 13.84 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 3.62 110.421 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.69 -31.65 68.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 2.48 111.213 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 13.9 mt-30 -109.35 17.35 21.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 2.24 110.736 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.24 114.48 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.37 . . . . 0.8 110.922 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 m -101.35 106.24 17.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.049 -0.523 . . . . 1.06 110.734 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -85.42 151.49 23.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.799 -0.637 . . . . 1.26 109.712 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.24 -57.54 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.74 111.545 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -167.34 159.63 12.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.64 0.257 . . . . 3.17 111.036 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 14.1 tt -104.99 140.6 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.317 -0.623 . . . . 0.64 109.317 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -130.29 140.53 50.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.115 0.483 . . . . 0.96 111.555 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.22 108.6 20.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.732 -1.211 . . . . 1.49 107.732 170.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -137.83 71.55 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.572 -0.851 . . . . 1.83 111.791 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.62 -75.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 119.941 -1.123 . . . . 1.64 112.851 159.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 243' ' ' ASN . 52.4 t-80 -112.59 -12.85 13.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.056 0.391 . . . . 3.33 112.056 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -154.2 175.99 12.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.997 0.427 . . . . 1.38 111.748 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.79 103.8 9.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.414 -0.958 . . . . 2.74 108.414 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.94 134.97 47.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.155 0.502 . . . . 1.76 111.87 -170.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 48.4 t -100.25 112.13 31.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.309 -0.626 . . . . 1.15 109.309 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.48 130.87 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 2.02 112.198 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -111.87 163.7 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.397 -0.964 . . . . 1.66 108.397 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.05 121.49 27.09 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.614 -0.434 . . . . 1.33 111.372 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.624 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 10.0 t0 -114.72 60.42 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.884 0.849 . . . . 2.65 109.75 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 t -116.47 -15.49 10.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 1.61 110.134 165.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -137.6 160.79 38.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.496 -0.557 . . . . 2.35 109.496 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -82.33 64.71 7.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.27 0.557 . . . . 1.92 110.207 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 67.6 mttm -79.18 -51.22 9.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.434 -0.803 . . . . 1.77 110.003 -177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . . . -115.88 105.2 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.76 109.215 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.14 139.98 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.046 0.451 . . . . 1.27 110.914 -172.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.498 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 14.7 tp -109.55 148.89 30.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.819 -0.628 . . . . 1.29 110.969 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 93.5 mttt -116.55 141.51 48.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.024 -1.102 . . . . 2.54 108.024 164.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.2 168.73 31.42 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.271 -0.966 . . . . 1.31 112.229 -165.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.63 -146.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 112.263 -0.335 . . . . 1.9 112.263 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.43 121.66 9.42 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.09 1.86 . . . . 2.91 112.095 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 88' ' ' TYR . 8.3 tp -179.63 157.57 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.024 -1.102 . . . . 4.11 108.024 -175.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.57 111.32 13.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.987 1.106 . . . . 4.95 113.987 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.1 -101.66 0.96 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.441 -0.885 . . . . 2.25 114.858 161.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.469 HG22 ' HG3' ' A' ' 89' ' ' ARG . 33.4 m -130.95 103.92 6.83 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.487 -0.56 . . . . 1.91 109.487 -167.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.498 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 1.3 m-85 -95.44 91.52 6.24 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.608 -0.437 . . . . 3.7 110.044 -172.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 55.9 mtt180 -107.27 146.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.717 0.294 . . . . 3.54 110.568 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 57.8 tp -77.84 123.86 27.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.552 -0.536 . . . . 1.14 109.552 171.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.1 -40.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.176 -0.465 . . . . 1.68 110.02 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -174.89 168.51 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.764 -0.653 . . . . 1.55 109.715 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.28 150.01 47.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.199 -0.667 . . . . 0.86 109.199 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 7.6 p-80 -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.632 0.254 . . . . 0.93 110.863 -172.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -134.37 158.89 42.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 3.17 110.347 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -165.13 179.39 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.644 0.259 . . . . 1.68 111.36 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.632 ' CD1' ' HA ' ' A' ' 242' ' ' ASP . 2.9 t90 74.0 -100.46 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.066 0.946 . . . . 5.18 110.407 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 53.02 15.58 3.57 Favored Glycine 0 N--CA 1.475 1.241 0 N-CA-C 115.278 0.871 . . . . 2.13 115.278 174.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.585 ' H ' ' HD1' ' A' ' 97' ' ' TRP . 48.3 p -45.7 -53.92 8.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.896 0.702 . . . . 2.9 112.896 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.7 mt -128.53 146.86 50.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.477 -0.564 . . . . 3.03 109.477 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.69 -13.23 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 3.85 111.613 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.55 -10.26 41.59 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.347 -0.93 . . . . 1.94 113.017 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.39 119.27 2.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.579 0.704 . . . . 2.45 111.725 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.28 41.32 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.658 -0.701 . . . . 1.47 111.794 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.4 p -105.8 -14.09 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 2.0 112.298 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.76 174.23 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.463 -0.569 . . . . 3.72 109.463 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.613 ' HE2' ' CD ' ' A' ' 117' ' ' GLU . 14.9 p80 44.09 68.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.312 1.053 . . . . 3.52 111.426 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.6 t -75.97 130.41 38.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.515 -1.22 . . . . 2.52 110.681 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 23.3 t -101.76 105.69 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 114.378 -1.283 . . . . 2.48 110.171 -172.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 55.31 50.76 14.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.568 -0.742 . . . . 2.8 109.472 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 68.33 1.14 2.77 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.238 -0.892 . . . . 4.98 112.607 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 47.8 tptt -89.75 123.72 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 3.23 110.968 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.69 155.96 27.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.809 -0.632 . . . . 2.82 110.31 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.69 168.89 9.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.101 -0.703 . . . . 1.62 109.101 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.43 79.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.274 0.472 . . . . 1.03 112.274 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.46 171.32 7.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.219 -0.66 . . . . 0.75 109.219 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.613 ' CD ' ' HE2' ' A' ' 107' ' ' HIS . 28.8 tt0 -142.24 138.43 31.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.067 0.461 . . . . 1.58 110.509 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.3 tp -102.43 126.49 49.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.43 -0.804 . . . . 1.07 109.448 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.413 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 42.4 m170 -107.98 110.27 21.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 1.77 111.147 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 6.8 mp -94.68 103.44 15.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.678 -0.49 . . . . 0.93 109.678 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.482 HG22 HG12 ' A' ' 142' ' ' VAL . 19.3 t -76.85 100.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.008 -0.542 . . . . 0.61 110.436 -176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 90' ' ' LEU . 3.2 p80 -138.97 76.19 1.56 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.755 1.021 . . . . 2.13 113.755 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.0 t90 178.91 99.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.345 0.658 . . . . 4.26 109.856 149.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' A' ' 133' ' ' ALA . 24.8 t-20 -124.62 90.48 3.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 118.612 -0.708 . . . . 2.02 111.561 157.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.5 m -81.28 -51.98 7.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 120.819 1.645 . . . . 2.34 111.492 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HD2' ' HA2' ' A' ' 139' ' ' GLY . 13.0 ptpt -43.57 -32.77 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 114.549 1.314 . . . . 3.35 114.549 -173.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.98 -16.35 6.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.133 -0.627 . . . . 3.1 111.851 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.38 38.91 51.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.583 -0.607 . . . . 2.37 111.583 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 12.3 t70 -169.33 110.48 0.47 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.675 -0.861 . . . . 3.93 108.675 -171.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -63.44 -32.12 73.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.943 0.349 . . . . 3.0 111.943 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.71 98.64 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.921 -0.657 . . . . 2.15 112.818 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 31.7 mmmt -74.32 -20.99 59.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.276 0.56 . . . . 3.43 110.311 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.612 ' HB2' ' ND2' ' A' ' 124' ' ' ASN . . . -74.75 -20.95 59.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 1.76 111.988 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.6 t -61.11 -22.08 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.566 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -98.18 8.09 45.32 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.158 -0.339 . . . . 3.55 111.572 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.488 ' NE2' ' HD2' ' A' ' 137' ' ' PRO . 12.9 mm100 -122.86 127.47 25.72 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.662 0.267 . . . . 3.02 111.161 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.488 ' HD2' ' NE2' ' A' ' 136' ' ' GLN . 11.2 Cg_endo -55.3 -32.96 83.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.604 2.869 . . . . 1.6 113.465 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.61 28.42 8.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.796 -0.446 . . . . 2.29 109.796 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.404 ' HA2' ' HD2' ' A' ' 126' ' ' LYS . . . -67.19 -27.91 73.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.048 -0.596 . . . . 1.22 114.319 -175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.8 mt -137.19 170.29 16.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.459 . . . . 1.57 111.564 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.14 118.58 6.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 1.38 109.472 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 121' ' ' VAL . 33.8 m -113.4 142.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 1.73 111.064 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.0 tp -95.46 103.85 15.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.786 . . . . 2.42 108.879 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.6 3.66 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.044 -0.598 . . . . 0.86 112.223 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 32.3 mt -102.62 124.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.866 -0.42 . . . . 0.76 109.866 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 48.8 m-85 -68.2 148.2 51.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 1.2 110.898 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.6 mp -118.56 138.3 52.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.498 -0.556 . . . . 0.88 109.498 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.1 ptmm? -143.23 146.55 33.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.891 -0.781 . . . . 2.03 108.891 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 95.7 t -83.79 130.87 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.099 0.476 . . . . 1.27 111.663 -171.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.45 -110.14 0.24 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.872 -0.891 . . . . 1.53 110.872 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 t -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.313 -0.625 . . . . 1.54 109.313 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.0 158.27 23.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.608 0.242 . . . . 0.78 110.987 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -115.94 106.2 50.06 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.922 -0.399 . . . . 1.22 109.922 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 51.1 Cg_exo -54.96 -35.77 90.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.08 2.52 . . . . 1.05 112.362 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.58 71.98 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.992 -0.623 . . . . 0.7 112.645 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.485 ' HB3' HE22 ' A' ' 221' ' ' GLN . 19.1 tp -88.05 -20.25 26.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.47 -0.567 . . . . 0.77 109.47 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 19.8 mm-40 -52.82 -37.34 59.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.647 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 175' ' ' PHE . 57.3 mttp -54.01 -54.27 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.458 0.474 . . . . 2.86 111.601 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 162' ' ' VAL . 11.4 p -74.62 -37.26 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.91 0.386 . . . . 1.38 110.762 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 80.6 t -64.94 -34.97 74.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.419 0.628 . . . . 1.11 110.808 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.66 -32.84 71.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.063 -0.517 . . . . 1.22 111.317 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 159' ' ' VAL . 9.3 p -89.58 -20.74 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.17 0.433 . . . . 1.41 112.17 -173.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.485 HD13 HD11 ' A' ' 228' ' ' LEU . 3.0 pp -67.84 -16.92 64.33 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.071 0.463 . . . . 1.39 111.161 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.8 t70 -65.04 -23.35 67.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 2.31 110.325 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.7 m -89.73 1.71 55.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 1.4 111.935 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.96 39.23 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.513 0.673 . . . . 0.85 110.078 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 89.0 tttt -59.62 -22.59 62.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.146 -0.933 . . . . 1.59 111.666 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.1 p -120.18 137.56 54.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.51 -0.314 . . . . 0.77 110.812 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 230' ' ' PHE . 15.0 ptmm? -56.07 137.09 51.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.053 -0.521 . . . . 2.29 111.348 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.33 -30.46 8.23 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.976 -0.63 . . . . 0.85 111.816 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -81.8 153.79 26.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.06 0.457 . . . . 1.7 110.91 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.9 t -145.84 151.84 38.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.622 -0.717 . . . . 1.37 109.499 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -133.58 126.29 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.604 -0.271 . . . . 0.61 110.312 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.38 131.15 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 1.8 110.495 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -144.55 86.09 1.8 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 1.04 110.523 -176.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.6 p -95.99 160.92 14.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.703 0.287 . . . . 1.17 111.485 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 21.1 m120 65.19 29.8 11.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.774 -0.648 . . . . 1.77 112.331 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -87.47 119.9 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.464 -0.569 . . . . 3.99 109.464 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.74 112.7 63.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.995 0.426 . . . . 2.51 111.024 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.49 -17.83 60.92 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.82 2.347 . . . . 1.26 111.723 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -53.95 -40.07 66.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.554 -0.748 . . . . 2.76 110.861 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -64.89 -18.33 64.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.666 -0.697 . . . . 1.12 113.704 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.8 mt -96.83 -11.96 24.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.261 0.53 . . . . 1.73 111.701 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 96.7 mt -63.85 123.72 82.64 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.727 0.299 . . . . 3.45 111.563 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.498 ' HB2' ' HG2' ' A' ' 213' ' ' GLU . 2.5 Cg_endo -82.49 -170.04 0.86 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.221 2.614 . . . . 2.08 112.154 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.47 -66.19 0.92 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.159 0.8 . . . . 3.23 113.159 -174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 20.1 m -65.48 114.66 5.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.15 0.5 . . . . 1.66 111.357 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 47' ' ' LEU . 17.8 tp -103.15 70.57 1.07 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 1.99 110.744 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.458 ' O ' HD12 ' A' ' 211' ' ' LEU . 3.0 m-20 -130.33 174.32 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.39 -0.967 . . . . 1.81 108.39 176.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 38.4 p90 -166.36 154.7 10.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.559 0.948 . . . . 5.01 113.559 -164.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.617 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 4.1 m95 -107.78 149.74 27.84 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.239 -1.393 . . . . 3.93 107.239 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.7 t -138.38 103.03 4.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.97 0.804 . . . . 2.13 112.799 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.39 157.84 69.88 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.924 -0.58 . . . . 5.21 110.492 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.04 137.21 78.28 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.731 2.288 . . . . 2.12 112.366 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -134.25 156.97 22.66 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.303 -0.475 . . . . 1.75 113.563 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 C--N 1.33 -0.254 0 C-N-CA 122.642 0.377 . . . . 2.99 110.04 179.781 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.764 0.316 . . . . 2.96 110.53 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.4 66.77 0.89 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.861 0.838 . . . . 3.37 109.581 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.0 11.76 30.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.774 -1.103 . . . . 2.15 111.026 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.73 149.63 22.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.077 0.465 . . . . 1.26 111.414 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.4 m -103.03 107.86 18.82 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 2.08 107.989 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -80.89 100.08 8.68 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.737 -0.468 . . . . 5.53 109.737 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 55.3 mt -99.91 100.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.01 -0.541 . . . . 1.63 109.742 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 45.4 t -85.11 119.35 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.251 -0.432 . . . . 1.62 110.852 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 189' ' ' ASP . 46.2 tp -80.41 122.43 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.439 . . . . 1.73 110.612 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -48.44 -28.74 3.46 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.082 1.142 . . . . 2.98 114.082 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 185' ' ' PRO . 5.7 tp10 -102.98 114.42 65.25 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.396 -0.522 . . . . 1.47 110.926 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.45 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 90.5 Cg_endo -80.01 148.61 19.6 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.803 2.335 . . . . 0.96 111.893 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 34.4 pt -101.88 149.44 6.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 1.25 110.559 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 1.7 p -101.93 117.53 35.02 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.462 -0.79 . . . . 1.29 110.098 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 32.6 m -115.76 168.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.137 -0.483 . . . . 1.02 110.049 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.3 t -90.65 148.78 22.41 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.741 -0.384 . . . . 1.08 110.417 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.56 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 10.6 p -53.66 -45.0 70.11 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.507 0.505 . . . . 1.33 111.502 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.0 -31.53 71.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.647 -0.251 . . . . 2.51 111.306 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.485 HE22 ' HB3' ' A' ' 156' ' ' LEU . 54.5 mt-30 -62.51 -51.09 68.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.7 0.286 . . . . 0.7 110.628 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.65 -26.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.933 -0.307 . . . . 1.36 111.156 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 219' ' ' SER . 88.3 mt -69.44 -36.07 76.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 1.03 110.883 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -66.11 -31.44 72.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.064 0.459 . . . . 1.75 110.764 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -69.7 -39.32 76.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.594 -0.73 . . . . 2.47 109.754 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -72.0 -3.62 23.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.24 -0.891 . . . . 3.04 111.011 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 98.5 mttt -94.34 -1.38 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 2.31 110.665 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.485 HD11 HD13 ' A' ' 163' ' ' LEU . 55.6 mt -90.41 155.08 19.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.037 -0.529 . . . . 0.95 110.775 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -112.36 155.7 23.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.51 -0.314 . . . . 1.13 110.354 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.532 ' O ' ' HD2' ' A' ' 169' ' ' LYS . 50.4 p90 -111.52 -18.42 12.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.215 -0.448 . . . . 3.74 110.293 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.573 HD22 ' HB2' ' A' ' 235' ' ' GLU . 6.2 p-10 -71.51 -31.83 67.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.62 111.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.471 ' CA ' ' HG2' ' A' ' 169' ' ' LYS . . . 97.99 -159.71 20.79 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.564 -0.827 . . . . 1.16 113.018 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.17 150.38 20.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.686 0.279 . . . . 3.56 110.34 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.19 4.22 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.01 -0.615 . . . . 2.08 112.685 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.573 ' HB2' HD22 ' A' ' 231' ' ' ASN . 41.6 mt-10 -134.92 159.55 71.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.447 -0.575 . . . . 2.59 109.447 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.91 129.92 37.87 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.772 2.315 . . . . 1.36 112.005 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.64 114.35 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 3.4 111.839 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.71 117.82 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.393 -0.595 . . . . 2.47 109.393 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.21 136.24 55.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.789 -0.642 . . . . 2.14 111.206 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.5 ttm -81.32 89.94 6.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.668 -0.697 . . . . 1.68 109.49 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.73 153.59 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 1.27 109.804 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.632 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 13.6 t70 64.75 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.885 0.741 . . . . 2.18 110.607 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . 0.46 ' HB3' ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER 52.23 27.33 4.61 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.56 0.948 . . . . 2.15 113.56 179.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 73.8 m95 -139.84 169.32 17.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.902 0.382 . . . . 4.59 110.81 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -117.35 148.91 43.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 6.13 111.573 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -33.23 138.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.921 3.747 . . . . 3.28 115.014 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -54.91 143.82 24.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.683 -1.144 . . . . 2.98 112.209 -175.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 28.4 mm-40 -107.97 130.36 22.9 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 4.32 110.894 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 248' ' ' GLN . 27.4 Cg_exo -63.23 175.17 2.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.52 2.813 . . . . 3.48 113.956 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.491 ' CD1' HG21 ' A' ' 37' ' ' THR . 49.8 mt -62.17 -11.19 13.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.207 -1.361 . . . . 4.63 113.402 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 18.5 ptpt -57.79 47.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.234 1.938 . . . . 5.34 116.234 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 7.5 t30 127.4 25.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 126.372 1.869 . . . . 4.64 111.106 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 252' ' ' ASN . 0.0 OUTLIER -141.94 110.76 6.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.083 -0.71 . . . . 6.11 109.083 166.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.02 121.81 45.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.072 -0.714 . . . . 3.08 109.072 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.6 mm -82.95 115.58 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.181 0.515 . . . . 2.6 112.262 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.56 127.5 40.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.639 -0.71 . . . . 2.63 109.555 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -116.37 146.09 42.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.717 -0.475 . . . . 1.71 109.717 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 19.5 m -142.41 96.43 2.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.426 0.631 . . . . 2.21 110.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.435 ' HA ' ' OD1' ' A' ' 189' ' ' ASP . 86.5 t80 -126.54 90.69 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.548 -0.908 . . . . 4.31 108.548 166.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.375 -0.821 . . . . 4.49 109.823 -177.54 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 113.465 0.913 . . . . 2.88 113.465 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 26.2 mm -101.6 134.37 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.718 -1.128 . . . . 2.32 111.2 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 37' ' ' THR . 16.2 t70 -107.32 113.45 26.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.963 -0.384 . . . . 2.82 109.963 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -56.67 -33.11 66.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.319 0.859 . . . . 2.24 113.319 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -75.07 -41.29 59.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.876 -0.329 . . . . 4.54 111.109 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 7.3 p -72.55 -27.53 62.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.801 0.334 . . . . 3.06 110.532 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -69.89 84.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.277 0.56 . . . . 1.72 110.443 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -79.73 134.43 36.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.692 -0.685 . . . . 3.69 109.656 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.616 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 2.5 p90 -81.68 124.52 29.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.194 0.521 . . . . 4.64 110.297 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -118.0 119.9 33.12 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 2.27 109.621 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.32 24.57 0.31 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.999 2.466 . . . . 2.15 113.728 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.8 p -95.86 -17.21 21.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.268 0.556 . . . . 4.29 109.51 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.77 124.51 30.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.493 -0.776 . . . . 4.74 109.768 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -115.15 136.57 22.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.122 -0.49 . . . . 3.77 110.922 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.07 122.84 12.42 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.825 2.35 . . . . 2.36 112.049 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.482 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 6.2 mp -78.62 132.96 37.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 2.55 110.904 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.6 t -84.56 138.04 32.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.466 -0.568 . . . . 2.38 109.466 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.0 t -118.37 121.78 67.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.192 -0.458 . . . . 1.59 110.832 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.3 p -111.55 89.91 3.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.438 -0.578 . . . . 1.45 109.438 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -109.84 10.01 24.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.687 -0.688 . . . . 3.62 110.098 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.8 -34.72 65.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.386 -0.825 . . . . 2.48 111.544 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.7 13.66 29.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.278 0.473 . . . . 2.24 112.278 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.29 113.57 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 0.8 111.923 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.8 m -107.33 109.83 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.847 -0.615 . . . . 1.06 110.547 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 178' ' ' PHE . 18.1 m -78.57 145.51 34.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.404 -0.362 . . . . 1.26 110.617 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -115.64 -55.77 2.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.74 111.718 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -166.6 159.09 13.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 3.17 111.271 -173.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 tt -112.16 137.5 44.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 0.64 109.934 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -129.39 135.76 49.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.894 0.378 . . . . 0.96 111.681 -173.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.99 117.99 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.375 -0.972 . . . . 1.49 108.375 172.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -137.48 71.02 1.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.662 -0.815 . . . . 1.83 112.311 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 230' ' ' PHE . . . 99.53 -58.84 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.342 -0.932 . . . . 1.64 113.885 157.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -125.56 -9.1 6.83 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.691 -0.403 . . . . 3.33 111.82 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -160.49 177.74 10.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.804 -0.443 . . . . 1.38 109.804 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -139.3 136.72 35.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.256 -1.016 . . . . 2.74 108.256 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.01 151.93 48.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.063 0.459 . . . . 1.76 111.941 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.8 127.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.381 -0.827 . . . . 1.15 109.51 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.82 137.03 33.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 2.02 110.984 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -112.95 170.1 8.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.356 -0.838 . . . . 1.66 109.475 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.414 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 14.3 t70 -98.89 132.16 44.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.005 0.431 . . . . 1.33 110.92 174.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.53 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 22.6 t70 -137.1 62.29 1.6 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.227 -0.897 . . . . 2.65 109.118 170.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -80.67 -4.52 54.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.116 0.96 . . . . 1.61 108.626 166.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.547 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -163.63 148.98 11.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.026 -1.842 . . . . 2.35 106.026 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -61.68 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.138 0.97 . . . . 1.92 111.783 -171.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.547 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 61.7 mttm -91.9 -53.2 4.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.906 -1.043 . . . . 1.77 111.021 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.39 104.61 10.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.994 -0.548 . . . . 0.76 109.638 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.6 t -117.44 153.03 19.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 -176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tt -147.7 112.65 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 1.29 109.561 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.95 132.52 8.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.642 0.734 . . . . 2.54 111.622 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 47' ' ' LEU . . . -76.48 174.36 53.78 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 114.899 -1.046 . . . . 1.31 112.152 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.66 -142.88 0.0 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 124.259 0.623 . . . . 1.9 113.942 168.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.66 122.37 8.75 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 121.456 1.438 . . . . 2.91 111.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 7.9 tp -157.53 -167.66 2.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.947 -1.024 . . . . 4.11 108.428 -166.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.483 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 16.4 m-20 -123.64 32.67 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.741 0.305 . . . . 4.95 110.65 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.02 145.53 4.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.692 -0.766 . . . . 2.25 113.081 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.3 m -93.1 113.73 26.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.322 -0.622 . . . . 1.91 109.322 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 70.2 m-85 -101.33 127.91 47.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.155 0.503 . . . . 3.7 111.72 -171.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 123' ' ' TRP . 22.8 ptt180 -99.76 142.31 31.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.886 -0.597 . . . . 3.54 110.786 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 120' ' ' LEU . 8.4 tt -92.42 120.09 32.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.371 -0.603 . . . . 1.14 109.371 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.643 HD12 ' CE3' ' A' ' 123' ' ' TRP . 36.8 mt -121.97 -15.65 6.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.42 -0.354 . . . . 1.68 111.099 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -166.54 162.71 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.167 -0.333 . . . . 1.55 110.227 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 41.4 p90 -140.49 140.5 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.22 -0.659 . . . . 0.86 109.22 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.4 p-80 -118.51 158.05 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.329 . . . . 0.93 110.227 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 116' ' ' ALA . 78.4 t80 -133.69 156.97 46.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.143 -0.48 . . . . 3.17 109.967 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -152.07 139.4 19.43 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.753 -0.462 . . . . 1.68 109.753 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 68.9 t-105 -104.01 137.61 41.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.944 -0.571 . . . . 5.18 110.006 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -70.02 -60.97 4.55 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.962 -0.563 . . . . 2.13 113.165 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 29.0 t 162.23 -64.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 2.9 108.166 -176.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.0 mt -110.31 164.79 12.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.082 -0.963 . . . . 3.03 109.151 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -83.04 56.02 3.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.673 0.749 . . . . 3.85 110.86 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.75 -2.66 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.645 -0.707 . . . . 1.94 113.105 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.11 155.98 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.076 0.438 . . . . 2.45 110.385 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 100.67 -13.98 59.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.801 -0.714 . . . . 1.47 112.643 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.9 t -75.01 -32.84 61.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.49 . . . . 2.0 109.927 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 58.83 -159.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.55 -0.75 . . . . 3.72 110.122 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m80 58.37 30.72 20.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.428 -1.323 . . . . 3.52 107.428 -168.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.32 129.33 34.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.882 -1.508 . . . . 2.52 111.781 -166.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.2 m -100.15 111.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.825 -1.08 . . . . 2.48 110.606 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.63 43.21 12.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.964 -1.016 . . . . 2.8 110.406 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 68.3 20.95 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.125 -0.943 . . . . 4.98 112.078 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HE3' ' CZ ' ' A' ' 114' ' ' TYR . 4.4 tmmm? -102.81 89.55 3.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.985 0.422 . . . . 3.23 109.926 173.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -79.22 157.36 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 2.82 110.028 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 112' ' ' LYS . 82.2 m-85 -102.68 178.92 4.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.614 -0.266 . . . . 1.62 110.75 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.14 -47.22 68.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 1.03 111.381 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB2' ' CE3' ' A' ' 97' ' ' TRP . . . -155.77 168.16 28.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.041 -0.527 . . . . 0.75 110.539 -173.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -134.94 135.32 41.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 1.58 109.896 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.35 126.76 55.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.591 -0.522 . . . . 1.07 109.591 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.483 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -122.12 109.6 14.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.077 0.465 . . . . 1.77 111.695 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.3 mp -91.55 117.84 30.07 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.88 -0.785 . . . . 0.93 108.88 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.62 143.79 11.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.438 -0.346 . . . . 0.61 110.698 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 53.7 m-70 -138.81 134.7 33.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.633 -0.877 . . . . 2.13 108.633 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.643 ' CE3' HD12 ' A' ' 91' ' ' ILE . 37.5 m0 -111.23 140.99 45.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.457 -0.571 . . . . 4.26 109.457 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.79 112.97 2.03 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.889 -0.412 . . . . 2.02 109.889 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 t -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 2.34 110.828 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -63.35 -16.88 61.76 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.948 0.351 . . . . 3.35 111.948 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.96 -6.28 35.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.728 0.299 . . . . 3.1 110.711 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.77 18.84 0.76 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.16 -0.927 . . . . 2.37 115.189 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 21.7 t70 -170.59 125.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.652 0.726 . . . . 3.93 110.386 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.625 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.5 p90 -57.07 -40.72 77.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.98 -1.009 . . . . 3.0 111.054 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.01 -37.41 79.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.256 -0.497 . . . . 2.15 112.893 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 41.5 mmtm -76.9 -28.76 55.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 3.43 110.333 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -75.36 -35.04 61.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 1.76 111.133 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 130' ' ' PHE . 77.2 t -65.01 -25.87 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 2.77 110.37 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -95.38 17.94 13.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.053 0.454 . . . . 3.55 110.668 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 139' ' ' GLY . 4.3 tp-100 -131.24 121.77 18.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.168 -0.469 . . . . 3.02 109.952 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 92.4 Cg_exo -45.79 -36.03 14.39 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.017 3.144 . . . . 1.6 113.619 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -110.74 27.65 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.965 0.412 . . . . 2.29 109.961 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 136' ' ' GLN . . . -84.68 -42.65 7.19 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.159 -0.543 . . . . 1.22 113.541 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 69.0 mt -104.03 153.54 20.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.38 0.59 . . . . 1.57 110.469 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -142.88 147.12 34.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.829 -0.623 . . . . 1.38 109.954 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.4 t -133.76 137.69 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.153 -0.476 . . . . 1.73 109.954 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -106.07 121.74 44.74 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.702 -0.481 . . . . 2.42 109.702 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.74 128.46 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.867 -0.682 . . . . 0.86 113.041 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.76 115.52 31.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.914 -0.402 . . . . 0.76 109.914 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -77.99 149.97 33.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.931 0.396 . . . . 1.2 111.168 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.04 134.94 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.835 -0.62 . . . . 0.88 110.361 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -127.16 144.52 51.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.471 -0.566 . . . . 2.03 109.471 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 19.6 m -86.75 130.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.389 0.614 . . . . 1.27 111.742 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.32 -104.54 0.18 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.224 -0.898 . . . . 1.53 111.391 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -81.19 150.98 28.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 1.54 109.919 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.31 149.84 45.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.224 -0.444 . . . . 0.78 111.229 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 216' ' ' SER . 22.5 tptm -119.45 96.14 49.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.003 -0.544 . . . . 1.22 109.904 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 54.0 Cg_exo -53.56 -37.94 83.34 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.22 2.613 . . . . 1.05 112.524 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.94 -37.88 86.75 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.7 113.172 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 160' ' ' VAL . 61.9 tp -93.05 -22.43 19.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.082 0.441 . . . . 0.77 110.456 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -57.24 -34.22 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 1.41 111.316 -178.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -56.49 -41.75 77.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 2.86 110.904 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.58 -41.86 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 1.38 110.249 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 25.8 t -61.88 -33.81 59.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.374 0.606 . . . . 1.11 110.588 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.99 -37.06 78.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.797 -0.638 . . . . 1.22 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.91 -18.88 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 111.913 0.338 . . . . 1.41 111.913 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -66.32 -17.13 64.57 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.738 -0.385 . . . . 1.39 111.91 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.7 -24.06 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 2.31 110.881 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.5 m -84.8 0.43 50.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.264 -0.426 . . . . 1.4 111.427 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.42 HG12 ' HA ' ' A' ' 163' ' ' LEU . 44.7 pt -137.4 44.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.345 0.593 . . . . 0.85 109.627 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.79 -36.98 80.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.436 -0.802 . . . . 1.59 111.697 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -114.51 151.93 32.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.708 -0.224 . . . . 0.77 110.734 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 21.4 pttm -63.56 140.85 58.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.046 0.45 . . . . 2.29 110.611 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.13 47.71 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.753 -0.737 . . . . 0.85 111.42 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.61 147.72 22.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.128 0.49 . . . . 1.7 111.144 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.3 p -144.11 150.42 38.08 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.502 -0.772 . . . . 1.37 109.49 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -135.43 133.71 38.88 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.737 -0.468 . . . . 0.61 109.737 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.07 129.83 43.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.156 0.503 . . . . 1.8 110.065 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -141.44 79.91 1.71 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.678 -0.86 . . . . 1.04 108.678 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.5 m -99.29 153.99 18.53 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.273 -0.876 . . . . 1.17 110.984 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.4 m120 54.78 77.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.188 0.595 . . . . 1.77 111.959 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.437 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 71.3 t80 -131.42 140.63 49.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.9 -0.591 . . . . 3.99 109.494 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.41 120.89 51.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.198 0.523 . . . . 2.51 110.639 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.27 -5.57 16.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.025 2.483 . . . . 1.26 111.948 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 181' ' ' ARG . 42.1 ttp-105 -55.54 -36.95 67.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.773 -0.649 . . . . 2.76 110.975 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.05 8.08 61.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.968 -0.634 . . . . 1.12 112.417 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.6 mt -117.28 -38.95 3.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.984 0.421 . . . . 1.73 109.989 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.518 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.3 mt -73.1 131.44 83.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.727 -0.669 . . . . 3.45 111.101 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 5.8 Cg_exo -77.65 179.73 6.23 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.002 2.468 . . . . 2.08 112.361 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -84.76 -63.8 1.27 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.26 0.467 . . . . 3.23 112.26 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.3 t -78.06 134.7 37.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.653 0.263 . . . . 1.66 110.964 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.8 mt -113.21 60.84 0.64 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.946 0.403 . . . . 1.99 110.288 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 212' ' ' LYS . 4.5 m-20 -140.22 144.42 36.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.41 -0.959 . . . . 1.81 108.41 173.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER 171.85 -171.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.415 -0.587 . . . . 5.01 109.415 -173.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 257' ' ' ALA . 25.7 p90 -81.3 151.24 28.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.487 -0.485 . . . . 3.93 110.127 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.451 ' OG1' HD13 ' A' ' 209' ' ' ILE . 4.7 t -167.29 116.92 0.84 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.573 0.702 . . . . 2.13 110.827 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.621 ' CD1' ' HD2' ' A' ' 251' ' ' LYS . 6.2 t80 -139.87 147.82 52.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.869 -0.789 . . . . 5.21 108.869 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 99.2 Cg_exo -47.64 151.19 3.51 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.628 2.219 . . . . 2.12 112.875 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.93 159.45 24.6 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.75 112.453 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 120.977 0.418 . . . . 2.99 110.166 -176.88 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.833 0.349 . . . . 2.96 110.988 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.86 93.23 4.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.177 -0.465 . . . . 3.37 111.707 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.7 p -139.25 24.49 2.51 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.779 0.659 . . . . 2.15 112.779 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.15 143.2 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.26 111.964 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 5.5 m -126.35 104.52 8.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.331 -0.618 . . . . 2.08 109.331 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -101.64 134.95 43.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.476 0.655 . . . . 5.53 112.144 -175.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.451 HD13 ' OG1' ' A' ' 192' ' ' THR . 7.9 mm -116.13 128.32 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.779 -1.1 . . . . 1.63 109.173 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 t -108.17 150.28 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.341 -0.614 . . . . 1.62 109.341 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.415 ' HB2' ' HG2' ' A' ' 185' ' ' PRO . 1.9 mm? -109.57 146.43 34.7 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.98 -0.288 . . . . 1.73 111.325 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.61 ' HA ' ' CD2' ' A' ' 190' ' ' TYR . 37.5 ttmt -52.99 -60.28 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.765 0.654 . . . . 2.98 112.765 -176.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 185' ' ' PRO . 11.4 mm-40 -72.86 114.88 34.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.696 -0.684 . . . . 1.47 111.68 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.37 147.32 22.77 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.156 1.904 . . . . 0.96 110.5 174.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 pt -89.4 140.08 16.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.459 -0.496 . . . . 1.25 110.21 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 18.4 t -97.32 127.48 43.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.052 -0.522 . . . . 1.29 109.734 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 29.8 m -127.0 156.39 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.729 -0.668 . . . . 1.02 109.737 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.5 t -85.83 154.58 21.46 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.179 -0.304 . . . . 1.08 110.179 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.561 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 46.2 m -53.46 -42.35 67.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.001 0.188 . . . . 1.33 111.398 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 9.9 pt-20 -56.94 -27.77 61.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.605 -0.27 . . . . 2.51 111.634 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -77.08 -46.91 21.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.028 -0.36 . . . . 0.7 110.028 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.723 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 26.7 m -70.83 -28.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.36 111.228 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.7 mt -64.48 -33.57 76.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.298 -0.41 . . . . 1.03 110.558 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 65.2 mttp -74.97 -24.22 58.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 1.75 111.238 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.723 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.3 m-85 -67.0 -35.13 79.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.202 0.525 . . . . 2.47 109.851 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -84.45 13.96 4.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.696 -0.684 . . . . 3.04 110.578 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.0 mmtt -100.63 -14.96 17.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.79 -0.448 . . . . 2.31 109.79 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.401 HD21 HD13 ' A' ' 163' ' ' LEU . 97.9 mt -77.64 152.75 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 0.95 111.546 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.494 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 11.6 m120 -117.58 154.31 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 1.13 109.273 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 45.5 p90 -102.97 -11.55 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.492 -0.483 . . . . 3.74 110.252 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -75.26 169.5 17.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.821 -0.627 . . . . 1.62 111.022 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -85.89 171.72 45.15 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.867 -0.606 . . . . 1.16 111.889 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.64 128.58 36.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.961 0.41 . . . . 3.56 110.779 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 98.58 9.43 52.92 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.671 -0.695 . . . . 2.08 112.191 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -111.54 160.87 27.83 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.088 -0.338 . . . . 2.59 110.088 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.23 127.81 27.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.485 2.124 . . . . 1.36 111.165 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.09 110.3 1.02 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 3.4 111.517 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -117.28 115.23 24.86 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.001 -0.74 . . . . 2.47 109.001 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.3 135.0 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.267 0.556 . . . . 2.14 111.73 -172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.9 ttm -81.66 90.21 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.994 -1.003 . . . . 1.68 108.955 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.62 153.38 38.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.182 -0.463 . . . . 1.27 110.667 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.438 ' O ' ' HD1' ' A' ' 244' ' ' TRP . 16.7 t70 66.27 -88.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.36 1.037 . . . . 2.18 111.369 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.1 t30 47.67 43.19 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.55 0.531 . . . . 2.15 111.301 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 20.5 m95 -144.08 159.7 42.17 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.6 -0.687 . . . . 4.59 110.03 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.415 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 6.3 ptp180 -113.36 116.82 46.08 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.569 -0.53 . . . . 6.13 109.569 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.452 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 45.3 Cg_exo -52.96 -86.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.177 2.585 . . . . 3.28 114.826 -167.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.452 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -108.29 99.49 8.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.239 0.542 . . . . 2.98 112.188 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 26.5 mm-40 -110.65 173.64 2.78 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 107.869 -1.16 . . . . 4.32 107.869 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 52.7 Cg_exo -57.25 94.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.798 1.666 . . . . 3.48 111.129 172.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.61 ' HG ' ' N ' ' A' ' 251' ' ' LYS . 1.6 pt? -64.34 -56.96 10.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.764 -0.653 . . . . 4.63 111.452 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.621 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 62.6 mmtt -122.46 -10.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.934 -0.306 . . . . 5.34 111.229 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.93 -48.19 0.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.152 0.981 . . . . 4.64 111.844 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -89.17 -80.78 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 6.11 110.246 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -157.53 156.55 32.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.513 -0.551 . . . . 3.08 109.513 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 11.5 tt -112.8 148.72 15.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.637 0.256 . . . . 2.6 110.432 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.1 153.47 20.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.222 0.534 . . . . 2.63 111.158 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -131.01 171.44 13.23 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.153 -0.93 . . . . 1.71 109.032 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.5 p -163.46 98.8 0.91 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.985 0.421 . . . . 2.21 110.783 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.03 102.43 6.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.732 0.777 . . . . 4.31 109.963 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 17.1 pttm . . . . . 0 C--O 1.248 0.982 0 CA-C-N 115.007 -0.997 . . . . 4.49 110.226 -174.558 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.821 -0.437 . . . . 2.88 109.821 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 108' ' ' THR . 24.7 mm -71.41 128.24 34.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.981 0.896 . . . . 2.32 111.895 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 36' ' ' HIS . 23.0 t70 -43.98 156.13 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.367 -1.742 . . . . 2.82 114.083 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' THR . 13.3 t -55.69 19.35 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.618 1.967 . . . . 2.24 113.434 172.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.613 ' H ' ' C ' ' A' ' 34' ' ' ASP . 33.5 p-80 -47.33 1.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.171 1.789 . . . . 4.54 114.663 -176.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' THR . 2.6 m -72.28 27.81 0.05 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.613 0.765 . . . . 3.06 109.086 163.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 36' ' ' HIS . . . -56.79 164.85 1.36 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.733 1.213 . . . . 1.72 112.884 -163.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.94 139.92 50.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.805 -1.088 . . . . 3.69 110.845 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.475 ' HB2' ' H ' ' A' ' 259' ' ' PHE . 7.9 p90 -59.93 123.76 18.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.141 -0.936 . . . . 4.64 112.241 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -86.72 133.16 40.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 2.27 110.618 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.84 -14.17 11.31 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.803 2.336 . . . . 2.15 114.354 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.9 p -93.11 -2.46 55.44 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.577 -0.449 . . . . 4.29 111.063 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.29 154.53 17.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.237 -0.438 . . . . 4.74 110.3 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HE3' HD11 ' A' ' 47' ' ' LEU . 61.9 tttp -115.44 106.89 50.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 3.77 109.935 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 52.8 Cg_exo -56.1 120.07 7.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.614 2.21 . . . . 2.36 112.089 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' PRO . 12.7 mt -169.99 116.92 0.55 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.432 0.901 . . . . 2.55 113.432 -173.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.411 ' HB3' HD11 ' A' ' 79' ' ' LEU . 66.6 m -157.75 79.55 0.86 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.562 -0.903 . . . . 2.38 108.562 152.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.72 95.12 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.354 0.872 . . . . 1.59 113.354 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 39.7 m -142.23 85.44 1.92 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 121.439 1.927 . . . . 1.45 109.267 155.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -134.18 19.14 3.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.208 -0.308 . . . . 3.62 111.052 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.73 -28.61 68.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 2.48 111.381 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 39.2 mt-30 -110.0 13.7 23.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.354 . . . . 2.24 111.634 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.1 127.01 29.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.8 111.383 -174.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -116.09 115.24 25.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.213 -0.449 . . . . 1.06 110.875 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 176' ' ' THR . 5.6 m -84.34 153.54 23.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.196 -0.456 . . . . 1.26 109.795 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -117.73 -57.23 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.74 111.926 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -170.01 164.63 9.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 3.17 111.436 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.2 tt -127.08 143.84 39.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.436 -0.802 . . . . 0.64 109.874 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 172' ' ' SER . 20.6 tp -144.75 121.14 10.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.955 0.354 . . . . 0.96 111.955 -173.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -68.5 109.1 3.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.967 -0.56 . . . . 1.49 109.495 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -141.4 70.63 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.786 -0.766 . . . . 1.83 112.766 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.67 -65.1 0.33 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.765 -1.207 . . . . 1.64 112.879 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -128.39 -11.92 5.08 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.948 -0.301 . . . . 3.33 111.473 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.96 -173.2 3.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 1.38 110.986 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.52 88.41 2.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 2.74 108.881 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.09 114.39 15.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.473 -0.785 . . . . 1.76 110.285 -171.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 5.5 p -94.1 124.13 46.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.887 -0.597 . . . . 1.15 110.184 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.87 132.62 40.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.867 -0.606 . . . . 2.02 111.604 -174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.25 152.63 22.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.184 -0.916 . . . . 1.66 109.784 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.76 129.4 45.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 1.33 109.828 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.09 63.97 1.4 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.89 -1.05 . . . . 2.65 109.961 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 p -79.91 -3.21 47.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.368 -0.833 . . . . 1.61 110.54 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.484 ' OE1' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -154.28 177.69 10.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.053 -1.462 . . . . 2.35 107.053 175.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.9 79.06 0.21 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.247 0.476 . . . . 1.92 111.5 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HE2' ' OE1' ' A' ' 74' ' ' GLN . 61.4 mttm -102.49 -66.13 0.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.597 -0.274 . . . . 1.77 110.682 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.01 84.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.391 0.615 . . . . 0.76 110.06 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 50' ' ' SER . 17.8 m -115.25 150.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 1.27 110.467 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 48' ' ' SER . 28.6 tp -100.6 124.6 46.4 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.978 -0.555 . . . . 1.29 110.413 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -125.67 133.4 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.718 -0.845 . . . . 2.54 108.718 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' CB ' ' A' ' 47' ' ' LEU . . . -149.93 170.79 30.0 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 119.477 -0.624 . . . . 1.31 111.666 -170.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.36 -146.69 0.0 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 123.859 0.388 . . . . 1.9 113.161 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.39 119.81 6.43 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 121.564 1.51 . . . . 2.91 111.781 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.1 mt -157.01 -178.07 7.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.454 -0.794 . . . . 4.11 109.843 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -127.45 67.2 1.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.338 -0.392 . . . . 4.95 111.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.2 -170.59 14.23 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.635 -0.793 . . . . 2.25 112.904 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.539 ' O ' HG22 ' A' ' 125' ' ' THR . 30.7 m -105.65 134.97 47.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 1.91 110.162 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' A' ' 139' ' ' GLY . 33.1 m-85 -114.87 119.37 36.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 3.7 110.428 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HD3' ' CB ' ' A' ' 125' ' ' THR . 39.6 mtp180 -91.93 143.33 26.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.376 -0.375 . . . . 3.54 111.085 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 tt -88.61 128.84 35.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.642 -0.503 . . . . 1.14 109.642 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.441 HG23 ' HG2' ' A' ' 92' ' ' GLN . 13.1 tt -113.62 -34.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 1.68 110.509 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.546 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 5.3 pt20 -165.44 174.86 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 1.55 109.54 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 119' ' ' HIS . 42.6 p90 -155.32 156.64 35.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.86 110.712 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -147.2 161.15 41.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.93 109.346 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' A' ' 118' ' ' LEU . 69.1 m-85 -107.06 166.7 10.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 3.17 111.002 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -128.99 146.62 50.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.464 -1.68 . . . . 1.68 106.464 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 242' ' ' ASP . 8.3 m-90 -133.53 -169.66 2.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.434 0.561 . . . . 5.18 111.388 -170.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.42 24.99 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.721 -1.351 . . . . 2.13 109.721 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.1 t -70.89 -15.07 62.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.128 0.964 . . . . 2.9 110.478 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.2 mt -128.86 150.49 50.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.881 -0.785 . . . . 3.03 108.881 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.82 6.36 2.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.285 0.476 . . . . 3.85 112.285 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.35 24.78 6.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.509 -0.853 . . . . 1.94 112.455 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 18.0 pt20 -158.67 162.76 37.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.995 -0.372 . . . . 2.45 109.995 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.7 -18.91 16.7 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.316 -0.945 . . . . 1.47 112.281 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 99.2 p -69.02 -34.6 75.5 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.258 -0.177 . . . . 2.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 107' ' ' HIS . 1.0 OUTLIER 71.03 -173.13 0.17 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.426 -0.953 . . . . 3.72 108.426 -175.109 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.593 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 1.8 m-70 57.86 37.75 27.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.647 0.736 . . . . 3.52 109.723 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.603 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.3 123.46 29.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.669 -1.151 . . . . 2.52 112.404 -173.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.65 102.37 13.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.237 -0.892 . . . . 2.48 110.469 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.86 55.08 5.62 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.673 -0.694 . . . . 2.8 109.663 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 68.27 24.31 7.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.035 -0.984 . . . . 4.98 112.22 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -93.21 90.49 6.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 3.23 110.53 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.59 146.74 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 2.82 110.437 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 94.5 m-85 -100.77 -168.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.381 -0.372 . . . . 1.62 110.107 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.16 34.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.723 0.297 . . . . 1.03 111.725 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.84 168.24 21.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.387 -0.369 . . . . 0.75 110.5 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -124.29 151.89 43.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 1.58 109.485 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.531 HD13 ' CE2' ' A' ' 95' ' ' PHE . 57.3 tp -115.61 147.72 40.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.233 -0.284 . . . . 1.07 110.233 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 93' ' ' PHE . 1.6 t-160 -121.75 114.91 21.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.393 -0.595 . . . . 1.77 109.393 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.58 91.58 4.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.843 0.354 . . . . 0.93 110.12 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.649 ' HA ' ' HB1' ' A' ' 141' ' ' ALA . 46.6 t -65.68 117.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.365 0.602 . . . . 0.61 111.701 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 76.8 m80 -138.66 125.58 21.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.089 -1.078 . . . . 2.13 108.089 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.678 ' CD1' ' HB2' ' A' ' 130' ' ' PHE . 88.4 m95 -110.82 144.91 39.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.622 -0.431 . . . . 4.26 111.258 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.449 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 56.4 t30 -62.69 100.79 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.419 -0.81 . . . . 2.02 110.317 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 87' ' ' THR . 10.3 t -70.63 -24.34 62.71 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.065 0.765 . . . . 2.34 113.065 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -68.14 -5.14 16.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.429 0.529 . . . . 3.35 112.429 -174.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -95.42 17.49 14.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.788 0.804 . . . . 3.1 109.543 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.22 -3.58 10.45 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.491 -1.231 . . . . 2.37 115.786 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -173.5 145.19 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.577 1.189 . . . . 3.93 109.949 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.678 ' HB2' ' CD1' ' A' ' 123' ' ' TRP . 25.1 p90 -67.95 -43.12 79.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.854 -0.612 . . . . 3.0 111.705 -176.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.15 -28.81 73.43 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.072 -0.585 . . . . 2.15 112.182 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -81.27 -34.75 31.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.496 -0.557 . . . . 3.43 109.496 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.39 66.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.745 -0.661 . . . . 1.76 111.63 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 130' ' ' PHE . 42.1 t -60.05 -19.39 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.297 0.57 . . . . 2.77 110.764 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.34 16.73 22.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 3.55 110.655 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.83 118.49 44.68 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.815 0.341 . . . . 3.02 111.133 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.547 ' HA ' ' SG ' ' A' ' 205' ' ' CYS . 25.0 Cg_exo -64.18 -20.61 67.31 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.691 2.261 . . . . 1.6 111.965 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.04 28.39 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.992 0.738 . . . . 2.29 112.992 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . 128.34 94.49 0.8 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.827 -1.654 . . . . 1.22 114.609 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 20.8 mt -97.0 -175.85 3.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.914 -0.772 . . . . 1.57 108.914 167.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 121' ' ' VAL . . . -71.2 124.85 25.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.581 0.705 . . . . 1.38 110.372 -167.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.1 m -77.93 164.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.506 -1.225 . . . . 1.73 112.331 -167.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.7 tp -85.54 143.86 28.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.665 -1.152 . . . . 2.42 111.264 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 170.94 42.69 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.782 -1.099 . . . . 0.86 112.186 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 214' ' ' PRO . 11.2 mt -86.63 142.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.572 0.225 . . . . 0.76 110.76 -176.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -63.13 157.09 23.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 1.2 111.532 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.4 mp -113.01 137.46 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.88 110.686 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -129.76 143.41 50.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.95 -0.759 . . . . 2.03 108.95 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 24.1 t -108.66 81.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.312 -0.555 . . . . 1.27 112.281 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -165.95 67.17 0.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.377 -0.916 . . . . 1.53 112.342 165.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 19.3 t 157.95 126.43 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.541 -1.281 . . . . 1.54 107.541 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 138.45 41.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.74 -0.384 . . . . 0.78 110.671 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -104.89 98.41 15.31 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.474 -0.565 . . . . 1.22 109.474 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.59 -24.44 69.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.599 2.199 . . . . 1.05 112.719 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.2 6.55 79.14 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.865 -0.683 . . . . 0.7 113.104 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -110.67 -13.99 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.77 110.904 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.76 -36.53 76.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 1.41 111.518 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -49.18 -44.19 42.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.713 0.292 . . . . 2.86 111.165 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.21 -42.01 37.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 1.38 110.437 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 48.7 t -63.74 -39.58 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.813 -0.631 . . . . 1.11 111.576 -176.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -69.98 -24.31 63.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.712 0.291 . . . . 1.22 111.698 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.87 -11.91 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.001 0.371 . . . . 1.41 112.001 -174.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -65.74 -17.07 64.36 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.963 -0.46 . . . . 1.39 111.559 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.403 ' N ' HD12 ' A' ' 163' ' ' LEU . 16.7 m-20 -66.42 -28.06 68.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 2.31 110.727 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.2 m -84.36 0.14 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.387 -0.369 . . . . 1.4 111.387 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.455 ' CG1' ' HA ' ' A' ' 163' ' ' LEU . 18.6 pt -137.97 57.1 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.85 109.337 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -74.71 -40.23 61.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.828 -0.623 . . . . 1.59 111.367 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.7 p -115.97 158.0 23.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.982 0.42 . . . . 0.77 111.647 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.21 132.76 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 2.29 110.484 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.52 -22.28 26.76 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.551 -0.833 . . . . 0.85 111.726 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -87.62 142.04 28.15 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.197 0.522 . . . . 1.7 110.736 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 60' ' ' LEU . 6.7 p -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.227 -0.897 . . . . 1.37 110.368 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.26 134.32 32.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.548 -0.538 . . . . 0.61 109.548 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.28 133.68 44.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.069 0.462 . . . . 1.8 109.918 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -142.07 81.36 1.75 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.572 -0.74 . . . . 1.04 109.36 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 56' ' ' SER . 7.1 m -104.97 162.22 13.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.468 -0.333 . . . . 1.17 111.317 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.7 57.16 3.3 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.42 0.688 . . . . 1.77 111.989 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -126.76 132.25 51.12 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.531 -0.544 . . . . 3.99 109.531 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 5.3 p-10 -107.87 126.89 28.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.442 -0.345 . . . . 2.51 110.365 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 22.4 Cg_exo -66.42 -3.84 9.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.417 2.745 . . . . 1.26 113.333 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -58.98 -31.82 69.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 2.76 111.04 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.6 -30.58 72.97 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.141 -0.552 . . . . 1.12 112.361 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.3 mt -72.7 -34.33 67.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.014 0.435 . . . . 1.73 110.334 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 mt -71.43 118.75 68.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 3.45 110.51 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 8.9 Cg_exo -73.9 -165.19 0.24 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.028 2.485 . . . . 2.08 113.289 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.92 -61.97 1.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.278 0.473 . . . . 3.23 112.278 -173.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.457 ' HB2' ' CG ' ' A' ' 213' ' ' GLU . 34.7 m -75.45 129.43 37.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 1.66 110.514 -176.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 46' ' ' PRO . 39.6 tp -105.43 63.43 0.69 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.016 -0.538 . . . . 1.99 110.082 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 21.9 m-20 -109.95 145.64 36.57 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.374 -0.973 . . . . 1.81 108.374 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -136.47 149.27 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.607 -0.837 . . . . 5.01 112.936 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.573 ' HB3' ' CG2' ' A' ' 255' ' ' ILE . 6.8 m-90 -93.78 141.68 28.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.49 -1.232 . . . . 3.93 108.445 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.9 t -136.8 109.92 7.76 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.456 0.646 . . . . 2.13 112.498 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.562 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 54.9 t80 -139.22 138.21 20.42 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.627 -0.715 . . . . 5.21 110.506 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 48.7 Cg_exo -57.47 128.49 29.61 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.315 2.01 . . . . 2.12 111.494 172.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 208' ' ' TRP . . . -122.52 157.22 17.14 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.961 -0.637 . . . . 1.75 113.456 -171.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 13.5 m . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 2.99 109.733 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 196' ' ' SER . 16.2 tp . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 109.616 -0.513 . . . . 2.96 109.616 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.85 28.11 8.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.193 0.521 . . . . 3.37 111.076 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 137' ' ' PRO . 68.3 m -80.06 -4.8 54.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.822 -0.626 . . . . 2.15 111.446 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 48.4 t -90.18 137.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.383 -0.229 . . . . 1.26 110.383 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.2 m -105.5 102.59 12.05 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.885 -0.413 . . . . 2.08 109.885 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.548 ' O ' ' HA ' ' A' ' 192' ' ' THR . 43.2 m0 -72.19 100.84 2.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.245 -0.28 . . . . 5.53 110.245 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 65.6 mt -105.51 99.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.211 -0.663 . . . . 1.63 109.211 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.6 t -111.21 122.46 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.244 -0.435 . . . . 1.62 110.67 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 3.7 mm? -69.28 134.09 48.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.328 0.585 . . . . 1.73 110.127 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.562 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 32.6 ttpt -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.676 -1.147 . . . . 2.98 111.509 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.457 ' CG ' ' HB2' ' A' ' 187' ' ' SER . 22.2 mm-40 -76.27 110.92 12.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 1.47 110.795 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 145' ' ' ILE . 61.3 Cg_endo -74.91 154.19 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.623 2.216 . . . . 0.96 112.025 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.15 110.94 10.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.103 -0.499 . . . . 1.25 109.902 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.525 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 79.2 p -93.18 118.66 31.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.741 -0.466 . . . . 1.29 109.741 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 30.8 m -120.98 157.78 23.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.02 110.539 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.3 t -90.58 157.96 17.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.071 -0.513 . . . . 1.08 109.978 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.672 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 20.3 m -55.09 -46.59 75.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 1.33 110.732 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -52.65 -34.87 53.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 2.51 111.603 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -71.14 -50.11 36.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.7 110.203 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -71.88 -22.48 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.839 0.311 . . . . 1.36 111.839 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 219' ' ' SER . 83.0 mt -64.48 -43.83 92.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.81 -0.441 . . . . 1.03 109.81 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.446 ' HB3' HD11 ' A' ' 163' ' ' LEU . 67.4 mttm -68.72 -29.56 68.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 1.75 111.382 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.62 -30.37 64.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.53 . . . . 2.47 109.907 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -80.06 -2.68 45.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.741 -0.663 . . . . 3.04 110.346 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 33.4 mmtp -90.41 -6.52 54.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 2.31 110.064 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.61 146.68 26.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.887 -0.597 . . . . 0.95 110.807 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.588 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.8 m120 -118.79 125.83 50.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.659 -0.701 . . . . 1.13 109.521 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -78.76 -7.74 58.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 3.74 111.38 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.588 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.2 p-10 -77.58 162.71 26.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.831 0.348 . . . . 1.62 110.236 171.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.8 159.89 36.73 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.098 -0.801 . . . . 1.16 111.098 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.86 134.27 56.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 3.56 110.957 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.67 11.61 70.77 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.776 -0.647 . . . . 2.08 112.922 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -112.93 158.61 37.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.69 -0.485 . . . . 2.59 109.69 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.55 122.81 11.5 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.593 2.196 . . . . 1.36 111.819 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 120.18 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.381 -0.827 . . . . 3.4 112.383 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -127.82 136.55 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.329 -0.989 . . . . 2.47 108.329 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.12 133.38 33.63 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.758 -0.46 . . . . 2.14 109.758 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 51.8 ttm -75.12 88.28 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.099 0.476 . . . . 1.68 109.757 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.15 167.36 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.861 -0.792 . . . . 1.27 108.861 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' TRP . 0.7 OUTLIER 61.75 -90.85 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.402 0.439 . . . . 2.18 110.814 -174.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 43.13 45.8 4.82 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.271 0.558 . . . . 2.15 111.923 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.442 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 60.9 t-105 -153.14 153.06 32.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.331 -0.85 . . . . 4.59 108.979 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -100.58 130.35 25.75 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.089 -0.337 . . . . 6.13 110.089 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.27 53.33 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.769 2.313 . . . . 3.28 111.937 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -114.14 121.79 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.401 -0.818 . . . . 2.98 109.978 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 33' ' ' ILE . 27.9 mp0 -90.3 152.43 45.69 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.226 -0.443 . . . . 4.32 110.84 -176.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.69 141.67 15.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.598 2.866 . . . . 3.48 112.807 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 251' ' ' LYS . 0.6 OUTLIER -40.59 -55.78 2.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.976 -1.011 . . . . 4.63 113.699 -171.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.546 ' N ' HD12 ' A' ' 250' ' ' LEU . 69.6 mmtt -114.33 -4.96 12.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.95 0.352 . . . . 5.34 111.95 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.1 p30 34.22 65.52 0.31 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.132 0.895 . . . . 4.64 112.345 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -70.85 -90.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.85 -0.34 . . . . 6.11 111.08 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -159.64 154.97 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.178 -0.675 . . . . 3.08 109.178 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.573 ' CG2' ' HB3' ' A' ' 191' ' ' TRP . 13.7 mt -118.78 113.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.159 -0.311 . . . . 2.6 110.159 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 62.3 pttt -76.85 165.76 24.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 2.63 110.706 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 191' ' ' TRP . . . -126.0 168.54 13.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 1.71 109.975 -175.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.9 p -138.07 95.99 3.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.201 0.524 . . . . 2.21 111.242 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.475 ' H ' ' HB2' ' A' ' 40' ' ' TYR . 49.9 t80 -136.91 119.06 15.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 4.31 110.304 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.612 -0.708 . . . . 4.49 109.577 175.601 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 107.951 -1.129 . . . . 2.88 107.951 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 59.9 mt -82.99 85.1 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.543 0.687 . . . . 2.32 109.381 -176.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -102.08 112.19 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.188 -0.914 . . . . 2.82 110.397 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m -54.85 -31.67 59.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 2.24 112.643 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -74.67 -38.6 62.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.126 0.488 . . . . 4.54 110.421 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 m -79.13 -29.26 43.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.737 -0.665 . . . . 3.06 111.083 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.22 116.2 6.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.72 110.695 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -92.42 129.49 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.146 -0.479 . . . . 3.69 109.921 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.3 p90 -63.2 121.91 14.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 4.64 110.256 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 19.7 t70 -105.65 125.78 32.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.54 -0.755 . . . . 2.27 109.397 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.448 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 15.5 Cg_exo -69.82 60.1 1.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.64 2.227 . . . . 2.15 111.789 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 m -63.5 -17.45 62.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 4.29 111.713 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 42' ' ' PRO . 80.5 mt 61.56 -86.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.394 0.677 . . . . 4.74 112.386 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 46' ' ' PRO . 85.7 tttt -65.66 130.79 94.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.916 0.389 . . . . 3.77 111.517 -175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 56.9 Cg_endo -71.2 171.01 16.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.819 2.346 . . . . 2.36 111.23 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.78 131.43 40.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.734 -0.469 . . . . 2.55 109.734 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.4 m -108.78 115.12 29.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.949 -0.389 . . . . 2.38 109.949 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 22.0 t -123.0 110.77 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 1.59 110.286 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.0 m -92.18 90.28 7.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.525 -0.546 . . . . 1.45 109.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.0 9.84 38.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 3.62 111.556 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.05 -37.03 81.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 2.48 111.047 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -97.26 27.05 4.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.293 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.33 56.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.146 0.498 . . . . 0.8 112.057 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -146.87 106.03 3.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.828 -0.624 . . . . 1.06 110.178 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.3 p -89.01 158.8 17.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.488 -0.56 . . . . 1.26 109.488 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.17 -56.68 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.178 0.436 . . . . 0.74 112.178 -173.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.57 157.75 32.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.909 -0.317 . . . . 3.17 110.728 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -114.26 136.99 49.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 0.64 109.348 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 172' ' ' SER . 64.9 tp -132.55 146.55 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.171 0.51 . . . . 0.96 111.306 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.1 111.54 24.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.591 -0.732 . . . . 1.49 109.354 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 HD23 ' A' ' 60' ' ' LEU . 55.3 m-80 -109.44 67.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.385 -0.526 . . . . 1.83 110.487 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.91 -51.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.752 0 O-C-N 124.808 1.317 . . . . 1.64 115.477 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -106.44 -26.46 11.43 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 122.487 0.315 . . . . 3.33 110.623 -172.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.68 171.38 16.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.562 -0.29 . . . . 1.38 110.51 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 95' ' ' PHE . 13.1 p90 -130.24 114.55 15.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.143 -0.688 . . . . 2.74 109.143 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -116.89 145.6 43.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.76 111.562 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.13 119.33 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 1.15 109.445 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.93 125.64 29.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.804 -0.634 . . . . 2.02 110.049 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -105.69 151.2 24.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.703 -0.68 . . . . 1.66 109.242 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -83.49 106.35 15.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.745 0.307 . . . . 1.33 110.33 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -124.36 57.44 1.24 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.982 0.896 . . . . 2.65 110.594 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -92.98 -5.28 51.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.185 -0.916 . . . . 1.61 109.327 169.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -158.72 169.82 23.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.878 -1.056 . . . . 2.35 108.757 -178.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -78.17 72.71 4.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 1.92 111.17 -174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 65.6 mttm -81.1 -53.25 6.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.986 -0.552 . . . . 1.77 110.458 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -119.75 112.18 18.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.096 -0.502 . . . . 0.76 110.09 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 91.8 t -113.4 137.04 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.632 -0.713 . . . . 1.27 110.496 -176.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tt -129.19 113.6 15.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.134 -0.321 . . . . 1.29 110.134 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -147.84 125.01 11.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 2.54 110.457 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.93 -177.77 19.62 Favored Glycine 0 C--O 1.219 -0.793 0 CA-C-O 118.937 -0.924 . . . . 1.31 111.151 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.83 -130.18 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 O-C-N 124.971 1.041 . . . . 1.9 115.498 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.61 169.49 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.68 2.92 . . . . 2.91 114.217 -170.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -31.07 102.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.268 1.509 . . . . 4.11 114.879 -147.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 8.4 p-10 -107.03 -100.9 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.19 -1.823 . . . . 4.95 112.793 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.561 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 94.05 152.73 29.62 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.385 -1.086 . . . . 2.25 110.385 -165.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.629 ' HB ' ' OG1' ' A' ' 125' ' ' THR . 14.5 m -69.67 113.9 7.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.932 0.866 . . . . 1.91 110.819 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.633 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 55.8 m-85 -110.19 107.12 16.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.365 . . . . 3.7 111.654 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 97.5 mtt180 -75.91 137.88 40.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 3.54 110.992 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.75 125.55 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.505 -0.554 . . . . 1.14 109.505 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 92' ' ' GLN . 4.5 tt -111.57 -38.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.952 0.406 . . . . 1.68 110.973 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 91' ' ' ILE . 24.8 pt20 -164.98 158.34 16.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.7 -0.482 . . . . 1.55 109.7 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.86 140.69 24.79 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.163 -0.31 . . . . 0.86 110.163 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -135.21 157.63 46.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.412 -0.358 . . . . 0.93 110.654 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 54.6 m-85 -113.77 169.16 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 3.17 110.495 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.422 ' CG ' ' HE1' ' A' ' 244' ' ' TRP . 0.3 OUTLIER -137.63 173.1 12.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.087 -0.708 . . . . 1.68 109.087 174.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.475 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 30.8 t-105 -151.33 127.03 10.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.857 -0.423 . . . . 5.18 109.857 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -94.24 140.85 15.25 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.093 -0.575 . . . . 2.13 112.255 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 t -46.82 -43.51 18.53 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.641 0.376 . . . . 2.9 111.863 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 103' ' ' GLN . 45.1 mt -122.78 152.71 40.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.532 -0.544 . . . . 3.03 109.532 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.05 -7.4 3.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.818 -0.628 . . . . 3.85 112.187 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.76 29.56 2.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.76 . . . . 1.94 112.505 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 7.6 tp60 -159.44 139.88 12.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.925 0.363 . . . . 2.45 110.873 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.579 ' O ' ' HB2' ' A' ' 244' ' ' TRP . . . 94.57 -28.99 9.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.861 -0.685 . . . . 1.47 112.402 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.457 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 1.2 m -89.55 -17.9 27.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.469 0.176 . . . . 2.0 111.127 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 60.02 -156.75 0.34 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.388 -0.369 . . . . 3.72 110.689 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.458 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 62.6 m80 63.33 69.37 0.57 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.381 -0.6 . . . . 3.52 109.381 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.436 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 5.6 t -104.09 118.38 36.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.113 0.482 . . . . 2.52 110.53 -167.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 41.0 t -85.54 105.65 14.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.365 -0.976 . . . . 2.48 108.365 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 66.88 -71.53 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.67 0.606 . . . . 2.8 110.652 -171.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -152.05 19.12 0.67 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 4.98 110.605 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 108' ' ' THR . 13.9 mmmm -107.75 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.018 -0.537 . . . . 3.23 111.553 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.436 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 54.4 mttm -80.31 156.19 26.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.91 . . . . 2.82 108.544 171.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -93.43 -171.29 2.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.8 0.333 . . . . 1.62 111.189 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.41 -27.36 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 1.03 111.752 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 147' ' ' LEU . . . -153.25 168.74 25.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.617 0.246 . . . . 0.75 110.533 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HG2' ' CE1' ' A' ' 107' ' ' HIS . 13.7 tp10 -151.8 152.6 32.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.372 -0.603 . . . . 1.58 109.372 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 95' ' ' PHE . 38.2 tp -125.79 131.38 52.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.712 0.291 . . . . 1.07 110.963 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 107.72 14.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.77 110.705 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.1 mp -102.22 109.55 21.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.105 -0.332 . . . . 0.93 110.105 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.02 129.22 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.188 -0.46 . . . . 0.61 111.49 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 19.0 m-70 -127.39 156.32 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 2.13 109.63 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.415 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 66.1 p-90 -127.49 150.51 49.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 4.26 111.554 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 19.6 t30 -69.21 116.45 9.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.064 -0.971 . . . . 2.02 111.811 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.629 ' OG1' ' HB ' ' A' ' 87' ' ' THR . 53.2 p -63.16 -32.79 74.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.655 0.983 . . . . 2.34 113.655 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 60.9 pttt -74.28 -4.56 36.88 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.338 -0.545 . . . . 3.35 111.923 -173.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -91.42 -5.65 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.34 0.59 . . . . 3.1 109.546 170.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.9 19.32 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 115.569 0.987 . . . . 2.37 115.569 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -177.91 133.13 0.16 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.883 0.841 . . . . 3.93 109.802 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.601 ' O ' HG23 ' A' ' 134' ' ' VAL . 40.3 p90 -66.33 -42.97 87.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.633 . . . . 3.0 111.345 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.27 -33.25 86.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.108 -0.568 . . . . 2.15 112.231 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB3' ' CE1' ' A' ' 127' ' ' TYR . 98.1 mttt -74.28 -34.11 63.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.027 -0.36 . . . . 3.43 110.027 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.35 66.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 1.76 110.765 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 130' ' ' PHE . 42.0 t -63.53 -18.25 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.203 0.525 . . . . 2.77 110.761 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.68 -9.62 53.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.126 -0.359 . . . . 3.55 111.178 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 205' ' ' CYS . 7.6 tt0 -104.41 126.44 31.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.232 -0.284 . . . . 3.02 110.232 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 73.1 Cg_exo -52.79 -31.2 50.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.548 2.832 . . . . 1.6 113.12 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.4 m-20 -112.14 28.15 9.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.185 0.517 . . . . 2.29 109.848 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.03 -30.91 24.55 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.826 -0.625 . . . . 1.22 113.408 -172.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 206' ' ' VAL . 91.3 mt -112.21 157.58 20.72 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.574 -0.368 . . . . 1.57 110.3 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.57 123.16 10.45 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.814 -0.439 . . . . 1.38 109.814 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.88 129.88 71.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 116.292 -0.413 . . . . 1.73 110.012 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 209' ' ' ILE . 35.8 tp -90.99 134.24 34.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 2.42 109.835 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -115.41 145.77 18.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.069 -0.586 . . . . 0.86 112.018 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 118' ' ' LEU . 62.4 mt -142.48 122.75 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.528 -0.545 . . . . 0.76 109.528 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.458 ' CZ ' HG11 ' A' ' 210' ' ' VAL . 44.2 m-85 -73.99 141.07 45.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.694 0.283 . . . . 1.2 111.032 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 9.0 mp -119.2 121.22 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 0.88 110.041 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.82 147.74 41.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.109 -0.496 . . . . 2.03 109.798 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 62.1 t -87.07 130.16 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.901 0.381 . . . . 1.27 110.863 -174.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.11 -105.29 0.19 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.291 -0.724 . . . . 1.53 111.291 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.2 t -81.89 146.18 29.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 1.54 109.521 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.472 ' CA ' ' HB2' ' A' ' 218' ' ' SER . . . -66.62 152.12 45.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.183 0.515 . . . . 0.78 112.222 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -109.39 102.99 51.56 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.335 -0.848 . . . . 1.22 108.735 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.55 -32.93 65.99 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 123.095 2.53 . . . . 1.05 112.835 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.18 -15.95 72.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.094 -0.574 . . . . 0.7 113.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.3 tp -99.62 -9.03 23.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.346 0.593 . . . . 0.77 110.298 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -45.49 88.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.502 -0.772 . . . . 1.41 112.19 -173.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.0 ptmm? -76.68 -27.89 55.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.433 -0.507 . . . . 2.86 111.813 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.37 -40.34 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.495 -0.482 . . . . 1.38 111.316 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.494 ' HA ' ' HG ' ' A' ' 163' ' ' LEU . 34.5 m -62.45 -28.74 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.197 0.522 . . . . 1.11 110.671 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.83 -30.55 71.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.556 -0.747 . . . . 1.22 111.173 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 158' ' ' LYS . 41.2 t -89.31 -16.33 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.41 111.269 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 77.0 mt -56.05 -31.8 63.49 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.229 0.455 . . . . 1.39 112.229 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.88 -30.12 70.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.78 0.324 . . . . 2.31 111.476 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.9 m -84.46 -3.15 58.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.567 -0.288 . . . . 1.4 111.769 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 44.5 pt -132.89 29.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.528 0.68 . . . . 0.85 109.312 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -60.06 -27.66 67.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.95 -1.023 . . . . 1.59 112.075 -172.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.8 p -119.54 152.97 36.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.77 111.598 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -54.39 127.94 29.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.064 -0.971 . . . . 2.29 111.648 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.18 -22.27 31.57 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.588 -0.815 . . . . 0.85 112.849 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -78.56 139.76 38.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.159 0.504 . . . . 1.7 111.307 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB2' HD13 ' A' ' 60' ' ' LEU . 27.4 t -127.06 146.56 50.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.178 -0.919 . . . . 1.37 109.39 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.38 127.08 23.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.438 -0.346 . . . . 0.61 110.08 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.7 132.03 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.501 . . . . 1.8 110.45 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.89 80.99 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.845 -0.616 . . . . 1.04 109.596 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 p -102.81 161.16 13.97 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.116 -0.493 . . . . 1.17 111.824 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 12.9 m120 57.04 66.71 1.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.569 -0.742 . . . . 1.77 111.546 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -119.86 139.18 52.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 3.99 110.191 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.509 ' OD1' ' HB3' ' A' ' 181' ' ' ARG . 17.1 t0 -102.0 106.77 49.45 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 2.51 110.938 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.48 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 23.6 Cg_exo -64.81 -15.08 48.5 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.008 2.472 . . . . 1.26 111.924 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.509 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 29.2 ttp180 -68.78 -21.88 64.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.655 -0.702 . . . . 2.76 110.345 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -77.67 -8.8 87.18 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.774 -0.726 . . . . 1.12 111.855 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 97.0 mt -106.11 -18.26 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.997 0.427 . . . . 1.73 109.884 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 83.3 mt -73.28 126.34 90.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 3.45 110.028 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 59.8 Cg_endo -69.73 -176.28 1.43 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.438 2.758 . . . . 2.08 113.637 -173.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.77 -50.48 64.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.297 -0.411 . . . . 3.23 111.879 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 15.4 m -88.68 136.79 32.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.75 0.31 . . . . 1.66 110.367 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.2 tp -106.09 64.73 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.706 . . . . 1.99 109.893 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.41 -176.32 3.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.953 -1.128 . . . . 1.81 107.953 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -163.52 154.33 16.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.886 0.766 . . . . 5.01 112.855 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -115.29 146.6 41.34 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.827 -1.175 . . . . 3.93 107.827 170.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -108.71 126.84 53.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.096 0.474 . . . . 2.13 111.126 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -133.17 154.08 81.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 5.21 109.989 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.31 129.82 15.45 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.404 2.069 . . . . 2.12 111.77 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -101.79 97.48 1.61 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.792 -0.718 . . . . 1.75 111.455 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 15.7 m . . . . . 0 C--N 1.319 -0.742 0 N-CA-C 112.91 0.707 . . . . 2.99 112.91 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.653 HD13 ' SG ' ' A' ' 205' ' ' CYS . 1.9 pp . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.798 0.333 . . . . 2.96 111.659 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 196' ' ' SER . 7.9 pt-20 -87.79 92.67 9.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.555 0.693 . . . . 3.37 111.083 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.653 ' SG ' HD13 ' A' ' 203' ' ' LEU . 93.9 m -138.83 32.84 2.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.804 -0.635 . . . . 2.15 110.709 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 140' ' ' LEU . 95.3 t -125.63 149.05 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.732 -0.667 . . . . 1.26 111.187 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.1 m -111.68 107.12 16.12 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.083 -1.08 . . . . 2.08 108.083 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -89.23 115.65 26.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.153 0.501 . . . . 5.53 110.333 -174.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.524 ' O ' HD12 ' A' ' 143' ' ' LEU . 63.5 mt -114.57 116.59 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.603 -0.726 . . . . 1.63 109.68 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.458 HG11 ' CZ ' ' A' ' 146' ' ' PHE . 24.3 t -109.71 129.8 63.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.253 -0.277 . . . . 1.62 110.253 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.73 126.44 29.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.818 0.342 . . . . 1.73 110.555 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -47.5 -24.16 0.78 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.561 0.948 . . . . 2.98 113.561 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 8.6 tp10 -106.81 123.7 37.76 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.644 0.259 . . . . 1.47 110.569 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 89.9 Cg_endo -81.77 158.63 18.77 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.671 2.248 . . . . 0.96 112.01 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 41.7 pt -113.97 154.35 15.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.844 0.354 . . . . 1.25 110.326 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.3 m -104.17 130.43 51.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.844 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 18.6 m -125.34 151.17 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.058 -0.719 . . . . 1.02 109.058 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.472 ' HB2' ' CA ' ' A' ' 152' ' ' ALA . 7.5 t -95.2 161.23 14.2 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.449 -0.501 . . . . 1.08 111.164 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.69 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 3.1 p -52.55 -47.18 66.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.32 -0.4 . . . . 1.33 111.658 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -52.6 -33.93 48.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.983 0.421 . . . . 2.51 111.382 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -78.48 -50.68 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 0.7 110.517 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.475 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 27.2 m -67.67 -23.53 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 1.36 111.653 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 219' ' ' SER . 84.7 mt -61.31 -33.39 73.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 1.03 110.717 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -74.76 -23.26 58.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 1.75 110.843 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 29.5 m-85 -68.88 -39.58 79.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.231 0.539 . . . . 2.47 109.802 174.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -76.08 -2.03 28.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.419 -0.81 . . . . 3.04 110.825 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 34.3 mmtp -91.88 -12.62 33.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.409 -0.359 . . . . 2.31 110.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 163' ' ' LEU . 90.4 mt -73.03 151.4 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 0.95 110.731 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.585 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 9.4 m120 -123.69 127.26 47.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.821 -0.627 . . . . 1.13 110.259 -175.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 65.4 m-85 -57.94 -33.62 69.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.767 -0.652 . . . . 3.74 111.004 173.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -72.69 164.19 26.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 1.62 111.884 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.73 171.75 43.56 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.536 -0.756 . . . . 1.16 111.309 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.91 123.27 17.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.994 0.426 . . . . 3.56 110.645 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 91.05 25.1 25.4 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.807 -0.633 . . . . 2.08 112.52 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 62.2 mt-10 -124.55 161.85 45.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.036 -0.357 . . . . 2.59 110.036 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 9.9 Cg_endo -52.15 123.06 11.74 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.164 2.576 . . . . 1.36 112.411 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.15 113.72 1.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.477 -0.783 . . . . 3.4 112.275 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -115.99 102.88 10.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.804 -0.813 . . . . 2.47 108.804 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.34 138.02 56.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.166 0.508 . . . . 2.14 111.332 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.637 ' HA ' ' CE1' ' A' ' 230' ' ' PHE . 50.4 ttm -79.1 90.77 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.166 -0.925 . . . . 1.68 110.54 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.9 m -124.44 153.31 30.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.19 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.477 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 76.7 m-20 72.04 -80.24 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.133 0.896 . . . . 2.18 109.678 -176.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 56.34 27.72 12.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.073 0.463 . . . . 2.15 111.393 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.579 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 26.8 m95 -142.37 156.67 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 4.59 110.597 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -106.4 137.75 19.52 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.477 -0.783 . . . . 6.13 109.803 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.86 146.14 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.069 3.179 . . . . 3.28 113.667 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.36 151.48 46.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.068 -0.969 . . . . 2.98 110.781 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.542 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 86.9 mm-40 -94.76 170.6 7.8 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.473 -0.785 . . . . 4.32 110.079 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 74.8 Cg_exo -44.05 143.21 3.4 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.415 2.076 . . . . 3.48 112.461 176.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.54 -38.45 55.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.03 -0.986 . . . . 4.63 109.749 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 253' ' ' ARG . 21.0 pttm -64.88 -14.8 60.79 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 115.209 1.559 . . . . 5.34 115.209 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.5 t30 24.58 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.783 2.512 . . . . 4.64 117.783 151.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 251' ' ' LYS . 15.5 tpp180 166.28 -125.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.912 -1.514 . . . . 6.11 106.912 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -127.48 133.95 49.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 3.08 109.88 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.6 131.06 35.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.83 -0.433 . . . . 2.6 109.83 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -120.7 133.21 55.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.115 -0.493 . . . . 2.63 110.898 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -143.82 129.41 19.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.246 -0.649 . . . . 1.71 109.246 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 p -92.23 97.6 10.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.827 -0.749 . . . . 2.21 111.172 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -126.01 92.4 3.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.683 0.754 . . . . 4.31 110.259 167.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.346 -0.843 . . . . 4.49 110.259 178.931 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.564 ' HB3' HD11 ' A' ' 250' ' ' LEU . 24.2 t70 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 122.054 0.93 . . . . 2.88 111.647 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 85.4 mt -102.82 141.79 18.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.33 -1.305 . . . . 2.32 109.918 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 19.3 t70 -120.93 121.62 38.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.827 0.346 . . . . 2.82 110.166 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -69.07 -28.77 66.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 2.24 112.054 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 35.1 m80 -60.54 -43.35 97.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.324 0.583 . . . . 4.54 110.314 173.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -71.98 -21.42 61.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.288 -0.869 . . . . 3.06 110.007 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' A' ' 257' ' ' ALA . . . -74.82 98.78 3.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.5 -0.773 . . . . 1.72 110.55 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -72.11 126.33 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.941 -0.572 . . . . 3.69 109.653 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 51.1 p90 -82.64 131.49 35.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 4.64 110.336 -172.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.14 138.74 26.57 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.821 -0.627 . . . . 2.27 110.005 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.81 13.2 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.223 2.615 . . . . 2.15 114.064 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -60.45 -52.48 65.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 4.29 109.899 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.1 mt 53.08 13.78 0.41 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.583 0.957 . . . . 4.74 113.583 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HD3' ' HD2' ' A' ' 46' ' ' PRO . 16.2 tppt? -56.72 111.55 3.44 Favored Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 123.408 0.443 . . . . 3.77 111.887 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 84.9 Cg_endo -87.33 157.3 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.919 2.413 . . . . 2.36 111.99 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -83.1 154.48 24.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.047 -0.524 . . . . 2.55 110.369 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 38.5 t -129.62 131.02 46.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.295 -0.631 . . . . 2.38 109.295 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.89 137.37 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 1.59 111.433 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 47.7 m -127.75 90.94 3.19 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.033 -0.728 . . . . 1.45 109.033 171.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -133.03 16.42 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.879 -0.328 . . . . 3.62 111.883 -176.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.14 -22.04 64.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.966 0.413 . . . . 2.48 110.951 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.03 3.72 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 2.24 111.228 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.84 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.187 0.517 . . . . 0.8 111.853 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.8 m -98.62 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.064 -0.516 . . . . 1.06 110.506 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 5.3 p -81.24 149.67 28.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 1.26 110.494 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.1 mt -115.85 -49.71 2.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.071 0.462 . . . . 0.74 110.844 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -160.59 161.96 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.026 -0.534 . . . . 3.17 110.726 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.09 133.75 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.941 -0.762 . . . . 0.64 108.941 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 171' ' ' LYS . 53.3 tp -129.34 131.21 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.975 0.417 . . . . 0.96 111.408 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -80.81 109.3 15.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.742 -0.663 . . . . 1.49 109.355 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.91 68.89 0.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.968 0.413 . . . . 1.83 110.166 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.33 -53.58 0.09 OUTLIER Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.279 -1.328 . . . . 1.64 115.208 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -110.1 -19.86 12.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.788 0.328 . . . . 3.33 111.32 -169.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.96 177.61 10.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 1.38 110.247 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.705 ' CE1' HD13 ' A' ' 228' ' ' LEU . 29.2 m-85 -117.38 112.84 21.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.304 -0.628 . . . . 2.74 109.304 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.4 m120 -90.72 105.2 17.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.47 . . . . 1.76 110.783 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 60.1 t -82.26 105.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.752 -0.833 . . . . 1.15 108.752 171.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.12 132.47 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.016 -0.538 . . . . 2.02 111.084 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 75.8 m-85 -112.02 155.74 23.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.462 -0.79 . . . . 1.66 109.032 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.14 110.39 15.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.933 0.397 . . . . 1.33 110.559 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -107.06 55.18 0.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.712 0.768 . . . . 2.65 109.939 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -96.94 -5.85 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.758 . . . . 1.61 110.771 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -154.03 166.63 32.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.372 -0.831 . . . . 2.35 109.18 178.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.91 36.74 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.36 0.504 . . . . 1.92 112.36 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 92.6 mttt -55.48 -63.58 1.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.246 -0.434 . . . . 1.77 110.656 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -103.55 115.96 31.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.872 -0.604 . . . . 0.76 110.341 -177.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.9 t -134.51 141.96 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.808 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . 58.6 tp -105.61 128.33 53.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.338 -0.616 . . . . 1.29 109.338 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 55.8 mtpt -119.92 124.76 46.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.244 0.545 . . . . 2.54 110.24 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.77 170.99 19.83 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.789 -0.924 . . . . 1.31 110.789 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.71 -148.95 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 O-C-N 123.657 0.269 . . . . 1.9 113.539 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.43 119.03 5.26 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 121.569 1.512 . . . . 2.91 112.451 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -159.66 -171.14 3.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.078 -0.965 . . . . 4.11 108.938 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -132.89 76.95 1.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.751 -0.38 . . . . 4.95 111.714 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.7 -178.68 17.29 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.247 -0.977 . . . . 2.25 114.206 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 m -105.76 120.1 40.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.859 -0.671 . . . . 1.91 109.363 176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 32.2 m-85 -105.41 104.79 14.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 3.7 111.436 -171.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 99.4 mtt180 -75.37 152.62 38.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.099 -0.5 . . . . 3.54 110.314 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.9 120.43 24.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.974 -0.38 . . . . 1.14 109.974 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.0 tt -110.26 -34.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.447 -0.342 . . . . 1.68 111.02 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 7.2 pt20 -173.86 174.52 3.04 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.661 -0.496 . . . . 1.55 109.661 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 20.4 p90 -147.09 161.65 40.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.861 -0.336 . . . . 0.86 111.02 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.7 p-80 -147.46 160.11 42.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -125.11 172.79 9.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.774 0.321 . . . . 3.17 110.899 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -127.24 117.14 21.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.712 -1.218 . . . . 1.68 107.712 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.58 ' NE1' ' HA ' ' A' ' 99' ' ' SER . 60.3 t-105 -101.49 112.33 24.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.778 0.323 . . . . 5.18 110.694 -173.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -63.32 -39.07 97.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.629 -0.714 . . . . 2.13 112.497 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.58 ' HA ' ' NE1' ' A' ' 97' ' ' TRP . 32.5 t 91.56 -17.92 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.266 1.026 . . . . 2.9 110.178 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 92.4 mt -112.57 137.85 50.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.134 -1.062 . . . . 3.03 108.134 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.21 -24.96 65.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.652 0.982 . . . . 3.85 113.652 -168.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.99 7.53 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.914 -1.136 . . . . 1.94 113.863 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.425 ' HG3' ' HB2' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -165.99 152.58 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.383 0.591 . . . . 2.45 111.023 176.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.484 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 122.89 -27.27 5.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.64 -0.791 . . . . 1.47 112.692 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 114' ' ' TYR . 39.2 t -71.29 -46.98 59.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.464 0.172 . . . . 2.0 111.464 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 61.46 -172.66 0.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.937 0.347 . . . . 3.72 111.937 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.9 m80 56.48 30.21 16.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.957 0.884 . . . . 3.52 108.664 -166.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 108' ' ' THR . 2.0 t -83.13 153.6 24.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.997 -1.456 . . . . 2.52 113.122 -169.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.0 m -101.52 93.45 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.397 -0.82 . . . . 2.48 111.382 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.64 71.55 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.039 -0.982 . . . . 2.8 111.329 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 59.41 21.29 9.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.091 -0.958 . . . . 4.98 113.417 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -97.82 73.55 2.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.332 -0.618 . . . . 3.23 109.332 172.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.9 150.9 23.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.279 -0.418 . . . . 2.82 109.97 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 105' ' ' SER . 76.6 m-85 -110.71 -173.79 2.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.751 -0.462 . . . . 1.62 109.751 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.9 -38.97 69.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.623 0.601 . . . . 1.03 112.623 -172.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.53 169.02 17.65 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.929 -0.308 . . . . 0.75 111.527 -170.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -136.17 140.07 43.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.612 -0.722 . . . . 1.58 109.107 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.5 tp -109.63 133.67 52.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 1.07 110.245 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.477 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 39.8 m170 -120.38 106.1 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 1.77 110.684 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.3 mp -86.83 114.92 23.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.757 -0.46 . . . . 0.93 109.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.03 134.14 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.225 0.536 . . . . 0.61 110.571 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.562 ' CE1' ' HB2' ' A' ' 79' ' ' LEU . 74.4 m-70 -119.68 150.82 39.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 2.13 111.521 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -110.17 123.84 50.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.819 -1.082 . . . . 4.26 110.008 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 40.5 t-20 -79.37 117.99 20.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.113 -0.494 . . . . 2.02 110.426 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -73.93 -32.21 63.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.17 -0.468 . . . . 2.34 112.193 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 19.6 ptmt -63.24 -25.19 68.21 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.112 0.412 . . . . 3.35 112.112 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.38 -11.87 31.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.906 0.384 . . . . 3.1 111.136 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.74 26.11 3.85 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.123 -0.944 . . . . 2.37 113.687 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -176.31 115.29 0.12 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.793 -0.447 . . . . 3.93 109.793 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 134' ' ' VAL . 50.8 p90 -57.81 -36.24 71.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 3.0 111.677 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.55 -44.9 96.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.875 -0.678 . . . . 2.15 112.444 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -64.4 -36.21 83.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.21 0.529 . . . . 3.43 109.984 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 139' ' ' GLY . . . -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 1.76 111.303 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 130' ' ' PHE . 72.0 t -61.73 -22.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.028 0.442 . . . . 2.77 111.083 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -77.0 -0.81 25.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 3.55 111.414 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.492 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 6.2 tt0 -126.26 131.77 24.07 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.79 -0.448 . . . . 3.02 109.79 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.17 -18.19 50.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.897 2.398 . . . . 1.6 112.76 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.492 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 13.1 m-20 -113.91 17.63 17.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.174 -0.676 . . . . 2.29 109.174 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.412 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -83.24 -11.23 81.11 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.437 -0.802 . . . . 1.22 113.934 -168.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.594 ' C ' HG12 ' A' ' 206' ' ' VAL . 80.1 mt -146.48 172.19 13.91 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.269 -0.271 . . . . 1.57 110.269 -175.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -156.94 121.34 4.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.363 -0.38 . . . . 1.38 110.671 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.51 ' O ' HG21 ' A' ' 209' ' ' ILE . 33.6 m -97.95 165.86 2.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 N-CA-C 108.637 -0.875 . . . . 1.73 108.637 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.5 tp -116.45 114.71 24.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.774 -0.454 . . . . 2.42 109.774 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -97.16 117.27 5.73 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.047 -0.597 . . . . 0.86 112.689 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.9 mt -118.87 127.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.306 -0.257 . . . . 0.76 110.306 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -78.4 147.22 34.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.366 -0.235 . . . . 1.2 110.366 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 8.1 mp -117.7 124.47 48.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.88 111.145 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -116.56 144.91 43.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.322 -0.622 . . . . 2.03 109.322 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 11.2 t -88.05 130.38 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.894 0.378 . . . . 1.27 110.356 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.09 -114.88 0.4 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.414 -0.674 . . . . 1.53 111.414 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.3 t -81.99 156.37 24.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.489 -0.56 . . . . 1.54 109.489 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.417 ' N ' ' HB2' ' A' ' 218' ' ' SER . . . -78.02 148.6 34.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 0.78 111.098 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 183' ' ' LEU . 82.5 tttt -113.19 110.4 51.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.771 -0.455 . . . . 1.22 109.771 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.5 -38.66 90.05 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.708 2.939 . . . . 1.05 113.565 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.3 -19.84 64.65 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.115 -0.564 . . . . 0.7 112.899 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -95.56 -16.56 22.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.025 0.44 . . . . 0.77 110.336 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -46.12 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.761 -0.654 . . . . 1.41 111.162 -173.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.29 -36.73 66.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.873 0.323 . . . . 2.86 111.873 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.12 -42.67 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.077 0.465 . . . . 1.38 110.556 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 156' ' ' LEU . 24.4 t -67.27 -29.73 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 1.11 110.811 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.21 -35.82 61.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.224 -0.444 . . . . 1.22 111.698 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.93 -19.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.654 0.264 . . . . 1.41 111.546 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 228' ' ' LEU . 3.4 pp -74.71 -12.79 60.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.947 -0.301 . . . . 1.39 111.501 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.06 -31.08 69.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.947 0.403 . . . . 2.31 111.081 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.3 m -87.57 1.55 53.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.328 0.492 . . . . 1.4 112.328 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.6 pt -139.74 39.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.563 0.697 . . . . 0.85 110.598 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.606 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 84.8 tttt -54.0 -31.68 51.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.672 -1.149 . . . . 1.59 112.688 -176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -111.65 150.17 30.51 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.196 0.522 . . . . 0.77 111.959 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -58.31 128.16 35.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.388 -0.824 . . . . 2.29 111.502 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.65 -18.83 19.6 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.578 -0.82 . . . . 0.85 112.537 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.404 ' O ' HD12 ' A' ' 60' ' ' LEU . 67.4 mttm -87.52 149.12 24.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.362 0.601 . . . . 1.7 111.215 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.5 p -134.96 157.26 47.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.053 -0.976 . . . . 1.37 109.702 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.81 139.05 29.13 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.153 -0.314 . . . . 0.61 110.153 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.55 135.04 48.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.623 -0.51 . . . . 1.8 109.623 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 178' ' ' PHE . 22.8 t80 -136.23 81.46 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.242 0.544 . . . . 1.04 109.812 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.0 m -79.97 138.6 37.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.664 -0.698 . . . . 1.17 112.32 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 52.34 76.09 0.2 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.105 -0.952 . . . . 1.77 113.281 169.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 52.0 t80 -92.13 137.52 32.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.758 -0.46 . . . . 3.99 109.758 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -105.09 94.58 8.0 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.4 0.619 . . . . 2.51 110.94 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 12.3 Cg_exo -71.83 -9.49 24.88 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.653 2.235 . . . . 1.26 112.321 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -49.81 -39.54 38.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.196 0.522 . . . . 2.76 110.87 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -56.23 -26.98 51.57 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.281 -0.872 . . . . 1.12 113.061 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 153' ' ' LYS . 90.2 mt -76.63 -29.65 56.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.73 112.571 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.402 ' HB2' ' HD3' ' A' ' 185' ' ' PRO . 85.9 mt -33.14 -47.73 0.58 Allowed Pre-proline 0 N--CA 1.483 1.185 0 N-CA-C 116.237 1.939 . . . . 3.45 116.237 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 184' ' ' LEU . 14.1 Cg_exo -71.73 48.89 1.12 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.556 1.504 . . . . 2.08 114.029 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 187' ' ' SER . 0.0 OUTLIER -109.45 -6.19 15.53 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.998 -0.439 . . . . 3.23 111.766 173.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.477 ' OG ' ' HE2' ' A' ' 212' ' ' LYS . 46.1 t 72.84 128.43 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.782 0.676 . . . . 1.66 111.038 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.503 ' HA ' HD22 ' A' ' 211' ' ' LEU . 96.0 mt -113.81 59.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.395 -0.366 . . . . 1.99 110.174 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -144.43 153.08 41.54 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.997 -0.742 . . . . 1.81 108.997 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.468 ' HB3' ' HB ' ' A' ' 210' ' ' VAL . 0.1 OUTLIER 171.58 -168.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.121 -1.066 . . . . 5.01 108.121 -178.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.61 ' HB3' ' HA ' ' A' ' 257' ' ' ALA . 1.5 p90 -75.87 147.97 38.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.09 0.472 . . . . 3.93 110.265 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.3 t -107.28 75.91 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.8 0.81 . . . . 2.13 110.811 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.423 ' OH ' ' HD3' ' A' ' 253' ' ' ARG . 20.8 t80 -138.43 138.5 22.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.635 -0.711 . . . . 5.21 110.057 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HA ' ' OG1' ' A' ' 207' ' ' THR . 33.0 Cg_endo -64.7 130.29 25.91 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.728 2.285 . . . . 2.12 112.832 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -125.29 142.85 14.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.862 -0.608 . . . . 1.75 112.12 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 C--N 1.325 -0.478 0 CA-C-O 121.579 0.704 . . . . 2.99 112.405 -177.784 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.978 0.418 . . . . 2.96 110.744 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -104.25 51.3 0.78 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 3.37 110.352 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 62.2 m -135.69 11.74 3.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.436 -0.802 . . . . 2.15 110.412 -176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.594 HG12 ' C ' ' A' ' 140' ' ' LEU . 15.9 m -136.23 100.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 1.26 110.46 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 194' ' ' PRO . 1.4 t -151.21 89.8 1.54 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 115.358 1.614 . . . . 2.08 115.358 170.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.504 ' O ' HG23 ' A' ' 209' ' ' ILE . 0.1 OUTLIER -151.96 85.5 1.29 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.569 -0.707 . . . . 5.53 109.322 143.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -163.16 98.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.177 0.436 . . . . 1.63 112.177 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.11 136.61 59.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.469 -0.769 . . . . 1.62 109.893 165.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 188' ' ' LEU . 51.6 mt -114.1 123.19 49.05 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 1.73 110.631 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.477 ' HE2' ' OG ' ' A' ' 187' ' ' SER . 62.3 pttt -67.62 -36.77 81.44 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.122 0.415 . . . . 2.98 112.122 -174.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 212' ' ' LYS . 25.0 mm-40 -99.14 117.21 64.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 1.47 111.166 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.65 148.25 58.89 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.525 2.15 . . . . 0.96 111.134 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -79.45 147.26 6.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 1.25 109.62 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.1 t -89.9 116.4 27.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.003 -0.544 . . . . 1.29 110.577 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -119.37 135.69 58.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.586 -0.894 . . . . 1.02 108.586 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 152' ' ' ALA . 13.2 t -96.95 170.43 9.16 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.992 -0.442 . . . . 1.08 111.502 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.58 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 11.0 p -51.48 -53.03 41.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.367 0.506 . . . . 1.33 112.367 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.47 -40.14 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 2.51 111.099 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -68.87 -51.08 44.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.966 -0.561 . . . . 0.7 110.071 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.9 m -69.25 -20.71 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 111.912 0.338 . . . . 1.36 111.912 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 219' ' ' SER . 57.9 mt -61.87 -42.41 99.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.019 0.437 . . . . 1.03 109.907 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.683 ' O ' ' HG ' ' A' ' 228' ' ' LEU . 62.5 mttm -66.62 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.511 -0.768 . . . . 1.75 110.865 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -73.23 -31.14 63.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.216 0.532 . . . . 2.47 110.496 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.439 ' HE ' ' HB2' ' A' ' 226' ' ' ARG . 5.7 ttm180 -83.35 -13.86 54.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.684 -0.689 . . . . 3.04 110.89 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -2.35 32.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.205 -0.452 . . . . 2.31 111.294 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.705 HD13 ' CE1' ' A' ' 66' ' ' PHE . 90.7 mt -73.62 152.43 40.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.064 0.459 . . . . 0.95 110.952 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.606 ' OD1' ' HE2' ' A' ' 167' ' ' LYS . 11.9 m120 -111.22 141.48 44.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.408 0.623 . . . . 1.13 111.037 -174.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.77 -31.47 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.731 -1.122 . . . . 3.74 108.815 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.8 p-10 -72.83 165.21 25.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.506 -1.224 . . . . 1.62 112.208 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.09 174.41 45.61 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.915 -1.039 . . . . 1.16 110.814 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.5 133.07 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.832 -0.433 . . . . 3.56 109.832 -176.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.26 3.84 88.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.694 -0.765 . . . . 2.08 113.27 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 32.6 mt-10 -98.66 164.34 17.18 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.657 -0.498 . . . . 2.59 109.657 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.44 126.51 22.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 1.36 111.571 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.51 109.34 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.647 -0.706 . . . . 3.4 111.763 -172.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -125.59 122.15 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.41 -0.814 . . . . 2.47 110.193 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.58 149.42 49.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.773 -0.649 . . . . 2.14 111.116 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 mtt -73.0 102.55 3.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 1.68 109.352 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.87 133.47 68.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 1.27 111.505 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.476 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 17.6 t70 63.62 -80.02 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.3 -0.864 . . . . 2.18 111.211 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 56.36 33.68 22.8 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.818 0.447 . . . . 2.15 111.804 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -125.35 144.75 50.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.468 -0.568 . . . . 4.59 109.468 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 0.1 OUTLIER -67.62 147.25 98.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.044 -0.525 . . . . 6.13 111.358 -178.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.594 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 61.1 Cg_exo -53.17 153.26 16.8 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.443 2.762 . . . . 3.28 112.348 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 118.57 16.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.317 -0.401 . . . . 2.98 111.585 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.55 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 48.6 mt-30 -68.89 171.44 6.37 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.771 -0.65 . . . . 4.32 109.684 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 66.1 Cg_exo -42.26 123.2 2.57 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.386 2.058 . . . . 3.48 111.853 173.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -55.96 -52.87 62.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.571 -0.74 . . . . 4.63 111.836 -163.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 253' ' ' ARG . 18.8 ptpt -62.21 -10.95 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.865 1.061 . . . . 5.34 113.865 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 10.4 p30 48.9 -42.59 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.887 2.551 . . . . 4.64 117.887 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 251' ' ' LYS . 20.0 ttt180 168.74 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.485 -0.931 . . . . 6.11 108.485 -164.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -129.33 136.12 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.063 -0.717 . . . . 3.08 109.063 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.457 HD13 HG23 ' A' ' 33' ' ' ILE . 36.1 mt -99.66 142.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.246 -0.279 . . . . 2.6 110.246 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -132.46 159.1 40.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.596 -0.275 . . . . 2.63 110.348 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.61 ' HA ' ' HB3' ' A' ' 191' ' ' TRP . . . -130.57 157.7 42.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 1.71 110.971 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 191' ' ' TRP . 14.0 p -163.91 98.31 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.387 . . . . 2.21 110.275 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -162.08 150.13 14.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.39 -0.368 . . . . 4.31 110.374 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.38 -0.819 . . . . 4.49 109.673 -177.817 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 27.6 t70 . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 120.547 0.213 . . . . 2.88 111.007 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' HB ' HG12 ' A' ' 109' ' ' VAL . 50.8 mt -85.49 135.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 116.353 -0.385 . . . . 2.32 110.626 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -105.82 111.46 24.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.744 -0.465 . . . . 2.82 109.744 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.5 p -60.61 -27.24 67.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.037 -0.529 . . . . 2.24 112.321 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -66.56 -45.7 78.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 4.54 110.818 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 m -78.74 -25.9 44.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 3.06 110.667 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.12 116.93 3.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.129 0.49 . . . . 1.72 111.248 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -94.24 128.7 40.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 3.69 110.918 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.1 p90 -76.69 140.05 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.262 -0.426 . . . . 4.64 110.18 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.34 98.46 13.92 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.899 0.381 . . . . 2.27 110.007 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.18 -10.5 27.41 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.181 2.587 . . . . 2.15 113.14 -175.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.6 p -78.96 -1.92 37.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.023 0.439 . . . . 4.29 110.565 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.51 HD12 ' OG ' ' A' ' 258' ' ' SER . 78.4 mt -89.54 138.27 31.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.387 -0.597 . . . . 4.74 109.387 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.36 140.25 26.3 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 3.77 110.879 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.44 138.07 84.44 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.128 2.552 . . . . 2.36 111.649 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.409 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 57.7 mt -72.94 138.3 46.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 2.55 110.457 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -91.81 120.52 32.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.009 -1.108 . . . . 2.38 108.009 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' CD1' ' A' ' 79' ' ' LEU . 1.9 t -116.45 110.93 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.522 -0.308 . . . . 1.59 110.624 -172.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.9 t -94.91 88.38 5.27 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.034 -0.728 . . . . 1.45 109.034 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 181' ' ' ARG . 1.4 p90 -107.25 1.1 23.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.892 -0.594 . . . . 3.62 111.36 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.35 -32.83 65.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.242 -0.435 . . . . 2.48 111.557 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.466 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 1.2 mp0 -101.5 6.89 42.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.24 111.138 -176.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.63 128.1 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.812 0.339 . . . . 0.8 111.537 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -112.31 107.03 15.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.954 -0.566 . . . . 1.06 110.721 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 t -79.67 150.51 30.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 1.26 108.95 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.7 mt -117.79 -54.52 2.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.74 111.825 -173.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -161.91 159.58 26.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.322 -0.399 . . . . 3.17 110.841 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.1 tt -115.31 141.5 32.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.312 -0.625 . . . . 0.64 109.312 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 171' ' ' LYS . 61.5 tp -127.6 138.26 52.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.37 . . . . 0.96 110.89 -173.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -92.99 119.78 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.063 0.459 . . . . 1.49 110.547 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 49.0 m-80 -127.74 146.53 50.55 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.339 -0.985 . . . . 1.83 108.339 170.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.22 6.34 7.6 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.976 -0.631 . . . . 1.64 113.932 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -114.33 -54.29 2.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.165 0.482 . . . . 3.33 109.713 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 62' ' ' ASN . . . -140.53 163.22 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.336 -0.393 . . . . 1.38 110.416 174.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 69.7 m-85 -111.47 99.77 8.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.805 -0.443 . . . . 2.74 109.805 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 94' ' ' HIS . 81.3 m-20 -86.55 138.83 31.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 1.76 111.72 -171.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.3 t -114.59 113.25 43.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.476 -0.784 . . . . 1.15 108.977 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -72.66 140.53 47.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.913 -0.585 . . . . 2.02 112.076 -172.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -125.68 144.32 50.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 1.66 110.1 172.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.65 139.5 30.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.148 -0.478 . . . . 1.33 111.068 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.02 64.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.033 -0.985 . . . . 2.65 109.868 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -77.82 -11.06 59.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.982 0.896 . . . . 1.61 108.65 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -149.25 160.05 43.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.927 -1.488 . . . . 2.35 107.824 -176.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.97 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.688 0.618 . . . . 1.92 111.865 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 53' ' ' GLN . 90.0 mttt -109.54 -59.41 1.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.65 0.611 . . . . 1.77 112.65 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.84 102.15 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.76 111.258 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.59 145.41 24.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.205 -0.452 . . . . 1.27 111.206 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 49' ' ' VAL . 31.8 tp -134.39 112.88 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.935 -0.395 . . . . 1.29 109.935 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -150.98 123.23 8.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 2.54 111.538 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -97.17 176.06 31.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.762 -1.021 . . . . 1.31 110.905 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.17 -141.28 0.0 OUTLIER Glycine 0 CA--C 1.541 1.71 0 N-CA-C 115.331 0.892 . . . . 1.9 115.331 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.64 122.21 8.47 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.227 1.952 . . . . 2.91 112.329 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 14.1 tp -165.44 -170.3 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.976 -1.12 . . . . 4.11 107.976 -171.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.583 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 27.0 t70 -122.23 41.72 3.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.294 0.497 . . . . 4.95 110.997 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.77 174.91 13.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.858 -1.163 . . . . 2.25 114.229 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.0 m -101.86 124.18 47.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.073 -0.564 . . . . 1.91 110.12 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -114.07 113.16 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.071 0.463 . . . . 3.7 111.55 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.79 153.93 20.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.372 -0.376 . . . . 3.54 110.431 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.89 124.33 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.819 0.342 . . . . 1.14 110.615 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.545 ' HB ' ' CE3' ' A' ' 123' ' ' TRP . 14.2 tt -105.62 -34.02 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.918 0.389 . . . . 1.68 110.117 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -173.93 164.67 4.24 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.854 -0.795 . . . . 1.55 108.854 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' A' ' 120' ' ' LEU . 14.9 p90 -136.71 154.66 50.54 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.566 -0.902 . . . . 0.86 108.566 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.481 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.7 p-80 -139.78 158.8 43.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.943 0.401 . . . . 0.93 110.962 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.12 166.84 20.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 3.17 109.426 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.432 ' HE1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -144.46 157.69 44.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.451 -0.574 . . . . 1.68 109.451 175.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 73.1 t-105 -128.51 139.5 52.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 5.18 110.228 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -95.06 -59.42 1.11 Allowed Glycine 0 C--O 1.218 -0.844 0 C-N-CA 120.837 -0.697 . . . . 2.13 112.74 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 28.8 p 163.07 -57.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.365 0.603 . . . . 2.9 110.648 -172.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.81 153.26 23.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.307 -0.86 . . . . 3.03 110.4 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.38 51.69 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.666 0.746 . . . . 3.85 110.243 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -176.02 1.64 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.151 -0.931 . . . . 1.94 112.434 -175.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -160.35 155.24 24.33 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.887 -0.782 . . . . 2.45 108.887 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 116.19 -27.12 8.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.192 -1.004 . . . . 1.47 111.873 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 t -70.39 -46.73 63.44 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.011 -0.366 . . . . 2.0 110.011 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.524 ' OE1' ' HD3' ' A' ' 113' ' ' LYS . 8.1 mm-40 58.89 177.39 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.044 -0.525 . . . . 3.72 111.808 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.453 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 24.6 m80 59.76 14.45 4.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.962 -0.563 . . . . 3.52 111.286 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 113' ' ' LYS . 7.3 t -82.38 -178.8 7.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.11 -0.95 . . . . 2.52 113.088 -172.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 33' ' ' ILE . 17.0 m -103.61 123.94 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.582 -1.19 . . . . 2.48 111.965 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 61.17 39.14 16.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.38 -1.282 . . . . 2.8 111.413 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 67.81 8.54 6.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.758 -0.656 . . . . 4.98 112.163 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.43 73.91 6.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.694 0.283 . . . . 3.23 110.707 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.524 ' HD3' ' OE1' ' A' ' 106' ' ' GLU . 91.9 mttt -69.07 150.25 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.222 0.534 . . . . 2.82 111.641 -176.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 81.4 m-85 -101.12 -177.26 3.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.174 -0.921 . . . . 1.62 109.848 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.63 67.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.917 0.389 . . . . 1.03 111.704 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.32 163.75 39.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.457 . . . . 0.75 110.224 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 44.3 tt0 -129.99 135.2 48.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.732 -0.47 . . . . 1.58 109.732 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.5 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 42.9 tp -110.78 132.5 54.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.066 -0.515 . . . . 1.07 109.907 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.481 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -128.09 111.34 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.792 0.33 . . . . 1.77 111.628 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 93' ' ' PHE . 6.6 mp -92.71 113.46 25.74 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.151 -0.315 . . . . 0.93 110.151 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.73 122.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.162 0.506 . . . . 0.61 111.37 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -120.92 146.64 46.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.95 -0.568 . . . . 2.13 109.513 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.545 ' CE3' ' HB ' ' A' ' 91' ' ' ILE . 2.1 p90 -119.56 148.83 42.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.615 -0.513 . . . . 4.26 109.615 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -68.99 114.73 7.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.278 0.561 . . . . 2.02 110.37 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -68.19 -21.87 64.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.235 -0.893 . . . . 2.34 112.101 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.87 -21.6 64.83 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.861 0.363 . . . . 3.35 111.506 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.3 -3.17 34.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.003 0.43 . . . . 3.1 110.125 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.79 30.22 6.67 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 114.714 -1.13 . . . . 2.37 114.98 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 30.5 t70 -173.42 129.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.037 0.918 . . . . 3.93 110.214 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.608 ' O ' HG23 ' A' ' 134' ' ' VAL . 85.8 t80 -60.0 -46.4 89.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.961 -1.018 . . . . 3.0 110.842 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.66 99.24 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.227 -0.511 . . . . 2.15 112.832 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.48 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 73.6 mmtt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.07 0.462 . . . . 3.43 110.316 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.688 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.66 -0.7 . . . . 1.76 110.738 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 130' ' ' PHE . 99.6 t -64.83 -26.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.022 -0.535 . . . . 2.77 111.493 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -83.87 -4.66 58.85 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.023 -0.423 . . . . 3.55 111.451 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.455 HE21 ' HA2' ' A' ' 139' ' ' GLY . 3.1 tt0 -107.28 132.36 21.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.885 -0.413 . . . . 3.02 109.885 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 74.4 Cg_exo -52.46 -30.37 43.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.426 2.751 . . . . 1.6 113.499 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.91 25.18 12.05 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.646 0.26 . . . . 2.29 110.472 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -70.87 -33.63 65.99 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.579 -0.819 . . . . 1.22 113.394 -172.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.7 mt -114.71 156.9 23.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.999 0.428 . . . . 1.57 110.069 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.0 106.57 6.14 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.284 -0.635 . . . . 1.38 109.284 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 91.3 t -103.94 116.45 47.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.093 -0.503 . . . . 1.73 110.353 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 44.5 tp -88.8 112.85 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.329 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -101.64 141.9 15.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.906 -0.664 . . . . 0.86 112.337 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.6 mt -133.64 131.75 57.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.453 -0.573 . . . . 0.76 109.453 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.4 148.99 25.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.921 -0.4 . . . . 1.2 109.921 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.9 mp -116.79 124.01 48.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.88 110.973 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 18.9 ptpt -108.1 150.52 27.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.271 -0.64 . . . . 2.03 109.271 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 92.3 t -95.01 130.55 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.133 0.492 . . . . 1.27 110.83 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.59 -103.61 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.794 -0.639 . . . . 1.53 111.731 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 p -71.07 147.22 48.71 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.839 0.352 . . . . 1.54 110.385 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -78.2 149.58 33.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.263 -0.426 . . . . 0.78 110.606 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.0 100.4 53.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.053 -0.521 . . . . 1.22 110.303 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.46 -35.02 64.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.41 2.74 . . . . 1.05 112.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.44 -21.36 64.47 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.347 -0.454 . . . . 0.7 113.524 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.507 ' HB3' ' NE2' ' A' ' 221' ' ' GLN . 27.1 tp -98.04 -6.25 32.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.3 0.55 . . . . 0.77 110.802 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.01 -41.24 74.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 1.41 111.805 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -66.04 -34.66 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.728 0.299 . . . . 2.86 111.085 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 162' ' ' VAL . 67.4 t -71.55 -50.29 40.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 1.38 110.823 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 224' ' ' LYS . 32.9 m -65.61 -24.89 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 1.11 111.255 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.74 -34.1 58.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.499 . . . . 1.22 111.495 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 159' ' ' VAL . 6.0 p -81.89 -8.77 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 1.41 110.749 -175.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.34 -27.22 63.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.966 -0.561 . . . . 1.39 111.391 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.15 -34.66 73.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 2.31 111.413 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.3 t -89.25 -1.55 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.664 -0.244 . . . . 1.4 111.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 38.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.05 0.452 . . . . 0.85 110.374 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.9 -35.33 72.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 1.59 111.023 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 p -106.39 149.02 27.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.396 0.617 . . . . 0.77 111.52 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -57.41 126.94 29.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.901 -1.045 . . . . 2.29 111.18 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.5 -22.24 20.2 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.748 -0.739 . . . . 0.85 112.642 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 60' ' ' LEU . 64.8 mttm -79.62 150.28 31.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.167 0.508 . . . . 1.7 111.472 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 60' ' ' LEU . 8.5 t -140.75 151.34 44.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.402 -0.817 . . . . 1.37 109.279 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -140.51 134.85 31.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.07 -0.344 . . . . 0.61 110.07 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.43 132.41 53.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.249 0.547 . . . . 1.8 110.402 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -141.51 80.79 1.75 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.611 -0.722 . . . . 1.04 109.585 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 32.0 p -101.34 160.9 14.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.274 0.472 . . . . 1.17 112.274 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.1 42.16 10.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.263 -0.88 . . . . 1.77 111.755 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.46 130.57 45.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 3.99 110.828 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 3.2 p30 -105.72 133.18 20.31 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 2.51 109.92 176.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 3.3 Cg_exo -77.93 -11.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.536 2.157 . . . . 1.26 111.439 173.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.52 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 18.4 mtm180 -57.68 -44.0 85.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.616 -0.72 . . . . 2.76 111.498 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.86 -6.48 56.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.83 -0.7 . . . . 1.12 112.978 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.454 ' O ' HG21 ' A' ' 215' ' ' ILE . 6.7 mp -108.7 -9.23 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.582 -0.364 . . . . 1.73 111.002 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 95.3 mt -70.75 140.83 86.81 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.913 0.387 . . . . 3.45 111.621 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.52 -167.98 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.273 2.648 . . . . 2.08 113.308 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.7 -59.74 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 3.23 111.309 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.578 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 9.7 m -91.05 140.44 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 1.66 110.949 -174.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 35.1 tp -106.02 62.78 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.549 0.69 . . . . 1.99 109.657 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 258' ' ' SER . 6.9 m-20 -122.45 171.79 8.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.829 -1.175 . . . . 1.81 107.829 176.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 51.7 p90 -167.71 163.5 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.831 1.049 . . . . 5.01 113.831 -163.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.575 ' HE3' HG13 ' A' ' 210' ' ' VAL . 13.4 m-90 -105.37 141.94 36.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.223 -1.399 . . . . 3.93 107.223 164.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.4 t -138.86 109.13 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.409 0.623 . . . . 2.13 112.558 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.528 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 8.9 t80 -139.88 129.03 13.6 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 5.21 109.671 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 89.0 Cg_exo -48.9 134.92 29.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.058 2.505 . . . . 2.12 112.92 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -107.48 153.39 16.83 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.82 -0.627 . . . . 1.75 113.659 -170.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.9 p . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 123.68 0.792 . . . . 2.99 111.243 179.583 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.907 0.384 . . . . 2.96 110.727 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -112.78 85.94 2.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.563 0.697 . . . . 3.37 110.502 -177.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.5 p -111.93 3.43 17.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.167 -0.47 . . . . 2.15 111.07 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.04 134.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.281 0.563 . . . . 1.26 111.819 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.5 m -102.9 97.85 7.92 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.079 -1.452 . . . . 2.08 107.079 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.422 ' HE1' ' CD2' ' A' ' 119' ' ' HIS . 9.2 t90 -88.77 120.35 30.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.076 0.465 . . . . 5.53 110.815 -169.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 71.3 mt -126.18 118.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 1.63 109.356 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.575 HG13 ' HE3' ' A' ' 191' ' ' TRP . 3.4 p -120.32 126.26 75.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.808 0.337 . . . . 1.62 110.602 -174.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.22 137.02 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.079 -0.51 . . . . 1.73 110.596 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.573 ' HG3' ' CZ2' ' A' ' 191' ' ' TRP . 33.6 ttmt -81.53 -1.36 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 2.98 110.756 -177.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.578 ' HG3' ' H ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -111.8 91.65 15.56 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.3 -0.63 . . . . 1.47 109.3 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 18.9 Cg_exo -66.61 147.44 81.81 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.775 2.317 . . . . 0.96 112.031 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.454 HG21 ' O ' ' A' ' 183' ' ' LEU . 38.8 pt -94.61 154.35 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 1.25 110.751 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.9 m -99.92 137.92 37.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.975 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 12.6 m -134.63 155.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.634 -0.712 . . . . 1.02 109.193 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 44.9 t -83.44 154.8 23.77 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.941 -0.303 . . . . 1.08 110.602 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.649 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 6.3 p -54.91 -45.56 74.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.583 -0.28 . . . . 1.33 110.531 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 43.5 mt-10 -55.69 -27.76 51.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.204 -0.453 . . . . 2.51 111.5 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 52.9 mt-30 -80.27 -47.39 14.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.7 110.454 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.608 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 35.1 m -71.91 -26.69 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 1.36 111.499 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.7 mt -66.72 -30.3 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.79 0.329 . . . . 1.03 110.445 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 160' ' ' VAL . 96.1 mttt -69.43 -24.29 63.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 1.75 110.765 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 21.9 m-85 -75.73 -25.01 56.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 2.47 109.774 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -79.29 -10.94 59.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 3.04 110.189 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -90.29 -8.78 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 2.31 110.35 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.26 150.48 48.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.95 110.425 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.7 m120 -110.21 136.35 49.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.409 0.623 . . . . 1.13 110.613 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -76.93 -30.5 56.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.758 -1.11 . . . . 3.74 109.739 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.6 p-10 -73.61 164.38 26.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.128 -0.942 . . . . 1.62 112.132 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.83 174.32 46.0 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.073 -0.967 . . . . 1.16 111.079 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.11 135.84 55.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.243 0.521 . . . . 3.56 110.511 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 90.69 7.91 66.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.859 -0.686 . . . . 2.08 112.434 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -112.53 159.24 34.88 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.244 -0.28 . . . . 2.59 110.244 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.26 124.0 15.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.453 2.102 . . . . 1.36 110.911 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.451 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.9 pt-20 -62.01 123.93 19.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.819 0.819 . . . . 3.4 111.909 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 43.5 mt-10 -116.97 125.27 51.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.843 -1.071 . . . . 2.47 108.486 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -70.05 147.57 49.88 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.117 -0.492 . . . . 2.14 110.619 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 11.9 tpt -73.94 92.13 2.07 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.528 -0.916 . . . . 1.68 108.528 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.0 m -140.21 142.12 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.674 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 30.1 t70 66.42 -95.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.226 -0.897 . . . . 2.18 109.497 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 m120 53.25 19.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.483 0.549 . . . . 2.15 112.483 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -150.08 164.31 35.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.792 0.33 . . . . 4.59 110.406 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.432 ' HE ' ' NE2' ' A' ' 248' ' ' GLN . 12.6 ptm180 -107.78 148.12 36.74 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.926 -0.579 . . . . 6.13 110.898 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.97 161.98 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.625 2.883 . . . . 3.28 113.623 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -71.2 143.66 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.334 -0.848 . . . . 2.98 110.695 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.432 ' NE2' ' HE ' ' A' ' 245' ' ' ARG . 41.9 mt-30 -124.69 170.54 8.79 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.867 -0.606 . . . . 4.32 111.1 -169.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 248' ' ' GLN . 6.5 Cg_exo -76.09 174.94 11.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.401 2.734 . . . . 3.48 115.031 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.42 -8.7 57.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 113.879 -1.51 . . . . 4.63 113.069 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 18.4 pttp -55.21 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.319 2.34 . . . . 5.34 117.319 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 3.3 p-10 134.62 28.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.976 1.71 . . . . 4.64 112.065 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.433 ' NE ' HD11 ' A' ' 255' ' ' ILE . 56.3 ttt180 -147.94 120.05 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.924 -0.399 . . . . 6.11 109.924 162.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -146.79 122.39 10.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.429 -1.322 . . . . 3.08 107.429 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 191' ' ' TRP . 14.8 mt -124.85 145.83 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.006 0.432 . . . . 2.6 111.803 -168.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.46 143.55 48.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 2.63 110.041 169.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -118.59 92.72 3.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.157 -0.474 . . . . 1.71 110.097 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 69.0 m -105.55 100.67 10.23 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.288 -0.565 . . . . 2.21 111.724 -172.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -126.27 100.43 6.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.136 -1.061 . . . . 4.31 108.136 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.503 -0.761 . . . . 4.49 110.808 -173.279 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 108.053 -1.091 . . . . 2.88 108.053 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 57.1 mt -65.62 103.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.41 0.624 . . . . 2.32 111.191 -169.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' A' ' 37' ' ' THR . 20.9 m-20 -83.44 102.66 12.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.929 -1.032 . . . . 2.82 108.947 176.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -55.02 -35.65 64.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.405 0.52 . . . . 2.24 112.405 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -84.66 -28.58 26.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.092 0.404 . . . . 4.54 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 5.7 m -89.12 -15.81 32.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.285 0.564 . . . . 3.06 110.91 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.02 142.16 56.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 1.72 110.747 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -104.32 116.45 32.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.376 -0.602 . . . . 3.69 109.376 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -87.59 87.18 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 4.64 110.835 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' OD2' ' HG ' ' A' ' 44' ' ' LEU . 19.6 t70 -73.93 119.72 77.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 2.27 110.91 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.57 -16.71 9.09 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.876 2.384 . . . . 2.15 112.918 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 m -70.25 -46.22 64.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.636 -0.505 . . . . 4.29 109.636 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.433 ' HG ' ' OD2' ' A' ' 41' ' ' ASP . 95.9 mt -54.29 144.52 20.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.417 -0.811 . . . . 4.74 111.008 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HD3' ' HD2' ' A' ' 46' ' ' PRO . 16.6 tppt? -117.1 124.07 29.49 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.672 -0.695 . . . . 3.77 109.835 -174.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 73.3 Cg_exo -51.52 122.76 10.81 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.258 1.972 . . . . 2.36 111.623 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.95 126.87 30.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.539 -0.755 . . . . 2.55 110.606 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.461 ' O ' HD12 ' A' ' 79' ' ' LEU . 53.7 p -67.35 136.19 54.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.706 -0.479 . . . . 2.38 109.706 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.46 97.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.818 -0.438 . . . . 1.59 109.818 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 9.8 m -97.14 88.62 4.53 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.478 -0.564 . . . . 1.45 109.478 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.55 ' CE1' ' HA ' ' A' ' 181' ' ' ARG . 1.0 OUTLIER -129.23 18.09 5.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.5 0.667 . . . . 3.62 109.896 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.06 -28.83 69.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.016 -0.993 . . . . 2.48 110.216 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.2 7.84 45.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 2.24 111.256 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . . . -62.71 133.64 55.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.738 0.304 . . . . 0.8 111.717 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.589 ' OG1' ' HE2' ' A' ' 76' ' ' LYS . 10.7 m -121.1 119.13 31.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.085 -0.507 . . . . 1.06 110.532 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 t -83.92 150.25 25.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.308 -0.405 . . . . 1.26 110.431 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.0 mt -116.71 -55.44 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.424 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -169.75 160.83 8.93 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.425 -0.352 . . . . 3.17 110.942 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 17.4 tt -109.32 144.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.64 109.281 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.6 tp -135.68 136.93 41.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.313 0.578 . . . . 0.96 111.779 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.458 ' CB ' ' HA ' ' A' ' 169' ' ' LYS . 4.2 m-20 -88.43 106.03 17.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.943 -1.026 . . . . 1.49 109.32 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 64' ' ' HIS . 44.6 m-80 -100.04 75.19 1.84 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.382 -0.372 . . . . 1.83 111.4 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 65.93 -26.15 0.15 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 115.56 0.984 . . . . 1.64 115.56 174.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' ASN . 25.5 p80 -163.76 -25.82 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.76 0.314 . . . . 3.33 111.533 -172.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.74 157.93 19.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.12 -0.326 . . . . 1.38 110.12 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -131.7 96.37 3.94 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.51 -0.922 . . . . 2.74 108.51 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -115.86 145.59 42.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.23 -0.896 . . . . 1.76 111.437 -170.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 58.8 t -93.71 121.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.781 -0.645 . . . . 1.15 110.049 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -86.52 125.05 33.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.69 -0.686 . . . . 2.02 109.787 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -103.83 164.38 11.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.919 0.39 . . . . 1.66 110.674 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.64 116.16 28.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.879 -0.6 . . . . 1.33 109.824 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -127.77 59.99 1.45 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.925 0.869 . . . . 2.65 110.795 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -75.9 -5.29 45.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.435 -0.802 . . . . 1.61 110.614 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -157.61 176.94 11.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 2.35 109.218 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.65 30.38 0.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.385 -0.371 . . . . 1.92 111.194 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HE2' ' OG1' ' A' ' 55' ' ' THR . 2.4 ptpp? -50.77 -44.94 58.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.75 -0.659 . . . . 1.77 111.628 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.15 99.54 6.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.367 . . . . 0.76 110.119 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.2 m -129.0 168.36 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.386 0.613 . . . . 1.27 111.739 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 48' ' ' SER . 38.7 tp -137.19 111.45 8.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.04 -0.982 . . . . 1.29 108.416 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -150.45 126.34 10.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 2.54 111.419 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 173.94 24.28 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.965 -0.561 . . . . 1.31 113.347 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.78 -134.11 0.0 OUTLIER Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.349 0.976 . . . . 1.9 114.545 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -44.9 169.92 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.226 2.618 . . . . 2.91 112.712 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -35.8 150.34 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.472 1.286 . . . . 4.11 114.472 -154.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 13.8 p-10 174.58 -66.61 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.797 -1.092 . . . . 4.95 111.227 -156.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.6 141.8 2.44 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.371 -0.691 . . . . 2.25 111.371 -170.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 125' ' ' THR . 23.3 m -88.51 125.69 34.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.695 0.747 . . . . 1.91 111.033 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.2 m-85 -118.65 126.36 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.325 -0.398 . . . . 3.7 111.24 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.4 mtt180 -83.0 135.63 34.79 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.55 -0.295 . . . . 3.54 111.024 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.45 117.02 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.48 -0.563 . . . . 1.14 109.48 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.454 HG23 ' HG2' ' A' ' 92' ' ' GLN . 6.9 tt -110.12 -36.34 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.335 -0.393 . . . . 1.68 111.241 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.454 ' HG2' HG23 ' A' ' 91' ' ' ILE . 20.6 pt20 -162.86 168.31 21.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.339 -0.245 . . . . 1.55 110.339 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 118' ' ' LEU . 23.4 p90 -141.1 149.31 41.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.921 -0.4 . . . . 0.86 109.921 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -140.4 158.02 44.64 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.151 0.282 . . . . 0.93 110.714 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.7 m-85 -108.86 153.2 23.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.407 -0.36 . . . . 3.17 110.108 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -105.52 153.55 21.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 1.68 111.903 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.655 ' CB ' ' HA2' ' A' ' 104' ' ' GLY . 0.7 OUTLIER 69.37 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.738 -1.119 . . . . 5.18 111.984 170.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 241' ' ' VAL . . . 69.69 118.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.161 -0.542 . . . . 2.13 112.055 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 23.1 t 176.16 -89.53 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.03 0.415 . . . . 2.9 111.435 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.72 170.82 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 3.03 111.382 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.05 45.14 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.409 -0.814 . . . . 3.85 111.341 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -176.56 20.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.905 . . . . 1.94 112.828 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -155.86 120.03 4.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 2.45 110.043 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.655 ' HA2' ' CB ' ' A' ' 97' ' ' TRP . . . 157.71 -26.52 0.45 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.817 -0.706 . . . . 1.47 111.551 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.526 ' HB2' ' H ' ' A' ' 114' ' ' TYR . 43.2 m -81.35 64.73 6.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.098 0.559 . . . . 2.0 110.283 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.15 143.06 55.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.75 -0.463 . . . . 3.72 109.75 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 34.7 m80 61.65 25.64 15.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.984 0.421 . . . . 3.52 111.618 174.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.4 t -82.68 -175.54 5.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.5 . . . . 2.52 111.512 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 15.0 m -71.07 106.81 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 2.48 111.715 -166.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.0 t70 58.2 31.11 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.991 -1.459 . . . . 2.8 109.724 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.5 mttp 66.81 28.67 8.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.984 -1.007 . . . . 4.98 112.479 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -69.24 72.31 0.29 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.168 0.509 . . . . 3.23 110.488 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.75 114.29 2.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.415 -0.811 . . . . 2.82 112.584 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.526 ' H ' ' HB2' ' A' ' 105' ' ' SER . 67.2 m-85 -106.31 -163.16 0.9 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.343 -0.844 . . . . 1.62 109.276 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.61 95.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.13 0.789 . . . . 1.03 113.13 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.11 169.66 15.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.456 0.539 . . . . 0.75 112.456 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -122.59 135.01 54.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.501 -1.227 . . . . 1.58 108.25 171.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.489 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.3 tp -116.06 116.41 27.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.243 -0.28 . . . . 1.07 110.243 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -106.25 110.3 22.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 1.77 111.314 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.2 mp -88.21 102.71 15.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.601 -0.888 . . . . 0.93 108.601 173.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.31 120.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.727 -0.67 . . . . 0.61 110.783 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 12.7 m-70 -117.1 141.99 47.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.984 -0.747 . . . . 2.13 108.984 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CZ2' ' HD2' ' A' ' 89' ' ' ARG . 61.5 p-90 -111.87 141.22 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.801 0.334 . . . . 4.26 110.854 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.469 HD21 ' HE2' ' A' ' 126' ' ' LYS . 44.4 t30 -62.12 110.63 1.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.473 0.654 . . . . 2.02 111.519 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.401 HG22 ' HB ' ' A' ' 87' ' ' THR . 11.3 t -61.5 -33.45 73.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.934 -1.03 . . . . 2.34 112.872 -170.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.469 ' HE2' HD21 ' A' ' 124' ' ' ASN . 21.4 pttm -72.02 -6.81 44.96 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.239 0.829 . . . . 3.35 113.239 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 136' ' ' GLN . 43.4 m-85 -97.93 -4.23 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.568 -0.453 . . . . 3.1 110.836 172.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.5 26.55 5.24 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.074 -0.966 . . . . 2.37 114.779 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.37 122.91 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.547 0.673 . . . . 3.93 109.669 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 134' ' ' VAL . 46.3 p90 -69.37 -31.98 70.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 3.0 111.521 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.24 -37.23 92.66 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.751 -0.738 . . . . 2.15 112.007 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -70.49 -32.88 70.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.35 0.595 . . . . 3.43 109.61 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.423 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.73 -25.27 64.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 1.76 111.085 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 130' ' ' PHE . 93.8 t -68.5 -25.89 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 2.77 110.394 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -81.58 -13.82 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 3.55 110.774 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 127' ' ' TYR . 14.2 mm100 -111.18 135.91 20.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.051 -0.522 . . . . 3.02 110.1 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.11 -21.41 55.88 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.671 2.248 . . . . 1.6 112.796 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -113.0 25.45 11.39 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.931 -0.396 . . . . 2.29 109.931 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.76 -30.04 49.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.693 . . . . 1.22 113.892 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 88.1 mt -123.67 158.62 31.15 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.352 -0.499 . . . . 1.57 110.546 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.7 121.05 7.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 1.38 110.031 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 m -110.52 119.65 59.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.022 0.439 . . . . 1.73 110.418 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.2 tp -83.41 104.87 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.467 -0.568 . . . . 2.42 109.467 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -90.36 114.92 4.49 Favored Glycine 0 N--CA 1.446 -0.65 0 O-C-N 123.652 0.595 . . . . 0.86 112.363 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.7 mt -117.06 105.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.389 -0.597 . . . . 0.76 109.389 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 86.6 m-85 -66.24 154.47 39.78 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.122 0.487 . . . . 1.2 111.712 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.451 HD23 HG11 ' A' ' 217' ' ' VAL . 7.8 mp -112.68 112.75 24.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.544 -0.753 . . . . 0.88 110.071 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -96.72 147.17 24.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.157 -0.683 . . . . 2.03 109.157 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.82 126.41 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 1.27 110.92 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.23 -106.79 0.22 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.421 -0.672 . . . . 1.53 111.421 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.7 m -69.13 140.64 54.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.824 -0.436 . . . . 1.54 109.824 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.43 152.62 45.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.562 -0.29 . . . . 0.78 110.805 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 154' ' ' PRO . 47.4 tptt -108.6 95.29 16.01 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.941 -0.762 . . . . 1.22 108.941 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 15.5 Cg_endo -57.02 -35.9 99.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.994 2.463 . . . . 1.05 112.966 -173.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.43 -18.4 79.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.913 -0.66 . . . . 0.7 113.061 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.4 tp -90.15 -20.8 22.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.921 0.391 . . . . 0.77 110.805 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.688 HE21 ' HA ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -55.82 -34.25 65.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.947 -0.569 . . . . 1.41 112.154 -175.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -51.75 -41.1 61.34 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 112.534 0.568 . . . . 2.86 112.534 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.5 p -85.56 -38.96 13.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.347 -0.541 . . . . 1.38 111.018 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.5 HG12 ' HD2' ' A' ' 224' ' ' LYS . 31.4 t -63.22 -47.22 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 1.11 111.765 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -18.35 62.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.065 0.394 . . . . 1.22 112.065 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 162' ' ' VAL . 44.4 t -96.22 -1.59 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 121.197 0.523 . . . . 1.41 111.013 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.8 -24.97 66.22 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.901 0.381 . . . . 1.39 111.304 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.9 -31.68 71.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.46 -0.336 . . . . 2.31 110.717 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 44.5 m -76.9 -5.07 47.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 1.4 111.628 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.5 pt -137.78 45.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.85 109.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -67.05 -28.97 68.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.418 -0.81 . . . . 1.59 110.986 -175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 p -116.38 149.05 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.724 0.297 . . . . 0.77 110.723 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.484 ' HD2' ' HA2' ' A' ' 63' ' ' GLY . 56.3 pttt -65.25 148.88 50.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.457 -0.338 . . . . 2.29 110.104 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.55 33.84 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.457 -0.878 . . . . 0.85 111.37 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -82.22 157.58 23.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.419 0.628 . . . . 1.7 111.146 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.2 p -141.72 154.04 45.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 1.37 109.122 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.13 122.95 20.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.969 -0.382 . . . . 0.61 109.969 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.25 144.66 56.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.967 -0.561 . . . . 1.8 111.314 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.36 81.2 1.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 1.04 110.327 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 p -112.25 159.12 18.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.495 -0.32 . . . . 1.17 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.6 43.59 25.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.06 -0.518 . . . . 1.77 111.386 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.08 140.35 52.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.401 -0.363 . . . . 3.99 110.23 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -92.15 110.33 43.59 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.392 -0.367 . . . . 2.51 110.467 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.23 -14.85 13.07 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.463 2.109 . . . . 1.26 112.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.55 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . 9.4 ttp180 -71.93 -24.15 61.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 2.76 111.267 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -61.3 -2.8 3.27 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.342 -0.39 . . . . 1.12 113.867 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.54 -8.77 57.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.93 0.365 . . . . 1.73 110.979 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.4 pp -48.05 137.28 10.94 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 113.425 0.898 . . . . 3.45 113.425 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HG3' HD21 ' A' ' 211' ' ' LEU . 69.1 Cg_endo -94.92 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.553 2.835 . . . . 2.08 111.483 170.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.8 mt-10 -90.35 -64.18 1.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.836 0.309 . . . . 3.23 111.836 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.489 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.1 m -99.32 146.93 25.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 1.66 111.627 -172.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 211' ' ' LEU . 83.9 mt -111.29 65.12 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.979 0.419 . . . . 1.99 111.197 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.486 ' O ' HD12 ' A' ' 211' ' ' LEU . 33.0 m-20 -108.41 168.68 9.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.038 -1.097 . . . . 1.81 108.038 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.667 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 13.2 p90 -159.58 154.13 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.252 -0.979 . . . . 5.01 112.988 -170.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.707 ' CE3' ' HB2' ' A' ' 257' ' ' ALA . 6.9 m95 -111.84 142.17 44.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.419 -1.264 . . . . 3.93 107.747 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.0 t -121.66 113.24 19.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.548 0.69 . . . . 2.13 112.434 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 49.6 t80 -138.24 131.21 16.38 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 5.21 110.534 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 193' ' ' TYR . 10.0 Cg_endo -54.66 139.39 76.55 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.86 2.374 . . . . 2.12 112.165 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -138.36 159.17 25.17 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.142 -0.552 . . . . 1.75 113.443 -170.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 107.79 -1.189 . . . . 2.99 107.79 175.364 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.457 0.17 . . . . 2.96 110.588 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -113.47 58.34 0.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.63 0.729 . . . . 3.37 110.392 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.64 -15.43 57.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.988 -1.006 . . . . 2.15 110.519 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 40.6 t -100.65 151.28 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.714 -0.675 . . . . 1.26 110.66 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -117.57 109.35 16.59 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.734 -0.839 . . . . 2.08 108.734 174.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.41 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.7 t90 -74.01 100.82 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.951 -0.759 . . . . 5.53 108.951 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.59 99.6 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.688 -0.856 . . . . 1.63 108.688 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 21.5 t -86.19 111.22 20.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.202 -0.454 . . . . 1.62 109.903 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 189' ' ' ASP . 20.6 tp -72.21 120.48 17.88 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.935 -0.765 . . . . 1.73 108.935 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -66.23 -14.91 62.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.243 -0.435 . . . . 2.98 111.708 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 186' ' ' GLU . 7.1 tp10 -104.71 96.49 10.6 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.573 0.225 . . . . 1.47 110.787 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.443 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 63.0 Cg_endo -77.4 144.98 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.461 2.107 . . . . 0.96 111.828 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.3 pt -88.78 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.178 -0.465 . . . . 1.25 111.291 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.4 m -94.68 126.71 40.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.663 . . . . 1.29 110.334 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 147' ' ' LEU . 33.8 m -127.49 158.79 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.765 -0.457 . . . . 1.02 109.765 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 55.1 p -95.85 158.69 15.33 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.912 -0.315 . . . . 1.08 111.07 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.613 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 63.8 m -56.55 -39.26 73.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.935 -0.575 . . . . 1.33 110.694 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.89 -31.02 26.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 2.51 111.372 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.91 -45.1 13.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.45 . . . . 0.7 110.175 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.38 -40.71 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.916 -0.584 . . . . 1.36 111.475 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 219' ' ' SER . 89.7 mt -59.24 -35.13 73.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 1.03 111.8 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.5 ' HD2' HG12 ' A' ' 160' ' ' VAL . 66.1 mttp -70.19 -23.47 62.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.628 -0.26 . . . . 1.75 111.473 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -72.87 -25.43 61.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.22 0.533 . . . . 2.47 110.094 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -80.8 -9.89 59.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 3.04 110.603 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -86.9 -10.13 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 2.31 110.444 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.22 148.63 48.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.886 -0.597 . . . . 0.95 110.853 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.595 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 11.5 m120 -113.84 139.43 49.17 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.419 0.628 . . . . 1.13 110.331 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -76.05 -30.62 58.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.768 -1.106 . . . . 3.74 109.568 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.438 ' C ' ' HG2' ' A' ' 169' ' ' LYS . 4.5 p-10 -76.24 171.08 15.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.118 -0.947 . . . . 1.62 112.247 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.87 -179.33 38.91 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.763 -1.108 . . . . 1.16 111.288 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.65 129.17 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 3.56 110.866 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.94 4.34 48.31 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.472 -0.785 . . . . 2.08 112.547 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -116.05 153.94 48.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.249 -0.278 . . . . 2.59 110.249 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.36 131.81 48.04 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.857 2.371 . . . . 1.36 111.774 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.595 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 31.2 tt0 -53.65 115.15 1.82 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.592 0.71 . . . . 3.4 112.755 -174.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -108.82 117.86 35.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.896 -1.15 . . . . 2.47 107.896 168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.68 125.46 25.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.678 0.275 . . . . 2.14 110.713 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.5 ttm -77.37 90.32 3.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.065 -0.717 . . . . 1.68 109.065 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 27.7 m -136.36 151.74 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.836 -0.62 . . . . 1.27 109.872 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 14.1 t70 69.67 -87.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.696 0.622 . . . . 2.18 110.588 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 48.98 15.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.364 1.246 . . . . 2.15 114.364 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.413 ' HD1' ' H ' ' A' ' 97' ' ' TRP . 98.5 m95 -150.46 177.97 9.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.272 0.487 . . . . 4.59 110.689 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -116.75 131.56 23.85 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.204 -0.295 . . . . 6.13 110.204 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 59.7 Cg_endo -73.72 -148.34 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.83 2.354 . . . . 3.28 112.772 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -82.95 136.1 34.66 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.924 -0.485 . . . . 2.98 111.486 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -123.09 162.31 40.01 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.791 -0.64 . . . . 4.32 110.215 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.51 177.82 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.804 3.003 . . . . 3.48 114.341 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.38 -4.7 0.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.245 1.418 . . . . 4.63 113.306 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 75.0 mmtt -54.11 49.4 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.489 1.515 . . . . 5.34 114.975 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 3.3 t30 132.67 62.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.911 2.084 . . . . 4.64 111.968 175.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.403 ' HB3' ' H ' ' A' ' 254' ' ' GLN . 29.8 mtm180 88.29 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.418 -1.265 . . . . 6.11 112.689 153.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.424 HE21 ' HB2' ' A' ' 254' ' ' GLN . 0.0 OUTLIER -157.83 163.7 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.645 -0.872 . . . . 3.08 108.645 -171.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.66 125.17 62.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.818 0.342 . . . . 2.6 111.461 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -106.8 177.14 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 2.63 109.896 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.707 ' HB2' ' CE3' ' A' ' 191' ' ' TRP . . . -136.67 171.78 13.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.772 0.32 . . . . 1.71 111.487 -170.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.3 m -129.43 97.31 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.262 0.553 . . . . 2.21 110.157 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -153.62 138.98 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.835 -0.802 . . . . 4.31 108.835 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.366 -0.826 . . . . 4.49 111.043 -175.378 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.871 -0.789 . . . . 2.88 108.871 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.53 ' HA ' HD13 ' A' ' 255' ' ' ILE . 64.7 mt -86.29 86.83 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.494 0.664 . . . . 2.32 110.888 -171.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -94.29 101.73 13.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.681 -0.69 . . . . 2.82 109.146 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -58.62 -25.31 62.54 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.612 0.597 . . . . 2.24 112.612 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -73.87 -44.14 56.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 4.54 110.455 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 m -81.36 -21.02 39.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.459 . . . . 3.06 111.284 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 255' ' ' ILE . . . -56.8 142.1 42.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.468 -0.333 . . . . 1.72 110.826 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -134.42 114.46 12.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.706 0.289 . . . . 3.69 110.557 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -63.18 135.67 57.28 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.559 -0.534 . . . . 4.64 109.559 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -108.37 120.59 46.12 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.358 -0.383 . . . . 2.27 110.0 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.39 -24.02 50.47 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.695 2.264 . . . . 2.15 112.982 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.0 m -77.89 -26.84 49.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.795 0.331 . . . . 4.29 111.026 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 92.1 mt -83.28 140.9 32.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 4.74 110.475 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.44 159.92 38.13 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.082 -0.508 . . . . 3.77 110.864 -174.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.78 162.91 6.14 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.235 2.623 . . . . 2.36 113.255 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.576 ' HG ' ' CE2' ' A' ' 190' ' ' TYR . 95.2 mt -71.14 132.64 45.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 2.55 111.27 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 m -100.06 97.11 7.99 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.245 -1.021 . . . . 2.38 108.245 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.72 103.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.086 -0.506 . . . . 1.59 109.853 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.5 m -99.59 89.47 4.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.302 -0.629 . . . . 1.45 109.302 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -112.2 10.13 20.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.209 -0.45 . . . . 3.62 111.207 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.84 -30.71 64.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.891 0.377 . . . . 2.48 111.547 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.5 mp0 -109.04 39.64 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.361 -0.381 . . . . 2.24 110.427 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.99 57.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.821 0.343 . . . . 0.8 111.762 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 63.4 m -138.55 107.11 5.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.06 110.645 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -92.47 153.61 19.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.523 -0.547 . . . . 1.26 109.523 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -116.27 -58.62 2.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.505 0.558 . . . . 0.74 112.505 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -169.17 163.19 10.99 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.357 -0.214 . . . . 3.17 110.824 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -114.45 144.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.237 -0.283 . . . . 0.64 110.237 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -132.13 144.6 50.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.96 110.952 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -111.54 115.86 29.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 1.49 109.909 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -110.52 72.97 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.371 0.605 . . . . 1.83 110.929 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.77 -35.25 0.48 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 114.721 -1.127 . . . . 1.64 115.146 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -150.6 -29.78 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 117.104 0.452 . . . . 3.33 111.514 -173.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.43 161.87 25.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.583 -0.525 . . . . 1.38 109.583 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -129.19 121.55 27.92 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.194 0.521 . . . . 2.74 110.354 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -111.87 139.8 47.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 1.76 110.088 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 40.8 t -100.77 117.64 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.655 -0.498 . . . . 1.15 109.655 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.81 119.34 21.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 2.02 110.37 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -108.36 150.68 27.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.644 -0.707 . . . . 1.66 109.63 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 9.5 t0 -81.87 109.88 16.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 1.33 110.803 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.84 56.36 0.81 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.564 0.697 . . . . 2.65 110.334 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -89.23 -9.07 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 1.61 111.804 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 76' ' ' LYS . 11.5 pt20 -163.35 177.91 8.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.549 . . . . 2.35 109.516 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -76.41 23.47 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.257 0.348 . . . . 1.92 111.731 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 16.9 ptpt -54.08 -39.67 66.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.473 -0.331 . . . . 1.77 111.717 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -133.18 101.27 5.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.114 0.483 . . . . 0.76 110.332 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 89' ' ' ARG . 11.8 m -125.28 166.12 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.979 -0.555 . . . . 1.27 111.087 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.92 115.06 7.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.724 . . . . 1.29 109.844 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -145.13 123.5 12.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.058 0.456 . . . . 2.54 111.315 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -73.41 175.89 45.65 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 119.092 -0.838 . . . . 1.31 111.154 164.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.08 -143.4 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 N-CA-C 115.124 0.81 . . . . 1.9 115.124 168.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 72.3 Cg_exo -49.34 120.0 5.19 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.697 1.598 . . . . 2.91 112.728 -173.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 mt -154.35 -168.08 2.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.561 -1.2 . . . . 4.11 108.798 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.93 44.13 2.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.753 0.311 . . . . 4.95 110.954 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.503 ' HA3' ' OD1' ' A' ' 124' ' ' ASN . . . 129.59 -177.84 17.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.971 -0.633 . . . . 2.25 112.829 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 m -107.76 133.8 51.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.455 -0.572 . . . . 1.91 109.455 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 51.5 m-85 -108.66 114.28 27.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.958 0.408 . . . . 3.7 111.948 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 98.5 mtt180 -79.15 140.53 37.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.103 -0.499 . . . . 3.54 110.468 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.53 124.6 24.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.762 -0.458 . . . . 1.14 109.762 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 tt -117.8 -41.6 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 111.701 0.26 . . . . 1.68 111.701 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 10.0 pt20 -159.11 165.21 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.858 -0.423 . . . . 1.55 109.858 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CB ' HD23 ' A' ' 120' ' ' LEU . 42.4 p90 -146.98 161.01 41.67 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.007 -0.277 . . . . 0.86 111.456 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.432 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 11.7 p-80 -146.56 160.22 42.43 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.914 -0.585 . . . . 0.93 109.861 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.3 m-85 -122.75 148.93 44.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.889 0.376 . . . . 3.17 111.396 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -105.55 175.89 5.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.335 -0.617 . . . . 1.68 109.335 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -172.81 114.19 0.27 Allowed 'General case' 0 N--CA 1.463 0.176 0 O-C-N 123.199 0.312 . . . . 5.18 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.761 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -79.03 154.5 39.32 Favored Glycine 0 C--O 1.226 -0.397 0 N-CA-C 111.435 -0.666 . . . . 2.13 111.435 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 t -65.11 -29.25 70.1 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.195 0.997 . . . . 2.9 110.063 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.9 mt -106.4 144.98 32.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.448 -0.797 . . . . 3.03 109.438 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.19 70.3 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.553 0.533 . . . . 3.85 111.003 176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.66 43.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 1.94 112.741 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' ALA . 13.0 pt20 -173.12 164.01 4.78 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 110.1 -0.333 . . . . 2.45 110.1 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.58 -1.78 49.38 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.509 -0.853 . . . . 1.47 114.1 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 p -90.63 -26.73 19.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.825 0.676 . . . . 2.0 112.825 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 244' ' ' TRP . 0.6 OUTLIER 71.58 -170.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.749 -1.204 . . . . 3.72 107.749 -169.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.2 m80 54.99 71.37 0.54 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.312 0.505 . . . . 3.52 110.612 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 113' ' ' LYS . 14.2 p -87.0 116.3 24.96 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.448 -0.501 . . . . 2.52 110.723 -165.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 26.4 t -82.7 93.62 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.874 -0.417 . . . . 2.48 109.874 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 58.64 54.57 5.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.457 -0.572 . . . . 2.8 109.457 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 69.51 -2.33 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.106 -0.952 . . . . 4.98 112.578 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 23.1 ttmm -86.36 124.03 32.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.081 0.467 . . . . 3.23 111.192 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.543 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -116.33 138.09 51.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.799 -0.637 . . . . 2.82 109.694 175.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -88.38 159.99 17.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.639 -0.71 . . . . 1.62 110.499 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.526 ' HA ' ' H ' ' A' ' 103' ' ' GLN . . . -64.46 -20.05 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.846 . . . . 1.03 112.372 -174.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 147' ' ' LEU . . . -166.05 168.73 15.27 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.951 -0.389 . . . . 0.75 109.951 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -154.27 142.75 20.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.596 -0.52 . . . . 1.58 109.596 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 95' ' ' PHE . 15.1 tp -100.79 127.69 47.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.748 -0.66 . . . . 1.07 109.85 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.432 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.1 m170 -114.55 101.48 9.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.26 0.552 . . . . 1.77 110.831 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 48.0 mt -83.2 107.89 16.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.229 -0.896 . . . . 0.93 109.834 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 142' ' ' VAL . 41.3 t -82.57 123.27 38.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.384 0.612 . . . . 0.61 111.459 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 36.6 m-70 -123.09 147.22 46.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.289 -0.868 . . . . 2.13 109.387 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.671 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 62.5 p-90 -120.53 142.58 49.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.979 0.418 . . . . 4.26 111.113 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.503 ' OD1' ' HA3' ' A' ' 86' ' ' GLY . 30.2 t30 -66.58 111.91 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.02 111.288 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.671 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 12.1 t -70.58 -16.35 62.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.564 -0.743 . . . . 2.34 111.784 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.405 ' HB3' HD21 ' A' ' 124' ' ' ASN . 38.2 ttpt -58.4 -20.82 47.4 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.224 0.453 . . . . 3.35 112.224 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.48 6.2 49.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.135 0.493 . . . . 3.1 111.265 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.82 -3.46 3.84 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.773 1.069 . . . . 2.37 115.773 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -172.75 148.45 1.88 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.696 1.248 . . . . 3.93 110.104 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 134' ' ' VAL . 38.4 p90 -60.67 -34.11 73.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.607 -1.179 . . . . 3.0 112.563 -173.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.41 97.88 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.013 -0.613 . . . . 2.15 112.748 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -76.7 -27.99 55.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.966 0.412 . . . . 3.43 110.473 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.696 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -62.44 -35.42 79.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 1.76 110.866 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 130' ' ' PHE . 47.4 t -65.32 -16.92 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.077 -0.51 . . . . 2.77 111.26 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.59 -13.57 57.85 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.071 -0.393 . . . . 3.55 111.144 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.457 HE21 ' HA2' ' A' ' 139' ' ' GLY . 5.7 tt0 -102.53 134.15 20.1 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.786 -0.45 . . . . 3.02 109.786 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 51.5 Cg_exo -55.37 -26.12 51.39 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.975 2.45 . . . . 1.6 112.618 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 23.0 m-20 -111.98 27.24 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.07 0.462 . . . . 2.29 109.863 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.696 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -79.13 -33.6 35.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.015 -0.612 . . . . 1.22 113.729 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.404 ' HB2' HG22 ' A' ' 206' ' ' VAL . 85.3 mt -110.44 157.01 20.04 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.706 -0.479 . . . . 1.57 109.706 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.31 127.07 13.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.723 0.297 . . . . 1.38 110.24 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 121' ' ' VAL . 27.9 m -116.51 139.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 120.767 0.318 . . . . 1.73 110.358 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.2 tp -99.07 109.26 22.01 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.347 -0.612 . . . . 2.42 109.347 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -91.72 111.84 4.08 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.75 -0.659 . . . . 0.86 112.298 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.7 mt -109.42 118.17 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.726 -0.472 . . . . 0.76 109.726 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -69.54 143.24 53.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.405 -0.361 . . . . 1.2 111.303 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 10.8 mp -112.92 120.02 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.133 -0.485 . . . . 0.88 110.185 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.08 142.11 43.68 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.792 -0.818 . . . . 2.03 108.792 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.06 135.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 1.27 110.802 -174.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.01 -95.53 0.11 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.126 -0.789 . . . . 1.53 111.126 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.1 m -82.08 141.83 32.82 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.721 -0.474 . . . . 1.54 109.721 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.61 41.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.897 -0.592 . . . . 0.78 111.825 -174.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.9 tptt -117.28 102.17 52.53 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.474 . . . . 1.22 110.104 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.62 -42.41 67.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.442 2.762 . . . . 1.05 112.487 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 182' ' ' GLY . . . -59.33 -33.69 76.92 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.073 -0.584 . . . . 0.7 112.954 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.73 -30.95 22.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.152 0.501 . . . . 0.77 110.536 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -37.4 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.41 110.662 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -52.98 -49.44 66.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.204 -0.907 . . . . 2.86 112.414 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.92 -38.62 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 1.38 111.415 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.436 HG12 ' HD2' ' A' ' 224' ' ' LYS . 88.3 t -59.1 -39.6 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.21 0.529 . . . . 1.11 111.293 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.36 -15.76 39.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 1.22 112.284 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.34 -11.15 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.802 0.334 . . . . 1.41 111.399 -176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.87 -33.6 67.01 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.954 0.724 . . . . 1.39 112.954 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.57 -26.69 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.884 0.373 . . . . 2.31 111.524 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.7 m -80.89 -1.03 41.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.951 0.352 . . . . 1.4 111.951 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.6 pt -131.92 36.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.85 110.069 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.19 -33.58 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 1.59 112.669 -170.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 230' ' ' PHE . 18.0 p -119.48 159.51 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.857 0.361 . . . . 0.77 111.396 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -52.6 131.73 34.72 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.594 -0.73 . . . . 2.29 112.043 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.44 -28.44 15.01 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.871 -0.68 . . . . 0.85 112.451 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.79 143.62 52.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.212 0.53 . . . . 1.7 111.188 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.7 m -134.21 150.41 51.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 1.37 109.147 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -136.87 129.79 30.77 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.176 -0.305 . . . . 0.61 110.176 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.22 137.02 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.059 0.457 . . . . 1.8 110.672 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -140.85 80.4 1.75 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.197 -0.668 . . . . 1.04 109.197 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.0 p -116.04 163.66 15.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.469 -0.332 . . . . 1.17 111.466 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 58.91 36.98 24.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.848 -0.615 . . . . 1.77 111.276 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -129.75 133.79 47.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 3.99 110.202 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 181' ' ' ARG . 4.2 p30 -109.39 145.83 32.68 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.496 -0.775 . . . . 2.51 111.067 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 6.0 Cg_exo -79.0 -5.58 14.61 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.026 2.484 . . . . 1.26 112.342 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.494 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 5.6 tmm_? -57.6 -38.57 75.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.184 -0.462 . . . . 2.76 110.508 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -68.02 -7.03 48.62 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.818 -0.628 . . . . 1.12 113.361 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.94 -12.27 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.129 0.465 . . . . 1.73 111.015 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.53 129.99 55.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 3.45 110.645 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.89 -170.02 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.02 2.48 . . . . 2.08 113.404 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.93 -65.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.065 0.765 . . . . 3.23 113.065 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 12.9 m -68.95 131.61 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 1.66 111.328 -172.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.86 62.87 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 1.99 110.832 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 212' ' ' LYS . 13.9 t0 -127.65 141.59 51.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.435 -0.95 . . . . 1.81 108.435 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 47' ' ' LEU . 51.9 p90 -149.23 158.24 44.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.967 0.413 . . . . 5.01 111.846 -166.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 9.2 m-90 -115.51 107.36 15.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.534 -0.757 . . . . 3.93 109.077 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 5.9 t -96.31 117.2 30.32 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.828 0.677 . . . . 2.13 112.828 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -139.21 128.51 14.11 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 5.21 109.989 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 58.4 Cg_exo -53.38 136.72 63.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.191 2.594 . . . . 2.12 113.674 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -140.49 156.7 25.37 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.027 -0.533 . . . . 1.75 112.839 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 32.4 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.241 0.543 . . . . 2.99 109.812 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 196' ' ' SER . 43.7 tp . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.804 -0.443 . . . . 2.96 109.804 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -106.33 62.67 0.65 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.381 0.61 . . . . 3.37 110.868 -173.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 73.9 m -108.64 15.1 24.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 2.15 110.868 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 95.2 t -117.9 137.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 1.26 111.082 -177.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.8 m -98.19 104.67 16.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.475 -0.935 . . . . 2.08 108.475 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' A' ' 192' ' ' THR . 0.0 OUTLIER -86.7 100.61 12.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 5.53 110.924 -174.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.568 HG23 ' CD1' ' A' ' 190' ' ' TYR . 75.1 mt -96.42 100.02 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 1.63 109.479 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 191' ' ' TRP . 16.3 m -99.6 125.64 53.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.183 0.515 . . . . 1.62 110.603 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.2 tp -87.44 137.3 32.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.634 -0.712 . . . . 1.73 109.595 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 20.5 pttp -72.44 -11.2 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.035 0.383 . . . . 2.98 112.035 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.2 tp10 -101.11 105.98 42.14 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.655 0.264 . . . . 1.47 110.944 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 5.9 Cg_exo -75.47 149.69 35.17 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.886 2.391 . . . . 0.96 111.771 175.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.9 pt -99.82 147.25 7.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.001 -0.37 . . . . 1.25 110.001 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 42.7 m -92.35 123.79 35.94 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.567 -0.531 . . . . 1.29 109.567 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.14 163.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.886 -0.597 . . . . 1.02 110.265 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 41.3 t -90.25 147.38 23.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.125 0.488 . . . . 1.08 110.226 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.7 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 7.5 p -56.49 -35.36 67.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 1.33 110.653 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -70.06 -21.84 63.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.678 -0.692 . . . . 2.51 111.188 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -80.17 -51.74 8.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.393 . . . . 0.7 110.132 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.606 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 13.0 m -64.84 -29.21 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.455 0.539 . . . . 1.36 112.455 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.9 mt -66.05 -27.36 68.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 1.03 111.01 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.467 ' HA ' ' CG ' ' A' ' 227' ' ' LYS . 68.6 mttm -74.6 -21.0 59.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.267 -0.424 . . . . 1.75 110.959 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 26.2 m-85 -66.89 -19.06 65.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.106 0.479 . . . . 2.47 110.178 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -103.68 9.43 37.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 3.04 110.257 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 224' ' ' LYS . 12.5 mmmm -91.0 1.46 57.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 2.31 111.028 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.24 133.77 35.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.206 -0.664 . . . . 0.95 109.206 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 238' ' ' GLU . 3.3 p30 -159.19 -178.72 7.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.931 0.345 . . . . 1.13 111.931 -176.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.455 ' HB3' HG22 ' A' ' 168' ' ' THR . 35.0 t80 52.94 81.14 0.09 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.094 -0.957 . . . . 3.74 112.48 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.584 ' CG ' ' H ' ' A' ' 232' ' ' GLY . 0.0 OUTLIER -54.41 -87.65 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.051 -0.522 . . . . 1.62 111.61 171.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' A' ' 231' ' ' ASN . . . -125.08 -158.7 10.1 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.839 -0.696 . . . . 1.16 112.26 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.09 145.32 24.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.148 -0.315 . . . . 3.56 110.148 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.95 14.61 82.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.77 . . . . 2.08 112.288 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -148.72 107.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.59 108.64 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.11 114.32 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 120.722 0.948 . . . . 1.36 111.116 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.402 ' HB3' ' ND2' ' A' ' 231' ' ' ASN . 10.5 tp10 -139.37 104.08 4.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.51 -0.768 . . . . 3.4 111.442 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 229' ' ' ASN . 7.3 pt-20 -154.27 94.96 1.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.714 0.768 . . . . 2.47 109.951 157.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.25 99.63 4.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.237 -0.892 . . . . 2.14 109.501 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -118.4 82.87 1.92 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.965 -1.124 . . . . 1.68 107.965 172.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.8 m -156.57 133.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.906 -1.043 . . . . 1.27 110.141 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.761 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER 63.52 -79.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.239 0.962 . . . . 2.18 112.481 173.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 48.4 47.57 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.318 0.386 . . . . 2.15 110.681 -171.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 106' ' ' GLU . 85.9 t90 -105.12 134.02 48.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.916 0.389 . . . . 4.59 110.792 -172.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 32.2 ptt180 -105.32 132.23 21.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.986 -0.552 . . . . 6.13 110.416 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.417 ' HA ' ' CH2' ' A' ' 244' ' ' TRP . 62.5 Cg_exo -53.97 128.0 27.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.163 2.576 . . . . 3.28 112.676 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.39 159.76 33.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.684 -0.689 . . . . 2.98 111.983 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -108.73 149.85 40.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 4.32 110.673 -173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 36.7 Cg_endo -63.7 147.3 92.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.641 2.894 . . . . 3.48 114.075 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 67.5 mt -68.23 -12.42 60.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.86 -1.063 . . . . 4.63 113.364 -171.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 61.6 pttt -61.08 42.84 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.382 1.623 . . . . 5.34 115.382 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 1.5 p30 125.42 -4.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.378 1.871 . . . . 4.64 109.926 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 30.7 mmt180 -116.69 82.67 1.83 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.438 -1.319 . . . . 6.11 107.438 168.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -134.69 158.1 44.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.102 -0.333 . . . . 3.08 110.102 -166.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 33' ' ' ILE . 5.1 pt -102.62 125.9 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.808 0.67 . . . . 2.6 112.808 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 81.7 mttt -101.64 144.2 30.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.396 -0.82 . . . . 2.63 109.028 165.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 190' ' ' TYR . . . -106.65 148.17 28.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.248 -0.649 . . . . 1.71 109.248 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 190' ' ' TYR . 5.4 m -131.64 95.1 3.65 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.887 -0.725 . . . . 2.21 111.864 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -156.95 133.48 9.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.967 -1.015 . . . . 4.31 108.674 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.569 -0.729 . . . . 4.49 110.363 -173.196 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.513 ' HB2' HD21 ' A' ' 250' ' ' LEU . 1.4 m-20 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 122.048 0.928 . . . . 2.88 111.956 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.0 127.56 38.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.219 -1.355 . . . . 2.32 110.015 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.29 99.27 10.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.169 -0.468 . . . . 2.82 109.985 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -54.25 -29.32 46.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 2.24 111.568 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -75.33 -28.64 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 4.54 110.675 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 m -81.69 -28.77 33.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.874 0.369 . . . . 3.06 110.487 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -67.05 108.71 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.532 . . . . 1.72 111.593 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -85.31 138.18 32.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.6 -0.727 . . . . 3.69 110.484 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 30.1 p90 -78.57 130.71 36.26 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.393 -0.595 . . . . 4.64 109.393 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -109.11 109.79 60.71 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.337 -0.392 . . . . 2.27 110.11 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.41 -17.36 57.26 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.031 2.488 . . . . 2.15 112.49 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 83' ' ' PRO . 49.1 m -75.58 -9.04 58.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 4.29 110.858 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -96.55 139.26 32.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.286 -0.415 . . . . 4.74 110.283 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.9 161.14 37.73 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.468 -0.567 . . . . 3.77 109.468 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.55 157.15 23.78 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.748 2.299 . . . . 2.36 112.816 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.419 ' HG ' ' CD2' ' A' ' 190' ' ' TYR . 91.9 mt -85.64 138.78 31.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 2.55 111.146 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -101.33 120.57 40.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.652 -0.87 . . . . 2.38 108.652 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.46 103.06 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.76 0.315 . . . . 1.59 110.659 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 91.25 3.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.264 -0.643 . . . . 1.45 109.264 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 p90 -137.95 20.01 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.923 0.392 . . . . 3.62 111.45 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.39 -18.8 64.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.304 -0.407 . . . . 2.48 111.21 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -103.18 10.74 37.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.534 -0.303 . . . . 2.24 110.737 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.66 125.74 24.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.863 0.363 . . . . 0.8 111.627 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.3 m -115.42 109.23 17.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.963 -0.562 . . . . 1.06 111.243 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -78.12 149.66 33.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.552 -0.536 . . . . 1.26 109.552 174.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -121.59 -54.97 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.974 0.416 . . . . 0.74 111.466 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 14.7 ptm180 -140.6 152.23 45.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.362 -0.381 . . . . 3.17 110.698 -175.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.0 tt -127.61 133.92 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.585 -0.895 . . . . 0.64 108.585 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.68 162.88 36.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.96 111.777 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 169' ' ' LYS . 5.9 m-20 -101.3 109.87 21.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.926 -1.034 . . . . 1.49 109.237 176.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.565 ' HB3' ' OD1' ' A' ' 67' ' ' ASN . 42.5 t30 -126.57 129.37 48.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.112 -0.495 . . . . 1.83 111.06 -174.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 26.4 -74.59 0.0 OUTLIER Glycine 0 N--CA 1.47 0.96 0 N-CA-C 117.45 1.74 . . . . 1.64 117.45 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' ASN . 25.7 m80 -83.14 -19.79 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.983 0.364 . . . . 3.33 111.983 -167.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 175.38 -141.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.966 -0.383 . . . . 1.38 109.966 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -118.12 143.79 46.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.072 -1.085 . . . . 2.74 108.072 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 13.5 m120 -128.24 128.62 45.03 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.086 -0.339 . . . . 1.76 110.086 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.97 121.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.209 0.528 . . . . 1.15 109.851 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 58' ' ' ARG . 55.7 mm-40 -90.07 138.98 31.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 2.02 111.433 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.92 157.26 22.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.493 -0.776 . . . . 1.66 109.235 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.77 108.37 13.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.216 -0.661 . . . . 1.33 109.216 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -108.51 58.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.663 0.744 . . . . 2.65 110.607 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -100.85 -13.58 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.573 -0.74 . . . . 1.61 111.416 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -152.09 177.59 10.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.103 -0.499 . . . . 2.35 109.942 -170.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -82.01 65.96 7.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 1.92 110.987 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 58.6 mttm -90.59 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.946 -0.57 . . . . 1.77 109.838 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -114.39 99.03 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 0.76 110.267 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.88 145.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.94 -0.573 . . . . 1.27 110.51 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 tp -137.58 112.08 8.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 1.29 109.725 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 22.1 pttm -153.8 126.13 8.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 2.54 111.743 175.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.87 177.93 46.64 Favored Glycine 0 C--O 1.221 -0.707 0 CA-C-N 115.462 -0.79 . . . . 1.31 112.753 173.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.91 -132.76 0.0 OUTLIER Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.73 1.157 . . . . 1.9 115.764 167.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 43' ' ' SER . 78.9 Cg_exo -44.12 170.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.179 3.253 . . . . 2.91 114.43 -171.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.3 tp -32.37 75.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.553 1.316 . . . . 4.11 114.553 -145.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 80' ' ' LYS . 15.1 p-10 -76.73 -71.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.314 -1.766 . . . . 4.95 112.635 173.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 82.06 127.45 0.99 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.384 -1.086 . . . . 2.25 110.384 -165.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.9 m -63.48 103.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.103 0.452 . . . . 1.91 111.734 -174.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.561 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 63.6 m-85 -95.04 126.99 40.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.867 -0.606 . . . . 3.7 111.026 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -103.85 143.97 32.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.312 -0.403 . . . . 3.54 110.243 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 34.4 tp -81.52 132.01 35.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 1.14 110.86 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.7 tt -109.21 -35.0 2.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.183 -0.462 . . . . 1.68 110.784 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 172.25 8.42 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.341 -0.39 . . . . 1.55 110.316 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 118' ' ' LEU . 9.4 p90 -151.4 153.36 34.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.86 110.347 169.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.485 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 13.5 p-80 -148.16 157.64 43.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.559 -0.746 . . . . 0.93 109.62 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB3' ' HA ' ' A' ' 118' ' ' LEU . 53.1 p90 -139.7 123.06 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.773 -0.771 . . . . 3.17 111.374 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -94.73 146.24 24.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.099 -0.955 . . . . 1.68 110.353 171.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -132.7 170.81 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.603 -0.518 . . . . 5.18 109.603 -176.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -95.89 173.83 31.0 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.488 -0.863 . . . . 2.13 112.777 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.5 t -68.26 -28.0 66.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.283 0.563 . . . . 2.9 109.957 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.63 141.14 47.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.589 -0.732 . . . . 3.03 109.091 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 149' ' ' VAL . 4.8 p-10 -68.26 -5.88 20.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.168 0.432 . . . . 3.85 112.168 -174.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.79 10.06 57.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.807 -0.711 . . . . 1.94 113.047 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -164.41 170.28 16.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.892 0.346 . . . . 2.45 110.916 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 113.41 -14.59 22.86 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.502 -0.856 . . . . 1.47 112.518 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.3 t -75.59 -34.59 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.411 0.148 . . . . 2.0 111.203 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.469 ' HG2' ' NE1' ' A' ' 244' ' ' TRP . 0.0 OUTLIER 66.35 -172.19 0.19 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.6 0.563 . . . . 3.72 110.036 -171.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.519 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 17.3 m80 52.44 44.69 29.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.66 0.743 . . . . 3.52 109.62 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -79.29 117.47 20.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.034 . . . . 2.52 111.397 -172.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.04 95.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.692 -1.14 . . . . 2.48 110.504 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 58.66 60.04 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.844 -1.071 . . . . 2.8 110.824 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm 69.71 11.51 7.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.73 -0.668 . . . . 4.98 112.527 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -96.23 97.19 9.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.826 0.346 . . . . 3.23 110.644 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.496 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 98.6 mttt -96.11 148.38 22.74 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.261 -0.644 . . . . 2.82 109.261 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -106.6 -176.6 3.12 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.6 -0.519 . . . . 1.62 109.6 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.4 -43.55 66.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.803 0.335 . . . . 1.03 111.19 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.52 164.04 37.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 0.75 110.269 -174.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.519 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 29.6 tt0 -130.38 124.16 31.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 1.58 109.792 176.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 94' ' ' HIS . 56.7 tp -91.04 114.97 27.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.797 . . . . 1.07 110.214 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.485 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 22.5 m170 -102.91 106.55 17.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.159 -0.473 . . . . 1.77 110.615 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -95.74 108.09 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.256 -0.646 . . . . 0.93 109.256 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -81.91 126.34 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.339 -0.392 . . . . 0.61 110.822 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 58.5 m80 -125.56 145.17 50.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.834 -0.432 . . . . 2.13 109.834 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -124.6 143.91 50.45 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.83 -0.804 . . . . 4.26 108.83 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 87' ' ' THR . 35.8 p30 -83.52 139.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.859 0.837 . . . . 2.02 111.687 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -66.08 -16.01 63.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.095 -0.957 . . . . 2.34 110.567 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -50.63 -44.35 57.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 3.35 112.097 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -93.6 6.95 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.513 -0.475 . . . . 3.1 111.092 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.47 1.52 1.77 Allowed Glycine 0 C--N 1.335 0.472 0 N-CA-C 115.523 0.969 . . . . 2.37 115.523 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 132' ' ' LYS . 16.6 t70 -169.14 137.04 1.9 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.739 0.769 . . . . 3.93 109.658 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.607 ' O ' HG23 ' A' ' 134' ' ' VAL . 26.5 p90 -60.22 -43.27 96.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.714 -0.676 . . . . 3.0 110.984 -177.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -35.52 90.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.274 -0.489 . . . . 2.15 112.599 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -68.36 -37.59 80.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.773 -0.455 . . . . 3.43 109.773 177.152 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.88 -29.27 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 1.76 110.705 178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -65.57 -20.03 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 2.77 111.315 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -88.53 -1.74 58.22 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.762 -0.586 . . . . 3.55 111.614 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -126.21 143.17 44.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.868 0.366 . . . . 3.02 110.483 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 26.6 Cg_endo -62.0 -24.63 76.97 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.431 2.754 . . . . 1.6 113.493 -175.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -110.41 27.03 10.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.904 -0.406 . . . . 2.29 109.904 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -81.25 -48.53 5.95 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.946 -0.645 . . . . 1.22 113.788 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.496 HD11 HG22 ' A' ' 134' ' ' VAL . 85.8 mt -107.79 161.13 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.085 0.469 . . . . 1.57 111.316 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.3 104.9 4.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.624 -0.716 . . . . 1.38 110.33 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.4 t -97.66 115.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.236 -0.438 . . . . 1.73 109.858 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 63.5 tp -88.11 111.54 21.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.867 -0.606 . . . . 2.42 109.684 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.79 108.85 3.61 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.189 -0.529 . . . . 0.86 111.935 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 mt -102.07 130.77 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.158 -0.312 . . . . 0.76 110.158 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 69.9 m-85 -75.55 145.75 41.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.663 -0.244 . . . . 1.2 110.527 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.35 117.68 30.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.695 -0.483 . . . . 0.88 109.695 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 216' ' ' SER . 20.5 ptmt -114.72 152.42 32.05 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.283 -0.636 . . . . 2.03 109.283 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 29.3 t -92.26 131.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 1.27 110.861 -176.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.86 -105.55 0.21 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.627 -0.989 . . . . 1.53 110.627 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.5 m -70.03 160.61 31.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.506 -0.553 . . . . 1.54 109.506 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.61 159.22 15.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.573 -0.285 . . . . 0.78 111.193 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 216' ' ' SER . 12.4 mmmm -111.03 99.89 44.68 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.573 -0.899 . . . . 1.22 108.573 172.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.75 -21.05 61.7 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.984 2.456 . . . . 1.05 113.355 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.19 -13.34 81.01 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.654 -0.784 . . . . 0.7 112.919 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.9 tp -87.13 -17.96 31.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.77 111.004 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -60.41 -39.5 87.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.41 112.265 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 162' ' ' VAL . 30.7 mmmt -58.29 -40.92 83.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.618 0.247 . . . . 2.86 111.02 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.87 -46.9 84.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.262 0.553 . . . . 1.38 110.166 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 46.9 t -67.19 -27.68 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 1.11 111.295 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.02 -34.57 66.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 1.22 111.562 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 158' ' ' LYS . 87.7 t -82.54 -23.39 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.417 -0.356 . . . . 1.41 111.781 -174.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.7 pp -69.56 -12.84 61.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.018 0.437 . . . . 1.39 111.428 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.31 -26.5 68.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.088 0.47 . . . . 2.31 110.444 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.1 t -81.31 0.74 35.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 1.4 111.432 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.14 43.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.268 -0.641 . . . . 0.85 109.268 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.4 -38.37 66.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.084 -0.962 . . . . 1.59 112.622 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.8 p -105.52 149.9 25.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.631 0.253 . . . . 0.77 110.945 -177.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.501 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 61.7 pttt -66.54 141.14 57.96 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.973 -0.38 . . . . 2.29 109.973 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.34 -22.44 30.91 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.43 -0.89 . . . . 0.85 111.681 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -82.57 156.17 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 1.7 110.488 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -145.96 153.57 40.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.208 -0.451 . . . . 1.37 109.986 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.12 154.35 45.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.827 -0.435 . . . . 0.61 109.827 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.29 135.42 39.62 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.845 -0.428 . . . . 1.8 109.845 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.56 80.39 1.77 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.728 -0.841 . . . . 1.04 108.728 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.5 p -113.41 165.12 12.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.703 -0.68 . . . . 1.17 112.065 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.2 t30 54.9 57.84 5.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.5 -0.773 . . . . 1.77 111.113 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -135.1 131.75 37.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.835 -0.62 . . . . 3.99 109.824 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 13.0 m-20 -106.19 118.48 54.77 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.851 -0.425 . . . . 2.51 109.851 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 2.7 Cg_exo -76.21 -4.57 15.26 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.943 2.429 . . . . 1.26 112.898 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -59.05 -42.85 91.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.32 . . . . 2.76 111.548 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.05 -3.04 9.64 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.208 -0.52 . . . . 1.12 113.601 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 180' ' ' PRO . 7.8 mp -100.57 -1.29 35.87 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.66 -0.318 . . . . 1.73 111.117 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.0 pp -54.69 150.13 19.32 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 112.742 0.645 . . . . 3.45 112.742 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -91.05 -176.17 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.453 2.769 . . . . 2.08 111.467 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -85.69 -64.68 1.11 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.523 -0.471 . . . . 3.23 111.56 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.5 m -87.22 135.15 33.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.817 0.341 . . . . 1.66 111.495 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.21 62.89 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.404 0.621 . . . . 1.99 110.295 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 6.4 m-20 -116.37 170.05 8.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.944 -1.132 . . . . 1.81 107.944 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.419 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 46.6 p90 -168.04 161.73 12.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.793 1.035 . . . . 5.01 113.793 -166.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.441 ' HD1' ' O ' ' A' ' 210' ' ' VAL . 2.9 m95 -101.09 138.73 37.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.724 -1.584 . . . . 3.93 106.724 167.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.1 t -137.7 105.22 5.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.61 0.719 . . . . 2.13 112.031 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.501 ' CG ' ' HD2' ' A' ' 194' ' ' PRO . 25.9 t80 -139.3 149.6 61.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.264 -0.643 . . . . 5.21 109.264 173.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 193' ' ' TYR . 93.6 Cg_exo -46.88 129.91 15.18 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.456 2.104 . . . . 2.12 111.652 172.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.486 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -138.57 161.29 25.74 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.444 -0.798 . . . . 1.75 113.177 -166.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 108.831 -0.803 . . . . 2.99 108.831 176.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 37.4 tp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.716 0.293 . . . . 2.96 110.459 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 10.5 pt-20 -92.99 40.07 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.923 -0.581 . . . . 3.37 111.584 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 25.6 p -86.96 -4.49 59.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.293 0.568 . . . . 2.15 110.557 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 27.4 t -112.18 150.03 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.637 -0.71 . . . . 1.26 111.14 -173.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.9 m -107.21 103.5 12.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.332 -1.358 . . . . 2.08 107.332 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.432 ' HB2' ' HA3' ' A' ' 195' ' ' GLY . 1.1 t90 -75.52 102.29 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.033 0.444 . . . . 5.53 110.107 -172.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 42.3 mm -95.68 100.42 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.537 -0.756 . . . . 1.63 109.364 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.441 ' O ' ' HD1' ' A' ' 191' ' ' TRP . 32.4 t -94.03 119.03 41.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.42 -0.585 . . . . 1.62 109.42 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 189' ' ' ASP . 17.1 tp -73.95 122.45 22.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.949 0.404 . . . . 1.73 110.389 -174.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 17.8 tppt? -61.59 -21.91 64.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 2.98 111.995 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -95.14 111.87 56.41 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.642 -0.254 . . . . 1.47 110.537 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.422 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 98.4 Cg_endo -82.73 134.14 7.25 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.511 2.14 . . . . 0.96 111.752 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.7 pt -88.79 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 1.25 109.487 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.613 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 24.6 t -103.83 125.66 50.42 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.978 0.418 . . . . 1.29 110.763 -175.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.1 m -116.75 155.07 18.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 1.02 109.486 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.4 t -102.93 161.78 13.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.918 -0.313 . . . . 1.08 110.782 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.641 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 t -49.62 -54.06 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.668 0.605 . . . . 1.33 111.849 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 36.6 tt0 -52.56 -39.23 61.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.751 0.31 . . . . 2.51 111.781 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.4 -50.58 69.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.468 -0.333 . . . . 0.7 110.556 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.27 -19.95 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.429 -0.351 . . . . 1.36 111.587 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.2 mt -73.65 -44.26 57.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 1.03 110.558 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 52.5 mtpt -65.35 -25.86 67.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 1.75 110.562 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -75.29 -28.1 59.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.455 0.645 . . . . 2.47 109.744 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 56.1 ttp180 -71.8 -0.94 12.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.325 -0.852 . . . . 3.04 110.928 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -84.22 -14.14 50.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.982 0.42 . . . . 2.31 110.115 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.473 HD22 HD21 ' A' ' 61' ' ' ASN . 68.2 mt -69.65 144.83 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.49 0.662 . . . . 0.95 111.257 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.3 m120 -108.56 139.58 43.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.325 -0.852 . . . . 1.13 109.645 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.501 ' O ' ' HD3' ' A' ' 169' ' ' LYS . 65.8 t80 -79.14 -30.81 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.744 . . . . 3.74 109.956 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -68.85 163.46 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 1.62 111.5 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.11 48.29 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.474 -1.05 . . . . 1.16 110.474 174.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.1 135.06 47.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.501 0.65 . . . . 3.56 110.553 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.29 41.71 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.749 . . . . 2.08 112.797 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.66 162.34 43.33 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.968 0.384 . . . . 2.59 110.017 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.15 127.55 26.78 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.221 1.947 . . . . 1.36 111.361 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.67 120.38 12.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.408 0.623 . . . . 3.4 111.776 -174.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 13.2 pt-20 -128.47 153.46 47.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.305 -0.861 . . . . 2.47 108.828 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.23 135.95 33.29 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.649 0.261 . . . . 2.14 110.761 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.9 ttm -80.1 88.43 5.41 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.832 -0.803 . . . . 1.68 108.832 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.5 m -142.55 144.17 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.834 -0.802 . . . . 1.27 108.834 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.44 -78.19 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.734 0.646 . . . . 2.18 110.397 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.1 t30 42.5 40.56 1.96 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.901 0.75 . . . . 2.15 112.176 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.469 ' NE1' ' HG2' ' A' ' 106' ' ' GLU . 38.6 t-105 -141.59 160.67 39.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.067 0.461 . . . . 4.59 111.341 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 245' ' ' ARG . 25.0 mmt180 -128.38 83.4 66.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.143 -1.058 . . . . 6.13 108.143 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -55.52 -87.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 124.053 3.169 . . . . 3.28 116.487 -160.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -81.08 102.3 10.15 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.293 1.22 . . . . 2.98 114.293 -162.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.657 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 12.0 mm100 -80.31 -178.0 1.05 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.243 -1.021 . . . . 4.32 108.243 160.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.657 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 34.1 Cg_exo -40.76 112.14 0.17 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 121.867 1.711 . . . . 3.48 112.355 175.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -60.05 -51.45 69.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 4.63 112.452 -164.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -60.83 -9.97 4.88 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.901 1.445 . . . . 5.34 114.901 -174.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 253' ' ' ARG . 8.5 p30 38.09 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 118.749 2.87 . . . . 4.64 118.749 167.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.614 ' NE ' ' HA ' ' A' ' 253' ' ' ARG . 0.4 OUTLIER 171.4 -156.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.324 1.049 . . . . 6.11 109.201 -165.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -131.72 130.15 41.6 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.726 -1.583 . . . . 3.08 106.726 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 43.8 mt -111.92 145.46 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.809 0.338 . . . . 2.6 111.416 -166.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -123.34 162.08 23.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 2.63 109.935 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -159.16 170.74 21.29 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.385 -0.598 . . . . 1.71 109.385 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 8.6 t -148.23 113.41 5.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.744 -0.382 . . . . 2.21 110.441 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.413 ' CD1' ' HG2' ' A' ' 212' ' ' LYS . 88.6 t80 -117.85 95.33 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 4.31 109.54 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.529 -0.748 . . . . 4.49 110.146 -178.366 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 23.9 t0 . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 108.317 -0.994 . . . . 2.88 108.317 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mt -102.82 105.87 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.461 -0.495 . . . . 2.32 111.105 -173.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.56 107.37 18.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.093 -1.077 . . . . 2.82 108.093 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -54.8 -31.44 59.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 2.24 112.411 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -77.82 -44.69 26.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.737 0.304 . . . . 4.54 110.944 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 m -73.83 -28.06 61.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.545 -0.298 . . . . 3.06 111.372 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.6 129.85 42.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.011 0.434 . . . . 1.72 111.608 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -91.16 124.47 35.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.876 -0.602 . . . . 3.69 110.942 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -75.34 127.68 33.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.975 -0.557 . . . . 4.64 109.569 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.87 134.04 20.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.608 -0.515 . . . . 2.27 109.608 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.43 56.83 2.8 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.857 2.371 . . . . 2.15 112.656 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' LYS . 39.4 t -74.72 -56.85 4.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.053 -0.521 . . . . 4.29 110.204 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 mt 64.09 -25.31 0.08 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.389 0.885 . . . . 4.74 113.389 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' SER . 62.8 mttp -70.48 142.75 89.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.949 0.404 . . . . 3.77 111.691 -175.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.56 158.82 7.89 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.078 2.519 . . . . 2.36 112.486 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.539 HD23 ' HA3' ' A' ' 81' ' ' GLY . 79.0 mt -86.81 132.81 33.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 2.55 109.717 174.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 t -90.88 109.98 21.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.714 -0.847 . . . . 2.38 108.714 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.4 t -119.63 97.41 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.893 -0.41 . . . . 1.59 109.893 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 23.5 m -89.37 89.15 7.76 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.223 -0.658 . . . . 1.45 109.223 177.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -100.1 -6.39 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 3.62 111.383 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.516 ' HA ' ' NH2' ' A' ' 181' ' ' ARG . 32.3 t70 -61.32 -24.85 66.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.682 0.277 . . . . 2.48 111.529 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.5 mp0 -101.04 5.0 42.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.55 -0.296 . . . . 2.24 110.997 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.1 27.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.8 111.462 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 m -120.04 119.51 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.983 -0.553 . . . . 1.06 110.609 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 p -88.13 153.26 21.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.125 -0.488 . . . . 1.26 110.19 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.09 -56.67 1.82 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.74 111.725 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HA ' ' H ' ' A' ' 175' ' ' PHE . 32.3 ptt180 -152.34 159.42 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.053 0.454 . . . . 3.17 111.819 -175.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 66' ' ' PHE . 13.9 tt -115.18 134.81 57.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.34 -0.845 . . . . 0.64 109.54 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -133.68 142.79 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.802 0.334 . . . . 0.96 111.637 -171.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -101.48 88.95 3.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.767 -0.827 . . . . 1.49 108.767 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -142.32 90.32 2.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.384 0.512 . . . . 1.83 112.384 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . 139.45 -54.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.271 -0.966 . . . . 1.64 110.778 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 28.8 p80 174.07 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.652 -0.774 . . . . 3.33 111.153 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.569 ' CB ' ' H ' ' A' ' 95' ' ' PHE . . . -165.77 -170.15 1.71 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.205 0.526 . . . . 1.38 111.461 -173.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 59' ' ' ILE . 2.4 p90 -106.63 87.23 2.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.787 -1.097 . . . . 2.74 109.417 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 3.0 m-20 -71.44 100.26 2.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.663 -1.153 . . . . 1.76 110.324 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 72.8 t -85.41 113.39 23.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.035 0.445 . . . . 1.15 110.197 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.93 122.69 27.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.327 -0.851 . . . . 2.02 110.379 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -101.7 157.67 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.656 -0.498 . . . . 1.66 109.656 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.1 115.58 20.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.831 0.348 . . . . 1.33 110.661 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -127.01 56.03 1.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.786 0.803 . . . . 2.65 109.96 175.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -91.59 -11.77 36.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.806 0.812 . . . . 1.61 109.164 170.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 162.8 39.5 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.643 -1.162 . . . . 2.35 108.886 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -75.61 77.26 2.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.224 0.535 . . . . 1.92 111.169 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 98.2 mttt -92.94 -50.75 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.429 -0.805 . . . . 1.77 110.646 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -111.9 100.14 8.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.822 -0.626 . . . . 0.76 109.682 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.456 HG13 HG23 ' A' ' 87' ' ' THR . 55.1 t -110.19 131.75 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.008 -0.542 . . . . 1.27 111.843 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.56 119.28 31.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.756 -0.656 . . . . 1.29 109.993 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -160.26 122.15 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.591 -0.522 . . . . 2.54 109.591 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.539 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -129.1 -177.97 15.14 Favored Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.923 -0.932 . . . . 1.31 111.118 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.39 -130.0 0.0 OUTLIER Glycine 0 CA--C 1.543 1.818 0 O-C-N 124.771 0.924 . . . . 1.9 115.398 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -44.05 170.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.632 2.888 . . . . 2.91 114.178 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.2 pt? -30.67 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.964 1.364 . . . . 4.11 114.231 -146.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.587 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 12.3 p-10 -110.9 -112.23 0.33 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.231 -1.804 . . . . 4.95 113.042 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.587 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 97.47 155.11 29.99 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.53 -1.428 . . . . 2.25 109.53 -163.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.456 HG23 HG13 ' A' ' 78' ' ' VAL . 15.9 m -77.72 102.14 6.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.777 0.789 . . . . 1.91 110.934 -177.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 74.0 m-85 -97.55 117.71 32.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.039 -0.356 . . . . 3.7 110.039 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.84 145.41 26.61 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.845 -0.428 . . . . 3.54 109.845 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.7 tp -74.59 120.22 19.85 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.376 -0.601 . . . . 1.14 109.376 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 tt -113.12 -42.12 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.713 0.292 . . . . 1.68 111.329 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.0 pt20 -167.74 168.88 12.15 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.322 -0.622 . . . . 1.55 109.322 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.572 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 4.1 p90 -134.89 164.23 28.05 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.35 -0.54 . . . . 0.86 111.418 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -138.37 160.3 39.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.653 -0.869 . . . . 0.93 108.653 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.569 ' H ' ' CB ' ' A' ' 65' ' ' ALA . 79.1 t80 -130.25 144.14 51.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.484 0.183 . . . . 3.17 111.185 -172.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.61 146.95 40.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.988 0.423 . . . . 1.68 110.558 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -161.05 150.99 17.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 5.18 108.557 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -90.11 155.87 24.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.906 . . . . 2.13 112.672 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -60.56 -28.11 68.2 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.133 0.492 . . . . 2.9 110.477 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.55 -154.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.679 -0.691 . . . . 3.03 110.516 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -136.61 48.29 2.13 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.433 -0.951 . . . . 3.85 108.433 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.24 41.97 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.196 -0.911 . . . . 1.94 112.136 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.406 ' CG ' ' HA3' ' A' ' 98' ' ' GLY . 10.5 pt20 -159.21 169.76 23.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.713 -0.477 . . . . 2.45 109.713 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.67 10.37 86.26 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.882 -0.675 . . . . 1.47 112.888 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.45 -2.7 57.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.489 0.552 . . . . 2.0 112.489 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.572 ' HG2' ' H ' ' A' ' 107' ' ' HIS . 18.2 tt0 67.35 178.96 0.23 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.642 -0.503 . . . . 3.72 109.642 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.572 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 29.6 m80 48.57 45.05 21.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.396 0.679 . . . . 3.52 112.11 174.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.0 t -81.0 127.6 32.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.731 0.777 . . . . 2.52 111.672 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.04 115.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.755 -1.111 . . . . 2.48 110.503 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.24 37.21 23.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.846 0.831 . . . . 2.8 109.591 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.18 14.72 8.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.529 -1.214 . . . . 4.98 111.619 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -89.32 114.48 25.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.147 -0.686 . . . . 3.23 109.147 172.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -107.06 173.62 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 2.82 110.186 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.4 172.95 7.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.979 -0.555 . . . . 1.62 109.895 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.51 77.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.75 0.278 . . . . 1.03 111.75 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.431 ' HB1' ' CZ ' ' A' ' 95' ' ' PHE . . . -167.43 170.56 11.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.131 -0.486 . . . . 0.75 110.017 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -150.06 141.87 23.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 1.58 110.67 174.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.482 HD11 ' CD2' ' A' ' 93' ' ' PHE . 50.3 tp -105.26 125.74 51.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.598 -0.728 . . . . 1.07 109.052 174.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.512 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -114.76 102.43 10.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 1.77 110.341 -172.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.572 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 5.8 mp -90.27 111.26 22.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.359 0.599 . . . . 0.93 110.781 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -77.82 119.82 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.466 -0.788 . . . . 0.61 111.099 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 73.9 m80 -106.57 137.64 44.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.485 -0.779 . . . . 2.13 109.347 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -110.38 128.07 55.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.123 -0.489 . . . . 4.26 111.205 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -69.98 105.29 2.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.03 -0.532 . . . . 2.02 109.907 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.0 t -62.73 -17.49 60.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.544 . . . . 2.34 111.735 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.47 -29.79 70.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.45 -0.341 . . . . 3.35 111.799 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -90.35 -1.24 57.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.36 . . . . 3.1 111.069 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.84 23.73 2.63 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 115.826 1.09 . . . . 2.37 115.826 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.584 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 32.2 t70 -176.87 126.8 0.16 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.986 0.893 . . . . 3.93 109.801 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -64.31 -37.87 89.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.685 -0.689 . . . . 3.0 111.715 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -28.61 70.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.103 -0.57 . . . . 2.15 112.578 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 39.6 mmtm -80.49 -41.02 25.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.505 -0.554 . . . . 3.43 109.505 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.604 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.33 -38.84 88.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.452 -0.795 . . . . 1.76 112.152 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.7 -15.11 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.789 0.328 . . . . 2.77 111.168 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.53 13.33 26.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.287 -0.415 . . . . 3.55 110.432 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 17.4 mm100 -121.03 135.35 24.77 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.78 -0.452 . . . . 3.02 109.78 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.504 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 11.3 Cg_endo -56.09 -29.85 76.36 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.355 2.703 . . . . 1.6 113.798 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -111.37 25.57 11.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.922 0.391 . . . . 2.29 110.208 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -62.05 -48.72 81.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.247 0.859 . . . . 1.22 115.247 -172.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 206' ' ' VAL . 40.0 mt -133.92 170.31 15.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.835 0.817 . . . . 1.57 111.138 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.94 105.36 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.513 -0.767 . . . . 1.38 109.851 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.658 ' O ' ' HB ' ' A' ' 209' ' ' ILE . 4.7 m -88.83 111.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 1.73 111.36 -176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -86.27 100.43 12.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.774 -0.648 . . . . 2.42 110.287 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.64 118.5 5.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.161 -0.542 . . . . 0.86 112.558 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.57 118.37 58.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.781 -0.452 . . . . 0.76 109.781 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -71.04 147.57 48.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.998 0.428 . . . . 1.2 111.586 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 10.6 mp -116.75 131.82 56.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.656 -0.702 . . . . 0.88 110.271 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -126.4 144.33 50.87 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.789 -0.819 . . . . 2.03 108.789 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.03 130.94 35.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.454 0.645 . . . . 1.27 111.353 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 177.06 -105.25 0.2 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.114 -0.948 . . . . 1.53 110.921 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.9 t -71.53 142.95 50.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.424 -0.584 . . . . 1.54 109.424 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.53 156.58 39.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.78 111.202 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -118.08 95.04 47.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.596 -0.52 . . . . 1.22 109.596 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.65 -37.15 91.23 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.146 2.564 . . . . 1.05 112.49 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.05 -31.01 79.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.7 112.619 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.3 tp -88.78 -31.68 18.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.517 -0.402 . . . . 0.77 109.948 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -39.33 63.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.711 -0.677 . . . . 1.41 110.151 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -49.39 -47.91 47.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.676 -0.693 . . . . 2.86 111.016 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.68 -43.18 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 1.38 111.065 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 156' ' ' LEU . 19.3 t -61.76 -35.47 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.184 0.516 . . . . 1.11 111.147 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.36 -30.46 67.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.309 -0.405 . . . . 1.22 111.589 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 175' ' ' PHE . 9.6 p -92.9 -18.51 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.829 -0.348 . . . . 1.41 111.875 -173.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -67.73 -13.01 61.75 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.988 0.423 . . . . 1.39 111.092 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.54 -19.72 65.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.31 110.498 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.0 t -85.47 0.58 51.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.02 -0.536 . . . . 1.4 111.423 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 59' ' ' ILE . 41.1 pt -135.83 46.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.581 0.705 . . . . 0.85 109.585 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.23 -32.47 71.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.079 -0.964 . . . . 1.59 111.264 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.5 p -112.66 145.21 40.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.895 0.378 . . . . 0.77 110.937 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.48 138.55 58.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 2.29 110.542 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.57 -20.89 33.67 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.624 -0.798 . . . . 0.85 112.473 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.72 152.3 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.109 0.48 . . . . 1.7 111.188 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 m -132.43 157.82 43.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.37 109.642 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.57 151.02 39.69 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.394 -0.595 . . . . 0.61 109.394 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.16 132.76 43.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.192 0.52 . . . . 1.8 110.406 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 162' ' ' VAL . 48.9 t80 -141.48 79.23 1.67 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 1.04 108.295 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' SER . 6.2 m -111.87 156.82 21.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.608 . . . . 1.17 111.558 -174.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 56.4 58.22 4.38 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.357 0.663 . . . . 1.77 112.384 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.45 134.68 41.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 3.99 109.632 172.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.578 ' CG ' ' HE ' ' A' ' 181' ' ' ARG . 10.2 t70 -108.22 129.62 23.84 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 2.51 111.111 -173.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.65 -3.74 9.76 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.637 2.892 . . . . 1.26 114.704 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.578 ' HE ' ' CG ' ' A' ' 179' ' ' ASP . 18.5 ptp180 -59.93 -26.27 65.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.745 0.307 . . . . 2.76 111.401 -178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -79.74 7.14 56.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.92 -0.657 . . . . 1.12 112.299 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.4 mt -115.28 -27.52 7.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 1.73 110.312 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.34 131.63 80.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.799 -0.637 . . . . 3.45 111.428 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.1 -177.07 3.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.97 2.446 . . . . 2.08 112.873 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.79 -55.21 6.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.884 0.327 . . . . 3.23 111.884 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 4.5 m -85.21 130.3 34.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.27 -0.27 . . . . 1.66 110.27 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 tp -111.75 82.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.329 -0.396 . . . . 1.99 110.448 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -118.19 177.4 4.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.56 -0.533 . . . . 1.81 109.56 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -162.93 145.48 10.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.929 0.714 . . . . 5.01 112.929 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.428 ' CD1' ' HB ' ' A' ' 210' ' ' VAL . 7.4 m0 -116.17 145.47 43.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.496 -1.298 . . . . 3.93 107.496 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -142.44 102.83 4.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.779 1.029 . . . . 2.13 113.779 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 255' ' ' ILE . 48.8 t80 -142.41 128.43 10.67 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 5.21 110.031 168.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.74 127.74 23.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.817 2.344 . . . . 2.12 113.618 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -141.76 161.54 27.07 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.248 -0.887 . . . . 1.75 112.283 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 29.6 t . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 109.683 -0.488 . . . . 2.99 109.683 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.522 ' HB3' ' SG ' ' A' ' 205' ' ' CYS . 97.0 mt . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.032 0.444 . . . . 2.96 110.174 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -86.82 78.24 9.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.647 -0.706 . . . . 3.37 109.757 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 203' ' ' LEU . 60.0 m -121.08 -15.4 8.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 2.15 111.992 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 140' ' ' LEU . 47.1 t -145.13 102.65 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 C-N-CA 119.641 -0.823 . . . . 1.26 112.333 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 193' ' ' TYR . 82.3 m -155.73 88.8 1.14 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 2.08 111.508 166.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' TRP . . . . . 0.724 ' O ' HG12 ' A' ' 209' ' ' ILE . 1.1 p90 -150.05 87.06 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.163 -1.015 . . . . 5.53 112.449 160.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.724 HG12 ' O ' ' A' ' 208' ' ' TRP . 9.4 mm -166.89 113.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 123.999 0.92 . . . . 1.63 109.122 157.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 191' ' ' TRP . 95.5 t -125.23 99.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.656 -0.498 . . . . 1.62 109.656 166.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -66.81 107.5 2.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 1.73 110.719 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -53.71 -23.07 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 2.98 111.408 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.5 tp10 -105.17 113.63 64.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.273 -0.422 . . . . 1.47 110.841 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -82.88 152.2 14.57 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.579 2.186 . . . . 0.96 111.707 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.1 pt -100.59 152.17 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.006 -0.368 . . . . 1.25 110.006 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 62.8 m -94.78 129.27 41.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.28 -0.418 . . . . 1.29 109.96 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.33 162.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.065 -0.516 . . . . 1.02 109.853 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.426 ' HB3' ' HG3' ' A' ' 221' ' ' GLN . 48.3 t -88.21 146.03 25.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.183 -0.462 . . . . 1.08 109.823 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.717 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.3 t -57.44 -33.87 68.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.626 -0.715 . . . . 1.33 110.329 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.44 -20.71 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 2.51 111.095 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.426 ' HG3' ' HB3' ' A' ' 218' ' ' SER . 55.9 mt-30 -78.67 -45.89 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.283 -0.417 . . . . 0.7 110.015 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.668 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 24.9 m -70.41 -24.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.52 -0.309 . . . . 1.36 111.369 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.4 mt -62.38 -36.55 82.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.774 0.321 . . . . 1.03 110.556 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -73.22 -25.4 60.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 1.75 111.488 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.668 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.3 m-85 -67.5 -30.87 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.345 0.593 . . . . 2.47 109.657 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -81.54 1.5 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.247 -0.888 . . . . 3.04 110.601 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.29 -13.02 19.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.167 0.508 . . . . 2.31 109.806 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.417 HD21 HD13 ' A' ' 163' ' ' LEU . 93.8 mt -75.1 155.19 37.36 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.759 -0.655 . . . . 0.95 110.482 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.5 m120 -115.53 150.14 37.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.82 -0.627 . . . . 1.13 109.837 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -88.29 -27.34 21.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.45 -0.796 . . . . 3.74 109.953 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.8 p-10 -76.54 168.52 19.92 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.272 -0.877 . . . . 1.62 111.395 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.26 167.71 30.46 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.19 -1.164 . . . . 1.16 110.19 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.17 142.54 51.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 3.56 110.199 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.33 51.06 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.738 -0.744 . . . . 2.08 112.77 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.68 153.57 77.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.33 -0.619 . . . . 2.59 109.33 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.31 122.89 12.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.188 1.925 . . . . 1.36 110.582 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.582 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 9.7 pt-20 -67.42 129.98 41.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.792 0.806 . . . . 3.4 112.47 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.0 mt-10 -115.13 120.18 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.666 -1.152 . . . . 2.47 109.002 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.71 132.88 47.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.994 0.426 . . . . 2.14 110.834 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.1 tpp -71.94 91.65 1.22 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.441 -0.799 . . . . 1.68 111.067 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.16 147.54 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.549 0.214 . . . . 1.27 110.941 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.501 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER 66.79 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.584 0.754 . . . . 2.18 111.886 179.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 47.58 34.18 3.4 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.58 0.352 . . . . 2.15 111.838 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' TRP . . . . . 0.565 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 21.5 t90 -129.61 150.04 51.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 4.59 110.721 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 2.8 tmt_? -113.71 132.58 22.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.604 -0.517 . . . . 6.13 109.604 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.405 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 94.2 Cg_exo -46.47 151.8 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.717 2.944 . . . . 3.28 113.76 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -70.58 158.28 36.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.939 . . . . 2.98 111.598 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLN . . . . . 0.404 ' CD ' ' HD2' ' A' ' 249' ' ' PRO . 56.2 tp60 -121.55 128.37 25.67 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.399 -0.364 . . . . 4.32 110.148 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.404 ' HD2' ' CD ' ' A' ' 248' ' ' GLN . 10.3 Cg_endo -50.26 169.92 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.452 3.434 . . . . 3.48 115.449 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 3.2 mm? -62.16 -12.55 20.39 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.828 -1.533 . . . . 4.63 113.071 -169.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 19.0 ptpt -60.11 41.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.377 1.621 . . . . 5.34 115.377 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 7.4 p30 130.29 -3.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 126.099 1.76 . . . . 4.64 111.023 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 57.5 mmt-85 -130.32 95.42 3.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.106 0.479 . . . . 6.11 110.205 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -137.34 104.25 5.33 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 3.08 108.483 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 193' ' ' TYR . 2.0 mp -84.78 132.57 31.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.189 -0.46 . . . . 2.6 111.191 -169.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -80.63 150.34 29.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 2.63 109.851 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -112.6 140.79 47.07 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.113 -0.328 . . . . 1.71 110.113 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 48.9 m -152.0 96.76 2.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.342 0.591 . . . . 2.21 110.499 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.05 123.15 19.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.213 0.53 . . . . 4.31 110.997 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 pttm . . . . . 0 C--O 1.248 1.001 0 CA-C-N 114.98 -1.009 . . . . 4.49 111.887 177.178 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 120.701 0.286 . . . . 17.49 110.336 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m 58.92 23.13 11.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.742 -0.663 . . . . 15.32 111.895 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -148.66 94.91 2.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 15.81 110.677 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -93.21 -23.28 18.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.695 0.76 . . . . 14.19 109.01 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -146.62 135.97 22.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.537 -1.21 . . . . 14.91 109.354 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.02 139.36 9.23 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.152 -0.779 . . . . 10.79 111.152 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 243' ' ' ASN . 10.5 t80 -79.7 99.52 7.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.363 0.601 . . . . 11.39 109.542 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.36 -86.11 0.18 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.41 -1.476 . . . . 9.0 109.41 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -92.5 134.84 34.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.616 -1.253 . . . . 9.76 107.616 166.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -50.67 -48.21 58.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.126 0.787 . . . . 11.19 113.126 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -103.87 24.67 10.92 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.555 -0.458 . . . . 10.8 111.505 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.84 122.96 4.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.742 . . . . 8.82 111.946 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.24 121.88 7.89 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.804 1.669 . . . . 7.87 112.783 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -82.25 -40.81 21.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.372 -0.831 . . . . 10.62 110.58 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -61.57 -38.57 88.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.695 -0.684 . . . . 9.87 110.724 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.433 ' HZ2' HD11 ' A' ' 197' ' ' LEU . 45.1 t-105 -49.33 -52.3 28.83 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.965 0.358 . . . . 8.48 111.965 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -63.74 -31.33 72.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.732 0.301 . . . . 7.13 111.299 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -90.24 -11.47 40.84 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.775 -0.37 . . . . 9.68 111.669 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -89.54 -27.87 19.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.21 0.528 . . . . 7.89 110.036 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.439 ' HB3' HG22 ' A' ' 22' ' ' ILE . 85.6 m-85 -107.62 99.68 30.45 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.541 -0.754 . . . . 7.17 109.484 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.64 -32.74 55.87 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.427 2.751 . . . . 7.76 112.751 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.439 HG22 ' HB3' ' A' ' 20' ' ' PHE . 11.0 tp -54.05 -9.69 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 112.959 0.725 . . . . 5.83 112.959 175.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.39 -14.77 53.79 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.058 0.456 . . . . 5.44 110.439 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -50.55 -22.05 1.8 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.566 -0.743 . . . . 7.78 111.853 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.56 -175.05 32.54 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.029 -0.828 . . . . 5.01 111.029 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -117.7 107.45 14.2 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 117.484 -1.686 . . . . 7.09 109.81 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.8 ptt-85 -166.41 127.01 1.68 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.48 -0.563 . . . . 5.13 109.48 160.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 29' ' ' SER . 6.3 pt20 -116.27 -52.0 2.6 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 118.48 -1.288 . . . . 7.12 112.809 162.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 28' ' ' GLN . 4.8 m -94.63 155.98 38.88 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.632 -0.258 . . . . 3.94 110.435 -169.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HB3' ' OG1' ' A' ' 198' ' ' THR . 26.5 Cg_endo -64.79 -41.84 17.08 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.757 1.638 . . . . 4.52 112.623 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.4 p -162.15 163.48 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.43 0.633 . . . . 4.54 112.121 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 53.2 t0 -159.68 115.15 2.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.625 -1.17 . . . . 2.88 107.848 172.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.542 ' HA ' HG13 ' A' ' 255' ' ' ILE . 36.5 mt -113.01 140.41 33.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 120.854 0.359 . . . . 2.32 111.415 -167.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -135.31 137.18 42.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.316 -0.994 . . . . 2.82 108.316 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -47.87 -39.34 18.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.042 0.449 . . . . 2.24 111.855 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -81.32 -28.74 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.076 -0.511 . . . . 4.54 111.075 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -96.78 20.39 11.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.472 0.653 . . . . 3.06 110.906 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.48 130.68 53.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.466 -0.568 . . . . 1.72 109.466 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 256' ' ' LYS . 75.6 mmtt -109.52 122.27 47.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.918 0.39 . . . . 3.69 110.513 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -70.56 139.98 51.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.969 -0.56 . . . . 4.64 111.121 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.47 147.25 36.31 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.523 -0.762 . . . . 2.27 109.602 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 44' ' ' LEU . 14.0 Cg_endo -54.99 144.88 66.12 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.549 2.833 . . . . 2.15 113.71 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.441 ' HB2' ' HA ' ' A' ' 260' ' ' LYS . 14.1 t -46.32 45.26 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.111 1.523 . . . . 4.29 115.111 166.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 42' ' ' PRO . 3.7 pp -59.59 171.36 0.86 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.009 -0.541 . . . . 4.74 110.084 168.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 34.9 mmtp -53.69 123.23 37.19 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 120.806 0.336 . . . . 3.77 111.756 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 36.3 Cg_exo -60.59 171.46 3.45 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.581 2.854 . . . . 2.36 113.27 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.511 HD23 ' HA3' ' A' ' 81' ' ' GLY . 68.0 mt -82.14 111.69 18.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.387 -0.824 . . . . 2.55 109.555 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 m -78.14 108.73 11.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.046 -0.353 . . . . 2.38 110.046 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -101.93 113.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.281 0.563 . . . . 1.59 110.573 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -126.55 92.29 3.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.988 -0.551 . . . . 1.45 109.851 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 7.7 p90 -129.04 23.16 5.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.944 -0.571 . . . . 3.62 110.961 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.95 -22.4 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.11 0.481 . . . . 2.48 110.093 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -99.47 7.75 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.72 -0.673 . . . . 2.24 110.646 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.68 121.27 14.11 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.142 -0.481 . . . . 0.8 111.182 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 m -109.12 106.84 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.847 -0.615 . . . . 1.06 110.435 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 p -78.58 147.22 33.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.26 109.478 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.67 -57.13 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.979 0.418 . . . . 0.74 111.766 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -147.23 156.48 42.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.242 -0.435 . . . . 3.17 110.911 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.93 134.06 67.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.196 -0.668 . . . . 0.64 109.196 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 172' ' ' SER . 66.8 tp -136.22 144.08 44.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.96 111.249 -170.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -105.29 118.54 36.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.568 -0.742 . . . . 1.49 109.296 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.03 66.33 0.97 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.29 -0.564 . . . . 1.83 111.09 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 230' ' ' PHE . . . 66.73 -52.93 0.22 Allowed Glycine 0 CA--C 1.523 0.568 0 CA-C-N 114.487 -1.233 . . . . 1.64 115.289 165.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -96.34 -26.62 15.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.898 0.38 . . . . 3.33 110.208 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.32 178.62 8.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 1.38 110.095 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -126.61 123.81 38.48 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.921 -0.77 . . . . 2.74 108.921 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -117.08 143.44 45.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.947 0.403 . . . . 1.76 111.36 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -114.75 123.46 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.542 -0.54 . . . . 1.15 109.542 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 2.02 111.329 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.57 152.65 27.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.628 -0.714 . . . . 1.66 109.17 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -83.63 135.04 34.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.787 0.327 . . . . 1.33 110.383 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -133.49 59.35 1.74 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.985 0.897 . . . . 2.65 109.576 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -87.07 -11.32 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 1.61 109.634 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -144.66 177.35 8.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.415 -1.328 . . . . 2.35 107.415 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.07 71.57 4.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.734 0.778 . . . . 1.92 110.423 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -82.75 -61.06 1.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.175 -0.92 . . . . 1.77 110.738 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -112.78 98.06 6.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.76 110.024 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.12 138.72 36.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.915 -0.584 . . . . 1.27 111.166 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.7 tp -136.67 113.47 10.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.152 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.65 124.15 7.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.466 0.65 . . . . 2.54 111.553 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -87.53 178.33 47.36 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.167 -0.924 . . . . 1.31 111.478 169.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -38.62 -142.13 0.0 OUTLIER Glycine 0 CA--C 1.535 1.299 0 O-C-N 124.669 0.864 . . . . 1.9 114.974 167.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -49.65 120.41 5.84 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 121.59 1.527 . . . . 2.91 112.152 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.5 mt -159.43 -169.48 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.706 -1.134 . . . . 4.11 109.173 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -126.78 41.8 3.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.717 0.294 . . . . 4.95 110.779 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.91 176.14 14.21 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.632 -0.794 . . . . 2.25 113.172 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 125' ' ' THR . 76.4 m -102.09 122.05 43.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.771 -0.455 . . . . 1.91 109.771 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 38.2 m-85 -104.01 106.42 16.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.019 0.437 . . . . 3.7 110.928 -175.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' NH2' ' HZ3' ' A' ' 123' ' ' TRP . 18.4 mtm180 -85.61 149.59 25.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.49 -0.323 . . . . 3.54 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.85 124.73 28.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.412 -0.358 . . . . 1.14 110.239 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.471 HG23 ' HG2' ' A' ' 92' ' ' GLN . 7.2 tt -109.16 -34.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.464 -0.334 . . . . 1.68 111.392 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' HG23 ' A' ' 91' ' ' ILE . 27.6 pt20 -169.98 169.17 8.27 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.865 -0.152 . . . . 1.55 110.718 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 11.3 p90 -153.66 160.39 42.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.694 0.283 . . . . 0.86 110.845 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -147.55 162.27 39.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.6 -0.727 . . . . 0.93 109.55 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 85.4 m-85 -106.2 152.3 23.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.06 0.457 . . . . 3.17 111.278 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 119' ' ' HIS . 13.6 m170 -108.72 142.85 38.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.814 -1.18 . . . . 1.68 107.814 173.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.597 ' HE1' ' HB ' ' A' ' 222' ' ' VAL . 6.4 t90 -152.61 116.67 4.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.529 -0.468 . . . . 5.18 110.74 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.74 154.75 31.25 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.953 -0.641 . . . . 2.13 112.003 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.1 t -67.58 -32.37 73.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.223 0.511 . . . . 2.9 110.617 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -106.56 140.36 39.57 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.943 -0.762 . . . . 3.03 108.943 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -64.05 -4.38 3.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.896 0.702 . . . . 3.85 112.896 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -110.17 21.4 24.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.439 -0.886 . . . . 1.94 112.847 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.6 pt20 -158.87 165.57 33.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.13 0.465 . . . . 2.45 110.415 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.95 -34.66 3.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.26 -0.971 . . . . 1.47 114.246 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.8 p -73.4 -34.76 65.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.388 0.594 . . . . 2.0 111.873 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.28 -163.86 0.16 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.445 -0.946 . . . . 3.72 108.445 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 50.62 55.4 9.57 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.485 0.66 . . . . 3.52 109.889 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.8 p -77.94 117.56 19.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.273 -0.876 . . . . 2.52 110.981 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.541 ' H ' ' HB2' ' A' ' 112' ' ' LYS . 29.9 t -88.51 92.58 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.48 109.947 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.35 -67.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.652 1.22 . . . . 2.8 111.723 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 109' ' ' VAL . 22.3 pttp -127.22 -3.53 6.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.337 -0.392 . . . . 4.98 111.503 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.541 ' HB2' ' H ' ' A' ' 109' ' ' VAL . 64.3 mttm -69.56 178.17 2.62 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.041 -0.264 . . . . 3.23 110.479 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.8 pttt 147.77 109.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.746 0.819 . . . . 2.82 108.926 -160.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -121.39 166.66 13.78 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.146 -0.346 . . . . 1.62 110.073 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' GLN . . . -79.55 -17.89 52.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 1.03 112.441 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 97' ' ' TRP . . . -156.65 164.36 38.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.932 0.396 . . . . 0.75 111.513 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.84 151.54 20.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.508 -0.769 . . . . 1.58 110.402 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.463 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 39.7 tp -104.23 127.44 51.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.675 -0.491 . . . . 1.07 109.675 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 96' ' ' HIS . 22.6 t-160 -118.19 105.84 12.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.372 -0.376 . . . . 1.77 110.227 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.2 mp -100.23 125.92 46.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.93 110.689 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 142' ' ' VAL . 46.4 t -98.5 125.18 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.926 0.393 . . . . 0.61 111.235 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -116.26 144.03 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.489 . . . . 2.13 109.681 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.47 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 11.2 t90 -117.9 137.93 52.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.16 -0.473 . . . . 4.26 111.294 -175.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.511 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 30.6 t30 -70.72 104.58 2.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.34 0.59 . . . . 2.02 111.238 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 87' ' ' THR . 7.7 t -67.62 -25.62 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.835 1.05 . . . . 2.34 113.835 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 64.8 pttt -68.39 -5.12 17.29 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.277 0.843 . . . . 3.35 113.277 -171.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -107.44 -0.78 22.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.049 -0.407 . . . . 3.1 111.638 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.88 30.3 4.89 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.149 -0.932 . . . . 2.37 115.148 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 14.9 t70 -163.27 121.27 1.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.931 0.865 . . . . 3.93 109.388 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.506 ' O ' HG23 ' A' ' 134' ' ' VAL . 55.3 p90 -66.44 -40.08 89.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 3.0 111.951 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -32.47 81.8 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.816 -0.707 . . . . 2.15 112.451 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 42.2 mmtm -66.34 -34.57 78.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.79 0.328 . . . . 3.43 110.215 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.34 -34.03 74.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.971 -0.558 . . . . 1.76 110.767 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 130' ' ' PHE . 63.3 t -65.06 -25.75 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 2.77 110.571 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.61 16.78 6.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 3.55 110.977 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 21.6 mt-30 -131.69 135.33 26.65 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 3.02 109.687 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 37.7 Cg_exo -60.59 -26.4 82.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.655 2.237 . . . . 1.6 112.725 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -113.92 19.18 16.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 2.29 111.07 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.15 -29.44 73.35 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.888 -0.672 . . . . 1.22 114.127 -172.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.8 158.61 34.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.066 0.433 . . . . 1.57 110.982 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -144.49 126.96 15.94 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.952 -0.759 . . . . 1.38 108.952 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 121' ' ' VAL . 32.2 m -125.49 149.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.933 0.397 . . . . 1.73 111.38 -173.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.53 122.7 47.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.614 -0.721 . . . . 2.42 110.187 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.8 109.76 2.89 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.29 -0.724 . . . . 0.86 111.29 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.415 HG12 HD12 ' A' ' 211' ' ' LEU . 23.7 mt -111.28 113.9 45.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.243 -0.28 . . . . 0.76 110.243 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -66.6 145.32 55.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.788 0.328 . . . . 1.2 111.01 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.48 124.09 51.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.779 -0.452 . . . . 0.88 109.779 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -116.2 141.97 47.44 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.559 -0.534 . . . . 2.03 109.559 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 45.1 t -85.45 132.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.061 0.457 . . . . 1.27 110.866 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.3 -105.08 0.21 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.997 -0.841 . . . . 1.53 110.997 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.7 t -71.19 142.33 50.65 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.301 -0.629 . . . . 1.54 109.301 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.68 151.86 45.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.558 -0.292 . . . . 0.78 111.059 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.0 tptt -108.48 99.11 31.32 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.657 -0.497 . . . . 1.22 109.657 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.54 -36.89 89.99 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.965 2.443 . . . . 1.05 112.742 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.07 75.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.991 -0.624 . . . . 0.7 113.115 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 160' ' ' VAL . 26.2 tp -83.92 -17.23 41.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.224 0.512 . . . . 0.77 110.373 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -41.56 63.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 1.41 110.768 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.434 ' HE3' ' OD1' ' A' ' 179' ' ' ASP . 65.3 mttm -49.2 -49.09 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.557 . . . . 2.86 112.415 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 14.8 p -79.99 -35.9 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.708 -0.397 . . . . 1.38 110.832 -177.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' A' ' 163' ' ' LEU . 78.2 t -59.8 -35.77 62.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.363 0.601 . . . . 1.11 110.452 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.52 -33.99 76.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.198 -0.91 . . . . 1.22 111.963 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.9 p -99.25 -3.66 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 111.793 0.294 . . . . 1.41 111.793 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 92.8 mt -55.6 -42.49 74.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.848 0.356 . . . . 1.39 111.916 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.99 -20.94 65.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.422 -0.353 . . . . 2.31 111.662 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 72.6 m -92.66 0.4 57.42 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.219 0.452 . . . . 1.4 112.219 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.09 34.52 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.578 -0.527 . . . . 0.85 109.578 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.449 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 82.6 tttt -62.02 -50.23 72.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.262 -0.881 . . . . 1.59 112.152 -172.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 171' ' ' LYS . 37.9 p -102.69 152.15 21.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.696 0.284 . . . . 0.77 111.118 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -71.62 146.6 48.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.885 0.374 . . . . 2.29 110.662 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.64 -30.15 9.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.529 -0.843 . . . . 0.85 112.5 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 168' ' ' THR . 21.5 ptmt -90.87 155.58 18.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 1.7 110.914 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.459 ' HB3' HD13 ' A' ' 60' ' ' LEU . 16.5 p -128.07 160.41 32.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.518 -0.765 . . . . 1.37 110.548 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -144.66 145.86 31.96 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.047 -0.353 . . . . 0.61 110.047 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.15 131.74 40.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.829 -0.434 . . . . 1.8 109.829 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -139.97 79.93 1.74 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.992 -0.744 . . . . 1.04 108.992 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 p -104.65 162.7 13.06 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.462 -0.79 . . . . 1.17 111.477 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 58.12 45.97 16.83 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.788 0.662 . . . . 1.77 112.788 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -99.06 135.46 40.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.974 -0.38 . . . . 3.99 109.974 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.434 ' OD1' ' HE3' ' A' ' 158' ' ' LYS . 6.3 p-10 -110.61 119.28 46.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 121.13 0.49 . . . . 2.51 110.675 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.86 -7.28 19.12 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.817 2.345 . . . . 1.26 112.639 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -63.36 -28.58 70.09 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.877 0.37 . . . . 2.76 110.688 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.63 -0.75 59.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.172 -0.537 . . . . 1.12 112.977 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 74.9 mt -102.32 -7.06 22.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.583 0.23 . . . . 1.73 111.396 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.82 130.27 88.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.622 0.601 . . . . 3.45 112.622 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.82 -171.59 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.892 2.395 . . . . 2.08 111.369 173.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.75 -62.47 1.68 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.959 0.409 . . . . 3.23 110.613 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.52 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.3 m -91.05 144.77 25.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 1.66 110.279 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 44.3 tp -109.81 63.34 0.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.362 0.601 . . . . 1.99 110.549 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 212' ' ' LYS . 4.2 m-20 -97.8 162.82 13.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.484 -0.932 . . . . 1.81 108.484 174.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.529 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.6 p90 -167.16 156.01 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.159 -0.616 . . . . 5.01 112.474 -174.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.436 ' NE1' ' HG2' ' A' ' 212' ' ' LYS . 12.1 m95 -107.25 149.16 28.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.875 -1.157 . . . . 3.93 107.875 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.8 t -131.28 103.46 6.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.472 0.653 . . . . 2.13 111.589 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.524 ' OH ' ' HA ' ' A' ' 253' ' ' ARG . 45.3 t80 -138.75 132.42 16.23 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 5.21 111.018 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 43.3 Cg_exo -58.3 130.07 35.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.596 2.198 . . . . 2.12 111.876 172.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -108.23 155.71 16.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.209 -0.519 . . . . 1.75 113.068 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 198' ' ' THR . 22.7 t -82.97 -137.8 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.431 0.692 . . . . 2.99 112.256 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.572 ' C ' ' H ' ' A' ' 199' ' ' THR . 32.0 tp -39.95 13.32 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 128.289 2.636 . . . . 4.75 117.46 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.546 ' OG1' ' HB3' ' A' ' 30' ' ' PRO . 3.8 m -67.7 24.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.617 -1.302 . . . . 5.1 111.333 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 197' ' ' LEU . 1.1 p -149.35 164.45 20.98 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 123.556 0.742 . . . . 5.53 109.029 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.433 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 59.7 Cg_exo -48.27 -50.49 12.0 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.306 2.004 . . . . 5.83 113.992 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 7.4 Cg_endo -88.92 147.71 5.71 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.224 1.95 . . . . 4.78 112.381 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.17 78.97 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 3.84 110.595 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.81 174.05 12.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.533 -0.303 . . . . 2.96 110.63 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 8.5 pt-20 -112.88 71.99 0.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.227 0.537 . . . . 3.37 110.746 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.463 ' SG ' HG21 ' A' ' 199' ' ' THR . 28.7 p -96.87 -9.6 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.15 110.645 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.89 141.06 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.782 -0.645 . . . . 1.26 111.395 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.3 m -113.18 108.8 17.78 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.002 -0.74 . . . . 2.08 109.002 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 192' ' ' THR . 33.6 m95 -82.31 119.22 23.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.936 0.398 . . . . 5.53 111.985 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 48.5 mm -108.78 99.55 8.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.379 -0.971 . . . . 1.63 108.379 170.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.6 t -101.65 119.36 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.316 -0.402 . . . . 1.62 110.386 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 40.1 mt -74.68 137.92 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.829 0.347 . . . . 1.73 110.254 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 85.2 mttt -83.06 -8.64 59.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 2.98 110.68 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 187' ' ' SER . 8.4 tp10 -105.26 101.38 30.61 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.255 -0.43 . . . . 1.47 110.501 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 15.7 Cg_exo -69.23 141.48 47.5 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.757 2.305 . . . . 0.96 111.713 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.8 pt -87.46 150.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.907 -0.405 . . . . 1.25 109.907 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 12.9 m -90.44 122.03 32.93 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.074 -0.512 . . . . 1.29 110.526 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.4 m -125.09 151.22 30.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.238 -0.653 . . . . 1.02 109.238 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 60.8 p -91.1 160.05 15.78 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.488 -0.485 . . . . 1.08 111.525 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.488 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.3 m -54.27 -45.56 72.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.768 0.318 . . . . 1.33 110.803 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -55.74 -32.5 63.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 2.51 111.434 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -76.87 -52.09 10.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.479 -0.328 . . . . 0.7 110.846 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.597 ' HB ' ' HE1' ' A' ' 97' ' ' TRP . 15.7 m -64.04 -34.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.081 0.4 . . . . 1.36 112.081 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.4 mt -63.39 -30.68 71.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.689 0.281 . . . . 1.03 111.385 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -78.8 -20.18 50.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.313 . . . . 1.75 111.621 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -71.96 -24.48 61.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.275 0.559 . . . . 2.47 109.866 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -80.69 1.28 30.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.59 -0.732 . . . . 3.04 110.533 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -91.61 -9.03 45.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 2.31 110.635 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.06 153.98 39.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.092 0.472 . . . . 0.95 110.638 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.3 m120 -119.31 150.87 39.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.958 -0.564 . . . . 1.13 110.928 -175.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 240' ' ' MET . 33.4 m-85 -77.46 -34.75 54.33 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.377 -0.972 . . . . 3.74 108.377 170.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.9 p-10 -74.31 163.84 27.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.078 -1.419 . . . . 1.62 112.39 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.72 -170.75 47.16 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.614 -1.175 . . . . 1.16 110.993 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.0 126.72 31.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.957 -0.386 . . . . 3.56 109.957 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.9 29.49 31.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.844 -0.694 . . . . 2.08 112.068 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 20.0 mm-40 -127.43 159.13 67.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.138 -0.319 . . . . 2.59 110.138 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.21 121.86 10.15 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 1.36 112.518 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.21 119.36 7.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.573 -0.74 . . . . 3.4 112.534 -174.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.3 mt-10 -131.72 146.74 52.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 2.47 109.206 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.2 mt -97.44 125.3 42.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.394 -0.224 . . . . 2.14 110.394 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.562 ' HA ' ' CE2' ' A' ' 230' ' ' PHE . 55.5 ttm -69.45 90.79 0.54 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.515 0.51 . . . . 1.68 110.176 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.42 157.26 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 1.27 110.979 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 12.9 t70 68.47 -85.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.114 -0.948 . . . . 2.18 111.066 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.49 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 56.2 m-80 50.06 35.47 10.02 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.911 0.708 . . . . 2.15 112.911 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.424 ' HE1' ' CG ' ' A' ' 96' ' ' HIS . 2.3 m95 -137.36 158.97 43.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.424 0.63 . . . . 4.59 111.6 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -111.22 146.87 35.44 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.181 -0.918 . . . . 6.13 110.357 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.89 151.26 20.69 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.926 2.417 . . . . 3.28 112.892 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -78.31 159.74 28.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.439 -0.8 . . . . 2.98 110.681 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -113.79 153.69 45.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.42 . . . . 4.32 111.404 -172.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.84 178.57 2.74 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.762 2.975 . . . . 3.48 113.39 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 252' ' ' ASN . 4.2 mm? -51.11 -11.15 0.09 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.056 0.942 . . . . 4.63 113.021 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -59.49 41.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.092 0.957 . . . . 5.34 113.492 170.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.545 ' H ' ' C ' ' A' ' 250' ' ' LEU . 2.9 t30 119.07 41.91 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.584 1.954 . . . . 4.64 112.296 169.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.645 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 7.4 ppt_? -145.52 121.44 10.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 6.11 110.896 160.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -137.48 122.4 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.656 -1.238 . . . . 3.08 107.656 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 33' ' ' ILE . 29.4 mm -91.49 144.1 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 2.6 112.416 -165.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 67.6 mttm -127.97 146.6 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 2.63 109.101 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.408 ' HB2' ' CE3' ' A' ' 191' ' ' TRP . . . -138.17 103.85 5.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.572 0.225 . . . . 1.71 110.785 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.8 p -92.77 98.52 11.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.013 0.435 . . . . 2.21 111.014 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.86 154.3 27.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.248 -0.433 . . . . 4.31 110.018 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 43' ' ' SER . 49.2 pttt . . . . . 0 C--O 1.246 0.895 0 O-C-N 123.613 0.571 . . . . 4.49 111.335 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.478 0.965 0 CA-C-O 120.554 0.216 . . . . 17.49 111.138 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 p -132.81 122.22 24.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 15.32 111.548 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -125.47 163.79 21.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.302 -0.408 . . . . 15.81 110.155 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.432 ' CD2' ' HG2' ' A' ' 9' ' ' LYS . 44.9 m80 -105.6 112.33 25.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.945 -0.57 . . . . 14.19 110.252 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -117.12 66.03 0.73 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.2 0.524 . . . . 14.91 110.859 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.21 158.58 12.45 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.783 -0.927 . . . . 10.79 110.783 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -78.22 97.41 5.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.248 0.547 . . . . 11.39 109.8 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.41 122.15 4.99 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.846 -0.901 . . . . 9.0 110.846 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 4' ' ' HIS . 87.8 mttt -60.28 119.45 7.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.419 0.155 . . . . 9.76 111.419 -176.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.7 m170 44.66 -87.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.06 0.944 . . . . 11.19 113.026 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -97.0 21.17 10.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 10.8 110.724 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -102.18 2.84 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.086 -1.206 . . . . 8.82 110.086 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HB2' ' HB2' ' A' ' 16' ' ' TRP . 2.4 Cg_endo -82.72 123.03 3.6 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.899 1.733 . . . . 7.87 110.559 166.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.7 -37.72 16.46 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.728 0.299 . . . . 10.62 110.984 -177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -80.54 -4.38 53.73 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.828 -0.349 . . . . 9.87 110.946 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 2.0 t90 -93.11 -46.97 7.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 8.48 110.209 -173.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -67.63 -4.64 12.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 111.963 0.357 . . . . 7.13 111.963 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -66.63 -37.53 85.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.467 0.651 . . . . 9.68 109.429 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.97 -26.27 25.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.11 -0.95 . . . . 7.89 110.627 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -129.88 91.83 38.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 7.17 110.236 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.533 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 24.9 Cg_exo -63.86 -25.73 67.54 Favored 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 123.299 2.666 . . . . 7.76 113.953 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.9 pt -61.72 -10.54 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 113.174 0.805 . . . . 5.83 113.174 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.67 -22.51 66.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.659 0.266 . . . . 5.44 111.48 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 22.3 pttp -102.77 23.84 11.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 7.78 110.601 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.48 -111.1 3.57 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 111.021 -0.832 . . . . 5.01 111.021 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -80.02 123.83 28.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.585 -1.265 . . . . 7.09 107.585 168.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.565 ' HG2' ' HB2' ' A' ' 252' ' ' ASN . 9.9 mpt_? -84.64 153.81 22.93 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.019 0.914 . . . . 5.13 111.878 -175.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 196' ' ' SER . 0.0 OUTLIER -149.73 24.21 0.87 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.926 -1.488 . . . . 7.12 109.374 -168.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.494 ' HB2' HG13 ' A' ' 31' ' ' VAL . 14.9 m -97.51 159.8 30.25 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 113.219 0.822 . . . . 3.94 113.219 -161.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.582 ' HA ' ' CE1' ' A' ' 107' ' ' HIS . 13.4 Cg_endo -54.61 35.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.174 1 C-N-CA 126.747 4.964 . . . . 4.52 115.742 174.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 248' ' ' GLN . 13.1 m -85.95 -176.31 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 118.401 0.546 . . . . 4.54 111.987 -162.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -90.17 135.23 33.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.16 -0.927 . . . . 2.88 110.668 -164.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HB ' HG22 ' A' ' 109' ' ' VAL . 41.1 mt -97.18 126.54 49.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.985 -0.552 . . . . 2.32 110.562 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 16.7 t70 -112.73 117.41 32.13 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.379 -0.6 . . . . 2.82 109.379 171.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 p -56.05 -27.67 54.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.945 -0.57 . . . . 2.24 112.458 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.506 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 43.5 m80 -74.29 -18.04 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.185 0.517 . . . . 4.54 110.318 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -117.87 18.9 13.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.497 -0.774 . . . . 3.06 109.851 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.63 85.33 2.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.394 -0.595 . . . . 1.72 109.394 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -75.8 121.93 23.31 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.453 -0.794 . . . . 3.69 111.535 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 40.4 p90 -84.2 143.45 29.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.297 -0.411 . . . . 4.64 110.318 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' HB2' ' HG ' ' A' ' 44' ' ' LEU . 25.4 m-20 -109.7 119.36 48.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.177 -0.465 . . . . 2.27 110.43 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.13 -15.24 46.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.758 2.305 . . . . 2.15 111.587 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.9 m -75.98 -19.21 58.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 4.29 110.746 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 89.5 mt -83.1 137.87 33.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.093 0.473 . . . . 4.74 110.259 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -118.54 135.19 23.53 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 3.77 110.73 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.99 158.09 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.94 3.094 . . . . 2.36 113.303 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.15 155.61 19.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 2.55 111.423 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 80' ' ' LYS . 34.7 p -129.1 136.04 49.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.402 -0.817 . . . . 2.38 108.984 173.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.31 136.78 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.383 -0.372 . . . . 1.59 110.981 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -119.29 89.34 3.11 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.508 -0.553 . . . . 1.45 109.508 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -103.1 5.72 38.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.786 -0.643 . . . . 3.62 110.254 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -51.88 -40.08 60.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 2.48 111.555 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -111.66 23.67 13.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.266 -0.425 . . . . 2.24 111.343 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.18 111.17 6.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.86 0.362 . . . . 0.8 111.014 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -106.22 108.47 20.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.282 -0.417 . . . . 1.06 110.863 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 176' ' ' THR . 17.3 m -77.43 148.74 35.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.223 -0.658 . . . . 1.26 109.223 174.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.44 -56.99 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.681 0.252 . . . . 0.74 111.681 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -154.18 164.9 37.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.161 0.505 . . . . 3.17 111.49 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.77 138.3 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.338 -0.846 . . . . 0.64 109.779 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.5 tp -130.29 139.57 50.73 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.593 -0.276 . . . . 0.96 111.09 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -91.46 117.02 29.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.195 0.521 . . . . 1.49 110.743 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -115.59 150.05 37.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.182 -1.414 . . . . 1.83 107.182 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.71 38.2 0.49 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.65 -0.786 . . . . 1.64 114.536 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -132.61 -39.7 0.99 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.188 -0.671 . . . . 3.33 109.188 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.24 -170.31 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.311 -0.996 . . . . 1.38 108.311 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -108.63 135.53 49.73 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.128 -0.694 . . . . 2.74 109.128 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.67 111.61 24.18 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.289 -0.414 . . . . 1.76 110.71 -176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.77 113.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.114 -0.698 . . . . 1.15 109.114 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.52 134.04 35.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.983 0.421 . . . . 2.02 111.032 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -103.28 155.61 18.32 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.504 -0.771 . . . . 1.66 109.33 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.13 119.82 22.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.809 0.338 . . . . 1.33 110.139 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -122.35 56.18 1.12 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.718 0.771 . . . . 2.65 109.988 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -87.2 -16.57 34.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.473 -0.785 . . . . 1.61 109.881 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -153.13 176.55 11.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.966 -1.015 . . . . 2.35 108.673 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.69 73.57 7.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.234 0.54 . . . . 1.92 111.012 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.449 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 81.4 mttt -97.47 -65.15 0.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 1.77 112.481 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 89' ' ' ARG . . . -101.49 101.51 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.76 110.223 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.1 t -119.56 143.4 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.993 0.425 . . . . 1.27 112.088 -169.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 tp -118.59 129.95 55.61 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.176 -0.675 . . . . 1.29 109.176 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 95.3 mttt -125.55 137.63 53.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.841 -0.429 . . . . 2.54 109.841 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.0 170.2 24.65 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.976 -0.557 . . . . 1.31 111.959 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.4 -147.88 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.817 0.363 . . . . 1.9 113.245 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 51.9 Cg_exo -52.19 119.7 6.18 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 121.904 1.736 . . . . 2.91 112.253 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 72.4 mt -155.03 -171.7 3.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.781 -1.1 . . . . 4.11 108.676 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.02 51.76 1.52 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 4.95 110.639 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.02 -173.78 19.74 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.531 -0.843 . . . . 2.25 112.902 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -108.48 127.6 54.06 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.015 -0.365 . . . . 1.91 110.015 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 124' ' ' ASN . 71.9 m-85 -103.66 101.77 11.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.404 0.621 . . . . 3.7 111.449 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 77' ' ' ALA . 41.8 ttm180 -79.09 144.0 34.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.481 -0.781 . . . . 3.54 110.427 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.76 120.79 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.501 -0.555 . . . . 1.14 109.501 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.18 -36.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.319 . . . . 1.68 111.698 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -172.11 167.76 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.252 -0.647 . . . . 1.55 109.252 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.48 ' CB ' HD23 ' A' ' 120' ' ' LEU . 35.9 p90 -140.01 167.81 21.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.278 -0.569 . . . . 0.86 112.17 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -147.36 160.94 41.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.826 -1.176 . . . . 0.93 107.826 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.95 172.0 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.652 0.66 . . . . 3.17 111.032 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -129.45 146.03 51.35 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.697 -0.853 . . . . 1.68 108.697 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -157.32 133.38 9.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.164 0.506 . . . . 5.18 110.667 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 78.94 165.28 28.85 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.635 -0.793 . . . . 2.13 112.673 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 33.3 t 156.42 -96.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.661 -1.237 . . . . 2.9 107.661 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 75.6 mt -83.14 -153.84 0.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.713 -0.676 . . . . 3.03 109.303 167.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -45.81 -33.54 3.18 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.038 0.535 . . . . 3.85 112.124 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 113' ' ' LYS . . . 176.91 89.92 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.9 -0.667 . . . . 1.94 112.129 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 27.5 mt-30 -127.37 -177.69 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.891 0.376 . . . . 2.45 111.183 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.6 -29.56 2.76 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 109.048 -1.621 . . . . 1.47 109.048 -172.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 117' ' ' GLU . 3.3 t -68.66 67.58 0.14 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.296 -1.452 . . . . 2.0 112.474 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' CA ' ' HE1' ' A' ' 244' ' ' TRP . 28.8 tt0 -56.62 155.05 7.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 110.117 -0.327 . . . . 3.72 110.117 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.582 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 44.4 m-70 58.89 64.61 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.994 -0.743 . . . . 3.52 108.994 -173.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.58 133.47 36.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.242 -0.89 . . . . 2.52 112.033 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 33' ' ' ILE . 40.6 t -78.61 90.61 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 114.922 -1.036 . . . . 2.48 108.894 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 33.7 t70 64.23 -71.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 O-C-N 124.135 0.897 . . . . 2.8 110.724 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.479 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 54.9 mttp -138.46 30.23 2.38 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.512 0.19 . . . . 4.98 111.512 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HB3' ' H ' ' A' ' 109' ' ' VAL . 25.4 ttpp -70.16 71.57 0.42 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.189 0.519 . . . . 3.23 110.086 174.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 102' ' ' GLY . 51.3 mtmt -99.77 96.45 7.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.45 . . . . 2.82 110.987 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.405 ' H ' ' HB2' ' A' ' 105' ' ' SER . 70.3 m-85 -91.57 156.56 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.492 -0.929 . . . . 1.62 108.492 170.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.71 -9.69 55.4 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.481 0.488 . . . . 1.03 112.025 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.39 163.96 17.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.412 0.445 . . . . 0.75 110.322 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 105' ' ' SER . 33.2 tt0 -158.71 138.6 12.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.673 -0.694 . . . . 1.58 109.657 176.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.558 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 57.7 tp -102.51 132.86 48.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.024 -0.535 . . . . 1.07 110.465 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -119.86 102.41 8.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.188 0.518 . . . . 1.77 110.261 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 93' ' ' PHE . 24.5 mt -83.96 116.98 23.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 0.93 110.581 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.54 127.23 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.34 0.59 . . . . 0.61 110.591 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 31.7 m-70 -124.45 144.11 50.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.898 -0.592 . . . . 2.13 110.062 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -111.42 131.23 55.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.891 -0.595 . . . . 4.26 110.755 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.508 ' HB2' ' CE1' ' A' ' 88' ' ' TYR . 22.0 t30 -72.84 110.43 7.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.202 0.525 . . . . 2.02 110.742 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 26.9 p -66.34 -21.47 66.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 2.34 112.165 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -53.51 -27.49 25.93 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.384 0.513 . . . . 3.35 112.384 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.93 8.88 44.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.128 0.418 . . . . 3.1 112.128 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.09 -1.22 0.64 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 116.175 1.23 . . . . 2.37 116.175 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -168.79 136.19 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.416 1.108 . . . . 3.93 109.715 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.2 p90 -66.41 -38.63 87.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 3.0 111.687 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.16 97.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.838 -0.696 . . . . 2.15 111.904 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -70.72 -31.9 68.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.486 . . . . 3.43 110.241 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.628 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -65.59 -25.74 67.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.777 -0.647 . . . . 1.76 110.887 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -63.72 -19.62 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 2.77 110.993 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.39 -11.91 59.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.96 -0.463 . . . . 3.55 110.996 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.436 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 7.3 tt0 -111.14 136.39 20.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.637 -0.256 . . . . 3.02 110.623 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.8 Cg_exo -55.9 -27.15 61.73 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.34 2.694 . . . . 1.6 113.351 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.436 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 3.7 m-20 -111.5 27.07 10.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.109 0.48 . . . . 2.29 110.064 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.06 -36.49 31.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 1.22 113.503 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.8 mt -121.56 163.35 19.03 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.475 -0.427 . . . . 1.57 110.375 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.44 147.67 34.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.154 -0.475 . . . . 1.38 110.179 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.15 113.57 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.906 -0.405 . . . . 1.73 109.906 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 48.7 tp -93.4 108.32 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.092 -0.504 . . . . 2.42 110.079 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -93.92 148.35 18.97 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.932 -0.576 . . . . 0.86 112.99 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.9 mt -137.41 125.28 31.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.598 -0.519 . . . . 0.76 109.598 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 18.0 m-85 -71.06 139.12 50.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.474 -0.195 . . . . 1.2 110.474 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.7 mp -113.29 110.65 20.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.468 . . . . 0.88 110.701 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.552 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 19.4 ptpt -98.94 152.3 19.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.157 -0.683 . . . . 2.03 109.157 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.61 121.07 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.018 0.437 . . . . 1.27 110.495 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.01 -114.49 0.35 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.503 -0.639 . . . . 1.53 111.503 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.4 t -66.93 147.25 53.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.88 -0.415 . . . . 1.54 109.88 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -72.78 158.84 34.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.91 0.386 . . . . 0.78 111.669 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 216' ' ' SER . 56.7 mmtt -114.58 96.48 43.78 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.824 -0.625 . . . . 1.22 109.433 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.49 -33.92 93.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.687 2.258 . . . . 1.05 111.873 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.41 71.12 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.743 -0.662 . . . . 0.7 112.357 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 160' ' ' VAL . 62.0 tp -86.53 -26.35 24.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.216 0.532 . . . . 0.77 109.616 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -37.25 69.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.201 -0.909 . . . . 1.41 110.184 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -59.4 -37.69 78.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.791 -0.641 . . . . 2.86 111.279 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 162' ' ' VAL . 42.2 t -72.82 -43.39 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.154 0.502 . . . . 1.38 110.314 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 156' ' ' LEU . 33.9 t -59.77 -34.24 54.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 1.11 110.756 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.26 -31.05 72.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.13 -0.486 . . . . 1.22 112.014 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 159' ' ' VAL . 5.2 p -86.32 -4.73 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 1.41 111.012 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.52 -25.72 67.46 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.355 -0.384 . . . . 1.39 111.236 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.17 -32.31 72.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 2.31 111.279 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 m -88.5 -3.25 58.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.989 0.366 . . . . 1.4 111.989 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 pt -141.58 41.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.327 0.584 . . . . 0.85 110.269 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.14 -31.24 70.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.675 -0.693 . . . . 1.59 111.421 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.9 p -117.43 158.17 24.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.785 -0.189 . . . . 0.77 111.174 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -55.03 147.0 16.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.351 0.596 . . . . 2.29 112.345 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.28 -22.01 31.89 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.331 -0.85 . . . . 0.85 112.25 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -72.84 139.84 47.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.116 0.484 . . . . 1.7 110.873 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.8 p -133.54 157.6 45.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.408 -0.814 . . . . 1.37 109.549 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.71 143.75 28.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.76 -0.459 . . . . 0.61 109.76 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.8 133.45 46.54 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.245 -0.65 . . . . 1.8 109.245 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -142.34 81.21 1.74 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.81 -0.632 . . . . 1.04 109.483 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' SER . 5.2 m -108.44 164.27 12.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.256 -0.429 . . . . 1.17 110.936 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.44 64.54 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.731 0.644 . . . . 1.77 111.773 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 53.2 t80 -115.22 144.65 43.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 3.99 110.145 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.61 102.33 25.59 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 2.51 111.348 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 16.0 Cg_exo -69.18 -12.16 33.33 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.917 2.412 . . . . 1.26 112.238 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -62.88 -24.48 67.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.393 -0.367 . . . . 2.76 110.957 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.55 6.62 68.28 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.601 -0.809 . . . . 1.12 111.797 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 83.5 mt -118.22 -38.01 3.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.646 -0.502 . . . . 1.73 109.646 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.07 131.71 83.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.731 -0.668 . . . . 3.45 110.566 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.84 -178.86 4.41 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.7 2.267 . . . . 2.08 112.727 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.65 -62.39 1.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.097 -0.501 . . . . 3.23 111.35 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.7 m -71.09 131.93 44.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.724 0.297 . . . . 1.66 110.885 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.3 mt -111.32 63.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.079 0.466 . . . . 1.99 111.597 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 19.5 m-20 -105.6 173.23 6.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.741 -1.207 . . . . 1.81 107.741 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 46.9 p90 -164.65 150.24 10.15 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.325 -0.95 . . . . 5.01 113.235 -171.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.452 ' CE3' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m95 -109.35 151.27 26.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.817 -1.549 . . . . 3.93 106.817 166.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.7 t -139.5 130.86 26.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.603 0.716 . . . . 2.13 112.55 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.436 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 51.3 t80 -138.76 142.22 33.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.214 -0.903 . . . . 5.21 109.205 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.436 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 76.8 Cg_exo -52.0 149.07 21.78 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.429 2.086 . . . . 2.12 112.006 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -117.9 125.12 6.34 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.839 -0.696 . . . . 1.75 112.968 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 28' ' ' GLN . 11.9 t -85.16 -137.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.557 0.743 . . . . 2.99 111.112 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 199' ' ' THR . 2.7 pt? -42.58 12.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.727 2.121 . . . . 4.75 116.727 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 196' ' ' SER . 2.1 m -68.21 25.51 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.011 0.823 . . . . 5.1 110.733 172.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.611 ' H ' ' C ' ' A' ' 197' ' ' LEU . 1.8 p -149.41 167.72 12.45 Favored Pre-proline 0 C--N 1.324 -0.534 0 C-N-CA 124.502 1.121 . . . . 5.53 108.531 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.508 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 53.9 Cg_exo -47.45 -48.86 14.33 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.854 1.703 . . . . 5.83 113.167 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 83.0 Cg_endo -98.63 145.37 0.54 Allowed 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.239 1.96 . . . . 4.78 112.585 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 197' ' ' LEU . 6.3 tt -67.15 89.83 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.881 -0.785 . . . . 3.84 108.881 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.2 tt -143.05 155.49 44.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.458 -0.792 . . . . 2.96 109.359 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.4 OUTLIER -88.77 43.96 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.927 0.394 . . . . 3.37 110.857 -176.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 2.1 p -86.37 -9.05 57.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.257 0.466 . . . . 2.15 112.257 -174.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.14 148.15 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.012 0.434 . . . . 1.26 111.077 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.3 m -117.5 108.22 15.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.026 -0.731 . . . . 2.08 109.026 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.428 ' CZ2' ' HB ' ' A' ' 210' ' ' VAL . 59.2 t90 -84.98 124.3 31.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.114 0.483 . . . . 5.53 110.013 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 73.2 mt -130.93 120.49 47.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.018 -0.734 . . . . 1.63 109.018 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 14.5 p -115.92 131.51 68.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.577 -0.449 . . . . 1.62 110.962 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 92.7 mt -71.98 129.09 37.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.125 -0.488 . . . . 1.73 110.208 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 0.7 OUTLIER -56.91 -24.05 49.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.116 -0.947 . . . . 2.98 111.435 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.93 115.05 65.98 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 1.47 110.68 -170.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.552 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 12.2 Cg_exo -71.89 157.76 54.25 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.639 2.226 . . . . 0.96 111.925 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.432 ' HB ' ' HE3' ' A' ' 153' ' ' LYS . 45.2 pt -114.09 151.43 15.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.172 -0.677 . . . . 1.25 109.172 172.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.585 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 2.6 p -101.53 126.6 48.37 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.847 0.356 . . . . 1.29 111.215 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.73 155.03 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.533 -0.758 . . . . 1.02 109.206 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.6 t -87.88 152.85 21.77 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.607 -0.437 . . . . 1.08 110.803 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 15.8 m -51.13 -48.13 61.84 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.287 0.367 . . . . 1.33 111.57 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 2.7 mp0 -53.94 -42.64 69.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 2.51 110.755 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -62.77 -45.48 92.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.657 . . . . 0.7 110.312 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.69 -37.44 79.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.965 -0.562 . . . . 1.36 110.565 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 219' ' ' SER . 97.7 mt -67.31 -34.01 76.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.63 . . . . 1.03 110.916 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 98.5 mttt -71.07 -22.83 62.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.326 . . . . 1.75 111.161 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -72.58 -31.0 64.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 2.47 109.189 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -78.26 -4.26 46.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.325 -0.852 . . . . 3.04 110.336 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 93.3 mttt -94.06 -0.15 55.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 2.31 110.094 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -73.75 150.99 40.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.95 109.66 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.504 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.5 m120 -111.97 125.26 53.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.601 0.715 . . . . 1.13 111.248 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.405 ' HA ' ' HE2' ' A' ' 240' ' ' MET . 90.0 t80 -64.74 -32.23 73.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.41 -1.268 . . . . 3.74 110.018 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -70.03 160.8 31.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.561 -0.745 . . . . 1.62 111.719 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.11 179.37 52.87 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.895 -0.882 . . . . 1.16 110.895 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.58 137.2 42.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.858 0.829 . . . . 3.56 110.434 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 80.8 20.31 65.97 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.027 -0.606 . . . . 2.08 112.059 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -121.95 155.79 60.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 122.399 0.279 . . . . 2.59 110.263 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.76 125.14 18.13 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.916 2.41 . . . . 1.36 111.358 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -58.25 133.2 55.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.748 0.785 . . . . 3.4 112.59 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.13 120.19 18.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.62 -1.173 . . . . 2.47 108.508 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.5 116.91 7.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.739 0.304 . . . . 2.14 110.228 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 230' ' ' PHE . 51.7 ttm -70.52 95.29 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.697 -0.683 . . . . 1.68 109.525 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.27 169.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.315 -0.402 . . . . 1.27 110.607 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.4 t70 71.35 -100.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.931 0.77 . . . . 2.18 109.983 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 45.55 32.58 1.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.489 . . . . 2.15 110.833 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.495 ' HE1' ' CA ' ' A' ' 106' ' ' GLU . 78.6 t90 -115.23 137.11 52.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.992 -0.373 . . . . 4.59 109.992 -171.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 82.5 mtm180 -90.55 127.04 54.19 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.546 -0.297 . . . . 6.13 111.043 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 245' ' ' ARG . 34.8 Cg_exo -61.14 150.77 82.84 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.262 2.642 . . . . 3.28 113.363 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' PRO . . . -96.58 95.43 7.97 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.663 -0.698 . . . . 2.98 111.762 -176.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.511 ' HB2' HG12 ' A' ' 31' ' ' VAL . 41.5 mt-30 -56.92 157.33 11.06 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.699 . . . . 4.32 112.104 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.79 177.84 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.747 2.964 . . . . 3.48 113.488 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.68 -10.96 21.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.982 -1.008 . . . . 4.63 111.397 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -52.86 49.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.626 1.713 . . . . 5.34 115.626 168.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.565 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER 139.91 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.759 2.024 . . . . 4.64 113.193 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.479 ' CG ' ' H ' ' A' ' 254' ' ' GLN . 5.5 ttp180 97.37 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.186 -1.825 . . . . 6.11 110.839 156.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.479 ' H ' ' CG ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -157.95 162.1 38.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.874 -0.788 . . . . 3.08 108.874 -167.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.476 HD12 HG12 ' A' ' 33' ' ' ILE . 9.5 mt -100.06 129.03 51.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.866 0.365 . . . . 2.6 110.667 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -81.95 152.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.426 -0.583 . . . . 2.63 109.426 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.73 166.27 14.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.278 -0.419 . . . . 1.71 110.975 -172.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 27.8 p -149.36 97.82 2.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.543 0.687 . . . . 2.21 110.724 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -132.53 104.93 6.93 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.151 -0.931 . . . . 4.31 108.728 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.599 -0.715 . . . . 4.49 109.96 -178.139 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 120.707 0.289 . . . . 17.49 110.342 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 m 59.1 55.92 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.862 -0.608 . . . . 15.32 110.799 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -98.6 118.02 34.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.962 -0.563 . . . . 15.81 110.629 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -144.85 130.14 18.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.694 -0.684 . . . . 14.19 110.364 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -138.39 137.2 37.05 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.026 -0.533 . . . . 14.91 110.174 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.54 -178.05 46.0 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.271 -0.731 . . . . 10.79 111.271 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -88.63 109.86 20.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.764 0.316 . . . . 11.39 110.723 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 12' ' ' GLY . . . 62.77 -172.76 9.95 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.88 -0.6 . . . . 9.0 113.961 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -88.22 128.77 35.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.471 -0.365 . . . . 9.76 110.344 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.6 m80 59.95 -85.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.62 -0.718 . . . . 11.19 112.261 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -108.09 -5.74 16.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.861 0.319 . . . . 10.8 111.861 -173.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.518 ' O ' ' HA3' ' A' ' 8' ' ' GLY . . . 148.15 -41.24 0.91 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 119.429 -1.367 . . . . 8.82 115.204 -178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -43.98 140.68 4.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.899 2.4 . . . . 7.87 114.24 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -71.64 5.47 2.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.401 -0.818 . . . . 10.62 112.791 -177.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -67.42 10.59 0.16 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.152 0.501 . . . . 9.87 111.442 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.481 ' H ' ' C ' ' A' ' 14' ' ' GLU . 20.1 t-105 -73.26 -2.22 21.02 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.834 0.854 . . . . 8.48 110.244 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -58.32 -10.43 2.05 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.544 -0.753 . . . . 7.13 112.596 -168.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -74.32 -28.62 61.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.015 0.436 . . . . 9.68 110.732 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -84.92 -17.97 36.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.946 -0.57 . . . . 7.89 110.525 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.67 95.51 44.65 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.56 -0.746 . . . . 7.17 109.716 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.449 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 56.6 Cg_exo -51.71 -45.46 37.95 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.321 2.681 . . . . 7.76 112.985 -175.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.553 ' H ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -71.89 -6.35 7.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.417 0.525 . . . . 5.83 112.417 -178.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HA ' HD11 ' A' ' 197' ' ' LEU . . . -80.64 -3.32 50.08 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.141 -0.35 . . . . 5.44 111.81 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -71.69 36.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.424 0.527 . . . . 7.78 112.424 176.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 23' ' ' ALA . . . -96.84 -175.63 35.14 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.747 -0.74 . . . . 5.01 111.339 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -114.69 113.25 24.07 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.52 -0.872 . . . . 7.09 109.017 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 5.2 tpp180 -152.33 -179.71 7.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.509 -0.477 . . . . 5.13 110.164 171.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.569 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 51.6 tt0 -34.14 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.668 1.187 . . . . 7.12 112.911 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.523 ' HB2' HG23 ' A' ' 31' ' ' VAL . 53.3 m -104.04 169.35 7.39 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 107.995 -1.113 . . . . 3.94 107.995 173.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' HG3' ' A' ' 14' ' ' GLU . 78.4 Cg_exo -54.39 28.92 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.405 0 C-N-CA 124.01 3.14 . . . . 4.52 115.165 171.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 32' ' ' ASP . 11.3 t -95.22 -175.59 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.772 0.829 . . . . 4.54 108.89 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.779 ' H ' HG12 ' A' ' 31' ' ' VAL . 29.3 m-20 -116.23 141.11 48.58 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.009 -0.432 . . . . 2.88 110.943 -171.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.513 ' HB ' ' CG ' ' A' ' 248' ' ' GLN . 0.4 OUTLIER -96.2 144.27 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 2.32 110.875 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -114.86 111.08 20.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 2.82 109.907 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -10.87 57.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.267 0.469 . . . . 2.24 112.267 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -59.77 -26.73 65.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.884 0.373 . . . . 4.54 110.934 175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -81.63 -15.42 54.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.441 -0.345 . . . . 3.06 111.357 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -62.19 109.84 1.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.472 0.654 . . . . 1.72 112.742 -175.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -107.23 120.61 42.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.748 -1.115 . . . . 3.69 109.405 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -85.12 130.68 34.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.762 -0.654 . . . . 4.64 109.805 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' OD2' ' HB3' ' A' ' 43' ' ' SER . 16.4 t70 -110.33 125.63 30.57 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.375 -0.375 . . . . 2.27 110.727 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.08 -9.73 23.76 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.951 2.434 . . . . 2.15 113.831 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . 43.4 t -78.88 -26.36 43.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.305 -0.628 . . . . 4.29 109.305 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.64 125.89 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 4.74 109.663 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -118.68 133.38 23.6 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.441 -0.8 . . . . 3.77 110.568 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.73 123.66 6.14 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.008 2.472 . . . . 2.36 111.539 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 79' ' ' LEU . 47.5 mt -59.19 144.39 46.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 2.55 111.523 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.8 t -93.49 114.42 26.79 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.014 -1.106 . . . . 2.38 108.014 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.76 133.11 64.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.987 -0.552 . . . . 1.59 111.85 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 20.0 m -120.54 90.88 3.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.912 -0.585 . . . . 1.45 109.601 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -108.42 -2.26 19.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.06 -0.518 . . . . 3.62 111.403 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.37 -30.29 63.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.044 0.449 . . . . 2.48 110.228 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 19.6 mt-30 -76.16 -21.77 56.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 2.24 110.435 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -69.33 150.69 47.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.755 -0.657 . . . . 0.8 111.501 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.754 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 77.9 m -141.41 128.82 21.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.867 -0.606 . . . . 1.06 110.274 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 176' ' ' THR . 22.9 m -74.91 147.76 40.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 1.26 110.056 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 71' ' ' ASP . 96.2 mt -115.04 -52.32 2.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.421 -0.354 . . . . 0.74 110.985 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HA ' ' N ' ' A' ' 175' ' ' PHE . 15.9 ptp180 -163.99 164.69 23.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 3.17 111.33 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 tt -126.6 139.18 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.64 -0.709 . . . . 0.64 109.548 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.4 tp -126.56 137.19 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.468 -0.333 . . . . 0.96 111.344 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -92.32 107.88 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.329 -0.989 . . . . 1.49 108.329 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -113.34 68.06 0.67 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.02 -0.672 . . . . 1.83 109.969 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.64 -57.26 0.08 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 113.961 -1.472 . . . . 1.64 115.097 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -107.97 -22.79 12.28 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.389 0.276 . . . . 3.33 111.436 -169.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.42 178.29 10.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.662 0.268 . . . . 1.38 110.466 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 228' ' ' LEU . 96.8 m-85 -111.04 143.46 41.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.367 -0.379 . . . . 2.74 110.168 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -122.08 108.51 13.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.637 -0.256 . . . . 1.76 110.816 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 22.0 t -94.92 112.07 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.528 -0.545 . . . . 1.15 109.528 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.2 132.16 39.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.018 0.437 . . . . 2.02 111.866 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -103.83 157.73 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 1.66 109.249 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.754 ' OD1' ' HB ' ' A' ' 55' ' ' THR . 1.6 p-10 -91.09 125.54 35.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.15 0.5 . . . . 1.33 109.846 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.563 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 6.9 t70 -152.96 63.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.464 0.649 . . . . 2.65 110.313 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 t -76.68 1.81 15.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.065 0.935 . . . . 1.61 109.088 167.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -163.72 140.28 6.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.55 -1.648 . . . . 2.35 106.55 -177.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.15 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.713 0.768 . . . . 1.92 112.801 -168.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 70.8 mmtt -101.16 -47.25 4.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.314 -0.857 . . . . 1.77 110.199 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -105.5 99.42 9.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.762 -0.654 . . . . 0.76 110.268 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.34 127.64 65.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.042 -0.526 . . . . 1.27 111.554 -171.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 47' ' ' LEU . 48.2 tp -119.56 117.37 28.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.697 -0.683 . . . . 1.29 109.783 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -160.82 122.68 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.173 -0.306 . . . . 2.54 110.173 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -119.83 -179.52 16.51 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-O 119.587 -0.563 . . . . 1.31 112.315 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -34.87 -135.43 0.0 OUTLIER Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.43 0.932 . . . . 1.9 115.43 166.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.69 167.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 123.365 2.71 . . . . 2.91 113.802 -172.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.4 pt? -33.51 82.33 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.622 1.341 . . . . 4.11 114.622 -146.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 21.7 p-10 -81.67 -77.3 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.437 -1.71 . . . . 4.95 112.543 175.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.438 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.22 131.93 0.81 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.723 -1.351 . . . . 2.25 109.723 -165.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.7 m -73.6 115.54 13.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.086 0.943 . . . . 1.91 111.769 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.6 m-85 -104.85 145.84 29.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.659 -0.7 . . . . 3.7 109.74 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 80.2 mtm180 -107.72 138.31 44.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.551 0.215 . . . . 3.54 110.777 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HB3' ' HB1' ' A' ' 77' ' ' ALA . 4.4 tt -88.73 112.45 23.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.921 -0.77 . . . . 1.14 108.921 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' CE3' ' A' ' 123' ' ' TRP . 54.7 mt -125.54 -23.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.518 -0.473 . . . . 1.68 111.567 -174.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.716 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.1 pt20 -156.49 159.56 38.73 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.101 -0.374 . . . . 1.55 110.715 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 31.9 p90 -150.82 164.23 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.86 110.285 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.538 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 4.2 p-80 -137.98 158.53 44.13 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.656 0.597 . . . . 0.93 110.58 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -136.0 168.83 18.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.954 -0.387 . . . . 3.17 109.954 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -165.43 146.31 7.15 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.951 -0.389 . . . . 1.68 109.951 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.461 ' CZ3' ' HB2' ' A' ' 226' ' ' ARG . 83.1 t90 -140.22 147.97 40.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.233 -0.44 . . . . 5.18 109.833 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . 84.76 165.61 40.11 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.682 -0.771 . . . . 2.13 113.164 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . 40.5 t 160.58 -89.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.115 0.966 . . . . 2.9 108.551 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.52 -156.55 0.55 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.983 -0.553 . . . . 3.03 110.027 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -51.79 -42.06 62.15 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.491 0.495 . . . . 3.85 111.361 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.28 46.63 0.56 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.351 -0.7 . . . . 1.94 111.351 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 104' ' ' GLY . 4.6 tt0 -116.74 -174.87 2.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.026 -0.731 . . . . 2.45 109.026 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 103' ' ' GLN . . . 131.39 -25.21 4.08 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.397 -0.906 . . . . 1.47 112.737 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 62.4 p -67.34 -36.58 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 245' ' ' ARG . 34.5 tt0 82.41 174.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.282 -1.377 . . . . 3.72 107.282 -166.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 98.2 m-70 55.66 58.86 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 3.52 111.605 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -82.26 122.2 27.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.249 0.547 . . . . 2.52 110.311 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 23.1 t -89.04 91.84 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.764 -0.653 . . . . 2.48 109.682 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.486 ' OD1' ' HG3' ' A' ' 111' ' ' LYS . 27.2 t70 64.84 -70.14 0.09 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.015 0.822 . . . . 2.8 110.65 -174.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.486 ' HG3' ' OD1' ' A' ' 110' ' ' ASP . 0.3 OUTLIER -142.21 11.81 1.97 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.013 -0.539 . . . . 4.98 111.094 174.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 40.1 ttmt -81.19 84.9 6.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.068 0.461 . . . . 3.23 109.795 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.493 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 17.6 pttp -110.87 132.97 53.75 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.548 -0.751 . . . . 2.82 110.82 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -107.07 167.42 9.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.471 -0.331 . . . . 1.62 110.307 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.439 ' HB1' ' NE1' ' A' ' 97' ' ' TRP . . . -65.16 -36.14 83.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.373 -0.376 . . . . 1.03 111.885 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.87 165.48 35.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.637 0.256 . . . . 0.75 110.998 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 105' ' ' SER . 51.9 tt0 -146.67 141.88 27.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.068 -0.716 . . . . 1.58 109.068 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' A' ' 93' ' ' PHE . 48.7 tp -101.57 116.41 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.936 -0.574 . . . . 1.07 109.496 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.538 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 18.8 m170 -107.42 105.44 15.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 1.77 110.69 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 4.7 mp -94.18 125.72 38.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.861 -0.609 . . . . 0.93 110.461 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -92.41 137.51 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 0.61 110.43 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 36.3 m80 -131.64 140.44 49.37 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.133 -0.692 . . . . 2.13 109.133 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.562 ' CE3' HD12 ' A' ' 91' ' ' ILE . 47.1 m0 -110.44 129.99 55.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.121 0.263 . . . . 4.26 110.492 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -63.21 114.72 3.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.084 0.469 . . . . 2.02 110.748 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -80.5 -26.79 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.842 -0.617 . . . . 2.34 111.642 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -59.1 -24.45 62.96 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.753 0.279 . . . . 3.35 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -91.06 9.77 29.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.323 0.583 . . . . 3.1 110.721 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . 67.72 -4.09 4.46 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.221 -0.899 . . . . 2.37 115.333 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 21.8 t70 175.21 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.131 0.966 . . . . 3.93 109.936 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 134' ' ' VAL . 35.4 p90 -58.08 -34.94 70.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.036 -0.529 . . . . 3.0 111.053 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.54 -38.73 88.82 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.201 -0.523 . . . . 2.15 112.706 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 8.9 mmpt? -78.39 -37.32 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.131 0.491 . . . . 3.43 109.98 175.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.608 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -64.88 -34.36 78.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.365 -0.834 . . . . 1.76 112.312 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 130' ' ' PHE . 27.9 m -67.94 -9.18 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.848 0.314 . . . . 2.77 111.848 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -93.06 -6.16 48.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.26 0.552 . . . . 3.55 110.309 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 5.9 tt0 -107.29 131.63 21.56 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.828 -0.624 . . . . 3.02 109.317 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 50.9 Cg_exo -55.03 -22.07 29.54 Favored 'Trans proline' 0 N--CA 1.473 0.321 0 C-N-CA 122.968 2.445 . . . . 1.6 112.879 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.575 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.9 m-20 -111.56 28.6 8.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 2.29 110.605 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -80.85 -40.29 12.25 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.086 -0.578 . . . . 1.22 114.524 -173.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.94 158.38 18.28 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.218 -0.578 . . . . 1.57 109.95 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -143.67 117.84 9.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.855 0.36 . . . . 1.38 110.716 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.75 121.38 61.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.141 -0.482 . . . . 1.73 110.06 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 209' ' ' ILE . 60.9 tp -93.83 119.42 32.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.486 -0.561 . . . . 2.42 109.486 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.75 111.35 3.76 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.977 -0.63 . . . . 0.86 112.615 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.7 mt -110.96 107.57 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 110.221 -0.288 . . . . 0.76 110.221 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 96.8 m-85 -63.15 149.46 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 1.2 111.323 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.8 mp -113.83 131.26 56.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.589 . . . . 0.88 110.121 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 216' ' ' SER . 17.4 ptpt -122.16 136.82 54.96 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.562 -0.532 . . . . 2.03 109.562 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 3.6 m -99.82 79.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.313 0.577 . . . . 1.27 112.262 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -157.89 60.05 0.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.684 -0.77 . . . . 1.53 112.024 168.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.594 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 7.7 t 158.78 126.35 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.64 -1.244 . . . . 1.54 107.64 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -76.43 139.07 40.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.815 0.34 . . . . 0.78 110.739 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 216' ' ' SER . 16.9 tptm -110.62 96.62 28.83 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.14 -0.482 . . . . 1.22 109.968 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.42 -36.18 97.13 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.971 2.448 . . . . 1.05 112.453 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.55 -6.68 66.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.196 -0.526 . . . . 0.7 113.597 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.1 tp -90.06 -21.18 22.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.773 0.787 . . . . 0.77 110.743 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.425 ' HA ' ' HB ' ' A' ' 160' ' ' VAL . 7.9 tp-100 -57.28 -34.77 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 1.41 111.648 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -47.37 -50.6 21.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.296 0.48 . . . . 2.86 112.296 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -81.05 -30.07 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.703 -0.399 . . . . 1.38 110.814 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 82.1 t -63.83 -35.62 73.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.2 0.524 . . . . 1.11 111.204 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.88 -22.51 60.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.293 -0.412 . . . . 1.22 111.516 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.55 -13.89 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.372 0.508 . . . . 1.41 112.372 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 164' ' ' ASP . 3.9 pp -60.13 -27.51 67.12 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.912 0.708 . . . . 1.39 112.912 -174.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.581 ' N ' HD12 ' A' ' 163' ' ' LEU . 14.7 t70 -70.97 -25.03 62.54 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.954 -0.466 . . . . 2.31 110.664 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.3 m -76.69 -3.52 38.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.063 0.459 . . . . 1.4 111.136 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.2 pt -137.36 36.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.341 -0.615 . . . . 0.85 109.341 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -74.85 -25.36 58.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.665 -0.698 . . . . 1.59 111.255 -171.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 231' ' ' ASN . 0.1 OUTLIER -119.54 148.55 43.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.936 0.398 . . . . 0.77 111.139 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -55.09 126.08 23.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.579 -0.737 . . . . 2.29 112.017 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.93 -16.51 36.26 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.69 -0.767 . . . . 0.85 112.077 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -88.69 152.74 21.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.321 0.581 . . . . 1.7 110.796 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 t -143.78 159.19 42.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.466 -0.788 . . . . 1.37 109.078 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.96 130.86 20.39 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.855 -0.424 . . . . 0.61 109.855 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.28 132.94 55.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.369 -0.604 . . . . 1.8 109.369 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.404 ' N ' ' HA ' ' A' ' 58' ' ' ARG . 27.2 t80 -140.69 77.94 1.63 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.019 -1.104 . . . . 1.04 108.019 -173.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 56' ' ' SER . 4.9 m -106.73 156.98 18.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 1.17 111.757 -173.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.16 60.28 2.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.916 0.886 . . . . 1.77 112.254 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -131.58 130.46 42.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.649 -1.159 . . . . 3.99 108.829 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.46 140.75 21.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.01 0.433 . . . . 2.51 111.462 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' A' ' 183' ' ' LEU . 73.5 Cg_endo -79.84 -6.52 14.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.918 2.412 . . . . 1.26 111.617 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -58.65 -42.41 88.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.305 -0.861 . . . . 2.76 111.568 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.06 -15.29 69.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.953 -0.641 . . . . 1.12 112.995 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 180' ' ' PRO . 3.9 mm? -88.45 -10.58 48.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.502 0.192 . . . . 1.73 111.45 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.11 141.35 40.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.83 0.348 . . . . 3.45 111.018 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.87 -175.58 2.83 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.915 2.41 . . . . 2.08 112.722 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.64 -59.94 2.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.337 -0.392 . . . . 3.23 111.044 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 m -83.8 137.35 33.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 1.66 111.264 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.1 tp -109.18 64.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.352 0.596 . . . . 1.99 110.351 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.408 ' O ' HD12 ' A' ' 211' ' ' LEU . 19.1 m-20 -108.01 166.16 10.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.807 -0.812 . . . . 1.81 108.807 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -164.89 163.89 20.94 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.156 -0.618 . . . . 5.01 112.224 -167.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.34 130.99 55.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.05 -0.977 . . . . 3.93 108.375 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.2 p -95.32 106.22 18.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.784 0.326 . . . . 2.13 111.393 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.446 ' OH ' ' HB2' ' A' ' 28' ' ' GLN . 54.1 t80 -135.99 125.43 16.02 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 5.21 111.882 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.38 132.55 5.15 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.694 2.263 . . . . 2.12 112.531 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -110.42 157.14 15.19 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.959 -0.564 . . . . 1.75 112.006 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 60.1 m -132.82 -160.62 1.06 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.595 -0.356 . . . . 2.99 111.206 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 23' ' ' ALA . 1.8 pp -71.93 6.68 1.94 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.51 0.93 . . . . 4.75 113.51 -172.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 27' ' ' ARG . 76.4 p -86.71 21.13 2.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.269 0.557 . . . . 5.1 110.532 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.615 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 18.3 p -125.32 179.74 1.07 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.879 -0.786 . . . . 5.53 108.879 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.615 ' HD2' ' HB ' ' A' ' 199' ' ' THR . 2.8 Cg_exo -33.77 -51.56 0.53 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.512 2.808 . . . . 5.83 114.364 171.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.59 126.91 4.82 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.475 1.45 . . . . 4.78 112.264 174.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.82 23.07 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 3.84 111.517 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.29 132.72 56.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.241 -0.436 . . . . 2.96 110.171 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 196' ' ' SER . 8.1 pt-20 -80.51 65.29 5.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.193 0.521 . . . . 3.37 110.989 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 11.4 p -128.53 13.9 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.44 0.904 . . . . 2.15 113.44 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.18 138.31 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.43 0.633 . . . . 1.26 112.181 -171.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 24.6 m -111.28 113.43 25.91 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.277 -1.009 . . . . 2.08 108.277 168.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -97.47 113.89 25.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.271 0.558 . . . . 5.53 110.331 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.478 ' O ' HD12 ' A' ' 143' ' ' LEU . 48.7 mm -103.49 102.99 14.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.587 -0.733 . . . . 1.63 109.277 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.06 125.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.412 -0.588 . . . . 1.62 109.412 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 189' ' ' ASP . 15.8 tp -80.09 116.85 20.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.058 -0.349 . . . . 1.73 110.058 -176.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -61.82 -33.38 74.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.95 -0.568 . . . . 2.98 110.401 -177.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -95.75 103.07 11.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 1.47 110.165 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 14.7 Cg_exo -71.23 171.58 15.74 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.725 2.283 . . . . 0.96 112.135 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.9 pt -112.44 149.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.566 . . . . 1.25 109.945 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 5.5 p -105.18 132.2 51.69 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.03 -0.532 . . . . 1.29 110.641 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 26.9 m -128.47 165.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.976 -0.556 . . . . 1.02 110.181 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 21.0 t -94.34 153.0 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.669 -0.241 . . . . 1.08 110.682 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.565 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 17.1 p -54.54 -48.14 72.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.49 0.186 . . . . 1.33 111.272 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -54.79 -29.41 54.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.392 -0.367 . . . . 2.51 111.63 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.88 -45.91 33.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.064 -0.516 . . . . 0.7 110.362 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 34.7 m -78.56 -21.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 1.36 111.91 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 219' ' ' SER . 77.1 mt -65.06 -31.62 72.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.411 . . . . 1.03 110.489 176.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 163' ' ' LEU . 53.2 mttm -74.61 -22.02 59.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.125 -0.489 . . . . 1.75 110.78 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.4 m-85 -77.48 -27.37 51.95 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.6 -0.889 . . . . 2.47 108.6 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.461 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 67.0 ttt180 -72.32 -20.06 61.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.535 -1.211 . . . . 3.04 110.651 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.16 -6.7 34.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 2.31 111.313 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.451 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 93.2 mt -65.22 154.78 37.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.916 0.389 . . . . 0.95 110.647 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -116.71 134.71 54.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.312 0.577 . . . . 1.13 110.713 -175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -78.72 -35.68 44.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.868 -1.06 . . . . 3.74 109.774 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.3 p-10 -72.64 169.35 16.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.049 -0.978 . . . . 1.62 111.888 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.01 177.25 38.19 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.303 -0.862 . . . . 1.16 111.177 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.37 125.37 25.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 3.56 110.487 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 103.14 7.74 42.99 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.728 -0.669 . . . . 2.08 113.397 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 44.3 mt-10 -112.32 157.54 39.73 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 117.393 0.597 . . . . 2.59 109.67 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.66 125.33 18.38 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.289 1.992 . . . . 1.36 110.613 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.43 118.48 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.84 0.829 . . . . 3.4 112.564 -171.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.99 116.37 31.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.583 -1.19 . . . . 2.47 107.901 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.1 mt -66.97 125.14 25.03 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.063 0.459 . . . . 2.14 110.584 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 60.7 ttm -78.94 89.78 4.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.655 -0.702 . . . . 1.68 110.59 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.01 167.6 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.766 -0.827 . . . . 1.27 108.766 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 19.5 t70 66.48 -88.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.764 0.665 . . . . 2.18 110.056 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 63.09 -11.26 0.09 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.354 0.872 . . . . 2.15 113.354 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.427 ' CZ3' ' HG3' ' A' ' 200' ' ' PRO . 98.0 m95 -153.77 175.11 13.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.142 -0.688 . . . . 4.59 109.142 -169.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 106' ' ' GLU . 39.0 mtp85 -129.39 147.54 65.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.212 -0.292 . . . . 6.13 110.212 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.99 82.48 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.748 2.298 . . . . 3.28 111.561 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.429 ' HB3' HE21 ' A' ' 28' ' ' GLN . . . -98.78 118.18 34.94 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.049 -0.523 . . . . 2.98 111.315 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.513 ' CG ' ' HB ' ' A' ' 33' ' ' ILE . 16.2 mm-40 -124.16 156.31 66.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 4.32 109.465 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 1.1 Cg_endo -43.18 129.54 6.03 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.404 2.736 . . . . 3.48 113.095 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -43.45 -57.21 3.19 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 124.121 0.888 . . . . 4.63 112.231 -171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 54.6 pttt -106.34 0.2 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.554 0.216 . . . . 5.34 111.422 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER 75.89 -47.97 0.58 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.601 0.761 . . . . 4.64 111.465 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 70.64 -108.81 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.607 -0.886 . . . . 6.11 108.607 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -140.93 136.75 32.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.231 -1.396 . . . . 3.08 107.231 165.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 75.6 mt -84.6 121.85 37.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.302 -0.559 . . . . 2.6 109.671 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -100.35 134.85 42.68 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.899 -0.778 . . . . 2.63 108.899 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.25 172.9 12.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.257 -0.429 . . . . 1.71 110.019 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.7 m -128.33 94.69 3.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.292 -0.563 . . . . 2.21 110.968 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -146.37 126.66 13.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.733 -0.839 . . . . 4.31 108.733 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 18.8 pttp . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.244 -0.884 . . . . 4.49 110.336 -179.42 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptm . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.707 0.289 . . . . 17.49 110.333 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -77.91 -24.54 48.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.356 0.598 . . . . 15.32 109.652 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -109.61 117.23 33.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.427 -0.806 . . . . 15.81 109.351 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -89.32 -8.15 53.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.386 -0.598 . . . . 14.19 109.386 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 70.12 -67.28 0.24 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.951 -1.022 . . . . 14.91 110.727 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' HA3' ' HA2' ' A' ' 12' ' ' GLY . . . -119.23 128.84 7.8 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.658 -0.782 . . . . 10.79 111.503 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.499 ' CE2' ' HG3' ' A' ' 245' ' ' ARG . 55.3 m-85 -81.13 103.03 10.65 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.608 0.718 . . . . 11.39 110.776 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.04 -84.83 0.19 Allowed Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.658 -1.155 . . . . 9.0 110.33 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -92.57 147.86 22.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.894 -0.78 . . . . 9.76 108.894 170.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -62.55 -24.17 67.39 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.043 0.386 . . . . 11.19 112.043 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -104.03 -2.25 26.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.394 0.616 . . . . 10.8 110.509 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' HA3' ' A' ' 6' ' ' GLY . . . 95.31 120.47 3.53 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.674 -0.774 . . . . 8.82 111.333 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.92 122.49 7.28 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.852 1.701 . . . . 7.87 112.933 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -92.28 -19.1 22.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.351 -0.84 . . . . 10.62 110.753 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -114.37 22.94 13.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.224 -0.444 . . . . 9.87 111.072 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.404 ' CD1' HD21 ' A' ' 202' ' ' LEU . 25.1 t-105 -66.8 -22.66 66.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.597 0.713 . . . . 8.48 109.748 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 30.6 p-80 -64.15 -9.82 19.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.542 -0.754 . . . . 7.13 111.762 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -78.23 -11.84 59.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.667 0.27 . . . . 9.68 111.353 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -123.66 -17.73 6.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 7.89 110.054 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 13.3 m-85 -140.55 89.77 10.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.08 -0.509 . . . . 7.17 109.646 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 74.9 Cg_exo -51.2 -35.11 51.24 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.121 2.548 . . . . 7.76 113.145 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.9 pt -57.65 -2.65 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 113.845 1.054 . . . . 5.83 113.845 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.14 -17.04 64.68 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.18 -0.325 . . . . 5.44 110.53 172.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 21' ' ' PRO . 61.7 mttp -45.1 -21.28 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.109 0.781 . . . . 7.78 113.109 169.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.95 -161.98 36.52 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.788 -0.925 . . . . 5.01 110.788 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -116.55 104.54 11.51 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 118.058 -1.457 . . . . 7.09 109.366 172.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HE ' ' HB2' ' A' ' 27' ' ' ARG . 5.3 ttm180 -165.73 129.77 2.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 118.305 -0.855 . . . . 5.13 108.813 164.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -111.47 -52.52 2.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 120.861 1.664 . . . . 7.12 111.423 159.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 m -100.52 162.38 20.98 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 110.125 -0.324 . . . . 3.94 110.125 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 246' ' ' PRO . 88.3 Cg_endo -99.4 -2.92 0.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.786 2.324 . . . . 4.52 114.579 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 107' ' ' HIS . 4.1 p -160.09 140.08 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 114.585 1.328 . . . . 4.54 114.585 -174.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -164.53 117.07 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.067 -1.457 . . . . 2.88 107.067 158.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 55.5 mt -93.96 90.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.237 0.541 . . . . 2.32 111.116 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -77.15 106.23 8.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.604 -0.726 . . . . 2.82 109.849 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -40.61 30.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.402 -0.817 . . . . 2.24 112.777 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -70.48 -33.75 71.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 4.54 110.885 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 m -89.34 -30.26 18.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.459 -0.337 . . . . 3.06 111.252 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.87 89.93 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.043 0.449 . . . . 1.72 112.035 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -97.97 138.75 34.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.944 -0.571 . . . . 3.69 110.145 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.772 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 48.0 p90 -84.26 123.4 30.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.928 0.394 . . . . 4.64 110.65 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.97 139.0 23.07 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.32 -0.4 . . . . 2.27 110.076 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -90.17 22.82 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.812 2.341 . . . . 2.15 112.324 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 m -89.35 -18.8 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 4.29 110.65 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.45 HD21 ' OG ' ' A' ' 258' ' ' SER . 3.4 pp -97.55 156.91 16.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 4.74 110.255 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -99.03 144.22 27.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.432 -0.349 . . . . 3.77 110.954 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 31.1 Cg_endo -64.37 165.35 20.23 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.128 2.552 . . . . 2.36 112.184 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.5 mt -89.6 146.23 24.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 2.55 111.743 -173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.3 m -110.61 107.15 16.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.678 -0.86 . . . . 2.38 108.678 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -90.76 102.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.411 -0.359 . . . . 1.59 110.873 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -119.26 89.47 3.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.119 0.485 . . . . 1.45 110.423 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.06 21.71 1.58 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.54 0.686 . . . . 3.62 110.423 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.31 -17.92 64.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.38 -0.827 . . . . 2.48 110.021 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.02 -5.02 38.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.729 -0.669 . . . . 2.24 109.811 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.61 158.76 35.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.707 -0.678 . . . . 0.8 111.838 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -150.16 143.38 25.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.199 -0.91 . . . . 1.06 109.076 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 176' ' ' THR . 14.5 m -91.1 165.37 13.54 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.14 -0.689 . . . . 1.26 109.14 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -119.36 -50.34 2.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.018 0.437 . . . . 0.74 111.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -157.9 152.58 25.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.256 -0.429 . . . . 3.17 111.072 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.551 HG13 HG22 ' A' ' 68' ' ' VAL . 14.6 tt -115.55 138.48 45.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.034 -0.728 . . . . 0.64 109.034 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 172' ' ' SER . 47.2 tp -135.82 141.17 44.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.207 0.527 . . . . 0.96 112.229 -170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -100.16 105.6 17.22 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.797 -1.186 . . . . 1.49 107.797 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -138.56 73.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.158 0.504 . . . . 1.83 112.09 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.59 -52.71 0.62 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.838 -1.173 . . . . 1.64 111.997 161.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -147.41 -51.24 0.19 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.98 0.419 . . . . 3.33 110.094 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.58 169.77 8.27 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 1.38 111.491 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 228' ' ' LEU . 34.4 m-85 -110.24 100.25 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.502 -0.772 . . . . 2.74 109.247 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -89.33 118.58 29.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 1.76 111.622 -170.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 59' ' ' ILE . 21.3 t -100.71 114.07 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.65 -0.5 . . . . 1.15 109.65 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -80.26 138.77 36.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.038 0.385 . . . . 2.02 112.038 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.454 ' CE2' ' HD1' ' A' ' 93' ' ' PHE . 65.9 m-85 -105.32 163.32 12.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.691 -0.686 . . . . 1.66 109.747 170.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.58 113.53 25.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.894 -0.41 . . . . 1.33 109.894 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -124.55 57.87 1.24 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.868 0.842 . . . . 2.65 111.034 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -87.71 -9.26 54.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.082 0.944 . . . . 1.61 108.926 167.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -154.25 171.3 19.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.445 -1.252 . . . . 2.35 108.057 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.28 73.15 2.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.38 0.609 . . . . 1.92 110.857 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -92.35 -56.48 3.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.815 . . . . 1.77 109.67 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.21 101.71 11.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.719 -0.673 . . . . 0.76 109.722 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.31 135.23 63.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.191 0.52 . . . . 1.27 110.746 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 tp -140.07 110.56 6.69 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.342 -0.985 . . . . 1.29 108.342 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -148.89 125.62 11.13 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.006 -0.678 . . . . 2.54 112.683 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . -66.22 173.86 23.18 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.354 -0.839 . . . . 1.31 111.663 159.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' O ' ' HG ' ' A' ' 84' ' ' LEU . . . -41.83 -143.93 0.0 OUTLIER Glycine 0 CA--C 1.538 1.485 0 N-CA-C 114.996 0.758 . . . . 1.9 114.996 169.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.88 122.69 9.45 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.955 1.77 . . . . 2.91 112.447 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 82' ' ' GLY . 82.1 mt -138.77 -168.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.899 -1.046 . . . . 4.11 110.216 -174.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.64 57.17 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.022 0.379 . . . . 4.95 112.022 -167.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.51 -116.94 2.26 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.024 -1.084 . . . . 2.25 113.995 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.417 HG21 ' HB ' ' A' ' 125' ' ' THR . 11.6 m -127.36 111.78 14.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.65 -0.5 . . . . 1.91 109.65 -171.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.73 ' HA ' ' CD2' ' A' ' 122' ' ' HIS . 9.8 m-85 -99.03 91.12 4.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.518 0.675 . . . . 3.7 112.3 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.57 146.77 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.016 -0.993 . . . . 3.54 109.532 172.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 120' ' ' LEU . 10.4 tp -89.61 130.33 35.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.633 -0.506 . . . . 1.14 109.633 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.5 tt -106.31 -32.78 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.677 0.275 . . . . 1.68 111.481 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 91' ' ' ILE . 3.8 pt20 -163.04 171.95 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 1.55 110.352 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.454 ' HD1' ' CE2' ' A' ' 70' ' ' PHE . 26.8 p90 -144.41 146.98 32.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.86 109.347 169.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.426 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 5.2 p-80 -134.28 160.16 38.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.8 -0.444 . . . . 0.93 109.8 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.17 167.91 19.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.948 0.404 . . . . 3.17 110.95 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.13 167.78 29.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.93 -0.767 . . . . 1.68 108.93 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -151.2 151.11 31.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.15 0.282 . . . . 5.18 110.245 -170.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -113.37 159.71 13.53 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.838 -0.696 . . . . 2.13 112.164 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 -39.76 79.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.869 0.366 . . . . 2.9 111.857 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.27 146.02 37.75 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.809 -0.812 . . . . 3.03 108.809 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.26 12.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.684 0.624 . . . . 3.85 112.684 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.66 17.83 10.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 1.94 111.97 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.429 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 14.0 pt20 -158.15 159.51 36.24 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.115 -0.328 . . . . 2.45 110.115 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.46 6.74 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 1.47 112.246 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.4 t -69.41 -45.81 68.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.748 0.309 . . . . 2.0 111.069 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.586 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 2.6 tp10 65.05 -162.64 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.528 -0.76 . . . . 3.72 109.093 -169.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.615 ' HA ' HG21 ' A' ' 31' ' ' VAL . 33.7 m80 53.27 49.28 20.19 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.171 0.986 . . . . 3.52 108.53 -167.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 t -79.72 131.58 35.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.815 -1.539 . . . . 2.52 112.171 -168.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 28.4 t -98.98 107.55 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 114.359 -1.291 . . . . 2.48 109.633 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.36 42.95 20.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.56 0.695 . . . . 2.8 110.096 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm 61.15 20.71 11.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.887 -1.051 . . . . 4.98 112.497 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -94.01 112.34 24.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.59 -0.522 . . . . 3.23 109.59 169.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 50.7 mttp -98.55 168.03 10.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.18 0.514 . . . . 2.82 111.174 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -119.53 176.55 5.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.3 -0.863 . . . . 1.62 109.453 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.91 94.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.1 0.407 . . . . 1.03 112.1 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.8 168.5 25.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.267 -0.424 . . . . 0.75 109.961 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -142.52 140.37 31.8 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.599 -0.519 . . . . 1.58 109.599 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 36.8 tp -103.3 125.75 50.11 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.323 -0.621 . . . . 1.07 109.323 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 12.3 m170 -118.76 109.93 16.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.1 0.476 . . . . 1.77 112.1 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -94.33 116.43 28.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.701 -0.681 . . . . 0.93 109.484 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.3 124.24 48.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.105 0.478 . . . . 0.61 112.013 -171.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.73 ' CD2' ' HA ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -89.62 140.96 29.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.884 -0.598 . . . . 2.13 111.005 175.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -112.64 141.53 46.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 4.26 109.542 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -93.22 96.01 9.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 2.02 110.927 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.417 ' HB ' HG21 ' A' ' 87' ' ' THR . 2.9 m -68.01 -16.94 64.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.934 -0.576 . . . . 2.34 111.251 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -52.63 -33.12 45.22 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.71 0.404 . . . . 3.35 111.804 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -107.85 -6.51 16.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.367 0.603 . . . . 3.1 110.484 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.52 38.55 9.5 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.232 -1.349 . . . . 2.37 113.785 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.56 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 22.8 t70 -166.31 110.48 0.79 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.634 -0.506 . . . . 3.93 109.634 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -57.26 -32.94 67.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 3.0 111.19 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -32.15 81.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.056 -0.593 . . . . 2.15 112.761 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.56 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 38.0 mmtm -88.29 -28.8 20.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 3.43 110.375 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.482 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -63.91 -36.28 83.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.021 -0.536 . . . . 1.76 110.685 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.483 ' O ' HD21 ' A' ' 203' ' ' LEU . 34.9 m -77.99 -2.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.372 -0.376 . . . . 2.77 111.236 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -109.01 19.23 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.278 0.561 . . . . 3.55 110.449 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -129.02 128.3 23.38 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.269 -1.011 . . . . 3.02 108.269 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.88 -31.59 73.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.097 2.532 . . . . 1.6 113.2 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -111.13 24.26 13.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.477 . . . . 2.29 109.997 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -66.01 -50.23 53.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.016 -0.538 . . . . 1.22 112.497 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 79.4 mt -109.28 151.98 25.83 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.418 -0.586 . . . . 1.57 109.418 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -145.99 123.91 12.02 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.748 -0.834 . . . . 1.38 108.748 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.55 116.83 53.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.879 -0.328 . . . . 1.73 110.899 -172.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 38.0 tp -83.38 115.69 22.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.668 -0.696 . . . . 2.42 109.696 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -106.16 128.88 9.52 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.038 -0.601 . . . . 0.86 112.623 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.7 122.61 70.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.387 -0.597 . . . . 0.76 109.387 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -69.75 146.39 51.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 1.2 110.301 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.34 130.46 56.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.413 -0.358 . . . . 0.88 110.149 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 216' ' ' SER . 26.2 pttm -125.32 151.59 45.84 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.457 -0.571 . . . . 2.03 109.457 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 40.7 t -84.84 121.42 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.094 0.473 . . . . 1.27 110.62 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.48 -114.72 0.33 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.504 -0.771 . . . . 1.53 111.201 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.3 p -74.01 156.3 37.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.206 -0.294 . . . . 1.54 110.206 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.22 148.88 37.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.808 0.337 . . . . 0.78 111.04 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 216' ' ' SER . 46.3 tptt -113.68 100.04 51.2 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.29 -0.414 . . . . 1.22 110.033 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 28.4 Cg_endo -63.32 -31.33 73.42 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.663 2.242 . . . . 1.05 112.543 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.94 -19.34 71.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.063 -0.589 . . . . 0.7 112.979 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 160' ' ' VAL . 37.0 tp -112.07 -12.04 13.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.054 0.454 . . . . 0.77 110.792 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -40.52 79.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.909 -0.587 . . . . 1.41 111.142 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.98 -26.86 62.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.972 0.415 . . . . 2.86 110.314 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 162' ' ' VAL . 59.0 t -72.3 -44.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.504 -0.554 . . . . 1.38 109.504 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.563 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 41.6 t -62.58 -34.31 64.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.691 . . . . 1.11 110.361 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.2 -28.74 68.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.443 -0.798 . . . . 1.22 111.562 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 159' ' ' VAL . 8.8 p -97.73 -14.57 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.794 -0.363 . . . . 1.41 111.883 -173.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.4 pp -70.75 -20.42 62.63 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.618 -0.433 . . . . 1.39 111.891 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 30.7 t70 -67.39 -24.42 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.235 0.54 . . . . 2.31 110.398 176.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.0 m -79.81 1.16 27.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 1.4 111.229 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 59' ' ' ILE . 40.5 pt -137.28 37.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.779 -0.823 . . . . 0.85 108.779 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 87.1 tttt -58.45 -32.01 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.861 -1.063 . . . . 1.59 111.854 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -119.92 154.17 34.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.31 -0.404 . . . . 0.77 110.485 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.46 135.37 57.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 2.29 110.663 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.7 38.18 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.71 -0.757 . . . . 0.85 111.715 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -89.77 143.47 26.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 1.7 110.711 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.488 ' HB3' HD13 ' A' ' 60' ' ' LEU . 65.3 p -139.88 156.59 46.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.033 -0.53 . . . . 1.37 109.659 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.6 140.37 40.91 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.118 -0.327 . . . . 0.61 110.118 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.92 130.8 44.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.553 -0.536 . . . . 1.8 109.553 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.38 79.79 1.68 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.797 -0.446 . . . . 1.04 109.797 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 56' ' ' SER . 21.7 p -106.76 164.98 11.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 1.17 111.148 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 56.65 71.32 0.58 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.432 0.457 . . . . 1.77 111.255 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.473 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 55.1 t80 -123.59 142.37 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.754 0.311 . . . . 3.99 110.293 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.47 102.3 14.11 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.823 -0.626 . . . . 2.51 110.061 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 2.9 Cg_exo -75.83 -19.83 15.82 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.637 2.224 . . . . 1.26 111.688 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -56.6 -38.55 72.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.287 -0.87 . . . . 2.76 111.663 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.08 6.94 2.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.125 -0.489 . . . . 1.12 113.863 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.57 -13.61 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.272 0.536 . . . . 1.73 110.352 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.3 130.43 87.79 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.591 . . . . 3.45 111.356 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.62 -171.95 1.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.443 2.095 . . . . 2.08 111.384 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.91 -62.37 1.67 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.936 0.398 . . . . 3.23 110.203 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.4 m -75.06 123.1 24.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 1.66 110.936 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.3 tp -101.52 64.1 0.98 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.625 0.726 . . . . 1.99 109.47 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 258' ' ' SER . 12.3 m-20 -124.91 147.64 48.73 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.398 -0.964 . . . . 1.81 108.398 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.457 ' CD1' HG23 ' A' ' 209' ' ' ILE . 53.1 p90 -144.43 158.71 43.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.562 0.949 . . . . 5.01 113.562 -166.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -93.02 140.08 29.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.42 -1.326 . . . . 3.93 107.42 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 9.3 t -136.57 116.72 13.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.713 0.688 . . . . 2.13 112.684 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -140.31 132.38 14.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 5.21 110.632 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.18 125.4 10.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.598 1.532 . . . . 2.12 110.575 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.34 160.13 26.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 121.035 -0.602 . . . . 1.75 113.249 -168.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 14.0 m -63.4 152.83 37.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.65 -0.5 . . . . 2.99 109.65 173.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.527 ' H ' HD12 ' A' ' 197' ' ' LEU . 5.7 mp -61.99 -50.86 70.37 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.18 -0.608 . . . . 4.75 112.055 -169.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 200' ' ' PRO . 23.5 p -122.47 -44.93 2.22 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.0 -0.28 . . . . 5.1 111.54 175.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 200' ' ' PRO . 1.9 m 157.71 -57.34 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 125.579 1.552 . . . . 5.53 109.118 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 199' ' ' THR . 53.4 Cg_exo -51.09 -43.55 47.55 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.326 2.018 . . . . 5.83 113.948 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.578 ' O ' ' HB3' ' A' ' 196' ' ' SER . 3.0 Cg_endo -83.37 109.11 1.58 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.034 1.823 . . . . 4.78 111.144 172.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 202' ' ' LEU . 1.8 mm? -78.58 50.42 0.96 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.439 0.638 . . . . 3.84 110.29 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 196' ' ' SER . 30.9 tp -116.18 120.34 38.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.359 -0.837 . . . . 2.96 108.905 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -98.89 51.55 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.381 0.61 . . . . 3.37 110.897 -171.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.7 p -91.89 -5.72 52.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.926 -0.579 . . . . 2.15 110.859 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 133.18 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.064 0.459 . . . . 1.26 110.575 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 21.7 m -105.91 103.51 13.02 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.126 -0.694 . . . . 2.08 109.126 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 192' ' ' THR . 96.3 m95 -76.16 110.39 10.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.301 -0.409 . . . . 5.53 110.43 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 74.3 mt -115.38 101.18 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.201 -0.666 . . . . 1.63 109.201 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 41.3 t -113.44 126.03 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 121.035 -0.266 . . . . 1.62 110.852 -171.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 137.25 41.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.291 0.567 . . . . 1.73 111.306 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -68.38 -10.35 54.46 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.346 -0.843 . . . . 2.98 112.376 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -114.61 107.75 50.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.815 -0.354 . . . . 1.47 111.198 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.81 143.49 50.77 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.133 2.555 . . . . 0.96 112.417 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -96.43 158.86 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.29 -0.633 . . . . 1.25 109.29 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 6.6 m -106.91 139.36 41.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.967 0.413 . . . . 1.29 111.425 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -124.18 148.42 28.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.02 109.024 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.7 t -94.98 164.78 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.149 -0.315 . . . . 1.08 110.149 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 m -47.23 -48.09 24.43 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.775 0.658 . . . . 1.33 112.775 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -53.55 -33.98 56.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 2.51 111.413 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -78.38 -43.32 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.262 -0.426 . . . . 0.7 110.049 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.72 -38.93 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 1.36 110.929 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.4 mt -57.63 -36.03 71.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.766 -0.652 . . . . 1.03 111.303 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -77.2 -24.33 51.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.318 -0.401 . . . . 1.75 110.961 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -72.13 -34.04 68.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.377 0.608 . . . . 2.47 109.491 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -70.87 -11.1 60.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.093 -0.958 . . . . 3.04 110.987 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 99.6 mttt -89.96 -19.36 24.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.3 -0.409 . . . . 2.31 111.338 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.436 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 95.7 mt -64.61 146.03 55.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.321 0.582 . . . . 0.95 112.199 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.09 149.2 37.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.408 -0.815 . . . . 1.13 109.901 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -86.4 -32.12 21.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.464 -0.789 . . . . 3.74 110.027 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -71.95 166.49 22.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.085 -0.962 . . . . 1.62 111.959 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.99 -177.8 36.31 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.548 -0.751 . . . . 1.16 111.433 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -63.05 130.76 46.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.838 0.352 . . . . 3.56 110.743 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.6 33.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.808 -0.71 . . . . 2.08 112.919 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.84 160.48 66.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.37 -0.604 . . . . 2.59 109.37 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -53.06 123.02 12.18 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.476 2.117 . . . . 1.36 111.46 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.413 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 54.1 mt-10 -68.65 112.74 5.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 3.4 111.413 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -116.42 121.42 41.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.05 -0.977 . . . . 2.47 109.268 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -67.54 148.42 51.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.062 0.458 . . . . 2.14 111.06 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 57.0 tpp -76.68 97.38 4.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.233 -0.894 . . . . 1.68 109.202 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 15.6 m -133.16 135.12 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.955 0.354 . . . . 1.27 111.955 -171.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.595 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 38.9 t70 70.59 -59.98 0.51 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.242 1.017 . . . . 2.18 111.037 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 84.24 -28.11 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.976 -1.011 . . . . 2.15 113.023 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -165.04 152.66 11.27 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.264 0.484 . . . . 4.59 112.07 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 31.6 tpt180 -139.72 71.99 36.19 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.408 -0.815 . . . . 6.13 109.565 173.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 31.2 Cg_endo -120.25 57.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 123.498 2.798 . . . . 3.28 115.378 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 31' ' ' VAL . . . -115.26 122.31 45.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.634 1.106 . . . . 2.98 110.827 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 253' ' ' ARG . 16.5 mm-40 -122.91 162.7 37.56 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 111.697 0.258 . . . . 4.32 111.697 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.24 174.02 11.38 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.976 2.451 . . . . 3.48 113.512 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 252' ' ' ASN . 3.3 mm? -60.68 -11.01 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.591 -1.186 . . . . 4.63 113.451 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 252' ' ' ASN . 19.6 ptpt -59.44 41.25 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.611 1.338 . . . . 5.34 114.611 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 251' ' ' LYS . 6.3 t-20 118.48 -33.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.539 1.935 . . . . 4.64 110.069 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.55 ' N ' ' HD3' ' A' ' 253' ' ' ARG . 0.5 OUTLIER -90.69 89.6 7.59 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.586 0.708 . . . . 6.11 110.107 -177.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -155.39 154.1 31.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.92 -1.141 . . . . 3.08 107.92 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 31' ' ' VAL . 14.9 mt -124.84 136.82 59.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.602 -0.439 . . . . 2.6 110.766 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.48 ' O ' HG22 ' A' ' 255' ' ' ILE . 40.5 mtmt -76.99 165.53 24.53 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 2.63 109.472 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.772 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -121.48 159.01 27.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.532 -0.544 . . . . 1.71 109.532 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 41.8 m -151.91 97.64 2.36 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.884 -0.413 . . . . 2.21 109.884 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.38 110.46 10.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.651 -0.704 . . . . 4.31 109.249 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.438 -0.792 . . . . 4.49 110.165 178.759 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 121.137 0.494 . . . . 17.49 110.148 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 t -94.19 156.38 16.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.657 -0.701 . . . . 15.32 110.036 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -111.03 0.99 17.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.255 -0.646 . . . . 15.81 109.255 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -79.23 -61.36 2.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.825 -0.625 . . . . 14.19 109.758 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 -93.51 132.83 37.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.163 0.506 . . . . 14.91 110.746 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.42 142.92 3.69 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.563 -1.015 . . . . 10.79 110.563 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -57.68 133.27 55.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.049 0.452 . . . . 11.39 110.592 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.23 -26.98 18.74 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.691 -0.686 . . . . 9.0 113.39 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 3.5 mptp? -79.73 139.11 37.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.294 0.547 . . . . 9.76 112.215 -173.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.6 m170 69.38 -82.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.097 -0.956 . . . . 11.19 111.808 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.25 -7.82 12.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.232 0.539 . . . . 10.8 110.087 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.02 -121.08 2.78 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.955 -1.258 . . . . 8.82 109.955 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.63 124.21 5.65 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.36 1.373 . . . . 7.87 110.697 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -90.28 -33.18 16.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.852 0.358 . . . . 10.62 110.52 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -71.66 -38.01 70.72 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.953 -0.758 . . . . 9.87 108.953 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -75.56 -11.94 60.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.501 -0.772 . . . . 8.48 110.614 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -75.95 -27.7 57.65 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.53 -0.544 . . . . 7.13 109.53 172.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -83.17 -29.09 28.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.131 -0.486 . . . . 9.68 110.262 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -77.53 -28.93 52.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.067 -0.515 . . . . 7.89 110.168 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -131.38 80.7 67.04 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.68 -0.691 . . . . 7.17 109.44 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -57.7 -25.96 70.68 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.167 2.578 . . . . 7.76 113.617 -176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.619 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 9.7 tp -81.04 7.64 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.886 0.374 . . . . 5.83 111.608 -176.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.08 14.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.666 0.617 . . . . 5.44 112.666 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -88.95 59.83 5.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.937 0.398 . . . . 7.78 111.043 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.42 -38.45 3.01 Favored Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 111.134 -0.786 . . . . 5.01 111.134 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 28.9 mm-40 -51.49 129.79 26.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.903 -0.648 . . . . 7.09 109.341 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.556 ' CD ' ' HB3' ' A' ' 252' ' ' ASN . 7.8 mtm180 -81.38 130.27 34.97 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.448 0.642 . . . . 5.13 112.582 -167.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' A' ' 248' ' ' GLN . 41.1 tt0 -136.0 -16.42 1.69 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.976 -1.011 . . . . 7.12 110.1 170.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.4 p -102.01 165.55 13.71 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 108.912 -0.773 . . . . 3.94 108.912 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 20.4 Cg_exo -67.22 -49.51 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 CA-C-N 119.748 0.946 . . . . 4.52 112.474 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.451 HG21 HG13 ' A' ' 255' ' ' ILE . 12.9 p -170.94 143.01 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.55 0.574 . . . . 4.54 112.55 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.17 116.68 24.52 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.212 -1.033 . . . . 2.88 108.212 157.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 61.3 mt -90.57 102.86 13.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 2.32 111.794 -167.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.08 105.22 17.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 2.82 109.944 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -60.1 -32.55 71.08 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.367 0.877 . . . . 2.24 113.367 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -68.85 -45.14 71.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.73 0.3 . . . . 4.54 111.083 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 m -82.09 -19.65 39.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.365 -0.38 . . . . 3.06 111.004 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.3 134.74 50.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.989 0.423 . . . . 1.72 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.76 116.31 28.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 3.69 110.401 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -74.51 124.4 26.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.198 0.523 . . . . 4.64 109.82 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.659 ' O ' ' HA ' ' A' ' 258' ' ' SER . 29.9 t70 -118.9 143.37 33.6 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.128 -0.942 . . . . 2.27 110.137 -170.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 44' ' ' LEU . 21.1 Cg_exo -67.36 119.13 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.157 1.905 . . . . 2.15 111.815 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 m -53.38 43.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.025 1.12 . . . . 4.29 114.025 169.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' H ' ' A' ' 45' ' ' LYS . 2.0 pt? -14.32 -66.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.304 1.842 . . . . 4.74 114.044 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.613 ' H ' ' HG ' ' A' ' 44' ' ' LEU . 27.5 mmtp -117.16 148.6 42.76 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 121.717 -0.615 . . . . 3.77 109.807 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.23 137.66 31.68 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.747 2.298 . . . . 2.36 112.696 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.462 HD11 ' CD2' ' A' ' 190' ' ' TYR . 95.1 mt -66.61 127.41 32.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 2.55 111.06 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 22.7 t -84.12 115.16 22.25 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.652 -0.87 . . . . 2.38 108.652 174.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.9 107.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.053 -0.521 . . . . 1.59 110.092 -173.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 78' ' ' VAL . 19.5 t -133.63 91.74 2.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.142 0.496 . . . . 1.45 110.834 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -108.98 0.53 20.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.795 -0.639 . . . . 3.62 110.192 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.495 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . 4.1 m-20 -69.29 -30.88 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 2.48 111.816 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.495 ' NE2' ' HB2' ' A' ' 52' ' ' ASP . 1.0 OUTLIER -98.67 -2.58 37.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.716 -0.394 . . . . 2.24 110.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.13 130.15 40.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.054 -0.521 . . . . 0.8 111.785 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -106.33 106.88 17.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.96 -0.564 . . . . 1.06 110.975 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.0 OUTLIER -74.47 143.0 44.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.277 -0.419 . . . . 1.26 110.109 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 71' ' ' ASP . 86.4 mt -114.71 -57.26 2.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.825 0.345 . . . . 0.74 111.85 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -155.41 159.28 39.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.302 -0.408 . . . . 3.17 111.052 -170.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 66' ' ' PHE . 13.2 tt -126.1 137.11 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.2 -0.667 . . . . 0.64 109.2 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' OG ' ' A' ' 172' ' ' SER . 27.3 tp -140.87 110.83 6.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.827 0.346 . . . . 0.96 111.809 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 66' ' ' PHE . 40.8 t30 -75.73 117.74 17.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.898 -0.778 . . . . 1.49 108.898 170.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -140.3 69.39 1.35 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.244 -0.583 . . . . 1.83 111.301 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.52 -67.3 0.51 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.497 -0.859 . . . . 1.64 112.798 165.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.517 ' CE1' ' HB3' ' A' ' 243' ' ' ASN . 49.8 t60 -101.11 -29.53 12.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 3.33 111.1 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.79 -171.75 1.68 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.942 -0.572 . . . . 1.38 109.757 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 61' ' ' ASN . 30.9 p90 -118.16 123.17 44.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.194 0.521 . . . . 2.74 109.712 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -94.43 114.96 27.07 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.539 -0.755 . . . . 1.76 110.364 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 59.8 t -90.6 105.88 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.597 -0.52 . . . . 1.15 109.597 173.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.9 137.77 32.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.994 0.426 . . . . 2.02 111.472 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.99 170.07 8.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 1.66 110.681 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 57' ' ' LEU . 24.3 t70 -97.45 101.43 12.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.831 -0.622 . . . . 1.33 109.345 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.549 ' OD1' ' HB3' ' A' ' 90' ' ' LEU . 16.0 m-20 -120.9 60.62 0.9 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.65 111.038 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.7 t -108.82 1.1 20.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.487 -0.779 . . . . 1.61 111.195 173.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.24 172.59 12.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.673 0.273 . . . . 2.35 111.03 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.41 65.7 5.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.891 -0.595 . . . . 1.92 110.989 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -130.77 1.92 4.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.532 . . . . 1.77 110.587 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HB1' ' CD2' ' A' ' 90' ' ' LEU . . . -154.01 84.49 1.15 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.272 -0.64 . . . . 0.76 109.272 -168.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 50' ' ' SER . 27.1 m -139.54 149.17 22.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.375 0.607 . . . . 1.27 112.539 -173.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 48' ' ' SER . 40.0 tp -148.56 112.36 5.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.864 -1.062 . . . . 1.29 108.826 170.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 87' ' ' THR . 45.3 pttt -150.13 141.0 22.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.483 0.549 . . . . 2.54 112.483 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -57.68 172.68 2.87 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 115.628 -0.715 . . . . 1.31 111.928 156.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.94 -143.99 0.0 OUTLIER Glycine 0 CA--C 1.54 1.649 0 N-CA-C 117.793 1.877 . . . . 1.9 117.793 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.17 124.36 7.48 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.185 2.59 . . . . 2.91 114.174 -163.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 12.3 tp -142.13 -168.15 2.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.748 -1.569 . . . . 4.11 107.142 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.511 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 8.1 p-10 -148.82 89.08 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.13 0.877 . . . . 4.95 109.181 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 99.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.589 -0.815 . . . . 2.25 111.098 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 80' ' ' LYS . 46.2 m -104.61 103.2 12.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.62 0.724 . . . . 1.91 112.494 -172.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.0 m-85 -126.34 98.26 5.37 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.203 -1.036 . . . . 3.7 108.203 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 27.5 mmt180 -141.69 89.03 2.17 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 112.192 0.441 . . . . 3.54 112.192 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.549 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 40.6 tp -156.82 158.89 37.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.745 -1.576 . . . . 1.14 106.745 160.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.511 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 6.1 tp -161.88 -46.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.816 1.189 . . . . 1.68 112.287 169.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 8.6 pt20 -158.8 172.2 18.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.988 0.423 . . . . 1.55 111.479 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -146.57 144.05 29.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.118 -0.697 . . . . 0.86 109.118 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.6 p-80 -142.32 159.89 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.267 -0.424 . . . . 0.93 110.48 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.597 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 81.3 m-85 -117.73 168.11 10.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.86 0.362 . . . . 3.17 110.646 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -122.91 170.99 9.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.085 -0.709 . . . . 1.68 109.085 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -156.24 129.37 8.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.868 0.366 . . . . 5.18 110.131 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 103' ' ' GLN . . . -89.59 -50.86 3.03 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.769 -0.65 . . . . 2.13 113.14 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.577 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 26.3 t 149.06 -50.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.348 1.059 . . . . 2.9 108.74 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.69 160.88 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 3.03 109.398 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 115' ' ' ALA . 35.0 t70 -71.71 67.16 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.423 0.63 . . . . 3.85 110.607 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.46 42.91 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.701 -0.761 . . . . 1.94 112.941 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.647 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 12.9 pt20 -172.27 143.03 1.41 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.018 0.409 . . . . 2.45 110.423 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.91 15.21 81.84 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 120.786 -0.721 . . . . 1.47 112.35 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 41.6 t -89.14 -8.34 53.93 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.12 0.415 . . . . 2.0 112.12 -177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HA ' ' NE1' ' A' ' 244' ' ' TRP . 7.7 tp10 72.3 157.46 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.287 0.367 . . . . 3.72 110.471 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.46 ' CG ' ' HG3' ' A' ' 106' ' ' GLU . 29.6 m170 54.61 67.31 1.03 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.074 0.464 . . . . 3.52 111.863 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -80.21 127.25 32.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.892 0.853 . . . . 2.52 111.016 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 38.1 t -103.29 105.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.58 -1.191 . . . . 2.48 110.157 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.03 45.43 21.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.371 0.605 . . . . 2.8 110.293 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 64.27 14.29 8.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.685 -1.143 . . . . 4.98 112.077 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -89.03 126.16 35.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.69 -0.485 . . . . 3.23 109.69 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.61 155.08 21.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.046 -0.724 . . . . 2.82 109.046 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -109.51 -170.24 1.62 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.344 -0.389 . . . . 1.62 110.287 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.435 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -46.6 18.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.374 . . . . 1.03 110.916 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.09 163.95 38.42 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.945 -0.571 . . . . 0.75 110.448 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -129.11 145.56 51.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 1.58 110.046 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.597 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 24.6 tp -111.73 112.2 23.72 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.246 -0.434 . . . . 1.07 109.861 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.431 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 46.9 m170 -110.93 105.27 14.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.15 -0.477 . . . . 1.77 111.335 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.7 mp -91.01 110.77 22.03 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.5 t -86.9 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.047 0.451 . . . . 0.61 110.195 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 89' ' ' ARG . 38.6 m80 -131.22 125.31 32.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.905 -0.588 . . . . 2.13 109.838 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.511 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -111.02 151.53 27.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.052 -0.721 . . . . 4.26 109.052 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.585 ' ND2' ' HA ' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -93.2 101.53 13.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.787 0.803 . . . . 2.02 111.244 178.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -64.49 -10.02 22.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.39 -0.823 . . . . 2.34 112.813 -173.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -69.65 -47.94 61.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.842 0.353 . . . . 3.35 110.468 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -84.4 -21.11 30.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.375 0.607 . . . . 3.1 110.493 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.46 -2.28 64.97 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.813 -1.315 . . . . 2.37 109.813 -171.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.585 ' HA ' ' ND2' ' A' ' 124' ' ' ASN . 12.0 t70 73.3 -87.0 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.0 -1.1 . . . . 3.93 112.957 171.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -46.38 -40.12 11.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.069 0.766 . . . . 3.0 113.069 -168.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 134' ' ' VAL . . . -55.22 -61.12 7.73 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.022 -0.609 . . . . 2.15 112.324 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -73.69 -28.19 61.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.742 0.275 . . . . 3.43 111.742 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.63 62.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.473 0.546 . . . . 1.76 112.473 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 203' ' ' LEU . 34.4 m -64.92 -31.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.857 -0.337 . . . . 2.77 111.157 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 134' ' ' VAL . 41.6 mt-30 -100.66 -28.3 12.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 3.55 110.855 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.541 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 8.9 tt0 -76.05 119.85 79.03 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 3.02 110.848 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.95 -17.1 54.96 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.585 2.19 . . . . 1.6 111.365 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.541 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 m-20 -105.31 27.07 8.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.159 -0.928 . . . . 2.29 109.418 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.09 -82.24 0.05 OUTLIER Glycine 0 C--O 1.226 -0.382 0 CA-C-N 116.115 -0.493 . . . . 1.22 112.554 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.43 148.9 25.35 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.21 0.529 . . . . 1.57 110.661 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.46 104.51 7.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.486 -0.779 . . . . 1.38 109.177 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.59 129.29 60.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.314 -0.403 . . . . 1.73 111.28 -172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 34.4 tp -97.47 127.27 43.3 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.173 -0.677 . . . . 2.42 109.173 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -111.23 131.18 10.17 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.783 -0.722 . . . . 0.86 112.736 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.4 mt -137.69 106.78 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 0.76 109.508 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -62.93 156.43 24.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.936 0.398 . . . . 1.2 111.889 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.75 123.2 49.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.88 110.097 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.3 ptmm? -115.64 138.39 51.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.817 -0.629 . . . . 2.03 109.823 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 47.8 t -88.1 133.97 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.711 0.291 . . . . 1.27 110.991 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.624 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . 126.64 58.63 0.14 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.847 -0.692 . . . . 1.53 113.361 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.624 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 3.2 t 160.26 122.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.26 -1.015 . . . . 1.54 108.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.31 134.64 39.68 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.941 -0.304 . . . . 0.78 110.271 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -114.91 95.85 42.85 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.303 -0.408 . . . . 1.22 110.462 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.84 -39.25 92.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.152 2.568 . . . . 1.05 112.341 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -66.66 -21.05 70.67 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.926 -0.654 . . . . 0.7 112.82 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 160' ' ' VAL . 60.7 tp -91.88 -31.27 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 0.77 110.412 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.462 ' NE2' ' HG2' ' A' ' 221' ' ' GLN . 8.7 tp-100 -53.37 -40.98 65.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 1.41 112.27 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.5 pttt -55.41 -37.45 67.65 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.642 0.608 . . . . 2.86 112.642 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 162' ' ' VAL . 12.0 p -85.16 -32.64 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.434 -0.507 . . . . 1.38 110.959 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.619 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 44.1 t -64.96 -38.97 84.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.301 0.572 . . . . 1.11 110.909 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.97 -35.3 79.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.78 -0.646 . . . . 1.22 111.429 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 175' ' ' PHE . 8.3 p -88.04 -17.35 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.777 0.288 . . . . 1.41 111.777 -172.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.1 pp -74.42 -15.23 60.92 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.31 -0.556 . . . . 1.39 110.512 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.43 -24.62 64.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 2.31 110.434 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.2 m -84.47 1.85 43.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.838 -0.619 . . . . 1.4 111.359 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 30.4 pt -138.56 38.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.973 -0.751 . . . . 0.85 108.973 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -53.14 -41.54 65.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.837 -1.074 . . . . 1.59 111.947 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.6 p -102.69 149.83 24.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.426 -0.352 . . . . 0.77 110.434 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -64.16 137.4 57.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 2.29 110.31 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.64 -24.55 17.07 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.556 -0.831 . . . . 0.85 111.664 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -78.09 132.33 37.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.138 0.494 . . . . 1.7 110.734 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.434 ' OG ' HD13 ' A' ' 60' ' ' LEU . 4.0 m -117.71 154.11 32.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.845 -0.798 . . . . 1.37 108.845 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -145.21 137.5 25.85 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.869 -0.419 . . . . 0.61 109.869 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.88 131.99 47.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.543 -0.539 . . . . 1.8 109.543 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.468 ' CE2' HG11 ' A' ' 162' ' ' VAL . 20.2 t80 -138.46 78.1 1.66 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.178 -1.045 . . . . 1.04 108.178 -176.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 56' ' ' SER . 13.0 m -97.45 139.81 32.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.508 -0.769 . . . . 1.17 112.817 -173.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 24.7 m120 42.61 73.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.834 -1.075 . . . . 1.77 113.516 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.27 101.4 7.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.723 -0.671 . . . . 3.99 109.575 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -55.88 119.42 25.93 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 2.51 111.895 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.65 -5.46 17.11 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.682 2.254 . . . . 1.26 111.165 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 52' ' ' ASP . 57.1 ttp180 -57.76 -37.17 73.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.76 111.272 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.15 -24.11 60.53 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.257 -0.497 . . . . 1.12 112.969 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.8 mt -81.12 -24.3 37.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.835 0.35 . . . . 1.73 111.01 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.37 128.37 92.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 3.45 111.089 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.48 -170.16 0.77 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.992 2.462 . . . . 2.08 113.375 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -75.5 -64.16 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.18 0.437 . . . . 3.23 112.18 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.633 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 3.5 m -80.26 134.32 36.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 1.66 111.17 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 95.0 mt -108.3 64.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.197 0.522 . . . . 1.99 110.96 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.495 ' HB2' ' HE3' ' A' ' 212' ' ' LYS . 55.9 m-20 -123.74 144.16 49.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.723 -1.214 . . . . 1.81 107.723 173.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.462 ' CD2' HD11 ' A' ' 47' ' ' LEU . 30.4 p90 -133.39 144.94 49.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.979 1.103 . . . . 5.01 113.979 -163.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.464 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 17.5 m95 -90.24 131.6 35.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.45 -1.25 . . . . 3.93 107.675 168.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 256' ' ' LYS . 4.9 t -128.05 118.13 22.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.436 0.636 . . . . 2.13 111.737 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 194' ' ' PRO . 20.0 p90 -139.75 153.84 70.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 5.21 110.678 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 193' ' ' TYR . 9.7 Cg_exo -72.39 136.43 26.34 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.813 2.342 . . . . 2.12 110.937 172.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.727 ' HA3' ' CD1' ' A' ' 208' ' ' TRP . . . -137.99 158.78 24.86 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.364 -0.922 . . . . 1.75 113.062 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 t -97.04 153.07 18.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.12 0.486 . . . . 2.99 111.005 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -81.97 14.92 2.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.031 -0.986 . . . . 4.75 110.387 178.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.4 t -64.57 25.25 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.856 1.428 . . . . 5.1 114.856 -161.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.577 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.1 OUTLIER -85.55 -64.7 0.22 Allowed Pre-proline 0 C--N 1.319 -0.742 0 O-C-N 121.334 -0.854 . . . . 5.53 109.042 172.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 199' ' ' THR . 1.2 Cg_endo -83.71 -68.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.665 0 C-N-CA 121.629 1.553 . . . . 5.83 113.101 166.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 200' ' ' PRO . 97.9 Cg_endo -104.47 157.63 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.436 2.091 . . . . 4.78 112.74 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 23.7 tp -90.81 68.04 6.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.499 0.666 . . . . 3.84 110.696 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 134' ' ' VAL . 56.9 tp -108.39 122.0 46.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.517 -0.765 . . . . 2.96 110.847 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -92.24 77.72 5.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.273 0.559 . . . . 3.37 111.186 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 85.2 m -147.81 43.29 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 2.15 110.349 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.25 146.07 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 1.26 110.956 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 48.9 m -114.28 121.45 43.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.302 -0.629 . . . . 2.08 109.302 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.727 ' CD1' ' HA3' ' A' ' 195' ' ' GLY . 36.9 m95 -106.4 130.13 54.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 5.53 110.977 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 49.1 mm -121.71 116.06 48.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.85 . . . . 1.63 109.54 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 98.0 t -111.29 133.88 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.302 -0.259 . . . . 1.62 110.302 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 143' ' ' LEU . 88.1 mt -86.37 143.93 27.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.234 0.54 . . . . 1.73 110.751 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 189' ' ' ASP . 26.8 ttmt -53.24 -23.02 7.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.945 -1.025 . . . . 2.98 112.231 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.633 ' HG3' ' H ' ' A' ' 187' ' ' SER . 68.7 mm-40 -110.55 121.03 42.38 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.424 -0.353 . . . . 1.47 111.068 -174.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -84.02 171.62 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.61 2.207 . . . . 0.96 111.246 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 31.0 pt -111.48 147.25 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.964 0.411 . . . . 1.25 109.963 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 23.0 p -100.17 146.42 26.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.334 0.588 . . . . 1.29 111.234 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -140.66 146.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.208 -0.905 . . . . 1.02 109.418 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 222' ' ' VAL . 59.5 m -101.86 168.22 9.57 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.887 -0.325 . . . . 1.08 111.372 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.555 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 49.1 m -48.49 -51.0 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.092 0.775 . . . . 1.33 113.092 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.7 -48.06 82.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.698 0.285 . . . . 2.51 111.275 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.475 ' HB2' ' CG2' ' A' ' 217' ' ' VAL . 18.1 mt-30 -59.3 -44.63 92.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.764 -0.458 . . . . 0.7 109.764 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.513 ' O ' ' HG3' ' A' ' 226' ' ' ARG . 95.9 t -60.51 -40.69 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.721 -0.672 . . . . 1.36 110.874 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 219' ' ' SER . 93.6 mt -60.43 -37.03 79.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.027 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.41 ' HD2' HG12 ' A' ' 160' ' ' VAL . 93.2 mttt -66.62 -33.86 76.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.472 -0.331 . . . . 1.75 110.887 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -67.46 -30.8 70.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.328 0.585 . . . . 2.47 109.751 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 222' ' ' VAL . 23.6 mtp180 -79.14 -3.93 47.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.487 -0.779 . . . . 3.04 111.294 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 47.3 mmtm -87.82 -19.49 27.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.104 -0.332 . . . . 2.31 110.104 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.25 139.82 57.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.921 -0.581 . . . . 0.95 111.434 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.429 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.93 149.32 38.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 1.13 110.315 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -79.57 -31.77 41.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 3.74 109.749 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 4.5 p-10 -73.95 165.16 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.129 -0.941 . . . . 1.62 112.397 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.77 171.23 42.89 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.506 -1.225 . . . . 1.16 110.834 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.01 141.58 57.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.216 0.508 . . . . 3.56 110.688 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.76 3.88 73.47 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.701 -0.761 . . . . 2.08 111.908 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -114.01 157.67 41.42 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.369 -0.234 . . . . 2.59 110.369 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 127.62 26.81 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.89 2.394 . . . . 1.36 111.785 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -61.42 116.93 5.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.068 -0.515 . . . . 3.4 111.547 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -121.68 119.75 32.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.577 -0.738 . . . . 2.47 109.127 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 226' ' ' ARG . 83.9 mt -67.1 149.5 50.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.921 -0.581 . . . . 2.14 111.861 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 55.7 tpp -75.36 103.76 5.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.084 -0.962 . . . . 1.68 108.903 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.23 139.16 49.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 1.27 112.121 -171.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 21.8 t70 67.83 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.648 -1.16 . . . . 2.18 111.31 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 33.1 m-80 55.76 31.37 17.41 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.044 0.537 . . . . 2.15 111.945 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' A' ' 106' ' ' GLU . 30.6 t90 -134.17 144.53 48.56 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.199 -0.313 . . . . 4.59 110.414 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.569 ' O ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -111.12 149.05 39.93 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.424 -0.213 . . . . 6.13 110.424 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.73 132.91 3.95 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 124.33 3.353 . . . . 3.28 114.246 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.38 151.0 46.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.223 -0.899 . . . . 2.98 110.926 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.507 ' HG3' ' HA ' ' A' ' 27' ' ' ARG . 77.0 mm-40 -123.81 150.09 61.24 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 4.32 110.466 -174.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.37 175.26 10.29 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.598 2.865 . . . . 3.48 115.261 -169.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 82.7 mt -63.53 -8.81 10.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 113.368 -1.742 . . . . 4.63 113.432 -173.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 16.9 ttmm -58.17 44.36 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.467 1.284 . . . . 5.34 114.467 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.556 ' HB3' ' CD ' ' A' ' 27' ' ' ARG . 7.5 t-20 119.21 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 127.017 2.127 . . . . 4.64 109.52 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.583 ' HD2' ' O ' ' A' ' 30' ' ' PRO . 42.8 mmt-85 -126.2 84.87 2.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.413 -0.958 . . . . 6.11 108.413 168.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -115.9 142.4 46.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 3.08 110.012 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.451 HG13 HG21 ' A' ' 31' ' ' VAL . 3.1 mp -103.76 122.99 57.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 2.6 111.064 -174.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 1.0 OUTLIER -97.86 145.13 26.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.523 -0.917 . . . . 2.63 108.523 167.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -123.64 93.01 3.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.512 -0.551 . . . . 1.71 109.512 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 54.1 m -80.18 97.41 6.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.628 0.728 . . . . 2.21 110.924 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -135.12 103.72 5.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.375 -1.284 . . . . 4.31 109.253 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 C--O 1.248 1.01 0 CA-C-N 116.154 -0.476 . . . . 4.49 110.67 178.49 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.115 0.483 . . . . 17.49 110.055 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 t -138.82 40.7 2.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.419 0.628 . . . . 15.32 109.341 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -139.32 33.44 2.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.54 0.686 . . . . 15.81 109.66 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -110.27 -38.74 5.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.107 -0.952 . . . . 14.19 109.464 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -96.1 81.63 3.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.4 -0.818 . . . . 14.91 109.819 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' HA3' ' HA3' ' A' ' 12' ' ' GLY . . . -159.32 135.21 4.06 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.463 -0.875 . . . . 10.79 112.2 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -104.66 100.07 9.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.066 0.46 . . . . 11.39 111.35 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.65 158.04 33.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.707 -0.758 . . . . 9.0 113.392 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -45.7 134.99 7.08 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.285 -0.458 . . . . 9.76 111.736 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 81.66 -25.28 0.16 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.886 -1.052 . . . . 11.19 111.699 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -102.51 -14.49 16.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.175 0.512 . . . . 10.8 110.43 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' HA3' ' HA3' ' A' ' 6' ' ' GLY . . . -179.74 -152.45 10.79 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.844 -0.902 . . . . 8.82 110.844 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.16 129.19 11.97 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.695 2.264 . . . . 7.87 111.52 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -82.27 -21.26 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.004 0.431 . . . . 10.62 110.359 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.471 ' HB3' ' HD3' ' A' ' 18' ' ' LYS . 41.8 m80 -112.16 22.78 14.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.434 0.635 . . . . 9.87 109.379 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -54.18 -26.2 26.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.889 -1.051 . . . . 8.48 112.231 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -77.19 -6.13 51.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.879 0.371 . . . . 7.13 110.649 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 15' ' ' HIS . 56.5 mtpt -89.12 -41.93 11.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.424 -0.353 . . . . 9.68 110.487 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -68.72 -27.65 66.12 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.116 0.484 . . . . 7.89 110.336 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.47 ' HB3' HG22 ' A' ' 22' ' ' ILE . 20.7 m-85 -108.16 92.68 9.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.676 -0.693 . . . . 7.17 110.749 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.52 -21.05 53.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.71 2.273 . . . . 7.76 111.996 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 20' ' ' PHE . 7.7 tp -42.89 -29.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.565 -0.743 . . . . 5.83 112.649 173.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -39.75 -37.18 0.5 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.765 0.654 . . . . 5.44 112.765 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -71.71 34.24 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.407 -0.36 . . . . 7.78 111.775 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 23' ' ' ALA . . . -167.48 -65.03 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.169 -0.772 . . . . 5.01 111.169 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 204' ' ' GLU . 0.0 OUTLIER -45.25 169.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.067 0.937 . . . . 7.09 113.277 171.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -149.19 170.57 18.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.614 -2.365 . . . . 5.13 104.614 -165.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.716 ' NE2' ' HA ' ' A' ' 252' ' ' ASN . 1.1 mp0 -53.79 152.83 5.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 120.4 1.455 . . . . 7.12 113.233 175.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -48.08 167.04 0.2 Allowed Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 113.951 -1.477 . . . . 3.94 114.568 176.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HA ' ' CE2' ' A' ' 208' ' ' TRP . 54.5 Cg_exo -43.24 35.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 1 C-N-CA 127.164 5.243 . . . . 4.52 117.006 169.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 32' ' ' ASP . 4.1 p -89.82 -174.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 118.557 0.617 . . . . 4.54 110.184 -170.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.755 ' H ' HG22 ' A' ' 31' ' ' VAL . 95.3 m-20 -51.94 141.53 17.58 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.776 1.028 . . . . 2.88 113.776 -169.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 58.8 mt -98.97 139.66 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.372 -1.285 . . . . 2.32 110.981 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.509 ' H ' ' CD1' ' A' ' 255' ' ' ILE . 24.3 t70 -112.14 118.31 34.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.833 -0.432 . . . . 2.82 109.833 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.82 -43.79 73.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.397 -0.82 . . . . 2.24 113.138 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -65.77 -42.1 91.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 4.54 110.792 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 255' ' ' ILE . 22.9 m -72.67 -28.11 62.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.019 -0.537 . . . . 3.06 110.904 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 255' ' ' ILE . . . -75.22 93.59 2.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.264 0.554 . . . . 1.72 110.95 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.94 142.19 28.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.475 -0.784 . . . . 3.69 110.665 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.5 m-85 -58.07 122.48 13.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.472 -0.785 . . . . 4.64 110.975 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.63 133.96 27.26 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.764 . . . . 2.27 109.857 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.15 59.75 3.06 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.971 2.447 . . . . 2.15 112.497 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.402 ' CB ' ' HB2' ' A' ' 258' ' ' SER . 36.9 t -69.72 -53.59 17.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 4.29 110.121 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp 72.04 -54.66 0.68 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.31 -0.859 . . . . 4.74 111.733 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HB2' ' HA3' ' A' ' 82' ' ' GLY . 43.7 mmtm -75.62 132.64 74.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 3.77 110.371 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.29 167.02 26.6 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.641 2.227 . . . . 2.36 112.273 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.44 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 61.3 tp -93.54 116.9 29.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.942 -0.572 . . . . 2.55 109.842 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 32.1 t -86.87 121.65 29.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.427 -0.583 . . . . 2.38 109.427 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.75 134.82 57.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.973 0.416 . . . . 1.59 110.716 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 28.4 t -128.54 91.03 3.16 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.309 0.576 . . . . 1.45 109.652 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.85 9.02 32.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 3.62 109.647 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 8.3 t70 -55.49 -39.1 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.404 -0.816 . . . . 2.48 111.201 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.2 mp0 -99.44 15.59 25.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 2.24 111.238 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 121.72 17.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.8 111.374 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -114.37 106.98 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.12 -0.491 . . . . 1.06 110.519 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.0 m -76.14 146.68 39.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.354 -0.61 . . . . 1.26 109.354 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.28 -56.69 1.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.74 111.925 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.45 155.8 32.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.724 0.297 . . . . 3.17 111.282 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.1 tt -122.02 138.5 52.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.116 -0.493 . . . . 0.64 109.906 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 172' ' ' SER . 38.2 tp -134.63 138.48 44.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.013 0.435 . . . . 0.96 111.905 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -96.05 114.49 26.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.267 -0.879 . . . . 1.49 109.13 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -115.26 70.15 0.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 1.83 110.308 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.2 -59.04 0.16 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.164 -1.38 . . . . 1.64 115.531 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -110.91 -17.02 13.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.842 0.353 . . . . 3.33 111.089 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.38 174.66 14.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.981 -0.748 . . . . 1.38 108.981 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -138.4 135.47 35.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.637 -0.505 . . . . 2.74 109.637 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' A' ' 94' ' ' HIS . 15.5 m120 -126.58 152.39 46.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.214 -0.448 . . . . 1.76 110.508 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 7.1 p -111.49 129.07 67.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.079 -0.51 . . . . 1.15 109.751 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.79 131.63 34.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.081 -0.509 . . . . 2.02 111.433 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -103.84 153.21 21.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.634 -0.712 . . . . 1.66 109.674 172.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.558 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 33.0 t70 -72.15 92.65 1.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.084 -0.507 . . . . 1.33 110.137 176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -108.4 56.47 0.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.657 0.742 . . . . 2.65 111.206 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -103.16 -3.39 25.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.749 -0.66 . . . . 1.61 111.317 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.481 ' CG ' ' HE3' ' A' ' 76' ' ' LYS . 9.5 pt20 -148.66 165.0 32.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.215 -0.448 . . . . 2.35 110.122 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -81.1 73.28 8.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.189 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HD2' ' O ' ' A' ' 71' ' ' ASP . 15.2 ptpt -102.39 -41.18 6.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.591 -0.731 . . . . 1.77 110.998 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -113.2 96.9 6.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.676 -0.49 . . . . 0.76 109.676 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 95.3 t -124.16 150.91 28.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.768 -0.651 . . . . 1.27 110.856 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 79' ' ' LEU . 2.5 pt? -149.19 115.74 5.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.772 0.32 . . . . 1.29 110.523 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -139.04 125.09 19.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.808 0.337 . . . . 2.54 110.62 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 47' ' ' LEU . . . -133.95 -178.19 15.44 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 109.521 -1.432 . . . . 1.31 109.521 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -26.51 -127.93 0.0 OUTLIER Glycine 0 N--CA 1.486 2.024 0 C-N-CA 125.089 1.328 . . . . 1.9 115.991 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.66 170.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.075 2.517 . . . . 2.91 112.99 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.7 pt? -31.9 114.14 0.14 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.389 1.255 . . . . 4.11 114.389 -144.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 9.8 p-10 -128.27 -128.09 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 113.424 -1.717 . . . . 4.95 112.284 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 106.05 161.3 22.73 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.193 -1.163 . . . . 2.25 110.193 -166.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 125' ' ' THR . 20.1 m -73.66 102.99 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.987 0.893 . . . . 1.91 110.715 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 68.2 m-85 -100.78 133.5 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 3.7 110.544 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HD2' ' CZ2' ' A' ' 123' ' ' TRP . 99.7 mtt180 -102.49 142.78 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.225 -0.443 . . . . 3.54 110.42 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.3 tp -77.64 125.15 28.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.618 -0.512 . . . . 1.14 109.618 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.4 tt -111.73 -40.72 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.834 0.35 . . . . 1.68 110.886 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -165.15 169.36 16.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.714 -0.476 . . . . 1.55 109.714 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.486 ' HB3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 p90 -143.81 158.23 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.356 -0.238 . . . . 0.86 110.356 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.546 ' HB3' ' ND2' ' A' ' 67' ' ' ASN . 5.4 p-80 -132.34 158.91 40.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.616 -0.513 . . . . 0.93 109.616 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.82 149.93 28.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.467 -0.333 . . . . 3.17 110.375 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.485 ' ND1' ' HB3' ' A' ' 117' ' ' GLU . 13.4 m170 -100.48 153.05 19.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.504 -0.924 . . . . 1.68 108.504 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 75.0 t-105 -161.73 125.61 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.023 -0.362 . . . . 5.18 110.023 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -87.42 -171.51 47.27 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 111.319 -0.712 . . . . 2.13 111.319 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' A' ' 241' ' ' VAL . 11.2 t -78.52 -46.94 18.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.736 0.768 . . . . 2.9 109.995 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 102' ' ' GLY . 92.6 mt -83.95 146.61 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.429 . . . . 3.03 110.135 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.21 32.59 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.765 0.654 . . . . 3.85 112.765 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 100' ' ' LEU . . . -155.4 21.93 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.921 -0.656 . . . . 1.94 112.344 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.402 ' HG3' ' HA3' ' A' ' 98' ' ' GLY . 3.1 pt20 -150.46 169.58 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.211 -0.292 . . . . 2.45 110.211 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.422 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 86.95 17.41 59.58 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.668 -0.777 . . . . 1.47 113.111 169.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 77.8 p -80.58 -8.86 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.963 0.382 . . . . 2.0 111.701 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 66.48 164.68 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.101 -0.703 . . . . 3.72 109.101 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.426 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 29.4 m80 58.11 46.73 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 3.52 110.704 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.5 m -78.4 117.71 19.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 2.52 110.097 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 46.2 t -84.22 99.67 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 114.549 -1.205 . . . . 2.48 110.887 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 69.58 -72.27 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.709 0.631 . . . . 2.8 110.599 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -146.06 5.56 0.99 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.814 -0.439 . . . . 4.98 109.814 173.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.06 97.15 11.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.973 -0.558 . . . . 3.23 110.085 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -110.89 145.22 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 2.82 109.512 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 46.1 m-85 -105.06 179.03 4.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.303 -0.408 . . . . 1.62 110.203 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.72 -33.02 53.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.026 0.441 . . . . 1.03 110.668 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.35 23.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.75 110.049 -172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 31.0 tt0 -147.73 146.38 29.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.97 -0.559 . . . . 1.58 110.255 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.6 tp -99.45 107.3 19.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.548 -0.751 . . . . 1.07 109.604 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -109.52 102.41 11.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.11 0.481 . . . . 1.77 110.176 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 93' ' ' PHE . 5.0 mp -87.49 128.1 35.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.93 111.158 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 142' ' ' VAL . 45.2 t -96.45 127.6 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.965 -0.561 . . . . 0.61 110.393 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 20.9 m80 -126.77 138.11 53.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.608 -0.516 . . . . 2.13 109.608 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.586 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 44.9 p-90 -112.52 144.78 41.43 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.545 0.528 . . . . 4.26 110.592 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.672 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 41.8 t-20 -75.38 109.89 9.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 2.02 110.752 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.586 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 8.9 t -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.068 0.766 . . . . 2.34 113.068 -172.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.672 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 21.3 ptmt -71.3 -7.68 48.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.166 0.432 . . . . 3.35 112.166 -172.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -123.09 -17.59 6.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.349 0.595 . . . . 3.1 110.459 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.45 -4.95 85.64 Favored Glycine 0 C--N 1.325 -0.042 0 N-CA-C 109.734 -1.347 . . . . 2.37 109.734 -167.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 123' ' ' TRP . 13.1 t70 71.55 -86.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.193 -1.504 . . . . 3.93 112.224 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.443 ' O ' HG23 ' A' ' 134' ' ' VAL . 95.7 m-85 -45.27 -31.4 1.53 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.256 1.206 . . . . 3.0 114.256 -168.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.53 -65.03 2.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.344 -0.932 . . . . 2.15 111.803 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -72.23 -30.78 65.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.979 0.363 . . . . 3.43 111.979 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -26.34 49.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.141 0.422 . . . . 1.76 112.141 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 130' ' ' PHE . 59.7 t -60.66 -34.75 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 2.77 110.71 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -119.9 18.77 12.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.479 -0.328 . . . . 3.55 111.466 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 7.9 tt0 -132.16 113.83 14.79 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.755 -0.461 . . . . 3.02 109.755 -173.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.524 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 38.0 Cg_exo -60.69 -14.63 32.54 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.023 2.482 . . . . 1.6 113.785 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.77 27.15 9.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.303 . . . . 2.29 110.552 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.444 ' O ' ' HE1' ' A' ' 88' ' ' TYR . . . -66.61 -86.84 0.07 OUTLIER Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.947 -0.57 . . . . 1.22 114.211 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.8 mt -87.76 161.21 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.562 0.696 . . . . 1.57 112.708 -168.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.43 110.58 5.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.939 . . . . 1.38 110.177 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 208' ' ' TRP . 21.2 m -107.32 152.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.812 -0.44 . . . . 1.73 109.812 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 10.2 tt -131.92 125.25 31.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.315 -0.254 . . . . 2.42 110.315 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.86 131.9 10.22 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.843 -0.694 . . . . 0.86 113.025 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -119.57 122.87 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.208 -0.293 . . . . 0.76 110.208 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -68.38 146.95 52.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.466 -0.334 . . . . 1.2 111.628 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.444 HD23 ' HB ' ' A' ' 215' ' ' ILE . 80.2 mt -124.47 114.52 19.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 0.88 110.219 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -107.24 153.73 22.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.71 -0.478 . . . . 2.03 109.71 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 44.1 t -90.08 127.64 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.987 0.423 . . . . 1.27 110.848 -175.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.07 -105.12 0.19 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.217 -0.753 . . . . 1.53 111.217 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.0 m -76.23 146.58 38.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.04 -0.356 . . . . 1.54 110.04 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -70.0 146.99 50.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.78 111.298 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 216' ' ' SER . 51.6 tptt -112.89 99.76 49.2 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.603 -0.726 . . . . 1.22 109.67 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 11.1 Cg_endo -55.55 -36.34 94.26 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.735 2.29 . . . . 1.05 111.919 -178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.12 -28.89 72.88 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.8 -0.636 . . . . 0.7 113.06 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.436 ' HG ' HG23 ' A' ' 160' ' ' VAL . 21.4 tp -93.82 -19.85 20.62 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.226 -0.573 . . . . 0.77 110.153 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -46.01 91.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.174 -0.466 . . . . 1.41 110.461 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.9 pttp -57.42 -40.7 78.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.677 0.621 . . . . 2.86 112.677 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.68 -36.01 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.263 -0.575 . . . . 1.38 110.73 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 75.8 t -64.03 -36.45 76.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.125 0.488 . . . . 1.11 110.757 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.39 -31.34 70.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.04 -0.527 . . . . 1.22 110.465 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 158' ' ' LYS . 73.0 t -83.55 -27.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.41 111.476 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 4.3 pp -70.77 -13.39 62.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.222 0.534 . . . . 1.39 110.31 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.42 -24.8 65.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.85 -0.613 . . . . 2.31 110.211 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.3 m -83.41 -1.64 53.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.31 . . . . 1.4 111.556 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 163' ' ' LEU . 47.2 pt -139.67 26.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 0.85 109.962 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 229' ' ' ASN . 48.9 pttt -74.89 16.15 0.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.038 -0.528 . . . . 1.59 112.334 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.76 140.23 46.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.902 0.382 . . . . 0.77 110.408 174.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.412 ' HB3' ' HA2' ' A' ' 232' ' ' GLY . 74.2 tttt -56.32 120.16 7.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 2.29 111.876 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.49 30.72 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.631 -0.795 . . . . 0.85 112.462 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -88.17 148.98 24.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.908 0.385 . . . . 1.7 110.687 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 60' ' ' LEU . 11.6 p -145.57 157.28 44.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.874 -0.603 . . . . 1.37 110.158 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -147.61 149.43 32.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.67 0.271 . . . . 0.61 110.52 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.97 136.79 46.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.017 0.437 . . . . 1.8 110.268 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -140.55 79.91 1.73 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.797 -0.816 . . . . 1.04 108.797 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.3 p -109.44 159.86 16.68 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.275 0.472 . . . . 1.17 112.275 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 55.35 47.16 21.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.509 -0.769 . . . . 1.77 112.345 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.13 98.29 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.891 0.377 . . . . 3.99 110.186 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.08 136.25 82.19 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.884 -0.598 . . . . 2.51 111.136 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.03 -4.27 13.18 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.123 2.549 . . . . 1.26 112.226 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 70.0 mtp180 -55.07 -42.68 73.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.872 -0.604 . . . . 2.76 112.136 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -58.97 -13.55 19.87 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 116.176 -0.465 . . . . 1.12 113.675 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.21 -7.65 44.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.852 0.326 . . . . 1.73 111.168 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.62 128.78 68.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.667 -0.242 . . . . 3.45 110.595 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.07 -178.39 4.15 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.827 2.351 . . . . 2.08 112.527 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.81 -63.21 1.46 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.561 0.219 . . . . 3.23 110.749 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.0 m -70.41 130.42 41.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 1.66 110.712 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.04 62.55 0.6 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.255 0.55 . . . . 1.99 110.107 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -94.21 128.28 40.56 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.329 -0.989 . . . . 1.81 108.329 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 52.6 p90 -139.66 147.45 41.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.067 0.766 . . . . 5.01 113.067 -169.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 28.6 m-90 -86.76 135.84 33.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.286 -0.87 . . . . 3.93 108.928 169.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 192' ' ' THR . 7.1 t -119.69 103.26 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.641 0.734 . . . . 2.13 110.346 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' A' ' 208' ' ' TRP . 4.6 t80 -137.48 137.08 21.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.098 -0.501 . . . . 5.21 110.783 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -89.56 128.83 1.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.745 2.297 . . . . 2.12 112.279 173.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -140.09 157.65 25.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.276 -0.487 . . . . 1.75 112.696 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 201' ' ' PRO . 1.7 m -65.41 148.41 51.75 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.395 -0.594 . . . . 2.99 109.395 174.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 201' ' ' PRO . 8.2 mp -56.4 -53.29 59.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.285 0.476 . . . . 4.75 112.285 -168.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 18.0 m -125.58 -45.98 1.76 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.95 0.405 . . . . 5.1 110.13 166.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.73 -55.7 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.103 -0.953 . . . . 5.53 111.177 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.466 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 52.3 Cg_exo -53.12 -44.49 48.44 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.276 1.984 . . . . 5.83 113.581 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.509 ' HB2' HD13 ' A' ' 197' ' ' LEU . 12.2 Cg_exo -73.9 78.53 2.48 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.559 1.506 . . . . 4.78 110.398 169.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 65.0 mt -51.56 -27.24 10.37 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.348 1.03 . . . . 3.84 113.327 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 196' ' ' SER . 42.9 tp -53.54 145.25 15.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.29 0.567 . . . . 2.96 110.967 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.445 ' HB3' ' CB ' ' A' ' 26' ' ' GLU . 12.2 pt-20 -95.96 41.46 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.498 -0.774 . . . . 3.37 109.57 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 137' ' ' PRO . 4.6 p -84.11 2.49 39.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 2.15 112.362 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.448 ' CG2' ' HG ' ' A' ' 197' ' ' LEU . 73.7 t -105.03 129.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 120.95 0.405 . . . . 1.26 109.943 175.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.3 m -107.76 100.83 10.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.715 -0.846 . . . . 2.08 108.715 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.554 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 4.4 p-90 -90.24 100.96 13.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.914 0.864 . . . . 5.53 111.72 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 51.3 mm -88.85 105.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.065 -1.425 . . . . 1.63 109.671 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 43.1 t -106.78 128.99 61.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.965 -0.294 . . . . 1.62 110.544 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.5 mp -85.89 140.85 30.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.419 0.628 . . . . 1.73 111.448 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -83.86 -21.71 31.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.149 -0.932 . . . . 2.98 110.92 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.403 ' OE1' ' HD2' ' A' ' 214' ' ' PRO . 11.3 tp10 -88.33 113.38 55.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.271 -0.422 . . . . 1.47 109.873 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 83.0 Cg_endo -82.93 155.81 15.25 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.668 2.245 . . . . 0.96 113.11 -177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.444 ' HB ' HD23 ' A' ' 147' ' ' LEU . 26.8 mm -106.19 146.44 12.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.771 -0.649 . . . . 1.25 109.609 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 15.1 m -99.57 127.93 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.451 -0.34 . . . . 1.29 111.322 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.9 m -122.48 151.51 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.921 -0.77 . . . . 1.02 108.921 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 8.0 t -97.1 163.82 12.77 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.277 -0.569 . . . . 1.08 111.159 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.542 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 24.9 m -50.82 -50.62 56.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 1.33 111.886 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -50.98 -36.29 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.934 0.397 . . . . 2.51 111.573 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.95 -48.32 54.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.146 -0.479 . . . . 0.7 110.894 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.424 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 29.4 m -74.92 -22.08 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 1.36 111.277 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 219' ' ' SER . 94.7 mt -68.28 -45.2 73.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.032 -0.359 . . . . 1.03 110.032 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -67.8 -29.46 68.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 1.75 110.659 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.49 -42.49 82.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 2.47 110.041 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 67.0 ttt180 -73.93 10.88 1.01 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.72 -0.673 . . . . 3.04 111.011 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.46 -8.6 38.03 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.06 -0.348 . . . . 2.31 110.06 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.81 132.45 52.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.08 -0.509 . . . . 0.95 111.039 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 167' ' ' LYS . 0.9 OUTLIER -101.53 140.41 35.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.907 -0.588 . . . . 1.13 110.218 178.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -78.86 -34.94 44.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.781 -1.099 . . . . 3.74 109.668 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 4.6 p-10 -70.8 163.86 26.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.84 -1.073 . . . . 1.62 111.875 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 169' ' ' LYS . . . -83.92 174.4 51.25 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.231 -0.895 . . . . 1.16 111.197 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.55 127.5 32.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.95 0.375 . . . . 3.56 110.062 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 100.22 -2.58 56.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.859 -0.686 . . . . 2.08 112.635 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 41.3 mt-10 -102.2 159.97 27.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.065 -0.346 . . . . 2.59 110.065 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.96 128.68 30.89 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.181 . . . . 1.36 111.519 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -59.38 125.63 24.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 3.4 112.734 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 44.8 mt-10 -130.57 150.24 51.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.091 -1.078 . . . . 2.47 108.091 170.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.7 mt -90.97 133.38 35.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.525 -0.47 . . . . 2.14 110.866 -175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 ttm -76.83 89.3 3.45 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.359 -0.978 . . . . 1.68 108.359 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 99' ' ' SER . 21.7 m -133.55 153.24 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 1.27 110.198 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.4 t70 67.36 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.004 0.815 . . . . 2.18 110.356 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 43.39 32.22 0.48 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.555 0.534 . . . . 2.15 111.743 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -104.5 136.66 43.65 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.082 0.468 . . . . 4.59 110.597 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.585 ' H ' ' HD2' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -70.3 144.3 91.93 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.267 -0.879 . . . . 6.13 110.434 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.63 131.93 43.49 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.792 2.328 . . . . 3.28 111.965 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.99 132.37 49.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 2.98 111.584 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.519 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 66.8 mm-40 -85.17 172.79 8.11 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.854 -0.795 . . . . 4.32 108.854 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.556 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 73.4 Cg_exo -43.06 110.51 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.406 2.071 . . . . 3.48 112.03 174.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -58.42 4.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.443 -1.253 . . . . 4.63 113.586 -167.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 37' ' ' THR . 5.2 ptpp? -69.59 -7.0 34.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.624 0.972 . . . . 5.34 113.624 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.716 ' HA ' ' NE2' ' A' ' 28' ' ' GLN . 7.7 p30 36.33 54.27 1.03 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.718 1.007 . . . . 4.64 113.718 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 252' ' ' ASN . 13.4 mmt180 76.11 -89.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.391 -0.596 . . . . 6.11 109.391 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.47 136.52 21.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.975 -1.12 . . . . 3.08 107.975 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.515 ' H ' HG22 ' A' ' 37' ' ' THR . 17.0 mt -94.24 150.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.691 0.281 . . . . 2.6 111.033 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -104.55 131.44 51.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 2.63 110.558 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.31 97.55 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.256 -0.429 . . . . 1.71 110.164 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.402 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 22.3 p -95.73 96.46 9.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.367 -0.533 . . . . 2.21 111.609 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.486 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 24.8 p90 -166.71 154.4 9.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 4.31 110.047 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.997 -0.547 . . . . 4.49 110.605 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.999 -0.371 . . . . 17.49 109.999 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.1 t 68.17 98.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.505 0.669 . . . . 15.32 111.57 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -98.93 23.53 8.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.254 -0.647 . . . . 15.81 109.254 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -87.97 94.51 9.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.596 -0.729 . . . . 14.19 110.709 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -84.4 86.1 7.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.34 0.591 . . . . 14.91 109.933 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.26 154.33 23.39 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.097 -0.801 . . . . 10.79 111.097 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -92.24 97.08 10.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.764 0.792 . . . . 11.39 110.622 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.93 -87.08 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.251 -1.34 . . . . 9.0 110.649 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -74.81 117.86 17.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.581 -0.896 . . . . 9.76 108.581 172.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.2 m80 56.65 174.81 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.335 0.588 . . . . 11.19 111.184 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 245' ' ' ARG . 7.2 m120 -113.18 13.55 19.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.64 0.733 . . . . 10.8 110.024 174.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.33 160.16 28.21 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.261 -1.536 . . . . 8.82 109.261 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.89 121.14 9.08 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 CA-C-N 119.302 1.551 . . . . 7.87 111.804 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.35 2.4 50.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.913 -0.585 . . . . 10.62 112.116 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -114.91 -26.32 7.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.97 0.414 . . . . 9.87 110.949 -176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -76.89 -15.06 59.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.13 -0.487 . . . . 8.48 111.059 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -70.26 -15.66 62.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 7.13 110.459 176.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -87.69 -30.65 20.22 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.129 0.49 . . . . 9.68 109.893 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.57 -32.22 65.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.766 -0.652 . . . . 7.89 110.389 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.471 ' HB3' HG22 ' A' ' 22' ' ' ILE . 95.9 m-85 -124.65 98.18 37.78 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.425 -0.807 . . . . 7.17 109.862 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 50.0 Cg_exo -54.93 -29.13 62.54 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.387 2.725 . . . . 7.76 112.92 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' A' ' 20' ' ' PHE . 14.5 tt -44.82 -28.17 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 113.073 0.768 . . . . 5.83 113.073 175.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 17' ' ' HIS . . . -61.48 -10.12 7.1 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.83 0.678 . . . . 5.44 112.83 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 21' ' ' PRO . 34.1 mmtp -59.82 -16.16 26.29 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 122.154 -0.341 . . . . 7.78 111.293 168.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.67 -73.48 0.92 Allowed Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.321 -0.712 . . . . 5.01 111.321 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.49 168.73 1.06 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 122.753 0.421 . . . . 7.09 110.022 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 165.42 29.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 104.878 -2.267 . . . . 5.13 104.878 -165.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -55.97 -50.0 72.01 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.753 1.161 . . . . 7.12 112.342 -166.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.536 ' HB2' ' HA ' ' A' ' 248' ' ' GLN . 70.3 m -94.44 145.34 29.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.424 -0.353 . . . . 3.94 110.327 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HA ' ' OG ' ' A' ' 196' ' ' SER . 74.4 Cg_endo -75.72 -41.88 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.032 2.488 . . . . 4.52 115.588 -166.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG23 ' CD1' ' A' ' 193' ' ' TYR . 7.4 p -161.54 157.09 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.715 -0.394 . . . . 4.54 111.846 -174.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.498 ' HB2' ' H ' ' A' ' 248' ' ' GLN . 32.2 t70 -163.01 132.9 4.35 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.109 -0.7 . . . . 2.88 109.109 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 210' ' ' VAL . 54.2 mt -101.98 103.57 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.904 0.705 . . . . 2.32 112.904 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -93.69 102.14 14.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.053 -0.721 . . . . 2.82 109.053 165.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 m -56.99 -28.46 62.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 2.24 112.353 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -69.84 -34.27 73.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.563 0.221 . . . . 4.54 111.281 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -85.7 -23.29 27.46 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.955 -0.298 . . . . 3.06 111.126 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -61.54 105.28 0.51 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.283 0.563 . . . . 1.72 111.716 174.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -99.28 138.05 36.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.526 -0.761 . . . . 3.69 111.235 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 99.2 m-85 -73.93 132.41 42.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.529 . . . . 4.64 110.112 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -120.81 124.09 27.67 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.427 -0.351 . . . . 2.27 110.725 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.35 -23.22 44.72 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.767 2.312 . . . . 2.15 112.036 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 m -65.7 -27.81 68.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.524 . . . . 4.29 111.396 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.7 mt -70.52 119.26 14.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.028 0.442 . . . . 4.74 111.01 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.605 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 59.0 tttm -99.29 131.43 25.14 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.407 -0.815 . . . . 3.77 109.294 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.3 154.44 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.862 3.041 . . . . 2.36 114.034 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.64 125.21 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.066 -0.97 . . . . 2.55 110.729 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.2 m -96.87 98.42 10.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.239 -0.652 . . . . 2.38 109.239 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.43 HG22 ' HG ' ' A' ' 79' ' ' LEU . 8.9 t -102.9 127.98 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.912 -0.585 . . . . 1.59 110.649 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -129.58 91.4 3.15 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.82 -0.437 . . . . 1.45 109.82 175.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -106.35 11.63 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.864 0.364 . . . . 3.62 110.92 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 2.48 111.067 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 48.9 mt-30 -94.33 6.17 49.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.987 -0.552 . . . . 2.24 111.964 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -67.51 133.72 49.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.8 111.603 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 m -113.38 106.24 14.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.455 . . . . 1.06 110.467 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 m -72.34 138.05 47.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.162 -0.472 . . . . 1.26 109.832 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 71' ' ' ASP . 82.6 mt -113.74 -58.21 2.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.74 112.427 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -158.9 161.44 36.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.868 0.366 . . . . 3.17 111.448 -173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -121.17 133.2 68.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.651 -0.87 . . . . 0.64 108.651 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 57.9 tp -137.3 119.05 15.08 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.56 0.578 . . . . 0.96 112.56 -171.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -79.18 114.06 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.102 -1.073 . . . . 1.49 108.102 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 169' ' ' LYS . 53.8 t30 -140.34 70.59 1.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.654 -0.819 . . . . 1.83 112.423 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 103.27 -67.01 0.33 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.137 -1.03 . . . . 1.64 113.132 162.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.471 ' HB3' ' OD1' ' A' ' 243' ' ' ASN . 51.7 m80 -103.82 -27.55 12.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.048 0.452 . . . . 3.33 110.895 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.96 -169.98 2.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.755 -0.657 . . . . 1.38 110.159 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 95' ' ' PHE . 34.8 p90 -133.8 134.03 42.37 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.271 -1.011 . . . . 2.74 108.271 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 8.3 p30 -132.71 151.87 51.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.055 0.455 . . . . 1.76 111.398 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 98.2 t -106.46 118.35 53.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 1.15 109.84 176.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.39 138.38 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.464 . . . . 2.02 111.417 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.82 150.69 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.339 -0.846 . . . . 1.66 109.135 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB2' HD21 ' A' ' 57' ' ' LEU . 22.4 t70 -75.2 124.44 27.06 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.009 -0.367 . . . . 1.33 110.009 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -125.81 58.31 1.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.08 0.943 . . . . 2.65 110.448 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 p -96.41 -5.25 40.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.51 -0.768 . . . . 1.61 109.75 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -143.17 157.69 44.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.834 -1.075 . . . . 2.35 108.813 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.58 70.25 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.549 0.69 . . . . 1.92 109.769 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 68.5 mttm -92.75 -54.64 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.287 -0.869 . . . . 1.77 111.538 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -110.5 110.42 21.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.282 -0.417 . . . . 0.76 110.283 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.75 144.24 34.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.392 -0.367 . . . . 1.27 110.613 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HG ' HG22 ' A' ' 49' ' ' VAL . 9.6 tt -149.9 113.04 4.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.707 -0.849 . . . . 1.29 108.707 172.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -151.43 127.44 10.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.156 0.503 . . . . 2.54 111.385 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -67.89 174.01 30.01 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.784 -0.644 . . . . 1.31 111.635 164.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 45' ' ' LYS . . . -39.2 -142.73 0.0 OUTLIER Glycine 0 N--CA 1.472 1.076 0 N-CA-C 115.813 1.085 . . . . 1.9 115.813 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.52 121.32 6.95 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 121.856 1.704 . . . . 2.91 112.37 -173.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.8 mt -147.81 -168.17 3.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.528 -1.214 . . . . 4.11 108.713 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -129.24 70.3 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.444 0.535 . . . . 4.95 112.444 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 131.19 -125.56 4.5 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.794 -1.193 . . . . 2.25 115.072 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.776 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 85.6 m -131.51 115.68 16.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.692 -0.754 . . . . 1.91 109.755 -169.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -115.01 91.36 3.59 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.037 -0.665 . . . . 3.7 111.739 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.29 142.49 34.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.477 -0.783 . . . . 3.54 110.109 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -73.77 121.86 21.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 1.14 110.331 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.519 HG23 ' HG2' ' A' ' 92' ' ' GLN . 5.2 tp -107.92 -38.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 1.68 111.088 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HG2' HG23 ' A' ' 91' ' ' ILE . 8.7 pt20 -170.25 168.06 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.625 -0.262 . . . . 1.55 110.498 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 41.6 p90 -141.31 145.89 36.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.648 -0.501 . . . . 0.86 109.648 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.459 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.8 p-80 -128.9 159.81 34.63 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.329 0.393 . . . . 0.93 110.695 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 t80 -135.74 158.13 45.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.959 -0.386 . . . . 3.17 109.959 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -162.65 171.12 17.37 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.734 0.302 . . . . 1.68 111.713 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.506 ' CZ2' ' HB ' ' A' ' 222' ' ' VAL . 23.1 m95 -138.99 148.74 43.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.588 -0.733 . . . . 5.18 110.459 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 99' ' ' SER . . . -79.18 -37.38 25.02 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-N 116.022 -0.535 . . . . 2.13 113.499 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 47.1 t 162.93 -70.56 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.57 0.748 . . . . 2.9 109.35 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.38 158.33 26.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.359 -0.837 . . . . 3.03 109.68 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.22 62.05 0.13 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.558 0.536 . . . . 3.85 111.463 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.23 32.31 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.649 -0.786 . . . . 1.94 113.029 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.522 ' NE2' ' HB3' ' A' ' 99' ' ' SER . 13.6 pt20 -161.29 157.21 25.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.898 0.349 . . . . 2.45 110.485 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.494 ' HA3' ' N ' ' A' ' 98' ' ' GLY . . . 99.11 45.92 2.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.867 -0.682 . . . . 1.47 112.482 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 45.2 t -103.88 -28.4 11.62 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.284 -0.166 . . . . 2.0 111.264 -177.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 105' ' ' SER . 8.5 tp10 68.07 169.3 0.27 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.196 -0.668 . . . . 3.72 109.196 -167.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.6 m170 60.59 35.13 20.07 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.482 0.658 . . . . 3.52 110.414 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.476 ' CG2' ' HA ' ' A' ' 113' ' ' LYS . 73.2 p -82.73 119.59 24.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.167 -0.924 . . . . 2.52 111.637 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 87.9 t -76.42 117.0 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.214 -0.903 . . . . 2.48 109.878 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.71 35.42 16.93 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.128 -0.693 . . . . 2.8 109.128 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.7 mttp 59.91 27.49 16.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.073 -0.967 . . . . 4.98 112.342 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -77.3 86.87 3.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.114 -0.328 . . . . 3.23 110.114 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.476 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 98.9 mttt -61.69 113.05 2.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.066 0.46 . . . . 2.82 111.477 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -83.88 177.34 8.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.551 -0.75 . . . . 1.62 109.108 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.86 -53.7 54.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.914 0.338 . . . . 1.03 111.914 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.2 169.56 4.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.124 -0.325 . . . . 0.75 110.124 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.4 ' HB2' ' OG ' ' A' ' 105' ' ' SER . 26.8 tt0 -148.94 141.81 24.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.987 -0.375 . . . . 1.58 109.987 -178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 34.5 tp -99.74 125.89 45.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.871 -0.604 . . . . 1.07 109.493 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.4 m170 -110.69 107.9 17.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 1.77 111.516 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 120' ' ' LEU . 5.4 mp -93.39 113.35 25.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.786 -0.643 . . . . 0.93 110.19 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.04 127.65 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.294 0.569 . . . . 0.61 111.527 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.9 139.88 50.5 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.017 -1.105 . . . . 2.13 108.017 172.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.94 154.36 46.64 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.57 -0.452 . . . . 4.26 111.559 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.776 ' HA ' ' O ' ' A' ' 87' ' ' THR . 53.1 t30 -76.43 89.58 3.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 2.02 110.988 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.9 p -73.45 -9.2 58.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.538 0.94 . . . . 2.34 113.538 -171.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 13.5 ptmm? -71.52 -46.02 60.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.963 -0.695 . . . . 3.35 109.736 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.516 ' CG ' ' HG3' ' A' ' 132' ' ' LYS . 67.6 m-85 -94.19 -15.56 24.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 3.1 111.138 173.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 129' ' ' ASP . . . 101.23 -1.04 54.2 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.835 -0.698 . . . . 2.37 111.57 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 128' ' ' GLY . 32.8 t70 81.52 -78.16 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.834 0.854 . . . . 3.93 112.185 172.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -56.3 -19.87 16.26 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.438 0.903 . . . . 3.0 113.438 -168.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.09 -67.52 1.62 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.723 -0.751 . . . . 2.15 112.165 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HG3' ' CG ' ' A' ' 127' ' ' TYR . 45.0 mmtm -72.13 -21.25 61.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.416 0.524 . . . . 3.43 112.416 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.63 56.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 1.76 111.427 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 203' ' ' LEU . 70.1 t -61.62 -36.29 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 2.77 110.418 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -106.4 -24.66 12.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.661 0.267 . . . . 3.55 111.283 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -95.47 105.13 18.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 3.02 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 72.4 Cg_endo -76.52 -0.46 10.45 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.424 2.083 . . . . 1.6 112.419 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.53 27.07 10.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.425 -0.352 . . . . 2.29 110.39 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.87 -53.92 8.96 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 120.808 -0.711 . . . . 1.22 112.849 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 91.5 mt -89.32 151.0 22.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.192 0.52 . . . . 1.57 110.784 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.47 106.63 5.75 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.485 -0.78 . . . . 1.38 109.286 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 44.4 t -107.3 117.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.457 -0.338 . . . . 1.73 110.803 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.99 126.18 33.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.833 -0.621 . . . . 2.42 109.62 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.19 115.43 4.45 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.737 -0.744 . . . . 0.86 112.638 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.6 mt -104.91 111.48 34.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.137 -0.319 . . . . 0.76 110.137 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -67.99 144.61 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.695 0.283 . . . . 1.2 110.981 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.2 mp -115.71 131.94 56.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.43 -0.35 . . . . 0.88 110.315 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -121.5 143.91 49.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.147 -0.686 . . . . 2.03 109.147 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 42.5 t -88.43 129.6 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 1.27 111.374 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.59 -104.12 0.18 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.532 -0.758 . . . . 1.53 111.279 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 p -81.66 146.73 29.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.197 -0.297 . . . . 1.54 110.197 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.33 148.86 47.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.086 0.469 . . . . 0.78 111.621 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 216' ' ' SER . 49.3 tptt -111.5 103.76 55.39 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.799 -0.637 . . . . 1.22 109.444 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.83 -38.11 94.89 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.002 2.468 . . . . 1.05 112.299 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.466 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -62.13 -29.21 72.18 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 116.031 -0.531 . . . . 0.7 113.035 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.5 tp -94.48 -17.58 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.271 0.535 . . . . 0.77 110.392 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -43.78 92.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.828 -0.624 . . . . 1.41 110.233 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 47.0 pttt -56.87 -32.39 65.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 2.86 111.853 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.6 t -77.07 -41.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 1.38 110.47 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 156' ' ' LEU . 72.4 t -57.57 -36.93 55.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.745 -0.662 . . . . 1.11 111.331 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.02 -20.6 65.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.967 -0.56 . . . . 1.22 112.405 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.0 t -96.6 -7.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.902 0.382 . . . . 1.41 111.332 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 84.6 mt -57.66 -42.1 82.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.854 0.687 . . . . 1.39 112.854 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.94 -24.81 66.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.81 0.338 . . . . 2.31 111.386 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.0 m -81.15 -8.98 59.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.476 -0.329 . . . . 1.4 111.26 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -134.21 36.61 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.364 0.602 . . . . 0.85 109.739 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.58 -32.92 74.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 1.59 111.451 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.9 p -116.93 155.73 28.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.888 0.375 . . . . 0.77 111.528 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 62' ' ' ASN . 42.5 tttm -59.73 132.42 53.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.868 -0.605 . . . . 2.29 110.611 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.36 -17.14 40.73 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.756 -0.735 . . . . 0.85 111.555 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -75.28 107.83 7.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.941 0.4 . . . . 1.7 110.602 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.0 m -98.95 140.74 32.65 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.262 -0.644 . . . . 1.37 109.262 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.28 129.35 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.825 -0.435 . . . . 0.61 109.825 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.45 134.13 56.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 1.8 109.825 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.41 79.85 1.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.833 . . . . 1.04 108.752 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.0 p -105.27 152.87 22.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 1.17 112.095 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.27 62.98 2.33 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.724 -0.671 . . . . 1.77 112.131 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -134.67 98.1 3.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 3.99 110.768 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.15 140.44 88.15 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.822 -0.626 . . . . 2.51 111.112 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.16 -3.48 13.15 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.178 2.585 . . . . 1.26 112.17 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.5 -42.59 74.67 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.863 -0.608 . . . . 2.76 112.302 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -63.0 -16.95 58.1 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.046 -0.597 . . . . 1.12 113.285 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.75 -16.26 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 1.73 110.948 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.05 133.8 36.42 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.456 . . . . 3.45 110.896 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.61 -170.47 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.921 2.414 . . . . 2.08 112.426 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.63 -49.87 60.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.621 0.248 . . . . 3.23 111.601 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.422 ' HB2' ' HG3' ' A' ' 213' ' ' GLU . 36.6 m -94.73 141.19 28.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.392 -0.367 . . . . 1.66 110.732 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.5 64.09 0.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.534 0.683 . . . . 1.99 109.735 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.434 ' O ' HD12 ' A' ' 211' ' ' LEU . 0.9 OUTLIER -80.45 163.59 23.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.514 -0.766 . . . . 1.81 109.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.714 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 30.6 p90 -165.57 142.88 5.68 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.679 -0.408 . . . . 5.01 110.872 -177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -123.91 106.64 10.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.026 -1.102 . . . . 3.93 108.026 170.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.4 HG23 ' HE2' ' A' ' 256' ' ' LYS . 2.7 t -82.61 121.48 26.87 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.811 0.671 . . . . 2.13 112.811 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.488 ' CD1' HG23 ' A' ' 31' ' ' VAL . 83.7 t80 -137.21 131.9 17.82 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.773 . . . . 5.21 110.387 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 193' ' ' TYR . 16.8 Cg_exo -66.77 129.36 20.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.738 2.292 . . . . 2.12 112.379 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.512 ' HA3' ' NE1' ' A' ' 208' ' ' TRP . . . -119.8 157.03 15.69 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.389 -0.434 . . . . 1.75 113.006 -174.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' A' ' 30' ' ' PRO . 22.7 p -107.15 143.68 34.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.41 0.624 . . . . 2.99 111.801 -175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 203' ' ' LEU . 55.5 mt -90.77 19.56 5.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.224 -0.898 . . . . 4.75 110.704 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 196' ' ' SER . 1.0 OUTLIER -61.93 27.31 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.6 1.704 . . . . 5.1 115.6 -161.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.712 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 46.2 p -80.25 -154.29 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 107.182 -1.414 . . . . 5.53 107.182 166.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.712 ' CD ' ' HB ' ' A' ' 199' ' ' THR . 84.3 Cg_exo -48.02 -44.76 27.07 Favored 'Trans proline' 0 C--N 1.364 1.361 0 CA-C-N 122.512 1.933 . . . . 5.83 114.069 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.465 ' HD2' ' OG1' ' A' ' 199' ' ' THR . 2.7 Cg_exo -78.51 79.0 3.45 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.125 1.883 . . . . 4.78 111.689 172.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.13 80.48 0.96 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.847 -0.615 . . . . 3.84 112.079 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 30.9 tp -152.05 120.5 6.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.815 -0.175 . . . . 2.96 111.335 172.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 5.6 pt-20 -80.83 109.79 15.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.543 0.687 . . . . 3.37 111.03 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 23.5 p -140.67 21.96 2.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.944 0.402 . . . . 2.15 110.668 172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.487 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 58.1 t -104.8 138.12 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.005 0.431 . . . . 1.26 111.185 -176.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.6 m -112.84 111.83 22.88 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.074 -0.713 . . . . 2.08 109.074 170.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.512 ' NE1' ' HA3' ' A' ' 195' ' ' GLY . 97.4 m95 -81.97 116.78 21.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.648 0.261 . . . . 5.53 110.476 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 38.4 mm -101.73 98.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.695 -0.854 . . . . 1.63 108.695 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 38.1 t -85.67 116.99 29.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 1.62 111.937 -174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 189' ' ' ASP . 56.0 tp -80.23 113.89 18.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.846 -0.427 . . . . 1.73 109.846 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.562 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 6.2 tmmm? -60.99 -21.62 63.72 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.399 0.518 . . . . 2.98 112.399 -176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 187' ' ' SER . 34.5 mm-40 -99.64 106.07 37.83 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 111.874 0.324 . . . . 1.47 111.874 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 10.1 Cg_exo -73.77 138.55 26.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.059 2.506 . . . . 0.96 111.689 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -91.58 152.12 3.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.839 0.352 . . . . 1.25 110.334 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 3.1 p -96.08 122.29 38.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.959 -0.564 . . . . 1.29 111.147 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 27.5 m -123.75 153.18 29.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.799 -0.637 . . . . 1.02 109.791 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 t -88.19 158.97 18.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.592 0.234 . . . . 1.08 111.23 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.523 ' HA ' HG22 ' A' ' 222' ' ' VAL . 29.6 t -54.6 -42.85 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 1.33 110.513 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -56.31 -27.3 55.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.51 111.78 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.2 -49.75 9.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.343 -0.389 . . . . 0.7 110.15 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.1 m -66.51 -31.13 52.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 1.36 111.27 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 89.6 mt -60.52 -39.77 89.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 1.03 110.673 177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -74.46 -25.03 59.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.12 -0.491 . . . . 1.75 111.157 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.69 -28.86 61.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.201 0.524 . . . . 2.47 109.749 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -86.29 -3.35 58.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.92 -0.582 . . . . 3.04 110.279 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.5 mmtt -88.05 -9.3 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 2.31 109.948 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.44 HD11 HD22 ' A' ' 163' ' ' LEU . 91.9 mt -71.37 150.14 45.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.659 -0.7 . . . . 0.95 110.722 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -108.26 142.93 37.81 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.532 0.682 . . . . 1.13 110.393 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -78.49 -32.19 48.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.592 -1.185 . . . . 3.74 109.166 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.5 p-10 -76.98 169.98 17.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.93 -1.032 . . . . 1.62 111.987 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 169' ' ' LYS . . . -96.34 179.05 34.64 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.006 -0.997 . . . . 1.16 111.204 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.52 137.67 57.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 3.56 110.426 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.17 62.69 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 2.08 112.894 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -124.49 153.26 69.39 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 117.085 0.443 . . . . 2.59 109.838 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.8 125.1 17.96 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.348 2.032 . . . . 1.36 111.187 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.439 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.8 pt-20 -64.16 127.57 32.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.577 0.703 . . . . 3.4 112.325 -172.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.79 124.05 38.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.768 -1.106 . . . . 2.47 108.365 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.9 mt -66.14 145.89 55.28 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.956 0.408 . . . . 2.14 111.159 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 30.6 mtt -65.81 102.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.647 -0.706 . . . . 1.68 110.074 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.35 142.04 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.567 -0.742 . . . . 1.27 110.436 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 244' ' ' TRP . 38.9 t70 68.35 -90.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.326 -0.852 . . . . 2.18 110.487 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 64' ' ' HIS . 47.8 t30 65.75 -23.46 0.09 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.313 0.857 . . . . 2.15 113.313 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.419 ' H ' ' C ' ' A' ' 242' ' ' ASP . 63.3 t-105 -146.85 134.04 20.52 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.674 -0.641 . . . . 4.59 111.323 -169.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.573 ' CD ' ' H ' ' A' ' 245' ' ' ARG . 0.1 OUTLIER -93.22 102.57 7.54 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.222 -0.899 . . . . 6.13 108.975 174.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 4.2 Cg_exo -74.83 -91.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.888 2.392 . . . . 3.28 115.101 -166.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.24 129.88 38.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.873 0.694 . . . . 2.98 112.873 -159.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.536 ' HA ' ' HB2' ' A' ' 29' ' ' SER . 24.5 pt20 -82.53 179.16 2.04 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.575 -0.739 . . . . 4.32 110.176 171.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 248' ' ' GLN . 69.0 Cg_exo -53.83 132.79 51.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.829 1.686 . . . . 3.48 111.58 170.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.9 -39.68 19.62 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.666 -1.152 . . . . 4.63 112.606 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 253' ' ' ARG . 22.3 ptmt -61.29 -12.19 12.63 Favored 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 115.654 1.724 . . . . 5.34 115.654 -176.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 9.2 p30 37.82 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 118.806 2.891 . . . . 4.64 118.806 165.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 251' ' ' LYS . 35.2 ttm180 142.98 -118.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.399 1.88 . . . . 6.11 105.964 -163.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 253' ' ' ARG . 19.5 tt0 -146.27 128.74 15.96 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.246 -1.39 . . . . 3.08 107.246 161.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 60.8 mt -91.04 146.37 6.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.783 -0.451 . . . . 2.6 109.783 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.4 ' HE2' HG23 ' A' ' 192' ' ' THR . 19.3 pttm -116.61 137.03 52.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.63 110.499 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -122.25 160.64 24.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.19 -0.914 . . . . 1.71 109.503 -176.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 32.9 t -143.17 98.02 3.19 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.053 -0.659 . . . . 2.21 111.502 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -132.87 90.88 2.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.916 . . . . 4.31 108.584 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.243 0.736 0 CA-C-O 118.364 -0.827 . . . . 4.49 110.518 -176.699 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 246' ' ' PRO . 66.6 mtt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.747 0.308 . . . . 17.49 110.754 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -70.9 129.82 40.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.033 0.444 . . . . 15.32 111.146 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -133.25 49.16 2.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.994 -0.548 . . . . 15.81 109.59 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -67.15 112.93 4.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 14.19 110.094 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.2 t-105 71.05 -60.96 0.5 Allowed 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.989 0.806 . . . . 14.91 111.408 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.98 129.93 10.06 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.758 -0.735 . . . . 10.79 111.964 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -91.06 96.4 10.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.121 0.486 . . . . 11.39 110.463 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.35 -71.06 0.51 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.407 -1.077 . . . . 9.0 110.407 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' PRO . 54.1 mtpt -91.47 170.26 10.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.547 -0.908 . . . . 9.76 108.547 170.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -59.83 -51.86 67.93 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.776 -0.37 . . . . 11.19 110.347 177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -83.81 -15.87 46.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.402 0.62 . . . . 10.8 110.387 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' HA2' ' HD3' ' A' ' 13' ' ' PRO . . . 110.84 137.46 7.46 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.635 -0.712 . . . . 8.82 111.581 -176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD3' ' HA2' ' A' ' 12' ' ' GLY . 5.1 Cg_exo -77.95 128.26 9.07 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.563 2.175 . . . . 7.87 111.781 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.43 -19.86 61.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.515 0.674 . . . . 10.62 109.89 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -109.66 27.61 9.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.054 -0.975 . . . . 9.87 110.038 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -64.15 -22.44 66.94 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.816 0.817 . . . . 8.48 109.108 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -48.48 -48.9 37.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.246 -1.343 . . . . 7.13 109.753 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -93.07 -42.2 9.54 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.159 0.429 . . . . 9.68 112.159 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.68 16.95 0.59 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.001 1.112 . . . . 7.89 114.001 -171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -152.67 105.83 2.71 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.758 -0.83 . . . . 7.17 108.758 -170.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.441 ' O ' HG22 ' A' ' 22' ' ' ILE . 88.2 Cg_exo -41.98 126.19 3.42 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.013 2.476 . . . . 7.76 113.133 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 21' ' ' PRO . 10.5 tp 53.8 44.52 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.936 1.294 . . . . 5.83 112.474 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.15 6.03 32.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.544 . . . . 5.44 111.376 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 24' ' ' LYS . 3.2 mmmp? -85.67 -6.98 59.07 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.954 -0.758 . . . . 7.78 108.954 173.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 170.42 78.03 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.651 -1.38 . . . . 5.01 109.651 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -48.55 149.2 1.73 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.028 0.751 . . . . 7.09 113.028 -172.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -136.9 176.1 9.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.898 -1.046 . . . . 5.13 110.052 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.569 ' H ' ' NE2' ' A' ' 28' ' ' GLN . 2.2 mp0 -48.1 105.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.935 0.874 . . . . 7.12 111.895 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.56 ' H ' ' HG2' ' A' ' 253' ' ' ARG . 18.8 m -102.74 162.45 20.13 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 113.977 -1.465 . . . . 3.94 112.007 -175.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -43.06 39.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 1 C-N-CA 127.116 5.21 . . . . 4.52 116.564 165.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 248' ' ' GLN . 15.7 m -88.64 -175.14 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.326 0.584 . . . . 4.54 111.247 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.678 ' HA ' ' OG1' ' A' ' 108' ' ' THR . 31.7 t70 -98.56 108.35 21.02 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.978 -0.749 . . . . 2.88 108.978 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 110' ' ' ASP . 72.4 mt -67.47 126.95 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.807 -0.633 . . . . 2.32 110.917 -173.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.8 114.6 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.93 -0.577 . . . . 2.82 110.489 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -63.69 -31.54 72.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.24 111.728 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -76.19 -4.4 41.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.815 0.34 . . . . 4.54 111.533 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.0 m -102.41 -8.22 21.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.464 0.649 . . . . 3.06 109.929 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -78.2 120.39 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 1.72 110.758 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -95.41 132.34 40.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.252 -0.431 . . . . 3.69 110.232 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.736 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 27.4 m-85 -82.46 130.28 35.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.486 0.66 . . . . 4.64 111.883 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 258' ' ' SER . 25.3 t70 -125.2 140.55 36.35 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 2.27 109.248 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.96 90.94 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.801 2.334 . . . . 2.15 113.295 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.1 t -60.28 -38.18 82.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.933 -0.576 . . . . 4.29 110.392 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt 72.21 -67.1 0.27 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.464 -0.789 . . . . 4.74 111.996 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -101.44 128.08 30.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.51 0.195 . . . . 3.77 110.979 -175.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.55 160.91 26.13 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.048 2.499 . . . . 2.36 111.874 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.561 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 11.0 mp -80.0 143.76 33.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.368 0.507 . . . . 2.55 112.368 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -106.86 99.41 8.98 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.317 -0.856 . . . . 2.38 108.723 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 t -117.0 108.1 24.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.028 -0.533 . . . . 1.59 110.268 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.6 m -102.12 89.46 3.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.077 -0.51 . . . . 1.45 109.705 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -101.57 3.43 40.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.94 -0.763 . . . . 3.62 108.94 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.58 -33.06 69.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.45 -1.25 . . . . 2.48 111.859 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -103.6 13.14 33.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.693 0.257 . . . . 2.24 111.693 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -63.83 122.94 17.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.905 0.383 . . . . 0.8 111.496 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 23.1 m -103.26 111.96 24.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.938 -0.573 . . . . 1.06 110.386 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -76.73 141.84 40.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.735 -0.468 . . . . 1.26 109.735 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 71' ' ' ASP . 84.8 mt -118.54 -57.29 2.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.277 0.473 . . . . 0.74 112.277 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -156.49 148.1 22.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.643 -0.253 . . . . 3.17 110.722 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -108.92 137.21 42.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.608 -0.516 . . . . 0.64 109.608 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.8 tp -128.4 145.47 51.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.299 -0.41 . . . . 0.96 110.395 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -117.16 124.18 48.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.933 0.397 . . . . 1.49 111.196 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.23 153.03 46.62 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.184 -1.043 . . . . 1.83 108.184 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.581 ' HA2' ' SD ' ' A' ' 240' ' ' MET . . . -69.91 33.08 0.39 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 115.478 0.951 . . . . 1.64 115.478 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -131.95 -36.96 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.521 -0.548 . . . . 3.33 109.521 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -171.01 -179.62 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.399 -0.963 . . . . 1.38 108.399 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -117.2 144.9 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.797 -1.186 . . . . 2.74 107.797 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 4.6 p30 -131.33 141.33 49.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.02 0.438 . . . . 1.76 111.468 -172.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.7 t -106.15 116.48 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.787 -0.642 . . . . 1.15 109.903 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -78.85 128.47 33.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.654 -0.703 . . . . 2.02 110.901 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -105.8 159.26 16.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.847 -0.615 . . . . 1.66 110.458 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 26.1 t70 -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.847 -0.615 . . . . 1.33 109.613 174.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.47 60.96 1.65 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.036 0.922 . . . . 2.65 110.334 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 m -92.2 -5.75 51.92 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.575 -0.739 . . . . 1.61 110.203 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 74' ' ' GLN . 1.6 mp0 -145.7 176.44 9.64 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.405 -0.961 . . . . 2.35 108.405 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' CG ' HH21 ' A' ' 89' ' ' ARG . 18.1 m-20 -75.33 65.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.158 0.504 . . . . 1.92 110.675 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -84.8 -59.0 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 1.77 110.223 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -114.59 97.3 6.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.518 -0.764 . . . . 0.76 109.749 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.52 146.5 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.168 -0.469 . . . . 1.27 110.083 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tt -137.22 113.4 9.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.463 -0.569 . . . . 1.29 109.463 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.609 ' HD2' HG23 ' A' ' 87' ' ' THR . 12.6 ptmm? -148.09 124.23 10.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.258 0.552 . . . . 2.54 110.959 172.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -86.12 175.64 48.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.981 -0.848 . . . . 1.31 110.981 167.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.59 -142.92 0.0 OUTLIER Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.304 0.649 . . . . 1.9 114.508 165.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.49 120.6 5.95 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.518 1.478 . . . . 2.91 112.19 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -158.62 -168.23 2.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.838 -1.074 . . . . 4.11 108.883 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -125.34 45.71 2.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 121.181 -0.208 . . . . 4.95 110.989 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.74 158.79 7.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.43 -0.89 . . . . 2.25 113.123 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.609 HG23 ' HD2' ' A' ' 80' ' ' LYS . 92.1 m -98.23 114.74 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 1.91 109.814 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 65.6 m-85 -102.25 132.92 47.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.19 0.441 . . . . 3.7 112.19 -171.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 75' ' ' ASP . 98.2 mtt180 -103.59 147.09 27.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.212 -0.449 . . . . 3.54 109.86 173.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 121' ' ' VAL . 48.4 tp -77.44 130.14 36.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.559 -0.291 . . . . 1.14 110.949 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -110.28 -40.12 4.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.372 -0.376 . . . . 1.68 110.954 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -170.53 168.07 7.84 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.821 -0.437 . . . . 1.55 109.821 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 67' ' ' ASN . 19.4 p90 -135.88 157.51 46.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.174 -0.21 . . . . 0.86 110.688 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -143.09 158.94 43.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.54 -0.541 . . . . 0.93 109.54 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.657 ' CE2' ' HG ' ' A' ' 118' ' ' LEU . 42.1 m-85 -111.76 166.16 11.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.589 0.233 . . . . 3.17 110.654 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 2.0 m80 -122.39 139.14 54.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.029 -0.73 . . . . 1.68 109.029 171.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.456 ' HB2' ' HA2' ' A' ' 102' ' ' GLY . 39.6 p90 -159.39 142.71 14.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.782 -0.451 . . . . 5.18 109.782 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.487 ' HA2' ' HB ' ' A' ' 241' ' ' VAL . . . 174.69 -168.04 40.53 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.181 -1.009 . . . . 2.13 112.913 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.2 t 43.77 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.465 1.106 . . . . 2.9 112.312 -173.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' GLY . 89.3 mt -85.26 -159.32 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 3.03 109.647 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.61 66.48 9.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.91 0.386 . . . . 3.85 110.071 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 97' ' ' TRP . . . 82.29 120.39 0.6 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.889 -0.672 . . . . 1.94 112.595 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? 178.94 157.21 0.51 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.753 0.421 . . . . 2.45 110.491 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 96' ' ' HIS . . . 128.6 109.84 1.48 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.378 -0.915 . . . . 1.47 113.918 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.47 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 30.5 t -91.64 -47.23 7.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.604 -0.887 . . . . 2.0 108.604 169.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -119.17 48.14 1.55 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.744 -1.947 . . . . 3.72 105.744 170.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 78.2 t60 64.69 2.05 1.55 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.455 -1.702 . . . . 3.52 111.616 -171.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.678 ' OG1' ' HA ' ' A' ' 32' ' ' ASP . 21.2 p -144.27 179.41 7.25 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.765 -0.828 . . . . 2.52 108.765 158.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.0 t -142.31 92.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.332 0.515 . . . . 2.48 111.559 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.696 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 36.5 t70 42.36 44.11 3.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.394 0.678 . . . . 2.8 112.513 172.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 67.51 -43.29 0.46 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.291 0.636 . . . . 4.98 111.368 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 110' ' ' ASP . 9.2 mmmm -79.23 71.66 5.76 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.492 0.317 . . . . 3.23 110.389 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 108' ' ' THR . 57.6 mttp -52.54 120.81 6.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.39 -0.368 . . . . 2.82 110.389 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -104.84 -164.67 1.06 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 1.62 110.44 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 222' ' ' VAL . . . -61.85 -51.61 67.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.712 0.634 . . . . 1.03 112.712 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.4 172.41 6.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.31 -0.255 . . . . 0.75 110.31 -172.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HB3' ' HD1' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -138.77 135.75 34.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.352 -0.61 . . . . 1.58 109.352 175.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.657 ' HG ' ' CE2' ' A' ' 95' ' ' PHE . 1.2 tt -108.47 118.45 36.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.284 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.599 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -110.97 100.36 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.904 0.383 . . . . 1.77 110.837 -176.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.9 mp -88.03 108.62 19.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.269 -0.423 . . . . 0.93 110.451 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 90' ' ' LEU . 33.2 t -79.3 123.15 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.828 -0.624 . . . . 0.61 111.187 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 61.3 m80 -118.25 156.98 27.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.326 -0.62 . . . . 2.13 109.326 175.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.641 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 52.3 p-90 -133.9 144.04 48.63 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.264 -0.273 . . . . 4.26 110.264 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -65.82 107.64 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 2.02 111.069 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.641 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 9.5 t -69.46 -14.84 63.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 2.34 112.12 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -64.18 -14.1 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 3.35 111.231 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.69 3.72 53.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.413 . . . . 3.1 110.617 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 62.42 -1.3 1.58 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.503 0.961 . . . . 2.37 115.503 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -169.6 139.46 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.141 0.97 . . . . 3.93 110.116 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -58.39 -44.06 88.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.919 -0.582 . . . . 3.0 111.294 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.407 ' O ' HG12 ' A' ' 134' ' ' VAL . . . -61.65 -34.91 90.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.106 -0.568 . . . . 2.15 112.156 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -72.47 -38.86 68.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.857 0.361 . . . . 3.43 110.656 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.594 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.07 -38.42 82.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 1.76 111.825 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 131' ' ' GLY . 8.9 p -67.41 -11.9 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.24 0.543 . . . . 2.77 111.285 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.6 15.06 10.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.987 0.422 . . . . 3.55 110.91 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -126.15 138.57 32.46 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 60.9 Cg_exo -53.6 -32.04 62.42 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.361 2.708 . . . . 1.6 113.439 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.7 28.97 8.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.068 0.461 . . . . 2.29 110.252 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.99 -36.32 28.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.018 -0.61 . . . . 1.22 113.263 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.0 mt -108.34 157.63 18.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.769 0.319 . . . . 1.57 110.643 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 207' ' ' THR . . . -142.5 107.43 4.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.082 0.468 . . . . 1.38 110.522 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 119' ' ' HIS . 7.8 m -94.02 119.67 42.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.188 0.518 . . . . 1.73 110.857 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 46.5 tp -89.1 112.5 23.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.889 -0.596 . . . . 2.42 109.837 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.462 ' HA3' ' HE1' ' A' ' 208' ' ' TRP . . . -99.49 132.18 10.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.812 -0.709 . . . . 0.86 112.321 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.8 mt -129.54 124.27 59.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.666 -0.494 . . . . 0.76 109.666 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.89 140.62 43.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.752 0.31 . . . . 1.2 110.709 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.487 HD23 HG11 ' A' ' 217' ' ' VAL . 10.3 mp -118.6 128.55 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.429 -0.582 . . . . 0.88 109.429 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 15.6 ptpt -122.71 151.09 41.9 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.062 -0.348 . . . . 2.03 110.062 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 14.2 m -70.44 107.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.472 0.654 . . . . 1.27 111.716 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -155.16 -135.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.495 -0.775 . . . . 1.53 111.272 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.0 m -70.28 121.68 18.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.656 -0.498 . . . . 1.54 109.656 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.59 ' HB2' ' CB ' ' A' ' 218' ' ' SER . . . -83.64 104.53 13.84 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.337 -0.246 . . . . 0.78 110.337 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -70.68 126.43 92.2 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.031 -0.359 . . . . 1.22 110.031 174.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.28 -14.02 31.88 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.04 2.494 . . . . 1.05 112.556 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.536 ' O ' ' HE2' ' A' ' 158' ' ' LYS . . . -58.64 -25.53 58.66 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.98 -0.555 . . . . 0.7 112.936 176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 159' ' ' VAL . 48.0 tp -91.95 -32.05 15.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.189 0.519 . . . . 0.77 110.406 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -52.49 -38.93 60.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 1.41 112.142 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 41.6 pttt -61.27 -33.86 74.24 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.499 0.555 . . . . 2.86 112.499 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 162' ' ' VAL . 13.3 p -84.58 -36.81 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 120.581 -0.448 . . . . 1.38 110.775 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 156' ' ' LEU . 19.5 t -65.16 -39.18 84.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.312 0.577 . . . . 1.11 110.72 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.2 -28.03 66.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.519 -0.764 . . . . 1.22 112.695 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 159' ' ' VAL . 10.0 p -92.2 -2.76 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.978 0.418 . . . . 1.41 111.136 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' HD21 ' A' ' 228' ' ' LEU . 75.3 mt -60.29 -28.03 67.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.333 -0.394 . . . . 1.39 111.529 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -67.34 -25.21 65.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.497 -0.319 . . . . 2.31 111.431 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.7 t -84.4 -1.76 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 1.4 110.811 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.41 33.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.356 -0.979 . . . . 0.85 108.356 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -55.62 -35.55 66.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.479 -1.237 . . . . 1.59 111.787 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.1 p -106.72 152.62 23.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.082 0.468 . . . . 0.77 111.163 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -57.94 136.67 57.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 2.29 111.296 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.46 -15.04 57.75 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.734 -0.746 . . . . 0.85 112.917 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -86.81 151.23 23.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 1.7 111.34 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.5 p -142.2 151.43 42.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.394 -0.821 . . . . 1.37 109.816 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.65 148.51 44.13 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.911 -0.403 . . . . 0.61 109.911 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.59 135.53 51.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.791 0.329 . . . . 1.8 110.125 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -138.61 80.17 1.78 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.734 -0.839 . . . . 1.04 108.734 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.5 p -124.13 169.09 12.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.796 -0.638 . . . . 1.17 111.232 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.56 38.68 22.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.019 -0.537 . . . . 1.77 111.313 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -120.98 137.72 54.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.291 -0.413 . . . . 3.99 110.363 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -80.76 118.85 74.23 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.757 -0.656 . . . . 2.51 110.752 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.89 -21.66 27.92 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.929 2.419 . . . . 1.26 112.766 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -77.27 -2.52 35.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 2.76 111.05 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -60.11 -17.92 46.59 Favored Glycine 0 CA--C 1.522 0.501 0 CA-C-N 116.168 -0.469 . . . . 1.12 113.262 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.33 -38.09 65.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.63 0.215 . . . . 1.73 110.531 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 79.9 mt 54.69 85.17 0.2 Allowed Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.755 . . . . 3.45 112.778 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.33 136.76 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.296 2.664 . . . . 2.08 112.133 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -107.84 27.34 9.31 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.365 0.666 . . . . 3.23 110.501 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 213' ' ' GLU . 35.0 t -153.51 103.14 2.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.661 -0.496 . . . . 1.66 109.661 -159.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.16 59.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.594 -0.443 . . . . 1.99 110.839 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -125.88 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.033 -1.099 . . . . 1.81 108.033 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.575 ' HB2' HG23 ' A' ' 209' ' ' ILE . 5.6 p90 -162.47 144.94 11.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.855 -0.738 . . . . 5.01 111.816 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 256' ' ' LYS . 48.6 m0 -92.63 129.07 38.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.778 -0.823 . . . . 3.93 108.778 168.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.4 t -84.67 94.04 8.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.12 0.962 . . . . 2.13 110.432 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.63 119.16 18.15 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 5.21 109.349 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 26.7 Cg_exo -62.24 150.21 87.75 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.008 1.805 . . . . 2.12 111.218 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.86 123.27 5.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.475 -0.869 . . . . 1.75 112.824 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 198' ' ' THR . 22.0 t -95.53 -135.34 0.21 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.273 -0.64 . . . . 2.99 109.273 175.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.612 ' C ' ' H ' ' A' ' 199' ' ' THR . 2.5 pt? -46.55 11.4 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.604 1.705 . . . . 4.75 115.604 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.517 ' H ' ' C ' ' A' ' 196' ' ' SER . 20.1 p -66.5 27.73 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.784 0.802 . . . . 5.1 111.679 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.612 ' H ' ' C ' ' A' ' 197' ' ' LEU . 1.3 p -165.43 170.14 6.45 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.002 -1.454 . . . . 5.53 108.726 -170.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.431 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 74.0 Cg_exo -48.01 -48.51 16.19 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 121.928 1.752 . . . . 5.83 113.254 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 5.2 Cg_exo -80.9 136.14 10.36 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.222 1.948 . . . . 4.78 112.31 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 197' ' ' LEU . 40.7 tp -68.74 -40.36 79.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.97 -1.014 . . . . 3.84 111.584 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 203' ' ' LEU . 2.7 pp -56.06 147.43 20.12 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.477 0.656 . . . . 2.96 111.988 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 204' ' ' GLU . 0.0 OUTLIER -77.78 73.74 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.172 -0.922 . . . . 3.37 111.584 -172.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 7.8 p -99.52 7.24 45.52 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.441 -0.799 . . . . 2.15 110.702 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 142' ' ' VAL . 10.9 t -118.86 151.05 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.292 0.568 . . . . 1.26 112.079 -169.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 13.4 m -121.75 121.73 37.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.194 -1.039 . . . . 2.08 108.194 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.507 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.3 t90 -86.73 125.97 34.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.105 0.479 . . . . 5.53 110.214 -175.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 190' ' ' TYR . 44.4 mm -109.69 100.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.438 -0.801 . . . . 1.63 108.965 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 3.9 t -92.91 129.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.844 -0.342 . . . . 1.62 111.556 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.958 -0.756 . . . . 1.73 108.958 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.23 2.12 37.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.042 0.756 . . . . 2.98 113.042 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 187' ' ' SER . 10.9 tp10 -111.65 105.31 56.66 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 121.072 -0.251 . . . . 1.47 110.915 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 19.6 Cg_exo -67.67 141.14 53.75 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.856 2.371 . . . . 0.96 112.326 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 40.0 pt -96.98 153.59 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.322 -0.399 . . . . 1.25 110.188 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.5 m -89.4 128.16 35.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.226 -0.443 . . . . 1.29 111.59 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 35.5 m -137.83 137.95 44.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.606 -0.725 . . . . 1.02 109.11 174.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.59 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 8.5 t -87.8 159.87 18.25 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.278 -0.569 . . . . 1.08 111.804 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.552 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.4 m -48.26 -46.02 35.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.615 -0.72 . . . . 1.33 111.586 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -55.86 -26.29 46.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.961 -0.563 . . . . 2.51 112.33 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -80.86 -48.36 12.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.582 -0.525 . . . . 0.7 109.582 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.467 HG21 ' HB1' ' A' ' 115' ' ' ALA . 22.0 t -62.99 -39.1 83.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.221 -0.899 . . . . 1.36 111.477 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.8 mt -62.05 -25.92 67.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 1.03 111.72 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -76.71 -19.67 57.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.584 -0.28 . . . . 1.75 111.337 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -68.92 -34.44 75.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.439 0.638 . . . . 2.47 110.072 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 28.2 ttm180 -76.23 -2.92 33.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.374 -0.83 . . . . 3.04 110.948 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -86.7 -3.75 59.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.922 0.392 . . . . 2.31 110.299 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 163' ' ' LEU . 94.8 mt -78.91 145.29 34.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.865 -0.607 . . . . 0.95 110.568 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.596 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 12.8 m120 -115.08 127.62 55.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.709 -0.678 . . . . 1.13 111.071 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -60.94 -34.37 74.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.914 -1.039 . . . . 3.74 110.874 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 5.0 p-10 -69.49 162.38 27.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.674 -0.694 . . . . 1.62 111.933 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.84 166.4 42.96 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.677 -0.969 . . . . 1.16 110.677 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.79 133.43 50.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 3.56 110.803 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 95.51 6.71 59.59 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 2.08 111.87 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -119.01 158.04 49.04 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.518 -0.549 . . . . 2.59 109.518 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.08 122.99 12.11 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.919 2.413 . . . . 1.36 112.134 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.417 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 10.6 pt-20 -62.32 126.3 26.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 3.4 112.178 -174.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 10.6 tp10 -124.55 134.53 52.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.288 -0.869 . . . . 2.47 110.221 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.81 107.97 2.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.575 . . . . 2.14 110.083 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.581 ' SD ' ' HA2' ' A' ' 63' ' ' GLY . 51.1 ttp -74.33 91.24 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 1.68 109.374 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.487 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 27.6 m -135.38 157.71 39.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.628 -0.715 . . . . 1.27 111.293 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 70.42 -81.47 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 124.129 0.893 . . . . 2.18 110.939 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.564 HD21 ' HG2' ' A' ' 240' ' ' MET . 73.4 m-20 50.43 29.18 3.74 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.753 0.649 . . . . 2.15 112.753 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -148.07 152.76 37.92 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 4.59 108.876 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.415 HH12 ' HB2' ' A' ' 21' ' ' PRO . 17.1 ptp180 -80.38 148.94 67.88 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.609 -0.145 . . . . 6.13 110.609 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.475 ' HG2' ' O ' ' A' ' 1' ' ' MET . 80.6 Cg_exo -48.89 164.11 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.485 2.79 . . . . 3.28 113.598 177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . . . -68.77 98.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.596 -0.729 . . . . 2.98 112.504 -170.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 27.0 mm-40 -61.25 163.83 9.94 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.537 -0.756 . . . . 4.32 110.586 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.622 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 72.0 Cg_endo -75.09 161.1 39.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.416 2.077 . . . . 3.48 113.366 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -8.83 34.59 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.2 -0.909 . . . . 4.63 112.315 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 47.9 mmtm -55.29 49.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.571 1.693 . . . . 5.34 115.571 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.682 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER 124.91 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.979 2.112 . . . . 4.64 110.149 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 249' ' ' PRO . 4.3 mpt_? -138.42 100.25 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.336 -0.987 . . . . 6.11 108.336 167.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -128.84 148.43 50.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.581 -0.526 . . . . 3.08 109.581 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 21.6 mm -102.0 147.66 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.341 -0.391 . . . . 2.6 110.517 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 191' ' ' TRP . 45.3 mttp -135.71 166.39 23.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.637 -0.875 . . . . 2.63 108.637 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.736 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -144.28 114.89 7.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.634 -0.136 . . . . 1.71 110.634 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 21.3 m -97.2 100.71 12.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.283 0.563 . . . . 2.21 110.702 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -145.13 131.64 19.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.588 -0.733 . . . . 4.31 110.242 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.782 -0.627 . . . . 4.49 109.759 178.218 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.962 -0.384 . . . . 17.49 109.962 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 m -76.36 84.61 3.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 15.32 111.057 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -99.99 -11.81 20.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.587 -0.733 . . . . 15.81 109.225 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -79.12 123.0 26.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.458 -0.792 . . . . 14.19 109.433 170.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.15 112.67 25.88 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.421 -0.585 . . . . 14.91 109.421 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.04 134.22 11.8 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.615 -0.802 . . . . 10.79 112.317 -176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -69.84 105.59 2.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.911 0.386 . . . . 11.39 110.174 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.53 -160.43 43.61 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.624 -0.717 . . . . 9.0 111.835 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -59.88 120.71 10.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.466 -0.198 . . . . 9.76 110.466 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 177.55 -66.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.691 0.619 . . . . 11.19 109.747 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -126.61 30.6 5.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.04 0.448 . . . . 10.8 110.47 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.28 106.62 1.5 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.915 -0.659 . . . . 8.82 111.574 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.87 125.91 14.46 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.497 2.131 . . . . 7.87 112.603 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -87.03 -30.46 21.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.258 -1.016 . . . . 10.62 108.258 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -87.55 26.34 1.29 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.977 -1.465 . . . . 9.87 109.483 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -45.95 -39.2 8.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.736 0.814 . . . . 8.48 112.923 -173.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -74.9 -38.07 61.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.855 0.36 . . . . 7.13 110.862 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -70.6 -17.52 62.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.927 -0.579 . . . . 9.68 110.649 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -83.7 11.18 7.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.773 0.796 . . . . 7.89 109.828 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -131.14 103.26 15.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.202 -0.908 . . . . 7.17 108.677 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.56 86.05 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.717 2.278 . . . . 7.76 112.754 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 27' ' ' ARG . 10.4 tp 43.26 51.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.207 1.003 . . . . 5.83 111.72 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.93 23.44 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.739 -0.664 . . . . 5.44 112.665 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -103.98 17.47 24.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.911 0.862 . . . . 7.78 109.098 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.03 89.31 0.45 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 108.996 -1.642 . . . . 5.01 108.996 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' HG23 ' A' ' 22' ' ' ILE . 2.4 mp0 -62.19 122.3 15.24 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.752 0.787 . . . . 7.09 112.344 -164.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.526 ' O ' HG21 ' A' ' 22' ' ' ILE . 56.8 mtt180 -148.34 126.97 12.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.179 -1.373 . . . . 5.13 107.446 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' OE1' HD11 ' A' ' 197' ' ' LEU . 9.2 tt0 -147.45 -91.84 0.08 Allowed 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.727 -0.472 . . . . 7.12 109.727 172.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.8 m -71.99 104.54 1.02 Allowed Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 108.983 -0.747 . . . . 3.94 108.983 171.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.474 ' HG3' ' HD2' ' A' ' 194' ' ' PRO . 54.7 Cg_endo -67.67 -42.6 6.59 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.315 2.01 . . . . 4.52 113.773 -165.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 248' ' ' GLN . 0.1 OUTLIER -160.6 169.73 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.13 0.491 . . . . 4.54 111.402 -175.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.42 143.58 26.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.073 -0.967 . . . . 2.88 108.856 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 49.8 mt -88.34 91.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.372 0.606 . . . . 2.32 109.796 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.97 119.45 39.5 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.766 -0.652 . . . . 2.82 109.444 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 m -55.34 -33.41 63.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.448 -0.797 . . . . 2.24 112.812 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -76.73 -34.83 58.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.12 0.486 . . . . 4.54 110.705 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -88.01 18.06 4.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.599 -0.728 . . . . 3.06 110.438 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.16 150.26 36.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.2 -0.667 . . . . 1.72 109.2 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -119.35 122.78 42.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.039 0.447 . . . . 3.69 110.472 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -82.59 126.22 32.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.673 -0.694 . . . . 4.64 109.952 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -145.8 97.74 4.55 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.773 -0.454 . . . . 2.27 109.773 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.04 28.89 0.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.657 2.238 . . . . 2.15 112.677 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -99.9 -5.92 27.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.289 -0.414 . . . . 4.29 110.827 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.66 152.1 21.54 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.545 -0.539 . . . . 4.74 109.545 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.25 135.72 20.22 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.681 -0.236 . . . . 3.77 110.723 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.35 136.94 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 2.36 111.364 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.65 131.6 43.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.857 0.361 . . . . 2.55 111.208 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -66.47 122.95 18.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.639 -0.71 . . . . 2.38 109.677 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 79' ' ' LEU . 3.0 t -109.38 103.0 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.237 -0.438 . . . . 1.59 110.141 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.713 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 6.7 m -105.18 89.33 3.1 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.81 -0.811 . . . . 1.45 108.81 177.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.3 p90 -124.46 6.43 8.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.906 0.384 . . . . 3.62 111.461 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.7 -19.27 65.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.409 -0.359 . . . . 2.48 111.418 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.9 mp0 -98.64 6.55 46.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.575 -0.284 . . . . 2.24 110.403 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -55.15 133.82 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.546 . . . . 0.8 111.675 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.5 m -120.75 106.37 11.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.888 -0.596 . . . . 1.06 110.186 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.9 p -79.4 150.81 31.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.685 -0.487 . . . . 1.26 109.685 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.9 mt -122.07 -55.4 1.88 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.832 0.349 . . . . 0.74 111.616 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -154.8 152.37 29.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.452 -0.34 . . . . 3.17 111.016 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 tt -115.15 137.39 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.559 -0.534 . . . . 0.64 109.559 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 172' ' ' SER . 39.5 tp -134.07 142.32 47.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.726 0.298 . . . . 0.96 111.11 -173.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -111.09 108.04 17.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.876 -0.787 . . . . 1.49 108.876 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -142.51 72.59 1.38 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.685 0.624 . . . . 1.83 112.685 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.14 -71.41 0.4 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.437 -1.363 . . . . 1.64 113.569 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -142.55 0.04 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.775 0.321 . . . . 3.33 111.585 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.44 174.75 13.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.803 -0.814 . . . . 1.38 108.803 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 95' ' ' PHE . 49.7 p90 -115.38 121.97 44.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.465 -0.569 . . . . 2.74 109.465 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -96.53 116.22 28.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.549 -0.751 . . . . 1.76 110.46 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 42.0 t -93.05 106.1 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.584 -0.524 . . . . 1.15 109.584 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.62 129.26 37.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.887 -0.597 . . . . 2.02 111.589 -174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -111.52 153.98 25.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.347 -0.842 . . . . 1.66 110.265 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -76.54 110.95 11.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.922 -0.581 . . . . 1.33 110.626 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' CD ' ' A' ' 89' ' ' ARG . 6.2 p-10 -116.26 55.53 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.298 0.571 . . . . 2.65 111.392 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -104.91 -6.5 20.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.483 . . . . 1.61 111.025 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -137.94 176.56 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.206 -0.664 . . . . 2.35 109.206 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -82.14 41.8 0.7 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.18 0.514 . . . . 1.92 110.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 34.9 mmtp -51.32 -60.69 2.85 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.897 -1.047 . . . . 1.77 110.673 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -130.87 96.75 4.15 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.285 -0.871 . . . . 0.76 110.159 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 16.5 m -111.95 147.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.404 0.621 . . . . 1.27 111.605 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.9 tp -129.29 119.43 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.857 -1.065 . . . . 1.29 108.466 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 87' ' ' THR . 57.3 pttt -158.97 121.14 3.51 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.5 -0.48 . . . . 2.54 111.764 -173.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.62 176.9 40.15 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 114.337 0.495 . . . . 1.31 114.337 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.33 -137.43 0.0 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.156 1.36 . . . . 1.9 115.755 168.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.8 148.76 3.58 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.081 2.521 . . . . 2.91 113.166 -168.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.1 pt? -39.95 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.038 1.866 . . . . 4.11 116.038 -157.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -85.94 -48.55 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.519 -0.764 . . . . 4.95 109.663 162.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 123.79 163.48 11.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.167 -0.54 . . . . 2.25 112.223 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.466 ' HA ' ' HB3' ' A' ' 80' ' ' LYS . 49.1 m -94.69 103.15 15.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 1.91 110.04 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 21.7 m-85 -95.76 102.1 13.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.286 -0.416 . . . . 3.7 110.081 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' CD ' ' HB2' ' A' ' 72' ' ' ASP . 16.0 ptp180 -82.03 152.36 26.68 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.211 -0.306 . . . . 3.54 110.183 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.3 tp -76.47 122.86 25.15 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.737 -0.468 . . . . 1.14 109.737 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -108.38 -32.81 2.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.906 0.384 . . . . 1.68 110.164 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.3 pt20 -171.64 169.66 5.93 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.691 -0.485 . . . . 1.55 109.691 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -140.72 158.43 43.99 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.412 -0.588 . . . . 0.86 109.412 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -147.41 158.73 44.09 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.19 0.306 . . . . 0.93 110.73 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 66.5 m-85 -123.08 165.55 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 3.17 110.773 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -172.6 126.89 0.51 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.266 0.626 . . . . 1.68 109.661 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.517 ' CE3' ' HB1' ' A' ' 116' ' ' ALA . 14.8 p90 -161.8 -174.51 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.591 -0.277 . . . . 5.18 110.375 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 241' ' ' VAL . . . 89.92 99.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.512 -0.851 . . . . 2.13 111.681 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.7 t -143.08 -82.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.711 -0.848 . . . . 2.9 108.711 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD12 ' OE1' ' A' ' 103' ' ' GLN . 84.2 mt -95.75 -155.18 0.46 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.143 -0.688 . . . . 3.03 109.143 169.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.82 -48.31 67.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.077 0.399 . . . . 3.85 112.077 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.71 63.68 0.36 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.602 -0.808 . . . . 1.94 111.448 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 114' ' ' TYR . 13.1 pt20 -150.65 -172.11 4.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 2.45 110.761 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.29 8.71 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.47 111.474 -168.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.444 ' HB2' ' N ' ' A' ' 116' ' ' ALA . 48.2 t -78.46 -33.5 48.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.338 0.495 . . . . 2.0 112.338 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.466 ' CG ' ' H ' ' A' ' 107' ' ' HIS . 0.9 OUTLIER 69.85 -156.32 0.15 Allowed 'General case' 0 C--N 1.343 0.316 0 N-CA-C 107.363 -1.347 . . . . 3.72 107.363 -173.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 4.3 m-70 53.04 69.79 0.66 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.161 0.437 . . . . 3.52 110.046 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 5.3 t -98.71 117.43 33.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 120.024 -0.671 . . . . 2.52 110.136 -165.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 14.7 m -92.18 103.44 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.161 0.505 . . . . 2.48 110.785 -177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.2 t70 54.01 58.83 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.555 -0.748 . . . . 2.8 109.735 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 67.23 4.83 3.85 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.866 -1.061 . . . . 4.98 113.19 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 109' ' ' VAL . 37.5 ttmt -90.36 111.68 22.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.949 -0.389 . . . . 3.23 109.949 175.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -93.08 146.6 23.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.569 -0.9 . . . . 2.82 108.569 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 96.8 m-85 -95.93 176.44 6.11 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.601 -0.439 . . . . 1.62 109.935 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.0 -39.03 20.18 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.664 0.616 . . . . 1.03 112.664 -171.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HB1' ' CE3' ' A' ' 97' ' ' TRP . . . -145.34 149.97 35.76 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.606 -0.438 . . . . 0.75 111.801 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.436 ' OE1' ' NE2' ' A' ' 107' ' ' HIS . 3.5 tp10 -110.88 141.55 44.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.055 -0.52 . . . . 1.58 110.563 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.681 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 13.0 tp -121.73 121.86 38.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.771 -0.649 . . . . 1.07 110.045 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -118.35 104.34 10.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 1.77 111.446 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -89.81 111.01 21.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.031 -0.531 . . . . 0.93 109.589 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -82.75 123.62 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.316 0.579 . . . . 0.61 110.766 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 29.8 m-70 -115.74 145.53 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.64 -0.709 . . . . 2.13 109.912 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.458 ' HZ2' ' N ' ' A' ' 129' ' ' ASP . 9.1 t90 -112.0 133.47 54.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.973 -0.558 . . . . 4.26 110.719 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -78.17 111.84 14.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.231 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 t -58.34 -21.66 50.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.719 -0.673 . . . . 2.34 112.111 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -46.79 -32.18 3.51 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.557 0.947 . . . . 3.35 113.557 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.43 ' CE2' ' HB2' ' A' ' 136' ' ' GLN . 4.8 m-85 -97.38 -4.62 38.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.648 0.61 . . . . 3.1 112.648 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.87 14.9 2.91 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 114.575 0.59 . . . . 2.37 114.575 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' N ' ' HZ2' ' A' ' 123' ' ' TRP . 18.1 t70 -172.11 117.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.853 -0.795 . . . . 3.93 108.853 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -65.52 -33.14 75.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.819 0.303 . . . . 3.0 111.819 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 134' ' ' VAL . . . -61.45 -33.66 85.51 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.881 -0.676 . . . . 2.15 112.133 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 69.9 mmtt -83.79 -24.98 30.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.797 0.332 . . . . 3.43 110.979 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.475 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -69.49 -21.85 63.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.358 -0.383 . . . . 1.76 111.912 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 131' ' ' GLY . 31.3 m -73.05 3.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.381 0.511 . . . . 2.77 112.381 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 2.5 pt20 -97.15 -11.0 24.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 3.55 110.182 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.456 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 29.9 tt0 -101.81 136.48 19.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 3.02 109.867 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 25.3 Cg_endo -60.65 -28.39 86.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.28 2.654 . . . . 1.6 112.656 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.456 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 7.8 p-10 -112.24 27.71 9.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 2.29 109.447 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -68.36 -37.64 86.29 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.725 -0.67 . . . . 1.22 111.747 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 206' ' ' VAL . 86.8 mt -122.37 158.01 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.018 -0.734 . . . . 1.57 109.018 173.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.52 122.69 12.93 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.2 -0.296 . . . . 1.38 110.2 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.91 126.87 69.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.015 0.436 . . . . 1.73 110.697 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 49.0 tp -93.04 117.83 30.51 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.621 -0.718 . . . . 2.42 109.777 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -104.4 127.61 9.16 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.275 -0.488 . . . . 0.86 112.132 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.88 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.756 -0.461 . . . . 0.76 109.756 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.7 141.9 49.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.798 -0.183 . . . . 1.2 110.556 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 9.7 mp -121.27 135.32 55.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.118 0.485 . . . . 0.88 110.676 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 216' ' ' SER . 54.6 pttt -123.54 156.3 35.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.839 -0.8 . . . . 2.03 108.839 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 46.6 t -94.34 126.62 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.875 0.369 . . . . 1.27 110.568 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.22 -105.89 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.634 -0.586 . . . . 1.53 111.634 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.8 m -67.04 154.99 39.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.655 0.264 . . . . 1.54 110.315 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.33 157.27 16.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.015 -0.365 . . . . 0.78 110.015 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 216' ' ' SER . 28.2 mtpp -128.06 103.0 21.14 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.069 -0.345 . . . . 1.22 110.069 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.65 -33.93 61.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.362 2.708 . . . . 1.05 112.612 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.85 -28.64 73.67 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.7 112.502 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.7 tp -102.64 -23.64 13.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.77 110.543 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -38.43 70.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.757 -0.656 . . . . 1.41 110.047 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.3 -29.73 70.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.935 -0.575 . . . . 2.86 111.235 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.24 -48.54 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.21 0.528 . . . . 1.38 110.15 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.441 HG11 ' HA ' ' A' ' 221' ' ' GLN . 43.2 t -65.33 -36.0 76.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.698 -0.683 . . . . 1.11 111.205 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.58 -28.22 69.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.032 -0.531 . . . . 1.22 112.231 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.52 -1.37 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.73 -0.388 . . . . 1.41 111.482 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.51 ' HB3' HD21 ' A' ' 228' ' ' LEU . 79.6 mt -58.99 -22.21 60.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 1.39 111.778 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -66.6 -28.83 68.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.445 0.164 . . . . 2.31 111.366 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 66.4 p -83.26 -0.54 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.301 . . . . 1.4 111.739 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.29 34.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.85 108.883 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.425 ' HA ' HD23 ' A' ' 228' ' ' LEU . 84.1 tttt -67.73 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.87 -1.059 . . . . 1.59 111.883 -169.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.66 148.77 49.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.141 0.496 . . . . 0.77 110.706 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -59.61 126.34 27.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.351 -0.84 . . . . 2.29 111.084 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 114.51 -21.46 14.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.819 -0.705 . . . . 0.85 112.693 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -88.67 153.15 21.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 1.7 111.26 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.429 ' HB3' HD13 ' A' ' 60' ' ' LEU . 42.6 p -144.21 161.62 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 1.37 110.732 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -146.47 151.63 37.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.148 -0.478 . . . . 0.61 109.816 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.64 131.95 41.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.815 -0.439 . . . . 1.8 109.815 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -141.53 81.77 1.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.085 -0.507 . . . . 1.04 109.839 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 46.0 p -98.85 166.54 11.25 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.278 -0.419 . . . . 1.17 111.363 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 66.17 32.2 8.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.814 -0.63 . . . . 1.77 112.418 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.604 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 68.3 t80 -66.63 132.3 47.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.331 -0.248 . . . . 3.99 110.331 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -81.22 100.25 0.68 Allowed Pre-proline 0 N--CA 1.465 0.314 0 O-C-N 123.621 0.575 . . . . 2.51 110.567 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 11.1 Cg_exo -71.16 -36.24 7.54 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.71 2.274 . . . . 1.26 112.445 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.3 -9.96 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 2.76 110.637 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -70.93 0.97 26.64 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.063 -0.517 . . . . 1.12 113.14 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 86.4 mt -91.68 -14.58 29.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.197 -0.297 . . . . 1.73 110.197 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 78.5 mt 42.84 73.7 0.89 Allowed Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 113.462 0.912 . . . . 3.45 113.462 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.39 119.11 1.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.148 2.565 . . . . 2.08 111.127 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.3 mt-10 -112.39 25.08 11.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.778 0.431 . . . . 3.23 111.346 -171.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.472 ' CB ' ' HB2' ' A' ' 213' ' ' GLU . 0.3 OUTLIER -168.3 90.06 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.047 -0.661 . . . . 1.66 110.605 -160.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.68 63.91 0.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.008 -1.108 . . . . 1.99 108.008 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 258' ' ' SER . 8.6 m-20 -87.71 -51.18 6.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.652 0.982 . . . . 1.81 113.652 -166.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 257' ' ' ALA . 51.0 p90 -146.85 144.62 29.44 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.267 -0.573 . . . . 5.01 111.955 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -136.72 129.01 29.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.682 -0.69 . . . . 3.93 110.595 174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 256' ' ' LYS . 7.6 t -171.91 74.01 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.93 0.872 . . . . 2.13 111.134 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 208' ' ' TRP . 82.9 m-85 -139.36 137.33 18.85 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.123 -0.489 . . . . 5.21 111.092 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 30' ' ' PRO . 97.7 Cg_endo -84.83 132.21 4.68 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.829 2.353 . . . . 2.12 111.812 175.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.431 ' HA3' ' HB ' ' A' ' 206' ' ' VAL . . . -99.22 106.27 3.19 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.532 -0.842 . . . . 1.75 112.61 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 198' ' ' THR . 22.9 t -84.21 -138.03 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 122.922 0.489 . . . . 2.99 111.752 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.591 ' C ' ' H ' ' A' ' 199' ' ' THR . 4.4 pp -45.25 8.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 117.252 2.316 . . . . 4.75 117.252 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 196' ' ' SER . 7.1 m -73.86 25.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.116 -0.99 . . . . 5.1 109.619 171.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.598 HG21 ' SG ' ' A' ' 205' ' ' CYS . 9.4 t -144.9 151.07 48.27 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 114.737 -1.12 . . . . 5.53 108.966 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.434 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 72.8 Cg_exo -46.9 -53.46 6.22 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 122.805 2.337 . . . . 5.83 114.9 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 68.3 Cg_endo -82.84 20.59 1.12 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.017 1.811 . . . . 4.78 114.611 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 62.64 -60.73 0.13 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.488 0.921 . . . . 3.84 113.488 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 pp -43.23 153.47 0.1 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.809 0.844 . . . . 2.96 112.945 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.78 88.74 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.469 -0.787 . . . . 3.37 111.458 -171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.598 ' SG ' HG21 ' A' ' 199' ' ' THR . 3.3 p -118.15 16.46 14.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.097 -0.956 . . . . 2.15 109.561 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 140' ' ' LEU . 51.0 t -117.57 149.71 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.835 -1.075 . . . . 1.26 109.744 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 87.3 m -117.19 117.13 28.73 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.374 -0.602 . . . . 2.08 109.374 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 193' ' ' TYR . 36.9 m0 -84.98 133.05 34.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.375 0.607 . . . . 5.53 110.7 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 67.4 mt -121.29 141.78 40.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.363 -0.977 . . . . 1.63 108.363 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.42 146.33 31.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.201 0.524 . . . . 1.62 111.681 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.83 131.45 55.05 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.928 -0.768 . . . . 1.73 108.928 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 53.9 tttm -69.12 -7.6 37.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 2.98 111.644 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 186' ' ' GLU . 10.1 tp10 -94.04 112.32 56.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.436 -0.347 . . . . 1.47 111.177 -175.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 4.9 Cg_exo -78.65 130.51 9.8 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.658 2.239 . . . . 0.96 111.09 171.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.404 HG13 ' HG ' ' A' ' 147' ' ' LEU . 34.1 pt -99.22 154.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.447 -0.575 . . . . 1.25 109.447 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.512 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 27.4 p -103.68 126.76 51.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.703 0.287 . . . . 1.29 111.711 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 17.1 m -114.83 147.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.15 -0.685 . . . . 1.02 109.15 173.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -93.6 166.55 12.18 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.532 -0.467 . . . . 1.08 110.78 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.574 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 44.0 m -50.19 -47.92 54.4 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.438 0.461 . . . . 1.33 112.209 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.69 -38.14 69.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.588 0.232 . . . . 2.51 111.391 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.441 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.1 mt-30 -67.38 -43.11 82.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.097 0.475 . . . . 0.7 110.176 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.0 -41.78 90.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 1.36 111.031 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 219' ' ' SER . 90.2 mt -67.84 -44.1 77.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 1.03 111.689 -176.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -65.88 -24.42 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.912 0.338 . . . . 1.75 111.912 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -71.64 -36.03 70.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.033 0.444 . . . . 2.47 110.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -78.56 17.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.658 0.742 . . . . 3.04 110.439 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.57 -19.22 18.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.196 -0.668 . . . . 2.31 109.196 171.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 163' ' ' LEU . 88.7 mt -68.05 134.51 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.603 -0.726 . . . . 0.95 111.236 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 12.4 m120 -96.92 144.23 27.04 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 1.13 110.147 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -79.79 -28.92 40.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.778 -1.101 . . . . 3.74 108.79 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -83.4 174.81 10.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.608 -1.178 . . . . 1.62 111.585 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.73 179.1 27.65 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.04 -0.982 . . . . 1.16 111.545 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.8 125.46 23.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.988 0.423 . . . . 3.56 111.579 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 85.84 31.72 20.1 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.845 -0.616 . . . . 2.08 113.507 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -133.14 157.22 78.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.898 0.349 . . . . 2.59 110.079 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.98 122.69 12.26 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.557 2.171 . . . . 1.36 111.692 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.521 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 38.5 tt0 -57.25 117.94 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.235 0.828 . . . . 3.4 113.235 -173.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 60.0 mm-40 -115.27 142.12 47.11 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.583 -1.189 . . . . 2.47 108.042 169.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.11 127.05 38.51 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.968 -0.293 . . . . 2.14 110.214 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 52.6 ttp -81.23 94.96 6.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.16 0.505 . . . . 1.68 110.07 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 98' ' ' GLY . 21.8 m -137.95 156.41 31.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.673 -0.694 . . . . 1.27 110.752 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.39 -80.23 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.914 0.758 . . . . 2.18 110.953 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 47.37 32.16 2.14 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.176 0.591 . . . . 2.15 112.193 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -146.89 174.55 11.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.232 0.539 . . . . 4.59 111.657 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -127.68 145.7 55.86 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.598 -0.728 . . . . 6.13 110.261 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.17 174.16 3.48 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.548 2.166 . . . . 3.28 112.48 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.86 158.86 34.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.785 -0.643 . . . . 2.98 112.33 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 52.2 mt-30 -114.45 170.5 5.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.491 -0.777 . . . . 4.32 109.601 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.83 175.77 9.88 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.859 2.373 . . . . 3.48 113.489 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.8 -7.39 1.61 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.788 1.235 . . . . 4.63 112.88 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -55.87 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.517 2.043 . . . . 5.34 116.517 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.574 HD22 ' C ' ' A' ' 252' ' ' ASN . 0.2 OUTLIER 131.04 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 126.665 1.986 . . . . 4.64 113.298 177.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.418 ' CB ' ' HB2' ' A' ' 30' ' ' PRO . 5.9 tpp180 -172.71 133.93 0.6 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.022 0.439 . . . . 6.11 111.574 166.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -114.16 150.61 33.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.394 -0.821 . . . . 3.08 109.486 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.8 mm -85.91 113.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.827 0.346 . . . . 2.6 110.573 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.514 ' HB3' HG21 ' A' ' 192' ' ' THR . 41.8 ttmt -109.34 143.41 38.9 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.058 -0.719 . . . . 2.63 109.058 175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 190' ' ' TYR . . . -136.95 164.0 29.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.724 0.297 . . . . 1.71 110.924 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 36.0 m -151.12 97.41 2.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.996 0.427 . . . . 2.21 109.985 175.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.84 95.95 4.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.215 -0.661 . . . . 4.31 109.215 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.718 -0.658 . . . . 4.49 110.399 -177.132 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.908 0.385 . . . . 17.49 110.723 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.2 p -107.76 18.36 21.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.298 -0.41 . . . . 15.32 111.523 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -99.28 127.78 45.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.782 0.325 . . . . 15.81 110.44 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 5' ' ' TRP . 18.0 m-70 -81.71 93.86 6.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.195 -0.457 . . . . 14.19 109.924 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 11' ' ' ASN . 92.6 m95 74.66 155.3 0.16 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.324 1.015 . . . . 14.91 110.964 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.19 170.59 40.54 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.438 -0.887 . . . . 10.79 112.182 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.436 ' CG ' ' HA ' ' A' ' 243' ' ' ASN . 6.1 p90 -88.44 100.2 12.86 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.377 0.608 . . . . 11.39 110.841 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.41 -117.64 0.81 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.79 -0.719 . . . . 9.0 111.899 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 17.0 tppt? -92.13 119.5 31.85 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.434 -0.58 . . . . 9.76 109.434 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 44.47 -94.5 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.408 0.892 . . . . 11.19 113.408 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 12.2 m120 -111.31 20.41 17.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.275 0.56 . . . . 10.8 110.68 -173.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.71 128.46 2.65 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.845 -0.902 . . . . 8.82 110.845 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 9' ' ' LYS . 57.0 Cg_endo -72.15 119.97 6.51 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.483 1.455 . . . . 7.87 112.415 -175.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 74.3 mm-40 -88.1 -28.91 21.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.537 -0.756 . . . . 10.62 112.328 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -66.12 -40.28 90.57 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.705 -0.398 . . . . 9.87 110.07 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -50.79 -52.62 39.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.147 -0.479 . . . . 8.48 111.835 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -58.46 -34.05 70.42 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.56 0.219 . . . . 7.13 111.104 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 75.6 mmtt -66.73 -49.11 67.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 9.68 110.677 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -70.87 -29.22 65.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.319 -0.4 . . . . 7.89 111.826 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.66 81.16 40.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.786 0.327 . . . . 7.17 110.283 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.63 -12.44 33.73 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.597 2.198 . . . . 7.76 112.205 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.7 tt -60.16 -12.04 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.043 0.449 . . . . 5.83 110.906 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.94 63.44 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.328 -0.396 . . . . 5.44 110.577 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -59.01 -8.15 1.33 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.122 -0.49 . . . . 7.78 112.287 170.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.5 179.23 41.77 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.275 -1.13 . . . . 5.01 110.275 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.8 106.82 14.28 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 117.433 -1.707 . . . . 7.09 110.881 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 202' ' ' LEU . 0.2 OUTLIER -166.18 124.47 1.49 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 119.205 -0.426 . . . . 5.13 110.18 158.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.497 ' HG3' ' H ' ' A' ' 29' ' ' SER . 2.8 pt20 -148.99 -58.04 0.21 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.377 0.99 . . . . 7.12 110.283 150.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.497 ' H ' ' HG3' ' A' ' 28' ' ' GLN . 4.3 p -107.53 99.77 30.57 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.257 -1.338 . . . . 3.94 107.479 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.85 -48.25 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 121.078 1.185 . . . . 4.52 114.314 -166.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -160.08 148.26 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.801 0.334 . . . . 4.54 110.552 -175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -90.09 109.13 20.2 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.479 -0.934 . . . . 2.88 108.479 168.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 108' ' ' THR . 75.5 mt -67.55 125.25 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.59 0.709 . . . . 2.32 111.645 -173.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.88 122.91 29.57 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.935 -1.029 . . . . 2.82 108.81 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.6 p -57.22 -24.86 57.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.936 0.717 . . . . 2.24 112.936 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -81.34 -27.19 35.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 4.54 111.263 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 m -95.39 -28.7 14.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.422 . . . . 3.06 111.14 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.31 121.18 13.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 1.72 110.651 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -83.13 116.24 22.25 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.817 -0.438 . . . . 3.69 109.817 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -65.41 136.83 56.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 4.64 110.402 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 258' ' ' SER . 19.0 t70 -130.63 132.79 24.18 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.745 -0.661 . . . . 2.27 110.23 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.588 ' O ' HD23 ' A' ' 44' ' ' LEU . 23.3 Cg_exo -65.17 108.98 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.213 1.942 . . . . 2.15 112.55 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.698 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -53.08 -18.39 2.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.699 -0.682 . . . . 4.29 111.468 171.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 43' ' ' SER . 0.8 OUTLIER 50.65 -84.99 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.94 1.296 . . . . 4.74 113.177 177.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' H ' ' CG ' ' A' ' 44' ' ' LEU . 88.4 tttt -89.69 133.05 35.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.141 -0.318 . . . . 3.77 110.141 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.47 136.98 57.39 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.636 2.224 . . . . 2.36 111.519 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.03 141.66 43.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 2.55 110.096 -177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -102.48 97.19 7.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.898 -0.778 . . . . 2.38 108.898 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.26 108.7 23.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.589 -0.732 . . . . 1.59 109.175 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.695 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 61.5 m -108.31 91.51 3.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.982 0.42 . . . . 1.45 110.356 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 181' ' ' ARG . 7.8 p90 -102.85 8.95 39.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.922 -0.581 . . . . 3.62 109.542 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.09 -29.59 57.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.963 -1.017 . . . . 2.48 111.156 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' A' ' 53' ' ' GLN . 5.9 mt-30 -113.31 23.04 13.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.659 -0.7 . . . . 2.24 110.997 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HB1' ' HG2' ' A' ' 180' ' ' PRO . . . -72.3 114.02 9.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.035 0.445 . . . . 0.8 110.54 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -115.56 112.26 21.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.617 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 p -77.96 156.18 30.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.077 -0.511 . . . . 1.26 110.246 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.4 mt -121.63 -56.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.612 -0.267 . . . . 0.74 111.449 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.73 156.67 23.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 3.17 111.515 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.519 HG12 HD13 ' A' ' 166' ' ' ILE . 12.0 tt -107.12 137.73 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.515 -0.766 . . . . 0.64 109.7 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 172' ' ' SER . 24.0 tp -135.4 150.55 49.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.203 0.525 . . . . 0.96 111.683 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 166' ' ' ILE . 49.0 t-20 -113.33 111.87 22.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.254 -1.387 . . . . 1.49 107.254 169.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -135.64 71.41 1.43 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.811 -0.756 . . . . 1.83 111.875 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.03 -83.67 0.62 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 119.917 -1.135 . . . . 1.64 112.918 160.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -112.29 -7.29 14.01 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 121.156 -0.218 . . . . 3.33 111.381 -173.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.4 167.26 24.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 1.38 111.612 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 46.1 m-85 -110.34 105.53 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.632 -0.877 . . . . 2.74 108.632 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -99.0 124.82 44.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.469 -0.332 . . . . 1.76 111.764 -168.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 59' ' ' ILE . 49.0 t -107.68 115.26 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.074 -0.713 . . . . 1.15 109.074 172.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.29 163.29 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.705 0.764 . . . . 2.02 112.581 -170.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.57 164.64 27.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.424 -1.262 . . . . 1.66 108.372 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 106.15 14.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.689 -0.485 . . . . 1.33 109.689 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -112.24 57.05 0.65 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.575 0.702 . . . . 2.65 110.102 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.1 p -95.83 -20.85 18.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.953 -0.567 . . . . 1.61 111.425 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.465 ' HG3' ' HG3' ' A' ' 76' ' ' LYS . 7.9 pt20 -145.8 177.97 8.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 2.35 110.784 -171.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' OD2' HG21 ' A' ' 78' ' ' VAL . 11.4 t70 -71.21 63.44 0.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.556 -0.747 . . . . 1.92 110.586 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' A' ' 74' ' ' GLN . 48.0 mttm -86.0 -69.02 0.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.956 -0.565 . . . . 1.77 111.356 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -115.21 102.48 9.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.76 109.61 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.405 HG21 ' OD2' ' A' ' 75' ' ' ASP . 39.0 t -117.05 142.74 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.186 -0.461 . . . . 1.27 111.788 -171.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 tp -123.31 121.24 35.33 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 1.29 109.324 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -159.96 121.17 3.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.193 0.52 . . . . 2.54 110.696 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.7 28.55 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 119.606 -0.552 . . . . 1.31 112.033 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -41.01 -140.27 0.0 OUTLIER Glycine 0 CA--C 1.534 1.236 0 O-C-N 124.606 0.827 . . . . 1.9 114.373 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.09 122.94 8.05 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 121.918 1.745 . . . . 2.91 111.525 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 13.2 tp -175.2 -168.27 0.32 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.367 -1.345 . . . . 4.11 107.367 -165.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 20.8 t70 -135.9 72.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.798 0.726 . . . . 4.95 110.294 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 164.47 20.26 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 2.25 113.094 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.3 m -105.77 129.44 53.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.529 -0.545 . . . . 1.91 109.529 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 8.5 m-85 -115.3 109.99 18.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.392 . . . . 3.7 111.09 -171.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.8 mtt180 -83.65 155.87 22.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.782 -0.451 . . . . 3.54 109.782 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 51.5 tp -83.21 131.61 35.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.132 -0.322 . . . . 1.14 110.132 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.676 ' HB ' ' CD1' ' A' ' 123' ' ' TRP . 7.8 tt -116.64 -47.52 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 1.68 111.375 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -166.56 165.11 16.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.732 -0.47 . . . . 1.55 109.732 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CD2' HD11 ' A' ' 118' ' ' LEU . 15.5 p90 -133.84 167.2 21.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.945 -0.302 . . . . 0.86 110.418 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 66' ' ' PHE . 8.2 p-80 -147.51 158.6 44.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.164 -0.68 . . . . 0.93 109.164 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.74 163.65 23.86 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.376 -0.231 . . . . 3.17 110.376 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.583 ' HD1' ' HB3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -124.03 165.24 17.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.694 -0.854 . . . . 1.68 108.694 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.628 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 65.6 t-105 -133.03 140.54 47.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.964 0.412 . . . . 5.18 110.626 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.576 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -91.46 -71.17 1.2 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.726 -0.67 . . . . 2.13 112.732 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 24.7 t 165.48 -65.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.277 -1.009 . . . . 2.9 108.277 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.4 mt -111.36 168.02 9.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.312 -0.858 . . . . 3.03 108.869 173.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.71 61.78 3.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.564 0.697 . . . . 3.85 110.943 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -154.95 -24.35 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.505 -0.855 . . . . 1.94 113.537 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -152.15 176.51 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.304 0.552 . . . . 2.45 110.581 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.576 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 97.04 -33.15 5.97 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.788 -0.72 . . . . 1.47 113.003 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.3 p -71.1 -27.77 63.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.119 0.485 . . . . 2.0 110.76 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.511 ' HG3' ' H ' ' A' ' 107' ' ' HIS . 3.6 tp10 58.81 -158.07 0.31 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.958 -1.127 . . . . 3.72 107.958 -166.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.511 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 19.3 m-70 54.76 65.21 1.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.817 -0.809 . . . . 3.52 108.817 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.509 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -93.05 133.61 36.03 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 2.52 109.953 -168.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -109.48 104.61 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.015 -0.365 . . . . 2.48 110.015 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.97 53.74 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.429 -0.805 . . . . 2.8 110.449 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 77.97 -11.22 1.23 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.201 -0.908 . . . . 4.98 111.826 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -93.97 108.82 20.59 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.168 0.432 . . . . 3.23 112.168 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 64.0 mttp -81.69 176.44 9.63 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.752 -0.833 . . . . 2.82 108.752 166.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -124.11 -173.19 2.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.243 -0.183 . . . . 1.62 111.094 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.6 -35.43 58.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.938 0.348 . . . . 1.03 111.938 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.77 168.65 26.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.37 -0.377 . . . . 0.75 110.165 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.583 ' HB3' ' HD1' ' A' ' 96' ' ' HIS . 1.7 tm-20 -145.3 147.3 32.19 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.067 -0.716 . . . . 1.58 109.067 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 93' ' ' PHE . 39.5 tp -126.02 122.03 34.69 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.291 0.369 . . . . 1.07 111.047 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -108.69 109.74 20.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.431 -0.35 . . . . 1.77 110.669 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.512 HD23 ' CB ' ' A' ' 93' ' ' PHE . 18.4 mt -93.67 105.21 17.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.935 -0.394 . . . . 0.93 109.935 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.6 118.34 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.334 0.587 . . . . 0.61 112.054 -173.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 52.0 m-70 -110.36 134.09 52.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.472 -0.785 . . . . 2.13 109.482 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.676 ' CD1' ' HB ' ' A' ' 91' ' ' ILE . 25.3 p-90 -111.18 148.05 33.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.152 -0.476 . . . . 4.26 111.885 -172.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.9 110.2 1.27 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.41 -0.814 . . . . 2.02 111.181 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -60.46 -30.4 69.64 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.314 0.857 . . . . 2.34 113.314 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -80.3 -56.84 3.92 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.331 0.493 . . . . 3.35 112.331 -171.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.34 -19.24 56.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 3.1 111.719 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.61 -4.41 72.68 Favored Glycine 0 C--N 1.318 -0.419 0 N-CA-C 110.314 -1.114 . . . . 2.37 110.314 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.628 ' OD2' ' HG ' ' A' ' 140' ' ' LEU . 22.7 t70 78.48 -78.07 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.95 -1.125 . . . . 3.93 113.162 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -50.33 -21.12 1.28 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.055 1.131 . . . . 3.0 114.055 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.99 -69.14 1.38 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.954 -1.117 . . . . 2.15 112.555 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 72.4 mmtt -89.15 -40.14 13.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.533 0.568 . . . . 3.43 112.533 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . . . -66.8 -29.91 69.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.035 0.383 . . . . 1.76 112.035 -171.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.16 -6.41 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.279 0.562 . . . . 2.77 110.848 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -114.6 19.1 16.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 3.55 110.311 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 22.9 mt-30 -131.25 127.2 21.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 108.782 -0.822 . . . . 3.02 108.782 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.23 -29.93 48.96 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.108 2.539 . . . . 1.6 113.688 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -111.96 24.26 12.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.728 0.299 . . . . 2.29 110.459 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.97 -70.41 1.07 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.073 -0.512 . . . . 1.22 113.829 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HG ' ' OD2' ' A' ' 129' ' ' ASP . 6.5 mp -89.05 171.29 9.95 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.832 0.349 . . . . 1.57 110.801 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -141.39 104.11 4.53 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.618 -0.512 . . . . 1.38 109.618 172.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.67 111.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.799 -0.445 . . . . 1.73 109.799 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 57.8 tp -82.73 104.86 13.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 2.42 110.345 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -84.86 151.33 26.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.847 -0.692 . . . . 0.86 112.145 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.03 129.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.102 -0.332 . . . . 0.76 110.102 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 107' ' ' HIS . 3.2 m-85 -70.75 137.82 49.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.419 -0.355 . . . . 1.2 110.641 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.93 108.08 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.0 0.429 . . . . 0.88 110.445 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 215' ' ' ILE . 58.9 pttt -106.02 164.5 11.92 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 2.03 108.863 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.8 m -106.3 138.42 31.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.261 0.553 . . . . 1.27 111.847 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.24 -96.83 0.1 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.092 -0.958 . . . . 1.53 110.952 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.2 p -87.88 153.78 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.776 -0.453 . . . . 1.54 109.776 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.77 158.37 36.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.194 0.521 . . . . 0.78 112.113 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 216' ' ' SER . 30.5 mmmt -112.31 100.13 48.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.4 -0.818 . . . . 1.22 109.01 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.05 -40.4 59.31 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.089 2.526 . . . . 1.05 112.251 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.81 74.89 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.091 -0.576 . . . . 0.7 113.143 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.2 tp -92.41 -26.23 18.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.46 0.63 . . . . 0.77 110.2 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -35.66 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.41 109.638 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.47 -39.65 84.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.538 -0.755 . . . . 2.86 110.995 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.1 t -71.98 -48.04 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.184 0.516 . . . . 1.38 110.146 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.618 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 67.3 t -58.93 -32.62 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 1.11 110.971 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.41 -21.51 64.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.569 -0.741 . . . . 1.22 111.891 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.29 -12.92 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.505 0.558 . . . . 1.41 112.505 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -57.48 -21.49 37.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.718 0.636 . . . . 1.39 112.718 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.503 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.9 p-10 -64.61 -18.99 65.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.799 0.333 . . . . 2.31 111.086 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -88.7 -5.99 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.855 0.36 . . . . 1.4 110.9 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 61' ' ' ASN . 14.3 pt -126.64 39.19 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.526 0.679 . . . . 0.85 109.983 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.66 -28.18 69.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.547 -0.751 . . . . 1.59 111.184 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.7 p -130.96 147.66 52.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.362 -0.381 . . . . 0.77 110.709 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -58.57 140.37 54.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.842 -0.617 . . . . 2.29 111.005 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.09 -10.77 55.34 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.951 -0.642 . . . . 0.85 112.131 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 60' ' ' LEU . 97.8 mttt -104.9 144.58 31.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.449 . . . . 1.7 111.041 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 60' ' ' LEU . 23.7 p -141.82 156.47 45.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.627 -0.715 . . . . 1.37 110.181 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.63 136.37 35.86 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.482 -0.327 . . . . 0.61 110.282 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.02 129.36 41.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.143 -0.481 . . . . 1.8 110.762 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -138.94 77.86 1.64 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.004 -1.11 . . . . 1.04 108.004 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.98 156.11 21.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.672 -0.694 . . . . 1.17 111.261 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 54.78 56.33 6.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.123 0.487 . . . . 1.77 112.003 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.544 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 73.0 m-85 -124.75 143.62 50.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.932 -0.576 . . . . 3.99 109.852 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 181' ' ' ARG . 6.4 m-20 -93.12 107.31 24.26 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 2.51 111.844 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 19.4 Cg_exo -69.1 -13.52 36.48 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.934 2.423 . . . . 1.26 112.001 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.435 ' HG2' ' HB3' ' A' ' 179' ' ' ASP . 16.7 ptt180 -66.09 -16.85 64.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.886 0.375 . . . . 2.76 110.48 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.49 6.84 67.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.853 -0.612 . . . . 1.12 111.822 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 67.1 mt -110.96 -32.0 6.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.286 0.565 . . . . 1.73 109.557 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.06 127.11 73.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.41 -0.814 . . . . 3.45 111.339 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.37 -174.57 1.46 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 123.244 2.629 . . . . 2.08 113.099 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.77 -58.72 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.834 0.679 . . . . 3.23 112.834 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 19.7 m -61.52 125.06 22.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.801 0.334 . . . . 1.66 111.008 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 36.0 tp -104.22 62.67 0.74 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.588 0.708 . . . . 1.99 109.87 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.452 ' O ' HD12 ' A' ' 211' ' ' LEU . 24.2 m-20 -133.67 -177.86 4.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.994 -1.113 . . . . 1.81 107.994 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 48.2 p90 -163.01 155.03 18.14 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.308 -0.957 . . . . 5.01 112.625 -169.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.471 ' CE2' ' HG3' ' A' ' 212' ' ' LYS . 57.4 m95 -96.35 142.31 28.63 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.752 -1.113 . . . . 3.93 109.331 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 256' ' ' LYS . 19.1 m -74.81 79.23 2.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.081 0.467 . . . . 2.13 109.786 173.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.413 ' HB3' ' CG2' ' A' ' 210' ' ' VAL . 41.0 t80 -117.89 103.08 50.7 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.629 . . . . 5.21 109.967 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.408 ' N ' ' HB3' ' A' ' 208' ' ' TRP . 45.1 Cg_exo -56.65 146.36 76.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.255 2.637 . . . . 2.12 113.087 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.67 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -139.66 153.15 22.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.508 -0.853 . . . . 1.75 112.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 40.8 t -107.38 137.03 46.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.882 0.372 . . . . 2.99 110.154 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 199' ' ' THR . 2.0 pp -76.73 -34.6 58.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.9 -0.591 . . . . 4.75 111.004 -176.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.458 ' HB ' ' HG ' ' A' ' 202' ' ' LEU . 1.4 m -82.48 29.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.423 0.63 . . . . 5.1 109.57 176.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 15.8 p 68.53 156.68 0.15 Allowed Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 113.829 -1.532 . . . . 5.53 109.905 -168.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' A' ' 199' ' ' THR . 11.0 Cg_exo -27.86 -58.99 0.1 Allowed 'Trans proline' 0 CA--C 1.545 1.062 1 C-N-CA 125.379 4.052 . . . . 5.83 116.578 -174.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.08 66.54 7.82 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.558 1.506 . . . . 4.78 113.501 -170.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.458 ' HG ' ' HB ' ' A' ' 198' ' ' THR . 0.2 OUTLIER -148.53 -85.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.589 -0.444 . . . . 3.84 111.668 174.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.96 163.94 29.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 2.96 112.022 -172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.41 67.12 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.732 0.777 . . . . 3.37 110.281 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 58.9 m -118.24 24.71 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.223 -0.899 . . . . 2.15 110.491 -176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 70.7 t -120.38 134.39 64.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.65 -0.705 . . . . 1.26 110.159 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.2 m -73.63 121.7 21.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.597 -0.729 . . . . 2.08 109.629 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.435 ' CE3' HG23 ' A' ' 192' ' ' THR . 0.0 OUTLIER -64.48 99.49 0.31 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.072 -0.967 . . . . 5.53 111.981 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 58.3 mt -142.43 100.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.326 -0.397 . . . . 1.63 110.368 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 73.3 t -117.25 119.14 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.286 -0.264 . . . . 1.62 110.286 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 189' ' ' ASP . 9.8 tp -62.06 123.2 17.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.228 -0.286 . . . . 1.73 110.228 -173.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.471 ' HG3' ' CE2' ' A' ' 191' ' ' TRP . 29.2 ttpp -65.59 -8.31 19.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.716 1.376 . . . . 2.98 114.716 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 36.3 tt0 -105.93 110.06 63.74 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 119.776 -0.77 . . . . 1.47 111.096 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.448 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 25.7 Cg_exo -64.49 137.66 56.18 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.776 2.317 . . . . 0.96 111.578 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.405 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 38.6 pt -97.49 149.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.745 -0.465 . . . . 1.25 109.745 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 17.0 t -103.34 120.7 41.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.207 -0.664 . . . . 1.29 109.207 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.47 162.95 8.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.996 -0.372 . . . . 1.02 109.996 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 16.2 t -81.92 151.09 27.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.121 -0.325 . . . . 1.08 110.121 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.643 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 13.9 m -55.67 -43.17 76.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.405 -0.361 . . . . 1.33 110.83 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 12.3 tp10 -59.42 -32.51 70.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 2.51 111.019 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.421 ' HA ' HG11 ' A' ' 160' ' ' VAL . 56.2 mt-30 -67.18 -49.92 62.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.7 110.741 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.628 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 31.2 m -71.0 -29.75 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.351 . . . . 1.36 111.944 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 219' ' ' SER . 91.1 mt -63.9 -26.54 68.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 1.03 110.84 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 58.1 mtpt -82.68 -22.67 34.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 1.75 110.86 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.6 m-85 -70.12 -34.05 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.514 -0.55 . . . . 2.47 109.514 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -66.92 -14.62 62.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 3.04 111.042 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -95.61 -3.12 46.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.406 -0.361 . . . . 2.31 111.528 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.69 154.6 21.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.226 0.536 . . . . 0.95 111.224 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.3 m120 -119.81 159.48 24.48 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.266 -0.642 . . . . 1.13 109.266 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -105.62 -4.64 20.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 3.74 110.424 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.8 p-10 -85.1 176.14 8.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 1.62 110.091 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -104.09 169.12 17.37 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.143 -0.783 . . . . 1.16 111.143 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -55.24 143.58 27.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 3.56 110.647 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.76 23.83 54.8 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.052 -0.594 . . . . 2.08 112.923 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.4 153.33 76.2 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 117.247 0.523 . . . . 2.59 109.851 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.06 127.74 23.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.531 2.154 . . . . 1.36 111.01 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.0 118.68 4.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.623 0.725 . . . . 3.4 112.783 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -114.13 110.39 19.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.855 -1.066 . . . . 2.47 109.121 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.55 139.64 47.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.336 -0.393 . . . . 2.14 111.077 -176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.6 ttm -87.52 91.52 8.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.391 -0.596 . . . . 1.68 109.391 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.69 154.0 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.203 -0.453 . . . . 1.27 111.356 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 16.5 t70 69.06 -79.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.077 0.861 . . . . 2.18 110.524 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.436 ' HA ' ' CG ' ' A' ' 7' ' ' TYR . 58.9 t30 56.3 20.38 4.59 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.177 0.806 . . . . 2.15 113.177 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -151.32 167.44 27.87 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.056 -0.403 . . . . 4.59 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -125.09 147.7 57.91 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 115.802 -0.635 . . . . 6.13 110.675 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -43.9 146.54 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.051 2.501 . . . . 3.28 112.553 168.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 29' ' ' SER . . . -72.94 142.65 47.84 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.196 1.184 . . . . 2.98 114.196 -166.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -74.76 159.55 82.89 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.675 -1.148 . . . . 4.32 110.303 171.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.57 174.48 8.76 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.454 2.77 . . . . 3.48 113.729 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 89.2 mt -66.14 -9.5 32.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.81 -1.086 . . . . 4.63 112.081 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 74.3 mmtt -58.67 46.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.623 1.342 . . . . 5.34 114.623 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 51.5 t30 120.19 6.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.559 1.944 . . . . 4.64 110.721 176.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 1.2 mpt_? -132.98 104.02 6.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.716 -0.674 . . . . 6.11 109.298 171.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -114.5 145.63 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.757 0.313 . . . . 3.08 111.099 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.3 mm -100.88 126.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.027 -0.533 . . . . 2.6 110.35 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.553 ' HB2' ' OG1' ' A' ' 192' ' ' THR . 96.4 mttt -117.19 150.78 38.17 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.703 -0.851 . . . . 2.63 108.703 172.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -115.94 95.8 5.28 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.705 -0.479 . . . . 1.71 109.705 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 68.6 m -80.69 94.66 6.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.728 -0.789 . . . . 2.21 110.506 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -140.19 111.02 6.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.3 -1.318 . . . . 4.31 108.833 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-N 116.053 -0.521 . . . . 4.49 110.956 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.295 -0.261 . . . . 17.49 110.295 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m 65.13 -175.44 0.18 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.656 0.597 . . . . 15.32 111.263 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 56.14 65.25 1.48 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.386 0.613 . . . . 15.81 110.502 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -101.34 132.79 46.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.044 -0.525 . . . . 14.19 110.537 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 60.46 -164.0 0.24 Allowed 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.919 0.762 . . . . 14.91 111.051 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.16 -174.84 43.64 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.882 -0.887 . . . . 10.79 110.882 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.02 98.56 4.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.189 0.519 . . . . 11.39 109.696 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.19 144.77 10.35 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.523 -0.762 . . . . 9.0 111.783 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -47.83 129.45 14.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.531 0.681 . . . . 9.76 112.555 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -155.51 -58.33 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.164 -0.925 . . . . 11.19 108.734 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -117.89 30.69 7.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.289 -0.869 . . . . 10.8 109.477 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.6 116.29 1.01 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.002 -0.839 . . . . 8.82 111.002 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.6 124.74 9.53 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.065 1.843 . . . . 7.87 112.037 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.46 -20.28 25.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.215 0.531 . . . . 10.62 110.371 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 33.7 m170 -114.22 24.47 11.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.634 -0.712 . . . . 9.87 111.62 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -45.03 -53.35 7.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.757 0.651 . . . . 8.48 112.757 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -74.47 -9.63 58.78 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.504 -0.478 . . . . 7.13 111.241 -174.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HA ' HD11 ' A' ' 202' ' ' LEU . 28.0 ttpt -67.62 -18.08 64.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.372 0.606 . . . . 9.68 110.071 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -77.74 -9.85 59.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.736 -0.666 . . . . 7.89 111.001 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 61.1 m-85 -110.93 102.91 53.89 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.293 -0.632 . . . . 7.17 109.293 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -52.53 -21.41 14.12 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.832 3.021 . . . . 7.76 114.932 -172.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 22' ' ' ILE . 9.9 tp -146.1 51.74 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 122.1 0.952 . . . . 5.83 110.761 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 20' ' ' PHE . . . -65.04 -32.37 74.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.594 -0.73 . . . . 5.44 111.59 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -138.98 -45.86 0.47 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.306 0.574 . . . . 7.78 110.835 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.79 -44.73 0.24 Allowed Glycine 0 CA--C 1.504 -0.616 0 N-CA-C 109.16 -1.576 . . . . 5.01 109.16 -175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 202' ' ' LEU . 6.9 pt-20 -48.55 154.62 0.63 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.55 -0.825 . . . . 7.09 110.071 165.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.47 165.8 35.28 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.653 -1.98 . . . . 5.13 105.653 -168.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.62 -59.85 4.34 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.003 1.274 . . . . 7.12 112.612 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.594 ' CB ' ' HA ' ' A' ' 247' ' ' ALA . 29.6 t -103.66 150.44 38.13 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.984 -1.117 . . . . 3.94 107.984 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.497 ' HG3' ' CZ3' ' A' ' 208' ' ' TRP . 20.5 Cg_endo -60.73 -48.16 11.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 CA-C-N 120.402 1.179 . . . . 4.52 111.885 -176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 255' ' ' ILE . 10.7 p -169.5 143.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 111.799 0.296 . . . . 4.54 111.799 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 19.2 t70 -89.33 117.32 28.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.252 -1.018 . . . . 2.88 108.252 162.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -97.67 126.15 50.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.732 0.301 . . . . 2.32 111.757 -170.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.85 117.48 34.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.426 -0.352 . . . . 2.82 110.239 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -30.42 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.782 -0.645 . . . . 2.24 112.148 177.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -83.14 -15.61 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.589 -0.278 . . . . 4.54 111.495 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 250' ' ' LEU . 88.5 m -98.23 -29.35 13.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.655 0.264 . . . . 3.06 111.26 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 130.62 44.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 1.72 111.259 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.39 124.31 45.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 3.69 109.93 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.14 113.33 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.488 -0.56 . . . . 4.64 109.488 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -118.62 118.72 33.32 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 2.27 109.669 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -53.82 91.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 123.583 2.855 . . . . 2.15 113.599 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 p -58.89 -30.85 68.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.743 -0.662 . . . . 4.29 110.844 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt 71.28 -64.92 0.36 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.323 -0.853 . . . . 4.74 111.65 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -76.0 130.63 77.74 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.737 0.303 . . . . 3.77 110.729 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.58 158.58 32.23 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.723 2.282 . . . . 2.36 111.925 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 48' ' ' SER . 6.5 tt -91.52 140.29 29.89 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.333 -0.617 . . . . 2.55 109.333 -178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.502 ' N ' HD23 ' A' ' 47' ' ' LEU . 2.0 t -144.6 139.33 28.02 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.848 -0.797 . . . . 2.38 108.848 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.33 128.88 75.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.048 0.452 . . . . 1.59 111.929 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.5 t -118.94 90.04 3.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.079 -0.711 . . . . 1.45 109.079 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.76 13.84 17.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 3.62 110.421 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.69 -31.65 68.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 2.48 111.213 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 13.9 mt-30 -109.35 17.35 21.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 2.24 110.736 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.24 114.48 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.37 . . . . 0.8 110.922 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 m -101.35 106.24 17.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.049 -0.523 . . . . 1.06 110.734 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -85.42 151.49 23.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.799 -0.637 . . . . 1.26 109.712 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.24 -57.54 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.74 111.545 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -167.34 159.63 12.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.64 0.257 . . . . 3.17 111.036 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 14.1 tt -104.99 140.6 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.317 -0.623 . . . . 0.64 109.317 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -130.29 140.53 50.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.115 0.483 . . . . 0.96 111.555 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -100.22 108.6 20.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.732 -1.211 . . . . 1.49 107.732 170.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -137.83 71.55 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.572 -0.851 . . . . 1.83 111.791 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.62 -75.38 0.36 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 119.941 -1.123 . . . . 1.64 112.851 159.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 243' ' ' ASN . 52.4 t-80 -112.59 -12.85 13.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.056 0.391 . . . . 3.33 112.056 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -154.2 175.99 12.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.997 0.427 . . . . 1.38 111.748 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -119.79 103.8 9.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.414 -0.958 . . . . 2.74 108.414 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.94 134.97 47.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.155 0.502 . . . . 1.76 111.87 -170.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 48.4 t -100.25 112.13 31.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.309 -0.626 . . . . 1.15 109.309 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.48 130.87 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 2.02 112.198 -172.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -111.87 163.7 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.397 -0.964 . . . . 1.66 108.397 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.05 121.49 27.09 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.614 -0.434 . . . . 1.33 111.372 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.624 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 10.0 t0 -114.72 60.42 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.884 0.849 . . . . 2.65 109.75 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 t -116.47 -15.49 10.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 1.61 110.134 165.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -137.6 160.79 38.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.496 -0.557 . . . . 2.35 109.496 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -82.33 64.71 7.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.27 0.557 . . . . 1.92 110.207 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 67.6 mttm -79.18 -51.22 9.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.434 -0.803 . . . . 1.77 110.003 -177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . . . -115.88 105.2 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.76 109.215 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.14 139.98 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.046 0.451 . . . . 1.27 110.914 -172.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.498 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 14.7 tp -109.55 148.89 30.48 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.819 -0.628 . . . . 1.29 110.969 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 93.5 mttt -116.55 141.51 48.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.024 -1.102 . . . . 2.54 108.024 164.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.2 168.73 31.42 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.271 -0.966 . . . . 1.31 112.229 -165.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.63 -146.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 112.263 -0.335 . . . . 1.9 112.263 169.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.43 121.66 9.42 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.09 1.86 . . . . 2.91 112.095 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 88' ' ' TYR . 8.3 tp -179.63 157.57 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.024 -1.102 . . . . 4.11 108.024 -175.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -128.57 111.32 13.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.987 1.106 . . . . 4.95 113.987 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.1 -101.66 0.96 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.441 -0.885 . . . . 2.25 114.858 161.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.469 HG22 ' HG3' ' A' ' 89' ' ' ARG . 33.4 m -130.95 103.92 6.83 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.487 -0.56 . . . . 1.91 109.487 -167.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.498 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 1.3 m-85 -95.44 91.52 6.24 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.608 -0.437 . . . . 3.7 110.044 -172.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HD2' ' OD1' ' A' ' 72' ' ' ASP . 55.9 mtt180 -107.27 146.36 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.717 0.294 . . . . 3.54 110.568 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 57.8 tp -77.84 123.86 27.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.552 -0.536 . . . . 1.14 109.552 171.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.1 -40.87 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.176 -0.465 . . . . 1.68 110.02 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -174.89 168.51 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.764 -0.653 . . . . 1.55 109.715 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -137.28 150.01 47.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.199 -0.667 . . . . 0.86 109.199 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 7.6 p-80 -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.632 0.254 . . . . 0.93 110.863 -172.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -134.37 158.89 42.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 3.17 110.347 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -165.13 179.39 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.644 0.259 . . . . 1.68 111.36 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.632 ' CD1' ' HA ' ' A' ' 242' ' ' ASP . 2.9 t90 74.0 -100.46 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.066 0.946 . . . . 5.18 110.407 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 53.02 15.58 3.57 Favored Glycine 0 N--CA 1.475 1.241 0 N-CA-C 115.278 0.871 . . . . 2.13 115.278 174.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.585 ' H ' ' HD1' ' A' ' 97' ' ' TRP . 48.3 p -45.7 -53.92 8.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.896 0.702 . . . . 2.9 112.896 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.7 mt -128.53 146.86 50.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.477 -0.564 . . . . 3.03 109.477 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.69 -13.23 62.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 3.85 111.613 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.55 -10.26 41.59 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.347 -0.93 . . . . 1.94 113.017 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.39 119.27 2.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.579 0.704 . . . . 2.45 111.725 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.28 41.32 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.658 -0.701 . . . . 1.47 111.794 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.4 p -105.8 -14.09 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 2.0 112.298 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.76 174.23 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.463 -0.569 . . . . 3.72 109.463 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.613 ' HE2' ' CD ' ' A' ' 117' ' ' GLU . 14.9 p80 44.09 68.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.312 1.053 . . . . 3.52 111.426 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.6 t -75.97 130.41 38.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.515 -1.22 . . . . 2.52 110.681 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 23.3 t -101.76 105.69 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 114.378 -1.283 . . . . 2.48 110.171 -172.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 55.31 50.76 14.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.568 -0.742 . . . . 2.8 109.472 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 68.33 1.14 2.77 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.238 -0.892 . . . . 4.98 112.607 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 47.8 tptt -89.75 123.72 34.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.885 0.374 . . . . 3.23 110.968 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.69 155.96 27.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.809 -0.632 . . . . 2.82 110.31 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.69 168.89 9.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.101 -0.703 . . . . 1.62 109.101 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.43 79.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.274 0.472 . . . . 1.03 112.274 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.46 171.32 7.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.219 -0.66 . . . . 0.75 109.219 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.613 ' CD ' ' HE2' ' A' ' 107' ' ' HIS . 28.8 tt0 -142.24 138.43 31.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.067 0.461 . . . . 1.58 110.509 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.3 tp -102.43 126.49 49.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.43 -0.804 . . . . 1.07 109.448 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.413 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 42.4 m170 -107.98 110.27 21.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 1.77 111.147 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 6.8 mp -94.68 103.44 15.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.678 -0.49 . . . . 0.93 109.678 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.482 HG22 HG12 ' A' ' 142' ' ' VAL . 19.3 t -76.85 100.28 2.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.008 -0.542 . . . . 0.61 110.436 -176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 90' ' ' LEU . 3.2 p80 -138.97 76.19 1.56 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.755 1.021 . . . . 2.13 113.755 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.0 t90 178.91 99.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.345 0.658 . . . . 4.26 109.856 149.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' A' ' 133' ' ' ALA . 24.8 t-20 -124.62 90.48 3.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 118.612 -0.708 . . . . 2.02 111.561 157.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.5 m -81.28 -51.98 7.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 120.819 1.645 . . . . 2.34 111.492 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HD2' ' HA2' ' A' ' 139' ' ' GLY . 13.0 ptpt -43.57 -32.77 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 114.549 1.314 . . . . 3.35 114.549 -173.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.98 -16.35 6.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.133 -0.627 . . . . 3.1 111.851 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 52.38 38.91 51.16 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.583 -0.607 . . . . 2.37 111.583 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 12.3 t70 -169.33 110.48 0.47 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.675 -0.861 . . . . 3.93 108.675 -171.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -63.44 -32.12 73.48 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.943 0.349 . . . . 3.0 111.943 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.71 98.64 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.921 -0.657 . . . . 2.15 112.818 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 31.7 mmmt -74.32 -20.99 59.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.276 0.56 . . . . 3.43 110.311 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.612 ' HB2' ' ND2' ' A' ' 124' ' ' ASN . . . -74.75 -20.95 59.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 1.76 111.988 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.6 t -61.11 -22.08 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.566 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -98.18 8.09 45.32 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.158 -0.339 . . . . 3.55 111.572 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.488 ' NE2' ' HD2' ' A' ' 137' ' ' PRO . 12.9 mm100 -122.86 127.47 25.72 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.662 0.267 . . . . 3.02 111.161 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.488 ' HD2' ' NE2' ' A' ' 136' ' ' GLN . 11.2 Cg_endo -55.3 -32.96 83.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.604 2.869 . . . . 1.6 113.465 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.61 28.42 8.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.796 -0.446 . . . . 2.29 109.796 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.404 ' HA2' ' HD2' ' A' ' 126' ' ' LYS . . . -67.19 -27.91 73.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.048 -0.596 . . . . 1.22 114.319 -175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.8 mt -137.19 170.29 16.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.459 . . . . 1.57 111.564 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.14 118.58 6.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 1.38 109.472 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 121' ' ' VAL . 33.8 m -113.4 142.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 1.73 111.064 -175.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.0 tp -95.46 103.85 15.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.786 . . . . 2.42 108.879 172.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.6 3.66 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.044 -0.598 . . . . 0.86 112.223 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 32.3 mt -102.62 124.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.866 -0.42 . . . . 0.76 109.866 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 48.8 m-85 -68.2 148.2 51.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 1.2 110.898 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.6 mp -118.56 138.3 52.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.498 -0.556 . . . . 0.88 109.498 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 216' ' ' SER . 14.1 ptmm? -143.23 146.55 33.74 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.891 -0.781 . . . . 2.03 108.891 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 95.7 t -83.79 130.87 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.099 0.476 . . . . 1.27 111.663 -171.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -173.45 -110.14 0.24 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.872 -0.891 . . . . 1.53 110.872 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 t -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.313 -0.625 . . . . 1.54 109.313 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.0 158.27 23.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.608 0.242 . . . . 0.78 110.987 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -115.94 106.2 50.06 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.922 -0.399 . . . . 1.22 109.922 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 51.1 Cg_exo -54.96 -35.77 90.6 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.08 2.52 . . . . 1.05 112.362 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.58 71.98 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.992 -0.623 . . . . 0.7 112.645 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.485 ' HB3' HE22 ' A' ' 221' ' ' GLN . 19.1 tp -88.05 -20.25 26.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.47 -0.567 . . . . 0.77 109.47 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 19.8 mm-40 -52.82 -37.34 59.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.647 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 175' ' ' PHE . 57.3 mttp -54.01 -54.27 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.458 0.474 . . . . 2.86 111.601 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 162' ' ' VAL . 11.4 p -74.62 -37.26 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.91 0.386 . . . . 1.38 110.762 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 80.6 t -64.94 -34.97 74.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.419 0.628 . . . . 1.11 110.808 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.66 -32.84 71.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.063 -0.517 . . . . 1.22 111.317 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 159' ' ' VAL . 9.3 p -89.58 -20.74 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.17 0.433 . . . . 1.41 112.17 -173.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.485 HD13 HD11 ' A' ' 228' ' ' LEU . 3.0 pp -67.84 -16.92 64.33 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.071 0.463 . . . . 1.39 111.161 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.457 ' N ' HD12 ' A' ' 163' ' ' LEU . 9.8 t70 -65.04 -23.35 67.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 2.31 110.325 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.7 m -89.73 1.71 55.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 1.4 111.935 -178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.96 39.23 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.513 0.673 . . . . 0.85 110.078 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 227' ' ' LYS . 89.0 tttt -59.62 -22.59 62.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.146 -0.933 . . . . 1.59 111.666 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.1 p -120.18 137.56 54.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.51 -0.314 . . . . 0.77 110.812 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 230' ' ' PHE . 15.0 ptmm? -56.07 137.09 51.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.053 -0.521 . . . . 2.29 111.348 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.33 -30.46 8.23 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.976 -0.63 . . . . 0.85 111.816 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -81.8 153.79 26.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.06 0.457 . . . . 1.7 110.91 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.9 t -145.84 151.84 38.54 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.622 -0.717 . . . . 1.37 109.499 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -133.58 126.29 30.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.604 -0.271 . . . . 0.61 110.312 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.38 131.15 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 1.8 110.495 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -144.55 86.09 1.8 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 1.04 110.523 -176.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.6 p -95.99 160.92 14.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.703 0.287 . . . . 1.17 111.485 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 21.1 m120 65.19 29.8 11.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.774 -0.648 . . . . 1.77 112.331 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -87.47 119.9 28.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.464 -0.569 . . . . 3.99 109.464 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.74 112.7 63.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.995 0.426 . . . . 2.51 111.024 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.49 -17.83 60.92 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.82 2.347 . . . . 1.26 111.723 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -53.95 -40.07 66.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.554 -0.748 . . . . 2.76 110.861 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -64.89 -18.33 64.18 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.666 -0.697 . . . . 1.12 113.704 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.8 mt -96.83 -11.96 24.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.261 0.53 . . . . 1.73 111.701 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 96.7 mt -63.85 123.72 82.64 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.727 0.299 . . . . 3.45 111.563 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.498 ' HB2' ' HG2' ' A' ' 213' ' ' GLU . 2.5 Cg_endo -82.49 -170.04 0.86 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.221 2.614 . . . . 2.08 112.154 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.47 -66.19 0.92 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.159 0.8 . . . . 3.23 113.159 -174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 20.1 m -65.48 114.66 5.02 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.15 0.5 . . . . 1.66 111.357 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.43 HD11 HD22 ' A' ' 47' ' ' LEU . 17.8 tp -103.15 70.57 1.07 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 1.99 110.744 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.458 ' O ' HD12 ' A' ' 211' ' ' LEU . 3.0 m-20 -130.33 174.32 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.39 -0.967 . . . . 1.81 108.39 176.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 38.4 p90 -166.36 154.7 10.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.559 0.948 . . . . 5.01 113.559 -164.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.617 ' O ' ' HA ' ' A' ' 209' ' ' ILE . 4.1 m95 -107.78 149.74 27.84 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.239 -1.393 . . . . 3.93 107.239 171.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.7 t -138.38 103.03 4.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.97 0.804 . . . . 2.13 112.799 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.39 157.84 69.88 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.924 -0.58 . . . . 5.21 110.492 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.04 137.21 78.28 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.731 2.288 . . . . 2.12 112.366 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -134.25 156.97 22.66 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.303 -0.475 . . . . 1.75 113.563 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 41.8 t -94.77 143.12 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.642 0.377 . . . . 2.99 110.04 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 62.1 tp -94.99 -46.06 6.99 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.854 0.687 . . . . 4.75 112.854 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.68 ' O ' ' HD2' ' A' ' 200' ' ' PRO . 13.7 m -116.37 -43.09 2.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.881 -0.328 . . . . 5.1 110.812 -175.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.41 ' CB ' ' O ' ' A' ' 198' ' ' THR . 53.0 m 105.42 -63.01 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.804 0 O-C-N 124.956 1.41 . . . . 5.53 113.193 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 198' ' ' THR . 5.8 Cg_exo -39.71 -55.47 1.65 Allowed 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.194 2.596 . . . . 5.83 115.387 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.95 -9.37 18.05 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 121.456 1.437 . . . . 4.78 112.374 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . 68.1 mt 64.95 66.16 0.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.269 -1.332 . . . . 3.84 110.813 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.2 mt -116.21 121.92 43.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.24 -0.436 . . . . 2.96 110.53 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.4 66.77 0.89 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.861 0.838 . . . . 3.37 109.581 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.0 11.76 30.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.774 -1.103 . . . . 2.15 111.026 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.73 149.63 22.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.077 0.465 . . . . 1.26 111.414 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.4 m -103.03 107.86 18.82 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 2.08 107.989 169.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.497 ' CZ3' ' HG3' ' A' ' 30' ' ' PRO . 1.3 t-105 -80.89 100.08 8.68 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.737 -0.468 . . . . 5.53 109.737 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 55.3 mt -99.91 100.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.01 -0.541 . . . . 1.63 109.742 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 45.4 t -85.11 119.35 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.251 -0.432 . . . . 1.62 110.852 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 189' ' ' ASP . 46.2 tp -80.41 122.43 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.439 . . . . 1.73 110.612 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -48.44 -28.74 3.46 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.082 1.142 . . . . 2.98 114.082 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 185' ' ' PRO . 5.7 tp10 -102.98 114.42 65.25 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.396 -0.522 . . . . 1.47 110.926 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.45 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 90.5 Cg_endo -80.01 148.61 19.6 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.803 2.335 . . . . 0.96 111.893 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 34.4 pt -101.88 149.44 6.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 1.25 110.559 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 148' ' ' LYS . 1.7 p -101.93 117.53 35.02 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.462 -0.79 . . . . 1.29 110.098 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 32.6 m -115.76 168.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.137 -0.483 . . . . 1.02 110.049 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.3 t -90.65 148.78 22.41 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.741 -0.384 . . . . 1.08 110.417 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.56 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 10.6 p -53.66 -45.0 70.11 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.507 0.505 . . . . 1.33 111.502 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.0 -31.53 71.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.647 -0.251 . . . . 2.51 111.306 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.485 HE22 ' HB3' ' A' ' 156' ' ' LEU . 54.5 mt-30 -62.51 -51.09 68.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.7 0.286 . . . . 0.7 110.628 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.65 -26.52 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.933 -0.307 . . . . 1.36 111.156 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 219' ' ' SER . 88.3 mt -69.44 -36.07 76.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.657 -0.247 . . . . 1.03 110.883 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -66.11 -31.44 72.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.064 0.459 . . . . 1.75 110.764 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -69.7 -39.32 76.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.594 -0.73 . . . . 2.47 109.754 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -72.0 -3.62 23.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.24 -0.891 . . . . 3.04 111.011 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 223' ' ' LEU . 98.5 mttt -94.34 -1.38 53.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 2.31 110.665 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.485 HD11 HD13 ' A' ' 163' ' ' LEU . 55.6 mt -90.41 155.08 19.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.037 -0.529 . . . . 0.95 110.775 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -112.36 155.7 23.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.51 -0.314 . . . . 1.13 110.354 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.532 ' O ' ' HD2' ' A' ' 169' ' ' LYS . 50.4 p90 -111.52 -18.42 12.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.215 -0.448 . . . . 3.74 110.293 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.573 HD22 ' HB2' ' A' ' 235' ' ' GLU . 6.2 p-10 -71.51 -31.83 67.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.62 111.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.471 ' CA ' ' HG2' ' A' ' 169' ' ' LYS . . . 97.99 -159.71 20.79 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.564 -0.827 . . . . 1.16 113.018 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.17 150.38 20.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.686 0.279 . . . . 3.56 110.34 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.19 4.22 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.01 -0.615 . . . . 2.08 112.685 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.573 ' HB2' HD22 ' A' ' 231' ' ' ASN . 41.6 mt-10 -134.92 159.55 71.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.447 -0.575 . . . . 2.59 109.447 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.91 129.92 37.87 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.772 2.315 . . . . 1.36 112.005 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -59.64 114.35 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 3.4 111.839 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.71 117.82 29.27 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.393 -0.595 . . . . 2.47 109.393 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.21 136.24 55.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.789 -0.642 . . . . 2.14 111.206 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.5 ttm -81.32 89.94 6.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.668 -0.697 . . . . 1.68 109.49 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.73 153.59 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 1.27 109.804 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.632 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 13.6 t70 64.75 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.885 0.741 . . . . 2.18 110.607 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.46 ' HB3' ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER 52.23 27.33 4.61 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.56 0.948 . . . . 2.15 113.56 179.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.453 ' CZ3' ' HD3' ' A' ' 30' ' ' PRO . 73.8 m95 -139.84 169.32 17.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.902 0.382 . . . . 4.59 110.81 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 29' ' ' SER . 24.1 mmt180 -117.35 148.91 43.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 6.13 111.573 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -33.23 138.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.921 3.747 . . . . 3.28 115.014 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' A' ' 29' ' ' SER . . . -54.91 143.82 24.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.683 -1.144 . . . . 2.98 112.209 -175.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' A' ' 29' ' ' SER . 28.4 mm-40 -107.97 130.36 22.9 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 4.32 110.894 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 248' ' ' GLN . 27.4 Cg_exo -63.23 175.17 2.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.52 2.813 . . . . 3.48 113.956 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.491 ' CD1' HG21 ' A' ' 37' ' ' THR . 49.8 mt -62.17 -11.19 13.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.207 -1.361 . . . . 4.63 113.402 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 18.5 ptpt -57.79 47.22 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.234 1.938 . . . . 5.34 116.234 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 7.5 t30 127.4 25.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 126.372 1.869 . . . . 4.64 111.106 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 252' ' ' ASN . 0.0 OUTLIER -141.94 110.76 6.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.083 -0.71 . . . . 6.11 109.083 166.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.02 121.81 45.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.072 -0.714 . . . . 3.08 109.072 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.615 HD11 HG21 ' A' ' 31' ' ' VAL . 47.6 mm -82.95 115.58 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.181 0.515 . . . . 2.6 112.262 -174.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -94.56 127.5 40.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.639 -0.71 . . . . 2.63 109.555 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -116.37 146.09 42.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.717 -0.475 . . . . 1.71 109.717 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 19.5 m -142.41 96.43 2.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.426 0.631 . . . . 2.21 110.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.435 ' HA ' ' OD1' ' A' ' 189' ' ' ASP . 86.5 t80 -126.54 90.69 3.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.548 -0.908 . . . . 4.31 108.548 166.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.375 -0.821 . . . . 4.49 109.823 -177.54 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttp . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.748 0.309 . . . . 17.49 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 p -68.02 -47.14 69.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 15.32 111.573 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -102.67 44.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.429 0.633 . . . . 15.81 111.462 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -98.02 94.22 6.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.362 -0.977 . . . . 14.19 108.362 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -81.84 141.95 32.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.077 0.465 . . . . 14.91 111.573 -172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 11' ' ' ASN . . . 169.08 177.62 39.95 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.623 -0.717 . . . . 10.79 111.442 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -92.8 105.08 17.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.85 0.357 . . . . 11.39 111.032 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.44 176.7 51.51 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.874 -0.603 . . . . 9.0 112.84 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.575 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 3.4 mppt? -58.62 153.93 15.41 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.412 -0.218 . . . . 9.76 110.412 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 74.81 -54.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.523 0.729 . . . . 11.19 111.424 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 15.9 m120 -78.74 -16.75 56.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.149 0.499 . . . . 10.8 109.822 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.69 -139.56 3.67 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.904 -0.878 . . . . 8.82 110.904 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.06 135.18 10.91 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.631 2.221 . . . . 7.87 110.852 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 41.3 tt0 -78.78 -9.93 59.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.526 0.679 . . . . 10.62 110.01 -176.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -123.75 23.69 8.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.579 -0.737 . . . . 9.87 110.017 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -65.39 -21.59 66.69 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.874 -0.603 . . . . 8.48 110.514 -175.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -58.82 -29.53 66.95 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.364 -0.38 . . . . 7.13 111.39 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -89.4 -40.8 12.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.63 0.252 . . . . 9.68 111.252 -176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.52 -8.61 58.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.165 0.507 . . . . 7.89 110.893 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -137.59 103.93 8.47 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.295 -1.002 . . . . 7.17 108.295 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.12 70.47 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.187 2.591 . . . . 7.76 113.726 -172.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.445 ' HA ' ' HG3' ' A' ' 26' ' ' GLU . 1.9 mp -106.56 -44.03 7.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.293 0.568 . . . . 5.83 110.17 172.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.0 -2.68 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.71 -0.677 . . . . 5.44 112.172 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -88.51 10.33 20.67 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.626 0.232 . . . . 7.78 111.626 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.73 49.39 0.85 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.438 -0.887 . . . . 5.01 112.903 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 22' ' ' ILE . 23.6 mm-40 -106.43 121.77 44.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.769 0.318 . . . . 7.09 110.655 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -76.72 138.4 39.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.672 0.748 . . . . 5.13 111.562 174.259 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' HB3' ' H ' ' A' ' 29' ' ' SER . 28.2 mt-30 -131.53 -150.64 0.43 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.695 -1.139 . . . . 7.12 112.059 -171.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 8.3 m -47.65 160.48 0.38 Allowed Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 115.653 1.723 . . . . 3.94 115.653 -172.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 29' ' ' SER . 38.5 Cg_exo -63.11 34.46 0.08 OUTLIER 'Trans proline' 0 N--CA 1.484 0.956 1 C-N-CA 125.979 4.453 . . . . 4.52 114.662 173.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 m -87.92 -168.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 119.295 -0.383 . . . . 4.54 110.37 -170.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -47.31 123.12 5.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.465 0.913 . . . . 2.88 113.465 -159.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 26.2 mm -101.6 134.37 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.718 -1.128 . . . . 2.32 111.2 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 37' ' ' THR . 16.2 t70 -107.32 113.45 26.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.963 -0.384 . . . . 2.82 109.963 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -56.67 -33.11 66.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.319 0.859 . . . . 2.24 113.319 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -75.07 -41.29 59.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.876 -0.329 . . . . 4.54 111.109 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 7.3 p -72.55 -27.53 62.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.801 0.334 . . . . 3.06 110.532 176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -69.89 84.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.277 0.56 . . . . 1.72 110.443 174.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -79.73 134.43 36.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.692 -0.685 . . . . 3.69 109.656 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.616 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 2.5 p90 -81.68 124.52 29.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.194 0.521 . . . . 4.64 110.297 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -118.0 119.9 33.12 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 2.27 109.621 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.32 24.57 0.31 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.999 2.466 . . . . 2.15 113.728 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.8 p -95.86 -17.21 21.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.268 0.556 . . . . 4.29 109.51 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.77 124.51 30.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.493 -0.776 . . . . 4.74 109.768 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -115.15 136.57 22.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.122 -0.49 . . . . 3.77 110.922 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.07 122.84 12.42 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.825 2.35 . . . . 2.36 112.049 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.482 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 6.2 mp -78.62 132.96 37.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.726 -0.67 . . . . 2.55 110.904 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.6 t -84.56 138.04 32.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.466 -0.568 . . . . 2.38 109.466 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.0 t -118.37 121.78 67.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.192 -0.458 . . . . 1.59 110.832 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 13.3 p -111.55 89.91 3.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.438 -0.578 . . . . 1.45 109.438 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -109.84 10.01 24.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.687 -0.688 . . . . 3.62 110.098 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.8 -34.72 65.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.386 -0.825 . . . . 2.48 111.544 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.7 13.66 29.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.278 0.473 . . . . 2.24 112.278 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.29 113.57 5.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 0.8 111.923 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.8 m -107.33 109.83 21.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.847 -0.615 . . . . 1.06 110.547 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 178' ' ' PHE . 18.1 m -78.57 145.51 34.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.404 -0.362 . . . . 1.26 110.617 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -115.64 -55.77 2.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.74 111.718 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -166.6 159.09 13.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 3.17 111.271 -173.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 tt -112.16 137.5 44.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 0.64 109.934 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -129.39 135.76 49.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.894 0.378 . . . . 0.96 111.681 -173.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.99 117.99 35.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.375 -0.972 . . . . 1.49 108.375 172.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -137.48 71.02 1.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.662 -0.815 . . . . 1.83 112.311 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 230' ' ' PHE . . . 99.53 -58.84 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.342 -0.932 . . . . 1.64 113.885 157.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -125.56 -9.1 6.83 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.691 -0.403 . . . . 3.33 111.82 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -160.49 177.74 10.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.804 -0.443 . . . . 1.38 109.804 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -139.3 136.72 35.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.256 -1.016 . . . . 2.74 108.256 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.01 151.93 48.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.063 0.459 . . . . 1.76 111.941 -171.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.8 127.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.381 -0.827 . . . . 1.15 109.51 175.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.82 137.03 33.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 2.02 110.984 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -112.95 170.1 8.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.356 -0.838 . . . . 1.66 109.475 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.414 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 14.3 t70 -98.89 132.16 44.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.005 0.431 . . . . 1.33 110.92 174.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.53 ' OD1' ' HD2' ' A' ' 89' ' ' ARG . 22.6 t70 -137.1 62.29 1.6 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.227 -0.897 . . . . 2.65 109.118 170.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -80.67 -4.52 54.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.116 0.96 . . . . 1.61 108.626 166.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -163.63 148.98 11.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.026 -1.842 . . . . 2.35 106.026 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -61.68 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 122.138 0.97 . . . . 1.92 111.783 -171.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.547 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 61.7 mttm -91.9 -53.2 4.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.906 -1.043 . . . . 1.77 111.021 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.39 104.61 10.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.994 -0.548 . . . . 0.76 109.638 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.6 t -117.44 153.03 19.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 -176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tt -147.7 112.65 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 1.29 109.561 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.95 132.52 8.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.642 0.734 . . . . 2.54 111.622 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 47' ' ' LEU . . . -76.48 174.36 53.78 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 114.899 -1.046 . . . . 1.31 112.152 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.66 -142.88 0.0 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 124.259 0.623 . . . . 1.9 113.942 168.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.66 122.37 8.75 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 121.456 1.438 . . . . 2.91 111.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 7.9 tp -157.53 -167.66 2.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.947 -1.024 . . . . 4.11 108.428 -166.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.483 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 16.4 m-20 -123.64 32.67 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.741 0.305 . . . . 4.95 110.65 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.02 145.53 4.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.692 -0.766 . . . . 2.25 113.081 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.3 m -93.1 113.73 26.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.322 -0.622 . . . . 1.91 109.322 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 70.2 m-85 -101.33 127.91 47.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.155 0.503 . . . . 3.7 111.72 -171.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 123' ' ' TRP . 22.8 ptt180 -99.76 142.31 31.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.886 -0.597 . . . . 3.54 110.786 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 120' ' ' LEU . 8.4 tt -92.42 120.09 32.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.371 -0.603 . . . . 1.14 109.371 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.643 HD12 ' CE3' ' A' ' 123' ' ' TRP . 36.8 mt -121.97 -15.65 6.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.42 -0.354 . . . . 1.68 111.099 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -166.54 162.71 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.167 -0.333 . . . . 1.55 110.227 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 41.4 p90 -140.49 140.5 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.22 -0.659 . . . . 0.86 109.22 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.4 p-80 -118.51 158.05 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.329 . . . . 0.93 110.227 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 116' ' ' ALA . 78.4 t80 -133.69 156.97 46.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.143 -0.48 . . . . 3.17 109.967 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -152.07 139.4 19.43 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.753 -0.462 . . . . 1.68 109.753 175.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 68.9 t-105 -104.01 137.61 41.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.944 -0.571 . . . . 5.18 110.006 -176.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -70.02 -60.97 4.55 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.962 -0.563 . . . . 2.13 113.165 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 29.0 t 162.23 -64.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.166 -1.05 . . . . 2.9 108.166 -176.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.0 mt -110.31 164.79 12.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.082 -0.963 . . . . 3.03 109.151 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -83.04 56.02 3.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.673 0.749 . . . . 3.85 110.86 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.75 -2.66 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.645 -0.707 . . . . 1.94 113.105 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.11 155.98 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.076 0.438 . . . . 2.45 110.385 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 100.67 -13.98 59.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.801 -0.714 . . . . 1.47 112.643 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.9 t -75.01 -32.84 61.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.49 . . . . 2.0 109.927 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 58.83 -159.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.55 -0.75 . . . . 3.72 110.122 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m80 58.37 30.72 20.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.428 -1.323 . . . . 3.52 107.428 -168.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.32 129.33 34.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.882 -1.508 . . . . 2.52 111.781 -166.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.2 m -100.15 111.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.825 -1.08 . . . . 2.48 110.606 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.63 43.21 12.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.964 -1.016 . . . . 2.8 110.406 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 68.3 20.95 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.125 -0.943 . . . . 4.98 112.078 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HE3' ' CZ ' ' A' ' 114' ' ' TYR . 4.4 tmmm? -102.81 89.55 3.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.985 0.422 . . . . 3.23 109.926 173.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -79.22 157.36 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.861 -0.609 . . . . 2.82 110.028 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 112' ' ' LYS . 82.2 m-85 -102.68 178.92 4.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.614 -0.266 . . . . 1.62 110.75 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.14 -47.22 68.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.997 0.427 . . . . 1.03 111.381 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB2' ' CE3' ' A' ' 97' ' ' TRP . . . -155.77 168.16 28.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.041 -0.527 . . . . 0.75 110.539 -173.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -134.94 135.32 41.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 1.58 109.896 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.35 126.76 55.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.591 -0.522 . . . . 1.07 109.591 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.483 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -122.12 109.6 14.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.077 0.465 . . . . 1.77 111.695 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.3 mp -91.55 117.84 30.07 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.88 -0.785 . . . . 0.93 108.88 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.62 143.79 11.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.438 -0.346 . . . . 0.61 110.698 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 53.7 m-70 -138.81 134.7 33.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.633 -0.877 . . . . 2.13 108.633 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.643 ' CE3' HD12 ' A' ' 91' ' ' ILE . 37.5 m0 -111.23 140.99 45.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.457 -0.571 . . . . 4.26 109.457 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.79 112.97 2.03 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.889 -0.412 . . . . 2.02 109.889 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 t -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 2.34 110.828 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -63.35 -16.88 61.76 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.948 0.351 . . . . 3.35 111.948 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.96 -6.28 35.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.728 0.299 . . . . 3.1 110.711 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.77 18.84 0.76 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.16 -0.927 . . . . 2.37 115.189 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 21.7 t70 -170.59 125.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.652 0.726 . . . . 3.93 110.386 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.625 ' O ' HG23 ' A' ' 134' ' ' VAL . 22.5 p90 -57.07 -40.72 77.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.98 -1.009 . . . . 3.0 111.054 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -57.01 -37.41 79.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.256 -0.497 . . . . 2.15 112.893 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.516 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 41.5 mmtm -76.9 -28.76 55.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 3.43 110.333 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -75.36 -35.04 61.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.849 -0.614 . . . . 1.76 111.133 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 130' ' ' PHE . 77.2 t -65.01 -25.87 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 2.77 110.37 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -95.38 17.94 13.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.053 0.454 . . . . 3.55 110.668 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 139' ' ' GLY . 4.3 tp-100 -131.24 121.77 18.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.168 -0.469 . . . . 3.02 109.952 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 92.4 Cg_exo -45.79 -36.03 14.39 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.017 3.144 . . . . 1.6 113.619 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -110.74 27.65 9.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.965 0.412 . . . . 2.29 109.961 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 136' ' ' GLN . . . -84.68 -42.65 7.19 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.159 -0.543 . . . . 1.22 113.541 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 69.0 mt -104.03 153.54 20.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.38 0.59 . . . . 1.57 110.469 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -142.88 147.12 34.82 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.829 -0.623 . . . . 1.38 109.954 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.4 t -133.76 137.69 52.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.153 -0.476 . . . . 1.73 109.954 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -106.07 121.74 44.74 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.702 -0.481 . . . . 2.42 109.702 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.74 128.46 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.867 -0.682 . . . . 0.86 113.041 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.76 115.52 31.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.914 -0.402 . . . . 0.76 109.914 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -77.99 149.97 33.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.931 0.396 . . . . 1.2 111.168 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.4 mp -113.04 134.94 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.835 -0.62 . . . . 0.88 110.361 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -127.16 144.52 51.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.471 -0.566 . . . . 2.03 109.471 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 19.6 m -86.75 130.36 36.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.389 0.614 . . . . 1.27 111.742 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.32 -104.54 0.18 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.224 -0.898 . . . . 1.53 111.391 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -81.19 150.98 28.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.919 -0.4 . . . . 1.54 109.919 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.31 149.84 45.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.224 -0.444 . . . . 0.78 111.229 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 216' ' ' SER . 22.5 tptm -119.45 96.14 49.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.003 -0.544 . . . . 1.22 109.904 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 54.0 Cg_exo -53.56 -37.94 83.34 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.22 2.613 . . . . 1.05 112.524 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.94 -37.88 86.75 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.7 113.172 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 160' ' ' VAL . 61.9 tp -93.05 -22.43 19.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.082 0.441 . . . . 0.77 110.456 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -57.24 -34.22 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 1.41 111.316 -178.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -56.49 -41.75 77.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 2.86 110.904 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.58 -41.86 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 1.38 110.249 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 25.8 t -61.88 -33.81 59.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.374 0.606 . . . . 1.11 110.588 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.99 -37.06 78.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.797 -0.638 . . . . 1.22 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.91 -18.88 8.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 111.913 0.338 . . . . 1.41 111.913 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -66.32 -17.13 64.57 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.738 -0.385 . . . . 1.39 111.91 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.7 -24.06 66.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 2.31 110.881 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.5 m -84.8 0.43 50.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.264 -0.426 . . . . 1.4 111.427 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.42 HG12 ' HA ' ' A' ' 163' ' ' LEU . 44.7 pt -137.4 44.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.345 0.593 . . . . 0.85 109.627 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.79 -36.98 80.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.436 -0.802 . . . . 1.59 111.697 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -114.51 151.93 32.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.708 -0.224 . . . . 0.77 110.734 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 21.4 pttm -63.56 140.85 58.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.046 0.45 . . . . 2.29 110.611 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.13 47.71 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.753 -0.737 . . . . 0.85 111.42 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -91.61 147.72 22.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.128 0.49 . . . . 1.7 111.144 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.3 p -144.11 150.42 38.08 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.502 -0.772 . . . . 1.37 109.49 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -135.43 133.71 38.88 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.737 -0.468 . . . . 0.61 109.737 -177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.07 129.83 43.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.156 0.503 . . . . 1.8 110.065 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -141.44 79.91 1.71 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.678 -0.86 . . . . 1.04 108.678 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.5 m -99.29 153.99 18.53 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.273 -0.876 . . . . 1.17 110.984 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.4 m120 54.78 77.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.188 0.595 . . . . 1.77 111.959 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.437 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 71.3 t80 -131.42 140.63 49.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.9 -0.591 . . . . 3.99 109.494 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.41 120.89 51.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.198 0.523 . . . . 2.51 110.639 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.27 -5.57 16.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.025 2.483 . . . . 1.26 111.948 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 181' ' ' ARG . 42.1 ttp-105 -55.54 -36.95 67.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.773 -0.649 . . . . 2.76 110.975 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -82.05 8.08 61.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.968 -0.634 . . . . 1.12 112.417 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.6 mt -117.28 -38.95 3.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.984 0.421 . . . . 1.73 109.989 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.518 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.3 mt -73.1 131.44 83.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.727 -0.669 . . . . 3.45 111.101 -177.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 5.8 Cg_exo -77.65 179.73 6.23 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.002 2.468 . . . . 2.08 112.361 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -84.76 -63.8 1.27 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.26 0.467 . . . . 3.23 112.26 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.3 t -78.06 134.7 37.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.653 0.263 . . . . 1.66 110.964 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.8 mt -113.21 60.84 0.64 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.946 0.403 . . . . 1.99 110.288 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 212' ' ' LYS . 4.5 m-20 -140.22 144.42 36.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.41 -0.959 . . . . 1.81 108.41 173.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER 171.85 -171.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.415 -0.587 . . . . 5.01 109.415 -173.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 257' ' ' ALA . 25.7 p90 -81.3 151.24 28.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.487 -0.485 . . . . 3.93 110.127 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.451 ' OG1' HD13 ' A' ' 209' ' ' ILE . 4.7 t -167.29 116.92 0.84 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.573 0.702 . . . . 2.13 110.827 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.621 ' CD1' ' HD2' ' A' ' 251' ' ' LYS . 6.2 t80 -139.87 147.82 52.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.869 -0.789 . . . . 5.21 108.869 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 99.2 Cg_exo -47.64 151.19 3.51 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.628 2.219 . . . . 2.12 112.875 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.93 159.45 24.6 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.75 112.453 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.8 t -115.68 152.81 32.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.977 0.418 . . . . 2.99 110.166 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.541 ' O ' ' HD2' ' A' ' 201' ' ' PRO . 65.7 mt -88.9 11.61 17.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.634 -0.712 . . . . 4.75 110.574 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 201' ' ' PRO . 11.9 t -66.81 23.19 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.027 1.121 . . . . 5.1 114.027 -168.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.583 ' CB ' ' HD3' ' A' ' 200' ' ' PRO . 0.1 OUTLIER -76.36 -63.9 0.55 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 O-C-N 121.642 -0.661 . . . . 5.53 109.238 169.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 199' ' ' THR . 1.9 Cg_endo -82.96 -67.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.556 1.62 0 C-N-CA 121.847 1.698 . . . . 5.83 113.496 166.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' A' ' 198' ' ' THR . 51.9 Cg_endo -100.72 141.77 0.27 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.15 1.9 . . . . 4.78 113.22 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.5 tp -74.71 66.92 1.52 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.2 0.524 . . . . 3.84 110.999 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.8 tp -128.95 129.97 46.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 2.96 110.988 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.86 93.23 4.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.177 -0.465 . . . . 3.37 111.707 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.7 p -139.25 24.49 2.51 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.779 0.659 . . . . 2.15 112.779 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.15 143.2 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.26 111.964 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 5.5 m -126.35 104.52 8.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.331 -0.618 . . . . 2.08 109.331 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -101.64 134.95 43.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.476 0.655 . . . . 5.53 112.144 -175.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.451 HD13 ' OG1' ' A' ' 192' ' ' THR . 7.9 mm -116.13 128.32 73.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 114.779 -1.1 . . . . 1.63 109.173 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 t -108.17 150.28 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.341 -0.614 . . . . 1.62 109.341 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.415 ' HB2' ' HG2' ' A' ' 185' ' ' PRO . 1.9 mm? -109.57 146.43 34.7 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.98 -0.288 . . . . 1.73 111.325 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.61 ' HA ' ' CD2' ' A' ' 190' ' ' TYR . 37.5 ttmt -52.99 -60.28 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.765 0.654 . . . . 2.98 112.765 -176.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 185' ' ' PRO . 11.4 mm-40 -72.86 114.88 34.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.696 -0.684 . . . . 1.47 111.68 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.37 147.32 22.77 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.156 1.904 . . . . 0.96 110.5 174.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 pt -89.4 140.08 16.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.459 -0.496 . . . . 1.25 110.21 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 18.4 t -97.32 127.48 43.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.052 -0.522 . . . . 1.29 109.734 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 29.8 m -127.0 156.39 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.729 -0.668 . . . . 1.02 109.737 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.5 t -85.83 154.58 21.46 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.179 -0.304 . . . . 1.08 110.179 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.561 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 46.2 m -53.46 -42.35 67.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.001 0.188 . . . . 1.33 111.398 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 9.9 pt-20 -56.94 -27.77 61.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.605 -0.27 . . . . 2.51 111.634 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -77.08 -46.91 21.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.028 -0.36 . . . . 0.7 110.028 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.723 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 26.7 m -70.83 -28.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.36 111.228 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 219' ' ' SER . 95.7 mt -64.48 -33.57 76.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.298 -0.41 . . . . 1.03 110.558 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 65.2 mttp -74.97 -24.22 58.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 1.75 111.238 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.723 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 22.3 m-85 -67.0 -35.13 79.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.202 0.525 . . . . 2.47 109.851 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -84.45 13.96 4.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.696 -0.684 . . . . 3.04 110.578 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 75.0 mmtt -100.63 -14.96 17.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.79 -0.448 . . . . 2.31 109.79 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.401 HD21 HD13 ' A' ' 163' ' ' LEU . 97.9 mt -77.64 152.75 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 0.95 111.546 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.494 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 11.6 m120 -117.58 154.31 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 1.13 109.273 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 45.5 p90 -102.97 -11.55 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.492 -0.483 . . . . 3.74 110.252 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -75.26 169.5 17.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.821 -0.627 . . . . 1.62 111.022 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -85.89 171.72 45.15 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.867 -0.606 . . . . 1.16 111.889 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.64 128.58 36.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.961 0.41 . . . . 3.56 110.779 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 98.58 9.43 52.92 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.671 -0.695 . . . . 2.08 112.191 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -111.54 160.87 27.83 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.088 -0.338 . . . . 2.59 110.088 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.23 127.81 27.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.485 2.124 . . . . 1.36 111.165 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.09 110.3 1.02 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 3.4 111.517 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -117.28 115.23 24.86 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.001 -0.74 . . . . 2.47 109.001 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.3 135.0 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.267 0.556 . . . . 2.14 111.73 -172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.9 ttm -81.66 90.21 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.994 -1.003 . . . . 1.68 108.955 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.62 153.38 38.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.182 -0.463 . . . . 1.27 110.667 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.438 ' O ' ' HD1' ' A' ' 244' ' ' TRP . 16.7 t70 66.27 -88.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.36 1.037 . . . . 2.18 111.369 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.1 t30 47.67 43.19 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.55 0.531 . . . . 2.15 111.301 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 242' ' ' ASP . 20.5 m95 -144.08 159.7 42.17 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.6 -0.687 . . . . 4.59 110.03 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.446 ' NH1' ' HA ' ' A' ' 199' ' ' THR . 6.3 ptp180 -113.36 116.82 46.08 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.569 -0.53 . . . . 6.13 109.569 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.452 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 45.3 Cg_exo -52.96 -86.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.177 2.585 . . . . 3.28 114.826 -167.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.452 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -108.29 99.49 8.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.239 0.542 . . . . 2.98 112.188 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 26.5 mm-40 -110.65 173.64 2.78 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 107.869 -1.16 . . . . 4.32 107.869 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 52.7 Cg_exo -57.25 94.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.798 1.666 . . . . 3.48 111.129 172.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.61 ' HG ' ' N ' ' A' ' 251' ' ' LYS . 1.6 pt? -64.34 -56.96 10.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.764 -0.653 . . . . 4.63 111.452 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.621 ' HD2' ' CD1' ' A' ' 193' ' ' TYR . 62.6 mmtt -122.46 -10.23 8.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.934 -0.306 . . . . 5.34 111.229 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.93 -48.19 0.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.152 0.981 . . . . 4.64 111.844 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -89.17 -80.78 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.699 0.285 . . . . 6.11 110.246 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -157.53 156.55 32.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.513 -0.551 . . . . 3.08 109.513 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 11.5 tt -112.8 148.72 15.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.637 0.256 . . . . 2.6 110.432 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.1 153.47 20.26 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.222 0.534 . . . . 2.63 111.158 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -131.01 171.44 13.23 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.153 -0.93 . . . . 1.71 109.032 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.5 p -163.46 98.8 0.91 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.985 0.421 . . . . 2.21 110.783 173.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.03 102.43 6.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.732 0.777 . . . . 4.31 109.963 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 17.1 pttm . . . . . 0 C--O 1.248 0.982 0 CA-C-N 115.007 -0.997 . . . . 4.49 110.226 -174.558 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 109.896 -0.409 . . . . 17.49 109.896 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 t -79.52 131.86 36.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.068 0.461 . . . . 15.32 110.741 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -116.72 13.19 15.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.841 -0.618 . . . . 15.81 109.684 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.425 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 5.5 p80 -134.44 146.26 49.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.311 -0.859 . . . . 14.19 110.411 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.464 ' H ' ' HA ' ' A' ' 13' ' ' PRO . 95.4 m95 60.77 25.98 15.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.853 0.835 . . . . 14.91 109.802 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.697 ' O ' ' HA2' ' A' ' 12' ' ' GLY . . . -164.58 -170.68 29.86 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 109.565 -1.414 . . . . 10.79 109.565 -177.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 243' ' ' ASN . 57.0 m-85 -71.84 97.72 1.86 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.346 0.573 . . . . 11.39 109.783 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.15 -105.21 0.2 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.888 -0.672 . . . . 9.0 112.357 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 97.1 mttt -88.01 150.73 23.25 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.254 0.464 . . . . 9.76 112.254 -175.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 58.49 -100.61 0.11 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.332 -0.849 . . . . 11.19 111.33 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.428 ' HB3' ' CG ' ' A' ' 200' ' ' PRO . 10.3 p30 -126.16 -1.35 7.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.133 0.492 . . . . 10.8 110.111 176.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 6' ' ' GLY . . . 156.38 -78.66 0.19 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.287 -0.87 . . . . 8.82 111.01 -172.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HA ' ' H ' ' A' ' 5' ' ' TRP . 5.9 Cg_exo -80.25 125.1 5.65 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.488 2.126 . . . . 7.87 111.265 172.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 4' ' ' HIS . 10.6 pt-20 -80.38 0.58 32.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.398 . . . . 10.62 111.499 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -119.48 22.3 11.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.903 0.859 . . . . 9.87 108.712 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.1 t90 -66.3 -25.49 66.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.404 -1.271 . . . . 8.48 110.163 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 19.4 p80 -66.76 -4.88 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.583 -0.735 . . . . 7.13 112.194 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -88.38 -30.9 19.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.878 0.371 . . . . 9.68 110.22 173.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -92.62 -38.2 12.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 7.89 110.142 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -144.56 75.55 14.79 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.164 -0.925 . . . . 7.17 108.881 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.503 ' O ' HG22 ' A' ' 22' ' ' ILE . 70.9 Cg_exo -39.45 -82.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.269 3.313 . . . . 7.76 114.833 -169.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 21' ' ' PRO . 7.8 tp 51.52 9.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.235 1.014 . . . . 5.83 112.605 -176.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.03 -16.54 59.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.196 0.522 . . . . 5.44 110.465 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -85.42 16.44 3.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.722 -0.672 . . . . 7.78 110.265 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.38 31.7 0.12 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.594 -0.812 . . . . 5.01 113.222 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.71 168.52 9.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.989 0.395 . . . . 7.09 110.031 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' CZ ' ' HE2' ' A' ' 251' ' ' LYS . 2.4 ptp180 -156.0 125.9 6.47 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.237 -1.023 . . . . 5.13 108.237 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.411 HE21 HG21 ' A' ' 199' ' ' THR . 35.0 tt0 -150.21 65.96 0.96 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.462 -0.495 . . . . 7.12 111.921 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 248' ' ' GLN . 14.4 m -47.66 113.26 2.51 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.2 0.445 . . . . 3.94 112.2 171.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.2 28.78 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.742 2.961 . . . . 4.52 111.375 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.46 -174.22 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.197 -0.91 . . . . 4.54 111.338 -166.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -83.77 140.73 31.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.094 -0.503 . . . . 2.88 109.821 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 108' ' ' THR . 24.7 mm -71.41 128.24 34.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.981 0.896 . . . . 2.32 111.895 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 36' ' ' HIS . 23.0 t70 -43.98 156.13 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.367 -1.742 . . . . 2.82 114.083 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' THR . 13.3 t -55.69 19.35 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.618 1.967 . . . . 2.24 113.434 172.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.613 ' H ' ' C ' ' A' ' 34' ' ' ASP . 33.5 p-80 -47.33 1.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.171 1.789 . . . . 4.54 114.663 -176.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 35' ' ' THR . 2.6 m -72.28 27.81 0.05 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.613 0.765 . . . . 3.06 109.086 163.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 36' ' ' HIS . . . -56.79 164.85 1.36 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.733 1.213 . . . . 1.72 112.884 -163.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.94 139.92 50.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.805 -1.088 . . . . 3.69 110.845 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' HB2' ' H ' ' A' ' 259' ' ' PHE . 7.9 p90 -59.93 123.76 18.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.141 -0.936 . . . . 4.64 112.241 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -86.72 133.16 40.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 2.27 110.618 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.84 -14.17 11.31 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.803 2.336 . . . . 2.15 114.354 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.9 p -93.11 -2.46 55.44 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.577 -0.449 . . . . 4.29 111.063 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.29 154.53 17.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.237 -0.438 . . . . 4.74 110.3 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HE3' HD11 ' A' ' 47' ' ' LEU . 61.9 tttp -115.44 106.89 50.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 3.77 109.935 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 52.8 Cg_exo -56.1 120.07 7.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.614 2.21 . . . . 2.36 112.089 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' PRO . 12.7 mt -169.99 116.92 0.55 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.432 0.901 . . . . 2.55 113.432 -173.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.411 ' HB3' HD11 ' A' ' 79' ' ' LEU . 66.6 m -157.75 79.55 0.86 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.562 -0.903 . . . . 2.38 108.562 152.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.72 95.12 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.354 0.872 . . . . 1.59 113.354 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 39.7 m -142.23 85.44 1.92 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 121.439 1.927 . . . . 1.45 109.267 155.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -134.18 19.14 3.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.208 -0.308 . . . . 3.62 111.052 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.73 -28.61 68.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 2.48 111.381 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 39.2 mt-30 -110.0 13.7 23.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.354 . . . . 2.24 111.634 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.1 127.01 29.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.8 111.383 -174.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.2 m -116.09 115.24 25.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.213 -0.449 . . . . 1.06 110.875 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 176' ' ' THR . 5.6 m -84.34 153.54 23.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.196 -0.456 . . . . 1.26 109.795 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.2 mt -117.73 -57.23 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.74 111.926 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -170.01 164.63 9.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 3.17 111.436 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.2 tt -127.08 143.84 39.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.436 -0.802 . . . . 0.64 109.874 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 172' ' ' SER . 20.6 tp -144.75 121.14 10.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.955 0.354 . . . . 0.96 111.955 -173.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -68.5 109.1 3.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.967 -0.56 . . . . 1.49 109.495 168.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -141.4 70.63 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.786 -0.766 . . . . 1.83 112.766 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.67 -65.1 0.33 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.765 -1.207 . . . . 1.64 112.879 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -128.39 -11.92 5.08 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.948 -0.301 . . . . 3.33 111.473 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.96 -173.2 3.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 1.38 110.986 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.52 88.41 2.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 2.74 108.881 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.09 114.39 15.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.473 -0.785 . . . . 1.76 110.285 -171.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 5.5 p -94.1 124.13 46.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.887 -0.597 . . . . 1.15 110.184 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.87 132.62 40.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.867 -0.606 . . . . 2.02 111.604 -174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.25 152.63 22.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.184 -0.916 . . . . 1.66 109.784 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.76 129.4 45.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 1.33 109.828 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.09 63.97 1.4 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.89 -1.05 . . . . 2.65 109.961 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 p -79.91 -3.21 47.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.368 -0.833 . . . . 1.61 110.54 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.484 ' OE1' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -154.28 177.69 10.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.053 -1.462 . . . . 2.35 107.053 175.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.9 79.06 0.21 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.247 0.476 . . . . 1.92 111.5 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HE2' ' OE1' ' A' ' 74' ' ' GLN . 61.4 mttm -102.49 -66.13 0.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.597 -0.274 . . . . 1.77 110.682 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.01 84.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.391 0.615 . . . . 0.76 110.06 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 50' ' ' SER . 17.8 m -115.25 150.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 1.27 110.467 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 48' ' ' SER . 28.6 tp -100.6 124.6 46.4 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.978 -0.555 . . . . 1.29 110.413 -178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -125.67 133.4 52.19 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.718 -0.845 . . . . 2.54 108.718 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' CB ' ' A' ' 47' ' ' LEU . . . -149.93 170.79 30.0 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 119.477 -0.624 . . . . 1.31 111.666 -170.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.36 -146.69 0.0 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 123.859 0.388 . . . . 1.9 113.161 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.39 119.81 6.43 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 121.564 1.51 . . . . 2.91 111.781 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.1 mt -157.01 -178.07 7.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.454 -0.794 . . . . 4.11 109.843 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -127.45 67.2 1.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.338 -0.392 . . . . 4.95 111.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.2 -170.59 14.23 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.635 -0.793 . . . . 2.25 112.904 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.539 ' O ' HG22 ' A' ' 125' ' ' THR . 30.7 m -105.65 134.97 47.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 1.91 110.162 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' A' ' 139' ' ' GLY . 33.1 m-85 -114.87 119.37 36.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.461 -0.336 . . . . 3.7 110.428 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HD3' ' CB ' ' A' ' 125' ' ' THR . 39.6 mtp180 -91.93 143.33 26.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.376 -0.375 . . . . 3.54 111.085 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 tt -88.61 128.84 35.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.642 -0.503 . . . . 1.14 109.642 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.441 HG23 ' HG2' ' A' ' 92' ' ' GLN . 13.1 tt -113.62 -34.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 1.68 110.509 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.546 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 5.3 pt20 -165.44 174.86 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.55 . . . . 1.55 109.54 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 119' ' ' HIS . 42.6 p90 -155.32 156.64 35.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.86 110.712 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -147.2 161.15 41.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.785 -0.643 . . . . 0.93 109.346 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' A' ' 118' ' ' LEU . 69.1 m-85 -107.06 166.7 10.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 3.17 111.002 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.41 ' HD1' ' CG ' ' A' ' 117' ' ' GLU . 4.6 m80 -128.99 146.62 50.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.464 -1.68 . . . . 1.68 106.464 172.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 242' ' ' ASP . 8.3 m-90 -133.53 -169.66 2.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.434 0.561 . . . . 5.18 111.388 -170.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.42 24.99 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.721 -1.351 . . . . 2.13 109.721 170.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.1 t -70.89 -15.07 62.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.128 0.964 . . . . 2.9 110.478 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.2 mt -128.86 150.49 50.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.881 -0.785 . . . . 3.03 108.881 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.82 6.36 2.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.285 0.476 . . . . 3.85 112.285 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.35 24.78 6.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.509 -0.853 . . . . 1.94 112.455 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 18.0 pt20 -158.67 162.76 37.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.995 -0.372 . . . . 2.45 109.995 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.7 -18.91 16.7 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.316 -0.945 . . . . 1.47 112.281 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 99.2 p -69.02 -34.6 75.5 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.258 -0.177 . . . . 2.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 107' ' ' HIS . 1.0 OUTLIER 71.03 -173.13 0.17 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.426 -0.953 . . . . 3.72 108.426 -175.109 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.593 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 1.8 m-70 57.86 37.75 27.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.647 0.736 . . . . 3.52 109.723 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.603 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.3 123.46 29.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.669 -1.151 . . . . 2.52 112.404 -173.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.65 102.37 13.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.237 -0.892 . . . . 2.48 110.469 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.86 55.08 5.62 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.673 -0.694 . . . . 2.8 109.663 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 68.27 24.31 7.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.035 -0.984 . . . . 4.98 112.22 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -93.21 90.49 6.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.772 0.32 . . . . 3.23 110.53 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.59 146.74 27.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 2.82 110.437 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 94.5 m-85 -100.77 -168.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.381 -0.372 . . . . 1.62 110.107 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.16 34.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.723 0.297 . . . . 1.03 111.725 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.84 168.24 21.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.387 -0.369 . . . . 0.75 110.5 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.41 ' CG ' ' HD1' ' A' ' 96' ' ' HIS . 5.4 tp10 -124.29 151.89 43.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 1.58 109.485 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.531 HD13 ' CE2' ' A' ' 95' ' ' PHE . 57.3 tp -115.61 147.72 40.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.233 -0.284 . . . . 1.07 110.233 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 93' ' ' PHE . 1.6 t-160 -121.75 114.91 21.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.393 -0.595 . . . . 1.77 109.393 172.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.58 91.58 4.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.843 0.354 . . . . 0.93 110.12 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.649 ' HA ' ' HB1' ' A' ' 141' ' ' ALA . 46.6 t -65.68 117.39 6.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.365 0.602 . . . . 0.61 111.701 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 76.8 m80 -138.66 125.58 21.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.089 -1.078 . . . . 2.13 108.089 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.678 ' CD1' ' HB2' ' A' ' 130' ' ' PHE . 88.4 m95 -110.82 144.91 39.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.622 -0.431 . . . . 4.26 111.258 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.449 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 56.4 t30 -62.69 100.79 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.419 -0.81 . . . . 2.02 110.317 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 87' ' ' THR . 10.3 t -70.63 -24.34 62.71 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.065 0.765 . . . . 2.34 113.065 -169.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -68.14 -5.14 16.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.429 0.529 . . . . 3.35 112.429 -174.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -95.42 17.49 14.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.788 0.804 . . . . 3.1 109.543 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.22 -3.58 10.45 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.491 -1.231 . . . . 2.37 115.786 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -173.5 145.19 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.577 1.189 . . . . 3.93 109.949 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.678 ' HB2' ' CD1' ' A' ' 123' ' ' TRP . 25.1 p90 -67.95 -43.12 79.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.854 -0.612 . . . . 3.0 111.705 -176.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.15 -28.81 73.43 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.072 -0.585 . . . . 2.15 112.182 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -81.27 -34.75 31.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.496 -0.557 . . . . 3.43 109.496 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.39 66.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.745 -0.661 . . . . 1.76 111.63 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 130' ' ' PHE . 42.1 t -60.05 -19.39 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.297 0.57 . . . . 2.77 110.764 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.34 16.73 22.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 3.55 110.655 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -112.83 118.49 44.68 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.815 0.341 . . . . 3.02 111.133 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.547 ' HA ' ' SG ' ' A' ' 205' ' ' CYS . 25.0 Cg_exo -64.18 -20.61 67.31 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.691 2.261 . . . . 1.6 111.965 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.04 28.39 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.992 0.738 . . . . 2.29 112.992 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 88' ' ' TYR . . . 128.34 94.49 0.8 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.827 -1.654 . . . . 1.22 114.609 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 20.8 mt -97.0 -175.85 3.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.914 -0.772 . . . . 1.57 108.914 167.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 121' ' ' VAL . . . -71.2 124.85 25.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.581 0.705 . . . . 1.38 110.372 -167.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.1 m -77.93 164.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.506 -1.225 . . . . 1.73 112.331 -167.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.7 tp -85.54 143.86 28.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.665 -1.152 . . . . 2.42 111.264 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 170.94 42.69 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.782 -1.099 . . . . 0.86 112.186 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 214' ' ' PRO . 11.2 mt -86.63 142.9 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.572 0.225 . . . . 0.76 110.76 -176.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -63.13 157.09 23.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 1.2 111.532 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.4 mp -113.01 137.46 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.88 110.686 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -129.76 143.41 50.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.95 -0.759 . . . . 2.03 108.95 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 24.1 t -108.66 81.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.312 -0.555 . . . . 1.27 112.281 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 151' ' ' SER . . . -165.95 67.17 0.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.377 -0.916 . . . . 1.53 112.342 165.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 150' ' ' GLY . 19.3 t 157.95 126.43 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 107.541 -1.281 . . . . 1.54 107.541 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 138.45 41.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.74 -0.384 . . . . 0.78 110.671 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -104.89 98.41 15.31 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.474 -0.565 . . . . 1.22 109.474 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.59 -24.44 69.85 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.599 2.199 . . . . 1.05 112.719 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.2 6.55 79.14 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.865 -0.683 . . . . 0.7 113.104 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -110.67 -13.99 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.77 110.904 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.76 -36.53 76.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 1.41 111.518 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -49.18 -44.19 42.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.713 0.292 . . . . 2.86 111.165 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.21 -42.01 37.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 1.38 110.437 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 48.7 t -63.74 -39.58 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.813 -0.631 . . . . 1.11 111.576 -176.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -69.98 -24.31 63.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.712 0.291 . . . . 1.22 111.698 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.87 -11.91 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.001 0.371 . . . . 1.41 112.001 -174.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.9 pp -65.74 -17.07 64.36 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.963 -0.46 . . . . 1.39 111.559 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.403 ' N ' HD12 ' A' ' 163' ' ' LEU . 16.7 m-20 -66.42 -28.06 68.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 2.31 110.727 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.2 m -84.36 0.14 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.387 -0.369 . . . . 1.4 111.387 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.455 ' CG1' ' HA ' ' A' ' 163' ' ' LEU . 18.6 pt -137.97 57.1 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.85 109.337 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -74.71 -40.23 61.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.828 -0.623 . . . . 1.59 111.367 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.7 p -115.97 158.0 23.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.982 0.42 . . . . 0.77 111.647 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.21 132.76 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.644 -0.707 . . . . 2.29 110.484 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.52 -22.28 26.76 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.551 -0.833 . . . . 0.85 111.726 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -87.62 142.04 28.15 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.197 0.522 . . . . 1.7 110.736 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 60' ' ' LEU . 6.7 p -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.227 -0.897 . . . . 1.37 110.368 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -139.26 134.32 32.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.548 -0.538 . . . . 0.61 109.548 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.28 133.68 44.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.069 0.462 . . . . 1.8 109.918 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -142.07 81.36 1.75 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.572 -0.74 . . . . 1.04 109.36 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 56' ' ' SER . 7.1 m -104.97 162.22 13.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.468 -0.333 . . . . 1.17 111.317 -177.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.7 57.16 3.3 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.42 0.688 . . . . 1.77 111.989 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -126.76 132.25 51.12 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.531 -0.544 . . . . 3.99 109.531 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 5.3 p-10 -107.87 126.89 28.78 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.442 -0.345 . . . . 2.51 110.365 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 22.4 Cg_exo -66.42 -3.84 9.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.417 2.745 . . . . 1.26 113.333 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -58.98 -31.82 69.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 2.76 111.04 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -68.6 -30.58 72.97 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.141 -0.552 . . . . 1.12 112.361 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 81.3 mt -72.7 -34.33 67.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.014 0.435 . . . . 1.73 110.334 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 mt -71.43 118.75 68.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 3.45 110.51 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 184' ' ' LEU . 8.9 Cg_exo -73.9 -165.19 0.24 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.028 2.485 . . . . 2.08 113.289 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.92 -61.97 1.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.278 0.473 . . . . 3.23 112.278 -173.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.457 ' HB2' ' CG ' ' A' ' 213' ' ' GLU . 34.7 m -75.45 129.43 37.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 1.66 110.514 -176.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 46' ' ' PRO . 39.6 tp -105.43 63.43 0.69 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.016 -0.538 . . . . 1.99 110.082 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 211' ' ' LEU . 21.9 m-20 -109.95 145.64 36.57 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.374 -0.973 . . . . 1.81 108.374 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -136.47 149.27 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.607 -0.837 . . . . 5.01 112.936 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.573 ' HB3' ' CG2' ' A' ' 255' ' ' ILE . 6.8 m-90 -93.78 141.68 28.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.49 -1.232 . . . . 3.93 108.445 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 4.9 t -136.8 109.92 7.76 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.456 0.646 . . . . 2.13 112.498 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.562 ' CD2' ' HD2' ' A' ' 194' ' ' PRO . 54.9 t80 -139.22 138.21 20.42 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.627 -0.715 . . . . 5.21 110.506 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 48.7 Cg_exo -57.47 128.49 29.61 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.315 2.01 . . . . 2.12 111.494 172.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 208' ' ' TRP . . . -122.52 157.22 17.14 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.961 -0.637 . . . . 1.75 113.456 -171.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 13.5 m -92.63 119.05 31.66 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 2.99 109.733 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.99 -44.49 63.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.284 -0.416 . . . . 4.75 111.187 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.41 ' O ' ' HB ' ' A' ' 199' ' ' THR . 7.1 p -113.37 -40.11 3.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.433 -0.349 . . . . 5.1 111.027 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.547 ' O ' HD23 ' A' ' 202' ' ' LEU . 87.3 m 106.43 -60.13 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 124.874 1.359 . . . . 5.53 113.107 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 199' ' ' THR . 51.7 Cg_exo -52.8 -51.53 10.91 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.053 1.835 . . . . 5.83 115.037 -176.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.53 -7.86 22.09 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.377 1.385 . . . . 4.78 112.358 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 199' ' ' THR . 67.2 mt 65.78 56.75 0.88 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.829 -1.078 . . . . 3.84 110.628 175.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 196' ' ' SER . 16.2 tp -95.66 118.02 31.57 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.616 -0.513 . . . . 2.96 109.616 -176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.85 28.11 8.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.193 0.521 . . . . 3.37 111.076 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 137' ' ' PRO . 68.3 m -80.06 -4.8 54.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.822 -0.626 . . . . 2.15 111.446 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 48.4 t -90.18 137.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.383 -0.229 . . . . 1.26 110.383 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.2 m -105.5 102.59 12.05 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.885 -0.413 . . . . 2.08 109.885 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.548 ' O ' ' HA ' ' A' ' 192' ' ' THR . 43.2 m0 -72.19 100.84 2.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.245 -0.28 . . . . 5.53 110.245 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' TRP . 65.6 mt -105.51 99.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.211 -0.663 . . . . 1.63 109.211 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.6 t -111.21 122.46 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.244 -0.435 . . . . 1.62 110.67 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 189' ' ' ASP . 3.7 mm? -69.28 134.09 48.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.328 0.585 . . . . 1.73 110.127 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.562 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 32.6 ttpt -57.43 -40.38 78.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.676 -1.147 . . . . 2.98 111.509 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.457 ' CG ' ' HB2' ' A' ' 187' ' ' SER . 22.2 mm-40 -76.27 110.92 12.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 1.47 110.795 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 145' ' ' ILE . 61.3 Cg_endo -74.91 154.19 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.623 2.216 . . . . 0.96 112.025 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.15 110.94 10.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.103 -0.499 . . . . 1.25 109.902 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.525 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 79.2 p -93.18 118.66 31.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.741 -0.466 . . . . 1.29 109.741 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 30.8 m -120.98 157.78 23.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.874 -0.603 . . . . 1.02 110.539 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.3 t -90.58 157.96 17.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.071 -0.513 . . . . 1.08 109.978 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.672 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 20.3 m -55.09 -46.59 75.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 1.33 110.732 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -52.65 -34.87 53.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.058 -0.519 . . . . 2.51 111.603 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -71.14 -50.11 36.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.237 -0.438 . . . . 0.7 110.203 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -71.88 -22.48 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 111.839 0.311 . . . . 1.36 111.839 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 219' ' ' SER . 83.0 mt -64.48 -43.83 92.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.81 -0.441 . . . . 1.03 109.81 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.446 ' HB3' HD11 ' A' ' 163' ' ' LEU . 67.4 mttm -68.72 -29.56 68.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 1.75 111.382 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.62 -30.37 64.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.53 . . . . 2.47 109.907 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -80.06 -2.68 45.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.741 -0.663 . . . . 3.04 110.346 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 33.4 mmtp -90.41 -6.52 54.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 2.31 110.064 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.61 146.68 26.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.887 -0.597 . . . . 0.95 110.807 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.588 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 8.8 m120 -118.79 125.83 50.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.659 -0.701 . . . . 1.13 109.521 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -78.76 -7.74 58.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 3.74 111.38 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.588 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.2 p-10 -77.58 162.71 26.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.831 0.348 . . . . 1.62 110.236 171.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -83.8 159.89 36.73 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.098 -0.801 . . . . 1.16 111.098 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.86 134.27 56.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 3.56 110.957 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 86.67 11.61 70.77 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.776 -0.647 . . . . 2.08 112.922 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -112.93 158.61 37.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.69 -0.485 . . . . 2.59 109.69 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -52.55 122.81 11.5 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.593 2.196 . . . . 1.36 111.819 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 120.18 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.381 -0.827 . . . . 3.4 112.383 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -127.82 136.55 51.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.329 -0.989 . . . . 2.47 108.329 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.3 mt -87.12 133.38 33.63 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.758 -0.46 . . . . 2.14 109.758 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 51.8 ttm -75.12 88.28 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.099 0.476 . . . . 1.68 109.757 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.15 167.36 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.861 -0.792 . . . . 1.27 108.861 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' TRP . 0.7 OUTLIER 61.75 -90.85 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.402 0.439 . . . . 2.18 110.814 -174.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 54.4 m-80 43.13 45.8 4.82 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.271 0.558 . . . . 2.15 111.923 -175.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.442 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 60.9 t-105 -153.14 153.06 32.02 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.331 -0.85 . . . . 4.59 108.979 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -100.58 130.35 25.75 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.089 -0.337 . . . . 6.13 110.089 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.27 53.33 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.769 2.313 . . . . 3.28 111.937 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -114.14 121.79 44.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.401 -0.818 . . . . 2.98 109.978 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 33' ' ' ILE . 27.9 mp0 -90.3 152.43 45.69 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.226 -0.443 . . . . 4.32 110.84 -176.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.69 141.67 15.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.598 2.866 . . . . 3.48 112.807 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 251' ' ' LYS . 0.6 OUTLIER -40.59 -55.78 2.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.976 -1.011 . . . . 4.63 113.699 -171.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.546 ' N ' HD12 ' A' ' 250' ' ' LEU . 69.6 mmtt -114.33 -4.96 12.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.95 0.352 . . . . 5.34 111.95 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.1 p30 34.22 65.52 0.31 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.132 0.895 . . . . 4.64 112.345 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -70.85 -90.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.85 -0.34 . . . . 6.11 111.08 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -159.64 154.97 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.178 -0.675 . . . . 3.08 109.178 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.573 ' CG2' ' HB3' ' A' ' 191' ' ' TRP . 13.7 mt -118.78 113.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.159 -0.311 . . . . 2.6 110.159 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 62.3 pttt -76.85 165.76 24.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 2.63 110.706 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 191' ' ' TRP . . . -126.0 168.54 13.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 1.71 109.975 -175.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.9 p -138.07 95.99 3.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.201 0.524 . . . . 2.21 111.242 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.475 ' H ' ' HB2' ' A' ' 40' ' ' TYR . 49.9 t80 -136.91 119.06 15.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 4.31 110.304 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.612 -0.708 . . . . 4.49 109.577 175.601 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.63 0.252 . . . . 17.49 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.8 t -138.35 156.96 47.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.904 0.383 . . . . 15.32 110.628 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -126.07 71.64 1.26 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.096 0.474 . . . . 15.81 110.536 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -132.87 100.69 4.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 14.19 109.686 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -132.47 154.13 50.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.171 -0.468 . . . . 14.91 110.759 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.74 -170.33 29.55 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 109.908 -1.277 . . . . 10.79 109.908 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 86.5 t80 -70.19 96.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.073 0.936 . . . . 11.39 108.571 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 12' ' ' GLY . . . 87.21 151.35 20.54 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.849 -0.9 . . . . 9.0 110.849 -172.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 56.9 mttp -45.87 124.2 5.1 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.986 0.735 . . . . 9.76 112.986 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.3 t60 66.79 -78.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.021 -1.445 . . . . 11.19 112.238 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -124.04 -12.89 7.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.953 -0.299 . . . . 10.8 111.53 -172.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' A' ' 7' ' ' TYR . . . 165.26 -67.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.389 -1.386 . . . . 8.82 113.989 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HB3' ' HB2' ' A' ' 16' ' ' TRP . 37.9 Cg_endo -66.63 121.97 9.3 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.571 1.514 . . . . 7.87 111.897 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 36.2 tt0 -86.04 -41.98 14.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 10.62 110.36 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -116.95 -31.0 5.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.155 -0.475 . . . . 9.87 111.156 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 13' ' ' PRO . 9.2 m0 -51.96 -35.65 46.82 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.895 0.702 . . . . 8.48 112.895 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -67.64 -13.91 62.49 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.677 -0.409 . . . . 7.13 111.095 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -83.27 -46.89 12.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.195 -0.457 . . . . 9.68 110.267 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.18 -22.27 59.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.036 -0.529 . . . . 7.89 110.634 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.69 88.9 17.22 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.656 -0.868 . . . . 7.17 108.656 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.66 -14.36 35.41 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.12 2.547 . . . . 7.76 113.418 -174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 22' ' ' ILE . 12.3 tt -108.13 22.62 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.852 0.834 . . . . 5.83 110.415 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -73.61 -8.1 54.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.055 -0.52 . . . . 5.44 111.113 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -73.75 20.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.094 0.473 . . . . 7.78 111.256 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 23' ' ' ALA . . . -145.55 43.38 0.93 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.942 -0.863 . . . . 5.01 110.942 177.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HA ' HD21 ' A' ' 197' ' ' LEU . 40.8 mt-10 -56.65 141.82 42.14 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.187 0.518 . . . . 7.09 111.935 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -151.82 129.85 11.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.069 -0.969 . . . . 5.13 110.126 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 244' ' ' TRP . 23.2 mm-40 -143.37 -83.55 0.16 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.322 -0.992 . . . . 7.12 108.322 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.3 m -78.97 104.92 2.46 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.54 -0.911 . . . . 3.94 108.54 164.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 28' ' ' GLN . 52.1 Cg_endo -71.29 -31.34 14.42 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.246 1.964 . . . . 4.52 112.474 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.32 161.81 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.376 0.608 . . . . 4.54 111.305 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.458 ' H ' HD23 ' A' ' 250' ' ' LEU . 5.9 m-20 -82.93 140.63 32.71 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.951 -1.129 . . . . 2.88 107.951 168.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 59.9 mt -82.99 85.1 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.543 0.687 . . . . 2.32 109.381 -176.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -102.08 112.19 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.188 -0.914 . . . . 2.82 110.397 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m -54.85 -31.67 59.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.369 -0.832 . . . . 2.24 112.643 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -74.67 -38.6 62.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.126 0.488 . . . . 4.54 110.421 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 m -79.13 -29.26 43.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.737 -0.665 . . . . 3.06 111.083 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.22 116.2 6.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.72 110.695 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -92.42 129.49 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.146 -0.479 . . . . 3.69 109.921 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.3 p90 -63.2 121.91 14.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 4.64 110.256 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 19.7 t70 -105.65 125.78 32.44 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.54 -0.755 . . . . 2.27 109.397 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.448 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 15.5 Cg_exo -69.82 60.1 1.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.64 2.227 . . . . 2.15 111.789 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.7 m -63.5 -17.45 62.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 4.29 111.713 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 42' ' ' PRO . 80.5 mt 61.56 -86.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.394 0.677 . . . . 4.74 112.386 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 46' ' ' PRO . 85.7 tttt -65.66 130.79 94.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.916 0.389 . . . . 3.77 111.517 -175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 56.9 Cg_endo -71.2 171.01 16.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.819 2.346 . . . . 2.36 111.23 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.78 131.43 40.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.734 -0.469 . . . . 2.55 109.734 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.4 m -108.78 115.12 29.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.949 -0.389 . . . . 2.38 109.949 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 22.0 t -123.0 110.77 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.285 -0.416 . . . . 1.59 110.286 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.0 m -92.18 90.28 7.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.525 -0.546 . . . . 1.45 109.525 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.0 9.84 38.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 3.62 111.556 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.05 -37.03 81.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.359 -0.382 . . . . 2.48 111.047 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -97.26 27.05 4.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.293 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.33 56.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.146 0.498 . . . . 0.8 112.057 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 m -146.87 106.03 3.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.828 -0.624 . . . . 1.06 110.178 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.3 p -89.01 158.8 17.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.488 -0.56 . . . . 1.26 109.488 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.17 -56.68 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.178 0.436 . . . . 0.74 112.178 -173.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.57 157.75 32.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.909 -0.317 . . . . 3.17 110.728 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -114.26 136.99 49.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.348 -0.612 . . . . 0.64 109.348 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 172' ' ' SER . 64.9 tp -132.55 146.55 52.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.171 0.51 . . . . 0.96 111.306 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -104.1 111.54 24.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.591 -0.732 . . . . 1.49 109.354 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 HD23 ' A' ' 60' ' ' LEU . 55.3 m-80 -109.44 67.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.385 -0.526 . . . . 1.83 110.487 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.91 -51.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.752 0 O-C-N 124.808 1.317 . . . . 1.64 115.477 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -106.44 -26.46 11.43 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 122.487 0.315 . . . . 3.33 110.623 -172.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.68 171.38 16.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.562 -0.29 . . . . 1.38 110.51 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 95' ' ' PHE . 13.1 p90 -130.24 114.55 15.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.143 -0.688 . . . . 2.74 109.143 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -116.89 145.6 43.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.576 -0.738 . . . . 1.76 111.562 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.13 119.33 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.666 -0.697 . . . . 1.15 109.445 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.93 125.64 29.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.804 -0.634 . . . . 2.02 110.049 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -105.69 151.2 24.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.703 -0.68 . . . . 1.66 109.242 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -83.49 106.35 15.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.745 0.307 . . . . 1.33 110.33 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -124.36 57.44 1.24 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.982 0.896 . . . . 2.65 110.594 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -92.98 -5.28 51.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.185 -0.916 . . . . 1.61 109.327 169.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -158.72 169.82 23.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.878 -1.056 . . . . 2.35 108.757 -178.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -78.17 72.71 4.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 1.92 111.17 -174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 65.6 mttm -81.1 -53.25 6.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.986 -0.552 . . . . 1.77 110.458 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -119.75 112.18 18.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.096 -0.502 . . . . 0.76 110.09 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 91.8 t -113.4 137.04 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.632 -0.713 . . . . 1.27 110.496 -176.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tt -129.19 113.6 15.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.134 -0.321 . . . . 1.29 110.134 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -147.84 125.01 11.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 2.54 110.457 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.93 -177.77 19.62 Favored Glycine 0 C--O 1.219 -0.793 0 CA-C-O 118.937 -0.924 . . . . 1.31 111.151 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.83 -130.18 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 O-C-N 124.971 1.041 . . . . 1.9 115.498 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.61 169.49 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.68 2.92 . . . . 2.91 114.217 -170.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -31.07 102.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.268 1.509 . . . . 4.11 114.879 -147.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 8.4 p-10 -107.03 -100.9 0.35 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.19 -1.823 . . . . 4.95 112.793 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.561 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 94.05 152.73 29.62 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.385 -1.086 . . . . 2.25 110.385 -165.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.629 ' HB ' ' OG1' ' A' ' 125' ' ' THR . 14.5 m -69.67 113.9 7.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.932 0.866 . . . . 1.91 110.819 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.633 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 55.8 m-85 -110.19 107.12 16.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.365 . . . . 3.7 111.654 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 97.5 mtt180 -75.91 137.88 40.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 3.54 110.992 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.75 125.55 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.505 -0.554 . . . . 1.14 109.505 173.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 92' ' ' GLN . 4.5 tt -111.57 -38.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.952 0.406 . . . . 1.68 110.973 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 91' ' ' ILE . 24.8 pt20 -164.98 158.34 16.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.7 -0.482 . . . . 1.55 109.7 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -147.86 140.69 24.79 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.163 -0.31 . . . . 0.86 110.163 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -135.21 157.63 46.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.412 -0.358 . . . . 0.93 110.654 -174.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 54.6 m-85 -113.77 169.16 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.42 -0.355 . . . . 3.17 110.495 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.422 ' CG ' ' HE1' ' A' ' 244' ' ' TRP . 0.3 OUTLIER -137.63 173.1 12.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.087 -0.708 . . . . 1.68 109.087 174.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.475 ' CZ3' ' HB ' ' A' ' 222' ' ' VAL . 30.8 t-105 -151.33 127.03 10.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.857 -0.423 . . . . 5.18 109.857 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -94.24 140.85 15.25 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.093 -0.575 . . . . 2.13 112.255 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 t -46.82 -43.51 18.53 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.641 0.376 . . . . 2.9 111.863 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 103' ' ' GLN . 45.1 mt -122.78 152.71 40.39 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.532 -0.544 . . . . 3.03 109.532 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.05 -7.4 3.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.818 -0.628 . . . . 3.85 112.187 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.76 29.56 2.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.76 . . . . 1.94 112.505 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 7.6 tp60 -159.44 139.88 12.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.925 0.363 . . . . 2.45 110.873 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.579 ' O ' ' HB2' ' A' ' 244' ' ' TRP . . . 94.57 -28.99 9.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.861 -0.685 . . . . 1.47 112.402 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.457 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 1.2 m -89.55 -17.9 27.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.469 0.176 . . . . 2.0 111.127 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 60.02 -156.75 0.34 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.388 -0.369 . . . . 3.72 110.689 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.458 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 62.6 m80 63.33 69.37 0.57 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.381 -0.6 . . . . 3.52 109.381 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.436 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 5.6 t -104.09 118.38 36.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.113 0.482 . . . . 2.52 110.53 -167.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 41.0 t -85.54 105.65 14.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.365 -0.976 . . . . 2.48 108.365 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 66.88 -71.53 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.67 0.606 . . . . 2.8 110.652 -171.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -152.05 19.12 0.67 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.817 0.341 . . . . 4.98 110.605 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 108' ' ' THR . 13.9 mmmm -107.75 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.018 -0.537 . . . . 3.23 111.553 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.436 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 54.4 mttm -80.31 156.19 26.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.91 . . . . 2.82 108.544 171.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -93.43 -171.29 2.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.8 0.333 . . . . 1.62 111.189 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.41 -27.36 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 1.03 111.752 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 147' ' ' LEU . . . -153.25 168.74 25.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.617 0.246 . . . . 0.75 110.533 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HG2' ' CE1' ' A' ' 107' ' ' HIS . 13.7 tp10 -151.8 152.6 32.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.372 -0.603 . . . . 1.58 109.372 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 95' ' ' PHE . 38.2 tp -125.79 131.38 52.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.712 0.291 . . . . 1.07 110.963 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 107.72 14.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.77 110.705 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 4.1 mp -102.22 109.55 21.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.105 -0.332 . . . . 0.93 110.105 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.02 129.22 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.188 -0.46 . . . . 0.61 111.49 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 19.0 m-70 -127.39 156.32 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 2.13 109.63 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.415 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 66.1 p-90 -127.49 150.51 49.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 4.26 111.554 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 19.6 t30 -69.21 116.45 9.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.064 -0.971 . . . . 2.02 111.811 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.629 ' OG1' ' HB ' ' A' ' 87' ' ' THR . 53.2 p -63.16 -32.79 74.26 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.655 0.983 . . . . 2.34 113.655 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 60.9 pttt -74.28 -4.56 36.88 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.338 -0.545 . . . . 3.35 111.923 -173.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -91.42 -5.65 54.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.34 0.59 . . . . 3.1 109.546 170.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.1 21.9 19.32 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 115.569 0.987 . . . . 2.37 115.569 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -177.91 133.13 0.16 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.883 0.841 . . . . 3.93 109.802 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.601 ' O ' HG23 ' A' ' 134' ' ' VAL . 40.3 p90 -66.33 -42.97 87.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.633 . . . . 3.0 111.345 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.27 -33.25 86.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.108 -0.568 . . . . 2.15 112.231 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB3' ' CE1' ' A' ' 127' ' ' TYR . 98.1 mttt -74.28 -34.11 63.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.027 -0.36 . . . . 3.43 110.027 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.35 66.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 1.76 110.765 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 130' ' ' PHE . 42.0 t -63.53 -18.25 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.203 0.525 . . . . 2.77 110.761 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -87.68 -9.62 53.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.126 -0.359 . . . . 3.55 111.178 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 205' ' ' CYS . 7.6 tt0 -104.41 126.44 31.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.232 -0.284 . . . . 3.02 110.232 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 73.1 Cg_exo -52.79 -31.2 50.27 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.548 2.832 . . . . 1.6 113.12 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 9.4 m-20 -112.14 28.15 9.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.185 0.517 . . . . 2.29 109.848 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.03 -30.91 24.55 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.826 -0.625 . . . . 1.22 113.408 -172.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 206' ' ' VAL . 91.3 mt -112.21 157.58 20.72 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.574 -0.368 . . . . 1.57 110.3 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.57 123.16 10.45 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.814 -0.439 . . . . 1.38 109.814 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.88 129.88 71.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 116.292 -0.413 . . . . 1.73 110.012 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 209' ' ' ILE . 35.8 tp -90.99 134.24 34.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.904 -0.589 . . . . 2.42 109.835 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -115.41 145.77 18.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.069 -0.586 . . . . 0.86 112.018 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 118' ' ' LEU . 62.4 mt -142.48 122.75 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.528 -0.545 . . . . 0.76 109.528 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.458 ' CZ ' HG11 ' A' ' 210' ' ' VAL . 44.2 m-85 -73.99 141.07 45.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.694 0.283 . . . . 1.2 111.032 -178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 9.0 mp -119.2 121.22 39.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 0.88 110.041 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -116.82 147.74 41.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.109 -0.496 . . . . 2.03 109.798 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 62.1 t -87.07 130.16 37.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.901 0.381 . . . . 1.27 110.863 -174.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.11 -105.29 0.19 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.291 -0.724 . . . . 1.53 111.291 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.2 t -81.89 146.18 29.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 1.54 109.521 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.472 ' CA ' ' HB2' ' A' ' 218' ' ' SER . . . -66.62 152.12 45.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.183 0.515 . . . . 0.78 112.222 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -109.39 102.99 51.56 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.335 -0.848 . . . . 1.22 108.735 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.55 -32.93 65.99 Favored 'Trans proline' 0 N--CA 1.472 0.255 0 C-N-CA 123.095 2.53 . . . . 1.05 112.835 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.18 -15.95 72.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.094 -0.574 . . . . 0.7 113.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.3 tp -99.62 -9.03 23.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.346 0.593 . . . . 0.77 110.298 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -45.49 88.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.502 -0.772 . . . . 1.41 112.19 -173.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 162' ' ' VAL . 13.0 ptmm? -76.68 -27.89 55.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.433 -0.507 . . . . 2.86 111.813 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 p -78.37 -40.34 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.495 -0.482 . . . . 1.38 111.316 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.494 ' HA ' ' HG ' ' A' ' 163' ' ' LEU . 34.5 m -62.45 -28.74 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.197 0.522 . . . . 1.11 110.671 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.83 -30.55 71.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.556 -0.747 . . . . 1.22 111.173 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 158' ' ' LYS . 41.2 t -89.31 -16.33 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.41 111.269 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 160' ' ' VAL . 77.0 mt -56.05 -31.8 63.49 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.229 0.455 . . . . 1.39 112.229 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.88 -30.12 70.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.78 0.324 . . . . 2.31 111.476 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.9 m -84.46 -3.15 58.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.567 -0.288 . . . . 1.4 111.769 -175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 44.5 pt -132.89 29.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.528 0.68 . . . . 0.85 109.312 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -60.06 -27.66 67.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.95 -1.023 . . . . 1.59 112.075 -172.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.8 p -119.54 152.97 36.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.175 0.512 . . . . 0.77 111.598 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -54.39 127.94 29.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.064 -0.971 . . . . 2.29 111.648 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.18 -22.27 31.57 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.588 -0.815 . . . . 0.85 112.849 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -78.56 139.76 38.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.159 0.504 . . . . 1.7 111.307 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB2' HD13 ' A' ' 60' ' ' LEU . 27.4 t -127.06 146.56 50.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.178 -0.919 . . . . 1.37 109.39 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.38 127.08 23.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.438 -0.346 . . . . 0.61 110.08 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.7 132.03 48.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.501 . . . . 1.8 110.45 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.89 80.99 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.845 -0.616 . . . . 1.04 109.596 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 p -102.81 161.16 13.97 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.116 -0.493 . . . . 1.17 111.824 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 12.9 m120 57.04 66.71 1.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.569 -0.742 . . . . 1.77 111.546 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -119.86 139.18 52.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.191 -0.3 . . . . 3.99 110.191 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.509 ' OD1' ' HB3' ' A' ' 181' ' ' ARG . 17.1 t0 -102.0 106.77 49.45 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 2.51 110.938 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.48 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 23.6 Cg_exo -64.81 -15.08 48.5 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.008 2.472 . . . . 1.26 111.924 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.509 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 29.2 ttp180 -68.78 -21.88 64.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.655 -0.702 . . . . 2.76 110.345 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -77.67 -8.8 87.18 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.774 -0.726 . . . . 1.12 111.855 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 97.0 mt -106.11 -18.26 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.997 0.427 . . . . 1.73 109.884 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 83.3 mt -73.28 126.34 90.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 3.45 110.028 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 59.8 Cg_endo -69.73 -176.28 1.43 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.438 2.758 . . . . 2.08 113.637 -173.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.77 -50.48 64.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.297 -0.411 . . . . 3.23 111.879 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 15.4 m -88.68 136.79 32.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.75 0.31 . . . . 1.66 110.367 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 32.2 tp -106.09 64.73 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.706 . . . . 1.99 109.893 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.41 -176.32 3.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.953 -1.128 . . . . 1.81 107.953 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -163.52 154.33 16.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.886 0.766 . . . . 5.01 112.855 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -115.29 146.6 41.34 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.827 -1.175 . . . . 3.93 107.827 170.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 t -108.71 126.84 53.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.096 0.474 . . . . 2.13 111.126 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -133.17 154.08 81.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 5.21 109.989 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.31 129.82 15.45 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.404 2.069 . . . . 2.12 111.77 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -101.79 97.48 1.61 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.792 -0.718 . . . . 1.75 111.455 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 204' ' ' GLU . 15.7 m -83.17 -140.48 0.06 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.91 0.707 . . . . 2.99 112.91 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.588 ' C ' ' H ' ' A' ' 199' ' ' THR . 4.6 pp -50.24 12.73 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 117.029 2.233 . . . . 4.75 117.029 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.411 HG23 HG21 ' A' ' 206' ' ' VAL . 9.8 t -66.79 29.91 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.0 0.905 . . . . 5.1 111.039 174.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.588 ' H ' ' C ' ' A' ' 197' ' ' LEU . 24.2 p -124.18 156.5 66.42 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-N 114.823 -1.08 . . . . 5.53 110.159 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.5 -54.51 5.05 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.222 1.948 . . . . 5.83 114.032 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.58 26.08 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.548 2.165 . . . . 4.78 113.442 -174.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.2 tt 47.25 78.65 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.631 0.772 . . . . 3.84 111.758 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.653 HD13 ' SG ' ' A' ' 205' ' ' CYS . 1.9 pp -152.49 150.06 29.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.176 -0.466 . . . . 2.96 111.659 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 196' ' ' SER . 7.9 pt-20 -87.79 92.67 9.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.555 0.693 . . . . 3.37 111.083 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.653 ' SG ' HD13 ' A' ' 203' ' ' LEU . 93.9 m -138.83 32.84 2.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.804 -0.635 . . . . 2.15 110.709 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 140' ' ' LEU . 95.3 t -125.63 149.05 30.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.732 -0.667 . . . . 1.26 111.187 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.1 m -111.68 107.12 16.12 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.083 -1.08 . . . . 2.08 108.083 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -89.23 115.65 26.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.153 0.501 . . . . 5.53 110.333 -174.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.524 ' O ' HD12 ' A' ' 143' ' ' LEU . 63.5 mt -114.57 116.59 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.603 -0.726 . . . . 1.63 109.68 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.458 HG11 ' CZ ' ' A' ' 146' ' ' PHE . 24.3 t -109.71 129.8 63.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.253 -0.277 . . . . 1.62 110.253 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.73 126.44 29.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.818 0.342 . . . . 1.73 110.555 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -47.5 -24.16 0.78 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.561 0.948 . . . . 2.98 113.561 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 8.6 tp10 -106.81 123.7 37.76 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.644 0.259 . . . . 1.47 110.569 -172.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 213' ' ' GLU . 89.9 Cg_endo -81.77 158.63 18.77 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.671 2.248 . . . . 0.96 112.01 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 41.7 pt -113.97 154.35 15.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.844 0.354 . . . . 1.25 110.326 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.3 m -104.17 130.43 51.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.844 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 18.6 m -125.34 151.17 30.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.058 -0.719 . . . . 1.02 109.058 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.472 ' HB2' ' CA ' ' A' ' 152' ' ' ALA . 7.5 t -95.2 161.23 14.2 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.449 -0.501 . . . . 1.08 111.164 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.69 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 3.1 p -52.55 -47.18 66.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.32 -0.4 . . . . 1.33 111.658 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -52.6 -33.93 48.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.983 0.421 . . . . 2.51 111.382 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -78.48 -50.68 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 0.7 110.517 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.475 ' HB ' ' CZ3' ' A' ' 97' ' ' TRP . 27.2 m -67.67 -23.53 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 1.36 111.653 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 219' ' ' SER . 84.7 mt -61.31 -33.39 73.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 1.03 110.717 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -74.76 -23.26 58.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 1.75 110.843 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 29.5 m-85 -68.88 -39.58 79.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.231 0.539 . . . . 2.47 109.802 174.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -76.08 -2.03 28.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.419 -0.81 . . . . 3.04 110.825 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 223' ' ' LEU . 34.3 mmtp -91.88 -12.62 33.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.409 -0.359 . . . . 2.31 110.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 163' ' ' LEU . 90.4 mt -73.03 151.4 41.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 0.95 110.731 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.585 ' HB3' ' OD1' ' A' ' 231' ' ' ASN . 9.4 m120 -123.69 127.26 47.93 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.821 -0.627 . . . . 1.13 110.259 -175.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 65.4 m-85 -57.94 -33.62 69.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.767 -0.652 . . . . 3.74 111.004 173.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 229' ' ' ASN . 3.7 p-10 -72.69 164.19 26.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 1.62 111.884 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.73 171.75 43.56 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.536 -0.756 . . . . 1.16 111.309 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.91 123.27 17.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.994 0.426 . . . . 3.56 110.645 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 91.05 25.1 25.4 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.807 -0.633 . . . . 2.08 112.52 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 62.2 mt-10 -124.55 161.85 45.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.036 -0.357 . . . . 2.59 110.036 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 9.9 Cg_endo -52.15 123.06 11.74 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.164 2.576 . . . . 1.36 112.411 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.15 113.72 1.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.477 -0.783 . . . . 3.4 112.275 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.4 mt-10 -115.99 102.88 10.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.804 -0.813 . . . . 2.47 108.804 171.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.5 mt -67.34 138.02 56.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.166 0.508 . . . . 2.14 111.332 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.637 ' HA ' ' CE1' ' A' ' 230' ' ' PHE . 50.4 ttm -79.1 90.77 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.166 -0.925 . . . . 1.68 110.54 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.9 m -124.44 153.31 30.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.19 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.477 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 76.7 m-20 72.04 -80.24 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.133 0.896 . . . . 2.18 109.678 -176.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 56.34 27.72 12.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.073 0.463 . . . . 2.15 111.393 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.579 ' HB2' ' O ' ' A' ' 104' ' ' GLY . 26.8 m95 -142.37 156.67 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.039 0.447 . . . . 4.59 110.597 175.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.658 ' NH2' ' HA3' ' A' ' 12' ' ' GLY . 16.1 mmm180 -106.4 137.75 19.52 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.477 -0.783 . . . . 6.13 109.803 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.86 146.14 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.069 3.179 . . . . 3.28 113.667 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.36 151.48 46.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.068 -0.969 . . . . 2.98 110.781 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.542 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 86.9 mm-40 -94.76 170.6 7.8 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.473 -0.785 . . . . 4.32 110.079 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 74.8 Cg_exo -44.05 143.21 3.4 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.415 2.076 . . . . 3.48 112.461 176.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 32' ' ' ASP . 3.3 tm? -76.54 -38.45 55.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.03 -0.986 . . . . 4.63 109.749 -169.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 253' ' ' ARG . 21.0 pttm -64.88 -14.8 60.79 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 115.209 1.559 . . . . 5.34 115.209 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 9.5 t30 24.58 -53.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.783 2.512 . . . . 4.64 117.783 151.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 251' ' ' LYS . 15.5 tpp180 166.28 -125.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.912 -1.514 . . . . 6.11 106.912 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -127.48 133.95 49.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 3.08 109.88 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.6 131.06 35.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.83 -0.433 . . . . 2.6 109.83 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -120.7 133.21 55.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.115 -0.493 . . . . 2.63 110.898 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -143.82 129.41 19.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.246 -0.649 . . . . 1.71 109.246 176.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.1 p -92.23 97.6 10.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.827 -0.749 . . . . 2.21 111.172 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -126.01 92.4 3.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.683 0.754 . . . . 4.31 110.259 167.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.346 -0.843 . . . . 4.49 110.259 178.931 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.958 0.409 . . . . 17.49 110.572 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p -120.16 122.4 40.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.855 -0.611 . . . . 15.32 110.304 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -114.94 96.44 5.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.087 -0.506 . . . . 15.81 110.193 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -155.37 177.6 11.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.013 -0.539 . . . . 14.19 109.994 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 63.41 119.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.846 0.716 . . . . 14.91 111.796 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 12' ' ' GLY . . . -172.92 155.17 22.38 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.578 -0.82 . . . . 10.79 112.215 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -82.11 102.04 10.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.499 0.666 . . . . 11.39 110.479 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.16 -88.02 0.18 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.933 -1.031 . . . . 9.0 110.618 -175.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 18.4 tptm -90.5 158.81 16.84 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.725 -1.213 . . . . 9.76 107.725 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -72.22 -5.57 36.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.839 0.352 . . . . 11.19 111.661 -173.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -124.69 15.84 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.9 -0.591 . . . . 10.8 109.538 174.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 6' ' ' GLY . . . 91.98 131.82 5.51 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.405 -1.078 . . . . 8.82 110.405 -172.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 20.5 Cg_endo -62.4 118.77 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 CA-C-N 119.069 1.434 . . . . 7.87 111.932 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 36.9 mt-10 -89.08 -3.59 58.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.223 -0.899 . . . . 10.62 110.828 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -59.65 -38.21 80.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.421 . . . . 9.87 110.224 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -45.16 -54.47 6.82 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.814 -0.63 . . . . 8.48 112.207 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -78.54 -34.25 47.29 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.19 -0.319 . . . . 7.13 111.741 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 57.8 mtpt -62.02 -42.04 98.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.84 0.352 . . . . 9.68 111.227 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.34 -25.23 17.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.33 -0.395 . . . . 7.89 111.577 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' HB3' HG22 ' A' ' 22' ' ' ILE . 79.2 m-85 -131.42 93.88 28.0 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.819 0.342 . . . . 7.17 110.33 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 -25.95 51.22 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.926 2.417 . . . . 7.76 112.213 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.411 HG22 ' HB3' ' A' ' 20' ' ' PHE . 14.4 tt -60.23 -17.64 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 115.421 -0.809 . . . . 5.83 111.936 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 202' ' ' LEU . . . -56.51 -30.07 62.59 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.167 0.432 . . . . 5.44 112.167 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -91.44 26.82 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.704 0.288 . . . . 7.78 111.44 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.44 158.31 51.16 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.621 -0.992 . . . . 5.01 110.621 172.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 27' ' ' ARG . 33.4 tt0 -107.9 112.67 25.4 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.243 -0.983 . . . . 7.09 110.707 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 26' ' ' GLU . 29.7 mmt180 -142.28 177.09 8.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.736 -1.209 . . . . 5.13 107.736 167.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . 29.0 tt0 -66.11 87.54 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.307 0.575 . . . . 7.12 109.593 172.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 31' ' ' VAL . 23.3 t -47.33 144.66 4.32 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.542 -1.208 . . . . 3.94 111.956 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 46.0 Cg_endo -67.47 25.69 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.022 3.148 . . . . 4.52 113.761 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 33' ' ' ILE . 34.5 m -94.91 -173.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.252 -0.431 . . . . 4.54 110.363 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.564 ' HB3' HD11 ' A' ' 250' ' ' LEU . 24.2 t70 -52.59 114.2 1.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.054 0.93 . . . . 2.88 111.647 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 31' ' ' VAL . 85.4 mt -102.82 141.79 18.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.33 -1.305 . . . . 2.32 109.918 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 36' ' ' HIS . 19.3 t70 -120.93 121.62 38.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.827 0.346 . . . . 2.82 110.166 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -69.07 -28.77 66.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 2.24 112.054 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 35.1 m80 -60.54 -43.35 97.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.324 0.583 . . . . 4.54 110.314 173.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -71.98 -21.42 61.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.288 -0.869 . . . . 3.06 110.007 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' A' ' 257' ' ' ALA . . . -74.82 98.78 3.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.5 -0.773 . . . . 1.72 110.55 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -72.11 126.33 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.941 -0.572 . . . . 3.69 109.653 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 51.1 p90 -82.64 131.49 35.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 4.64 110.336 -172.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.14 138.74 26.57 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.821 -0.627 . . . . 2.27 110.005 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.81 13.2 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.223 2.615 . . . . 2.15 114.064 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -60.45 -52.48 65.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 4.29 109.899 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.1 mt 53.08 13.78 0.41 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.583 0.957 . . . . 4.74 113.583 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HD3' ' HD2' ' A' ' 46' ' ' PRO . 16.2 tppt? -56.72 111.55 3.44 Favored Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 123.408 0.443 . . . . 3.77 111.887 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 84.9 Cg_endo -87.33 157.3 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.919 2.413 . . . . 2.36 111.99 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -83.1 154.48 24.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.047 -0.524 . . . . 2.55 110.369 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 38.5 t -129.62 131.02 46.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.295 -0.631 . . . . 2.38 109.295 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.89 137.37 57.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 1.59 111.433 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 47.7 m -127.75 90.94 3.19 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.033 -0.728 . . . . 1.45 109.033 171.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -133.03 16.42 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.879 -0.328 . . . . 3.62 111.883 -176.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.14 -22.04 64.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.966 0.413 . . . . 2.48 110.951 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.03 3.72 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 2.24 111.228 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.66 110.84 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.187 0.517 . . . . 0.8 111.853 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.8 m -98.62 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.064 -0.516 . . . . 1.06 110.506 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 5.3 p -81.24 149.67 28.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.724 -0.671 . . . . 1.26 110.494 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.1 mt -115.85 -49.71 2.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.071 0.462 . . . . 0.74 110.844 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -160.59 161.96 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.026 -0.534 . . . . 3.17 110.726 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.09 133.75 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.941 -0.762 . . . . 0.64 108.941 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 171' ' ' LYS . 53.3 tp -129.34 131.21 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.975 0.417 . . . . 0.96 111.408 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -80.81 109.3 15.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.742 -0.663 . . . . 1.49 109.355 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -110.91 68.89 0.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.968 0.413 . . . . 1.83 110.166 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.33 -53.58 0.09 OUTLIER Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.279 -1.328 . . . . 1.64 115.208 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -110.1 -19.86 12.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.788 0.328 . . . . 3.33 111.32 -169.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -159.96 177.61 10.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 1.38 110.247 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.705 ' CE1' HD13 ' A' ' 228' ' ' LEU . 29.2 m-85 -117.38 112.84 21.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.304 -0.628 . . . . 2.74 109.304 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.4 m120 -90.72 105.2 17.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.47 . . . . 1.76 110.783 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 60.1 t -82.26 105.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.752 -0.833 . . . . 1.15 108.752 171.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.12 132.47 34.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.016 -0.538 . . . . 2.02 111.084 -173.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 56' ' ' SER . 75.8 m-85 -112.02 155.74 23.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.462 -0.79 . . . . 1.66 109.032 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.14 110.39 15.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.933 0.397 . . . . 1.33 110.559 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -107.06 55.18 0.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.712 0.768 . . . . 2.65 109.939 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -96.94 -5.85 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.758 . . . . 1.61 110.771 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -154.03 166.63 32.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.372 -0.831 . . . . 2.35 109.18 178.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.91 36.74 0.63 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.36 0.504 . . . . 1.92 112.36 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 92.6 mttt -55.48 -63.58 1.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.246 -0.434 . . . . 1.77 110.656 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -103.55 115.96 31.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.872 -0.604 . . . . 0.76 110.341 -177.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.9 t -134.51 141.96 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.808 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . 58.6 tp -105.61 128.33 53.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.338 -0.616 . . . . 1.29 109.338 173.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 55.8 mtpt -119.92 124.76 46.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.244 0.545 . . . . 2.54 110.24 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.77 170.99 19.83 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.789 -0.924 . . . . 1.31 110.789 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.71 -148.95 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 O-C-N 123.657 0.269 . . . . 1.9 113.539 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.43 119.03 5.26 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 121.569 1.512 . . . . 2.91 112.451 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.2 mt -159.66 -171.14 3.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.078 -0.965 . . . . 4.11 108.938 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -132.89 76.95 1.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.751 -0.38 . . . . 4.95 111.714 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 129.7 -178.68 17.29 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.247 -0.977 . . . . 2.25 114.206 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 m -105.76 120.1 40.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.859 -0.671 . . . . 1.91 109.363 176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 32.2 m-85 -105.41 104.79 14.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 3.7 111.436 -171.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 99.4 mtt180 -75.37 152.62 38.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.099 -0.5 . . . . 3.54 110.314 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.9 120.43 24.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.974 -0.38 . . . . 1.14 109.974 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.0 tt -110.26 -34.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.447 -0.342 . . . . 1.68 111.02 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 7.2 pt20 -173.86 174.52 3.04 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.661 -0.496 . . . . 1.55 109.661 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 20.4 p90 -147.09 161.65 40.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.861 -0.336 . . . . 0.86 111.02 172.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 8.7 p-80 -147.46 160.11 42.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -125.11 172.79 9.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.774 0.321 . . . . 3.17 110.899 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -127.24 117.14 21.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.712 -1.218 . . . . 1.68 107.712 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.58 ' NE1' ' HA ' ' A' ' 99' ' ' SER . 60.3 t-105 -101.49 112.33 24.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.778 0.323 . . . . 5.18 110.694 -173.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.484 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -63.32 -39.07 97.4 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.629 -0.714 . . . . 2.13 112.497 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.58 ' HA ' ' NE1' ' A' ' 97' ' ' TRP . 32.5 t 91.56 -17.92 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.266 1.026 . . . . 2.9 110.178 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 92.4 mt -112.57 137.85 50.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.134 -1.062 . . . . 3.03 108.134 169.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.21 -24.96 65.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.652 0.982 . . . . 3.85 113.652 -168.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.99 7.53 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.914 -1.136 . . . . 1.94 113.863 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.425 ' HG3' ' HB2' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -165.99 152.58 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.383 0.591 . . . . 2.45 111.023 176.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.484 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 122.89 -27.27 5.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.64 -0.791 . . . . 1.47 112.692 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 114' ' ' TYR . 39.2 t -71.29 -46.98 59.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.464 0.172 . . . . 2.0 111.464 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 11.1 mm-40 61.46 -172.66 0.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.937 0.347 . . . . 3.72 111.937 -177.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.9 m80 56.48 30.21 16.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.957 0.884 . . . . 3.52 108.664 -166.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 108' ' ' THR . 2.0 t -83.13 153.6 24.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.997 -1.456 . . . . 2.52 113.122 -169.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.0 m -101.52 93.45 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.397 -0.82 . . . . 2.48 111.382 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.64 71.55 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.039 -0.982 . . . . 2.8 111.329 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 59.41 21.29 9.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.091 -0.958 . . . . 4.98 113.417 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -97.82 73.55 2.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.332 -0.618 . . . . 3.23 109.332 172.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -86.9 150.9 23.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.279 -0.418 . . . . 2.82 109.97 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 105' ' ' SER . 76.6 m-85 -110.71 -173.79 2.33 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.751 -0.462 . . . . 1.62 109.751 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.9 -38.97 69.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.623 0.601 . . . . 1.03 112.623 -172.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.53 169.02 17.65 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.929 -0.308 . . . . 0.75 111.527 -170.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -136.17 140.07 43.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.612 -0.722 . . . . 1.58 109.107 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.5 tp -109.63 133.67 52.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 1.07 110.245 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.477 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 39.8 m170 -120.38 106.1 11.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.895 0.379 . . . . 1.77 110.684 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.3 mp -86.83 114.92 23.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.757 -0.46 . . . . 0.93 109.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.03 134.14 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.225 0.536 . . . . 0.61 110.571 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.562 ' CE1' ' HB2' ' A' ' 79' ' ' LEU . 74.4 m-70 -119.68 150.82 39.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 2.13 111.521 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -110.17 123.84 50.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.819 -1.082 . . . . 4.26 110.008 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 40.5 t-20 -79.37 117.99 20.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.113 -0.494 . . . . 2.02 110.426 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -73.93 -32.21 63.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.17 -0.468 . . . . 2.34 112.193 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 124' ' ' ASN . 19.6 ptmt -63.24 -25.19 68.21 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.112 0.412 . . . . 3.35 112.112 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.38 -11.87 31.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.906 0.384 . . . . 3.1 111.136 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.74 26.11 3.85 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.123 -0.944 . . . . 2.37 113.687 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -176.31 115.29 0.12 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.793 -0.447 . . . . 3.93 109.793 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 134' ' ' VAL . 50.8 p90 -57.81 -36.24 71.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 3.0 111.677 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.55 -44.9 96.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.875 -0.678 . . . . 2.15 112.444 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -64.4 -36.21 83.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.21 0.529 . . . . 3.43 109.984 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 139' ' ' GLY . . . -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.647 -0.706 . . . . 1.76 111.303 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 130' ' ' PHE . 72.0 t -61.73 -22.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.028 0.442 . . . . 2.77 111.083 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -77.0 -0.81 25.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 3.55 111.414 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.492 ' HG2' ' H ' ' A' ' 138' ' ' ASP . 6.2 tt0 -126.26 131.77 24.07 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.79 -0.448 . . . . 3.02 109.79 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.17 -18.19 50.2 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.897 2.398 . . . . 1.6 112.76 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.492 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 13.1 m-20 -113.91 17.63 17.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.174 -0.676 . . . . 2.29 109.174 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.412 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -83.24 -11.23 81.11 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.437 -0.802 . . . . 1.22 113.934 -168.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.594 ' C ' HG12 ' A' ' 206' ' ' VAL . 80.1 mt -146.48 172.19 13.91 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.269 -0.271 . . . . 1.57 110.269 -175.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 122' ' ' HIS . . . -156.94 121.34 4.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.363 -0.38 . . . . 1.38 110.671 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.51 ' O ' HG21 ' A' ' 209' ' ' ILE . 33.6 m -97.95 165.86 2.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 N-CA-C 108.637 -0.875 . . . . 1.73 108.637 173.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.5 tp -116.45 114.71 24.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.774 -0.454 . . . . 2.42 109.774 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -97.16 117.27 5.73 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.047 -0.597 . . . . 0.86 112.689 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.9 mt -118.87 127.05 75.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.306 -0.257 . . . . 0.76 110.306 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -78.4 147.22 34.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.366 -0.235 . . . . 1.2 110.366 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 8.1 mp -117.7 124.47 48.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.88 111.145 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -116.56 144.91 43.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.322 -0.622 . . . . 2.03 109.322 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 11.2 t -88.05 130.38 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.894 0.378 . . . . 1.27 110.356 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.09 -114.88 0.4 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.414 -0.674 . . . . 1.53 111.414 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.3 t -81.99 156.37 24.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.489 -0.56 . . . . 1.54 109.489 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.417 ' N ' ' HB2' ' A' ' 218' ' ' SER . . . -78.02 148.6 34.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 0.78 111.098 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 183' ' ' LEU . 82.5 tttt -113.19 110.4 51.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.771 -0.455 . . . . 1.22 109.771 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.5 -38.66 90.05 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.708 2.939 . . . . 1.05 113.565 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.3 -19.84 64.65 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.115 -0.564 . . . . 0.7 112.899 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 tp -95.56 -16.56 22.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.025 0.44 . . . . 0.77 110.336 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -46.12 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.761 -0.654 . . . . 1.41 111.162 -173.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.29 -36.73 66.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.873 0.323 . . . . 2.86 111.873 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.12 -42.67 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.077 0.465 . . . . 1.38 110.556 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 156' ' ' LEU . 24.4 t -67.27 -29.73 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 1.11 110.811 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -75.21 -35.82 61.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.224 -0.444 . . . . 1.22 111.698 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.93 -19.55 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.654 0.264 . . . . 1.41 111.546 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 228' ' ' LEU . 3.4 pp -74.71 -12.79 60.5 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 120.947 -0.301 . . . . 1.39 111.501 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.06 -31.08 69.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.947 0.403 . . . . 2.31 111.081 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.3 m -87.57 1.55 53.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.328 0.492 . . . . 1.4 112.328 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.6 pt -139.74 39.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.563 0.697 . . . . 0.85 110.598 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.606 ' HE2' ' OD1' ' A' ' 229' ' ' ASN . 84.8 tttt -54.0 -31.68 51.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.672 -1.149 . . . . 1.59 112.688 -176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -111.65 150.17 30.51 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.196 0.522 . . . . 0.77 111.959 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -58.31 128.16 35.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.388 -0.824 . . . . 2.29 111.502 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.65 -18.83 19.6 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.578 -0.82 . . . . 0.85 112.537 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.404 ' O ' HD12 ' A' ' 60' ' ' LEU . 67.4 mttm -87.52 149.12 24.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.362 0.601 . . . . 1.7 111.215 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.5 p -134.96 157.26 47.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.053 -0.976 . . . . 1.37 109.702 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.81 139.05 29.13 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.153 -0.314 . . . . 0.61 110.153 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.55 135.04 48.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.623 -0.51 . . . . 1.8 109.623 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 178' ' ' PHE . 22.8 t80 -136.23 81.46 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.242 0.544 . . . . 1.04 109.812 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.0 m -79.97 138.6 37.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.664 -0.698 . . . . 1.17 112.32 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 52.34 76.09 0.2 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.105 -0.952 . . . . 1.77 113.281 169.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' O ' ' HD3' ' A' ' 180' ' ' PRO . 52.0 t80 -92.13 137.52 32.29 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.758 -0.46 . . . . 3.99 109.758 172.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -105.09 94.58 8.0 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.4 0.619 . . . . 2.51 110.94 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 178' ' ' PHE . 12.3 Cg_exo -71.83 -9.49 24.88 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.653 2.235 . . . . 1.26 112.321 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -49.81 -39.54 38.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.196 0.522 . . . . 2.76 110.87 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -56.23 -26.98 51.57 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.281 -0.872 . . . . 1.12 113.061 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 153' ' ' LYS . 90.2 mt -76.63 -29.65 56.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.571 0.582 . . . . 1.73 112.571 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.402 ' HB2' ' HD3' ' A' ' 185' ' ' PRO . 85.9 mt -33.14 -47.73 0.58 Allowed Pre-proline 0 N--CA 1.483 1.185 0 N-CA-C 116.237 1.939 . . . . 3.45 116.237 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 184' ' ' LEU . 14.1 Cg_exo -71.73 48.89 1.12 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.556 1.504 . . . . 2.08 114.029 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 187' ' ' SER . 0.0 OUTLIER -109.45 -6.19 15.53 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.998 -0.439 . . . . 3.23 111.766 173.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.477 ' OG ' ' HE2' ' A' ' 212' ' ' LYS . 46.1 t 72.84 128.43 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.782 0.676 . . . . 1.66 111.038 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.503 ' HA ' HD22 ' A' ' 211' ' ' LEU . 96.0 mt -113.81 59.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.395 -0.366 . . . . 1.99 110.174 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -144.43 153.08 41.54 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.997 -0.742 . . . . 1.81 108.997 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.468 ' HB3' ' HB ' ' A' ' 210' ' ' VAL . 0.1 OUTLIER 171.58 -168.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.121 -1.066 . . . . 5.01 108.121 -178.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.61 ' HB3' ' HA ' ' A' ' 257' ' ' ALA . 1.5 p90 -75.87 147.97 38.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.09 0.472 . . . . 3.93 110.265 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.3 t -107.28 75.91 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.8 0.81 . . . . 2.13 110.811 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.471 ' CD1' ' HB2' ' A' ' 28' ' ' GLN . 20.8 t80 -138.43 138.5 22.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.635 -0.711 . . . . 5.21 110.057 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HA ' ' OG1' ' A' ' 207' ' ' THR . 33.0 Cg_endo -64.7 130.29 25.91 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.728 2.285 . . . . 2.12 112.832 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -125.29 142.85 14.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.862 -0.608 . . . . 1.75 112.12 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.4 m -65.3 130.81 44.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.579 0.704 . . . . 2.99 112.405 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.451 ' HG ' HG23 ' A' ' 206' ' ' VAL . 0.2 OUTLIER -95.92 16.86 16.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.523 -1.217 . . . . 4.75 109.857 176.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.7 p -62.95 32.55 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.279 1.432 . . . . 5.1 114.47 -170.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.592 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 6.6 p -77.46 -177.71 0.86 Allowed Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 118.838 -0.601 . . . . 5.53 109.472 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.592 ' HD2' ' HB ' ' A' ' 199' ' ' THR . 2.7 Cg_exo -37.31 -46.41 1.62 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.704 2.269 . . . . 5.83 113.174 169.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 8.3 Cg_exo -76.4 95.56 1.05 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.516 1.477 . . . . 4.78 109.388 161.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 23' ' ' ALA . 18.3 tp -87.08 43.46 1.1 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 3.84 111.943 -166.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 52.9 tp -87.5 117.51 26.34 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.573 -0.451 . . . . 2.96 110.744 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -104.25 51.3 0.78 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 3.37 110.352 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 62.2 m -135.69 11.74 3.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.436 -0.802 . . . . 2.15 110.412 -176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.594 HG12 ' C ' ' A' ' 140' ' ' LEU . 15.9 m -136.23 100.52 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 1.26 110.46 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 194' ' ' PRO . 1.4 t -151.21 89.8 1.54 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 115.358 1.614 . . . . 2.08 115.358 170.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.504 ' O ' HG23 ' A' ' 209' ' ' ILE . 0.1 OUTLIER -151.96 85.5 1.29 Allowed 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.569 -0.707 . . . . 5.53 109.322 143.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -163.16 98.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.177 0.436 . . . . 1.63 112.177 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.11 136.61 59.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.469 -0.769 . . . . 1.62 109.893 165.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 188' ' ' LEU . 51.6 mt -114.1 123.19 49.05 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 1.73 110.631 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.477 ' HE2' ' OG ' ' A' ' 187' ' ' SER . 62.3 pttt -67.62 -36.77 81.44 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.122 0.415 . . . . 2.98 112.122 -174.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 212' ' ' LYS . 25.0 mm-40 -99.14 117.21 64.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 1.47 111.166 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.65 148.25 58.89 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.525 2.15 . . . . 0.96 111.134 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -79.45 147.26 6.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.62 -0.511 . . . . 1.25 109.62 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.1 t -89.9 116.4 27.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.003 -0.544 . . . . 1.29 110.577 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 7.2 p -119.37 135.69 58.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.586 -0.894 . . . . 1.02 108.586 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 152' ' ' ALA . 13.2 t -96.95 170.43 9.16 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.992 -0.442 . . . . 1.08 111.502 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.58 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 11.0 p -51.48 -53.03 41.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.367 0.506 . . . . 1.33 112.367 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.47 -40.14 65.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 2.51 111.099 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -68.87 -51.08 44.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.966 -0.561 . . . . 0.7 110.071 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 219' ' ' SER . 35.9 m -69.25 -20.71 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 111.912 0.338 . . . . 1.36 111.912 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 219' ' ' SER . 57.9 mt -61.87 -42.41 99.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.019 0.437 . . . . 1.03 109.907 174.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.683 ' O ' ' HG ' ' A' ' 228' ' ' LEU . 62.5 mttm -66.62 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.511 -0.768 . . . . 1.75 110.865 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -73.23 -31.14 63.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.216 0.532 . . . . 2.47 110.496 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.439 ' HE ' ' HB2' ' A' ' 226' ' ' ARG . 5.7 ttm180 -83.35 -13.86 54.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.684 -0.689 . . . . 3.04 110.89 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -2.35 32.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.205 -0.452 . . . . 2.31 111.294 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.705 HD13 ' CE1' ' A' ' 66' ' ' PHE . 90.7 mt -73.62 152.43 40.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.064 0.459 . . . . 0.95 110.952 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.606 ' OD1' ' HE2' ' A' ' 167' ' ' LYS . 11.9 m120 -111.22 141.48 44.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.408 0.623 . . . . 1.13 111.037 -174.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.77 -31.47 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.731 -1.122 . . . . 3.74 108.815 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 235' ' ' GLU . 3.8 p-10 -72.83 165.21 25.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.506 -1.224 . . . . 1.62 112.208 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.09 174.41 45.61 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.915 -1.039 . . . . 1.16 110.814 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.5 133.07 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.832 -0.433 . . . . 3.56 109.832 -176.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.26 3.84 88.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.694 -0.765 . . . . 2.08 113.27 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 231' ' ' ASN . 32.6 mt-10 -98.66 164.34 17.18 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.657 -0.498 . . . . 2.59 109.657 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.44 126.51 22.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.532 2.155 . . . . 1.36 111.571 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.51 109.34 2.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.647 -0.706 . . . . 3.4 111.763 -172.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -125.59 122.15 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.41 -0.814 . . . . 2.47 110.193 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.58 149.42 49.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.773 -0.649 . . . . 2.14 111.116 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 53.5 mtt -73.0 102.55 3.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 1.68 109.352 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.87 133.47 68.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 1.27 111.505 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.476 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 17.6 t70 63.62 -80.02 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.3 -0.864 . . . . 2.18 111.211 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 56.36 33.68 22.8 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.818 0.447 . . . . 2.15 111.804 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -125.35 144.75 50.35 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.468 -0.568 . . . . 4.59 109.468 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 0.1 OUTLIER -67.62 147.25 98.71 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.044 -0.525 . . . . 6.13 111.358 -178.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.594 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 61.1 Cg_exo -53.17 153.26 16.8 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.443 2.762 . . . . 3.28 112.348 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.15 118.57 16.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.317 -0.401 . . . . 2.98 111.585 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.55 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 48.6 mt-30 -68.89 171.44 6.37 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.771 -0.65 . . . . 4.32 109.684 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 66.1 Cg_exo -42.26 123.2 2.57 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.386 2.058 . . . . 3.48 111.853 173.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -55.96 -52.87 62.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.571 -0.74 . . . . 4.63 111.836 -163.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 253' ' ' ARG . 18.8 ptpt -62.21 -10.95 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.865 1.061 . . . . 5.34 113.865 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 10.4 p30 48.9 -42.59 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.887 2.551 . . . . 4.64 117.887 172.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 251' ' ' LYS . 20.0 ttt180 168.74 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.485 -0.931 . . . . 6.11 108.485 -164.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -129.33 136.12 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.063 -0.717 . . . . 3.08 109.063 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.457 HD13 HG23 ' A' ' 33' ' ' ILE . 36.1 mt -99.66 142.84 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.246 -0.279 . . . . 2.6 110.246 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -132.46 159.1 40.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.596 -0.275 . . . . 2.63 110.348 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.61 ' HA ' ' HB3' ' A' ' 191' ' ' TRP . . . -130.57 157.7 42.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.132 -0.486 . . . . 1.71 110.971 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 191' ' ' TRP . 14.0 p -163.91 98.31 0.85 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.914 0.387 . . . . 2.21 110.275 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -162.08 150.13 14.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.39 -0.368 . . . . 4.31 110.374 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.38 -0.819 . . . . 4.49 109.673 -177.817 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.627 0.251 . . . . 17.49 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 p -89.19 -30.78 18.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.969 0.414 . . . . 15.32 110.872 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -97.54 175.87 6.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.17 -0.468 . . . . 15.81 110.279 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -135.92 4.81 3.04 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.272 0.471 . . . . 14.19 112.272 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -176.01 134.12 0.26 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.227 0.536 . . . . 14.91 111.642 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.549 ' O ' ' HA2' ' A' ' 12' ' ' GLY . . . -146.64 128.86 3.13 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.309 -1.116 . . . . 10.79 110.309 170.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -68.73 117.9 11.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.883 0.342 . . . . 11.39 110.951 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.65 -113.26 0.29 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.884 -0.674 . . . . 9.0 112.513 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -79.55 138.5 37.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.763 0.316 . . . . 9.76 111.091 -176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 65.23 -100.45 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.435 -0.802 . . . . 11.19 110.087 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -126.8 -15.15 5.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.116 0.484 . . . . 10.8 110.652 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 6' ' ' GLY . . . 179.16 -112.05 0.35 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.954 -0.641 . . . . 8.82 111.977 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' O ' ' HE3' ' A' ' 16' ' ' TRP . 6.2 Cg_exo -78.58 157.49 28.53 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.622 2.215 . . . . 7.87 111.543 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -85.89 -17.44 35.53 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.605 0.717 . . . . 10.62 109.461 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -90.27 29.92 1.19 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.754 -1.112 . . . . 9.87 109.724 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' HE3' ' O ' ' A' ' 13' ' ' PRO . 7.2 p90 -61.03 -12.01 10.23 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.815 -0.63 . . . . 8.48 112.015 -170.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -66.05 -48.66 70.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.096 -0.502 . . . . 7.13 109.82 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.8 ttmm -92.33 -52.57 4.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.107 -0.497 . . . . 9.68 111.327 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -81.21 16.42 1.59 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.553 1.316 . . . . 7.89 114.553 -168.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -152.42 91.18 3.62 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 119.156 -1.018 . . . . 7.17 109.435 -171.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' O ' HD21 ' A' ' 202' ' ' LEU . 58.0 Cg_endo -71.48 64.77 2.92 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.031 2.488 . . . . 7.76 113.538 -173.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 tp -173.08 -32.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.068 -0.515 . . . . 5.83 110.926 173.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.72 33.23 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 5.44 111.542 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -95.64 -26.66 15.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.705 0.764 . . . . 7.78 109.007 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.39 176.79 19.66 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 109.531 -1.428 . . . . 5.01 109.531 170.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -111.73 111.23 22.06 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 118.59 -1.244 . . . . 7.09 109.548 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HG3' ' CB ' ' A' ' 204' ' ' GLU . 24.6 mmt180 -149.51 176.33 10.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.351 -0.611 . . . . 5.13 109.351 168.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.536 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . 27.3 tt0 -45.93 103.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.617 0.722 . . . . 7.12 112.045 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.603 ' HB2' HG13 ' A' ' 31' ' ' VAL . 49.7 m -93.02 166.63 15.95 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.844 -1.071 . . . . 3.94 109.939 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HG2' HE22 ' A' ' 248' ' ' GLN . 10.0 Cg_endo -52.7 31.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 125.198 3.932 . . . . 4.52 115.042 170.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.659 HG12 ' HB2' ' A' ' 248' ' ' GLN . 3.8 m -93.81 -171.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 122.971 0.508 . . . . 4.54 109.756 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 27.6 t70 -110.54 140.33 44.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.547 0.213 . . . . 2.88 111.007 -167.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' HB ' HG12 ' A' ' 109' ' ' VAL . 50.8 mt -85.49 135.34 25.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 CA-C-N 116.353 -0.385 . . . . 2.32 110.626 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -105.82 111.46 24.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.744 -0.465 . . . . 2.82 109.744 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.5 p -60.61 -27.24 67.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.037 -0.529 . . . . 2.24 112.321 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -66.56 -45.7 78.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.944 0.402 . . . . 4.54 110.818 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 m -78.74 -25.9 44.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 3.06 110.667 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.12 116.93 3.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.129 0.49 . . . . 1.72 111.248 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -94.24 128.7 40.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 3.69 110.918 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 44.1 p90 -76.69 140.05 40.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.262 -0.426 . . . . 4.64 110.18 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.34 98.46 13.92 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.899 0.381 . . . . 2.27 110.007 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.18 -10.5 27.41 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.181 2.587 . . . . 2.15 113.14 -175.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.6 p -78.96 -1.92 37.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.023 0.439 . . . . 4.29 110.565 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.51 HD12 ' OG ' ' A' ' 258' ' ' SER . 78.4 mt -89.54 138.27 31.61 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.387 -0.597 . . . . 4.74 109.387 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -116.36 140.25 26.3 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.222 -0.444 . . . . 3.77 110.879 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.44 138.07 84.44 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.128 2.552 . . . . 2.36 111.649 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.409 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 57.7 mt -72.94 138.3 46.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 2.55 110.457 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -91.81 120.52 32.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.009 -1.108 . . . . 2.38 108.009 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' CD1' ' A' ' 79' ' ' LEU . 1.9 t -116.45 110.93 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.522 -0.308 . . . . 1.59 110.624 -172.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.9 t -94.91 88.38 5.27 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.034 -0.728 . . . . 1.45 109.034 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 181' ' ' ARG . 1.4 p90 -107.25 1.1 23.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.892 -0.594 . . . . 3.62 111.36 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.35 -32.83 65.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.242 -0.435 . . . . 2.48 111.557 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.466 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 1.2 mp0 -101.5 6.89 42.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.24 111.138 -176.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.63 128.1 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.812 0.339 . . . . 0.8 111.537 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.5 m -112.31 107.03 15.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.954 -0.566 . . . . 1.06 110.721 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.4 t -79.67 150.51 30.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 1.26 108.95 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.7 mt -117.79 -54.52 2.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.74 111.825 -173.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -161.91 159.58 26.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.322 -0.399 . . . . 3.17 110.841 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.1 tt -115.31 141.5 32.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.312 -0.625 . . . . 0.64 109.312 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 171' ' ' LYS . 61.5 tp -127.6 138.26 52.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.37 . . . . 0.96 110.89 -173.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -92.99 119.78 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.063 0.459 . . . . 1.49 110.547 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 49.0 m-80 -127.74 146.53 50.55 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.339 -0.985 . . . . 1.83 108.339 170.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.22 6.34 7.6 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.976 -0.631 . . . . 1.64 113.932 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -114.33 -54.29 2.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.165 0.482 . . . . 3.33 109.713 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 62' ' ' ASN . . . -140.53 163.22 33.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.336 -0.393 . . . . 1.38 110.416 174.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 69.7 m-85 -111.47 99.77 8.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.805 -0.443 . . . . 2.74 109.805 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 94' ' ' HIS . 81.3 m-20 -86.55 138.83 31.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 1.76 111.72 -171.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.3 t -114.59 113.25 43.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.476 -0.784 . . . . 1.15 108.977 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -72.66 140.53 47.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.913 -0.585 . . . . 2.02 112.076 -172.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -125.68 144.32 50.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.756 . . . . 1.66 110.1 172.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.65 139.5 30.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.148 -0.478 . . . . 1.33 111.068 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.02 64.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.033 -0.985 . . . . 2.65 109.868 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -77.82 -11.06 59.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.982 0.896 . . . . 1.61 108.65 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -149.25 160.05 43.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.927 -1.488 . . . . 2.35 107.824 -176.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.97 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.688 0.618 . . . . 1.92 111.865 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 53' ' ' GLN . 90.0 mttt -109.54 -59.41 1.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.65 0.611 . . . . 1.77 112.65 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.84 102.15 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.76 111.258 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.5 t -118.59 145.41 24.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.205 -0.452 . . . . 1.27 111.206 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 49' ' ' VAL . 31.8 tp -134.39 112.88 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.935 -0.395 . . . . 1.29 109.935 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -150.98 123.23 8.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.171 0.51 . . . . 2.54 111.538 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -97.17 176.06 31.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-O 118.762 -1.021 . . . . 1.31 110.905 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -38.17 -141.28 0.0 OUTLIER Glycine 0 CA--C 1.541 1.71 0 N-CA-C 115.331 0.892 . . . . 1.9 115.331 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.64 122.21 8.47 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.227 1.952 . . . . 2.91 112.329 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 85' ' ' ASP . 14.1 tp -165.44 -170.3 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.976 -1.12 . . . . 4.11 107.976 -171.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.583 ' H ' ' HG ' ' A' ' 84' ' ' LEU . 27.0 t70 -122.23 41.72 3.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.294 0.497 . . . . 4.95 110.997 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.77 174.91 13.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.858 -1.163 . . . . 2.25 114.229 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.0 m -101.86 124.18 47.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.073 -0.564 . . . . 1.91 110.12 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -114.07 113.16 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.071 0.463 . . . . 3.7 111.55 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.79 153.93 20.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.372 -0.376 . . . . 3.54 110.431 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.89 124.33 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.819 0.342 . . . . 1.14 110.615 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.545 ' HB ' ' CE3' ' A' ' 123' ' ' TRP . 14.2 tt -105.62 -34.02 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.918 0.389 . . . . 1.68 110.117 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -173.93 164.67 4.24 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.854 -0.795 . . . . 1.55 108.854 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' A' ' 120' ' ' LEU . 14.9 p90 -136.71 154.66 50.54 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.566 -0.902 . . . . 0.86 108.566 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.481 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 6.7 p-80 -139.78 158.8 43.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.943 0.401 . . . . 0.93 110.962 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.12 166.84 20.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 3.17 109.426 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' HE1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -144.46 157.69 44.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.451 -0.574 . . . . 1.68 109.451 175.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CH2' ' HB ' ' A' ' 222' ' ' VAL . 73.1 t-105 -128.51 139.5 52.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 5.18 110.228 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 104' ' ' GLY . . . -95.06 -59.42 1.11 Allowed Glycine 0 C--O 1.218 -0.844 0 C-N-CA 120.837 -0.697 . . . . 2.13 112.74 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 28.8 p 163.07 -57.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.365 0.603 . . . . 2.9 110.648 -172.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.2 mt -107.81 153.26 23.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.307 -0.86 . . . . 3.03 110.4 -170.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.38 51.69 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.666 0.746 . . . . 3.85 110.243 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 113' ' ' LYS . . . -176.02 1.64 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.151 -0.931 . . . . 1.94 112.434 -175.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -160.35 155.24 24.33 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.887 -0.782 . . . . 2.45 108.887 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 98' ' ' GLY . . . 116.19 -27.12 8.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.192 -1.004 . . . . 1.47 111.873 -174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.7 t -70.39 -46.73 63.44 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.011 -0.366 . . . . 2.0 110.011 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.524 ' OE1' ' HD3' ' A' ' 113' ' ' LYS . 8.1 mm-40 58.89 177.39 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.044 -0.525 . . . . 3.72 111.808 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.453 ' HD1' ' CD ' ' A' ' 117' ' ' GLU . 24.6 m80 59.76 14.45 4.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.962 -0.563 . . . . 3.52 111.286 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 113' ' ' LYS . 7.3 t -82.38 -178.8 7.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.11 -0.95 . . . . 2.52 113.088 -172.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 33' ' ' ILE . 17.0 m -103.61 123.94 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.582 -1.19 . . . . 2.48 111.965 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 61.17 39.14 16.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.38 -1.282 . . . . 2.8 111.413 170.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 67.81 8.54 6.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.758 -0.656 . . . . 4.98 112.163 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -90.43 73.91 6.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.694 0.283 . . . . 3.23 110.707 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.524 ' HD3' ' OE1' ' A' ' 106' ' ' GLU . 91.9 mttt -69.07 150.25 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.222 0.534 . . . . 2.82 111.641 -176.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 81.4 m-85 -101.12 -177.26 3.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.174 -0.921 . . . . 1.62 109.848 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.63 67.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.917 0.389 . . . . 1.03 111.704 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.32 163.75 39.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.196 -0.457 . . . . 0.75 110.224 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' CD ' ' HD1' ' A' ' 107' ' ' HIS . 44.3 tt0 -129.99 135.2 48.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.732 -0.47 . . . . 1.58 109.732 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.5 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 42.9 tp -110.78 132.5 54.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.066 -0.515 . . . . 1.07 109.907 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.481 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 23.2 m170 -128.09 111.34 13.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.792 0.33 . . . . 1.77 111.628 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 93' ' ' PHE . 6.6 mp -92.71 113.46 25.74 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.151 -0.315 . . . . 0.93 110.151 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.73 122.24 39.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.162 0.506 . . . . 0.61 111.37 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -120.92 146.64 46.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.95 -0.568 . . . . 2.13 109.513 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.545 ' CE3' ' HB ' ' A' ' 91' ' ' ILE . 2.1 p90 -119.56 148.83 42.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.615 -0.513 . . . . 4.26 109.615 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -68.99 114.73 7.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.278 0.561 . . . . 2.02 110.37 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -68.19 -21.87 64.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.235 -0.893 . . . . 2.34 112.101 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.87 -21.6 64.83 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.861 0.363 . . . . 3.35 111.506 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.3 -3.17 34.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.003 0.43 . . . . 3.1 110.125 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.79 30.22 6.67 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 114.714 -1.13 . . . . 2.37 114.98 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 30.5 t70 -173.42 129.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.037 0.918 . . . . 3.93 110.214 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.608 ' O ' HG23 ' A' ' 134' ' ' VAL . 85.8 t80 -60.0 -46.4 89.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.961 -1.018 . . . . 3.0 110.842 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.66 99.24 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.227 -0.511 . . . . 2.15 112.832 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.48 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 73.6 mmtt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.07 0.462 . . . . 3.43 110.316 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.688 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.66 -0.7 . . . . 1.76 110.738 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 130' ' ' PHE . 99.6 t -64.83 -26.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.022 -0.535 . . . . 2.77 111.493 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -83.87 -4.66 58.85 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.023 -0.423 . . . . 3.55 111.451 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.455 HE21 ' HA2' ' A' ' 139' ' ' GLY . 3.1 tt0 -107.28 132.36 21.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.885 -0.413 . . . . 3.02 109.885 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 74.4 Cg_exo -52.46 -30.37 43.76 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.426 2.751 . . . . 1.6 113.499 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.91 25.18 12.05 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.646 0.26 . . . . 2.29 110.472 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -70.87 -33.63 65.99 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.579 -0.819 . . . . 1.22 113.394 -172.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.7 mt -114.71 156.9 23.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.999 0.428 . . . . 1.57 110.069 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.0 106.57 6.14 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.284 -0.635 . . . . 1.38 109.284 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 91.3 t -103.94 116.45 47.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.093 -0.503 . . . . 1.73 110.353 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 44.5 tp -88.8 112.85 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.329 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -101.64 141.9 15.48 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.906 -0.664 . . . . 0.86 112.337 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.6 mt -133.64 131.75 57.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.453 -0.573 . . . . 0.76 109.453 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -86.4 148.99 25.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.921 -0.4 . . . . 1.2 109.921 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' TYR . 7.9 mp -116.79 124.01 48.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.88 110.973 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 214' ' ' PRO . 18.9 ptpt -108.1 150.52 27.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.271 -0.64 . . . . 2.03 109.271 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 92.3 t -95.01 130.55 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.133 0.492 . . . . 1.27 110.83 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.59 -103.61 0.18 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.794 -0.639 . . . . 1.53 111.731 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 p -71.07 147.22 48.71 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.839 0.352 . . . . 1.54 110.385 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 218' ' ' SER . . . -78.2 149.58 33.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.263 -0.426 . . . . 0.78 110.606 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.0 100.4 53.36 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.053 -0.521 . . . . 1.22 110.303 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -52.46 -35.02 64.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.41 2.74 . . . . 1.05 112.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.44 -21.36 64.47 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.347 -0.454 . . . . 0.7 113.524 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.507 ' HB3' ' NE2' ' A' ' 221' ' ' GLN . 27.1 tp -98.04 -6.25 32.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.3 0.55 . . . . 0.77 110.802 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.01 -41.24 74.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 1.41 111.805 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -66.04 -34.66 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.728 0.299 . . . . 2.86 111.085 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 162' ' ' VAL . 67.4 t -71.55 -50.29 40.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.283 -0.417 . . . . 1.38 110.823 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 224' ' ' LYS . 32.9 m -65.61 -24.89 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 1.11 111.255 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.74 -34.1 58.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.499 . . . . 1.22 111.495 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 159' ' ' VAL . 6.0 p -81.89 -8.77 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 1.41 110.749 -175.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.34 -27.22 63.96 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.966 -0.561 . . . . 1.39 111.391 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.15 -34.66 73.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 2.31 111.413 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.3 t -89.25 -1.55 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.664 -0.244 . . . . 1.4 111.6 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 38.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.05 0.452 . . . . 0.85 110.374 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.9 -35.33 72.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 1.59 111.023 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 p -106.39 149.02 27.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.396 0.617 . . . . 0.77 111.52 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -57.41 126.94 29.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.901 -1.045 . . . . 2.29 111.18 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.5 -22.24 20.2 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.748 -0.739 . . . . 0.85 112.642 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 60' ' ' LEU . 64.8 mttm -79.62 150.28 31.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.167 0.508 . . . . 1.7 111.472 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 60' ' ' LEU . 8.5 t -140.75 151.34 44.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.402 -0.817 . . . . 1.37 109.279 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -140.51 134.85 31.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.07 -0.344 . . . . 0.61 110.07 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.43 132.41 53.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.249 0.547 . . . . 1.8 110.402 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -141.51 80.79 1.75 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.611 -0.722 . . . . 1.04 109.585 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 32.0 p -101.34 160.9 14.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.274 0.472 . . . . 1.17 112.274 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.1 42.16 10.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.263 -0.88 . . . . 1.77 111.755 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.46 130.57 45.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 3.99 110.828 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 3.2 p30 -105.72 133.18 20.31 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 2.51 109.92 176.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 3.3 Cg_exo -77.93 -11.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.536 2.157 . . . . 1.26 111.439 173.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.52 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 18.4 mtm180 -57.68 -44.0 85.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.616 -0.72 . . . . 2.76 111.498 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -69.86 -6.48 56.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.83 -0.7 . . . . 1.12 112.978 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.454 ' O ' HG21 ' A' ' 215' ' ' ILE . 6.7 mp -108.7 -9.23 15.28 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.582 -0.364 . . . . 1.73 111.002 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 180' ' ' PRO . 95.3 mt -70.75 140.83 86.81 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.913 0.387 . . . . 3.45 111.621 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.52 -167.98 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.273 2.648 . . . . 2.08 113.308 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.7 -59.74 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 3.23 111.309 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.578 ' H ' ' HG3' ' A' ' 213' ' ' GLU . 9.7 m -91.05 140.44 29.83 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 1.66 110.949 -174.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 35.1 tp -106.02 62.78 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.549 0.69 . . . . 1.99 109.657 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 258' ' ' SER . 6.9 m-20 -122.45 171.79 8.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.829 -1.175 . . . . 1.81 107.829 176.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 44' ' ' LEU . 51.7 p90 -167.71 163.5 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.831 1.049 . . . . 5.01 113.831 -163.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.575 ' HE3' HG13 ' A' ' 210' ' ' VAL . 13.4 m-90 -105.37 141.94 36.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.223 -1.399 . . . . 3.93 107.223 164.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.4 t -138.86 109.13 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.409 0.623 . . . . 2.13 112.558 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.536 ' CD1' ' HB2' ' A' ' 28' ' ' GLN . 8.9 t80 -139.88 129.03 13.6 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.656 . . . . 5.21 109.671 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 193' ' ' TYR . 89.0 Cg_exo -48.9 134.92 29.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.058 2.505 . . . . 2.12 112.92 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 28' ' ' GLN . . . -107.48 153.39 16.83 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.82 -0.627 . . . . 1.75 113.659 -170.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 198' ' ' THR . 72.9 p -92.7 -134.45 0.15 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.68 0.792 . . . . 2.99 111.243 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.639 ' C ' ' H ' ' A' ' 199' ' ' THR . 40.4 tp -45.57 10.11 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 126.387 1.875 . . . . 4.75 116.03 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 196' ' ' SER . 1.4 p -68.01 26.0 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.789 -1.195 . . . . 5.1 110.898 166.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.639 ' H ' ' C ' ' A' ' 197' ' ' LEU . 9.7 t -148.48 149.69 32.07 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 114.658 -1.156 . . . . 5.53 108.449 -175.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.442 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 77.6 Cg_exo -44.19 -51.35 6.81 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.066 2.511 . . . . 5.83 115.245 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 11.1 Cg_endo -91.16 158.69 3.83 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.307 2.005 . . . . 4.78 112.61 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 202' ' ' LEU . 0.7 OUTLIER -75.43 74.59 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.292 0.568 . . . . 3.84 110.206 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.7 pp -151.81 174.55 13.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.663 -0.699 . . . . 2.96 110.727 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -112.78 85.94 2.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.563 0.697 . . . . 3.37 110.502 -177.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.5 p -111.93 3.43 17.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.167 -0.47 . . . . 2.15 111.07 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.04 134.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.281 0.563 . . . . 1.26 111.819 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.5 m -102.9 97.85 7.92 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.079 -1.452 . . . . 2.08 107.079 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.422 ' HE1' ' CD2' ' A' ' 119' ' ' HIS . 9.2 t90 -88.77 120.35 30.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.076 0.465 . . . . 5.53 110.815 -169.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 71.3 mt -126.18 118.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 1.63 109.356 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.575 HG13 ' HE3' ' A' ' 191' ' ' TRP . 3.4 p -120.32 126.26 75.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.808 0.337 . . . . 1.62 110.602 -174.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.22 137.02 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.079 -0.51 . . . . 1.73 110.596 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.573 ' HG3' ' CZ2' ' A' ' 191' ' ' TRP . 33.6 ttmt -81.53 -1.36 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 2.98 110.756 -177.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.578 ' HG3' ' H ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -111.8 91.65 15.56 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.3 -0.63 . . . . 1.47 109.3 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 18.9 Cg_exo -66.61 147.44 81.81 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.775 2.317 . . . . 0.96 112.031 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.454 HG21 ' O ' ' A' ' 183' ' ' LEU . 38.8 pt -94.61 154.35 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 1.25 110.751 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 22.9 m -99.92 137.92 37.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.975 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 12.6 m -134.63 155.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.634 -0.712 . . . . 1.02 109.193 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 152' ' ' ALA . 44.9 t -83.44 154.8 23.77 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.941 -0.303 . . . . 1.08 110.602 -176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.649 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 6.3 p -54.91 -45.56 74.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.583 -0.28 . . . . 1.33 110.531 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 43.5 mt-10 -55.69 -27.76 51.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.204 -0.453 . . . . 2.51 111.5 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 52.9 mt-30 -80.27 -47.39 14.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.7 110.454 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.608 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 35.1 m -71.91 -26.69 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 1.36 111.499 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 219' ' ' SER . 96.7 mt -66.72 -30.3 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.79 0.329 . . . . 1.03 110.445 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 160' ' ' VAL . 96.1 mttt -69.43 -24.29 63.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 1.75 110.765 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 21.9 m-85 -75.73 -25.01 56.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 2.47 109.774 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -79.29 -10.94 59.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 3.04 110.189 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -90.29 -8.78 50.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 2.31 110.35 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.26 150.48 48.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.95 110.425 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.7 m120 -110.21 136.35 49.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.409 0.623 . . . . 1.13 110.613 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -76.93 -30.5 56.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.758 -1.11 . . . . 3.74 109.739 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.6 p-10 -73.61 164.38 26.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.128 -0.942 . . . . 1.62 112.132 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -86.83 174.32 46.0 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.073 -0.967 . . . . 1.16 111.079 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.11 135.84 55.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.243 0.521 . . . . 3.56 110.511 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 90.69 7.91 66.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.859 -0.686 . . . . 2.08 112.434 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -112.53 159.24 34.88 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 110.244 -0.28 . . . . 2.59 110.244 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.26 124.0 15.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.453 2.102 . . . . 1.36 110.911 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.451 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 11.9 pt-20 -62.01 123.93 19.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.819 0.819 . . . . 3.4 111.909 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 43.5 mt-10 -116.97 125.27 51.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.843 -1.071 . . . . 2.47 108.486 172.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 73.1 mt -70.05 147.57 49.88 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.117 -0.492 . . . . 2.14 110.619 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 11.9 tpt -73.94 92.13 2.07 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.528 -0.916 . . . . 1.68 108.528 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 16.0 m -140.21 142.12 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.674 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 30.1 t70 66.42 -95.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.226 -0.897 . . . . 2.18 109.497 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 m120 53.25 19.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.483 0.549 . . . . 2.15 112.483 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -150.08 164.31 35.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.792 0.33 . . . . 4.59 110.406 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.432 ' HE ' ' NE2' ' A' ' 248' ' ' GLN . 12.6 ptm180 -107.78 148.12 36.74 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.926 -0.579 . . . . 6.13 110.898 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.97 161.98 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.625 2.883 . . . . 3.28 113.623 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -71.2 143.66 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.334 -0.848 . . . . 2.98 110.695 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.659 ' HB2' HG12 ' A' ' 31' ' ' VAL . 41.9 mt-30 -124.69 170.54 8.79 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.867 -0.606 . . . . 4.32 111.1 -169.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 248' ' ' GLN . 6.5 Cg_exo -76.09 174.94 11.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.401 2.734 . . . . 3.48 115.031 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.42 -8.7 57.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 113.879 -1.51 . . . . 4.63 113.069 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 18.4 pttp -55.21 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.319 2.34 . . . . 5.34 117.319 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 3.3 p-10 134.62 28.71 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.976 1.71 . . . . 4.64 112.065 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.433 ' NE ' HD11 ' A' ' 255' ' ' ILE . 56.3 ttt180 -147.94 120.05 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.924 -0.399 . . . . 6.11 109.924 162.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -146.79 122.39 10.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.429 -1.322 . . . . 3.08 107.429 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 191' ' ' TRP . 14.8 mt -124.85 145.83 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.006 0.432 . . . . 2.6 111.803 -168.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.46 143.55 48.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.625 -0.716 . . . . 2.63 110.041 169.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -118.59 92.72 3.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.157 -0.474 . . . . 1.71 110.097 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 69.0 m -105.55 100.67 10.23 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.288 -0.565 . . . . 2.21 111.724 -172.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -126.27 100.43 6.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.136 -1.061 . . . . 4.31 108.136 168.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.503 -0.761 . . . . 4.49 110.808 -173.279 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.702 0.287 . . . . 17.49 110.829 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 p -97.2 -24.97 15.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.148 -0.221 . . . . 15.32 111.465 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -86.55 25.02 1.3 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.074 0.464 . . . . 15.81 111.211 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -77.82 95.47 4.72 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.727 -0.842 . . . . 14.19 108.727 174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -88.31 139.6 30.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.817 0.341 . . . . 14.91 110.57 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.71 163.7 30.86 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.431 -0.667 . . . . 10.79 111.431 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -86.99 99.3 11.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.536 0.208 . . . . 11.39 110.607 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.65 157.11 21.29 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.705 -0.76 . . . . 9.0 112.367 175.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 56.0 tttp -58.29 148.46 27.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.241 -0.281 . . . . 9.76 110.241 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 91.1 m-70 73.72 -46.56 0.63 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.64 0.776 . . . . 11.19 111.354 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -78.26 -16.2 58.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.485 0.659 . . . . 10.8 109.596 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.73 -127.08 2.46 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.331 -0.85 . . . . 8.82 111.351 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 16' ' ' TRP . 57.9 Cg_endo -72.89 131.88 17.62 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.355 2.037 . . . . 7.87 111.895 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -87.69 -41.21 13.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.721 -0.672 . . . . 10.62 110.916 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -107.04 26.39 10.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.996 -0.547 . . . . 9.87 110.505 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 74.1 t90 -46.78 -41.94 16.17 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.61 -0.723 . . . . 8.48 112.053 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.435 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 31.9 m-70 -70.67 -23.47 62.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.895 0.379 . . . . 7.13 111.153 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -87.45 -35.12 18.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 9.68 110.437 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.07 -24.97 59.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.895 -0.593 . . . . 7.89 110.655 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -114.67 93.45 33.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.731 -0.668 . . . . 7.17 109.749 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.43 -31.19 46.91 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.344 2.696 . . . . 7.76 113.14 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -51.19 -27.58 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.46 0.541 . . . . 5.83 112.46 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HA ' HD13 ' A' ' 202' ' ' LEU . . . -64.36 -29.5 70.57 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.735 0.302 . . . . 5.44 111.348 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 17' ' ' HIS . 31.5 mmtp -68.42 -11.73 60.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.268 0.556 . . . . 7.78 110.47 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.37 36.38 2.59 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.591 -1.004 . . . . 5.01 110.591 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -62.92 152.76 35.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.257 -0.471 . . . . 7.09 112.031 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -147.95 127.26 13.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.763 -0.828 . . . . 5.13 108.763 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.643 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 33.6 tt0 -142.68 170.58 15.44 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.558 -0.905 . . . . 7.12 108.558 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.567 ' N ' ' HG2' ' A' ' 28' ' ' GLN . 16.0 m -88.94 100.06 1.89 Allowed Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.092 -0.707 . . . . 3.94 109.092 170.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.643 ' HD3' ' O ' ' A' ' 28' ' ' GLN . 74.4 Cg_endo -101.08 -17.4 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.004 2.469 . . . . 4.52 113.605 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 253' ' ' ARG . 27.7 m -95.63 172.93 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.046 0.45 . . . . 4.54 111.697 -168.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -127.55 145.38 50.88 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.053 -1.091 . . . . 2.88 108.053 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 109' ' ' VAL . 57.1 mt -65.62 103.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.41 0.624 . . . . 2.32 111.191 -169.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' A' ' 37' ' ' THR . 20.9 m-20 -83.44 102.66 12.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.929 -1.032 . . . . 2.82 108.947 176.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -55.02 -35.65 64.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.405 0.52 . . . . 2.24 112.405 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -84.66 -28.58 26.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.092 0.404 . . . . 4.54 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 5.7 m -89.12 -15.81 32.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.285 0.564 . . . . 3.06 110.91 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.02 142.16 56.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 1.72 110.747 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -104.32 116.45 32.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.376 -0.602 . . . . 3.69 109.376 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -87.59 87.18 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.31 0.576 . . . . 4.64 110.835 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' OD2' ' HG ' ' A' ' 44' ' ' LEU . 19.6 t70 -73.93 119.72 77.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 2.27 110.91 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.57 -16.71 9.09 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.876 2.384 . . . . 2.15 112.918 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 m -70.25 -46.22 64.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.636 -0.505 . . . . 4.29 109.636 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.433 ' HG ' ' OD2' ' A' ' 41' ' ' ASP . 95.9 mt -54.29 144.52 20.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.417 -0.811 . . . . 4.74 111.008 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HD3' ' HD2' ' A' ' 46' ' ' PRO . 16.6 tppt? -117.1 124.07 29.49 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.672 -0.695 . . . . 3.77 109.835 -174.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 73.3 Cg_exo -51.52 122.76 10.81 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.258 1.972 . . . . 2.36 111.623 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.95 126.87 30.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.539 -0.755 . . . . 2.55 110.606 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.461 ' O ' HD12 ' A' ' 79' ' ' LEU . 53.7 p -67.35 136.19 54.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.706 -0.479 . . . . 2.38 109.706 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.46 97.25 5.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.818 -0.438 . . . . 1.59 109.818 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 9.8 m -97.14 88.62 4.53 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.478 -0.564 . . . . 1.45 109.478 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.55 ' CE1' ' HA ' ' A' ' 181' ' ' ARG . 1.0 OUTLIER -129.23 18.09 5.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.5 0.667 . . . . 3.62 109.896 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.06 -28.83 69.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.016 -0.993 . . . . 2.48 110.216 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.2 7.84 45.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.262 -0.426 . . . . 2.24 111.256 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . . . -62.71 133.64 55.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.738 0.304 . . . . 0.8 111.717 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.589 ' OG1' ' HE2' ' A' ' 76' ' ' LYS . 10.7 m -121.1 119.13 31.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.085 -0.507 . . . . 1.06 110.532 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 t -83.92 150.25 25.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.308 -0.405 . . . . 1.26 110.431 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.0 mt -116.71 -55.44 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.424 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -169.75 160.83 8.93 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.425 -0.352 . . . . 3.17 110.942 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 17.4 tt -109.32 144.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.64 109.281 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.6 tp -135.68 136.93 41.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.313 0.578 . . . . 0.96 111.779 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.458 ' CB ' ' HA ' ' A' ' 169' ' ' LYS . 4.2 m-20 -88.43 106.03 17.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.943 -1.026 . . . . 1.49 109.32 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 64' ' ' HIS . 44.6 m-80 -100.04 75.19 1.84 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.382 -0.372 . . . . 1.83 111.4 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA2' ' HD2' ' A' ' 169' ' ' LYS . . . 65.93 -26.15 0.15 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 115.56 0.984 . . . . 1.64 115.56 174.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' ASN . 25.5 p80 -163.76 -25.82 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.76 0.314 . . . . 3.33 111.533 -172.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.74 157.93 19.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.12 -0.326 . . . . 1.38 110.12 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -131.7 96.37 3.94 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.51 -0.922 . . . . 2.74 108.51 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -115.86 145.59 42.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.23 -0.896 . . . . 1.76 111.437 -170.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 58.8 t -93.71 121.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.781 -0.645 . . . . 1.15 110.049 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -86.52 125.05 33.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.69 -0.686 . . . . 2.02 109.787 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -103.83 164.38 11.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.919 0.39 . . . . 1.66 110.674 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.64 116.16 28.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.879 -0.6 . . . . 1.33 109.824 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -127.77 59.99 1.45 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.925 0.869 . . . . 2.65 110.795 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -75.9 -5.29 45.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.435 -0.802 . . . . 1.61 110.614 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -157.61 176.94 11.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.734 -0.666 . . . . 2.35 109.218 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.65 30.38 0.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.385 -0.371 . . . . 1.92 111.194 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HE2' ' OG1' ' A' ' 55' ' ' THR . 2.4 ptpp? -50.77 -44.94 58.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.75 -0.659 . . . . 1.77 111.628 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -120.15 99.54 6.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.367 . . . . 0.76 110.119 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.2 m -129.0 168.36 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.386 0.613 . . . . 1.27 111.739 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 48' ' ' SER . 38.7 tp -137.19 111.45 8.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.04 -0.982 . . . . 1.29 108.416 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -150.45 126.34 10.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 2.54 111.419 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 173.94 24.28 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.965 -0.561 . . . . 1.31 113.347 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -36.78 -134.11 0.0 OUTLIER Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.349 0.976 . . . . 1.9 114.545 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -44.9 169.92 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.226 2.618 . . . . 2.91 112.712 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -35.8 150.34 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.472 1.286 . . . . 4.11 114.472 -154.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 13.8 p-10 174.58 -66.61 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.797 -1.092 . . . . 4.95 111.227 -156.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 85' ' ' ASP . . . 79.6 141.8 2.44 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.371 -0.691 . . . . 2.25 111.371 -170.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 125' ' ' THR . 23.3 m -88.51 125.69 34.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.695 0.747 . . . . 1.91 111.033 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 85.2 m-85 -118.65 126.36 51.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.325 -0.398 . . . . 3.7 111.24 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 99.4 mtt180 -83.0 135.63 34.79 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.55 -0.295 . . . . 3.54 111.024 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.45 117.02 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.48 -0.563 . . . . 1.14 109.48 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.454 HG23 ' HG2' ' A' ' 92' ' ' GLN . 6.9 tt -110.12 -36.34 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.335 -0.393 . . . . 1.68 111.241 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.454 ' HG2' HG23 ' A' ' 91' ' ' ILE . 20.6 pt20 -162.86 168.31 21.48 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.339 -0.245 . . . . 1.55 110.339 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 118' ' ' LEU . 23.4 p90 -141.1 149.31 41.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.921 -0.4 . . . . 0.86 109.921 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -140.4 158.02 44.64 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.151 0.282 . . . . 0.93 110.714 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.7 m-85 -108.86 153.2 23.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.407 -0.36 . . . . 3.17 110.108 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -105.52 153.55 21.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 1.68 111.903 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.655 ' CB ' ' HA2' ' A' ' 104' ' ' GLY . 0.7 OUTLIER 69.37 -88.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.738 -1.119 . . . . 5.18 111.984 170.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 241' ' ' VAL . . . 69.69 118.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.161 -0.542 . . . . 2.13 112.055 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 98' ' ' GLY . 23.1 t 176.16 -89.53 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.03 0.415 . . . . 2.9 111.435 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.72 170.82 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 3.03 111.382 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.05 45.14 0.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.409 -0.814 . . . . 3.85 111.341 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -176.56 20.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.905 . . . . 1.94 112.828 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -155.86 120.03 4.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 2.45 110.043 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.655 ' HA2' ' CB ' ' A' ' 97' ' ' TRP . . . 157.71 -26.52 0.45 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.817 -0.706 . . . . 1.47 111.551 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.526 ' HB2' ' H ' ' A' ' 114' ' ' TYR . 43.2 m -81.35 64.73 6.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.098 0.559 . . . . 2.0 110.283 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.15 143.06 55.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.75 -0.463 . . . . 3.72 109.75 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 34.7 m80 61.65 25.64 15.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.984 0.421 . . . . 3.52 111.618 174.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.4 t -82.68 -175.54 5.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.5 . . . . 2.52 111.512 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 15.0 m -71.07 106.81 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 2.48 111.715 -166.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.0 t70 58.2 31.11 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.991 -1.459 . . . . 2.8 109.724 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.5 mttp 66.81 28.67 8.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.984 -1.007 . . . . 4.98 112.479 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -69.24 72.31 0.29 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.168 0.509 . . . . 3.23 110.488 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -58.75 114.29 2.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.415 -0.811 . . . . 2.82 112.584 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.526 ' H ' ' HB2' ' A' ' 105' ' ' SER . 67.2 m-85 -106.31 -163.16 0.9 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.343 -0.844 . . . . 1.62 109.276 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.61 95.18 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.13 0.789 . . . . 1.03 113.13 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.11 169.66 15.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.456 0.539 . . . . 0.75 112.456 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -122.59 135.01 54.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.501 -1.227 . . . . 1.58 108.25 171.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.489 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 40.3 tp -116.06 116.41 27.82 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.243 -0.28 . . . . 1.07 110.243 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -106.25 110.3 22.49 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 1.77 111.314 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 6.2 mp -88.21 102.71 15.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.601 -0.888 . . . . 0.93 108.601 173.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.31 120.55 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.727 -0.67 . . . . 0.61 110.783 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 12.7 m-70 -117.1 141.99 47.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.984 -0.747 . . . . 2.13 108.984 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CZ2' ' HD2' ' A' ' 89' ' ' ARG . 61.5 p-90 -111.87 141.22 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.801 0.334 . . . . 4.26 110.854 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.469 HD21 ' HE2' ' A' ' 126' ' ' LYS . 44.4 t30 -62.12 110.63 1.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.473 0.654 . . . . 2.02 111.519 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.401 HG22 ' HB ' ' A' ' 87' ' ' THR . 11.3 t -61.5 -33.45 73.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.934 -1.03 . . . . 2.34 112.872 -170.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.469 ' HE2' HD21 ' A' ' 124' ' ' ASN . 21.4 pttm -72.02 -6.81 44.96 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.239 0.829 . . . . 3.35 113.239 -172.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 136' ' ' GLN . 43.4 m-85 -97.93 -4.23 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.568 -0.453 . . . . 3.1 110.836 172.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.5 26.55 5.24 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.074 -0.966 . . . . 2.37 114.779 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.37 122.91 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.547 0.673 . . . . 3.93 109.669 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 134' ' ' VAL . 46.3 p90 -69.37 -31.98 70.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 3.0 111.521 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.24 -37.23 92.66 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.751 -0.738 . . . . 2.15 112.007 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -70.49 -32.88 70.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.35 0.595 . . . . 3.43 109.61 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.423 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -68.73 -25.27 64.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 1.76 111.085 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 130' ' ' PHE . 93.8 t -68.5 -25.89 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.182 0.515 . . . . 2.77 110.394 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -81.58 -13.82 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 3.55 110.774 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 127' ' ' TYR . 14.2 mm100 -111.18 135.91 20.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.051 -0.522 . . . . 3.02 110.1 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.11 -21.41 55.88 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.671 2.248 . . . . 1.6 112.796 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -113.0 25.45 11.39 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.931 -0.396 . . . . 2.29 109.931 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -78.76 -30.04 49.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.693 . . . . 1.22 113.892 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 206' ' ' VAL . 88.1 mt -123.67 158.62 31.15 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.352 -0.499 . . . . 1.57 110.546 -177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.7 121.05 7.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 1.38 110.031 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 m -110.52 119.65 59.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.022 0.439 . . . . 1.73 110.418 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 59.2 tp -83.41 104.87 13.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.467 -0.568 . . . . 2.42 109.467 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -90.36 114.92 4.49 Favored Glycine 0 N--CA 1.446 -0.65 0 O-C-N 123.652 0.595 . . . . 0.86 112.363 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.7 mt -117.06 105.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.389 -0.597 . . . . 0.76 109.389 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 86.6 m-85 -66.24 154.47 39.78 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.122 0.487 . . . . 1.2 111.712 -178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.451 HD23 HG11 ' A' ' 217' ' ' VAL . 7.8 mp -112.68 112.75 24.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.544 -0.753 . . . . 0.88 110.071 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -96.72 147.17 24.19 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.157 -0.683 . . . . 2.03 109.157 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.82 126.41 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 1.27 110.92 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 176.23 -106.79 0.22 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.421 -0.672 . . . . 1.53 111.421 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.7 m -69.13 140.64 54.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.824 -0.436 . . . . 1.54 109.824 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.43 152.62 45.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.562 -0.29 . . . . 0.78 110.805 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 154' ' ' PRO . 47.4 tptt -108.6 95.29 16.01 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.941 -0.762 . . . . 1.22 108.941 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 153' ' ' LYS . 15.5 Cg_endo -57.02 -35.9 99.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.994 2.463 . . . . 1.05 112.966 -173.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.43 -18.4 79.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.913 -0.66 . . . . 0.7 113.061 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.4 tp -90.15 -20.8 22.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.921 0.391 . . . . 0.77 110.805 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.688 HE21 ' HA ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -55.82 -34.25 65.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.947 -0.569 . . . . 1.41 112.154 -175.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -51.75 -41.1 61.34 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 112.534 0.568 . . . . 2.86 112.534 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.5 p -85.56 -38.96 13.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.347 -0.541 . . . . 1.38 111.018 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.5 HG12 ' HD2' ' A' ' 224' ' ' LYS . 31.4 t -63.22 -47.22 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.322 -0.399 . . . . 1.11 111.765 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -18.35 62.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.065 0.394 . . . . 1.22 112.065 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 162' ' ' VAL . 44.4 t -96.22 -1.59 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 121.197 0.523 . . . . 1.41 111.013 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.8 -24.97 66.22 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.901 0.381 . . . . 1.39 111.304 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -67.9 -31.68 71.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.46 -0.336 . . . . 2.31 110.717 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 44.5 m -76.9 -5.07 47.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 1.4 111.628 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.5 pt -137.78 45.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.85 109.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -67.05 -28.97 68.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.418 -0.81 . . . . 1.59 110.986 -175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.9 p -116.38 149.05 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.724 0.297 . . . . 0.77 110.723 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.484 ' HD2' ' HA2' ' A' ' 63' ' ' GLY . 56.3 pttt -65.25 148.88 50.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.457 -0.338 . . . . 2.29 110.104 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.55 33.84 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.457 -0.878 . . . . 0.85 111.37 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -82.22 157.58 23.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.419 0.628 . . . . 1.7 111.146 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.2 p -141.72 154.04 45.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 1.37 109.122 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -137.13 122.95 20.01 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.969 -0.382 . . . . 0.61 109.969 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.25 144.66 56.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.967 -0.561 . . . . 1.8 111.314 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.36 81.2 1.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 1.04 110.327 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 p -112.25 159.12 18.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.495 -0.32 . . . . 1.17 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 56.6 43.59 25.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.06 -0.518 . . . . 1.77 111.386 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.08 140.35 52.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.401 -0.363 . . . . 3.99 110.23 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -92.15 110.33 43.59 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.392 -0.367 . . . . 2.51 110.467 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.23 -14.85 13.07 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.463 2.109 . . . . 1.26 112.361 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.55 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . 9.4 ttp180 -71.93 -24.15 61.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 2.76 111.267 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -61.3 -2.8 3.27 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.342 -0.39 . . . . 1.12 113.867 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.54 -8.77 57.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.93 0.365 . . . . 1.73 110.979 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.4 pp -48.05 137.28 10.94 Favored Pre-proline 0 C--O 1.236 0.371 0 N-CA-C 113.425 0.898 . . . . 3.45 113.425 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.403 ' HG3' HD21 ' A' ' 211' ' ' LEU . 69.1 Cg_endo -94.92 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.553 2.835 . . . . 2.08 111.483 170.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 31.8 mt-10 -90.35 -64.18 1.17 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.836 0.309 . . . . 3.23 111.836 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.489 ' H ' ' HG2' ' A' ' 213' ' ' GLU . 4.1 m -99.32 146.93 25.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 1.66 111.627 -172.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 211' ' ' LEU . 83.9 mt -111.29 65.12 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.979 0.419 . . . . 1.99 111.197 177.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.486 ' O ' HD12 ' A' ' 211' ' ' LEU . 33.0 m-20 -108.41 168.68 9.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.038 -1.097 . . . . 1.81 108.038 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.667 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 13.2 p90 -159.58 154.13 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.252 -0.979 . . . . 5.01 112.988 -170.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.707 ' CE3' ' HB2' ' A' ' 257' ' ' ALA . 6.9 m95 -111.84 142.17 44.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.419 -1.264 . . . . 3.93 107.747 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.0 t -121.66 113.24 19.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.548 0.69 . . . . 2.13 112.434 -174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 49.6 t80 -138.24 131.21 16.38 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 5.21 110.534 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 193' ' ' TYR . 10.0 Cg_endo -54.66 139.39 76.55 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.86 2.374 . . . . 2.12 112.165 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.472 ' HA2' ' OG ' ' A' ' 29' ' ' SER . . . -138.36 159.17 25.17 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.142 -0.552 . . . . 1.75 113.443 -170.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.6 t -114.08 129.82 56.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.79 -1.189 . . . . 2.99 107.79 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.47 -47.74 66.3 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.419 0.896 . . . . 4.75 113.419 -161.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 200' ' ' PRO . 1.3 t -121.81 -46.92 2.21 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.863 -0.735 . . . . 5.1 112.723 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.721 ' OG1' ' HD3' ' A' ' 200' ' ' PRO . 0.3 OUTLIER 156.08 -66.33 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 124.73 1.212 . . . . 5.53 111.455 -176.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.721 ' HD3' ' OG1' ' A' ' 199' ' ' THR . 52.5 Cg_exo -55.49 -41.28 79.51 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.339 2.693 . . . . 5.83 116.337 -170.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.73 -24.48 55.32 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 121.636 1.557 . . . . 4.78 112.961 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 200' ' ' PRO . 94.8 mt 53.98 23.55 4.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.952 -1.022 . . . . 3.84 112.922 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.01 172.47 8.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.703 -0.226 . . . . 2.96 110.588 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -113.47 58.34 0.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.63 0.729 . . . . 3.37 110.392 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.64 -15.43 57.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.988 -1.006 . . . . 2.15 110.519 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 40.6 t -100.65 151.28 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.714 -0.675 . . . . 1.26 110.66 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -117.57 109.35 16.59 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.734 -0.839 . . . . 2.08 108.734 174.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.41 ' CD1' HG22 ' A' ' 210' ' ' VAL . 3.7 t90 -74.01 100.82 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.951 -0.759 . . . . 5.53 108.951 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.59 99.6 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.688 -0.856 . . . . 1.63 108.688 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 190' ' ' TYR . 21.5 t -86.19 111.22 20.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 116.202 -0.454 . . . . 1.62 109.903 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 189' ' ' ASP . 20.6 tp -72.21 120.48 17.88 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.935 -0.765 . . . . 1.73 108.935 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -66.23 -14.91 62.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.243 -0.435 . . . . 2.98 111.708 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 186' ' ' GLU . 7.1 tp10 -104.71 96.49 10.6 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.573 0.225 . . . . 1.47 110.787 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.443 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 63.0 Cg_endo -77.4 144.98 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.461 2.107 . . . . 0.96 111.828 176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 36.3 pt -88.78 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.178 -0.465 . . . . 1.25 111.291 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.4 m -94.68 126.71 40.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.663 . . . . 1.29 110.334 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 147' ' ' LEU . 33.8 m -127.49 158.79 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.765 -0.457 . . . . 1.02 109.765 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 55.1 p -95.85 158.69 15.33 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.912 -0.315 . . . . 1.08 111.07 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.613 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 63.8 m -56.55 -39.26 73.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.935 -0.575 . . . . 1.33 110.694 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.89 -31.02 26.44 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 2.51 111.372 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.91 -45.1 13.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.45 . . . . 0.7 110.175 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.38 -40.71 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.916 -0.584 . . . . 1.36 111.475 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 219' ' ' SER . 89.7 mt -59.24 -35.13 73.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 1.03 111.8 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.5 ' HD2' HG12 ' A' ' 160' ' ' VAL . 66.1 mttp -70.19 -23.47 62.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.628 -0.26 . . . . 1.75 111.473 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -72.87 -25.43 61.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.22 0.533 . . . . 2.47 110.094 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -80.8 -9.89 59.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.809 -0.632 . . . . 3.04 110.603 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -86.9 -10.13 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 2.31 110.444 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.22 148.63 48.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.886 -0.597 . . . . 0.95 110.853 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.595 ' ND2' ' HG3' ' A' ' 237' ' ' GLU . 11.5 m120 -113.84 139.43 49.17 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.419 0.628 . . . . 1.13 110.331 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -76.05 -30.62 58.48 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.768 -1.106 . . . . 3.74 109.568 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.438 ' C ' ' HG2' ' A' ' 169' ' ' LYS . 4.5 p-10 -76.24 171.08 15.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.118 -0.947 . . . . 1.62 112.247 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -93.87 -179.33 38.91 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.763 -1.108 . . . . 1.16 111.288 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.65 129.17 38.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 3.56 110.866 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.94 4.34 48.31 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.472 -0.785 . . . . 2.08 112.547 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -116.05 153.94 48.43 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.249 -0.278 . . . . 2.59 110.249 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.36 131.81 48.04 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.857 2.371 . . . . 1.36 111.774 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.595 ' HG3' ' ND2' ' A' ' 229' ' ' ASN . 31.2 tt0 -53.65 115.15 1.82 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.592 0.71 . . . . 3.4 112.755 -174.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -108.82 117.86 35.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.896 -1.15 . . . . 2.47 107.896 168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.68 125.46 25.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.678 0.275 . . . . 2.14 110.713 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.5 ttm -77.37 90.32 3.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.065 -0.717 . . . . 1.68 109.065 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 27.7 m -136.36 151.74 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.836 -0.62 . . . . 1.27 109.872 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 14.1 t70 69.67 -87.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.696 0.622 . . . . 2.18 110.588 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 48.98 15.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.364 1.246 . . . . 2.15 114.364 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.413 ' HD1' ' H ' ' A' ' 97' ' ' TRP . 98.5 m95 -150.46 177.97 9.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.272 0.487 . . . . 4.59 110.689 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -116.75 131.56 23.85 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.204 -0.295 . . . . 6.13 110.204 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 247' ' ' ALA . 59.7 Cg_endo -73.72 -148.34 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.83 2.354 . . . . 3.28 112.772 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 246' ' ' PRO . . . -82.95 136.1 34.66 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.924 -0.485 . . . . 2.98 111.486 -171.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 73.6 mm-40 -123.09 162.31 40.01 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.791 -0.64 . . . . 4.32 110.215 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.51 177.82 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.804 3.003 . . . . 3.48 114.341 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.38 -4.7 0.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.245 1.418 . . . . 4.63 113.306 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 252' ' ' ASN . 75.0 mmtt -54.11 49.4 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.489 1.515 . . . . 5.34 114.975 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 251' ' ' LYS . 3.3 t30 132.67 62.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.911 2.084 . . . . 4.64 111.968 175.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.546 ' O ' HG11 ' A' ' 31' ' ' VAL . 29.8 mtm180 88.29 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.418 -1.265 . . . . 6.11 112.689 153.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.424 HE21 ' HB2' ' A' ' 254' ' ' GLN . 0.0 OUTLIER -157.83 163.7 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.645 -0.872 . . . . 3.08 108.645 -171.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.66 125.17 62.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.818 0.342 . . . . 2.6 111.461 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -106.8 177.14 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 2.63 109.896 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.707 ' HB2' ' CE3' ' A' ' 191' ' ' TRP . . . -136.67 171.78 13.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.772 0.32 . . . . 1.71 111.487 -170.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.3 m -129.43 97.31 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.262 0.553 . . . . 2.21 110.157 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -153.62 138.98 17.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.835 -0.802 . . . . 4.31 108.835 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.366 -0.826 . . . . 4.49 111.043 -175.378 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.97 0.414 . . . . 17.49 110.557 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 m -155.98 92.18 1.34 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.735 -0.839 . . . . 15.32 108.735 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.402 ' HB3' ' H ' ' A' ' 4' ' ' HIS . 4.6 t60 -75.62 -84.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.036 -0.529 . . . . 15.81 110.641 -174.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.402 ' H ' ' HB3' ' A' ' 3' ' ' HIS . 2.4 m80 -166.36 -75.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.348 -0.612 . . . . 14.19 109.348 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -110.42 -176.89 3.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.047 -0.524 . . . . 14.91 109.779 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.11 134.38 3.24 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.196 -1.002 . . . . 10.79 112.692 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -90.45 99.6 12.59 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.869 -0.419 . . . . 11.39 109.869 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.01 -62.22 0.5 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.758 -0.734 . . . . 9.0 111.739 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.563 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -49.88 127.11 15.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.274 -0.269 . . . . 9.76 110.274 173.357 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -69.97 2.05 3.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.115 -0.493 . . . . 11.19 111.599 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.589 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 9.6 t30 -116.84 -15.23 10.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.282 -0.417 . . . . 10.8 110.337 174.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.95 -97.17 1.89 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.839 -0.696 . . . . 8.82 111.934 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 11' ' ' ASN . 17.8 Cg_endo -60.48 160.83 22.45 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.134 2.556 . . . . 7.87 113.039 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.22 3.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.619 1.168 . . . . 10.62 113.902 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -68.09 -19.66 64.87 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.92 0.867 . . . . 9.87 108.988 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.42 ' CE3' ' HB2' ' A' ' 11' ' ' ASN . 5.7 t-105 -62.75 -8.59 7.05 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.18 -1.373 . . . . 8.48 111.813 175.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 20' ' ' PHE . 8.7 p-80 -59.48 -3.5 0.46 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.056 1.132 . . . . 7.13 114.056 -172.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -52.59 -29.37 25.44 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.484 0.55 . . . . 9.68 112.484 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -123.49 12.49 9.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.185 0.517 . . . . 7.89 111.037 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' O ' HG22 ' A' ' 22' ' ' ILE . 78.6 m-85 -124.88 106.3 29.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.701 -0.681 . . . . 7.17 110.114 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.04 -26.91 19.98 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.588 2.858 . . . . 7.76 114.226 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.58 HD12 HD22 ' A' ' 202' ' ' LEU . 4.5 tt -14.0 -47.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 114.544 1.313 . . . . 5.83 114.544 169.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.32 -24.52 4.7 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.756 0.651 . . . . 5.44 112.756 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -117.79 -10.77 10.43 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.077 0.399 . . . . 7.78 112.077 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.96 -87.29 0.06 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 119.979 -1.105 . . . . 5.01 113.416 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.657 ' HA ' ' OE2' ' A' ' 204' ' ' GLU . 1.2 mp0 -40.83 168.8 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.893 1.072 . . . . 7.09 113.893 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.486 HH21 ' CD ' ' A' ' 204' ' ' GLU . 14.4 ptp180 -151.61 138.2 18.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.32 -0.993 . . . . 5.13 108.32 -153.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -73.26 -62.64 1.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.457 0.572 . . . . 7.12 110.9 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.6 m -105.91 155.05 38.98 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 107.307 -1.368 . . . . 3.94 107.307 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 253' ' ' ARG . 1.6 Cg_endo -82.18 -50.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.249 0 CA-C-N 120.114 1.076 . . . . 4.52 112.468 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 255' ' ' ILE . 6.3 p -169.1 143.25 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.726 -0.39 . . . . 4.54 111.632 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 31' ' ' VAL . 1.1 p-10 -84.62 139.74 31.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.871 -0.789 . . . . 2.88 108.871 164.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.53 ' HA ' HD13 ' A' ' 255' ' ' ILE . 64.7 mt -86.29 86.83 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.494 0.664 . . . . 2.32 110.888 -171.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -94.29 101.73 13.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.681 -0.69 . . . . 2.82 109.146 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -58.62 -25.31 62.54 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.612 0.597 . . . . 2.24 112.612 -175.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -73.87 -44.14 56.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.8 0.333 . . . . 4.54 110.455 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 m -81.36 -21.02 39.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.459 . . . . 3.06 111.284 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 255' ' ' ILE . . . -56.8 142.1 42.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.468 -0.333 . . . . 1.72 110.826 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -134.42 114.46 12.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.706 0.289 . . . . 3.69 110.557 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -63.18 135.67 57.28 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.559 -0.534 . . . . 4.64 109.559 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -108.37 120.59 46.12 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.358 -0.383 . . . . 2.27 110.0 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.39 -24.02 50.47 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.695 2.264 . . . . 2.15 112.982 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.0 m -77.89 -26.84 49.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.795 0.331 . . . . 4.29 111.026 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 92.1 mt -83.28 140.9 32.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 4.74 110.475 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.44 159.92 38.13 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.082 -0.508 . . . . 3.77 110.864 -174.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.78 162.91 6.14 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.235 2.623 . . . . 2.36 113.255 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.576 ' HG ' ' CE2' ' A' ' 190' ' ' TYR . 95.2 mt -71.14 132.64 45.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.324 -0.853 . . . . 2.55 111.27 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 m -100.06 97.11 7.99 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.245 -1.021 . . . . 2.38 108.245 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.72 103.03 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.086 -0.506 . . . . 1.59 109.853 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 16.5 m -99.59 89.47 4.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.302 -0.629 . . . . 1.45 109.302 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -112.2 10.13 20.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.209 -0.45 . . . . 3.62 111.207 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.84 -30.71 64.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.891 0.377 . . . . 2.48 111.547 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 1.5 mp0 -109.04 39.64 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.361 -0.381 . . . . 2.24 110.427 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.99 57.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.821 0.343 . . . . 0.8 111.762 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 71' ' ' ASP . 63.4 m -138.55 107.11 5.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.06 110.645 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -92.47 153.61 19.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.523 -0.547 . . . . 1.26 109.523 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -116.27 -58.62 2.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.505 0.558 . . . . 0.74 112.505 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -169.17 163.19 10.99 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 122.357 -0.214 . . . . 3.17 110.824 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -114.45 144.78 21.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.237 -0.283 . . . . 0.64 110.237 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -132.13 144.6 50.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.96 110.952 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -111.54 115.86 29.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 1.49 109.909 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -110.52 72.97 0.81 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.371 0.605 . . . . 1.83 110.929 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.77 -35.25 0.48 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-N 114.721 -1.127 . . . . 1.64 115.146 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -150.6 -29.78 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 117.104 0.452 . . . . 3.33 111.514 -173.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.43 161.87 25.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.583 -0.525 . . . . 1.38 109.583 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -129.19 121.55 27.92 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.194 0.521 . . . . 2.74 110.354 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -111.87 139.8 47.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 1.76 110.088 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 40.8 t -100.77 117.64 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.655 -0.498 . . . . 1.15 109.655 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.81 119.34 21.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 2.02 110.37 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -108.36 150.68 27.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.644 -0.707 . . . . 1.66 109.63 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 9.5 t0 -81.87 109.88 16.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 1.33 110.803 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.84 56.36 0.81 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.564 0.697 . . . . 2.65 110.334 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -89.23 -9.07 52.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 1.61 111.804 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 76' ' ' LYS . 11.5 pt20 -163.35 177.91 8.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.549 . . . . 2.35 109.516 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -76.41 23.47 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.257 0.348 . . . . 1.92 111.731 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 16.9 ptpt -54.08 -39.67 66.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.473 -0.331 . . . . 1.77 111.717 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -133.18 101.27 5.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.114 0.483 . . . . 0.76 110.332 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 89' ' ' ARG . 11.8 m -125.28 166.12 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.979 -0.555 . . . . 1.27 111.087 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 tp -143.92 115.06 7.91 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.724 . . . . 1.29 109.844 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -145.13 123.5 12.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.058 0.456 . . . . 2.54 111.315 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 47' ' ' LEU . . . -73.41 175.89 45.65 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 119.092 -0.838 . . . . 1.31 111.154 164.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -39.08 -143.4 0.0 OUTLIER Glycine 0 CA--C 1.54 1.608 0 N-CA-C 115.124 0.81 . . . . 1.9 115.124 168.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 44' ' ' LEU . 72.3 Cg_exo -49.34 120.0 5.19 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.697 1.598 . . . . 2.91 112.728 -173.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.9 mt -154.35 -168.08 2.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.561 -1.2 . . . . 4.11 108.798 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.93 44.13 2.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.753 0.311 . . . . 4.95 110.954 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.503 ' HA3' ' OD1' ' A' ' 124' ' ' ASN . . . 129.59 -177.84 17.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.971 -0.633 . . . . 2.25 112.829 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 m -107.76 133.8 51.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.455 -0.572 . . . . 1.91 109.455 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 123' ' ' TRP . 51.5 m-85 -108.66 114.28 27.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.958 0.408 . . . . 3.7 111.948 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 98.5 mtt180 -79.15 140.53 37.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.103 -0.499 . . . . 3.54 110.468 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.53 124.6 24.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.762 -0.458 . . . . 1.14 109.762 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 tt -117.8 -41.6 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 111.701 0.26 . . . . 1.68 111.701 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 10.0 pt20 -159.11 165.21 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.858 -0.423 . . . . 1.55 109.858 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CB ' HD23 ' A' ' 120' ' ' LEU . 42.4 p90 -146.98 161.01 41.67 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.007 -0.277 . . . . 0.86 111.456 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.432 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 11.7 p-80 -146.56 160.22 42.43 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.914 -0.585 . . . . 0.93 109.861 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 118' ' ' LEU . 84.3 m-85 -122.75 148.93 44.77 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.889 0.376 . . . . 3.17 111.396 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -105.55 175.89 5.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.335 -0.617 . . . . 1.68 109.335 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -172.81 114.19 0.27 Allowed 'General case' 0 N--CA 1.463 0.176 0 O-C-N 123.199 0.312 . . . . 5.18 110.54 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.761 ' HA2' ' H ' ' A' ' 242' ' ' ASP . . . -79.03 154.5 39.32 Favored Glycine 0 C--O 1.226 -0.397 0 N-CA-C 111.435 -0.666 . . . . 2.13 111.435 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 t -65.11 -29.25 70.1 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.195 0.997 . . . . 2.9 110.063 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.9 mt -106.4 144.98 32.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.448 -0.797 . . . . 3.03 109.438 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.19 70.3 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.553 0.533 . . . . 3.85 111.003 176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.66 43.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.073 -0.584 . . . . 1.94 112.741 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' ALA . 13.0 pt20 -173.12 164.01 4.78 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 110.1 -0.333 . . . . 2.45 110.1 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.58 -1.78 49.38 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.509 -0.853 . . . . 1.47 114.1 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 p -90.63 -26.73 19.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.825 0.676 . . . . 2.0 112.825 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 244' ' ' TRP . 0.6 OUTLIER 71.58 -170.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.749 -1.204 . . . . 3.72 107.749 -169.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.2 m80 54.99 71.37 0.54 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.312 0.505 . . . . 3.52 110.612 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 113' ' ' LYS . 14.2 p -87.0 116.3 24.96 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.448 -0.501 . . . . 2.52 110.723 -165.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 26.4 t -82.7 93.62 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.874 -0.417 . . . . 2.48 109.874 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 58.64 54.57 5.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.457 -0.572 . . . . 2.8 109.457 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 69.51 -2.33 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.106 -0.952 . . . . 4.98 112.578 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 23.1 ttmm -86.36 124.03 32.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.081 0.467 . . . . 3.23 111.192 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.543 ' H ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -116.33 138.09 51.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.799 -0.637 . . . . 2.82 109.694 175.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -88.38 159.99 17.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.639 -0.71 . . . . 1.62 110.499 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.526 ' HA ' ' H ' ' A' ' 103' ' ' GLN . . . -64.46 -20.05 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.846 . . . . 1.03 112.372 -174.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 147' ' ' LEU . . . -166.05 168.73 15.27 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.951 -0.389 . . . . 0.75 109.951 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -154.27 142.75 20.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.596 -0.52 . . . . 1.58 109.596 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 95' ' ' PHE . 15.1 tp -100.79 127.69 47.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.748 -0.66 . . . . 1.07 109.85 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.432 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 25.1 m170 -114.55 101.48 9.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.26 0.552 . . . . 1.77 110.831 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 48.0 mt -83.2 107.89 16.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.229 -0.896 . . . . 0.93 109.834 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 142' ' ' VAL . 41.3 t -82.57 123.27 38.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.384 0.612 . . . . 0.61 111.459 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 36.6 m-70 -123.09 147.22 46.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.289 -0.868 . . . . 2.13 109.387 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.671 ' CZ3' ' HA ' ' A' ' 125' ' ' THR . 62.5 p-90 -120.53 142.58 49.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.979 0.418 . . . . 4.26 111.113 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.503 ' OD1' ' HA3' ' A' ' 86' ' ' GLY . 30.2 t30 -66.58 111.91 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.02 111.288 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.671 ' HA ' ' CZ3' ' A' ' 123' ' ' TRP . 12.1 t -70.58 -16.35 62.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.564 -0.743 . . . . 2.34 111.784 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.405 ' HB3' HD21 ' A' ' 124' ' ' ASN . 38.2 ttpt -58.4 -20.82 47.4 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.224 0.453 . . . . 3.35 112.224 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.48 6.2 49.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.135 0.493 . . . . 3.1 111.265 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.82 -3.46 3.84 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.773 1.069 . . . . 2.37 115.773 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -172.75 148.45 1.88 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.696 1.248 . . . . 3.93 110.104 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 134' ' ' VAL . 38.4 p90 -60.67 -34.11 73.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.607 -1.179 . . . . 3.0 112.563 -173.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.41 97.88 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.013 -0.613 . . . . 2.15 112.748 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -76.7 -27.99 55.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.966 0.412 . . . . 3.43 110.473 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.696 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -62.44 -35.42 79.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 1.76 110.866 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 130' ' ' PHE . 47.4 t -65.32 -16.92 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.077 -0.51 . . . . 2.77 111.26 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.59 -13.57 57.85 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.071 -0.393 . . . . 3.55 111.144 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.457 HE21 ' HA2' ' A' ' 139' ' ' GLY . 5.7 tt0 -102.53 134.15 20.1 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.786 -0.45 . . . . 3.02 109.786 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 51.5 Cg_exo -55.37 -26.12 51.39 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.975 2.45 . . . . 1.6 112.618 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' A' ' 136' ' ' GLN . 23.0 m-20 -111.98 27.24 9.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.07 0.462 . . . . 2.29 109.863 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.696 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -79.13 -33.6 35.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.015 -0.612 . . . . 1.22 113.729 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.404 ' HB2' HG22 ' A' ' 206' ' ' VAL . 85.3 mt -110.44 157.01 20.04 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.706 -0.479 . . . . 1.57 109.706 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -147.31 127.07 13.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.723 0.297 . . . . 1.38 110.24 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 121' ' ' VAL . 27.9 m -116.51 139.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 120.767 0.318 . . . . 1.73 110.358 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.2 tp -99.07 109.26 22.01 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.347 -0.612 . . . . 2.42 109.347 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 118' ' ' LEU . . . -91.72 111.84 4.08 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.75 -0.659 . . . . 0.86 112.298 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.7 mt -109.42 118.17 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.726 -0.472 . . . . 0.76 109.726 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -69.54 143.24 53.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.405 -0.361 . . . . 1.2 111.303 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 10.8 mp -112.92 120.02 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.133 -0.485 . . . . 0.88 110.185 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.08 142.11 43.68 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.792 -0.818 . . . . 2.03 108.792 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.06 135.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 1.27 110.802 -174.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 171.01 -95.53 0.11 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.126 -0.789 . . . . 1.53 111.126 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.1 m -82.08 141.83 32.82 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.721 -0.474 . . . . 1.54 109.721 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.61 41.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.897 -0.592 . . . . 0.78 111.825 -174.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 216' ' ' SER . 53.9 tptt -117.28 102.17 52.53 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.474 . . . . 1.22 110.104 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.62 -42.41 67.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.442 2.762 . . . . 1.05 112.487 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 182' ' ' GLY . . . -59.33 -33.69 76.92 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.073 -0.584 . . . . 0.7 112.954 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.73 -30.95 22.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.152 0.501 . . . . 0.77 110.536 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -37.4 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.41 110.662 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -52.98 -49.44 66.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.204 -0.907 . . . . 2.86 112.414 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.92 -38.62 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 1.38 111.415 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.436 HG12 ' HD2' ' A' ' 224' ' ' LYS . 88.3 t -59.1 -39.6 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.21 0.529 . . . . 1.11 111.293 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.36 -15.76 39.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 1.22 112.284 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.34 -11.15 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.802 0.334 . . . . 1.41 111.399 -176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.87 -33.6 67.01 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.954 0.724 . . . . 1.39 112.954 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.57 -26.69 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.884 0.373 . . . . 2.31 111.524 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.7 m -80.89 -1.03 41.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.951 0.352 . . . . 1.4 111.951 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.6 pt -131.92 36.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.85 110.069 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.19 -33.58 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 1.59 112.669 -170.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 230' ' ' PHE . 18.0 p -119.48 159.51 24.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.857 0.361 . . . . 0.77 111.396 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -52.6 131.73 34.72 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.594 -0.73 . . . . 2.29 112.043 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.44 -28.44 15.01 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.871 -0.68 . . . . 0.85 112.451 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.79 143.62 52.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.212 0.53 . . . . 1.7 111.188 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.7 m -134.21 150.41 51.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.381 -0.827 . . . . 1.37 109.147 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -136.87 129.79 30.77 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.176 -0.305 . . . . 0.61 110.176 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.22 137.02 58.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.059 0.457 . . . . 1.8 110.672 -177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -140.85 80.4 1.75 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.197 -0.668 . . . . 1.04 109.197 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.0 p -116.04 163.66 15.59 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.469 -0.332 . . . . 1.17 111.466 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 58.91 36.98 24.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.848 -0.615 . . . . 1.77 111.276 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -129.75 133.79 47.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 3.99 110.202 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 181' ' ' ARG . 4.2 p30 -109.39 145.83 32.68 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.496 -0.775 . . . . 2.51 111.067 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 6.0 Cg_exo -79.0 -5.58 14.61 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.026 2.484 . . . . 1.26 112.342 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.494 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 5.6 tmm_? -57.6 -38.57 75.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.184 -0.462 . . . . 2.76 110.508 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -68.02 -7.03 48.62 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.818 -0.628 . . . . 1.12 113.361 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.94 -12.27 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.129 0.465 . . . . 1.73 111.015 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.53 129.99 55.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 3.45 110.645 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.89 -170.02 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.02 2.48 . . . . 2.08 113.404 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.93 -65.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.065 0.765 . . . . 3.23 113.065 -171.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 12.9 m -68.95 131.61 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 1.66 111.328 -172.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.86 62.87 0.61 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 1.99 110.832 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 212' ' ' LYS . 13.9 t0 -127.65 141.59 51.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.435 -0.95 . . . . 1.81 108.435 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 47' ' ' LEU . 51.9 p90 -149.23 158.24 44.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.967 0.413 . . . . 5.01 111.846 -166.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 256' ' ' LYS . 9.2 m-90 -115.51 107.36 15.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.534 -0.757 . . . . 3.93 109.077 172.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 208' ' ' TRP . 5.9 t -96.31 117.2 30.32 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.828 0.677 . . . . 2.13 112.828 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -139.21 128.51 14.11 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 5.21 109.989 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 206' ' ' VAL . 58.4 Cg_exo -53.38 136.72 63.81 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.191 2.594 . . . . 2.12 113.674 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -140.49 156.7 25.37 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.027 -0.533 . . . . 1.75 112.839 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 32.4 t -65.61 126.08 27.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.241 0.543 . . . . 2.99 109.812 173.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 197' ' ' LEU . 2.3 pt? -59.67 -47.05 87.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.968 -1.015 . . . . 4.75 113.646 -168.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.465 ' N ' ' HG ' ' A' ' 197' ' ' LEU . 3.5 t -121.1 -25.4 5.32 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.918 -0.313 . . . . 5.1 111.54 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.43 ' HB ' ' HD3' ' A' ' 200' ' ' PRO . 32.5 m 105.67 -57.59 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.087 1.355 . . . . 5.53 113.647 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 201' ' ' PRO . 82.1 Cg_exo -42.61 -51.41 5.19 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.603 2.202 . . . . 5.83 115.701 -177.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 71.6 Cg_endo -76.34 -15.98 17.58 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.709 1.606 . . . . 4.78 112.124 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.58 HD22 HD12 ' A' ' 22' ' ' ILE . 88.0 mt 55.61 70.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.746 -0.661 . . . . 3.84 110.988 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 196' ' ' SER . 43.7 tp -131.15 132.15 44.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.513 -0.767 . . . . 2.96 109.804 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.657 ' OE2' ' HA ' ' A' ' 26' ' ' GLU . 8.2 pt-20 -106.33 62.67 0.65 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.381 0.61 . . . . 3.37 110.868 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 73.9 m -108.64 15.1 24.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 2.15 110.868 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 95.2 t -117.9 137.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 1.26 111.082 -177.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.8 m -98.19 104.67 16.72 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.475 -0.935 . . . . 2.08 108.475 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' A' ' 192' ' ' THR . 0.0 OUTLIER -86.7 100.61 12.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 5.53 110.924 -174.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.568 HG23 ' CD1' ' A' ' 190' ' ' TYR . 75.1 mt -96.42 100.02 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 1.63 109.479 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 191' ' ' TRP . 16.3 m -99.6 125.64 53.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.183 0.515 . . . . 1.62 110.603 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 13.2 tp -87.44 137.3 32.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.634 -0.712 . . . . 1.73 109.595 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 20.5 pttp -72.44 -11.2 60.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.035 0.383 . . . . 2.98 112.035 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.2 tp10 -101.11 105.98 42.14 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.655 0.264 . . . . 1.47 110.944 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 5.9 Cg_exo -75.47 149.69 35.17 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.886 2.391 . . . . 0.96 111.771 175.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.9 pt -99.82 147.25 7.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.001 -0.37 . . . . 1.25 110.001 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 153' ' ' LYS . 42.7 m -92.35 123.79 35.94 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.567 -0.531 . . . . 1.29 109.567 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.14 163.48 21.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.886 -0.597 . . . . 1.02 110.265 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 41.3 t -90.25 147.38 23.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.125 0.488 . . . . 1.08 110.226 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.7 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 7.5 p -56.49 -35.36 67.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 1.33 110.653 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -70.06 -21.84 63.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.678 -0.692 . . . . 2.51 111.188 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -80.17 -51.74 8.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.393 . . . . 0.7 110.132 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.606 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 13.0 m -64.84 -29.21 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.455 0.539 . . . . 1.36 112.455 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.9 mt -66.05 -27.36 68.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 1.03 111.01 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.467 ' HA ' ' CG ' ' A' ' 227' ' ' LYS . 68.6 mttm -74.6 -21.0 59.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.267 -0.424 . . . . 1.75 110.959 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 26.2 m-85 -66.89 -19.06 65.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.106 0.479 . . . . 2.47 110.178 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -103.68 9.43 37.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 3.04 110.257 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 224' ' ' LYS . 12.5 mmmm -91.0 1.46 57.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 2.31 111.028 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 45.4 mt -92.24 133.77 35.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.206 -0.664 . . . . 0.95 109.206 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 238' ' ' GLU . 3.3 p30 -159.19 -178.72 7.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.931 0.345 . . . . 1.13 111.931 -176.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.455 ' HB3' HG22 ' A' ' 168' ' ' THR . 35.0 t80 52.94 81.14 0.09 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.094 -0.957 . . . . 3.74 112.48 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.584 ' CG ' ' H ' ' A' ' 232' ' ' GLY . 0.0 OUTLIER -54.41 -87.65 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.051 -0.522 . . . . 1.62 111.61 171.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' A' ' 231' ' ' ASN . . . -125.08 -158.7 10.1 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.839 -0.696 . . . . 1.16 112.26 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.09 145.32 24.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.148 -0.315 . . . . 3.56 110.148 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.95 14.61 82.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.77 . . . . 2.08 112.288 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -148.72 107.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.64 -0.874 . . . . 2.59 108.64 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.11 114.32 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 120.722 0.948 . . . . 1.36 111.116 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.402 ' HB3' ' ND2' ' A' ' 231' ' ' ASN . 10.5 tp10 -139.37 104.08 4.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.51 -0.768 . . . . 3.4 111.442 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 229' ' ' ASN . 7.3 pt-20 -154.27 94.96 1.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.714 0.768 . . . . 2.47 109.951 157.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.25 99.63 4.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.237 -0.892 . . . . 2.14 109.501 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -118.4 82.87 1.92 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.965 -1.124 . . . . 1.68 107.965 172.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.8 m -156.57 133.32 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.906 -1.043 . . . . 1.27 110.141 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.761 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER 63.52 -79.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.239 0.962 . . . . 2.18 112.481 173.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 48.4 47.57 19.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.318 0.386 . . . . 2.15 110.681 -171.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 106' ' ' GLU . 85.9 t90 -105.12 134.02 48.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.916 0.389 . . . . 4.59 110.792 -172.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 32.2 ptt180 -105.32 132.23 21.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.986 -0.552 . . . . 6.13 110.416 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.417 ' HA ' ' CH2' ' A' ' 244' ' ' TRP . 62.5 Cg_exo -53.97 128.0 27.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.163 2.576 . . . . 3.28 112.676 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.39 159.76 33.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.684 -0.689 . . . . 2.98 111.983 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -108.73 149.85 40.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 4.32 110.673 -173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 253' ' ' ARG . 36.7 Cg_endo -63.7 147.3 92.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.641 2.894 . . . . 3.48 114.075 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 67.5 mt -68.23 -12.42 60.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.86 -1.063 . . . . 4.63 113.364 -171.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 61.6 pttt -61.08 42.84 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.382 1.623 . . . . 5.34 115.382 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 1.5 p30 125.42 -4.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.378 1.871 . . . . 4.64 109.926 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 30.7 mmt180 -116.69 82.67 1.83 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.438 -1.319 . . . . 6.11 107.438 168.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -134.69 158.1 44.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.102 -0.333 . . . . 3.08 110.102 -166.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 33' ' ' ILE . 5.1 pt -102.62 125.9 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.808 0.67 . . . . 2.6 112.808 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 191' ' ' TRP . 81.7 mttt -101.64 144.2 30.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.396 -0.82 . . . . 2.63 109.028 165.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 190' ' ' TYR . . . -106.65 148.17 28.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.248 -0.649 . . . . 1.71 109.248 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 190' ' ' TYR . 5.4 m -131.64 95.1 3.65 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.887 -0.725 . . . . 2.21 111.864 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -156.95 133.48 9.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.967 -1.015 . . . . 4.31 108.674 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.569 -0.729 . . . . 4.49 110.363 -173.196 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttp . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.962 0.41 . . . . 17.49 110.464 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 p -162.63 -81.71 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 15.32 110.103 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -141.79 -55.9 0.46 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.22 -0.659 . . . . 15.81 109.22 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -142.22 161.83 37.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.35 -0.841 . . . . 14.19 110.008 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -90.55 135.23 33.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.348 -0.387 . . . . 14.91 110.342 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.09 176.89 38.47 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.735 -0.946 . . . . 10.79 110.735 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 9.1 p90 -80.05 110.63 15.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.332 0.566 . . . . 11.39 109.977 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.8 148.08 7.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.8 -0.714 . . . . 9.0 112.017 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 16' ' ' TRP . 13.2 mptt -53.14 123.18 11.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.017 0.437 . . . . 9.76 111.782 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.665 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 6.1 t-160 61.37 -88.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.009 0.923 . . . . 11.19 112.349 175.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -95.12 -14.76 23.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.785 0.326 . . . . 10.8 110.777 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 7' ' ' TYR . . . 135.45 -59.72 0.65 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.644 -0.789 . . . . 8.82 112.037 -174.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.98 126.12 18.79 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.213 1.942 . . . . 7.87 111.846 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' OE2' ' HD3' ' A' ' 9' ' ' LYS . 6.0 mm-40 -64.17 0.05 1.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.698 -0.683 . . . . 10.62 112.64 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -63.99 -4.3 3.3 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.163 0.506 . . . . 9.87 111.445 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.665 ' CD1' ' HB2' ' A' ' 10' ' ' HIS . 73.9 t-105 -87.13 -2.69 58.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.413 0.625 . . . . 8.48 109.866 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -56.53 -6.28 0.28 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.111 -0.95 . . . . 7.13 112.888 -170.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -58.91 -37.0 75.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.041 0.448 . . . . 9.68 110.768 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 31.5 t70 -68.0 -19.83 64.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.651 -0.704 . . . . 7.89 110.885 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -109.69 93.22 13.8 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.034 -0.53 . . . . 7.17 109.673 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 19' ' ' ASP . 50.1 Cg_exo -53.81 -45.35 41.64 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.889 2.393 . . . . 7.76 112.731 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.5 tt -59.16 -18.14 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.773 0.657 . . . . 5.83 112.773 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.06 -17.5 63.24 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.818 0.342 . . . . 5.44 110.973 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -72.02 3.74 4.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 7.78 111.182 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.82 168.12 46.99 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 111.375 -0.69 . . . . 5.01 111.375 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -115.32 115.77 27.18 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.173 -0.611 . . . . 7.09 109.97 -176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 1.8 mpt_? -136.61 169.31 17.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.385 0.539 . . . . 5.13 110.914 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.451 HE21 HD13 ' A' ' 255' ' ' ILE . 7.4 tm0? -45.4 112.31 0.44 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 124.093 0.87 . . . . 7.12 110.398 173.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 31' ' ' VAL . 40.9 m -98.88 145.61 30.26 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 115.545 -0.752 . . . . 3.94 110.48 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HA ' ' CD2' ' A' ' 107' ' ' HIS . 59.1 Cg_endo -71.92 25.6 0.25 Allowed 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 123.488 2.792 . . . . 4.52 113.112 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 247' ' ' ALA . 23.0 m -96.36 -175.47 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.4 -0.364 . . . . 4.54 111.201 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.513 ' HB2' HD21 ' A' ' 250' ' ' LEU . 1.4 m-20 -51.44 104.73 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 122.048 0.928 . . . . 2.88 111.956 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.0 127.56 38.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.219 -1.355 . . . . 2.32 110.015 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.29 99.27 10.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.169 -0.468 . . . . 2.82 109.985 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -54.25 -29.32 46.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 2.24 111.568 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -75.33 -28.64 59.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 4.54 110.675 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 m -81.69 -28.77 33.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.874 0.369 . . . . 3.06 110.487 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 255' ' ' ILE . . . -67.05 108.71 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.532 . . . . 1.72 111.593 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -85.31 138.18 32.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.6 -0.727 . . . . 3.69 110.484 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 30.1 p90 -78.57 130.71 36.26 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.393 -0.595 . . . . 4.64 109.393 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -109.11 109.79 60.71 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.337 -0.392 . . . . 2.27 110.11 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.41 -17.36 57.26 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.031 2.488 . . . . 2.15 112.49 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 83' ' ' PRO . 49.1 m -75.58 -9.04 58.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 4.29 110.858 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -96.55 139.26 32.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.286 -0.415 . . . . 4.74 110.283 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -118.9 161.14 37.73 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.468 -0.567 . . . . 3.77 109.468 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.55 157.15 23.78 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.748 2.299 . . . . 2.36 112.816 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.419 ' HG ' ' CD2' ' A' ' 190' ' ' TYR . 91.9 mt -85.64 138.78 31.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 2.55 111.146 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -101.33 120.57 40.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.652 -0.87 . . . . 2.38 108.652 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.46 103.06 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.76 0.315 . . . . 1.59 110.659 -174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 91.25 3.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.264 -0.643 . . . . 1.45 109.264 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 p90 -137.95 20.01 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.923 0.392 . . . . 3.62 111.45 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.39 -18.8 64.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.304 -0.407 . . . . 2.48 111.21 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -103.18 10.74 37.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.534 -0.303 . . . . 2.24 110.737 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.66 125.74 24.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.863 0.363 . . . . 0.8 111.627 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.3 m -115.42 109.23 17.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.963 -0.562 . . . . 1.06 111.243 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m -78.12 149.66 33.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.552 -0.536 . . . . 1.26 109.552 174.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -121.59 -54.97 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.974 0.416 . . . . 0.74 111.466 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 14.7 ptm180 -140.6 152.23 45.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.362 -0.381 . . . . 3.17 110.698 -175.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.0 tt -127.61 133.92 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.585 -0.895 . . . . 0.64 108.585 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.68 162.88 36.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.96 111.777 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 169' ' ' LYS . 5.9 m-20 -101.3 109.87 21.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.926 -1.034 . . . . 1.49 109.237 176.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.565 ' HB3' ' OD1' ' A' ' 67' ' ' ASN . 42.5 t30 -126.57 129.37 48.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.112 -0.495 . . . . 1.83 111.06 -174.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 26.4 -74.59 0.0 OUTLIER Glycine 0 N--CA 1.47 0.96 0 N-CA-C 117.45 1.74 . . . . 1.64 117.45 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' ASN . 25.7 m80 -83.14 -19.79 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.983 0.364 . . . . 3.33 111.983 -167.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 175.38 -141.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.966 -0.383 . . . . 1.38 109.966 -170.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -118.12 143.79 46.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.072 -1.085 . . . . 2.74 108.072 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 13.5 m120 -128.24 128.62 45.03 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.086 -0.339 . . . . 1.76 110.086 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.97 121.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.209 0.528 . . . . 1.15 109.851 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 58' ' ' ARG . 55.7 mm-40 -90.07 138.98 31.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 2.02 111.433 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.92 157.26 22.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.493 -0.776 . . . . 1.66 109.235 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.77 108.37 13.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.216 -0.661 . . . . 1.33 109.216 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -108.51 58.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.663 0.744 . . . . 2.65 110.607 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -100.85 -13.58 18.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.573 -0.74 . . . . 1.61 111.416 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -152.09 177.59 10.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.103 -0.499 . . . . 2.35 109.942 -170.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -82.01 65.96 7.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 1.92 110.987 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 58.6 mttm -90.59 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.946 -0.57 . . . . 1.77 109.838 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . . . -114.39 99.03 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.864 -0.607 . . . . 0.76 110.267 177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -117.88 145.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.94 -0.573 . . . . 1.27 110.51 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 tp -137.58 112.08 8.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.725 -0.472 . . . . 1.29 109.725 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 22.1 pttm -153.8 126.13 8.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 2.54 111.743 175.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.87 177.93 46.64 Favored Glycine 0 C--O 1.221 -0.707 0 CA-C-N 115.462 -0.79 . . . . 1.31 112.753 173.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.91 -132.76 0.0 OUTLIER Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.73 1.157 . . . . 1.9 115.764 167.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 43' ' ' SER . 78.9 Cg_exo -44.12 170.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.179 3.253 . . . . 2.91 114.43 -171.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.3 tp -32.37 75.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.553 1.316 . . . . 4.11 114.553 -145.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 80' ' ' LYS . 15.1 p-10 -76.73 -71.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.314 -1.766 . . . . 4.95 112.635 173.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 82.06 127.45 0.99 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.384 -1.086 . . . . 2.25 110.384 -165.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 124' ' ' ASN . 88.9 m -63.48 103.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.103 0.452 . . . . 1.91 111.734 -174.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.561 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 63.6 m-85 -95.04 126.99 40.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.867 -0.606 . . . . 3.7 111.026 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -103.85 143.97 32.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.312 -0.403 . . . . 3.54 110.243 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 34.4 tp -81.52 132.01 35.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 1.14 110.86 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.7 tt -109.21 -35.0 2.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.183 -0.462 . . . . 1.68 110.784 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 172.25 8.42 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.341 -0.39 . . . . 1.55 110.316 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 118' ' ' LEU . 9.4 p90 -151.4 153.36 34.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.86 110.347 169.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.485 ' NE2' ' HB2' ' A' ' 119' ' ' HIS . 13.5 p-80 -148.16 157.64 43.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.559 -0.746 . . . . 0.93 109.62 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB3' ' HA ' ' A' ' 118' ' ' LEU . 53.1 p90 -139.7 123.06 17.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.773 -0.771 . . . . 3.17 111.374 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -94.73 146.24 24.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.099 -0.955 . . . . 1.68 110.353 171.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -132.7 170.81 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.603 -0.518 . . . . 5.18 109.603 -176.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' CA ' ' HA3' ' A' ' 104' ' ' GLY . . . -95.89 173.83 31.0 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.488 -0.863 . . . . 2.13 112.777 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.5 t -68.26 -28.0 66.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.283 0.563 . . . . 2.9 109.957 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.63 141.14 47.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.589 -0.732 . . . . 3.03 109.091 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 149' ' ' VAL . 4.8 p-10 -68.26 -5.88 20.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.168 0.432 . . . . 3.85 112.168 -174.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -101.79 10.06 57.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.807 -0.711 . . . . 1.94 113.047 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -164.41 170.28 16.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.892 0.346 . . . . 2.45 110.916 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA3' ' CA ' ' A' ' 98' ' ' GLY . . . 113.41 -14.59 22.86 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.502 -0.856 . . . . 1.47 112.518 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.3 t -75.59 -34.59 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.411 0.148 . . . . 2.0 111.203 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.469 ' HG2' ' NE1' ' A' ' 244' ' ' TRP . 0.0 OUTLIER 66.35 -172.19 0.19 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.6 0.563 . . . . 3.72 110.036 -171.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.561 ' CD2' ' HA ' ' A' ' 30' ' ' PRO . 17.3 m80 52.44 44.69 29.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.66 0.743 . . . . 3.52 109.62 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -79.29 117.47 20.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.034 . . . . 2.52 111.397 -172.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.04 95.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.692 -1.14 . . . . 2.48 110.504 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 58.66 60.04 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.844 -1.071 . . . . 2.8 110.824 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm 69.71 11.51 7.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.73 -0.668 . . . . 4.98 112.527 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -96.23 97.19 9.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.826 0.346 . . . . 3.23 110.644 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.496 ' HG2' ' HB ' ' A' ' 108' ' ' THR . 98.6 mttt -96.11 148.38 22.74 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.261 -0.644 . . . . 2.82 109.261 176.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -106.6 -176.6 3.12 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.6 -0.519 . . . . 1.62 109.6 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.4 -43.55 66.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.803 0.335 . . . . 1.03 111.19 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.52 164.04 37.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 0.75 110.269 -174.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -130.38 124.16 31.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 1.58 109.792 176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 94' ' ' HIS . 56.7 tp -91.04 114.97 27.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.797 . . . . 1.07 110.214 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.485 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . 22.5 m170 -102.91 106.55 17.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.159 -0.473 . . . . 1.77 110.615 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 5.0 mp -95.74 108.09 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.256 -0.646 . . . . 0.93 109.256 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.5 t -81.91 126.34 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.339 -0.392 . . . . 0.61 110.822 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 58.5 m80 -125.56 145.17 50.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.834 -0.432 . . . . 2.13 109.834 177.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -124.6 143.91 50.45 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.83 -0.804 . . . . 4.26 108.83 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 87' ' ' THR . 35.8 p30 -83.52 139.63 32.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.859 0.837 . . . . 2.02 111.687 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 t -66.08 -16.01 63.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.095 -0.957 . . . . 2.34 110.567 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -50.63 -44.35 57.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 3.35 112.097 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -93.6 6.95 46.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.513 -0.475 . . . . 3.1 111.092 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 60.47 1.52 1.77 Allowed Glycine 0 C--N 1.335 0.472 0 N-CA-C 115.523 0.969 . . . . 2.37 115.523 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 132' ' ' LYS . 16.6 t70 -169.14 137.04 1.9 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.739 0.769 . . . . 3.93 109.658 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.607 ' O ' HG23 ' A' ' 134' ' ' VAL . 26.5 p90 -60.22 -43.27 96.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.714 -0.676 . . . . 3.0 110.984 -177.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.49 -35.52 90.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.274 -0.489 . . . . 2.15 112.599 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -68.36 -37.59 80.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.773 -0.455 . . . . 3.43 109.773 177.152 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.88 -29.27 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 1.76 110.705 178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 130' ' ' PHE . 58.0 t -65.57 -20.03 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 2.77 111.315 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -88.53 -1.74 58.22 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.762 -0.586 . . . . 3.55 111.614 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -126.21 143.17 44.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.868 0.366 . . . . 3.02 110.483 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 26.6 Cg_endo -62.0 -24.63 76.97 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.431 2.754 . . . . 1.6 113.493 -175.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -110.41 27.03 10.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.904 -0.406 . . . . 2.29 109.904 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -81.25 -48.53 5.95 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.946 -0.645 . . . . 1.22 113.788 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.496 HD11 HG22 ' A' ' 134' ' ' VAL . 85.8 mt -107.79 161.13 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.085 0.469 . . . . 1.57 111.316 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.3 104.9 4.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.624 -0.716 . . . . 1.38 110.33 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.4 t -97.66 115.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.236 -0.438 . . . . 1.73 109.858 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 209' ' ' ILE . 63.5 tp -88.11 111.54 21.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.867 -0.606 . . . . 2.42 109.684 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.79 108.85 3.61 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.189 -0.529 . . . . 0.86 111.935 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.2 mt -102.07 130.77 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.158 -0.312 . . . . 0.76 110.158 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 214' ' ' PRO . 69.9 m-85 -75.55 145.75 41.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.663 -0.244 . . . . 1.2 110.527 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.35 117.68 30.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.695 -0.483 . . . . 0.88 109.695 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 216' ' ' SER . 20.5 ptmt -114.72 152.42 32.05 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.283 -0.636 . . . . 2.03 109.283 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 217' ' ' VAL . 29.3 t -92.26 131.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 1.27 110.861 -176.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.86 -105.55 0.21 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.627 -0.989 . . . . 1.53 110.627 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.5 m -70.03 160.61 31.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.506 -0.553 . . . . 1.54 109.506 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.61 159.22 15.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.573 -0.285 . . . . 0.78 111.193 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 216' ' ' SER . 12.4 mmmm -111.03 99.89 44.68 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.573 -0.899 . . . . 1.22 108.573 172.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.75 -21.05 61.7 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.984 2.456 . . . . 1.05 113.355 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.19 -13.34 81.01 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.654 -0.784 . . . . 0.7 112.919 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.9 tp -87.13 -17.96 31.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.77 111.004 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -60.41 -39.5 87.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 1.41 112.265 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.519 ' O ' HG23 ' A' ' 162' ' ' VAL . 30.7 mmmt -58.29 -40.92 83.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.618 0.247 . . . . 2.86 111.02 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.87 -46.9 84.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.262 0.553 . . . . 1.38 110.166 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 163' ' ' LEU . 46.9 t -67.19 -27.68 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 1.11 111.295 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.02 -34.57 66.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 1.22 111.562 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 158' ' ' LYS . 87.7 t -82.54 -23.39 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.417 -0.356 . . . . 1.41 111.781 -174.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.7 pp -69.56 -12.84 61.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.018 0.437 . . . . 1.39 111.428 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.31 -26.5 68.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.088 0.47 . . . . 2.31 110.444 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.1 t -81.31 0.74 35.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 1.4 111.432 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.14 43.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.268 -0.641 . . . . 0.85 109.268 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -54.4 -38.37 66.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.084 -0.962 . . . . 1.59 112.622 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.8 p -105.52 149.9 25.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.631 0.253 . . . . 0.77 110.945 -177.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.501 ' HD3' ' O ' ' A' ' 230' ' ' PHE . 61.7 pttt -66.54 141.14 57.96 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.973 -0.38 . . . . 2.29 109.973 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.34 -22.44 30.91 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.43 -0.89 . . . . 0.85 111.681 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -82.57 156.17 24.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 1.7 110.488 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -145.96 153.57 40.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.208 -0.451 . . . . 1.37 109.986 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -141.12 154.35 45.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.827 -0.435 . . . . 0.61 109.827 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.29 135.42 39.62 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.845 -0.428 . . . . 1.8 109.845 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.56 80.39 1.77 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.728 -0.841 . . . . 1.04 108.728 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.5 p -113.41 165.12 12.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.703 -0.68 . . . . 1.17 112.065 -176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.2 t30 54.9 57.84 5.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.5 -0.773 . . . . 1.77 111.113 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -135.1 131.75 37.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.835 -0.62 . . . . 3.99 109.824 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 13.0 m-20 -106.19 118.48 54.77 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.851 -0.425 . . . . 2.51 109.851 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 179' ' ' ASP . 2.7 Cg_exo -76.21 -4.57 15.26 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.943 2.429 . . . . 1.26 112.898 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -59.05 -42.85 91.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.32 . . . . 2.76 111.548 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.05 -3.04 9.64 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.208 -0.52 . . . . 1.12 113.601 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 180' ' ' PRO . 7.8 mp -100.57 -1.29 35.87 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.66 -0.318 . . . . 1.73 111.117 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.0 pp -54.69 150.13 19.32 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 112.742 0.645 . . . . 3.45 112.742 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -91.05 -176.17 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.453 2.769 . . . . 2.08 111.467 171.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -85.69 -64.68 1.11 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.523 -0.471 . . . . 3.23 111.56 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.5 m -87.22 135.15 33.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.817 0.341 . . . . 1.66 111.495 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 98.2 mt -105.21 62.89 0.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.404 0.621 . . . . 1.99 110.295 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 212' ' ' LYS . 6.4 m-20 -116.37 170.05 8.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.944 -1.132 . . . . 1.81 107.944 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.419 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 46.6 p90 -168.04 161.73 12.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.793 1.035 . . . . 5.01 113.793 -166.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.441 ' HD1' ' O ' ' A' ' 210' ' ' VAL . 2.9 m95 -101.09 138.73 37.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.724 -1.584 . . . . 3.93 106.724 167.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.1 t -137.7 105.22 5.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.61 0.719 . . . . 2.13 112.031 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.501 ' CG ' ' HD2' ' A' ' 194' ' ' PRO . 25.9 t80 -139.3 149.6 61.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.264 -0.643 . . . . 5.21 109.264 173.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 193' ' ' TYR . 93.6 Cg_exo -46.88 129.91 15.18 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.456 2.104 . . . . 2.12 111.652 172.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.486 ' O ' ' HB ' ' A' ' 206' ' ' VAL . . . -138.57 161.29 25.74 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.444 -0.798 . . . . 1.75 113.177 -166.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -99.59 131.66 45.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.831 -0.803 . . . . 2.99 108.831 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 197' ' ' LEU . 2.1 pt? -56.11 -48.21 76.61 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.673 1.36 . . . . 4.75 114.673 -163.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 197' ' ' LEU . 20.6 m -121.02 -44.08 2.42 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.065 -0.654 . . . . 5.1 112.344 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.401 ' HB ' ' OE1' ' A' ' 14' ' ' GLU . 50.0 p -104.9 162.19 20.51 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.4 -0.818 . . . . 5.53 111.471 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.463 ' HB3' ' HD2' ' A' ' 201' ' ' PRO . 74.6 Cg_exo -52.03 169.79 0.26 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.921 2.414 . . . . 5.83 111.767 169.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 200' ' ' PRO . 24.6 Cg_exo -16.98 111.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 1 C-N-CA 125.339 4.026 . . . . 4.78 115.849 -171.044 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 202' ' ' LEU . 2.0 tm? -151.59 -83.82 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.86 -1.063 . . . . 3.84 109.711 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 37.4 tp -118.45 131.97 56.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.293 . . . . 2.96 110.459 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 10.5 pt-20 -92.99 40.07 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.923 -0.581 . . . . 3.37 111.584 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 25.6 p -86.96 -4.49 59.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.293 0.568 . . . . 2.15 110.557 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 195' ' ' GLY . 27.4 t -112.18 150.03 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.637 -0.71 . . . . 1.26 111.14 -173.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.9 m -107.21 103.5 12.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.332 -1.358 . . . . 2.08 107.332 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.432 ' HB2' ' HA3' ' A' ' 195' ' ' GLY . 1.1 t90 -75.52 102.29 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.033 0.444 . . . . 5.53 110.107 -172.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 42.3 mm -95.68 100.42 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.537 -0.756 . . . . 1.63 109.364 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.441 ' O ' ' HD1' ' A' ' 191' ' ' TRP . 32.4 t -94.03 119.03 41.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.42 -0.585 . . . . 1.62 109.42 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 189' ' ' ASP . 17.1 tp -73.95 122.45 22.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.949 0.404 . . . . 1.73 110.389 -174.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 189' ' ' ASP . 17.8 tppt? -61.59 -21.91 64.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 2.98 111.995 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -95.14 111.87 56.41 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.642 -0.254 . . . . 1.47 110.537 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.422 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 98.4 Cg_endo -82.73 134.14 7.25 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.511 2.14 . . . . 0.96 111.752 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.7 pt -88.79 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 1.25 109.487 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.613 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 24.6 t -103.83 125.66 50.42 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.978 0.418 . . . . 1.29 110.763 -175.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 149' ' ' VAL . 22.1 m -116.75 155.07 18.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.68 . . . . 1.02 109.486 176.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.4 t -102.93 161.78 13.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.918 -0.313 . . . . 1.08 110.782 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.641 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 22.2 t -49.62 -54.06 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.668 0.605 . . . . 1.33 111.849 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 224' ' ' LYS . 36.6 tt0 -52.56 -39.23 61.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.751 0.31 . . . . 2.51 111.781 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.4 -50.58 69.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.468 -0.333 . . . . 0.7 110.556 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.27 -19.95 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.429 -0.351 . . . . 1.36 111.587 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.2 mt -73.65 -44.26 57.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 1.03 110.558 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 220' ' ' GLU . 52.5 mtpt -65.35 -25.86 67.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 1.75 110.562 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -75.29 -28.1 59.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.455 0.645 . . . . 2.47 109.744 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 56.1 ttp180 -71.8 -0.94 12.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.325 -0.852 . . . . 3.04 110.928 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -84.22 -14.14 50.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.982 0.42 . . . . 2.31 110.115 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.473 HD22 HD21 ' A' ' 61' ' ' ASN . 68.2 mt -69.65 144.83 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.49 0.662 . . . . 0.95 111.257 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 12.3 m120 -108.56 139.58 43.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.325 -0.852 . . . . 1.13 109.645 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.501 ' O ' ' HD3' ' A' ' 169' ' ' LYS . 65.8 t80 -79.14 -30.81 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.744 . . . . 3.74 109.956 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -68.85 163.46 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 1.62 111.5 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.11 48.29 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.474 -1.05 . . . . 1.16 110.474 174.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.1 135.06 47.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.501 0.65 . . . . 3.56 110.553 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.29 41.71 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.749 . . . . 2.08 112.797 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.66 162.34 43.33 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.968 0.384 . . . . 2.59 110.017 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.15 127.55 26.78 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.221 1.947 . . . . 1.36 111.361 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.67 120.38 12.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.408 0.623 . . . . 3.4 111.776 -174.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 13.2 pt-20 -128.47 153.46 47.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.305 -0.861 . . . . 2.47 108.828 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.23 135.95 33.29 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.649 0.261 . . . . 2.14 110.761 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 56.9 ttm -80.1 88.43 5.41 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.832 -0.803 . . . . 1.68 108.832 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.5 m -142.55 144.17 24.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.834 -0.802 . . . . 1.27 108.834 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.44 -78.19 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.734 0.646 . . . . 2.18 110.397 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.1 t30 42.5 40.56 1.96 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.901 0.75 . . . . 2.15 112.176 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.469 ' NE1' ' HG2' ' A' ' 106' ' ' GLU . 38.6 t-105 -141.59 160.67 39.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.067 0.461 . . . . 4.59 111.341 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 245' ' ' ARG . 25.0 mmt180 -128.38 83.4 66.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.143 -1.058 . . . . 6.13 108.143 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -55.52 -87.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 124.053 3.169 . . . . 3.28 116.487 -160.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -81.08 102.3 10.15 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.293 1.22 . . . . 2.98 114.293 -162.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.657 ' HB3' ' HD2' ' A' ' 249' ' ' PRO . 12.0 mm100 -80.31 -178.0 1.05 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.243 -1.021 . . . . 4.32 108.243 160.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.657 ' HD2' ' HB3' ' A' ' 248' ' ' GLN . 34.1 Cg_exo -40.76 112.14 0.17 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 121.867 1.711 . . . . 3.48 112.355 175.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -60.05 -51.45 69.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 4.63 112.452 -164.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -60.83 -9.97 4.88 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.901 1.445 . . . . 5.34 114.901 -174.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 253' ' ' ARG . 8.5 p30 38.09 -50.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 118.749 2.87 . . . . 4.64 118.749 167.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.614 ' NE ' ' HA ' ' A' ' 253' ' ' ARG . 0.4 OUTLIER 171.4 -156.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.324 1.049 . . . . 6.11 109.201 -165.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -131.72 130.15 41.6 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.726 -1.583 . . . . 3.08 106.726 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 43.8 mt -111.92 145.46 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.809 0.338 . . . . 2.6 111.416 -166.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -123.34 162.08 23.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 2.63 109.935 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -159.16 170.74 21.29 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.385 -0.598 . . . . 1.71 109.385 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 189' ' ' ASP . 8.6 t -148.23 113.41 5.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.744 -0.382 . . . . 2.21 110.441 176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.413 ' CD1' ' HG2' ' A' ' 212' ' ' LYS . 88.6 t80 -117.85 95.33 4.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 4.31 109.54 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.529 -0.748 . . . . 4.49 110.146 -178.366 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.002 0.43 . . . . 17.49 110.429 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 p -152.81 162.08 41.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.267 -0.424 . . . . 15.32 110.596 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -121.41 175.49 6.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.978 -0.555 . . . . 15.81 110.292 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -144.64 95.48 2.71 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.294 -0.632 . . . . 14.19 109.294 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -107.79 174.06 6.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.036 0.446 . . . . 14.91 111.317 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.42 -171.6 35.23 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.562 -1.015 . . . . 10.79 110.562 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -83.98 98.11 9.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 117.28 0.54 . . . . 11.39 110.779 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.81 -148.42 31.6 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.373 -0.831 . . . . 9.0 113.33 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.66 167.76 19.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 9.76 110.059 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 69.09 -66.6 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.717 0.636 . . . . 11.19 111.378 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.49 -15.05 56.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.945 0.402 . . . . 10.8 110.695 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -135.27 -168.08 11.52 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.813 -0.708 . . . . 8.82 111.811 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.519 ' O ' ' HE3' ' A' ' 16' ' ' TRP . 96.6 Cg_endo -80.27 135.74 10.97 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.511 2.141 . . . . 7.87 111.829 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.73 3.48 25.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.016 -0.538 . . . . 10.62 110.588 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -111.2 22.51 15.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.803 -0.635 . . . . 9.87 110.36 -172.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.519 ' HE3' ' O ' ' A' ' 13' ' ' PRO . 15.1 p90 -64.1 -18.58 64.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.608 -0.269 . . . . 8.48 111.557 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -68.01 -19.94 64.96 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.839 -0.43 . . . . 7.13 109.839 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -85.13 -36.13 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 9.68 110.69 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 74.8 m-20 -84.63 -29.75 25.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 7.89 111.054 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -107.44 102.46 44.31 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.223 -0.444 . . . . 7.17 110.562 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 19' ' ' ASP . 32.1 Cg_exo -58.16 -40.39 77.02 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.826 2.351 . . . . 7.76 112.273 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mt -54.76 -27.19 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.232 -0.44 . . . . 5.83 112.058 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' N ' HD13 ' A' ' 202' ' ' LEU . . . -59.88 -33.56 71.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 5.44 110.476 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -80.05 -5.53 55.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 7.78 111.08 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.85 -101.05 2.35 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.399 -0.68 . . . . 5.01 111.399 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.02 140.03 9.61 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.253 0.549 . . . . 7.09 110.827 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 27' ' ' ARG . 8.3 mpt_? -87.61 131.45 34.42 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.113 -0.494 . . . . 5.13 110.439 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 199' ' ' THR . 4.1 pt20 -83.63 37.21 0.57 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.946 0.879 . . . . 7.12 110.54 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 p -100.45 115.88 64.94 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 114.678 -1.146 . . . . 3.94 109.466 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.48 -44.95 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.293 1.328 . . . . 4.52 112.379 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG11 ' H ' ' A' ' 107' ' ' HIS . 7.2 p -165.42 143.02 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 112.336 0.495 . . . . 4.54 112.336 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HB2' ' HB1' ' A' ' 247' ' ' ALA . 23.9 t0 -147.05 107.85 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.317 -0.994 . . . . 2.88 108.317 164.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mt -102.82 105.87 18.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.461 -0.495 . . . . 2.32 111.105 -173.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.56 107.37 18.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.093 -1.077 . . . . 2.82 108.093 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -54.8 -31.44 59.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 2.24 112.411 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -77.82 -44.69 26.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.737 0.304 . . . . 4.54 110.944 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 m -73.83 -28.06 61.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.545 -0.298 . . . . 3.06 111.372 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.6 129.85 42.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.011 0.434 . . . . 1.72 111.608 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -91.16 124.47 35.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.876 -0.602 . . . . 3.69 110.942 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -75.34 127.68 33.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.975 -0.557 . . . . 4.64 109.569 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.87 134.04 20.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.608 -0.515 . . . . 2.27 109.608 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.43 56.83 2.8 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.857 2.371 . . . . 2.15 112.656 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' LYS . 39.4 t -74.72 -56.85 4.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.053 -0.521 . . . . 4.29 110.204 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 mt 64.09 -25.31 0.08 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.389 0.885 . . . . 4.74 113.389 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' SER . 62.8 mttp -70.48 142.75 89.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.949 0.404 . . . . 3.77 111.691 -175.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.56 158.82 7.89 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.078 2.519 . . . . 2.36 112.486 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.539 HD23 ' HA3' ' A' ' 81' ' ' GLY . 79.0 mt -86.81 132.81 33.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 2.55 109.717 174.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 t -90.88 109.98 21.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.714 -0.847 . . . . 2.38 108.714 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.4 t -119.63 97.41 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.893 -0.41 . . . . 1.59 109.893 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 23.5 m -89.37 89.15 7.76 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.223 -0.658 . . . . 1.45 109.223 177.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -100.1 -6.39 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 3.62 111.383 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.516 ' HA ' ' NH2' ' A' ' 181' ' ' ARG . 32.3 t70 -61.32 -24.85 66.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.682 0.277 . . . . 2.48 111.529 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.5 mp0 -101.04 5.0 42.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.55 -0.296 . . . . 2.24 110.997 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.1 27.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.8 111.462 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 m -120.04 119.51 33.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.983 -0.553 . . . . 1.06 110.609 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 p -88.13 153.26 21.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.125 -0.488 . . . . 1.26 110.19 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.09 -56.67 1.82 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.74 111.725 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HA ' ' H ' ' A' ' 175' ' ' PHE . 32.3 ptt180 -152.34 159.42 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.053 0.454 . . . . 3.17 111.819 -175.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 66' ' ' PHE . 13.9 tt -115.18 134.81 57.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.34 -0.845 . . . . 0.64 109.54 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -133.68 142.79 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.802 0.334 . . . . 0.96 111.637 -171.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -101.48 88.95 3.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.767 -0.827 . . . . 1.49 108.767 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -142.32 90.32 2.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.384 0.512 . . . . 1.83 112.384 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 64' ' ' HIS . . . 139.45 -54.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.271 -0.966 . . . . 1.64 110.778 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 28.8 p80 174.07 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.652 -0.774 . . . . 3.33 111.153 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.569 ' CB ' ' H ' ' A' ' 95' ' ' PHE . . . -165.77 -170.15 1.71 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.205 0.526 . . . . 1.38 111.461 -173.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 59' ' ' ILE . 2.4 p90 -106.63 87.23 2.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.787 -1.097 . . . . 2.74 109.417 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 3.0 m-20 -71.44 100.26 2.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.663 -1.153 . . . . 1.76 110.324 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 92' ' ' GLN . 72.8 t -85.41 113.39 23.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.035 0.445 . . . . 1.15 110.197 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.93 122.69 27.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.327 -0.851 . . . . 2.02 110.379 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -101.7 157.67 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.656 -0.498 . . . . 1.66 109.656 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.1 115.58 20.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.831 0.348 . . . . 1.33 110.661 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -127.01 56.03 1.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.786 0.803 . . . . 2.65 109.96 175.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -91.59 -11.77 36.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.806 0.812 . . . . 1.61 109.164 170.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 162.8 39.5 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.643 -1.162 . . . . 2.35 108.886 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -75.61 77.26 2.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.224 0.535 . . . . 1.92 111.169 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 98.2 mttt -92.94 -50.75 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.429 -0.805 . . . . 1.77 110.646 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 50' ' ' SER . . . -111.9 100.14 8.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.822 -0.626 . . . . 0.76 109.682 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.456 HG13 HG23 ' A' ' 87' ' ' THR . 55.1 t -110.19 131.75 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.008 -0.542 . . . . 1.27 111.843 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.56 119.28 31.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.756 -0.656 . . . . 1.29 109.993 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -160.26 122.15 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.591 -0.522 . . . . 2.54 109.591 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.539 ' HA3' HD23 ' A' ' 47' ' ' LEU . . . -129.1 -177.97 15.14 Favored Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.923 -0.932 . . . . 1.31 111.118 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -30.39 -130.0 0.0 OUTLIER Glycine 0 CA--C 1.543 1.818 0 O-C-N 124.771 0.924 . . . . 1.9 115.398 168.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -44.05 170.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 123.632 2.888 . . . . 2.91 114.178 -173.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 2.2 pt? -30.67 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.964 1.364 . . . . 4.11 114.231 -146.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.587 ' CG ' ' H ' ' A' ' 86' ' ' GLY . 12.3 p-10 -110.9 -112.23 0.33 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 113.231 -1.804 . . . . 4.95 113.042 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.587 ' H ' ' CG ' ' A' ' 85' ' ' ASP . . . 97.47 155.11 29.99 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 109.53 -1.428 . . . . 2.25 109.53 -163.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.456 HG23 HG13 ' A' ' 78' ' ' VAL . 15.9 m -77.72 102.14 6.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.777 0.789 . . . . 1.91 110.934 -177.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 122' ' ' HIS . 74.0 m-85 -97.55 117.71 32.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.039 -0.356 . . . . 3.7 110.039 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.84 145.41 26.61 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.845 -0.428 . . . . 3.54 109.845 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.7 tp -74.59 120.22 19.85 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.376 -0.601 . . . . 1.14 109.376 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 tt -113.12 -42.12 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.713 0.292 . . . . 1.68 111.329 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.0 pt20 -167.74 168.88 12.15 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.322 -0.622 . . . . 1.55 109.322 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.572 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 4.1 p90 -134.89 164.23 28.05 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.35 -0.54 . . . . 0.86 111.418 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -138.37 160.3 39.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.653 -0.869 . . . . 0.93 108.653 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.569 ' H ' ' CB ' ' A' ' 65' ' ' ALA . 79.1 t80 -130.25 144.14 51.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.484 0.183 . . . . 3.17 111.185 -172.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.61 146.95 40.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.988 0.423 . . . . 1.68 110.558 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -161.05 150.99 17.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 5.18 108.557 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 242' ' ' ASP . . . -90.11 155.87 24.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.398 -0.906 . . . . 2.13 112.672 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.9 t -60.56 -28.11 68.2 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.133 0.492 . . . . 2.9 110.477 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.55 -154.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.679 -0.691 . . . . 3.03 110.516 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -136.61 48.29 2.13 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.433 -0.951 . . . . 3.85 108.433 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.24 41.97 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.196 -0.911 . . . . 1.94 112.136 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.406 ' CG ' ' HA3' ' A' ' 98' ' ' GLY . 10.5 pt20 -159.21 169.76 23.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.713 -0.477 . . . . 2.45 109.713 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.67 10.37 86.26 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.882 -0.675 . . . . 1.47 112.888 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.45 -2.7 57.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.489 0.552 . . . . 2.0 112.489 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.572 ' HG2' ' H ' ' A' ' 107' ' ' HIS . 18.2 tt0 67.35 178.96 0.23 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.642 -0.503 . . . . 3.72 109.642 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.572 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 29.6 m80 48.57 45.05 21.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.396 0.679 . . . . 3.52 112.11 174.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.0 t -81.0 127.6 32.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.731 0.777 . . . . 2.52 111.672 -176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.04 115.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.755 -1.111 . . . . 2.48 110.503 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.24 37.21 23.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.846 0.831 . . . . 2.8 109.591 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.18 14.72 8.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.529 -1.214 . . . . 4.98 111.619 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -89.32 114.48 25.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.147 -0.686 . . . . 3.23 109.147 172.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -107.06 173.62 6.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 2.82 110.186 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -118.4 172.95 7.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.979 -0.555 . . . . 1.62 109.895 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.51 77.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.75 0.278 . . . . 1.03 111.75 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.431 ' HB1' ' CZ ' ' A' ' 95' ' ' PHE . . . -167.43 170.56 11.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.131 -0.486 . . . . 0.75 110.017 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -150.06 141.87 23.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 1.58 110.67 174.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.482 HD11 ' CD2' ' A' ' 93' ' ' PHE . 50.3 tp -105.26 125.74 51.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.598 -0.728 . . . . 1.07 109.052 174.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.512 ' CD2' ' HB ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -114.76 102.43 10.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 1.77 110.341 -172.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.572 ' HA ' ' CB ' ' A' ' 93' ' ' PHE . 5.8 mp -90.27 111.26 22.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.359 0.599 . . . . 0.93 110.781 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -77.82 119.82 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.466 -0.788 . . . . 0.61 111.099 -176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 88' ' ' TYR . 73.9 m80 -106.57 137.64 44.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.485 -0.779 . . . . 2.13 109.347 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -110.38 128.07 55.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.123 -0.489 . . . . 4.26 111.205 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -69.98 105.29 2.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.03 -0.532 . . . . 2.02 109.907 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.0 t -62.73 -17.49 60.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.544 . . . . 2.34 111.735 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.47 -29.79 70.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.45 -0.341 . . . . 3.35 111.799 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -90.35 -1.24 57.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.36 . . . . 3.1 111.069 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.84 23.73 2.63 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 115.826 1.09 . . . . 2.37 115.826 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.584 ' OD2' ' HG2' ' A' ' 132' ' ' LYS . 32.2 t70 -176.87 126.8 0.16 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.986 0.893 . . . . 3.93 109.801 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -64.31 -37.87 89.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.685 -0.689 . . . . 3.0 111.715 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.1 -28.61 70.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.103 -0.57 . . . . 2.15 112.578 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 39.6 mmtm -80.49 -41.02 25.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.505 -0.554 . . . . 3.43 109.505 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.604 ' O ' ' HA3' ' A' ' 139' ' ' GLY . . . -61.33 -38.84 88.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.452 -0.795 . . . . 1.76 112.152 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.7 -15.11 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.789 0.328 . . . . 2.77 111.168 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.53 13.33 26.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.287 -0.415 . . . . 3.55 110.432 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 132' ' ' LYS . 17.4 mm100 -121.03 135.35 24.77 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.78 -0.452 . . . . 3.02 109.78 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.504 ' O ' ' HH2' ' A' ' 208' ' ' TRP . 11.3 Cg_endo -56.09 -29.85 76.36 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.355 2.703 . . . . 1.6 113.798 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -111.37 25.57 11.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.922 0.391 . . . . 2.29 110.208 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 133' ' ' ALA . . . -62.05 -48.72 81.34 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.247 0.859 . . . . 1.22 115.247 -172.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 206' ' ' VAL . 40.0 mt -133.92 170.31 15.81 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.835 0.817 . . . . 1.57 111.138 -173.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.94 105.36 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.513 -0.767 . . . . 1.38 109.851 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.658 ' O ' ' HB ' ' A' ' 209' ' ' ILE . 4.7 m -88.83 111.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 1.73 111.36 -176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 120' ' ' LEU . 14.2 tp -86.27 100.43 12.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.774 -0.648 . . . . 2.42 110.287 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.64 118.5 5.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.161 -0.542 . . . . 0.86 112.558 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.57 118.37 58.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.781 -0.452 . . . . 0.76 109.781 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -71.04 147.57 48.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.998 0.428 . . . . 1.2 111.586 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 116' ' ' ALA . 10.6 mp -116.75 131.82 56.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.656 -0.702 . . . . 0.88 110.271 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -126.4 144.33 50.87 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.789 -0.819 . . . . 2.03 108.789 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.03 130.94 35.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.454 0.645 . . . . 1.27 111.353 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 177.06 -105.25 0.2 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.114 -0.948 . . . . 1.53 110.921 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.9 t -71.53 142.95 50.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.424 -0.584 . . . . 1.54 109.424 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.53 156.58 39.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.78 111.202 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -118.08 95.04 47.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.596 -0.52 . . . . 1.22 109.596 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.65 -37.15 91.23 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.146 2.564 . . . . 1.05 112.49 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.05 -31.01 79.38 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.7 112.619 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.3 tp -88.78 -31.68 18.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.517 -0.402 . . . . 0.77 109.948 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -39.33 63.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.711 -0.677 . . . . 1.41 110.151 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -49.39 -47.91 47.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.676 -0.693 . . . . 2.86 111.016 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.68 -43.18 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 1.38 111.065 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 156' ' ' LEU . 19.3 t -61.76 -35.47 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.184 0.516 . . . . 1.11 111.147 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.36 -30.46 67.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.309 -0.405 . . . . 1.22 111.589 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 175' ' ' PHE . 9.6 p -92.9 -18.51 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.829 -0.348 . . . . 1.41 111.875 -173.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 160' ' ' VAL . 3.5 pp -67.73 -13.01 61.75 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.988 0.423 . . . . 1.39 111.092 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.54 -19.72 65.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.31 110.498 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.0 t -85.47 0.58 51.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.02 -0.536 . . . . 1.4 111.423 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 59' ' ' ILE . 41.1 pt -135.83 46.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.581 0.705 . . . . 0.85 109.585 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.23 -32.47 71.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.079 -0.964 . . . . 1.59 111.264 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.5 p -112.66 145.21 40.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.895 0.378 . . . . 0.77 110.937 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.48 138.55 58.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 2.29 110.542 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 106.57 -20.89 33.67 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.624 -0.798 . . . . 0.85 112.473 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.72 152.3 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.109 0.48 . . . . 1.7 111.188 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 m -132.43 157.82 43.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.37 109.642 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -143.57 151.02 39.69 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.394 -0.595 . . . . 0.61 109.394 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.16 132.76 43.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.192 0.52 . . . . 1.8 110.406 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 162' ' ' VAL . 48.9 t80 -141.48 79.23 1.67 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 1.04 108.295 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' SER . 6.2 m -111.87 156.82 21.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.608 . . . . 1.17 111.558 -174.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 56.4 58.22 4.38 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.357 0.663 . . . . 1.77 112.384 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.45 134.68 41.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.968 -0.56 . . . . 3.99 109.632 172.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.578 ' CG ' ' HE ' ' A' ' 181' ' ' ARG . 10.2 t70 -108.22 129.62 23.84 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 2.51 111.111 -173.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.65 -3.74 9.76 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.637 2.892 . . . . 1.26 114.704 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.578 ' HE ' ' CG ' ' A' ' 179' ' ' ASP . 18.5 ptp180 -59.93 -26.27 65.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.745 0.307 . . . . 2.76 111.401 -178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -79.74 7.14 56.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.92 -0.657 . . . . 1.12 112.299 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.4 mt -115.28 -27.52 7.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 1.73 110.312 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.0 mt -74.34 131.63 80.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.799 -0.637 . . . . 3.45 111.428 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.1 -177.07 3.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.97 2.446 . . . . 2.08 112.873 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.79 -55.21 6.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.884 0.327 . . . . 3.23 111.884 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 213' ' ' GLU . 4.5 m -85.21 130.3 34.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.27 -0.27 . . . . 1.66 110.27 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 tp -111.75 82.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.329 -0.396 . . . . 1.99 110.448 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -118.19 177.4 4.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.56 -0.533 . . . . 1.81 109.56 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -162.93 145.48 10.51 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.929 0.714 . . . . 5.01 112.929 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.428 ' CD1' ' HB ' ' A' ' 210' ' ' VAL . 7.4 m0 -116.17 145.47 43.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.496 -1.298 . . . . 3.93 107.496 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -142.44 102.83 4.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.779 1.029 . . . . 2.13 113.779 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 255' ' ' ILE . 48.8 t80 -142.41 128.43 10.67 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 5.21 110.031 168.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.74 127.74 23.96 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.817 2.344 . . . . 2.12 113.618 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -141.76 161.54 27.07 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.248 -0.887 . . . . 1.75 112.283 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 203' ' ' LEU . 29.6 t -61.31 144.56 53.69 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.683 -0.488 . . . . 2.99 109.683 173.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.94 -53.41 58.24 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.988 0.366 . . . . 4.75 111.988 -164.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.651 HG23 ' HD2' ' A' ' 200' ' ' PRO . 1.7 t -127.56 -46.4 1.45 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.783 -0.367 . . . . 5.1 111.471 167.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.602 ' HB ' ' HD3' ' A' ' 200' ' ' PRO . 1.8 m 169.18 -60.39 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.774 1.229 . . . . 5.53 110.275 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.651 ' HD2' HG23 ' A' ' 198' ' ' THR . 48.8 Cg_exo -55.35 -46.36 33.1 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 121.861 1.707 . . . . 5.83 113.901 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 200' ' ' PRO . 24.1 Cg_exo -65.3 106.92 0.9 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.374 1.383 . . . . 4.78 110.608 172.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.415 ' CD2' ' HB3' ' A' ' 28' ' ' GLN . 54.3 mt -77.62 46.03 0.52 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.788 -0.642 . . . . 3.84 111.806 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.522 ' HB3' ' SG ' ' A' ' 205' ' ' CYS . 97.0 mt -127.03 118.78 25.14 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.032 0.444 . . . . 2.96 110.174 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -86.82 78.24 9.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.647 -0.706 . . . . 3.37 109.757 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 203' ' ' LEU . 60.0 m -121.08 -15.4 8.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 2.15 111.992 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 140' ' ' LEU . 47.1 t -145.13 102.65 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 C-N-CA 119.641 -0.823 . . . . 1.26 112.333 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 193' ' ' TYR . 82.3 m -155.73 88.8 1.14 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 2.08 111.508 166.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' TRP . . . . . 0.724 ' O ' HG12 ' A' ' 209' ' ' ILE . 1.1 p90 -150.05 87.06 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.163 -1.015 . . . . 5.53 112.449 160.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.724 HG12 ' O ' ' A' ' 208' ' ' TRP . 9.4 mm -166.89 113.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 123.999 0.92 . . . . 1.63 109.122 157.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 191' ' ' TRP . 95.5 t -125.23 99.59 6.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.656 -0.498 . . . . 1.62 109.656 166.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -66.81 107.5 2.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 1.73 110.719 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -53.71 -23.07 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 2.98 111.408 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 187' ' ' SER . 9.5 tp10 -105.17 113.63 64.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.273 -0.422 . . . . 1.47 110.841 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -82.88 152.2 14.57 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.579 2.186 . . . . 0.96 111.707 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 44.1 pt -100.59 152.17 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.006 -0.368 . . . . 1.25 110.006 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 62.8 m -94.78 129.27 41.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.28 -0.418 . . . . 1.29 109.96 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.33 162.7 25.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.065 -0.516 . . . . 1.02 109.853 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.426 ' HB3' ' HG3' ' A' ' 221' ' ' GLN . 48.3 t -88.21 146.03 25.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.183 -0.462 . . . . 1.08 109.823 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.717 ' O ' ' HG ' ' A' ' 223' ' ' LEU . 9.3 t -57.44 -33.87 68.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.626 -0.715 . . . . 1.33 110.329 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.44 -20.71 65.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 2.51 111.095 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.426 ' HG3' ' HB3' ' A' ' 218' ' ' SER . 55.9 mt-30 -78.67 -45.89 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.283 -0.417 . . . . 0.7 110.015 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.668 ' HA ' ' CD2' ' A' ' 225' ' ' PHE . 24.9 m -70.41 -24.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.52 -0.309 . . . . 1.36 111.369 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 219' ' ' SER . 74.4 mt -62.38 -36.55 82.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.774 0.321 . . . . 1.03 110.556 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -73.22 -25.4 60.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 1.75 111.488 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.668 ' CD2' ' HA ' ' A' ' 222' ' ' VAL . 23.3 m-85 -67.5 -30.87 70.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.345 0.593 . . . . 2.47 109.657 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -81.54 1.5 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.247 -0.888 . . . . 3.04 110.601 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.29 -13.02 19.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.167 0.508 . . . . 2.31 109.806 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.417 HD21 HD13 ' A' ' 163' ' ' LEU . 93.8 mt -75.1 155.19 37.36 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.759 -0.655 . . . . 0.95 110.482 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 238' ' ' GLU . 13.5 m120 -115.53 150.14 37.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.82 -0.627 . . . . 1.13 109.837 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -88.29 -27.34 21.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.45 -0.796 . . . . 3.74 109.953 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 237' ' ' GLU . 4.8 p-10 -76.54 168.52 19.92 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.272 -0.877 . . . . 1.62 111.395 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -92.26 167.71 30.46 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.19 -1.164 . . . . 1.16 110.19 175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.17 142.54 51.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 3.56 110.199 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.33 51.06 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.738 -0.744 . . . . 2.08 112.77 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.68 153.57 77.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.33 -0.619 . . . . 2.59 109.33 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.31 122.89 12.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.188 1.925 . . . . 1.36 110.582 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.582 ' HA ' ' OD1' ' A' ' 231' ' ' ASN . 9.7 pt-20 -67.42 129.98 41.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.792 0.806 . . . . 3.4 112.47 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 229' ' ' ASN . 42.0 mt-10 -115.13 120.18 38.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.666 -1.152 . . . . 2.47 109.002 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.71 132.88 47.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.994 0.426 . . . . 2.14 110.834 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 50.1 tpp -71.94 91.65 1.22 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.441 -0.799 . . . . 1.68 111.067 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.16 147.54 32.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.549 0.214 . . . . 1.27 110.941 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.501 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER 66.79 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.584 0.754 . . . . 2.18 111.886 179.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 47.58 34.18 3.4 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.58 0.352 . . . . 2.15 111.838 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' TRP . . . . . 0.565 ' HE1' ' HG3' ' A' ' 106' ' ' GLU . 21.5 t90 -129.61 150.04 51.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 4.59 110.721 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 246' ' ' PRO . 2.8 tmt_? -113.71 132.58 22.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.604 -0.517 . . . . 6.13 109.604 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.405 ' O ' ' HD3' ' A' ' 245' ' ' ARG . 94.2 Cg_exo -46.47 151.8 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.717 2.944 . . . . 3.28 113.76 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 32' ' ' ASP . . . -70.58 158.28 36.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.134 -0.939 . . . . 2.98 111.598 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLN . . . . . 0.404 ' CD ' ' HD2' ' A' ' 249' ' ' PRO . 56.2 tp60 -121.55 128.37 25.67 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.399 -0.364 . . . . 4.32 110.148 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.404 ' HD2' ' CD ' ' A' ' 248' ' ' GLN . 10.3 Cg_endo -50.26 169.92 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.452 3.434 . . . . 3.48 115.449 -173.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 253' ' ' ARG . 3.2 mm? -62.16 -12.55 20.39 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.828 -1.533 . . . . 4.63 113.071 -169.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 252' ' ' ASN . 19.0 ptpt -60.11 41.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.377 1.621 . . . . 5.34 115.377 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 251' ' ' LYS . 7.4 p30 130.29 -3.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 126.099 1.76 . . . . 4.64 111.023 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 250' ' ' LEU . 57.5 mmt-85 -130.32 95.42 3.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.106 0.479 . . . . 6.11 110.205 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -137.34 104.25 5.33 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 3.08 108.483 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 193' ' ' TYR . 2.0 mp -84.78 132.57 31.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.189 -0.46 . . . . 2.6 111.191 -169.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -80.63 150.34 29.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 2.63 109.851 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -112.6 140.79 47.07 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.113 -0.328 . . . . 1.71 110.113 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 48.9 m -152.0 96.76 2.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.342 0.591 . . . . 2.21 110.499 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.05 123.15 19.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.213 0.53 . . . . 4.31 110.997 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 19.1 pttm . . . . . 0 C--O 1.248 1.001 0 CA-C-N 114.98 -1.009 . . . . 4.49 111.887 177.178 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_